cn;concept;cuis;isdefault;cn_override;cleaned
 -10;> $nmbr$  < = $nmbr$;NA;NA;NA;$nmbr$ $nmbr$
 -10;< = $nmbr$ . $nmbr$ %;NA;NA;NA;$nmbr$ $nmbr$
 -10;< = $nmbr$ %;NA;NA;NA;$nmbr$
 -10;< = $nmbr$;NA;NA;NA;$nmbr$
 -10;> - $nmbr$ . $nmbr$;NA;NA;NA;$nmbr$ $nmbr$
 -10;< - $nmbr$ . $nmbr$;NA;NA;NA;$nmbr$ $nmbr$
 -10;x $nmbr$ = $nmbr$  p = $nmbr$ - $nmbr$;NA;NA;NA;x $nmbr$ $nmbr$ p $nmbr$ $nmbr$
 -10;x $nmbr$ = $nmbr$ - l  p = $nmbr$ - $nmbr$;NA;NA;NA;x $nmbr$ $nmbr$ l p $nmbr$ $nmbr$
 -10;x $nmbr$ = $nmbr$ - $nmbr$  p = $nmbr$ - $nmbr$;NA;NA;NA;x $nmbr$ $nmbr$ $nmbr$ p $nmbr$ $nmbr$
 -10;x $nmbr$  n ( % );NA;NA;NA;x $nmbr$ n
 -10;x ? = l - $nmbr$  p = $nmbr$ - $nmbr$;NA;NA;NA;x l $nmbr$ p $nmbr$ $nmbr$
 -10;x ? = $nmbr$ - l  p = $nmbr$ - $nmbr$;NA;NA;NA;x $nmbr$ l p $nmbr$ $nmbr$
 -10;x ? = $nmbr$ - $nmbr$  p = $nmbr$ - $nmbr$;NA;NA;NA;x $nmbr$ $nmbr$ p $nmbr$ $nmbr$
 -10;v $nmbr$ ( n = $nmbr$;NA;NA;NA;v $nmbr$ n $nmbr$
 -10;t ( n = $nmbr$  $nmbr$ );C2986835;NA;NA;t n $nmbr$ $nmbr$
 -10;q $nmbr$ w ( n = $nmbr$ );NA;NA;NA;q $nmbr$ w n $nmbr$
 -10;q $nmbr$ w ( n $nmbr$ $nmbr$ );NA;NA;NA;q $nmbr$ w n $nmbr$ $nmbr$
 -10;q $nmbr$ ( n   = $nmbr$ );NA;NA;NA;q $nmbr$ n $nmbr$
 -10;q $nmbr$ - q $nmbr$;NA;NA;NA;q $nmbr$ q $nmbr$
 -10;q ( q $nmbr$ \;NA;NA;NA;q q $nmbr$ \
 -10;e $nmbr$ / s $nmbr$ ( n = $nmbr$ );C3846405;NA;NA;e $nmbr$ s $nmbr$ n $nmbr$
 -10;e $nmbr$ ( n = $nmbr$ );NA;NA;NA;e $nmbr$ n $nmbr$
 -10;e $nmbr$ + a $nmbr$;NA;NA;NA;e $nmbr$ a $nmbr$
 -10;b + a ( n = $nmbr$ );NA;NA;NA;b a n $nmbr$
 -10;a $nmbr$ . $nmbr$ ± $nmbr$ a . $nmbr$;NA;NA;NA;a $nmbr$ $nmbr$ $nmbr$ a $nmbr$
 -10;a $nmbr$ c > s . $nmbr$ - s . $nmbr$ %;NA;NA;NA;a $nmbr$ c s $nmbr$ s $nmbr$
 -10;a $nmbr$ c > $nmbr$ . $nmbr$ %;NA;NA;NA;a $nmbr$ c $nmbr$ $nmbr$
 -10;a $nmbr$ c > $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ %;NA;NA;NA;a $nmbr$ c $nmbr$ $nmbr$ $nmbr$ $nmbr$
 -10;a $nmbr$ c  %;NA;NA;NA;a $nmbr$ c
 -10;a $nmbr$ c < $nmbr$ . $nmbr$ %;NA;NA;NA;a $nmbr$ c $nmbr$ $nmbr$
 -10;a / c;NA;NA;NA;a c
 -10;a;NA;NA;NA;a
 -10;$nmbr$ ( $nmbr$ j ) z $nmbr$ ( $nmbr$ . e;NA;NA;NA;$nmbr$ $nmbr$ j z $nmbr$ $nmbr$ e
 -10;$nmbr$ - $nmbr$ y  n ( % );NA;NA;NA;$nmbr$ $nmbr$ y n
 -10;$nmbr$ . $nmbr$ ± b . b;NA;NA;NA;$nmbr$ $nmbr$ b b
 -10;$nmbr$ q $nmbr$ w ( n = $nmbr$ );NA;NA;NA;$nmbr$ q $nmbr$ w n $nmbr$
 -10;$nmbr$ c . t;NA;NA;NA;$nmbr$ c t
 -10;$nmbr$ - $nmbr$ ( s $nmbr$ - $nmbr$ ) t;C0718146;NA;NA;$nmbr$ $nmbr$ s $nmbr$ $nmbr$ t
 -10;> $nmbr$ y ( n = $nmbr$  $nmbr$ . $nmbr$ % );NA;NA;NA;$nmbr$ y n $nmbr$ $nmbr$ $nmbr$
 -10;< $nmbr$ y ( n = $nmbr$  $nmbr$ . $nmbr$ % );NA;NA;NA;$nmbr$ y n $nmbr$ $nmbr$ $nmbr$
 -10;- $nmbr$ . $nmbr$ ( - $nmbr$ . $nmbr$  - c ) . $nmbr$ r;C0722969;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ c $nmbr$ r
 -10;< $nmbr$ . $nmbr$ ( % );NA;NA;NA;$nmbr$ $nmbr$
 -10;> $nmbr$ . $nmbr$ ( % );NA;NA;NA;$nmbr$ $nmbr$
 -10;$nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ . $nmbr$ . $nmbr$ );NA;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 -10;$nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ );NA;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 -10;$nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ – $nmbr$ . $nmbr$ );NA;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 -10;( % ) ( $nmbr$ - $nmbr$ );NA;NA;NA;$nmbr$ $nmbr$
 -10;( % ) ( $nmbr$ . $nmbr$ );NA;NA;NA;$nmbr$ $nmbr$
 -10;$nmbr$ . $nmbr$ % - $nmbr$ . $nmbr$ %;NA;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$
 -10;$nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ );NA;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$
 -10;$nmbr$ / $nmbr$ ( $nmbr$ . $nmbr$ );NA;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$
 -10;$nmbr$  $nmbr$ - < $nmbr$ . $nmbr$;NA;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$
 -10;$nmbr$  $nmbr$ ( $nmbr$ . $nmbr$ );NA;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$
 -10;$nmbr$ . $nmbr$ - < $nmbr$ . $nmbr$ %;NA;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$
 -10;$nmbr$ $nmbr$ ( $nmbr$ . $nmbr$ );NA;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$
 -10;$nmbr$ . $nmbr$ + $nmbr$ . $nmbr$;NA;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$
 -10;$nmbr$ . $nmbr$ - $nmbr$ . $nmbr$;NA;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$
 -10;> $nmbr$ . $nmbr$ - < $nmbr$ . $nmbr$;NA;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$
 -10;$nmbr$ - $nmbr$ - $nmbr$ - $nmbr$;NA;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$
 -10;> $nmbr$ - $nmbr$ - $nmbr$ - $nmbr$;NA;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$
 -10;$nmbr$ . $nmbr$ - < $nmbr$ . $nmbr$;NA;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$
 -10;> $nmbr$ y . n ( % );NA;NA;NA;$nmbr$ y n
 -10;> $nmbr$ y  n ( % );NA;NA;NA;$nmbr$ y n
 -10;> = $nmbr$ ( % );NA;NA;NA;$nmbr$
 -10;> = $nmbr$ * ( % );NA;NA;NA;$nmbr$
 -10;< $nmbr$ ( % );NA;NA;NA;$nmbr$
 -10;^ $nmbr$ y  n ( % );NA;NA;NA;$nmbr$ y n
 -10;< $nmbr$ y  n ( % );NA;NA;NA;$nmbr$ y n
 -10;< $nmbr$ { % );NA;NA;NA;$nmbr$
 -10;a $nmbr$ c ( % );NA;NA;NA;a $nmbr$ c
 -10;> $nmbr$ ( % );NA;NA;NA;$nmbr$
 -10;$nmbr$ - < $nmbr$ . $nmbr$;NA;NA;NA;$nmbr$ $nmbr$ $nmbr$
 -10;$nmbr$ . $nmbr$ % ( $nmbr$ );NA;NA;NA;$nmbr$ $nmbr$ $nmbr$
 -10;$nmbr$ ( $nmbr$ . $nmbr$ );NA;NA;NA;$nmbr$ $nmbr$ $nmbr$
 -10;$nmbr$ - $nmbr$ . $nmbr$;NA;NA;NA;$nmbr$ $nmbr$ $nmbr$
 -10;> $nmbr$ - $nmbr$ - $nmbr$;NA;NA;NA;$nmbr$ $nmbr$ $nmbr$
 -10;$nmbr$ ( $nmbr$ e < $nmbr$ % );NA;NA;NA;$nmbr$ $nmbr$ e $nmbr$
 -10;$nmbr$ ( $nmbr$ . $nmbr$ % );NA;NA;NA;$nmbr$ $nmbr$ $nmbr$
 -10;$nmbr$ ( $nmbr$  $nmbr$ );NA;NA;NA;$nmbr$ $nmbr$ $nmbr$
 -10;$nmbr$ / $nmbr$ ( $nmbr$ );NA;NA;NA;$nmbr$ $nmbr$ $nmbr$
 -10;$nmbr$ e < $nmbr$ %;NA;NA;NA;$nmbr$ e $nmbr$
 -10;> $nmbr$  < $nmbr$;NA;NA;NA;$nmbr$ $nmbr$
 -10;^ $nmbr$;NA;NA;NA;$nmbr$
 -10;£ $nmbr$;NA;NA;NA;$nmbr$
 -10;« = $nmbr$;NA;NA;NA;$nmbr$
 -10;> $nmbr$ - $nmbr$;NA;NA;NA;$nmbr$ $nmbr$
 -10;y $nmbr$;NA;NA;NA;y $nmbr$
 -10;> = $nmbr$;NA;NA;NA;$nmbr$
 -10;< $nmbr$ . $nmbr$;NA;NA;NA;$nmbr$ $nmbr$
 -10;b;NA;NA;NA;b
 -10;x / n *;NA;NA;NA;x n
 -10;> $nmbr$ . $nmbr$;NA;NA;NA;$nmbr$ $nmbr$
 -10;$nmbr$ . $nmbr$ %;NA;NA;NA;$nmbr$ $nmbr$
 -10;> $nmbr$ . $nmbr$ %;NA;NA;NA;$nmbr$ $nmbr$
 -10;> = $nmbr$ y;NA;NA;NA;$nmbr$ y
 -10;> $nmbr$ - < $nmbr$;NA;NA;NA;$nmbr$ $nmbr$
 -10;$nmbr$ - < $nmbr$ ( % );NA;NA;NA;$nmbr$ $nmbr$
 -10;£ $nmbr$ %;NA;NA;NA;$nmbr$
 -10;c;NA;NA;NA;c
 -10;≥ $nmbr$;NA;NA;NA;$nmbr$
 -10;%;NA;NA;NA;
 -10;> $nmbr$ y ( n = $nmbr$ );NA;NA;NA;$nmbr$ y n $nmbr$
 -10;$nmbr$ — < $nmbr$;NA;NA;NA;$nmbr$ $nmbr$
 -10;> = $nmbr$ . $nmbr$;NA;NA;NA;$nmbr$ $nmbr$
 -10;$ $nmbr$ %;NA;NA;NA;$ $nmbr$
 -10;e;NA;NA;NA;e
 -10;$nmbr$ y;NA;NA;NA;$nmbr$ y
 -10;< $nmbr$ y;NA;NA;NA;$nmbr$ y
 -10;m / f;C1306057;NA;NA;m f
 -10;$nmbr$ - $nmbr$;NA;NA;NA;$nmbr$ $nmbr$
 -10;\ $nmbr$;NA;NA;NA;\ $nmbr$
 -10;$nmbr$ e $nmbr$;NA;NA;NA;$nmbr$ e $nmbr$
 -10;> $nmbr$ < $nmbr$;NA;NA;NA;$nmbr$ $nmbr$
 -10;» $nmbr$ y;NA;NA;NA;$nmbr$ y
 -10;$nmbr$ . $nmbr$;NA;NA;NA;$nmbr$ $nmbr$
 -10;< $nmbr$ - $nmbr$;NA;NA;NA;$nmbr$ $nmbr$
 -10;$nmbr$ - < $nmbr$ y;NA;NA;NA;$nmbr$ $nmbr$ y
 -10;< $nmbr$ %;NA;NA;NA;$nmbr$
 -10;« $nmbr$ - $nmbr$;NA;NA;NA;$nmbr$ $nmbr$
 -10;= $nmbr$;NA;NA;NA;$nmbr$
 -10;v ( n = $nmbr$ );NA;NA;NA;v n $nmbr$
 -10;$nmbr$ ( $nmbr$ % );NA;NA;NA;$nmbr$ $nmbr$
 -10;< $nmbr$ y ( n = $nmbr$ );NA;NA;NA;$nmbr$ y n $nmbr$
 -10;$nmbr$ / $nmbr$;NA;NA;NA;$nmbr$ $nmbr$
 -10;$nmbr$ ( < $nmbr$ % );NA;NA;NA;$nmbr$ $nmbr$
 -10;$nmbr$ §;NA;NA;NA;$nmbr$
 -10;$nmbr$ - < $nmbr$;NA;NA;NA;$nmbr$ $nmbr$
 -10;> $nmbr$;NA;NA;NA;$nmbr$
 -10;w;NA;NA;NA;w
 -10;. $nmbr$;NA;NA;NA;$nmbr$
 -10;a $nmbr$;NA;NA;NA;a $nmbr$
 -10;$ $nmbr$;NA;NA;NA;$ $nmbr$
 -10;$nmbr$ - < $nmbr$ %;NA;NA;NA;$nmbr$ $nmbr$
 -10;a $nmbr$ c;NA;NA;NA;a $nmbr$ c
 -10;≤ $nmbr$ . $nmbr$ %;NA;NA;NA;$nmbr$ $nmbr$
 -10;$nmbr$ < - $nmbr$;NA;NA;NA;$nmbr$ $nmbr$
 -10;> $nmbr$ y;NA;NA;NA;$nmbr$ y
 -10;≥ $nmbr$ %;NA;NA;NA;$nmbr$
 -10;^ $nmbr$ - $nmbr$;NA;NA;NA;$nmbr$ $nmbr$
 -10;$nmbr$ % - $nmbr$ %;NA;NA;NA;$nmbr$ $nmbr$
 -10;< $nmbr$ . $nmbr$ %;NA;NA;NA;$nmbr$ $nmbr$
 -10;\ $nmbr$ %;NA;NA;NA;\ $nmbr$
 -10;≤ $nmbr$ %;NA;NA;NA;$nmbr$
 -10;$nmbr$;NA;NA;NA;$nmbr$
 -10;> $nmbr$ $nmbr$;NA;NA;NA;$nmbr$ $nmbr$
 -10;x / n;NA;NA;NA;x n
 -10;$nmbr$ +;NA;NA;NA;$nmbr$
 -10;< $nmbr$ » < $nmbr$ y;NA;NA;NA;$nmbr$ $nmbr$ y
 -10;$nmbr$ % $nmbr$;NA;NA;NA;$nmbr$ $nmbr$
 -10;< $nmbr$;NA;NA;NA;$nmbr$
 -10;> $nmbr$ %;NA;NA;NA;$nmbr$
 -10;$nmbr$ $nmbr$;NA;NA;NA;$nmbr$ $nmbr$
 -10;> $nmbr$ % $nmbr$;NA;NA;NA;$nmbr$ $nmbr$
 -10;$nmbr$ ( > $nmbr$ % );NA;NA;NA;$nmbr$ $nmbr$
 -10;≤ $nmbr$;NA;NA;NA;$nmbr$
 -10;% $nmbr$ - $nmbr$;NA;NA;NA;$nmbr$ $nmbr$
 -10;之 $nmbr$;NA;NA;NA;$nmbr$
 -10;$nmbr$ . $nmbr$ - < $nmbr$;NA;NA;NA;$nmbr$ $nmbr$ $nmbr$
 -10;$nmbr$ % c . i .;C1547546;NA;NA;$nmbr$ c i
 -10;= $nmbr$ ’ );NA;NA;NA;$nmbr$
 -10;£ $nmbr$ . $nmbr$ % * *;NA;NA;NA;$nmbr$ $nmbr$
 -10;a a ( $nmbr$ ( % );NA;NA;NA;a a $nmbr$
 -10;$nmbr$ e < $nmbr$ %  n ( % );NA;NA;NA;$nmbr$ e $nmbr$ n
 -10;$nmbr$ / $nmbr$  $nmbr$ ( $nmbr$ . $nmbr$ );NA;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 -10;$nmbr$ . $nmbr$ ( $nmbr$ $nmbr$ . $nmbr$ );NA;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 -10;e $nmbr$ + a $nmbr$ -;NA;NA;NA;e $nmbr$ a $nmbr$
 -10;$nmbr$  $nmbr$ / $nmbr$  $nmbr$ ( $nmbr$ . $nmbr$ );NA;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 -10;( % ) $nmbr$ - $nmbr$;NA;NA;NA;$nmbr$ $nmbr$
1834;r $nmbr$ + ezio ( n = $nmbr$ );C0687673;NA;NA;r $nmbr$ ezio n $nmbr$
1834;r $nmbr$ ( n = $nmbr$ );C0687673;NA;NA;r $nmbr$ n $nmbr$
1833;d / mi / idr / st;"C0036056;C0073187;C0332173;C3272372;C3810814;C4484261";NA;NA;d mi idr st
1833;d / mi / idfvst;"C0073187;C0332173;C3810814;C4484261";NA;NA;d mi idfvst
1833;d $nmbr$ % ( n / n );"C0073187;C0332173;C4484261";NA;NA;d $nmbr$ n n
1833;d;"C0073187;C0332173;C4484261";NA;NA;d
1833;$nmbr$ or $nmbr$ d / wk;"C0073187;C0332173;C0332174;C0439230;C4484261";NA;NA;$nmbr$ or $nmbr$ d wk
1832;ze + statin;C0360714;NA;NA;ze statin
1832;[ zi = $nmbr$ ] $nmbr$ ( $nmbr$ . $nmbr$ );C0043476;NA;NA;zi $nmbr$ $nmbr$ $nmbr$ $nmbr$
1832;$nmbr$ ( $nmbr$ . $nmbr$ ) / $nmbr$ z ( $nmbr$ ze );NA;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ z $nmbr$ ze
1831;feno + eze;NA;NA;NA;feno eze
1831;feno $nmbr$ mg / eze $nmbr$ mg ( n = $nmbr$ );C1319635;NA;NA;feno $nmbr$ mg eze $nmbr$ mg n $nmbr$
1828;esrd or $nmbr$ % dedine in gfr;"C0017654;C0022661;C0035078;C1424601;C2316810";NA;NA;esrd or $nmbr$ dedine in gfr
1828;esrd or $nmbr$ % decline in gfr;"C0017654;C0022661;C0035078;C1424601;C2316810";NA;NA;esrd or $nmbr$ decline in gfr
1826;l / c;"C0439394;C1706495;C3642217";FALSE; -10;l c
1826;l;"C0439394;C1706495;C3642217";FALSE; -10;l
1826;l $nmbr$ - $nmbr$ vs l $nmbr$ - $nmbr$ - $nmbr$;"C0439394;C1706495;C3642217";FALSE; -10;l $nmbr$ $nmbr$ vs l $nmbr$ $nmbr$ $nmbr$
1826;l $nmbr$ - $nmbr$ vs placebo;"C0032042;C0439394;C1696465;C1706408;C1706495;C3642217";FALSE; -10;l $nmbr$ $nmbr$ vs placebo
1826;( l ) t;"C0439394;C1706495;C3642217";FALSE; -10;l t
1826;l vs . c;"C0439394;C1706495;C3642217";FALSE; -10;l vs c
1827;l ( < l );C3539687;FALSE; -10;l l
1827;l . l ± $nmbr$ . $nmbr$;C3539687;FALSE; -10;l l $nmbr$ $nmbr$
1827;$nmbr$ l ( l $nmbr$ );C3539687;FALSE; -10;$nmbr$ l l $nmbr$
1827;$nmbr$ . l ( $nmbr$ l . $nmbr$ );C3539687;FALSE; -10;$nmbr$ l $nmbr$ l $nmbr$
1827;$nmbr$ l . $nmbr$ ( l $nmbr$ . $nmbr$ );C3539687;FALSE; -10;$nmbr$ l $nmbr$ l $nmbr$ $nmbr$
1827;$nmbr$ l . $nmbr$ ( l $nmbr$ . $nmbr$ l );C3539687;FALSE; -10;$nmbr$ l $nmbr$ l $nmbr$ $nmbr$ l
1827;< $nmbr$ . $nmbr$ l - g / l;"C0439267;C3539687";FALSE; -10;$nmbr$ $nmbr$ l g l
1827;$nmbr$ . $nmbr$ ± l . l;C3539687;FALSE; -10;$nmbr$ $nmbr$ l l
1827;$nmbr$ . $nmbr$ ( $nmbr$ l . l );C3539687;FALSE; -10;$nmbr$ $nmbr$ $nmbr$ l l
1827;$nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ - l . l );C3539687;FALSE; -10;$nmbr$ $nmbr$ $nmbr$ $nmbr$ l l
1828;gfr as assessed by mdrd;"C0017654;C1424601;C1516048;C3839656";FALSE; 592;gfr as assessed by mdrd
1828;gfr $nmbr$ $nmbr$;"C0017654;C1424601";FALSE; 592;gfr $nmbr$ $nmbr$
1828;gmr;"C1522544;C1704695";FALSE; 592;gmr
1828;gfr > $nmbr$;"C0017654;C1424601";FALSE; 592;gfr $nmbr$
1828;gfr < $nmbr$;"C0017654;C1424601";FALSE; 592;gfr $nmbr$
1828;estimated gfr — no . ( % ) $nmbr$;"C0017654;C0750572;C1424601";FALSE; 592;estimated gfr no $nmbr$
1828;estimated gfr — no . ( % ) ^ |;"C0017654;C0750572;C1424601";FALSE; 592;estimated gfr no
1828;estimated gfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m ^ — no . ( % );"C0017654;C0369637;C0439445;C0441923;C0750572;C1424601";FALSE; 592;estimated gfr $nmbr$ ml min $nmbr$ $nmbr$ m no
1828;estimated gfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$  no . ( % );"C0017654;C0369637;C0439445;C0441923;C0750572;C1424601";FALSE; 592;estimated gfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ no
1829;hazard ratio glp - $nmbr$ analogue vs placebo [ $nmbr$ % cl ];"C0018301;C0032042;C0243071;C0596019;C1422069;C1425391;C1539338;C1696465;C1706408;C2350813;C2985465";FALSE;1861;hazard ratio glp $nmbr$ analogue vs placebo $nmbr$ cl
1829;glp - $nmbr$ receptor agonist;"C0018301;C1422069;C1425391;C1539338;C2350813;C4543206";FALSE;1153;glp $nmbr$ receptor agonist
1829;glp - $nmbr$ analogue;"C0018301;C0243071;C1422069;C1425391;C1539338;C2350813";FALSE;1153;glp $nmbr$ analogue
1829;glp - $nmbr$ receptor agonist ( other than study drug );"C0013175;C0018301;C1422069;C1425391;C1539338;C2350813;C4543206";FALSE;1153;glp $nmbr$ receptor agonist other than study drug
1829;glp - $nmbr$ receptor agonists;"C0018301;C1422069;C1425391;C1539338;C2350813;C4543206";FALSE;1153;glp $nmbr$ receptor agonists
1830;gly;"C0017890;C0523677";FALSE; -10;gly
1831;eze / simva ( n = $nmbr$ );NA;FALSE;1862;eze simva n $nmbr$
1830;gly $nmbr$ μ g bid;"C0017890;C0439267;C0523677";FALSE; -10;gly $nmbr$ g bid
1830;ind / glyb n = $nmbr$;"C1415124;C4049864";FALSE;1509;ind glyb n $nmbr$
1830;ind / gly;"C0017890;C0523677;C4049864";FALSE;1509;ind gly
1830;ind / gly $nmbr$ / $nmbr$ pg o . d . n = $nmbr$;"C0017890;C0523677;C2827928;C4049864";FALSE;1509;ind gly $nmbr$ $nmbr$ pg o d n $nmbr$
1831;eze / simva;NA;FALSE;1862;eze simva
1831;eze / simva  $nmbr$ / $nmbr$ mg dr = $nmbr$ );"C0013014;C0024671;C0026410;C0031831;C0439269;C1707664;C1960952;C2346927;C2348314;C3540849;C4321396;C4521761";FALSE;1862;eze simva $nmbr$ $nmbr$ mg dr $nmbr$
1831;eze / simva  $nmbr$ / $nmbr$ mg + feno  $nmbr$ mg dn = $nmbr$ );"C1319635;C1333964;C1707618";FALSE;1862;eze simva $nmbr$ $nmbr$ mg feno $nmbr$ mg dn $nmbr$
1831;eze / simva $nmbr$ / $nmbr$ mg n = $nmbr$;"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;1862;eze simva $nmbr$ $nmbr$ mg n $nmbr$
1831;eze / simva $nmbr$ / $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;1862;eze simva $nmbr$ $nmbr$ mg n $nmbr$
1830;ind / gly ( n = $nmbr$ );"C0017890;C0523677;C4049864";FALSE;1509;ind gly n $nmbr$
1830;ind + gly ( n = $nmbr$ );"C0017890;C0523677;C4049864";FALSE;1509;ind gly n $nmbr$
1830;ind / gly n = $nmbr$;"C0017890;C0523677;C4049864";FALSE;1509;ind gly n $nmbr$
1830;no . of patients ind / gly sfc;"C0017890;C0030705;C0523677;C4049864;C4521536";FALSE;1509;no of patients ind gly sfc
1825;positive for anti - cyclic citrullinated peptide antibody — no . ( % ) f;"C0016327;C0741132;C1320283";NA;NA;positive for anti cyclic citrullinated peptide antibody no f
1825;natalizumab ( n = $nmbr$ ) f;"C0016327;C1172734";NA;NA;natalizumab n $nmbr$ f
1825;f emale;C0016327;NA;NA;f emale
1823;p blockersubgroup;"C0369773;C2603361";NA;NA;p blockersubgroup
1823;p blocker before admission;"C0184666;C0369773;C0809949;C2603361";NA;NA;p blocker before admission
1823;p blocker;"C0369773;C2603361";NA;NA;p blocker
1823;p . o );"C0369773;C2603361";NA;NA;p o
1823;p - blocking agents  selective;"C0036576;C0233660;C0332206;C0369773;C0450442;C1254351;C1521826;C1707391;C2603361";NA;NA;p blocking agents selective
1823;p - blocker intake at randomisation ( n = $nmbr$ o );"C0034656;C0369773;C1512806;C2603361";NA;NA;p blocker intake at randomisation n $nmbr$ o
1823;p - blocker intake at randomisation ( n = $nmbr$ );"C0034656;C0369773;C1512806;C2603361";NA;NA;p blocker intake at randomisation n $nmbr$
1823;p - blocker;"C0369773;C2603361";NA;NA;p blocker
1823;p +;"C0369773;C2603361";NA;NA;p
1823;p *;"C0369773;C2603361";NA;NA;p
1823;p $nmbr$ z $nmbr$ ( n = $nmbr$ );"C0369773;C2603361";NA;NA;p $nmbr$ z $nmbr$ n $nmbr$
1823;p $nmbr$ y $nmbr$ antagonists;"C0243076;C0369773;C2603361";NA;NA;p $nmbr$ y $nmbr$ antagonists
1823;p $nmbr$ y $nmbr$ antagonist;"C0231491;C0369773;C2603361";NA;NA;p $nmbr$ y $nmbr$ antagonist
1823;p  regional difference *;"C0369773;C0682132;C2603361";NA;NA;p regional difference
1823;p  regional difference;"C0369773;C0682132;C2603361";NA;NA;p regional difference
1823;p;"C0369773;C2603361";NA;NA;p
1822;ppci ( n = $nmbr$ );NA;NA;NA;ppci n $nmbr$
1822;ppci;NA;NA;NA;ppci
1822;pnorpci;NA;NA;NA;pnorpci
1822;fpci vs . ppci in men;C0025266;NA;NA;fpci vs ppci in men
1821;fpg;NA;NA;NA;fpg
1821;baseline fpg  mean ( s . e . );"C0168634;C0444504;C1442488;C2347634;C2348143";NA;NA;baseline fpg mean s e
1821;baseline fpg;"C0168634;C1442488";NA;NA;baseline fpg
1820;ratio fp / sal : sal ( $nmbr$ % ci );"C0008107;C0016704;C0036140;C0037494;C0206136;C0456603;C1419068;C1419906;C1547037;C3259781;C3541238;C3541412";NA;NA;ratio fp sal sal $nmbr$ ci
1820;fp versus no ics;"C0016704;C0815320;C1419068;C1419906;C3541238;C3541412;C4551720";NA;NA;fp versus no ics
1820;fp ( n   = $nmbr$  $nmbr$ );"C0016704;C1419068;C1419906;C3541238;C3541412";NA;NA;fp n $nmbr$ $nmbr$
1820;fp ( n [ $nmbr$ );"C0016704;C1419068;C1419906;C3541238;C3541412";NA;NA;fp n $nmbr$
1820;fp ( n = $nmbr$ );"C0016704;C1419068;C1419906;C3541238;C3541412";NA;NA;fp n $nmbr$
1820;fp $nmbr$ mg;"C0016704;C0024671;C0026410;C0439269;C1419068;C1419906;C1960952;C2346927;C3541238;C3541412;C4321396;C4521761";NA;NA;fp $nmbr$ mg
1820;fp;"C0016704;C1419068;C1419906;C3541238;C3541412";NA;NA;fp
1819;prior cancer;"C0006826;C0332152;C0998265;C1306459;C2826257";NA;NA;prior cancer
1819;previous cancer — no . ( % );"C0006826;C0205156;C0998265;C1306459;C1552607";NA;NA;previous cancer no
1819;previous cancer  n ( % );"C0006826;C0205156;C0998265;C1306459;C1552607";NA;NA;previous cancer n
1819;previous cancer;"C0006826;C0205156;C0998265;C1306459;C1552607";NA;NA;previous cancer
1819;no prior cancer;"C0006826;C0332152;C0998265;C1306459;C2826257";NA;NA;no prior cancer
1819;no adk / e cancer;"C0006826;C0998265;C1306459;C1412243";NA;NA;no adk e cancer
1819;no active cancer;"C0006826;C0205177;C0998265;C1306459;C3853793;C3888249";NA;NA;no active cancer
1819;medical history : cancer;"C0006826;C0262926;C0998265;C1306459;C1704706";NA;NA;medical history cancer
1819;cancer — no . ( % );"C0006826;C0998265;C1306459";NA;NA;cancer no
1819;cancer §;"C0006826;C0998265;C1306459";NA;NA;cancer
1819;cancer n ( % );"C0006826;C0998265;C1306459";NA;NA;cancer n
1810;numbers of events ( % ) :;C4330837;NA;NA;numbers of events
1823;p vaiue;"C0369773;C2603361";FALSE;1872;p vaiue
1819;prostate cancer;"C0376358;C0600139;C2984325;C3541264";FALSE;1866;prostate cancer
1823;p valuec;"C0369773;C2603361";FALSE;1872;p valuec
1823;p - valuec;"C0369773;C2603361";FALSE;1872;p valuec
1823;p valued;"C0369773;C1522609;C2603361";FALSE;1872;p valued
1823;p valuej ';"C0369773;C2603361";FALSE;1872;p valuej
1823;p valuer;"C0369773;C0401806;C2603361";FALSE;1872;p valuer
1823;p valuey;"C0369773;C2603361";FALSE;1872;p valuey
1823;* p for heterogeneity of treatment effect between tertiles > $nmbr$ . $nmbr$ .;"C0019409;C0242960;C0369773;C1518681;C2603361";FALSE;1873;p for heterogeneity of treatment effect between tertiles $nmbr$ $nmbr$
1823;p - heterogeneity;"C0019409;C0242960;C0369773;C2603361";FALSE;1873;p heterogeneity
1823;p - interactio n;"C0369773;C2603361";FALSE;1874;p interactio n
1823;p - inte faction;"C0369773;C2603361";FALSE;1874;p inte faction
1823;p - for interaetion;"C0369773;C2603361";FALSE;1874;p for interaetion
1823;p for i;"C0021966;C0221138;C0369773;C2603361";FALSE;1874;p for i
1824;$nmbr$ . $nmbr$ ( $nmbr$ . o - $nmbr$ . o );C0483204;FALSE; -10;$nmbr$ $nmbr$ $nmbr$ o $nmbr$ o
1824;$nmbr$ - $nmbr$ ( o - $nmbr$ - i - $nmbr$ );"C0021966;C0221138;C0483204";FALSE; -10;$nmbr$ $nmbr$ o $nmbr$ i $nmbr$
1824;$nmbr$ - $nmbr$ ( o - $nmbr$ - i - o $nmbr$ );"C0021966;C0221138;C0483204";FALSE; -10;$nmbr$ $nmbr$ o $nmbr$ i o $nmbr$
1824;$nmbr$ - $nmbr$ ( o $nmbr$ o - i - i $nmbr$ );"C0021966;C0221138;C0483204";FALSE; -10;$nmbr$ $nmbr$ o $nmbr$ o i i $nmbr$
1824;$nmbr$ - $nmbr$ ( o - $nmbr$ - o - $nmbr$ );C0483204;FALSE; -10;$nmbr$ $nmbr$ o $nmbr$ o $nmbr$
1824;$nmbr$ - $nmbr$ ( o $nmbr$ - o - $nmbr$ );C0483204;FALSE; -10;$nmbr$ $nmbr$ o $nmbr$ o $nmbr$
1824;$nmbr$ - $nmbr$ ( o - $nmbr$ - o - $nmbr$ o );C0483204;FALSE; -10;$nmbr$ $nmbr$ o $nmbr$ o $nmbr$ o
1824;$nmbr$ - $nmbr$ ( o - $nmbr$ o - o - $nmbr$ );C0483204;FALSE; -10;$nmbr$ $nmbr$ o $nmbr$ o o $nmbr$
1824;$nmbr$ - $nmbr$ ( o - $nmbr$ s - i - $nmbr$ );"C0021966;C0221138;C0483204";FALSE; -10;$nmbr$ $nmbr$ o $nmbr$ s i $nmbr$
1824;$nmbr$ - $nmbr$ ( o - $nmbr$ s - o - $nmbr$ );C0483204;FALSE; -10;$nmbr$ $nmbr$ o $nmbr$ s o $nmbr$
1824;$nmbr$ ( o - $nmbr$ - o - $nmbr$ );C0483204;FALSE; -10;$nmbr$ o $nmbr$ o $nmbr$
1824;$nmbr$ o / $nmbr$ o $nmbr$ ( $nmbr$ - $nmbr$ % );C0483204;FALSE; -10;$nmbr$ o $nmbr$ o $nmbr$ $nmbr$ $nmbr$
1824;$nmbr$ ( o - o $nmbr$ - o - $nmbr$ );C0483204;FALSE; -10;$nmbr$ o o $nmbr$ o $nmbr$
1824;o $nmbr$;C0483204;FALSE; -10;o $nmbr$
1824;o;C0483204;FALSE; -10;o
1824;> o - $nmbr$ - i - i;"C0021966;C0221138;C0483204";FALSE; -10;o $nmbr$ i i
1824;- o $nmbr$ o ( - $nmbr$ - loto - $nmbr$ - $nmbr$ );C0483204;FALSE; -10;o $nmbr$ o $nmbr$ loto $nmbr$ $nmbr$
1824;o - oi $nmbr$ ( - $nmbr$ - $nmbr$ to $nmbr$ - $nmbr$ );"C0029118;C0029434;C0483204";FALSE; -10;o oi $nmbr$ $nmbr$ $nmbr$ to $nmbr$ $nmbr$
1825;f;C0016327;FALSE; -10;f
1825;f * >;C0016327;FALSE; -10;f
1825;$nmbr$ f $nmbr$ q % );C0016327;FALSE; -10;$nmbr$ f $nmbr$ q
1825;$nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ % f;C0016327;FALSE; -10;$nmbr$ $nmbr$ $nmbr$ $nmbr$ f
1825;accp bleeding risk at inclusion  no . ( % ) f;"C0007637;C0016327;C1512693;C3251812";FALSE; -10;accp bleeding risk at inclusion no f
1825;ancestry ( % ) f;C0016327;FALSE; -10;ancestry f
1825;$nmbr$ f $nmbr$ l % $nmbr$;C0016327;FALSE; -10;$nmbr$ f $nmbr$ l $nmbr$
1825;? f ? n;C0016327;FALSE; -10;f n
1825;la grade b  n ( % ) f;"C0016327;C1881342";FALSE; -10;la grade b n f
1819;cancer medications;"C0006826;C0013227;C0802604;C0998265;C1306459;C2598133;C4284232";NA;NA;cancer medications
1819;cancer * *;"C0006826;C0998265;C1306459";NA;NA;cancer
1819;cancer *;"C0006826;C0998265;C1306459";NA;NA;cancer
1819;cancer ( n = $nmbr$ );"C0006826;C0998265;C1306459";NA;NA;cancer n $nmbr$
1819;cancer  fatal and nonfatal;"C0006826;C0998265;C1302234;C1306459;C1705232";NA;NA;cancer fatal and nonfatal
1819;cancer;"C0006826;C0998265;C1306459";NA;NA;cancer
1819;all cancer;"C0006826;C0998265;C1306459";NA;NA;all cancer
1819;active or previous cancer;"C0006826;C0205156;C0205177;C0998265;C1306459;C1552607;C3853793;C3888249";NA;NA;active or previous cancer
1819;active cancer — no . ( % );"C0006826;C0205177;C0998265;C1306459;C3853793;C3888249";NA;NA;active cancer no
1819;active cancer at randomization  n ( % );"C0006826;C0034656;C0205177;C0998265;C1306459;C3853793;C3888249";NA;NA;active cancer at randomization n
1819;active cancer at randomization;"C0006826;C0034656;C0205177;C0998265;C1306459;C3853793;C3888249";NA;NA;active cancer at randomization
1819;active cancer at randomisation;"C0006826;C0034656;C0205177;C0998265;C1306459;C3853793;C3888249";NA;NA;active cancer at randomisation
1819;active cancer at baseline;"C0006826;C0168634;C0205177;C0998265;C1306459;C1442488;C3853793;C3888249";NA;NA;active cancer at baseline
1819;active cancer at any timeb;"C0006826;C0205177;C0998265;C1306459;C3853793;C3888249";NA;NA;active cancer at any timeb
1773;other lipid lowering drugs;C0086440;NA;NA;other lipid lowering drugs
1819;active cancer;"C0006826;C0205177;C0998265;C1306459;C3853793;C3888249";NA;NA;active cancer
1819;ac tve cancer;"C0001246;C0003354;C0006826;C0998265;C1306459;C1412573;C2000891;C3539770";NA;NA;ac tve cancer
1818;non - colorectal cancer;"C0009402;C0346629;C1518422;C1527249;C2984278;C3542412";NA;NA;non colorectal cancer
1818;colorectal cancer;"C0009402;C0346629;C1527249;C2984278;C3542412";NA;NA;colorectal cancer
 -10;oxcarbazepine;C0069751;NA;NA;oxcarbazepine
1816;caffeine users  n ( % );C3532939;NA;NA;caffeine users n
1816;caffeine user  n ( % );C3532939;NA;NA;caffeine user n
1816;caffeine user;C3532939;NA;NA;caffeine user
1816;caffeine consumption *;C0948365;NA;NA;caffeine consumption
1816;caffeine consumption ( yes ) ( n );"C0948365;C1549445;C1705108;C1710701";NA;NA;caffeine consumption yes n
1816;caffeine;"C0006644;C0236734";NA;NA;caffeine
1815;not - japan n = $nmbr$  $nmbr$;"C0022341;C1518422";NA;NA;not japan n $nmbr$ $nmbr$
1815;not - japan;"C0022341;C1518422";NA;NA;not japan
1815;japan n = $nmbr$;C0022341;NA;NA;japan n $nmbr$
1815;japan and south korea;"C0022341;C0022773";NA;NA;japan and south korea
1815;japan;C0022341;NA;NA;japan
1815;calima japan ( n = $nmbr$ );C0022341;NA;NA;calima japan n $nmbr$
1813;overallb;NA;NA;NA;overallb
1813;overall quality of life;C3641830;NA;NA;overall quality of life
1813;( ofl );NA;NA;NA;ofl
1812;otherj ^ :;NA;NA;NA;otherj
1812;other forms of;"C0348078;C0376315";NA;NA;other forms of
1812;history of other medical conditions  n ( % );"C0012634;C0262926;C0348080;C1705253;C3864998";NA;NA;history of other medical conditions n
   8;valve repair / replacement with or without cabg;"C0010055;C0035139;C0043240;C0184252;C0374711;C0559956;C1186983;C1555302;C1704414;C3888056;C4319951;C4553149";NA;NA;valve repair replacement with or without cabg
   8;valve repair / replacement only;"C0035139;C0043240;C0184252;C0205171;C0374711;C0559956;C1186983;C1555302;C1704414;C1720467;C3888056;C4319951;C4553149";NA;NA;valve repair replacement only
   8;cabg or valve;"C0010055;C0184252;C1186983;C1704414;C3888056";NA;NA;cabg or valve
   7;use of cgm interaction test p - value ^ =;"C0022885;C0039593;C0392366;C0456984;C1515976;C1524063;C1704675;C1709380;C3831328;C4318744";NA;NA;use of cgm interaction test p value
   7;univariate p - value;C1709380;NA;NA;univariate p value
   7;test for interaction ( p value );"C0022885;C0039593;C0392366;C0456984;C1515976;C1704675;C1709380;C3831328;C4318744";NA;NA;test for interaction p value
   7;subgroup p value 本;"C1079230;C1515021;C1709380";NA;NA;subgroup p value
   7;subgroup p value !;"C1079230;C1515021;C1709380";NA;NA;subgroup p value
   7;subgroup p - value $nmbr$;"C1079230;C1515021;C1709380";NA;NA;subgroup p value $nmbr$
1811;† includes patients originally randomized to placebo who were switched to secukinumab per the study designs .   ‡ aes that occurred in at least $nmbr$ . $nmbr$ % of the patients in the any secukinumab group during the $nmbr$ ‐ week placebo ‐ controlled period and events with an eair of at least $nmbr$ . $nmbr$ cases per $nmbr$ patient ‐ years in the any secukinumab group during the entire treatment period . events listed according to preferred term in the medical dictionary for regulatory activities ( meddra version $nmbr$ . $nmbr$ )  sorted in descending order of eair in the any secukinumab group for the entire treatment period . the entire treatment period for safety data was from baseline to week $nmbr$ visit of the last patient enrolled in these studies . ae  adverse event  as  ankylosing spondylitis  eair  exposure adjusted incidence rates    n  number of randomized patients  sae  serious adverse event  urti  upper respiratory tract infection .;"C0012113;C0021149;C0030705;C0032042;C0034656;C0035171;C0036043;C0038013;C0039798;C0041912;C0087111;C0168634;C0205386;C0220856;C0220905;C0274281;C0332157;C0332174;C0332257;C0333052;C0374505;C0439230;C0439234;C0439531;C0439751;C0441471;C0441655;C0441833;C0444667;C0456081;C0680240;C0687744;C0745732;C0868928;C0871208;C0877248;C0947630;C1140263;C1257890;C1412268;C1442488;C1511726;C1512346;C1519255;C1519504;C1521828;C1522326;C1533148;C1533734;C1547177;C1547401;C1552866;C1622657;C1696465;C1704735;C1705169;C1705187;C1705428;C1705429;C1706408;C1707719;C1709305;C1709637;C1948053;C2347664;C2360800;C2607870;C2699274;C2700399;C2983265;C2986888;C3179547;C3245479;C3272378;C3538994;C3541888;C3714741;C3815594;C3887670;C3887704;C4553214;C4684790";NA;NA;includes patients originally randomized to placebo who were switched to secukinumab per the study designs aes that occurred in at least $nmbr$ $nmbr$ of the patients in the any secukinumab group during the $nmbr$ week placebo controlled period and events with an eair of at least $nmbr$ $nmbr$ cases per $nmbr$ patient years in the any secukinumab group during the entire treatment period events listed according to preferred term in the medical dictionary for regulatory activities meddra version $nmbr$ $nmbr$ sorted in descending order of eair in the any secukinumab group for the entire treatment period the entire treatment period for safety data was from baseline to week $nmbr$ visit of the last patient enrolled in these studies ae adverse event as ankylosing spondylitis eair exposure adjusted incidence rates n number of randomized patients sae serious adverse event urti upper respiratory tract infection
1811;“ off ”;NA;NA;NA;off
1811;previous number of ciu / csu medications;"C0205156;C0578870;C1552607;C1718138";NA;NA;previous number of ciu csu medications
1811;off omt ( n = $nmbr$ );NA;NA;NA;off omt n $nmbr$
1811;off omt;NA;NA;NA;off omt
1811;number of “ off ” periods;"C0237753;C0439531;C0449788;C1948053";NA;NA;number of off periods
1811;number of treated patients;"C1522326;C2360800";NA;NA;number of treated patients
1811;number of patients with fractures;"C0016658;C2360800";NA;NA;number of patients with fractures
1811;number of patients with events;"C0441471;C2360800;C3541888";NA;NA;number of patients with events
1811;number of patients with dose available;"C0178602;C0470187;C0869039;C1114758;C2360800";NA;NA;number of patients with dose available
1811;number of patients with;C2360800;NA;NA;number of patients with
1811;number of patients ( % ) or mean ± sd;"C0444504;C2347634;C2348143;C2360800;C2699239";NA;NA;number of patients or mean sd
1811;number of patients;C2360800;NA;NA;number of patients
1811;number of medications  n ( % );C1718138;NA;NA;number of medications n
1811;number of individuals;C1549735;NA;NA;number of individuals
1811;number ( % ) of patients;C2360800;NA;NA;number of patients
1814;japanese;"C0376247;C1556094";FALSE;1815;japanese
1818;concern;C2699424;FALSE; -10;concern
1818;golden - $nmbr$;NA;FALSE; -10;golden $nmbr$
1818;golden - $nmbr$ and - $nmbr$;NA;FALSE; -10;golden $nmbr$ and $nmbr$
1812;other forms of atherosclerosis ^;"C0003850;C0004153;C0348078;C0376315";FALSE;1698;other forms of atherosclerosis
1812;other forms of atherosclerosis ’;"C0003850;C0004153;C0348078;C0376315";FALSE;1698;other forms of atherosclerosis
1813;korea  republic of;C0022773;FALSE;1871;korea republic of
1810;number of events ( annualised rate [ % ] );"C0871208;C1521828;C4330837";NA;NA;number of events annualised rate
1810;number of events  event per $nmbr$ person - years;"C0027361;C0439234;C2347489;C4330837";NA;NA;number of events event per $nmbr$ person years
1810;number of events;C4330837;NA;NA;number of events
1809;extent of disease — no . / total no . ( % ) § ^ |;"C0439175;C0439810;C0449279;C4553144";NA;NA;extent of disease no total no
1809;extent of disease  n ( % );"C0449279;C4553144";NA;NA;extent of disease n
1809;extent of disease  %;"C0449279;C4553144";NA;NA;extent of disease
1809;extent of disease;"C0449279;C4553144";NA;NA;extent of disease
1809;angiographic extent of disease;"C0002978;C0449279;C4553144";NA;NA;angiographic extent of disease
1807;effect of covariates on slopes;"C0807955;C1280500;C1518681;C2348382";NA;NA;effect of covariates on slopes
1807;covariates;NA;NA;NA;covariates
1807;covariate;NA;NA;NA;covariate
1807;ap - value from an ancova with corresponding baseline lipid value as the covariate and with a effect for treatment group .;"C0002680;C0023779;C0039798;C0087111;C0168634;C0441833;C0687744;C0814908;C1257890;C1280500;C1442488;C1518681;C1519504;C1522326;C1522609;C1533734;C1705169;C1705428;C1705429;C2348382;C3538994;C3887704;C3887950";NA;NA;ap value from an ancova with corresponding baseline lipid value as the covariate and with a effect for treatment group
1806;median blood eosinophil count ( cells per pl ) t;"C0200638;C0549183;C0876920;C2347635;C2348144;C2939193;C3897966;C4049765";NA;NA;median blood eosinophil count cells per pl t
1806;local eosinophil count ( cells per pl ) t;"C0007584;C0007634;C0200638;C0205276;C0750879;C3897966;C4049765";NA;NA;local eosinophil count cells per pl t
1806;eosinophil count ( cells per pl );"C0007584;C0007634;C0200638;C0750879;C3897966;C4049765";NA;NA;eosinophil count cells per pl
1790;established cardiovascular disease;"C0007222;C0443211;C1272684";NA;NA;established cardiovascular disease
1806;eosinophil count ( cells / pl )  median ( range ) c;"C0007584;C0007634;C0200638;C0549183;C0750879;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016;C3897966;C4049765";NA;NA;eosinophil count cells pl median range c
1806;eosinophil counf cells pl ';"C0682547;C3897966;C4049765";NA;NA;eosinophil counf cells pl
1806;eos count ( cells / pl );"C0007584;C0007634;C0750480;C1623465;C1705566;C1861303;C3897966;C4049765";NA;NA;eos count cells pl
1806;biomarker high ( periostin > $nmbr$ ng / ml or blood eosinophils > $nmbr$ cells per pl ) t;"C0005516;C0005773;C0007584;C0007634;C0014467;C0200638;C0205250;C0219433;C0439275;C1299351;C1424662;C2700149;C3812270;C3887512;C3889660;C3897966;C4049765;C4321237;C4522209";NA;NA;biomarker high periostin $nmbr$ ng ml or blood eosinophils $nmbr$ cells per pl t
1806;baseline eosinophil < $nmbr$ cells / pl;"C0168634;C0682547;C1442488;C3897966;C4049765";NA;NA;baseline eosinophil $nmbr$ cells pl
1806;baseline eosinophil $nmbr$ cells / pl;"C0168634;C0682547;C1442488;C3897966;C4049765";NA;NA;baseline eosinophil $nmbr$ cells pl
1806;( cells per pl ) t;"C0007584;C0007634;C3897966;C4049765";NA;NA;cells per pl t
1805;neutrophils  $nmbr$ / nl;"C0027778;C0027950;C0560008;C3892223";NA;NA;neutrophils $nmbr$ nl
1805;monocytes  $nmbr$ / nl;"C0026473;C0027778;C0560008;C3892223";NA;NA;monocytes $nmbr$ nl
1805;leukocytes  $nmbr$ / nl;"C0023516;C0027778;C0560008;C3892223";NA;NA;leukocytes $nmbr$ nl
1804;proximal gl tract  n ( % );"C0018229;C0205107;C1185740;C1423073;C1427674;C4489236";NA;NA;proximal gl tract n
1804;involved gl areas;"C0018229;C1423073;C1427674;C1879646";NA;NA;involved gl areas
1804;hemoglobin ( gl ' );"C0018229;C0019046;C1423073;C1427674";NA;NA;hemoglobin gl
1804;bsl hb  gl - $nmbr$;"C0018229;C0019046;C1423073;C1427674;C1549954";NA;NA;bsl hb gl $nmbr$
1803;positive hla - b $nmbr$ status  n ( % );"C0439178;C0449438;C1426226;C1446409;C1514241;C2825490;C3812269";NA;NA;positive hla b $nmbr$ status n
1803;positive for hla - b $nmbr$  n ( % );"C0019737;C0439178;C0550853;C1415561;C1446409;C1514241;C2825490;C3812269";NA;NA;positive for hla b $nmbr$ n
1803;hla ‐ b $nmbr$ positive    n   ( % );"C0439178;C1426226;C1446409;C1514241;C2825490;C3812269";NA;NA;hla b $nmbr$ positive n
1803;hla - b $nmbr$  n ( % ) ⁎ ⁎;C1426226;NA;NA;hla b $nmbr$ n
1803;hla - b $nmbr$;"C0019737;C0550853;C1415561";NA;NA;hla b $nmbr$
1802;mean platelet volume  fl;"C0200665;C0344388;C1300812;C1708024";NA;NA;mean platelet volume fl
1800;pdqol scale;"C0175659;C0349674;C1947916";NA;NA;pdqol scale
1799;hrqol;"C4279947;C4300252";NA;NA;hrqol
1799;health - related quality of life;C4279947;NA;NA;health related quality of life
1798;right;"C0205090;C0444532";NA;NA;right
1797;hfpef ( ef n $nmbr$ )  ( % );NA;NA;NA;hfpef ef n $nmbr$
1797;ef b $nmbr$ %;NA;NA;NA;ef b $nmbr$
1797;ef > $nmbr$ % hfpef ( n = $nmbr$  $nmbr$ % );NA;NA;NA;ef $nmbr$ hfpef n $nmbr$ $nmbr$
1797;ef > $nmbr$ % ( n = $nmbr$  $nmbr$ );NA;NA;NA;ef $nmbr$ n $nmbr$ $nmbr$
1797;ef > $nmbr$ %;NA;NA;NA;ef $nmbr$
1797;ef < $nmbr$ % n = $nmbr$;NA;NA;NA;ef $nmbr$ n $nmbr$
1797;ef < $nmbr$ % ( n = $nmbr$  $nmbr$ );NA;NA;NA;ef $nmbr$ n $nmbr$ $nmbr$
1797;ef $nmbr$ - $nmbr$ . $nmbr$ % ( n $nmbr$ $nmbr$ );NA;NA;NA;ef $nmbr$ $nmbr$ $nmbr$ n $nmbr$ $nmbr$
1797;ef $nmbr$ - $nmbr$ % hfmref ( n = $nmbr$  $nmbr$ % );NA;NA;NA;ef $nmbr$ $nmbr$ hfmref n $nmbr$ $nmbr$
1797;ef $nmbr$ - $nmbr$ %;NA;NA;NA;ef $nmbr$ $nmbr$
1809;dates of recruitment;"C0011008;C2348077;C2949735";FALSE;1863;dates of recruitment
1808;$nmbr$ . $nmbr$ ± l . ot;"C0439394;C1318464;C1418208;C1705587;C1706495;C3642217";FALSE; -10;$nmbr$ $nmbr$ l ot
1808;exlertl ot disease;"C0012634;C1318464;C1418208;C1705587";FALSE; -10;exlertl ot disease
1810;number of treated lesions;"C0449791;C1522326";FALSE;1870;number of treated lesions
1810;number of treated lesions ( per patient );"C0030705;C0449791;C1522326";FALSE;1870;number of treated lesions per patient
1798;r ight coronary;"C0018787;C0205090;C0684010;C2603358";FALSE; 224;r ight coronary
1798;r ight coronar y artery;"C0003842;C0205090;C0226004;C0684010;C2603358";FALSE; 224;r ight coronar y artery
1798;right ventriculardysfunction atinclusion;"C0205090;C0444532";FALSE;1882;right ventriculardysfunction atinclusion
1798;r $nmbr$;"C0205090;C0684010;C2603358";FALSE; -10;r $nmbr$
1798;canvas - r;"C0205090;C0684010;C2603358;C3281223";FALSE; -10;canvas r
1798;r;"C0205090;C0684010;C2603358";FALSE; -10;r
1800;psaqol;NA;FALSE;1883;psaqol
1801;hbalc < medan;NA;FALSE;1176;hbalc medan
1801;hbalc  median ( ql  q $nmbr$ )  %;"C0549183;C0876920;C2347635;C2348144;C2939193";FALSE;1176;hbalc median ql q $nmbr$
1801;hbalc  mmol / mol;C3829066;FALSE;1176;hbalc mmol mol
1801;hbalc < $nmbr$ mmol / mol ( £ $nmbr$ . $nmbr$ % ) ( n = $nmbr$ / $nmbr$ );C3829066;FALSE;1176;hbalc $nmbr$ mmol mol $nmbr$ $nmbr$ n $nmbr$ $nmbr$
1801;hbalc > $nmbr$ mmol / mol ( > $nmbr$ . $nmbr$ % ) ( n = $nmbr$ / $nmbr$ );C3829066;FALSE;1176;hbalc $nmbr$ mmol mol $nmbr$ $nmbr$ n $nmbr$ $nmbr$
1801;hbalc £ $nmbr$ mmol / mol ( < $nmbr$ . $nmbr$ % ) ( n = $nmbr$ / $nmbr$ );C3829066;FALSE;1176;hbalc $nmbr$ mmol mol $nmbr$ $nmbr$ n $nmbr$ $nmbr$
1801;hbalc £ $nmbr$ mmol / mol ( £ $nmbr$ . $nmbr$ % ) ( n = $nmbr$ / $nmbr$ );C3829066;FALSE;1176;hbalc $nmbr$ mmol mol $nmbr$ $nmbr$ n $nmbr$ $nmbr$
1801;hbalc < $nmbr$ % ( < $nmbr$ mmol / mol )  n ( % );C3829066;FALSE;1176;hbalc $nmbr$ $nmbr$ mmol mol n
1801;hbalc > $nmbr$ - < $nmbr$ mmol / mol ( > $nmbr$ . $nmbr$ - < $nmbr$ . $nmbr$ % ) ( n = $nmbr$ / $nmbr$ );C3829066;FALSE;1176;hbalc $nmbr$ $nmbr$ mmol mol $nmbr$ $nmbr$ $nmbr$ $nmbr$ n $nmbr$ $nmbr$
1801;mean ( s . d . ) hbalc  mmol / mol;"C0444504;C2347634;C2348143;C3829066";FALSE;1176;mean s d hbalc mmol mol
1802;fl ( $nmbr$ b );"C1300812;C1708024";FALSE; -10;fl $nmbr$ b
1802;fl ( $nmbr$ . $nmbr$ );"C1300812;C1708024";FALSE; -10;fl $nmbr$ $nmbr$
1802;history of atrial fibrillation or fl utter;"C0729790;C1300812;C1708024";FALSE;1009;history of atrial fibrillation or fl utter
1797;ef  %;NA;NA;NA;ef
1795;previous cd related surgery ( ref ) a;"C0007928;C0034283;C0038894;C0038895;C0205156;C0439849;C0445223;C0543467;C1274039;C1425988;C1552607;C4552032";NA;NA;previous cd related surgery ref a
1794;prior electrical cardioversion for af ( n = $nmbr$ $nmbr$ );"C0013778;C0332152;C0344434;C0542380;C2826257;C4049859";NA;NA;prior electrical cardioversion for af n $nmbr$ $nmbr$
1794;prior af ablation  n ( % );"C0332152;C0344434;C0547070;C1261381;C2826257;C4049859";NA;NA;prior af ablation n
1794;previous af;"C0205156;C0344434;C1552607;C4049859";NA;NA;previous af
1794;maf;NA;NA;NA;maf
1794;black / af rican american;"C0085756;C0344434;C4049859";NA;NA;black af rican american
1794;af pattern;"C0344434;C0449774;C4049859";NA;NA;af pattern
1794;af alone;"C0205171;C0344434;C0439044;C0679994;C4049859";NA;NA;af alone
1794;af;"C0344434;C4049859";NA;NA;af
 -10;qids - sr $nmbr$;C4331197;NA;NA;qids sr $nmbr$
1792;rivaroxaban $nmbr$ . $nmbr$ mg bid + aspirin $nmbr$ mg od;"C0004057;C0229089;C0439164;C1319635;C1512019;C1739768;C3273373;C3665488";NA;NA;rivaroxaban $nmbr$ $nmbr$ mg bid aspirin $nmbr$ mg od
1791;> $nmbr$ beds;C0004916;NA;NA;$nmbr$ beds
1791;< $nmbr$ beds;C0004916;NA;NA;$nmbr$ beds
1790;prior cvd;"C0007222;C0332152;C2826257";NA;NA;prior cvd
1790;prior cardiovascular disease;"C0007222;C0332152;C2826257";NA;NA;prior cardiovascular disease
1790;patients with no prior cvd ( primary;"C0007222;C0030705;C0205225;C0332152;C0439612;C0439631;C2826257";NA;NA;patients with no prior cvd primary
1790;patients with established cv disease aged > $nmbr$ years .;"C0007222;C0030705;C0443211;C1272684;C1510829";NA;NA;patients with established cv disease aged $nmbr$ years
1790;no prior cvd;"C0007222;C0332152;C2826257";NA;NA;no prior cvd
1790;no cvd;C0007222;NA;NA;no cvd
1790;no cardiovascular disorder $nmbr$ ';C0007222;NA;NA;no cardiovascular disorder $nmbr$
1790;no cardiovascular disease ( n = $nmbr$ );C0007222;NA;NA;no cardiovascular disease n $nmbr$
1790;n ( % ) patients with risk faetors for cv disease aged > $nmbr$;"C0001779;C0001792;C0007222;C0030705;C0035647;C0369718;C0441922;C1999167;C4552904";NA;NA;n patients with risk faetors for cv disease aged $nmbr$
1790;lisinopril cvd total;"C0007222;C0065374;C0439175;C0439810";NA;NA;lisinopril cvd total
1790;cvd without ml ^ troke;"C0007222;C0439526;C1705224;C3887665";NA;NA;cvd without ml troke
1790;cvd without ml / stroke;"C0007222;C0038454;C0439526;C1705224;C3887665;C4554100";NA;NA;cvd without ml stroke
1790;cvd without miatroke;C0007222;NA;NA;cvd without miatroke
1790;cvd  total;"C0007222;C0439175;C0439810";NA;NA;cvd total
1790;cvd;C0007222;NA;NA;cvd
1790;cv disease;C0007222;NA;NA;cv disease
1790;cardiovascular disorder  n ( % );C0007222;NA;NA;cardiovascular disorder n
1790;cardiovascular disorder;C0007222;NA;NA;cardiovascular disorder
1790;cardiovascular disease n ( % );C0007222;NA;NA;cardiovascular disease n
1790;cardiovascular disease history ‡;"C0007222;C0007226;C0012634;C0019664;C0019665;C0262512;C0262926;C0683519;C1705255;C1880008;C2004062;C3887460";NA;NA;cardiovascular disease history
1790;cardiovascular disease history  n ( % ) *;"C0007222;C0007226;C0012634;C0019664;C0019665;C0262512;C0262926;C0683519;C1705255;C1880008;C2004062;C3887460";NA;NA;cardiovascular disease history n
1790;cardiovascular disease history;"C0007222;C0007226;C0012634;C0019664;C0019665;C0262512;C0262926;C0683519;C1705255;C1880008;C2004062;C3887460";NA;NA;cardiovascular disease history
1790;cardiovascular disease *;C0007222;NA;NA;cardiovascular disease
1790;cardiovascular disease ( n = $nmbr$ );C0007222;NA;NA;cardiovascular disease n $nmbr$
1790;cardiovascular disease;C0007222;NA;NA;cardiovascular disease
1790;baseline cardiovascular disease;"C0007222;C0168634;C1442488";NA;NA;baseline cardiovascular disease
1790;any cardiovascular disease history  n ( % );"C0007222;C0007226;C0012634;C0019664;C0019665;C0262512;C0262926;C0683519;C1705255;C1880008;C2004062;C3887460";NA;NA;any cardiovascular disease history n
1790;any cardiovascular disease;C0007222;NA;NA;any cardiovascular disease
1790;$nmbr$ - $nmbr$ with cv disease ( n = $nmbr$ );C0007222;NA;NA;$nmbr$ $nmbr$ with cv disease n $nmbr$
1790;$nmbr$ - $nmbr$  cv disease ( n = $nmbr$  $nmbr$ );C0007222;NA;NA;$nmbr$ $nmbr$ cv disease n $nmbr$ $nmbr$
1789;apremilast;C1678805;NA;NA;apremilast
1788;gliclazide ( modified release ) 一 no . ( % ) ^;"C0017631;C1709058;C4544813";NA;NA;gliclazide modified release no
1787;history of elms  n ( % );"C0019664;C0019665;C0262512;C0262926;C0330531;C1705255;C2004062;C2980688";NA;NA;history of elms n
1787;elms  n ( % );"C0330531;C2980688";NA;NA;elms n
1786;> $nmbr$ cells / mm ^;"C0007584;C0007634;C4330985;C4554674";FALSE; -10;$nmbr$ cells mm
1786;> $nmbr$ to < $nmbr$ cells / mm ^;"C0007584;C0007634;C4330985;C4554674";FALSE; -10;$nmbr$ to $nmbr$ cells mm
1786;> $nmbr$ to < $nmbr$ cells / mm ’;"C0007584;C0007634;C4330985;C4554674";FALSE; -10;$nmbr$ to $nmbr$ cells mm
1787;$nmbr$ — $nmbr$ nlmw;NA;FALSE; -10;$nmbr$ $nmbr$ nlmw
1788;reteplase;C0256103;FALSE;1876;reteplase
1789;roflumilast ( n = $nmbr$  $nmbr$ );C0965618;FALSE;1877;roflumilast n $nmbr$ $nmbr$
1791;number of arterial beds involved;"C0003842;C0004916;C0221464;C0237753;C0449788;C1314939";FALSE;1878;number of arterial beds involved
1792;bid;NA;FALSE; -10;bid
1792;idegasp bid;NA;FALSE; -10;idegasp bid
1792;$nmbr$ μ g bid ( n = $nmbr$ );C0439267;FALSE; -10;$nmbr$ g bid n $nmbr$
1795;ef < $nmbr$ % hfref ( n = $nmbr$  $nmbr$ % );NA;FALSE;1879;ef $nmbr$ hfref n $nmbr$ $nmbr$
1795;hfref;NA;FALSE;1879;hfref
1795;nothfref;NA;FALSE;1879;nothfref
1795;hfref ( n = $nmbr$ );NA;FALSE;1879;hfref n $nmbr$
1795;history of bowel resection ( ref );"C0019664;C0019665;C0262512;C0262926;C0741614;C1425988;C1705255;C2004062";FALSE;1880;history of bowel resection ref
1795;no history of extra - intestinal manifestations of ibd ( ref );"C0019664;C0019665;C0021853;C0262512;C0262926;C1280464;C1425988;C1705255;C1883702;C2004062";FALSE;1880;no history of extra intestinal manifestations of ibd ref
1795;( d ) aza treatment ( ref );"C0004482;C0039798;C0073187;C0087111;C0332173;C1425988;C1522326;C1533734;C1705169;C3538994;C3887704;C4484261";FALSE;1881;d aza treatment ref
1795;$nmbr$ . $nmbr$ ( ref . );C1425988;FALSE; -10;$nmbr$ $nmbr$ ref
1795;$nmbr$ ( ref );C1425988;FALSE; -10;$nmbr$ ref
1795;( ref );C1425988;FALSE; -10;ref
1795;ref .;C1425988;FALSE; -10;ref
1795;ref §;C1425988;FALSE; -10;ref
1796;ef < $nmbr$ % ( n $nmbr$ $nmbr$ );NA;FALSE; 887;ef $nmbr$ n $nmbr$ $nmbr$
1796;ef > $nmbr$ % ( n $nmbr$ $nmbr$ );NA;FALSE; 887;ef $nmbr$ n $nmbr$ $nmbr$
1797;dysfunction  ef = erectile function  iief = i;"C0021966;C0030847;C0031843;C0031847;C0221138;C0277785;C0542341;C0700205;C1705273;C3641331;C3887504;C3887505";FALSE;1536;dysfunction ef erectile function iief i
1796;reduced ef;C0392756;FALSE; 887;reduced ef
1796;hf ' without known reduced ef;"C0018488;C0205309;C0392756;C1313497;C1538440;C3273279";FALSE;1273;hf without known reduced ef
1796;hf without known reduced ef;"C0018488;C0205309;C0392756;C1313497;C1538440;C3273279";FALSE;1273;hf without known reduced ef
1796;hf without known reduced ef ( n = $nmbr$ );"C0018488;C0205309;C0392756;C1313497;C1538440;C3273279";FALSE;1273;hf without known reduced ef n $nmbr$
1784;« s $nmbr$ - $nmbr$;"C0565930;C2603362";NA;NA;s $nmbr$ $nmbr$
1784;| : s blocker;"C0565930;C2603362";NA;NA;s blocker
1784;s £ $nmbr$;"C0565930;C2603362";NA;NA;s $nmbr$
1784;s fs $nmbr$;"C0565930;C1517317;C2603362;C3814419";NA;NA;s fs $nmbr$
1784;s . e .;"C0565930;C2603362";NA;NA;s e
1784;s ( s $nmbr$;"C0565930;C2603362";NA;NA;s s $nmbr$
1784;s $nmbr$ yrs;"C0565930;C2603362";NA;NA;s $nmbr$ yrs
1784;s $nmbr$ - $nmbr$ - s $nmbr$ . $nmbr$ %;"C0565930;C2603362";NA;NA;s $nmbr$ $nmbr$ s $nmbr$ $nmbr$
1784;s $nmbr$ ( $nmbr$ . s );"C0565930;C2603362";NA;NA;s $nmbr$ $nmbr$ s
1784;s $nmbr$ %;"C0565930;C2603362";NA;NA;s $nmbr$
1784;s $nmbr$;"C0565930;C2603362";NA;NA;s $nmbr$
1784;s;"C0565930;C2603362";NA;NA;s
1784;= s $nmbr$;"C0565930;C2603362";NA;NA;s $nmbr$
1784;$nmbr$ s f $nmbr$ );"C0016327;C0565930;C2603362";NA;NA;$nmbr$ s f $nmbr$
1784;$nmbr$ s . $nmbr$ ± s . $nmbr$;"C0565930;C2603362";NA;NA;$nmbr$ s $nmbr$ s $nmbr$
1784;$nmbr$ ( $nmbr$ s . s );"C0565930;C2603362";NA;NA;$nmbr$ $nmbr$ s s
1783;second year !;"C0205436;C0439234;C0439508;C0457385;C0565930;C1561503;C1705190";NA;NA;second year
1783;second mi;"C0205436;C0457385;C0565930;C1561503;C1705190;C3810814";NA;NA;second mi
1783;second loading dose;"C0205436;C0457385;C0565930;C1561503;C1705190;C3714444";NA;NA;second loading dose
1783;second - generation stent;"C0038257;C0079411;C0205436;C0457385;C0565930;C1561503;C1705190;C3146294";NA;NA;second generation stent
1783;second ( n = $nmbr$ );"C0205436;C0457385;C0565930;C1561503;C1705190";NA;NA;second n $nmbr$
1783;no second mi;"C0205436;C0457385;C0565930;C1561503;C1705190;C3810814";NA;NA;no second mi
1782;short form $nmbr$ ( sf - $nmbr$ );"C0037712;C2964478";NA;NA;short form $nmbr$ sf $nmbr$
1782;sf ‐ $nmbr$ pcs  ls mean change ± se;"C0023668;C0036919;C0037712;C0392747;C0443172;C0444504;C1705241;C1864389;C1882368;C2347634;C2348143;C4319952";NA;NA;sf $nmbr$ pcs ls mean change se
1782;sf ‐ $nmbr$ health survey;"C0018762;C0037712";NA;NA;sf $nmbr$ health survey
1782;sf - $nmbr$ v $nmbr$ pcs  mean [ sd ];"C0037712;C0444504;C1864389;C1882368;C2347634;C2348143;C2699239";NA;NA;sf $nmbr$ v $nmbr$ pcs mean sd
1782;sf - $nmbr$ v $nmbr$ mcs  mean [ sd ];"C0037712;C0444504;C2347634;C2348143;C2699239";NA;NA;sf $nmbr$ v $nmbr$ mcs mean sd
1782;sf - $nmbr$ summary scores;"C0037712;C0449820;C1552616;C1706244;C4050231";NA;NA;sf $nmbr$ summary scores
1782;sf - $nmbr$ score;"C0037712;C0449820;C4050231";NA;NA;sf $nmbr$ score
1782;sf - $nmbr$ pcs score;"C0037712;C0449820;C1864389;C1882368;C4050231";NA;NA;sf $nmbr$ pcs score
1782;sf - $nmbr$ pcs  mean ± sd;"C0037712;C0444504;C1864389;C1882368;C2347634;C2348143;C2699239";NA;NA;sf $nmbr$ pcs mean sd
1782;sf - $nmbr$ pcs  ls mean change from baseline   ±   se;"C0023668;C0036919;C0037712;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C1864389;C1882368;C2347634;C2348143;C4319952";NA;NA;sf $nmbr$ pcs ls mean change from baseline se
1782;sf - $nmbr$ pcs;"C0037712;C1864389;C1882368";NA;NA;sf $nmbr$ pcs
1782;sf - $nmbr$ mcs score;"C0037712;C0449820;C4050231";NA;NA;sf $nmbr$ mcs score
1782;sf - $nmbr$ mcs  mean ± sd;"C0037712;C0444504;C2347634;C2348143;C2699239";NA;NA;sf $nmbr$ mcs mean sd
1782;sf - $nmbr$ mcs;C0037712;NA;NA;sf $nmbr$ mcs
1782;sf - $nmbr$ ( health transition score );"C0037712;C0376627;C0449820;C4050231";NA;NA;sf $nmbr$ health transition score
1782;sf $nmbr$ - pcs;"C0037712;C1864389;C1882368";NA;NA;sf $nmbr$ pcs
1781;density lipoprotein  csf =;"C0023820;C0178587;C3540512;C3889436";NA;NA;density lipoprotein csf
1781;csii;NA;NA;NA;csii
1781;csf cholesterol;"C0008377;C3540512;C3889436";NA;NA;csf cholesterol
1781;csf;"C3540512;C3889436";NA;NA;csf
 -10;uvb;"C0454530;C0564461";NA;NA;uvb
1779;tvr;NA;NA;NA;tvr
1779;ischemic tvr;C0475224;NA;NA;ischemic tvr
1779;avr;C0449217;NA;NA;avr
1778;jvp > $nmbr$ cm;NA;NA;NA;jvp $nmbr$ cm
1778;jvp ( 〉 $nmbr$ cm );NA;NA;NA;jvp $nmbr$ cm
1778;jvp $ $nmbr$ cm h $nmbr$ o;C0455483;NA;NA;jvp $ $nmbr$ cm h $nmbr$ o
1778;jvp  ( % );NA;NA;NA;jvp
1778;jvd $ $nmbr$ cm h $nmbr$ o  %;"C0425687;C0455483";NA;NA;jvd $ $nmbr$ cm h $nmbr$ o
1777;qualifying cv event  n ( % );"C0441471;C1514624;C3538987;C4019010;C4048877;C4318503";NA;NA;qualifying cv event n
1777;prior cv history  n ( % );"C0019664;C0019665;C0262512;C0262926;C0332152;C1705255;C2004062;C2826257;C3538987;C4048877;C4318503";NA;NA;prior cv history n
1777;prior cv history;"C0019664;C0019665;C0262512;C0262926;C0332152;C1705255;C2004062;C2826257;C3538987;C4048877;C4318503";NA;NA;prior cv history
1777;prior cv event at randomization !;"C0034656;C0332152;C0441471;C2826257;C3538987;C4019010;C4048877;C4318503";NA;NA;prior cv event at randomization
1777;prior cv event;"C0332152;C0441471;C2826257;C3538987;C4019010;C4048877;C4318503";NA;NA;prior cv event
1777;previous cv events;"C0205156;C0441471;C1552607;C3538987;C3541888;C4048877;C4318503";NA;NA;previous cv events
1777;previous cv event;"C0205156;C0441471;C1552607;C3538987;C4019010;C4048877;C4318503";NA;NA;previous cv event
1777;non cv mortality;"C0026565;C0026566;C1518422;C3538987;C4048877;C4318503";NA;NA;non cv mortality
1777;non - cv mortality;"C0026565;C0026566;C1518422;C3538987;C4048877;C4318503";NA;NA;non cv mortality
1777;no prior cv event;"C0332152;C0441471;C2826257;C3538987;C4019010;C4048877;C4318503";NA;NA;no prior cv event
1777;no previous cv event;"C0205156;C0441471;C1552607;C3538987;C4019010;C4048877;C4318503";NA;NA;no previous cv event
1777;no cv event ( n = $nmbr$  $nmbr$ );"C0441471;C3538987;C4019010;C4048877;C4318503";NA;NA;no cv event n $nmbr$ $nmbr$
1777;no ascvd + additional cv risk factors  n ( % );"C0035648;C1524062;C1553898;C3538987;C3665365;C4048877;C4318503";NA;NA;no ascvd additional cv risk factors n
1777;incidence rate of cv events  n ( % );"C0441471;C1708485;C3538987;C3541888;C4048877;C4318503";NA;NA;incidence rate of cv events n
1777;hospitalization for heart failure or cv death;"C0011065;C1306577;C3538987;C3898876;C4048877;C4082313;C4318503;C4552775";NA;NA;hospitalization for heart failure or cv death
1777;hospitalization for heart failure or cv;"C3538987;C3898876;C4048877;C4318503";NA;NA;hospitalization for heart failure or cv
1777;heart failure hospitalisation or cv death;"C0011065;C1306577;C3538987;C3898876;C4048877;C4082313;C4318503;C4552775";NA;NA;heart failure hospitalisation or cv death
1777;first cv hospitalization;"C0019993;C0205435;C1279901;C3538987;C4048877;C4318503";NA;NA;first cv hospitalization
1777;expanded cv endpoint;"C0205229;C2349179;C2826544;C3538987;C4048877;C4318503";NA;NA;expanded cv endpoint
1777;estimated cv risk at baseline;"C0168634;C1442488;C1519101;C3538987;C4048877;C4318503";NA;NA;estimated cv risk at baseline
1777;cv risk factors and history;"C0019664;C0019665;C0035648;C0262512;C0262926;C1553898;C1705255;C2004062;C3538987;C4048877;C4318503";NA;NA;cv risk factors and history
1777;cv risk factors;"C0035648;C1553898;C3538987;C4048877;C4318503";NA;NA;cv risk factors
1777;cv risk factor - no . ( % );"C0035648;C3538987;C4048877;C4318503";NA;NA;cv risk factor no
1777;cv risk factor;"C0035648;C3538987;C4048877;C4318503";NA;NA;cv risk factor
1777;cv mortality;"C0026565;C0026566;C3538987;C4048877;C4318503";NA;NA;cv mortality
1777;cv historya;"C3538987;C4048877;C4318503";NA;NA;cv historya
1777;cv endpoints n ( % );"C2349179;C3538987;C4048877;C4318503";NA;NA;cv endpoints n
1777;cv disease history  no . ( % ) §;"C0007222;C0019664;C0019665;C0262512;C0262926;C0683519;C1705255;C2004062;C3538987;C4048877;C4318503";NA;NA;cv disease history no
1786;< $nmbr$ cells / mm ^;"C0007584;C0007634;C4330985;C4554674";FALSE; -10;$nmbr$ cells mm
1786;$nmbr$ to < $nmbr$ cells;"C0007584;C0007634";FALSE; -10;$nmbr$ to $nmbr$ cells
1777;cv;"C3538987;C4048877;C4318503";NA;NA;cv
1777;baseline cv medications  n ( % );"C0013227;C0168634;C0802604;C1442488;C2598133;C3538987;C4048877;C4284232;C4318503";NA;NA;baseline cv medications n
1777;baseline cv medications;"C0013227;C0168634;C0802604;C1442488;C2598133;C3538987;C4048877;C4284232;C4318503";NA;NA;baseline cv medications
1777;baseline ( geometric mean  cv );"C0168634;C1442488;C2986759;C3538987;C4048877;C4318503";NA;NA;baseline geometric mean cv
1777;ascvdor > $nmbr$ cv risk factors;"C0035648;C1553898;C3538987;C4048877;C4318503";NA;NA;ascvdor $nmbr$ cv risk factors
1777;any cv history / risk factors  n ( % );"C0019664;C0019665;C0035648;C0262512;C0262926;C1553898;C1705255;C2004062;C3538987;C4048877;C4318503";NA;NA;any cv history risk factors n
1777;> $nmbr$ additional cv risk factors $nmbr$;"C0035648;C1524062;C1553898;C3538987;C4048877;C4318503";NA;NA;$nmbr$ additional cv risk factors $nmbr$
1776;sokolow – lyon voltage ( mv );"C0598352;C1454484;C1705503;C4281602";NA;NA;sokolow lyon voltage mv
1776;sokoiow - lyon voitage  mv;"C1454484;C1705503;C4281602";NA;NA;sokoiow lyon voitage mv
1776;cornell voltage duration ( mv × ms );"C0449238;C0598352;C1454484;C1705503;C2349943;C2926735;C3539704;C3713294;C4281602";NA;NA;cornell voltage duration mv ms
1775;no mvd ( n - $nmbr$  $nmbr$ );"C1417507;C3272839";NA;NA;no mvd n $nmbr$ $nmbr$
1775;mvd ( n - $nmbr$  $nmbr$ );"C1417507;C3272839";NA;NA;mvd n $nmbr$ $nmbr$
1774;use of concomitant lipid - lowering therapy - no . ( % );"C0521115;C0585943;C1524063";NA;NA;use of concomitant lipid lowering therapy no
1774;statin and / or other lipid - lowering agent therapy;"C0039798;C0086440;C0087111;C0360714;C0450442;C0585943;C1254351;C1363945;C1521826";NA;NA;statin and or other lipid lowering agent therapy
1774;lipid ‐ lowering therapies  n ( % );C0585943;NA;NA;lipid lowering therapies n
1774;lipid lowering therapy;C0585943;NA;NA;lipid lowering therapy
1774;lipid - lowering therapy — no . ( % );C0585943;NA;NA;lipid lowering therapy no
1774;lipid - lowering therapy - no . ( % );C0585943;NA;NA;lipid lowering therapy no
1774;lipid - lowering therapy;C0585943;NA;NA;lipid lowering therapy
1774;lipc;C1416867;NA;NA;lipc
   7;subgroup by treatment interaction p - value;"C0039798;C0087111;C1079230;C1515021;C1522326;C1533734;C1704675;C1705169;C1709380;C3538994;C3887704";NA;NA;subgroup by treatment interaction p value
1774;hyperlipidaemia therapy use  n ( % ) * no lipid - lowering agent therapy;"C0020473;C0039798;C0042153;C0086440;C0087111;C0428465;C0450442;C0457083;C0585943;C1254351;C1363945;C1521826;C1947944;C4555212";NA;NA;hyperlipidaemia therapy use n no lipid lowering agent therapy
1774;concomitant lipid - lowering therapy ( any );"C0521115;C0585943";NA;NA;concomitant lipid lowering therapy any
1774;concomitant lipid - lowering therapy  n ( % );"C0521115;C0585943";NA;NA;concomitant lipid lowering therapy n
1774;background lipid - lowering therapy;"C0585943;C1706907";NA;NA;background lipid lowering therapy
1774;any other lipid ‐ lowering therapy  n ( % );C0585943;NA;NA;any other lipid lowering therapy n
1773;without lipid - lowering agents;C0086440;NA;NA;without lipid lowering agents
1773;with lipid - lowering agents;C0086440;NA;NA;with lipid lowering agents
1773;revascularisation but no antiplatelets  lipid - lowering agents  or p blockers;"C0086440;C0369773;C0581603;C2603361";NA;NA;revascularisation but no antiplatelets lipid lowering agents or p blockers
1773;revascularisation + antiplatelets + lipid - lowering agents + p blockers;"C0086440;C0581603";NA;NA;revascularisation antiplatelets lipid lowering agents p blockers
1773;non - smokers receiving lipid lowering drugs  ( $nmbr$ blockers  and either an ace inhibitor or angiotension receptor blocker;"C0003015;C0086440;C0337672;C0597357;C1514756;C3844638;C4541021;C4554605";NA;NA;non smokers receiving lipid lowering drugs $nmbr$ blockers and either an ace inhibitor or angiotension receptor blocker
1773;non - smokers receiving lipid - lowering drugs  p blockers  and either an ace inhibitor or angiotension receptor blocker;"C0003015;C0086440;C0337672;C0597357;C1514756;C3844638;C4541021;C4554605";NA;NA;non smokers receiving lipid lowering drugs p blockers and either an ace inhibitor or angiotension receptor blocker
1773;non - smokers receiving lipid - lowering drugs  p blockers;"C0086440;C0337672;C1514756;C4554605";NA;NA;non smokers receiving lipid lowering drugs p blockers
1773;lipid lowering drugs;C0086440;NA;NA;lipid lowering drugs
1773;lipid lowering agents;C0086440;NA;NA;lipid lowering agents
1773;lipid lowering agent n ( % );C0086440;NA;NA;lipid lowering agent n
1773;lipid disorder;C0154251;NA;NA;lipid disorder
1773;lipid - lowering drugs  n ( % );C0086440;NA;NA;lipid lowering drugs n
1773;lipid - lowering drugs;C0086440;NA;NA;lipid lowering drugs
1773;lipid - lowering drug * *;C0086440;NA;NA;lipid lowering drug
1773;lipid - lowering drug;C0086440;NA;NA;lipid lowering drug
1773;lipid - lowering agents ( % );C0086440;NA;NA;lipid lowering agents
1773;lipid - lowering agents;C0086440;NA;NA;lipid lowering agents
1773;lipid - lowering agent §;C0086440;NA;NA;lipid lowering agent
1773;lipid - lowering agent;C0086440;NA;NA;lipid lowering agent
1773;fibrate or other lipid - lowering agent;C0086440;NA;NA;fibrate or other lipid lowering agent
1773;any lipid - lowering agent use;"C0042153;C0086440;C0457083;C1947944";NA;NA;any lipid lowering agent use
1773;any lipid - lowering agent;C0086440;NA;NA;any lipid lowering agent
1772;select lipids and lipoproteins;"C0023779;C0023820;C1707391";NA;NA;select lipids and lipoproteins
1772;other lipid - modifying drug use at study entry  n ( % );"C0013175;C0013227;C0023779;C0042153;C0242510;C0392747;C0457083;C0557651;C0869040;C1254351;C1705654;C1947944;C2603343";NA;NA;other lipid modifying drug use at study entry n
1772;metabolic syndrome $nmbr$ baseline lipids  mg / dl;"C0023779;C0168634;C0439269;C0524620;C1442488";NA;NA;metabolic syndrome $nmbr$ baseline lipids mg dl
1772;mean lipid values  mg / dl;"C0023779;C0042295;C0439269;C0444504;C2347634;C2348143";NA;NA;mean lipid values mg dl
1772;lipids — mg / dl;"C0023779;C0439269";NA;NA;lipids mg dl
1772;lipids;C0023779;NA;NA;lipids
1772;lipid values  mmol / l;"C0023779;C0042295;C1532563";NA;NA;lipid values mmol l
1772;lipid values  mean ( sd );"C0023779;C0042295;C0444504;C2347634;C2348143;C2699239";NA;NA;lipid values mean sd
1772;lipid values;"C0023779;C0042295";NA;NA;lipid values
1772;lipid profile;"C0023779;C1979963;C2003903";NA;NA;lipid profile
1772;lipid modifiers;"C0023779;C4284280";NA;NA;lipid modifiers
1772;lipid concentrations total cholesterol ( mmol / l );"C0023779;C0086045;C0201950;C0543421;C1532563";NA;NA;lipid concentrations total cholesterol mmol l
1772;lipid concentrations;"C0023779;C0086045";NA;NA;lipid concentrations
1772;lipid - lowerinq druq;C0023779;NA;NA;lipid lowerinq druq
1772;lipid;C0023779;NA;NA;lipid
1772;drinking  n ( % ) lipid values  mmol / l;"C0001948;C0023779;C0042295;C0684271;C1532563";NA;NA;drinking n lipid values mmol l
1772;baseline lipids  mg / dl;"C0023779;C0168634;C0439269;C1442488";NA;NA;baseline lipids mg dl
1772;baseline lipid profile  mg / dl  mean ( sd );"C0023779;C0168634;C0439269;C0444504;C1442488;C1979963;C2003903;C2347634;C2348143;C2699239";NA;NA;baseline lipid profile mg dl mean sd
1771;losmapimod ( n = $nmbr$ );C3272847;NA;NA;losmapimod n $nmbr$
1771;losmapimod;C3272847;NA;NA;losmapimod
1771;blisibimod ( n = $nmbr$ );C3713826;NA;NA;blisibimod n $nmbr$
1770;dyslipidemia — no . { % );C0242339;NA;NA;dyslipidemia no
1770;dyslipidemia — no . ( % ) |;C0242339;NA;NA;dyslipidemia no
1770;dyslipidemia — no . ( % );C0242339;NA;NA;dyslipidemia no
1770;dyslipidemia $nmbr$;C0242339;NA;NA;dyslipidemia $nmbr$
1770;dyslipidemia  n ( % );C0242339;NA;NA;dyslipidemia n
1770;dyslipidemia;C0242339;NA;NA;dyslipidemia
1770;dyslipidaemiat;NA;NA;NA;dyslipidaemiat
1770;dyslipidaemiaj;NA;NA;NA;dyslipidaemiaj
1773;blockers;NA;FALSE; -10;blockers
1770;dyslipidaemia 本;C0242339;NA;NA;dyslipidaemia
1770;dyslipidaemia — no . ( % );C0242339;NA;NA;dyslipidaemia no
1770;dyslipidaemia including hypercholesterol — no . ( % );"C0242339;C0332257";NA;NA;dyslipidaemia including hypercholesterol no
1770;dyslipidaemia and hypertension  n ( % );"C0020538;C0242339;C1963138";NA;NA;dyslipidaemia and hypertension n
1770;dyslipidaemia  n ( % );C0242339;NA;NA;dyslipidaemia n
1770;dyslipidaemia;C0242339;NA;NA;dyslipidaemia
1770;baseline dyslipidemia;"C0168634;C0242339;C1442488";NA;NA;baseline dyslipidemia
1769;lp ( a ) §;"C0065058;C1439335;C4553379";NA;NA;lp a
1769;lp ( a ) ( μ mol / l );"C0065058;C0347982;C1439335;C4553379";NA;NA;lp a mol l
1769;lp ( a ) ( week $nmbr$ );"C0065058;C0332174;C0439230;C1439335;C4553379";NA;NA;lp a week $nmbr$
1769;lp ( a ) ( pmol / l );"C0065058;C0439284;C1439335;C4553379";NA;NA;lp a pmol l
1769;lipoprotein ( a ) ( nmol / l );"C0065058;C0125953;C0439282;C1096202;C1439335";NA;NA;lipoprotein a nmol l
1769;lipoprotein ( a ) ( mg / dl );"C0065058;C0125953;C0439269;C1096202;C1439335";NA;NA;lipoprotein a mg dl
1769;lipoprotein ( a )  median ( ql  q $nmbr$ )  nmol / l;"C0065058;C0125953;C0439282;C0549183;C0876920;C1096202;C1439335;C2347635;C2348144;C2939193";NA;NA;lipoprotein a median ql q $nmbr$ nmol l
1769;lipoprotein ( a )  median ( qi  q $nmbr$ )  nmol / l;"C0065058;C0125953;C0376586;C0439282;C0549183;C0876920;C1096202;C1439335;C2347635;C2348144;C2939193";NA;NA;lipoprotein a median qi q $nmbr$ nmol l
1769;change in lp ( a );"C0065058;C0392747;C0443172;C1439335;C1705241;C4319952;C4553379";NA;NA;change in lp a
1769;baseline lipoprotein ( a ) ( nmol / l )  median ( iqr );"C0065058;C0125953;C0168634;C0439282;C0549183;C0876920;C1096202;C1439335;C1442488;C2347635;C2348144;C2939193";NA;NA;baseline lipoprotein a nmol l median iqr
1768;range iga modified $nmbr$ score  n ( % );"C0392747;C0449820;C1514721;C2348147;C2825347;C3542016;C3889737;C4050231";NA;NA;range iga modified $nmbr$ score n
1768;iga mod $nmbr$ score  n ( % );"C0011860;C0449820;C2825347;C4050231";NA;NA;iga mod $nmbr$ score n
1768;iga $nmbr$ / $nmbr$;C2825347;NA;NA;iga $nmbr$ $nmbr$
1767;placebo → golimumab $nmbr$ mg / $nmbr$ mga  b;"C0024671;C0026410;C0032042;C0065879;C0439269;C1696465;C1706408;C1960952;C2346927;C2353893;C4321396;C4521761";NA;NA;placebo golimumab $nmbr$ mg $nmbr$ mga b
  28;* plus – minus values are means ± sd . percentages may not total $nmbr$ because of rounding . the body - mass index is the weight in kilograms divided by the square of the height in meters . to convert the values for creatinine to micromoles per liter  multiply by $nmbr$ . $nmbr$ . ace denotes angiotensin - converting enzyme  cabg coronary - artery bypass grafting  nt - probnp n - terminal pro - b – type natriuretic peptide  nyha new york heart association  and pci percutaneous coro - nary intervention . † race was reported by the investigators . ‡ one patient in nyha class i was mistakenly included in the placebo group . § this category includes any angina - like symptoms at any time in the past  with no confirmation of diagnosis of coro - nary heart disease required . ¶ possible scores range from $nmbr$ to $nmbr$  with lower scores indicating a better quality of life . ∥ anemia was defined by world health organization criteria as a hemoglobin level of less than $nmbr$ g per deciliter in men and less than $nmbr$ g per deciliter in women . * * nt - probnp levels are influenced by a variety of factors  including age  sex  body - mass index  and renal function . no clinically useful normal range has been established . † † some patients were taking both loop and thiazide diuretics .;"C0001779;C0002871;C0004083;C0005893;C0005910;C0009253;C0010055;C0010294;C0012802;C0018787;C0022709;C0025266;C0027976;C0030705;C0032042;C0034510;C0035173;C0036864;C0040223;C0040363;C0041260;C0042295;C0043100;C0043210;C0043237;C0079399;C0086715;C0184661;C0205088;C0205120;C0205447;C0232804;C0243161;C0332126;C0332149;C0332257;C0332272;C0332288;C0332306;C0332307;C0332490;C0332849;C0376558;C0439092;C0439165;C0439175;C0439194;C0439209;C0439241;C0439267;C0439810;C0439849;C0441074;C0441833;C0441889;C0441994;C0443211;C0445022;C0449820;C0475211;C0489786;C0521091;C0522523;C0578022;C0596306;C0596672;C0683312;C0687744;C0699792;C0804628;C0814287;C0858277;C0886296;C1000483;C1144709;C1257890;C1272684;C1273869;C1275491;C1281911;C1292769;C1305855;C1305866;C1314687;C1317554;C1444637;C1449832;C1452534;C1514721;C1514873;C1515187;C1518422;C1519504;C1522384;C1547052;C1548802;C1549488;C1552595;C1552866;C1561533;C1561535;C1696465;C1704788;C1704970;C1705104;C1705314;C1705315;C1705428;C1705429;C1705910;C1706408;C1706779;C1709908;C1719797;C1882084;C1883351;C1883525;C2003888;C2346866;C2348147;C2362652;C2699239;C2700399;C2709270;C2825907;C2911648;C3537020;C3539106;C3541383;C3542016;C3827682;C3853635;C3889152;C3889287;C4049621;C4050156;C4283901;C4284014;C4284038;C4284302;C4522046;C4554633";FALSE;1835;plus minus values are means sd percentages may not total $nmbr$ because of rounding the body mass index is the weight in kilograms divided by the square of the height in meters to convert the values for creatinine to micromoles per liter multiply by $nmbr$ $nmbr$ ace denotes angiotensin converting enzyme cabg coronary artery bypass grafting nt probnp n terminal pro b type natriuretic peptide nyha new york heart association and pci percutaneous coro nary intervention race was reported by the investigators one patient in nyha class i was mistakenly included in the placebo group this category includes any angina like symptoms at any time in the past with no confirmation of diagnosis of coro nary heart disease required possible scores range from $nmbr$ to $nmbr$ with lower scores indicating a better quality of life anemia was defined by world health organization criteria as a hemoglobin level of less than $nmbr$ g per deciliter in men and less than $nmbr$ g per deciliter in women nt probnp levels are influenced by a variety of factors including age sex body mass index and renal function no clinically useful normal range has been established some patients were taking both loop and thiazide diuretics
1767;$nmbr$ / $nmbr$ mga ( n = $nmbr$ );C0065879;NA;NA;$nmbr$ $nmbr$ mga n $nmbr$
1766;sua < $nmbr$ . $nmbr$;NA;NA;NA;sua $nmbr$ $nmbr$
1766;spga > $nmbr$;NA;NA;NA;spga $nmbr$
1766;ptga ⁎ ⁎ ⁎;NA;NA;NA;ptga
1766;ptga  $nmbr$ - $nmbr$;NA;NA;NA;ptga $nmbr$ $nmbr$
1766;mean ( sd ) ptga vas *;"C0042815;C0444504;C2347634;C2348143;C2699239;C3536884;C3827561";NA;NA;mean sd ptga vas
1766;baseline sua  mean ± sd mg / dl;"C0168634;C0439269;C0444504;C1442488;C2347634;C2348143;C2699239";NA;NA;baseline sua mean sd mg dl
1766;baseline spga  mean ( sd );"C0168634;C0444504;C1442488;C2347634;C2348143;C2699239";NA;NA;baseline spga mean sd
1764;symptomatic infarct swelling;"C0013604;C0021308;C0038999;C0231220";NA;NA;symptomatic infarct swelling
1764;swollen;C0038999;NA;NA;swollen
1764;question $nmbr$ ( pain / swelling in joints other than neck / back / hips );"C0003862;C0004600;C0013604;C0019552;C0027530;C0038999;C0205095;C0460009;C1522634;C1995000;C3159206";NA;NA;question $nmbr$ pain swelling in joints other than neck back hips
1764;number of swollen joints ( $nmbr$ assessed );"C0038999;C0449813;C1516048";NA;NA;number of swollen joints $nmbr$ assessed
1764;number of swollen joints ( $nmbr$ - $nmbr$ )  mean ( sd );"C0038999;C0444504;C0449813;C2347634;C2348143;C2699239";NA;NA;number of swollen joints $nmbr$ $nmbr$ mean sd
1764;number of swollen joints ( $nmbr$ - $nmbr$ );"C0038999;C0449813";NA;NA;number of swollen joints $nmbr$ $nmbr$
1763;other !;NA;NA;NA;other
1763;other;NA;NA;NA;other
1763;or;NA;NA;NA;or
1763;any other llts ( other than statin );"C0360714;C2347090";NA;NA;any other llts other than statin
1762;• iii : death from cv causes  nonfatal mi  hospitalization for ua  all revascularization > $nmbr$ days  nonfatal stroke;"C0011065;C0015127;C0019993;C0038454;C0041580;C0042014;C0439070;C0439228;C0581603;C1306577;C1314792;C1524003;C1705160;C3538987;C3810814;C4048877;C4082313;C4318503;C4552775;C4554100";NA;NA;iii death from cv causes nonfatal mi hospitalization for ua all revascularization $nmbr$ days nonfatal stroke
1762;• any stroke;"C0038454;C4554100";NA;NA;any stroke
1762;• $nmbr$ : death from any cause  major coronary event  or nonfatal stroke;"C0011065;C0015127;C0038454;C0205082;C0205164;C0741923;C1306577;C1524003;C4082313;C4318856;C4521762;C4552775;C4554100";NA;NA;$nmbr$ death from any cause major coronary event or nonfatal stroke
1762;toast classification of qualifying stroke ( % );"C0038454;C1514624;C1710306;C4521230;C4554100";NA;NA;toast classification of qualifying stroke
1762;toast classification of qualifying stroke  no . ( % );"C0038454;C1514624;C1710306;C4521230;C4554100";NA;NA;toast classification of qualifying stroke no
1762;toast classification of qualifying stroke;"C0038454;C1514624;C1710306;C4521230;C4554100";NA;NA;toast classification of qualifying stroke
1762;time from qualifying stroke to randomization;"C0034656;C0038454;C0040223;C1514624;C3541383;C4554100";NA;NA;time from qualifying stroke to randomization
1762;time from onset of qualifying stroke to randomization;"C0034656;C0038454;C0449244;C1514624;C4554100";NA;NA;time from onset of qualifying stroke to randomization
1762;stroke — no . / total no . ( % );"C0038454;C0439175;C0439810;C4554100";NA;NA;stroke no total no
1762;stroke — no . ( % );"C0038454;C4554100";NA;NA;stroke no
1762;stroke thought due to atherothrombotic disease;"C0012634;C0038454;C0039869;C0678226;C4319827;C4554100";NA;NA;stroke thought due to atherothrombotic disease
1762;stroke subtype  n ( % );"C0038454;C0449560;C4554100";NA;NA;stroke subtype n
1762;stroke subtype;"C0038454;C0449560;C4554100";NA;NA;stroke subtype
1762;stroke ortiab;"C0038454;C4554100";NA;NA;stroke ortiab
1762;stroke ortia;"C0038454;C4554100";NA;NA;stroke ortia
1762;stroke or transient ischemic attack;"C0007787;C0038454;C0917805;C4554100";NA;NA;stroke or transient ischemic attack
1762;stroke or tia — no . ( % );"C0007787;C0038454;C0917805;C1054154;C4554100";NA;NA;stroke or tia no
1762;stroke or tia;"C0007787;C0038454;C0917805;C1054154;C4554100";NA;NA;stroke or tia
1765;bloodpressure  mean ( sd )  m m hg;"C0025424;C0428257;C0428886;C1709500;C2347108;C2347109;C2348272;C2699239";FALSE; 615;bloodpressure mean sd m m hg
1765;sbp > $nmbr$ mnn hg;"C0025424;C0085805;C0428257;C2347108;C2347109;C2348272";FALSE; 615;sbp $nmbr$ mnn hg
1767;hscrp < $nmbr$ . $nmbr$ mga . $nmbr$ ( $nmbr$ . $nmbr$ x $nmbr$ ( $nmbr$ . $nmbr$ );C0065879;FALSE; 286;hscrp $nmbr$ $nmbr$ mga $nmbr$ $nmbr$ $nmbr$ x $nmbr$ $nmbr$ $nmbr$
1767;hscrp > $nmbr$ . $nmbr$ mga .;C0065879;FALSE; 286;hscrp $nmbr$ $nmbr$ mga
1762;stroke or systemic embolism;"C0013922;C0038454;C0205373;C1704212;C4554100";NA;NA;stroke or systemic embolism
1762;stroke or systemic;"C0038454;C0205373;C4554100";NA;NA;stroke or systemic
1762;stroke or se ( s / se );"C0036919;C0038454;C4554100";NA;NA;stroke or se s se
1762;stroke or;"C0038454;C4554100";NA;NA;stroke or
1762;stroke of any etiology;"C0015127;C0038454;C1314792;C1524003;C4554100";NA;NA;stroke of any etiology
1762;stroke n = $nmbr$;"C0038454;C4554100";NA;NA;stroke n $nmbr$
1762;stroke n ( % );"C0038454;C4554100";NA;NA;stroke n
1762;stroke at entry ( vs transient ischemic attack );"C0007787;C0038454;C0917805;C1705654;C4554100";NA;NA;stroke at entry vs transient ischemic attack
1762;stroke at entry;"C0038454;C1705654;C4554100";NA;NA;stroke at entry
1762;stroke any;"C0038454;C4554100";NA;NA;stroke any
1762;stroke and tia  n ( % );"C0007787;C0038454;C0917805;C1054154;C4554100";NA;NA;stroke and tia n
1762;stroke / transient ischemic attack;"C0007787;C0038454;C0917805;C4554100";NA;NA;stroke transient ischemic attack
1762;stroke / se;"C0036919;C0038454;C4554100";NA;NA;stroke se
1762;stroke / non -;"C0038454;C1518422;C4554100";NA;NA;stroke non
1762;stroke / m $nmbr$;"C0038454;C0369637;C0441923;C4554100";NA;NA;stroke m $nmbr$
1762;stroke / embolism;"C0013922;C0038454;C1704212;C4554100";NA;NA;stroke embolism
1762;stroke  total;"C0038454;C0439175;C0439810;C4554100";NA;NA;stroke total
1762;stroke  n ( % );"C0038454;C4554100";NA;NA;stroke n
1762;stroke;"C0038454;C4554100";NA;NA;stroke
1762;sensorimotor stroke;"C0038454;C4554100";NA;NA;sensorimotor stroke
1762;qualifying stroke;"C0038454;C1514624;C4554100";NA;NA;qualifying stroke
1762;pure sensory stroke;"C0038454;C0445254;C2247561;C4554100";NA;NA;pure sensory stroke
1762;prior stroke or transient ischemic attack;"C0007787;C0038454;C0332152;C0917805;C2826257;C4554100";NA;NA;prior stroke or transient ischemic attack
1762;previous stroke 一 no . ( % );"C0038454;C0205156;C1552607;C4554100";NA;NA;previous stroke no
   7;strata modelb hr  $nmbr$ % ci  p value;"C0008107;C1709380;C3259781";NA;NA;strata modelb hr $nmbr$ ci p value
1762;previous stroke — no . ( % ) concomitant treatment — no . ( % );"C0038454;C0039798;C0087111;C0205156;C0521115;C1522326;C1533734;C1552607;C1705169;C3538994;C3887704;C4554100";NA;NA;previous stroke no concomitant treatment no
1762;previous stroke — no . ( % );"C0038454;C0205156;C1552607;C4554100";NA;NA;previous stroke no
1762;previous stroke ortransient ischaemic attack ( % );"C0038454;C0205156;C0745413;C1552607;C4554100";NA;NA;previous stroke ortransient ischaemic attack
1762;previous stroke ortia $nmbr$ - $nmbr$;"C0038454;C0205156;C1552607;C4554100";NA;NA;previous stroke ortia $nmbr$ $nmbr$
1762;previous stroke ortia;"C0038454;C0205156;C1552607;C4554100";NA;NA;previous stroke ortia
1762;previous stroke or transient ischemic attack — no . / total;"C0007787;C0038454;C0205156;C0439175;C0439810;C0917805;C1552607;C4554100";NA;NA;previous stroke or transient ischemic attack no total
1762;previous stroke or transient ischemic attack  no . / total no . ( % );"C0007787;C0038454;C0205156;C0439175;C0439810;C0917805;C1552607;C4554100";NA;NA;previous stroke or transient ischemic attack no total no
1762;previous stroke or tl a $nmbr$ - $nmbr$;"C0038454;C0205156;C0220928;C1552607;C4554100";NA;NA;previous stroke or tl a $nmbr$ $nmbr$
1762;previous stroke or tl a;"C0038454;C0205156;C0220928;C1552607;C4554100";NA;NA;previous stroke or tl a
1762;previous stroke or tia  n ( % );"C0007787;C0038454;C0205156;C0917805;C1054154;C1552607;C4554100";NA;NA;previous stroke or tia n
1762;previous stroke / tia;"C0007787;C0038454;C0205156;C0917805;C1054154;C1552607;C4554100";NA;NA;previous stroke tia
1762;previous stroke *;"C0038454;C0205156;C1552607;C4554100";NA;NA;previous stroke
1762;previous stroke  n ( % );"C0038454;C0205156;C1552607;C4554100";NA;NA;previous stroke n
1762;previous stroke;"C0038454;C0205156;C1552607;C4554100";NA;NA;previous stroke
1762;previous clinical stroke or transient ischemic attack ( % );"C0007787;C0038454;C0205156;C0205210;C0917805;C1552607;C4554100";NA;NA;previous clinical stroke or transient ischemic attack
1762;previous clinical stroke or tia;"C0007787;C0038454;C0205156;C0205210;C0917805;C1054154;C1552607;C4554100";NA;NA;previous clinical stroke or tia
1762;no stroke n = $nmbr$ $nmbr$;"C0038454;C4554100";NA;NA;no stroke n $nmbr$ $nmbr$
1380;exercise  n ( % );"C0015259;C1522704";NA;NA;exercise n
1762;no stroke / tia;"C0007787;C0038454;C0917805;C1054154;C4554100";NA;NA;no stroke tia
1762;no stroke ( n = $nmbr$ );"C0038454;C4554100";NA;NA;no stroke n $nmbr$
1762;no previous stroke ortia;"C0038454;C0205156;C1552607;C4554100";NA;NA;no previous stroke ortia
1762;no previous stroke / tia;"C0007787;C0038454;C0205156;C0917805;C1054154;C1552607;C4554100";NA;NA;no previous stroke tia
1762;no . of strokes / no . of patients in category ( and % );"C0030705;C0038454;C0683312;C3889287";NA;NA;no of strokes no of patients in category and
1762;no . of strokes ( % );C0038454;NA;NA;no of strokes
1762;no . ( % ) of patients with stroke;"C0030705;C0038454;C4554100";NA;NA;no of patients with stroke
1762;new stroke *;"C0038454;C0205314;C4554100";NA;NA;new stroke
1762;months from qualifying stroke *   ( % );"C0038454;C0439231;C1514624;C4554100";NA;NA;months from qualifying stroke
1762;hx mi or stroke;"C0038454;C0262926;C3810814;C3814444;C4554100";NA;NA;hx mi or stroke
1762;history of stroke or tia — no . ( % );"C0007787;C0019664;C0019665;C0038454;C0262512;C0262926;C0917805;C1054154;C1705255;C2004062;C4554100";NA;NA;history of stroke or tia no
1762;hemispheric stroke n = $nmbr$;"C0038454;C0205139;C4554100";NA;NA;hemispheric stroke n $nmbr$
1762;disabling stroke;"C0038454;C4554100";NA;NA;disabling stroke
1762;death or disabling stroke;"C0011065;C0038454;C1306577;C4082313;C4552775;C4554100";NA;NA;death or disabling stroke
1762;cvd without mi or stroke ( n = $nmbr$ );"C0007222;C0038454;C3810814;C4554100";NA;NA;cvd without mi or stroke n $nmbr$
1762;cvd / mi / stroke / urgent vascular hospitalization;"C0005847;C0007222;C0019993;C0038454;C0439609;C1558950;C1801960;C3272275;C3810814;C4554100";NA;NA;cvd mi stroke urgent vascular hospitalization
1762;cvd / mi / stroke;"C0007222;C0038454;C3810814;C4554100";NA;NA;cvd mi stroke
1762;cerebrovascular accident / tia;"C0007787;C0038454;C0917805;C1054154";NA;NA;cerebrovascular accident tia
1762;cerebrovascular accident;C0038454;NA;NA;cerebrovascular accident
1762;atherothrombotic stroke  n ( % );"C0038454;C4554100";NA;NA;atherothrombotic stroke n
1762;any stroke ( n = $nmbr$ );"C0038454;C4554100";NA;NA;any stroke n $nmbr$
1762;any stroke;"C0038454;C4554100";NA;NA;any stroke
1762;all strokes *;"C0038454;C4554100";NA;NA;all strokes
1762;all strokes  n ( % );"C0038454;C0369718;C0441922;C4554100";NA;NA;all strokes n
1762;all strokes;"C0038454;C4554100";NA;NA;all strokes
1762;all stroke;"C0038454;C4554100";NA;NA;all stroke
1762;a stroke;"C0038454;C4554100";NA;NA;a stroke
1762;$nmbr$ days stroke ( ischemic );"C0038454;C0439228;C0475224;C4554100";NA;NA;$nmbr$ days stroke ischemic
1761;rotigotine n = $nmbr$;"C1700683;C4318637";NA;NA;rotigotine n $nmbr$
1761;rotigotine ( n = $nmbr$ );"C1700683;C4318637";NA;NA;rotigotine n $nmbr$
1761;rosiglitazone versus metformin;"C0025598;C0289313";NA;NA;rosiglitazone versus metformin
1761;rosiglitazone versus glyburide;"C0017628;C0289313";NA;NA;rosiglitazone versus glyburide
1761;rosiglitazone ( n = $nmbr$ );C0289313;NA;NA;rosiglitazone n $nmbr$
1761;rosiglitazone;C0289313;NA;NA;rosiglitazone
1761;p value for heterogeneity （ rosiglitazone versus glyburide ）;"C0017628;C0019409;C0242960;C0289313;C1709380";NA;NA;p value for heterogeneity rosiglitazone versus glyburide
1760;pioglitazone pts / n ( % );"C0071097;C1419129;C2698747";NA;NA;pioglitazone pts n
1760;pioglitazone events / n ( % );"C0071097;C0441471;C3541888";NA;NA;pioglitazone events n
1760;pioglitazone dose  mean ( sd )  mg;"C0024671;C0026410;C0071097;C0178602;C0439269;C0444504;C0869039;C1114758;C1960952;C2346927;C2347634;C2348143;C2699239;C4321396;C4521761";NA;NA;pioglitazone dose mean sd mg
1760;pioglitazone ( n = $nmbr$ );C0071097;NA;NA;pioglitazone n $nmbr$
1760;pioglitazone ( n = $nmbr$  $nmbr$ );C0071097;NA;NA;pioglitazone n $nmbr$ $nmbr$
1760;pioglitazone;C0071097;NA;NA;pioglitazone
1759;eplerenone ( n   = $nmbr$ );C0961485;NA;NA;eplerenone n $nmbr$
1759;canrenone ( n z $nmbr$ );C0006882;NA;NA;canrenone n z $nmbr$
1758;ras - aldosterone inhibitor ^;"C0002006;C0002007;C0034678;C0525678;C1514727";NA;NA;ras aldosterone inhibitor
1758;aldosterone inhibitor;C0002007;NA;NA;aldosterone inhibitor
1758;aldosterone antagonists ( e . g . spironolactone );"C0002007;C0037982;C2757004";NA;NA;aldosterone antagonists e g spironolactone
1758;aldosterone antagonists;"C0002007;C2757004";NA;NA;aldosterone antagonists
1758;aldosterone antagonist;"C0002007;C2757004;C3536833";NA;NA;aldosterone antagonist
1757;peri - op amiodarone : no ( n = $nmbr$ );"C0002598;C0347985;C0369718;C0441922";NA;NA;peri op amiodarone no n $nmbr$
1757;no amiodarone;C0002598;NA;NA;no amiodarone
1757;amiodarone vs . placebo no . hazard ratio ( $nmbr$ . $nmbr$ % cl );"C0002598;C0032042;C0596019;C1696465;C1706408;C2985465";NA;NA;amiodarone vs placebo no hazard ratio $nmbr$ $nmbr$ cl
1757;amiodarone vs . placebo;"C0002598;C0032042;C1696465;C1706408";NA;NA;amiodarone vs placebo
1757;amiodarone use at baseline;"C0002598;C0042153;C0168634;C0457083;C1442488;C1947944";NA;NA;amiodarone use at baseline
1757;amiodarone ote at baseline;"C0002598;C0168634;C1442488";NA;NA;amiodarone ote at baseline
1757;amiodarone ( n = $nmbr$ );C0002598;NA;NA;amiodarone n $nmbr$
1757;amiodarone ( n  % );C0002598;NA;NA;amiodarone n
1757;amiodarone  n ( % );C0002598;NA;NA;amiodarone n
1757;amiodarone;C0002598;NA;NA;amiodarone
   7;rr ( $nmbr$ aci ) [ p value ];"C0814206;C1510682;C1709380;C2346870;C4050575;C4554402";NA;NA;rr $nmbr$ aci p value
   7;p — value for interaction;"C1704675;C1709380";NA;NA;p value for interaction
   7;p ‐ value *;C1709380;NA;NA;p value
1756;fibrinolytic agent — no . ( % ) : t;"C0016018;C2603360";NA;NA;fibrinolytic agent no t
1755;ra;"C3538806;C4048756";NA;NA;ra
1755;patients without ra  as  or psa ( n = $nmbr$  $nmbr$ );"C0030705;C3538806;C3810537;C3813209;C4048756";NA;NA;patients without ra as or psa n $nmbr$ $nmbr$
1755;patients with ra  as  or psa ( n = $nmbr$ );"C0030705;C3538806;C3810537;C3813209;C4048756";NA;NA;patients with ra as or psa n $nmbr$
1755;no . of patients with ra;"C0030705;C3538806;C4048756";NA;NA;no of patients with ra
1755;months since ra was first diagnosed  mean ( sd );"C0011900;C0205435;C0439231;C0444504;C1279901;C2347634;C2348143;C2699239;C3538806;C4048756";NA;NA;months since ra was first diagnosed mean sd
1754;epa / aa ratio;"C0282379;C0456603;C1235746;C1547037;C1882141;C4554792";NA;NA;epa aa ratio
1754;aa / g;"C0282379;C0439267;C1235746;C1882141;C4554792";NA;NA;aa g
1754;aa  mol %;"C0027960;C0282379;C0324740;C0439189;C1235746;C1456781;C1824986;C1882141;C3665593;C4554792";NA;NA;aa mol
1754;aa;"C0282379;C1235746;C1882141;C4554792";NA;NA;aa
1753;numab;NA;NA;NA;numab
1753;dmab ( n = $nmbr$ );C0012411;NA;NA;dmab n $nmbr$
1753;azl - ma;"C0024443;C3887485";NA;NA;azl ma
1752;symptomatic pad of lower extremities *;"C0023216;C0182158;C0231220;C0332568;C3540603;C3669270;C3814046;C4319657";NA;NA;symptomatic pad of lower extremities
1752;risk factors for pad;"C0035648;C0182158;C0332568;C1553898;C3540603;C3669270;C3814046;C4319657";NA;NA;risk factors for pad
1752;pad symptoms ( % );"C0182158;C0332568;C0683368;C1457887;C3540603;C3669270;C3814046;C4319657";NA;NA;pad symptoms
1752;pad lower extremities;"C0023216;C0182158;C0332568;C3540603;C3669270;C3814046;C4319657";NA;NA;pad lower extremities
1752;pad details  n ( % );"C0182158;C0332568;C0369718;C0441922;C1522508;C1561567;C3540603;C3669270;C3814046;C4319657";NA;NA;pad details n
1752;pad at baseline;"C0168634;C0182158;C0332568;C1442488;C3540603;C3669270;C3814046;C4319657";NA;NA;pad at baseline
1752;pad ( n - $nmbr$  $nmbr$ );"C0182158;C0332568;C3540603;C3669270;C3814046;C4319657";NA;NA;pad n $nmbr$ $nmbr$
1752;pad;"C0182158;C0332568;C3540603;C3669270;C3814046;C4319657";NA;NA;pad
1752;no pad baseline;"C0168634;C0182158;C0332568;C1442488;C3540603;C3669270;C3814046;C4319657";NA;NA;no pad baseline
1752;no pad ( n - $nmbr$  $nmbr$ );"C0182158;C0332568;C3540603;C3669270;C3814046;C4319657";NA;NA;no pad n $nmbr$ $nmbr$
1751;vas ( $nmbr$ - $nmbr$ );"C0042815;C3536884;C3827561";NA;NA;vas $nmbr$ $nmbr$
1751;ptga ( $nmbr$ - $nmbr$ cm vas );"C0042815;C3536884;C3827561";NA;NA;ptga $nmbr$ $nmbr$ cm vas
1751;physician global assessment of disease activity ( vas $nmbr$ - $nmbr$ mm );"C0042815;C3536884;C3827561;C4050369;C4330985;C4554674";NA;NA;physician global assessment of disease activity vas $nmbr$ $nmbr$ mm
1751;physician global assessment of disease activity ( $nmbr$ - $nmbr$ cm  vas );"C0042815;C3536884;C3827561;C4050369";NA;NA;physician global assessment of disease activity $nmbr$ $nmbr$ cm vas
1751;physician global assessment ( $nmbr$ - $nmbr$ mm vas );"C0042815;C3536884;C3827561;C4050369;C4330985;C4554674";NA;NA;physician global assessment $nmbr$ $nmbr$ mm vas
1751;physician ' s global assessment of disease activity ( $nmbr$ - $nmbr$ mm vas )  mean ( sd );"C0042815;C0444504;C2347634;C2348143;C2699239;C3536884;C3827561;C4050369;C4330985;C4554674";NA;NA;physician s global assessment of disease activity $nmbr$ $nmbr$ mm vas mean sd
1751;physician ' s global assessment ( vas );"C0042815;C3536884;C3827561;C4050369";NA;NA;physician s global assessment vas
1751;physician ' s assessment of disease activity ( vas )  mm;"C0031831;C0042815;C0456681;C0804815;C1261322;C1292728;C1516048;C3536884;C3827561";NA;NA;physician s assessment of disease activity vas mm
1743;overall;"C0282416;C1561607";NA;NA;overall
1743;overaii ( n = $nmbr$ );NA;NA;NA;overaii n $nmbr$
1757;dronedarone;C0766326;FALSE;1923;dronedarone
1757;dronedarone ( n = $nmbr$ );C0766326;FALSE;1923;dronedarone n $nmbr$
1757;dronedarone ( n = $nmbr$ ) $nmbr$ . $nmbr$ ± $nmbr$ . $nmbr$;C0766326;FALSE;1923;dronedarone n $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
1756;$nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ % t;C2603360;FALSE; -10;$nmbr$ $nmbr$ $nmbr$ $nmbr$ t
1756;$nmbr$ . ' ^ / $nmbr$ t $nmbr$ c } u;"C0439148;C2603360";FALSE; -10;$nmbr$ $nmbr$ t $nmbr$ c u
1756;t;C2603360;FALSE; -10;t
1756;t - jj ( $nmbr$ - $nmbr$ );C2603360;FALSE; -10;t jj $nmbr$ $nmbr$
1756;t $nmbr$ d;C2603360;FALSE; -10;t $nmbr$ d
1753;body mass index ( kg / ma );"C0005893;C0022718;C0024443;C0439209;C0578022;C1305855;C3887485;C4054209";FALSE;1734;body mass index kg ma
1753;< $nmbr$ kg / ma $nmbr$;"C0022718;C0024443;C0439209;C3887485;C4054209";FALSE;1734;$nmbr$ kg ma $nmbr$
1753;> = $nmbr$ kg / ma $nmbr$;"C0022718;C0024443;C0439209;C3887485;C4054209";FALSE;1734;$nmbr$ kg ma $nmbr$
1755;all - baricitinib ra ( n = $nmbr$ ) *;"C3538806;C4044947;C4048756";FALSE;1956;all baricitinib ra n $nmbr$
1751;patient global assessment of disease activity ( vas $nmbr$ - $nmbr$ mm );"C0042815;C3536884;C3827561;C4054228;C4330985;C4554674";NA;NA;patient global assessment of disease activity vas $nmbr$ $nmbr$ mm
1751;patient global assessment of disease activity ( $nmbr$ - $nmbr$ cm  vas );"C0042815;C3536884;C3827561;C4054228";NA;NA;patient global assessment of disease activity $nmbr$ $nmbr$ cm vas
1751;patient global assessment ( $nmbr$ - $nmbr$ mm vas );"C0042815;C3536884;C3827561;C4054229;C4330985;C4554674";NA;NA;patient global assessment $nmbr$ $nmbr$ mm vas
1751;patient ' s global assessment ( vas );"C0042815;C3536884;C3827561;C4054229";NA;NA;patient s global assessment vas
1751;pain ( vas );C0042815;NA;NA;pain vas
1751;mean ( sd ) pain vas *;"C0042815;C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd pain vas
1751;general health vas  $nmbr$ - $nmbr$ mm;"C0042815;C0424575;C3536884;C3827561;C4018875;C4330985;C4554674";NA;NA;general health vas $nmbr$ $nmbr$ mm
1751;baseline skin pain vas  mean ( sd );"C0042815;C0168634;C0241136;C0444099;C0444504;C1123023;C1442488;C1963195;C2347634;C2348143;C2699239;C3536884;C3827561;C4520765";NA;NA;baseline skin pain vas mean sd
1751;activity ( $nmbr$ - $nmbr$ vas );"C0042815;C0205177;C0439167;C0441655;C1561536;C3536884;C3668946;C3827561;C4049938;C4049939";NA;NA;activity $nmbr$ $nmbr$ vas
1751;( $nmbr$ - $nmbr$ - cm vas );"C0042815;C3536884;C3827561";NA;NA;$nmbr$ $nmbr$ cm vas
1750;physician ' s ga  $nmbr$ - $nmbr$ mmvas;"C0016993;C0031831;C0804815";NA;NA;physician s ga $nmbr$ $nmbr$ mmvas
1750;patient ' s ga  $nmbr$ - $nmbr$ mm vas;"C0016993;C0030705;C0042815;C3536884;C3827561;C4330985;C4554674";NA;NA;patient s ga $nmbr$ $nmbr$ mm vas
1750;ga / a;C0016993;NA;NA;ga a
1750;ga;C0016993;NA;NA;ga
1750;a / ga;C0016993;NA;NA;a ga
1749;less than $nmbr$ mm hg;"C0439092;C0439475";NA;NA;less than $nmbr$ mm hg
1749;less than $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439092;C0439445;C0441923";NA;NA;less than $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
1749;less than $nmbr$ kg / m $nmbr$;"C0439092;C1532718";NA;NA;less than $nmbr$ kg m $nmbr$
1749;less than $nmbr$ . $nmbr$ %;C0439092;NA;NA;less than $nmbr$ $nmbr$
1749;less than $nmbr$ %;C0439092;NA;NA;less than $nmbr$
1749;less than $nmbr$;C0439092;NA;NA;less than $nmbr$
1748;total stent length - mm;"C0038257;C0439175;C0439810;C1444754;C1706316;C4330985;C4554674";NA;NA;total stent length mm
1748;total stent length ( mm )  mean ± sd;"C0038257;C0439175;C0439810;C0444504;C1444754;C1706316;C2347634;C2348143;C2699239;C4330985;C4554674";NA;NA;total stent length mm mean sd
1748;total stent length  mm;"C0038257;C0439175;C0439810;C1444754;C1706316;C4330985;C4554674";NA;NA;total stent length mm
1748;total stent length;"C0038257;C0439175;C0439810;C1444754;C1706316";NA;NA;total stent length
1747;oral anticoagulants;C0354604;NA;NA;oral anticoagulants
1747;oral anticoagulant — no . / total no . ( % );"C0354604;C0439175;C0439810";NA;NA;oral anticoagulant no total no
1747;oral anticoagulant n ( % );C0354604;NA;NA;oral anticoagulant n
1747;oral anticoagulant drugs  n ( % );C0354604;NA;NA;oral anticoagulant drugs n
1747;oral anticoagulant drugs;C0354604;NA;NA;oral anticoagulant drugs
1747;oral anticoagulant agent;C0354604;NA;NA;oral anticoagulant agent
1747;oral anticoagulant  n ( % );C0354604;NA;NA;oral anticoagulant n
1747;oral anticoagulant;C0354604;NA;NA;oral anticoagulant
1746;oral β - adrenergics  n ( % );"C0001637;C0442027;C4521986";NA;NA;oral adrenergics n
1746;oral treprostinil ( n = $nmbr$ );"C0442027;C1145760;C4521986";NA;NA;oral treprostinil n $nmbr$
1746;oral blood glucose - lowering drug $nmbr$ ( $nmbr$ . $nmbr$ );"C0005802;C0013227;C0017725;C0018938;C0441994;C0442027;C1254351;C2003888;C4521986";NA;NA;oral blood glucose lowering drug $nmbr$ $nmbr$ $nmbr$
1746;oral blood glucose - lowering;"C0005802;C0441994;C0442027;C2003888;C4521986";NA;NA;oral blood glucose lowering
1746;oral antidiabetic drugs / insulin ( % / % );"C0021641;C0029167;C0175795;C0304289;C0442027;C0935929;C1533581;C1579433;C3714501;C4521986";NA;NA;oral antidiabetic drugs insulin
1746;oral antidiabetic drugs;"C0029167;C0175795;C0304289;C0442027;C0935929;C4521986";NA;NA;oral antidiabetic drugs
1746;oral antidiabetes monotherapya  n ( % );"C0442027;C4521986";NA;NA;oral antidiabetes monotherapya n
1746;oral ( % );"C0442027;C4521986";NA;NA;oral
1746;oral;"C0442027;C4521986";NA;NA;oral
1746;concomitant oral glucose - lowering agents  zz ( % );"C0017725;C0441994;C0442027;C2003888;C2347310;C2347852;C4521986";NA;NA;concomitant oral glucose lowering agents zz
1746;baseline prednisone or oral prednisone equivalent daily dose;"C0032952;C0168634;C0205163;C0439185;C0442027;C1442488;C2348070;C4521986";NA;NA;baseline prednisone or oral prednisone equivalent daily dose
1745;patent foramen ovale;"C0016522;C0344724";NA;NA;patent foramen ovale
1745;ovary;"C0029939;C0227898";NA;NA;ovary
1744;other oral hypoglycemic drug ( s );C0359086;NA;NA;other oral hypoglycemic drug s
1744;oral hypoglycemics hormone replacement;"C0282402;C0359086";NA;NA;oral hypoglycemics hormone replacement
1744;oral hypoglycemics;C0359086;NA;NA;oral hypoglycemics
1744;oral hypoglycemic drug;C0359086;NA;NA;oral hypoglycemic drug
1744;oral hypoglycemic agentsj;C0359086;NA;NA;oral hypoglycemic agentsj
1744;oral hypoglycemic agents;C0359086;NA;NA;oral hypoglycemic agents
1744;oral hypoglycemic agent;C0359086;NA;NA;oral hypoglycemic agent
1744;oral hypoglycemic;C0359086;NA;NA;oral hypoglycemic
1744;oral antihyperglycaemic  n ( % );C0359086;NA;NA;oral antihyperglycaemic n
1743;teaes reported by ≥ $nmbr$ % patients in the overall brv group    n   ( % );"C0030705;C0155502;C0282416;C0441848;C1561607;C1709908";NA;NA;teaes reported by $nmbr$ patients in the overall brv group n
1743;qveral;NA;NA;NA;qveral
1743;overally;NA;NA;NA;overally
1743;overall ® $nmbr$ . $nmbr$;"C0282416;C1561607";NA;NA;overall $nmbr$ $nmbr$
1743;overall vero population;"C0032659;C0282416;C1257890;C1561607";NA;NA;overall vero population
1743;overall treatment effect;"C0282416;C1518681;C1561607";NA;NA;overall treatment effect
1743;overall population ( n = $nmbr$ );"C0032659;C0282416;C1257890;C1561607";NA;NA;overall population n $nmbr$
1743;overall population ( n - $nmbr$ );"C0032659;C0282416;C1257890;C1561607";NA;NA;overall population n $nmbr$
1743;overall population;"C0032659;C0282416;C1257890;C1561607";NA;NA;overall population
1743;overall pad;"C0182158;C0282416;C0332568;C1561607;C3540603;C3669270;C3814046;C4319657";NA;NA;overall pad
1743;overall n = $nmbr$  $nmbr$;"C0282416;C1561607";NA;NA;overall n $nmbr$ $nmbr$
1743;overall effect;"C0282416;C1280500;C1518681;C1561607;C2348382";NA;NA;overall effect
1743;overall ctd;"C0282416;C1335071;C1442905;C1561607";NA;NA;overall ctd
1743;overall a phase population;"C0032659;C0205390;C0282416;C1257890;C1561607;C1710475";NA;NA;overall a phase population
1743;overall ( w = $nmbr$ )  $nmbr$ / $nmbr$;"C0282416;C1561607";NA;NA;overall w $nmbr$ $nmbr$ $nmbr$
1743;overall ( pp ) ( n = $nmbr$ );"C0030375;C0063017;C0282416;C1561607;C4319755";NA;NA;overall pp n $nmbr$
1743;overall ( per protocol ) ( n = $nmbr$ );"C0282416;C1561607;C1698058";NA;NA;overall per protocol n $nmbr$
1743;overall ( n = u $nmbr$ );"C0282416;C0439148;C1561607";NA;NA;overall n u $nmbr$
1743;overall ( n = $nmbr$ vs $nmbr$ );"C0282416;C1561607";NA;NA;overall n $nmbr$ vs $nmbr$
1743;overall ( n = $nmbr$ );"C0282416;C1561607";NA;NA;overall n $nmbr$
1743;overall ( n = $nmbr$  $nmbr$ );"C0282416;C1561607";NA;NA;overall n $nmbr$ $nmbr$
1743;overall ( itt ) ( n = $nmbr$ );"C0282416;C1561607";NA;NA;overall itt n $nmbr$
1743;overall ( $nmbr$  $nmbr$ );"C0282416;C1561607";NA;NA;overall $nmbr$ $nmbr$
1743;overall $nmbr$;"C0282416;C1561607";NA;NA;overall $nmbr$
1743;overall  qvai $nmbr$ - sfc;"C0282416;C1561607;C4521536";NA;NA;overall qvai $nmbr$ sfc
1743;overall  n = $nmbr$;"C0282416;C1561607";NA;NA;overall n $nmbr$
1748;laa length;"C1444754;C1706316";FALSE;1922;laa length
1749;ta;"C0039297;C1506978;C1705538;C3272501;C4553364";FALSE; -10;ta
1743;overaii;NA;NA;NA;overaii
1743;omeprazole;C0028978;NA;NA;omeprazole
1743;metrex overall modified intention - to - treat population ? :;"C0032659;C0087111;C0162425;C0282416;C0392747;C1257890;C1283828;C1292734;C1522326;C1561607;C3889737";NA;NA;metrex overall modified intention to treat population
1743;calima overall ( n = $nmbr$ );"C0282416;C1561607";NA;NA;calima overall n $nmbr$
1743;brv overalla ( n = $nmbr$ );C0155502;NA;NA;brv overalla n $nmbr$
1743;brv overall ( n = $nmbr$ );"C0155502;C0282416;C1561607";NA;NA;brv overall n $nmbr$
1743;brv overall;"C0155502;C0282416;C1561607";NA;NA;brv overall
1742;infarct on brain imaging 丰;"C0011923;C0079595;C0751955";NA;NA;infarct on brain imaging
1742;infarct on brain imaging ^;"C0011923;C0079595;C0751955";NA;NA;infarct on brain imaging
1742;brazil;C0006137;NA;NA;brazil
1741;non - frail;"C0871754;C1518422";NA;NA;non frail
1741;frail;C0871754;NA;NA;frail
1741;fragile;C0302113;NA;NA;fragile
1740;stratified log - rank   p   value;"C0205363;C0667477;C0699794;C1708728;C1709380;C2986775";NA;NA;stratified log rank p value
1740;stratified log - rank p value;"C0205363;C0667477;C0699794;C1708728;C1709380;C2986775";NA;NA;stratified log rank p value
1740;log rank p - value;"C0667477;C0699794;C1708728;C1709380;C2986775";NA;NA;log rank p value
1740;log - rank p value;"C0667477;C0699794;C1708728;C1709380;C2986775";NA;NA;log rank p value
1740;log - rank;"C0667477;C0699794;C1708728;C2986775";NA;NA;log rank
   7;p ‐ value;C1709380;NA;NA;p value
1740;cmann whitney u test / wilcoxon sum rank test .;"C0439148;C0667477;C0683443;C0699794;C1515051";NA;NA;cmann whitney u test wilcoxon sum rank test
1740;amann whitney u test / wilcoxon sum rank test .;"C0439148;C0667477;C0683443;C0699794;C1515051";NA;NA;amann whitney u test wilcoxon sum rank test
1739;strain ( % );"C0080194;C0456178;C1518614;C2987481";NA;NA;strain
1739;brain volume  cm ';C1113695;NA;NA;brain volume cm
1739;brain volume  cm $nmbr$;C1113695;NA;NA;brain volume cm $nmbr$
1738;regular ppi use;"C0042153;C0205272;C0358591;C0457083;C0871125;C1947944;C3811894";NA;NA;regular ppi use
1738;ppi use ( p = $nmbr$ . $nmbr$ t );"C0042153;C0358591;C0369773;C0457083;C0871125;C1947944;C2603361;C3811894";NA;NA;ppi use p $nmbr$ $nmbr$ t
1738;ppi use ( p = $nmbr$ - $nmbr$ t );"C0042153;C0358591;C0369773;C0457083;C0871125;C1947944;C2603361;C3811894";NA;NA;ppi use p $nmbr$ $nmbr$ t
1738;ppi use;"C0042153;C0358591;C0457083;C0871125;C1947944;C3811894";NA;NA;ppi use
1738;ppi;"C0358591;C0871125;C3811894";NA;NA;ppi
1738;pi;"C0122626;C0429863;C3537219;C3539772";NA;NA;pi
1738;phi ( n = $nmbr$ );"C1333690;C1704947;C1706536;C2975867;C4084801";NA;NA;phi n $nmbr$
1738;phi ( n - $nmbr$ );"C1333690;C1704947;C1706536;C2975867;C4084801";NA;NA;phi n $nmbr$
1738;pgi - s  n ( % ) y :;"C0523816;C1333690;C1412792;C1704947;C2975867;C3810522;C4522133";NA;NA;pgi s n y
1738;noppi;NA;NA;NA;noppi
1738;nontrial ppi;"C0358591;C0871125;C3811894";NA;NA;nontrial ppi
1738;non - study ppi use;"C0042153;C0358591;C0457083;C0557651;C0871125;C1518422;C1947944;C2603343;C3811894";NA;NA;non study ppi use
1738;no regular ppi use;"C0042153;C0205272;C0358591;C0457083;C0871125;C1947944;C3811894";NA;NA;no regular ppi use
1738;combinations of aspirin and ppi use ( p = $nmbr$ . $nmbr$ t );"C0004057;C0042153;C0358591;C0453882;C0457083;C0871125;C1947944;C3539181;C3539182;C3539954;C3539955;C3539956;C3539957;C3539959;C3539960;C3539961;C3539962;C3539963;C3539964;C3539965;C3539966;C3539967;C3539968;C3539969;C3539970;C3539971;C3539972;C3539973;C3539974;C3539975;C3539976;C3539977;C3539978;C3539979;C3540026;C3540027;C3540028;C3540030;C3540031;C3540719;C3540720;C3540721;C3540722;C3540723;C3540724;C3540740;C3811894;C3854036";NA;NA;combinations of aspirin and ppi use p $nmbr$ $nmbr$ t
1737;pb;"C1415801;C3819255";NA;NA;pb
1737;median feno ( ppb ) f;"C0016327;C0549183;C0876920;C1415800;C2347635;C2348144;C2939193";NA;NA;median feno ppb f
1737;mean ( sd ) feno  ppb;"C0444504;C1415800;C2347634;C2348143;C2699239";NA;NA;mean sd feno ppb
1737;high feno subgroup ( > $nmbr$ . $nmbr$ ppb ) ( n = $nmbr$ );"C0205250;C1079230;C1299351;C1415800;C1515021;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;high feno subgroup $nmbr$ $nmbr$ ppb n $nmbr$
1737;feno — ppb;C1415800;NA;NA;feno ppb
1737;> $nmbr$ to < $nmbr$ ppb;C1415800;NA;NA;$nmbr$ to $nmbr$ ppb
1737;> $nmbr$ ppb;C1415800;NA;NA;$nmbr$ ppb
1737;< $nmbr$ ppb;C1415800;NA;NA;$nmbr$ ppb
1736;tenecteplase and pci ( n = $nmbr$ );"C0872913;C4049621";NA;NA;tenecteplase and pci n $nmbr$
1736;single vessel pci;"C0005847;C0037179;C0087136;C0205171;C4049621";NA;NA;single vessel pci
1736;ret / abx - facil . pci;"C0389252;C4049621";NA;NA;ret abx facil pci
1736;prerandomization pci;C4049621;NA;NA;prerandomization pci
1736;pre - randomization pci;"C0034656;C0332152;C0740175;C2257086;C3669034;C4049621";NA;NA;pre randomization pci
1736;poci ( n = $nmbr$ );NA;NA;NA;poci n $nmbr$
1736;poci;NA;NA;NA;poci
1736;pci — no . { % );C4049621;NA;NA;pci no
1736;pci — no . ( % );C4049621;NA;NA;pci no
1736;pci revascularization;"C0581603;C4049621";NA;NA;pci revascularization
1736;pci orcabg;C4049621;NA;NA;pci orcabg
1736;pci :;C4049621;NA;NA;pci
1736;pci ( % );C4049621;NA;NA;pci
1736;pci  n ( % );C4049621;NA;NA;pci n
1736;pci;C4049621;NA;NA;pci
1736;no pci or cabg — no . ( % );"C0010055;C4049621";NA;NA;no pci or cabg no
1736;no pci;C4049621;NA;NA;no pci
1736;multivessel pci;C4049621;NA;NA;multivessel pci
1736;interval study drug to pci;"C0013175;C1272706;C1552654;C1552713;C4049621";NA;NA;interval study drug to pci
1735;bmi $nmbr$ - $nmbr$ - $nmbr$ - $nmbr$;C0578022;NA;NA;bmi $nmbr$ $nmbr$ $nmbr$ $nmbr$
1736;history of pci — no . / total no . ( % ) : t;"C0019664;C0019665;C0262512;C0262926;C0439175;C0439810;C1705255;C2004062;C2603360;C4049621";NA;NA;history of pci no total no t
1736;glycoprotein ilb / iiia inhibitor before pci ];"C0017968;C1999216;C4049621;C4697913";NA;NA;glycoprotein ilb iiia inhibitor before pci
1736;facilitated pci ( n = $nmbr$ );C4049621;NA;NA;facilitated pci n $nmbr$
1736;combo - facilitated pci;C4049621;NA;NA;combo facilitated pci
1736;clopidogrel dose on / before pci;"C0070166;C0178602;C0869039;C1114758;C4049621";NA;NA;clopidogrel dose on before pci
1736;before pci;C4049621;NA;NA;before pci
1736;and after pci  median ( iqr )  d;"C0549183;C0876920;C2347635;C2348144;C2939193;C4049621";NA;NA;and after pci median iqr d
1736;after pci;C4049621;NA;NA;after pci
1736;abx - facil . pci;C4049621;NA;NA;abx facil pci
1736;abciximab - facilitated pci ( n = $nmbr$ );"C0288672;C4049621";NA;NA;abciximab facilitated pci n $nmbr$
1736;$nmbr$ vessel pci;"C0005847;C4049621";NA;NA;$nmbr$ vessel pci
1735;subpopulation analyses according to bmi;"C0578022;C0680240;C1514228";NA;NA;subpopulation analyses according to bmi
1735;screening bmi ( kg / m $nmbr$ );"C0220908;C0220909;C0578022;C1532718;C1698960;C1710031;C1710032;C1710477;C2348164";NA;NA;screening bmi kg m $nmbr$
1735;risk factors bmi ( kg / m $nmbr$ )  mean + sd;"C0035648;C0444504;C0578022;C1532718;C1553898;C2347634;C2348143;C2699239";NA;NA;risk factors bmi kg m $nmbr$ mean sd
1735;obese ( bmi £ $nmbr$ );"C0028754;C0578022";NA;NA;obese bmi $nmbr$
1735;normal weight ( bmi < $nmbr$ );"C0005910;C0043100;C0578022;C1305866;C1705104;C2712185;C4229017";NA;NA;normal weight bmi $nmbr$
1735;normal ( bmi < $nmbr$ );C4229017;NA;NA;normal bmi $nmbr$
1735;mean ± s . d . bmi  kg / m $nmbr$;"C0444504;C0578022;C1532718;C2347634;C2348143";NA;NA;mean s d bmi kg m $nmbr$
1735;mean bmi ( kg / m $nmbr$ ) ( sd );"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";NA;NA;mean bmi kg m $nmbr$ sd
1735;mean bmi ( $nmbr$ % ci );"C0008107;C0444504;C0578022;C2347634;C2348143;C3259781";NA;NA;mean bmi $nmbr$ ci
1735;mean bmi  kg / m $nmbr$ ( sd );"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";NA;NA;mean bmi kg m $nmbr$ sd
1735;mean bmi  kg / m $nmbr$ ( s . d . );"C0022718;C0439209;C0444504;C0578022;C1512018;C2347634;C2348143;C4054209";NA;NA;mean bmi kg m $nmbr$ s d
1735;mean bmi  kg / m $nmbr$;"C0444504;C0578022;C1532718;C2347634;C2348143";NA;NA;mean bmi kg m $nmbr$
1735;mean bmi;"C0444504;C0578022;C2347634;C2348143";NA;NA;mean bmi
1735;mean baseline bmi;"C0168634;C0444504;C0578022;C1442488;C2347634;C2348143";NA;NA;mean baseline bmi
1735;mean ( sd ) bmi ( kg / m $nmbr$ );"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";NA;NA;mean sd bmi kg m $nmbr$
1735;mean ( s . d . ) bmi  kg / m $nmbr$;"C0444504;C0578022;C1532718;C2347634;C2348143";NA;NA;mean s d bmi kg m $nmbr$
1735;bms;NA;NA;NA;bms
1735;bmit;NA;NA;NA;bmit
1735;bmij;NA;NA;NA;bmij
1735;bmia;NA;NA;NA;bmia
1735;bmi — mean ( sd ) ( kg / m $nmbr$ );"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";NA;NA;bmi mean sd kg m $nmbr$
1735;bmi £ $nmbr$ kg / m * ( n = $nmbr$ / $nmbr$ );"C0578022;C1532718";NA;NA;bmi $nmbr$ kg m n $nmbr$ $nmbr$
1735;bmi   kg · m − $nmbr$;"C0578022;C1532718";NA;NA;bmi kg m $nmbr$
1735;bmi o $nmbr$ kg / m $nmbr$  n ( % );"C0578022;C1532718";NA;NA;bmi o $nmbr$ kg m $nmbr$ n
1735;bmi kg · m − $nmbr$;"C0578022;C1532718";NA;NA;bmi kg m $nmbr$
1735;bmi category ( kg / m $nmbr$ );"C0578022;C0683312;C1532718;C3889287";NA;NA;bmi category kg m $nmbr$
1735;bmi category ( % );"C0578022;C0683312;C3889287";NA;NA;bmi category
1735;bmi category  no . ( % );"C0578022;C0683312;C3889287";NA;NA;bmi category no
1735;bmi category;"C0578022;C0683312;C3889287";NA;NA;bmi category
1735;bmi categories  n ( % );"C0578022;C0683312";NA;NA;bmi categories n
1735;bmi a $nmbr$;C0578022;NA;NA;bmi a $nmbr$
1735;bmi ^;C0578022;NA;NA;bmi
1735;bmi [ kg / m $nmbr$ ];"C0578022;C1532718";NA;NA;bmi kg m $nmbr$
1735;bmi > = $nmbr$ kg / m $nmbr$;"C0578022;C1532718";NA;NA;bmi $nmbr$ kg m $nmbr$
1735;bmi > = $nmbr$;C0578022;NA;NA;bmi $nmbr$
1735;bmi > $nmbr$ — no . { % ) $;C0578022;NA;NA;bmi $nmbr$ no $
1735;bmi > $nmbr$ — no . ( % ) f;"C0016327;C0578022";NA;NA;bmi $nmbr$ no f
1735;bmi > $nmbr$ obese;"C0028754;C0578022";NA;NA;bmi $nmbr$ obese
1735;bmi > $nmbr$ kg / m ^ ( n = $nmbr$ / $nmbr$ );"C0578022;C1532718";NA;NA;bmi $nmbr$ kg m n $nmbr$ $nmbr$
1735;bmi > $nmbr$ kg / m $nmbr$ *;"C0578022;C1532718";NA;NA;bmi $nmbr$ kg m $nmbr$
1735;bmi > $nmbr$ kg / m $nmbr$  n ( % );"C0578022;C1532718";NA;NA;bmi $nmbr$ kg m $nmbr$ n
1735;bmi > $nmbr$ kg / m $nmbr$;"C0578022;C1532718";NA;NA;bmi $nmbr$ kg m $nmbr$
1735;bmi > $nmbr$ ( % );C0578022;NA;NA;bmi $nmbr$
1735;bmi > $nmbr$  n ( % );C0578022;NA;NA;bmi $nmbr$ n
1735;bmi > $nmbr$;C0578022;NA;NA;bmi $nmbr$
1735;bmi < = $nmbr$;C0578022;NA;NA;bmi $nmbr$
1735;bmi < $nmbr$ kg / m ^ ( n = $nmbr$ / $nmbr$ );"C0578022;C1532718";NA;NA;bmi $nmbr$ kg m n $nmbr$ $nmbr$
1735;bmi < $nmbr$ kg / m * ( n = $nmbr$ / $nmbr$ );"C0578022;C1532718";NA;NA;bmi $nmbr$ kg m n $nmbr$ $nmbr$
1735;bmi < $nmbr$ kg / m $nmbr$ ( n = $nmbr$ / $nmbr$ );"C0578022;C1532718";NA;NA;bmi $nmbr$ kg m $nmbr$ n $nmbr$ $nmbr$
1735;bmi < $nmbr$ kg / m $nmbr$;"C0578022;C1532718";NA;NA;bmi $nmbr$ kg m $nmbr$
1735;bmi < $nmbr$ kg / m  ( n = $nmbr$ / $nmbr$ );"C0578022;C1532718";NA;NA;bmi $nmbr$ kg m n $nmbr$ $nmbr$
1735;bmi < $nmbr$;C0578022;NA;NA;bmi $nmbr$
1735;bmi : > $nmbr$ . $nmbr$ kg / m $nmbr$;"C0578022;C1532718";NA;NA;bmi $nmbr$ $nmbr$ kg m $nmbr$
1735;bmi : < $nmbr$ . $nmbr$ kg / m $nmbr$;"C0578022;C1532718";NA;NA;bmi $nmbr$ $nmbr$ kg m $nmbr$
1735;bmi - kg / m $nmbr$;"C0578022;C1532718";NA;NA;bmi kg m $nmbr$
1735;bmi ( median  iqr )  kg / m $nmbr$;"C0549183;C0578022;C0876920;C1532718;C2347635;C2348144;C2939193";NA;NA;bmi median iqr kg m $nmbr$
1735;bmi ( kg = m $nmbr$ );"C0578022;C1532718";NA;NA;bmi kg m $nmbr$
1735;bmi ( kg / m ’ );"C0578022;C1532718";NA;NA;bmi kg m
1735;bmi ( kg / m ^ )  mean ± s . d .;"C0022718;C0369637;C0439209;C0439493;C0441923;C0444504;C0578022;C1275571;C1513009;C2347634;C2348143;C4054209";NA;NA;bmi kg m mean s d
1735;bmi ( kg / m ^ );"C0578022;C1532718";NA;NA;bmi kg m
1735;bmi ( kg / m );"C0578022;C1532718";NA;NA;bmi kg m
1735;bmi ( kg / m $nmbr$ ) mean ( sd );"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";NA;NA;bmi kg m $nmbr$ mean sd
1735;bmi ( kg / m $nmbr$ ) cardiovascular history;"C0578022;C1532718;C1880008";NA;NA;bmi kg m $nmbr$ cardiovascular history
1735;bmi ( kg / m $nmbr$ ) cardiac parameters;"C0018787;C0449381;C0578022;C1522601;C1532718";NA;NA;bmi kg m $nmbr$ cardiac parameters
1735;bmi ( kg / m $nmbr$ ) a;"C0578022;C1532718";NA;NA;bmi kg m $nmbr$ a
1735;bmi ( kg / m $nmbr$ ) [ mean - sd ];"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";NA;NA;bmi kg m $nmbr$ mean sd
1735;bmi ( kg / m $nmbr$ ) : mean ± sd;"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";NA;NA;bmi kg m $nmbr$ mean sd
1735;bmi ( kg / m $nmbr$ ) *;"C0578022;C1532718";NA;NA;bmi kg m $nmbr$
1735;bmi ( kg / m $nmbr$ )  mean ± sd;"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";NA;NA;bmi kg m $nmbr$ mean sd
1735;bmi ( kg / m $nmbr$ )  mean ( sd );"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";NA;NA;bmi kg m $nmbr$ mean sd
1735;bmi ( kg / m $nmbr$ );"C0578022;C1532718";NA;NA;bmi kg m $nmbr$
1735;bmi ( kg / ( m ) $nmbr$ );"C0578022;C1532718";NA;NA;bmi kg m $nmbr$
1735;bmi ( . kg / m - ) *;"C0578022;C1532718";NA;NA;bmi kg m
1735;bmi $nmbr$ - < $nmbr$ kg / m ^ ( n = $nmbr$ / $nmbr$ );"C0578022;C1532718";NA;NA;bmi $nmbr$ $nmbr$ kg m n $nmbr$ $nmbr$
1735;bmi $nmbr$ - < $nmbr$ kg / m - ( n = $nmbr$ / $nmbr$ );"C0578022;C1532718";NA;NA;bmi $nmbr$ $nmbr$ kg m n $nmbr$ $nmbr$
1735;bmi $nmbr$ - < $nmbr$ kg / m * ( n = $nmbr$ / $nmbr$ );"C0578022;C1532718";NA;NA;bmi $nmbr$ $nmbr$ kg m n $nmbr$ $nmbr$
1735;bmi $nmbr$ - < $nmbr$ kg / m  ( n = $nmbr$ / $nmbr$ );"C0578022;C1532718";NA;NA;bmi $nmbr$ $nmbr$ kg m n $nmbr$ $nmbr$
1735;bmi $nmbr$ - $nmbr$ - $nmbr$ $nmbr$;C0578022;NA;NA;bmi $nmbr$ $nmbr$ $nmbr$ $nmbr$
1735;bmi $nmbr$ $nmbr$ - $nmbr$ $nmbr$;C0578022;NA;NA;bmi $nmbr$ $nmbr$ $nmbr$ $nmbr$
1735;bmi $nmbr$;C0578022;NA;NA;bmi $nmbr$
1735;bmi  x $nmbr$ kg / m $nmbr$;"C0578022;C1532718";NA;NA;bmi x $nmbr$ kg m $nmbr$
1735;bmi  no . ( % );C0578022;NA;NA;bmi no
1735;bmi  n ( % );C0578022;NA;NA;bmi n
1735;bmi  median ( iqr );"C0549183;C0578022;C0876920;C2347635;C2348144;C2939193";NA;NA;bmi median iqr
1735;bmi  mean  kg / m $nmbr$;"C0444504;C0578022;C1532718;C2347634;C2348143";NA;NA;bmi mean kg m $nmbr$
1735;bmi  kg per m $nmbr$;"C0578022;C1532718";NA;NA;bmi kg per m $nmbr$
1735;bmi  kg / m ’;"C0578022;C1532718";NA;NA;bmi kg m
1735;bmi  kg / m ^  mean ( sd ) ’;"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";NA;NA;bmi kg m mean sd
1735;bmi  kg / m $nmbr$  n;"C0578022;C1532718";NA;NA;bmi kg m $nmbr$ n
1735;bmi  kg / m $nmbr$  median ( iqr );"C0549183;C0578022;C0876920;C1532718;C2347635;C2348144;C2939193";NA;NA;bmi kg m $nmbr$ median iqr
1735;bmi  kg / m $nmbr$  mean ( sd );"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";NA;NA;bmi kg m $nmbr$ mean sd
1735;bmi  kg / m $nmbr$;"C0578022;C1532718";NA;NA;bmi kg m $nmbr$
1735;bmi;C0578022;NA;NA;bmi
1735;bm i < $nmbr$;"C0006416;C0021966;C0221138";NA;NA;bm i $nmbr$
1735;baseline bmi > $nmbr$ kg / m $nmbr$  n = $nmbr$ change from baseline to $nmbr$ weeks;"C0168634;C0392747;C0439230;C0443172;C0578022;C1442488;C1532718;C1705241;C4319952";NA;NA;baseline bmi $nmbr$ kg m $nmbr$ n $nmbr$ change from baseline to $nmbr$ weeks
1735;baseline bmi ( kg / m ^ );"C0168634;C0578022;C1442488;C1532718";NA;NA;baseline bmi kg m
1735;baseline bmi ( kg / m $nmbr$ );"C0168634;C0578022;C1442488;C1532718";NA;NA;baseline bmi kg m $nmbr$
1735;baseline bmi;"C0168634;C0578022;C1442488";NA;NA;baseline bmi
1735;> $nmbr$ years bmi;"C0439234;C0578022";NA;NA;$nmbr$ years bmi
1735;( a ) bmi subgroups;"C0578022;C1079230";NA;NA;a bmi subgroups
1735;$nmbr$ < bmi < $nmbr$;C0578022;NA;NA;$nmbr$ bmi $nmbr$
1734;• j . the body - mass index is the weight in kilograms divided by the square of the;"C0005893;C0005910;C0043100;C0205120;C0332849;C0439209;C0578022;C1305855;C1305866;C1552595;C1705104";NA;NA;j the body mass index is the weight in kilograms divided by the square of the
1734;median body mass index  kg / m $nmbr$ ( range );"C0005893;C0549183;C0578022;C0876920;C1305855;C1514721;C1532718;C2347635;C2348144;C2348147;C2939193;C3542016";NA;NA;median body mass index kg m $nmbr$ range
1734;median body mass index  kg / m $nmbr$ ( iqr );"C0005893;C0549183;C0578022;C0876920;C1305855;C1532718;C2347635;C2348144;C2939193";NA;NA;median body mass index kg m $nmbr$ iqr
1734;mean body mass index ( sd )  kg / m $nmbr$;"C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239";NA;NA;mean body mass index sd kg m $nmbr$
1734;mean body mass index ( kg / m $nmbr$ ) *;"C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143";NA;NA;mean body mass index kg m $nmbr$
1734;mean body mass index ( kg / m $nmbr$ );"C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143";NA;NA;mean body mass index kg m $nmbr$
1734;mean body mass index  kg / m $nmbr$;"C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143";NA;NA;mean body mass index kg m $nmbr$
1734;mean body - mass index ( = sd )  kg / m $nmbr$;"C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239";NA;NA;mean body mass index sd kg m $nmbr$
1734;mean body - mass index  kg / m $nmbr$   ( sd ) *;"C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239";NA;NA;mean body mass index kg m $nmbr$ sd
1734;mean body - mass index  kg / m $nmbr$ ( sd ) *;"C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239";NA;NA;mean body mass index kg m $nmbr$ sd
1734;mean body - mass index  kg / m $nmbr$;"C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143";NA;NA;mean body mass index kg m $nmbr$
1734;mean ( sd ) body mass index  kg / m $nmbr$;"C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239";NA;NA;mean sd body mass index kg m $nmbr$
1734;body mass index subgroups;"C0005893;C0578022;C1079230;C1305855";NA;NA;body mass index subgroups
1734;body mass index mean kg / m $nmbr$ ( sd );"C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239";NA;NA;body mass index mean kg m $nmbr$ sd
1734;body mass index group ( kg / m $nmbr$ ) ≥ $nmbr$ kg / m $nmbr$ — no . ( % );"C0005893;C0022718;C0439209;C0441833;C0578022;C0687744;C1257890;C1305855;C1519504;C1705428;C1705429;C1709500;C4054209";NA;NA;body mass index group kg m $nmbr$ $nmbr$ kg m $nmbr$ no
1734;body mass index category  no . ( % ) l;"C0005893;C0439394;C0578022;C0683312;C1305855;C1706495;C3642217;C3889287";NA;NA;body mass index category no l
1734;body mass index blood pressure — mmhg;"C0005823;C0005893;C0439475;C0578022;C1271104;C1272641;C1305855";NA;NA;body mass index blood pressure mmhg
1734;body mass index ^;"C0005893;C0578022;C1305855";NA;NA;body mass index
1734;body mass index [ kg / m $nmbr$ ]  mean ± sd;"C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239";NA;NA;body mass index kg m $nmbr$ mean sd
1734;body mass index > $nmbr$ — no . ( % ) f;"C0005893;C0016327;C0578022;C1305855";NA;NA;body mass index $nmbr$ no f
1734;body mass index > $nmbr$ t;"C0005893;C0578022;C1305855";NA;NA;body mass index $nmbr$ t
1734;body mass index > $nmbr$ kg / m  n ( % );"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index $nmbr$ kg m n
1734;body mass index > $nmbr$  n ( % );"C0005893;C0578022;C1305855";NA;NA;body mass index $nmbr$ n
1734;body mass index :;"C0005893;C0578022;C1305855";NA;NA;body mass index
1734;body mass index / mean ( sd );"C0005893;C0444504;C0578022;C1305855;C2347634;C2348143;C2699239";NA;NA;body mass index mean sd
1734;body mass index - mean ( sd );"C0005893;C0444504;C0578022;C1305855;C2347634;C2348143;C2699239";NA;NA;body mass index mean sd
1734;body mass index - kg / m $nmbr$ t;"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index kg m $nmbr$ t
1734;body mass index +;"C0005893;C0578022;C1305855";NA;NA;body mass index
1734;body mass index *;"C0005893;C0578022;C1305855";NA;NA;body mass index
1734;body mass index ( kgm _ $nmbr$ );"C0005893;C0578022;C1305855";NA;NA;body mass index kgm _ $nmbr$
1734;body mass index ( kg / m “ ) ^;"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index kg m
1734;body mass index ( kg / m ’ ) ^;"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index kg m
1734;body mass index ( kg / m ^ ) ^;"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index kg m
1734;body mass index ( kg / m );"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index kg m
1734;body mass index ( kg / m $nmbr$ ) baseline systolic blood;"C0005767;C0005768;C0005893;C0039155;C0168634;C0229664;C0578022;C1305855;C1442488;C1532718";NA;NA;body mass index kg m $nmbr$ baseline systolic blood
1734;body mass index ( kg / m $nmbr$ ) - mean ± sd;"C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239";NA;NA;body mass index kg m $nmbr$ mean sd
1734;body mass index ( kg / m $nmbr$ ) * ';"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index kg m $nmbr$
1734;body mass index ( kg / m $nmbr$ )  mean ( sd ) c;"C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239";NA;NA;body mass index kg m $nmbr$ mean sd c
1734;body mass index ( kg / m $nmbr$ );"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index kg m $nmbr$
1734;body mass index ( bmi )  kg / m $nmbr$;"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index bmi kg m $nmbr$
1734;body mass index $nmbr$;"C0005893;C0578022;C1305855";NA;NA;body mass index $nmbr$
1734;body mass index  median  ( $nmbr$ th — $nmbr$ th percentiles )  kg / m $nmbr$;"C0005893;C0039725;C0039738;C0549183;C0578022;C0876920;C1264641;C1305855;C1420718;C1532718;C2347635;C2348144;C2939193;C4282123;C4285344";NA;NA;body mass index median $nmbr$ th $nmbr$ th percentiles kg m $nmbr$
1734;body mass index  mean ± sd ( kg / m $nmbr$ );"C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239";NA;NA;body mass index mean sd kg m $nmbr$
1734;body mass index  mean kg / m ^ ( sd );"C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239";NA;NA;body mass index mean kg m sd
1730;study druga;"C0557651;C2603343";NA;NA;study druga
1734;body mass index  mean + sd ( kg / m );"C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239";NA;NA;body mass index mean sd kg m
1734;body mass index  mean ( sd ) t;"C0005893;C0444504;C0578022;C1305855;C2347634;C2348143;C2699239";NA;NA;body mass index mean sd t
1734;body mass index  mean ( sd ) kg / m $nmbr$;"C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239";NA;NA;body mass index mean sd kg m $nmbr$
1734;body mass index  mean ( sd ) d;"C0005893;C0444504;C0578022;C1305855;C2347634;C2348143;C2699239";NA;NA;body mass index mean sd d
1734;body mass index  mean ( sd ) [ range ] a;"C0005893;C0444504;C0578022;C1305855;C1514721;C2347634;C2348143;C2348147;C2699239;C3542016";NA;NA;body mass index mean sd range a
1734;body mass index  mean ( sd ) ( kg m ) $nmbr$ );"C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239";NA;NA;body mass index mean sd kg m $nmbr$
1734;body mass index  mean ( sd )  kg / m $nmbr$;"C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239";NA;NA;body mass index mean sd kg m $nmbr$
1734;body mass index  mean ( sd );"C0005893;C0444504;C0578022;C1305855;C2347634;C2348143;C2699239";NA;NA;body mass index mean sd
1734;body mass index  kg / rn \ mean ( sd );"C0005893;C0022718;C0439209;C0444504;C0578022;C1305855;C2347634;C2348143;C2699239;C2827110;C3540639;C4054209;C4281819";NA;NA;body mass index kg rn \ mean sd
1323;womens;NA;NA;NA;womens
1734;body mass index  kg / m ’;"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index kg m
1734;body mass index  kg / m ^ mean ( sd );"C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239";NA;NA;body mass index kg m mean sd
1734;body mass index  kg / m ^ ( meanisd );"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index kg m meanisd
1734;body mass index  kg / m ^;"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index kg m
1734;body mass index  kg / m $nmbr$   ( sd );"C0005893;C0578022;C1305855;C1532718;C2699239";NA;NA;body mass index kg m $nmbr$ sd
1734;body mass index  kg / m $nmbr$ ( sd );"C0005893;C0578022;C1305855;C1532718;C2699239";NA;NA;body mass index kg m $nmbr$ sd
1734;body mass index  kg / m $nmbr$ ( mean ± sd );"C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239";NA;NA;body mass index kg m $nmbr$ mean sd
   7;p   values of interaction;"C1704675;C1709380";NA;NA;p values of interaction
1734;body mass index  kg / m $nmbr$  median ( q $nmbr$  q $nmbr$ );"C0005893;C0549183;C0578022;C0876920;C1305855;C1532718;C2347635;C2348144;C2939193";NA;NA;body mass index kg m $nmbr$ median q $nmbr$ q $nmbr$
1734;body mass index  kg / m $nmbr$  mean ± sd;"C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239";NA;NA;body mass index kg m $nmbr$ mean sd
1734;body mass index  kg / m $nmbr$  mean + sd;"C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239";NA;NA;body mass index kg m $nmbr$ mean sd
1734;body mass index  kg / m $nmbr$  mean ( sd ) §;"C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239";NA;NA;body mass index kg m $nmbr$ mean sd
1734;body mass index  kg / m $nmbr$  mean ( sd );"C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239";NA;NA;body mass index kg m $nmbr$ mean sd
1734;body mass index  kg / m $nmbr$;"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index kg m $nmbr$
1734;body mass index  * kg / m $nmbr$;"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index kg m $nmbr$
1734;body mass index  %;"C0005893;C0578022;C1305855";NA;NA;body mass index
1734;body mass index;"C0005893;C0578022;C1305855";NA;NA;body mass index
1734;body - mass index ”;"C0005893;C0578022;C1305855";NA;NA;body mass index
1734;body - mass index — no . ( % ) : i :;"C0005893;C0021966;C0221138;C0578022;C1305855";NA;NA;body mass index no i
1734;body - mass index — no . ( % ) $;"C0005893;C0578022;C1305855";NA;NA;body mass index no $
1734;body - mass index §;"C0005893;C0578022;C1305855";NA;NA;body mass index
1734;body - mass index categories — no . ( % ) : c;"C0005893;C0578022;C0683312;C1305855";NA;NA;body mass index categories no c
1734;body - mass index ^ :;"C0005893;C0578022;C1305855";NA;NA;body mass index
1734;body - mass index ^;"C0005893;C0578022;C1305855";NA;NA;body mass index
1734;body - mass index \ kg / m $nmbr$;"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index \ kg m $nmbr$
1734;body - mass index > $nmbr$  n ( % );"C0005893;C0578022;C1305855";NA;NA;body mass index $nmbr$ n
1734;body - mass index > $nmbr$;"C0005893;C0578022;C1305855";NA;NA;body mass index $nmbr$
1734;body - mass index : ! :;"C0005893;C0578022;C1305855";NA;NA;body mass index
1734;body - mass index - kg / m $nmbr$  median ( iqr );"C0005893;C0549183;C0578022;C0876920;C1305855;C1532718;C2347635;C2348144;C2939193";NA;NA;body mass index kg m $nmbr$ median iqr
1734;body - mass index - ! ';"C0005893;C0578022;C1305855";NA;NA;body mass index
1734;body - mass index *;"C0005893;C0578022;C1305855";NA;NA;body mass index
1734;body - mass index ) -;"C0005893;C0578022;C1305855";NA;NA;body mass index
1734;body - mass index ) ';"C0005893;C0578022;C1305855";NA;NA;body mass index
1734;body - mass index );"C0005893;C0578022;C1305855";NA;NA;body mass index
1734;body - mass index ( kg / m   $nmbr$ );"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index kg m $nmbr$
1734;body - mass index ( kg / m - );"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index kg m
1734;body - mass index ( kg / m ' );"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index kg m
1734;body - mass index ( kg / m $nmbr$ ) t;"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index kg m $nmbr$ t
1734;body - mass index ( kg / m $nmbr$ ) *;"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index kg m $nmbr$
1734;body - mass index ( kg / m $nmbr$ ) ( mean  sd );"C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239";NA;NA;body mass index kg m $nmbr$ mean sd
1734;body - mass index ( kg / m $nmbr$ )  mean ( sd );"C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239";NA;NA;body mass index kg m $nmbr$ mean sd
1734;body - mass index ( kg / m $nmbr$ );"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index kg m $nmbr$
1734;body - mass index ( kg / cm $nmbr$ );"C0005893;C0578022;C1305855;C4054689";NA;NA;body mass index kg cm $nmbr$
1734;body - mass index $;"C0005893;C0578022;C1305855";NA;NA;body mass index $
1734;body - mass index  mean ( sd );"C0005893;C0444504;C0578022;C1305855;C2347634;C2348143;C2699239";NA;NA;body mass index mean sd
1734;body - mass index  kq / nrn;"C0005893;C0578022;C1305855;C1425210";NA;NA;body mass index kq nrn
1734;body - mass index  !;"C0005893;C0578022;C1305855";NA;NA;body mass index
1734;body - mass index;"C0005893;C0578022;C1305855";NA;NA;body mass index
1734;bmi ( $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ );C0578022;NA;NA;bmi $nmbr$ $nmbr$ $nmbr$ $nmbr$
1734;baseline body mass index;"C0005893;C0168634;C0578022;C1305855;C1442488";NA;NA;baseline body mass index
1733;fibrous  mm ’;"C0016059;C0439709;C4330985;C4554674";NA;NA;fibrous mm
1733;fibrous;"C0016059;C0439709";NA;NA;fibrous
1733;fibrofatty  mm ^;"C4330985;C4554674";NA;NA;fibrofatty mm
1733;fibrofatty;NA;NA;NA;fibrofatty
1733;fibrates;"C1449704;C3540783";NA;NA;fibrates
1732;study population;C2348561;NA;NA;study population
1732;placebo - control study;C0683952;NA;NA;placebo control study
1732;overall study population;"C0282416;C1561607;C2348561";NA;NA;overall study population
1731;temporary discontinuation of study drug;"C0013175;C0205374;C0457454;C1444662;C1548539;C3245481;C4552847";NA;NA;temporary discontinuation of study drug
1731;teaes leading to discontinuation of study drug;"C0013175;C0332152;C0457454;C1444662;C1522538;C4552847";NA;NA;teaes leading to discontinuation of study drug
1731;study drug;C0013175;NA;NA;study drug
1731;median duration of study - drug administration;"C0013175;C0549183;C0876920;C2347635;C2348144;C2348354;C2939193";NA;NA;median duration of study drug administration
1731;leading to study drug discontinuation;"C0013175;C0040363;C0041260;C0332152;C0457454;C1444662;C1522538;C1883351;C4552847";NA;NA;leading to study drug discontinuation
1731;duration of study - drug administration — hr;"C0013175;C2348354";NA;NA;duration of study drug administration hr
1730;this study;"C0557651;C2603343";NA;NA;this study
1730;study $nmbr$ . $nmbr$;"C0557651;C2603343";NA;NA;study $nmbr$ $nmbr$
1730;study $nmbr$;"C0557651;C2603343";NA;NA;study $nmbr$
1730;study;"C0557651;C2603343";NA;NA;study
1730;six - study placebo - controlled set;"C0036849;C0205452;C0557651;C1442518;C1705195;C1706408;C2603343";NA;NA;six study placebo controlled set
1730;related to study druga;"C0040363;C0041260;C0439849;C0445223;C0557651;C1883351;C2603343";NA;NA;related to study druga
1730;pool of fh i and ii studies;"C0337051;C0557651;C0947630;C1260386;C1509144;C2349200;C2603343";NA;NA;pool of fh i and ii studies
1730;permanently stopped study drug because of adverse events;"C0041755;C0557651;C1272691;C2603343";NA;NA;permanently stopped study drug because of adverse events
1730;no inducer at core study entry;"C0444669;C0557651;C1167518;C1705654;C1706352;C1882467;C2603343;C3274653;C3898767";NA;NA;no inducer at core study entry
1730;induction study treatment;"C0205263;C0557651;C0857127;C1521826;C2603343;C4049995";NA;NA;induction study treatment
1730;included in this study ( n = $nmbr$ );"C0332257;C0557651;C2603343";NA;NA;included in this study n $nmbr$
1730;in extension study;"C0231448;C0557651;C1880641;C2603343";NA;NA;in extension study
1708;medication prior to admission  ( % );"C0013227;C0184666;C0332152;C0809949;C3244316;C4284232";NA;NA;medication prior to admission
1730;enrolled from re - cover study — no . ( % );"C0180153;C0556581;C0557651;C1999244;C2603343;C2986904;C3888055;C4684790";NA;NA;enrolled from re cover study no
1730;duration of treatment in the healing study  n;"C0043240;C0205249;C0444921;C0557651;C2603343";NA;NA;duration of treatment in the healing study n
1730;concurrent treatment at study entry — no . ( % ) * *;"C0009247;C0039798;C0087111;C0205420;C0557651;C0679827;C1521826;C1522326;C1533734;C1705169;C1705654;C2603343;C3161471;C3538994;C3887704";NA;NA;concurrent treatment at study entry no
1729;tzd;NA;NA;NA;tzd
1729;met / tzd;"C0428210;C1550543;C4317104";NA;NA;met tzd
1729;met / su / tzd;"C0038642;C0428210;C1550543;C1705534;C4317104";NA;NA;met su tzd
1729;did not meet atopy and ige $nmbr$ - $nmbr$ ku / lcriteriaa ( n = $nmbr$  $nmbr$ );"C0022804;C0392707;C1337080;C1518422;C1532717;C1550543;C1881335;C3539705";NA;NA;did not meet atopy and ige $nmbr$ $nmbr$ ku lcriteriaa n $nmbr$ $nmbr$
1729;> $nmbr$ % and < $nmbr$ %;NA;NA;NA;$nmbr$ and $nmbr$
1728;woscops;NA;NA;NA;woscops
1728;patients with evaluable endoscopy;"C0014245;C2986511";NA;NA;patients with evaluable endoscopy
1728;endoscopy subscore  n ( % );C0014245;NA;NA;endoscopy subscore n
1728;endoscopy subscore;C0014245;NA;NA;endoscopy subscore
1728;colonoscopy;"C0009378;C1548837";NA;NA;colonoscopy
1727;std n ( n / loopy );"C0181687;C0445022";NA;NA;std n n loopy
1727;overall n ( n / loopy );"C0181687;C0282416;C0445022;C1561607";NA;NA;overall n n loopy
1727;glargine n ( n / loopy );"C0181687;C0445022;C0907402";NA;NA;glargine n n loopy
1726;prior copd medicationa  n ( % );"C0024117;C0332152;C1412502;C2826257;C3714496";NA;NA;prior copd medicationa n
1726;prior copd medication;"C0013227;C0024117;C0332152;C1412502;C2826257;C3244316;C3714496;C4284232";NA;NA;prior copd medication
1726;previous respiratory disease other than copd — no . ( % );"C0024117;C0035204;C0035242;C0205156;C1412502;C1552607;C3714496";NA;NA;previous respiratory disease other than copd no
1726;previous copd treatment  n ( % ) *;"C0024117;C0039798;C0087111;C0205156;C1412502;C1522326;C1533734;C1552607;C1705169;C3538994;C3714496;C3887704";NA;NA;previous copd treatment n
1726;patients with prior copd - related;"C0024117;C0030705;C0332152;C0439849;C0445223;C1412502;C2826257;C3714496";NA;NA;patients with prior copd related
1726;overall night - time copd symptom severity scorec;"C0024117;C0240526;C0282416;C1319166;C1412502;C1561607;C3714496";NA;NA;overall night time copd symptom severity scorec
1726;no previous copd medication;"C0013227;C0024117;C0205156;C1412502;C1552607;C3244316;C3714496;C4284232";NA;NA;no previous copd medication
1726;mean copd duration  y ( sd );"C0024117;C0444504;C0449238;C1412502;C2347634;C2348143;C2699239;C2926735;C3714496";NA;NA;mean copd duration y sd
1726;mean ( sd ) duration of copd  years;"C0024117;C0439234;C0444504;C0449238;C1412502;C2347634;C2348143;C2699239;C2926735;C3714496";NA;NA;mean sd duration of copd years
1726;grade $nmbr$ ( moderate copd )  n ( % );"C0024117;C0205081;C0441800;C0919553;C1412502;C1881878;C3244287;C3714496;C4049705;C4049706;C4085643;C4321335";NA;NA;grade $nmbr$ moderate copd n
1726;duration of copd — yr;"C0024117;C0439234;C0449238;C1412502;C2926735;C3714496";NA;NA;duration of copd yr
1726;duration of copd — days ^;"C0024117;C0439228;C0449238;C1412502;C2926735;C3714496";NA;NA;duration of copd days
1726;duration of copd ( yr ) f;"C0016327;C0024117;C0439234;C0449238;C1412502;C2926735;C3714496";NA;NA;duration of copd yr f
1726;duration of copd ( yr );"C0024117;C0439234;C0449238;C1412502;C2926735;C3714496";NA;NA;duration of copd yr
1726;duration of copd ( years )  mean ( sd );"C0024117;C0439234;C0444504;C0449238;C1412502;C2347634;C2348143;C2699239;C2926735;C3714496";NA;NA;duration of copd years mean sd
1726;duration of copd ( years );"C0024117;C0439234;C0449238;C1412502;C2926735;C3714496";NA;NA;duration of copd years
1726;duration of copd  yr;"C0024117;C0439234;C0449238;C1412502;C2926735;C3714496";NA;NA;duration of copd yr
1726;duration of copd  years;"C0024117;C0439234;C0449238;C1412502;C2926735;C3714496";NA;NA;duration of copd years
1726;duration of copd  y;"C0024117;C0449238;C1412502;C2926735;C3714496";NA;NA;duration of copd y
1726;duration of copd;"C0024117;C0449238;C1412502;C2926735;C3714496";NA;NA;duration of copd
1726;data are mean ( sd ) or number ( % ) . bmi = body - mass index . sbp = systolic blood pressure . dbp = diastolic blood pressure . lvef = left ventricular ejection fraction . hf = heart failure . ami = acute myocardial infarction . cabg = coronary artery bypass graft . pci = percutaneous coronary intervention . icd = implantable cardioverter de ﬁ brillator . copd = chronic obstructive pulmonary disease . ace = angiotensin - converting enzyme . arbs = angiotensin receptor blockers . * available for $nmbr$ patients ( $nmbr$ rosuvastatin  $nmbr$ placebo ) .;"C0010055;C0011198;C0014442;C0017480;C0018801;C0021122;C0024117;C0030705;C0032042;C0042508;C0085805;C0155626;C0162589;C0205091;C0237753;C0428772;C0428883;C0443246;C0444504;C0449788;C0470187;C0488055;C0488728;C0521942;C0815017;C0871470;C0965129;C1305855;C1306620;C1452534;C1511726;C1532338;C1552822;C1696465;C1706408;C2347634;C2348143;C2699239;C3245479;C3541240;C3714741;C3888198;C4284014;C4521602";NA;NA;data are mean sd or number bmi body mass index sbp systolic blood pressure dbp diastolic blood pressure lvef left ventricular ejection fraction hf heart failure ami acute myocardial infarction cabg coronary artery bypass graft pci percutaneous coronary intervention icd implantable cardioverter de brillator copd chronic obstructive pulmonary disease ace angiotensin converting enzyme arbs angiotensin receptor blockers available for $nmbr$ patients $nmbr$ rosuvastatin $nmbr$ placebo
1726;copd — no . ( % ) medication use;"C0024117;C0240320;C1412502;C3714496";NA;NA;copd no medication use
1726;copd type;"C0024117;C0332307;C1412502;C1547052;C3714496";NA;NA;copd type
1726;copd population ( n = $nmbr$ );"C0024117;C0032659;C1257890;C1412502;C3714496";NA;NA;copd population n $nmbr$
1726;copd or asthma  ( % );"C0004096;C0024117;C1412502;C2984299;C3714496";NA;NA;copd or asthma
1726;copd or asthma;"C0004096;C0024117;C1412502;C2984299;C3714496";NA;NA;copd or asthma
1726;copd medication at study entry;"C0013175;C0024117;C1412502;C1705654;C3714496";NA;NA;copd medication at study entry
1726;copd duration  y;"C0024117;C0449238;C1412502;C2926735;C3714496";NA;NA;copd duration y
1726;copd ( n = $nmbr$ );"C0024117;C1412502;C3714496";NA;NA;copd n $nmbr$
1726;copd ( % );"C0024117;C1412502;C3714496";NA;NA;copd
1726;copd    n   ( % );"C0024117;C1412502;C3714496";NA;NA;copd n
1726;copd;"C0024117;C1412502;C3714496";NA;NA;copd
1726;clinical copd phenotype ^;"C0024117;C0031437;C0205210;C1285572;C1412502;C3714496";NA;NA;clinical copd phenotype
1726;chronic obstructive pulmonary disease — no . ( % );C0024117;NA;NA;chronic obstructive pulmonary disease no
1726;chronic obstructive pulmonary disease  n ( % );C0024117;NA;NA;chronic obstructive pulmonary disease n
1726;chronic obstructive pulmonary disease;C0024117;NA;NA;chronic obstructive pulmonary disease
1726;chronic obstructive lung disease;C0024117;NA;NA;chronic obstructive lung disease
1726;augment copd;"C0024117;C0205217;C1412502;C3714496";NA;NA;augment copd
1677;< $nmbr$ . $nmbr$ ld;C0694649;NA;NA;$nmbr$ $nmbr$ ld
1726;any copd medication;"C0013227;C0024117;C1412502;C3244316;C3714496;C4284232";NA;NA;any copd medication
 -10;computed tomographic angiography;C1536105;NA;NA;computed tomographic angiography
1724;time from randomization to coronary angiography — hr;"C0034656;C0040223;C0085532;C1548829;C3541383";NA;NA;time from randomization to coronary angiography hr
1724;normal coronary angiography;C0853522;NA;NA;normal coronary angiography
1724;coronary angiography — no . ( % );"C0085532;C1548829";NA;NA;coronary angiography no
1724;coronary angiography during the index hospital stay;"C0002978;C0085532;C0428776;C0600653;C0918012;C1548829;C1552854;C1637833;C2986546;C3489408";NA;NA;coronary angiography during the index hospital stay
1724;coronary angiography;"C0085532;C1548829";NA;NA;coronary angiography
1723;randomization to angiography;"C0002978;C0034656";NA;NA;randomization to angiography
1723;randomization - to - angiography distribution time;"C0002978;C0034656;C0681683";NA;NA;randomization to angiography distribution time
1723;randomization - to - angiography;"C0002978;C0034656";NA;NA;randomization to angiography
1727;loop;C0445022;FALSE; 991;loop
1727;loop at last follow - up;"C0445022;C0589120;C1522577;C1704685;C3274571";FALSE; 991;loop at last follow up
1723;intravenous anticoagulant prior to pre - pci angiography;"C0002978;C0003280;C0332152;C0348016;C0740175;C0848112;C2257086;C3536711;C3669034;C4049621";NA;NA;intravenous anticoagulant prior to pre pci angiography
1723;interval from randomization to angiography;"C0002978;C0034656;C1272706;C1552654;C1552713";NA;NA;interval from randomization to angiography
1723;glycoprotein iib / iiia inhibitor use before angiography;"C0002978;C0016011;C0042153;C0457083;C1947944;C1999216";NA;NA;glycoprotein iib iiia inhibitor use before angiography
1723;diagnostic angiography;C0002978;NA;NA;diagnostic angiography
1723;contrast angiography;"C0002978;C0009924;C1979874";NA;NA;contrast angiography
1723;angiography — no . ( % );C0002978;NA;NA;angiography no
1723;angiography and revascularization;"C0002978;C0581603";NA;NA;angiography and revascularization
1723;angiography;C0002978;NA;NA;angiography
1723;additional angiography;"C0002978;C1524062";NA;NA;additional angiography
1723;> $nmbr$ ( ml ) additional angiography;"C0002978;C0439526;C1524062;C1705224;C3887665";NA;NA;$nmbr$ ml additional angiography
1722;prior angioplasty;"C0162577;C0332152;C1548817;C2826257";NA;NA;prior angioplasty
1722;previous angioplasty  n ( % );"C0162577;C0205156;C1548817;C1552607";NA;NA;previous angioplasty n
1722;peripheral angioplasty;"C0162577;C0205100;C1548817";NA;NA;peripheral angioplasty
1722;cabg or angioplasty;"C0010055;C0162577;C1548817";NA;NA;cabg or angioplasty
1722;angioplasty;"C0162577;C1548817";NA;NA;angioplasty
1721;previous balloon angioplasty  n ( % );"C0002996;C0002997;C0205156;C1552607";NA;NA;previous balloon angioplasty n
1721;previous balloon angioplasty;"C0002996;C0002997;C0205156;C1552607";NA;NA;previous balloon angioplasty
1721;balloon angioplasty — no . ( % );"C0002996;C0002997";NA;NA;balloon angioplasty no
1721;balloon angioplasty plus abciximab;"C0002996;C0002997;C0288672;C0332287";NA;NA;balloon angioplasty plus abciximab
1721;balloon angioplasty;"C0002996;C0002997";NA;NA;balloon angioplasty
 -10;lymphadenopathy;"C0497156;C4282165";NA;NA;lymphadenopathy
1719;retinopathy — no . ( % );"C0035309;C1962966";NA;NA;retinopathy no
1719;retinopathy — %;"C0035309;C1962966";NA;NA;retinopathy
1719;retinopathy;"C0035309;C1962966";NA;NA;retinopathy
1719;micro - / macro - albuminuria  ckd and / or retinopathy;"C0001925;C0035309;C0085672;C1553035;C1561643;C1962966;C2984010;C3811161;C4049106";NA;NA;micro macro albuminuria ckd and or retinopathy
1718;peripheral sensory neuropathy;"C0151313;C4554142";NA;NA;peripheral sensory neuropathy
1718;peripheral neuropathy;C0031117;NA;NA;peripheral neuropathy
1718;neuropathy — no . ( % );C0442874;NA;NA;neuropathy no
1718;neuropathy;C0442874;NA;NA;neuropathy
1718;myopathyt;NA;NA;NA;myopathyt
1718;myopathy;C0026848;NA;NA;myopathy
1718;autonomic neuropathy;C0259749;NA;NA;autonomic neuropathy
 -10;radionuclide ventriculography;"C0017200;C0034610";NA;NA;radionuclide ventriculography
1716;spiralcomputedtomographyangiography;NA;NA;NA;spiralcomputedtomographyangiography
1716;duplex ultrasonography;C3825392;NA;NA;duplex ultrasonography
1715;nice secondary prevention onlyb;"C0679699;C4087029";NA;NA;nice secondary prevention onlyb
1715;nice primary prevention onlyb;"C0033144;C4087029";NA;NA;nice primary prevention onlyb
1715;gissi prevention $nmbr$ / $nmbr$ - $nmbr$ / $nmbr$;"C0199176;C1706420;C2700409";NA;NA;gissi prevention $nmbr$ $nmbr$ $nmbr$ $nmbr$
1714;interruption ( n = $nmbr$ );"C0332453;C1512900";NA;NA;interruption n $nmbr$
1714;interruption;"C0332453;C1512900";NA;NA;interruption
1714;history of percutaneous coronary intervention;"C1320647;C4554713";NA;NA;history of percutaneous coronary intervention
1714;$nmbr$ early intervention ( n = $nmbr$ );"C0242687;C1964029";NA;NA;$nmbr$ early intervention n $nmbr$
1713;vka  only reason;"C0205171;C0392360;C1720467";NA;NA;vka only reason
1713;redon;NA;NA;NA;redon
1713;pci indication;"C0392360;C3146298;C4049621";NA;NA;pci indication
1713;patient ' s preference not to take vka  only reason * *;"C0040363;C0041260;C0205171;C0376409;C0392360;C1515187;C1518422;C1720467;C1883351";NA;NA;patient s preference not to take vka only reason
1713;indication for stent;"C0038257;C0392360;C3146298";NA;NA;indication for stent
1713;indication for pci;"C0392360;C3146298;C4049621";NA;NA;indication for pci
1713;indication for index pci;"C0392360;C0600653;C0918012;C1552854;C1637833;C2986546;C3146298;C4049621";NA;NA;indication for index pci
1713;indication;"C0392360;C3146298";NA;NA;indication
1712;steroid - sparing remission *;"C0038317;C0544452;C0687702";NA;NA;steroid sparing remission
1712;steroid - free remission;"C0038317;C0332296;C0544452;C0687702;C1880497;C1996904";NA;NA;steroid free remission
1712;remission in overall population;"C0032659;C0282416;C0544452;C0687702;C1257890;C1561607";NA;NA;remission in overall population
1712;remission component of variable;"C0439828;C0449432;C0544452;C0687702;C1705248;C4553760";NA;NA;remission component of variable
1712;remission by : baseline steroid doses;"C0038317;C0168634;C0178602;C0544452;C0687702;C1442488";NA;NA;remission by baseline steroid doses
1712;remission  n ( % );"C0544452;C0687702";NA;NA;remission n
1712;remission;"C0544452;C0687702";NA;NA;remission
1712;asdas inactive disease  %;C0544452;NA;NA;asdas inactive disease
1711;no regular consumption;"C0009830;C0205272;C1947907";NA;NA;no regular consumption
1711;constitutional;C1511487;NA;NA;constitutional
1711;constipation;"C0009806;C1963087;C3641755;C4084722;C4084723;C4084724";NA;NA;constipation
1710;priorother ( predefined ) medical conditions;"C0012634;C0199168;C0205476;C0348080;C1705253;C3864998";NA;NA;priorother predefined medical conditions
1710;priorother ( not predefined ) medical conditions;"C0012634;C0199168;C0205476;C0348080;C1518422;C1705253;C3864998";NA;NA;priorother not predefined medical conditions
1710;prespecified medical conditions  n ( % ) f;"C0012634;C0016327;C0199168;C0205476;C0348080;C1705253;C3864998";NA;NA;prespecified medical conditions n f
1710;presenting condition  n ( % );"C0012634;C0348080;C0449450;C1705253;C3864998";NA;NA;presenting condition n
1710;medical conditions  no . ( % );"C0012634;C0199168;C0205476;C0348080;C1705253;C3864998";NA;NA;medical conditions no
1710;known thrombophilic condition — no . ( % );"C0012634;C0205309;C0348080;C0398623;C1705253;C3864998";NA;NA;known thrombophilic condition no
1710;currentother ( notpredefined ) medical conditions;"C0012634;C0199168;C0205476;C0348080;C1705253;C3864998";NA;NA;currentother notpredefined medical conditions
1710;current other ( predefined ) medical conditions;"C0012634;C0199168;C0205476;C0348080;C0521116;C1705253;C1705970;C3864998";NA;NA;current other predefined medical conditions
1710;contusion;C0009938;NA;NA;contusion
1710;condition $nmbr$ ( $nmbr$ . $nmbr$ );"C0012634;C0348080;C1705253;C3864998";NA;NA;condition $nmbr$ $nmbr$ $nmbr$
1710;coexisting conditions — no . ( % );"C0012634;C0348080;C1705253;C3864998";NA;NA;coexisting conditions no
1710;coexisting conditions;C0679225;NA;NA;coexisting conditions
1710;any condition;"C0012634;C0348080;C1705253;C3864998";NA;NA;any condition
1709;time from randomization to study - drug initiation — hr;"C0013175;C0013227;C0034656;C0040223;C0040227;C0589507;C1158830;C1254351;C1704686;C2349982;C3541383";NA;NA;time from randomization to study drug initiation hr
1709;time from randomization to study - drug administration — hr;"C0013175;C0034656;C0040227;C0150270;C0206209;C2349982;C3469597";NA;NA;time from randomization to study drug administration hr
1709;time from acs to randomization ( median  iqr );"C0034656;C0040223;C0549183;C0742343;C0876920;C2347635;C2348144;C2939193;C3541383;C4318612";NA;NA;time from acs to randomization median iqr
1709;time from acs to randomization;"C0034656;C0040223;C0742343;C3541383;C4318612";NA;NA;time from acs to randomization
1709;randomization to arterial sheath insertion;"C0003842;C0021107;C0034656;C0221464;C0227952;C0441587;C1512796;C1883719";NA;NA;randomization to arterial sheath insertion
1709;randomization to;C0034656;NA;NA;randomization to
1709;randomization - to -;C0034656;NA;NA;randomization to
1709;history of diagnosed hypertension prior to randomization  n ( % );"C0011900;C0034656;C0455527";NA;NA;history of diagnosed hypertension prior to randomization n
1709;days from acs to randomization;"C0034656;C0439228;C0742343;C4318612";NA;NA;days from acs to randomization
1709;$nmbr$ tol ( n = $nmbr$ );NA;NA;NA;$nmbr$ tol n $nmbr$
1708;interval pain onset to admission;"C0184666;C0809949;C1272706;C1507009;C1552654;C1552713";NA;NA;interval pain onset to admission
1708;$nmbr$ b ( $nmbr$ b to > $nmbr$ a );NA;NA;NA;$nmbr$ b $nmbr$ b to $nmbr$ a
1708;$nmbr$ b ( $nmbr$ b to $nmbr$ a );NA;NA;NA;$nmbr$ b $nmbr$ b to $nmbr$ a
1707;immobilization — no . ( % );"C0020944;C4048292";NA;NA;immobilization no
1707;immobilization at randomization  n ( % );"C0020944;C0034656;C4048292";NA;NA;immobilization at randomization n
1707;immobilization;"C0020944;C4048292";NA;NA;immobilization
1707;immobazaton;NA;NA;NA;immobazaton
1706;tni ultrapositive ≥ $nmbr$ . $nmbr$ µ g / l  n   =   $nmbr$   $nmbr$;"C0077401;C0439294;C0456615";NA;NA;tni ultrapositive $nmbr$ $nmbr$ g l n $nmbr$ $nmbr$
1706;tni ultrapositive  ≥ $nmbr$ . $nmbr$ µ g / l  n   =   $nmbr$   $nmbr$;"C0077401;C0439294;C0456615";NA;NA;tni ultrapositive $nmbr$ $nmbr$ g l n $nmbr$ $nmbr$
1706;apolipoprotein b ( g / l );"C0003593;C0439294;C0456615";NA;NA;apolipoprotein b g l
1706;apolipoprotein b  mean ( sd )  g / l;"C0003593;C0439294;C0444504;C0456615;C2347634;C2348143;C2699239";NA;NA;apolipoprotein b mean sd g l
1706;> $nmbr$ . $nmbr$ - g / l;"C0439294;C0456615";NA;NA;$nmbr$ $nmbr$ g l
1706;$nmbr$ . $nmbr$ ( g . l );"C0439294;C0456615";NA;NA;$nmbr$ $nmbr$ g l
1705;use of parenteral antithrombotic agents — no . ( % );"C0030547;C1524063;C1704311;C4522267";NA;NA;use of parenteral antithrombotic agents no
1705;antithrombotic agents  n ( % );C1704311;NA;NA;antithrombotic agents n
1705;antithrombotic agents;C1704311;NA;NA;antithrombotic agents
1705;antithrombotic / coagulant;C0009117;NA;NA;antithrombotic coagulant
1705;antithrombotic;NA;NA;NA;antithrombotic
1705;$nmbr$ prolonged antithrombotic pretreatment ( n = $nmbr$ );"C0439590;C1550147;C2709094;C3539075;C3539076";NA;NA;$nmbr$ prolonged antithrombotic pretreatment n $nmbr$
1704;short - acting anticholinergics;"C0079613;C0242896;C1282927;C1704930;C1806781;C1869853;C2350002;C3537307;C3540711;C3890007;C4048375";NA;NA;short acting anticholinergics
1704;baseline short - acting anticholinergics  n ( % );"C0079613;C0168634;C0242896;C1282927;C1442488;C1704930;C1806781;C1869853;C2350002;C3537307;C3540711;C3890007;C4048375";NA;NA;baseline short acting anticholinergics n
1704;baseline short - acting anticholinergics;"C0079613;C0168634;C0242896;C1282927;C1442488;C1704930;C1806781;C1869853;C2350002;C3537307;C3540711;C3890007;C4048375";NA;NA;baseline short acting anticholinergics
1704;anticholinergics;"C0242896;C3537307;C3540711";NA;NA;anticholinergics
1704;anticholinergic use  n ( % );"C0042153;C0242896;C0457083;C1947944;C3537004";NA;NA;anticholinergic use n
1704;anticholinergic drug;C0242896;NA;NA;anticholinergic drug
1704;anticholinergic;"C0242896;C3537004";NA;NA;anticholinergic
1703;time from symptom onset to start of fibrinolytic therapy — hr;"C0040044;C0040223;C0040363;C0041260;C0439659;C0449244;C1457887;C1883351;C3541383;C3854129;C4086878";NA;NA;time from symptom onset to start of fibrinolytic therapy hr
1703;time from onset of symptoms to start of fibrinolytic therapy — hr;"C0040044;C0040363;C0041260;C0439659;C1320528;C1883351";NA;NA;time from onset of symptoms to start of fibrinolytic therapy hr
1703;time from fibrinolytic therapy to study - drug administration — no . / total no . ( % );"C0013175;C0013216;C0040044;C0040223;C0040227;C0150270;C0206209;C0439175;C0439810;C0557651;C1611232;C2349982;C2603343;C3469597;C3541383;C3665478";NA;NA;time from fibrinolytic therapy to study drug administration no total no
1703;thrombolytic therapy;C0040044;NA;NA;thrombolytic therapy
1703;fibrinolytics;C0040044;NA;NA;fibrinolytics
1703;fibrinolytic therapy — no . ( % );C0040044;NA;NA;fibrinolytic therapy no
1703;fibrinolytic;C0040044;NA;NA;fibrinolytic
1702;tonic – clonic;C3543842;NA;NA;tonic clonic
1702;tonic;C3543842;NA;NA;tonic
1702;functional assessment of chronic illness;"C0008679;C0278372";NA;NA;functional assessment of chronic illness
1702;clonic;NA;NA;NA;clonic
1701;patients without chronic;"C0030705;C0205191";NA;NA;patients without chronic
1701;patients with chronic;"C0030705;C0205191";NA;NA;patients with chronic
1701;in patients with a history of chronic angina who have presented with an acute;"C0002962;C0205178;C0205191;C0449450;C0679831";NA;NA;in patients with a history of chronic angina who have presented with an acute
1701;chronic cvd;"C0007222;C0205191";NA;NA;chronic cvd
1701;chronic cox $nmbr$ inhibitors;"C0085387;C0205191";NA;NA;chronic cox $nmbr$ inhibitors
1701;chronic bronchitist;C0205191;NA;NA;chronic bronchitist
1701;cholecystitis chronic;"C0008325;C0205191;C1963083;C4553186";NA;NA;cholecystitis chronic
1700;nordic countries;C0036273;NA;NA;nordic countries
1700;nordic;C0331873;NA;NA;nordic
1700;hordic;NA;NA;NA;hordic
1700;aortic valve disease ( n = $nmbr$ $nmbr$ );"C1260873;C4553103";NA;NA;aortic valve disease n $nmbr$ $nmbr$
1700;aortic - valve replacement;C0003506;NA;NA;aortic valve replacement
1700;aortic;C0003483;NA;NA;aortic
1699;abdominal aortic — no . ( % );C0003484;NA;NA;abdominal aortic no
1699;$nmbr$ mortis;NA;NA;NA;$nmbr$ mortis
1698;risk factors for atherosclerosis;"C0003850;C0004153;C0035648;C1553898";NA;NA;risk factors for atherosclerosis
1698;qualifying type of atherosclerosis — no . ( % );"C0003850;C0004153;C0332307;C1514624;C1547052";NA;NA;qualifying type of atherosclerosis no
1698;qualifying type of atherosclerosis  n ( % );"C0003850;C0004153;C0332307;C1514624;C1547052";NA;NA;qualifying type of atherosclerosis n
1698;qualifying atherosclerosis;"C0003850;C0004153;C1514624";NA;NA;qualifying atherosclerosis
1698;large - artery atherosclerosis;"C0003850;C0004153;C0226003";NA;NA;large artery atherosclerosis
1698;high risk with atherosclerotic vascular disease *;"C0004153;C0332167;C3272283;C4050568;C4319571";NA;NA;high risk with atherosclerotic vascular disease
1698;established atherosclerotic cardiovascular disease — no . { % );"C0004153;C0443211;C1272684";NA;NA;established atherosclerotic cardiovascular disease no
1698;established atherosclerotic cardiovascular disease;"C0004153;C0443211;C1272684";NA;NA;established atherosclerotic cardiovascular disease
1698;atherosclerotic vascular disease — no .;C0004153;NA;NA;atherosclerotic vascular disease no
1698;atherosclerotic vascular disease  n ( % ) §;C0004153;NA;NA;atherosclerotic vascular disease n
1698;atherosclerotic cardiovascular disease *;C0004153;NA;NA;atherosclerotic cardiovascular disease
1698;atherosclerotic cardiovascular disease;C0004153;NA;NA;atherosclerotic cardiovascular disease
1698;atherosclerosis ^  n ( % );"C0003850;C0004153";NA;NA;atherosclerosis n
1698;atherosclerosis;"C0003850;C0004153";NA;NA;atherosclerosis
1698;arteriosclerosis;C0003850;NA;NA;arteriosclerosis
1696;rosuvastain + fenofibric acid   n   =   $nmbr$;C0060179;NA;NA;rosuvastain fenofibric acid n $nmbr$
1696;rosuvastain + fenofibric acid $nmbr$ = $nmbr$;C0060179;NA;NA;rosuvastain fenofibric acid $nmbr$ $nmbr$
1696;fenofibric acid   n   =   $nmbr$;C0060179;NA;NA;fenofibric acid n $nmbr$
1696;fenofibric acid + moderate - dose statin;"C0060179;C0360714;C1709056";NA;NA;fenofibric acid moderate dose statin
1696;fenofibric acid $nmbr$ = $nmbr$;C0060179;NA;NA;fenofibric acid $nmbr$ $nmbr$
1696;fenofibric acid;C0060179;NA;NA;fenofibric acid
1696;fenofibric;NA;NA;NA;fenofibric
1696;drosuvastatin + fenofibric acid vs . fenofibric acid monotherapy .;C0060179;NA;NA;drosuvastatin fenofibric acid vs fenofibric acid monotherapy
1695;gemfibrozil ( n = $nmbr$;C0017245;NA;NA;gemfibrozil n $nmbr$
1695;gemfibrozil;C0017245;NA;NA;gemfibrozil
1694;aerobic exercise;C0001701;NA;NA;aerobic exercise
1694;aerobic activity;C0001701;NA;NA;aerobic activity
1693;notable abnormalities;"C0000768;C0000769;C4288581";NA;NA;notable abnormalities
1697;other atherosclerotic cvdd  e;"C0333482;C1859330";FALSE;1698;other atherosclerotic cvdd e
1697;other atherosclerotic cvd st depression on;"C0007222;C0333482;C0520887";FALSE;1698;other atherosclerotic cvd st depression on
1697;other atherosclerotic event;"C0333482;C0441471;C4019010";FALSE;1698;other atherosclerotic event
1693;concordant stress test abnormalities;"C0000768;C0000769;C0015260;C3494508;C4553529";NA;NA;concordant stress test abnormalities
1692;subscale  and $nmbr$ to $nmbr$ for the function subscale  normalized scores can range from $nmbr$ to $nmbr$ . scores for the health assessment question -;"C0031843;C0040363;C0041260;C0175637;C0449820;C0459443;C0542341;C0700205;C1514721;C1522634;C1705273;C1882115;C1883351;C2348147;C3542016";NA;NA;subscale and $nmbr$ to $nmbr$ for the function subscale normalized scores can range from $nmbr$ to $nmbr$ scores for the health assessment question
1692;normalized;C1882115;NA;NA;normalized
1691;oral aminosalicylates;"C0368663;C0442027;C4521986";NA;NA;oral aminosalicylates
1691;no aminosalicylates  n;C0368663;NA;NA;no aminosalicylates n
1691;concomitant aminosalicylates  n [ % ] concomitant corticosteroids  n [ % ] mayo score  mean [ sd ];"C0001617;C0368663;C0444504;C0449820;C0454788;C0521115;C1077578;C2347634;C2348143;C2699239;C3539185;C3540725;C3540726;C3540727;C4050231";NA;NA;concomitant aminosalicylates n concomitant corticosteroids n mayo score mean sd
1691;aminosalicylates * *;C0368663;NA;NA;aminosalicylates
1691;aminosalicylates  n;C0368663;NA;NA;aminosalicylates n
1691;aminosalicylates;C0368663;NA;NA;aminosalicylates
1691;aminosalicylate;"C0368663;C2825094";NA;NA;aminosalicylate
1691;$nmbr$ - aminosalicylates ’ i  i ‘;"C0021966;C0221138;C0368663";NA;NA;$nmbr$ aminosalicylates i i
1691;$nmbr$ - aminosalicylates | | | |;C0368663;NA;NA;$nmbr$ aminosalicylates
1691;$nmbr$ - aminosalicylates {;C0368663;NA;NA;$nmbr$ aminosalicylates
1690;poor compliance / noncompliance;"C0032646;C0376405;C0457432";NA;NA;poor compliance noncompliance
1690;noncompliant;C0457432;NA;NA;noncompliant
1690;non - compliance;"C0376405;C0457432";NA;NA;non compliance
1689;nonblack ( n = $nmbr$ )  adjusted hazard ratio *;"C0456081;C2985465";NA;NA;nonblack n $nmbr$ adjusted hazard ratio
1689;nonblack ( n = $nmbr$ );NA;NA;NA;nonblack n $nmbr$
1689;nonblack;NA;NA;NA;nonblack
1688;not at goal;"C0018017;C1518422;C1571704";NA;NA;not at goal
1688;goal;"C0018017;C1571704";NA;NA;goal
1688;distance to ldl - c goal;"C0012751;C0018017;C1571704";NA;NA;distance to ldl c goal
1688;at ldl - c ( bq ) goal * at baseline - no . ( % );"C0018017;C0168634;C0560038;C1442488;C1571704;C3541236";NA;NA;at ldl c bq goal at baseline no
1688;at goal;"C0018017;C1571704";NA;NA;at goal
1688;% to goal;"C0018017;C1571704";NA;NA;to goal
1687;ldl - c goal attainment;C0680230;NA;NA;ldl c goal attainment
1687;dual bp / ldl - c goal attainment;"C0037623;C0205173;C0680230;C1415692;C1554184;C1708288;C4318478";NA;NA;dual bp ldl c goal attainment
1687;bp goal attainment;"C0037623;C0680230;C1415692;C1708288;C4318478";NA;NA;bp goal attainment
1686;getgoal - s;NA;NA;NA;getgoal s
1686;getgoal - l - asia;C0003980;NA;NA;getgoal l asia
1685;total ldl - c *;"C0439175;C0439810";NA;NA;total ldl c
1685;total body ( without head );"C0018670;C0229960;C1706305";NA;NA;total body without head
1685;total body;C0229960;NA;NA;total body
1685;total bleeds;C0232100;NA;NA;total bleeds
1685;total bleeding;C0232100;NA;NA;total bleeding
1685;ldl *;NA;NA;NA;ldl
1684;total bilirubin > $nmbr$ x uln $nmbr$;"C0005437;C0368753;C1519815";NA;NA;total bilirubin $nmbr$ x uln $nmbr$
1684;total bilirubin  mg / dl;"C0005437;C0368753;C0439269";NA;NA;total bilirubin mg dl
1683;mitral regurgitation  n ( % );C0026266;NA;NA;mitral regurgitation n
1683;mitral regurgitation  ( % );C0026266;NA;NA;mitral regurgitation
1683;mitral insufficiency  n ( % );C0026266;NA;NA;mitral insufficiency n
1683;mitral insufficiency;C0026266;NA;NA;mitral insufficiency
1683;italy ( n = $nmbr$ );C0022277;NA;NA;italy n $nmbr$
1683;italy;C0022277;NA;NA;italy
1682;nonfatal mi + fatal chdt;"C1302234;C1705232;C3810814";NA;NA;nonfatal mi fatal chdt
1682;non - fatal mi;"C1302234;C1518422;C1705232;C3810814";NA;NA;non fatal mi
1682;mi ( fatal / nonfatal );"C1302234;C1705232;C3810814";NA;NA;mi fatal nonfatal
1682;fatal or nonfatal myocardial infarction;"C0027051;C0428953;C1302234;C1705232;C2926063;C3810814;C4552959";NA;NA;fatal or nonfatal myocardial infarction
1682;fatal or non - fatal myocardial infarction;"C0027051;C0428953;C1302234;C1518422;C1705232;C2926063;C3810814;C4552959";NA;NA;fatal or non fatal myocardial infarction
1682;fatal chd and nonfatal mia;"C0280604;C1302234;C1417154;C1705232;C3542407";NA;NA;fatal chd and nonfatal mia
1682;fatal / nonfatal mi  n ( % );"C1302234;C1705232;C3810814";NA;NA;fatal nonfatal mi n
1682;fatal & nonfatal ccvd;"C1302234;C1705232";NA;NA;fatal nonfatal ccvd
1682;fatal;"C1302234;C1705232";NA;NA;fatal
1682;disabling or fatal stroke;"C0038454;C1302234;C1705232;C4554100";NA;NA;disabling or fatal stroke
1682;disabling or fatal;"C1302234;C1705232";NA;NA;disabling or fatal
1682;cv death  non - fatal mi or non - fatal stroke;"C0011065;C0038454;C1302234;C1306577;C1518422;C1705232;C3538987;C3810814;C4048877;C4082313;C4318503;C4552775;C4554100";NA;NA;cv death non fatal mi or non fatal stroke
1682;chd ( nonfatal mi + fatal chd );"C0280604;C1302234;C1705232;C3542407;C3810814";NA;NA;chd nonfatal mi fatal chd
1681;oil;"C0028908;C0032085;C1517288;C3541397";NA;NA;oil
1681;fish oil ( n = $nmbr$ );C0016157;NA;NA;fish oil n $nmbr$
1681;fish oil;C0016157;NA;NA;fish oil
1681;- oil;"C0028908;C0032085;C1517288;C3541397";NA;NA;oil
1680;mean percentage change from baseline to final visit;"C0168634;C0205088;C0392747;C0439165;C0443172;C0444504;C0545082;C1442488;C1512346;C1546485;C1549488;C1561533;C1705241;C2347634;C2348143;C2826704;C3853528;C4319952";NA;NA;mean percentage change from baseline to final visit
1680;final mean  mg / dl;"C0205088;C0439269;C0444504;C1546485;C2347634;C2348143;C3853528";NA;NA;final mean mg dl
1680;final mean;"C0205088;C0444504;C1546485;C2347634;C2348143;C3853528";NA;NA;final mean
1680;final a $nmbr$ c ( % );"C0205088;C1546485;C3853528";NA;NA;final a $nmbr$ c
1680;final ( mg / dl );"C0205088;C0439269;C1546485;C3853528";NA;NA;final mg dl
1680;final;"C0205088;C1546485;C3853528";NA;NA;final
1680;change from baseline to final apbm;"C0168634;C0205088;C0392747;C0443172;C1442488;C1546485;C1705241;C3853528;C4319952";NA;NA;change from baseline to final apbm
1679;triglycerides  mmol / lf;"C0041004;C0439190;C1416933;C2986618;C4554443";NA;NA;triglycerides mmol lf
1679;serum creatinine  umol / lf;"C0201976;C0439194;C0600061;C1416933;C2986618;C4554443";NA;NA;serum creatinine umol lf
1679;$nmbr$ . $nmbr$ ± $nmbr$ . lf;"C1416933;C2986618;C4554443";NA;NA;$nmbr$ $nmbr$ $nmbr$ lf
1679;$nmbr$ % clf;"C3540486;C4553190";NA;NA;$nmbr$ clf
1678;ldl cholesterol  mmol / lt;"C0023376;C0023824;C0202117;C0230426;C0439190;C3887647;C4521399";NA;NA;ldl cholesterol mmol lt
1678;hdl cholesterol  mmol / lt;"C0023376;C0023822;C0230426;C0392885;C0439190;C3887647;C4521399";NA;NA;hdl cholesterol mmol lt
1678;fpg  mmol / lt;"C0023376;C0230426;C0439190;C3887647;C4521399";NA;NA;fpg mmol lt
1678;$nmbr$ . $nmbr$ ± o . lt;"C0023376;C0230426;C0483204;C3887647;C4521399";NA;NA;$nmbr$ $nmbr$ o lt
1677;time from ld to pci  min  median ( q $nmbr$ – q $nmbr$ );"C0040223;C0549183;C0694649;C0702093;C0876920;C1524029;C2347635;C2348144;C2939193;C3541383;C3813700;C4049621";NA;NA;time from ld to pci min median q $nmbr$ q $nmbr$
1677;ld;C0694649;NA;NA;ld
1677;cg / ld;"C0043444;C0694649;C1567075;C3540479";NA;NA;cg ld
1677;$nmbr$ mg ld;"C0024671;C0026410;C0439269;C0694649;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ mg ld
1676;normal ( ≤   uln ) n   =   $nmbr$;"C0205307;C0231683;C0439166;C1519815;C2347086;C4553972";NA;NA;normal uln n $nmbr$
1676;cpk > $nmbr$ times uln;"C0040223;C1519815;C1632851";NA;NA;cpk $nmbr$ times uln
1676;ast > $nmbr$ x uln on two consecutive visits;"C0205448;C0545082;C1415181;C1512346;C1519815;C1707491;C3891303";NA;NA;ast $nmbr$ x uln on two consecutive visits
1676;alt or ast > $nmbr$ x uln $nmbr$;"C1266129;C1415181;C1519815;C3891303;C4553172";NA;NA;alt or ast $nmbr$ x uln $nmbr$
1676;alt and / or ast > $nmbr$ times uln consecutive #;"C0040223;C1266129;C1415181;C1519815;C1632851;C1707491;C3891303;C4553172";NA;NA;alt and or ast $nmbr$ times uln consecutive
1676;alt > $nmbr$ x uln on two consecutive visits;"C0205448;C0545082;C1266129;C1512346;C1519815;C1707491;C4553172";NA;NA;alt $nmbr$ x uln on two consecutive visits
1676;alt  ast  or both > $nmbr$ x uln;"C1519815;C3831581";NA;NA;alt ast or both $nmbr$ x uln
1676;> $nmbr$ uln;C1519815;NA;NA;$nmbr$ uln
1675;ck > $nmbr$ xuln;"C0009212;C0010287;C1872855";NA;NA;ck $nmbr$ xuln
1675;ck > $nmbr$ x uln $nmbr$;"C0009212;C0010287;C1519815;C1872855";NA;NA;ck $nmbr$ x uln $nmbr$
1675;< $nmbr$ xuln;NA;NA;NA;$nmbr$ xuln
1674;cardiac rhythm disorders;C0264886;NA;NA;cardiac rhythm disorders
1674;cardiac rhythm disorder at baseline no;"C0168634;C0264886;C1442488";NA;NA;cardiac rhythm disorder at baseline no
1674;cardiac rhythm;C0232187;NA;NA;cardiac rhythm
1673;sinus rhythm at baseline;"C0168634;C0232201;C1442488";NA;NA;sinus rhythm at baseline
1673;sinus rhythm;C0232201;NA;NA;sinus rhythm
1672;mixed chronic bronchitis and emphysema;"C0008677;C0013990;C0034067;C0205430;C3160715";NA;NA;mixed chronic bronchitis and emphysema
1672;emphysema ( n = $nmbr$ );"C0013990;C0034067";NA;NA;emphysema n $nmbr$
1672;emphysema ( itt ) ( n = $nmbr$ );"C0013990;C0034067";NA;NA;emphysema itt n $nmbr$
1672;emphysema ( % );"C0013990;C0034067";NA;NA;emphysema
1672;emphysema;"C0013990;C0034067";NA;NA;emphysema
1672;centrilobular emphysema;C0221227;NA;NA;centrilobular emphysema
1671;psycholeptics;C3653516;NA;NA;psycholeptics
1671;psychogenic;C0458006;NA;NA;psychogenic
1671;psychoactivesd;NA;NA;NA;psychoactivesd
1670;non - ischemic;"C0475224;C1518422";NA;NA;non ischemic
1670;non - ischaemic cause;"C0015127;C0475224;C1518422;C1524003";NA;NA;non ischaemic cause
1670;non - ischaemic ( n = $nmbr$ o $nmbr$ );"C0475224;C1518422";NA;NA;non ischaemic n $nmbr$ o $nmbr$
1670;non - ischaemic ( n = $nmbr$ );"C0475224;C1518422";NA;NA;non ischaemic n $nmbr$
1670;non - ischaemic;"C0475224;C1518422";NA;NA;non ischaemic
1670;ischemic outcomes;"C0475224;C1274040";NA;NA;ischemic outcomes
1670;ischemic cause;"C0015127;C0475224;C1524003";NA;NA;ischemic cause
1670;ischemic;C0475224;NA;NA;ischemic
1670;ischaemic skin lesions;"C0037284;C0475224";NA;NA;ischaemic skin lesions
1670;ischaemic cause;"C0015127;C0475224;C1524003";NA;NA;ischaemic cause
1670;ischaemic ( n = $nmbr$ l $nmbr$ );C0475224;NA;NA;ischaemic n $nmbr$ l $nmbr$
1670;ischaemic ( n = $nmbr$ );C0475224;NA;NA;ischaemic n $nmbr$
1670;ischaemic  n ( % );C0475224;NA;NA;ischaemic n
1670;ischaemic;C0475224;NA;NA;ischaemic
1669;• ischemic stroke;C0948008;NA;NA;ischemic stroke
1669;prior ischemic stroke;"C0332152;C0948008;C2826257";NA;NA;prior ischemic stroke
1669;previous ischemic stroke ortia;"C0205156;C0948008;C1552607";NA;NA;previous ischemic stroke ortia
1669;previous ischemic stroke / tia ( n = $nmbr$  $nmbr$ . $nmbr$ % );"C0007787;C0205156;C0917805;C0948008;C1054154;C1552607";NA;NA;previous ischemic stroke tia n $nmbr$ $nmbr$ $nmbr$
1669;previous ischemic stroke  n ( % );"C0205156;C0948008;C1552607";NA;NA;previous ischemic stroke n
1669;post - acute ischemic stroke;"C0205178;C0475224;C0687676;C0751956;C0948008;C1704687;C3469826";NA;NA;post acute ischemic stroke
1669;nonfatal ischemic stroke;C0948008;NA;NA;nonfatal ischemic stroke
1669;no previous ischemic stroke / tia ( n = $nmbr$ $nmbr$  $nmbr$ . $nmbr$ % );"C0007787;C0205156;C0917805;C0948008;C1054154;C1552607";NA;NA;no previous ischemic stroke tia n $nmbr$ $nmbr$ $nmbr$ $nmbr$
1669;minor ischaemic stroke;"C0026193;C0205165;C0948008";NA;NA;minor ischaemic stroke
1669;ischemic stroke with hemnrrhnaic cnnversinn;C0948008;NA;NA;ischemic stroke with hemnrrhnaic cnnversinn
1669;ischemic stroke subtype;"C0449560;C0948008";NA;NA;ischemic stroke subtype
1669;ischemic stroke ( % );C0948008;NA;NA;ischemic stroke
1669;ischemic stroke;C0948008;NA;NA;ischemic stroke
1669;ischaemic stroke  n ( % );C0948008;NA;NA;ischaemic stroke n
1669;ischaemic stroke;C0948008;NA;NA;ischaemic stroke
1669;cvdeath  ml  or ischemic stroke;"C0439526;C0948008;C1705224;C3887665";NA;NA;cvdeath ml or ischemic stroke
1669;cv death  ml  ischemic stroke  hosp . for hf  cor . revasc .  ua;"C0011065;C0018488;C0018787;C0041580;C0042014;C0056331;C0378365;C0439526;C0948008;C1306577;C1313497;C1538440;C1705224;C3273279;C3538987;C3887665;C4048877;C4082313;C4318503;C4552775";NA;NA;cv death ml ischemic stroke hosp for hf cor revasc ua
1669;cv death  ml  ischemic stroke;"C0011065;C0439526;C0948008;C1306577;C1705224;C3538987;C3887665;C4048877;C4082313;C4318503;C4552775";NA;NA;cv death ml ischemic stroke
1669;all ischemic stroke;C0948008;NA;NA;all ischemic stroke
1668;severe recurrent ischemia;"C0022116;C0205082;C1455761;C2945760;C4050465;C4050466;C4321499";NA;NA;severe recurrent ischemia
1668;recurrent ischemia - urgent revascularization;"C0022116;C0439609;C0581603;C1455761;C2945760;C3272275;C4321499";NA;NA;recurrent ischemia urgent revascularization
1668;recurrent ischemia;"C0022116;C1455761;C2945760;C4321499";NA;NA;recurrent ischemia
1668;rec . ischemia requiring revasc;"C0022116;C0378365;C1424025;C2606415;C4321499";NA;NA;rec ischemia requiring revasc
1668;rec . ischemia leading to hosp;"C0022116;C0332152;C1424025;C1522538;C2606415;C4321499";NA;NA;rec ischemia leading to hosp
1668;rec . ischemia leading to hasp;"C0022116;C0332152;C1424025;C1522538;C2606415;C4321499";NA;NA;rec ischemia leading to hasp
1668;rec . ischemia;"C0022116;C1424025;C2606415;C4321499";NA;NA;rec ischemia
1668;no p value for ischemia ischemia hr ( $nmbr$ % ci ) interaction;"C0008107;C0022116;C1704675;C1709380;C3259781;C4321499";NA;NA;no p value for ischemia ischemia hr $nmbr$ ci interaction
1668;no ischemia ( n = $nmbr$  $nmbr$ );"C0022116;C4321499";NA;NA;no ischemia n $nmbr$ $nmbr$
1668;ischemia on cecg ( n = $nmbr$  $nmbr$ );"C0022116;C4321499";NA;NA;ischemia on cecg n $nmbr$ $nmbr$
1668;ischemia on cecg ( % );"C0022116;C4321499";NA;NA;ischemia on cecg
1668;ischemia driven revascularization;"C0022116;C0581603;C4321499;C4683688";NA;NA;ischemia driven revascularization
1668;ischemia - driven revascularization;"C0022116;C0581603;C4321499;C4683688";NA;NA;ischemia driven revascularization
1668;ischemia;"C0022116;C4321499";NA;NA;ischemia
1668;global ischemia ( % ) * *;"C0022116;C0205246;C2348867;C4321499";NA;NA;global ischemia
1668;global ischemia;"C0022116;C0205246;C2348867;C4321499";NA;NA;global ischemia
1668;effect of ranolazine compared with placebo on angina and recurrent ischemia;"C0002962;C0022116;C0032042;C0073633;C1280500;C1455761;C1518681;C1696465;C1706408;C1707455;C2348382;C2945760;C4321499";NA;NA;effect of ranolazine compared with placebo on angina and recurrent ischemia
1668;anti - ischaemia agents *;"C0022116;C0040616;C4321499";NA;NA;anti ischaemia agents
1667;haq score ( $nmbr$ – $nmbr$ scale );"C0102923;C0175659;C0349674;C0449820;C0451208;C1947916;C4050231";NA;NA;haq score $nmbr$ $nmbr$ scale
1667;haq score;"C0102923;C0449820;C0451208;C4050231";NA;NA;haq score
1667;haq pain score;"C0102923;C0451208;C0582148";NA;NA;haq pain score
1667;haq alternative disability score;"C0102923;C0231170;C0449820;C0451208;C1523987;C4050231";NA;NA;haq alternative disability score
1667;haq;"C0102923;C0451208";NA;NA;haq
1666;total hands score;"C0018563;C0439175;C0439810;C0449820;C1552914;C4050231";NA;NA;total hands score
1666;hands;"C0018563;C1552914";NA;NA;hands
1666;hand;"C0018563;C1552914";NA;NA;hand
1665;mean score on haq - di §;"C3533236;C3826998;C4321476";NA;NA;mean score on haq di
1323;women — no . ( % );C0043210;NA;NA;women no
1665;health assessment questionnaire - disability index;C4321476;NA;NA;health assessment questionnaire disability index
1665;haq di score ( range $nmbr$ - $nmbr$ )  mean ± sd;"C0444504;C0449820;C1514721;C2347634;C2348143;C2348147;C2699239;C3542016;C3826998;C4050231;C4321476";NA;NA;haq di score range $nmbr$ $nmbr$ mean sd
1665;haq di score ( $nmbr$ - $nmbr$ );"C0449820;C3826998;C4050231;C4321476";NA;NA;haq di score $nmbr$ $nmbr$
1665;haq di ( range $nmbr$ - $nmbr$ );"C1514721;C2348147;C3542016;C3826998;C4321476";NA;NA;haq di range $nmbr$ $nmbr$
1665;haq di;"C3826998;C4321476";NA;NA;haq di
1665;haq - di scoreff;"C3826998;C4321476";NA;NA;haq di scoreff
1665;haq - di scored;"C0449820;C3826998;C4321476";NA;NA;haq di scored
1665;haq - di score ( $nmbr$ - $nmbr$ )  mean ( sd );"C0444504;C0449820;C2347634;C2348143;C2699239;C3826998;C4050231;C4321476";NA;NA;haq di score $nmbr$ $nmbr$ mean sd
1665;haq - di score ( $nmbr$ - $nmbr$ );"C0449820;C3826998;C4050231;C4321476";NA;NA;haq di score $nmbr$ $nmbr$
1665;haq - di score;"C0449820;C3826998;C4050231;C4321476";NA;NA;haq di score
1665;haq - di mcide;"C3826998;C4321476";NA;NA;haq di mcide
1665;haq - di improvement from baseline to week $nmbr$;"C0168634;C0332174;C0439230;C1442488;C2986411;C3826998;C4321476";NA;NA;haq di improvement from baseline to week $nmbr$
1665;haq - di improvement > $nmbr$ . $nmbr$;"C2986411;C3826998;C4321476";NA;NA;haq di improvement $nmbr$ $nmbr$
1665;haq - di * *;"C3826998;C4321476";NA;NA;haq di
1665;haq - di *;"C3826998;C4321476";NA;NA;haq di
1665;haq - di ( range $nmbr$ - $nmbr$ );"C1514721;C2348147;C3542016;C3826998;C4321476";NA;NA;haq di range $nmbr$ $nmbr$
1665;haq - di ( $nmbr$ - $nmbr$ );"C3826998;C4321476";NA;NA;haq di $nmbr$ $nmbr$
1665;haq - di  range $nmbr$ - $nmbr$  mean ( sd );"C0444504;C1514721;C2347634;C2348143;C2348147;C2699239;C3542016;C3826998;C4321476";NA;NA;haq di range $nmbr$ $nmbr$ mean sd
1665;haq - di  number ( % );"C0237753;C0449788;C3826998;C4321476";NA;NA;haq di number
1665;haq - di;"C3826998;C4321476";NA;NA;haq di
1665;change in haq - di ( mean ) t;"C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C3826998;C4319952;C4321476";NA;NA;change in haq di mean t
1665;assessment of physical function ( $nmbr$ - $nmbr$  haq - di );"C0031809;C0031843;C0516981;C0542341;C0700205;C1261322;C1516048;C1705273;C3826998;C4049916;C4321476";NA;NA;assessment of physical function $nmbr$ $nmbr$ haq di
1665;( haq - di  $nmbr$ - $nmbr$ );"C3826998;C4321476";NA;NA;haq di $nmbr$ $nmbr$
1665;% with haq - di decrease > $nmbr$ . $nmbr$;"C0392756;C0547047;C3826998;C4321476";NA;NA;with haq di decrease $nmbr$ $nmbr$
1664;ipah / hpah;"C0152171;C0340543;C0637939;C1150929";NA;NA;ipah hpah
1664;ipah  hpah  hiv  drug or toxin induced;"C0013227;C0019682;C0019699;C0040549;C0152171;C0205263;C0340543;C0637939;C1150929;C1254351;C4522020";NA;NA;ipah hpah hiv drug or toxin induced
1664;hi ) ah ( % );"C0018619;C0239849;C1412082;C1412316;C1431594;C1836672;C4552857";NA;NA;hi ah
1663;time from pah diagnosis months;"C0011900;C0030123;C0556969;C1704338;C1704656;C3203102;C4284467";NA;NA;time from pah diagnosis months
1663;pooled pah - mctd and pah;"C0026272;C0030123;C1709595;C2349200;C3203102;C4284467;C4522255";NA;NA;pooled pah mctd and pah
1663;pah - ssc;"C0030123;C3203102;C3897657;C4284467";NA;NA;pah ssc
1663;pah - sle;"C0024141;C0030123;C3203102;C4284467";NA;NA;pah sle
1663;pah - mctd / ctd - other;"C0026272;C0030123;C1335071;C1442905;C3203102;C4284467";NA;NA;pah mctd ctd other
1663;pah - ctd;"C0030123;C1335071;C1442905;C3203102;C4284467";NA;NA;pah ctd
1662;subcutaneous unfractionated heparin;C0353681;NA;NA;subcutaneous unfractionated heparin
1662;subcutaneous injections;C0021499;NA;NA;subcutaneous injections
1662;subcutaneous ( n = $nmbr$ );C0443315;NA;NA;subcutaneous n $nmbr$
1662;mucocutaneous;NA;NA;NA;mucocutaneous
1661;prior percutaneous coronary intervention — no . / total no . ( % );"C0332152;C0439175;C0439810;C1532338;C2826257";NA;NA;prior percutaneous coronary intervention no total no
1661;prior percutaneous coronary intervention — no . ( % );"C0332152;C1532338;C2826257";NA;NA;prior percutaneous coronary intervention no
1661;prior percutaneous coronary intervention  n ( % );"C0332152;C1532338;C2826257";NA;NA;prior percutaneous coronary intervention n
1661;prior percutaneous coronary intervention;"C0332152;C1532338;C2826257";NA;NA;prior percutaneous coronary intervention
1661;previous percutaneous coronary intervention  %;"C0205156;C1532338;C1552607";NA;NA;previous percutaneous coronary intervention
1661;previous percutaneous coronary intervention;"C0205156;C1532338;C1552607";NA;NA;previous percutaneous coronary intervention
1661;percutaneous coronary revascularization;C1532338;NA;NA;percutaneous coronary revascularization
1661;percutaneous coronary intervention §;C1532338;NA;NA;percutaneous coronary intervention
1661;percutaneous coronary intervention n ( % );C1532338;NA;NA;percutaneous coronary intervention n
1661;percutaneous coronary intervention done *;C1532338;NA;NA;percutaneous coronary intervention done
1661;percutaneous coronary intervention  n ( % );C1532338;NA;NA;percutaneous coronary intervention n
1661;percutaneous coronary intervention;C1532338;NA;NA;percutaneous coronary intervention
1661;index percutaneous coronary intervention;"C0600653;C0918012;C1532338;C1552854;C1637833;C2986546";NA;NA;index percutaneous coronary intervention
1660;othert;NA;NA;NA;othert
1660;other supraventricular tachycardia;"C0039240;C1963244;C3815188";NA;NA;other supraventricular tachycardia
1660;nutraceuticals  n ( % );C1518478;NA;NA;nutraceuticals n
1660;any llt other than nutraceuticals  n ( % );"C1518478;C2347090";NA;NA;any llt other than nutraceuticals n
 -10;cutoffs;C1442160;NA;NA;cutoffs
1658;other bph - luts therapy;"C0005001;C0039798;C0087111;C0574785;C1363945;C1704272";NA;NA;other bph luts therapy
1658;luts severity;"C0439793;C0522510;C0574785";NA;NA;luts severity
1658;luts = lower urinary tract symptoms  is =;C0574785;NA;NA;luts lower urinary tract symptoms is
1658;luts / bph characteristics;"C0005001;C0574785;C1521970;C1704272";NA;NA;luts bph characteristics
1658;is domain luts severity ( % );"C0439793;C0522510;C0574785;C1880389;C1883221;C3541951";NA;NA;is domain luts severity
1658;bph - luts severity;"C0005001;C0439793;C0522510;C0574785;C1704272";NA;NA;bph luts severity
1658;baseline luts severity * :;"C0168634;C0439793;C0522510;C0574785;C1442488";NA;NA;baseline luts severity
1658;baseline luts severity  n ( % ) :;"C0168634;C0439793;C0522510;C0574785;C1442488";NA;NA;baseline luts severity n
1657;subsets;C1515021;NA;NA;subsets
1657;subset of patients on metformin;"C0025598;C0030705;C1515021";NA;NA;subset of patients on metformin
1657;subset of patients not on metformin;"C0025598;C0030705;C1515021;C1518422";NA;NA;subset of patients not on metformin
1657;other climate subset;"C0008946;C1515021";NA;NA;other climate subset
1657;hot climate subset;"C0178683;C1515021";NA;NA;hot climate subset
1656;musculoskeletal stiffness;"C0427008;C0497254;C2707260";NA;NA;musculoskeletal stiffness
1656;musculoskeletal;"C0497254;C2707260";NA;NA;musculoskeletal
1655;total subjects;"C0439175;C0439810;C0681850;C1550501;C1706203;C2349001;C2697811";NA;NA;total subjects
1655;subjects with prevalent vertebral fracture  n ( % ) prevalent vertebral fracture;"C0033105;C0080179;C0220900;C0681850;C1550501;C1706203;C2349001;C2697811";NA;NA;subjects with prevalent vertebral fracture n prevalent vertebral fracture
1655;subjects who did receive labd prior to the study;"C0332152;C0396059;C0557651;C0681850;C1514756;C1550501;C1706203;C2349001;C2603343;C2697811";NA;NA;subjects who did receive labd prior to the study
1655;subjects who did not receive labd prior to the study;"C0332152;C0396059;C0557651;C0681850;C1514756;C1518422;C1550501;C1706203;C2349001;C2603343;C2697811";NA;NA;subjects who did not receive labd prior to the study
1655;subjects randomized;"C0034656;C0681850;C1550501;C1706203;C2349001;C2697811;C3815594";NA;NA;subjects randomized
1655;subjects n;"C0369718;C0441922;C0681850;C1550501;C1706203;C2349001;C2697811";NA;NA;subjects n
1655;subjects ( n );"C0369718;C0441922;C0681850;C1550501;C1706203;C2349001;C2697811";NA;NA;subjects n
1655;subjects;"C0681850;C1550501;C1706203;C2349001;C2697811";NA;NA;subjects
1655;subject disposition  n ( % );"C0681850;C0743223;C1550501;C1705555;C1706203;C2349001;C2697811";NA;NA;subject disposition n
1655;subject completion status  n ( % );"C0205197;C0449438;C0681850;C0805732;C1550501;C1554962;C1706203;C2348577;C2349001;C2697811;C3891295";NA;NA;subject completion status n
1655;number of subjects in analysis;"C0002778;C0237753;C0449788;C0681850;C0936012;C1524024;C1550501;C1706203;C2349001;C2697811";NA;NA;number of subjects in analysis
1655;number of subjects;"C0237753;C0449788;C0681850;C1550501;C1706203;C2349001;C2697811";NA;NA;number of subjects
1655;no . of subjects;"C0681850;C1550501;C1706203;C2349001;C2697811";NA;NA;no of subjects
1655;n events / n subjects;"C0369718;C0441471;C0441922;C0681850;C1550501;C1706203;C2349001;C2697811;C3541888";NA;NA;n events n subjects
1655;mrf subjects;"C0312443;C0681850;C1412879;C1550501;C1706203;C2349001;C2697811";NA;NA;mrf subjects
1655;male subjects ( n = $nmbr$  $nmbr$ );"C0086582;C0369718;C0441922;C0681850;C1550501;C1706180;C1706203;C1706428;C1706429;C2349001;C2697811";NA;NA;male subjects n $nmbr$ $nmbr$
1655;in therapeutic range for warfarin subjects;"C0043031;C0460097;C0681850;C1550501;C1706203;C2349001;C2697811";NA;NA;in therapeutic range for warfarin subjects
1655;female subjects ( n = $nmbr$ );"C0043210;C0086287;C0369718;C0441922;C0681850;C1550501;C1705497;C1705498;C1706203;C2349001;C2697811";NA;NA;female subjects n $nmbr$
1655;diabetic subjects  n = $nmbr$;"C0241863;C0681850;C1550501;C1706203;C2349001;C2697811";NA;NA;diabetic subjects n $nmbr$
1655;cvd subjects;"C0007222;C0681850;C1550501;C1706203;C2349001;C2697811";NA;NA;cvd subjects
1655;concomitant medications in > $nmbr$ % of subjects  no . ( % );"C0013227;C0521115;C0681850;C0802604;C1550501;C1706203;C2349001;C2598133;C2697811;C4284232";NA;NA;concomitant medications in $nmbr$ of subjects no
1655;all subjects - n;"C0369718;C0441922;C0681850;C1550501;C1706203;C2349001;C2697811";NA;NA;all subjects n
1655;all subjects;"C0681850;C1550501;C1706203;C2349001;C2697811";NA;NA;all subjects
1655;( $nmbr$ subjects );"C0681850;C1550501;C1706203;C2349001;C2697811";NA;NA;$nmbr$ subjects
1654;exacerbations requiring oral steroids / antibiotics ( past year ) ( % );"C0003232;C0003237;C0038317;C0442027;C3540704;C3540705;C3540706;C3540707;C3540708;C3540709;C3540710;C4086268;C4086728;C4521986";NA;NA;exacerbations requiring oral steroids antibiotics past year
1654;antibiotics * *;"C0003232;C0003237;C3540704;C3540705;C3540706;C3540707;C3540708;C3540709;C3540710";NA;NA;antibiotics
1653;daily activities / social functioning;"C0037395;C0871707";NA;NA;daily activities social functioning
1653;daily activities;C0871707;NA;NA;daily activities
1652;table $nmbr$ . characteristics of the patients at baseline . *;"C0039224;C0168634;C0815172;C1442488;C1706074";NA;NA;table $nmbr$ characteristics of the patients at baseline
1652;subject characteristics;"C0681884;C1519021;C1706465";NA;NA;subject characteristics
1652;patients with specific disease characteristics  n ( % );"C0030705;C0205369;C0599878;C1552740";NA;NA;patients with specific disease characteristics n
1652;patients with specific disease characteristics;"C0030705;C0205369;C0599878;C1552740";NA;NA;patients with specific disease characteristics
1652;patients ' characteristics;C0815172;NA;NA;patients characteristics
1652;patient characteristics at randomization;"C0034656;C0815172";NA;NA;patient characteristics at randomization
1652;patient characteristics;C0815172;NA;NA;patient characteristics
1652;lesion characteristics;C1286326;NA;NA;lesion characteristics
1652;disease characteristics *;C0599878;NA;NA;disease characteristics
1652;disease characteristics;C0599878;NA;NA;disease characteristics
1652;demographic / disease characteristics at baseline;"C0011298;C0012634;C0168634;C0599878;C0683970;C1442488;C4684572";NA;NA;demographic disease characteristics at baseline
1652;characteristicsa;NA;NA;NA;characteristicsa
1652;characteristica;NA;NA;NA;characteristica
1652;anatomic complexity characteristics;"C0439855;C0502371;C1704241";NA;NA;anatomic complexity characteristics
1651;stricturing;C1261287;NA;NA;stricturing
1651;stenosis > $nmbr$ %;"C0678234;C1261287;C2632116";NA;NA;stenosis $nmbr$
1651;prior known stenosis > $nmbr$ %;"C0205309;C0332152;C0678234;C1261287;C2632116;C2826257";NA;NA;prior known stenosis $nmbr$
1651;prior angiography showing stenosis ≥ $nmbr$ %  n   =   $nmbr$   $nmbr$ a;"C0002978;C0332152;C0678234;C1261287;C1547282;C2632116;C2826257";NA;NA;prior angiography showing stenosis $nmbr$ n $nmbr$ $nmbr$ a
1651;prior angiography showing stenosis > $nmbr$ %  n = $nmbr$ °;"C0002978;C0332152;C0678234;C1261287;C1547282;C2632116;C2826257";NA;NA;prior angiography showing stenosis $nmbr$ n $nmbr$
1651;percent stenosis [ investigator ];"C0035173;C0439165;C0678234;C1261287;C2632116";NA;NA;percent stenosis investigator
1651;percent stenosis [ core lab ];"C0439165;C0678234;C1261287;C2632116;C4684837";NA;NA;percent stenosis core lab
1651;no . of vessels with > $nmbr$ % stenosis;"C0005847;C0678234;C1261287;C2632116";NA;NA;no of vessels with $nmbr$ stenosis
1651;no . of coronary vessels with > $nmbr$ % diameter stenosis;"C0010075;C0678234;C1261287;C1301886;C2632116";NA;NA;no of coronary vessels with $nmbr$ diameter stenosis
1651;maximal diameter stenosis;"C0205289;C0678234;C0806909;C1261287;C1301886;C2632116;C4049713";NA;NA;maximal diameter stenosis
1651;ica stenosis $nmbr$ % - $nmbr$ % f;"C0016327;C0201519;C0678234;C1261287;C2632116";NA;NA;ica stenosis $nmbr$ $nmbr$ f
1651;diameter stenosis  mean ( sd )  %;"C0552409;C0678234;C1261287;C2632116;C2699239";NA;NA;diameter stenosis mean sd
1651;% stenosis ( investigator );"C0035173;C0678234;C1261287;C2632116";NA;NA;stenosis investigator
1651;% stenosis ( core lab );"C0678234;C1261287;C2632116;C4684837";NA;NA;stenosis core lab
1651;% stenosis  as assessed by investigator;"C0035173;C0678234;C1261287;C1516048;C2632116";NA;NA;stenosis as assessed by investigator
1650;time to first inhaled corticosteroid ( % );"C0001617;C0004048;C0040223;C0205435;C1279901;C3536709;C3541383";NA;NA;time to first inhaled corticosteroid
1650;required corticosteroid and / or antibiotic ( without hospitalization );"C0001617;C0003232;C0019993;C1514873;C3536709";NA;NA;required corticosteroid and or antibiotic without hospitalization
1650;refractory to corticosteroids  n ( % );"C0001617;C0205269;C3539185;C3540725;C3540726;C3540727";NA;NA;refractory to corticosteroids n
1650;receiving concomitant corticosteroids;"C0001617;C0521115;C1514756;C3539185;C3540725;C3540726;C3540727";NA;NA;receiving concomitant corticosteroids
1650;prior corticosteroid treatment;"C0001617;C1514463;C3536709";NA;NA;prior corticosteroid treatment
1650;patients taking oral corticosteroids at baseline  n ( % );"C0001617;C0030705;C0168634;C0442027;C1442488;C1515187;C3539185;C3540725;C3540726;C3540727;C4521986";NA;NA;patients taking oral corticosteroids at baseline n
1650;patients receiving corticosteroids at baseline;"C0001617;C0030705;C0168634;C1442488;C1514756;C3539185;C3540725;C3540726;C3540727";NA;NA;patients receiving corticosteroids at baseline
1650;patients not receiving corticosteroids at baseline;"C0001617;C0030705;C0168634;C1442488;C1514756;C1518422;C3539185;C3540725;C3540726;C3540727";NA;NA;patients not receiving corticosteroids at baseline
1650;oral corticosteroids;"C0001617;C0442027;C3539185;C3540725;C3540726;C3540727;C4521986";NA;NA;oral corticosteroids
1650;oral corticosteroid use at enrolmentt;"C0001617;C0239126;C0442027;C1527415;C3536709;C4521986";NA;NA;oral corticosteroid use at enrolmentt
1650;oral corticosteroid use at baseline;"C0001617;C0168634;C0239126;C0442027;C1442488;C1527415;C3536709;C4521986";NA;NA;oral corticosteroid use at baseline
1650;oral corticosteroid use  n ( % );"C0001617;C0239126;C0442027;C1527415;C3536709;C4521986";NA;NA;oral corticosteroid use n
1650;oral corticosteroid;"C0001617;C0442027;C3536709;C4521986";NA;NA;oral corticosteroid
1650;no corticosteroids or immunosuppressants;"C0001617;C0021081;C3539185;C3540725;C3540726;C3540727";NA;NA;no corticosteroids or immunosuppressants
1650;no corticosteroid + no imm  n;"C0001617;C0205470;C3536709";NA;NA;no corticosteroid no imm n
1650;no corticosteroid  no imm;"C0001617;C0205470;C3536709";NA;NA;no corticosteroid no imm
1650;no corticosteroid;"C0001617;C3536709";NA;NA;no corticosteroid
1650;no baseline corticosteroids;"C0001617;C0168634;C1442488;C3539185;C3540725;C3540726;C3540727";NA;NA;no baseline corticosteroids
1650;neither corticosteroid nor immunosuppressant;"C0001617;C0021081;C3536709";NA;NA;neither corticosteroid nor immunosuppressant
1650;inhaled corticosteroids;"C0001617;C0004048;C3539185;C3540725;C3540726;C3540727";NA;NA;inhaled corticosteroids
1650;inhaled corticosteroid - yes  n ( % );"C0001617;C0004048;C1549445;C1705108;C1710701;C3536709";NA;NA;inhaled corticosteroid yes n
1650;inhaled corticosteroid;"C0001617;C0004048;C3536709";NA;NA;inhaled corticosteroid
1650;immy ( without corticosteroid )  n;"C0001617;C3536709";NA;NA;immy without corticosteroid n
1650;immunosuppressant ( with or without corticosteroid );"C0001617;C0021081;C3536709";NA;NA;immunosuppressant with or without corticosteroid
1650;imm + corticosteroid  n;"C0001617;C0205470;C3536709";NA;NA;imm corticosteroid n
1650;imm ( without corticosteroid );"C0001617;C0205470;C3536709";NA;NA;imm without corticosteroid
1650;dmard or corticosteroid;"C0001617;C0242708;C3536709";NA;NA;dmard or corticosteroid
1650;current oral corticosteroid use;"C0001617;C0239126;C0442027;C0521116;C1527415;C1705970;C3536709;C4521986";NA;NA;current oral corticosteroid use
1650;corticosteroidsa;NA;NA;NA;corticosteroidsa
1650;corticosteroids only;"C0001617;C0205171;C1720467;C3539185;C3540725;C3540726;C3540727";NA;NA;corticosteroids only
1650;corticosteroids and immunosuppressants;"C0001617;C0021081;C3539185;C3540725;C3540726;C3540727";NA;NA;corticosteroids and immunosuppressants
1650;corticosteroids and antimalarials only;"C0001617;C0003374;C0205171;C1720467;C3539185;C3540725;C3540726;C3540727";NA;NA;corticosteroids and antimalarials only
1650;corticosteroids . immunosuppressants . and antimalarials;"C0001617;C0003374;C0021081;C3539185;C3540725;C3540726;C3540727";NA;NA;corticosteroids immunosuppressants and antimalarials
1650;corticosteroids ( excluding budesonide );"C0001617;C0054201;C0332196;C2828389;C3539185;C3540725;C3540726;C3540727";NA;NA;corticosteroids excluding budesonide
1650;corticosteroids ' $nmbr$;"C0001617;C3539185;C3540725;C3540726;C3540727";NA;NA;corticosteroids $nmbr$
1650;corticosteroids;"C0001617;C3539185;C3540725;C3540726;C3540727";NA;NA;corticosteroids
1650;corticosteroid or immunosuppressant;"C0001617;C0021081;C3536709";NA;NA;corticosteroid or immunosuppressant
1650;corticosteroid and immunosuppressant;"C0001617;C0021081;C3536709";NA;NA;corticosteroid and immunosuppressant
1650;corticosteroid + imm;"C0001617;C0205470;C3536709";NA;NA;corticosteroid imm
1650;corticosteroid ( without imm )  n;"C0001617;C0205470;C3536709";NA;NA;corticosteroid without imm n
1650;corticosteroid ( without imm );"C0001617;C0205470;C3536709";NA;NA;corticosteroid without imm
1650;corticosteroid ( with or without immunosuppressants );"C0001617;C0021081;C3536709";NA;NA;corticosteroid with or without immunosuppressants
1650;corticosteroid;"C0001617;C3536709";NA;NA;corticosteroid
1650;concomitant use of corticosteroids;"C0001617;C0521115;C1524063;C3539185;C3540725;C3540726;C3540727";NA;NA;concomitant use of corticosteroids
1650;concomitant oral corticosteroids  n ( % ) * *;"C0001617;C0442027;C0521115;C3539185;C3540725;C3540726;C3540727;C4521986";NA;NA;concomitant oral corticosteroids n
1650;catecholamines or corticosteroids without hospitalization;"C0001617;C0007412;C0019993;C3539185;C3540725;C3540726;C3540727";NA;NA;catecholamines or corticosteroids without hospitalization
1650;baseline corticosteroids *;"C0001617;C0168634;C1442488;C3539185;C3540725;C3540726;C3540727";NA;NA;baseline corticosteroids
1650;b ) those on inhaled corticosteroids and long - acting bronchodilators as previous treatment use .;"C0001617;C0004048;C0006280;C0039798;C0042153;C0079613;C0087111;C0205156;C0205166;C0457083;C1522326;C1533734;C1552607;C1704930;C1705169;C1706317;C1869853;C1947944;C3538994;C3539185;C3540725;C3540726;C3540727;C3887704;C3890007;C4048375";NA;NA;b those on inhaled corticosteroids and long acting bronchodilators as previous treatment use
1650;any ( including corticosteroid );"C0001617;C0332257;C3536709";NA;NA;any including corticosteroid
1650;> $nmbr$ corticosteroids or immunosuppressants;"C0001617;C0021081;C3539185;C3540725;C3540726;C3540727";NA;NA;$nmbr$ corticosteroids or immunosuppressants
1649;time to first oral or systemic corticosteroid ( % );"C0040223;C0205435;C0442027;C1279901;C3541383;C4053960;C4521986";NA;NA;time to first oral or systemic corticosteroid
1649;systemic corticosteroids — no . ( % );C4053960;NA;NA;systemic corticosteroids no
1649;systemic corticosteroids  n ( % ) a;C4053960;NA;NA;systemic corticosteroids n a
1649;systemic corticosteroids  n ( % );C4053960;NA;NA;systemic corticosteroids n
1649;rate of oral or systemic corticosteroid;"C0442027;C0871208;C1521828;C4053960;C4521986";NA;NA;rate of oral or systemic corticosteroid
1649;oral or other systemic corticosteroid;"C0442027;C4053960;C4521986";NA;NA;oral or other systemic corticosteroid
1648;steroids § §;C0038317;NA;NA;steroids
1648;steroids ( other );C0038317;NA;NA;steroids other
1648;steroids ( n = $nmbr$ vs $nmbr$ );C0038317;NA;NA;steroids n $nmbr$ vs $nmbr$
1648;steroids ( inhaled ) a;"C0004048;C0038317";NA;NA;steroids inhaled a
1648;steroids  n ( % );C0038317;NA;NA;steroids n
1648;other steroids;C0038317;NA;NA;other steroids
1648;no steroids ( n = $nmbr$ vs $nmbr$ );C0038317;NA;NA;no steroids n $nmbr$ vs $nmbr$
1647;dutasteride ( w = $nmbr$ )  $nmbr$ / $nmbr$;C0754659;NA;NA;dutasteride w $nmbr$ $nmbr$ $nmbr$
1647;dutasteride ( n = $nmbr$ );C0754659;NA;NA;dutasteride n $nmbr$
1647;dutasteride;C0754659;NA;NA;dutasteride
1647;combined ( dutasteride / ta msu losi n );"C0024776;C0039297;C0205195;C0754659;C1412759;C1506978;C1705538;C3272501;C4553364";NA;NA;combined dutasteride ta msu losi n
1646;statini;NA;NA;NA;statini
1646;statin therapy;C1278454;NA;NA;statin therapy
1646;standard therapy ( n = $nmbr$ );C2936643;NA;NA;standard therapy n $nmbr$
1646;standard therapy;C2936643;NA;NA;standard therapy
1646;prerandomization statin therapy;C1278454;NA;NA;prerandomization statin therapy
1646;combined therapy vsta msu iosin;"C0024776;C0033972;C1412759";NA;NA;combined therapy vsta msu iosin
1646;combined therapy vsdutasteride;C0033972;NA;NA;combined therapy vsdutasteride
1646;combined therapy ( / v = $nmbr$ )  $nmbr$ / $nmbr$;C0033972;NA;NA;combined therapy v $nmbr$ $nmbr$ $nmbr$
1645;tertiary endpoints :;"C0205372;C2349179";NA;NA;tertiary endpoints
1645;tertiary end points;"C0205372;C2349179";NA;NA;tertiary end points
1645;tertiary amines;C3653356;NA;NA;tertiary amines
1645;tertiary;C0205372;NA;NA;tertiary
1644;toward;NA;NA;NA;toward
1644;third yeart;C0205437;NA;NA;third yeart
1644;third heart sound  n ( % );"C0232237;C0232278";NA;NA;third heart sound n
1644;third heart sound;"C0232237;C0232278";NA;NA;third heart sound
1644;slowest third;"C0205437;C0439834";NA;NA;slowest third
1644;one - third radius;"C0034627;C0205437;C0205447;C1306504";NA;NA;one third radius
1644;in thirds;C0205437;NA;NA;in thirds
1644;distal one - third of radius;"C0034627;C0205437;C0205447;C0450168;C0588207;C1306504";NA;NA;distal one third of radius
1643;residual deep - vein thrombosis  no . ( % );"C0149871;C1609982";NA;NA;residual deep vein thrombosis no
1643;previousdistaldeep - veinthrombosisorsuperficial - vein thrombosis;C0042487;NA;NA;previousdistaldeep veinthrombosisorsuperficial vein thrombosis
1643;patients with deep - vein thrombosis only;"C0030705;C0149871;C0205171;C1720467";NA;NA;patients with deep vein thrombosis only
1643;isolated deep - vein thrombosis;"C0149871;C0205409;C1548221";NA;NA;isolated deep vein thrombosis
1643;deep vein thrombosis only;"C0149871;C0205171;C1720467";NA;NA;deep vein thrombosis only
1643;deep - vein thrombosis only;"C0149871;C0205171;C1720467";NA;NA;deep vein thrombosis only
1643;deep - vein thrombosis ( % );C0149871;NA;NA;deep vein thrombosis
1643;deep - vein thrombosis;C0149871;NA;NA;deep vein thrombosis
1642;direct thrombin inhibitors;"C0003440;C3541936";NA;NA;direct thrombin inhibitors
1642;antithrombin;"C0003438;C0003440;C4521254";NA;NA;antithrombin
1641;thrombus aspiration done per lesion †;"C0087086;C0220787;C0221198;C0302148;C0349707;C0700198;C1272695;C1546698;C2712334;C2827071;C3146237";NA;NA;thrombus aspiration done per lesion
1641;thrombus aspiration;"C0087086;C0220787;C0302148;C0349707;C0700198;C2712334;C2827071;C3146237";NA;NA;thrombus aspiration
1641;thrombus - containing lesion;"C0087086;C0221198;C0302148;C0332256;C1546698;C2700400;C3146237";NA;NA;thrombus containing lesion
1641;new or suspected thrombus;"C0087086;C0205314;C0302148;C0332147;C0750491;C3146237";NA;NA;new or suspected thrombus
1641;increased - risk for thrombotic cardiovascular;"C0007226;C0087086;C3887460;C4699158";NA;NA;increased risk for thrombotic cardiovascular
1641;anti - thrombotics;C0087086;NA;NA;anti thrombotics
1640;low risk and more symptoms ( group b );"C0205172;C0683368;C1457887;C3272281;C3538919;C4522078";NA;NA;low risk and more symptoms group b
1640;high risk and more symptoms ( group d );"C0205172;C0332167;C0441838;C0683368;C1457887;C3272283;C4050568;C4319571";NA;NA;high risk and more symptoms group d
1640;group d;C0441838;NA;NA;group d
1640;group c;C0441837;NA;NA;group c
1640;group b;C4522078;NA;NA;group b
1640;group a;"C0441835;C4522145";NA;NA;group a
1640;gold group c;"C0018026;C0441837;C1304897";NA;NA;gold group c
1640;gold group a;"C0018026;C0441835;C1304897;C4522145";NA;NA;gold group a
1639;glycaemic control group;"C0005802;C0009932";NA;NA;glycaemic control group
1639;events / control group;"C0009932;C0441471;C3541888";NA;NA;events control group
1639;control group;C0009932;NA;NA;control group
1638;total group ( n = $nmbr$ );"C0439175;C0439810;C0441848";NA;NA;total group n $nmbr$
1638;rate - control group ( n = $nmbr$ );"C0441848;C0489879";NA;NA;rate control group n $nmbr$
1638;racial group  n ( % );"C0034510;C0441848;C1706779;C3669213;C3853635";NA;NA;racial group n
1638;pioglitazone group ( n = $nmbr$ );"C0071097;C0441848";NA;NA;pioglitazone group n $nmbr$
1638;no epa group n = $nmbr$;C0441848;NA;NA;no epa group n $nmbr$
1638;group c ( n = $nmbr$ );C0441848;NA;NA;group c n $nmbr$
1638;group b ( n = $nmbr$ );C0441848;NA;NA;group b n $nmbr$
1638;group a ( n = $nmbr$ );C0441848;NA;NA;group a n $nmbr$
1638;epa group n = $nmbr$;C0441848;NA;NA;epa group n $nmbr$
1638;diclofenac group ( n = $nmbr$ $nmbr$ );"C0012091;C0441848";NA;NA;diclofenac group n $nmbr$ $nmbr$
1638;colesevelam hydrochloride group ( n = $nmbr$ );"C0441848;C0541154";NA;NA;colesevelam hydrochloride group n $nmbr$
1638;certolizumab group ( n = $nmbr$ );"C0441848;C1872109";NA;NA;certolizumab group n $nmbr$
1638;c group ( n = $nmbr$ );C0441848;NA;NA;c group n $nmbr$
1638;benazepril - hydrochlorothiazide group ( n = $nmbr$ );"C0441848;C0717481";NA;NA;benazepril hydrochlorothiazide group n $nmbr$
1638;benazepril - amlodipine group ( n = $nmbr$ );"C0051696;C0053091;C0441848";NA;NA;benazepril amlodipine group n $nmbr$
1637;tpm subgroup  n = $nmbr$;"C0076829;C1079230;C1515021";NA;NA;tpm subgroup n $nmbr$
1637;the plot shows hazard ratios and $nmbr$ % confidence intervals for the primary outcome  with patients stratified according to eight sub - groups prespecified in the statistical analysis plan . no heterogeneity was observed for these subgroups .;"C0009667;C0019409;C0205225;C0205363;C0205454;C0242960;C0270724;C0439612;C0439631;C0441833;C0542339;C0599880;C0680240;C0687744;C0871424;C1079230;C1257890;C1264637;C1301732;C1441672;C1519504;C1547282;C1547647;C1552839;C1705428;C1705429;C2985465";NA;NA;the plot shows hazard ratios and $nmbr$ confidence intervals for the primary outcome with patients stratified according to eight sub groups prespecified in the statistical analysis plan no heterogeneity was observed for these subgroups
1637;subgroupt;NA;NA;NA;subgroupt
1637;subgroups;C1079230;NA;NA;subgroups
1637;subgroup_level;"C0441889;C0456079;C1079230;C1515021;C1547707;C2946261";NA;NA;subgroup_level
1637;subgroup p valuef;"C1079230;C1515021";NA;NA;subgroup p valuef
1637;subgroup overall;"C0282416;C1079230;C1515021;C1561607";NA;NA;subgroup overall
1637;subgroup no .;"C1079230;C1515021";NA;NA;subgroup no
1637;subgroup name / level;"C0027365;C0441889;C0456079;C1079230;C1515021;C1547383;C1547707;C2946261;C4522128";NA;NA;subgroup name level
1637;subgroup levels;"C0441889;C1079230;C1515021";NA;NA;subgroup levels
1637;subgroup level;"C0441889;C0456079;C1079230;C1515021;C1547707;C2946261";NA;NA;subgroup level
1637;subgroup based on :;"C1079230;C1515021;C1527178;C1705938";NA;NA;subgroup based on
1637;subgroup $nmbr$;"C1079230;C1515021";NA;NA;subgroup $nmbr$
1637;subgroup;"C1079230;C1515021";NA;NA;subgroup
1637;secondary prevention subgroup;"C0679699;C1079230;C1515021";NA;NA;secondary prevention subgroup
1637;renal subgroup;"C0022646;C1079230;C1515021";NA;NA;renal subgroup
1637;renal function subgroups;"C0232804;C1079230";NA;NA;renal function subgroups
1637;primary prevention subgroup;"C0033144;C1079230;C1515021";NA;NA;primary prevention subgroup
1637;prespecified subgroups;C1079230;NA;NA;prespecified subgroups
1637;p  subgroup *;"C0369773;C1079230;C1515021;C2603361";NA;NA;p subgroup
1637;outcome_subgroup;"C1079230;C1274040;C1515021";NA;NA;outcome_subgroup
1637;m $nmbr$ subgroup;"C0369637;C0441923;C1079230;C1515021";NA;NA;m $nmbr$ subgroup
1637;latin american subgroup;"C1079230;C1515021;C1553378";NA;NA;latin american subgroup
1637;genetic subgroup;"C0017296;C0314603;C1079230;C1515021";NA;NA;genetic subgroup
1637;female subgroup;"C0043210;C0086287;C1079230;C1515021;C1705497;C1705498";NA;NA;female subgroup
1637;diuretic subgroup;"C0012798;C1079230;C1515021";NA;NA;diuretic subgroup
1637;baseline subgroup;"C0168634;C1079230;C1442488;C1515021";NA;NA;baseline subgroup
1637;baseline mtss subgroup;"C0168634;C1079230;C1442488;C1515021";NA;NA;baseline mtss subgroup
1637;baseline hba $nmbr$ c subgroup;"C0019016;C0168634;C1079230;C1442488;C1515021;C1825777;C3538758";NA;NA;baseline hba $nmbr$ c subgroup
1637;asubset of the ≥ $nmbr$ years subgroup .;"C0439234;C1079230;C1515021";NA;NA;asubset of the $nmbr$ years subgroup
1637;( subgroup );"C1079230;C1515021";NA;NA;subgroup
1636;subgroup analyses;C2986480;NA;NA;subgroup analyses
1636;prespecified subgroup analyses;C2986480;NA;NA;prespecified subgroup analyses
1636;additional subgroup analyses;"C1524062;C2986480";NA;NA;additional subgroup analyses
1635;tamong those enrolling via bnp stratum . the study - qualifying bnp or;"C0054015;C0557651;C1095989;C1417808;C1514624;C2603343;C2982014";NA;NA;tamong those enrolling via bnp stratum the study qualifying bnp or
1635;nptercile $nmbr$ ( bnp $nmbr$ - $nmbr$ pg / ml  nt - probnp $nmbr$ - $nmbr$  $nmbr$ pg / ml ) ( n - $nmbr$ );"C0054015;C0439297;C1095989;C1317554;C1417808;C2825907;C2982014;C4284038";NA;NA;nptercile $nmbr$ bnp $nmbr$ $nmbr$ pg ml nt probnp $nmbr$ $nmbr$ $nmbr$ pg ml n $nmbr$
1635;np tercile $nmbr$ ( bnp > $nmbr$ pg / ml  nt - probnp > $nmbr$  $nmbr$ pg / ml ) ( n - $nmbr$ );"C0054015;C0065827;C0439297;C1095989;C1317554;C1417808;C1706141;C2825907;C2982014;C3887659;C4284038";NA;NA;np tercile $nmbr$ bnp $nmbr$ pg ml nt probnp $nmbr$ $nmbr$ pg ml n $nmbr$
1635;np tercile $nmbr$ ( bnp < $nmbr$ pg / ml  nt - probnp < $nmbr$ pg / ml ) ( n - $nmbr$ );"C0054015;C0065827;C0439297;C1095989;C1317554;C1417808;C1706141;C2825907;C2982014;C3887659;C4284038";NA;NA;np tercile $nmbr$ bnp $nmbr$ pg ml nt probnp $nmbr$ pg ml n $nmbr$
   7;p   value for interaction;"C1704675;C1709380";NA;NA;p value for interaction
   7;p   value;C1709380;NA;NA;p value
1635;normal bnp  ^ $nmbr$ pg / ml ( n = $nmbr$  $nmbr$ );"C0054015;C0205307;C0231683;C0439166;C0439297;C1095989;C1417808;C2347086;C2982014;C4553972";NA;NA;normal bnp $nmbr$ pg ml n $nmbr$ $nmbr$
1635;nesiritide ( n = $nmbr$ );C0054015;NA;NA;nesiritide n $nmbr$
1635;nesiritide  % z;C0054015;NA;NA;nesiritide z
1635;median bnp ( iqr ) – pg / ml;"C0054015;C0439297;C0549183;C0876920;C1095989;C1417808;C2347635;C2348144;C2939193;C2982014";NA;NA;median bnp iqr pg ml
1635;mean ( $nmbr$ th to $nmbr$ thquartile ) bnp ( pg / ml );"C0039725;C0039738;C0054015;C0439297;C0444504;C1095989;C1417808;C1420718;C2347634;C2348143;C2982014;C4282123;C4285344";NA;NA;mean $nmbr$ th to $nmbr$ thquartile bnp pg ml
1635;elevated bnp ( $nmbr$ pg / ml )  %;"C0054015;C0205250;C0439297;C1095989;C1417808;C2982014;C3163633";NA;NA;elevated bnp $nmbr$ pg ml
1635;elevated bnp  > $nmbr$ pg / ml ( n = $nmbr$  $nmbr$ );"C0054015;C0205250;C0439297;C1095989;C1417808;C2982014;C3163633";NA;NA;elevated bnp $nmbr$ pg ml n $nmbr$ $nmbr$
1635;elevated bnp;"C0054015;C0205250;C1095989;C1417808;C2982014;C3163633";NA;NA;elevated bnp
1635;bnp — pg / ml  i;"C0021966;C0023806;C0030827;C0054015;C0072225;C0221138;C0439297;C1095989;C1266240;C1417808;C2982014";NA;NA;bnp pg ml i
1635;bnp — pg / ml;"C0054015;C0439297;C1095989;C1417808;C2982014";NA;NA;bnp pg ml
1621;days with heartburna ( days );C0439228;NA;NA;days with heartburna days
1323;women t;C0043210;NA;NA;women t
1637;additional antihypertensive subgroup;"C0003364;C1079230;C1515021;C1524062";FALSE;1579;additional antihypertensive subgroup
1638;etoricoxib group ( n = $nmbr$ $nmbr$ );"C0441848;C0972314";FALSE;1130;etoricoxib group n $nmbr$ $nmbr$
1635;bnp o $nmbr$ pg / ml or nt pro - bnp o $nmbr$ pg / ml  n ( % );"C0033382;C0054015;C0439297;C0523852;C1095989;C1417808;C2982014;C2987124;C4284038";NA;NA;bnp o $nmbr$ pg ml or nt pro bnp o $nmbr$ pg ml n
1635;bnp indicates brain natriuretic peptide  and nyha  new york heart association .;"C0004083;C0018787;C0027976;C0054015;C0439849;C0596306;C0699792;C1095989;C1275491;C1417808;C2982014";NA;NA;bnp indicates brain natriuretic peptide and nyha new york heart association
1635;bnp > $nmbr$ pg / ml or nt pro - bnp > $nmbr$ pg / ml  n ( % );"C0033382;C0054015;C0439297;C0523852;C1095989;C1417808;C2982014;C2987124;C4284038";NA;NA;bnp $nmbr$ pg ml or nt pro bnp $nmbr$ pg ml n
1635;bnp > $nmbr$ pg / ml n = $nmbr$;"C0054015;C0439297;C1095989;C1417808;C2982014";NA;NA;bnp $nmbr$ pg ml n $nmbr$
1635;bnp > $nmbr$ pg / ml  n   =   $nmbr$   $nmbr$;"C0054015;C0439297;C1095989;C1417808;C2982014";NA;NA;bnp $nmbr$ pg ml n $nmbr$ $nmbr$
1635;bnp > $nmbr$ pg / ml  n   =   $nmbr$   $nmbr$;"C0054015;C0439297;C1095989;C1417808;C2982014";NA;NA;bnp $nmbr$ pg ml n $nmbr$ $nmbr$
1635;bnp > $nmbr$ pg / ml  n = $nmbr$;"C0054015;C0439297;C1095989;C1417808;C2982014";NA;NA;bnp $nmbr$ pg ml n $nmbr$
1635;bnp < $nmbr$ pg / ml n = $nmbr$;"C0054015;C0439297;C1095989;C1417808;C2982014";NA;NA;bnp $nmbr$ pg ml n $nmbr$
1635;bnp / nt - probnp;"C0054015;C0669479;C0754710;C1095989;C1417808;C2982014";NA;NA;bnp nt probnp
1635;bnp ( pg / ml ) h;"C0030827;C0033727;C0054015;C0072225;C0369286;C0439297;C0439391;C0439526;C0441932;C0564385;C1095989;C1266240;C1417808;C1705224;C2827929;C2982014;C3887665;C4528284";NA;NA;bnp pg ml h
1635;bnp ( pg / ml );"C0054015;C0439297;C1095989;C1417808;C2982014";NA;NA;bnp pg ml
1635;bnp ( n = $nmbr$ );"C0054015;C1095989;C1417808;C2982014";NA;NA;bnp n $nmbr$
1635;bnp  pg / mlt;"C0030827;C0054015;C0072225;C1095989;C1266240;C1417808;C2982014;C4553833";NA;NA;bnp pg mlt
1635;bnp  pg / ml;"C0054015;C0439297;C1095989;C1417808;C2982014";NA;NA;bnp pg ml
1635;bnp  median ( iqr )  pg / ml;"C0054015;C0439297;C0549183;C0876920;C1095989;C1417808;C2347635;C2348144;C2939193;C2982014";NA;NA;bnp median iqr pg ml
1635;bnp  * median ( iqr )  pg / ml;"C0054015;C0439297;C0549183;C0876920;C1095989;C1417808;C2347635;C2348144;C2939193;C2982014";NA;NA;bnp median iqr pg ml
1635;bnp;"C0054015;C1095989;C1417808;C2982014";NA;NA;bnp
1634;tr jet velocity ( m / sec );"C0108801;C0336862;C0439493;C0439830;C1539482;C1547053;C1705610;C1872943;C3811249;C3811250;C3814152";NA;NA;tr jet velocity m sec
1634;m $nmbr$ s;"C0439493;C1513009";NA;NA;m $nmbr$ s
1633;treatment comparison ( mg / day ) t;"C0039798;C0087111;C0439422;C1522326;C1533734;C1705169;C1707455;C3538994;C3887704";NA;NA;treatment comparison mg day t
1633;treatment comparison;"C0039798;C0087111;C1522326;C1533734;C1705169;C1707455;C3538994;C3887704";NA;NA;treatment comparison
1633;pairwise comparison;C1707455;NA;NA;pairwise comparison
1633;l compared wi;"C0043193;C0439394;C1520135;C1706495;C1707455;C3642217";NA;NA;l compared wi
1633;comparison with baseline ( mean;"C0168634;C0444504;C1442488;C1707455;C2347634;C2348143";NA;NA;comparison with baseline mean
1633;comparison with baseline;"C0168634;C1442488;C1707455";NA;NA;comparison with baseline
1633;comparison;C1707455;NA;NA;comparison
1633;ci  confidence interval  esrd  end - stage renal disease  n / n  number of patients who had an event / total number of patients . aadjusted with terms including treatment ( losartan or placebo )  geographic region  genotype  and the treatment  genotype interaction . bp value for treatment  genotype interaction ( i . e .  comparison of the losartan treatment effect between the $nmbr$ genotype groups ) .;"C0008107;C0009667;C0017431;C0017446;C0022661;C0030705;C0032042;C0037623;C0039798;C0087111;C0126174;C0205147;C0233324;C0332257;C0441471;C0441833;C0683454;C0687744;C1257890;C1280500;C1415692;C1515273;C1517526;C1518681;C1519504;C1522326;C1522609;C1533734;C1552839;C1696465;C1704675;C1705169;C1705313;C1705428;C1705429;C1706408;C1707455;C1708288;C2348382;C2360800;C2826302;C3259781;C3538994;C3887704;C4019010;C4288115;C4318478";NA;NA;ci confidence interval esrd end stage renal disease n n number of patients who had an event total number of patients aadjusted with terms including treatment losartan or placebo geographic region genotype and the treatment genotype interaction bp value for treatment genotype interaction i e comparison of the losartan treatment effect between the $nmbr$ genotype groups
1633;a compared wi;"C0043193;C1520135;C1707455";NA;NA;a compared wi
1633;a compared w;C1707455;NA;NA;a compared w
1632;total comparators ( n = $nmbr$ );"C0439175;C0439810;C1707454;C4553389;C4553390";NA;NA;total comparators n $nmbr$
1632;total comparators  patients with events / total patients;"C0030705;C0439175;C0439810;C0441471;C1707454;C3541888;C4553389;C4553390";NA;NA;total comparators patients with events total patients
1632;favors comparator;"C0309049;C1707454;C4553389;C4553390";NA;NA;favors comparator
1632;comparator;"C1707454;C4553389;C4553390";NA;NA;comparator
1631;renal composite *;"C0022646;C0205199;C1547335";NA;NA;renal composite
1631;primary composite endpoint ‡;"C0205199;C1547335;C2986535";NA;NA;primary composite endpoint
1631;primary composite end point ‡;"C0205199;C1547335;C2986535";NA;NA;primary composite end point
1631;primary composite end point;"C0205199;C1547335;C2986535";NA;NA;primary composite end point
1631;disease - progression composite outcome !;"C0205199;C0242656;C0449258;C0679250;C1274040;C1335499;C1547335;C1947900;C3542417;C4552808";NA;NA;disease progression composite outcome
1631;cromoglicate;C0010347;NA;NA;cromoglicate
1631;composite vascular endpoint;"C0005847;C0205199;C1547335;C1558950;C1801960;C2349179;C2826544";NA;NA;composite vascular endpoint
1631;composite of doubling of serum creatinine  end - stage kidney disease  or death from renal causes;"C0007465;C0022646;C0022658;C0201976;C0205088;C0205173;C0205199;C0600061;C1547335;C1705764";NA;NA;composite of doubling of serum creatinine end stage kidney disease or death from renal causes
1631;composite ocular end point ^;"C0015392;C0042789;C0205199;C0700042;C1299003;C1547335;C2349179;C2826544;C4521296";NA;NA;composite ocular end point
1631;composite microvascular end point *;"C0205199;C0443258;C1547335;C2349179;C2826544";NA;NA;composite microvascular end point
1631;composite endpoint ( a $nmbr$ c < $nmbr$ . $nmbr$ %  bp;"C0037623;C0205199;C1415692;C1547335;C1708288;C2349179;C2826544;C4318478";NA;NA;composite endpoint a $nmbr$ c $nmbr$ $nmbr$ bp
1631;composite endpoint;"C0205199;C1547335;C2349179;C2826544";NA;NA;composite endpoint
1631;composite;"C0205199;C1547335";NA;NA;composite
1631;components of primary composite end point — secondary end points;"C0205199;C1547335;C1882460;C4528314";NA;NA;components of primary composite end point secondary end points
1631;( composite endpoint );"C0205199;C1547335;C2349179;C2826544";NA;NA;composite endpoint
1630;hospitalized without airway compromise;"C0701159;C4055482";NA;NA;hospitalized without airway compromise
1630;airway compromise;C4055482;NA;NA;airway compromise
1629;implanted pacemaker;C0848753;NA;NA;implanted pacemaker
1629;impacts;"C1825598;C4049986";NA;NA;impacts
1628;implanted cardioverter defibrillator;"C0021102;C0810516;C2828363";NA;NA;implanted cardioverter defibrillator
1628;implanted cardioverter - defibrillator;"C0021102;C0810516;C2828363";NA;NA;implanted cardioverter defibrillator
1628;implantable cardioverter - defibrillator n ( % );"C0162589;C2825184";NA;NA;implantable cardioverter defibrillator n
1628;implantable cardioverter - defibrillator;"C0162589;C2825184";NA;NA;implantable cardioverter defibrillator
1621;day $nmbr$ oral glucocorticoid use — no . { % );"C0017710;C0042153;C0332173;C0439228;C0439505;C0442027;C0457083;C1947944;C4521986";NA;NA;day $nmbr$ oral glucocorticoid use no
1621;conversion to sinus rhythm in < $nmbr$ days;"C0439228;C1321500";NA;NA;conversion to sinus rhythm in $nmbr$ days
1621;change from baseline in rescue medication use ( puffs per day );"C0168634;C0240320;C0332173;C0392747;C0439228;C0439505;C0443172;C1442488;C1533107;C1705241;C4319952";NA;NA;change from baseline in rescue medication use puffs per day
1621;baseline focal seizure frequency / $nmbr$ days  median ( q $nmbr$ - q $nmbr$ );"C0149775;C0168634;C0205234;C0376249;C0439228;C0439603;C0549183;C0751495;C0871396;C0876920;C1442488;C1561548;C1705502;C2347635;C2348144;C2939193;C3898838;C4321352";NA;NA;baseline focal seizure frequency $nmbr$ days median q $nmbr$ q $nmbr$
1621;baseline focal seizure frequency / $nmbr$ days  median ( q $nmbr$  q $nmbr$ );"C0149775;C0168634;C0205234;C0376249;C0439228;C0439603;C0549183;C0751495;C0871396;C0876920;C1442488;C1561548;C1705502;C2347635;C2348144;C2939193;C3898838;C4321352";NA;NA;baseline focal seizure frequency $nmbr$ days median q $nmbr$ q $nmbr$
1621;absolute time spent “ on ”  h / day;"C0033727;C0332173;C0369286;C0439228;C0439505;C0439546;C0441932;C0564385;C0680968;C4528284";NA;NA;absolute time spent on h day
1628;data are mean ( sd ) or number ( % ) . pufa = polyunsaturated fatty acids  bmi = body - mass index . sbp = systolic blood pressure . dbp = diastolic blood pressure . nyha = newyork heart association . lvef = left ventricular ejection fraction . hf = heartfailure . ami = acute myocardial infarction . cabg = coronary artery bypass graft . pci = percutaneous coronary intervention . icd = implantable cardioverter defibrillator . copd = chronic obstructive pulmonary disease . ace = angiotensin - converting enzyme . arbs = angiotensin receptor blockers . * available for $nmbr$ patients ( $nmbr$ n - $nmbr$ pufa  $nmbr$ placebo ) .;"C0004083;C0005823;C0010055;C0012000;C0018787;C0018801;C0021122;C0022709;C0024117;C0030705;C0032042;C0032615;C0085805;C0155626;C0162589;C0185098;C0205042;C0237753;C0428772;C0439849;C0444504;C0449788;C0470187;C0488055;C0488728;C0521942;C0536221;C0596306;C0699792;C0815017;C0871470;C1264633;C1271104;C1272641;C1275491;C1305855;C1306620;C1511726;C1532338;C1554103;C1696465;C1706408;C2347634;C2348143;C2699239;C2733342;C2825184;C3245479;C3714741;C3813197;C3888198;C4281799";NA;NA;data are mean sd or number pufa polyunsaturated fatty acids bmi body mass index sbp systolic blood pressure dbp diastolic blood pressure nyha newyork heart association lvef left ventricular ejection fraction hf heartfailure ami acute myocardial infarction cabg coronary artery bypass graft pci percutaneous coronary intervention icd implantable cardioverter defibrillator copd chronic obstructive pulmonary disease ace angiotensin converting enzyme arbs angiotensin receptor blockers available for $nmbr$ patients $nmbr$ n $nmbr$ pufa $nmbr$ placebo
1627;subjects with imputed value for end ‐ of ‐ treatment body weight;"C0039798;C0087111;C0681850;C1522326;C1522609;C1533734;C1550501;C1705169;C1706203;C2349001;C2697811;C2699638;C2983672;C3538994;C3887704";NA;NA;subjects with imputed value for end of treatment body weight
1627;imputed;C2699638;NA;NA;imputed
1627;bocf - iike imputation ( random . ) ( n = $nmbr$ );"C0034656;C0439605;C2699638;C2984917";NA;NA;bocf iike imputation random n $nmbr$
1626;eos serum k +  meq / l;"C0302353;C0439375;C1623465;C1861303";NA;NA;eos serum k meq l
1626;elevated bun ( > $nmbr$ . $nmbr$ meq / l );"C0151539;C0439375";NA;NA;elevated bun $nmbr$ $nmbr$ meq l
1626;baseline : > $nmbr$ . $nmbr$ meq / l eos : > $nmbr$ . $nmbr$ meq / l;"C0168634;C0439375;C1442488;C1623465;C1861303";NA;NA;baseline $nmbr$ $nmbr$ meq l eos $nmbr$ $nmbr$ meq l
1626;baseline : > $nmbr$ . $nmbr$ meq / l eos : < $nmbr$ . $nmbr$ meq / l;"C0168634;C0439375;C1442488;C1623465;C1861303";NA;NA;baseline $nmbr$ $nmbr$ meq l eos $nmbr$ $nmbr$ meq l
1626;baseline : < $nmbr$ . $nmbr$ meq / l eos : > $nmbr$ . $nmbr$ or < $nmbr$ . $nmbr$ meq / l;"C0168634;C0439375;C1442488;C1623465;C1861303";NA;NA;baseline $nmbr$ $nmbr$ meq l eos $nmbr$ $nmbr$ or $nmbr$ $nmbr$ meq l
1626;$nmbr$ mq / kq *;C0024853;NA;NA;$nmbr$ mq kq
1625;ssomgdayp . eq .;"C0205163;C0439185";NA;NA;ssomgdayp eq
1625;eq - $nmbr$ dprofile - mobility  n ( % );"C0080078;C0205163;C0425245;C0439185;C0449580;C4318935";NA;NA;eq $nmbr$ dprofile mobility n
1625;eq - $nmbr$ d mobility;"C0080078;C0205163;C0425245;C0439185;C0449580;C4318935";NA;NA;eq $nmbr$ d mobility
1625;eq - $nmbr$ d ( visual analog score );"C0205163;C0234621;C0243071;C0439185;C0449820;C4050231";NA;NA;eq $nmbr$ d visual analog score
1625;eq $nmbr$ da health index status score;"C0011318;C0018759;C0205163;C0439185;C0449820;C0600653;C0918012;C1552854;C1637833;C2986546;C3668815;C4050231";NA;NA;eq $nmbr$ da health index status score
1625;< $nmbr$ mgday p . eq .;"C0205163;C0439185";NA;NA;$nmbr$ mgday p eq
1623;plasma dha  mean ( sd ) weight  %;"C0005910;C0032105;C0043100;C0142831;C0444504;C1305866;C1550098;C1705104;C2347634;C2348143;C2348308;C2699239;C4521445";NA;NA;plasma dha mean sd weight
1623;dha ( n = $nmbr$ );"C0142831;C2348308";NA;NA;dha n $nmbr$
1622;radiate;C0332301;NA;NA;radiate
1622;ohs graduate;"C0268353;C0588053;C1547183;C1861455";NA;NA;ohs graduate
1622;hs graduate / ged;"C0588053;C1547183;C1880947";NA;NA;hs graduate ged
1621;vte at day $nmbr$ +;"C0332173;C0439228;C0439505;C0630906";NA;NA;vte at day $nmbr$
1621;use of rescue albuterol  puffs / day *;"C0001927;C0332173;C0439228;C0439505;C1524063;C1533107";NA;NA;use of rescue albuterol puffs day
1621;treatment duration before randomization — days;"C0034656;C0439228;C0444921;C3259042";NA;NA;treatment duration before randomization days
1621;treatment duration  days;"C0439228;C0444921;C3259042";NA;NA;treatment duration days
1621;treatment before randomization — days;"C0034656;C0039798;C0087111;C0439228;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;treatment before randomization days
1621;time from onset of symptoms to randomization — days;"C0034656;C0439228;C1320528";NA;NA;time from onset of symptoms to randomization days
1621;time from index acs event to randomisation ( days );"C0034656;C0040223;C0439228;C0441471;C0600653;C0742343;C0918012;C1552854;C1637833;C2986546;C3541383;C4019010;C4318612";NA;NA;time from index acs event to randomisation days
1621;time from event to randomization — days;"C0034656;C0040223;C0439228;C0441471;C3541383;C4019010";NA;NA;time from event to randomization days
1621;subacute ( $nmbr$ - $nmbr$ days );"C0205365;C0439228";NA;NA;subacute $nmbr$ $nmbr$ days
1621;slo days;"C0439228;C1416602;C3539661";NA;NA;slo days
1621;saba puffs per day at baseline;"C0168634;C0332173;C0439228;C0439505;C1442488;C1533107";NA;NA;saba puffs per day at baseline
1621;recent use of allopurinol ( within $nmbr$ days of;"C0002144;C0332185;C0439228;C1524063";NA;NA;recent use of allopurinol within $nmbr$ days of
1621;recent cardioversion ( within $nmbr$ days before randomization ) — no . ( % );"C0013778;C0034656;C0332185;C0439228";NA;NA;recent cardioversion within $nmbr$ days before randomization no
1621;recent cardioversion ( within $nmbr$ days before randomization ) —;"C0013778;C0034656;C0332185;C0439228";NA;NA;recent cardioversion within $nmbr$ days before randomization
1621;patient status after wake - up  % of days patient woke :;"C0439228;C0442696;C0449437;C0585034;C1170730";NA;NA;patient status after wake up of days patient woke
1621;no . of days to randomization — median ( iqr );"C0034656;C0439228;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;no of days to randomization median iqr
1621;medications at discharge or day $nmbr$  if earlier ( % );"C0332173;C0439228;C0439505;C0806915;C1279919";NA;NA;medications at discharge or day $nmbr$ if earlier
1621;medication within $nmbr$ days before enrolment;"C0013227;C0439228;C1516879;C1696073;C3244316;C3888021;C4284232";NA;NA;medication within $nmbr$ days before enrolment
1621;median duration of study - drug administration ( iqr ) — days;"C0013175;C0439228;C0549183;C0876920;C2347635;C2348144;C2348354;C2939193";NA;NA;median duration of study drug administration iqr days
1621;median ( days );"C0439228;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median days
1621;mean ( sd ) extent of exposure  days;"C0274281;C0332157;C0439228;C0439792;C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd extent of exposure days
1621;insulin dose — lu / day;"C0024171;C0024176;C0332173;C0366513;C0439228;C0439505;C2697939";NA;NA;insulin dose lu day
1621;insulin dose ( lu / day );"C0024171;C0024176;C0332173;C0366513;C0439228;C0439505;C2697939";NA;NA;insulin dose lu day
1621;infarction > $nmbr$ days previously;"C0021308;C0439228";NA;NA;infarction $nmbr$ days previously
1621;infarction $nmbr$ - $nmbr$ days;"C0021308;C0439228";NA;NA;infarction $nmbr$ $nmbr$ days
1621;infarct ion w ithin previous $nmbr$ day s;"C0021308;C0022023;C0205156;C0332173;C0439228;C0439505;C1552607;C1700702";NA;NA;infarct ion w ithin previous $nmbr$ day s
1621;index stroke > $nmbr$ days before randomization — no . ( % );"C0034656;C0439228;C0456712";NA;NA;index stroke $nmbr$ days before randomization no
1621;hospital stay ( days );"C0439228;C3489408";NA;NA;hospital stay days
1621;hospital stay  days;"C0439228;C3489408";NA;NA;hospital stay days
1621;exposure to study drug — days;"C0013175;C0332157;C0439228";NA;NA;exposure to study drug days
1621;every day;"C0332173;C0439228;C0439505";NA;NA;every day
1621;ended > $nmbr$ days before trial entry;"C0008976;C0439228;C1272693;C1705654;C2746065";NA;NA;ended $nmbr$ days before trial entry
1621;elevated natriuretic peptides in previous $nmbr$ days — no . ( % ) : ! :;"C0205156;C0205250;C0439228;C1144709;C1552607;C3163633";NA;NA;elevated natriuretic peptides in previous $nmbr$ days no
1621;elevated natriuretic peptides in previous $nmbr$ days — no . ( % ) $;"C0205156;C0205250;C0439228;C1144709;C1552607;C3163633";NA;NA;elevated natriuretic peptides in previous $nmbr$ days no $
1626;serum potassium level  mean ( sd )  meq / l;"C0302353;C0439375;C0444504;C0543465;C2347634;C2348143;C2699239";FALSE;1959;serum potassium level mean sd meq l
1626;serum potassium  meq / l;"C0302353;C0439375;C0543465";FALSE;1959;serum potassium meq l
1621;aspirin < $nmbr$ day;"C0004057;C0332173;C0439228;C0439505";NA;NA;aspirin $nmbr$ day
1621;as - needed inhalations / day;"C0004048;C0332173;C0354922;C0439228;C0439505;C1879745;C1883728";NA;NA;as needed inhalations day
1621;a ngina > $nmbr$ day s previously *;"C0332173;C0439228;C0439505";NA;NA;a ngina $nmbr$ day s previously
1621;^ $nmbr$ days;C0439228;NA;NA;$nmbr$ days
1621;> = medion ( $nmbr$ days );C0439228;NA;NA;medion $nmbr$ days
1621;> = median ( $nmbr$ days );"C0439228;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median $nmbr$ days
1621;> = $nmbr$ days;C0439228;NA;NA;$nmbr$ days
1621;> $nmbr$ days warfarin;"C0043031;C0439228";NA;NA;$nmbr$ days warfarin
1621;> $nmbr$ days ( % );C0439228;NA;NA;$nmbr$ days
1621;> $nmbr$ days;C0439228;NA;NA;$nmbr$ days
1621;> $nmbr$ / day;"C0332173;C0439228;C0439505";NA;NA;$nmbr$ day
1621;< median ( $nmbr$ days );"C0439228;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median $nmbr$ days
1621;< $nmbr$ days ( n = $nmbr$ );C0439228;NA;NA;$nmbr$ days n $nmbr$
1621;< $nmbr$ days ( % );C0439228;NA;NA;$nmbr$ days
1621;< $nmbr$ days;C0439228;NA;NA;$nmbr$ days
1621;( iqr ) — days;C0439228;NA;NA;iqr days
1621;$nmbr$ — $nmbr$ days;C0439228;NA;NA;$nmbr$ $nmbr$ days
1621;$nmbr$ or $nmbr$ days;C0439228;NA;NA;$nmbr$ or $nmbr$ days
1621;$nmbr$ days new mi or definite acute st;"C0036056;C0205178;C0205314;C0439228;C0439544;C1704787;C3272372;C3810814";NA;NA;$nmbr$ days new mi or definite acute st
1621;$nmbr$ days new mi;"C0205314;C0439228;C3810814";NA;NA;$nmbr$ days new mi
1621;$nmbr$ days;C0439228;NA;NA;$nmbr$ days
1621;$nmbr$ day l;"C0332173;C0439228;C0439505";NA;NA;$nmbr$ day l
1621;$nmbr$ / day;"C0332173;C0439228;C0439505";NA;NA;$nmbr$ day
1621;$nmbr$ - day mortality;"C0026565;C0026566;C0332173;C0439228;C0439505";NA;NA;$nmbr$ day mortality
1621;$nmbr$ - day cce;"C0332173;C0439228;C0439505";NA;NA;$nmbr$ day cce
1621;$nmbr$ - $nmbr$ days ( % );C0439228;NA;NA;$nmbr$ $nmbr$ days
1621;$nmbr$ - $nmbr$ days;C0439228;NA;NA;$nmbr$ $nmbr$ days
1621;$nmbr$ - $nmbr$ / day;"C0332173;C0439228;C0439505";NA;NA;$nmbr$ $nmbr$ day
1620;treatment ( de vs warfarin ) by thrombophilia interaction;"C0011198;C0017480;C0039798;C0043031;C0087111;C0398623;C1522326;C1533734;C1704675;C1705169;C3538994;C3541240;C3887704";NA;NA;treatment de vs warfarin by thrombophilia interaction
1620;hemoglobin ( gm / dl );"C0017480;C0019046;C3642216;C3854019";NA;NA;hemoglobin gm dl
1620;germany;C0017480;NA;NA;germany
1620;de ( n = $nmbr$ );"C0011198;C0017480;C3541240";NA;NA;de n $nmbr$
1620;de $nmbr$ n = $nmbr$;"C0011198;C0017480;C3541240";NA;NA;de $nmbr$ n $nmbr$
1620;de $nmbr$ mg bid ( n - $nmbr$  $nmbr$ );"C0011198;C0017480;C0024671;C0026410;C0439269;C1960952;C2346927;C3541240;C4321396;C4521761";NA;NA;de $nmbr$ mg bid n $nmbr$ $nmbr$
1620;de;"C0011198;C0017480;C3541240";NA;NA;de
1619;treatment during or after catheterization;"C0007430;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;treatment during or after catheterization
1619;or = $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ – $nmbr$ . $nmbr$ ) < $nmbr$ . $nmbr$;NA;NA;NA;or $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
1619;or = $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ – $nmbr$ . $nmbr$ ) $nmbr$ . $nmbr$;NA;NA;NA;or $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
1619;fibrinolytic agents before or after entry;"C0016018;C1705654";NA;NA;fibrinolytic agents before or after entry
1618;on or after e ^ andomization;NA;NA;NA;on or after e andomization
1618;after $nmbr$ h;"C0033727;C0369286;C0441932;C0564385;C4528284";NA;NA;after $nmbr$ h
1618;$nmbr$ hr after glucose challenge;C3840385;NA;NA;$nmbr$ hr after glucose challenge
1617;leader;NA;NA;NA;leader
1617;laser or vitrectomy;"C0023089;C0042903;C0458142;C1023865;C1706315";NA;NA;laser or vitrectomy
1617;greater than or equal to $nmbr$ mm hg;"C0205163;C0439093;C0439475";NA;NA;greater than or equal to $nmbr$ mm hg
1617;greater than or equal to $nmbr$ %;"C0205163;C0439093";NA;NA;greater than or equal to $nmbr$
1617;$nmbr$ or greater;C1704243;NA;NA;$nmbr$ or greater
1616;othera;NA;NA;NA;othera
1616;other teaes;NA;NA;NA;other teaes
1616;other ischaemic heart disease ( non - infarction );"C0010054;C0021308;C0151744;C1518422";NA;NA;other ischaemic heart disease non infarction
1616;other antihyperglycemic agents  not listed;"C0020616;C0745732;C1518422;C3272378";NA;NA;other antihyperglycemic agents not listed
1616;other *;NA;NA;NA;other
1616;other ( $nmbr$ . $nmbr$ % ) t;C2603360;NA;NA;other $nmbr$ $nmbr$ t
1616;other ';NA;NA;NA;other
1615;tnfi ( no other bdmard taken ) t  n ( % );"C1883727;C2986835";NA;NA;tnfi no other bdmard taken t n
1615;other bdmards ( no tnfi taken ) t  n ( % );"C1883727;C2986835";NA;NA;other bdmards no tnfi taken t n
1615;other bdmard §;NA;NA;NA;other bdmard
1614;testing order;"C0039593;C0392366;C1705175;C1705176;C1705177;C1705178;C1882348;C3889825;C4284072";NA;NA;testing order
1614;hder *;C3898895;NA;NA;hder
1613;nontraumatic leg or foot amputation;"C0023216;C0188605;C1140621";NA;NA;nontraumatic leg or foot amputation
1613;lower limbs;C0023216;NA;NA;lower limbs
1613;lower limb fractures;"C0016658;C0023216";NA;NA;lower limb fractures
1613;lower limb fracture;"C0016658;C0023216;C0441994;C0596838;C1548802;C2003888";NA;NA;lower limb fracture
1613;lower - limb arterial — no . ( % );"C0003842;C0023216;C0221464";NA;NA;lower limb arterial no
1612;other blood glucose - lowering agents;"C0005802;C0441994;C0450442;C1254351;C1521826;C2003888";NA;NA;other blood glucose lowering agents
1612;other : :;NA;NA;NA;other
1612;lower than normal range — % ^;"C0086715;C0441994;C1548802;C2003888";NA;NA;lower than normal range
1612;lower tertile : b $nmbr$ . $nmbr$;"C0441994;C1548802;C2003888";NA;NA;lower tertile b $nmbr$ $nmbr$
1612;lower;"C0441994;C1548802;C2003888";NA;NA;lower
1612;distal lower;"C0205108;C0441994;C1548802;C2003888;C4522154";NA;NA;distal lower
1611;liver disorder;C0023895;NA;NA;liver disorder
1611;hepatic disorders;C0023895;NA;NA;hepatic disorders
1610;neurocognitive disorders;"C0029227;C4041080";NA;NA;neurocognitive disorders
1610;gastrointestinal disorders;C0017178;NA;NA;gastrointestinal disorders
1610;gastrointestinal ( gi ) disorders;"C0017178;C1708130;C3539617;C4050121";NA;NA;gastrointestinal gi disorders
1609;pacific islander;C0242191;NA;NA;pacific islander
1609;other pacific islander;C0242191;NA;NA;other pacific islander
1609;islander;NA;NA;NA;islander
1609;bladder;"C0005682;C4319531";NA;NA;bladder
1609;asian or pacific islander;"C0078988;C0242191";NA;NA;asian or pacific islander
1609;asian / pacific islander  n ( % );"C0078988;C0242191";NA;NA;asian pacific islander n
1608;mucolytics;C0026698;NA;NA;mucolytics
1608;mucolytic agent;C0026698;NA;NA;mucolytic agent
1607;myoclonic;NA;NA;NA;myoclonic
1607;juvenile myoclonic epilepsy;C0270853;NA;NA;juvenile myoclonic epilepsy
1606;pathological q waves;C0429090;NA;NA;pathological q waves
1606;pathologic q waves — no . ( % );C0429090;NA;NA;pathologic q waves no
1606;pathologic q waves  n ( % );C0429090;NA;NA;pathologic q waves n
1606;hematologic;"C0018943;C0205488";NA;NA;hematologic
1606;haematological;"C0018943;C0200627";NA;NA;haematological
1605;troponin t;"C0077404;C1420827";NA;NA;troponin t
1605;troponin ( - );C0041199;NA;NA;troponin
1605;elevated troponin — %;"C0041199;C0205250;C3163633";NA;NA;elevated troponin
1605;elevated troponin t ( > $nmbr$ . $nmbr$ / xg / l );"C0017209;C0077404;C0205250;C1292284;C1420827;C1421532;C3163633";NA;NA;elevated troponin t $nmbr$ $nmbr$ xg l
1605;elevated troponin ( > $nmbr$ . $nmbr$ pg / l );"C0041199;C0205250;C0439278;C3163633";NA;NA;elevated troponin $nmbr$ $nmbr$ pg l
1592;previous tia;"C0007787;C0205156;C0917805;C1054154;C1552607";NA;NA;previous tia
1605;elevated troponin ( > $nmbr$ . $nmbr$ mg / l )  %;"C0041199;C0205250;C0439268;C3163633";NA;NA;elevated troponin $nmbr$ $nmbr$ mg l
1605;elevated troponin;"C0041199;C0205250;C3163633";NA;NA;elevated troponin
1604;cryptogenic localization - related;"C0332240;C0439849;C0445223;C0475264;C1744691";NA;NA;cryptogenic localization related
1604;cryptogenic;C0332240;NA;NA;cryptogenic
1603;troponin ( + );C0041199;NA;NA;troponin
1603;troponin $nmbr$ at baseline *;"C0041199;C0168634;C1442488";NA;NA;troponin $nmbr$ at baseline
1603;troponin $nmbr$ at baseline;"C0041199;C0168634;C1442488";NA;NA;troponin $nmbr$ at baseline
1603;troponin;C0041199;NA;NA;troponin
1603;positive troponin or ck - mb;"C0010290;C0041199;C0439178;C1446409;C1514241;C2825490;C3812269";NA;NA;positive troponin or ck mb
1602;result;"C1274040;C1546471;C2825142";NA;NA;result
1602;outcomes during accord;"C0680240;C1274040";NA;NA;outcomes during accord
1602;outcomes;C1274040;NA;NA;outcomes
1602;outcome severity;"C0439793;C0522510;C1274040";NA;NA;outcome severity
1602;outcome according to stage of cancer — no . / total no . ( % );"C0027646;C0439175;C0439810;C0680240;C1274040";NA;NA;outcome according to stage of cancer no total no
1602;outcome according to primary cancer site — no . / total no . ( % );"C0439175;C0439810;C0680240;C0872338;C1274040";NA;NA;outcome according to primary cancer site no total no
1602;outcome according to no . of risk factors for vte;"C0035648;C0630906;C0680240;C1274040;C1553898";NA;NA;outcome according to no of risk factors for vte
1602;outcome - variant;"C0205419;C1274040";NA;NA;outcome variant
1602;outcome ( n  % };C1274040;NA;NA;outcome n
1602;outcome;C1274040;NA;NA;outcome
1602;other outcomes;C1274040;NA;NA;other outcomes
1602;microvascular outcome;"C0443258;C1274040";NA;NA;microvascular outcome
1602;exploratory kidney and microvascular outcomes;"C0022646;C0227665;C0443258;C1274040";NA;NA;exploratory kidney and microvascular outcomes
1602;clinical outcome;"C0205210;C1274040";NA;NA;clinical outcome
1602;characteristic / outcome;"C1274040;C1521970";NA;NA;characteristic outcome
1602;baseline outcomes;"C0168634;C1274040;C1442488";NA;NA;baseline outcomes
1602;ancova result;"C0814908;C1274040;C1546471;C2825142";NA;NA;ancova result
1602;adverse outcome;C1274040;NA;NA;adverse outcome
1601;trough fevi l;"C0429706;C0444506;C0849974;C1561566;C4528367";NA;NA;trough fevi l
1601;proportion of patients with trough fevi > $nmbr$ ml above baseline  n ( % );"C0030705;C0168634;C0429706;C0439526;C0444506;C0849974;C1442488;C1561566;C1705224;C1709707;C3887665;C4528367";NA;NA;proportion of patients with trough fevi $nmbr$ ml above baseline n
1601;prebronchodilator fevi — liters;"C0429706;C0475211;C0849974;C1561566;C2599602;C4528367";NA;NA;prebronchodilator fevi liters
1601;prebronchodilator fevi ( % predicted );"C0681842;C0849974;C1561566;C1882327;C2599602;C4528367";NA;NA;prebronchodilator fevi predicted
1601;pre - bronchodilator fevi change;"C0392747;C0443172;C0849974;C1561566;C1705241;C2599602;C4319952;C4528367";NA;NA;pre bronchodilator fevi change
1601;post - bronchodilator fevi $nmbr$ % predicted;"C0681842;C0849974;C1561566;C1882327;C2599594;C4528367";NA;NA;post bronchodilator fevi $nmbr$ predicted
1601;post - bronchodilator fevi  n ( % );"C0429706;C0849974;C1561566;C2599594;C4528367";NA;NA;post bronchodilator fevi n
1601;mean ( sd ) fevi / evc  %;"C0013903;C0429706;C0429711;C0444504;C0849974;C1414479;C1561566;C2347634;C2348143;C2699239;C4528367";NA;NA;mean sd fevi evc
1601;mean ( sd ) fevi  ml;"C0429706;C0439526;C0444504;C0849974;C1561566;C1705224;C2347634;C2348143;C2699239;C3887665;C4528367";NA;NA;mean sd fevi ml
1601;fevi percent predicted ( % );"C0429706;C0439165;C0681842;C0849974;C1561566;C1882327;C4528367";NA;NA;fevi percent predicted
1601;fevi auc $nmbr$ - $nmbr$ l;"C0376690;C0429706;C0849974;C1561566;C4528367";NA;NA;fevi auc $nmbr$ $nmbr$ l
1601;fevi $nmbr$ l;"C0429706;C0849974;C1561566;C4528367";NA;NA;fevi $nmbr$ l
1601;fevi  l *;"C0429706;C0849974;C1561566;C4528367";NA;NA;fevi l
1601;fevi  l;"C0429706;C0849974;C1561566;C4528367";NA;NA;fevi l
1601;fevi  % predicted *;"C0681842;C0849974;C1561566;C1882327;C4528367";NA;NA;fevi predicted
1601;adjusted mean ( se ) trough fevi  ml;"C0036919;C0429706;C0439526;C0444504;C0444506;C0456081;C0849974;C1561566;C1705224;C2347634;C2348143;C3887665;C4528367";NA;NA;adjusted mean se trough fevi ml
1601;$nmbr$ ( fevi ^ $nmbr$ % pred );"C0032952;C0044955;C0849974;C1561566;C4528367";NA;NA;$nmbr$ fevi $nmbr$ pred
1601;$nmbr$ ( fevi $nmbr$ - < $nmbr$ % pred );"C0032952;C0044955;C0849974;C1561566;C4528367";NA;NA;$nmbr$ fevi $nmbr$ $nmbr$ pred
1600;pre - bronchodilator fevi / fvc  %;"C0802741;C2599602;C3815113";NA;NA;pre bronchodilator fevi fvc
1600;mean ( sd ) fevi / fvc  %;"C0444504;C0802741;C2347634;C2348143;C2699239;C3815113";NA;NA;mean sd fevi fvc
1600;fevi / fvc ( % );"C0802741;C3815113";NA;NA;fevi fvc
1599;trough fev $nmbr$;"C0444506;C3714541";NA;NA;trough fev $nmbr$
1599;severe ( fev  < $nmbr$ % predicted );"C0205082;C0681842;C1882327;C3714541;C4050465;C4050466";NA;NA;severe fev $nmbr$ predicted
1599;screening fev $nmbr$   % predicted;"C0220908;C0220909;C0681842;C1698960;C1710031;C1710032;C1710477;C1882327;C2348164;C3714541";NA;NA;screening fev $nmbr$ predicted
1599;screening % predicted fev $nmbr$;"C0220908;C0220909;C0681842;C1698960;C1710031;C1710032;C1710477;C1882327;C2348164;C3714541";NA;NA;screening predicted fev $nmbr$
1599;ratio of fev $nmbr$ to fvc ( % );"C0456603;C1547037;C3714541";NA;NA;ratio of fev $nmbr$ to fvc
1599;ratio of fev $nmbr$ to fvc;"C0456603;C1547037;C3714541";NA;NA;ratio of fev $nmbr$ to fvc
1599;prebronchodilator fev $nmbr$ / fvc;"C2599602;C3714541";NA;NA;prebronchodilator fev $nmbr$ fvc
1599;prebronchodilator fev $nmbr$ ( l ) t;"C2599602;C3714541";NA;NA;prebronchodilator fev $nmbr$ l t
1599;prebronchodilator fev $nmbr$ ( l );"C2599602;C3714541";NA;NA;prebronchodilator fev $nmbr$ l
1599;prebronchodilator fev $nmbr$ ( %;"C2599602;C3714541";NA;NA;prebronchodilator fev $nmbr$
1599;prebronchodilator fev $nmbr$  mean ( sd )  l;"C0444504;C2347634;C2348143;C2599602;C2699239;C3714541";NA;NA;prebronchodilator fev $nmbr$ mean sd l
1599;prebronchodilator fev $nmbr$  l;"C2599602;C3714541";NA;NA;prebronchodilator fev $nmbr$ l
1599;prebronchodilator fev $nmbr$  % predicted;"C0681842;C1882327;C2599602;C3714541";NA;NA;prebronchodilator fev $nmbr$ predicted
1599;pre fev $nmbr$;"C0332152;C0740175;C2257086;C3669034;C3714541";NA;NA;pre fev $nmbr$
1599;pre - bronchodilator mean ( sd ) fev $nmbr$  . l;"C0444504;C2347634;C2348143;C2599602;C2699239;C3714541";NA;NA;pre bronchodilator mean sd fev $nmbr$ l
1599;pre - bronchodilator fev $nmbr$ / fvc ratio *;"C0456603;C1547037;C2599602;C3714541";NA;NA;pre bronchodilator fev $nmbr$ fvc ratio
1599;pre - bronchodilator fev $nmbr$ / fvc ( % );"C2599602;C3714541";NA;NA;pre bronchodilator fev $nmbr$ fvc
1599;pre - bronchodilator fev $nmbr$  l *;"C2599602;C3714541";NA;NA;pre bronchodilator fev $nmbr$ l
1599;pre - bronchodilator fev $nmbr$;"C2599602;C3714541";NA;NA;pre bronchodilator fev $nmbr$
1599;pre - bronchodilation fvc;"C0439566;C3714541";NA;NA;pre bronchodilation fvc
1599;pre - bronchodilation fev $nmbr$;"C0439566;C3714541";NA;NA;pre bronchodilation fev $nmbr$
1599;postdose fev / fvc at screening;"C0220908;C0220909;C0439568;C1698960;C1710031;C1710032;C1710477;C2348164;C3714541";NA;NA;postdose fev fvc at screening
1599;postbronchodilator fev $nmbr$ / fvc  %;"C2599594;C3714541";NA;NA;postbronchodilator fev $nmbr$ fvc
1599;postbronchodilator fev $nmbr$  l;"C2599594;C3714541";NA;NA;postbronchodilator fev $nmbr$ l
1599;post fev $nmbr$;"C0687676;C1704687;C3469826;C3714541";NA;NA;post fev $nmbr$
1599;post - bronchodilator percent of predicted fev $nmbr$  % ( sd );"C1882327;C2599594;C2699239;C3714541";NA;NA;post bronchodilator percent of predicted fev $nmbr$ sd
1599;post - bronchodilator fev $nmbr$ / fvc ratio  mean ( sd );"C0444504;C0456603;C1547037;C2347634;C2348143;C2599594;C2699239;C3714541";NA;NA;post bronchodilator fev $nmbr$ fvc ratio mean sd
1599;post - bronchodilator fev $nmbr$  % predicted  mean ( sd ) c;"C0444504;C0681842;C1882327;C2347634;C2348143;C2599594;C2699239;C3714541";NA;NA;post bronchodilator fev $nmbr$ predicted mean sd c
1599;post - bronchodilation fvc;"C0439576;C3714541";NA;NA;post bronchodilation fvc
1599;post - bronchodilation fev $nmbr$;"C0439576;C3714541";NA;NA;post bronchodilation fev $nmbr$
1323;women / men [ % ];"C0025266;C0043210";NA;NA;women men
1599;post - albuterol % predicted fev $nmbr$ mean ( sd ) e;"C0001927;C0444504;C0681842;C0687676;C1704687;C1882327;C2347634;C2348143;C2699239;C3469826;C3714541";NA;NA;post albuterol predicted fev $nmbr$ mean sd e
1599;percent of predicted fev $nmbr$;"C1882327;C3714541";NA;NA;percent of predicted fev $nmbr$
1599;mild ( fev  > $nmbr$ % predicted );"C0681842;C1882327;C2945599;C3714541";NA;NA;mild fev $nmbr$ predicted
1568;ularitide n / n ( % );C0077910;NA;NA;ularitide n n
1599;mean prebronchodilator fev $nmbr$ ( sd )  % predicted;"C0444504;C0681842;C1882327;C2347634;C2348143;C2599602;C2699239;C3714541";NA;NA;mean prebronchodilator fev $nmbr$ sd predicted
1599;mean postbronchodilatora fev $nmbr$  % predicted ( sd );"C0444504;C0681842;C1882327;C2347634;C2348143;C2699239;C3714541";NA;NA;mean postbronchodilatora fev $nmbr$ predicted sd
1599;mean fvc ± sd;"C0444504;C2347634;C2348143;C2699239;C3714541";NA;NA;mean fvc sd
1599;mean ( sd ) postbronchodilator fev $nmbr$ / fvc  %;"C0444504;C2347634;C2348143;C2599594;C2699239;C3714541";NA;NA;mean sd postbronchodilator fev $nmbr$ fvc
1599;mean ( sd ) postbronchodilator fev $nmbr$ % predicted;"C0444504;C0681842;C1882327;C2347634;C2348143;C2599594;C2699239;C3714541";NA;NA;mean sd postbronchodilator fev $nmbr$ predicted
1599;mean ( sd ) post - bronchodilator fev $nmbr$ percentage predicted;"C0439165;C0444504;C0681842;C1549488;C1561533;C1882327;C2347634;C2348143;C2599594;C2699239;C3714541";NA;NA;mean sd post bronchodilator fev $nmbr$ percentage predicted
1599;mean ( sd ) fev $nmbr$ postbronchodilator  l;"C0444504;C2347634;C2348143;C2599594;C2699239;C3714541";NA;NA;mean sd fev $nmbr$ postbronchodilator l
1599;mean ( sd ) fev $nmbr$ ( l ) pre - bronchodilator;"C0444504;C2347634;C2348143;C2599602;C2699239;C3714541";NA;NA;mean sd fev $nmbr$ l pre bronchodilator
1599;mean ( sd ) fev $nmbr$ ( l ) post - bronchodilator;"C0444504;C2347634;C2348143;C2599594;C2699239;C3714541";NA;NA;mean sd fev $nmbr$ l post bronchodilator
1599;mean ( sd ) % predicted normal fev $nmbr$;"C0205307;C0231683;C0439166;C0444504;C0681842;C1882327;C2347086;C2347634;C2348143;C2699239;C3714541;C4553972";NA;NA;mean sd predicted normal fev $nmbr$
1599;mean % predicted fvc ( sd );"C0444504;C0681842;C1882327;C2347634;C2348143;C2699239;C3714541";NA;NA;mean predicted fvc sd
1599;iv : fev $nmbr$ < $nmbr$ % predicted;"C0022326;C0681842;C1882327;C3714541;C4265176";NA;NA;iv fev $nmbr$ $nmbr$ predicted
1599;iii : fev $nmbr$ > $nmbr$ % - < $nmbr$ % predicted;"C0439070;C0681842;C1705160;C1882327;C3714541";NA;NA;iii fev $nmbr$ $nmbr$ $nmbr$ predicted
1599;gold grades $nmbr$ - $nmbr$ ( percent - predicted fev ( )  n;"C0018026;C0439165;C0441800;C0681842;C0919553;C1304897;C1882327;C3244287;C3714541";NA;NA;gold grades $nmbr$ $nmbr$ percent predicted fev n
1599;fvc ∗;C3714541;NA;NA;fvc
1599;fvc — liters;"C0475211;C3714541";NA;NA;fvc liters
1599;fvc change;"C0392747;C0443172;C1705241;C3714541;C4319952";NA;NA;fvc change
1599;fvc > $nmbr$ % predicted;"C0681842;C1882327;C3714541";NA;NA;fvc $nmbr$ predicted
1599;fvc < $nmbr$ % predicted;"C0681842;C1882327;C3714541";NA;NA;fvc $nmbr$ predicted
1599;fvc ( liters );"C0475211;C3714541";NA;NA;fvc liters
1599;fvc ( l ) *;C3714541;NA;NA;fvc l
1599;fvc ( l );C3714541;NA;NA;fvc l
1599;fvc ( % predicted );"C0681842;C1882327;C3714541";NA;NA;fvc predicted
1599;fvc % predicted !  t;"C0681842;C1882327;C2603360;C3714541";NA;NA;fvc predicted t
1599;fvc  l;C3714541;NA;NA;fvc l
1599;fvc  % predicted  mean ( sd );"C0444504;C0681842;C1882327;C2347634;C2348143;C2699239;C3714541";NA;NA;fvc predicted mean sd
1599;fvc  % predicted;"C0681842;C1882327;C3714541";NA;NA;fvc predicted
1599;fvc;C3714541;NA;NA;fvc
1599;fevt : fvc ratio — % |;"C0016529;C0456603;C1547037;C3714541";NA;NA;fevt fvc ratio
1599;fev_ ( l ) :;C3714541;NA;NA;fev_ l
1599;fev $nmbr$ — liters;"C0475211;C3714541";NA;NA;fev $nmbr$ liters
1599;fev $nmbr$   at baseline ( randomization ) ∗;"C0034656;C0168634;C1442488;C3714541";NA;NA;fev $nmbr$ at baseline randomization
1599;fev $nmbr$ reversibilityz ( pre / post salbutamol )  %;"C0001927;C0332152;C0687676;C0740175;C1704687;C2257086;C3469826;C3669034;C3714541";NA;NA;fev $nmbr$ reversibilityz pre post salbutamol
1599;fev $nmbr$ reversibilityz ( pre / post ipratropium )  %;"C0027235;C0332152;C0687676;C0740175;C1704687;C2257086;C3469826;C3669034;C3714541";NA;NA;fev $nmbr$ reversibilityz pre post ipratropium
1599;fev $nmbr$ reversibility  pre - / post - albuterol  %;"C0001927;C0332152;C0449261;C0687676;C0740175;C1704687;C2257086;C3469826;C3669034;C3714541";NA;NA;fev $nmbr$ reversibility pre post albuterol
1599;fev $nmbr$ prebronchodilator [ l ]  mean ± sd;"C0444504;C2347634;C2348143;C2599602;C2699239;C3714541";NA;NA;fev $nmbr$ prebronchodilator l mean sd
1599;fev $nmbr$ prebronchodilator [ % pn ]  mean ± sd;"C0219433;C0444504;C1549735;C2347634;C2348143;C2599602;C2699239;C3541307;C3714541;C4049640;C4049767";NA;NA;fev $nmbr$ prebronchodilator pn mean sd
1599;fev $nmbr$ pre - bronchodilator ( l )  mean ( sd ) c;"C0444504;C2347634;C2348143;C2599602;C2699239;C3714541";NA;NA;fev $nmbr$ pre bronchodilator l mean sd c
1599;fev $nmbr$ post - bronchodilator;"C2599594;C3714541";NA;NA;fev $nmbr$ post bronchodilator
1599;fev $nmbr$ percent predicted ( sd );"C0439165;C0681842;C1882327;C2699239;C3714541";NA;NA;fev $nmbr$ percent predicted sd
1599;fev $nmbr$ at baseline;"C0168634;C1442488;C3714541";NA;NA;fev $nmbr$ at baseline
1599;fev $nmbr$ : fvc ratio;"C0456603;C1547037;C3714541";NA;NA;fev $nmbr$ fvc ratio
1599;fev $nmbr$ / fvc ratio *;"C0456603;C1547037;C3714541";NA;NA;fev $nmbr$ fvc ratio
1599;fev $nmbr$ / fvc ratio  % ( sd );"C0456603;C1547037;C2699239;C3714541";NA;NA;fev $nmbr$ fvc ratio sd
1599;fev $nmbr$ / fvc ratio  %;"C0456603;C1547037;C3714541";NA;NA;fev $nmbr$ fvc ratio
1599;fev $nmbr$ / fvc prebronchodilatort;C3714541;NA;NA;fev $nmbr$ fvc prebronchodilatort
1599;fev $nmbr$ / fvc prebronchodilator  mean ± sd;"C0444504;C2347634;C2348143;C2599602;C2699239;C3714541";NA;NA;fev $nmbr$ fvc prebronchodilator mean sd
1599;fev $nmbr$ / fvc at baseline ( randomization ) ( % ) ∗;"C0034656;C0168634;C1442488;C3714541";NA;NA;fev $nmbr$ fvc at baseline randomization
1599;fev $nmbr$ / fvc ( post salbutamol );"C0001927;C0687676;C1704687;C3469826;C3714541";NA;NA;fev $nmbr$ fvc post salbutamol
1599;fev $nmbr$ / fvc %;C3714541;NA;NA;fev $nmbr$ fvc
1599;fev $nmbr$ / fvc  % a;C3714541;NA;NA;fev $nmbr$ fvc a
1599;fev $nmbr$ / fvc  % *;C3714541;NA;NA;fev $nmbr$ fvc
1599;fev $nmbr$ / fvc;C3714541;NA;NA;fev $nmbr$ fvc
1599;fev $nmbr$ ( pre - albuterol )  l;"C0001927;C0332152;C0740175;C2257086;C3669034;C3714541";NA;NA;fev $nmbr$ pre albuterol l
1599;fev $nmbr$ ( post - albuterol )  l;"C0001927;C0687676;C1704687;C3469826;C3714541";NA;NA;fev $nmbr$ post albuterol l
1599;fev $nmbr$ ( liters );"C0475211;C3714541";NA;NA;fev $nmbr$ liters
1599;fev $nmbr$ ( l );C3714541;NA;NA;fev $nmbr$ l
1599;fev $nmbr$ ( % predicted );"C0681842;C1882327;C3714541";NA;NA;fev $nmbr$ predicted
1599;fev $nmbr$ % predicted ≥ $nmbr$ %;"C0681842;C1882327;C3714541";NA;NA;fev $nmbr$ predicted $nmbr$
1599;fev $nmbr$ % predicted at baseline;"C0168634;C0681842;C1442488;C1882327;C3714541";NA;NA;fev $nmbr$ predicted at baseline
1599;fev $nmbr$ % predicted < $nmbr$ %;"C0681842;C1882327;C3714541";NA;NA;fev $nmbr$ predicted $nmbr$
1599;fev $nmbr$ % predicted ( sd );"C0681842;C1882327;C2699239;C3714541";NA;NA;fev $nmbr$ predicted sd
1599;fev $nmbr$ % predicted ( post salbutamol );"C0001927;C0681842;C0687676;C1704687;C1882327;C3469826;C3714541";NA;NA;fev $nmbr$ predicted post salbutamol
1599;fev $nmbr$ % predicted  post - albuterol  %;"C0001927;C0681842;C0687676;C1704687;C1882327;C3469826;C3714541";NA;NA;fev $nmbr$ predicted post albuterol
1599;fev $nmbr$ % predicted  mean ( sd );"C0444504;C0681842;C1882327;C2347634;C2348143;C2699239;C3714541";NA;NA;fev $nmbr$ predicted mean sd
1599;fev $nmbr$ % predicted;"C0681842;C1882327;C3714541";NA;NA;fev $nmbr$ predicted
1599;fev $nmbr$ % pred . ( post - albuterol )  %;"C0001927;C0032952;C0044955;C0687676;C1704687;C3469826;C3714541";NA;NA;fev $nmbr$ pred post albuterol
1599;fev $nmbr$  pre - albuterol  l;"C0001927;C0332152;C0740175;C2257086;C3669034;C3714541";NA;NA;fev $nmbr$ pre albuterol l
1599;fev $nmbr$  post - albuterol  l;"C0001927;C0687676;C1704687;C3469826;C3714541";NA;NA;fev $nmbr$ post albuterol l
1599;fev $nmbr$  mean  l;"C0444504;C2347634;C2348143;C3714541";NA;NA;fev $nmbr$ mean l
1323;women / men  %;"C0025266;C0043210";NA;NA;women men
1599;fev $nmbr$  mean  % predicted;"C0444504;C0681842;C1882327;C2347634;C2348143;C3714541";NA;NA;fev $nmbr$ mean predicted
1599;fev $nmbr$  litres ( pre salbutamol )  mean ( sd );"C0001927;C0332152;C0444504;C0475211;C0740175;C2257086;C2347634;C2348143;C2699239;C3669034;C3714541";NA;NA;fev $nmbr$ litres pre salbutamol mean sd
1568;ularitide ( n = $nmbr$ );C0077910;NA;NA;ularitide n $nmbr$
1599;fev $nmbr$  litres ( pre ipratropium )  mean ( sd );"C0027235;C0332152;C0444504;C0475211;C0740175;C2257086;C2347634;C2348143;C2699239;C3669034;C3714541";NA;NA;fev $nmbr$ litres pre ipratropium mean sd
1599;fev $nmbr$  litres ( post ipratropium )  mean ( sd );"C0027235;C0444504;C0475211;C0687676;C1704687;C2347634;C2348143;C2699239;C3469826;C3714541";NA;NA;fev $nmbr$ litres post ipratropium mean sd
1599;fev $nmbr$  l prebronchodilator fev $nmbr$  % predicted;"C0681842;C1882327;C2599602;C3714541";NA;NA;fev $nmbr$ l prebronchodilator fev $nmbr$ predicted
1599;fev $nmbr$  l *;C3714541;NA;NA;fev $nmbr$ l
1599;fev $nmbr$  l;C3714541;NA;NA;fev $nmbr$ l
1599;fev $nmbr$  % predicteda;C3714541;NA;NA;fev $nmbr$ predicteda
1599;fev $nmbr$  % predicted  mean ( sd );"C0444504;C0681842;C1882327;C2347634;C2348143;C2699239;C3714541";NA;NA;fev $nmbr$ predicted mean sd
1599;fev $nmbr$  % predicted;"C0681842;C1882327;C3714541";NA;NA;fev $nmbr$ predicted
1599;fev $nmbr$;C3714541;NA;NA;fev $nmbr$
1599;fev  at baseline;"C0168634;C1442488;C3714541";NA;NA;fev at baseline
1599;fev  > $nmbr$ % predicted;"C0681842;C1882327;C3714541";NA;NA;fev $nmbr$ predicted
1599;fev  < $nmbr$ % predicted;"C0681842;C1882327;C3714541";NA;NA;fev $nmbr$ predicted
1599;fev  % predicted;"C0681842;C1882327;C3714541";NA;NA;fev predicted
1599;fev;C3714541;NA;NA;fev
1599;change from baseline in % predicted fev $nmbr$;"C0168634;C0392747;C0443172;C0681842;C1442488;C1705241;C1882327;C3714541;C4319952";NA;NA;change from baseline in predicted fev $nmbr$
1599;c $nmbr$ ml decrease in trough fev $nmbr$;"C0392756;C0439526;C0444506;C0547047;C1705224;C3714541;C3887665";NA;NA;c $nmbr$ ml decrease in trough fev $nmbr$
1599;baseline post - bronchodilator % predicted fev  > $nmbr$ % and no concurrent tiotropium;"C0168634;C0205420;C0213771;C0681842;C1442488;C1882327;C2599594;C3714541";NA;NA;baseline post bronchodilator predicted fev $nmbr$ and no concurrent tiotropium
1599;baseline post - bronchodilator % predicted fev  > $nmbr$ % and concurrent tiotropium use;"C0042153;C0168634;C0205420;C0213771;C0457083;C0681842;C1442488;C1882327;C1947944;C2599594;C3714541";NA;NA;baseline post bronchodilator predicted fev $nmbr$ and concurrent tiotropium use
1599;baseline fvc  l;"C0168634;C1442488;C3714541";NA;NA;baseline fvc l
1599;baseline fev $nmbr$ % predicted;"C0168634;C0681842;C1442488;C1882327;C3714541";NA;NA;baseline fev $nmbr$ predicted
1599;baseline fev $nmbr$ #;"C0168634;C1442488;C3714541";NA;NA;baseline fev $nmbr$
1599;baseline fev $nmbr$  median ( range )  l;"C0168634;C0549183;C0876920;C1442488;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016;C3714541";NA;NA;baseline fev $nmbr$ median range l
1599;baseline fev $nmbr$  l *;"C0168634;C1442488;C3714541";NA;NA;baseline fev $nmbr$ l
1599;baseline fev $nmbr$;"C0168634;C1442488;C3714541";NA;NA;baseline fev $nmbr$
1599;baseline fev  ( l );"C0168634;C1442488;C3714541";NA;NA;baseline fev l
1599;baseline % predicted fev $nmbr$;"C0168634;C0681842;C1442488;C1882327;C3714541";NA;NA;baseline predicted fev $nmbr$
1599;absolute decline in fvc > $nmbr$ % predicted or death  n ( % );"C0011065;C0205344;C0681842;C1306577;C1882327;C3714541;C4082313;C4552775";NA;NA;absolute decline in fvc $nmbr$ predicted or death n
1599;absolute decline in fvc > $nmbr$ % predicted;"C0205344;C0681842;C1882327;C3714541";NA;NA;absolute decline in fvc $nmbr$ predicted
1599;% predicted ” fev  at baseline  % *;"C0168634;C0681842;C1442488;C1882327;C3714541";NA;NA;predicted fev at baseline
1599;% predicted prebronchodilator fev $nmbr$  mean ( sd )  l;"C0444504;C0681842;C1882327;C2347634;C2348143;C2599602;C2699239;C3714541";NA;NA;predicted prebronchodilator fev $nmbr$ mean sd l
1599;% predicted post - bronchodilator fev  ( sd ) ml;"C0439526;C0681842;C1705224;C1882327;C2599594;C2699239;C3714541;C3887665";NA;NA;predicted post bronchodilator fev sd ml
1599;% predicted fev ^;"C0681842;C1882327;C3714541";NA;NA;predicted fev
1599;% predicted fev $nmbr$;"C0681842;C1882327;C3714541";NA;NA;predicted fev $nmbr$
1599;% predicted fev;"C0681842;C1882327;C3714541";NA;NA;predicted fev
1598;oral fi - blockers;"C0442027;C4050619;C4521986";NA;NA;oral fi blockers
1598;fh ii;C1854107;NA;NA;fh ii
1598;fh $nmbr$;NA;NA;NA;fh $nmbr$
1598;% fhg;NA;NA;NA;fhg
1598;$nmbr$ . $nmbr$ ( fi . $nmbr$ );C4050619;NA;NA;$nmbr$ $nmbr$ fi $nmbr$
1597;ff – $nmbr$ % ( $nmbr$ % ci – $nmbr$ – $nmbr$ % );"C0008107;C3259781;C4554348";NA;NA;ff $nmbr$ $nmbr$ ci $nmbr$ $nmbr$
1597;ff / vi $nmbr$ / $nmbr$ gg ( n = $nmbr$  $nmbr$ );"C0017454;C0018370;C0205999;C4554348";NA;NA;ff vi $nmbr$ $nmbr$ gg n $nmbr$ $nmbr$
1597;ff / vi $nmbr$ % ( $nmbr$ %  $nmbr$ % );"C0205999;C4554348";NA;NA;ff vi $nmbr$ $nmbr$ $nmbr$
1597;ff / vi;"C0205999;C4554348";NA;NA;ff vi
1597;ff - blocker;C4554348;NA;NA;ff blocker
1597;ff - $nmbr$ % ( - $nmbr$ %  $nmbr$ % );C4554348;NA;NA;ff $nmbr$ $nmbr$ $nmbr$
1597;ff $nmbr$   µ g;"C0439267;C4554348";NA;NA;ff $nmbr$ g
1597;ff $nmbr$ pgod;C4554348;NA;NA;ff $nmbr$ pgod
1597;ff $nmbr$ gg ( n = $nmbr$  $nmbr$ );"C0017454;C0018370;C4554348";NA;NA;ff $nmbr$ gg n $nmbr$ $nmbr$
1597;ff $nmbr$ % ( - $nmbr$ %  $nmbr$ % );C4554348;NA;NA;ff $nmbr$ $nmbr$ $nmbr$
1597;ff $nmbr$ % ( $nmbr$ % ci – $nmbr$ – $nmbr$ % );"C0008107;C3259781;C4554348";NA;NA;ff $nmbr$ $nmbr$ ci $nmbr$ $nmbr$
1597;difference ff / vi versus uc  %;"C0205999;C1705241;C1705242;C4554348";NA;NA;difference ff vi versus uc
1597;bdp / ff / g ( n = $nmbr$ );"C0004906;C0439267;C1422585;C1538710;C4554348";NA;NA;bdp ff g n $nmbr$
1596;sinus tracts / perforation  ' ^ n ( % );"C0544791;C0549099;C0854572;C1185740;C1881710";NA;NA;sinus tracts perforation n
1596;patients without draining fistulae at baseline [ n = $nmbr$ ];"C0030705;C0168634;C0544791;C1442488";NA;NA;patients without draining fistulae at baseline n $nmbr$
1596;patients with draining fistulae at baseline [ n = $nmbr$ ];"C0030705;C0168634;C0544791;C1442488";NA;NA;patients with draining fistulae at baseline n $nmbr$
1596;number of draining fistulae per patient  n;"C0030705;C0237753;C0449788;C0544791";NA;NA;number of draining fistulae per patient n
1596;no draining fistulas *;C0544791;NA;NA;no draining fistulas
1596;draining fistulae  n ( % );C0544791;NA;NA;draining fistulae n
1595;patients with fistulas at baseline;"C0016169;C0030705;C0168634;C1442488";NA;NA;patients with fistulas at baseline
1595;fistula at baseline  n ( % );"C0016169;C0168634;C1442488";NA;NA;fistula at baseline n
1595;fistula  ' n ( % );C0016169;NA;NA;fistula n
1594;r - tpa;C0032143;NA;NA;r tpa
1594;alteplase group ( n = $nmbr$ );"C0032143;C0441848";NA;NA;alteplase group n $nmbr$
1594;alteplase ( n = $nmbr$ );C0032143;NA;NA;alteplase n $nmbr$
1594;alteplase;C0032143;NA;NA;alteplase
1593;type ic;"C0020750;C0332307;C1547052;C4554818";NA;NA;type ic
1593;partial evolving to secondarily generalized ( ic );"C0020750;C0205246;C0332253;C0728938;C1550516;C4554818";NA;NA;partial evolving to secondarily generalized ic
1593;early ichaem ic stroke;"C0020750;C0038454;C1279919;C4554100;C4554818";NA;NA;early ichaem ic stroke
1593;$nmbr$ to $nmbr$ y ( n = $nmbr$  $nmbr$ . $nmbr$ % );NA;NA;NA;$nmbr$ to $nmbr$ y n $nmbr$ $nmbr$ $nmbr$
1592;transient ischemic attack ( % ) type of lacunar syndrome ( % );"C0007787;C0332307;C0917805;C1547052;C3178801";NA;NA;transient ischemic attack type of lacunar syndrome
1592;transient ischemic attack;"C0007787;C0917805";NA;NA;transient ischemic attack
1592;transient ischaemic attack — no . ( % );"C0007787;C0917805";NA;NA;transient ischaemic attack no
1592;transient ischaemic attack;"C0007787;C0917805";NA;NA;transient ischaemic attack
1592;tia  n ( % );"C0007787;C0917805;C1054154";NA;NA;tia n
1592;tia;"C0007787;C0917805;C1054154";NA;NA;tia
1592;stroke / tia;"C0007787;C0038454;C0917805;C1054154;C4554100";NA;NA;stroke tia
1592;stroke ( vs tia );"C0007787;C0038454;C0917805;C1054154;C4554100";NA;NA;stroke vs tia
1592;previous transient ischemic attack;"C0007787;C0205156;C0917805;C1552607";NA;NA;previous transient ischemic attack
1592;previous tia or stroke;"C0007787;C0038454;C0205156;C0917805;C1054154;C1552607;C4554100";NA;NA;previous tia or stroke
1592;previous stroke or tia ( n = $nmbr$ );"C0007787;C0038454;C0205156;C0917805;C1054154;C1552607;C4554100";NA;NA;previous stroke or tia n $nmbr$
1592;previous stroke or tia ( % );"C0007787;C0038454;C0205156;C0917805;C1054154;C1552607;C4554100";NA;NA;previous stroke or tia
1592;previous stroke or tia;"C0007787;C0038454;C0205156;C0917805;C1054154;C1552607;C4554100";NA;NA;previous stroke or tia
1592;no previous stroke or tia ( n = $nmbr$ );"C0007787;C0038454;C0205156;C0917805;C1054154;C1552607;C4554100";NA;NA;no previous stroke or tia n $nmbr$
1592;no history of tia / stroke;"C0007787;C0019664;C0019665;C0038454;C0262512;C0262926;C0917805;C1054154;C1705255;C2004062;C4554100";NA;NA;no history of tia stroke
1592;ischemic stroke ( vs . tia );"C0007787;C0917805;C0948008;C1054154";NA;NA;ischemic stroke vs tia
1592;hx stroke / tia;"C0007787;C0038454;C0262926;C0917805;C1054154;C3814444;C4554100";NA;NA;hx stroke tia
1592;history of tia / stroke;"C0007787;C0019664;C0019665;C0038454;C0262512;C0262926;C0917805;C1054154;C1705255;C2004062;C4554100";NA;NA;history of tia stroke
1592;hemispheric tia n = $nmbr$;"C0007787;C0205139;C0917805;C1054154";NA;NA;hemispheric tia n $nmbr$
1591;nc group ( n = $nmbr$ );"C0027964;C0028407;C0067895;C0265987;C0441848";NA;NA;nc group n $nmbr$
1591;nc;"C0027964;C0028407;C0067895;C0265987";NA;NA;nc
1590;uac =;NA;NA;NA;uac
1590;bmi  kg / m $nmbr$ uac  no . ( % );"C0578022;C1532718";NA;NA;bmi kg m $nmbr$ uac no
1589;uc duration  y  mean ( range );"C0444504;C0449238;C1514721;C2347634;C2348143;C2348147;C2926735;C3542016";NA;NA;uc duration y mean range
1589;uc ( n   =   $nmbr$ );NA;NA;NA;uc n $nmbr$
1589;tjc ( $nmbr$ - $nmbr$ )  mean ( sd );"C0444504;C2347634;C2348143;C2699239";NA;NA;tjc $nmbr$ $nmbr$ mean sd
1589;tjc  mean ( sd );"C0444504;C2347634;C2348143;C2699239";NA;NA;tjc mean sd
1589;tjc  $nmbr$ - $nmbr$;NA;NA;NA;tjc $nmbr$ $nmbr$
1589;tjc;NA;NA;NA;tjc
1589;sjc ( $nmbr$ - $nmbr$ )  mean ( sd );"C0444504;C2347634;C2348143;C2699239";NA;NA;sjc $nmbr$ $nmbr$ mean sd
1589;sjc  mean ( sd );"C0444504;C2347634;C2348143;C2699239";NA;NA;sjc mean sd
1589;sjc  $nmbr$ - $nmbr$;NA;NA;NA;sjc $nmbr$ $nmbr$
1589;sjc;NA;NA;NA;sjc
1589;baseline tjc  mean ( s . e . );"C0168634;C0444504;C1442488;C2347634;C2348143";NA;NA;baseline tjc mean s e
1589;baseline sjc  mean ( s . e . );"C0168634;C0444504;C1442488;C2347634;C2348143";NA;NA;baseline sjc mean s e
1588;udy entry;C1705654;NA;NA;udy entry
1588;statin use at study entry  n ( % );"C0360714;C0869040;C1705654";NA;NA;statin use at study entry n
1588;remission at maintenance - trial entry — no . ( % );"C0008976;C0024501;C0544452;C0687702;C1705654";NA;NA;remission at maintenance trial entry no
1588;entry hip fracture location  n ( % );"C1705654;C3260017";NA;NA;entry hip fracture location n
1588;controllertreatment before entry *;C1705654;NA;NA;controllertreatment before entry
1588;at entry;C1705654;NA;NA;at entry
1587;etn  no;"C0014758;C0717758";NA;NA;etn no
1587;etanercept ( n = $nmbr$ );C0717758;NA;NA;etanercept n $nmbr$
1587;etanercept;C0717758;NA;NA;etanercept
1586;snp;"C0752046;C1527094";NA;NA;snp
1586;ntbnp ( n = $nmbr$ );NA;NA;NA;ntbnp n $nmbr$
1586;bnp / ntbnp ( n = $nmbr$ );"C0054015;C1095989;C1417808;C2982014";NA;NA;bnp ntbnp n $nmbr$
1585;— no . ( % );NA;NA;NA;no
1585;thromboaspiration — no . ( % );NA;NA;NA;thromboaspiration no
1585;omega - $nmbr$ fa intake $nmbr$ nd third;"C0205437;C1512806;C1719844";NA;NA;omega $nmbr$ fa intake $nmbr$ nd third
1585;no p - blocker intake at randomisation ( n = $nmbr$ );"C0034656;C0369773;C1512806;C2603361";NA;NA;no p blocker intake at randomisation n $nmbr$
1585;no . ( % );NA;NA;NA;no
1585;nd;NA;NA;NA;nd
1585;$nmbr$ nd > $nmbr$ . $nmbr$ / < $nmbr$ . $nmbr$;NA;NA;NA;$nmbr$ nd $nmbr$ $nmbr$ $nmbr$ $nmbr$
1584;statins used during follow - up;"C0360714;C0589120;C1273517;C1522577;C1704685;C3274571";NA;NA;statins used during follow up
1584;fracture during follow - up;"C0016658;C0589120;C1522577;C1704685;C3274571";NA;NA;fracture during follow up
1584;follow - up;"C0589120;C1522577;C1704685;C3274571";NA;NA;follow up
1584;end of follow - up;"C0444930;C0589120;C1522577;C1704685;C2746065;C3274571";NA;NA;end of follow up
1584;at end of follow - up — no . / total no . ( % );"C0439175;C0439810;C0444930;C0589120;C1522577;C1704685;C2746065;C3274571";NA;NA;at end of follow up no total no
1584;at end of follow - up — no . ( % );"C0444930;C0589120;C1522577;C1704685;C2746065;C3274571";NA;NA;at end of follow up no
1584;at end of follow - up;"C0444930;C0589120;C1522577;C1704685;C2746065;C3274571";NA;NA;at end of follow up
1583;ufh only;"C0205171;C1720467";NA;NA;ufh only
1583;ufh;NA;NA;NA;ufh
1582;pump;C0182537;NA;NA;pump
1582;proton pump inhibitors;"C0358591;C1384478;C3540020";NA;NA;proton pump inhibitors
1582;proton pump inhibitor use;"C0042153;C0358591;C0457083;C1947944;C3536754;C4521480";NA;NA;proton pump inhibitor use
1582;proton pump inhibitor ( n  % );"C0358591;C3536754;C4521480";NA;NA;proton pump inhibitor n
1582;proton pump inhibitor;"C0358591;C3536754;C4521480";NA;NA;proton pump inhibitor
1582;proton - pump inhibitors;"C0358591;C1384478;C3540020";NA;NA;proton pump inhibitors
1582;proton - pump inhibitor;"C0358591;C3536754;C4521480";NA;NA;proton pump inhibitor
1582;on pump;C3842462;NA;NA;on pump
1582;on - pump;C3842462;NA;NA;on pump
1582;off pump;"C0182537;C1518543";NA;NA;off pump
1582;off - pump;"C0182537;C1518543";NA;NA;off pump
1581;unadjusted p value;"C1439367;C1709380";NA;NA;unadjusted p value
1581;unadjusted p - value for interaction;"C1439367;C1704675;C1709380";NA;NA;unadjusted p value for interaction
1581;unadjusted hr .;C1439367;NA;NA;unadjusted hr
1581;unadjusted hr ( $nmbr$ % ci ) for $nmbr$ standard deviation increment;"C0008107;C0871420;C1439367;C1705117;C3259781";NA;NA;unadjusted hr $nmbr$ ci for $nmbr$ standard deviation increment
1581;unadjusted hr ( $nmbr$ % ci ) for $nmbr$ sd increment;"C0008107;C1439367;C1705117;C2699239;C3259781";NA;NA;unadjusted hr $nmbr$ ci for $nmbr$ sd increment
1581;unadjusted hr ( $nmbr$ % ci ) a;"C0008107;C1439367;C3259781";NA;NA;unadjusted hr $nmbr$ ci a
1581;unadjusted hr;C1439367;NA;NA;unadjusted hr
1581;unadjusted;C1439367;NA;NA;unadjusted
1581;score ( > $nmbr$ ) at $nmbr$ monthsb unadjusted or;"C0449820;C1439367;C4050231";NA;NA;score $nmbr$ at $nmbr$ monthsb unadjusted or
1581;or ( unadjusted );C1439367;NA;NA;or unadjusted
1580;p value for adjusted hr;"C0456081;C1709380";NA;NA;p value for adjusted hr
1580;black ( n = $nmbr$ )  adjusted hazard ratio *;"C0005680;C0027567;C0085756;C0439541;C0456081;C2985465";NA;NA;black n $nmbr$ adjusted hazard ratio
1580;adjustedaor;NA;NA;NA;adjustedaor
1580;adjustedahr;NA;NA;NA;adjustedahr
1580;adjusted *   hr;C0456081;NA;NA;adjusted hr
1580;adjusted;C0456081;NA;NA;adjusted
1573;risedronate ( n   =   $nmbr$ );C0246719;NA;NA;risedronate n $nmbr$
1573;risedronate ( n = $nmbr$ );C0246719;NA;NA;risedronate n $nmbr$
1573;current alendronate use;"C0042153;C0102118;C0457083;C0521116;C1705970;C1947944";NA;NA;current alendronate use
1573;alendronate ( n = $nmbr$ );C0102118;NA;NA;alendronate n $nmbr$
1573;alendronate;C0102118;NA;NA;alendronate
1572;aspartate aminotransferase increased;"C0004002;C0205217;C0442805";NA;NA;aspartate aminotransferase increased
1572;aspartate aminotransferase  u / l;"C0004002;C0439339";NA;NA;aspartate aminotransferase u l
1572;alanine aminotransferase or aspartate aminotransferase > $nmbr$ x upper limit of normal ( n = $nmbr$ );"C0001899;C0004002;C0057041;C1415274;C1519815;C3887708";NA;NA;alanine aminotransferase or aspartate aminotransferase $nmbr$ x upper limit of normal n $nmbr$
1572;alanine aminotransferase increased;"C0001899;C0057041;C0205217;C0442805;C1415274;C3887708";NA;NA;alanine aminotransferase increased
1572;alanine aminotransferase  u / l;"C0001899;C0057041;C0439339;C1415274;C3887708";NA;NA;alanine aminotransferase u l
1579;use of antihypertensive drugs;"C0003364;C1524063";NA;NA;use of antihypertensive drugs
1579;types of antihypertensive medications at $nmbr$ year   †;"C0003364;C0332307;C0439234;C0439508";NA;NA;types of antihypertensive medications at $nmbr$ year
1579;type of antihypertensive medication use among patients using antihypertensive medications  n ( % );"C0003364;C0030705;C0332307;C1524063;C1547052";NA;NA;type of antihypertensive medication use among patients using antihypertensive medications n
1539;$nmbr$ . $nmbr$ % or more;C0205172;NA;NA;$nmbr$ $nmbr$ or more
1579;taking antihypertensive medication at baseline  no . ( % ) e;"C0003364;C0168634;C1442488;C1515187";NA;NA;taking antihypertensive medication at baseline no e
1579;prior antihypertensive medication  n ( % );"C0003364;C0332152;C2826257";NA;NA;prior antihypertensive medication n
1579;previous antihypertensive treatment — no . ( % );"C0003364;C0039798;C0087111;C0205156;C1522326;C1533734;C1552607;C1705169;C3538994;C3887704";NA;NA;previous antihypertensive treatment no
1579;previous antihypertensive treatment;"C0003364;C0039798;C0087111;C0205156;C1522326;C1533734;C1552607;C1705169;C3538994;C3887704";NA;NA;previous antihypertensive treatment
1579;patients on antihypertensive medications  n ( % ) | |;"C0003364;C0030705";NA;NA;patients on antihypertensive medications n
1579;other blood pressure - lowering drugs;C0003364;NA;NA;other blood pressure lowering drugs
1579;other blood - pressure drug;C0003364;NA;NA;other blood pressure drug
1579;other antihypertensive medications;C0003364;NA;NA;other antihypertensive medications
1579;other antihypertensive drug;C0003364;NA;NA;other antihypertensive drug
1579;other antihypertensive agents;C0003364;NA;NA;other antihypertensive agents
1579;other antihypertensive;C0003364;NA;NA;other antihypertensive
1579;other anti - hypertensives;C0003364;NA;NA;other anti hypertensives
1579;other anti - hypertensive;C0003364;NA;NA;other anti hypertensive
1579;or taking antihypertensive medication;"C0003364;C1290952";NA;NA;or taking antihypertensive medication
1579;one antihypertensive medication;"C0003364;C0205447";NA;NA;one antihypertensive medication
1579;on antihypertensive treatment  n ( % );"C0003364;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;on antihypertensive treatment n
1579;on antihypertensive medication at baseline  n ( % ) ‡;"C0003364;C0168634;C1442488";NA;NA;on antihypertensive medication at baseline n
1579;number of antihypertensive medications at study entry;"C0003364;C0557651;C1705654;C1718138;C2603343";NA;NA;number of antihypertensive medications at study entry
1579;number of antihypertensive medications  n ( % );"C0003364;C1718138";NA;NA;number of antihypertensive medications n
1579;medications antihypertensive drugs;"C0003364;C0013227;C0802604;C2598133;C4284232";NA;NA;medications antihypertensive drugs
1579;mean number of antihypertensive medications at $nmbr$ year   *;"C0003364;C0439234;C0439508;C0444504;C1718138;C2347634;C2348143";NA;NA;mean number of antihypertensive medications at $nmbr$ year
1579;hypertension ( bp > $nmbr$ / $nmbr$ mmhg or using antihypertensive medication );"C0003364;C0020538;C0037623;C0439475;C1415692;C1524063;C1708288;C1963138;C4318478";NA;NA;hypertension bp $nmbr$ $nmbr$ mmhg or using antihypertensive medication
1579;baseline anti - hypertensive usea;"C0003364;C0168634;C1442488";NA;NA;baseline anti hypertensive usea
1579;any antihypertensive drug;C0003364;NA;NA;any antihypertensive drug
1579;any antihypertensive agent;C0003364;NA;NA;any antihypertensive agent
1579;any anti - hypertensive agent;C0003364;NA;NA;any anti hypertensive agent
1579;antihypertensives ' *;C0003364;NA;NA;antihypertensives
1579;antihypertensives  n ( % );C0003364;NA;NA;antihypertensives n
1579;antihypertensives;C0003364;NA;NA;antihypertensives
1579;antihypertensive use;"C0003364;C0042153;C0457083;C1947944";NA;NA;antihypertensive use
1579;antihypertensive treatments;"C0003364;C0087111";NA;NA;antihypertensive treatments
1579;antihypertensive treatment  n ( % );"C0003364;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;antihypertensive treatment n
1579;antihypertensive treatment;"C0003364;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;antihypertensive treatment
1579;antihypertensive medication use  n ( % );"C0003364;C0042153;C0457083;C1947944";NA;NA;antihypertensive medication use n
1579;antihypertensive medication or;C0003364;NA;NA;antihypertensive medication or
1579;antihypertensive medication );C0003364;NA;NA;antihypertensive medication
1579;antihypertensive medication $nmbr$ ';C0003364;NA;NA;antihypertensive medication $nmbr$
1579;antihypertensive medication;C0003364;NA;NA;antihypertensive medication
1579;antihypertensive drugs;C0003364;NA;NA;antihypertensive drugs
1579;antihypertensive drug  %;C0003364;NA;NA;antihypertensive drug
1579;antihypertensive agents *;C0003364;NA;NA;antihypertensive agents
1579;antihypertensive agents ( n per patient );"C0003364;C0030705";NA;NA;antihypertensive agents n per patient
1579;antihypertensive agents  n ( % );C0003364;NA;NA;antihypertensive agents n
1579;antihypertensive agents;C0003364;NA;NA;antihypertensive agents
1579;antihypertensive agent use;"C0003364;C0042153;C0457083;C1947944";NA;NA;antihypertensive agent use
1579;antihypertensive;C0003364;NA;NA;antihypertensive
1579;anti - hypertensives;C0003364;NA;NA;anti hypertensives
1579;anti - hypertensive;C0003364;NA;NA;anti hypertensive
1579;> $nmbr$ antihypertensive medications;C0003364;NA;NA;$nmbr$ antihypertensive medications
1579;$nmbr$ antihypertensive medication;C0003364;NA;NA;$nmbr$ antihypertensive medication
1578;death or absolute fvc decrease > $nmbr$ %;"C0011065;C0205344;C0392756;C0547047;C1306577;C3714541;C4082313;C4552775";NA;NA;death or absolute fvc decrease $nmbr$
1578;absolute fvc decrease > $nmbr$ %;"C0205344;C0392756;C0547047;C3714541";NA;NA;absolute fvc decrease $nmbr$
1578;absolute decrease > $nmbr$ %;"C0205344;C0392756;C0547047";NA;NA;absolute decrease $nmbr$
1578;absolute change;C1549031;NA;NA;absolute change
1578;absolute ( l );C0205344;NA;NA;absolute l
1578;absolute  litres;"C0205344;C0475211";NA;NA;absolute litres
1577;hospitalization for acute limb ischemia;"C0019993;C0205178;C2945695";NA;NA;hospitalization for acute limb ischemia
1577;acute reaction;"C0205178;C0443286";NA;NA;acute reaction
1577;acute and delayed reaction;"C0205178;C0205421;C0443286;C1545665;C3272602";NA;NA;acute and delayed reaction
1577;acute ( < $nmbr$ hr );C0205178;NA;NA;acute $nmbr$ hr
1576;prosper;NA;NA;NA;prosper
1576;hormone - refractory prostate carcinoma;C1328504;NA;NA;hormone refractory prostate carcinoma
1575;prostate volume ( ml );"C0439526;C1441416;C1705224;C3887665";NA;NA;prostate volume ml
1575;prostate volume ( cm $nmbr$ );C1441416;NA;NA;prostate volume cm $nmbr$
1574;valproate;C0080356;NA;NA;valproate
1574;inappropriate;"C1548788;C3537135;C3542467";NA;NA;inappropriate
1573;time since prior alendronate use  n ( % );"C0040223;C0042153;C0102118;C0332152;C0457083;C1947944;C2826257;C3541383";NA;NA;time since prior alendronate use n
1573;still taking alendronate at study entry  n ( % );"C0102118;C0557651;C1515187;C1705654;C2603343";NA;NA;still taking alendronate at study entry n
1573;risedronate n / n ( % );C0246719;NA;NA;risedronate n n
1571;subgoup_name;"C0027365;C1547383;C4522128";NA;NA;subgoup_name
1571;characteristic_name;"C0027365;C1521970;C1547383;C4522128";NA;NA;characteristic_name
1570;physical and cognitive examination : ! :;"C0031809;C0205485;C1509143;C1516691;C4321457";NA;NA;physical and cognitive examination
1570;impaired cognitive;C0338656;NA;NA;impaired cognitive
1570;cognitive functioning;"C0392334;C0392335";NA;NA;cognitive functioning
1570;cognitive;C1516691;NA;NA;cognitive
1569;unstable angina ( biomarker negative );"C0002965;C0005516;C0205160;C1513916;C2825415;C2825491;C3853545";NA;NA;unstable angina biomarker negative
1569;troponin negative ( n = $nmbr$ );"C0041199;C0205160;C1513916;C2825415;C2825491;C3853545";NA;NA;troponin negative n $nmbr$
1569;rf and acpa negative $nmbr$;"C0035448;C0201660;C0205160;C0748398;C1513916;C1525410;C1547111;C1706063;C2825415;C2825491;C3853545";NA;NA;rf and acpa negative $nmbr$
1569;rf and acpa negative  n ( % );"C0035448;C0201660;C0205160;C0748398;C1513916;C1525410;C1547111;C1706063;C2825415;C2825491;C3853545";NA;NA;rf and acpa negative n
1569;patients with negative anti - dsdna;"C0030705;C0205160;C0741099;C1513916;C2825415;C2825491;C3853545";NA;NA;patients with negative anti dsdna
1569;negative ctnl ( n = $nmbr$  $nmbr$ );"C0205160;C1513916;C2825415;C2825491;C3853545";NA;NA;negative ctnl n $nmbr$ $nmbr$
1569;negative ( < $nmbr$ . $nmbr$ )  n ( % );"C0205160;C1513916;C2825415;C2825491;C3853545";NA;NA;negative $nmbr$ $nmbr$ n
1569;negative;"C0205160;C1513916;C2825415;C2825491;C3853545";NA;NA;negative
1569;anti - gad negative ( n = $nmbr$ );"C0205160;C0270549;C0432633;C1414925;C1513916;C2825415;C2825491;C3853545";NA;NA;anti gad negative n $nmbr$
1569;anti - gad negative;"C0205160;C0270549;C1414925;C1513916;C2825415;C2825491;C3853545";NA;NA;anti gad negative
1568;dulaglutide $nmbr$ . $nmbr$ mgf;"C1366394;C3179549;C3712803;C3887684";NA;NA;dulaglutide $nmbr$ $nmbr$ mgf
1567;sustain $nmbr$ : semaglutide vs . sitagliptin $nmbr$ mg;"C0024671;C0026410;C0439269;C0443318;C1565750;C1960952;C2346927;C2732140;C3885068;C4321396;C4521761";NA;NA;sustain $nmbr$ semaglutide vs sitagliptin $nmbr$ mg
1567;semaglutide exposure  nmol / l;"C0274281;C0332157;C0439282;C3885068";NA;NA;semaglutide exposure nmol l
1567;semaglutide ( n = $nmbr$ );C3885068;NA;NA;semaglutide n $nmbr$
1567;semaglutide $nmbr$ . $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C3885068;C4321396;C4521761";NA;NA;semaglutide $nmbr$ $nmbr$ mg
1567;semaglutide;C3885068;NA;NA;semaglutide
1566;n ( % ) liraglutide $nmbr$ placebo;"C0032042;C0369718;C0441922;C1456408;C1696465;C1706408";NA;NA;n liraglutide $nmbr$ placebo
1566;liraglutide n ( % );C1456408;NA;NA;liraglutide n
1566;liraglutide ( « = $nmbr$ );C1456408;NA;NA;liraglutide $nmbr$
1566;liraglutide ( n = $nmbr$ );C1456408;NA;NA;liraglutide n $nmbr$
1566;liraglutide ( n = $nmbr$  $nmbr$ );C1456408;NA;NA;liraglutide n $nmbr$ $nmbr$
1566;liraglutide ( $nmbr$ . $nmbr$ mg ) ± oad;"C0024671;C0026410;C0439269;C1456408;C1960952;C2346927;C4321396;C4521761";NA;NA;liraglutide $nmbr$ $nmbr$ mg oad
1566;liraglutide $nmbr$ . $nmbr$ mg n = $nmbr$;"C0024671;C0026410;C0439269;C1456408;C1960952;C2346927;C4321396;C4521761";NA;NA;liraglutide $nmbr$ $nmbr$ mg n $nmbr$
1566;liraglutide $nmbr$ . $nmbr$ mg mean ( n );"C0024671;C0026410;C0439269;C0444504;C1456408;C1960952;C2346927;C2347634;C2348143;C4321396;C4521761";NA;NA;liraglutide $nmbr$ $nmbr$ mg mean n
1566;liraglutide $nmbr$ . $nmbr$ mg ls means ( n );"C0023668;C0024671;C0026410;C0439269;C1456408;C1704970;C1960952;C2346927;C4321396;C4521761";NA;NA;liraglutide $nmbr$ $nmbr$ mg ls means n
1566;liraglutide $nmbr$ . $nmbr$ mg / day ( n = $nmbr$ );"C0439422;C1456408";NA;NA;liraglutide $nmbr$ $nmbr$ mg day n $nmbr$
1566;liraglutide $nmbr$ . $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1456408;C1960952;C2346927;C4321396;C4521761";NA;NA;liraglutide $nmbr$ $nmbr$ mg n $nmbr$
1566;liraglutide $nmbr$ . $nmbr$ mg  n = $nmbr$  $nmbr$;"C0024671;C0026410;C0439269;C1456408;C1960952;C2346927;C4321396;C4521761";NA;NA;liraglutide $nmbr$ $nmbr$ mg n $nmbr$ $nmbr$
1566;liraglutide $nmbr$ . $nmbr$ mg  n = $nmbr$;"C0024671;C0026410;C0439269;C1456408;C1960952;C2346927;C4321396;C4521761";NA;NA;liraglutide $nmbr$ $nmbr$ mg n $nmbr$
1566;liraglutide $nmbr$ . $nmbr$ mg;"C0024671;C0026410;C0439269;C1456408;C1960952;C2346927;C4321396;C4521761";NA;NA;liraglutide $nmbr$ $nmbr$ mg
1566;liraglutide $nmbr$ - $nmbr$ mg mean ( n );"C0024671;C0026410;C0439269;C0444504;C1456408;C1960952;C2346927;C2347634;C2348143;C4321396;C4521761";NA;NA;liraglutide $nmbr$ $nmbr$ mg mean n
1566;liraglutide $nmbr$ - $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1456408;C1960952;C2346927;C4321396;C4521761";NA;NA;liraglutide $nmbr$ $nmbr$ mg n $nmbr$
1566;liraglutide;C1456408;NA;NA;liraglutide
1565;progestins;C0033306;NA;NA;progestins
1565;country : argentina ( n = $nmbr$ );"C0003761;C0454664;C1504311;C1511538";NA;NA;country argentina n $nmbr$
1565;argentina;"C0003761;C1504311";NA;NA;argentina
1564;congestion *;"C0700148;C2826600";NA;NA;congestion
1563;univariate logistic modela;C0242415;NA;NA;univariate logistic modela
1563;multivariate logistic modelb;C0242415;NA;NA;multivariate logistic modelb
1563;logistic regression;C0206031;NA;NA;logistic regression
1563;bmultivariate logistic regression with variables forced in the modela;"C0206031;C0439828;C0441722;C0443221";NA;NA;bmultivariate logistic regression with variables forced in the modela
1563;aunivariate logistic regression .;C0206031;NA;NA;aunivariate logistic regression
1562;premature treatment discontinuation;"C0039798;C0087111;C0151526;C0205252;C0457454;C1444662;C1522326;C1533734;C1705169;C3538994;C3887704;C4018905;C4552847";NA;NA;premature treatment discontinuation
1562;premature discontinuation;"C0151526;C0205252;C0457454;C1444662;C4018905;C4552847";NA;NA;premature discontinuation
1562;discontinued;C1444662;NA;NA;discontinued
1562;discontinuations teaes;C0457454;NA;NA;discontinuations teaes
1562;discontinuations;C0457454;NA;NA;discontinuations
1562;discontinuation of lama prior to baseline  n ( % );"C0168634;C0457454;C0999593;C1416775;C1442488;C1444662;C4552847";NA;NA;discontinuation of lama prior to baseline n
1561;data are mean ± standard deviation for continuous variables and number ( % ) for categoric variables . p;"C0237753;C0439828;C0444504;C0449788;C0549178;C0683312;C0871420;C1442989;C1511726;C1828170;C2347634;C2348143;C2828392;C3245479;C3714741;C3889287";NA;NA;data are mean standard deviation for continuous variables and number for categoric variables p
1561;continuous;C0549178;NA;NA;continuous
1561;continued thienopyridine n = $nmbr$ subjects;"C0549178;C0681850;C1120149;C1550501;C1706203;C2349001;C2697811";NA;NA;continued thienopyridine n $nmbr$ subjects
1561;continued thienopyridine n ( % );"C0549178;C1120149";NA;NA;continued thienopyridine n
1561;continued thienopyridine ( n = $nmbr$ );"C0549178;C1120149";NA;NA;continued thienopyridine n $nmbr$
1561;continued thienopyridine ( n $nmbr$ $nmbr$ );"C0549178;C1120149";NA;NA;continued thienopyridine n $nmbr$ $nmbr$
1561;continued thienopyridine %;"C0549178;C1120149";NA;NA;continued thienopyridine
1561;continue thienopyridine n = $nmbr$;"C0549178;C1120149";NA;NA;continue thienopyridine n $nmbr$
1561;$nmbr$ / $nmbr$ ( $nmbr$ . $nmbr$ ) ( continued );C0549178;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ continued
1561;$nmbr$ ( $nmbr$ . $nmbr$ ) ( continued );C0549178;NA;NA;$nmbr$ $nmbr$ $nmbr$ continued
1560;other †;NA;NA;NA;other
1560;other countries;C0454664;NA;NA;other countries
1560;country  n ( % );"C0454664;C1511538";NA;NA;country n
1560;country;"C0454664;C1511538";NA;NA;country
1560;black region or country ( % );"C0005680;C0017446;C0027567;C0085756;C0205147;C0439541;C0454664;C1511538";NA;NA;black region or country
1559;southern hemisphere;"C0205139;C1710133";NA;NA;southern hemisphere
1566;pramlintide;C0537551;FALSE;2289;pramlintide
1559;south or central american;"C0238914;C1710133";NA;NA;south or central american
1559;south or central america;"C0007674;C1710133";NA;NA;south or central america
1559;south  n ( % );C1710133;NA;NA;south n
1559;central / south;"C0205099;C1710133;C1879652";NA;NA;central south
1558;sacral and / or lumbar;"C0024090;C0036037";NA;NA;sacral and or lumbar
1558;lumbar epidural;C0581283;NA;NA;lumbar epidural
1558;lumbar;C0024090;NA;NA;lumbar
1558;general and lumbar epidural;"C0205246;C0581283;C3812897;C3891294;C4521767";NA;NA;general and lumbar epidural
1557;number of co - aeds  n ( % );"C0180309;C0237753;C0449788;C3245499";NA;NA;number of co aeds n
1557;colombia;C3245499;NA;NA;colombia
1556;numbera;NA;NA;NA;numbera
1556;number ste  t > $nmbr$;"C0237753;C0449788;C1420459;C3811127";NA;NA;number ste t $nmbr$
1556;number resulting in hospital admission;"C0184666;C0237753;C0449788;C0678226";NA;NA;number resulting in hospital admission
1556;number resulting in emergency department visit;"C0237753;C0332294;C0449788;C0545082;C0553618;C0562508;C1512346;C1704729;C2826704";NA;NA;number resulting in emergency department visit
1556;number resulting in ed visit;"C0237753;C0332294;C0449788;C0545082;C1512346;C2826704;C3538926";NA;NA;number resulting in ed visit
1556;number of vessels disease;"C0042373;C0237753;C0449788";NA;NA;number of vessels disease
1556;number of prior csdmards  n ( % );"C0237753;C0332152;C0449788;C2826257";NA;NA;number of prior csdmards n
1556;number of prior aeds    n   ( % );"C0180309;C0237753;C0332152;C0449788;C2826257";NA;NA;number of prior aeds n
1556;number of prior aeds  n ( % ) b;"C0180309;C0237753;C0332152;C0449788;C2826257";NA;NA;number of prior aeds n b
1556;number of prior aeds  n ( % );"C0180309;C0237753;C0332152;C0449788;C2826257";NA;NA;number of prior aeds n
1556;number of prior aeds;"C0180309;C0237753;C0332152;C0449788;C2826257";NA;NA;number of prior aeds
1556;number of previous reported aeds;"C0180309;C0205156;C0237753;C0449788;C0684224;C0700287;C1552607;C4319718";NA;NA;number of previous reported aeds
1556;number of previous dmards;"C0205156;C0237753;C0242708;C0449788;C1552607";NA;NA;number of previous dmards
1556;number of previous anti - tnf treatments for psa  n ( % );"C0087111;C0205156;C0237753;C0449788;C1448177;C1552607;C3810537;C3813209";NA;NA;number of previous anti tnf treatments for psa n
1556;number of people ( n );"C0027361;C0237753;C0449788";NA;NA;number of people n
1556;number of participants with an event;"C0237753;C0441471;C0449788;C0679646;C4019010";NA;NA;number of participants with an event
1556;number of participants;"C0237753;C0449788;C0679646";NA;NA;number of participants
1556;number of exacerbations in the $nmbr$ months before screening;"C0220908;C0220909;C0237753;C0439231;C0449788;C1698960;C1710031;C1710032;C1710477;C2348164;C4086268";NA;NA;number of exacerbations in the $nmbr$ months before screening
1556;number of e;"C0237753;C0449788";NA;NA;number of e
1556;number of copd exacerbations within $nmbr$ months  mean ( sd );"C0237753;C0439231;C0444504;C0449788;C0740304;C2347634;C2348143;C2699239";NA;NA;number of copd exacerbations within $nmbr$ months mean sd
1556;number of concomitant csdmards  n ( % );"C0237753;C0449788;C0521115";NA;NA;number of concomitant csdmards n
1556;number of concomitant aedsc;"C0237753;C0449788;C0521115";NA;NA;number of concomitant aedsc
1556;number of antihypertensive agent reported;"C0003364;C0237753;C0449788;C0684224;C0700287;C4319718";NA;NA;number of antihypertensive agent reported
1556;number of antidiabetes drugs at screening  n ( % );"C0013227;C0220908;C0220909;C0237753;C0449788;C1698960;C1710031;C1710032;C1710477;C2348164;C3687832";NA;NA;number of antidiabetes drugs at screening n
1556;number insulin glargine;"C0237753;C0449788;C0907402";NA;NA;number insulin glargine
1556;number ( % ) reporting migraine on $nmbr$ - month questionnaire;"C0034394;C0149931;C0237753;C0332177;C0439231;C0449788;C0700287";NA;NA;number reporting migraine on $nmbr$ month questionnaire
1556;number ( % );"C0237753;C0449788";NA;NA;number
1556;number;"C0237753;C0449788";NA;NA;number
1556;missing — number / n ( % );"C0237753;C0449788;C1551393;C1705492;C3272743";NA;NA;missing number n
1556;female sex — number ( % );"C0086287;C0237753;C0449788";NA;NA;female sex number
1556;> q $nmbr$ ( $nmbr$ . $nmbr$ ) — number / n ( % );"C0237753;C0449788";NA;NA;q $nmbr$ $nmbr$ $nmbr$ number n
1556;> q $nmbr$ ( $nmbr$ . $nmbr$ ) - q $nmbr$ ( $nmbr$ . $nmbr$ ) — number / n ( % );"C0237753;C0449788";NA;NA;q $nmbr$ $nmbr$ $nmbr$ q $nmbr$ $nmbr$ $nmbr$ number n
1556;> q $nmbr$ ( $nmbr$ . $nmbr$ ) - q $nmbr$ ( $nmbr$ ) — number / n ( % );"C0237753;C0449788";NA;NA;q $nmbr$ $nmbr$ $nmbr$ q $nmbr$ $nmbr$ number n
1556;> q $nmbr$ ( $nmbr$ ) — number / n ( % );"C0237753;C0449788";NA;NA;q $nmbr$ $nmbr$ number n
1556;> q $nmbr$ ( $nmbr$ ) - q $nmbr$ ( $nmbr$ . $nmbr$ ) — number / n ( % );"C0237753;C0449788";NA;NA;q $nmbr$ $nmbr$ q $nmbr$ $nmbr$ $nmbr$ number n
1556;> $nmbr$ months — number / n ( % );"C0237753;C0439231;C0449788";NA;NA;$nmbr$ months number n
1556;< q $nmbr$ ( $nmbr$ . $nmbr$ ) — number / n ( % );"C0237753;C0449788";NA;NA;q $nmbr$ $nmbr$ $nmbr$ number n
1556;< q $nmbr$ ( $nmbr$ ) — number / n ( % );"C0237753;C0449788";NA;NA;q $nmbr$ $nmbr$ number n
1556;< $nmbr$ months — number / n ( % );"C0237753;C0439231;C0449788";NA;NA;$nmbr$ months number n
1555;limb amputation;C0002689;NA;NA;limb amputation
1555;limb ( sd );"C0015385;C2699239";NA;NA;limb sd
1555;limb;C0015385;NA;NA;limb
1554;upper limbs;C1140618;NA;NA;upper limbs
1554;upper limb fractures;"C0016658;C1140618";NA;NA;upper limb fractures
1554;upper limb fracture;C0178316;NA;NA;upper limb fracture
1554;upper limb;C1140618;NA;NA;upper limb
1553;≥ $nmbr$ a ( n = $nmbr$ );"C0369718;C0441922";NA;NA;$nmbr$ a n $nmbr$
1553;us n = $nmbr$;"C0369718;C0441922";NA;NA;us n $nmbr$
1553;us ( n = $nmbr$ );"C0369718;C0441922";NA;NA;us n $nmbr$
1553;type b $nmbr$ / c lesions  n ( % );"C0221198;C0369718;C0441922;C1546698;C4264484";NA;NA;type b $nmbr$ c lesions n
1553;total phase $nmbr$ pooled ( n = $nmbr$ );"C0205390;C0369718;C0439175;C0439810;C0441922;C1709595;C1710475;C2349200;C4522255";NA;NA;total phase $nmbr$ pooled n $nmbr$
1553;tophi present  n ( % );"C0150312;C0221248;C0369718;C0441922;C0449450";NA;NA;tophi present n
1553;patients analyzed  n;"C0030705;C0369718;C0441922;C0936012";NA;NA;patients analyzed n
1553;non - us ( n = $nmbr$ );"C0369718;C0441922;C1518422";NA;NA;non us n $nmbr$
1553;neither n = $nmbr$  $nmbr$;"C0369718;C0441922";NA;NA;neither n $nmbr$ $nmbr$
1553;n_;"C0369718;C0441922";NA;NA;n_
1553;n t % );"C0369718;C0441922";NA;NA;n t
1553;n observed;"C0369718;C0441922;C1441672";NA;NA;n observed
1553;n o;"C0369718;C0441922";NA;NA;n o
1553;n events / n at risk;"C0369718;C0441471;C0441922;C1444641;C3541888";NA;NA;n events n at risk
1553;n analysed;"C0369718;C0441922";NA;NA;n analysed
1553;n = $nmbr$ t;"C0369718;C0441922";NA;NA;n $nmbr$ t
1553;n = $nmbr$ lesions;"C0221198;C0369718;C0441922;C1546698";NA;NA;n $nmbr$ lesions
1553;n = $nmbr$;"C0369718;C0441922";NA;NA;n $nmbr$
1553;n =;"C0369718;C0441922";NA;NA;n
1553;n / r;"C0205090;C0369718;C0441922;C0684010;C2603358";NA;NA;n r
1553;n / n   ( % );"C0369718;C0441922";NA;NA;n n
1553;n / n ( % );"C0369718;C0441922";NA;NA;n n
1553;n / n $nmbr$ / $nmbr$;"C0369718;C0441922";NA;NA;n n $nmbr$ $nmbr$
1553;n / n;"C0369718;C0441922";NA;NA;n n
1553;n .;"C0369718;C0441922";NA;NA;n
1553;n - $nmbr$ pufa events / patients ( % );"C0030705;C0032615;C0369718;C0441471;C0441922;C3541888";NA;NA;n $nmbr$ pufa events patients
1553;n - $nmbr$ pufa ( n = $nmbr$ );"C0032615;C0369718;C0441922";NA;NA;n $nmbr$ pufa n $nmbr$
1553;n - $nmbr$ pufa;"C0032615;C0369718;C0441922";NA;NA;n $nmbr$ pufa
1553;n - $nmbr$ fatty acit;"C0369718;C0441922";NA;NA;n $nmbr$ fatty acit
1553;n - $nmbr$ fatty acids slope lsm ± se ( mm / year );"C0015684;C0036919;C0369718;C0439234;C0439508;C0441922;C0807955;C4330985;C4554674";NA;NA;n $nmbr$ fatty acids slope lsm se mm year
1323;women - no . ( % );C0043210;NA;NA;women no
1553;n - $nmbr$ fatty acids - placebo lsm ( $nmbr$ % cl );"C0015684;C0032042;C0369718;C0441922;C0596019;C1696465;C1706408";NA;NA;n $nmbr$ fatty acids placebo lsm $nmbr$ cl
1553;n - $nmbr$ fatty acids ( n = $nmbr$ );"C0015684;C0369718;C0441922";NA;NA;n $nmbr$ fatty acids n $nmbr$
1553;n - $nmbr$ fatty acids;"C0015684;C0369718;C0441922";NA;NA;n $nmbr$ fatty acids
1553;n - $nmbr$ - pufa ( n = $nmbr$ );"C0032615;C0369718;C0441922";NA;NA;n $nmbr$ pufa n $nmbr$
1553;n + v ( n = $nmbr$ );"C0369718;C0441922";NA;NA;n v n $nmbr$
1553;n *;"C0369718;C0441922";NA;NA;n
1553;n ( lesions );"C0221198;C0369718;C0441922;C1546698";NA;NA;n lesions
1553;n ( iqr );"C0369718;C0441922";NA;NA;n iqr
1553;n ( % ) unless otherwise specified;"C0205369;C0369718;C0441922";NA;NA;n unless otherwise specified
1553;n ( % );"C0369718;C0441922";NA;NA;n
1553;n %;"C0369718;C0441922";NA;NA;n
1553;n $nmbr$ yrs;"C0369718;C0441922";NA;NA;n $nmbr$ yrs
1553;n $nmbr$ / n $nmbr$;"C0369718;C0441922";NA;NA;n $nmbr$ n $nmbr$
1553;n $nmbr$;"C0369718;C0441922";NA;NA;n $nmbr$
1553;n;"C0369718;C0441922";NA;NA;n
1553;ll  n ( % );"C0369718;C0441922";NA;NA;ll n
1553;igehigh ( > i $nmbr$ ku / l  n = i  $nmbr$ );"C0021966;C0221138;C0369718;C0439340;C0441922";NA;NA;igehigh i $nmbr$ ku l n i $nmbr$
1553;duration of as  n ( % );"C0369718;C0441922;C0449238;C2926735";NA;NA;duration of as n
1553;diabetics • no ( n = $nmbr$  $nmbr$ );"C0241863;C0369718;C0441922";NA;NA;diabetics no n $nmbr$ $nmbr$
1553;diabetics - no ( n = $nmbr$  $nmbr$ );"C0241863;C0369718;C0441922";NA;NA;diabetics no n $nmbr$ $nmbr$
1553;clinical and patient reported outcomes  % ( observed n ) unless otherwise indicated;"C0205210;C0369718;C0441922;C1441672;C1444656;C2987124";NA;NA;clinical and patient reported outcomes observed n unless otherwise indicated
1553;a $nmbr$ n = $nmbr$;"C0369718;C0441922";NA;NA;a $nmbr$ n $nmbr$
1553;a $nmbr$ / $nmbr$ ( n = $nmbr$ );"C0369718;C0441922";NA;NA;a $nmbr$ $nmbr$ n $nmbr$
1553;a $nmbr$ + ezio a $nmbr$ ( n = $nmbr$ ) ( n = $nmbr$ );"C0369718;C0441922";NA;NA;a $nmbr$ ezio a $nmbr$ n $nmbr$ n $nmbr$
1553;> $nmbr$ . $nmbr$ ( n — $nmbr$ );"C0369718;C0441922";NA;NA;$nmbr$ $nmbr$ n $nmbr$
1553;> $nmbr$ . $nmbr$  n ( % );"C0369718;C0441922";NA;NA;$nmbr$ $nmbr$ n
1553;> $nmbr$ ( n — $nmbr$ );"C0369718;C0441922";NA;NA;$nmbr$ n $nmbr$
1553;> $nmbr$ ( n = $nmbr$ l $nmbr$ );"C0369718;C0441922";NA;NA;$nmbr$ n $nmbr$ l $nmbr$
1553;> $nmbr$ ( n = $nmbr$ );"C0369718;C0441922";NA;NA;$nmbr$ n $nmbr$
1553;> $nmbr$ % ( n = $nmbr$ );"C0369718;C0441922";NA;NA;$nmbr$ n $nmbr$
1553;> $nmbr$ %  n ( % );"C0369718;C0441922";NA;NA;$nmbr$ n
1553;> $nmbr$  n ( % );"C0369718;C0441922";NA;NA;$nmbr$ n
1553;< $nmbr$ . $nmbr$ ( n — $nmbr$ );"C0369718;C0441922";NA;NA;$nmbr$ $nmbr$ n $nmbr$
1553;< $nmbr$ ( n — $nmbr$ );"C0369718;C0441922";NA;NA;$nmbr$ n $nmbr$
1553;< $nmbr$ ( n z $nmbr$ );"C0369718;C0441922";NA;NA;$nmbr$ n z $nmbr$
1553;< $nmbr$ ( n = $nmbr$ );"C0369718;C0441922";NA;NA;$nmbr$ n $nmbr$
1553;< $nmbr$ % ( n = $nmbr$ );"C0369718;C0441922";NA;NA;$nmbr$ n $nmbr$
1553;< $nmbr$ %  n ( % );"C0369718;C0441922";NA;NA;$nmbr$ n
1553;< $nmbr$  n ( % );"C0369718;C0441922";NA;NA;$nmbr$ n
1553;( n = l $nmbr$ );"C0369718;C0441922";NA;NA;n l $nmbr$
1553;( n = $nmbr$ l $nmbr$ );"C0369718;C0441922";NA;NA;n $nmbr$ l $nmbr$
1553;( n = $nmbr$ ) ( n = $nmbr$ );"C0369718;C0441922";NA;NA;n $nmbr$ n $nmbr$
1553;( n = $nmbr$ )  ' ( n = $nmbr$ );"C0369718;C0441922";NA;NA;n $nmbr$ n $nmbr$
1553;( n = $nmbr$ );"C0369718;C0441922";NA;NA;n $nmbr$
1553;( n = $nmbr$;"C0369718;C0441922";NA;NA;n $nmbr$
1553;( n $nmbr$ $nmbr$ );"C0369718;C0441922";NA;NA;n $nmbr$ $nmbr$
1553;$nmbr$ n qi;"C0369718;C0376586;C0441922";NA;NA;$nmbr$ n qi
1553;$nmbr$ n / n;"C0369718;C0441922";NA;NA;$nmbr$ n n
1553;$nmbr$ - $nmbr$ ( n = $nmbr$ );"C0369718;C0441922";NA;NA;$nmbr$ $nmbr$ n $nmbr$
1553;$nmbr$ - $nmbr$ ( n = $nmbr$  $nmbr$ );"C0369718;C0441922";NA;NA;$nmbr$ $nmbr$ n $nmbr$ $nmbr$
1553;$nmbr$ ( n = $nmbr$ );"C0369718;C0441922";NA;NA;$nmbr$ n $nmbr$
1553;$nmbr$ ( n = $nmbr$  $nmbr$ );"C0369718;C0441922";NA;NA;$nmbr$ n $nmbr$ $nmbr$
1553;$nmbr$ ( n $nmbr$ $nmbr$ );"C0369718;C0441922";NA;NA;$nmbr$ n $nmbr$ $nmbr$
1553;$ $nmbr$ ( n = $nmbr$ );"C0369718;C0441922";NA;NA;$ $nmbr$ n $nmbr$
1553;$ $nmbr$ %  n ( % );"C0369718;C0441922";NA;NA;$ $nmbr$ n
1552;uas $nmbr$;NA;NA;NA;uas $nmbr$
1552;uae ( p  g / min );"C0560021;C1519789";NA;NA;uae p g min
1552;in - clinic uask;"C0002424;C0150312;C0332285;C0442592;C1707101";NA;NA;in clinic uask
1552;in - clinic uas $nmbr$;"C0002424;C0150312;C0332285;C0442592;C1707101";NA;NA;in clinic uas $nmbr$
1551;spinal;C0521329;NA;NA;spinal
1551;mean lumbar spine t score;"C0024091;C3533236;C3887615";NA;NA;mean lumbar spine t score
1551;lumbar spine bmd t - score;"C0024091;C0449820;C3887615;C4050231";NA;NA;lumbar spine bmd t score
1551;lumbar spine bmd t -;"C0024091;C3887615";NA;NA;lumbar spine bmd t
1551;lumbar spine;"C0024091;C3887615";NA;NA;lumbar spine
   7;p values;C1709380;NA;NA;p values
1551;flex baseline bmd t - score at lumbar spine ( meanisd );"C0024091;C0168634;C0449820;C1442488;C3887615;C4050231";NA;NA;flex baseline bmd t score at lumbar spine meanisd
1550;usa and canada;"C0006823;C0041703";NA;NA;usa and canada
1550;usa / canada;"C0006823;C0041703";NA;NA;usa canada
1550;usa ( n = $nmbr$ );C0041703;NA;NA;usa n $nmbr$
1550;usa ( n = $nmbr$  $nmbr$ );C0041703;NA;NA;usa n $nmbr$ $nmbr$
1550;usa;C0041703;NA;NA;usa
1550;united states or canada;"C0006823;C0041703";NA;NA;united states or canada
1550;united states and canada;"C0006823;C0041703";NA;NA;united states and canada
1550;united states ( n   = $nmbr$  $nmbr$ );C0041703;NA;NA;united states n $nmbr$ $nmbr$
1550;united states;C0041703;NA;NA;united states
1550;umied;NA;NA;NA;umied
1550;region united states;"C0017446;C0041703;C0205147";NA;NA;region united states
1550;non usa;"C0041703;C1518422";NA;NA;non usa
1549;necrosis  n ( % ) a;"C0027540;C1334928";NA;NA;necrosis n a
1549;cross - clamp;"C0175721;C1883710;C2828360;C3810601";NA;NA;cross clamp
1548;necrotic core  mm ^;"C0027540;C0444669;C1167518;C1706352;C1882467;C3274653;C4330985;C4554674";NA;NA;necrotic core mm
1548;necrotic core;"C0027540;C0444669;C1167518;C1706352;C1882467;C3274653";NA;NA;necrotic core
1548;core laboratory percent stenosis;"C0022877;C0439165;C0444669;C0678234;C1167518;C1261287;C1706352;C1882467;C2632116;C3244292;C3274653;C4283904";NA;NA;core laboratory percent stenosis
1548;% stenosis  as assessed by core laboratory;"C0022877;C0444669;C0678234;C1167518;C1261287;C1516048;C1706352;C1882467;C2632116;C3244292;C3274653;C4283904";NA;NA;stenosis as assessed by core laboratory
1547;ultrasound carotid arteries;C0948945;NA;NA;ultrasound carotid arteries
1547;carotid revascularization;"C0581603;C0741968";NA;NA;carotid revascularization
1547;carotid infarct;"C0021308;C0741968";NA;NA;carotid infarct
1547;carotid artery — no . ( % );"C0007272;C0162859";NA;NA;carotid artery no
1547;carotid artery diseaset;"C0007272;C0162859";NA;NA;carotid artery diseaset
1547;carotid;C0741968;NA;NA;carotid
1547;> $nmbr$ % stenosis of coronary  carotid  or lower extremity arteries;"C0007282;C0018787;C0226415;C0242231;C0741968";NA;NA;$nmbr$ stenosis of coronary carotid or lower extremity arteries
1546;severitya;NA;NA;NA;severitya
1546;severity of copda  combined assessment of copd  n ( % );"C0024117;C0205195;C0439793;C0522510;C1261322;C1412502;C1516048;C3714496";NA;NA;severity of copda combined assessment of copd n
1546;severity of copd — no . ( % ) f;"C0016327;C0024117;C0439793;C0522510;C1412502;C3714496";NA;NA;severity of copd no f
1546;severity of copd *  n ( % );"C0024117;C0439793;C0522510;C1412502;C3714496";NA;NA;severity of copd n
1517;$nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ ) pty = $nmbr$;NA;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ pty $nmbr$
1546;severity of copd  n ( % ) *;"C0024117;C0439793;C0522510;C1412502;C3714496";NA;NA;severity of copd n
1546;severity of copd  combined assessment  n ( % );"C0024117;C0205195;C0439793;C0522510;C1261322;C1412502;C1516048;C3714496";NA;NA;severity of copd combined assessment n
1546;severity of copd  ( gold $nmbr$ )  %;"C0018026;C0024117;C0439793;C0522510;C1304897;C1412502;C3714496";NA;NA;severity of copd gold $nmbr$
1546;severity of copd;"C0024117;C0439793;C0522510;C1412502;C3714496";NA;NA;severity of copd
1546;nice classification of copd severity of obstruction  n ( % ) [ $nmbr$ ];"C0008902;C0008903;C0024117;C0028778;C0439793;C0522510;C0678229;C1412502;C1882136;C3714496;C4087029";NA;NA;nice classification of copd severity of obstruction n $nmbr$
1546;copd severityy;"C0024117;C1412502;C3714496";NA;NA;copd severityy
1546;copd severitya    n   ( % );"C0024117;C1412502;C3714496";NA;NA;copd severitya n
1546;copd severity : severe / very severe;"C0024117;C0439793;C0442824;C0522510;C1412502;C2984081;C3714496";NA;NA;copd severity severe very severe
1546;copd severity : mild / moderate;"C0024117;C0439793;C0522510;C1299392;C1412502;C3714496";NA;NA;copd severity mild moderate
1546;copd severity ( gold $nmbr$ );"C0018026;C0024117;C0439793;C0522510;C1304897;C1412502;C3714496";NA;NA;copd severity gold $nmbr$
1546;copd severity  n ( % ) a;"C0024117;C0439793;C0522510;C1412502;C3714496";NA;NA;copd severity n a
1546;copd severity  n ( % ) *;"C0024117;C0439793;C0522510;C1412502;C3714496";NA;NA;copd severity n
1546;copd severity  n ( % );"C0024117;C0439793;C0522510;C1412502;C3714496";NA;NA;copd severity n
1546;copd severity  %;"C0024117;C0439793;C0522510;C1412502;C3714496";NA;NA;copd severity
1546;copd severity;"C0024117;C0439793;C0522510;C1412502;C3714496";NA;NA;copd severity
1546;copd disease severity;"C0024117;C0521117;C1412502;C3714496";NA;NA;copd disease severity
1545;patients with baseline crp concentration £ $nmbr$ mg / l;"C0030705;C0086045;C0168634;C0439268;C1442488;C1446561;C3827302;C3890735;C4048285";NA;NA;patients with baseline crp concentration $nmbr$ mg l
1545;patients with baseline crp concentration < $nmbr$ mg / l;"C0030705;C0086045;C0168634;C0439268;C1442488;C1446561;C3827302;C3890735;C4048285";NA;NA;patients with baseline crp concentration $nmbr$ mg l
1545;hs - crp mg / l;"C0439268;C3890735;C4048285";NA;NA;hs crp mg l
1380;exercise;"C0015259;C1522704";NA;NA;exercise
1545;hs - crp j $nmbr$ . $nmbr$ mg / l;"C0439268;C3890735;C4048285";NA;NA;hs crp j $nmbr$ $nmbr$ mg l
1545;hs - crp _ = $nmbr$ . $nmbr$ mg / l;"C0439268;C3890735;C4048285";NA;NA;hs crp _ $nmbr$ $nmbr$ mg l
1545;hs - crp > $nmbr$ . $nmbr$ mg / l;"C0439268;C3890735;C4048285";NA;NA;hs crp $nmbr$ $nmbr$ mg l
1545;hs - crp < $nmbr$ . $nmbr$ nlg l;"C3890735;C4048285";NA;NA;hs crp $nmbr$ $nmbr$ nlg l
1545;hs - crp < $nmbr$ . $nmbr$ mg / l;"C0439268;C3890735;C4048285";NA;NA;hs crp $nmbr$ $nmbr$ mg l
1545;hs - crp < $nmbr$ . $nmbr$ g / l;"C0439294;C0456615;C3890735;C4048285";NA;NA;hs crp $nmbr$ $nmbr$ g l
1545;hs - crp ( mg / l );"C0439268;C3890735;C4048285";NA;NA;hs crp mg l
1545;hs - crp ( mg / l  median );"C0439268;C0549183;C0876920;C2347635;C2348144;C2939193;C3890735;C4048285";NA;NA;hs crp mg l median
1545;hs - crp ( median  iqr )  mg / l;"C0439268;C0549183;C0876920;C2347635;C2348144;C2939193;C3890735;C4048285";NA;NA;hs crp median iqr mg l
1545;hs - crp  mg / l;"C0439268;C3890735;C4048285";NA;NA;hs crp mg l
1545;hs - crp;"C3890735;C4048285";NA;NA;hs crp
1545;crp   ≤   uln;"C1519815;C3890735;C4048285";NA;NA;crp uln
1545;crp   >   uln;"C1519815;C3890735;C4048285";NA;NA;crp uln
1545;crp concentration > $nmbr$ mg / l  n ( % ) \;"C0086045;C0439268;C1446561;C3827302;C3890735;C4048285";NA;NA;crp concentration $nmbr$ mg l n \
1545;crp ( mg / l ) ( cv );"C0439268;C3538987;C3890735;C4048285;C4048877;C4318503";NA;NA;crp mg l cv
1545;crp ( mg / l );"C0439268;C3890735;C4048285";NA;NA;crp mg l
1545;crp;"C3890735;C4048285";NA;NA;crp
1545;crj;NA;NA;NA;crj
1545;baseline hs - crp tertiles ( mg / i ];"C0021966;C0024671;C0026410;C0168634;C0221138;C0439269;C1442488;C1960952;C2346927;C3890735;C4048285;C4321396;C4521761";NA;NA;baseline hs crp tertiles mg i
1545;baseline high - sensitivity crp;"C0168634;C1441604;C1442488;C3890735;C4048285";NA;NA;baseline high sensitivity crp
1545;baseline crp < $nmbr$ mg / l;"C0168634;C0439268;C1442488;C3890735;C4048285";NA;NA;baseline crp $nmbr$ mg l
1545;baseline crp;"C0168634;C1442488;C3890735;C4048285";NA;NA;baseline crp
1545;baseline asdas - crp;"C0168634;C1442488;C3890735;C4048285";NA;NA;baseline asdas crp
1545;asdas - crp   <   $nmbr$ . $nmbr$;"C3890735;C4048285";NA;NA;asdas crp $nmbr$ $nmbr$
1545;asdas - crp δ   ≥   $nmbr$ . $nmbr$;"C3890735;C4048285";NA;NA;asdas crp $nmbr$ $nmbr$
1545;asdas - crp *;"C3890735;C4048285";NA;NA;asdas crp
1545;> $nmbr$ mg / dl baseline high - sensitivity crp;"C0168634;C0439269;C1441604;C1442488;C3890735;C4048285";NA;NA;$nmbr$ mg dl baseline high sensitivity crp
1544;ticagrelor $nmbr$ mg vs . placebo hr ( $nmbr$ % ci );"C0008107;C0024671;C0026410;C0032042;C0439269;C1696465;C1706408;C1960952;C1999375;C2346927;C3259781;C4321396;C4521761";NA;NA;ticagrelor $nmbr$ mg vs placebo hr $nmbr$ ci
1544;rr ^ ( $nmbr$ % ci );"C0008107;C3259781;C4554402";NA;NA;rr $nmbr$ ci
1544;rr ( $nmbr$ % ci ) c;"C0008107;C3259781;C4554402";NA;NA;rr $nmbr$ ci c
1544;rr ( $nmbr$ % ci ) *;"C0008107;C3259781;C4554402";NA;NA;rr $nmbr$ ci
1544;rr ( $nmbr$ % ci );"C0008107;C3259781;C4554402";NA;NA;rr $nmbr$ ci
1544;rr $nmbr$ - $nmbr$ ( $nmbr$ . $nmbr$  $nmbr$  $nmbr$ ) ’;NA;NA;NA;rr $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
1544;rr;NA;NA;NA;rr
1544;hr ‡;NA;NA;NA;hr
1544;hr vs placebo ( $nmbr$ % ci );"C0008107;C0032042;C1696465;C1706408;C3259781";NA;NA;hr vs placebo $nmbr$ ci
1544;hr and $nmbr$ % ci *;"C0008107;C3259781";NA;NA;hr and $nmbr$ ci
1544;hr * or rr † ( $nmbr$ % ci );"C0008107;C3259781;C4554402";NA;NA;hr or rr $nmbr$ ci
1544;hr ( $nmbr$ % ci ) “;"C0008107;C3259781";NA;NA;hr $nmbr$ ci
1544;hr ( $nmbr$ % ci ) *;"C0008107;C3259781";NA;NA;hr $nmbr$ ci
1544;hr ( $nmbr$ % ci )  univariate cox proportional - hazard regression;"C0008107;C0205351;C0598697;C0684320;C0684321;C1565830;C1836830;C3259781";NA;NA;hr $nmbr$ ci univariate cox proportional hazard regression
1544;hr ( $nmbr$ % ci )  multivariate cox proportional - hazard regression;"C0008107;C0205351;C0598697;C0684320;C0684321;C1565830;C1836830;C3259781";NA;NA;hr $nmbr$ ci multivariate cox proportional hazard regression
1544;hr ( $nmbr$ % ci );"C0008107;C3259781";NA;NA;hr $nmbr$ ci
1544;hr $nmbr$ % ci;"C0008107;C3259781";NA;NA;hr $nmbr$ ci
1544;esrd only rr ( ci ) “;"C0008107;C0022661;C0035078;C0205171;C1720467;C2316810;C3259781;C4554402";NA;NA;esrd only rr ci
1544;doubling of baseline serum creatinine or esrd rr ( ci ) “;"C0008107;C0022661;C0035078;C0168634;C0201976;C0205173;C0600061;C1442488;C1705764;C2316810;C3259781;C4554402";NA;NA;doubling of baseline serum creatinine or esrd rr ci
1544;cox hr ( $nmbr$ % ci );"C0008107;C1565830;C3259781";NA;NA;cox hr $nmbr$ ci
1544;cmh rr ( $nmbr$ % ci );"C0008107;C3259781;C4554402";NA;NA;cmh rr $nmbr$ ci
1543;patients with only mrf hr ( $nmbr$ % cl );"C0030705;C0205171;C0312443;C0596019;C1412879;C1720467";NA;NA;patients with only mrf hr $nmbr$ cl
1543;mrf;"C0312443;C1412879";NA;NA;mrf
1542;western europe hr ( $nmbr$ % cl );"C0043129;C0596019";NA;NA;western europe hr $nmbr$ cl
1542;rrr ( $nmbr$ % cl );C0596019;NA;NA;rrr $nmbr$ cl
1542;rrr;NA;NA;NA;rrr
1542;rr reduction  $nmbr$ / $nmbr$ ( $nmbr$ / $nmbr$ cl );"C0301630;C0392756;C0596019;C1293152;C4551656;C4554402";NA;NA;rr reduction $nmbr$ $nmbr$ $nmbr$ $nmbr$ cl
1542;rr ( cl );"C0596019;C4554402";NA;NA;rr cl
1542;rr ( $nmbr$ % cl ) p value;"C0596019;C1709380;C4554402";NA;NA;rr $nmbr$ cl p value
1542;rr ( $nmbr$ % cl ) [ / ’ value ];"C0596019;C1522609;C4554402";NA;NA;rr $nmbr$ cl value
1542;rr ( $nmbr$ % cl );"C0596019;C4554402";NA;NA;rr $nmbr$ cl
1542;patients with prior ml hr ( $nmbr$ % cl );"C0030705;C0332152;C0439526;C0596019;C1705224;C2826257;C3887665";NA;NA;patients with prior ml hr $nmbr$ cl
1516;symptomatic pe;"C0070939;C0231220;C1880476;C4284304";NA;NA;symptomatic pe
1542;patients with ascvd but no prior ml hr ( $nmbr$ % cl );"C0030705;C0332152;C0439526;C0596019;C1705224;C2826257;C3665365;C3887665";NA;NA;patients with ascvd but no prior ml hr $nmbr$ cl
1542;hr vs control ( $nmbr$ % cl ) *;"C0243148;C0596019;C1550141;C1882979;C2587213;C3274648;C4553389";NA;NA;hr vs control $nmbr$ cl
1542;hr ( enl vs lcz ) ( $nmbr$ % cl );C0596019;NA;NA;hr enl vs lcz $nmbr$ cl
1542;hr ( $nmbr$ s % a );NA;NA;NA;hr $nmbr$ s a
1542;hr ( $nmbr$ % cl ) *;C0596019;NA;NA;hr $nmbr$ cl
1542;hr ( $nmbr$ % c ! );NA;NA;NA;hr $nmbr$ c
1542;hr  ( $nmbr$ % cl );C0596019;NA;NA;hr $nmbr$ cl
1541;soe or sue;NA;NA;NA;soe or sue
1541;or : $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ )  p = $nmbr$ . $nmbr$;"C0369773;C2603361";NA;NA;or $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ p $nmbr$ $nmbr$
1541;intravenous inotropes or vasopressors ( % );"C0042397;C0348016;C1258199";NA;NA;intravenous inotropes or vasopressors
1541;barc types $nmbr$  $nmbr$  or $nmbr$;C0332307;NA;NA;barc types $nmbr$ $nmbr$ or $nmbr$
1541;barc $nmbr$ - $nmbr$;NA;NA;NA;barc $nmbr$ $nmbr$
1540;laba or lamab n = $nmbr$;NA;NA;NA;laba or lamab n $nmbr$
1540;conieosieroids and / or $nmbr$ - mp;C0024944;NA;NA;conieosieroids and or $nmbr$ mp
1540;$nmbr$ or $nmbr$  n ( % );"C0369718;C0441922";NA;NA;$nmbr$ or $nmbr$ n
1539;three or more drugs;"C0013227;C0205172;C0205449;C3687832";NA;NA;three or more drugs
1539;one or more medications;"C0013227;C0205172;C0205447;C0802604;C2598133;C4284232";NA;NA;one or more medications
1539;one or more exacerbations;"C0205172;C0205447;C4086268";NA;NA;one or more exacerbations
1539;one or more blood pressure medications  n ( % );"C0005823;C0013227;C0033095;C0205172;C0205447;C0460139;C0802604;C0849164;C1271104;C1272641;C1306345;C2598133;C4284008;C4284232";NA;NA;one or more blood pressure medications n
1539;no new a or and no more than $nmbr$ new bilag b domain score  %;"C0205172;C0205314;C0449820;C1880389;C1883221;C3541951;C4050231";NA;NA;no new a or and no more than $nmbr$ new bilag b domain score
1539;college graduate or more;"C0205172;C0682187";NA;NA;college graduate or more
1539;$nmbr$ yrs or more;C0205172;NA;NA;$nmbr$ yrs or more
1539;$nmbr$ years or more;"C0205172;C0439234";NA;NA;$nmbr$ years or more
1539;$nmbr$ or more;C0205172;NA;NA;$nmbr$ or more
1539;$nmbr$ . $nmbr$ or more;C0205172;NA;NA;$nmbr$ $nmbr$ or more
1538;using hrt or raloxifene at baseline ( % );"C0168634;C0244404;C0282402;C1442488;C1524063";NA;NA;using hrt or raloxifene at baseline
1538;or raloxifene;C0244404;NA;NA;or raloxifene
1538;benzodiazepine or bzra ‡;"C0005064;C3536850;C4048284";NA;NA;benzodiazepine or bzra
1537;ors ( $nmbr$ % cis ) :;"C0069590;C1504308;C1742862;C1963718";NA;NA;ors $nmbr$ cis
1537;$nmbr$ or $nmbr$;NA;NA;NA;$nmbr$ or $nmbr$
1537;$nmbr$ ( or $nmbr$  if female only );"C0043210;C0086287;C0205171;C1705497;C1705498;C1720467";NA;NA;$nmbr$ or $nmbr$ if female only
1536;erectile dysfunction;"C0242350;C1961100";NA;NA;erectile dysfunction
1535;severe dysfunction;C3274777;NA;NA;severe dysfunction
1535;moderate dysfunction ( crcl $nmbr$ - $nmbr$ ml / min  n = $nmbr$ [ $nmbr$ . $nmbr$ % ] );"C0439445;C1846718;C3274776";NA;NA;moderate dysfunction crcl $nmbr$ $nmbr$ ml min n $nmbr$ $nmbr$ $nmbr$
1535;moderate dysfunction;C3274776;NA;NA;moderate dysfunction
1534;utis;C0042029;NA;NA;utis
1534;uti;"C0042029;C0077906;C1412376";NA;NA;uti
1534;urinary tract infection;"C0042029;C0262655;C4554638";NA;NA;urinary tract infection
1534;events consistent with uti;"C0042029;C0077906;C0332290;C0441471;C1412376;C3541888";NA;NA;events consistent with uti
1533;social functioning;C0037395;NA;NA;social functioning
1533;social function;C0037395;NA;NA;social function
1533;physical functioning;"C0516981;C4049916";NA;NA;physical functioning
1533;physical function;"C0516981;C4049916";NA;NA;physical function
1533;opaqb physical function score;"C0031843;C0449820;C0516981;C0542341;C0700205;C1705273;C4049916;C4050231;C4483112";NA;NA;opaqb physical function score
1532;renal function : creatinine clearance;"C0232804;C0812399";NA;NA;renal function creatinine clearance
1532;renal function : ! : n ( % );C0232804;NA;NA;renal function n
1532;renal function *;C0232804;NA;NA;renal function
1532;renal function ( egfr ) according to mdrd  n ( % );"C0232804;C0680240;C1739039;C3811844;C3812682;C3839656";NA;NA;renal function egfr according to mdrd n
1532;renal function  bn ( % );"C0005005;C0034700;C0232804;C1706574;C4551963";NA;NA;renal function bn
1532;renal function;C0232804;NA;NA;renal function
1532;deterioration in renal function ( investigator reported );"C0035173;C0232804;C0684224;C0700287;C0868945;C4319718";NA;NA;deterioration in renal function investigator reported
1532;baseline renal function ( eclcr );"C0168634;C0232804;C1442488";NA;NA;baseline renal function eclcr
   7;p value 十;C1709380;NA;NA;p value
   7;p value ∥;C1709380;NA;NA;p value
   7;p value § ® ( w;C1709380;NA;NA;p value w
1531;physical function ( $nmbr$ - $nmbr$  short form - $nmbr$ subscale );"C0031843;C0348078;C0376315;C0516981;C0542341;C0597240;C0700205;C0700329;C1282927;C1522492;C1705273;C1806781;C2350002;C2964478;C4049916;C4255237";NA;NA;physical function $nmbr$ $nmbr$ short form $nmbr$ subscale
1531;nyha functional classification — no . ( % ) i;"C0021966;C0205245;C0221138;C0542341;C1275491;C2700217";NA;NA;nyha functional classification no i
1531;nyha functional classification — no . ( % );"C0205245;C0542341;C1275491;C2700217";NA;NA;nyha functional classification no
1531;nyha functional class i;"C0205245;C0542341;C1882084;C2700217";NA;NA;nyha functional class i
1531;nyha functional class at screening;"C0205245;C0220908;C0220909;C0542341;C1698960;C1710031;C1710032;C1710477;C1882083;C2348164;C2700217";NA;NA;nyha functional class at screening
1531;nyha functional class at randomization;"C0034656;C0205245;C0542341;C1882083;C2700217";NA;NA;nyha functional class at randomization
1531;nyha functional class ( % );"C0205245;C0542341;C1882083;C2700217";NA;NA;nyha functional class
1531;nyha functional class $nmbr$;"C0205245;C0542341;C1882083;C2700217";NA;NA;nyha functional class $nmbr$
1531;nyha functional class  n ( % );"C0205245;C0542341;C1882083;C2700217";NA;NA;nyha functional class n
1531;nyha functional class;"C0205245;C0542341;C1882083;C2700217";NA;NA;nyha functional class
1531;lv function > $nmbr$ . $nmbr$ and < $nmbr$ . $nmbr$  n ( % ) medications  n ( % of patients );"C0013227;C0023128;C0030705;C0031843;C0369718;C0441922;C0542341;C0700205;C0731033;C0802604;C1705273;C1881413;C2598133;C4284232";NA;NA;lv function $nmbr$ $nmbr$ and $nmbr$ $nmbr$ n medications n of patients
1531;lv function;"C0023128;C0031843;C0542341;C0700205;C0731033;C1705273;C1881413";NA;NA;lv function
1531;inhibitors — no . { % ) se - $nmbr$ physical functioning score ^ ^;"C0036919;C0205245;C0243077;C0542341;C4483112;C4552744";NA;NA;inhibitors no se $nmbr$ physical functioning score
1531;haemodynamics and lv function;"C0019010;C0023128;C0031843;C0542341;C0700205;C0731033;C1705273;C1881413;C4281788";NA;NA;haemodynamics and lv function
1531;functional outcome ( mrs $nmbr$ - $nmbr$ );"C0205245;C0542341;C1274040;C1522706;C2349188;C2700217;C3714939;C3854213";NA;NA;functional outcome mrs $nmbr$ $nmbr$
1531;function subscale;"C0031843;C0542341;C0700205;C1705273";NA;NA;function subscale
1531;emotional function;"C0013987;C0031843;C0542341;C0700205;C0849912;C1705273";NA;NA;emotional function
1530;significant worsening in kccq clinical score ( > $nmbr$ ) at $nmbr$ months $nmbr$;"C0332271;C0439231;C0449820;C1457868;C1546960;C2826293;C3476798;C4050231";NA;NA;significant worsening in kccq clinical score $nmbr$ at $nmbr$ months $nmbr$
1530;s $nmbr$ months;"C0439231;C0565930;C2603362";NA;NA;s $nmbr$ months
1507;oxypurinol ( n = $nmbr$ );C0030086;NA;NA;oxypurinol n $nmbr$
1530;symptoms of atrial fibrillation in the $nmbr$ months before randomiza -;"C0004238;C0344434;C0439231;C0683368;C1457887;C1963067";FALSE;  90;symptoms of atrial fibrillation in the $nmbr$ months before randomiza
1530;ppi use within $nmbr$ months of randomization;"C0034656;C0358591;C0439231;C0871125;C1524063;C3811894";NA;NA;ppi use within $nmbr$ months of randomization
1530;poor outcome at $nmbr$ months;"C0439231;C3806166";NA;NA;poor outcome at $nmbr$ months
1530;months ( log - transformed );"C0439231;C1510411;C1708728;C2986775";NA;NA;months log transformed
1530;mi > $nmbr$ months *;"C0439231;C3810814";NA;NA;mi $nmbr$ months
1530;mi < $nmbr$ months *;"C0439231;C3810814";NA;NA;mi $nmbr$ months
1530;kccq ( $nmbr$ months );"C0439231;C3476798";NA;NA;kccq $nmbr$ months
1530;fall in last $nmbr$ months ( % );"C0085639;C0238715;C0439231;C4553726";NA;NA;fall in last $nmbr$ months
1530;duration of prior alendronate use  months;"C0102118;C0332152;C0439231;C1881378;C2826257;C2826775";NA;NA;duration of prior alendronate use months
1530;duration of previous use of vka  months;"C0205156;C0439231;C1552607;C1881378;C2826775";NA;NA;duration of previous use of vka months
1530;duration of metformin therapy ( months );"C0025598;C0439231;C0444917";NA;NA;duration of metformin therapy months
1530;duration of dementia symptoms  months;"C0011265;C0436359;C0439231;C0497327";NA;NA;duration of dementia symptoms months
1530;copd medication taken for at least $nmbr$ months before study entry;"C0013227;C0024117;C0439231;C0557651;C1412502;C1705654;C1883727;C2603343;C3244316;C3714496;C4284232";NA;NA;copd medication taken for at least $nmbr$ months before study entry
1530;change in sbp ( $nmbr$ months );"C0085805;C0392747;C0439231;C0443172;C1705241;C4319952";NA;NA;change in sbp $nmbr$ months
1530;change in nt - probnp at $nmbr$ months ( log - transformed );"C0392747;C0439231;C0443172;C0669479;C0754710;C1510411;C1705241;C1708728;C2986775;C4319952";NA;NA;change in nt probnp at $nmbr$ months log transformed
1530;blood eosinophil count > $nmbr$ / mm $nmbr$ in $nmbr$ months before screening — no . ( % );"C0005767;C0005768;C0014467;C0200638;C0220908;C0220909;C0229664;C0439231;C0750480;C0750879;C1698960;C1705566;C1710031;C1710032;C1710477;C2348164;C4330985;C4554674";NA;NA;blood eosinophil count $nmbr$ mm $nmbr$ in $nmbr$ months before screening no
1530;^ $nmbr$ months;C0439231;NA;NA;$nmbr$ months
1530;> $nmbr$ months ( n = $nmbr$  $nmbr$ );C0439231;NA;NA;$nmbr$ months n $nmbr$ $nmbr$
1530;> $nmbr$ months  n ( % );C0439231;NA;NA;$nmbr$ months n
1530;> $nmbr$ months;C0439231;NA;NA;$nmbr$ months
1530;< $nmbr$ months in - $nmbr$ kill;"C0162388;C0439231;C0681205;C1550555";NA;NA;$nmbr$ months in $nmbr$ kill
1530;< $nmbr$ months  n ( % );C0439231;NA;NA;$nmbr$ months n
1530;< $nmbr$ months;C0439231;NA;NA;$nmbr$ months
1530;$nmbr$ – $nmbr$ months;C0439231;NA;NA;$nmbr$ $nmbr$ months
1530;$nmbr$ tob $nmbr$ months  n ( % );"C0439231;C1420851";NA;NA;$nmbr$ tob $nmbr$ months n
1530;$nmbr$ tob $nmbr$ months;"C0439231;C1420851";NA;NA;$nmbr$ tob $nmbr$ months
1530;$nmbr$ montlts;NA;NA;NA;$nmbr$ montlts
1530;$nmbr$ months;C0439231;NA;NA;$nmbr$ months
1530;$nmbr$ - < $nmbr$ months  n ( % );C0439231;NA;NA;$nmbr$ $nmbr$ months n
1530;$nmbr$ - $nmbr$ months fn = $nmbr$ . $nmbr$ );"C0439231;C1570610";NA;NA;$nmbr$ $nmbr$ months fn $nmbr$ $nmbr$
1530;$nmbr$ - $nmbr$ months ( n = $nmbr$ );C0439231;NA;NA;$nmbr$ $nmbr$ months n $nmbr$
1530;$nmbr$ - $nmbr$ months  n ( % );C0439231;NA;NA;$nmbr$ $nmbr$ months n
1530;$nmbr$ - $nmbr$ months;C0439231;NA;NA;$nmbr$ $nmbr$ months
1529;intensified ( n 二 $nmbr$ );NA;NA;NA;intensified n $nmbr$
1529;intensified $nmbr$ months ( n - $nmbr$ );C0439231;NA;NA;intensified $nmbr$ months n $nmbr$
1528;montelukast ( n = $nmbr$ );C0298130;NA;NA;montelukast n $nmbr$
1528;monteiukast vs placebo;"C0032042;C1696465;C1706408";NA;NA;monteiukast vs placebo
1528;monteiukast ( n = $nmbr$ );NA;NA;NA;monteiukast n $nmbr$
1528;monteiukast;NA;NA;NA;monteiukast
1527;panel b;"C0441833;C1706365;C1999270";NA;NA;panel b
1527;panel a;"C0441833;C1706365;C1999270";NA;NA;panel a
1527;device group;C1706365;NA;NA;device group
1526;vascular disease ( % of group );"C0042373;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429";NA;NA;vascular disease of group
1526;treatment group  on - treatment il - $nmbr$ threshold;"C0020898;C0021764;C0022271;C0039798;C0087111;C0441833;C0449864;C0687744;C1257890;C1519504;C1522326;C1533734;C1705169;C1705428;C1705429;C3538994;C3887704";NA;NA;treatment group on treatment il $nmbr$ threshold
   7;p value § ( < $nmbr$ vs . > = $nmbr$ years );"C0439234;C1709380";NA;NA;p value $nmbr$ vs $nmbr$ years
1526;total group;"C0439175;C0439810;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429";NA;NA;total group
1526;table_group;"C0039224;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C1706074";NA;NA;table_group
1526;subject group;"C0441833;C0681850;C0687744;C1257890;C1519504;C1550501;C1705428;C1705429;C1706203;C2349001;C2697811";NA;NA;subject group
1526;statin group;"C0360714;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429";NA;NA;statin group
1526;salmeterol - fluticasone group;"C0441833;C0687744;C0939232;C1257890;C1519504;C1705428;C1705429";NA;NA;salmeterol fluticasone group
1526;risk factors ( % of group );"C0035648;C0441833;C0687744;C1257890;C1519504;C1553898;C1705428;C1705429";NA;NA;risk factors of group
1526;randomized group by subgroup interaction;"C0034656;C0441833;C0687744;C1079230;C1257890;C1515021;C1519504;C1704675;C1705428;C1705429;C3815594";NA;NA;randomized group by subgroup interaction
1526;randomization groups $nmbr$ and $nmbr$;"C0034656;C0441833;C0687744;C1257890;C1519504;C1552839;C1705428;C1705429";NA;NA;randomization groups $nmbr$ and $nmbr$
1526;randomization group;"C0034656;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429";NA;NA;randomization group
1526;previous coronary procedure ( % of group );"C0018787;C0018821;C0205156;C0441833;C0687744;C1257890;C1279986;C1519504;C1552607;C1705428;C1705429;C2986530";NA;NA;previous coronary procedure of group
1526;p value between groups;"C0441833;C0441849;C0687744;C1257890;C1519504;C1522609;C1552839;C1705428;C1705429;C1709380";NA;NA;p value between groups
1526;no statin group;"C0360714;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429";NA;NA;no statin group
1526;no . of diseased vessels ( % of group );"C0005847;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429";NA;NA;no of diseased vessels of group
1526;indacaterol - glycopyrronium group;"C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C1722260;C3814772";NA;NA;indacaterol glycopyrronium group
1526;hbaic group ( % );"C0441833;C0687744;C1257890;C1519504;C1705428;C1705429";NA;NA;hbaic group
1526;groups;"C0441833;C0687744;C1257890;C1519504;C1552839;C1705428;C1705429";NA;NA;groups
1526;group — no . ( % );"C0441833;C0687744;C1257890;C1519504;C1705428;C1705429";NA;NA;group no
1526;group dif . ( $nmbr$ );"C0441833;C0687744;C0812246;C1257890;C1519504;C1705428;C1705429;C1710304";NA;NA;group dif $nmbr$
1526;group;"C0441833;C0687744;C1257890;C1519504;C1705428;C1705429";NA;NA;group
1526;for combined hemoglobin groups;"C0019046;C0205195;C0441833;C0687744;C1257890;C1519504;C1552839;C1705428;C1705429";NA;NA;for combined hemoglobin groups
1526;ezetimibe / simvastatin group;"C0441833;C0687744;C1257890;C1519504;C1532737;C1705428;C1705429";NA;NA;ezetimibe simvastatin group
1526;experimental treatment group;"C0441833;C0687744;C0949266;C1257890;C1519504;C1705428;C1705429;C2585119";NA;NA;experimental treatment group
1526;dabigatran group;"C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C2348066";NA;NA;dabigatran group
1526;coronary procedure ( % of group );"C0018787;C0018821;C0441833;C0687744;C1257890;C1279986;C1519504;C1705428;C1705429;C2986530";NA;NA;coronary procedure of group
1526;certolizumab group;"C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C1872109";NA;NA;certolizumab group
1526;bmi group — no . ( % );"C0441833;C0578022;C0687744;C1257890;C1519504;C1705428;C1705429";NA;NA;bmi group no
1526;aga group;"C0441833;C0687744;C1257890;C1519504;C1705428;C1705429";NA;NA;aga group
1526;( % of group );"C0441833;C0687744;C1257890;C1519504;C1705428;C1705429";NA;NA;of group
1525;the square of the height in meters . patient ' s and physician ' s global assessment scores can range from $nmbr$ to $nmbr$ . scores for the western;"C0030705;C0205120;C0441074;C0449820;C0489786;C1514721;C1552595;C1705493;C2348147;C3542016;C4050369";NA;NA;the square of the height in meters patient s and physician s global assessment scores can range from $nmbr$ to $nmbr$ scores for the western
1525;physician global assessment of disease activity  mean ( sd );"C0444504;C2347634;C2348143;C2699239;C4050369";NA;NA;physician global assessment of disease activity mean sd
1525;physician global assessment of disease;"C0012634;C4050369";NA;NA;physician global assessment of disease
1525;physician ' s global assessment of dis -;"C0451119;C1444662;C1970187;C4050369";NA;NA;physician s global assessment of dis
1525;physician ' s global assessment . mean $nmbr$ sd;"C0444504;C2347634;C2348143;C2699239;C4050369";NA;NA;physician s global assessment mean $nmbr$ sd
1525;physician ' s global assessment !;C4050369;NA;NA;physician s global assessment
1525;physician ' s global assessment;C4050369;NA;NA;physician s global assessment
1525;pga subscore;"C0016410;C3541266;C4050369";NA;NA;pga subscore
1525;pga score ( range );"C0016410;C0449820;C1514721;C2348147;C3541266;C3542016;C4050231;C4050369";NA;NA;pga score range
1525;pga score  mean ( sd );"C0016410;C0444504;C0449820;C2347634;C2348143;C2699239;C3541266;C4050231;C4050369";NA;NA;pga score mean sd
1525;pga  $nmbr$ - $nmbr$;"C0016410;C3541266;C4050369";NA;NA;pga $nmbr$ $nmbr$
1525;no worsening in pga  %;"C0016410;C0332271;C1457868;C1546960;C3541266;C4050369";NA;NA;no worsening in pga
1525;mean pga score ± sd;"C0016410;C2699239;C3533236;C3541266;C4050369";NA;NA;mean pga score sd
1525;mean ( sd ) pga vas *;"C0016410;C0042815;C0444504;C2347634;C2348143;C2699239;C3536884;C3541266;C3827561;C4050369";NA;NA;mean sd pga vas
1524;ptca or pci;"C2936173;C4049621";NA;NA;ptca or pci
1524;ptca / cabg;"C0010055;C2936173";NA;NA;ptca cabg
1524;prior ptca or cabg;"C0010055;C0332152;C2826257;C2936173";NA;NA;prior ptca or cabg
1524;cabg or ptca / pci;"C0010055;C2936173;C4049621";NA;NA;cabg or ptca pci
1524;cabg or ptca ( % );"C0010055;C2936173";NA;NA;cabg or ptca
1524;both ptca and cabg;"C0010055;C2936173";NA;NA;both ptca and cabg
1523;phakic;NA;NA;NA;phakic
1523;participation in phase a;"C0205390;C0679823;C1710475";NA;NA;participation in phase a
1523;double - dummy phase * *;"C0205390;C1710475;C4684647";NA;NA;double dummy phase
1523;aphasia;C0003537;NA;NA;aphasia
1522;ulpasi $nmbr$;NA;NA;NA;ulpasi $nmbr$
1522;tpasi $nmbr$;NA;NA;NA;tpasi $nmbr$
1522;pasia;NA;NA;NA;pasia
1522;pasi score > $nmbr$ *;"C0449820;C4050231;C4528685";NA;NA;pasi score $nmbr$
1522;pasi score ( $nmbr$ – $nmbr$ scale );"C0175659;C0349674;C0449820;C1947916;C4050231;C4528685";NA;NA;pasi score $nmbr$ $nmbr$ scale
1522;pasi score ( $nmbr$ - $nmbr$ ) d;"C0449820;C4050231;C4528685";NA;NA;pasi score $nmbr$ $nmbr$ d
1522;pasi score ( $nmbr$ - $nmbr$ );"C0449820;C4050231;C4528685";NA;NA;pasi score $nmbr$ $nmbr$
1522;pasi score $nmbr$;"C0449820;C4050231;C4528685";NA;NA;pasi score $nmbr$
1522;pasi score ! * *;"C0449820;C4050231;C4528685";NA;NA;pasi score
1522;pasi score  $nmbr$ - $nmbr$ *;"C0449820;C4050231;C4528685";NA;NA;pasi score $nmbr$ $nmbr$
1522;pasi score;"C0449820;C4050231;C4528685";NA;NA;pasi score
1522;pasi response by baseline mtx use  no . / total no . ( % ) * pasi $nmbr$;"C0025677;C0042153;C0168634;C0439175;C0439810;C0457083;C0871261;C1417487;C1442488;C1704632;C1706817;C1947944;C2911692;C4528685";NA;NA;pasi response by baseline mtx use no total no pasi $nmbr$
1522;pasi ^ i;"C0021966;C0221138;C4528685";NA;NA;pasi i
1522;pasi < $nmbr$ *;C4528685;NA;NA;pasi $nmbr$
1522;pasi *;C4528685;NA;NA;pasi
1522;pasi $nmbr$ a;C4528685;NA;NA;pasi $nmbr$ a
1522;pasi $nmbr$  no . / total no . ( % ) $nmbr$;"C0439175;C0439810;C4528685";NA;NA;pasi $nmbr$ no total no $nmbr$
1522;pasi $nmbr$;C4528685;NA;NA;pasi $nmbr$
1522;pasi;C4528685;NA;NA;pasi
1522;median pasi score { range ) ' i  i ';"C0021966;C0221138;C0449820;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016;C4050231;C4528685";NA;NA;median pasi score range i i
1522;llpasi $nmbr$;NA;NA;NA;llpasi $nmbr$
1522;baseline pasi score;"C0168634;C0449820;C1442488;C4050231;C4528685";NA;NA;baseline pasi score
 -10;erysipelas;C0014733;NA;NA;erysipelas
1520;physician ' s judgment that vka inappropriate ];"C0022423;C0031831;C0804815;C1548788;C3537135;C3542467";NA;NA;physician s judgment that vka inappropriate
1520;physician ' s judgment that vka inappropriate;"C0022423;C0031831;C0804815;C1548788;C3537135;C3542467";NA;NA;physician s judgment that vka inappropriate
1520;physician ' s judgment that vka;"C0022423;C0031831;C0804815";NA;NA;physician s judgment that vka
1520;physician;"C0031831;C0804815";NA;NA;physician
1520;bone erosion ( judged by physician )  n ( % );"C0031831;C0221191;C0587240;C0804815";NA;NA;bone erosion judged by physician n
1519;study $nmbr$ - item short - form general health survey ( sf - $nmbr$ ) can range from $nmbr$ to $nmbr$ for the physical component and from $nmbr$ to $nmbr$ for the mental;"C0031809;C0037712;C0040363;C0041260;C0205485;C0229992;C0348078;C0376315;C0449432;C0557651;C1282927;C1509143;C1514721;C1522492;C1551338;C1705248;C1806781;C1883351;C2348147;C2350002;C2603343;C3481509;C3542016;C4255237;C4554251";NA;NA;study $nmbr$ item short form general health survey sf $nmbr$ can range from $nmbr$ to $nmbr$ for the physical component and from $nmbr$ to $nmbr$ for the mental
1519;sf - $nmbr$ physical component summaryjj;"C0031809;C0037712;C0205485;C0449432;C1509143;C1705248";NA;NA;sf $nmbr$ physical component summaryjj
1519;physical examinations;C0031809;NA;NA;physical examinations
1519;physical examination;"C0031809;C1744699";NA;NA;physical examination
1519;physical component summary;"C0031809;C0205485;C0449432;C1509143;C1552616;C1705248;C1706244";NA;NA;physical component summary
1519;physical component;"C0031809;C0205485;C0449432;C1509143;C1705248";NA;NA;physical component
1519;physical characteristics;"C0031809;C0205485;C1509143;C1521970";NA;NA;physical characteristics
1519;and physical examination;"C0031809;C1744699";NA;NA;and physical examination
1518;pr / virgin islands  n ( % );"C0042752;C0279759;C0279766;C1418864;C3538934;C3538935;C3889640;C4048189;C4082178;C4082184;C4085573;C4552913;C4552914";NA;NA;pr virgin islands n
1518;n / pyr;"C0369718;C0441922";NA;NA;n pyr
1518;$nmbr$ . $nmbr$ per $nmbr$ pyr;NA;NA;NA;$nmbr$ $nmbr$ per $nmbr$ pyr
1518;$nmbr$ . $nmbr$ per $nmbr$ $nmbr$ . $nmbr$ per $nmbr$ pyr pyr;NA;NA;NA;$nmbr$ $nmbr$ per $nmbr$ $nmbr$ $nmbr$ per $nmbr$ pyr pyr
1518;$nmbr$ ( $nmbr$ . $nmbr$ % )  $nmbr$ . $nmbr$ per $nmbr$ pyr;NA;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ per $nmbr$ pyr
1518;$nmbr$ ( $nmbr$ . $nmbr$ % )  $nmbr$ ( $nmbr$ . $nmbr$ % )  $nmbr$ . $nmbr$ per $nmbr$ . $nmbr$ per $nmbr$ pyr $nmbr$ pyr;NA;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ per $nmbr$ $nmbr$ per $nmbr$ pyr $nmbr$ pyr
1518;$nmbr$ ( $nmbr$ . $nmbr$ % )  $nmbr$ ( $nmbr$ . $nmbr$ % )  $nmbr$ . $nmbr$ per $nmbr$ $nmbr$ . $nmbr$ per pyr $nmbr$ pyr;NA;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ per $nmbr$ $nmbr$ $nmbr$ per pyr $nmbr$ pyr
1517;standard care n ( % ) / $nmbr$ py;"C0030428;C1442989;C1947933;C2828392;C3538810";NA;NA;standard care n $nmbr$ py
1517;py = $nmbr$ . $nmbr$ );"C0030428;C3538810";NA;NA;py $nmbr$ $nmbr$
1517;py = $nmbr$ );"C0030428;C3538810";NA;NA;py $nmbr$
1517;py *;"C0030428;C3538810";NA;NA;py
1517;pa;"C0030428;C3541314";NA;NA;pa
1517;no pa;"C0030428;C3541314";NA;NA;no pa
1517;insulin glargine n ( % ) / $nmbr$ py;"C0030428;C0907402;C3538810";NA;NA;insulin glargine n $nmbr$ py
1517;$nmbr$ events  $nmbr$ . $nmbr$ per $nmbr$ py ( $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ );"C0030428;C0441471;C3538810;C3541888";NA;NA;$nmbr$ events $nmbr$ $nmbr$ per $nmbr$ py $nmbr$ $nmbr$ $nmbr$ $nmbr$
1517;$nmbr$ event  $nmbr$ . $nmbr$ per $nmbr$ py ( $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ );"C0030428;C0441471;C3538810;C4019010";NA;NA;$nmbr$ event $nmbr$ $nmbr$ per $nmbr$ py $nmbr$ $nmbr$ $nmbr$ $nmbr$
1517;$nmbr$ . $nmbr$ { $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ } pty = $nmbr$;NA;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ pty $nmbr$
1517;$nmbr$ . $nmbr$ { $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ ) pty = $nmbr$;NA;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ pty $nmbr$
1517;$nmbr$ . $nmbr$ per $nmbr$ py;"C0030428;C3538810";NA;NA;$nmbr$ $nmbr$ per $nmbr$ py
1507;allopurinolt;NA;NA;NA;allopurinolt
1516;sco . ’ ita ' rojs dvt . ' pe;"C0022277;C0070939;C0149871;C1880476;C2926618;C2986561;C3899446;C4284304";NA;NA;sco ita rojs dvt pe
1516;ruled out non - fatal pe with or;"C0070939;C0439787;C0849355;C1302234;C1446409;C1518422;C1705232;C1880476;C4284304";NA;NA;ruled out non fatal pe with or
1516;pre ' rtous eptscde ( s } d dvt / pe;"C0070939;C0149871;C0332152;C0740175;C1880476;C2257086;C2926618;C3669034;C3899446;C4284304";NA;NA;pre rtous eptscde s d dvt pe
1516;pe ± dvt;"C0070939;C0149871;C1880476;C2926618;C3899446;C4284304";NA;NA;pe dvt
1516;pe with / without dvt;"C0070939;C0149871;C1880476;C2926618;C3899446;C4284304";NA;NA;pe with without dvt
1516;pe only;"C0070939;C0205171;C1720467;C1880476;C4284304";NA;NA;pe only
1516;pe associated with dvt at diagnosis;"C0011900;C0070939;C0149871;C0332281;C1704338;C1704656;C1880476;C2926618;C3899446;C4284304";NA;NA;pe associated with dvt at diagnosis
1516;pe and dvt;"C0070939;C0149871;C1880476;C2926618;C3899446;C4284304";NA;NA;pe and dvt
1516;pe ( with or without dvt );"C0070939;C0149871;C1880476;C2926618;C3899446;C4284304";NA;NA;pe with or without dvt
1516;pe;"C0070939;C1880476;C4284304";NA;NA;pe
1516;neither pe nor dvt;"C0070939;C0149871;C1880476;C2926618;C3899446;C4284304";NA;NA;neither pe nor dvt
1516;initial symptomatic pe;"C0070939;C0205265;C0231220;C1279901;C1555582;C1705685;C1880476;C4284304";NA;NA;initial symptomatic pe
1516;index events : pe ± dvt n ( % );"C0070939;C0149871;C0441471;C0600653;C0918012;C1552854;C1637833;C1880476;C2926618;C2986546;C3541888;C3899446;C4284304";NA;NA;index events pe dvt n
1516;extent of index pe ' ( n  % of pe patients );"C0030705;C0070939;C0439792;C0600653;C0918012;C1552854;C1637833;C1880476;C2986546;C4284304";NA;NA;extent of index pe n of pe patients
1516;death  with pe not;"C0011065;C0070939;C1306577;C1518422;C1880476;C4082313;C4284304;C4552775";NA;NA;death with pe not
1516;causes of dvt or pe — no . ( % ) ^ |;"C0015127;C0070939;C0149871;C1314792;C1880476;C2926618;C3899446;C4284304";NA;NA;causes of dvt or pe no
1516;causes of dvt or pe  n ( % );"C0015127;C0070939;C0149871;C1314792;C1880476;C2926618;C3899446;C4284304";NA;NA;causes of dvt or pe n
1516;cause of dvt or pe — no . ( % );"C0015127;C0070939;C0149871;C1524003;C1880476;C2926618;C3899446;C4284304";NA;NA;cause of dvt or pe no
1515;stroke or pvd  ( % );"C0038454;C0085096;C4521226;C4554100";NA;NA;stroke or pvd
1515;pvd;"C0085096;C4521226";NA;NA;pvd
1515;puva;"C0853073;C1704892";NA;NA;puva
1514;vdz / pla n = $nmbr$;C0456170;NA;NA;vdz pla n $nmbr$
1514;pla « = $nmbr$;C0456170;NA;NA;pla $nmbr$
1514;pla n = $nmbr$;C0456170;NA;NA;pla n $nmbr$
1514;pla;C0456170;NA;NA;pla
1514;atio - pla;C0456170;NA;NA;atio pla
1513;pt . years = $nmbr$;"C0032743;C0439234;C0699718";NA;NA;pt years $nmbr$
1513;pt;"C0032743;C0699718";NA;NA;pt
1513;patients entering pt period n = $nmbr$;"C0030705;C0032743;C0439531;C0699718;C1522196;C1948053";NA;NA;patients entering pt period n $nmbr$
1513;event / patients ( $nmbr$ / pt - y );"C0030705;C0032743;C0441471;C0699718;C4019010";NA;NA;event patients $nmbr$ pt y
1513;diet diet + pravastatin event / patients ( $nmbr$ ooo / pt - y );"C0012155;C0012159;C0030705;C0032743;C0085542;C0441471;C0699718;C1519433;C2983588;C3668949;C4019010";NA;NA;diet diet pravastatin event patients $nmbr$ ooo pt y
1512;pts;"C1419129;C2698747";NA;NA;pts
1512;placebo pts / n ( % );"C0032042;C1419129;C1696465;C1706408;C2698747";NA;NA;placebo pts n
1512;no . pts;"C1419129;C2698747";NA;NA;no pts
1512;# pts;"C1419129;C2698747";NA;NA;pts
1511;ntprobnp ( pg / ml );"C0439297;C0669479;C0754710";NA;NA;ntprobnp pg ml
1511;nt - probnp ， pmol / h;"C0033727;C0369286;C0439192;C0441932;C0564385;C0669479;C0754710;C4528284";NA;NA;nt probnp pmol h
1511;nt - probnp — pg / ml * *;"C0439297;C0669479;C0754710";NA;NA;nt probnp pg ml
1511;nt - probnp — pg / ml;"C0439297;C0669479;C0754710";NA;NA;nt probnp pg ml
1511;nt - probnp ( pg / ml ) h;"C0030827;C0033727;C0072225;C0369286;C0439297;C0439391;C0439526;C0441932;C0564385;C0669479;C0754710;C1266240;C1705224;C2827929;C3887665;C4528284";NA;NA;nt probnp pg ml h
1511;nt - probnp ( pg / ml ) ( q $nmbr$ - q $nmbr$ );"C0439297;C0669479;C0754710";NA;NA;nt probnp pg ml q $nmbr$ q $nmbr$
1511;nt - probnp ( pg / ml );"C0439297;C0669479;C0754710";NA;NA;nt probnp pg ml
1511;nt - probnp $nmbr$ pmol - l - $nmbr$;"C0439284;C0669479;C0754710";NA;NA;nt probnp $nmbr$ pmol l $nmbr$
1511;nt - probnp  pmol / l ^;"C0439284;C0669479;C0754710";NA;NA;nt probnp pmol l
1511;nt - probnp  pmol / l;"C0439284;C0669479;C0754710";NA;NA;nt probnp pmol l
1511;nt - probnp  pmol / h;"C0033727;C0369286;C0439192;C0441932;C0564385;C0669479;C0754710;C4528284";NA;NA;nt probnp pmol h
1511;nt - probnp  pg / ml;"C0439297;C0669479;C0754710";NA;NA;nt probnp pg ml
1511;nt - pro bnp;"C0669479;C0754710";NA;NA;nt pro bnp
1511;nt - pro - bnp — pmol / literf;"C0439192;C0669479;C0754710";NA;NA;nt pro bnp pmol literf
1511;nt - pro - bnp — pmol / liter - j -;"C0439192;C0475211;C0669479;C0754710";NA;NA;nt pro bnp pmol liter j
1511;nt - pro - bnp;"C0669479;C0754710";NA;NA;nt pro bnp
1511;n - terminal pro - bnp — pg / ml §;"C0439297;C0669479";NA;NA;n terminal pro bnp pg ml
1510;versus tiotropium + olodaterol $nmbr$ . $nmbr$ / $nmbr$ pg;"C0030827;C0072225;C1266240;C4032878";NA;NA;versus tiotropium olodaterol $nmbr$ $nmbr$ $nmbr$ pg
1510;versus tiotropium $nmbr$ pg tiotropium + olodaterol $nmbr$ . $nmbr$ / $nmbr$ pg;"C0030827;C0072225;C1266240;C4032878";NA;NA;versus tiotropium $nmbr$ pg tiotropium olodaterol $nmbr$ $nmbr$ $nmbr$ pg
1510;versus tiotropium $nmbr$ pg tiotropium + olodaterol $nmbr$ - $nmbr$ / $nmbr$ pg;"C0030827;C0072225;C1266240;C4032878";NA;NA;versus tiotropium $nmbr$ pg tiotropium olodaterol $nmbr$ $nmbr$ $nmbr$ pg
1510;versus olodaterol $nmbr$ pg;"C0030827;C0072225;C1266240;C2934193";NA;NA;versus olodaterol $nmbr$ pg
1510;tiotropium + olodaterol $nmbr$ / $nmbr$ pg;"C0030827;C0072225;C1266240;C4032878";NA;NA;tiotropium olodaterol $nmbr$ $nmbr$ pg
1510;tiotropium + olodaterol $nmbr$ / $nmbr$;C4032878;NA;NA;tiotropium olodaterol $nmbr$ $nmbr$
1510;tiotropium + olodaterol $nmbr$ . $nmbr$ / $nmbr$ pg;"C0030827;C0072225;C1266240;C4032878";NA;NA;tiotropium olodaterol $nmbr$ $nmbr$ $nmbr$ pg
1510;olodaterol sgg;C2934193;NA;NA;olodaterol sgg
1510;olodaterol $nmbr$ pg;"C0030827;C0072225;C1266240;C2934193";NA;NA;olodaterol $nmbr$ pg
1510;olodaterol $nmbr$ m g;"C0456715;C2934193";NA;NA;olodaterol $nmbr$ m g
1510;olodaterol $nmbr$ jig;C2934193;NA;NA;olodaterol $nmbr$ jig
1510;olodaterol $nmbr$ gg ( n = $nmbr$ );"C0017454;C0018370;C2934193";NA;NA;olodaterol $nmbr$ gg n $nmbr$
1510;olodaterol;C2934193;NA;NA;olodaterol
1509;indacaterol / glycopyrronium $nmbr$ / $nmbr$   μ g o . d .;"C0439417;C1722260;C3814772";NA;NA;indacaterol glycopyrronium $nmbr$ $nmbr$ g o d
1509;indacaterol - glycopyrronium group ( n = $nmbr$ );"C0441848;C1722260;C3814772";NA;NA;indacaterol glycopyrronium group n $nmbr$
1508;salmeterol ( n [ $nmbr$ );C0073992;NA;NA;salmeterol n $nmbr$
1508;salmeterol ( n = $nmbr$ );C0073992;NA;NA;salmeterol n $nmbr$
1508;salmeterol $nmbr$ gg bid;"C0017454;C0018370;C0073992";NA;NA;salmeterol $nmbr$ gg bid
1508;salmeterol;C0073992;NA;NA;salmeterol
1508;formoterol $nmbr$   μ g ( n   =   $nmbr$ );"C0060657;C0439267";NA;NA;formoterol $nmbr$ g n $nmbr$
1508;formoterol $nmbr$ gg bid;"C0017454;C0018370;C0060657";NA;NA;formoterol $nmbr$ gg bid
1508;formoterol $nmbr$ gg ( n = $nmbr$ );"C0017454;C0018370;C0060657";NA;NA;formoterol $nmbr$ gg n $nmbr$
1507;allopurinol $nmbr$ mg ( n = $nmbr$ ) +;"C0002144;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;allopurinol $nmbr$ mg n $nmbr$
1507;allopurinol $nmbr$ / $nmbr$ mg n = $nmbr$;"C0002144;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;allopurinol $nmbr$ $nmbr$ mg n $nmbr$
1507;allopurinol $nmbr$ / $nmbr$ mg daily n = $nmbr$;"C0002144;C0024671;C0026410;C0332173;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;allopurinol $nmbr$ $nmbr$ mg daily n $nmbr$
1507;allopurinol;C0002144;NA;NA;allopurinol
1506;lansoprazole ( n = $nmbr$ );C0050940;NA;NA;lansoprazole n $nmbr$
1506;dexlansoprazole mr ( n = $nmbr$ );"C0024485;C1417249;C2347167;C2348248;C3254418;C4050513";NA;NA;dexlansoprazole mr n $nmbr$
1506;dexlansoprazole mr $nmbr$ mg qd;"C0024485;C0024671;C0026410;C0332173;C0439269;C1417249;C1960952;C2346927;C2347167;C2348248;C3254418;C4050513;C4321396;C4521761";NA;NA;dexlansoprazole mr $nmbr$ mg qd
1506;dexlansoprazole mr $nmbr$ mg  n = $nmbr$;"C0024485;C0024671;C0026410;C0439269;C1417249;C1960952;C2346927;C2347167;C2348248;C3254418;C4050513;C4321396;C4521761";NA;NA;dexlansoprazole mr $nmbr$ mg n $nmbr$
1506;dexlansoprazole mr;"C0024485;C1417249;C2347167;C2348248;C3254418;C4050513";NA;NA;dexlansoprazole mr
1504;total cholesterol — mg / dl;"C0201950;C0439269;C0543421";NA;NA;total cholesterol mg dl
1504;total cholesterol ^;"C0201950;C0543421";NA;NA;total cholesterol
1504;total cholesterol > $nmbr$ mg / dl;"C0201950;C0439269;C0543421";NA;NA;total cholesterol $nmbr$ mg dl
1504;total cholesterol - mg / dl * *;"C0201950;C0439269;C0543421";NA;NA;total cholesterol mg dl
1504;total cholesterol *;"C0201950;C0543421";NA;NA;total cholesterol
1504;total cholesterol ( sd )  mg / dl;"C0201950;C0439269;C0543421;C2699239";NA;NA;total cholesterol sd mg dl
1504;total cholesterol ( mmol / l ) :;"C0201950;C0543421;C1532563";NA;NA;total cholesterol mmol l
1504;total cholesterol ( mmol / l )  mean ( sd );"C0201950;C0444504;C0543421;C1532563;C2347634;C2348143;C2699239";NA;NA;total cholesterol mmol l mean sd
1504;total cholesterol ( mmol / l );"C0201950;C0543421;C1532563";NA;NA;total cholesterol mmol l
1504;total cholesterol ( mmo $nmbr$ / $nmbr$ );"C0201950;C0543421";NA;NA;total cholesterol mmo $nmbr$ $nmbr$
1504;total cholesterol ( mg / dl )  mean + sd  available for $nmbr$ patients;"C0030705;C0201950;C0439269;C0444504;C0470187;C0543421;C2347634;C2348143;C2699239";NA;NA;total cholesterol mg dl mean sd available for $nmbr$ patients
1504;total cholesterol ( mg / dl );"C0201950;C0439269;C0543421";NA;NA;total cholesterol mg dl
1504;total cholesterol $nmbr$ > $nmbr$ mg / dl;"C0201950;C0439269;C0543421";NA;NA;total cholesterol $nmbr$ $nmbr$ mg dl
1504;total cholesterol $nmbr$ < $nmbr$ mg / dl;"C0201950;C0439269;C0543421";NA;NA;total cholesterol $nmbr$ $nmbr$ mg dl
1504;total cholesterol  mmol / l 本;"C0201950;C0543421;C1532563";NA;NA;total cholesterol mmol l
1504;total cholesterol  mmol / l ( sd );"C0201950;C0543421;C1532563;C2699239";NA;NA;total cholesterol mmol l sd
1504;total cholesterol  mmol / l  mean ( sd );"C0201950;C0444504;C0543421;C1532563;C2347634;C2348143;C2699239";NA;NA;total cholesterol mmol l mean sd
1504;total cholesterol  mmol / l;"C0201950;C0543421;C1532563";NA;NA;total cholesterol mmol l
1504;total cholesterol  mg / dl ^;"C0201950;C0439269;C0543421";NA;NA;total cholesterol mg dl
1504;total cholesterol  mg / dl  mean ( sd );"C0201950;C0439269;C0444504;C0543421;C2347634;C2348143;C2699239";NA;NA;total cholesterol mg dl mean sd
1504;total cholesterol  mg / dl  ^;"C0201950;C0439269;C0543421";NA;NA;total cholesterol mg dl
1504;total cholesterol  mg / dl;"C0201950;C0439269;C0543421";NA;NA;total cholesterol mg dl
1504;total cholesterol  mean ( sd )  mg / dl;"C0201950;C0439269;C0444504;C0543421;C2347634;C2348143;C2699239";NA;NA;total cholesterol mean sd mg dl
1501;hdl cholesterol  ( mmol / l );"C0023822;C0392885;C1532563";FALSE; 821;hdl cholesterol mmol l
1504;total cholesterol  mean ( sd );"C0201950;C0444504;C0543421;C2347634;C2348143;C2699239";NA;NA;total cholesterol mean sd
1504;total cholesterol  %;"C0201950;C0543421";NA;NA;total cholesterol
1504;total cholesterol;"C0201950;C0543421";NA;NA;total cholesterol
1504;total cholesterohhdl cholesterol ratio;"C0201950;C0456603;C0543421;C1547037";NA;NA;total cholesterohhdl cholesterol ratio
1504;median total cholesterol  mmol / l;"C0201950;C0543421;C0549183;C0876920;C1532563;C2347635;C2348144;C2939193";NA;NA;median total cholesterol mmol l
1504;cholesterol  mg / dl total;"C0201950;C0439269;C0543421";NA;NA;cholesterol mg dl total
1504;baseline total cholesterol;"C0168634;C0201950;C0543421;C1442488";NA;NA;baseline total cholesterol
1503;p - sitosterol / total c ( | imol / mmol );"C0037215;C0220914;C0369773;C0439175;C0439190;C0439810;C2603361";NA;NA;p sitosterol total c imol mmol
1503;p - sitosterol / lathosterol;"C0037215;C0064673;C0220914;C0369773;C2603361";NA;NA;p sitosterol lathosterol
1503;cilostazol;C0055729;NA;NA;cilostazol
1503;( $nmbr$ - sitosterol ( p . mol / l );"C0037215;C0220914;C0347982";NA;NA;$nmbr$ sitosterol p mol l
1502;lathosterol / total c ( | imol / mmol );"C0064673;C0439175;C0439190;C0439810";NA;NA;lathosterol total c imol mmol
1502;lathosterol ( jimol / l );C0064673;NA;NA;lathosterol jimol l
1502;csf lathosterol ( | jlg / cll );"C0023434;C0064673;C3540512;C3889436";NA;NA;csf lathosterol jlg cll
1502;alathosterol ( % );NA;NA;NA;alathosterol
1501;high - density lipoprotein cholesterol — mg / dl;"C0023822;C0439269";FALSE; 821;high density lipoprotein cholesterol mg dl
1501;kdl cholesterol ( mmol / );"C0008377;C0439190";FALSE; 821;kdl cholesterol mmol
1501;high - density lipoprotein cholesterol mean ( mg / dl ± sd );"C0023822;C0439269;C0444504;C2347634;C2348143;C2699239";FALSE; 821;high density lipoprotein cholesterol mean mg dl sd
1501;hdl cholesterol ( sd )  mg / dl;"C0023822;C0392885;C0439269;C2699239";FALSE; 821;hdl cholesterol sd mg dl
1501;hdl cholesterol ( mmol / l ) ( median  iqr );"C0023822;C0392885;C0549183;C0876920;C1532563;C2347635;C2348144;C2939193";FALSE; 821;hdl cholesterol mmol l median iqr
1501;hdl cholesterol  mmol / 冲;"C0023822;C0392885;C0439190";FALSE; 821;hdl cholesterol mmol
1501;totalhdl cholesterol ratio;"C0008377;C0456603;C1547037";FALSE; 821;totalhdl cholesterol ratio
1501;hdl cholesterol ( mmol / l );"C0023822;C0392885;C1532563";FALSE; 821;hdl cholesterol mmol l
1501;hdl cholesterol < $nmbr$ mg / dl *;"C0023822;C0392885;C0439269";FALSE; 821;hdl cholesterol $nmbr$ mg dl
1501;hdl cholesterol level;"C0023822;C0201950;C0392885;C0428466;C0441889;C0456079;C1547707;C2946261;C3715113";FALSE; 821;hdl cholesterol level
1501;high density lipoprotein cholesterol  mg / dl ^;"C0023822;C0439269";FALSE; 821;high density lipoprotein cholesterol mg dl
1501;hdl cholesterol ( mmol / l ) :;"C0023822;C0392885;C1532563";FALSE; 821;hdl cholesterol mmol l
1501;hdl cholesterol < $nmbr$ - $nmbr$ mmol / l;"C0023822;C0392885;C1532563";FALSE; 821;hdl cholesterol $nmbr$ $nmbr$ mmol l
1501;high density lipoprotein cholesterol - mg / dl * *;"C0023822;C0439269";FALSE; 821;high density lipoprotein cholesterol mg dl
1501;hdl cholesterol ( mg / dl );"C0023822;C0392885;C0439269";FALSE; 821;hdl cholesterol mg dl
1501;hdl cholesterol > $nmbr$ - $nmbr$ mmol / l;"C0023822;C0392885;C1532563";FALSE; 821;hdl cholesterol $nmbr$ $nmbr$ mmol l
1505;hdlcholesterol;NA;FALSE; 821;hdlcholesterol
1501;hdl cholesterol — mg / dl;"C0023822;C0392885;C0439269";FALSE; 821;hdl cholesterol mg dl
1501;high - density lipoprotein cholesterol  mg / dl;"C0023822;C0439269";FALSE; 821;high density lipoprotein cholesterol mg dl
1501;terol  hdl - c  high - density lipoprotein cholesterol;C0023822;FALSE; 821;terol hdl c high density lipoprotein cholesterol
1505;tolal choleslerol;NA;FALSE;1504;tolal choleslerol
1505;tolal choleslerol - lo - hdl choleslerol ralio;"C0206579;C1232424;C3715113";FALSE;1504;tolal choleslerol lo hdl choleslerol ralio
1505;total cholesterol - to - hdl cholesterol ratio;C0428619;FALSE;1504;total cholesterol to hdl cholesterol ratio
1505;total cholesterol : hdl - c ratio;"C0439175;C0439810;C0523558";FALSE;1504;total cholesterol hdl c ratio
1501;hba $nmbr$ c — % cholesterol — mmol / l;"C0008377;C0019016;C1532563;C1825777;C3538758";NA;NA;hba $nmbr$ c cholesterol mmol l
1501;cholesterol — mmol / liter;"C0008377;C0439190;C0475211";NA;NA;cholesterol mmol liter
1501;cholesterol ( mmol / l );"C0008377;C1532563";NA;NA;cholesterol mmol l
1501;cholesterol ( % );C0008377;NA;NA;cholesterol
1501;cholesterol  mmol / l;"C0008377;C1532563";NA;NA;cholesterol mmol l
1501;cholesterol  ( . $nmbr$ . $nmbr$ mmol / l )  n ( % );"C0008377;C1532563";NA;NA;cholesterol $nmbr$ $nmbr$ mmol l n
1501;cholesterol;C0008377;NA;NA;cholesterol
   7;p value interaction;"C1704675;C1709380";NA;NA;p value interaction
   7;p value heart failure vs no heart failure;"C0018801;C0018802;C1709380;C4554158";NA;NA;p value heart failure vs no heart failure
   7;p value for trend across tertiles;"C1521798;C1709380;C4554533";NA;NA;p value for trend across tertiles
   7;p value for trend *;"C1521798;C1709380;C4554533";NA;NA;p value for trend
   7;p value for trend;"C1521798;C1709380;C4554533";NA;NA;p value for trend
   7;p value for mra vs no mra;"C0243032;C1609165;C1709380;C3891069";NA;NA;p value for mra vs no mra
   7;p value for interactiont;C1709380;NA;NA;p value for interactiont
   7;p value for interaction ® vertebral fracture at flex baseline :;"C0080179;C0168634;C1442488;C1704675;C1709380";NA;NA;p value for interaction vertebral fracture at flex baseline
   7;p value for interaction ®;"C1704675;C1709380";NA;NA;p value for interaction
   7;p value for interaction by region;"C0017446;C0205147;C1704675;C1709380";NA;NA;p value for interaction by region
   7;p value for interaction ^;"C1704675;C1709380";NA;NA;p value for interaction
   7;p value for interaction ( age groups ) *;"C0027362;C1704675;C1709380";NA;NA;p value for interaction age groups
   7;p value for interaction;"C1704675;C1709380";NA;NA;p value for interaction
   7;p value for;C1709380;NA;NA;p value for
   7;p value fo interactio;C1709380;NA;NA;p value fo interactio
   7;p value f;"C0016327;C1709380";NA;NA;p value f
1493;family history of premature chd;"C0151526;C0205252;C0241889;C0280604;C3542407;C4018905";NA;NA;family history of premature chd
1493;family history of premature;"C0151526;C0205252;C0241889;C4018905";NA;NA;family history of premature
1123;mca;C0149566;NA;NA;mca
1501;- hdl cholesterol;"C0023822;C0392885";FALSE; 821;hdl cholesterol
1501;hdl cholesterol;"C0023822;C0392885";FALSE; 821;hdl cholesterol
1501;hdl - cholesterol;"C0023822;C0392885";FALSE; 821;hdl cholesterol
1500;baseline ldl cholesterol;"C0023824;C0168634;C0202117;C1442488";FALSE;1068;baseline ldl cholesterol
1500;ldl cholesicrol ( minol / l );NA;FALSE;1068;ldl cholesicrol minol l
1500;baseline ldl cholesterol ( derived );"C0023824;C0168634;C0202117;C1441547;C1442488;C3245521";FALSE;1068;baseline ldl cholesterol derived
1500;ldl cholesterol;"C0023824;C0202117";FALSE;1068;ldl cholesterol
1500;ldl - cholesterol;"C0023824;C0202117";FALSE;1068;ldl cholesterol
1501;hdl - cholesterol  mmol / l;"C0023822;C0392885;C1532563";FALSE; 821;hdl cholesterol mmol l
1501;hdl - cholesterol ( mmol / l );"C0023822;C0392885;C1532563";FALSE; 821;hdl cholesterol mmol l
1500;ldl - cholesterol (;"C0023824;C0202117";FALSE;1068;ldl cholesterol
1500;- ldl cholesterol;"C0023824;C0202117";FALSE;1068;ldl cholesterol
1500;ldl cholesterol ^ :;"C0023824;C0202117";FALSE;1068;ldl cholesterol
1501;hdl cholesterol  mmol / l *;"C0023822;C0392885;C1532563";FALSE; 821;hdl cholesterol mmol l
1501;hdl cholesterol  mmol / l;"C0023822;C0392885;C1532563";FALSE; 821;hdl cholesterol mmol l
1500;ldl cholesterol level;"C0023824;C0201950;C0202117;C0428466;C0441889;C0456079;C1547707;C2946261";FALSE;1068;ldl cholesterol level
1500;ldl cholesterol mean;"C0023824;C0202117;C0444504;C2347634;C2348143";FALSE;1068;ldl cholesterol mean
1500;ldl - cholesterol ( mmol / );"C0023824;C0202117;C0439190";FALSE;1068;ldl cholesterol mmol
1500;ldl - cholesterol  mmol / lf;"C0023824;C0202117;C0439190;C1416933;C2986618;C4554443";FALSE;1068;ldl cholesterol mmol lf
1500;ldl $nmbr$ - c;NA;FALSE;1068;ldl $nmbr$ c
1501;hdl - cholesterol  mmol / le;"C0023190;C0023822;C0392885;C0439090;C0439190;C1423767;C2697858";FALSE; 821;hdl cholesterol mmol le
1500;mean ( s . d . ) measured ldl cholesterol;"C0023824;C0202117;C0444504;C0444706;C2347634;C2348143;C3541902";FALSE;1068;mean s d measured ldl cholesterol
1501;hdl cholesterol  mmol / l  men  mean ± sd;"C0023822;C0025266;C0392885;C0444504;C1532563;C2347634;C2348143;C2699239";FALSE; 821;hdl cholesterol mmol l men mean sd
1501;hdl - cholesterol ( mg / dl );"C0023822;C0392885;C0439269";FALSE; 821;hdl cholesterol mg dl
1501;> $nmbr$ . $nmbr$ hdl cholesterol level;"C0023822;C0201950;C0392885;C0428466;C0441889;C0456079;C1547707;C2946261;C3715113";FALSE; 821;$nmbr$ $nmbr$ hdl cholesterol level
1501;hdl cholesterol  mg / dl;"C0023822;C0392885;C0439269";FALSE; 821;hdl cholesterol mg dl
1501;baseline high - density lipoprotein cholesterol ( mg / dl );"C0023822;C0168634;C0439269;C1442488";FALSE; 821;baseline high density lipoprotein cholesterol mg dl
1501;aldl cholesterol;C0008377;FALSE;1068;aldl cholesterol
1500;atrial fibrillation ldl cholesterol level;"C0004238;C0023824;C0202117;C0344434;C0441889;C0456079;C1547707;C1963067;C2946261";FALSE;1068;atrial fibrillation ldl cholesterol level
1500;mean ( s . d . ) calculated ldl cholesterol;"C0023824;C0202117;C0444504;C0444686;C1441506;C2347634;C2348143";FALSE;1068;mean s d calculated ldl cholesterol
1500;low - density lipoprotein cholesterol  %;C0023824;FALSE;1068;low density lipoprotein cholesterol
1500;visit $nmbr$ ldl cholesterol strata;"C0023824;C0202117;C0545082;C1512346;C2826704";FALSE;1068;visit $nmbr$ ldl cholesterol strata
1499;chylomicron triglycerides;"C0008731;C0041004;C1325761";NA;NA;chylomicron triglycerides
1499;chylomicron cholesterol;"C0008377;C0008731;C1325761";NA;NA;chylomicron cholesterol
1498;no history of hypertension ( n = $nmbr$ );C0455527;NA;NA;no history of hypertension n $nmbr$
1498;hyperlipidmemia;NA;NA;NA;hyperlipidmemia
1498;hypercholesterolemiat;NA;NA;NA;hypercholesterolemiat
1498;history of systemic hypertension;"C0205373;C0455527";NA;NA;history of systemic hypertension
1498;history of hypertension — no . ( % );C0455527;NA;NA;history of hypertension no
1498;history of hypertension for $nmbr$ mo or more;"C0026544;C0205172;C0332177;C0455527";NA;NA;history of hypertension for $nmbr$ mo or more
1498;history of hypertension ^  %;C0455527;NA;NA;history of hypertension
1498;history of hypertension . no . ( % );C0455527;NA;NA;history of hypertension no
1498;history of hypertension - n ( % );C0455527;NA;NA;history of hypertension n
1498;history of hypertension *;C0455527;NA;NA;history of hypertension
1498;history of hypertension ( n = $nmbr$ );C0455527;NA;NA;history of hypertension n $nmbr$
1498;history of hypertension ( a ) c;C0455527;NA;NA;history of hypertension a c
1498;history of hypertension ( % );C0455527;NA;NA;history of hypertension
1498;history of hypertension  no . ( % );C0455527;NA;NA;history of hypertension no
1498;history of hypertension  n ( % );C0455527;NA;NA;history of hypertension n
1498;history of hypertension;C0455527;NA;NA;history of hypertension
1498;history of hyperlipidemia ( % );C4695788;NA;NA;history of hyperlipidemia
1498;history of hypercholesterolemia  n ( % );C1533076;NA;NA;history of hypercholesterolemia n
1498;history of hypercholesterolemia;C1533076;NA;NA;history of hypercholesterolemia
1498;history of diagnosed hypertension n ( % );"C0011900;C0455527";NA;NA;history of diagnosed hypertension n
1497;csf $nmbr$ s - hydroxy -;"C0700307;C3540512;C3889436";NA;NA;csf $nmbr$ s hydroxy
1497;a $nmbr$ s - hydroxy -;C0700307;NA;NA;a $nmbr$ s hydroxy
1496;lv hypertrophy  n ( % );C0149721;NA;NA;lv hypertrophy n
1496;lelt ventricular hypertrophy *;C0340279;NA;NA;lelt ventricular hypertrophy
1496;left ventricular hypertrophy — no . ( % );"C0149721;C3484363";NA;NA;left ventricular hypertrophy no
1496;left ventricular hypertrophy on echo;"C0058928;C0149721;C1655045;C3484363";NA;NA;left ventricular hypertrophy on echo
1496;left ventricular hypertrophy * *;"C0149721;C3484363";NA;NA;left ventricular hypertrophy
1496;left ventricular hypertrophy ( % );"C0149721;C3484363";NA;NA;left ventricular hypertrophy
1496;left ventricular hypertrophy  n ( % );"C0149721;C3484363";NA;NA;left ventricular hypertrophy n
1496;left ventricular hypertrophy;"C0149721;C3484363";NA;NA;left ventricular hypertrophy
1496;hypertension and left ventricular hypertrophy;"C0020538;C0149721;C1963138;C3484363";NA;NA;hypertension and left ventricular hypertrophy
1495;hypertrophy  n ( % );C0020564;NA;NA;hypertrophy n
1494;prior history of cardiovascular disease  n ( % );"C0332152;C0455539;C2826257";NA;NA;prior history of cardiovascular disease n
1494;history of postmenopausal fracture *;"C0232970;C1272071";NA;NA;history of postmenopausal fracture
1494;history of osteoporotic fracture  n ( % ) a;C4075937;NA;NA;history of osteoporotic fracture n a
1494;history of falls;"C1561668;C2919132";NA;NA;history of falls
1494;history of clinical fracture ( > $nmbr$ years );"C0205210;C0439234;C1272071";NA;NA;history of clinical fracture $nmbr$ years
1494;history of cerebrovascular disease — no . { % );C0585890;NA;NA;history of cerebrovascular disease no
1494;history of cerebrovascular disease;C0585890;NA;NA;history of cerebrovascular disease
1494;history of cardiovascular disease — no . { % );C0455539;NA;NA;history of cardiovascular disease no
1494;history of cardiovascular disease — no . ( % ) ^ |;C0455539;NA;NA;history of cardiovascular disease no
1494;history of cardiovascular disease — no . ( % );C0455539;NA;NA;history of cardiovascular disease no
1494;history of cardiovascular disease;C0455539;NA;NA;history of cardiovascular disease
1494;family history of premature coronary heart disease;"C0151526;C0205252;C0260520;C1313980;C2317524;C4018905";NA;NA;family history of premature coronary heart disease
1494;family history of coronary artery disease;C2317524;NA;NA;family history of coronary artery disease
1493;no history of migraine;C0455512;NA;NA;no history of migraine
1493;no history of cancer;C0455471;NA;NA;no history of cancer
1493;no family history of chd ( n = $nmbr$  $nmbr$ );"C0241889;C0280604;C3542407";NA;NA;no family history of chd n $nmbr$ $nmbr$
1493;history of pvd  no . ( % );C4534349;NA;NA;history of pvd no
1493;history of pvd  n ( % );C4534349;NA;NA;history of pvd n
1493;history of pvd;C4534349;NA;NA;history of pvd
1493;history of cancer;C0455471;NA;NA;history of cancer
1493;family history of vte;"C0241889;C0630906";NA;NA;family history of vte
1493;family history of venous thromboembolism ( % );"C0015576;C0042449;C0241889;C0348013;C0455533;C1704727;C1997614";NA;NA;family history of venous thromboembolism
1493;family history of premature chdj;"C0151526;C0205252;C0241889;C4018905";NA;NA;family history of premature chdj
1493;family history of premature chd * *;"C0151526;C0205252;C0241889;C0280604;C3542407;C4018905";NA;NA;family history of premature chd
1494;no history of heart failure at baseline;"C0168634;C0455531;C1442488";FALSE;  12;no history of heart failure at baseline
1494;pinteraction for treatment and history of heart failure;"C0039798;C0087111;C0455531;C1522326;C1533734;C1705169;C3538994;C3887704";FALSE;  12;pinteraction for treatment and history of heart failure
1495;hypertrophy per ecg ( n = $nmbr$ $nmbr$ );"C0020564;C1623258";FALSE;1496;hypertrophy per ecg n $nmbr$ $nmbr$
1493;family history of chd ( n = $nmbr$  $nmbr$ );"C0241889;C0280604;C3542407";NA;NA;family history of chd n $nmbr$ $nmbr$
1493;family history of cancerf;C0241889;NA;NA;family history of cancerf
1493;family history of cancera;C0241889;NA;NA;family history of cancera
1493;family history ^;C0241889;NA;NA;family history
1493;family history  n ( % );C0241889;NA;NA;family history n
1492;patient ' s history of :;"C0679831;C1369882";NA;NA;patient s history of
1492;paternal history  n ( % );C0424909;NA;NA;paternal history n
1492;medical history  n ( % of patients );"C0679831;C1369882;C1609576";NA;NA;medical history n of patients
1492;maternal history  n ( % );C0559473;NA;NA;maternal history n
1492;history of intermittent claudication and abi < $nmbr$ - $nmbr$ or substantial peripheral arterial stenosis > $nmbr$ %;"C0205267;C1328319;C2315493;C3888326;C4025272";NA;NA;history of intermittent claudication and abi $nmbr$ $nmbr$ or substantial peripheral arterial stenosis $nmbr$
1492;history of claudication;C2315493;NA;NA;history of claudication
1492;history of cardiac arrhythmia;C3494593;NA;NA;history of cardiac arrhythmia
1491;positive family history of type $nmbr$ diabetes ( % );"C0332307;C0439178;C1313937;C1446409;C1514241;C1547052;C2825490;C3812269";NA;NA;positive family history of type $nmbr$ diabetes
1491;ol / l );NA;NA;NA;ol l
1491;history of diabetes mellitus ( n = $nmbr$ );C0455488;NA;NA;history of diabetes mellitus n $nmbr$
1491;history of diabetes mellitus  no . ( % );C0455488;NA;NA;history of diabetes mellitus no
1491;history of diabetes mellitus  n ( % );C0455488;NA;NA;history of diabetes mellitus n
1491;history of diabetes mellitus;C0455488;NA;NA;history of diabetes mellitus
1491;family history ol diabetes ?;C1313937;NA;NA;family history ol diabetes
1491;family history of diabetes — no . ( % );C1313937;NA;NA;family history of diabetes no
1491;family history of diabetes mellitus — no . { % );"C0260526;C1313937";NA;NA;family history of diabetes mellitus no
1491;family history of diabetes mellitus — no . ( % );"C0260526;C1313937";NA;NA;family history of diabetes mellitus no
1491;family history of diabetes ( - );C1313937;NA;NA;family history of diabetes
1491;family history of diabetes ( + );C1313937;NA;NA;family history of diabetes
1491;family history of diabetes ( % ) *;C1313937;NA;NA;family history of diabetes
1490;medical and lifestyle history;"C0019664;C0019665;C0023676;C0199168;C0205476;C0262512;C0262926;C1705255;C2004062";NA;NA;medical and lifestyle history
1490;lifestyle modifications;"C0870811;C2960841";NA;NA;lifestyle modifications
1490;lifestyle behaviours;"C0004927;C0023676;C0677505";NA;NA;lifestyle behaviours
1490;lifestyle behaviors;"C0004927;C0023676;C0677505";NA;NA;lifestyle behaviors
1490;lifestyle;C0023676;NA;NA;lifestyle
1489;very elderly patients ( n - $nmbr$ );"C0442824;C0870602;C2984081";NA;NA;very elderly patients n $nmbr$
1489;non ‐ elderly;"C0001792;C1518422;C1999167";NA;NA;non elderly
1489;non - elderly ( < $nmbr$ years );"C0001792;C0439234;C1518422;C1999167";NA;NA;non elderly $nmbr$ years
1489;elderly patients ( n — $nmbr$ );C0870602;NA;NA;elderly patients n $nmbr$
1489;elderly;"C0001792;C1999167";NA;NA;elderly
1488;daily iglar dose at week $nmbr$ ( u );"C0560588;C2348070";NA;NA;daily iglar dose at week $nmbr$ u
1488;daily dose of study medication prescribed;"C0013175;C0278329;C2348070";NA;NA;daily dose of study medication prescribed
1488;daily;C0332173;NA;NA;daily
1488;baseline insulin daily dose / kg;"C0021641;C0022718;C0168634;C0332173;C0366513;C0439209;C1442488;C1533581;C1579433;C2348070;C3714501;C4054209";NA;NA;baseline insulin daily dose kg
1488;average daily dose;"C1510992;C2348070;C2825518";NA;NA;average daily dose
1487;patients with early cd ( n = $nmbr$ );"C0007928;C0030705;C0034283;C1279919;C4552032";NA;NA;patients with early cd n $nmbr$
1487;overall early - morning copd symptom severity scorec;"C0024117;C0282416;C0332170;C1279919;C1319166;C1412502;C1561607;C3714496";NA;NA;overall early morning copd symptom severity scorec
1487;non - early crohn ' s disease;"C0010346;C1279919;C1518422";NA;NA;non early crohn s disease
1487;early use intended;"C0042153;C0457083;C1279919;C1283828;C1551357;C1947944";NA;NA;early use intended
1487;early routine;"C0205547;C1279919";NA;NA;early routine
1487;early eptifibatide;"C0253563;C1279919";NA;NA;early eptifibatide
1487;early crohn ' s disease *;"C0010346;C1279919";NA;NA;early crohn s disease
1487;early clopidogrel intended;"C0070166;C1279919;C1283828;C1551357";NA;NA;early clopidogrel intended
1487;early - start group ( n = $nmbr$ );"C0439659;C0441848;C1279919";NA;NA;early start group n $nmbr$
1487;early - eptifibatide group ( n = $nmbr$ );"C0253563;C0441848;C1279919";NA;NA;early eptifibatide group n $nmbr$
1487;early ( n = $nmbr$ );C1279919;NA;NA;early n $nmbr$
1487;early  n ( % );C1279919;NA;NA;early n
1487;early;C1279919;NA;NA;early
1487;$nmbr$ mg / day early - start;"C0439422;C0439659;C1279919";NA;NA;$nmbr$ mg day early start
1486;hgb  g / dl < $nmbr$ men  < $nmbr$ women;"C0019029;C0019046;C0025266;C0043210;C0439267;C0518015;C1424337";NA;NA;hgb g dl $nmbr$ men $nmbr$ women
1486;hgb  g / dl;"C0019029;C0019046;C0439267;C0518015;C1424337";NA;NA;hgb g dl
1486;hemoglobin 一 g / dl;"C0019046;C0439267;C1319312;C3642216";NA;NA;hemoglobin g dl
1486;hemoglobin — g / dl;"C0019046;C0439267;C1319312;C3642216";NA;NA;hemoglobin g dl
1486;hemoglobin ( g / dl );"C0019046;C0439267;C1319312;C3642216";NA;NA;hemoglobin g dl
1486;hemoglobin  g / dl;"C0019046;C0439267;C1319312;C3642216";NA;NA;hemoglobin g dl
1486;hb decrease ≥ $nmbr$ g / dl;"C0019046;C0392756;C0439267;C0547047;C3642216;C3843510";NA;NA;hb decrease $nmbr$ g dl
1486;hb  g / dl;"C0019046;C0439267;C3642216;C3843510";NA;NA;hb g dl
1486;haemoglobin ( g / dl );"C0019046;C0439267;C1319312;C3642216";NA;NA;haemoglobin g dl
1486;glu $nmbr$ asp g . t;"C0125690;C0439267";NA;NA;glu $nmbr$ asp g t
1486;g - blockers;C0439267;NA;NA;g blockers
1486;g + c;C0439267;NA;NA;g c
1486;creatinine clearance by c - g ( ml / min );"C0151280;C0439267";NA;NA;creatinine clearance by c g ml min
1486;baseline trig > $nmbr$ millycerides g / dl;"C0168634;C0202236;C0439267;C1442488;C1519533";NA;NA;baseline trig $nmbr$ millycerides g dl
1486;baseline hemoglobin  median ( iqr  g / dl );"C0019046;C0168634;C0439267;C0549183;C0876920;C1319312;C1442488;C2347635;C2348144;C2939193;C3642216";NA;NA;baseline hemoglobin median iqr g dl
1486;$nmbr$ μ g ( n = $nmbr$ );C0439267;NA;NA;$nmbr$ g n $nmbr$
1486;$nmbr$ a . g;C0439267;NA;NA;$nmbr$ a g
1485;very g ood / ex cellent;"C0439267;C0442824;C2984081;C4267693";NA;NA;very g ood ex cellent
1485;g;C0439267;NA;NA;g
1485;aclidinium $nmbr$   μ g bid ( n   =   $nmbr$ );"C0439267;C2699757";NA;NA;aclidinium $nmbr$ g bid n $nmbr$
1485;aclidinium $nmbr$   μ g ( n   =   $nmbr$ ) b;"C0439267;C2699757";NA;NA;aclidinium $nmbr$ g n $nmbr$ b
1485;aclidinium $nmbr$   μ g ( n   =   $nmbr$ ) a;"C0439267;C2699757";NA;NA;aclidinium $nmbr$ g n $nmbr$ a
1485;aclidinium $nmbr$   μ g ( n   =   $nmbr$ );"C0439267;C2699757";NA;NA;aclidinium $nmbr$ g n $nmbr$
1484;sedentary;C0205254;NA;NA;sedentary
1484;secondary pci;"C0027627;C0175668;C0205436;C4049621";NA;NA;secondary pci
1484;secondary p;"C0027627;C0175668;C0205436";NA;NA;secondary p
1484;secondary outcomes;"C0027627;C0175668;C0205436;C1274040";NA;NA;secondary outcomes
1484;secondary outcome;"C0027627;C0175668;C0205436;C1274040";NA;NA;secondary outcome
1469;> $nmbr$ . $nmbr$ mm hg;C0439475;FALSE;1888;$nmbr$ $nmbr$ mm hg
1484;secondary nonresponse;"C0027627;C0175668;C0205436";NA;NA;secondary nonresponse
1484;secondary kidney composite outcome;"C0022646;C0027627;C0175668;C0205199;C0205436;C0227665;C1274040;C1547335";NA;NA;secondary kidney composite outcome
1484;secondary ip;"C0027627;C0175668;C0205436;C1308226;C4049997";NA;NA;secondary ip
1484;secondary iii *;"C0027627;C0175668;C0205436;C0439070;C1705160";NA;NA;secondary iii
1484;secondary end points iii;"C0027627;C0175668;C0205436;C0439070;C1705160;C2349179";NA;NA;secondary end points iii
1484;secondary end points ii;"C0027627;C0175668;C0205436;C1710602;C2349179;C4082587";NA;NA;secondary end points ii
1484;secondary end points $nmbr$;"C0027627;C0175668;C0205436;C2349179";NA;NA;secondary end points $nmbr$
1484;secondary end points;"C0027627;C0175668;C0205436;C2349179";NA;NA;secondary end points
1484;secondary dvt . ' fe;"C0027627;C0149871;C0175668;C0205436;C2926618;C3848561;C3899446";NA;NA;secondary dvt fe
1484;secondary *;"C0027627;C0175668;C0205436";NA;NA;secondary
1484;secondary ( change in total updrs score from baseline to final visit in phase $nmbr$ );"C0027627;C0168634;C0175668;C0205088;C0205436;C0392747;C0439175;C0439810;C0443172;C0449820;C0545082;C1442488;C1512346;C1705241;C2826704;C3639721;C4050231;C4319952";NA;NA;secondary change in total updrs score from baseline to final visit in phase $nmbr$
1484;secondary ' outcomes;"C0027627;C0175668;C0205436;C1274040";NA;NA;secondary outcomes
1484;secondary # $nmbr$;"C0027627;C0175668;C0205436";NA;NA;secondary $nmbr$
1484;key secondary end points;"C0027627;C0175668;C0205436;C2349179";NA;NA;key secondary end points
1483;selected key secondary efficacy endpoints;"C1280519;C1707391;C1707887;C4528314";NA;NA;selected key secondary efficacy endpoints
1483;secondary endpoints :;C4528314;NA;NA;secondary endpoints
1482;standard therapyy ( n = $nmbr$ );"C1442989;C2828392";NA;NA;standard therapyy n $nmbr$
1482;standard control ( n = $nmbr$ ) no . of patients ( percent );"C0030705;C0243148;C0439165;C1442989;C1550141;C1882979;C2587213;C2828392;C3274648;C4553389";NA;NA;standard control n $nmbr$ no of patients percent
1482;standard control;"C0243148;C1442989;C1550141;C1882979;C2587213;C2828392;C3274648;C4553389";NA;NA;standard control
1482;standard care n ( % );"C1442989;C1947933;C2828392";NA;NA;standard care n
1482;standard care allocation;"C1442989;C1706778;C1947933;C2828392";NA;NA;standard care allocation
1482;standard care ( n = $nmbr$ );"C1442989;C1947933;C2828392";NA;NA;standard care n $nmbr$
1482;standard care;"C1442989;C1947933;C2828392";NA;NA;standard care
1482;standard bp lowering  < $nmbr$ mm hg ( n = $nmbr$ );"C0037623;C0439475;C0441994;C1415692;C1442989;C1708288;C2003888;C2828392;C4318478";NA;NA;standard bp lowering $nmbr$ mm hg n $nmbr$
   7;p value c;C1709380;NA;NA;p value c
1482;standard allocation;"C1442989;C1706778;C2828392";NA;NA;standard allocation
1482;standard ( n = $nmbr$ );"C1442989;C2828392";NA;NA;standard n $nmbr$
1482;standard ( $nmbr$ );"C1442989;C2828392";NA;NA;standard $nmbr$
1482;standard;"C1442989;C2828392";NA;NA;standard
1482;size ( cm $nmbr$ ) ( mean ± standard deviation );"C0444504;C0456389;C0871420;C1442989;C1828170;C2347634;C2348143;C2828392";NA;NA;size cm $nmbr$ mean standard deviation
1482;sd  standard;"C1442989;C2699239;C2828392";NA;NA;sd standard
1482;number standard care;"C0237753;C0449788;C1442989;C1947933;C2828392";NA;NA;number standard care
1482;data are reported as percentage or mean ± standard deviation  unless otherwise indicated . ng  normoglycemia  igm  impaired glucose metabolism  ldl  low - density lipoprotein  hdl  high - density lipoprotein  fpg  fasting plasma glucose . a median ( interquartile range ) . * p < $nmbr$ . $nmbr$ vs . ng . † p < $nmbr$ . $nmbr$ vs . ng .;"C0015663;C0017725;C0017887;C0023820;C0023821;C0028074;C0178587;C0202042;C0205251;C0221099;C0439165;C0444504;C0455280;C0549183;C0580545;C0596620;C0684224;C0700287;C0871420;C0876920;C1154908;C1442989;C1444656;C1511726;C1549488;C1550472;C1561533;C1706005;C1711350;C1828170;C2347634;C2347635;C2348143;C2348144;C2828392;C2939193;C3245479;C3714741;C3890211;C4048187;C4319718;C4321351;C4522223";NA;NA;data are reported as percentage or mean standard deviation unless otherwise indicated ng normoglycemia igm impaired glucose metabolism ldl low density lipoprotein hdl high density lipoprotein fpg fasting plasma glucose a median interquartile range p $nmbr$ $nmbr$ vs ng p $nmbr$ $nmbr$ vs ng
1482;a mini - mental state examination  insulin glargine vs standard care;"C0451306;C0907402;C1442989;C1947933;C2828392";NA;NA;a mini mental state examination insulin glargine vs standard care
1482;$nmbr$ standard ( n = $nmbr$ );"C1442989;C2828392";NA;NA;$nmbr$ standard n $nmbr$
1481;urgent cor revasc;"C0018787;C0056331;C0378365;C0439609;C3272275";NA;NA;urgent cor revasc
1481;treated vessel - native coronary;"C0005847;C0018787;C0302891;C1522326";NA;NA;treated vessel native coronary
1481;symptomatic heart fail;"C0018787;C0231175;C0231220";NA;NA;symptomatic heart fail
1481;prior cardiac surgery  n ( % );"C0018787;C0018821;C0332152;C0455610;C0524727;C1522601;C2826257";NA;NA;prior cardiac surgery n
1481;pre - operative cardiac medications *;"C0018787;C1522601;C1882154;C2347660";NA;NA;pre operative cardiac medications
1481;native coronary;"C0018787;C0302891";NA;NA;native coronary
1481;major coronary;"C0018787;C0205082;C0205164;C4318856;C4521762";NA;NA;major coronary
1481;hospitaiization for heart faiiure;C0018787;NA;NA;hospitaiization for heart faiiure
1481;family history of premature heart disease;"C0018787;C0151526;C0205252;C0850707;C4018905";NA;NA;family history of premature heart disease
1481;family history of coronary disease;"C0018787;C0850707";NA;NA;family history of coronary disease
1481;documented asymptomatic cardiac ischemiac;"C0018787;C0231221;C1301725;C1522601;C1609436";NA;NA;documented asymptomatic cardiac ischemiac
1481;coronary;C0018787;NA;NA;coronary
1481;cor revasc;"C0018787;C0056331;C0378365";NA;NA;cor revasc
1481;cardiac stretch;"C0018787;C0600080;C1522601";NA;NA;cardiac stretch
1481;cardiac parameters;"C0018787;C0449381;C1522601";NA;NA;cardiac parameters
1481;cardiac mediations;"C0018787;C0680727;C1522601";NA;NA;cardiac mediations
1481;cardiac enzyates raised;"C0018787;C0442818;C1522601";NA;NA;cardiac enzyates raised
1481;cardiac diseasec;"C0018787;C1522601";NA;NA;cardiac diseasec
1481;cardiac and echocardiography parameters;"C0013516;C0018787;C0449381;C1522601";NA;NA;cardiac and echocardiography parameters
1481;cardiac;"C0018787;C1522601";NA;NA;cardiac
 -10;very good or excellent;"C1548784;C1961136;C3641222";NA;NA;very good or excellent
 -10;large / very large;"C0442824;C0549177;C2984081";NA;NA;large very large
1478;very high vs . normalb;"C0442804;C4321397";NA;NA;very high vs normalb
1478;very high ( >   $nmbr$ xuln ) n   =   $nmbr$;"C0442804;C4321397";NA;NA;very high $nmbr$ xuln n $nmbr$
1478;very high;"C0442804;C4321397";NA;NA;very high
1478;coronary heart disease  n ( % ) cardiovascular risk ( per protocol )  n ( % ) very high;"C0007226;C0442711;C0442804;C1277690;C1507394;C1522729;C1698058;C2348563;C2599718;C3715209;C3887460;C4282383;C4321397";NA;NA;coronary heart disease n cardiovascular risk per protocol n very high
1477;nonobese ( < $nmbr$ kg / nr );"C0022718;C0027496;C0439209;C3844738;C4054209";NA;NA;nonobese $nmbr$ kg nr
1477;> $nmbr$ ky / nr;"C0027496;C3844738";NA;NA;$nmbr$ ky nr
1477;< $nmbr$ ky / nr;"C0027496;C3844738";NA;NA;$nmbr$ ky nr
1476;time since diagnosis — mo;"C0011900;C0026544;C0040223;C0332177;C1704338;C1704656;C3541383";NA;NA;time since diagnosis mo
1476;smoking ( during the previous month );"C0332177;C0439231;C2114448";NA;NA;smoking during the previous month
1476;placebo monthly ( n = $nmbr$ );"C0032042;C0332177;C1696465;C1706408";NA;NA;placebo monthly n $nmbr$
1476;pci > $nmbr$ month ago;"C0332177;C0439231;C4049621";NA;NA;pci $nmbr$ month ago
1476;one or more requiring hospitalization in $nmbr$ mo before screening — no . ( % ) $nmbr$;"C0019993;C0026544;C0205172;C0205447;C0220908;C0220909;C0332177;C1698960;C1710031;C1710032;C1710477;C2348164";NA;NA;one or more requiring hospitalization in $nmbr$ mo before screening no $nmbr$
1476;no . in the $nmbr$ mo before screening;"C0026544;C0220908;C0220909;C0332177;C1698960;C1710031;C1710032;C1710477;C2348164";NA;NA;no in the $nmbr$ mo before screening
1476;monthly;C0332177;NA;NA;monthly
1476;month $nmbr$;"C0332177;C0439231";NA;NA;month $nmbr$
1476;median duration of chf — mo;"C0018802;C0026544;C0332177;C0449238;C0549183;C0876920;C2347635;C2348144;C2926735;C2939193";NA;NA;median duration of chf mo
1476;lvef within $nmbr$ mo  %;"C0026544;C0332177;C0428772;C0488728";NA;NA;lvef within $nmbr$ mo
1476;left ventricular ejection fraction within previous $nmbr$ mo — no . / total no . ( % ) $nmbr$;"C0026544;C0205156;C0332177;C0428772;C0439175;C0439810;C0488728;C1552607";NA;NA;left ventricular ejection fraction within previous $nmbr$ mo no total no $nmbr$
1476;left ventricular ejection fraction within previous $nmbr$ mo |;"C0026544;C0205156;C0332177;C0428772;C0488728;C1552607";NA;NA;left ventricular ejection fraction within previous $nmbr$ mo
1476;hba $nmbr$ c month $nmbr$ ( % );"C0019016;C0332177;C0439231;C1825777;C3538758";NA;NA;hba $nmbr$ c month $nmbr$
1476;fall in last $nmbr$ mo;"C0026544;C0085639;C0238715;C0332177;C4553726";NA;NA;fall in last $nmbr$ mo
1476;exacerbations in previous $nmbr$ mo ( n )  mean ( sd );"C0026544;C0205156;C0332177;C0444504;C1552607;C2347634;C2348143;C2699239;C4086268";NA;NA;exacerbations in previous $nmbr$ mo n mean sd
1476;exacerbations in past $nmbr$ mo — no . ( % );"C0026544;C0332177;C1444637;C4086268;C4284302";NA;NA;exacerbations in past $nmbr$ mo no
1476;exacerbation within previous $nmbr$ mo  no . ( % );"C0026544;C0205156;C0332177;C1552607;C4086268";NA;NA;exacerbation within previous $nmbr$ mo no
1476;exacerbation within $nmbr$ mo  %;"C0026544;C0332177;C4086268";NA;NA;exacerbation within $nmbr$ mo
1476;duration of macular edema  mo;"C0024440;C0026544;C0271051;C0332177;C0449238;C2926735";NA;NA;duration of macular edema mo
1476;duration of initial anticoagulation  mean ( sd )  mo;"C0003281;C0026544;C0205265;C0332177;C0444504;C0449238;C1279901;C1555582;C1705685;C2347634;C2348143;C2699239;C2917212;C2919015;C2926735;C3537050";NA;NA;duration of initial anticoagulation mean sd mo
1476;duration of full - dose warfarin therapy before enrollment ( mo );"C0026544;C0332177;C0366686;C0443225;C0444917;C1516879;C1696073;C3888021";NA;NA;duration of full dose warfarin therapy before enrollment mo
1476;duration of disease — mo;"C0026544;C0332177;C0872146";NA;NA;duration of disease mo
1476;change in hba $nmbr$ c $nmbr$ to month $nmbr$ ( % );"C0019016;C0332177;C0392747;C0439231;C0443172;C1705241;C1825777;C3538758;C4319952";NA;NA;change in hba $nmbr$ c $nmbr$ to month $nmbr$
1305;icsa;NA;NA;NA;icsa
1476;ccsc at $nmbr$ month before enrollment;"C0332177;C0439231;C1516705;C1516879;C1696073;C3888021";NA;NA;ccsc at $nmbr$ month before enrollment
1476;atenolol use at $nmbr$ month;"C0004147;C0042153;C0332177;C0439231;C0457083;C1947944";NA;NA;atenolol use at $nmbr$ month
1476;at least $nmbr$ / mo;"C0026544;C0332177";NA;NA;at least $nmbr$ mo
1476;> $nmbr$ month n = $nmbr$;"C0332177;C0439231";NA;NA;$nmbr$ month n $nmbr$
1476;> $nmbr$ mo;"C0026544;C0332177";NA;NA;$nmbr$ mo
1476;< $nmbr$ month n = $nmbr$;"C0332177;C0439231";NA;NA;$nmbr$ month n $nmbr$
1476;< $nmbr$ mo  n ( % );"C0026544;C0332177";NA;NA;$nmbr$ mo n
1476;< $nmbr$ mo;"C0026544;C0332177";NA;NA;$nmbr$ mo
1476;$nmbr$ to < $nmbr$ mo;"C0026544;C0332177";NA;NA;$nmbr$ to $nmbr$ mo
1476;$nmbr$ or $nmbr$ d / mo;"C0026544;C0073187;C0332173;C0332177;C4484261";NA;NA;$nmbr$ or $nmbr$ d mo
1476;$nmbr$ month l;"C0332177;C0439231";NA;NA;$nmbr$ month l
1476;$nmbr$ mo - $nmbr$ y;"C0026544;C0332177";NA;NA;$nmbr$ mo $nmbr$ y
1476;$nmbr$ mo  mean ( sd ) x;"C0026544;C0332177;C0444504;C2347634;C2348143;C2699239";NA;NA;$nmbr$ mo mean sd x
1476;$nmbr$ mo;"C0026544;C0332177";NA;NA;$nmbr$ mo
1476;$nmbr$ - month follow - up median ( iq range );"C0332177;C0439231;C0549183;C0589120;C0876920;C1514721;C1522577;C1704685;C2347635;C2348144;C2348147;C2939193;C3274571;C3542016";NA;NA;$nmbr$ month follow up median iq range
1476;$nmbr$ - < $nmbr$ mo  n ( % );"C0026544;C0332177";NA;NA;$nmbr$ $nmbr$ mo n
1476;$nmbr$ - $nmbr$ mo;"C0026544;C0332177";NA;NA;$nmbr$ $nmbr$ mo
1476;$nmbr$ - $nmbr$ / month;"C0332177;C0439231";NA;NA;$nmbr$ $nmbr$ month
1475;£ $nmbr$ ml / minute;"C0439232;C0439526;C0700321;C0702093;C1282918;C1705224;C2347166;C3887665";NA;NA;$nmbr$ ml minute
1475;£ $nmbr$ min;"C0702093;C1524029;C3813700";NA;NA;$nmbr$ min
1475;£ $nmbr$ . $nmbr$ min;"C0702093;C1524029;C3813700";NA;NA;$nmbr$ $nmbr$ min
1475;time to treatment initiation ( min );"C0589507;C0702093;C1158830;C1524029;C1704686;C3494202;C3813700";NA;NA;time to treatment initiation min
1475;time to treatment initiation ( min;"C0589507;C0702093;C1158830;C1524029;C1704686;C3494202;C3813700";NA;NA;time to treatment initiation min
1475;time to treatment ( min ) t;"C0702093;C1524029;C3494202;C3813700";NA;NA;time to treatment min t
1475;time to balloon / needle  min *;"C0027551;C0040223;C0336867;C0441144;C0702093;C1524029;C1882041;C3541383;C3813700";NA;NA;time to balloon needle min
1475;time to admission  min;"C0702093;C1524029;C3813700;C3854258;C3854259";NA;NA;time to admission min
1475;time from sx onset to baseline ecg  min;"C0168634;C0449244;C0702093;C1442488;C1519428;C1524029;C1623258;C3539997;C3813700;C3815196";NA;NA;time from sx onset to baseline ecg min
1475;symptoms onset to first balloon inflation  min;"C0021398;C0205435;C0336867;C0441144;C0702093;C1279901;C1318493;C1524029;C3813700;C4086878";NA;NA;symptoms onset to first balloon inflation min
1475;stiffness ( min );"C0427008;C0702093;C1524029;C3813700";NA;NA;stiffness min
1475;range : min  max;"C0702093;C1514721;C1524029;C2348147;C3542016;C3813700";NA;NA;range min max
1475;range ( min  max );"C0702093;C1514721;C1524029;C2348147;C3542016;C3813700";NA;NA;range min max
1475;range  ( min  max );"C0702093;C1514721;C1524029;C2348147;C3542016;C3813700";NA;NA;range min max
1475;randomization to first balloon inflation  min;"C0021398;C0034656;C0205435;C0336867;C0441144;C0702093;C1279901;C1318493;C1524029;C3813700";NA;NA;randomization to first balloon inflation min
1475;qrs > $nmbr$ msec $nmbr$ - min walk test;"C0439223;C0702093;C1524029;C3813700;C4277740";NA;NA;qrs $nmbr$ msec $nmbr$ min walk test
1475;pra  median ( min  max )  ng / ml / h;"C0033727;C0369286;C0441932;C0549183;C0564385;C0633231;C0702093;C0876920;C1141951;C1419788;C1524029;C1533072;C2347635;C2348144;C2827900;C2939193;C3274822;C3669212;C3813700;C4050009;C4283900;C4528284";NA;NA;pra median min max ng ml h
1475;pifr l / min;"C0702093;C1524029;C3813700";NA;NA;pifr l min
1475;pefpm   ( l / min ) ∗;"C0702093;C1524029;C3813700";NA;NA;pefpm l min
1475;pefam   ( l / min ) ∗;"C0702093;C1524029;C3813700";NA;NA;pefam l min
1475;pef at baseline  l_ / min;"C0030771;C0168634;C0702093;C1442488;C1518922;C1524029;C1542834;C3813700";NA;NA;pef at baseline l_ min
1475;pasi [ c ]  median ( min - max );"C0549183;C0702093;C0876920;C1524029;C2347635;C2348144;C2939193;C3813700;C4528685";NA;NA;pasi c median min max
1475;on - pump time : < l : $nmbr$ hrs : min ( n = $nmbr$ );"C0040223;C0702093;C1524029;C1568891;C3541383;C3813700;C3842462";NA;NA;on pump time l $nmbr$ hrs min n $nmbr$
1475;normal ( £ $nmbr$ ml / minute );"C0205307;C0231683;C0439166;C0439232;C0439526;C0700321;C0702093;C1282918;C1705224;C2347086;C2347166;C3887665;C4553972";NA;NA;normal $nmbr$ ml minute
1475;mtss  median ( min  max );"C0549183;C0702093;C0876920;C1524029;C2347635;C2348144;C2939193;C3813700";NA;NA;mtss median min max
1475;morning stiffness duration  min;"C0449238;C0457086;C0702093;C1524029;C2926735;C3813700";NA;NA;morning stiffness duration min
1475;min – max;"C0702093;C1524029;C3813700";NA;NA;min max
1475;min per $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0441923;C0702093;C1524029;C3813700";NA;NA;min per $nmbr$ $nmbr$ m $nmbr$
1475;min - ’;"C0702093;C1524029;C3813700";NA;NA;min
1475;min - max;"C0702093;C1524029;C3813700";NA;NA;min max
1475;min  max;"C0702093;C1524029;C3813700";NA;NA;min max
1475;median ( min  max );"C0549183;C0702093;C0876920;C1524029;C2347635;C2348144;C2939193;C3813700";NA;NA;median min max
1476;heart failure $nmbr$ mo before admission;"C0018801;C0018802;C0026544;C0184666;C0332177;C0809949;C4554158";FALSE;  12;heart failure $nmbr$ mo before admission
1469;> $nmbr$ - < $nmbr$ mmhg;C0439475;FALSE;1888;$nmbr$ $nmbr$ mmhg
1475;mean score ( min  max range );"C0702093;C1514721;C1524029;C2348147;C3533236;C3542016;C3813700";NA;NA;mean score min max range
1475;mean duration of surgery ± sd  min;"C0038894;C0038895;C0444504;C0449238;C0543467;C0702093;C1274039;C1524029;C2347634;C2348143;C2699239;C2926735;C3813700";NA;NA;mean duration of surgery sd min
1475;jsn  median ( min  max );"C0549183;C0702093;C0876920;C1524029;C2347635;C2348144;C2939193;C3813700";NA;NA;jsn median min max
1475;iduration of symptoms > $nmbr$ min;"C0683368;C0702093;C1457887;C1524029;C3813700";NA;NA;iduration of symptoms $nmbr$ min
1475;esr ( mm / h )  median ( min - max );"C0033727;C0369286;C0441932;C0456680;C0549183;C0564385;C0702093;C0876920;C1524029;C2347635;C2348144;C2939193;C3642211;C3811131;C3813700;C4528284";NA;NA;esr mm h median min max
1475;esr ( mm / h )  median ( min  max );"C0033727;C0369286;C0441932;C0456680;C0549183;C0564385;C0702093;C0876920;C1524029;C2347635;C2348144;C2939193;C3642211;C3811131;C3813700;C4528284";NA;NA;esr mm h median min max
1475;erosion score  median ( min  max );"C0333307;C0449820;C0549183;C0702093;C0876920;C1524029;C1880549;C1959609;C2347635;C2348144;C2939193;C3813700;C3887524;C4050231";NA;NA;erosion score median min max
1475;egfr  ml / minute / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439232;C0439526;C0441923;C0700321;C0702093;C1282918;C1705224;C1739039;C2347166;C3811844;C3812682;C3887665";NA;NA;egfr ml minute $nmbr$ $nmbr$ m $nmbr$
1475;duration of symptoms > $nmbr$ min;"C0436359;C0702093;C1524029;C3813700";NA;NA;duration of symptoms $nmbr$ min
1475;crp ( mg / l )  median ( min  max );"C0439268;C0549183;C0702093;C0876920;C1524029;C2347635;C2348144;C2939193;C3813700;C3890735;C4048285";NA;NA;crp mg l median min max
1475;cross - damp time : < l : llhrs : min ( n = $nmbr$ );"C0040223;C0205381;C0702093;C1524029;C2828360;C3541383;C3813700;C3891560";NA;NA;cross damp time l llhrs min n $nmbr$
1475;baseline pos frequency per $nmbr$ days  median ( min  max );"C0168634;C0549183;C0585290;C0702093;C0876920;C1262869;C1442488;C1524029;C2347635;C2348144;C2939193;C3496112;C3496399;C3813700";NA;NA;baseline pos frequency per $nmbr$ days median min max
1475;baseline in - check * ’ pifr ( l / min );"C0168634;C0702093;C1283174;C1442488;C1524029;C1555524;C3813700;C4321547";NA;NA;baseline in check pifr l min
1475;[ min  max ];"C0702093;C1524029;C3813700";NA;NA;min max
1469;blood pressure  mmhg  mean ( sd );"C0428886;C0439475;C2699239";NA;NA;blood pressure mmhg mean sd
1475;> $nmbr$ to < $nmbr$ ml / min / l $nmbr$ nr;"C0027496;C0702093;C1524029;C1635169;C3813700;C3844738";NA;NA;$nmbr$ to $nmbr$ ml min l $nmbr$ nr
1475;> $nmbr$ months  median ( min  max );"C0439231;C0549183;C0702093;C0876920;C1524029;C2347635;C2348144;C2939193;C3813700";NA;NA;$nmbr$ months median min max
1475;> $nmbr$ min;"C0702093;C1524029;C3813700";NA;NA;$nmbr$ min
1475;> $nmbr$ mi / min;"C0702093;C1524029;C3810814;C3813700";NA;NA;$nmbr$ mi min
1475;> $nmbr$ beats / min;"C0702093;C1524029;C3813700";NA;NA;$nmbr$ beats min
1475;> $nmbr$ : $nmbr$ hrs : min ( n = $nmbr$ );"C0702093;C1524029;C1568891;C3813700";NA;NA;$nmbr$ $nmbr$ hrs min n $nmbr$
1475;> $nmbr$ . $nmbr$ min;"C0702093;C1524029;C3813700";NA;NA;$nmbr$ $nmbr$ min
1475;< $nmbr$ months  median ( min  max );"C0439231;C0549183;C0702093;C0876920;C1524029;C2347635;C2348144;C2939193;C3813700";NA;NA;$nmbr$ months median min max
1475;< $nmbr$ ml / minute );"C0439232;C0439526;C0700321;C0702093;C1282918;C1705224;C2347166;C3887665";NA;NA;$nmbr$ ml minute
1475;< $nmbr$ ml / minute;"C0439232;C0439526;C0700321;C0702093;C1282918;C1705224;C2347166;C3887665";NA;NA;$nmbr$ ml minute
1475;< $nmbr$ min;"C0702093;C1524029;C3813700";NA;NA;$nmbr$ min
1475;< $nmbr$ mi / min;"C0702093;C1524029;C3810814;C3813700";NA;NA;$nmbr$ mi min
1475;< $nmbr$ beats / min;"C0702093;C1524029;C3813700";NA;NA;$nmbr$ beats min
1475;< $nmbr$ . $nmbr$ min;"C0702093;C1524029;C3813700";NA;NA;$nmbr$ $nmbr$ min
1475;( min ) *;"C0702093;C1524029;C3813700";NA;NA;min
1475;( < $nmbr$ ml / minute ) *;"C0439232;C0439526;C0700321;C0702093;C1282918;C1705224;C2347166;C3887665";NA;NA;$nmbr$ ml minute
1475;$nmbr$ to < $nmbr$ ml / minute;"C0439232;C0439526;C0700321;C0702093;C1282918;C1705224;C2347166;C3887665";NA;NA;$nmbr$ to $nmbr$ ml minute
1475;$nmbr$ min / time );"C0040223;C0702093;C1524029;C3541383;C3813700";NA;NA;$nmbr$ min time
1475;$nmbr$ min;"C0702093;C1524029;C3813700";NA;NA;$nmbr$ min
1475;$nmbr$ . $nmbr$ min;"C0702093;C1524029;C3813700";NA;NA;$nmbr$ $nmbr$ min
1475;$nmbr$ - min walk distance m;"C0369637;C0429886;C0441923;C0702093;C1524029;C3813700";NA;NA;$nmbr$ min walk distance m
1475;$nmbr$ - min walk distance  ft;"C0429886;C0702093;C1524029;C1881534;C3813700;C3890579";NA;NA;$nmbr$ min walk distance ft
1475;$nmbr$ - lead ecg heart rate  beats / min;"C0018810;C0179504;C0702093;C1524029;C3813700";NA;NA;$nmbr$ lead ecg heart rate beats min
1475;$nmbr$ - $nmbr$ min;"C0702093;C1524029;C3813700";NA;NA;$nmbr$ $nmbr$ min
1474;timi minor bleeding;"C0019080;C0026193;C0205165";NA;NA;timi minor bleeding
1474;timi minor;"C0026193;C0205165";NA;NA;timi minor
1474;timi major or minor bleeding;"C0019080;C0026193;C0205082;C0205164;C0205165;C4318856;C4521762";NA;NA;timi major or minor bleeding
1474;minor bleeding;"C0019080;C0026193;C0205165";NA;NA;minor bleeding
1474;minor bleed;"C0019080;C0026193;C0205165";NA;NA;minor bleed
1474;minor;"C0026193;C0205165";NA;NA;minor
1474;acuity minor;"C0026193;C0205165;C0750509";NA;NA;acuity minor
1474;acuity - bleeding major / minor;"C0019080;C0750509;C4441842";NA;NA;acuity bleeding major minor
1474;> $nmbr$ mon ( n = $nmbr$ );NA;NA;NA;$nmbr$ mon n $nmbr$
1474;< $nmbr$ mon ( n = $nmbr$ );NA;NA;NA;$nmbr$ mon n $nmbr$
1474;$nmbr$ ( mono );"C1551432;C1551969";NA;NA;$nmbr$ mono
1473;updrs iii ( motor );"C0439070;C1513492;C1705160;C1705994;C3639721";NA;NA;updrs iii motor
1473;updrs  part iii ( motor );"C0439070;C0449719;C1513492;C1705160;C1705994;C1709471;C3639721";NA;NA;updrs part iii motor
1473;pure motor hemiparesis;"C0018989;C1513492;C1705994;C2247561";NA;NA;pure motor hemiparesis
1473;motor weakness;"C1513492;C1705994;C3714552";NA;NA;motor weakness
1473;motor updrs subscore ( baseline )  mean ( sd );"C0168634;C0444504;C1442488;C1513492;C1705994;C2347634;C2348143;C2699239;C3639721";NA;NA;motor updrs subscore baseline mean sd
1473;motor;"C1513492;C1705994";NA;NA;motor
1475;heart rate  / min;"C0018810;C0702093;C1524029;C3813700";FALSE;1105;heart rate min
1475;heart rate ( min − $nmbr$ );"C0018810;C0702093;C1524029;C3813700";FALSE;1105;heart rate min $nmbr$
1475;heart rate  min_ $nmbr$ ( mean );"C0018810;C0444504;C0702093;C1524029;C2347634;C2348143;C3813700";FALSE;1105;heart rate min_ $nmbr$ mean
1475;heart rates ( beats / minutes );"C0018810;C0439232;C0700321;C0702093;C1282918;C2347166";FALSE;1105;heart rates beats minutes
1475;heart rate 一 beats / min;"C0018810;C0702093;C1524029;C3813700";FALSE;1105;heart rate beats min
1469;< $nmbr$ mmhg;C0439475;FALSE;1888;$nmbr$ mmhg
1472;timi non - cabg major;"C0010055;C0205082;C0205164;C1518422;C4318856;C4521762";FALSE;2079;timi non cabg major
1472;timi major or;"C0205082;C0205164;C4318856;C4521762";FALSE;2079;timi major or
1472;timi major bleeding;"C0019080;C0205082;C0205164;C4318856;C4521762";FALSE;2079;timi major bleeding
1472;timi major;"C0205082;C0205164;C4318856;C4521762";FALSE;2079;timi major
1472;previous major bleeding;"C0019080;C0205082;C0205156;C0205164;C1552607;C4318856;C4521762";FALSE;2076;previous major bleeding
1472;net clinical benefit : on - treatment vte or major bleeding;"C0019080;C0039798;C0087111;C0205082;C0205164;C0630906;C0814225;C1456447;C1516635;C1522326;C1533734;C1705169;C3538994;C3853572;C3887704;C3887809;C3890893;C4318856;C4521762;C4684590";NA;NA;net clinical benefit on treatment vte or major bleeding
1472;minor / major;"C0026193;C0205082;C0205164;C0205165;C4318856;C4521762";NA;NA;minor major
1472;major secondary end pointf;"C0027627;C0175668;C0205082;C0205164;C0205436;C0444930;C2746065;C4318856;C4521762";NA;NA;major secondary end pointf
1472;major cvd /;"C0007222;C0205082;C0205164;C4318856;C4521762";NA;NA;major cvd
1472;major and crnm bleeds;"C0019080;C0205082;C0205164;C4318856;C4521762";NA;NA;major and crnm bleeds
1472;major amputationsb;"C0205082;C0205164;C4318856;C4521762";NA;NA;major amputationsb
1472;major adverse cardiovascular events;"C0007226;C0205082;C0205164;C0877248;C1705413;C3887460;C4318856;C4521762";NA;NA;major adverse cardiovascular events
1472;major / crnm bleed;"C0019080;C0205082;C0205164;C4318856;C4521762";NA;NA;major crnm bleed
1472;major;"C0205082;C0205164;C4318856;C4521762";NA;NA;major
1472;intracranial disease of major artery 寸;"C0205082;C0205164;C0524466;C0852949;C4318856;C4521762";NA;NA;intracranial disease of major artery
1472;intracranial disease of major artery disease t;"C0012634;C0205082;C0205164;C0752138;C4318856;C4521762";NA;NA;intracranial disease of major artery disease t
1472;hospitalization in previous year with management of heart failure as major component — no . ( % );"C0001554;C0018801;C0018802;C0019993;C0205082;C0205156;C0205164;C0376636;C0439234;C0439508;C0449432;C1273870;C1552607;C1705248;C3273539;C4318856;C4521762;C4554158";NA;NA;hospitalization in previous year with management of heart failure as major component no
1472;history of major cardiovascular disease  n ( % );"C0205082;C0205164;C0455539;C4318856;C4521762";NA;NA;history of major cardiovascular disease n
1472;as major component — no . ( % );"C0205082;C0205164;C0449432;C1705248;C4318856;C4521762";NA;NA;as major component no
1472;amputationsa;NA;NA;NA;amputationsa
1472;acuity major or;"C0205082;C0205164;C0750509;C4318856;C4521762";NA;NA;acuity major or
1472;acuity major;"C0205082;C0205164;C0750509;C4318856;C4521762";NA;NA;acuity major
1472;> $nmbr$ % stenosis of major artery  n ( % );"C0038449;C0205082;C0205164;C4318856;C4521762";NA;NA;$nmbr$ stenosis of major artery n
1471;mssbp ± sd  mmhg;"C0439475;C2699239";NA;NA;mssbp sd mmhg
1471;mssbp > $nmbr$ mmhg;C0439475;NA;NA;mssbp $nmbr$ mmhg
1471;mssbp / msdbp;NA;NA;NA;mssbp msdbp
1471;mssbp  mmhg ( sd );"C0439475;C2699239";NA;NA;mssbp mmhg sd
1471;mssbp;NA;NA;NA;mssbp
1471;msdbp ± sd  mmhg;"C0439475;C2699239";NA;NA;msdbp sd mmhg
1471;msdbp  mmhg ( sd );"C0439475;C2699239";NA;NA;msdbp mmhg sd
1471;msdbp;NA;NA;NA;msdbp
1469;systolic blood pressure  mm hg < $nmbr$;"C0439475;C0488055;C0871470;C1306620";NA;NA;systolic blood pressure mm hg $nmbr$
1304;multivariable;NA;NA;NA;multivariable
1471;changes from baseline in mssbp and msdbp are shown as least - squares mean sem . * p $nmbr$ . $nmbr$ vs $nmbr$ y .;"C0023189;C0168634;C0392747;C0443172;C0444504;C1442488;C1547282;C2347634;C2348143";NA;NA;changes from baseline in mssbp and msdbp are shown as least squares mean sem p $nmbr$ $nmbr$ vs $nmbr$ y
1471;bmi ¼ body mass index  hctz ¼ hydrochlorothiazide  msdbp ¼ mean sitting diastolic blood pressure  mssbp ¼ mean sitting systolic blood pressure  sd ¼ standard deviation;"C0020261;C0277814;C0444504;C0488055;C0871420;C0871470;C1305855;C1306620;C1319894;C2347634;C2348143;C2584297;C2699239;C4050224";NA;NA;bmi body mass index hctz hydrochlorothiazide msdbp mean sitting diastolic blood pressure mssbp mean sitting systolic blood pressure sd standard deviation
1471;baseline mssbp ( mmhg )  mean ± sd;"C0168634;C0439475;C0444504;C1442488;C2347634;C2348143;C2699239";NA;NA;baseline mssbp mmhg mean sd
1471;baseline msdbp ( mmhg )  mean ± sd;"C0168634;C0439475;C0444504;C1442488;C2347634;C2348143;C2699239";NA;NA;baseline msdbp mmhg mean sd
1470;mean blood pressure  mmhg ( s . d . j;"C0428886;C0488053;C2347155";NA;NA;mean blood pressure mmhg s d j
1470;> = $nmbr$ mmhq;NA;NA;NA;$nmbr$ mmhq
1469;visit $nmbr$ sbp  mm hg;"C0085805;C0439475;C0545082;C1512346;C2826704";NA;NA;visit $nmbr$ sbp mm hg
1469;untreated at baseline  mm hg : sbp  mean ( sd );"C0085805;C0168634;C0332155;C0439475;C0444504;C1442488;C2347634;C2348143;C2699239";NA;NA;untreated at baseline mm hg sbp mean sd
1469;untreated at baseline  mean ( sd )  mm hg;"C0168634;C0332155;C0439475;C0444504;C1442488;C2347634;C2348143;C2699239";NA;NA;untreated at baseline mean sd mm hg
1469;treated at baseline  mm hg : sbp  mean ( sd );"C0085805;C0168634;C0439475;C0444504;C1442488;C1522326;C2347634;C2348143;C2699239";NA;NA;treated at baseline mm hg sbp mean sd
1469;systolic — mm hg;"C0039155;C0439475";NA;NA;systolic mm hg
1469;systolic — mean ( sd ) ( mm hg );"C0039155;C0439475;C0444504;C2347634;C2348143;C2699239";NA;NA;systolic mean sd mm hg
1469;systolic pulmonary arterial pressure  mean ( sd )  mm hg;"C0024109;C0039155;C0439475;C0444504;C0871470;C1168098;C2347634;C2348143;C2699239;C2707265;C2709248;C4522268";NA;NA;systolic pulmonary arterial pressure mean sd mm hg
1469;systolic pressure — mm hg;"C0439475;C0871470";NA;NA;systolic pressure mm hg
1469;systolic pressure  mm hg;"C0439475;C0871470";NA;NA;systolic pressure mm hg
1469;systolic bp ( mmhg ) *;"C0439475;C0871470";NA;NA;systolic bp mmhg
1469;systolic bp ( mmhg );"C0439475;C0871470";NA;NA;systolic bp mmhg
1469;systolic bp ( mm hg );"C0439475;C0871470";NA;NA;systolic bp mm hg
1469;systolic bp  mmhg ( sd );"C0439475;C0871470;C2699239";NA;NA;systolic bp mmhg sd
1408;other ^;NA;NA;NA;other
1472;major bleeding ( mb );"C0019080;C0024853;C0205082;C0205164;C4318856;C4521762";FALSE;2076;major bleeding mb
1472;major bleeding $nmbr$ to $nmbr$;"C0019080;C0205082;C0205164;C4318856;C4521762";FALSE;2076;major bleeding $nmbr$ to $nmbr$
1472;major gastro - intestinal bleeding;"C0017181;C0205082;C0205164;C4318856;C4521762";FALSE;2076;major gastro intestinal bleeding
1472;major gl bleeding;"C0018229;C0019080;C0205082;C0205164;C1423073;C1427674;C4318856;C4521762";FALSE;2076;major gl bleeding
1472;major cardiovascular;"C0007226;C0205082;C0205164;C3887460;C4318856;C4521762";FALSE;2077;major cardiovascular
1472;major cardiovascular event;"C0205082;C0205164;C1320716;C4318856;C4521762";FALSE;2077;major cardiovascular event
1472;major cardiovascular event *;"C0205082;C0205164;C1320716;C4318856;C4521762";FALSE;2077;major cardiovascular event
1472;major clinical response;"C0205082;C0205164;C4055223;C4318856;C4521762";FALSE;2077;major clinical response
1472;major cardiovascular events;"C0205082;C0205164;C1320716;C4318856;C4521762";FALSE;2077;major cardiovascular events
1472;major coronary event;"C0205082;C0205164;C0741923;C4318856;C4521762";FALSE;2077;major coronary event
1472;major cv event;"C0205082;C0205164;C0441471;C3538987;C4019010;C4048877;C4318503;C4318856;C4521762";FALSE;2077;major cv event
1472;major macrovascular events;"C0205082;C0205164;C0441471;C3541888;C4318856;C4521762";FALSE;2077;major macrovascular events
1472;all major cardiovascular events;"C0205082;C0205164;C1320716;C4318856;C4521762";FALSE;2077;all major cardiovascular events
1472;b major cardiovascular events;"C0205082;C0205164;C1320716;C4318856;C4521762";FALSE;2077;b major cardiovascular events
1472;combined major macrovascular events .;"C0205082;C0205164;C0205195;C0441471;C3541888;C4318856;C4521762";FALSE;2077;combined major macrovascular events
1472;major st depression or;"C0036056;C0041696;C0205082;C0205164;C0520887;C1269683;C3272372;C4318856;C4521762";FALSE;1091;major st depression or
1472;major st depression or t - wave;"C0036056;C0041696;C0205082;C0205164;C0429103;C0520887;C1269683;C3272372;C4318856;C4521762";FALSE;1091;major st depression or t wave
1469;systolic bp  mmhg  mean ± sd;"C0039155;C0439475;C0444504;C0488053;C0871470;C2347634;C2348143;C2699239";NA;NA;systolic bp mmhg mean sd
1469;systolic bp  mmhg  mean ( sd );"C0039155;C0439475;C0444504;C0488053;C0871470;C2347634;C2348143;C2699239";NA;NA;systolic bp mmhg mean sd
1469;systolic bp  mmhg;"C0439475;C0871470";NA;NA;systolic bp mmhg
1469;systolic bp  mm   hg  mean ( sd );"C0039155;C0439475;C0444504;C0488053;C0871470;C2347634;C2348143;C2699239";NA;NA;systolic bp mm hg mean sd
1469;systolic bp  mm hg ( mean ) nyha class;"C0039155;C0439475;C0444504;C0488053;C0871470;C1882083;C2347634;C2348143";NA;NA;systolic bp mm hg mean nyha class
1469;systolic bp  mm hg  mean ( sd );"C0039155;C0439475;C0444504;C0488053;C0871470;C2347634;C2348143;C2699239";NA;NA;systolic bp mm hg mean sd
1469;systolic bp  mm hg;"C0439475;C0871470";NA;NA;systolic bp mm hg
1469;systolic blood pressurea  mm hg;"C0005767;C0005768;C0039155;C0229664;C0439475";NA;NA;systolic blood pressurea mm hg
1469;systolic blood pressure — mmhg;"C0439475;C0488055;C0871470;C1306620";NA;NA;systolic blood pressure mmhg
1469;systolic blood pressure — mm hg;"C0439475;C0488055;C0871470;C1306620";NA;NA;systolic blood pressure mm hg
1469;systolic blood pressure mmhg  mean ( sd );"C0039155;C0428886;C0439475;C0444504;C0488055;C0871470;C1306620;C2347634;C2348143;C2699239";NA;NA;systolic blood pressure mmhg mean sd
1469;systolic blood pressure [ mmhg ] ( interaction : p = $nmbr$ . $nmbr$ );"C0439475;C0488055;C0871470;C1306620;C1704675";NA;NA;systolic blood pressure mmhg interaction p $nmbr$ $nmbr$
1469;systolic blood pressure > $nmbr$ mm hg — no . ( % );"C0439475;C0488055;C0871470;C1306620";NA;NA;systolic blood pressure $nmbr$ mm hg no
1469;systolic blood pressure > $nmbr$ mm hg or diastolic blood pressure > $nmbr$ mm hg;"C0428883;C0439475;C0488055;C0871470;C1305849;C1306620";NA;NA;systolic blood pressure $nmbr$ mm hg or diastolic blood pressure $nmbr$ mm hg
1469;systolic blood pressure > $nmbr$ mm hg or diastolic;"C0012000;C0439475;C0488055;C0871470;C1306620";NA;NA;systolic blood pressure $nmbr$ mm hg or diastolic
1469;systolic blood pressure > $nmbr$ mm hg  n ( % );"C0439475;C0488055;C0871470;C1306620";NA;NA;systolic blood pressure $nmbr$ mm hg n
1469;systolic blood pressure > $nmbr$ mm hg;"C0439475;C0488055;C0871470;C1306620";NA;NA;systolic blood pressure $nmbr$ mm hg
1469;systolic blood pressure < $nmbr$ mm hg and diastolic blood pressure < $nmbr$ mm hg;"C0428883;C0439475;C0488055;C0871470;C1305849;C1306620";NA;NA;systolic blood pressure $nmbr$ mm hg and diastolic blood pressure $nmbr$ mm hg
1469;systolic blood pressure < $nmbr$ mm hg and diastolic;"C0012000;C0439475;C0488055;C0871470;C1306620";NA;NA;systolic blood pressure $nmbr$ mm hg and diastolic
1469;systolic blood pressure - mmhg;"C0439475;C0488055;C0871470;C1306620";NA;NA;systolic blood pressure mmhg
1469;systolic blood pressure ( mmhg )  mean ± sd;"C0039155;C0428886;C0439475;C0444504;C0488055;C0871470;C1306620;C2347634;C2348143;C2699239";NA;NA;systolic blood pressure mmhg mean sd
1469;systolic blood pressure ( mm hg )  mean ( sd );"C0039155;C0428886;C0439475;C0444504;C0488055;C0871470;C1306620;C2347634;C2348143;C2699239";NA;NA;systolic blood pressure mm hg mean sd
1469;systolic blood pressure ( mm hg );"C0439475;C0488055;C0871470;C1306620";NA;NA;systolic blood pressure mm hg
1469;systolic blood pressure  mmhg *;"C0439475;C0488055;C0871470;C1306620";NA;NA;systolic blood pressure mmhg
1469;systolic blood pressure  mmhg  mean ( sd );"C0039155;C0428886;C0439475;C0444504;C0488055;C0871470;C1306620;C2347634;C2348143;C2699239";NA;NA;systolic blood pressure mmhg mean sd
1469;systolic blood pressure  mm   hg;"C0439475;C0488055;C0871470;C1306620";NA;NA;systolic blood pressure mm hg
1469;systolic blood pressure  mm hg ^;"C0439475;C0488055;C0871470;C1306620";NA;NA;systolic blood pressure mm hg
1303;lavolta ii;"C1710602;C4082587";NA;NA;lavolta ii
1469;systolic blood pressure  mm hg ( sd );"C0439475;C0488055;C0871470;C1306620;C2699239";NA;NA;systolic blood pressure mm hg sd
1469;systolic blood pressure  mm hg  mean ± sd;"C0039155;C0428886;C0439475;C0444504;C0488055;C0871470;C1306620;C2347634;C2348143;C2699239";NA;NA;systolic blood pressure mm hg mean sd
1469;systolic blood pressure  mm hg  mean ( sd );"C0039155;C0428886;C0439475;C0444504;C0488055;C0871470;C1306620;C2347634;C2348143;C2699239";NA;NA;systolic blood pressure mm hg mean sd
1469;systolic blood pressure  mm hg;"C0439475;C0488055;C0871470;C1306620";NA;NA;systolic blood pressure mm hg
1469;systolic blood pressure  mean ( sd )  mm hg;"C0039155;C0428886;C0439475;C0444504;C0488055;C0871470;C1306620;C2347634;C2348143;C2699239";NA;NA;systolic blood pressure mean sd mm hg
1469;systolic blood pressure  ( mm hg );"C0439475;C0488055;C0871470;C1306620";NA;NA;systolic blood pressure mm hg
1469;systolic ( mmhg );"C0039155;C0439475";NA;NA;systolic mmhg
1469;systolic ( mm hg );"C0039155;C0439475";NA;NA;systolic mm hg
1469;sl $nmbr$ mm hg;C0439475;NA;NA;sl $nmbr$ mm hg
1469;sitting systolic blood pressure ( mm hg );"C0277814;C0439475;C0488055;C0871470;C1306620;C2584297;C4050224";NA;NA;sitting systolic blood pressure mm hg
1469;sitting diastolic blood pressure ( mm hg );"C0439475;C1319894";NA;NA;sitting diastolic blood pressure mm hg
1469;sitting blood pressure — mmhg;"C0439475;C0580946";NA;NA;sitting blood pressure mmhg
1469;sbp > $nmbr$ mm hg;"C0085805;C0439475";NA;NA;sbp $nmbr$ mm hg
1469;sbp < $nmbr$ mm hg;"C0085805;C0439475";NA;NA;sbp $nmbr$ mm hg
1469;sbp  mm   hg;"C0085805;C0439475";NA;NA;sbp mm hg
1469;sbp  mm hg;"C0085805;C0439475";NA;NA;sbp mm hg
1469;s $nmbr$ mmhg;"C0439475;C0565930;C2603362";NA;NA;s $nmbr$ mmhg
1469;receiving antihypertensive treatment  n ( % ) blood pressure  mm hg  mean ( sd );"C0003364;C0039798;C0087111;C0428886;C0439475;C1514756;C1522326;C1533734;C1705169;C2699239;C3538994;C3887704";NA;NA;receiving antihypertensive treatment n blood pressure mm hg mean sd
1469;nob systolic blood pressure ( mm hg );"C0439475;C0488055;C0871470;C1306620";NA;NA;nob systolic blood pressure mm hg
1469;nighttime mean dbp ( abpm ) at week $nmbr$  mmhg;"C0240526;C0332174;C0439230;C0439475;C0444504;C0536221;C2347634;C2348143;C3813197;C4281799";NA;NA;nighttime mean dbp abpm at week $nmbr$ mmhg
1469;n ( % ) blood pressure - mean ( sd ) mm hg;"C0369718;C0428886;C0439475;C0441922;C2699239";NA;NA;n blood pressure mean sd mm hg
1469;mssbp < $nmbr$ mmhg;C0439475;NA;NA;mssbp $nmbr$ mmhg
1469;mssbp ( mm hg );C0439475;NA;NA;mssbp mm hg
1469;mssbp  mm hg;C0439475;NA;NA;mssbp mm hg
1469;msdbp ( mm hg );C0439475;NA;NA;msdbp mm hg
1469;msdbp  mm hg;C0439475;NA;NA;msdbp mm hg
1469;mm hg;C0439475;NA;NA;mm hg
1469;mean — mm hg;"C0439475;C0444504;C2347634;C2348143";NA;NA;mean mm hg
1469;mean ± sd msdbp  mm hg;"C0439475;C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd msdbp mm hg
1469;mean systolic bp  mmhg  mean = sd;"C0439475;C0444504;C0871470;C2347634;C2348143;C2699239";NA;NA;mean systolic bp mmhg mean sd
1469;mean systolic blood pressure ( sd )  mm hg;"C0039155;C0428886;C0439475;C0444504;C0488053;C0488055;C0871470;C1306620;C2347634;C2348143;C2699239";NA;NA;mean systolic blood pressure sd mm hg
1469;mean systolic blood pressure  mm hg ( sd );"C0039155;C0428886;C0439475;C0444504;C0488053;C0488055;C0871470;C1306620;C2347634;C2348143;C2699239";NA;NA;mean systolic blood pressure mm hg sd
1469;mean systolic blood pressure  mm hg;"C0039155;C0428886;C0439475;C0444504;C0488053;C0488055;C0871470;C1306620;C2347634;C2348143";NA;NA;mean systolic blood pressure mm hg
1469;mean sd mssbp  mm hg;"C0439475;C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd mssbp mm hg
1469;mean pulmonary artery pressure  mm hg;"C0439475;C3854605";NA;NA;mean pulmonary artery pressure mm hg
1469;mean diastolic blood pressure ( sd )  mm hg;"C0012000;C0428883;C0428886;C0439475;C0444504;C0488053;C1305849;C2347634;C2348143;C2699239";NA;NA;mean diastolic blood pressure sd mm hg
1469;mean diastolic blood pressure  mm hg;"C0012000;C0428883;C0428886;C0439475;C0444504;C0488053;C1305849;C2347634;C2348143";NA;NA;mean diastolic blood pressure mm hg
1469;mean bp ( mmhg );"C0037623;C0439475;C0444504;C1415692;C1708288;C2347634;C2348143;C4318478";NA;NA;mean bp mmhg
1469;mean blood pressure  mm hg;"C0428886;C0439475;C0488053";NA;NA;mean blood pressure mm hg
1469;mean ( s . d . ) systolic blood pressure  mm hg;"C0039155;C0428886;C0439475;C0444504;C0488053;C0488055;C0871470;C1306620;C2347634;C2348143";NA;NA;mean s d systolic blood pressure mm hg
1099;< $nmbr$ yea ' s;NA;NA;NA;$nmbr$ yea s
1469;mean ( s . d . ) diastolic blood pressure  mm hg;"C0012000;C0428883;C0428886;C0439475;C0444504;C0488053;C1305849;C2347634;C2348143";NA;NA;mean s d diastolic blood pressure mm hg
1469;map ( mmhg );"C0024779;C0439475;C1706473;C4050322";NA;NA;map mmhg
1469;diastolic — mm hg;"C0012000;C0439475";NA;NA;diastolic mm hg
1469;diastolic — mean ( sd ) ( mm hg );"C0012000;C0439475;C0444504;C2347634;C2348143;C2699239";NA;NA;diastolic mean sd mm hg
1469;diastolic pressure  mm hg;"C0428883;C0439475";NA;NA;diastolic pressure mm hg
1469;diastolic blood pressurea  mmhg;"C0005767;C0005768;C0012000;C0229664;C0439475";NA;NA;diastolic blood pressurea mmhg
1469;diastolic blood pressure — mm hg;"C0428883;C0439475;C1305849";NA;NA;diastolic blood pressure mm hg
1469;diastolic blood pressure mmhg  mean ( sd );"C0012000;C0428883;C0428886;C0439475;C0444504;C1305849;C2347634;C2348143;C2699239";NA;NA;diastolic blood pressure mmhg mean sd
1469;diastolic blood pressure > $nmbr$ mm hg;"C0428883;C0439475;C1305849";NA;NA;diastolic blood pressure $nmbr$ mm hg
1469;diastolic blood pressure - mmhg;"C0428883;C0439475;C1305849";NA;NA;diastolic blood pressure mmhg
1469;diastolic blood pressure ( mmhg );"C0428883;C0439475;C1305849";NA;NA;diastolic blood pressure mmhg
1469;diastolic blood pressure ( mm hg ) :;"C0428883;C0439475;C1305849";NA;NA;diastolic blood pressure mm hg
1469;diastolic blood pressure ( mm hg )  mean ( sd );"C0012000;C0428883;C0428886;C0439475;C0444504;C1305849;C2347634;C2348143;C2699239";NA;NA;diastolic blood pressure mm hg mean sd
1469;diastolic blood pressure  mmhg  mean ( sd );"C0012000;C0428883;C0428886;C0439475;C0444504;C1305849;C2347634;C2348143;C2699239";NA;NA;diastolic blood pressure mmhg mean sd
1469;diastolic blood pressure  mmhg;"C0428883;C0439475;C1305849";NA;NA;diastolic blood pressure mmhg
1469;diastolic blood pressure  mm   hg;"C0428883;C0439475;C1305849";NA;NA;diastolic blood pressure mm hg
1469;diastolic blood pressure  mm hg ^;"C0428883;C0439475;C1305849";NA;NA;diastolic blood pressure mm hg
1469;diastolic blood pressure  mm hg ( sd );"C0428883;C0439475;C1305849;C2699239";NA;NA;diastolic blood pressure mm hg sd
1469;diastolic blood pressure  mm hg  mean ± sd;"C0012000;C0428883;C0428886;C0439475;C0444504;C1305849;C2347634;C2348143;C2699239";NA;NA;diastolic blood pressure mm hg mean sd
1469;diastolic blood pressure  mm hg  mean ( sd );"C0012000;C0428883;C0428886;C0439475;C0444504;C1305849;C2347634;C2348143;C2699239";NA;NA;diastolic blood pressure mm hg mean sd
1469;diastolic blood pressure  ( mm hg );"C0428883;C0439475;C1305849";NA;NA;diastolic blood pressure mm hg
1469;diastolic ( mmhg );"C0012000;C0439475";NA;NA;diastolic mmhg
1469;diastolic ( mm hg );"C0012000;C0439475";NA;NA;diastolic mm hg
1469;diastolic  mean ( sd )  mm hg;"C0012000;C0439475;C0444504;C2347634;C2348143;C2699239";NA;NA;diastolic mean sd mm hg
1469;daytime mean dbp ( abpm ) at week $nmbr$  mmhg;"C0332169;C0332174;C0439230;C0439475;C0444504;C0536221;C2347634;C2348143;C3813197;C4281799";NA;NA;daytime mean dbp abpm at week $nmbr$ mmhg
1469;change in bp  mm hg;"C0439475;C1268766";NA;NA;change in bp mm hg
1469;change from baseline  mmhg;"C0168634;C0392747;C0439475;C0443172;C1442488;C1705241;C4319952";NA;NA;change from baseline mmhg
1469;blood pressure systolic  mm hg;"C0005823;C0039155;C0439475;C1271104;C1272641";NA;NA;blood pressure systolic mm hg
1469;blood pressure in mm hg  mean ( sd );"C0428886;C0439475;C0488053;C2699239";NA;NA;blood pressure in mm hg mean sd
1469;blood pressure : systolic / diastolic ( mm hg ) ( mean  sd );"C0439475;C0444504;C2347634;C2348143;C2699239;C2704328";NA;NA;blood pressure systolic diastolic mm hg mean sd
1469;blood pressure ( mm hg ) systolic;"C0005823;C0039155;C0439475;C1271104;C1272641";NA;NA;blood pressure mm hg systolic
1303;lavolta $nmbr$;NA;NA;NA;lavolta $nmbr$
1469;blood pressure  mm hg  mean ( sd );"C0428886;C0439475;C2699239";NA;NA;blood pressure mm hg mean sd
1469;blood pressure  mean ± sd mm hg;"C0428886;C0439475;C2699239";NA;NA;blood pressure mean sd mm hg
1469;blood pressure  mean ( sd ) [ range ]  mm hg;"C0428886;C0439475;C1514721;C2348147;C2699239;C3542016";NA;NA;blood pressure mean sd range mm hg
1469;blood pressure  mean ( sd )  mm hg systolic;"C0039155;C0428886;C0439475;C2699239";NA;NA;blood pressure mean sd mm hg systolic
1469;blood pressure  mean ( sd )  mm hg;"C0428886;C0439475;C2699239";NA;NA;blood pressure mean sd mm hg
1469;bl mean ( mmhg );"C0005918;C0006413;C0439475;C0444504;C1552663;C2347634;C2348143;C2827109";NA;NA;bl mean mmhg
1469;baseline systolic blood pressure ( mm hg );"C0439475;C4274438";NA;NA;baseline systolic blood pressure mm hg
1469;baseline systolic blood pressure  mean ( sd )  mm hg;"C0439475;C0444504;C2347634;C2348143;C2699239;C4274438";NA;NA;baseline systolic blood pressure mean sd mm hg
1469;baseline sitting sbp  $nmbr$ mm hg;"C0085805;C0168634;C0277814;C0439475;C1442488;C2584297;C4050224";NA;NA;baseline sitting sbp $nmbr$ mm hg
1469;baseline sedbp  mean ( sd )  mm hg §;"C0168634;C0439475;C0444504;C1442488;C2347634;C2348143;C2699239";NA;NA;baseline sedbp mean sd mm hg
1469;baseline sbp ( mm hg );"C0085805;C0168634;C0439475;C1442488";NA;NA;baseline sbp mm hg
1469;baseline mssbp / msdbp  mm hg;"C0168634;C0439475;C1442488";NA;NA;baseline mssbp msdbp mm hg
1469;baseline diastolic blood pressure ( mm hg );"C0439475;C4274392";NA;NA;baseline diastolic blood pressure mm hg
1469;baseline diastolic blood pressure  mean ( sd )  mm hg;"C0439475;C0444504;C2347634;C2348143;C2699239;C4274392";NA;NA;baseline diastolic blood pressure mean sd mm hg
1469;baseline  mm hg;"C0168634;C0439475;C1442488";NA;NA;baseline mm hg
1469;at home systolic pressure > $nmbr$ mm hg;"C0439475;C0871470;C4534363";NA;NA;at home systolic pressure $nmbr$ mm hg
1469;at home systolic pressure < $nmbr$ mm hg;"C0439475;C0871470;C4534363";NA;NA;at home systolic pressure $nmbr$ mm hg
1469;at home diastolic pressure > $nmbr$ mm hg;"C0428883;C0439475;C4534363";NA;NA;at home diastolic pressure $nmbr$ mm hg
1469;at home diastolic pressure < $nmbr$ mm hg;"C0428883;C0439475;C4534363";NA;NA;at home diastolic pressure $nmbr$ mm hg
1469;at clinic systolic pressure > $nmbr$ mm hg;"C0002424;C0439475;C0442592;C0871470";NA;NA;at clinic systolic pressure $nmbr$ mm hg
1469;at clinic systolic pressure < $nmbr$ mm hg;"C0002424;C0439475;C0442592;C0871470";NA;NA;at clinic systolic pressure $nmbr$ mm hg
1469;at clinic diastolic pressure > $nmbr$ mm hg;"C0002424;C0428883;C0439475;C0442592";NA;NA;at clinic diastolic pressure $nmbr$ mm hg
1469;at clinic diastolic pressure < $nmbr$ mm hg;"C0002424;C0428883;C0439475;C0442592";NA;NA;at clinic diastolic pressure $nmbr$ mm hg
1469;^ numbers do not always sum to group totals due to missing information for some variables . fbody mass index was calculated as weight in kilograms divided by the square of height in meters . ^ hypertension was defined as a self - reported systolic blood pressure > $nmbr$ mm hg  a diastolic blood pressure > $nmbr$ mm hg  or physician - diagnosed hypertension . § hyperlipidemia was defined as a self - reported total cholesterol > $nmbr$ mg / dl ( $nmbr$ . $nmbr$ mmol / l ) or physician - diagnosed high cholesterol . | | diabetes was defined by self - report .;"C0005910;C0011847;C0011849;C0011900;C0020443;C0020473;C0020538;C0025424;C0031831;C0043100;C0201950;C0205120;C0237753;C0332849;C0428257;C0428465;C0428883;C0439175;C0439209;C0439269;C0439475;C0439810;C0439828;C0441074;C0441833;C0444686;C0449788;C0488055;C0489786;C0543421;C0577559;C0577573;C0600653;C0678226;C0681906;C0687744;C0804815;C0871470;C0918012;C1096155;C1257890;C1305849;C1305866;C1306372;C1306620;C1441506;C1515051;C1518422;C1519504;C1522133;C1532563;C1552595;C1552854;C1637833;C1704788;C1705104;C1705428;C1705429;C1963138;C2003902;C2347108;C2347109;C2348272;C2700446;C2986546;C3146286;C3152252;C3539106;C3539882;C3812891;C4283905;C4330985;C4524803;C4554674;C4555212";NA;NA;numbers do not always sum to group totals due to missing information for some variables fbody mass index was calculated as weight in kilograms divided by the square of height in meters hypertension was defined as a self reported systolic blood pressure $nmbr$ mm hg a diastolic blood pressure $nmbr$ mm hg or physician diagnosed hypertension hyperlipidemia was defined as a self reported total cholesterol $nmbr$ mg dl $nmbr$ $nmbr$ mmol l or physician diagnosed high cholesterol diabetes was defined by self report
1469;^ $nmbr$ mm hg;C0439475;FALSE;1888;$nmbr$ mm hg
1469;> $nmbr$ mm hg — no . ( % );C0439475;FALSE;1888;$nmbr$ mm hg no
1469;> = $nmbr$ - < $nmbr$ mmhg;C0439475;FALSE;1888;$nmbr$ $nmbr$ mmhg
1469;> $nmbr$ / > $nmbr$ mm hg;C0439475;FALSE;1888;$nmbr$ $nmbr$ mm hg
1469;> $nmbr$ to < $nmbr$ mm hg;C0439475;FALSE;1888;$nmbr$ to $nmbr$ mm hg
1469;apasp ( per mmhg );C0439475;FALSE;1889;apasp per mmhg
1469;$nmbr$ l $nmbr$ mmhg;"C0439394;C0439475;C1706495;C3642217";NA;NA;$nmbr$ l $nmbr$ mmhg
1468;somnolence;"C0013144;C2830004;C4553740";NA;NA;somnolence
   7;p value * $nmbr$;C1709380;NA;NA;p value $nmbr$
   7;p value *;C1709380;NA;NA;p value
1468;abbreviations : egfr = estimated glomerular filtration rate  imt = intimal medial thickness  lv = left ventricular . * two - sample comparison t - tests were calculated based on log - transformed variables . * * geometric mean with $nmbr$ % confidence interval in parenthesis .;"C0000723;C0009667;C0023128;C0162864;C0205098;C0205448;C0225897;C0334121;C0370003;C0439828;C0444686;C0731033;C0871472;C1256463;C1280412;C1441506;C1510411;C1527178;C1704614;C1705938;C1707455;C1708728;C1739039;C1881413;C2347026;C2986759;C2986775;C3811844;C3812682;C4318736";NA;NA;abbreviations egfr estimated glomerular filtration rate imt intimal medial thickness lv left ventricular two sample comparison t tests were calculated based on log transformed variables geometric mean with $nmbr$ confidence interval in parenthesis
1467;incidencea;NA;NA;NA;incidencea
1467;incidence of each outcome;"C0021149;C0220856;C1274040";NA;NA;incidence of each outcome
1467;incidence ^;"C0021149;C0220856";NA;NA;incidence
1467;incidence *;"C0021149;C0220856";NA;NA;incidence
1467;incidence  ° / o ( $nmbr$ / $nmbr$ cl );"C0021149;C0220856;C0596019";NA;NA;incidence o $nmbr$ $nmbr$ cl
1467;incidence  %;"C0021149;C0220856";NA;NA;incidence
1467;event incidence / n;"C0021149;C0220856;C0441471;C4019010";NA;NA;event incidence n
1467;event / patients in group ( incidence / $nmbr$ person - year );"C0021149;C0027361;C0030705;C0220856;C0439234;C0439508;C0441471;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C2347489;C4019010";NA;NA;event patients in group incidence $nmbr$ person year
1467;cumulative incidence lyear;"C0021149;C0220856;C1511559";NA;NA;cumulative incidence lyear
1467;cumulative incidence $nmbr$ years;"C0021149;C0220856;C0439234;C1511559";NA;NA;cumulative incidence $nmbr$ years
1467;$nmbr$ - year cumulative incidence  % ( ci );"C0008107;C0021149;C0220856;C0439234;C0439508;C1511559;C3259781";NA;NA;$nmbr$ year cumulative incidence ci
1466;sbp  difference;"C0085805;C1705241;C1705242";NA;NA;sbp difference
1466;risk difference;"C0035647;C1705241;C1705242;C4552904";NA;NA;risk difference
1466;percentage difference ( $nmbr$ % cl );"C0439165;C0596019;C1549488;C1561533;C1705241;C1705242";NA;NA;percentage difference $nmbr$ cl
1466;mean arterial pressure  difference;"C0428886;C1705241;C1705242";NA;NA;mean arterial pressure difference
1466;lsm difference;"C1705241;C1705242";NA;NA;lsm difference
1466;laba + ics versus indzgly lsm difference ( $nmbr$ % cl );"C0596019;C0815320;C1705241;C1705242;C4551720";NA;NA;laba ics versus indzgly lsm difference $nmbr$ cl
1466;group difference;"C0441833;C0687744;C1257890;C1519504;C1705241;C1705242;C1705428;C1705429";NA;NA;group difference
1466;estimated treatment difference ( % );"C0039798;C0087111;C0750572;C1522326;C1533734;C1705169;C1705241;C1705242;C3538994;C3887704";NA;NA;estimated treatment difference
1466;estimated means and treatment differences ( % );"C0039798;C0087111;C0750572;C1522326;C1533734;C1704970;C1705169;C1705241;C1705242;C3538994;C3887704";NA;NA;estimated means and treatment differences
1466;estimated means and difference;"C0750572;C1704970;C1705241;C1705242";NA;NA;estimated means and difference
1466;estimated difference %;"C0750572;C1705241;C1705242";NA;NA;estimated difference
1466;estimated difference;"C0750572;C1705241;C1705242";NA;NA;estimated difference
1466;differencevs . pbof;NA;NA;NA;differencevs pbof
1466;difference vs pbo ( $nmbr$ % ci );"C0008107;C0031962;C1705241;C1705242;C3259781";NA;NA;difference vs pbo $nmbr$ ci
1466;difference vs . pbof mean ( s . e . ) t;"C0444504;C1705241;C1705242;C2347634;C2348143";NA;NA;difference vs pbof mean s e t
1466;difference in sbp between treatment;"C0039798;C0085805;C0087111;C1522326;C1533734;C1705169;C1705241;C1705242;C3538994;C3887704";NA;NA;difference in sbp between treatment
1466;difference in means ( $nmbr$ % cl );"C0596019;C1704970;C1705241;C1705242";NA;NA;difference in means $nmbr$ cl
1466;difference in means;"C1704970;C1705241;C1705242";NA;NA;difference in means
1466;difference in change;"C0392747;C0443172;C1705241;C1705242;C4319952";NA;NA;difference in change
1466;difference from baselinea;"C1705241;C1705242";NA;NA;difference from baselinea
1466;difference ( tiotropium - placebo ) ml ( $nmbr$ % ci );"C0008107;C0032042;C0213771;C0439526;C1696465;C1705224;C1705241;C1705242;C1706408;C3259781;C3887665";NA;NA;difference tiotropium placebo ml $nmbr$ ci
1466;difference ( % );"C1705241;C1705242";NA;NA;difference
1466;difference $nmbr$;"C1705241;C1705242";NA;NA;difference $nmbr$
1466;difference;"C1705241;C1705242";NA;NA;difference
1466;* plus - minus values are means ± sd . there were no significant differences ( at;"C0042295;C0237881;C0332288;C0750502;C1546944;C1704970;C1705241;C1705242;C2699239";NA;NA;plus minus values are means sd there were no significant differences at
1466;% - point difference ( $nmbr$ % ci ) c;"C0008107;C1552961;C1705241;C1705242;C2347617;C3259781;C3714763";NA;NA;point difference $nmbr$ ci c
1466;$nmbr$ % ci for difference;"C0008107;C1705241;C1705242;C3259781";NA;NA;$nmbr$ ci for difference
1465;medication adherence;C2364172;NA;NA;medication adherence
1465;adherence > $nmbr$ %;C1510802;NA;NA;adherence $nmbr$
1464;type of reference treatment strategy;"C0455708;C0679199;C1514811;C1706462";NA;NA;type of reference treatment strategy
1464;referent;C1706462;NA;NA;referent
1464;reference;"C1514811;C1706462";NA;NA;reference
1464;no ( reference );"C1514811;C1706462";NA;NA;no reference
1464;< $nmbr$ mg dl ( reference );"C0439269;C1514811;C1706462";NA;NA;$nmbr$ mg dl reference
1464;< $nmbr$ kg  mj ( reference );"C0022718;C0439209;C0439254;C1514811;C1706462;C4054209;C4284025";NA;NA;$nmbr$ kg mj reference
1464;$nmbr$ . $nmbr$ ( referent );C1706462;NA;NA;$nmbr$ $nmbr$ referent
1464;$nmbr$ . $nmbr$ ( reference );"C1514811;C1706462";NA;NA;$nmbr$ $nmbr$ reference
1463;sonti amenca;NA;NA;NA;sonti amenca
1463;region north america;"C0017446;C0028405;C0205147";NA;NA;region north america
1463;region - north america;"C0017446;C0028405;C0205147";NA;NA;region north america
1463;region  north america;"C0017446;C0028405;C0205147";NA;NA;region north america
1463;north america n z $nmbr$;C0028405;NA;NA;north america n z $nmbr$
1463;north america / oceania;"C0028405;C0282279;C4085681";NA;NA;north america oceania
1463;north america *;C0028405;NA;NA;north america
1469;$nmbr$ mmhg;C0439475;FALSE;1888;$nmbr$ mmhg
1469;$nmbr$ mm hg;C0439475;FALSE;1888;$nmbr$ mm hg
1469;< $nmbr$ mm hg heart rate;"C0018810;C0439475";FALSE;1888;$nmbr$ mm hg heart rate
1469;< $nmbr$ / $nmbr$ mm hg;C0439475;FALSE;1888;$nmbr$ $nmbr$ mm hg
1469;< $nmbr$ / $nmbr$ mm hg +;C0439475;FALSE;1888;$nmbr$ $nmbr$ mm hg
1469;< $nmbr$ . $nmbr$ mm hg;C0439475;FALSE;1888;$nmbr$ $nmbr$ mm hg
1469;< $nmbr$ . $nmbr$ mm hg diastolic blood pressure;"C0428883;C0439475;C1305849";FALSE;1888;$nmbr$ $nmbr$ mm hg diastolic blood pressure
1469;$nmbr$ - $nmbr$ / $nmbr$ - $nmbr$ mm hg;C0439475;FALSE;1888;$nmbr$ $nmbr$ $nmbr$ $nmbr$ mm hg
1469;$nmbr$ . $nmbr$ to < $nmbr$ . $nmbr$ mmhg;C0439475;FALSE;1888;$nmbr$ $nmbr$ to $nmbr$ $nmbr$ mmhg
1469;$nmbr$ o - i $nmbr$ mm hg;"C0021966;C0221138;C0439475;C0483204";FALSE;1888;$nmbr$ o i $nmbr$ mm hg
1469;$nmbr$ to < $nmbr$ mmhg;C0439475;FALSE;1888;$nmbr$ to $nmbr$ mmhg
1469;$nmbr$ to < $nmbr$ mm hg;C0439475;FALSE;1888;$nmbr$ to $nmbr$ mm hg
1469;$nmbr$ to $nmbr$ mm hg;C0439475;FALSE;1888;$nmbr$ to $nmbr$ mm hg
1466;absolute risk difference ( ci )  % *;"C0008107;C0035647;C1519101;C1549031;C1705241;C1705242;C3259781;C4552904";FALSE;2259;absolute risk difference ci
1468;relative risk ( $nmbr$ % confidence interval );"C0009667;C0242492";FALSE;2260;relative risk $nmbr$ confidence interval
1468;$nmbr$ % confidence interval;C0009667;FALSE;2261;$nmbr$ confidence interval
1463;north america ( plus america and new zealand );"C0027978;C0028405;C0324547;C0332287";NA;NA;north america plus america and new zealand
1463;north america ( n = $nmbr$ );C0028405;NA;NA;north america n $nmbr$
1463;north america ( % );C0028405;NA;NA;north america
1463;north america;C0028405;NA;NA;north america
1463;n america;"C0002454;C0369718;C0441922";NA;NA;n america
1463;latin and north america;C0028405;NA;NA;latin and north america
1463;geographic region - north america;"C0017446;C0028405";NA;NA;geographic region north america
1462;mexico  central / south america;"C0007674;C0025885;C0037713;C0205099;C1710133;C1879652";NA;NA;mexico central south america
1462;mexico;C0025885;NA;NA;mexico
1461;region latin american;"C0017446;C0205147;C1553378";NA;NA;region latin american
1461;latin ameriea;NA;NA;NA;latin ameriea
1461;latin american;C1553378;NA;NA;latin american
1461;latin america hr ( $nmbr$ % cl );"C0023122;C0596019";NA;NA;latin america hr $nmbr$ cl
1461;latin america ( n = $nmbr$ );C0023122;NA;NA;latin america n $nmbr$
1461;latin america;C0023122;NA;NA;latin america
1461;latin;NA;NA;NA;latin
1460;vka experienced;"C0237607;C0596545";NA;NA;vka experienced
1460;prior vka experience;"C0237607;C0332152;C0596545;C2826257";NA;NA;prior vka experience
1460;oac experienced  bn   ( % );"C0005005;C0034700;C0237607;C0596545;C1706574;C4551963";NA;NA;oac experienced bn
1460;experienced;"C0237607;C0596545";NA;NA;experienced
1460;experience ( n  % );"C0237607;C0596545";NA;NA;experience n
1460;experience;"C0237607;C0596545";NA;NA;experience
1460;clinic research experience  n ( % );"C0008972;C0237607;C0596545";NA;NA;clinic research experience n
1460;cdmard experience  n ( % );"C0237607;C0596545";NA;NA;cdmard experience n
1459;vldm n = $nmbr$;NA;NA;NA;vldm n $nmbr$
1459;hdm n = $nmbr$;NA;NA;NA;hdm n $nmbr$
1458;hd edoxaban vs warfarin;"C0043031;C2975435";NA;NA;hd edoxaban vs warfarin
1457;qd;C0332173;NA;NA;qd
1457;indacaterol $nmbr$ gg qd;"C0017454;C0018370;C0332173;C1722260";NA;NA;indacaterol $nmbr$ gg qd
1456;gall bladder adverse event ( n = $nmbr$ );"C0016976;C0877248";NA;NA;gall bladder adverse event n $nmbr$
1455;biomarker levels;"C0005516;C0441889";NA;NA;biomarker levels
1454;teaes ( > $nmbr$ % in any treatment group ) *;C0374505;NA;NA;teaes $nmbr$ in any treatment group
1454;teaes ( > $nmbr$ % in any treatment group );C0374505;NA;NA;teaes $nmbr$ in any treatment group
1454;any teaes;NA;NA;NA;any teaes
1454;any teae;NA;NA;NA;any teae
1454;all treatments;C0087111;NA;NA;all treatments
1454;all;NA;NA;NA;all
1452;alleles;C0002085;NA;NA;alleles
1451;ulcers / gangrene;"C0017086;C0041582";NA;NA;ulcers gangrene
1451;ulcer  n ( % ) a;"C0041582;C3887532";NA;NA;ulcer n a
1451;ulcer;"C0041582;C3887532";NA;NA;ulcer
1451;or ulcerations  ® n ( % );C0041582;NA;NA;or ulcerations n
1450;verapamil sr strategy ( n = $nmbr$  $nmbr$ );"C0679199;C1527129";NA;NA;verapamil sr strategy n $nmbr$ $nmbr$
1450;verapamil sr n = $nmbr$ no . ( % );C1527129;NA;NA;verapamil sr n $nmbr$ no
1450;verapamil sr n = $nmbr$;C1527129;NA;NA;verapamil sr n $nmbr$
1450;verapamil sr ( no . = $nmbr$ );C1527129;NA;NA;verapamil sr no $nmbr$
1450;verapamil sr;C1527129;NA;NA;verapamil sr
1450;verapamil - sr strategy;"C0679199;C1527129";NA;NA;verapamil sr strategy
1450;verapamil - sr ( « = $nmbr$ $nmbr$ );C1527129;NA;NA;verapamil sr $nmbr$ $nmbr$
1450;verapamil ( n  % );C0042523;NA;NA;verapamil n
1450;use of verapamil or quinidine;"C0034414;C0042523;C1524063";NA;NA;use of verapamil or quinidine
1449;varespladib ( n = $nmbr$ );C2713485;NA;NA;varespladib n $nmbr$
1449;varespladib;C2713485;NA;NA;varespladib
1448;vorapaxar placebo;"C0032042;C1696465;C1706408;C2974521";NA;NA;vorapaxar placebo
1448;vorapaxar no . ( $nmbr$ - y km % );"C2974521;C3887676";NA;NA;vorapaxar no $nmbr$ y km
1448;vorapaxar n = $nmbr$;C2974521;NA;NA;vorapaxar n $nmbr$
1450;diltiazem or verapamil;"C0012373;C0042523";FALSE;2244;diltiazem or verapamil
1451;irregular or ulcerated ica p ) laque : [ :;"C0041582;C0201519;C0205271;C3887532";FALSE;2245;irregular or ulcerated ica p laque
1276;male sex;C0086582;NA;NA;male sex
1451;irregular or ulcerated ica plaquef;"C0041582;C0201519;C0205271;C3887532";FALSE;2245;irregular or ulcerated ica plaquef
1452;allergic disease by historyb  n ( % );"C0020517;C0851444";FALSE;2246;allergic disease by historyb n
1452;ongoing atopic or allergic condition — no . { % );"C0392707;C0549178;C0851444";FALSE;2246;ongoing atopic or allergic condition no
1453;aes *;"C1412268;C2699274";FALSE;  47;aes
1453;aes in ≥ $nmbr$ japanese patients in a study arm  n ( % ) §;"C0030705;C0376247;C0446516;C0557651;C1412268;C1556094;C2603343;C2699274;C3715044;C4553528";FALSE;  47;aes in $nmbr$ japanese patients in a study arm n
1453;fatal aes;"C1302234;C1412268;C1705232;C2699274";FALSE;  47;fatal aes
1453;gallbladder - related aes;"C0016976;C0439849;C0445223;C1412268;C2699274";FALSE;  47;gallbladder related aes
1453;investigator - reported aes;"C0035173;C0684224;C0700287;C1412268;C2699274;C4319718";FALSE;  47;investigator reported aes
1453;most common aes ‡;"C0205214;C0205393;C1412268;C1522138;C2699274;C3245511";FALSE;  47;most common aes
1453;most common aes in any group;"C0205214;C0205393;C0441833;C0687744;C1257890;C1412268;C1519504;C1522138;C1705428;C1705429;C2699274;C3245511";FALSE;  47;most common aes in any group
1453;> $nmbr$ aes;"C1412268;C2699274";FALSE;  47;$nmbr$ aes
1453;osmotic diuresis - related aes;"C0232823;C0439849;C0445223;C1412268;C2699274";FALSE;  47;osmotic diuresis related aes
1453;other selected aes;"C1412268;C1707391;C2699274";FALSE;  47;other selected aes
1453;tier $nmbr$ aes;"C1412268;C2699274";FALSE;  47;tier $nmbr$ aes
1453;volume depletion - related aes;"C0439849;C0445223;C0546884;C1412268;C2699274";FALSE;  47;volume depletion related aes
1455;elevated biomarkers and st - segment changes;"C0005516;C0205250;C0232326;C3163633";FALSE;2247;elevated biomarkers and st segment changes
1455;sle markers  n ( % );"C0005516;C0024141";FALSE;2248;sle markers n
1457;d  mitral stenosis vhd ( n = $nmbr$ );"C0026269;C0073187;C0264766;C0332173;C4484261";FALSE;2249;d mitral stenosis vhd n $nmbr$
1457;tiotropium $nmbr$ gg qd;"C0017454;C0018370;C0213771;C0332173";FALSE;1372;tiotropium $nmbr$ gg qd
1457;a  no vhd ( n = $nmbr$ $nmbr$ );NA;FALSE; 103;a no vhd n $nmbr$ $nmbr$
1457;b  vhd ( n = $nmbr$ );NA;FALSE; 103;b vhd n $nmbr$
1457;no vhd;NA;FALSE; 103;no vhd
1458;hd ( n = $nmbr$ );NA;FALSE;2250;hd n $nmbr$
1459;vildagliptin + metformin ( vldm );"C0025598;C1570906";FALSE;2251;vildagliptin metformin vldm
1459;metformin ( hdm );C0025598;FALSE;1345;metformin hdm
1461;native american;"C0282204;C1515945";FALSE;2254;native american
1461;native american or alaska native;"C0282204;C0682125;C1515945";FALSE;2254;native american or alaska native
1461;native american / alaskan;"C0238611;C0282204;C0596070;C0682125;C1515945";FALSE;2254;native american alaskan
1461;native american or alaskan native;"C0238611;C0282204;C0302891;C1515945";FALSE;2254;native american or alaskan native
1461;indian ( american ) or alaskan native;"C0238611;C0302891;C0596070;C1524069";FALSE;2255;indian american or alaskan native
1461;american;C0596070;FALSE;2256;american
1461;hispanic american;C0019576;FALSE;2257;hispanic american
1461;hispanic / latin american;C0019576;FALSE;2257;hispanic latin american
1461;mexican;C0240339;FALSE;1462;mexican
1463;america;C0002454;FALSE;2258;america
1448;vorapaxar group ( n = $nmbr$ );"C0441848;C2974521";NA;NA;vorapaxar group n $nmbr$
1448;vorapaxar event rate ( n = $nmbr$ )  %;"C0441471;C0871208;C1521828;C2974521;C4019010";NA;NA;vorapaxar event rate n $nmbr$
1448;vorapaxar ( n = $nmbr$ . $nmbr$ );C2974521;NA;NA;vorapaxar n $nmbr$ $nmbr$
1448;vorapaxar ( n = $nmbr$ )  n ( % );C2974521;NA;NA;vorapaxar n $nmbr$ n
1448;vorapaxar ( n = $nmbr$ );C2974521;NA;NA;vorapaxar n $nmbr$
1448;vorapaxar ( n = $nmbr$ $nmbr$ );C2974521;NA;NA;vorapaxar n $nmbr$ $nmbr$
1448;vorapaxar ( n = $nmbr$  $nmbr$ );C2974521;NA;NA;vorapaxar n $nmbr$ $nmbr$
1448;vorapaxar $nmbr$ - y;C2974521;NA;NA;vorapaxar $nmbr$ y
1448;vorapaxar;C2974521;NA;NA;vorapaxar
1447;proximal - mainleft;"C0205107;C4489236";NA;NA;proximal mainleft
1447;proximal;"C0205107;C4489236";NA;NA;proximal
1446;paroxysmal atrial fibrillation — no . ( % );"C0235480;C4050122";NA;NA;paroxysmal atrial fibrillation no
1446;paroxysmal af;C0235480;NA;NA;paroxysmal af
1446;history of paroxysmal atrial fibrillation  n ( % );"C0205311;C0729790";NA;NA;history of paroxysmal atrial fibrillation n
1446;history of paroxysmal af;"C0019664;C0019665;C0235480;C0262512;C0262926;C1705255;C2004062";NA;NA;history of paroxysmal af
1445;post - procedure;C3272301;NA;NA;post procedure
1444;pressure;"C0033095;C0460139;C1306345;C4284008";NA;NA;pressure
 -10;czech repumc;C0337799;NA;NA;czech repumc
 -10;puerperium;"C0034042;C0086839;C1879329";NA;NA;puerperium
1441;rectum and sigmoid colon only;"C0034896;C0205171;C0227391;C1720467";NA;NA;rectum and sigmoid colon only
1440;rib;C0035561;NA;NA;rib
1440;( ri = $nmbr$ );"C0035487;C1826843";NA;NA;ri $nmbr$
1439;subgroup w . r . t . re - cover;"C0180153;C0232024;C0556581;C1079230;C1515021;C1999244;C2986904;C3888055";NA;NA;subgroup w r t re cover
1439;re - medy;"C0556581;C2986904";NA;NA;re medy
1438;time to rx;"C0040223;C1425688;C1521941;C2709207;C3541383";NA;NA;time to rx
 -10;qmaxi rn l / s;"C2827110;C3540639;C4281819";NA;NA;qmaxi rn l s
1436;> $nmbr$ rd quartile;"C0694666;C2828255;C4553350";NA;NA;$nmbr$ rd quartile
1436;> $nmbr$ nd and < $nmbr$ rd quartile;"C0694666;C2828255;C4553350";NA;NA;$nmbr$ nd and $nmbr$ rd quartile
1436;$nmbr$ rd tertile ( > $nmbr$ mg / dl [ > $nmbr$ . $nmbr$ mmol / l ] ) d;"C0439190;C0439269;C0475219;C0567349;C0694666;C2348885;C3642216;C4553350";NA;NA;$nmbr$ rd tertile $nmbr$ mg dl $nmbr$ $nmbr$ mmol l d
1436;$nmbr$ rd > $nmbr$ . $nmbr$;"C0694666;C4553350";NA;NA;$nmbr$ rd $nmbr$ $nmbr$
1435;seropositive ( rf + ve and / or acpa + ve ) subgroup;"C0035448;C0042469;C0201660;C0521143;C0748398;C1079230;C1515021;C1525410;C1547111;C1706063;C3714652;C4321495";NA;NA;seropositive rf ve and or acpa ve subgroup
1435;rheumatoid factor - positive;"C0035448;C0201660;C0439178;C1446409;C1514241;C2825490;C3812269";NA;NA;rheumatoid factor positive
1435;rheumatoid factor !;"C0035448;C0201660";NA;NA;rheumatoid factor
1435;rf positive — number ( % );"C0035448;C0201660;C0748398;C1547111;C3812269";NA;NA;rf positive number
1435;rf positive and acpa negative  n ( % );"C0035448;C0201660;C0205160;C0439178;C0748398;C1446409;C1513916;C1514241;C1525410;C1547111;C1706063;C2825415;C2825490;C2825491;C3812269;C3853545";NA;NA;rf positive and acpa negative n
1435;rf positive ( > $nmbr$ iu / ml )  n ( % );"C0035448;C0201660;C0439178;C0439458;C0748398;C1446409;C1514241;C1547111;C2825490;C3812269";NA;NA;rf positive $nmbr$ iu ml n
1435;rf positive  no . ( % );"C0035448;C0201660;C0439178;C0748398;C1446409;C1514241;C1547111;C2825490;C3812269";NA;NA;rf positive no
1435;rf positive  n ( % );"C0035448;C0201660;C0439178;C0748398;C1446409;C1514241;C1547111;C2825490;C3812269";NA;NA;rf positive n
1435;rf positive  %;"C0035448;C0201660;C0439178;C0748398;C1446409;C1514241;C1547111;C2825490;C3812269";NA;NA;rf positive
1435;rf positive;"C0035448;C0201660;C0439178;C0748398;C1446409;C1514241;C1547111;C2825490;C3812269";NA;NA;rf positive
1435;rf negative and acpa positive  n ( % );"C0035448;C0201660;C0205160;C0439178;C0748398;C1446409;C1513916;C1514241;C1525410;C1547111;C1706063;C2825415;C2825490;C2825491;C3812269;C3853545";NA;NA;rf negative and acpa positive n
1435;rf and acpa positive  n ( % );"C0035448;C0201660;C0439178;C0748398;C1446409;C1514241;C1525410;C1547111;C1706063;C2825490;C3812269";NA;NA;rf and acpa positive n
1435;rf - positive  > $nmbr$ iu / ml  %;"C0035448;C0201660;C0439178;C0439458;C0748398;C1446409;C1514241;C1547111;C2825490;C3812269";NA;NA;rf positive $nmbr$ iu ml
1435;rf ( mg / dl );"C0035448;C0201660;C0439269;C0748398;C1547111";NA;NA;rf mg dl
1429;beta - carotene ( n = $nmbr$  $nmbr$ );"C0053396;C0696105";FALSE;2233;beta carotene n $nmbr$ $nmbr$
1417;smoking  % current;"C0037369;C0453996;C0521116;C1705970;C1881674";FALSE;2224;smoking current
1435;rf ( mg / dl  per unit );"C0024671;C0026410;C0035448;C0201660;C0439148;C0439269;C0439453;C0748398;C1509845;C1519795;C1532632;C1547111;C1638407;C1704753;C1880519;C1960952;C2346927;C3642216;C3853603;C4321396;C4521761";NA;NA;rf mg dl per unit
1435;rf ( iu / ml );"C0035448;C0201660;C0439458;C0748398;C1547111";NA;NA;rf iu ml
1435;rf  % positive;"C0035448;C0201660;C0439178;C0748398;C1446409;C1514241;C1547111;C2825490;C3812269";NA;NA;rf positive
1435;positive for rheumatoid factor — no . ( % ) : t;"C0035448;C0201660;C0439178;C1446409;C1514241;C2603360;C2825490;C3812269";NA;NA;positive for rheumatoid factor no t
1435;% rf +;"C0035448;C0201660;C0748398;C1547111";NA;NA;rf
1434;tk;"C0041405;C0220928;C4050092";NA;NA;tk
1444;systoiic biood pressure  mm hg;"C0033095;C0439475;C0460139;C1306345;C4284008";FALSE;1469;systoiic biood pressure mm hg
1444;diastoiic biood pressure  mm hg;"C0033095;C0439475;C0460139;C1306345;C4284008";FALSE;1469;diastoiic biood pressure mm hg
1434;tc : hdlc;"C0039411;C0040642;C0041405;C0041698;C1704429;C1824670;C3272447;C4522122";FALSE;2236;tc hdlc
1444;any blood pressure medications ( % );"C0005823;C0013227;C0033095;C0460139;C0802604;C0849164;C1271104;C1272641;C1306345;C2598133;C4284008;C4284232";FALSE;1579;any blood pressure medications
1434;tc ( mg / dl );"C0039411;C0040642;C0041405;C0041698;C0439269;C1824670;C3272447;C4522122";FALSE; 368;tc mg dl
1434;tc ( mmol / l );"C0039411;C0040642;C0041405;C0041698;C1532563;C1824670;C3272447;C4522122";FALSE; 368;tc mmol l
1434;tc  mmol / l ( mg / dl );"C0039411;C0040642;C0041405;C0041698;C1824670;C3272447;C3642216;C3898312;C4522122";FALSE; 368;tc mmol l mg dl
1434;waist circumference women : > $nmbr$ in ( $nmbr$ cm ) men : > $nmbr$ in ( $nmbr$ cm ) tc $nmbr$ c $nmbr$ mg / dl;"C0025266;C0039411;C0040642;C0041405;C0041698;C0043210;C0439269;C0455829;C1824670;C3272447;C4522122";FALSE;1413;waist circumference women $nmbr$ in $nmbr$ cm men $nmbr$ in $nmbr$ cm tc $nmbr$ c $nmbr$ mg dl
1438;any new anti - hyperglycemic rx;"C0205314;C1425688;C1521941;C2709207";FALSE;  33;any new anti hyperglycemic rx
1440;primary ep ( cvd / mi / ri );"C0007222;C0035487;C0205225;C0439612;C0439631;C1826843;C1880476;C3810814;C4321526";FALSE; 230;primary ep cvd mi ri
1441;rectum;C0034896;FALSE;2237;rectum
1444;question $nmbr$ ( discomfort from any areas tender to touch / pressure );"C0033095;C0152054;C0205146;C0234234;C0439815;C0460139;C0702221;C1306345;C1522634;C2364135;C4284008;C4319729";FALSE;2238;question $nmbr$ discomfort from any areas tender to touch pressure
1444;pressure ( mm hg );"C0033095;C0439475;C0460139;C1306345;C4284008";FALSE;2239;pressure mm hg
1445;other diagnostic procedure *;"C0430022;C1546908";FALSE;2240;other diagnostic procedure
1445;pre - procedure;C3272300;FALSE;2241;pre procedure
1447;proximal gastrointestinal tract;"C0017189;C0205107;C0521362;C4489236";FALSE;2242;proximal gastrointestinal tract
1447;proximal gi tract;"C0017189;C0205107;C4489236";FALSE;2242;proximal gi tract
1447;proximal to the splenic flexure;"C0205107;C0227387;C4489236";FALSE;2242;proximal to the splenic flexure
1447;pyrexia;C0015967;FALSE;2243;pyrexia
1433;uacr  mg / g  median ( $nmbr$ th − $nmbr$ th percentile );"C0039725;C0039738;C0549183;C0876920;C1264641;C1300563;C1420718;C2347635;C2348144;C2939193;C4282123;C4285344";NA;NA;uacr mg g median $nmbr$ th $nmbr$ th percentile
1433;th c;"C0039725;C0039738;C1420718;C4282123;C4285344";NA;NA;th c
1433;th ( $nmbr$ % );"C0039725;C0039738;C1420718;C4282123;C4285344";NA;NA;th $nmbr$
1433;median ( $nmbr$ th  $nmbr$ th percentile );"C0039725;C0039738;C0549183;C0876920;C1264641;C1420718;C2347635;C2348144;C2939193;C4282123;C4285344";NA;NA;median $nmbr$ th $nmbr$ th percentile
1433;euroscore logistic  median ( $nmbr$ th  $nmbr$ th % ) £;"C0039725;C0039738;C0242415;C0549183;C0876920;C1420718;C2347635;C2348144;C2939193;C3164744;C4282123;C4285344";NA;NA;euroscore logistic median $nmbr$ th $nmbr$ th
1433;euroscore additive  median ( $nmbr$ th  $nmbr$ th % ) §;"C0039725;C0039738;C0442796;C0549183;C0876920;C1420718;C1550602;C2347635;C2348144;C2939193;C3164744;C4282123;C4285344";NA;NA;euroscore additive median $nmbr$ th $nmbr$ th
1433;$nmbr$ th — $nmbr$ th percentiles;"C0039725;C0039738;C1264641;C1420718;C4282123;C4285344";NA;NA;$nmbr$ th $nmbr$ th percentiles
1433;$nmbr$ th : $nmbr$ . $nmbr$ - $nmbr$ pmol / l;"C0039725;C0039738;C0439284;C1420718;C4282123;C4285344";NA;NA;$nmbr$ th $nmbr$ $nmbr$ $nmbr$ pmol l
1433;$nmbr$ th - $nmbr$ th percentiles;"C0039725;C0039738;C1264641;C1420718;C4282123;C4285344";NA;NA;$nmbr$ th $nmbr$ th percentiles
1432;any type  according to daily dose * *;"C0332307;C0680240;C1547052;C2348070";NA;NA;any type according to daily dose
1432;$nmbr$ % ( oto $nmbr$ );NA;NA;NA;$nmbr$ oto $nmbr$
1432;$nmbr$ % ( ito $nmbr$ );C0022283;NA;NA;$nmbr$ ito $nmbr$
1432;$nmbr$ % ( - ito $nmbr$ );C0022283;NA;NA;$nmbr$ ito $nmbr$
1431;$nmbr$ to $nmbr$ y  n ( % );NA;NA;NA;$nmbr$ to $nmbr$ y n
1430;tj ( $nmbr$ - $nmbr$ );C0039247;NA;NA;tj $nmbr$ $nmbr$
1430;tj ( $nmbr$ % );C0039247;NA;NA;tj $nmbr$
1430;- $nmbr$ . $nmbr$ ± $nmbr$ . $nmbr$ § ti;"C0039247;C0040302;C1553045;C1704756";NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ ti
1429;unadjusteda beta ( se );"C0036919;C0330390;C0439096;C2004068";NA;NA;unadjusteda beta se
1429;beta $nmbr$ selective;"C0036576;C0330390;C0439096;C1707391;C2004068";NA;NA;beta $nmbr$ selective
1429;adjustedb  c beta ( se );"C0036919;C0330390;C0439096;C2004068";NA;NA;adjustedb c beta se
1428;both adalimumab groups ( n = $nmbr$ ) baseline cd - related antibiotic use;"C0003232;C0007928;C0034283;C0042153;C0168634;C0369718;C0439849;C0441833;C0441922;C0445223;C0457083;C0687744;C1122087;C1257890;C1442488;C1519504;C1552839;C1705428;C1705429;C1947944;C4552032";NA;NA;both adalimumab groups n $nmbr$ baseline cd related antibiotic use
1428;both ( % );NA;NA;NA;both
1428;both;NA;NA;NA;both
1428;> $nmbr$ and / or > $nmbr$ moderate or severe deformity  or both ( n = $nmbr$ );"C0000768;C0205081;C0205082;C0221430;C0302142;C0369718;C0441922;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335";NA;NA;$nmbr$ and or $nmbr$ moderate or severe deformity or both n $nmbr$
1427;pci data;"C1511726;C3245479;C3714741;C4049621";NA;NA;pci data
1427;number of patients with available data;"C0470187;C1511726;C2360800;C3245479;C3714741";NA;NA;number of patients with available data
1427;no ef data | |;"C1511726;C3245479;C3714741";NA;NA;no ef data
1427;fpg data ';"C1511726;C3245479;C3714741";NA;NA;fpg data
1427;ecg and imaging data;"C0011923;C0079595;C1511726;C1623258;C3245479;C3714741";NA;NA;ecg and imaging data
1427;data  ' ' n;"C1511726;C3245479;C3714741";NA;NA;data n
1427;baseline data;"C0168634;C1442488;C1511726;C3245479;C3714741";NA;NA;baseline data
1427;available data;"C0470187;C1511726;C3245479;C3714741";NA;NA;available data
1427;at c data;"C1511726;C3245479;C3714741";NA;NA;at c data
1427;* data are expressed as median ± sd  except;"C0549183;C0876920;C1511726;C2347635;C2348144;C2699239;C2939193;C3245479;C3714741";NA;NA;data are expressed as median sd except
1427;* data are expr;"C1511726;C3245479;C3714741";NA;NA;data are expr
1426;transient monocular blindness;C0149793;NA;NA;transient monocular blindness
1425;immunomodulatory agents;C0005525;NA;NA;immunomodulatory agents
1425;immunomodulators;"C0001551;C0005525;C1527392";NA;NA;immunomodulators
1424;no glucocorticoids or immunosuppressants;"C0017710;C0021081;C3540777;C3540778";NA;NA;no glucocorticoids or immunosuppressants
1099;< $nmbr$ . $nmbr$ years;C0439234;NA;NA;$nmbr$ $nmbr$ years
1427;laboratory data;"C0022877;C1511726;C3244292;C3245479;C3714741;C4283904";FALSE;2232;laboratory data
1427;laboratory data  mean ( sd );"C0022877;C0444504;C1511726;C2347634;C2348143;C2699239;C3244292;C3245479;C3714741;C4283904";FALSE;2232;laboratory data mean sd
1429;beta receptor antagonist;"C0330390;C0439096;C2004068;C4543207";FALSE; 959;beta receptor antagonist
1429;beta bloekers;"C0330390;C0439096;C2004068";FALSE; 959;beta bloekers
1430;sou ti africa;"C0001737;C0039247;C0040302;C1553045;C1704756";FALSE;  48;sou ti africa
1429;beta - carotene;"C0053396;C0696105";FALSE;2233;beta carotene
1380;exercise ( % );"C0015259;C1522704";NA;NA;exercise
1433;age  median ( $nmbr$ th - $nmbr$ th percentiles )  y;"C0001779;C0039725;C0039738;C0549183;C0876920;C1264641;C1420718;C2347635;C2348144;C2939193;C4282123;C4285344";FALSE;2234;age median $nmbr$ th $nmbr$ th percentiles y
1431;due to ae;C3887670;FALSE;  47;due to ae
1431;due to drug - relateda ae;"C0013227;C1254351;C3887670";FALSE;  47;due to drug relateda ae
1431;discontinuations due to ae;"C0457454;C0678226;C3887670";FALSE;1974;discontinuations due to ae
1433;age  y ( $nmbr$ th  $nmbr$ th percentiles );"C0001779;C0039725;C0039738;C1264641;C1420718;C4282123;C4285344";FALSE;2234;age y $nmbr$ th $nmbr$ th percentiles
1433;weight  kg  median ( $nmbr$ th  $nmbr$ th );"C0005910;C0022718;C0039725;C0039738;C0043100;C0439209;C0549183;C0876920;C1305866;C1420718;C1705104;C2347635;C2348144;C2939193;C4054209;C4282123;C4285344";FALSE;2235;weight kg median $nmbr$ th $nmbr$ th
1433;weight ( kg / m $nmbr$ ) [ median ( $nmbr$ th to $nmbr$ th percentile ) ];"C0039725;C0039738;C0549183;C0552346;C0876920;C1420718;C1532718;C2347635;C2348144;C2939193;C4282123;C4285344";FALSE;2235;weight kg m $nmbr$ median $nmbr$ th to $nmbr$ th percentile
1433;weight  median ( $nmbr$ th — $nmbr$ th percentiles )  kg;"C0022718;C0039725;C0039738;C0439209;C0549183;C0552346;C0876920;C1420718;C2347635;C2348144;C2939193;C4054209;C4282123;C4285344";FALSE;2235;weight median $nmbr$ th $nmbr$ th percentiles kg
1433;time from onset of pain to randomization  median ( $nmbr$ th — $nmbr$ th percentiles )  n;"C0030193;C0034656;C0039725;C0039738;C0449244;C0518090;C0549183;C0876920;C1264641;C1420718;C1962977;C2347635;C2348144;C2939193;C2984058;C4085210;C4085211;C4085212;C4282123;C4285344;C4553004;C4554132";FALSE;2169;time from onset of pain to randomization median $nmbr$ th $nmbr$ th percentiles n
1434;= ezetimibe  tc = triglycerides  hdl - c = lg / dl l > $nmbr$ . $nmbr$ mmol / l ] ) . to qualify as having;"C0023128;C0039411;C0040363;C0040642;C0041260;C0041405;C0041698;C0062152;C0439190;C0694651;C1142985;C1824670;C1883351;C3272447;C3642216;C4522122";FALSE; -10;ezetimibe tc triglycerides hdl c lg dl l $nmbr$ $nmbr$ mmol l to qualify as having
1434;baseline tc  mg / dl;"C0039411;C0040642;C0041405;C0041698;C0168634;C0439269;C1442488;C1824670;C3272447;C4522122";FALSE; 368;baseline tc mg dl
1434;tc;"C0039411;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122";FALSE; 368;tc
1424;no concomitant immunosuppressive and / or prior anti - tnf use;"C0021081;C0042153;C0332152;C0457083;C0521115;C1448177;C1947944;C2826257";NA;NA;no concomitant immunosuppressive and or prior anti tnf use
1424;no baseline immunosuppressant use;"C0021081;C0042153;C0168634;C0457083;C1442488;C1947944";NA;NA;no baseline immunosuppressant use
1424;neither glucocorticoids nor immunosuppressive agents;"C0017710;C0021081;C3540777;C3540778";NA;NA;neither glucocorticoids nor immunosuppressive agents
1424;immunosuppressive use  n ( % );"C0021081;C0042153;C0457083;C1947944";NA;NA;immunosuppressive use n
1424;immunosuppressive agents only;"C0021081;C0205171;C1720467";NA;NA;immunosuppressive agents only
1424;immunosuppressants onlyff;C0021081;NA;NA;immunosuppressants onlyff
1424;immunosuppressants only;"C0021081;C0205171;C1720467";NA;NA;immunosuppressants only
1424;immunosuppressants;C0021081;NA;NA;immunosuppressants
1424;immunosuppressant use  %;"C0021081;C0042153;C0457083;C1947944";NA;NA;immunosuppressant use
1424;immunosuppressant ^ ^;C0021081;NA;NA;immunosuppressant
1424;immunosuppressant ^;C0021081;NA;NA;immunosuppressant
1424;glucocorticoids plus immunosuppressive agents;"C0017710;C0021081;C3540777;C3540778";NA;NA;glucocorticoids plus immunosuppressive agents
1424;glucocorticoids combined with immunosuppressive agents;"C0017710;C0021081;C0205195;C3540777;C3540778";NA;NA;glucocorticoids combined with immunosuppressive agents
1424;glucocorticoids and immunosuppressants;"C0017710;C0021081;C3540777;C3540778";NA;NA;glucocorticoids and immunosuppressants
1424;corticosteroids and immunosuppressants only;"C0001617;C0021081;C0205171;C1720467;C3539185;C3540725;C3540726;C3540727";NA;NA;corticosteroids and immunosuppressants only
1424;concomitant immunosuppressive and / or prior anti - tnf use;"C0021081;C0042153;C0332152;C0457083;C0521115;C1448177;C1947944;C2826257";NA;NA;concomitant immunosuppressive and or prior anti tnf use
1424;both adalimumab groups ( n = $nmbr$ ) baseline immunosuppressant use;"C0021081;C0042153;C0168634;C0369718;C0441833;C0441922;C0457083;C0687744;C1122087;C1257890;C1442488;C1519504;C1552839;C1705428;C1705429;C1947944";NA;NA;both adalimumab groups n $nmbr$ baseline immunosuppressant use
1424;any immunosuppressive agent;C0021081;NA;NA;any immunosuppressive agent
1423;• death from any cause;C0007465;NA;NA;death from any cause
1423;death from any cause;C0007465;NA;NA;death from any cause
1423;cause of death unknown;"C0007465;C0439673;C3541433;C4050014;C4050444";NA;NA;cause of death unknown
1423;by cause of death;"C0007465;C4050444";NA;NA;by cause of death
1422;crude analysis  n ( % );"C0002778;C0936012;C1524024";NA;NA;crude analysis n
1422;crude;NA;NA;NA;crude
1421;ocs maintained / increased;"C0205217;C0442805;C1314677";NA;NA;ocs maintained increased
1420;smoking status current smoker ( n = $nmbr$ );"C1519386;C3173209;C3241966";NA;NA;smoking status current smoker n $nmbr$
1420;smoking history : current smoker;"C1519384;C3173209;C3241966";NA;NA;smoking history current smoker
1420;smoking : current smoker;"C0037369;C0453996;C1881674;C3173209;C3241966";NA;NA;smoking current smoker
1420;former or current smokers ( % );"C0205156;C0750523;C3173209;C3241966";NA;NA;former or current smokers
1420;ex - / current smoker;"C0337671;C0521116;C1704625;C1705970;C3173209;C3241966;C4555205";NA;NA;ex current smoker
1420;current tobacco smoker ( % ) qualifying event ( % );"C0040329;C0086707;C0441471;C0521116;C0740009;C1514624;C1705970;C3173209;C3241966;C4019010;C4505217";NA;NA;current tobacco smoker qualifying event
1420;current tobacco smoker;"C0040329;C0086707;C0521116;C0740009;C1705970;C3173209;C3241966;C4505217";NA;NA;current tobacco smoker
1420;current smokers *;"C3173209;C3241966";NA;NA;current smokers
1420;current smokers ( n = $nmbr$ );"C3173209;C3241966";NA;NA;current smokers n $nmbr$
1420;current smokers ( itt ) ( n = $nmbr$ );"C3173209;C3241966";NA;NA;current smokers itt n $nmbr$
1420;current smokers ( % );"C3173209;C3241966";NA;NA;current smokers
1420;current smokers    n   ( % );"C3173209;C3241966";NA;NA;current smokers n
1420;current smokers  n ( % ) medicai history  n ( % );"C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C3173209;C3241966";NA;NA;current smokers n medicai history n
1420;current smokers  n ( % );"C3173209;C3241966";NA;NA;current smokers n
1420;current smokers  %;"C3173209;C3241966";NA;NA;current smokers
1420;current smokers;"C3173209;C3241966";NA;NA;current smokers
1420;current smoker — no . { % );"C3173209;C3241966";NA;NA;current smoker no
1420;current smoker »;"C3173209;C3241966";NA;NA;current smoker
1420;current smoker at screeninga  n ( % );"C3173209;C3241966";NA;NA;current smoker at screeninga n
1420;current smoker at screening  n ( % );"C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C3173209;C3241966";NA;NA;current smoker at screening n
1420;current smoker at baseline    n   ( % );"C0168634;C1442488;C3173209;C3241966";NA;NA;current smoker at baseline n
1420;current smoker : ex - smoker ( % );"C3173209;C3241966";NA;NA;current smoker ex smoker
1420;current smoker ( n z $nmbr$ );"C3173209;C3241966";NA;NA;current smoker n z $nmbr$
1420;current smoker ( n = $nmbr$ );"C3173209;C3241966";NA;NA;current smoker n $nmbr$
1420;current smoker ( n = $nmbr$  $nmbr$ ) former smoker ( n = $nmbr$  $nmbr$ );"C0205156;C0750523;C3173209;C3241966";NA;NA;current smoker n $nmbr$ $nmbr$ former smoker n $nmbr$ $nmbr$
1420;current smoker ( n = $nmbr$  $nmbr$ );"C3173209;C3241966";NA;NA;current smoker n $nmbr$ $nmbr$
1420;current smoker ( > $nmbr$ cigarettes / day ) — no . ( % );"C0332173;C0439228;C0439505;C0677453;C3173209;C3241966";NA;NA;current smoker $nmbr$ cigarettes day no
1420;current smoker ( % );"C3173209;C3241966";NA;NA;current smoker
1420;current smoker  n [ % ];"C3173209;C3241966";NA;NA;current smoker n
1420;current smoker  n / n ( % );"C3173209;C3241966";NA;NA;current smoker n n
1420;current smoker  n ( % };"C3173209;C3241966";NA;NA;current smoker n
1420;current smoker  n ( % of patients );"C0030705;C3173209;C3241966";NA;NA;current smoker n of patients
1420;current smoker  n ( % );"C3173209;C3241966";NA;NA;current smoker n
1420;current smoker  %;"C3173209;C3241966";NA;NA;current smoker
1420;current smoker;"C3173209;C3241966";NA;NA;current smoker
1420;current cigarette smoker or within past year;"C0337667;C0521116;C0677453;C1704760;C1705970;C3173209;C3241966;C3890423;C4086728";NA;NA;current cigarette smoker or within past year
1420;current cigarette smoker  n ( % );"C0337667;C0521116;C0677453;C1704760;C1705970;C3173209;C3241966;C3890423";NA;NA;current cigarette smoker n
1420;current cigarette smoker;"C0337667;C0521116;C0677453;C1704760;C1705970;C3173209;C3241966;C3890423";NA;NA;current cigarette smoker
1420;current / past smoker;"C1444637;C3173209;C3241966;C4284302";NA;NA;current past smoker
1420;> $nmbr$ . $nmbr$ bpm current smoker;"C3173209;C3241966";NA;NA;$nmbr$ $nmbr$ bpm current smoker
1419;any recurrent stroke;C2242682;NA;NA;any recurrent stroke
1419;all recurrent strokes;C1836785;NA;NA;all recurrent strokes
1418;concurrent illness;"C0205420;C0221423";NA;NA;concurrent illness
1099;( years );C0439234;NA;NA;years
1419;strokezsee;NA;FALSE;1762;strokezsee
1418;concurrent prednisolone;"C0032950;C0205420";FALSE;2226;concurrent prednisolone
1420;current drinker;C0556297;FALSE; 875;current drinker
1420;currentd;NA;FALSE; -10;currentd
1421;alt increased;"C0205217;C0442805;C1266129;C4553172";FALSE;2227;alt increased
1421;increased waist circumference;"C0205217;C0442805;C0455829";FALSE;1413;increased waist circumference
1421;increased risk for thrombotic cardiovascular event ^  n ( % );"C0087086;C0205217;C0442805;C1273410";FALSE;2228;increased risk for thrombotic cardiovascular event n
1421;pancreas;C0030274;FALSE;2229;pancreas
1423;nausea;"C0027497;C1963179;C2984057;C3829611;C4084796;C4085222;C4085661;C4085862;C4255480;C4552888;C4552889;C4553767";FALSE;2230;nausea
1421;ggt increased;"C0205217;C0442805;C1415053";FALSE;2262;ggt increased
1417;history of currently treated hypertension  n ( % );"C0455527;C0521116;C1522326";NA;NA;history of currently treated hypertension n
1417;currently;C0521116;NA;NA;currently
1417;current use of hormone therapy;"C0019932;C0279025;C0521116;C1524063;C1705970;C2827774;C4521914";NA;NA;current use of hormone therapy
   7;p value ( nominal );C1709380;NA;NA;p value nominal
1417;current prescribed medications;"C0521116;C1705970;C3166216;C3202967";NA;NA;current prescribed medications
1417;current or previous atrial fibrillation;"C0004238;C0205156;C0344434;C0521116;C1552607;C1705970;C1963067";NA;NA;current or previous atrial fibrillation
1417;current n z $nmbr$;"C0521116;C1705970";NA;NA;current n z $nmbr$
1417;current inhaler +;"C0021461;C0521116;C1705970;C1881212;C4319647";NA;NA;current inhaler
1417;current corticosteroid use  n;"C0239126;C0521116;C1705970";NA;NA;current corticosteroid use n
1417;current ( n   = $nmbr$  $nmbr$ );"C0521116;C1705970";NA;NA;current n $nmbr$ $nmbr$
1417;current ( % );"C0521116;C1705970";NA;NA;current
1417;current  n ( % );"C0521116;C1705970";NA;NA;current n
1417;current;"C0521116;C1705970";NA;NA;current
1416;current medication — no . ( % );C0746467;NA;NA;current medication no
1416;current medication  n ( % );C0746467;NA;NA;current medication n
 -10;chest discomfort;C0235710;NA;NA;chest discomfort
1414;left circumflex coronary artery;C0226037;NA;NA;left circumflex coronary artery
1414;left circumflex artery  n ( % );C0226037;NA;NA;left circumflex artery n
1414;left circumflex artery;C0226037;NA;NA;left circumflex artery
1414;left circumflex  n ( % );"C0205091;C0443246;C1552822;C1880089";NA;NA;left circumflex n
1414;left circumflex;"C0205091;C0443246;C1552822;C1880089";NA;NA;left circumflex
1413;waist circumference — cmj;C0455829;NA;NA;waist circumference cmj
1413;waist circumference — cm;C0455829;NA;NA;waist circumference cm
1413;waist circumference s $nmbr$ ( men ) or > $nmbr$ cm ( women );"C0025266;C0043210;C0455829";NA;NA;waist circumference s $nmbr$ men or $nmbr$ cm women
1413;waist circumference .;C0455829;NA;NA;waist circumference
1413;waist circumference ( cm ) : mean ± sd;"C0444504;C0455829;C2347634;C2348143;C2699239";NA;NA;waist circumference cm mean sd
1413;waist circumference ( cm );C0455829;NA;NA;waist circumference cm
1413;waist circumference  mean ( sd )  in;"C0444504;C0455829;C2347634;C2348143;C2699239";NA;NA;waist circumference mean sd in
1413;waist circumference  mean ( sd )  cm;"C0444504;C0455829;C2347634;C2348143;C2699239";NA;NA;waist circumference mean sd cm
1413;waist circumference  cm mean ( sd );"C0444504;C0455829;C2347634;C2348143;C2699239";NA;NA;waist circumference cm mean sd
1413;waist circumference  cm ( sd );"C0455829;C2699239";NA;NA;waist circumference cm sd
1413;waist circumference  cm  mean ( sd );"C0444504;C0455829;C2347634;C2348143;C2699239";NA;NA;waist circumference cm mean sd
1413;waist circumference  cm;C0455829;NA;NA;waist circumference cm
1413;waist circumference  ( cm );C0455829;NA;NA;waist circumference cm
1413;waist circumference;C0455829;NA;NA;waist circumference
1413;mean ± sd waist circumference  cm;"C0444504;C0455829;C2347634;C2348143;C2699239";NA;NA;mean sd waist circumference cm
1412;no atopy ( n = $nmbr$ );"C0392707;C3539705";NA;NA;no atopy n $nmbr$
1412;met atopy and ige $nmbr$ - $nmbr$ ku / l criteria  ( n = $nmbr$ );"C0243161;C0392707;C0428210;C0439340;C1550543;C3539705;C4317104";NA;NA;met atopy and ige $nmbr$ $nmbr$ ku l criteria n $nmbr$
1412;dermatitis atopic;"C0011603;C0392707";NA;NA;dermatitis atopic
1412;atopy ( specific ige ) c  n ( % );"C0205369;C0392707;C1552740;C3539705";NA;NA;atopy specific ige c n
1412;atopy ( n = $nmbr$  $nmbr$ );"C0392707;C3539705";NA;NA;atopy n $nmbr$ $nmbr$
1412;atopic at baseline : yes;"C0168634;C0392707;C1442488;C1549445;C1705108;C1710701";NA;NA;atopic at baseline yes
1411;atv n ( % );"C0210243;C0674679;C1145759;C1334862";NA;NA;atv n
1411;atv $nmbr$ mg study protocol;"C0024671;C0026410;C0210243;C0439269;C0674679;C1145759;C1334862;C1507394;C1960952;C2346927;C2348563;C2599718;C4321396;C4521761";NA;NA;atv $nmbr$ mg study protocol
1411;atv $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0210243;C0439269;C0674679;C1145759;C1334862;C1960952;C2346927;C4321396;C4521761";NA;NA;atv $nmbr$ mg n $nmbr$
1411;atv $nmbr$ mg;"C0024671;C0026410;C0210243;C0439269;C0674679;C1145759;C1334862;C1960952;C2346927;C4321396;C4521761";NA;NA;atv $nmbr$ mg
1410;> lto £ $nmbr$ symptom days per week;"C0677547;C1457887;C3854129";NA;NA;lto $nmbr$ symptom days per week
1410;> lto < $nmbr$ ( n = $nmbr$ );NA;NA;NA;lto $nmbr$ n $nmbr$
1410;> $nmbr$ days to $nmbr$ year ( n = $nmbr$ );C0556972;NA;NA;$nmbr$ days to $nmbr$ year n $nmbr$
1409;waist : hip ratio;C0205682;NA;NA;waist hip ratio
1409;waist - to - hip ratio;C0205682;NA;NA;waist to hip ratio
1409;waist - to - hip  female;"C0019552;C0022122;C0043210;C0086287;C0230097;C1505163;C1705497;C1705498;C3538851;C4284725";NA;NA;waist to hip female
1409;waist - hip ratio;C0205682;NA;NA;waist hip ratio
1409;body - mass index  !  waist - to - hip ratio;"C0005893;C0205682;C0578022;C1305855";NA;NA;body mass index waist to hip ratio
1408;ssz + mtx ( n = $nmbr$ );"C0025677;C1417487";NA;NA;ssz mtx n $nmbr$
1408;pbo + mtx to mtx;"C0025677;C0031962;C1417487";NA;NA;pbo mtx to mtx
1408;pbo + mtx n = $nmbr$;"C0025677;C0031962;C1417487";NA;NA;pbo mtx n $nmbr$
1408;pbo + mtx ^ mtx;"C0025677;C0031962;C1417487";NA;NA;pbo mtx mtx
1408;pbo + mtx;"C0025677;C0031962;C1417487";NA;NA;pbo mtx
1412;atonic;C0541791;FALSE; -10;atonic
1414;circumflex;C1880089;FALSE;2218;circumflex
1412;atopic;C0392707;FALSE;1412;atopic
1417;current angina;"C0002962;C0521116;C1705970";FALSE;2220;current angina
1417;current angina ( % );"C0002962;C0521116;C1705970";FALSE;2220;current angina
1417;current bone disease;"C0005940;C0521116;C1705970";FALSE;2221;current bone disease
1417;current enthesitis  n ( % ) ’;"C0521116;C1282952;C1705970";FALSE;2223;current enthesitis n
1417;current smoking;"C0037369;C0453996;C0521116;C1705970;C1881674";FALSE;2224;current smoking
1417;current smoking ( % );"C0037369;C0453996;C0521116;C1705970;C1881674";FALSE;2224;current smoking
1417;current smoking  %;"C0037369;C0453996;C0521116;C1705970;C1881674";FALSE;2224;current smoking
1417;smoking ( current );"C0037369;C0453996;C0521116;C1705970;C1881674";FALSE;2224;smoking current
1417;current nonsmokers;"C0337672;C0521116;C1705970;C4554605";FALSE;2224;current nonsmokers
1417;current or prior smoking  %;"C0037369;C0332152;C0453996;C0521116;C1705970;C1881674;C2826257";FALSE;2224;current or prior smoking
1417;current (  $nmbr$ cigs / day );"C0332173;C0439228;C0439505;C0521116;C1570610;C1705970";FALSE;2224;current $nmbr$ cigs day
1417;current ( $nmbr$ + cigs / day );"C0332173;C0439228;C0439505;C0521116;C1570610;C1705970";FALSE;2224;current $nmbr$ cigs day
1417;postmenopausal  current hormone;"C0019932;C0232970;C0521116;C1705970;C4521914";FALSE;2225;postmenopausal current hormone
1417;postmenopausal  current hormone therapy use;"C0019932;C0042153;C0232970;C0279025;C0457083;C0521116;C1705970;C1947944;C2827774;C4521914";FALSE;2225;postmenopausal current hormone therapy use
1417;current inhaled corticosteroid use;"C0004048;C0239126;C0521116;C1705970";FALSE;2182;current inhaled corticosteroid use
1417;current cigarette  n ( % );"C0521116;C0677453;C1704760;C1705970;C3890423";FALSE; 420;current cigarette n
1408;no mtx use at baseline;"C0025677;C0042153;C0168634;C0457083;C1417487;C1442488;C1947944";NA;NA;no mtx use at baseline
1408;no mtx at baseline;"C0025677;C0168634;C1417487;C1442488";NA;NA;no mtx at baseline
1408;mtx use at randomization  n ( % );"C0025677;C0034656;C0042153;C0457083;C1417487;C1947944";NA;NA;mtx use at randomization n
1408;mtx use at baseline;"C0025677;C0042153;C0168634;C0457083;C1417487;C1442488;C1947944";NA;NA;mtx use at baseline
1408;mtx plus infliximab;"C0025677;C0332287;C0666743;C1417487";NA;NA;mtx plus infliximab
1408;mtx only;"C0025677;C0205171;C1417487;C1720467";NA;NA;mtx only
1408;mtx naive or free;"C0025677;C0332296;C1417487;C1880497;C1996904";NA;NA;mtx naive or free
1408;mtx n = $nmbr$;"C0025677;C1417487";NA;NA;mtx n $nmbr$
1408;mtx at baseline  n ( % );"C0025677;C0168634;C1417487;C1442488";NA;NA;mtx at baseline n
1408;mtx at baseline;"C0025677;C0168634;C1417487;C1442488";NA;NA;mtx at baseline
1408;mtx + othetcsdmards;"C0025677;C1417487";NA;NA;mtx othetcsdmards
1408;mtx + other csomards;"C0025677;C1417487";NA;NA;mtx other csomards
1408;mtx + other csdmards;"C0025677;C1417487";NA;NA;mtx other csdmards
1408;mtx + non - mtx;"C0025677;C1417487;C1518422";NA;NA;mtx non mtx
1408;mtx ( n = $nmbr$ );"C0025677;C1417487";NA;NA;mtx n $nmbr$
1408;mtx ( n );"C0025677;C1417487";NA;NA;mtx n
1408;mtx;"C0025677;C1417487";NA;NA;mtx
1408;methotrexate user;"C0025677;C1548600;C1706077";NA;NA;methotrexate user
1408;methotrexate plus other csdmardfl;C0025677;NA;NA;methotrexate plus other csdmardfl
1408;methotrexate;C0025677;NA;NA;methotrexate
1408;lef + mtx ( n = $nmbr$ );"C0025677;C1417487";NA;NA;lef mtx n $nmbr$
1408;hcq + mtx ( n = $nmbr$ );"C0020336;C0025677;C1417487";NA;NA;hcq mtx n $nmbr$
1408;etn + mtx ( n = $nmbr$ );"C0014758;C0025677;C0717758;C1417487";NA;NA;etn mtx n $nmbr$
1408;etn $nmbr$ mg + mtx n = $nmbr$;"C0014758;C0024671;C0025677;C0026410;C0439269;C0717758;C1417487;C1960952;C2346927;C4321396;C4521761";NA;NA;etn $nmbr$ mg mtx n $nmbr$
1408;csdmards + mtx ( n = $nmbr$ );"C0025677;C1417487";NA;NA;csdmards mtx n $nmbr$
1408;csdmard otherthan methotrexate;C0025677;NA;NA;csdmard otherthan methotrexate
1408;concomitant use of mtx to week $nmbr$;"C0025677;C0332174;C0439230;C0521115;C1417487;C1524063";NA;NA;concomitant use of mtx to week $nmbr$
1408;concomitant mtx —;"C0025677;C0521115;C1417487";NA;NA;concomitant mtx
1408;concomitant mtx use  n ( % );"C0025677;C0042153;C0457083;C0521115;C1417487;C1947944";NA;NA;concomitant mtx use n
1408;concomitant methotrexate  n ( % );"C0025677;C0521115";NA;NA;concomitant methotrexate n
1408;$nmbr$ non - mtx;"C0025677;C1417487;C1518422";NA;NA;$nmbr$ non mtx
1407;ldl - cz;C0206578;NA;NA;ldl cz
1407;czech republic;C0206578;NA;NA;czech republic
1407;a $nmbr$ + ez n = $nmbr$ a $nmbr$ n = $nmbr$;C0206578;NA;NA;a $nmbr$ ez n $nmbr$ a $nmbr$ n $nmbr$
1407;a $nmbr$ + ez n = $nmbr$;C0206578;NA;NA;a $nmbr$ ez n $nmbr$
1407;a $nmbr$ + ez $nmbr$ a $nmbr$ ( n = $nmbr$ ) ( n = $nmbr$ );"C0206578;C0369718;C0441922";NA;NA;a $nmbr$ ez $nmbr$ a $nmbr$ n $nmbr$ n $nmbr$
1407;a $nmbr$ + ez $nmbr$;C0206578;NA;NA;a $nmbr$ ez $nmbr$
1406;week $nmbr$ czp dose combined ( n   =   $nmbr$ );"C0054841;C0178602;C0205195;C0332174;C0369718;C0439230;C0441922;C0869039;C1114758;C1861828;C1872109";NA;NA;week $nmbr$ czp dose combined n $nmbr$
1406;week $nmbr$ czp dose combined;"C0054841;C0178602;C0205195;C0332174;C0439230;C0869039;C1114758;C1861828;C1872109";NA;NA;week $nmbr$ czp dose combined
1406;czp combined arms ( n = $nmbr$ );"C0054841;C0205195;C0206655;C0446516;C1861828;C1872109;C2681631;C3715044;C4553528";NA;NA;czp combined arms n $nmbr$
1406;czp baseline;"C0054841;C0168634;C1442488;C1861828;C1872109";NA;NA;czp baseline
1406;certolizumab pegol ( n = $nmbr$ );C1872109;NA;NA;certolizumab pegol n $nmbr$
1405;values were reported for $nmbr$ patients in the spironolactone group and $nmbr$;"C0037982;C0042295;C0441833;C0588446;C0687744;C1257890;C1519504;C1705428;C1705429";NA;NA;values were reported for $nmbr$ patients in the spironolactone group and $nmbr$
1405;spironolactone ( n = $nmbr$ );C0037982;NA;NA;spironolactone n $nmbr$
1405;spironolactone  n ( % );C0037982;NA;NA;spironolactone n
1405;spironolactone;C0037982;NA;NA;spironolactone
1405;outcomes by treatment ( spironolactone vs placebo );"C0032042;C0037982;C0085415;C1696465;C1706408";NA;NA;outcomes by treatment spironolactone vs placebo
1405;mra ( spironolactone or eplerenone );"C0037982;C0243032;C0961485;C1609165;C3891069";NA;NA;mra spironolactone or eplerenone
1405;in the spironolactone group and $nmbr$ patients in the placebo group .;"C0030705;C0032042;C0037982;C0441833;C0687744;C1257890;C1519504;C1696465;C1705428;C1705429;C1706408";NA;NA;in the spironolactone group and $nmbr$ patients in the placebo group
1404;glucosamine + chondroitin sulfate;"C0008454;C0008466;C0017718;C0017720;C0038720;C0474702;C0475337;C0876712;C3536965";NA;NA;glucosamine chondroitin sulfate
1404;chondroitin sulfate ( n = $nmbr$ );C0008466;NA;NA;chondroitin sulfate n $nmbr$
1404;chondroitin sulfate;C0008466;NA;NA;chondroitin sulfate
1403;no methotrexate  hydroxychloroquine  or sulfasalazine treatment;"C0020336;C0025677;C0036078;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;no methotrexate hydroxychloroquine or sulfasalazine treatment
1403;hydroxychloroquine treatment §;"C0020336;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;hydroxychloroquine treatment
1403;hydroxychloroquine;C0020336;NA;NA;hydroxychloroquine
1402;whiteb;NA;NA;NA;whiteb
1402;white race — no . { % ) - i -;"C0007457;C0021966;C0034510;C0043157;C0220938;C0221138;C1706779;C3853635";NA;NA;white race no i
1402;white race — no . { % ) ' i ';"C0007457;C0021966;C0034510;C0043157;C0220938;C0221138;C1706779;C3853635";NA;NA;white race no i
1402;white race — no . { % ) $;"C0007457;C0034510;C0043157;C0220938;C1706779;C3853635";NA;NA;white race no $
1402;white race — no . / total no . ( % ) f;"C0007457;C0016327;C0034510;C0043157;C0220938;C0439175;C0439810;C1706779;C3853635";NA;NA;white race no total no f
1402;white race — no . / total no . ( % ) $;"C0007457;C0034510;C0043157;C0220938;C0439175;C0439810;C1706779;C3853635";NA;NA;white race no total no $
1402;white race — no . ( % ) f;"C0007457;C0016327;C0034510;C0043157;C0220938;C1706779;C3853635";NA;NA;white race no f
1402;white race — no . ( % ) : t;"C0007457;C0034510;C0043157;C0220938;C1706779;C2603360;C3853635";NA;NA;white race no t
1402;white race — no . ( % ) :;"C0007457;C0034510;C0043157;C0220938;C1706779;C3853635";NA;NA;white race no
1402;white race  n ( % );"C0007457;C0043157";NA;NA;white race n
1402;white race  %;"C0007457;C0043157";NA;NA;white race
1408;non - mtx csdmards;"C0025677;C1417487;C1518422";FALSE; 231;non mtx csdmards
1403;chloroquine;C0008269;FALSE;1965;chloroquine
1408;non - mtx;"C0025677;C1417487;C1518422";FALSE; 231;non mtx
1404;chondroitin;C0008454;FALSE;2216;chondroitin
1406;czp + mtx;"C0025677;C0054841;C1417487;C1861828;C1872109";FALSE;2217;czp mtx
1406;czp + mtx ^ mtx;"C0025677;C0054841;C1417487;C1861828;C1872109";FALSE;2217;czp mtx mtx
1407;all ez / simva;C0206578;FALSE;1862;all ez simva
1407;ez / simva;C0206578;FALSE;1862;ez simva
1407;ez / simva $nmbr$ mg;"C0024671;C0026410;C0206578;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;1862;ez simva $nmbr$ mg
1407;ez / simva < % >;C0206578;FALSE;1862;ez simva
1407;ez / simva n = $nmbr$ n ( % );C0206578;FALSE;1862;ez simva n $nmbr$ n
1402;white non - hispanic - n ( % );"C0007457;C0043157;C0220938;C1518422;C1518424;C1533020;C1533021";NA;NA;white non hispanic n
1402;white non - hispanic;"C0007457;C0043157;C0220938;C1518422;C1518424;C1533020;C1533021";NA;NA;white non hispanic
1402;white mtx ( n );"C0007457;C0025677;C0043157;C0220938;C1417487";NA;NA;white mtx n
1402;white : black : other;"C0005680;C0007457;C0027567;C0043157;C0085756;C0220938;C0439541";NA;NA;white black other
1402;white / other;"C0007457;C0043157;C0220938";NA;NA;white other
1402;white ( n — $nmbr$ );"C0007457;C0043157;C0220938";NA;NA;white n $nmbr$
1402;white ( n   = $nmbr$  $nmbr$ );"C0007457;C0043157;C0220938";NA;NA;white n $nmbr$ $nmbr$
1402;white ( n = $nmbr$ );"C0007457;C0043157;C0220938";NA;NA;white n $nmbr$
1402;white ( n = $nmbr$  $nmbr$ );"C0007457;C0043157;C0220938";NA;NA;white n $nmbr$ $nmbr$
1402;white ( $nmbr$ . $nmbr$ % );"C0007457;C0043157;C0220938";NA;NA;white $nmbr$ $nmbr$
1402;white  non - hispanic;"C0007457;C0043157;C0220938;C1518422;C1518424;C1533020;C1533021";NA;NA;white non hispanic
1402;white  no . ( % );"C0007457;C0043157;C0220938";NA;NA;white no
1402;white  n / n ( % );"C0007457;C0043157;C0220938";NA;NA;white n n
1402;white  n ( % );"C0007457;C0043157;C0220938";NA;NA;white n
1402;white  %;"C0007457;C0043157;C0220938";NA;NA;white
1402;white;"C0007457;C0043157;C0220938";NA;NA;white
1402;w hite;NA;NA;NA;w hite
1402;race_white  %;"C0007457;C0034510;C0043157;C0220938;C1706779;C3853635";NA;NA;race_white
1402;race  no . ( % ) white;"C0007457;C0034510;C0043157;C0220938;C1706779;C3853635";NA;NA;race no white
1402;non - hispanic white;"C0007457;C0043157;C0220938;C1518424";NA;NA;non hispanic white
1402;asian / black / white / hispanic / other ( % ) clinical parameters;"C0005680;C0007457;C0027567;C0043157;C0078988;C0085756;C0205210;C0220938;C0439541;C0449381;C1533017;C1533018;C1533020;C1533021";NA;NA;asian black white hispanic other clinical parameters
1401;race - nonwhite;"C0034510;C1706779;C3853635";NA;NA;race nonwhite
1401;race  % nonwhite;"C0034510;C1706779;C3853635";NA;NA;race nonwhite
1401;nonwhite race — no . ( % ) ejection fraction;"C0034510;C0489482;C1706779;C2700378;C3853635";NA;NA;nonwhite race no ejection fraction
1401;nonwhite race !;"C0034510;C1706779;C3853635";NA;NA;nonwhite race
1401;nonwhite race;"C0034510;C1706779;C3853635";NA;NA;nonwhite race
1401;nonwhite;NA;NA;NA;nonwhite
1400;sita / pio $nmbr$ / $nmbr$;"C0030800;C2347712";NA;NA;sita pio $nmbr$ $nmbr$
1400;sita $nmbr$ + pio $nmbr$;"C0030800;C2347712";NA;NA;sita $nmbr$ pio $nmbr$
1400;sita $nmbr$;NA;NA;NA;sita $nmbr$
1400;= sia;"C1225105;C1551538";NA;NA;sia
1399;type ia;"C0020980;C0332307;C0694634;C1547052;C1947960";NA;NA;type ia
1399;simple partial ( ia );"C0020980;C0205352;C0694634;C0728938;C1550516;C1947960";NA;NA;simple partial ia
1398;type ib;"C0332307;C1547052;C2744579;C3890035;C4283819";NA;NA;type ib
1398;ib ( $nmbr$ . $nmbr$ );"C2744579;C3890035;C4283819";NA;NA;ib $nmbr$ $nmbr$
1398;complex partial ( ib );"C0439855;C0728938;C1550516;C1704241;C2744579;C3890035;C4283819";NA;NA;complex partial ib
1398;class ib;"C0456387;C1518526;C1705943;C2744579;C3890035;C4283819";NA;NA;class ib
1397;tnfi - ir;"C0022065;C0022071;C1448132";NA;NA;tnfi ir
1397;tnf - ir;"C0022065;C0022071;C1448132;C1448177";NA;NA;tnf ir
1397;mtx ir;"C0022065;C0022071;C0025677;C1417487;C1448132";NA;NA;mtx ir
1397;mtx - ir;"C0022065;C0022071;C0025677;C1417487;C1448132";NA;NA;mtx ir
1397;homa - ir score;"C0022065;C0022071;C0449820;C1448132;C4050231";NA;NA;homa ir score
1397;homa - ir index — median ( iqr );"C0022065;C0022071;C0549183;C0600653;C0876920;C0918012;C1448132;C1552854;C1637833;C2347635;C2348144;C2939193;C2986546";NA;NA;homa ir index median iqr
1397;homa - ir index;"C0022065;C0022071;C0600653;C0918012;C1448132;C1552854;C1637833;C2986546";NA;NA;homa ir index
1397;homa - ir ( mu / l ^ mmol / l );"C0022065;C0022071;C0439190;C0439342;C1448132";NA;NA;homa ir mu l mmol l
1397;homa - ir ( % ) b;"C0022065;C0022071;C1448132";NA;NA;homa ir b
1397;homa - ir  mean ( sd ) ( mu / l $ mmol / l ) b;"C0022065;C0022071;C0439190;C0439342;C0444504;C1448132;C2347634;C2348143;C2699239";NA;NA;homa ir mean sd mu l $ mmol l b
1397;homa - ir;"C0022065;C0022071;C1448132";NA;NA;homa ir
1397;dmard - ir / anti - tnf - ir;"C0022065;C0022071;C0242708;C1448132;C1448177";NA;NA;dmard ir anti tnf ir
1397;dmard - ir;"C0022065;C0022071;C0242708;C1448132";NA;NA;dmard ir
1397;dmard - biologic ir;"C0005515;C0022065;C0022071;C0205460;C0242708;C1448132";NA;NA;dmard biologic ir
1397;bdmard - ir;"C0022065;C0022071;C1448132";NA;NA;bdmard ir
1397;anti - tnf ir;"C0022065;C0022071;C1448132;C1448177";NA;NA;anti tnf ir
1397;anti - tnf - ir patients;"C0022065;C0022071;C0030705;C1448132;C1448177";NA;NA;anti tnf ir patients
1395;coenzyme q $nmbr$ p  g / ml #;"C0041536;C1300565";NA;NA;coenzyme q $nmbr$ p g ml
1395;coenzyme q $nmbr$  ^ g / ml #;"C0041536;C1300565";NA;NA;coenzyme q $nmbr$ g ml
1395;coenzyme q $nmbr$;C0041536;NA;NA;coenzyme q $nmbr$
1395;all with coenzyme q $nmbr$ ( n = $nmbr$  $nmbr$ );C0041536;NA;NA;all with coenzyme q $nmbr$ n $nmbr$ $nmbr$
1395;$nmbr$ coenzyme q $nmbr$ subgroups for time to first hospitalization ( number of patients variable ) .;"C0019993;C0040223;C0041536;C0205435;C0439828;C1079230;C1279901;C2360800;C3541383;C4553760";NA;NA;$nmbr$ coenzyme q $nmbr$ subgroups for time to first hospitalization number of patients variable
1394;time from end of fit  years ( meanisd );"C0036572;C0439234;C1522314;C2349186;C4048158;C4553125";NA;NA;time from end of fit years meanisd
1394;seizure worry;"C0036572;C0233481;C1959629;C4553401";NA;NA;seizure worry
1394;seizure types reported during baselinee;"C0036572;C0332307;C0684224;C0700287;C1959629;C4319718;C4553401";NA;NA;seizure types reported during baselinee
1394;convulsion;"C0036572;C4048158";NA;NA;convulsion
1394;cluster seizures;"C0036572;C1555715;C1704332";NA;NA;cluster seizures
1393;laparoscopic cholecystectomy;C0162522;NA;NA;laparoscopic cholecystectomy
1393;cholecystectomy ( n = $nmbr$ );C0008320;NA;NA;cholecystectomy n $nmbr$
1392;cholesterol absorption inhibitor ( ezetimibe );"C0000854;C0003277;C1142985;C1999216;C2347023;C2347080;C2698776;C2825050;C2945742";FALSE;1165;cholesterol absorption inhibitor ezetimibe
1391;hvpercholesterolemia;NA;FALSE;1390;hvpercholesterolemia
1392;cabgorptca;NA;FALSE;1524;cabgorptca
1399;austral ia / new zealand;"C0020980;C0027978;C0324547;C0694634;C1947960";FALSE; 189;austral ia new zealand
1401;while;NA;FALSE;2215;while
1401;race  while;"C0034510;C1706779;C3853635";FALSE;1402;race while
1402;non white;"C0007457;C0043157;C0220938;C1518422";FALSE;1401;non white
1402;non - white;"C0007457;C0043157;C0220938;C1518422";FALSE;1401;non white
1402;non - white race;"C0007457;C0043157;C1518422";FALSE;1401;non white race
1402;non - white raceb;"C0007457;C0043157;C0220938;C1518422";FALSE;1401;non white raceb
1402;race  non - white;"C0007457;C0034510;C0043157;C0220938;C1518422;C1706779;C3853635";FALSE;1401;race non white
1402;race - non - white;"C0007457;C0034510;C0043157;C0220938;C1518422;C1706779;C3853635";FALSE;1401;race non white
1391;heterozygous familial hypercholesterolemia †;C0342882;NA;NA;heterozygous familial hypercholesterolemia
1391;heterozygous familial hypercholesterolemia;C0342882;NA;NA;heterozygous familial hypercholesterolemia
1390;reported high cholesterol ' !;"C0020443;C0684224;C0700287;C1522133;C4319718";NA;NA;reported high cholesterol
1390;hypertension — no . ( % ) hypercholesterolemia — no . ( % );"C0020443;C0020538;C1522133;C1963138";NA;NA;hypertension no hypercholesterolemia no
1390;hypercholesterolemia 一 no . ( % );"C0020443;C1522133";NA;NA;hypercholesterolemia no
1390;hypercholesterolemia — no . ( % ) *;"C0020443;C1522133";NA;NA;hypercholesterolemia no
1390;hypercholesterolemia — no . ( % );"C0020443;C1522133";NA;NA;hypercholesterolemia no
1390;hypercholesterolemia *;"C0020443;C1522133";NA;NA;hypercholesterolemia
1390;hypercholesterolemia ( > $nmbr$ mg / dl );"C0020443;C0439269;C1522133";NA;NA;hypercholesterolemia $nmbr$ mg dl
1390;hypercholesterolemia ( % );"C0020443;C1522133";NA;NA;hypercholesterolemia
1390;hypercholesterolemia  no . ( % );"C0020443;C1522133";NA;NA;hypercholesterolemia no
1390;hypercholesterolemia  n ( % );"C0020443;C1522133";NA;NA;hypercholesterolemia n
1390;hypercholesterolemia;"C0020443;C1522133";NA;NA;hypercholesterolemia
1390;hypercholesterolaemia ( % );"C0020443;C1522133";NA;NA;hypercholesterolaemia
1390;hypercholesterolaemia;"C0020443;C1522133";NA;NA;hypercholesterolaemia
1390;elevated cholesterol;C0020443;NA;NA;elevated cholesterol
1390;duration of hypercholesterolaemia  mean ± sd ( year );"C0020443;C0439234;C0439508;C0444504;C0449238;C1522133;C2347634;C2348143;C2699239;C2926735";NA;NA;duration of hypercholesterolaemia mean sd year
1389;< $nmbr$ with no historical count > $nmbr$;"C0750480;C1552658;C1552723;C1705566;C2004062";NA;NA;$nmbr$ with no historical count $nmbr$
1389;< $nmbr$ with historical count > $nmbr$;"C0750480;C1552658;C1552723;C1705566;C2004062";NA;NA;$nmbr$ with historical count $nmbr$
1389;< $nmbr$ regardless of historical count;"C0750480;C1552658;C1552723;C1705566;C2004062";NA;NA;$nmbr$ regardless of historical count
1388;rs - cough & sputumc;"C0010200;C0035970;C1961131;C3274924;C3714753;C3813325;C4084725;C4084726;C4084727";NA;NA;rs cough sputumc
1388;cough ( investigator reported );"C0010200;C0035173;C0684224;C0700287;C1961131;C3274924;C4084725;C4084726;C4084727;C4319718";NA;NA;cough investigator reported
1388;cough  n ( % );"C0010200;C1961131;C3274924;C4084725;C4084726;C4084727";NA;NA;cough n
1388;cough;"C0010200;C1961131;C3274924;C4084725;C4084726;C4084727";NA;NA;cough
1388;any cough;"C0010200;C1961131;C3274924;C4084725;C4084726;C4084727";NA;NA;any cough
1386;components;C0449432;NA;NA;components
1385;threatened abrupt vessel closure;"C0005847;C0185003;C1276802;C1521802";NA;NA;threatened abrupt vessel closure
1385;abrupt vessel closure;"C0005847;C0185003;C1276802;C1521802";NA;NA;abrupt vessel closure
1384;cyclosporine ( n = $nmbr$ );"C0010592;C0010594";NA;NA;cyclosporine n $nmbr$
1384;cyclosporin;"C0010592;C0010594";NA;NA;cyclosporin
1383;itt cohort  overall study period;"C0009247;C0282416;C0439531;C0557651;C0599755;C1561607;C1948053;C2603343";NA;NA;itt cohort overall study period
1382;residence in asia  n ( % );"C0003980;C0237096";NA;NA;residence in asia n
1382;region  asia / paafic;"C0003980;C0017446;C0205147";NA;NA;region asia paafic
1382;geo graphic region : asia;"C0003980;C0017446;C0017454;C0205147";NA;NA;geo graphic region asia
1382;east asia;C0015631;NA;NA;east asia
1382;asia pacific or other;C0003980;NA;NA;asia pacific or other
1382;asia pacific and south africa;"C0003980;C0037712";NA;NA;asia pacific and south africa
1382;asia pacific and other;C0003980;NA;NA;asia pacific and other
1382;asia pacific ( n = $nmbr$ );C0003980;NA;NA;asia pacific n $nmbr$
1382;asia pacific;C0003980;NA;NA;asia pacific
1382;asia and pacific islands;"C0003980;C0030168";NA;NA;asia and pacific islands
1382;asia / pacific / other;C0003980;NA;NA;asia pacific other
1382;asia / pacific ( % );C0003980;NA;NA;asia pacific
1382;asia / pacific;C0003980;NA;NA;asia pacific
1382;asia - pacific region and south africa;"C0003980;C0017446;C0037712;C0205147";NA;NA;asia pacific region and south africa
1382;asia - pacific hr ( $nmbr$ % cl );"C0003980;C0596019";NA;NA;asia pacific hr $nmbr$ cl
1382;asia - pacific and south africa;"C0003980;C0037712";NA;NA;asia pacific and south africa
1382;asia - pacific;C0003980;NA;NA;asia pacific
1382;asia ( n = $nmbr$ );C0003980;NA;NA;asia n $nmbr$
1382;asia ( n = $nmbr$  $nmbr$ );C0003980;NA;NA;asia n $nmbr$ $nmbr$
1382;asia #;C0003980;NA;NA;asia
1382;asia  pacific and other;C0003980;NA;NA;asia pacific and other
1382;asia;C0003980;NA;NA;asia
1381;saudi arabia;C0036243;NA;NA;saudi arabia
1380;with higher classes indicating greater limitations on physical activity owing to;"C0015259;C0026606;C0205250;C0449295;C0456387;C1518526;C1704243;C1705943;C4019422";NA;NA;with higher classes indicating greater limitations on physical activity owing to
1380;walk for exercise ( % );"C0015259;C0080331;C1522704";NA;NA;walk for exercise
1380;walk for exercise;"C0015259;C0080331;C1522704";NA;NA;walk for exercise
1380;some physical activity;"C0015259;C0026606";NA;NA;some physical activity
1380;physical activity §;"C0015259;C0026606";NA;NA;physical activity
1380;physical activity  kcal / wk < $nmbr$;"C0015259;C0026606;C0332174;C0439230;C0439259";NA;NA;physical activity kcal wk $nmbr$
1389;dactylitis count;"C0239161;C0750480;C1705566";FALSE; 492;dactylitis count
1386;chads $nmbr$ components  n ( % );"C0007928;C0449432;C1413373";FALSE;2128;chads $nmbr$ components n
1381;sa;"C0036243;C0038702;C1539696;C1825840;C3539736;C4521691";FALSE; -10;sa
1382;pacific;NA;FALSE;2207;pacific
1383;total cohort;"C0009247;C0439175;C0439810;C0599755";FALSE;2208;total cohort
1383;cohort;"C0009247;C0599755";FALSE;2208;cohort
1383;cohort $nmbr$ ( n = $nmbr$ );"C0009247;C0599755";FALSE;2208;cohort $nmbr$ n $nmbr$
1383;entire cohort gender;"C0009247;C0079399;C0439751;C0444667;C0599755;C1522384";FALSE;2208;entire cohort gender
1383;entire evaluable cohort;"C0009247;C0439751;C0444667;C0599755;C1516986";FALSE;2208;entire evaluable cohort
1383;full cohort;"C0009247;C0443225;C0599755";FALSE;2208;full cohort
1383;primary - prevention cohort;"C0009247;C0033144;C0599755";FALSE;2209;primary prevention cohort
1383;secondary - prevention cohort;"C0009247;C0599755;C0679699";FALSE;2210;secondary prevention cohort
1385;pfo closure;"C0185003;C1521802";FALSE;2211;pfo closure
1385;pfo closure group ( n = $nmbr$ );"C0185003;C0441848;C1521802";FALSE;2211;pfo closure group n $nmbr$
1385;closure;"C0185003;C1521802";FALSE;2212;closure
1387;$nmbr$ - aminosalicylic compounds — no . ( % );"C0205198;C1706082";FALSE;1691;$nmbr$ aminosalicylic compounds no
1387;$nmbr$ - asa compounds  n ( % );"C0004057;C0205198;C1706082;C3853627";FALSE;1691;$nmbr$ asa compounds n
1387;no use of $nmbr$ - asa compounds;"C0004057;C0205198;C1524063;C1706082;C3853627";FALSE;1691;no use of $nmbr$ asa compounds
1389;enthesitis count;"C0750480;C1282952;C1705566";FALSE;2213;enthesitis count
1389;tender joint count ( $nmbr$ - $nmbr$ possible joints );"C0022417;C0240094;C0332149;C0392905;C0750480;C1705566;C1705910;C2362652;C4554549;C4696258";FALSE;1139;tender joint count $nmbr$ $nmbr$ possible joints
1389;tender - or painful - joint count ( of $nmbr$ joints assessed ) — no .;"C0003862;C0234234;C0750480;C1516048;C1705566";FALSE;1139;tender or painful joint count of $nmbr$ joints assessed no
1389;eosinoohil count;"C0750480;C1705566";FALSE; 849;eosinoohil count
1380;physical activity  kcal / wk *;"C0015259;C0026606;C0332174;C0439230;C0439259";NA;NA;physical activity kcal wk
1380;physical activity  kcal / wk;"C0015259;C0026606;C0332174;C0439230;C0439259";NA;NA;physical activity kcal wk
   7;p value ( interaction );"C1704675;C1709380";NA;NA;p value interaction
1380;exercise times per week  ( minimum;"C0015259;C0456698;C1522704;C1524031;C1552614;C2826545";NA;NA;exercise times per week minimum
1380;exercise status;"C0015259;C0449438;C1522704";NA;NA;exercise status
1380;exercise at least weekly ( a );"C0015259;C0332174;C1522704";NA;NA;exercise at least weekly a
1380;exercise > once weekly ?;"C0015259;C0558293;C1522704";NA;NA;exercise once weekly
1380;exercise > once weekly;"C0015259;C0558293;C1522704";NA;NA;exercise once weekly
1380;daily exercise ( % );"C0015259;C0332173;C1522704";NA;NA;daily exercise
1379;serum sodium — meq / liter;"C0439152;C0475211;C0523891";NA;NA;serum sodium meq liter
1379;serum sodium . meq / l;"C0439375;C0523891";NA;NA;serum sodium meq l
1379;serum sodium  meq / l;"C0439375;C0523891";NA;NA;serum sodium meq l
1378;sodium  meq / l;"C0037473;C0439375;C0597484;C3541959;C3714642";NA;NA;sodium meq l
1378;sodium;"C0037473;C0597484;C3541959;C3714642";NA;NA;sodium
1377;small / medium;"C0009458;C0439536;C0700321;C1705217;C3244283;C4085196;C4522282;C4522283";NA;NA;small medium
1377;medium;"C0009458;C0439536;C1705217;C3244283;C4085196;C4522282;C4522283";NA;NA;medium
1376;minimum — maximum;"C0806909;C1524031;C1552614;C1552615;C2826545;C2826546";NA;NA;minimum maximum
1376;minimum — maxim um;"C0024968;C1524031;C1552614;C2826545";NA;NA;minimum maxim um
1376;minimum : maximum;"C0806909;C1524031;C1552614;C1552615;C2826545;C2826546";NA;NA;minimum maximum
1376;minimum / maximum;"C0806909;C1524031;C1552614;C1552615;C2826545;C2826546";NA;NA;minimum maximum
1376;minimum - maximum;"C0806909;C1524031;C1552614;C1552615;C2826545;C2826546";NA;NA;minimum maximum
1376;minimum  maximum;"C0806909;C1524031;C1552614;C1552615;C2826545;C2826546";NA;NA;minimum maximum
1376;median ( minimum – maximum ) focal seizure frequency / $nmbr$   days at baseline;"C0149775;C0168634;C0205234;C0376249;C0439228;C0439603;C0549183;C0751495;C0806909;C0871396;C0876920;C1442488;C1524031;C1552614;C1552615;C1561548;C1705502;C2347635;C2348144;C2826545;C2826546;C2939193;C3898838;C4321352";NA;NA;median minimum maximum focal seizure frequency $nmbr$ days at baseline
1375;belgium;C0004950;NA;NA;belgium
1374;non - calcium antagonist strategy ( ncas ) ( events / n );"C0006684;C0441471;C0679199;C1413309;C1518422;C3541888;C3813543";NA;NA;non calcium antagonist strategy ncas events n
1374;non - calcium antagonist strategy ( n = $nmbr$ $nmbr$ );"C0006684;C0679199;C1518422";NA;NA;non calcium antagonist strategy n $nmbr$ $nmbr$
1373;serum albumin - adjusted calcium ( mg / dl );"C0006675;C0006726;C0036773;C0439269;C0456081;C0728877;C2936886;C3540037;C3714611";NA;NA;serum albumin adjusted calcium mg dl
1373;dense calcium  mm ’;"C0006675;C0006726;C0439794;C2936886;C3540037;C3714611;C4330985;C4554674";NA;NA;dense calcium mm
1373;dense calcium;"C0006675;C0006726;C0439794;C2936886;C3540037;C3714611";NA;NA;dense calcium
1373;calcium ( mmol / l );"C0006675;C0006726;C1532563;C2936886;C3540037;C3714611";NA;NA;calcium mmol l
1373;calcium  mmol $nmbr$ $nmbr$;"C0006675;C0006726;C0439190;C2936886;C3540037;C3714611";NA;NA;calcium mmol $nmbr$ $nmbr$
1372;with tiotropium;C0213771;NA;NA;with tiotropium
1372;versus tiotropium $nmbr$ pg;"C0030827;C0072225;C0213771;C1266240";NA;NA;versus tiotropium $nmbr$ pg
1372;versus tiotropium $nmbr$ . $nmbr$ pg;"C0030827;C0072225;C0213771;C1266240";NA;NA;versus tiotropium $nmbr$ $nmbr$ pg
1372;tiotropiumc;NA;NA;NA;tiotropiumc
1372;tiotropium vs . salmeterol;"C0073992;C0213771";NA;NA;tiotropium vs salmeterol
1372;tiotropium group ( n = $nmbr$ );"C0213771;C0441848";NA;NA;tiotropium group n $nmbr$
1372;tiotropium + placeb ( n [ $nmbr$ );C0213771;NA;NA;tiotropium placeb n $nmbr$
1372;tiotropium ( nz $nmbr$ );"C0027978;C0213771";NA;NA;tiotropium nz $nmbr$
1372;tiotropium ( n z $nmbr$ );C0213771;NA;NA;tiotropium n z $nmbr$
1372;tiotropium ( n = $nmbr$ );C0213771;NA;NA;tiotropium n $nmbr$
1372;tiotropium $nmbr$   μ g ( n   =   $nmbr$ );"C0213771;C0439267";NA;NA;tiotropium $nmbr$ g n $nmbr$
1373;calcium supplements;"C0006675;C0006726;C0242295;C1947943;C2348609;C2936886;C3540037;C3714611";FALSE;2187;calcium supplements
1374;calcium channel antagonists  n ( % );"C0006684;C2757014";FALSE;1884;calcium channel antagonists n
1374;calcium - channel antagonists;"C0006684;C2757014";FALSE;1884;calcium channel antagonists
1374;calcium antagonist strategy ( n = $nmbr$ $nmbr$ );"C0006684;C0679199";FALSE;1884;calcium antagonist strategy n $nmbr$ $nmbr$
1374;calcium antagonist — no . ( % );C0006684;FALSE;1884;calcium antagonist no
1374;calcium antagonist;C0006684;FALSE;1884;calcium antagonist
1374;calcium aniagonisi;"C0006675;C0006726;C2936886;C3540037;C3714611";FALSE;1884;calcium aniagonisi
1375;calcium - channel blockerf;C0006685;FALSE;1884;calcium channel blockerf
1375;calcium - channel inhibitor;"C0006685;C1999216";FALSE;1884;calcium channel inhibitor
1375;calcium - channel blockersubgroup;C0006685;FALSE;1884;calcium channel blockersubgroup
1376;average maximum cimt ( mm );"C0806909;C1510992;C1552615;C2825518;C2826546;C4330985;C4554674";FALSE;1262;average maximum cimt mm
1376;average of maximum far wall cimt ( mm );"C0205108;C0677535;C0806909;C1510992;C1552615;C2825518;C2826546;C4330985;C4554674";FALSE;1262;average of maximum far wall cimt mm
1376;average of maximum common carotid cimt ( mm );"C0205214;C0741968;C0806909;C1510992;C1522138;C1552615;C2825518;C2826546;C3245511;C4330985;C4554674";FALSE;1262;average of maximum common carotid cimt mm
1374;aniagonisi;NA;FALSE; -10;aniagonisi
1375;calcium channel;C0006685;FALSE;2200;calcium channel
1376;maximum;"C0806909;C1552615;C2826546";FALSE;2201;maximum
1376;minimum;"C1524031;C1552614;C2826545";FALSE;2202;minimum
1376;( minimum - maximum ) focal seizure fre - quency / $nmbr$ days at baseline;"C0168634;C0439228;C0751495;C0806909;C1414819;C1442488;C1524031;C1552614;C1552615;C2826545;C2826546";FALSE;2203;minimum maximum focal seizure fre quency $nmbr$ days at baseline
1377;low - medium microalbuminuria ( n = $nmbr$ );"C0009458;C0205251;C0439536;C0730345;C1550472;C1705217;C3244283;C3890211;C4048187;C4085196;C4321351;C4522223;C4522282;C4522283";FALSE;2204;low medium microalbuminuria n $nmbr$
1377;low to medium microalbuminuria ( n = $nmbr$ );"C0009458;C0205251;C0439536;C0730345;C1550472;C1705217;C3244283;C3890211;C4048187;C4085196;C4321351;C4522223;C4522282;C4522283";FALSE;2204;low to medium microalbuminuria n $nmbr$
1377;medium - or low - intensity statin;"C0009458;C0360714;C0439536;C0596836;C1705217;C3244283;C4085196;C4522282;C4522283";FALSE;2205;medium or low intensity statin
1377;statin potency medium ( n = $nmbr$ );"C0009458;C0360714;C0439536;C1705217;C3244283;C3245505;C4085196;C4522282;C4522283";FALSE;2205;statin potency medium n $nmbr$
1378;sodium - glucose cotransporter $nmbr$ inhibitor;"C0017725;C0037473;C0597484;C1999216;C3541959;C3714642";FALSE;2206;sodium glucose cotransporter $nmbr$ inhibitor
1372;tiotropium $nmbr$ pg;"C0030827;C0072225;C0213771;C1266240";NA;NA;tiotropium $nmbr$ pg
   7;p value $nmbr$ . $nmbr$;C1709380;NA;NA;p value $nmbr$ $nmbr$
1372;tiotropium $nmbr$ meg ( n = $nmbr$ );"C0024489;C0025175;C0072225;C0213771";NA;NA;tiotropium $nmbr$ meg n $nmbr$
1372;tiotropium $nmbr$ m g;"C0213771;C0456715";NA;NA;tiotropium $nmbr$ m g
1372;tiotropium $nmbr$ . $nmbr$ μ g ( n   = $nmbr$ );"C0213771;C0439267";NA;NA;tiotropium $nmbr$ $nmbr$ g n $nmbr$
1372;tiotropium $nmbr$ . $nmbr$   μ g ( n   =   $nmbr$ );"C0213771;C0439267";NA;NA;tiotropium $nmbr$ $nmbr$ g n $nmbr$
1372;tiotropium $nmbr$ . $nmbr$ pg;"C0030827;C0072225;C0213771;C1266240";NA;NA;tiotropium $nmbr$ $nmbr$ pg
1372;tiotropium;C0213771;NA;NA;tiotropium
1372;patients using concurrent tiotropium;"C0030705;C0205420;C0213771;C1524063";NA;NA;patients using concurrent tiotropium
1372;non - tiotropium;"C0213771;C1518422";NA;NA;non tiotropium
1372;lama ( tiotropium )  b   n ( % );"C0213771;C0999593;C1416775";NA;NA;lama tiotropium b n
1372;formoterol tiotropium n = $nmbr$ non - tiotropium n = $nmbr$;"C0060657;C0213771;C1518422";NA;NA;formoterol tiotropium n $nmbr$ non tiotropium n $nmbr$
1372;( tiotropium n = $nmbr$ non - tiotropium n = $nmbr$ );"C0213771;C1518422";NA;NA;tiotropium n $nmbr$ non tiotropium n $nmbr$
1372;( tiotropium n = $nmbr$ non - tiotropium n = $nmbr$ $nmbr$;"C0213771;C1518422";NA;NA;tiotropium n $nmbr$ non tiotropium n $nmbr$ $nmbr$
1371;potassium — mmol / liter;"C0032821;C0202194;C0304475;C0439190;C0475211;C0597277;C3714637";NA;NA;potassium mmol liter
1371;potassium — mg / dl;"C0032821;C0202194;C0304475;C0439269;C0597277;C3714637";NA;NA;potassium mg dl
1371;potassium supplement;C0304475;NA;NA;potassium supplement
1371;potassium - sparing at enrollment;"C0032821;C0202194;C0304475;C0597277;C1516879;C1696073;C3714637;C3888021";NA;NA;potassium sparing at enrollment
1364;hypertension — no . ( % );"C0020538;C1963138";NA;NA;hypertension no
1371;potassium ( mmol / l );"C0032821;C0202194;C0304475;C0597277;C1532563;C3714637";NA;NA;potassium mmol l
1371;potassium ( mg / dl );"C0032821;C0202194;C0304475;C0439269;C0597277;C3714637";NA;NA;potassium mg dl
1371;potassium ( meql )  mean + sd  available for $nmbr$ patients;"C0030705;C0032821;C0202194;C0304475;C0444504;C0470187;C0597277;C2347634;C2348143;C2699239;C3714637";NA;NA;potassium meql mean sd available for $nmbr$ patients
1371;potassium ( meq / l );"C0032821;C0202194;C0304475;C0439375;C0597277;C3714637";NA;NA;potassium meq l
1371;potassium  mmol / l;"C0032821;C0202194;C0304475;C0597277;C1532563;C3714637";NA;NA;potassium mmol l
1371;potassium  meq / l;"C0032821;C0202194;C0304475;C0439375;C0597277;C3714637";NA;NA;potassium meq l
1371;potassium  meq / dl  mean;"C0032821;C0202194;C0304475;C0444504;C0597277;C1532568;C2347634;C2348143;C3714637";NA;NA;potassium meq dl mean
1371;potassium  mean ( sd )  meq / l;"C0032821;C0202194;C0304475;C0439375;C0444504;C0597277;C2347634;C2348143;C2699239;C3714637";NA;NA;potassium mean sd meq l
1371;potassium;"C0032821;C0202194;C0304475;C0597277;C3714637";NA;NA;potassium
1371;hyperkalemia ‡   ( potassium ≥ $nmbr$ . $nmbr$ mmol / l );"C0020461;C0032821;C0202194;C0304475;C0597277;C1532563;C3714637;C4552983";NA;NA;hyperkalemia potassium $nmbr$ $nmbr$ mmol l
1369;other asian;C0078988;NA;NA;other asian
1369;black or asian;"C0005680;C0027567;C0078988;C0085756;C0439541";NA;NA;black or asian
1369;asians ( n = $nmbr$ );C0078988;NA;NA;asians n $nmbr$
1369;asian *;C0078988;NA;NA;asian
1369;asian ( n — $nmbr$ );C0078988;NA;NA;asian n $nmbr$
1369;asian ( n   = $nmbr$ );C0078988;NA;NA;asian n $nmbr$
1369;asian ( n = $nmbr$ );C0078988;NA;NA;asian n $nmbr$
1369;asian ( n = $nmbr$  $nmbr$ );C0078988;NA;NA;asian n $nmbr$ $nmbr$
1369;asian ( $nmbr$ . $nmbr$ % );C0078988;NA;NA;asian $nmbr$ $nmbr$
1369;asian  n ( % );C0078988;NA;NA;asian n
1369;asian;C0078988;NA;NA;asian
1368;on $nmbr$;NA;NA;NA;on $nmbr$
1368;baseline use of adm  n ( % );"C0168634;C0215825;C1442488;C1524063;C4521767";NA;NA;baseline use of adm n
1368;baseline numberf of adm classes  n ( % );"C0168634;C0215825;C0456387;C1442488;C1518526;C1705943;C4019422;C4521767";NA;NA;baseline numberf of adm classes n
1366;without aspirin ( n = $nmbr$  $nmbr$ );C0004057;NA;NA;without aspirin n $nmbr$ $nmbr$
1366;with aspirin ( n = $nmbr$  $nmbr$ );C0004057;NA;NA;with aspirin n $nmbr$ $nmbr$
1366;spirono ( n = $nmbr$ );NA;NA;NA;spirono n $nmbr$
1366;no aspirin;C0004057;NA;NA;no aspirin
1366;long - term aspirin;"C0004057;C0443252";NA;NA;long term aspirin
1366;initial aspirin — no . ( % );"C0004057;C0205265;C1279901;C1555582;C1705685";NA;NA;initial aspirin no
1366;aspirin or thienopyridines ( % );"C0004057;C1120149;C2936588";NA;NA;aspirin or thienopyridines
1366;aspirin but no ppi;"C0004057;C0358591;C0871125;C3811894";NA;NA;aspirin but no ppi
1366;aspirin and ppi;"C0004057;C0358591;C0871125;C3811894";NA;NA;aspirin and ppi
1366;aspirin and other antiplatelet;C0004057;NA;NA;aspirin and other antiplatelet
1366;aspirin alone ( n = $nmbr$ ) $nmbr$ . $nmbr$ ± $nmbr$ . $nmbr$;"C0004057;C0205171;C0439044;C0679994";NA;NA;aspirin alone n $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
1366;aspirin alone ( n = $nmbr$ ) $nmbr$ . $nmbr$;"C0004057;C0205171;C0439044;C0679994";NA;NA;aspirin alone n $nmbr$ $nmbr$ $nmbr$
1366;aspirin alone ( n = $nmbr$ );"C0004057;C0205171;C0439044;C0679994";NA;NA;aspirin alone n $nmbr$
1366;aspirin alone ( n / n );"C0004057;C0205171;C0439044;C0679994";NA;NA;aspirin alone n n
1366;aspirin alone;"C0004057;C0205171;C0439044;C0679994";NA;NA;aspirin alone
1366;aspirin / antiplatelet;C0004057;NA;NA;aspirin antiplatelet
1366;aspirin - erdp clopidogrel no . of patients / total no .;"C0004057;C0030705;C0070166;C0439175;C0439810";NA;NA;aspirin erdp clopidogrel no of patients total no
1366;aspirin - erdp ( n = $nmbr$  $nmbr$ );C0004057;NA;NA;aspirin erdp n $nmbr$ $nmbr$
1366;aspirin ( n = $nmbr$ ) no . of participants with events ( % );"C0004057;C0441471;C0679646;C3541888";NA;NA;aspirin n $nmbr$ no of participants with events
1366;aspirin ( n = $nmbr$ $nmbr$ );C0004057;NA;NA;aspirin n $nmbr$ $nmbr$
1366;aspirin ( n = $nmbr$  $nmbr$ );C0004057;NA;NA;aspirin n $nmbr$ $nmbr$
1366;aspirin ( n  % );C0004057;NA;NA;aspirin n
1366;aspirin ( % );C0004057;NA;NA;aspirin
1366;aspirin  no . ( % );C0004057;NA;NA;aspirin no
1366;aspirin  n ( % );C0004057;NA;NA;aspirin n
1366;aspirin;C0004057;NA;NA;aspirin
1366;$nmbr$ aspirin ( n = $nmbr$ $nmbr$ );C0004057;NA;NA;$nmbr$ aspirin n $nmbr$ $nmbr$
1365;resistant htn n = $nmbr$;"C0020538;C0332325;C1514892;C1550464;C2827757";NA;NA;resistant htn n $nmbr$
1365;resistant htn : spiro n = $nmbr$;"C0020538;C0332325;C1514892;C1550464;C2827757";NA;NA;resistant htn spiro n $nmbr$
1365;resistant htn : placebo n = $nmbr$;"C0020538;C0032042;C0332325;C1514892;C1550464;C1696465;C1706408;C2827757";NA;NA;resistant htn placebo n $nmbr$
1365;prior hypertension yes;"C0020538;C0332152;C1549445;C1705108;C1710701;C1963138;C2826257";NA;NA;prior hypertension yes
1368;af on baseline ecg  n ( % );"C0168634;C0344434;C1442488;C1623258;C4049859";FALSE;1009;af on baseline ecg n
1368;atrial fibrillation on baseline ecg  n ( % );"C0168634;C0344434;C1442488";FALSE;1009;atrial fibrillation on baseline ecg n
1368;on aspirin at baseline;"C0004057;C0168634;C1442488";FALSE;1366;on aspirin at baseline
1370;aslan;NA;FALSE;1369;aslan
1370;non - asian;"C0078988;C1518422";FALSE;1369;non asian
1370;non - east asian §;"C0078988;C1518422;C1707877";FALSE;1369;non east asian
1370;non - asian ( n = $nmbr$ $nmbr$ );"C0078988;C1518422";FALSE;1369;non asian n $nmbr$ $nmbr$
1370;non - east asianf;"C1518422;C1707877";FALSE;1369;non east asianf
1370;p - value for east asian versus non - east asian *;"C0078988;C1518422;C1707877;C1709380";FALSE;1369;p value for east asian versus non east asian
1365;prior hypertension;"C0020538;C0332152;C1963138;C2826257";NA;NA;prior hypertension
1365;prior htn ( n = $nmbr$  $nmbr$ );"C0020538;C0332152;C2826257";NA;NA;prior htn n $nmbr$ $nmbr$
1365;no resistant htn n = $nmbr$  $nmbr$;"C0020538;C0332325;C1514892;C1550464;C2827757";NA;NA;no resistant htn n $nmbr$ $nmbr$
1365;no prior htn ( n = $nmbr$  $nmbr$ );"C0020538;C0332152;C2826257";NA;NA;no prior htn n $nmbr$ $nmbr$
1365;no htn;C0020538;NA;NA;no htn
1365;htn;C0020538;NA;NA;htn
1365;high blood pressure;"C0020538;C2926615";NA;NA;high blood pressure
1365;elevated blood pressure;"C0020538;C0497247";NA;NA;elevated blood pressure
1364;treated hypertension :;"C0020538;C1522326;C1963138";NA;NA;treated hypertension
1364;treated for hypertension  %;"C0020538;C1522326;C1963138";NA;NA;treated for hypertension
1364;systemic hypertension;C0020538;NA;NA;systemic hypertension
1364;systemic arterial hypertension  n ( % );C0020538;NA;NA;systemic arterial hypertension n
1364;reported hypertension *;"C0020538;C0684224;C0700287;C1963138;C4319718";NA;NA;reported hypertension
1364;previous hypertension;"C0020538;C0205156;C1552607;C1963138";NA;NA;previous hypertension
1364;patient - reported hypertension — no . { % );"C0020538;C0030705;C0684224;C0700287;C1963138;C4319718";NA;NA;patient reported hypertension no
1364;participant - reported hypertension — no . { % );"C0020538;C0679646;C0684224;C0700287;C1963138;C2698741;C4319718;C4554048";NA;NA;participant reported hypertension no
1364;no hypertension ( n = $nmbr$ );"C0020538;C1963138";NA;NA;no hypertension n $nmbr$
1364;no hypertension;"C0020538;C1963138";NA;NA;no hypertension
1364;medical history of hypertension;"C0020538;C0199168;C0205476;C0262926;C0455527;C1963138";NA;NA;medical history of hypertension
1364;isoiated systoiic hypertension *;"C0020538;C1963138";NA;NA;isoiated systoiic hypertension
1364;hypertension 本;"C0020538;C1963138";NA;NA;hypertension
1364;hypertension 一 no . ( % );"C0020538;C1963138";NA;NA;hypertension no
1364;hypertension — no . / total no . ( % );"C0020538;C0439175;C0439810;C1963138";NA;NA;hypertension no total no
1364;hypertension — no . ( % ) |;"C0020538;C1963138";NA;NA;hypertension no
1364;hypertension § yes;"C0020538;C1549445;C1705108;C1710701;C1963138";NA;NA;hypertension yes
1364;hypertension §;"C0020538;C1963138";NA;NA;hypertension
1364;hypertension serum lipid values;"C0020538;C0042295;C0428462;C1963138";NA;NA;hypertension serum lipid values
1364;hypertension n ( % );"C0020538;C1963138";NA;NA;hypertension n
1364;hypertension history;"C0019664;C0019665;C0020538;C0262512;C0262926;C1705255;C1963138;C2004062";NA;NA;hypertension history
1364;hypertension ^;"C0020538;C1963138";NA;NA;hypertension
1364;hypertension : no ( n = $nmbr$ );"C0020538;C0369718;C0441922;C1963138";NA;NA;hypertension no n $nmbr$
1364;hypertension / yes;"C0020538;C1549445;C1705108;C1710701;C1963138";NA;NA;hypertension yes
1364;hypertension *;"C0020538;C1963138";NA;NA;hypertension
1364;hypertension ( n 二 $nmbr$ );"C0020538;C1963138";NA;NA;hypertension n $nmbr$
1364;hypertension ( > $nmbr$ / $nmbr$ mm hg or taking;"C0020538;C0439475;C1515187;C1963138";NA;NA;hypertension $nmbr$ $nmbr$ mm hg or taking
1364;hypertension ( % ) : t;"C0020538;C1963138";NA;NA;hypertension t
1364;hypertension ( % );"C0020538;C1963138";NA;NA;hypertension
1364;hypertension $nmbr$ ( % );"C0020538;C1963138";NA;NA;hypertension $nmbr$
1364;hypertension !;"C0020538;C1963138";NA;NA;hypertension
1364;hypertension    n   ( % );"C0020538;C1963138";NA;NA;hypertension n
1364;hypertension  treated;"C0020538;C1522326;C1963138";NA;NA;hypertension treated
1364;hypertension  no . / total no . ( % ) medications in use at baseline  no . / total no . ( % );"C0013227;C0020538;C0042153;C0150312;C0168634;C0332285;C0439175;C0439810;C0457083;C0802604;C1442488;C1707101;C1947944;C1963138;C2598133;C4284232";NA;NA;hypertension no total no medications in use at baseline no total no
1364;hypertension  n / n ( % );"C0020538;C1963138";NA;NA;hypertension n n
1364;hypertension  n ( % ) yes;"C0020538;C1549445;C1705108;C1710701;C1963138";NA;NA;hypertension n yes
1364;hypertension  n ( % );"C0020538;C1963138";NA;NA;hypertension n
1364;hypertension  * n ( % );"C0020538;C1963138";NA;NA;hypertension n
1364;hypertension  ( % );"C0020538;C1963138";NA;NA;hypertension
1364;hypertension  %;"C0020538;C1963138";NA;NA;hypertension
1364;hypertension;"C0020538;C1963138";NA;NA;hypertension
1364;hyperlension;NA;NA;NA;hyperlension
1364;hyper - tension;"C0020538;C1963138";NA;NA;hyper tension
1364;hvpertension;NA;NA;NA;hvpertension
1364;grade of hypertension;"C0020538;C0441800;C0919553;C1963138;C3244287";NA;NA;grade of hypertension
1364;duration of hypertension ( years );"C0020538;C0439234;C0449238;C1963138;C2926735";NA;NA;duration of hypertension years
1364;duration of hypertension ( months );"C0020538;C0439231;C0449238;C1963138;C2926735";NA;NA;duration of hypertension months
1364;duration of hypertension  y;"C0020538;C0449238;C1963138;C2926735";NA;NA;duration of hypertension y
1364;duration of hypertension  n ( % );"C0020538;C0449238;C1963138;C2926735";NA;NA;duration of hypertension n
1364;arterial hypertension — no . ( % );C0020538;NA;NA;arterial hypertension no
1364;arterial hypertension *;C0020538;NA;NA;arterial hypertension
1364;arterial hypertension  no . ( % );C0020538;NA;NA;arterial hypertension no
1364;arterial hypertension  n ( % );C0020538;NA;NA;arterial hypertension n
1364;arterial hypertension;C0020538;NA;NA;arterial hypertension
1364;( including hypertension );"C0020538;C0332257;C1963138";NA;NA;including hypertension
1363;symptomatic ich;"C0019191;C0231220;C3272597;C3281105";NA;NA;symptomatic ich
1363;nd not due to swelling or ich;"C0013604;C0019191;C0038999;C0678226;C1518422;C3272597;C3281105";NA;NA;nd not due to swelling or ich
1363;ich;"C0019191;C3272597;C3281105";NA;NA;ich
1363;gusto moderate bleeding / ich;"C0019080;C0019191;C0205081;C1881878;C3272597;C3281105;C4049705;C4049706;C4085643;C4321335";NA;NA;gusto moderate bleeding ich
1362;itch nrs $nmbr$ - $nmbr$ ( v = $nmbr$ );"C0033774;C1422257;C2240043;C4050142";NA;NA;itch nrs $nmbr$ $nmbr$ v $nmbr$
1362;itch nrs $nmbr$ - $nmbr$ ( at = $nmbr$ );"C0033774;C1422257;C2240043;C4050142";NA;NA;itch nrs $nmbr$ $nmbr$ at $nmbr$
1362;itch nrs $nmbr$ - $nmbr$ ( a ' = $nmbr$ );"C0033774;C1422257;C2240043;C4050142";NA;NA;itch nrs $nmbr$ $nmbr$ a $nmbr$
1362;itch nrs $nmbr$ - $nmbr$ ( . \ ' = $nmbr$ );"C0033774;C1422257;C2240043;C4050142";NA;NA;itch nrs $nmbr$ $nmbr$ \ $nmbr$
1362;itch nrs $nmbr$ ( v = $nmbr$ );"C0033774;C1422257;C2240043;C4050142";NA;NA;itch nrs $nmbr$ v $nmbr$
1362;itch nrs;"C0033774;C1422257;C2240043;C4050142";NA;NA;itch nrs
1361;previous ischemic heart disease — no . ( % );"C0010054;C0151744;C0205156;C1552607";NA;NA;previous ischemic heart disease no
1361;myocardial ischaemia;"C0010054;C0151744";NA;NA;myocardial ischaemia
1361;ischemic heart disease indicator no ( n = $nmbr$ l );"C0010054;C0021212;C0151744;C0369718;C0441922;C1235732;C1522602";NA;NA;ischemic heart disease indicator no n $nmbr$ l
1361;ischemic heart disease *;"C0010054;C0151744";NA;NA;ischemic heart disease
1361;ischemic heart disease ( % );"C0010054;C0151744";NA;NA;ischemic heart disease
1361;ischemic heart disease  no . ( % );"C0010054;C0151744";NA;NA;ischemic heart disease no
1361;ischemic heart disease  n ( % );"C0010054;C0151744";NA;NA;ischemic heart disease n
1361;ischemic heart disease  ( % );"C0010054;C0151744";NA;NA;ischemic heart disease
1361;ischemic heart disease  %;"C0010054;C0151744";NA;NA;ischemic heart disease
1361;ischemic heart disease;"C0010054;C0151744";NA;NA;ischemic heart disease
1361;ischaemic heart disease or cerebrovascular disorder  n ( % );"C0007820;C0010054;C0151744";NA;NA;ischaemic heart disease or cerebrovascular disorder n
1361;ischaemic heart disease  n ( % );"C0010054;C0151744";NA;NA;ischaemic heart disease n
1361;ischaemic heart disease;"C0010054;C0151744";NA;NA;ischaemic heart disease
1361;ihd;C0151744;NA;NA;ihd
1099;% / yr;C0439234;NA;NA;yr
1361;combined ischaemic heart disease and / or cerebrovascular disorder *;"C0007820;C0010054;C0151744;C0205195";NA;NA;combined ischaemic heart disease and or cerebrovascular disorder
1360;relative risk comparing icd therapy and placebo;"C0021122;C0032042;C0039798;C0087111;C0242492;C1363945;C1696465;C1706408;C1707455";NA;NA;relative risk comparing icd therapy and placebo
1360;relative risk ( $nmbr$ % cl ) comparing icd therapy and placebo using a linear interaction term in the model ( shfmxicd ) *;"C0021122;C0023732;C0032042;C0039798;C0087111;C0233324;C0242492;C0596019;C1363945;C1515273;C1524063;C1696465;C1704675;C1705313;C1706408;C1707455;C2826302";NA;NA;relative risk $nmbr$ cl comparing icd therapy and placebo using a linear interaction term in the model shfmxicd
1360;pacemaker or icd;"C0021122;C0030163;C0810633;C1546728;C3275122;C3853703";NA;NA;pacemaker or icd
1360;icd vs . placebo;"C0021122;C0032042;C1696465;C1706408";NA;NA;icd vs placebo
1360;icd  n ( % );C0021122;NA;NA;icd n
1360;icd  %;C0021122;NA;NA;icd
1360;icd;C0021122;NA;NA;icd
1360;aicd  ( % );"C0972395;C2611803;C3537205;C3546309";NA;NA;aicd
1359;non - ics +;"C0815320;C1518422;C4551720";NA;NA;non ics
1359;no laba  no ics  n ( % );"C0815320;C4551720";NA;NA;no laba no ics n
1359;laba  no ics  n ( % );"C0815320;C4551720";NA;NA;laba no ics n
1359;ics subset;"C0815320;C1515021;C4551720";NA;NA;ics subset
1359;gold grade $nmbr$ and ics users at screening;"C0018026;C0220908;C0220909;C0441800;C0815320;C0919553;C1304897;C1698960;C1706077;C1710031;C1710032;C1710477;C2348164;C3244287;C4551720";NA;NA;gold grade $nmbr$ and ics users at screening
1359;gold grade $nmbr$ and ics non - users at screening;"C0018026;C0220908;C0220909;C0441800;C0815320;C0919553;C1304897;C1518422;C1698960;C1706077;C1710031;C1710032;C1710477;C2348164;C3244287;C4551720";NA;NA;gold grade $nmbr$ and ics non users at screening
1359;fp versus other ics;"C0016704;C0815320;C1419068;C1419906;C3541238;C3541412;C4551720";NA;NA;fp versus other ics
1359;discontinuation of ics / laba prior to baseline  n ( % );"C0168634;C0457454;C0815320;C1442488;C1444662;C4551720;C4552847";NA;NA;discontinuation of ics laba prior to baseline n
1349;blood glucose lowering treatment;"C0005802;C0017725;C0039798;C0087111;C0441994;C0596197;C1522326;C1533734;C1705169;C2003888;C3538994;C3887704";NA;NA;blood glucose lowering treatment
1359;calima overalldhigh - dosage ics / laba and baseline blood eosinophils > $nmbr$ cells / ml ( n = $nmbr$ );"C0014467;C0168634;C0178602;C0815320;C1442488;C2699156;C2986497;C4551720";NA;NA;calima overalldhigh dosage ics laba and baseline blood eosinophils $nmbr$ cells ml n $nmbr$
1359;baseline post - bronchodilator % predicted fev  > $nmbr$ % and no prior ics use;"C0042153;C0168634;C0332152;C0457083;C0681842;C0815320;C1442488;C1882327;C1947944;C2599594;C2826257;C3714541;C4551720";NA;NA;baseline post bronchodilator predicted fev $nmbr$ and no prior ics use
1358;without psoriasis ( zi = $nmbr$ );"C0033860;C0043476";NA;NA;without psoriasis zi $nmbr$
1358;without psoriasis ( zi = $nmbr$  $nmbr$ );"C0033860;C0043476";NA;NA;without psoriasis zi $nmbr$ $nmbr$
1358;without psoriasis ( n = $nmbr$ );C0033860;NA;NA;without psoriasis n $nmbr$
1358;without psoriasis ( n = $nmbr$  $nmbr$ );C0033860;NA;NA;without psoriasis n $nmbr$ $nmbr$
1358;with psoriasis ( zi = $nmbr$ );"C0033860;C0043476";NA;NA;with psoriasis zi $nmbr$
1358;with psoriasis ( n = $nmbr$ );C0033860;NA;NA;with psoriasis n $nmbr$
1358;psoriasis covering > $nmbr$ % bsa  n ( % ) §;"C0033860;C0180153;C0439844";NA;NA;psoriasis covering $nmbr$ bsa n
1358;scalp psoriasis  n ( % );C0406326;FALSE;2178;scalp psoriasis n
1359;ics;"C0815320;C4551720";FALSE;2182;ics
1359;ics # #;"C0815320;C4551720";FALSE;2182;ics
1359;icsf;NA;FALSE;2182;icsf
1359;ics  mg / day;"C0439422;C0815320;C4551720";FALSE;2182;ics mg day
1359;ics  n ( % );"C0815320;C4551720";FALSE;2182;ics n
1359;ics non - users;"C0815320;C1518422;C1706077;C4551720";FALSE;2182;ics non users
1359;ics : no;"C0815320;C4551720";FALSE;2182;ics no
1359;ics non - users at screening;"C0220908;C0220909;C0815320;C1518422;C1698960;C1706077;C1710031;C1710032;C1710477;C2348164;C4551720";FALSE;2182;ics non users at screening
1359;ics nonusers  n ( % );"C0815320;C4551720";FALSE;2182;ics nonusers n
1359;ics usage;"C0457083;C0815320;C4551720";FALSE;2182;ics usage
1359;ics use;"C0042153;C0457083;C0815320;C1947944;C4551720";FALSE;2182;ics use
1359;ics use  %;"C0042153;C0457083;C0815320;C1947944;C4551720";FALSE;2182;ics use
1359;ics use at baseline : no;"C0042153;C0168634;C0457083;C0815320;C1442488;C1947944;C4551720";FALSE;2182;ics use at baseline no
1359;ics use at screening;"C0042153;C0220908;C0220909;C0457083;C0815320;C1698960;C1710031;C1710032;C1710477;C1947944;C2348164;C4551720";FALSE;2182;ics use at screening
1359;ics use at screeningg  n ( % );"C0042153;C0457083;C0815320;C1947944;C4551720";FALSE;2182;ics use at screeningg n
1359;ics use at screening  n ( % );"C0042153;C0220908;C0220909;C0457083;C0815320;C1698960;C1710031;C1710032;C1710477;C1947944;C2348164;C4551720";FALSE;2182;ics use at screening n
1359;ics use no;"C0042153;C0457083;C0815320;C1947944;C4551720";FALSE;2182;ics use no
1359;ics users;"C0815320;C1706077;C4551720";FALSE;2182;ics users
1359;ics users at baseline  %;"C0168634;C0815320;C1442488;C1706077;C4551720";FALSE;2182;ics users at baseline
1359;ics users at baseline  n ( % );"C0168634;C0815320;C1442488;C1706077;C4551720";FALSE;2182;ics users at baseline n
1359;ics users at screening;"C0220908;C0220909;C0815320;C1698960;C1706077;C1710031;C1710032;C1710477;C2348164;C4551720";FALSE;2182;ics users at screening
1359;ics users  n ( % );"C0815320;C1706077;C4551720";FALSE;2182;ics users n
1359;no ics;"C0815320;C4551720";FALSE;2182;no ics
1359;ics no laba;"C0815320;C4551720";FALSE;2182;ics no laba
1359;ics  no laba  n ( % );"C0815320;C4551720";FALSE;2182;ics no laba n
1359;ics  no laba ( tiotropium n = $nmbr$  placebo n = $nmbr$ );"C0032042;C0213771;C0815320;C1696465;C1706408;C4551720";FALSE;2182;ics no laba tiotropium n $nmbr$ placebo n $nmbr$
1359;other ics;"C0815320;C4551720";FALSE;2182;other ics
1359;other ics versus no ics;"C0815320;C4551720";FALSE;2182;other ics versus no ics
1359;total ics dose at entry  / xg / d;"C0017209;C0815320;C1292284;C1421532;C1705654;C2986497;C4551720";FALSE;2182;total ics dose at entry xg d
1359;use of ics;"C0815320;C1524063;C4551720";FALSE;2182;use of ics
1359;use of ics at baseline  %;"C0168634;C0815320;C1442488;C1524063;C4551720";FALSE;2182;use of ics at baseline
1359;with concomitant ics;"C0521115;C0815320;C4551720";FALSE;2182;with concomitant ics
1359;with ics  n ( % );"C0815320;C4551720";FALSE;2182;with ics n
1359;without concomitant ics;"C0521115;C0815320;C4551720";FALSE;2182;without concomitant ics
1359;mean ics use at enrolment ( pg ) *;"C0030827;C0042153;C0072225;C0444504;C0457083;C0815320;C1266240;C1516879;C1696073;C1947944;C2347634;C2348143;C3888021;C4551720";FALSE;2182;mean ics use at enrolment pg
1360;acd;C4554601;FALSE; -10;acd
1359;+ ics / + laba nz $nmbr$;"C0027978;C0815320;C4551720";FALSE;2193;ics laba nz $nmbr$
1359;ics / laba subset;"C0815320;C1515021;C4551720";FALSE;2193;ics laba subset
1359;ics plus laba;"C0815320;C4551720";FALSE;2193;ics plus laba
1359;laba   +   ics;"C0815320;C4551720";FALSE;2193;laba ics
1359;laba plus ics  n ( % );"C0332287;C0815320;C4551720";FALSE;2193;laba plus ics n
1359;laba plus ics ( tiotropium n = $nmbr$  placebo n = $nmbr$ );"C0032042;C0213771;C0332287;C0815320;C1696465;C1706408;C4551720";FALSE;2193;laba plus ics tiotropium n $nmbr$ placebo n $nmbr$
1358;psoriasis characteristics;"C0033860;C1521970";NA;NA;psoriasis characteristics
1358;psoriasis > $nmbr$ % of bsa;C0033860;NA;NA;psoriasis $nmbr$ of bsa
1358;psoriasis ( n =;C0033860;NA;NA;psoriasis n
1358;psoriasis;C0033860;NA;NA;psoriasis
1358;patients without psoriasis ( n = $nmbr$ );"C0030705;C0033860";NA;NA;patients without psoriasis n $nmbr$
1358;patients with psoriasis ( n = $nmbr$ );"C0030705;C0033860";NA;NA;patients with psoriasis n $nmbr$
1358;facial psoriasis  n ( % );C1276112;NA;NA;facial psoriasis n
1357;organic;C0747055;NA;NA;organic
1356;severe oa symptoms at baselined;"C0029408;C0436345;C3887876";NA;NA;severe oa symptoms at baselined
1356;osteoarthritis;C0029408;NA;NA;osteoarthritis
1356;oa;"C0029408;C3887876";NA;NA;oa
1356;less severe oa symptoms at baseline;"C0029408;C0168634;C0436345;C0439092;C0547044;C1442488;C3887876";NA;NA;less severe oa symptoms at baseline
1356;duration of osteoarthritis symptoms — yr;"C0029408;C0436359;C0439234";NA;NA;duration of osteoarthritis symptoms yr
1355;sdai < $nmbr$ t;C3871128;NA;NA;sdai $nmbr$ t
1355;sdai < $nmbr$ . $nmbr$ *;C3871128;NA;NA;sdai $nmbr$ $nmbr$
1355;sdai ( $nmbr$ - $nmbr$ );C3871128;NA;NA;sdai $nmbr$ $nmbr$
1355;sdai  mean ( sd );"C0444504;C2347634;C2348143;C2699239;C3871128";NA;NA;sdai mean sd
1355;sdai;C3871128;NA;NA;sdai
1355;mean ( sd ) sdai *;"C0444504;C2347634;C2348143;C2699239;C3871128";NA;NA;mean sd sdai
1354;total basdai score  mean ( sd );"C0439175;C0439810;C0444504;C0449820;C1998004;C2347634;C2348143;C2699239;C4050231";NA;NA;total basdai score mean sd
1354;total basdai  mean ( sd );"C0439175;C0439810;C0444504;C1998004;C2347634;C2348143;C2699239";NA;NA;total basdai mean sd
1354;baseline basdai;"C0168634;C1442488;C1998004";NA;NA;baseline basdai
1354;basdai ⁎ ⁎;C1998004;NA;NA;basdai
1354;basdai responses at week $nmbr$;"C0332174;C0439230;C0871261;C1998004";NA;NA;basdai responses at week $nmbr$
1354;basdai $nmbr$  n ( % );C1998004;NA;NA;basdai $nmbr$ n
1354;basdai $nmbr$  %;C1998004;NA;NA;basdai $nmbr$
1352;vka at randomization;C0034656;NA;NA;vka at randomization
1352;vka;NA;NA;NA;vka
1352;no vka at randomization;C0034656;NA;NA;no vka at randomization
1351;glycemic indexes;C1136206;NA;NA;glycemic indexes
1350;glyburide dose duringthe study ( mg );"C0017628;C0024671;C0026410;C0178602;C0439269;C0557651;C0869039;C1114758;C1960952;C2346927;C2603343;C4321396;C4521761";NA;NA;glyburide dose duringthe study mg
1350;glyburide ( n = $nmbr$ );C0017628;NA;NA;glyburide n $nmbr$
1350;glyburide;C0017628;NA;NA;glyburide
1349;glycemic variability  mmol / lc;"C0005802;C0439190;C2827666";NA;NA;glycemic variability mmol lc
1349;glycemic characteristics;"C0005802;C1521970";NA;NA;glycemic characteristics
1349;blood glucose - lowering treatments  n ( % );"C0005802;C0017725;C0087111;C0441994;C0596197;C2003888";NA;NA;blood glucose lowering treatments n
1349;blood glucose;C0005802;NA;NA;blood glucose
1348;use of oral glucocorticoids;"C0017710;C0442027;C1524063;C3540777;C3540778;C4521986";NA;NA;use of oral glucocorticoids
1348;systemic glucocorticoid use at randomization  n ( % );"C0017710;C0034656;C0042153;C0205373;C0457083;C1947944";NA;NA;systemic glucocorticoid use at randomization n
1348;systemic glucocorticoid use at randomisation;"C0017710;C0034656;C0042153;C0205373;C0457083;C1947944";NA;NA;systemic glucocorticoid use at randomisation
1348;postoperative nsaid or glucocorticoid use post - randomisation characteristic * *;"C0003211;C0017710;C0032790;C0034656;C0042153;C0457083;C0687676;C1521970;C1704687;C1947944;C3469826;C3536840";NA;NA;postoperative nsaid or glucocorticoid use post randomisation characteristic
1348;postoperative nsaid or glucocorticoid use;"C0003211;C0017710;C0032790;C0042153;C0457083;C1947944;C3536840";NA;NA;postoperative nsaid or glucocorticoid use
1348;postoperative glucocorticoid use post - randomisation characteristic * *;"C0017710;C0032790;C0034656;C0042153;C0457083;C0687676;C1521970;C1704687;C1947944;C3469826";NA;NA;postoperative glucocorticoid use post randomisation characteristic
1348;postoperative glucocorticoid use;"C0017710;C0032790;C0042153;C0457083;C1947944";NA;NA;postoperative glucocorticoid use
1348;oral glucocorticoid use at baseline — no . ( % ) : t;"C0017710;C0168634;C1442488;C1527415;C2603360";NA;NA;oral glucocorticoid use at baseline no t
1348;oral glucocorticoid use;"C0017710;C1527415";NA;NA;oral glucocorticoid use
1348;no glucocorticoids at baseline;"C0017710;C0168634;C1442488;C3540777;C3540778";NA;NA;no glucocorticoids at baseline
1348;glucocorticoids only;"C0017710;C0205171;C1720467;C3540777;C3540778";NA;NA;glucocorticoids only
1348;glucocorticoids at baseline;"C0017710;C0168634;C1442488;C3540777;C3540778";NA;NA;glucocorticoids at baseline
1348;glucocorticoids *;"C0017710;C3540777;C3540778";NA;NA;glucocorticoids
1348;glucocorticoids;"C0017710;C3540777;C3540778";NA;NA;glucocorticoids
1348;glucocorticoid ];C0017710;NA;NA;glucocorticoid
1348;glucocorticoid;C0017710;NA;NA;glucocorticoid
1348;any glucocorticoid *;C0017710;NA;NA;any glucocorticoid
1353;previous vka use;"C0042153;C0205156;C0457083;C1552607;C1947944";FALSE;1352;previous vka use
1353;vka ( n   = $nmbr$ );NA;FALSE;1352;vka n $nmbr$
1355;mean selena - sledai score ± sd;"C0444504;C0449820;C0451528;C2347634;C2348143;C2699239;C4050231";FALSE;2175;mean selena sledai score sd
1355;selena - sledai mean score ( sd );"C0451528;C2699239;C3533236";FALSE;2175;selena sledai mean score sd
1357;psoriatic arthritis;C0003872;FALSE;2176;psoriatic arthritis
1357;psoriatic arthritis  %;C0003872;FALSE;2176;psoriatic arthritis
1357;psoriatic arthritis pain ];"C0003872;C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4317006;C4553004;C4554132";FALSE;2176;psoriatic arthritis pain
1357;number of previous anti - tnf treatments for psoriatic arthritis;"C0003872;C0087111;C0205156;C0237753;C0449788;C1448177;C1552607";FALSE; 362;number of previous anti tnf treatments for psoriatic arthritis
1358;patients with psoriasis > $nmbr$ % of body surface area;"C0017446;C0030705;C0033860;C0205146;C0489451";FALSE;2177;patients with psoriasis $nmbr$ of body surface area
1358;patients with > $nmbr$ % bsa psoriasis skin involvement  n ( % );"C0030705;C0033860;C0444099;C1123023;C1314939;C4520765";FALSE;2177;patients with $nmbr$ bsa psoriasis skin involvement n
1358;psoriasis body surface area > $nmbr$ %;"C0005902;C0033860";FALSE;2177;psoriasis body surface area $nmbr$
1358;bsa > $nmbr$ %  n ( % ) t;NA;FALSE;2177;bsa $nmbr$ n t
1358;patients with psoriasis ( bsa ≥   $nmbr$ % );"C0030705;C0033860";FALSE;2177;patients with psoriasis bsa $nmbr$
1348;use of inhaled glucocorticoids at baseline;"C0004048;C0017710;C0168634;C1442488;C1524063;C3540777;C3540778";FALSE;2182;use of inhaled glucocorticoids at baseline
1358;previous exposure to biologic systemic psoriasis therapyb ( yes )  n ( % );"C0005515;C0033860;C0205156;C0205373;C0205460;C0332157;C1549445;C1552607;C1705108;C1710701";FALSE;2181;previous exposure to biologic systemic psoriasis therapyb yes n
1358;previous exposure to non - biologic systemic psoriasis therapyb ( yes )  n ( % );"C0005515;C0033860;C0205156;C0205373;C0205460;C0332157;C1518422;C1549445;C1552607;C1705108;C1710701";FALSE;2181;previous exposure to non biologic systemic psoriasis therapyb yes n
1358;dlqi ( patients with £ $nmbr$ % bsa psoriasis );"C0030705;C0033860;C3899393";FALSE;2177;dlqi patients with $nmbr$ bsa psoriasis
1358;psoriasis affecting > $nmbr$ % of body - surface;"C0033860;C0392760;C0489451;C1314939";FALSE;2177;psoriasis affecting $nmbr$ of body surface
1358;psoriasis bsa > $nmbr$ %  n ( % );C0033860;FALSE;2177;psoriasis bsa $nmbr$ n
1347;baseline microalbumin : < $nmbr$;"C0168634;C0201838;C1442488;C2362049";NA;NA;baseline microalbumin $nmbr$
1347;albumin measurements ^ ^;C0201838;NA;NA;albumin measurements
1346;without tamsulosin;C0257343;NA;NA;without tamsulosin
1346;with tamsulosin;C0257343;NA;NA;with tamsulosin
1346;tamsulosin ( w = $nmbr$ )  $nmbr$ / $nmbr$;C0257343;NA;NA;tamsulosin w $nmbr$ $nmbr$ $nmbr$
1346;tamsulosin ( n = $nmbr$ );C0257343;NA;NA;tamsulosin n $nmbr$
1346;tamsulosin $nmbr$ . $nmbr$ mg vs . placebo;"C0024671;C0026410;C0032042;C0257343;C0439269;C1696465;C1706408;C1960952;C2346927;C4321396;C4521761";NA;NA;tamsulosin $nmbr$ $nmbr$ mg vs placebo
1346;tamsulosin $nmbr$ . $nmbr$ mg vs . $nmbr$ . $nmbr$ mg;"C0024671;C0026410;C0257343;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;tamsulosin $nmbr$ $nmbr$ mg vs $nmbr$ $nmbr$ mg
1346;tamsulosin $nmbr$ . $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0257343;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;tamsulosin $nmbr$ $nmbr$ mg n $nmbr$
1346;tamsulosin;C0257343;NA;NA;tamsulosin
1345;previous metformin use  %;"C0025598;C0042153;C0205156;C0457083;C1552607;C1947944";NA;NA;previous metformin use
1345;plus metformin;"C0025598;C0332287";NA;NA;plus metformin
1345;overall cohort ( post hoc analysis excluding metformin users );"C0025598;C0086027;C0282416;C0332196;C0687676;C1561607;C1704687;C1706077;C2828389;C3469826";NA;NA;overall cohort post hoc analysis excluding metformin users
1345;on metformin ir or metformin xr $nmbr$   mg / d;"C0022065;C0022071;C0025598;C0038976;C0043309;C0439422;C1448132;C1707968;C1962945";NA;NA;on metformin ir or metformin xr $nmbr$ mg d
1345;no metformin use;"C0025598;C0042153;C0457083;C1947944";NA;NA;no metformin use
1345;no metformin;C0025598;NA;NA;no metformin
1345;metformin 一 no . ( % );C0025598;NA;NA;metformin no
1345;metformin • pioglitazone;C1635037;NA;NA;metformin pioglitazone
1345;metformin — no . ( % );C0025598;NA;NA;metformin no
1345;metformin ± other oral anti - dm drugs;"C0011816;C0025598;C0029167;C0175795;C0304289;C3250443";NA;NA;metformin other oral anti dm drugs
1345;metformin use  n ( % );"C0025598;C0042153;C0457083;C1947944";NA;NA;metformin use n
1345;metformin use;"C0025598;C0042153;C0457083;C1947944";NA;NA;metformin use
1345;metformin open - label *;"C0025598;C1709323";NA;NA;metformin open label
1345;metformin monotherapy;C0025598;NA;NA;metformin monotherapy
1345;metformin ? pioglitazone;C1635037;NA;NA;metformin pioglitazone
1345;metformin ( n = $nmbr$ );C0025598;NA;NA;metformin n $nmbr$
1345;metformin ( n $nmbr$ $nmbr$ );C0025598;NA;NA;metformin n $nmbr$ $nmbr$
1345;metformin  n ( % );C0025598;NA;NA;metformin n
1345;metformin;C0025598;NA;NA;metformin
1345;merformin;NA;NA;NA;merformin
1345;baseline metformin;"C0025598;C0168634;C1442488";NA;NA;baseline metformin
1344;with lowest bwb;C1708760;NA;NA;with lowest bwb
1344;lowest activated clotting;"C0005778;C1328723;C1708760;C1879547";NA;NA;lowest activated clotting
1344;lowest;C1708760;NA;NA;lowest
1343;low molecular weight heparin;"C0019139;C3536766";NA;NA;low molecular weight heparin
1343;low molecular weight ( lmw ) heparin before randomisation;"C0019139;C0034656;C3536766";NA;NA;low molecular weight lmw heparin before randomisation
1343;low - molecular weight heparin or intravenous unfractionated heparin;"C0019139;C0354566;C3536766";NA;NA;low molecular weight heparin or intravenous unfractionated heparin
1343;low - molecular - weight heparin — no . ( % );"C0019139;C3536766";NA;NA;low molecular weight heparin no
1343;low - molecular - weight heparin only;"C0019139;C0205171;C1720467;C3536766";NA;NA;low molecular weight heparin only
1343;low - molecular - weight heparin;"C0019139;C3536766";NA;NA;low molecular weight heparin
1343;lmwh within $nmbr$ days before randomization — no . / total no . ( % );"C0019139;C0034656;C0439175;C0439228;C0439810;C3536766";NA;NA;lmwh within $nmbr$ days before randomization no total no
1343;lmwh;"C0019139;C3536766";NA;NA;lmwh
1342;left main coronary artery  n ( % );C1261082;NA;NA;left main coronary artery n
1342;left main coronary artery;C1261082;NA;NA;left main coronary artery
1341;ileum only  n ( % );"C0020885;C0205171;C1720467";NA;NA;ileum only n
1341;ileum only;"C0020885;C0205171;C1720467";NA;NA;ileum only
1341;ileum;C0020885;NA;NA;ileum
1340;womac pain score;C0582148;NA;NA;womac pain score
1340;scores for global and pain assessments §;"C0030198;C0205246;C0449820;C2348867";NA;NA;scores for global and pain assessments
1340;$nmbr$ % decrease in womac pain score;"C0392756;C0547047;C0582148";NA;NA;$nmbr$ decrease in womac pain score
1338;patient assessment of pain ( $nmbr$ - $nmbr$ mm )  mean ( sd );"C0030193;C0030198;C0030705;C0444504;C0518090;C0679830;C1962977;C2347634;C2348143;C2699239;C2984058;C4085210;C4085211;C4085212;C4330985;C4553004;C4554132;C4554674";NA;NA;patient assessment of pain $nmbr$ $nmbr$ mm mean sd
1338;patient ' s assessment of pain !;"C0030193;C0030198;C0030705;C0518090;C0679830;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132";NA;NA;patient s assessment of pain
1338;patient ' s assessment of pain;"C0030193;C0030198;C0030705;C0518090;C0679830;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132";NA;NA;patient s assessment of pain
1338;pain subscale;"C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132";NA;NA;pain subscale
1338;pain;"C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132";NA;NA;pain
1338;ontario and mcmaster universities osteoarthritis index ( womac ) can range from $nmbr$ to $nmbr$ for the pain subscale  $nmbr$ to $nmbr$ for the stiffness;"C0029040;C0029408;C0030193;C0041740;C0427008;C0518090;C0600653;C0918012;C1514721;C1552854;C1637833;C1962977;C2348147;C2984058;C2986546;C3542016;C4085210;C4085211;C4085212;C4553004;C4554132";NA;NA;ontario and mcmaster universities osteoarthritis index womac can range from $nmbr$ to $nmbr$ for the pain subscale $nmbr$ to $nmbr$ for the stiffness
   7;p value $nmbr$;C1709380;NA;NA;p value $nmbr$
1338;eq - $nmbr$ d - $nmbr$   l  no pain or discomfortf;"C0030193;C0205163;C0439185;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132";NA;NA;eq $nmbr$ d $nmbr$ l no pain or discomfortf
1338;eq - $nmbr$ d - $nmbr$   l  no pain or discomfortc;"C0030193;C0205163;C0439185;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132";NA;NA;eq $nmbr$ d $nmbr$ l no pain or discomfortc
1324;diclofenac $nmbr$ mg  n = $nmbr$  n ( % );"C0012091;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;diclofenac $nmbr$ mg n $nmbr$ n
1324;diclofenac;C0012091;NA;NA;diclofenac
1339;bodily pain;C3890602;FALSE;1338;bodily pain
1339;rest pain;C0234253;FALSE;1338;rest pain
1339;intensity of rest pain ( mmvas )  mean ± sd;"C0035253;C0234253;C0444504;C0522510;C1320357;C1622890;C2347634;C2348143;C2699239;C4085211";FALSE;1338;intensity of rest pain mmvas mean sd
1339;sf - $nmbr$ bodily pain  mean change from baselinee;"C0037712;C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C3890602;C4319952";FALSE;1338;sf $nmbr$ bodily pain mean change from baselinee
1340;spain;C0037747;FALSE;2170;spain
1340;spain ( n = $nmbr$ );C0037747;FALSE;2170;spain n $nmbr$
1340;oropharyngeal pain;"C2363731;C4554669";FALSE;2171;oropharyngeal pain
1340;upper abdominal pain;C0232492;FALSE;2172;upper abdominal pain
1340;shoulder pain;C0037011;FALSE;2173;shoulder pain
1342;lm $nmbr$ bid ( n = $nmbr$ );"C1261082;C1551056";FALSE; -10;lm $nmbr$ bid n $nmbr$
1342;lm $nmbr$ $nmbr$;"C1261082;C1551056";FALSE; -10;lm $nmbr$ $nmbr$
1344;with lowest hba $nmbr$ cd;"C0007928;C0019016;C0034283;C1708760;C1825777;C3538758;C4552032";FALSE; 820;with lowest hba $nmbr$ cd
1345;linagliptin / metformin;C3264599;FALSE;2252;linagliptin metformin
1337;total back pain score ( $nmbr$ – $nmbr$   mm scale )  mean   ±   sd;"C0004604;C0175659;C0349674;C0444504;C1947916;C1963071;C2347634;C2348143;C2699239;C2964552;C4330985;C4553945;C4554674";NA;NA;total back pain score $nmbr$ $nmbr$ mm scale mean sd
1337;total back pain  mean ( sd );"C0004604;C0439175;C0439810;C0444504;C1963071;C2347634;C2348143;C2699239;C4553945";NA;NA;total back pain mean sd
1337;question $nmbr$ ( neck / back / hip pain );"C0004600;C0004604;C0007859;C0019552;C0019559;C0022122;C0027530;C0205095;C0460009;C1505163;C1522634;C1963071;C1963180;C1995000;C3159206;C3538851;C4284725;C4551516;C4553909;C4553945";NA;NA;question $nmbr$ neck back hip pain
1337;back pain;"C0004604;C1963071;C4553945";NA;NA;back pain
1336;patient - reported outcomes;C2987124;NA;NA;patient reported outcomes
1336;patient - reported outcome measures;C4277735;NA;NA;patient reported outcome measures
1335;reported in ecrf;"C0684224;C0700287;C4319718;C4551412";NA;NA;reported in ecrf
1335;not reported in ecrf;"C0684224;C0700287;C1518422;C4319718;C4551412";NA;NA;not reported in ecrf
1335;in;NA;NA;NA;in
1334;patients taking mtx  no . ( % );"C0025677;C0030705;C1417487;C1515187";NA;NA;patients taking mtx no
1334;patients taking mtx  n ( % );"C0025677;C0030705;C1417487;C1515187";NA;NA;patients taking mtx n
1333;patients with eot data  n;C2707520;NA;NA;patients with eot data n
1333;* patient characterization data are reproduced from morrow et al . ( $nmbr$ ) .;"C0040028;C0202311;C1880022;C2707520";NA;NA;patient characterization data are reproduced from morrow et al $nmbr$
1332;taiwan;C0039260;NA;NA;taiwan
1331;native hawaiian or other pacific islander;"C0242191;C0337920";NA;NA;native hawaiian or other pacific islander
1331;native hawaiian or other pacific;C0337920;NA;NA;native hawaiian or other pacific
1331;native hawaiian or;C0337920;NA;NA;native hawaiian or
1331;native hawaiian / pacific islander;"C0242191;C0337920";NA;NA;native hawaiian pacific islander
1331;native hawaiian / other;C0337920;NA;NA;native hawaiian other
1331;hawaiian pacific islander;"C0242191;C0337920";NA;NA;hawaiian pacific islander
1331;hawaiian / pacific islander;"C0242191;C0337920";NA;NA;hawaiian pacific islander
1331;hawaiian / pacific;C0337920;NA;NA;hawaiian pacific
1330;watchman ( n = $nmbr$ );C0335390;NA;NA;watchman n $nmbr$
1330;device = watchman filter;"C0180860;C0335390";NA;NA;device watchman filter
1329;white or caucasian  n ( % );"C0007457;C0043157;C0220938";NA;NA;white or caucasian n
1329;white / caucasian;C0043157;NA;NA;white caucasian
1329;race  % caucasian;"C0007457;C0034510;C0043157;C1706779;C3853635";NA;NA;race caucasian
1329;noncaucasian;NA;NA;NA;noncaucasian
1329;non - caucasian simva ( „ = $nmbr$ };"C0007457;C0043157;C1518422";NA;NA;non caucasian simva $nmbr$
1329;non - caucasian simva ( n = $nmbr$ );"C0007457;C0043157;C1518422";NA;NA;non caucasian simva n $nmbr$
1329;non - caucasian simva;"C0007457;C0043157;C1518422";NA;NA;non caucasian simva
1329;non - caucasian eze / simva ( „ = $nmbr$ };"C0007457;C0043157;C1518422";NA;NA;non caucasian eze simva $nmbr$
1329;non - caucasian eze / simva ( n = $nmbr$ );"C0007457;C0043157;C1518422";NA;NA;non caucasian eze simva n $nmbr$
1329;non - caucasian eze / simva;"C0007457;C0043157;C1518422";NA;NA;non caucasian eze simva
1329;non - caucasian;"C0007457;C0043157;C1518422";NA;NA;non caucasian
1329;causaslan;NA;NA;NA;causaslan
1329;caucasians ( n = $nmbr$ );"C0007457;C0043157";NA;NA;caucasians n $nmbr$
1329;caucasians;"C0007457;C0043157";NA;NA;caucasians
1329;caucasiana ( % );NA;NA;NA;caucasiana
1329;caucasian simva ( „ = $nmbr$ };"C0007457;C0043157";NA;NA;caucasian simva $nmbr$
1329;caucasian simva ( n = $nmbr$ );"C0007457;C0043157";NA;NA;caucasian simva n $nmbr$
1329;caucasian race ( % );C0007457;NA;NA;caucasian race
1329;caucasian race;C0007457;NA;NA;caucasian race
1329;caucasian n = $nmbr$  $nmbr$;"C0007457;C0043157";NA;NA;caucasian n $nmbr$ $nmbr$
1329;caucasian eze / simva ( „ = $nmbr$ };"C0007457;C0043157";NA;NA;caucasian eze simva $nmbr$
1329;caucasian eze / simva ( n = $nmbr$ );"C0007457;C0043157";NA;NA;caucasian eze simva n $nmbr$
1329;caucasian eze / simva;"C0007457;C0043157";NA;NA;caucasian eze simva
1305;laba + ics;"C0815320;C4551720";NA;NA;laba ics
1329;caucasian ethnicity;"C0007457;C0015031;C0043157;C0243103";NA;NA;caucasian ethnicity
1329;caucasian ( % );"C0007457;C0043157";NA;NA;caucasian
1329;caucasian $nmbr$;"C0007457;C0043157";NA;NA;caucasian $nmbr$
1329;caucasian  n ( % ) *;"C0007457;C0043157";NA;NA;caucasian n
1329;caucasian  n ( % );"C0007457;C0043157";NA;NA;caucasian n
1329;caucasian  %;"C0007457;C0043157";NA;NA;caucasian
1329;caucasian;"C0007457;C0043157";NA;NA;caucasian
1328;concomitant use of bosentan  n ( % );"C0252643;C0521115;C1524063";NA;NA;concomitant use of bosentan n
1328;bosentan use :;"C0042153;C0252643;C0457083;C1947944";NA;NA;bosentan use
1328;bosentan ( n = $nmbr$ );C0252643;NA;NA;bosentan n $nmbr$
1328;bosentan;C0252643;NA;NA;bosentan
1327;use of supplemental oxygen  n ( % );"C4067893;C4554557";NA;NA;use of supplemental oxygen n
1327;supplementary oxygen;C0030054;NA;NA;supplementary oxygen
1327;supplemental oxygen;C4534306;NA;NA;supplemental oxygen
1324;diclofenac ( n = $nmbr$ );C0012091;NA;NA;diclofenac n $nmbr$
1324;diclofenac ( n = $nmbr$ $nmbr$ );C0012091;NA;NA;diclofenac n $nmbr$ $nmbr$
1324;diclofenac ( n = $nmbr$  $nmbr$ );C0012091;NA;NA;diclofenac n $nmbr$ $nmbr$
1324;diclofenac $nmbr$ mg ( n = $nmbr$ ) n ( % );"C0012091;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;diclofenac $nmbr$ mg n $nmbr$ n
1324;diclofenac $nmbr$ mg ( n $nmbr$ $nmbr$ )  . n . . . ( . % . . ) . . . . . . . . . . .;"C0012091;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;diclofenac $nmbr$ mg n $nmbr$ $nmbr$ n
1324;diclofenac $nmbr$ mg ( n $nmbr$ $nmbr$ )  . . n . . . ( . % . . ) . . . . . . . . . . . . . . . . .;"C0012091;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;diclofenac $nmbr$ mg n $nmbr$ $nmbr$ n
1324;diclofenac $nmbr$ mg ( n $nmbr$ $nmbr$ )  . . n . . ( . % . . ) . . . . . . . . . . .;"C0012091;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;diclofenac $nmbr$ mg n $nmbr$ $nmbr$ n
1324;diclofenac $nmbr$ mg ( n $nmbr$ $nmbr$ )  . . . n . . ( . % . . ) . . . . . . . . . . . .;"C0012091;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;diclofenac $nmbr$ mg n $nmbr$ $nmbr$ n
1324;diclofenac $nmbr$ mg ( n $nmbr$ $nmbr$ )  . . . n . . ( . % . . ) . . . . . . . . . . .;"C0012091;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;diclofenac $nmbr$ mg n $nmbr$ $nmbr$ n
1323;£ $nmbr$ ( men ) / £ $nmbr$ ( women );"C0025266;C0043210";NA;NA;$nmbr$ men $nmbr$ women
1332;previously taken dmards other than methotrexate  %;"C0025677;C0242708;C1883727";FALSE; 231;previously taken dmards other than methotrexate
1325;omega - $nmbr$ fa;C1719844;FALSE;1236;omega $nmbr$ fa
1328;levosimendan ( n   = $nmbr$ );C0246904;FALSE;2166;levosimendan n $nmbr$
1326;documented hypoglycaemiac;"C1301725;C1609436";FALSE;  35;documented hypoglycaemiac
1326;hypoglycaemiad  %;NA;FALSE;  35;hypoglycaemiad
1326;angina with documented ischemia;"C0002962;C0022116;C1301725;C1609436;C4321499";FALSE;1361;angina with documented ischemia
1326;documented mi;"C1301725;C1609436;C3810814";FALSE;1361;documented mi
1326;documented symptomatic chdb;"C0231220;C1301725;C1609436";FALSE;1361;documented symptomatic chdb
1332;previously taken tnfi  %;C1883727;FALSE; 362;previously taken tnfi
1334;taking statins  n ( % ) a;"C0360714;C1515187";FALSE;2167;taking statins n a
1337;neck pain;"C0007859;C1963180;C4553909";FALSE;2168;neck pain
1337;pin /;"C0175718;C1168556;C1704584";FALSE; -10;pin
1323;women ( n = $nmbr$ ) events;"C0043210;C0441471;C3541888";NA;NA;women n $nmbr$ events
1323;women ( n = $nmbr$ )  n / n ( % );C0043210;NA;NA;women n $nmbr$ n n
1323;women ( n = $nmbr$ );C0043210;NA;NA;women n $nmbr$
1323;women ( n ( % ) );C0043210;NA;NA;women n
1323;women ( % );C0043210;NA;NA;women
1323;women  no . ( % );C0043210;NA;NA;women no
1323;women  n ( % ) *;C0043210;NA;NA;women n
1323;women  n ( % );C0043210;NA;NA;women n
1323;women  %;C0043210;NA;NA;women
1323;women;C0043210;NA;NA;women
1323;woman;"C0043210;C4281745";NA;NA;woman
1323;no . women;C0043210;NA;NA;no women
1323;gmi ( women );C0043210;NA;NA;gmi women
1323;gender  women n  % );"C0043210;C0079399;C1522384";NA;NA;gender women n
1323;fpci vs . ppci in women;C0043210;NA;NA;fpci vs ppci in women
1323;all women;C0043210;NA;NA;all women
1323;< $nmbr$ ( men ) / < $nmbr$ ( women );"C0025266;C0043210";NA;NA;$nmbr$ men $nmbr$ women
1323;( women only );"C0043210;C0205171;C1720467";NA;NA;women only
1323;$nmbr$ - $nmbr$ ( women );C0043210;NA;NA;$nmbr$ $nmbr$ women
1322;open — no . ( % );C0175566;NA;NA;open no
1322;open triple ( n = $nmbr$ );"C0175566;C0205174";NA;NA;open triple n $nmbr$
1322;open;C0175566;NA;NA;open
1321;bowel function;C0011135;NA;NA;bowel function
1320;risk model endpoint;"C0035647;C2349179;C2826544;C3161035;C3274659;C3714583;C3853906;C4552904";NA;NA;risk model endpoint
1320;risk marker and model;"C1519104;C3161035;C3274659;C3714583;C3853906";NA;NA;risk marker and model
1320;model $nmbr$ §;"C3161035;C3274659;C3714583;C3853906";NA;NA;model $nmbr$
1320;model $nmbr$ t;"C3161035;C3274659;C3714583;C3853906";NA;NA;model $nmbr$ t
1320;model $nmbr$ +;"C3161035;C3274659;C3714583;C3853906";NA;NA;model $nmbr$
1320;model $nmbr$;"C3161035;C3274659;C3714583;C3853906";NA;NA;model $nmbr$
1320;model  n;"C3161035;C3274659;C3714583;C3853906";NA;NA;model n
 -10;proctosigmoiditis;C0033252;NA;NA;proctosigmoiditis
1318;seropositivity status  n;"C0449438;C0521143";NA;NA;seropositivity status n
1318;seropositivity;C0521143;NA;NA;seropositivity
1317;eligibility risk factorsa;"C0013893;C0035647;C1548635;C4552904";NA;NA;eligibility risk factorsa
1317;eligibility risk factors ’ );"C0013893;C0035648;C1548635;C1553898";NA;NA;eligibility risk factors
1317;eligibility risk factors — n ( % ) :;"C0013893;C0035648;C1548635;C1553898";NA;NA;eligibility risk factors n
1317;eligibility risk factors :;"C0013893;C0035648;C1548635;C1553898";NA;NA;eligibility risk factors
1317;eligibility risk factors /;"C0013893;C0035648;C1548635;C1553898";NA;NA;eligibility risk factors
1317;eligibility risk factors !;"C0013893;C0035648;C1548635;C1553898";NA;NA;eligibility risk factors
1317;eligibility risk factors  no . ( % ) t;"C0013893;C0035648;C1548635;C1553898;C2603360";NA;NA;eligibility risk factors no t
1317;eligibility risk factors  % t ascvo;"C0013893;C0035648;C1548635;C1553898";NA;NA;eligibility risk factors t ascvo
1317;eligibility risk factors;"C0013893;C0035648;C1548635;C1553898";NA;NA;eligibility risk factors
1317;* eligibility risk factors  n ( % ) *;"C0013893;C0035648;C1548635;C1553898";NA;NA;eligibility risk factors n
1315;screening absolute reversibility fev $nmbr$  ml;"C0205344;C0220908;C0220909;C0439526;C0449261;C1698960;C1705224;C1710031;C1710032;C1710477;C2348164;C3714541;C3887665";NA;NA;screening absolute reversibility fev $nmbr$ ml
1315;screening % reversibility fev $nmbr$;"C0220908;C0220909;C0449261;C1698960;C1710031;C1710032;C1710477;C2348164;C3714541";NA;NA;screening reversibility fev $nmbr$
1315;saba reversibility;C0449261;NA;NA;saba reversibility
1315;reversibility to salbutamolc  d  mean ( sd );"C0444504;C0449261;C2347634;C2348143;C2699239";NA;NA;reversibility to salbutamolc d mean sd
1315;reversibility of fev $nmbr$ ( % );"C0449261;C3714541";NA;NA;reversibility of fev $nmbr$
1315;reversibility ( b $nmbr$ - agonist )  %  mean ( sd ) $nmbr$;"C0444504;C0449261;C2347634;C2348143;C2699239;C2987634";NA;NA;reversibility b $nmbr$ agonist mean sd $nmbr$
1315;reversibility ( anticholinergic )  %  mean ( sd ) $;"C0242896;C0444504;C0449261;C2347634;C2348143;C2699239;C3537004";NA;NA;reversibility anticholinergic mean sd $
1315;reversibility ( % predicted fev $nmbr$ ) *;"C0449261;C0681842;C1882327;C3714541";NA;NA;reversibility predicted fev $nmbr$
1315;postbronchodilator fev $nmbr$ reversibility  %;"C0449261;C2599594;C3714541";NA;NA;postbronchodilator fev $nmbr$ reversibility
1305;laba  n ( % );NA;NA;NA;laba n
1305;laba;NA;NA;NA;laba
1315;post - bronchodilator fev i reversibility  % b;"C0021966;C0221138;C0449261;C2599594;C3714541";NA;NA;post bronchodilator fev i reversibility b
1315;post - bronchodilator fev $nmbr$ reversibility  % a;"C0449261;C2599594;C3714541";NA;NA;post bronchodilator fev $nmbr$ reversibility a
1315;post - bronchodilator fev $nmbr$ reversibility  %;"C0449261;C2599594;C3714541";NA;NA;post bronchodilator fev $nmbr$ reversibility
1315;post - bronchodilator fev  reversibility;"C0449261;C2599594;C3714541";NA;NA;post bronchodilator fev reversibility
1315;mean reversibility ( % );"C0444504;C0449261;C2347634;C2348143";NA;NA;mean reversibility
1315;mean ( sd ) postbronchodilator fev $nmbr$ reversibility  %;"C0444504;C0449261;C2347634;C2348143;C2599594;C2699239;C3714541";NA;NA;mean sd postbronchodilator fev $nmbr$ reversibility
1315;mean ( sd ) % reversibility fev $nmbr$ at;"C0444504;C0449261;C2347634;C2348143;C2699239;C3714541";NA;NA;mean sd reversibility fev $nmbr$ at
1315;reversibility to;C0449261;FALSE;2160;reversibility to
1315;reversibility ( % ) t;C0449261;FALSE;2160;reversibility t
1315;reversibility stratum *;C0449261;FALSE;2160;reversibility stratum
1315;reversibility < $nmbr$ % ( n = $nmbr$ );C0449261;FALSE;2160;reversibility $nmbr$ n $nmbr$
1315;reversibility : > $nmbr$ - < $nmbr$ %;C0449261;FALSE;2160;reversibility $nmbr$ $nmbr$
1315;reversibility > $nmbr$ % ( itt ) ( n = $nmbr$ );C0449261;FALSE;2160;reversibility $nmbr$ itt n $nmbr$
1315;reversibility < $nmbr$ % ( itt ) ( n = $nmbr$ );C0449261;FALSE;2160;reversibility $nmbr$ itt n $nmbr$
1315;reversibility : > $nmbr$ %;C0449261;FALSE;2160;reversibility $nmbr$
1315;reversibility : < $nmbr$ %;C0449261;FALSE;2160;reversibility $nmbr$
1315;reversibility ( % )  median ( range ) c;"C0449261;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016";FALSE;2160;reversibility median range c
1315;reversibility [ % ]  median ( range );"C0449261;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016";FALSE;2160;reversibility median range
1315;reversibility — %;C0449261;FALSE;2160;reversibility
1315;reversibility %;C0449261;FALSE;2160;reversibility
1315;reversibility *;C0449261;FALSE;2160;reversibility
1315;reversibility ( % );C0449261;FALSE;2160;reversibility
1315;reversibility ’ ' %;C0449261;FALSE;2160;reversibility
1315;reversibility  %;C0449261;FALSE;2160;reversibility
1315;reversibility;C0449261;FALSE;2160;reversibility
1316;fevi reversibility — %;C3830088;FALSE;1315;fevi reversibility
1316;reversibility to salbutamol  %;C1271924;FALSE;1315;reversibility to salbutamol
1317;eligibility strata;"C0013893;C1548635";FALSE;2161;eligibility strata
1317;eligibility stratum;"C0013893;C1548635";FALSE;2161;eligibility stratum
1320;unadjusted model hr  $nmbr$ % ci  p value;"C0008107;C1439367;C1709380;C3161035;C3259781;C3274659;C3714583;C3853906";FALSE;2162;unadjusted model hr $nmbr$ ci p value
1320;crude model hr ( $nmbr$ % ci );"C0008107;C3161035;C3259781;C3274659;C3714583;C3853906";FALSE;2162;crude model hr $nmbr$ ci
1321;bowel stricturing  ' n ( % );C0267465;FALSE;2163;bowel stricturing n
1321;daily bowel movements;"C0011135;C0332173";FALSE;2164;daily bowel movements
1322;statin ( open );"C0175566;C0360714";FALSE;2167;statin open
1315;fev $nmbr$ reversibility  % b;"C0449261;C3714541";NA;NA;fev $nmbr$ reversibility b
1315;fev $nmbr$ reversibility  % *;"C0449261;C3714541";NA;NA;fev $nmbr$ reversibility
1315;fev $nmbr$ % reversibility ( sd );"C0449261;C2699239;C3714541";NA;NA;fev $nmbr$ reversibility sd
1315;fev $nmbr$ % reversibility;"C0449261;C3714541";NA;NA;fev $nmbr$ reversibility
1315;bronchial reversibility %;"C0205039;C0449261;C1442216";NA;NA;bronchial reversibility
1315;albuterol reversibility  %;"C0001927;C0449261";NA;NA;albuterol reversibility
1315;airway reversibility  mean  %;"C0178987;C0444504;C0449261;C0458827;C2347634;C2348143";NA;NA;airway reversibility mean
1315;airway reversibility  %;"C0178987;C0449261;C0458827";NA;NA;airway reversibility
1315;airflow reversibility — no . ( % ) |;"C0231999;C0449261";NA;NA;airflow reversibility no
1315;absolute reversibility in fev $nmbr$  ml *;"C0205344;C0439526;C0449261;C1705224;C3714541;C3887665";NA;NA;absolute reversibility in fev $nmbr$ ml
1315;% reversibility in fev ^ at;"C0449261;C3714541";NA;NA;reversibility in fev at
1315;% bronchial reversibility ( sd );"C0205039;C0449261;C1442216;C2699239";NA;NA;bronchial reversibility sd
1314;ecg abnormality at entry;"C0522055;C1705654";NA;NA;ecg abnormality at entry
1314;any electrocardiographic abnormality — no . ( % );C0522055;NA;NA;any electrocardiographic abnormality no
1313;obesityj;NA;NA;NA;obesityj
1313;abdominal obesity *;C0311277;NA;NA;abdominal obesity
1313;abdominal obesity;C0311277;NA;NA;abdominal obesity
1312;shfm annual mortality;"C0026565;C0026566;C0332181";NA;NA;shfm annual mortality
1312;overall mortality;"C0026565;C0026566;C0282416;C1561607";NA;NA;overall mortality
1312;or morbidity and mortality;"C0026538;C0026565;C0026566;C0220880";NA;NA;or morbidity and mortality
1312;non - cvd mortality;"C0007222;C0026565;C0026566;C1518422";NA;NA;non cvd mortality
1312;non - cardiovascular mortality;"C0007226;C0026565;C0026566;C1518422;C3887460";NA;NA;non cardiovascular mortality
1312;mortality outcomes;"C0026565;C0026566;C1274040";NA;NA;mortality outcomes
1312;mortality;"C0026565;C0026566";NA;NA;mortality
1312;all - causa mortality;"C0026565;C0026566;C3903827";NA;NA;all causa mortality
1311;si . gni . fi . canr ecg changes  positive biomarkers  and age < $nmbr$ vrs;"C0001779;C0005516;C0392747;C0439178;C0443172;C0458261;C1446409;C1514241;C1623258;C1705241;C2825490;C3273608;C3812269;C4050619;C4319952";NA;NA;si gni fi canr ecg changes positive biomarkers and age $nmbr$ vrs
1311;bi ( $nmbr$ . $nmbr$ );NA;NA;NA;bi $nmbr$ $nmbr$
1311;age is > $nmbr$ vrs  significant ecg changes  and no positive bi . omark . ers;"C0001779;C0237881;C0439178;C0458261;C0750502;C0855329;C1446409;C1514241;C1546944;C1704489;C2825490;C2931783;C3273608;C3812269";NA;NA;age is $nmbr$ vrs significant ecg changes and no positive bi omark ers
1311;age is > $nmbr$ vrs  positive biomarkers  and no si . gni . fi . canr ecg changes;"C0001779;C0005516;C0392747;C0439178;C0443172;C0458261;C1446409;C1514241;C1623258;C1705241;C2825490;C3273608;C3812269;C4050619;C4319952";NA;NA;age is $nmbr$ vrs positive biomarkers and no si gni fi canr ecg changes
1311;- bi -;NA;NA;NA;bi
1311;$nmbr$ ( $nmbr$ si;NA;NA;NA;$nmbr$ $nmbr$ si
1310;wrist;"C0043262;C1322271";NA;NA;wrist
1310;hip  wrist  or spine *;"C0019552;C0022122;C0037949;C0043262;C1322271;C1505163;C2752558;C3538851;C4284725";NA;NA;hip wrist or spine
1309;white hispanic - n ( % );"C1533020;C1533021";NA;NA;white hispanic n
1309;white hispanic;"C1533020;C1533021";NA;NA;white hispanic
1308;patients with > $nmbr$ % bsa;C0030705;NA;NA;patients with $nmbr$ bsa
1308;patients with $ $nmbr$ % bsa at baseline  no .;"C0030705;C0168634;C1442488";NA;NA;patients with $ $nmbr$ bsa at baseline no
1308;bsa ( % );NA;NA;NA;bsa
1308;bsa  % *;NA;NA;NA;bsa
1307;yaa;NA;NA;NA;yaa
1307;laa ostium;C0444567;NA;NA;laa ostium
1307;laa closure ( n = $nmbr$ );"C0185003;C1521802";NA;NA;laa closure n $nmbr$
1307;laa closure ( n - $nmbr$ );"C0185003;C1521802";NA;NA;laa closure n $nmbr$
1307;laa closure;"C0185003;C1521802";NA;NA;laa closure
1307;laa;NA;NA;NA;laa
1305;sabaa;NA;NA;NA;sabaa
1305;previous ics / labd;"C0205156;C0396059;C0815320;C1552607;C4551720";NA;NA;previous ics labd
1305;percentage of patients using ics or ics / laba on entry;"C0030705;C0439165;C0815320;C1524063;C1549488;C1561533;C1705654;C4551720";NA;NA;percentage of patients using ics or ics laba on entry
1305;lamad;NA;NA;NA;lamad
1305;labaa;NA;NA;NA;labaa
1305;laba / lama / ics;"C0815320;C0999593;C1416775;C4551720";NA;NA;laba lama ics
1305;laba / ics #;"C0815320;C4551720";NA;NA;laba ics
1305;laba + ics n = $nmbr$;"C0815320;C4551720";NA;NA;laba ics n $nmbr$
1305;laba + ics ( free or fixed - dose combination );"C0178602;C0205195;C0332296;C0443218;C0815320;C0869039;C1114758;C1880497;C1947911;C1996904;C2827483;C3714578;C3811910;C4551720";NA;NA;laba ics free or fixed dose combination
1302;week $nmbr$  % ( n ) | | or for cana vs pbo ( $nmbr$ % ci ) §;"C0008107;C0031962;C0332174;C0439230;C1418845;C3259781";NA;NA;week $nmbr$ n or for cana vs pbo $nmbr$ ci
1302;week $nmbr$  % ( n ) $nmbr$ or for cana vs pbo ( $nmbr$ % ci ) | |;"C0008107;C0031962;C0332174;C0439230;C1418845;C3259781";NA;NA;week $nmbr$ n $nmbr$ or for cana vs pbo $nmbr$ ci
1302;week $nmbr$  % ( n ) # or for cana vs pbo ( $nmbr$ % ci ) | |;"C0008107;C0031962;C0332174;C0439230;C1418845;C3259781";NA;NA;week $nmbr$ n or for cana vs pbo $nmbr$ ci
1302;pooled non - canvas studies ( n = $nmbr$ ) : non - cana ( n = $nmbr$ )  cana $nmbr$ mg ( n = $nmbr$ )  cana $nmbr$ mg ( n = $nmbr$ );"C0369718;C0441922;C0557651;C0947630;C1319635;C1418845;C1518422;C1709595;C2349200;C2603343;C3281223;C4522255";NA;NA;pooled non canvas studies n $nmbr$ non cana n $nmbr$ cana $nmbr$ mg n $nmbr$ cana $nmbr$ mg n $nmbr$
1304;univariable;NA;FALSE;2154;univariable
1304;multivariable adjusted hr ( $nmbr$ % ci );"C0008107;C0456081;C3259781";FALSE; 975;multivariable adjusted hr $nmbr$ ci
1305;ics / lama;"C0815320;C0999593;C1416775;C4551720";FALSE;1650;ics lama
1306;cardiovascu lar subg roup;"C0276828;C1419115;C3814448";FALSE;2155;cardiovascu lar subg roup
1306;chajdsrvasc $nmbr$ - $nmbr$;NA;FALSE;2128;chajdsrvasc $nmbr$ $nmbr$
1309;whitea;C1021495;FALSE; -10;whitea
1312;cardiovascuiar mortaiity;NA;FALSE;2157;cardiovascuiar mortaiity
1305;icsa plus laba  n ( % );C0332287;FALSE;1650;icsa plus laba n
1305;ics / laba;"C0815320;C4551720";FALSE;1650;ics laba
1305;ics + laba;"C0815320;C4551720";FALSE;1650;ics laba
1305;- ics / + laba n z $nmbr$;"C0815320;C4551720";FALSE;1650;ics laba n z $nmbr$
1312;cardiovascular mortality;"C0007226;C0026565;C0026566;C3887460";FALSE;2157;cardiovascular mortality
1312;cardiovascular mortality or mi;"C0007226;C0026565;C0026566;C3810814;C3887460";FALSE;2157;cardiovascular mortality or mi
1312;cardiovascular mortality  mi  or revascularization;"C0007226;C0026565;C0026566;C0581603;C3810814;C3887460";FALSE;2157;cardiovascular mortality mi or revascularization
1312;vitality;C0424589;FALSE;2158;vitality
1314;nationality;C0027473;FALSE;2159;nationality
1315;% reversibility;C0449261;FALSE;2160;reversibility
1302;overall population ( n = $nmbr$ $nmbr$ ) : non - cana ( n = $nmbr$ )  cana $nmbr$ mg ( n = $nmbr$ )  cana $nmbr$ mg ( n = $nmbr$ );"C0032659;C0282416;C1257890;C1319635;C1418845;C1518422;C1561607";NA;NA;overall population n $nmbr$ $nmbr$ non cana n $nmbr$ cana $nmbr$ mg n $nmbr$ cana $nmbr$ mg n $nmbr$
1302;or for cana vs pbo ( $nmbr$ % ci ) §;"C0008107;C0031962;C1418845;C3259781";NA;NA;or for cana vs pbo $nmbr$ ci
1302;or for cana vs pbo ( $nmbr$ % ci ) | |;"C0008107;C0031962;C1418845;C3259781";NA;NA;or for cana vs pbo $nmbr$ ci
1302;non - cana ( n = $nmbr$ );"C1418845;C1518422";NA;NA;non cana n $nmbr$
1302;canvas ( n = $nmbr$ ) : placebo ( n = $nmbr$ )  cana $nmbr$ mg ( n = $nmbr$ )  cana $nmbr$ mg ( n = $nmbr$ );"C0032042;C1319635;C1418845;C1696465;C1706408;C3281223";NA;NA;canvas n $nmbr$ placebo n $nmbr$ cana $nmbr$ mg n $nmbr$ cana $nmbr$ mg n $nmbr$
1302;canvas;C3281223;NA;NA;canvas
1302;cana $nmbr$ ( n = $nmbr$ );C1418845;NA;NA;cana $nmbr$ n $nmbr$
1302;cana;C1418845;NA;NA;cana
1302;all cana;C1418845;NA;NA;all cana
1301;united states  canada;"C0006823;C0041703";NA;NA;united states canada
1301;canada or united states;"C0006823;C0041703";NA;NA;canada or united states
1300;samac;NA;NA;NA;samac
1300;sama $nmbr$;C1075468;NA;NA;sama $nmbr$
1300;sama  b   n ( % );C1075468;NA;NA;sama b n
1300;sama;C1075468;NA;NA;sama
1300;previous treatment with a laba and / or lama  n ( % ) c;"C0039798;C0087111;C0205156;C0999593;C1416775;C1522326;C1533734;C1552607;C1705169;C3538994;C3887704";NA;NA;previous treatment with a laba and or lama n c
1300;lama use  n ( % );"C0042153;C0457083;C0999593;C1416775;C1947944";NA;NA;lama use n
1300;lama +;"C0999593;C1416775";NA;NA;lama
1300;lama;"C0999593;C1416775";NA;NA;lama
1300;laba or lama ’;"C0999593;C1416775";NA;NA;laba or lama
1300;laba or lama;"C0999593;C1416775";NA;NA;laba or lama
1300;laba / lama;"C0999593;C1416775";NA;NA;laba lama
1300;current lama use;"C0042153;C0457083;C0521116;C0999593;C1416775;C1705970;C1947944";NA;NA;current lama use
1300;ama 士 s . e .;"C0002461;C0279755;C2825862";NA;NA;ama s e
1299;place of randomization;"C0034656;C0442504;C1533810;C1704765;C1882509";NA;NA;place of randomization
1299;place !;"C0442504;C1533810;C1704765;C1882509";NA;NA;place
1299;plac;C0048838;NA;NA;plac
1298;peace ( n = $nmbr$ );C0680443;NA;NA;peace n $nmbr$
1298;pace  no . ( $nmbr$ );"C0287990;C1552930;C4048252";NA;NA;pace no $nmbr$
1297;smoking history ( pack - years ) ∗;"C1277691;C1519384";NA;NA;smoking history pack years
1297;smoking history ( pack - years );"C1277691;C1519384";NA;NA;smoking history pack years
1297;smoking history  pack - years;"C1277691;C1519384";NA;NA;smoking history pack years
1297;smoking consumption pack - years;"C0425291;C1277691";NA;NA;smoking consumption pack years
1297;pack years;C1277691;NA;NA;pack years
1297;pack - years smoked;"C0037366;C0439994;C1277691;C1881674";NA;NA;pack years smoked
1297;number of pack years;"C0237753;C0449788;C1277691";NA;NA;number of pack years
1297;number of pack - years;"C0237753;C0449788;C1277691";NA;NA;number of pack years
1297;nicotine pack - years;"C0028040;C1277691";NA;NA;nicotine pack years
1297;estimated number of pack - years;"C0237753;C0449788;C0750572;C1277691";NA;NA;estimated number of pack years
1296;b lack;C0332268;NA;NA;b lack
1295;history of a transient ischaemic attack;C0455536;NA;NA;history of a transient ischaemic attack
1294;pcr after acs;"C0032520;C0742343;C3853643;C4050242;C4318612";NA;NA;pcr after acs
1293;uncontrolled : acq - $nmbr$ > $nmbr$ . $nmbr$;"C0205318;C2919686";NA;NA;uncontrolled acq $nmbr$ $nmbr$ $nmbr$
1293;acq score  mean;"C0444504;C0449820;C2347634;C2348143;C2919686;C4050231";NA;NA;acq score mean
1293;acq - $nmbr$ scoret;C2919686;NA;NA;acq $nmbr$ scoret
1293;acq - $nmbr$ score 本;"C0449820;C2919686;C4050231";NA;NA;acq $nmbr$ score
1293;acq - $nmbr$ score *;"C0449820;C2919686;C4050231";NA;NA;acq $nmbr$ score
1293;acq - $nmbr$ score ' ! ';"C0449820;C2919686;C4050231";NA;NA;acq $nmbr$ score
1293;acq - $nmbr$ score  mean ( sd ) e;"C0444504;C0449820;C2347634;C2348143;C2699239;C2919686;C4050231";NA;NA;acq $nmbr$ score mean sd e
1293;acq - $nmbr$ score;"C0449820;C2919686;C4050231";NA;NA;acq $nmbr$ score
1293;acq $nmbr$ score  mean ( sd );"C0444504;C0449820;C2347634;C2348143;C2699239;C2919686;C4050231";NA;NA;acq $nmbr$ score mean sd
1293;acq $nmbr$ score;"C0449820;C2919686;C4050231";NA;NA;acq $nmbr$ score
1294;nste acs;"C0742343;C4318612";FALSE;2146;nste acs
1294;nste - acs;"C0742343;C4318612";FALSE;2146;nste acs
1294;acs;"C0742343;C4318612";FALSE;2147;acs
1294;before index acs event;"C0441471;C0600653;C0742343;C0918012;C1552854;C1637833;C2986546;C4019010;C4318612";FALSE;2147;before index acs event
1294;hospitalization for acs;"C0019993;C0742343;C4318612";FALSE;2147;hospitalization for acs
1294;index acs ( % );"C0600653;C0742343;C0918012;C1552854;C1637833;C2986546;C4318612";FALSE;2147;index acs
1294;index acs event;"C0441471;C0600653;C0742343;C0918012;C1552854;C1637833;C2986546;C4019010;C4318612";FALSE;2147;index acs event
1294;no acs;"C0742343;C4318612";FALSE;2147;no acs
1294;qualifying acs event — no . ( % );"C0441471;C0742343;C1514624;C4019010;C4318612";FALSE;2147;qualifying acs event no
1294;days between acs and rand;"C0439228;C0742343;C1555436;C4318612";FALSE;2148;days between acs and rand
1294;time between index acs and randomization ( days );"C0034656;C0040223;C0439228;C0600653;C0742343;C0918012;C1552854;C1637833;C2986546;C3541383;C4318612";FALSE;2148;time between index acs and randomization days
1294;time between index acs and randomization — days;"C0034656;C0040223;C0439228;C0600653;C0742343;C0918012;C1552854;C1637833;C2986546;C3541383;C4318612";FALSE;2148;time between index acs and randomization days
1294;previous cabg ( before index acs ) *;"C0010055;C0205156;C0600653;C0742343;C0918012;C1552607;C1552854;C1637833;C2986546;C4318612";FALSE;2149;previous cabg before index acs
1294;myocardial infarction before index acs — no . ( % );"C0027051;C0428953;C0600653;C0742343;C0918012;C1552854;C1637833;C2926063;C2986546;C3810814;C4318612;C4552959";FALSE;2150;myocardial infarction before index acs no
1294;prior ml ( before index acs );"C0332152;C0439526;C0600653;C0742343;C0918012;C1552854;C1637833;C1705224;C2826257;C2986546;C3887665;C4318612";FALSE;2150;prior ml before index acs
1294;previous pci ( before index acs );"C0205156;C0600653;C0742343;C0918012;C1552607;C1552854;C1637833;C2986546;C4049621;C4318612";FALSE;1661;previous pci before index acs
1295;attack ( % );"C0277793;C1261512;C1304680";FALSE; -10;attack
1295;attain;NA;FALSE; -10;attain
1296;lack of effectiveness;C0235828;FALSE;2151;lack of effectiveness
1296;lack of efficacy;C0235828;FALSE;2151;lack of efficacy
1296;lack of efficacy with > $nmbr$ anti - interleukin $nmbr$;"C0021764;C0235828;C1527200";FALSE;2151;lack of efficacy with $nmbr$ anti interleukin $nmbr$
1296;lack of efficacy with > $nmbr$ bdmard;C0235828;FALSE;2151;lack of efficacy with $nmbr$ bdmard
1296;laci;"C1420705;C3273314;C4281721";FALSE;2152;laci
1296;laci ( n = $nmbr$ );"C1420705;C3273314;C4281721";FALSE;2152;laci n $nmbr$
1297;sack;NA;FALSE; -10;sack
1297;yearl;NA;FALSE; -10;yearl
1299;inhixanab $nmbr$ mgikg versus piacom;NA;FALSE; 154;inhixanab $nmbr$ mgikg versus piacom
1301;laaca;NA;FALSE;2153;laaca
1301;saaca;NA;FALSE;2153;saaca
1301;canada;C0006823;FALSE;2156;canada
1293;( sd ) l / min acq - $nmbr$ score  mean ( sd );"C0444504;C0449820;C0702093;C1524029;C2347634;C2348143;C2699239;C2919686;C3813700;C4050231";NA;NA;sd l min acq $nmbr$ score mean sd
1292;hematocrit  %;"C0018935;C0518014";NA;NA;hematocrit
1292;baseline hematocrit  median ( iqr );"C0018935;C0168634;C0518014;C0549183;C0876920;C1442488;C2347635;C2348144;C2939193";NA;NA;baseline hematocrit median iqr
1291;exact - pro total score  mean ( sd );"C0033382;C0444504;C0523852;C2347634;C2348143;C2699239;C2828393;C2964552;C2987124;C4050514";NA;NA;exact pro total score mean sd
1291;exact ( b );"C2828393;C4050514";NA;NA;exact b
1290;total cataract extraction;"C0007389;C0185115;C0439175;C0439810;C0684295;C3665439";NA;NA;total cataract extraction
1290;total cataract;C3665439;NA;NA;total cataract
1290;cataract removal;C0007389;NA;NA;cataract removal
1290;cataract;"C0086543;C4555209";NA;NA;cataract
1289;upper respiratory tract inflammation;C0877266;NA;NA;upper respiratory tract inflammation
1289;upper respiratory tract infection $nmbr$ ( $nmbr$ . $nmbr$ );C0041912;NA;NA;upper respiratory tract infection $nmbr$ $nmbr$ $nmbr$
1289;upper respiratory tract infection;C0041912;NA;NA;upper respiratory tract infection
1288;vertebrobasilar infarct;"C0021308;C0545733";NA;NA;vertebrobasilar infarct
1288;prior infarction;"C0021308;C0332152;C2826257";NA;NA;prior infarction
1288;no infarct visible;"C0021308;C0205379";NA;NA;no infarct visible
1288;infarct territory ( % );"C0021308;C1301808;C2983136";NA;NA;infarct territory
1288;infarct size;"C0021308;C0456389";NA;NA;infarct size
1288;atherothrombotic infarction  n ( % );C0021308;NA;NA;atherothrombotic infarction n
1288;any relevant infarct;"C0021308;C2347946";NA;NA;any relevant infarct
1288;any infarct;C0021308;NA;NA;any infarct
1287;± sd .;C2699239;NA;NA;sd
1287;years ( sd );"C0439234;C2699239";NA;NA;years sd
1287;week o ( baseline ) mean 士 sd;"C0168634;C0332174;C0439230;C0444504;C1442488;C2347634;C2348143;C2699239";NA;NA;week o baseline mean sd
1287;week $nmbr$ mean 士 sd;"C0332174;C0439230;C0444504;C2347634;C2348143;C2699239";NA;NA;week $nmbr$ mean sd
1287;week $nmbr$ mean ( sd );"C0332174;C0439230;C0444504;C2347634;C2348143;C2699239";NA;NA;week $nmbr$ mean sd
1287;week $nmbr$ ( mean  sd );"C0332174;C0439230;C0444504;C2347634;C2348143;C2699239";NA;NA;week $nmbr$ mean sd
1287;vital signs  mean ( sd );"C0150404;C0444504;C0518766;C2347634;C2348143;C2699239";NA;NA;vital signs mean sd
1287;vessel size  mean ( sd )  mm;"C0005847;C0444504;C0456389;C2347634;C2348143;C2699239;C4330985;C4554674";NA;NA;vessel size mean sd mm
1287;treated at baseline  mean ( sd )  mm hg;"C0168634;C0439475;C0444504;C1442488;C1522326;C2347634;C2348143;C2699239";NA;NA;treated at baseline mean sd mm hg
1287;total periventricular wml score  mean ( sd );"C0444504;C2347634;C2348143;C2699239;C2964552";NA;NA;total periventricular wml score mean sd
1287;total macular volume  mean ( sd )  mm $nmbr$;"C0332574;C0444504;C0449468;C2347634;C2348143;C2699239;C4330985;C4554674";NA;NA;total macular volume mean sd mm $nmbr$
1287;time from parkinson ’ s disease diagnosis in months  mean ( sd );"C0011900;C0030567;C0040223;C0439231;C0444504;C1704338;C1704656;C2347634;C2348143;C2699239;C3541383";NA;NA;time from parkinson s disease diagnosis in months mean sd
1287;systolic pressure at ankle level ( mmhg )  mean ± sd;"C0003086;C0003087;C0039155;C0439475;C0441889;C0444504;C0445074;C0456079;C0871470;C1547707;C2347634;C2348143;C2699239;C2946261";NA;NA;systolic pressure at ankle level mmhg mean sd
1287;symptom score ( sd );"C2699239;C3476546";NA;NA;symptom score sd
1287;sf - $nmbr$ v $nmbr$ domain scores  mean [ sd ];"C0037712;C0444504;C0449820;C1880389;C1883221;C2347634;C2348143;C2699239;C3541951;C4050231";NA;NA;sf $nmbr$ v $nmbr$ domain scores mean sd
1287;sd or %;C2699239;NA;NA;sd or
1287;sd;C2699239;NA;NA;sd
1287;ppbc score  mean ( sd );"C0444504;C0449820;C2347634;C2348143;C2699239;C4050231";NA;NA;ppbc score mean sd
   7;p value;C1709380;NA;NA;p value
1287;oab - q score  mean ( sd );"C0444504;C0449820;C2347634;C2348143;C2699239;C3641332;C4050231";NA;NA;oab q score mean sd
1287;number of patients ( % ) or mean 士 sd;"C0444504;C2347634;C2348143;C2360800;C2699239";NA;NA;number of patients or mean sd
1287;mean 土 sd ( n );"C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd n
1277;female ( % );"C0043210;C0086287;C1705497;C1705498";NA;NA;female
1287;scdbp  mean ( sd )  mmhgf;"C0444504;C2347634;C2348143;C2699239";FALSE;2127;scdbp mean sd mmhgf
1287;scsbp  mean ( sd )  mmhge;"C0444504;C2347634;C2348143;C2699239";FALSE;2127;scsbp mean sd mmhge
1287;sesbp ( mmhg ) [ mean - sd ] d;"C0439475;C0444504;C2347634;C2348143;C2699239";FALSE;2127;sesbp mmhg mean sd d
1287;sesbp ( mmhg ) [ mean _sd ] a;"C0439475;C0444504;C2347634;C2348143;C2699239";FALSE;2127;sesbp mmhg mean _sd a
1287;sedbp ( mmhg ) [ mean _sd ] d;"C0439475;C0444504;C2347634;C2348143;C2699239";FALSE;2127;sedbp mmhg mean _sd d
1287;sedbp ( mmhg ) [ mean_ sd ] a;"C0439475;C0444504;C2347634;C2348143;C2699239";FALSE;2127;sedbp mmhg mean_ sd a
1287;seated sbp  mean ( sd )  mmhg;"C0085805;C0277814;C0439475;C0444504;C1283233;C2347634;C2348143;C2699239";FALSE;2127;seated sbp mean sd mmhg
1287;systolic blood pressure  mean ( sd )  mm hga;"C0039155;C0428886;C0444504;C0488055;C0871470;C1306620;C2347634;C2348143;C2699239;C4330985;C4554674";FALSE;2127;systolic blood pressure mean sd mm hga
1287;systolic ( mean  sd );"C0039155;C0444504;C2347634;C2348143;C2699239";FALSE;2127;systolic mean sd
1287;systolic  mean ( sd )  mm hg h;"C0025424;C0039155;C0428257;C0444504;C0456680;C2347108;C2347109;C2347634;C2348143;C2348272;C2699239";FALSE;2127;systolic mean sd mm hg h
1287;post - bronchodilator fev $nmbr$  l  mean ( sd );"C0444504;C2347634;C2348143;C2599594;C2699239;C3714541";FALSE;2142;post bronchodilator fev $nmbr$ l mean sd
1287;post - bronchodilator fev $nmbr$  l  mean ( sd ) c;"C0444504;C2347634;C2348143;C2599594;C2699239;C3714541";FALSE;2142;post bronchodilator fev $nmbr$ l mean sd c
1287;post - bronchodilator fev $nmbr$  mean ( sd )  l;"C0444504;C2347634;C2348143;C2599594;C2699239;C3714541";FALSE;2142;post bronchodilator fev $nmbr$ mean sd l
1287;patient global assessment of disease activity  mean ( sd );"C0444504;C2347634;C2348143;C2699239;C4054228";FALSE;2143;patient global assessment of disease activity mean sd
1287;patient ' s global assessment of disease activity  mean ( sd );"C0444504;C2347634;C2348143;C2699239;C4054228";FALSE;2143;patient s global assessment of disease activity mean sd
1287;patient ' s global assessment of disease activity ( $nmbr$ - $nmbr$ mm vas )  mean ( sd );"C0042815;C0444504;C2347634;C2348143;C2699239;C3536884;C3827561;C4054228;C4330985;C4554674";FALSE;2143;patient s global assessment of disease activity $nmbr$ $nmbr$ mm vas mean sd
1288;nonfatai myocardiai infarction;C0021308;FALSE;2144;nonfatai myocardiai infarction
1288;nonfatal myocardiail infarction;C0021308;FALSE;2144;nonfatal myocardiail infarction
1288;myocardiai infarction;C0021308;FALSE;2144;myocardiai infarction
1288;q wave in the infarct territory at baseline *  %;"C0021308;C0168634;C0429089;C1301808;C1305738;C1442488;C2983136";FALSE;2145;q wave in the infarct territory at baseline
1288;q waves in the infarct territory at baseline *  %;"C0021308;C0168634;C0429089;C1301808;C1305738;C1442488;C2983136";FALSE;2145;q waves in the infarct territory at baseline
1289;trait;C0599883;FALSE; -10;trait
1287;mean ± sd $nmbr$ - h adbp  mm hg;"C0033727;C0168370;C0369286;C0439475;C0441932;C0444504;C0564385;C2347634;C2348143;C2699239;C4528284";NA;NA;mean sd $nmbr$ h adbp mm hg
1287;mean ± sd  n ( % );"C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd n
1287;mean   ±   sd;"C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd
1287;mean ucsd - sobq score * ( sd );"C2699239;C3533236";NA;NA;mean ucsd sobq score sd
1287;mean total ipss ( sd );"C0439175;C0439810;C0444504;C1019118;C1998280;C2347634;C2348143;C2699239;C2827405;C3811063";NA;NA;mean total ipss sd
1287;mean stent diameter per lesion  mm ( sd ) †;"C0038257;C0221198;C0552409;C1546698;C2699239;C4330985;C4554674";NA;NA;mean stent diameter per lesion mm sd
1287;mean sd $nmbr$ - h asbp  mm hg;"C0033727;C0369286;C0439475;C0441932;C0444504;C0564385;C2347634;C2348143;C2699239;C4528284";NA;NA;mean sd $nmbr$ h asbp mm hg
1287;mean fev $nmbr$  l ( sd );"C0444504;C2347634;C2348143;C2699239;C3714541";NA;NA;mean fev $nmbr$ l sd
1287;mean diastolic bp  mmhg  mean = sd;"C0428883;C0439475;C0444504;C2347634;C2348143;C2699239";NA;NA;mean diastolic bp mmhg mean sd
1287;mean bmi ( sd );"C0444504;C0578022;C2347634;C2348143;C2699239";NA;NA;mean bmi sd
1287;mean a ± sd ( mmhg );"C0439475;C0444504;C2347634;C2348143;C2699239";NA;NA;mean a sd mmhg
1287;mean ( ± sd ) baseline score;"C0168634;C1442488;C2699239;C3533236";NA;NA;mean sd baseline score
1287;mean ( sd ) nonstudy eye e - etdrs visual acuity letter score;"C0015392;C0042812;C0700042;C1096774;C2360551;C2699239;C3533236";NA;NA;mean sd nonstudy eye e etdrs visual acuity letter score
1287;mean ( sd ) improvement from baseline to week $nmbr$ in basdai questions *;"C0168634;C0332174;C0439230;C0444504;C1442488;C1522634;C1998004;C2347634;C2348143;C2699239;C2986411";NA;NA;mean sd improvement from baseline to week $nmbr$ in basdai questions
1287;mean ( sd ) improvement from baseline to week $nmbr$ in basdai;"C0168634;C0332174;C0439230;C0444504;C1442488;C1998004;C2347634;C2348143;C2699239;C2986411";NA;NA;mean sd improvement from baseline to week $nmbr$ in basdai
1287;mean ( sd ) eevi  ml;"C0439526;C0444504;C1705224;C2347634;C2348143;C2699239;C3887665";NA;NA;mean sd eevi ml
1287;mean ( sd ) e - etdrs visual acuity letter score ( snellen equivalent );"C0042812;C0183370;C0205163;C0439185;C1096774;C2360551;C2699239;C3533236";NA;NA;mean sd e etdrs visual acuity letter score snellen equivalent
1287;mean ( sd ) baseline scores;"C0168634;C0444504;C0449820;C1442488;C2347634;C2348143;C2699239;C4050231";NA;NA;mean sd baseline scores
1287;mean ( sd ) baseline;"C0168634;C0444504;C1442488;C2347634;C2348143;C2699239";NA;NA;mean sd baseline
1287;mean ( sd ) aqlq;"C0444504;C2347634;C2348143;C2699239;C4055434";NA;NA;mean sd aqlq
1287;mean ( sd )  y;"C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd y
1287;mean ( sd )  mmhg;"C0439475;C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd mmhg
1287;mean ( sd )  kg / m $nmbr$;"C0444504;C1532718;C2347634;C2348143;C2699239";NA;NA;mean sd kg m $nmbr$
1287;mean  sd;"C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd
1287;ldl - c in mmol / l ( mean ± sd for baseline [ n ]  mean ± se for week $nmbr$ [ n ] );"C0036919;C0168634;C0332174;C0439230;C0444504;C1442488;C1532563;C2347634;C2348143;C2699239";NA;NA;ldl c in mmol l mean sd for baseline n mean se for week $nmbr$ n
1287;jsn  mean ± sd;"C0444504;C2347634;C2348143;C2699239";NA;NA;jsn mean sd
1287;iuss score  mean ( sd );"C0439453;C0444504;C0449820;C2347634;C2348143;C2699239;C4050231";NA;NA;iuss score mean sd
1287;ipss ( mean ± sd );"C0444504;C1019118;C1998280;C2347634;C2348143;C2699239;C2827405;C3811063";NA;NA;ipss mean sd
1287;ibdq domain scores  mean [ sd ];"C0444504;C0449820;C1880389;C1883221;C2347634;C2348143;C2699239;C3541951;C4050231";NA;NA;ibdq domain scores mean sd
1287;ibdq  mean ± sd;"C0444504;C2347634;C2348143;C2699239";NA;NA;ibdq mean sd
1287;hrql mean ( sd );"C0444504;C2347634;C2348143;C2699239";NA;NA;hrql mean sd
1287;hours from clopidogrel loading  mean ( sd );"C0070166;C0439227;C0444504;C1708715;C2347634;C2348143;C2699239";NA;NA;hours from clopidogrel loading mean sd
1287;homa - ir  mean ( sd );"C0022065;C0022071;C0444504;C1448132;C2347634;C2348143;C2699239";NA;NA;homa ir mean sd
   7;p - value ‘ ’;C1709380;NA;NA;p value
   7;p - value ¶;C1709380;NA;NA;p value
1287;heart rate  mean ( sd ) [ range ]  beats / min;"C0018810;C0444504;C0702093;C1514721;C1524029;C2347634;C2348143;C2348147;C2699239;C3542016;C3813700";FALSE;1105;heart rate mean sd range beats min
1287;heart rate ( sd );"C0018810;C2699239";FALSE;1105;heart rate sd
1287;haq - di  mean ( sd );"C0444504;C2347634;C2348143;C2699239;C3826998;C4321476";FALSE;2138;haq di mean sd
1287;haq - di  mean [ sd ];"C0444504;C2347634;C2348143;C2699239;C3826998;C4321476";FALSE;2138;haq di mean sd
1287;haq - di total score  mean ( sd );"C0444504;C2347634;C2348143;C2699239;C2964552;C3826998;C4321476";FALSE;2138;haq di total score mean sd
1287;haq - di ( $nmbr$ - $nmbr$ )  mean ( sd );"C0444504;C2347634;C2348143;C2699239;C3826998;C4321476";FALSE;2138;haq di $nmbr$ $nmbr$ mean sd
1287;hba $nmbr$ c in patients with baseline hba $nmbr$ c > $nmbr$ % to < $nmbr$ % ( > $nmbr$ to < $nmbr$ mmol / mol )  % [ mmol / mol ]  la  n baseline ( sd ) adjusted mean change ( $nmbr$ % ci ) placebo subtracted change ( se );"C0008107;C0019016;C0023031;C0023749;C0030705;C0032042;C0036919;C0040363;C0041260;C0168634;C0230347;C0392747;C0443172;C0444504;C0456081;C1442488;C1696465;C1705241;C1706408;C1719767;C1825777;C1883351;C2346906;C2347634;C2348143;C2348589;C2699239;C3259781;C3538758;C3829066;C4319952;C4553351";FALSE;2139;hba $nmbr$ c in patients with baseline hba $nmbr$ c $nmbr$ to $nmbr$ $nmbr$ to $nmbr$ mmol mol mmol mol la n baseline sd adjusted mean change $nmbr$ ci placebo subtracted change se
1287;left ventricular ejection fraction  mean ( sd )  %;"C0428772;C0444504;C0488728;C2347634;C2348143;C2699239";FALSE;2140;left ventricular ejection fraction mean sd
1287;mean ( sd ) bmi;"C0444504;C0578022;C2347634;C2348143;C2699239";FALSE;2141;mean sd bmi
1287;mean ( sd ) change from pre - to post - bronchodilator fevi  nil;"C0332152;C0442734;C0444504;C0687676;C0740175;C1704687;C2257086;C2347634;C2348143;C2599594;C2599602;C2699239;C3469826;C3481639;C3669034";FALSE;2142;mean sd change from pre to post bronchodilator fevi nil
1287;mean ( sd ) fev $nmbr$ / fvc  %;"C0444504;C2347634;C2348143;C2699239;C3714541";FALSE;2142;mean sd fev $nmbr$ fvc
1287;mean ( sd ) fev $nmbr$  l;"C0444504;C2347634;C2348143;C2699239;C3714541";FALSE;2142;mean sd fev $nmbr$ l
1287;mean ( sd ) post - bronchodilator;"C0444504;C2347634;C2348143;C2599594;C2699239";FALSE;2142;mean sd post bronchodilator
1287;mean ( sd ) post - bronchodilator fev $nmbr$ reversibility  %;"C0444504;C0449261;C2347634;C2348143;C2599594;C2699239;C3714541";FALSE;2142;mean sd post bronchodilator fev $nmbr$ reversibility
1287;mean ( sd ) post - bronchodilator fev $nmbr$ / fvc  %;"C0444504;C2347634;C2348143;C2599594;C2699239;C3714541";FALSE;2142;mean sd post bronchodilator fev $nmbr$ fvc
1287;mean ( sd ) pre - bronchodilator;"C0444504;C2347634;C2348143;C2599602;C2699239";FALSE;2142;mean sd pre bronchodilator
1287;fsn score  mean ± sd;"C0444504;C0449820;C2347634;C2348143;C2699239;C4050231";NA;NA;fsn score mean sd
1287;dha intake on food frequency questionnaire  mean ( sd )  mg / d;"C0034394;C0142831;C0439422;C0444504;C1286336;C1512806;C2347634;C2348143;C2348308;C2699239;C2986698";NA;NA;dha intake on food frequency questionnaire mean sd mg d
1286;sun - $nmbr$ ( $nmbr$ );"C0038817;C0376223";NA;NA;sun $nmbr$ $nmbr$
1286;su  n ( % );"C0038642;C1705534";NA;NA;su n
1286;su;"C0038642;C1705534";NA;NA;su
1285;evolocumab + soc ( n = $nmbr$ );C3529352;NA;NA;evolocumab soc n $nmbr$
1284;abl - sc n / n;"C0023139;C0282380;C1704928;C3890208";NA;NA;abl sc n n
1287;data are number of patients ( % ) or mean ( sd )  unless otherwise indicated . cabg = coronary - artery bypass grafting . ptca = percutaneous transluminal coronary angioplasty  ldl = low - density lipoprotein . hdl = high - density lipoprotein . iqr = i nterquarti le range  hmg coa ri = $nmbr$ - hydroxy - $nmbr$ - methylglutaryl coenzyme a reductase inhibitor . bmi = body - mass index  which is weight in kg divided by the square of height in metres  * median ( iqr ) .;"C0005910;C0009235;C0010055;C0021966;C0022718;C0023190;C0023821;C0023823;C0035487;C0043100;C0047420;C0162577;C0189695;C0205120;C0221138;C0332849;C0439090;C0439209;C0444504;C0475209;C0489786;C0522520;C0522523;C0545743;C0549183;C0597153;C0700307;C0876920;C1305855;C1305866;C1423767;C1444656;C1511726;C1514721;C1522231;C1548817;C1552595;C1655741;C1705104;C1826843;C2347634;C2347635;C2348143;C2348144;C2348147;C2360800;C2697858;C2699239;C2936173;C2939193;C3245479;C3542016;C3714741;C4054209";NA;NA;data are number of patients or mean sd unless otherwise indicated cabg coronary artery bypass grafting ptca percutaneous transluminal coronary angioplasty ldl low density lipoprotein hdl high density lipoprotein iqr i nterquarti le range hmg coa ri $nmbr$ hydroxy $nmbr$ methylglutaryl coenzyme a reductase inhibitor bmi body mass index which is weight in kg divided by the square of height in metres median iqr
1287;cumulative nsaid score  mean   ±   sd;"C0003211;C0444504;C0449820;C1511559;C2347634;C2348143;C2699239;C3536840;C4050231";NA;NA;cumulative nsaid score mean sd
1287;comorbidity score  mean ( sd ) t;"C0009488;C0444504;C0449820;C2347634;C2348143;C2699239;C4050231";NA;NA;comorbidity score mean sd t
1287;bw  mean ( sd )  kg;"C0005910;C0006041;C0022718;C0439209;C0444504;C2347634;C2348143;C2699239;C2986891;C4054209";NA;NA;bw mean sd kg
1287;bsa ( % )  mean ( sd );"C0444504;C2347634;C2348143;C2699239";NA;NA;bsa mean sd
1287;bone erosion score  mean ( sd );"C0444504;C0449820;C0587240;C2347634;C2348143;C2699239;C4050231";NA;NA;bone erosion score mean sd
1287;blood oxygenation  mean ± sd;"C0005767;C0005768;C0229664;C0231940;C0282636;C0444504;C2347634;C2348143;C2699239";NA;NA;blood oxygenation mean sd
1287;bii ( mean ± sd );"C0444504;C1413059;C2347634;C2348143;C2699239";NA;NA;bii mean sd
1287;basmi ( linear )  mean ( sd );"C0205132;C0444504;C2347634;C2348143;C2699239";NA;NA;basmi linear mean sd
   7;p - value };C1709380;NA;NA;p value
1287;baseline pssi score  mean ( sd );"C0168634;C0444504;C0449820;C1442488;C2347634;C2348143;C2699239;C4050231";NA;NA;baseline pssi score mean sd
1287;baseline ppasi score  mean ( sd );"C0168634;C0444504;C0449820;C1442488;C2347634;C2348143;C2699239;C4050231";NA;NA;baseline ppasi score mean sd
1287;baseline pasi  mean ( sd );"C0168634;C0444504;C1442488;C2347634;C2348143;C2699239;C4528685";NA;NA;baseline pasi mean sd
1287;baseline mean fev $nmbr$ ( sd )  ml;"C0168634;C0439526;C0444504;C1442488;C1705224;C2347634;C2348143;C2699239;C3714541;C3887665";NA;NA;baseline mean fev $nmbr$ sd ml
1287;baseline mean ( sd )  % [ mmol / mol ];"C0168634;C0444504;C1442488;C2347634;C2348143;C2699239;C3829066";NA;NA;baseline mean sd mmol mol
1287;baseline mean ( sd );"C0168634;C0444504;C1442488;C2347634;C2348143;C2699239";NA;NA;baseline mean sd
1287;baseline hbi  mean ( sd );"C0168634;C0444504;C1442488;C2347634;C2348143;C2699239";NA;NA;baseline hbi mean sd
1287;baseline characteristics  mean ( sd ) a;"C0444504;C2347634;C2348143;C2699239;C4684572";NA;NA;baseline characteristics mean sd a
1287;baseline bsa  mean ( sd );"C0168634;C0444504;C1442488;C2347634;C2348143;C2699239";NA;NA;baseline bsa mean sd
1287;baseline bii  mean ( sd );"C0168634;C0444504;C1413059;C1442488;C2347634;C2348143;C2699239";NA;NA;baseline bii mean sd
1287;baseline . mean _ sd . mg / mg;"C0168634;C0444504;C1319635;C1442488;C2347634;C2348143;C2699239";NA;NA;baseline mean _ sd mg mg
1287;bmi ( kg / m $nmbr$ ) mean ± sd;"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";FALSE;2125;bmi kg m $nmbr$ mean sd
1287;bmi ( kg / m $nmbr$ )  mean ( sd ) a;"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";FALSE;2125;bmi kg m $nmbr$ mean sd a
1287;bmi  mean ( sd );"C0444504;C0578022;C2347634;C2348143;C2699239";FALSE;2125;bmi mean sd
1287;bmi  mean ± sd;"C0444504;C0578022;C2347634;C2348143;C2699239";FALSE;2125;bmi mean sd
1287;bmi  mean ( sd ) b;"C0444504;C0578022;C2347634;C2348143;C2699239";FALSE;2125;bmi mean sd b
1287;bmi  mean ( sd )  kg / m $nmbr$;"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";FALSE;2125;bmi mean sd kg m $nmbr$
1287;fev $nmbr$ / fvc  mean ( sd );"C0444504;C2347634;C2348143;C2699239;C3714541";FALSE;2126;fev $nmbr$ fvc mean sd
1287;fev $nmbr$ / fvc  %  mean ( sd ) $nmbr$;"C0444504;C2347634;C2348143;C2699239;C3714541";FALSE;2126;fev $nmbr$ fvc mean sd $nmbr$
1287;fev $nmbr$  l  mean ( sd );"C0444504;C2347634;C2348143;C2699239;C3714541";FALSE;2126;fev $nmbr$ l mean sd
1287;fev $nmbr$ ( l )  mean ( sd );"C0444504;C2347634;C2348143;C2699239;C3714541";FALSE;2126;fev $nmbr$ l mean sd
1287;fev $nmbr$  mean ( sd ) pre - bd fev $nmbr$ / fvc;"C0005126;C0332152;C0444504;C0740175;C2257086;C2344255;C2347634;C2348143;C2699239;C3669034;C3714541;C4050145";FALSE;2126;fev $nmbr$ mean sd pre bd fev $nmbr$ fvc
1287;baseline sesbp  mean ( sd )  mm hg §;"C0168634;C0439475;C0444504;C1442488;C2347634;C2348143;C2699239";FALSE;2127;baseline sesbp mean sd mm hg
1287;chads $nmbr$ score  mean ( ± sd );"C0007928;C0444504;C0449820;C1413373;C2347634;C2348143;C2699239;C4050231";FALSE;2128;chads $nmbr$ score mean sd
1287;chads $nmbr$ score  mean ± sd;"C0007928;C0444504;C0449820;C1413373;C2347634;C2348143;C2699239;C4050231";FALSE;2128;chads $nmbr$ score mean sd
1287;chads $nmbr$  mean ± sd;"C0007928;C0444504;C1413373;C2347634;C2348143;C2699239";FALSE;2128;chads $nmbr$ mean sd
1287;baseline total ipss  mean ( sd );"C0168634;C0439175;C0439810;C0444504;C1019118;C1442488;C1998280;C2347634;C2348143;C2699239;C2827405;C3811063";FALSE;2129;baseline total ipss mean sd
1287;diastolic ( mean  sd );"C0012000;C0444504;C2347634;C2348143;C2699239";FALSE;2130;diastolic mean sd
1287;diastolic bp  mmhg  mean ± sd;"C0012000;C0428883;C0439475;C0444504;C0488053;C2347634;C2348143;C2699239";FALSE;2130;diastolic bp mmhg mean sd
1287;ejection fraction  mean ( sd )  %;"C0444504;C0489482;C2347634;C2348143;C2699239;C2700378";FALSE;2131;ejection fraction mean sd
1287;ejection fraction — mean ± sd;"C0444504;C0489482;C2347634;C2348143;C2699239;C2700378";FALSE;2131;ejection fraction mean sd
1287;femoral neck t - score ( mean = sd );"C0015815;C0444504;C0449820;C2347634;C2348143;C2699239;C4050231";FALSE;2132;femoral neck t score mean sd
1287;erosion score  mean $nmbr$ sd;"C0333307;C0444504;C0449820;C1880549;C1959609;C2347634;C2348143;C2699239;C3887524;C4050231";FALSE;2133;erosion score mean $nmbr$ sd
1287;erosion score  mean ± sd;"C0333307;C0444504;C0449820;C1880549;C1959609;C2347634;C2348143;C2699239;C3887524;C4050231";FALSE;2133;erosion score mean sd
1287;dietary calcium intake  mean ( sd )  mg / d;"C0439422;C0444504;C0489458;C2347634;C2348143;C2699239";FALSE;2134;dietary calcium intake mean sd mg d
1287;fpi  mean ( sd )  pu / mlt;"C0018387;C0444504;C2347634;C2348143;C2699239;C4553833";FALSE;2135;fpi mean sd pu mlt
1287;fpi  mean ( sd )  pu / rnff;"C0018387;C0444504;C2347634;C2348143;C2699239";FALSE;2135;fpi mean sd pu rnff
1287;fvc  l  mean ( sd );"C0444504;C2347634;C2348143;C2699239;C3714541";FALSE;2136;fvc l mean sd
1287;gout history  mean ± sd years;"C0018099;C0019664;C0019665;C0262512;C0262926;C0439234;C0444504;C1705255;C2004062;C2347634;C2348143;C2699239";FALSE;2137;gout history mean sd years
1287;baseline ( mean  sd );"C0168634;C0444504;C1442488;C2347634;C2348143;C2699239";NA;NA;baseline mean sd
1287;baseline  mean ( sd );"C0168634;C0444504;C1442488;C2347634;C2348143;C2699239";NA;NA;baseline mean sd
1287;aqlq score  mean ( sd );"C0444504;C0449820;C2347634;C2348143;C2699239;C4050231;C4055434";NA;NA;aqlq score mean sd
1287;aqlq ( s ) + $nmbr$ score  mean ( sd ) c  f;"C0016327;C0444504;C0449820;C2347634;C2348143;C2699239;C4050231;C4055434";NA;NA;aqlq s $nmbr$ score mean sd c f
1287;albuterol use ( sd )  puffs / day;"C0001927;C0042153;C0332173;C0439228;C0439505;C0457083;C1533107;C1947944;C2699239";NA;NA;albuterol use sd puffs day
1287;[ sd ];C2699239;NA;NA;sd
1287;( sd );C2699239;NA;NA;sd
1287;( mean ± sd );"C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd
1287;( mean + . sd );"C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd
1284;abl - sc mean;"C0023139;C0282380;C0444504;C1704928;C2347634;C2348143;C3890208";NA;NA;abl sc mean
1284;abaloparatide - sc  n ( % );"C0282380;C4042342";NA;NA;abaloparatide sc n
1283;women  qva $nmbr$ - sfc;"C0043210;C4521536";NA;NA;women qva $nmbr$ sfc
1283;sfc ( n   = $nmbr$  $nmbr$ );C4521536;NA;NA;sfc n $nmbr$ $nmbr$
1283;sfc ( n [ $nmbr$ );C4521536;NA;NA;sfc n $nmbr$
1283;sfc ( n = $nmbr$ );C4521536;NA;NA;sfc n $nmbr$
1283;sfc $nmbr$ mg / $nmbr$ mg;"C1319635;C4521536";NA;NA;sfc $nmbr$ mg $nmbr$ mg
1283;sfc $nmbr$ / $nmbr$ mg twice daily ( n = $nmbr$ );"C0024671;C0026410;C0439269;C0585361;C1960952;C2346927;C4321396;C4521536;C4521761";NA;NA;sfc $nmbr$ $nmbr$ mg twice daily n $nmbr$
1283;sfc $nmbr$ / $nmbr$ mg twice daily ( n = $nmbr$  $nmbr$ );"C0024671;C0026410;C0439269;C0585361;C1960952;C2346927;C4321396;C4521536;C4521761";NA;NA;sfc $nmbr$ $nmbr$ mg twice daily n $nmbr$ $nmbr$
1283;sfc;C4521536;NA;NA;sfc
1283;severe cord * : qvai $nmbr$ - sfc;"C0205082;C1550235;C1706500;C3489532;C4050465;C4050466;C4521536";NA;NA;severe cord qvai $nmbr$ sfc
1283;moderate cord * : qva $nmbr$ - sfc;"C0205081;C1550235;C1706500;C1881878;C3489532;C4049705;C4049706;C4085643;C4321335;C4521536";NA;NA;moderate cord qva $nmbr$ sfc
1283;men : qvai $nmbr$ - sfc;"C0025266;C4521536";NA;NA;men qvai $nmbr$ sfc
1283;ics users : qvai $nmbr$ - sfc;"C0815320;C1706077;C4521536;C4551720";NA;NA;ics users qvai $nmbr$ sfc
1283;ics non - users : qvai $nmbr$ - sfc;"C0815320;C1518422;C1706077;C4521536;C4551720";NA;NA;ics non users qvai $nmbr$ sfc
1283;annualized rate ind / gly sfc;"C0017890;C0523677;C0871208;C1521828;C4049864;C4521536";NA;NA;annualized rate ind gly sfc
1283;age > $nmbr$ : qvai $nmbr$ - sfc;"C0001779;C4521536";NA;NA;age $nmbr$ qvai $nmbr$ sfc
1283;age < $nmbr$ : qvai $nmbr$ - sfc;"C0001779;C4521536";NA;NA;age $nmbr$ qvai $nmbr$ sfc
1282;≥ $nmbr$ sae;"C1519255;C1622657;C4553214";NA;NA;$nmbr$ sae
1282;saes;"C1519255;C1622657;C4553214";NA;NA;saes
1282;due to sae;"C1519255;C1622657;C4553214";NA;NA;due to sae
1282;due to drug - relateda sae;"C0013227;C1254351;C1519255;C1622657;C4553214";NA;NA;due to drug relateda sae
1282;drug - related saes;"C0013227;C0439849;C0445223;C1254351;C1519255;C1622657;C4553214";NA;NA;drug related saes
1282;because of sae;"C1519255;C1622657;C4553214";NA;NA;because of sae
1282;any sae;"C1519255;C1622657;C4553214";NA;NA;any sae
1281;sabae;NA;NA;NA;sabae
1281;saba §;NA;NA;NA;saba
1281;saba ( inhaled )  c   n ( % );C0004048;NA;NA;saba inhaled c n
1281;saba;NA;NA;NA;saba
   7;p - value vs . placebo;"C0032042;C1696465;C1706408;C1709380";NA;NA;p value vs placebo
   7;p - value n / n ( % );C1709380;NA;NA;p value n n
   7;p - value interaction;"C1704675;C1709380";NA;NA;p value interaction
   7;p - value for variance;"C1709380;C1711260;C2348152";NA;NA;p value for variance
1279;underlying disease;"C0012634;C4067746";NA;NA;underlying disease
1279;uc disease durslion;C0012634;NA;NA;uc disease durslion
1279;site of disease — no . ( % );"C0012634;C2945843";NA;NA;site of disease no
1279;serious gi disorder;"C0012634;C0205404;C1708130;C3539617;C4050121";NA;NA;serious gi disorder
1279;priorbone disease;C0012634;NA;NA;priorbone disease
1277;female $nmbr$;"C0043210;C0086287;C1705497;C1705498";NA;NA;female $nmbr$
1277;female  no . ( % );"C0043210;C0086287;C1705497;C1705498";NA;NA;female no
1280;nsaid;"C0003211;C3536840";FALSE;2121;nsaid
1280;other nsaids;C0003211;FALSE;2121;other nsaids
1280;cox - $nmbr$ selective nsaid;"C0003211;C0036576;C1565830;C1707391;C3536840";FALSE;2123;cox $nmbr$ selective nsaid
1280;cox - $nmbr$ selective nsaid use;"C0003211;C0036576;C0042153;C0457083;C1565830;C1707391;C1947944;C3536840";FALSE;2123;cox $nmbr$ selective nsaid use
1285;so;C0037640;FALSE; -10;so
1280;chronic non - steroidal antiinflammatory drugs;"C0003211;C0205191";FALSE;2122;chronic non steroidal antiinflammatory drugs
1280;never nsaid;"C0003211;C2003901;C3536840";FALSE;2122;never nsaid
1280;non - steroidal anti - inflammatory drugs;C0003211;FALSE;2122;non steroidal anti inflammatory drugs
1285;soc;NA;FALSE; -10;soc
1285;so $nmbr$ %;C0037640;FALSE; -10;so $nmbr$
1286;su monotherapy;"C0038642;C1705534";FALSE; 752;su monotherapy
1286;su / tzd;"C0038642;C1705534";FALSE; 752;su tzd
1286;baseline su dose > $nmbr$ / $nmbr$ maximal;"C0038642;C0168634;C0178602;C0205289;C0806909;C0869039;C1114758;C1442488;C1705534;C4049713";FALSE; 752;baseline su dose $nmbr$ $nmbr$ maximal
1286;baseline su dose < $nmbr$ / $nmbr$ maximal;"C0038642;C0168634;C0178602;C0205289;C0806909;C0869039;C1114758;C1442488;C1705534;C4049713";FALSE; 752;baseline su dose $nmbr$ $nmbr$ maximal
1286;su / met;"C0038642;C0428210;C1550543;C1705534;C4317104";FALSE;2253;su met
1286;metformin + su;"C0025598;C0038642;C1705534";FALSE;2253;metformin su
1286;metformin + su + tzd;"C0025598;C0038642;C1705534";FALSE;2253;metformin su tzd
1286;metformin ? su;"C0025598;C0038642;C1705534";FALSE;2253;metformin su
1279;most frequent gi disorders;"C0012634;C0205393;C0332183;C1708130;C3539617;C4050121";NA;NA;most frequent gi disorders
1279;mer ’ s disease assessment;"C0012634;C0673013;C1261322;C1516048;C3810521;C4281714";NA;NA;mer s disease assessment
1279;disorders ( soc );C0012634;NA;NA;disorders soc
1279;disease hare . no . ( % ) i;"C0012634;C0021966;C0221138;C0242372;C1425660";NA;NA;disease hare no i
1279;disease extent  n ( % );"C0012634;C0439792";NA;NA;disease extent n
1279;disease;C0012634;NA;NA;disease
1279;any disease;C0012634;NA;NA;any disease
1279;$nmbr$ - $nmbr$ with cv risk but not disease ( n = $nmbr$ );"C0012634;C0035647;C1518422;C3538987;C4048877;C4318503;C4552904";NA;NA;$nmbr$ $nmbr$ with cv risk but not disease n $nmbr$
1279;$nmbr$ - $nmbr$  risk  not disease ( n = $nmbr$  $nmbr$ );"C0012634;C0035647;C1518422;C4552904";NA;NA;$nmbr$ $nmbr$ risk not disease n $nmbr$ $nmbr$
1278;patients with cardiac disorders  n ( % ) §;"C0012634;C0018799;C0030705;C0741926";NA;NA;patients with cardiac disorders n
1278;patients with cardiac disorders  n ( % ) c;"C0012634;C0018799;C0030705;C0741926";NA;NA;patients with cardiac disorders n c
1278;no cardiac disease;C0018799;NA;NA;no cardiac disease
1278;no apparent heart disease;"C0018799;C0750489";NA;NA;no apparent heart disease
1278;cardiac disorders ( soc );C0018799;NA;NA;cardiac disorders soc
1278;cardiac disorder  n ( % ) §;C0018799;NA;NA;cardiac disorder n
1278;cardiac disorder;C0018799;NA;NA;cardiac disorder
1278;cardiac disease;C0018799;NA;NA;cardiac disease
1277;sex : female;C0086287;NA;NA;sex female
1277;sex ( female );C0086287;NA;NA;sex female
1277;sex  female    n   ( % );C0086287;NA;NA;sex female n
1277;sex  female  n ( % );C0086287;NA;NA;sex female n
1277;sex  female  %;C0086287;NA;NA;sex female
1277;sex  female;C0086287;NA;NA;sex female
1277;sex  % female;C0086287;NA;NA;sex female
1277;number of females n ( % );"C0086287;C0237753;C0449788";NA;NA;number of females n
1277;number of ( % ) females;"C0086287;C0237753;C0449788";NA;NA;number of females
1277;gender ( female : male  % );"C0043210;C0079399;C0086287;C0086582;C1522384;C1705497;C1705498;C1706180;C1706428;C1706429";NA;NA;gender female male
1277;femalesex;NA;NA;NA;femalesex
1277;females only;"C0086287;C0205171;C1720467";NA;NA;females only
1277;females ( n = $nmbr$ );C0086287;NA;NA;females n $nmbr$
1277;females ( itt ) ( n = $nmbr$ );C0086287;NA;NA;females itt n $nmbr$
1277;females  n ( % );C0086287;NA;NA;females n
1277;females  > $nmbr$ . $nmbr$;C0086287;NA;NA;females $nmbr$ $nmbr$
1277;females  > $nmbr$;C0086287;NA;NA;females $nmbr$
1277;females  < $nmbr$ . $nmbr$;C0086287;NA;NA;females $nmbr$ $nmbr$
1277;females  < $nmbr$;C0086287;NA;NA;females $nmbr$
1277;females  %;C0086287;NA;NA;females
1277;females;C0086287;NA;NA;females
1277;femaleb;NA;NA;NA;femaleb
1277;female — no . ( % );"C0043210;C0086287;C1705497;C1705498";NA;NA;female no
1277;female sex — no . { % );C0086287;NA;NA;female sex no
1277;female sex — no . ( % );C0086287;NA;NA;female sex no
1277;female sex — %;C0086287;NA;NA;female sex
1277;female sex ( % );C0086287;NA;NA;female sex
1277;female sex  no . / total ( % );"C0086287;C0439175;C0439810";NA;NA;female sex no total
1277;female sex  no . ( % );C0086287;NA;NA;female sex no
1277;female sex  n ( % );C0086287;NA;NA;female sex n
1277;female sex  %;C0086287;NA;NA;female sex
1277;female sex;C0086287;NA;NA;female sex
1277;female n ( % );"C0043210;C0086287;C1705497;C1705498";NA;NA;female n
1277;female gender n ( % );C0086287;NA;NA;female gender n
1277;female gender ( % );C0086287;NA;NA;female gender
1277;female gender;C0086287;NA;NA;female gender
1277;female eze / simva ( „ = $nmbr$ };"C0043210;C0086287;C1705497;C1705498";NA;NA;female eze simva $nmbr$
1277;female eze / simva ( n = $nmbr$ );"C0043210;C0086287;C1705497;C1705498";NA;NA;female eze simva n $nmbr$
1277;female - n ( % );"C0043210;C0086287;C1705497;C1705498";NA;NA;female n
1277;female ( n — $nmbr$ );"C0043210;C0086287;C1705497;C1705498";NA;NA;female n $nmbr$
1277;female ( n   = $nmbr$  $nmbr$ );"C0043210;C0086287;C1705497;C1705498";NA;NA;female n $nmbr$ $nmbr$
1277;female ( n z $nmbr$ );"C0043210;C0086287;C1705497;C1705498";NA;NA;female n z $nmbr$
1277;female ( n = lll $nmbr$ );"C0043210;C0086287;C1261077;C1705497;C1705498";NA;NA;female n lll $nmbr$
1277;female ( n = $nmbr$ );"C0043210;C0086287;C1705497;C1705498";NA;NA;female n $nmbr$
1277;female ( n = $nmbr$  $nmbr$ );"C0043210;C0086287;C1705497;C1705498";NA;NA;female n $nmbr$ $nmbr$
1279;multivessel disease;C0012634;FALSE;1867;multivessel disease
1279;multivessel disease  no . ( % );C0012634;FALSE;1867;multivessel disease no
1279;no polyvascular disease ( n = $nmbr$ $nmbr$ );C0012634;FALSE;1868;no polyvascular disease n $nmbr$ $nmbr$
1279;no polyvascular disease * ( n = $nmbr$ $nmbr$ );C0012634;FALSE;1868;no polyvascular disease n $nmbr$ $nmbr$
1279;polyvascular disease and no type $nmbr$ diabetes ( n = $nmbr$ );"C0012634;C1320657";FALSE;1868;polyvascular disease and no type $nmbr$ diabetes n $nmbr$
1279;microvascular disease *;"C0012634;C0443258";FALSE;1869;microvascular disease
1279;microvascular disease  n ( % );"C0012634;C0443258";FALSE;1869;microvascular disease n
1278;isehemie heart disease;C0018799;FALSE;1361;isehemie heart disease
1279;albuminuria and previous maerovaseular disease plus established renal disease ( egfr $nmbr$ - $nmbr$ ml / min / l $nmbr$ in - with an uacr > $nmbr$ mg / g or egfr $nmbr$ - < $nmbr$ ml / inin / l $nmbr$ in - with any uacr mg / g );"C0001925;C0012634;C0022658;C0205156;C0332287;C0443211;C0702093;C1272684;C1300563;C1524029;C1552607;C1635169;C1739039;C3811844;C3812682;C3813700";FALSE;2112;albuminuria and previous maerovaseular disease plus established renal disease egfr $nmbr$ $nmbr$ ml min l $nmbr$ in with an uacr $nmbr$ mg g or egfr $nmbr$ $nmbr$ ml inin l $nmbr$ in with any uacr mg g
1279;macrovascular disease  n ( % );C0012634;FALSE;2113;macrovascular disease n
1279;established atherosclerotic disease;"C0012634;C0333482;C0443211;C1272684";FALSE;2113;established atherosclerotic disease
1279;established atherosclerotic disease — no . { % );"C0012634;C0333482;C0443211;C1272684";FALSE;2113;established atherosclerotic disease no
1279;peripherai arteriai disease;C0012634;FALSE;2114;peripherai arteriai disease
1279;cerebrovascuiar disease;C0012634;FALSE;2115;cerebrovascuiar disease
1279;clinical atherosclerotic disease *;"C0012634;C0205210;C0333482";FALSE;2116;clinical atherosclerotic disease
1279;coronarv arterv disease;C0012634;FALSE;2117;coronarv arterv disease
1279;no multivessel disease;C0012634;FALSE;2118;no multivessel disease
1279;disease localization  n ( % );"C0012634;C0475264;C1744691";FALSE;2119;disease localization n
1279;disease localization ' ’  n ( % );"C0012634;C0475264;C1744691";FALSE;2119;disease localization n
1279;prior disease;"C0012634;C0332152;C2826257";FALSE;2120;prior disease
1279;prior disease - modifying drugs resulting in inadequate response — mean no . / patient;"C0012634;C0013227;C0030705;C0205412;C0332152;C0332294;C0392747;C0439856;C0444504;C0871261;C1704632;C1706817;C2347634;C2348143;C2826257;C2911692;C3687832";FALSE;2120;prior disease modifying drugs resulting in inadequate response mean no patient
1279;previous disease :;"C0012634;C0205156;C1552607";FALSE;2120;previous disease
1277;female  no ( % );"C0043210;C0086287;C1705497;C1705498";NA;NA;female no
1277;female  n ( % );"C0043210;C0086287;C1705497;C1705498";NA;NA;female n
1277;female  %;"C0043210;C0086287;C1705497;C1705498";NA;NA;female
1277;female;"C0043210;C0086287;C1705497;C1705498";NA;NA;female
1276;years male gender  n ( % );"C0086582;C0439234;C1706180";NA;NA;years male gender n
1276;sexa male;"C0086582;C1706180;C1706428;C1706429";NA;NA;sexa male
1276;sex : male ( n = $nmbr$ );C0086582;NA;NA;sex male n $nmbr$
1276;sex : male;C0086582;NA;NA;sex male
1276;sex ( male / female ) ( n );"C0043210;C0086287;C0086582;C1705497;C1705498;C1706180;C1706428;C1706429";NA;NA;sex male female n
1276;sex ( male / female );"C0043210;C0086287;C0086582;C1705497;C1705498;C1706180;C1706428;C1706429";NA;NA;sex male female
1276;sex ( male ) - no . ( % );C0086582;NA;NA;sex male no
1276;sex ( male )  n ( % );C0086582;NA;NA;sex male n
1276;sex ( male )  %;C0086582;NA;NA;sex male
1276;sex ( male );C0086582;NA;NA;sex male
1276;sex ( male  % );C0086582;NA;NA;sex male
1276;sex  n ( % ) male;C0086582;NA;NA;sex n male
1276;sex  male / female  %;"C0043210;C0086287;C0086582;C1705497;C1705498;C1706180;C1706428;C1706429";NA;NA;sex male female
1276;sex  male  no . ( % );C0086582;NA;NA;sex male no
1276;sex  male  n ( % );C0086582;NA;NA;sex male n
1276;sex  male;C0086582;NA;NA;sex male
1276;sex  % male;C0086582;NA;NA;sex male
1276;overall  male : female;"C0043210;C0086287;C0086582;C0282416;C1561607;C1705497;C1705498;C1706180;C1706428;C1706429";NA;NA;overall male female
1276;males [ n ( % ) ];C0086582;NA;NA;males n
1276;males ( n = $nmbr$ );C0086582;NA;NA;males n $nmbr$
1276;males ( itt ) ( n = $nmbr$ );C0086582;NA;NA;males itt n $nmbr$
1276;males ( % );C0086582;NA;NA;males
1276;males  n ( % );C0086582;NA;NA;males n
1276;males  > $nmbr$ . $nmbr$;C0086582;NA;NA;males $nmbr$ $nmbr$
1276;males  > $nmbr$;C0086582;NA;NA;males $nmbr$
1276;males  < $nmbr$ . $nmbr$;C0086582;NA;NA;males $nmbr$ $nmbr$
1276;males  < $nmbr$;C0086582;NA;NA;males $nmbr$
1276;males  %;C0086582;NA;NA;males
1276;males;C0086582;NA;NA;males
1276;male sex 一 no . ( % );C0086582;NA;NA;male sex no
1276;male sex — no . { % );C0086582;NA;NA;male sex no
1276;male sex — no . / total no . ( % );"C0086582;C0439175;C0439810";NA;NA;male sex no total no
1276;male sex — no . ( % ) race — no . ( % ) ) :;"C0034510;C0086582;C1706779;C3853635";NA;NA;male sex no race no
1276;male sex — no . ( % ) medical history — no . / total no . ( % );"C0086582;C0262926;C0439175;C0439810;C1704706";NA;NA;male sex no medical history no total no
1276;male sex — no . ( % ) f;"C0016327;C0086582";NA;NA;male sex no f
1276;male sex — no . ( % );C0086582;NA;NA;male sex no
1276;male sex — %;C0086582;NA;NA;male sex
1276;male sex ^;C0086582;NA;NA;male sex
1276;male sex \ no . ( % );C0086582;NA;NA;male sex \ no
1276;male sex ( % );C0086582;NA;NA;male sex
1276;male sex  no . / total no . ( % );"C0086582;C0439175;C0439810";NA;NA;male sex no total no
1276;male sex  no . ( % );C0086582;NA;NA;male sex no
1276;male sex  n [ % ];C0086582;NA;NA;male sex n
1276;male sex  n ( % );C0086582;NA;NA;male sex n
1276;male sex  ( % );C0086582;NA;NA;male sex
1276;male sex  %;C0086582;NA;NA;male sex
1276;male nyha class;"C0086582;C1706180;C1706428;C1706429;C1882083";NA;NA;male nyha class
1276;male gender ( % );"C0086582;C1706180";NA;NA;male gender
1276;male gender    n   ( % );"C0086582;C1706180";NA;NA;male gender n
1276;male gender  n ( % );"C0086582;C1706180";NA;NA;male gender n
1276;male gender;"C0086582;C1706180";NA;NA;male gender
1276;male / female  %;"C0043210;C0086287;C0086582;C1705497;C1705498;C1706180;C1706428;C1706429";NA;NA;male female
1276;male / female;"C0043210;C0086287;C0086582;C1705497;C1705498;C1706180;C1706428;C1706429";NA;NA;male female
1276;male - no . ( % );"C0086582;C1706180;C1706428;C1706429";NA;NA;male no
1276;male *  n ( % );"C0086582;C1706180;C1706428;C1706429";NA;NA;male n
1276;male ( n   = $nmbr$  $nmbr$ );"C0086582;C1706180;C1706428;C1706429";NA;NA;male n $nmbr$ $nmbr$
1276;male ( n z $nmbr$ );"C0086582;C1706180;C1706428;C1706429";NA;NA;male n z $nmbr$
1276;male ( n = $nmbr$ );"C0086582;C1706180;C1706428;C1706429";NA;NA;male n $nmbr$
1276;male ( n = $nmbr$  $nmbr$ );"C0086582;C1706180;C1706428;C1706429";NA;NA;male n $nmbr$ $nmbr$
1276;male ( n - $nmbr$ );"C0086582;C1706180;C1706428;C1706429";NA;NA;male n $nmbr$
1276;male ( % );"C0086582;C1706180;C1706428;C1706429";NA;NA;male
1276;male    n   ( % );"C0086582;C1706180;C1706428;C1706429";NA;NA;male n
1276;male  no ( % );"C0086582;C1706180;C1706428;C1706429";NA;NA;male no
1276;male  n / n ( % );"C0086582;C1706180;C1706428;C1706429";NA;NA;male n n
1276;male  n ( % );"C0086582;C1706180;C1706428;C1706429";NA;NA;male n
1276;male  n;"C0086582;C1706180;C1706428;C1706429";NA;NA;male n
1276;male  % ( n );"C0086582;C1706180;C1706428;C1706429";NA;NA;male n
1276;male  %;"C0086582;C1706180;C1706428;C1706429";NA;NA;male
1276;male;"C0086582;C1706180;C1706428;C1706429";NA;NA;male
1276;genital mycotic infections male $nmbr$;"C0086582;C0740330;C1706180;C1706428;C1706429";NA;NA;genital mycotic infections male $nmbr$
1276;gender male;"C0079399;C0086582;C1522384;C1706180;C1706428;C1706429";NA;NA;gender male
1276;gender : male    n   ( % );"C0079399;C0086582;C1522384;C1706180;C1706428;C1706429";NA;NA;gender male n
1276;gender - male  n ( % );"C0079399;C0086582;C1522384;C1706180;C1706428;C1706429";NA;NA;gender male n
1276;gender ( male / female ) ( number );"C0043210;C0079399;C0086287;C0086582;C0237753;C0449788;C1522384;C1705497;C1705498;C1706180;C1706428;C1706429";NA;NA;gender male female number
1276;gender ( male )  n ( % );"C0079399;C0086582;C1522384;C1706180;C1706428;C1706429";NA;NA;gender male n
1276;gender ( % ) male / female;"C0043210;C0079399;C0086287;C0086582;C1522384;C1705497;C1705498;C1706180;C1706428;C1706429";NA;NA;gender male female
1276;gender  n [ % ] male;"C0079399;C0086582;C1522384;C1706180;C1706428;C1706429";NA;NA;gender n male
1276;gender  n ( % ) male;"C0079399;C0086582;C1522384;C1706180;C1706428;C1706429";NA;NA;gender n male
1276;gender  male / female;"C0043210;C0079399;C0086287;C0086582;C1522384;C1705497;C1705498;C1706180;C1706428;C1706429";NA;NA;gender male female
1276;gender  male ( % );"C0079399;C0086582;C1522384;C1706180;C1706428;C1706429";NA;NA;gender male
1276;gender  male  n ( % );"C0079399;C0086582;C1522384;C1706180;C1706428;C1706429";NA;NA;gender male n
1276;gender  male;"C0079399;C0086582;C1522384;C1706180;C1706428;C1706429";NA;NA;gender male
1276;female / male ( % );"C0043210;C0086287;C0086582;C1705497;C1705498;C1706180;C1706428;C1706429";NA;NA;female male
1266;lb;NA;NA;NA;lb
1277;eze;NA;FALSE;2110;eze
1277;eze / simva ( „ = $nmbr$ };NA;FALSE;2110;eze simva $nmbr$
1277;caleitonin  ng / l  females mean ± sd;"C0086287;C0439297;C0444504;C2347634;C2348143;C2699239";FALSE;2111;caleitonin ng l females mean sd
1275;never used lev;"C0023556;C1273517;C2003901";NA;NA;never used lev
1275;lev - naive;C0023556;NA;NA;lev naive
1275;lev - exposed;"C0023556;C0332157";NA;NA;lev exposed
1275;lev ( n   =   $nmbr$ );C0023556;NA;NA;lev n $nmbr$
1274;triacylglycerol  mmol / le;"C0023190;C0041004;C0439090;C0439190;C1423767;C2697858";NA;NA;triacylglycerol mmol le
1274;fema le;"C0023190;C0439090;C1423767;C2697858";NA;NA;fema le
1273;white race — no . ( % ) y left ventricular ejection fraction — %;"C0007457;C0034510;C0043157;C0220938;C0428772;C0488728;C1706779;C3853635";NA;NA;white race no y left ventricular ejection fraction
1273;nyha ll / lll patients with lvef < $nmbr$ . $nmbr$ at baseline;"C0030705;C0168634;C0428772;C0488728;C1261077;C1275491;C1442488";NA;NA;nyha ll lll patients with lvef $nmbr$ $nmbr$ at baseline
1273;mean lvef;"C0428772;C0444504;C0488728;C2347634;C2348143";NA;NA;mean lvef
1273;lvef ≤ $nmbr$ %  n   =   $nmbr$   $nmbr$ a;"C0428772;C0488728";NA;NA;lvef $nmbr$ n $nmbr$ $nmbr$ a
1273;lvef ≤ $nmbr$ %  n   =   $nmbr$   $nmbr$ ) a;"C0428772;C0488728";NA;NA;lvef $nmbr$ n $nmbr$ $nmbr$ a
1273;lvef within $nmbr$ months  %;"C0428772;C0439231;C0488728";NA;NA;lvef within $nmbr$ months
1273;lvef ^ $nmbr$ . $nmbr$ and nyha class ii  iii at baseline;"C0168634;C0428772;C0439070;C0488728;C1442488;C1705160;C1710602;C1882085;C1882086;C4082587";NA;NA;lvef $nmbr$ $nmbr$ and nyha class ii iii at baseline
1273;lvef > $nmbr$ %;"C0428772;C0488728";NA;NA;lvef $nmbr$
1273;lvef < $nmbr$ . $nmbr$;"C0428772;C0488728";NA;NA;lvef $nmbr$ $nmbr$
1273;lvef < $nmbr$ %  n = $nmbr$ $nmbr$ ) “;"C0428772;C0488728";NA;NA;lvef $nmbr$ n $nmbr$ $nmbr$
1273;lvef < $nmbr$ %;"C0428772;C0488728";NA;NA;lvef $nmbr$
1273;lvef ( u );"C0428772;C0439148;C0488728";NA;NA;lvef u
1273;lvef ( mean ± sd );"C0428772;C0444504;C0488728;C2347634;C2348143;C2699239";NA;NA;lvef mean sd
1273;lvef ( % )  mean ± sd;"C0428772;C0444504;C0488728;C2347634;C2348143;C2699239";NA;NA;lvef mean sd
1273;lvef ( % );"C0428772;C0488728";NA;NA;lvef
1273;lvef  %;"C0428772;C0488728";NA;NA;lvef
1273;lvef;"C0428772;C0488728";NA;NA;lvef
1273;left ventricular ejection fraction — no . / total no . ( % );"C0428772;C0439175;C0439810;C0488728";NA;NA;left ventricular ejection fraction no total no
1273;left ventricular ejection fraction — % §;"C0428772;C0488728";NA;NA;left ventricular ejection fraction
1273;left ventricular ejection fraction — %;"C0428772;C0488728";NA;NA;left ventricular ejection fraction
1273;left ventricular ejection fraction < $nmbr$ %;"C0428772;C0488728";NA;NA;left ventricular ejection fraction $nmbr$
1273;left ventricular ejection fraction ( % );"C0428772;C0488728";NA;NA;left ventricular ejection fraction
1273;left ventricular ejection fraction  median ( iqr )  %;"C0428772;C0488728;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;left ventricular ejection fraction median iqr
1273;left ventricular ejection fraction  % af history;"C0019664;C0019665;C0262512;C0262926;C0344434;C0428772;C0488728;C1705255;C2004062;C4049859";NA;NA;left ventricular ejection fraction af history
1273;left ventricular ejection fraction  % *;"C0428772;C0488728";NA;NA;left ventricular ejection fraction
1273;left ventricular ejection fraction  %;"C0428772;C0488728";NA;NA;left ventricular ejection fraction
1273;left ventricular ejection fraction;"C0428772;C0488728";NA;NA;left ventricular ejection fraction
1273;history of hf or lvef b $nmbr$ % with index event  no . ( % );"C0018488;C0019664;C0019665;C0262512;C0262926;C0428772;C0441471;C0488728;C0600653;C0918012;C1313497;C1538440;C1552854;C1637833;C1705255;C2004062;C2986546;C3273279;C4019010";NA;NA;history of hf or lvef b $nmbr$ with index event no
1273;hf or lvef < $nmbr$ % associated with index event;"C0018488;C0332281;C0428772;C0441471;C0488728;C0600653;C0918012;C1313497;C1538440;C1552854;C1637833;C2986546;C3273279;C4019010";NA;NA;hf or lvef $nmbr$ associated with index event
1273;heart failure or lvef < $nmbr$ % associated with index acs event;"C0018801;C0018802;C0332281;C0428772;C0441471;C0488728;C0600653;C0742343;C0918012;C1552854;C1637833;C2986546;C4019010;C4318612;C4554158";NA;NA;heart failure or lvef $nmbr$ associated with index acs event
1257;class ll - iv;"C0022326;C0456387;C1518526;C1705943;C4265176";NA;NA;class ll iv
1273;heart failure  lvef < $nmbr$ %  or both;"C0018801;C0018802;C0428772;C0488728;C4554158";NA;NA;heart failure lvef $nmbr$ or both
1273;continuous lvef $nmbr$ treatment interaction;"C0039798;C0087111;C0428772;C0488728;C0549178;C1522326;C1533734;C1704675;C1705169;C3538994;C3887704";NA;NA;continuous lvef $nmbr$ treatment interaction
1273;baseline lvef  %;"C0168634;C0428772;C0488728;C1442488";NA;NA;baseline lvef
1273;baseline lvef;"C0168634;C0428772;C0488728;C1442488";NA;NA;baseline lvef
1272;lvh by minnesota code  no . ( % );"C0009219;C0026183;C0149721;C0805701;C3889831";NA;NA;lvh by minnesota code no
1272;lvh by minnesota code;"C0009219;C0026183;C0149721;C0805701;C3889831";NA;NA;lvh by minnesota code
1272;lvh by echocardiography;"C0013516;C0149721";NA;NA;lvh by echocardiography
1272;lvh by echocardiogram;"C0013516;C0149721;C2243117";NA;NA;lvh by echocardiogram
1272;lvh - n = $nmbr$;C0149721;NA;NA;lvh n $nmbr$
1272;lvh + n = $nmbr$;C0149721;NA;NA;lvh n $nmbr$
1272;lvh ( from echocardiogram );"C0013516;C0149721;C2243117";NA;NA;lvh from echocardiogram
1272;lvh;C0149721;NA;NA;lvh
1272;history of lvh on echocardiogram;"C0013516;C0019664;C0019665;C0149721;C0262512;C0262926;C1705255;C2004062;C2243117";NA;NA;history of lvh on echocardiogram
1271;lv heart structure;"C0018787;C0023128;C0731033;C1881413";NA;NA;lv heart structure
1270;ultra;C0728475;NA;NA;ultra
1270;lira;C1555441;NA;NA;lira
1269;la diameter;"C0023031;C0023749;C0230347;C1301886;C2346906;C4553351";NA;NA;la diameter
1268;years since last gout flare;"C0018099;C0439234;C1517205;C1517741;C3540542";NA;NA;years since last gout flare
1267;$nmbr$ . $nmbr$ ( ll . $nmbr$ );NA;NA;NA;$nmbr$ $nmbr$ ll $nmbr$
1266;lda  %;C4553195;NA;NA;lda
1273;alvef ( per $nmbr$ % );NA;FALSE; -10;alvef per $nmbr$
1267;class l / ll heart failure;"C0018801;C0018802;C0456387;C1518526;C1705943;C4554158";FALSE; 453;class l ll heart failure
1269;fev $nmbr$  la;"C0023031;C0023749;C0230347;C2346906;C3714541;C4553351";FALSE; 288;fev $nmbr$ la
1268;at least $nmbr$ severe flare;"C0205082;C1517205;C3540542;C4050465;C4050466";FALSE;2101;at least $nmbr$ severe flare
1268;at least $nmbr$ flare;"C1517205;C3540542";FALSE;2101;at least $nmbr$ flare
1271;latvia;C0023128;FALSE;2105;latvia
1271;lv ejection fraction;"C0023128;C0489482;C0731033;C1881413;C2700378";FALSE;2106;lv ejection fraction
1271;lv ejection fraction ( % );"C0023128;C0489482;C0731033;C1881413;C2700378";FALSE;2106;lv ejection fraction
1271;lv ejection fractionb;"C0023128;C0302131;C0336969;C0731033;C0812388;C1881413";FALSE;2106;lv ejection fractionb
1271;lv ejection fraction  % ( n = $nmbr$ );"C0023128;C0489482;C0731033;C1881413;C2700378";FALSE;2106;lv ejection fraction n $nmbr$
1271;lv ejection fraction > $nmbr$ % and < $nmbr$ %;"C0023128;C0489482;C0731033;C1881413;C2700378";FALSE;2106;lv ejection fraction $nmbr$ and $nmbr$
1271;lv systolic dysfunction  n ( % );"C0023128;C0731033;C0749225;C1881413";FALSE;2107;lv systolic dysfunction n
1271;lv diastolic dysfunction  n ( % );"C0023128;C0520863;C0731033;C1881413";FALSE;2108;lv diastolic dysfunction n
1274;total cholesterol  mmol / le;"C0023190;C0201950;C0439090;C0439190;C0543421;C1423767;C2697858";FALSE;1504;total cholesterol mmol le
1276;[ cm ( female ) / cm ( male ) ];"C0043210;C0086287;C0086582;C1705497;C1705498;C1706180;C1706428;C1706429";FALSE;2109;cm female cm male
1266;ascot - lla;C0718674;NA;NA;ascot lla
1266;> $nmbr$ lb;NA;NA;NA;$nmbr$ lb
1266;< $nmbr$ lb;NA;NA;NA;$nmbr$ lb
1265;other llt use;"C0042153;C0457083;C1947944;C2347090";NA;NA;other llt use
1265;allhat - llt;C2347090;NA;NA;allhat llt
1264;p value ( int );"C1709380;C3272375";NA;NA;p value int
1264;p int . f;"C0016327;C0369773;C2603361;C3272375";NA;NA;p int f
1264;p [ int ];"C0369773;C2603361;C3272375";NA;NA;p int
1264;p . b “ int;"C1539794;C3272375";NA;NA;p b int
1264;p . b * int;"C1539794;C3272375";NA;NA;p b int
1264;p - value ( int );"C1709380;C3272375";NA;NA;p value int
1264;p - int .;"C0369773;C2603361;C3272375";NA;NA;p int
1264;p - int;"C0369773;C2603361;C3272375";NA;NA;p int
1264;int . p *;C3272375;NA;NA;int p
1263;nt - probnp pg / mla ( iqr );"C0030827;C0072225;C0599973;C0669479;C0754710;C1266240";NA;NA;nt probnp pg mla iqr
1263;iqr;NA;NA;NA;iqr
1262;imt ( mm );"C0334121;C1704614;C4318736;C4330985;C4554674";NA;NA;imt mm
1262;carotid imt;"C0334121;C0741968;C1704614;C4318736";NA;NA;carotid imt
1261;immunologic;"C0152036;C0205470";NA;NA;immunologic
1261;imm only;"C0205171;C0205470;C1720467";NA;NA;imm only
1261;imm;C0205470;NA;NA;imm
1260;umec $nmbr$ . $nmbr$ | ig ( n = $nmbr$ );"C0021027;C0305052;C0360506";NA;NA;umec $nmbr$ $nmbr$ ig n $nmbr$
1260;tio $nmbr$ | ig ( n = $nmbr$ );"C0021027;C0305052;C0360506";NA;NA;tio $nmbr$ ig n $nmbr$
1260;sfc $nmbr$ / $nmbr$ | ig bid n = $nmbr$;"C0021027;C0305052;C0360506;C4521536";NA;NA;sfc $nmbr$ $nmbr$ ig bid n $nmbr$
1260;qva $nmbr$ $nmbr$ / $nmbr$ | ig od n = $nmbr$;"C0021027;C0229089;C0305052;C0360506;C0439164;C1512019;C3273373;C3665488";NA;NA;qva $nmbr$ $nmbr$ $nmbr$ ig od n $nmbr$
1260;olodaterol $nmbr$ | ig tiotropium n = $nmbr$ non - tiotropium n = $nmbr$;"C0021027;C0305052;C0360506;C1518422;C4032878";NA;NA;olodaterol $nmbr$ ig tiotropium n $nmbr$ non tiotropium n $nmbr$
1260;olodaterol $nmbr$ $nmbr$ | ig tiotropium n = $nmbr$ non - tiotropium n = $nmbr$;"C0021027;C0305052;C0360506;C1518422;C4032878";NA;NA;olodaterol $nmbr$ $nmbr$ ig tiotropium n $nmbr$ non tiotropium n $nmbr$
1260;igl ( n = $nmbr$ );"C0021037;C0314619;C2247518";NA;NA;igl n $nmbr$
1260;igg ( > $nmbr$ . $nmbr$ g / l )  %;"C0439294;C0456615";NA;NA;igg $nmbr$ $nmbr$ g l
1260;ig ( n = $nmbr$ );"C0021027;C0305052;C0360506";NA;NA;ig n $nmbr$
1260;ff / vi $nmbr$ / $nmbr$ | ig ( n = $nmbr$ );"C0021027;C0205999;C0305052;C0360506;C4554348";NA;NA;ff vi $nmbr$ $nmbr$ ig n $nmbr$
1260;ff $nmbr$ | ig ( n = $nmbr$ );"C0021027;C0305052;C0360506;C4554348";NA;NA;ff $nmbr$ ig n $nmbr$
1260;air + ig ( n = $nmbr$ );"C0001861;C0021027;C0305052;C0360506;C3536832";NA;NA;air ig n $nmbr$
1260;a . beuralizuinab $nmbr$ ing q $nmbr$ w;NA;NA;NA;a beuralizuinab $nmbr$ ing q $nmbr$ w
1259;who / idf ifg;"C1334085;C1708411";NA;NA;who idf ifg
1259;igt or ifg;"C1334085;C1708411";NA;NA;igt or ifg
1259;igt / ifg;"C1334085;C1708411";NA;NA;igt ifg
1259;ifg and igt;"C1334085;C1708411";NA;NA;ifg and igt
1259;ifg / igt;"C1334085;C1708411";NA;NA;ifg igt
1259;ifg;"C1334085;C1708411";NA;NA;ifg
1259;baseline ifg ( fpg $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ mmol / l ) - n;"C0168634;C1334085;C1442488;C1532563;C1708411";NA;NA;baseline ifg fpg $nmbr$ $nmbr$ $nmbr$ $nmbr$ mmol l n
1259;ada ifg;"C1060325;C1334085;C1708411;C3811629";NA;NA;ada ifg
1258;ivc ( n = $nmbr$ );C4085887;NA;NA;ivc n $nmbr$
1258;class iv only;"C0205171;C0441888;C1720467;C2698970";NA;NA;class iv only
1258;class iv;"C0441888;C2698970";NA;NA;class iv
1257;lll / iv;"C0022326;C1261077;C4265176";NA;NA;lll iv
1257;lll - iv;"C0022326;C1261077;C4265176";NA;NA;lll iv
1257;iv ( n z $nmbr$ );"C0022326;C4265176";NA;NA;iv n z $nmbr$
1257;iv ( $nmbr$ );"C0022326;C4265176";NA;NA;iv $nmbr$
1257;iv;"C0022326;C4265176";NA;NA;iv
1257;iii or iv;"C0022326;C0439070;C1705160;C4265176";NA;NA;iii or iv
1257;iii and iv;"C0022326;C0439070;C1705160;C4265176";NA;NA;iii and iv
1257;iii / iv;"C0022326;C0439070;C1705160;C4265176";NA;NA;iii iv
1257;iii - iv;"C0022326;C0439070;C1705160;C4265176";NA;NA;iii iv
1257;iii & iv;"C0022326;C0439070;C1705160;C4265176";NA;NA;iii iv
1257;ii - iv ( % );"C0022326;C1710602;C4082587;C4265176";NA;NA;ii iv
1257;ii - iv;"C0022326;C1710602;C4082587;C4265176";NA;NA;ii iv
1257;ii ( $nmbr$ );NA;NA;NA;ii $nmbr$
1257;dual iv;"C0022326;C0205173;C1554184;C4265176";NA;NA;dual iv
1257;class iv / iv - v;"C0022326;C0457166;C1880098;C4265176";NA;NA;class iv iv v
1257;ciass ll - iv;"C0022326;C4265176";NA;NA;ciass ll iv
1256;$nmbr$ ix;C0015491;NA;NA;$nmbr$ ix
1255;idm;C0270221;NA;NA;idm
1255;id genotype;"C0009450;C0017431;C0600091;C1441613";NA;NA;id genotype
1255;id ( n = $nmbr$ );"C0009450;C0600091;C1441613";NA;NA;id n $nmbr$
1255;id;"C0009450;C0600091;C1441613";NA;NA;id
1255;( id;"C0009450;C0600091;C1441613";NA;NA;id
1254;time since ipf diagnosisa  mean years ( sd );"C0034069;C0040223;C0439234;C0444504;C1800706;C2347634;C2348143;C2699239;C3541383";NA;NA;time since ipf diagnosisa mean years sd
1253;of variation )  iu;"C0049272;C0205419;C0439453;C0694756";NA;NA;of variation iu
1253;iu;"C0049272;C0439453;C0694756";NA;NA;iu
1253;dose ( iu );"C0049272;C0178602;C0439453;C0694756;C0869039;C1114758";NA;NA;dose iu
1252;iee at baseline : < $nmbr$ iu / l;"C0168634;C0439457;C1442488";NA;NA;iee at baseline $nmbr$ iu l
1262;imt ( $nmbr$ );"C0334121;C1704614;C4318736";FALSE; -10;imt $nmbr$
1256;ifx ( n = $nmbr$ );C0020823;FALSE; 154;ifx n $nmbr$
1254;ipf;"C0034069;C1800706";FALSE;1254;ipf
1256;ifx treatment;"C0020823;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704";FALSE; 154;ifx treatment
1257;nyha class iii or iv  n ( % );"C0022326;C1882086;C4265176";FALSE; 453;nyha class iii or iv n
1257;nyha class iii or iv ( n = $nmbr$ );"C0022326;C1882086;C4265176";FALSE; 453;nyha class iii or iv n $nmbr$
1257;nyha lll - iv;"C0022326;C1261077;C1275491;C4265176";FALSE; 453;nyha lll iv
1257;killip class ii - iv  n ( % );"C0022326;C1710602;C2697845;C2697847;C4082587;C4265176";FALSE; 846;killip class ii iv n
1257;angina class iii or iv — no . ( % );"C0022326;C0264677;C4265176";FALSE;2102;angina class iii or iv no
1257;angina class iii or iv prior;"C0022326;C0264677;C0332152;C2826257;C4265176";FALSE;2102;angina class iii or iv prior
1257;total diuretic dose ( iv + oral ) on day $nmbr$  mg;"C0012798;C0022326;C0439422;C0442027;C2986497;C4265176;C4521986";FALSE; 992;total diuretic dose iv oral on day $nmbr$ mg
1257;iii and iv ejection fraction;"C0022326;C0439070;C0489482;C1705160;C2700378;C4265176";FALSE; 453;iii and iv ejection fraction
1257;gold iii - iv;"C0018026;C0022326;C0439070;C1304897;C1705160;C4265176";FALSE;1836;gold iii iv
1258;class iv glomerulonephritis;"C0017658;C0441888;C2698970";FALSE;2103;class iv glomerulonephritis
1266;glycoprotein llb / illa inhibitor;"C0017968;C1999216";FALSE;2104;glycoprotein llb illa inhibitor
1266;glycoprotein llb / llla receptor inhibitor;"C0017968;C0597357;C1999216";FALSE;2104;glycoprotein llb llla receptor inhibitor
1266;glycoprotein llb / llia inhibitor;"C0017968;C1999216";FALSE;2104;glycoprotein llb llia inhibitor
1252;> $nmbr$ to < $nmbr$ iu / l;C0439457;NA;NA;$nmbr$ to $nmbr$ iu l
1252;> $nmbr$ iu / l;C0439457;NA;NA;$nmbr$ iu l
1251;body height ( cm );"C0005890;C0487985";NA;NA;body height cm
1250;yes ( % ) weight [ kg ] ( interaction : p = $nmbr$ . $nmbr$ );"C0005910;C0022718;C0043100;C0439209;C1305866;C1549445;C1704675;C1705104;C1705108;C1710701;C4054209";NA;NA;yes weight kg interaction p $nmbr$ $nmbr$
1250;weight — no . ( % );"C0005910;C0043100;C1305866;C1705104";NA;NA;weight no
1250;weight — kg cardiovascular history — no . ( % );"C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C1880008;C4054209";NA;NA;weight kg cardiovascular history no
1250;weight — kg ( median );"C0005910;C0022718;C0043100;C0439209;C0549183;C0876920;C1305866;C1705104;C2347635;C2348144;C2939193;C4054209";NA;NA;weight kg median
1250;weight of < $nmbr$ kg  n ( % );"C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C4054209";NA;NA;weight of $nmbr$ kg n
1250;weight in kg  median ( iqr );"C0005910;C0022718;C0043100;C0439209;C0549183;C0876920;C1305866;C1705104;C2347635;C2348144;C2939193;C4054209";NA;NA;weight in kg median iqr
1250;weight group  no . ( % );"C0005910;C0043100;C0441833;C0687744;C1257890;C1305866;C1519504;C1705104;C1705428;C1705429";NA;NA;weight group no
1250;weight category;"C0005910;C0043100;C0683312;C1305866;C1705104;C3889287";NA;NA;weight category
1250;weight ab  %;"C0005910;C0043100;C1305866;C1705104";NA;NA;weight ab
1250;weight ^;"C0005910;C0043100;C1305866;C1705104";NA;NA;weight
1250;weight > $nmbr$ kg;"C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C4054209";NA;NA;weight $nmbr$ kg
1250;weight < $nmbr$ kg;"C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C4054209";NA;NA;weight $nmbr$ kg
1250;weight < $nmbr$ . $nmbr$ kg  n;"C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C4054209";NA;NA;weight $nmbr$ $nmbr$ kg n
1250;weight < $nmbr$;"C0005910;C0043100;C1305866;C1705104";NA;NA;weight $nmbr$
1250;weight - kg  median ( iqr );"C0005910;C0022718;C0043100;C0439209;C0549183;C0876920;C1305866;C1705104;C2347635;C2348144;C2939193;C4054209";NA;NA;weight kg median iqr
1250;weight ( range ) ( kg );"C0005910;C0022718;C0043100;C0439209;C1305866;C1514721;C1705104;C2348147;C3542016;C4054209";NA;NA;weight range kg
1250;weight ( median [ iqr ] )  kg;"C0005910;C0022718;C0043100;C0439209;C0549183;C0876920;C1305866;C1705104;C2347635;C2348144;C2939193;C4054209";NA;NA;weight median iqr kg
1250;weight ( kg }  median ( min  max };"C0005910;C0043100;C0549183;C0876920;C1305866;C1532757;C1705104;C2347635;C2348144;C2939193";NA;NA;weight kg median min max
1250;weight ( kg ) bmi ( kg / m $nmbr$ );"C0005910;C0043100;C0369637;C0441923;C0578022;C1305866;C1319635;C1705104";NA;NA;weight kg bmi kg m $nmbr$
1250;weight ( kg ) *;"C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C4054209";NA;NA;weight kg
1250;weight ( kg )  median ( m / n  max );"C0005910;C0043100;C0549183;C0876920;C1305866;C1532718;C1705104;C2347635;C2348144;C2939193";NA;NA;weight kg median m n max
1250;weight ( kg )  median ( iqr );"C0005910;C0022718;C0043100;C0439209;C0549183;C0876920;C1305866;C1705104;C2347635;C2348144;C2939193;C4054209";NA;NA;weight kg median iqr
1250;weight $nmbr$ - $nmbr$;"C0005910;C0043100;C1305866;C1705104";NA;NA;weight $nmbr$ $nmbr$
1250;weight $nmbr$ +;"C0005910;C0043100;C1305866;C1705104";NA;NA;weight $nmbr$
1250;weight $ $nmbr$ . $nmbr$ kg  n;"C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C4054209";NA;NA;weight $ $nmbr$ $nmbr$ kg n
1250;weight $ $nmbr$ . $nmbr$ kg  < $nmbr$ . $nmbr$ kg  n;"C0005910;C0043100;C1305866;C1319635;C1705104";NA;NA;weight $ $nmbr$ $nmbr$ kg $nmbr$ $nmbr$ kg n
1250;weight # $nmbr$ kg;"C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C4054209";NA;NA;weight $nmbr$ kg
1250;weight  median ( iqr )  kg;"C0005910;C0022718;C0043100;C0439209;C0549183;C0876920;C1305866;C1705104;C2347635;C2348144;C2939193;C4054209";NA;NA;weight median iqr kg
1250;weight  median ( interquartile range )  kg;"C0005910;C0022718;C0043100;C0439209;C0549183;C0876920;C1305866;C1705104;C1711350;C2347635;C2348144;C2939193;C4054209";NA;NA;weight median interquartile range kg
1250;weight  mean ( sd ) lbs .;"C0005910;C0043100;C0439219;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C3161851";NA;NA;weight mean sd lbs
1250;weight  mean ( sd )  kgb;"C0005910;C0043100;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239";NA;NA;weight mean sd kgb
1250;weight  lbs;"C0005910;C0043100;C0439219;C1305866;C1705104;C3161851";NA;NA;weight lbs
1250;weight  kg duration of pah  n ( % );"C0005910;C0022718;C0030123;C0043100;C0439209;C0449238;C1305866;C1705104;C2926735;C3203102;C4054209;C4284467";NA;NA;weight kg duration of pah n
1250;weight  kg $nmbr$;"C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C4054209";NA;NA;weight kg $nmbr$
1250;weight  kg  median ( range );"C0005910;C0022718;C0043100;C0439209;C0549183;C0876920;C1305866;C1514721;C1705104;C2347635;C2348144;C2348147;C2939193;C3542016;C4054209";NA;NA;weight kg median range
1250;weight;"C0005910;C0043100;C1305866;C1705104";NA;NA;weight
1250;per body weight  u / kg;"C0005910;C1300561;C1305866";NA;NA;per body weight u kg
1238;known t ' rc - iitoji cccndilon;"C0205309;C1167159;C1419366";NA;NA;known t rc iitoji cccndilon
1250;male sex — no . ( % ) weight — no . ( % );"C0005910;C0043100;C0086582;C1305866;C1705104";NA;NA;male sex no weight no
1250;healthy weight;"C0005910;C0043100;C1305866;C1705104;C3898900";NA;NA;healthy weight
1250;body weight reduction > $nmbr$ %;"C0005910;C0242821;C0301630;C0392756;C0460148;C1262477;C1268086;C1293152;C1305866;C4082212;C4551656";NA;NA;body weight reduction $nmbr$
1250;body weight index ( kg / m $nmbr$ );"C0005910;C0600653;C0918012;C1305866;C1532718;C1552854;C1637833;C2986546";NA;NA;body weight index kg m $nmbr$
1250;body weight at randonization { ixrs );"C0005910;C1305866";NA;NA;body weight at randonization ixrs
1250;body weight *;"C0005910;C1305866";NA;NA;body weight
1250;body weight ( kg )  mean ( sd );"C0005910;C0022718;C0439209;C0444504;C1305866;C2347634;C2348143;C2699239;C4054209";NA;NA;body weight kg mean sd
1250;body weight ( kg )  mean ( s . d . );"C0005910;C0444504;C1275571;C1305866;C2347634;C2348143";NA;NA;body weight kg mean s d
1250;dose / weight ( iu / kg );"C0005910;C0043100;C0178602;C0439463;C0869039;C1114758;C1305866;C1705104";FALSE;1924;dose weight iu kg
1250;electrophysiological study — no . ( % ) weight — ibj;"C0005910;C0043100;C0850293;C1305866;C1705104";FALSE;1925;electrophysiological study no weight ibj
1251;body weighta  kg;"C0022718;C0242821;C0439209;C0460148;C1268086;C4054209;C4082212";FALSE;1250;body weighta kg
1251;body weiqht;"C0242821;C0460148;C1268086;C4082212";FALSE;1250;body weiqht
1251;body weight at randomization;"C0005910;C0034656;C0242821;C0460148;C1268086;C1305866;C2985844;C4082212";FALSE;1250;body weight at randomization
1251;> $nmbr$ kg body weight at randomization;"C0005910;C0022718;C0034656;C0242821;C0439209;C0460148;C1268086;C1305866;C2985844;C4054209;C4082212";FALSE;1250;$nmbr$ kg body weight at randomization
1251;no body weight at randomization ( ixrs );"C0005910;C0034656;C0242821;C0460148;C1268086;C1305866;C2985844;C4082212";FALSE;1250;no body weight at randomization ixrs
1251;w eight ( k g );"C0205454;C0439267;C0597277;C1708601";FALSE;1250;w eight k g
1237;fatty acid group ( n = $nmbr$ );"C0015684;C0441848";FALSE;1236;fatty acid group n $nmbr$
1250;body weight  mean ± sd  kg;"C0005910;C0022718;C0439209;C0444504;C1305866;C2347634;C2348143;C2699239;C4054209";NA;NA;body weight mean sd kg
1250;body weight  %;"C0005910;C1305866";NA;NA;body weight
1250;body weight;"C0005910;C1305866";NA;NA;body weight
1250;> $nmbr$ ( n  % ) weight  kg;"C0005910;C0022718;C0043100;C0369718;C0439209;C0441922;C1305866;C1705104;C4054209";NA;NA;$nmbr$ n weight kg
1249;height — cm;C0489786;NA;NA;height cm
1249;height loss ( cm );C0424641;NA;NA;height loss cm
1249;height loss;C0424641;NA;NA;height loss
1249;height ( cm ) ( mean ± sd );"C0444504;C0489786;C2347634;C2348143;C2699239";NA;NA;height cm mean sd
1249;height ( cm )  mean ( sd ) a;"C0444504;C0489786;C2347634;C2348143;C2699239";NA;NA;height cm mean sd a
1249;height ( cm )  mean ( s . e . );"C0439392;C0444504;C0489786;C2347634;C2348143";NA;NA;height cm mean s e
1249;height ( cm );C0489786;NA;NA;height cm
1249;height '  cm;C0489786;NA;NA;height cm
1249;height  mean ( sd )  cm;"C0444504;C0489786;C2347634;C2348143;C2699239";NA;NA;height mean sd cm
1249;height  inches;"C0439204;C0489786";NA;NA;height inches
1249;height  cm *;C0489786;NA;NA;height cm
1249;height  cm ( mean ± s . d . );"C0439392;C0444504;C0489786;C2347634;C2348143";NA;NA;height cm mean s d
1249;height  cm  mean ( sd );"C0444504;C0489786;C2347634;C2348143;C2699239";NA;NA;height cm mean sd
1249;height  cm;C0489786;NA;NA;height cm
1249;baseline height ( cm );"C0168634;C0489786;C1442488";NA;NA;baseline height cm
1248;overweight ( bmi £ $nmbr$ to < $nmbr$ );"C0497406;C0578022";NA;NA;overweight bmi $nmbr$ to $nmbr$
1248;overweight ( bmi = $nmbr$ - $nmbr$ . $nmbr$ );"C0497406;C0578022";NA;NA;overweight bmi $nmbr$ $nmbr$ $nmbr$
1248;overweight ( $nmbr$ to < $nmbr$ kg / m $nmbr$ );"C0497406;C1532718";NA;NA;overweight $nmbr$ to $nmbr$ kg m $nmbr$
1248;overweight;C0497406;NA;NA;overweight
1248;lisinopril vs chlorthalidone overweight;"C0008294;C0065374;C0497406";NA;NA;lisinopril vs chlorthalidone overweight
1248;bmi $nmbr$ – $nmbr$ overweight;"C0497406;C0578022";NA;NA;bmi $nmbr$ $nmbr$ overweight
1248;$nmbr$ - $nmbr$ . $nmbr$ : overweight;C0497406;NA;NA;$nmbr$ $nmbr$ $nmbr$ overweight
1248;$nmbr$ - $nmbr$ - $nmbr$  overweight;C0497406;NA;NA;$nmbr$ $nmbr$ $nmbr$ overweight
1247;cangrelor n / n ( % );C1121991;NA;NA;cangrelor n n
1247;cangrelor clopidogrel no . of events / total no . ( % );"C0070166;C0439175;C0439810;C0441471;C1121991;C3541888";NA;NA;cangrelor clopidogrel no of events total no
1247;cangrelor ( n = $nmbr$ ) n / n ( % );C1121991;NA;NA;cangrelor n $nmbr$ n n
1247;cangrelor ( n = $nmbr$ );C1121991;NA;NA;cangrelor n $nmbr$
1247;cangrelor  %;C1121991;NA;NA;cangrelor
1247;cangrelor;C1121991;NA;NA;cangrelor
1246;ticagrelor in ‐ hosp ( n = $nmbr$ );C1999375;NA;NA;ticagrelor in hosp n $nmbr$
1246;prehospital ticagrelor ( n = $nmbr$ );C1999375;NA;NA;prehospital ticagrelor n $nmbr$
1246;in hospital ticagrelor;"C0019994;C1510665;C1999375";NA;NA;in hospital ticagrelor
1246;in - hospital ticagrelor ( n = $nmbr$ );"C0019994;C1510665;C1999375";NA;NA;in hospital ticagrelor n $nmbr$
1245;posterior circulation;"C0005775;C0205095;C1516559";NA;NA;posterior circulation
1245;inferior or posterior;"C0205095;C0542339;C0678975";NA;NA;inferior or posterior
1245;inferior / posterior;"C0205095;C0542339;C0678975";NA;NA;inferior posterior
1245;inferior ( n  % );"C0542339;C0678975";NA;NA;inferior n
1245;inferior ( % );"C0542339;C0678975";NA;NA;inferior
1245;inferior;"C0542339;C0678975";NA;NA;inferior
1245;anterior circulation;"C0005775;C0205094;C1516559";NA;NA;anterior circulation
1244;infarct location anterior;"C0021308;C0205094;C0450429;C1515974;C4284930;C4284931";NA;NA;infarct location anterior
1244;anterior or non - anterior ml;"C0205094;C0439526;C1518422;C1705224;C3887665";NA;NA;anterior or non anterior ml
1243;nonanterior;NA;NA;NA;nonanterior
1243;anterior;C0205094;NA;NA;anterior
1242;time - to - first infusion;"C0040223;C0205435;C0574032;C1279901;C1827465;C3541383";NA;NA;time to first infusion
1242;time - to - first - infusion from hip surgery ( days )  n ( % );"C0040223;C0205435;C0439228;C0574032;C0596706;C1279901;C1827465;C3541383";NA;NA;time to first infusion from hip surgery days n
1242;no . of infusions;C0574032;NA;NA;no of infusions
1242;median infusions — no . ( range );"C0549183;C0574032;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016";NA;NA;median infusions no range
1242;glyceryl trinitrate infusion;"C0017887;C0574032;C1827465";NA;NA;glyceryl trinitrate infusion
1242;core study to first infusion;"C0205435;C0444669;C0557651;C0574032;C1167518;C1279901;C1706352;C1827465;C1882467;C2603343;C3274653";NA;NA;core study to first infusion
1242;c $nmbr$ e $nmbr$ fab bolus and infusion ( n = $nmbr$ );"C0574032;C1186706;C1511237;C1705509;C1827465;C3812160";NA;NA;c $nmbr$ e $nmbr$ fab bolus and infusion n $nmbr$
1242;bolus and infusion;"C0574032;C1186706;C1511237;C1705509;C1827465;C3812160";NA;NA;bolus and infusion
1242;and infusion;"C0574032;C1827465";NA;NA;and infusion
1241;transfusions;"C0005841;C0199960;C1879316";NA;NA;transfusions
1241;transfusion ≥ $nmbr$ units rbcs or whole blood;"C0005841;C0014792;C0199960;C0229664;C0370231;C0439148;C1519795;C1546552;C1608383;C1879316;C3853603";NA;NA;transfusion $nmbr$ units rbcs or whole blood
1241;transfusion;"C0005841;C0199960;C1879316";NA;NA;transfusion
1241;blood transfusion;"C0005841;C0281867";NA;NA;blood transfusion
1241;any blood transfusion;"C0005841;C0281867";NA;NA;any blood transfusion
1241;any blood product transfusion;"C0005841;C0199960;C0281867;C0456388;C1514468;C1547007;C1704444;C1879316";NA;NA;any blood product transfusion
1239;non - carrier ( n = $nmbr$ );C2986416;NA;NA;non carrier n $nmbr$
1239;cancert;NA;NA;NA;cancert
1238;no known frtrontxtfufoc cond aon;"C0205309;C1856054;C2826243;C4597943";NA;NA;no known frtrontxtfufoc cond aon
1238;known tiromtcch * c ccndifeon;C0205309;NA;NA;known tiromtcch c ccndifeon
1240;tnfi naive;NA;FALSE;  11;tnfi naive
1240;tnfi - naive;NA;FALSE;  11;tnfi naive
1240;# of prior tnfi among non - tnfi naive;"C0332152;C1518422;C2826257";FALSE;  11;of prior tnfi among non tnfi naive
1240;acei;NA;FALSE;  44;acei
1240;acei vs . non - acei;C1518422;FALSE;  44;acei vs non acei
1239;non – small - cell lung cancer;"C0007131;C2984258;C3539721";FALSE;2096;non small cell lung cancer
1247;p value ( cangrelor versus clopidogrel in men );"C0025266;C0070166;C1121991;C1709380";FALSE;2097;p value cangrelor versus clopidogrel in men
1247;p value ( cangrelor versus clopidogrel in women );"C0043210;C0070166;C1121991;C1709380";FALSE;2097;p value cangrelor versus clopidogrel in women
1243;left anterior descending;"C0205386;C0441998;C1547177";FALSE;2098;left anterior descending
1243;l eft anterior descending;"C0205094;C0205386;C0439394;C0451214;C1547177;C1706495;C3642217";FALSE;2098;l eft anterior descending
1243;left anterior descending artery;C0226032;FALSE;2098;left anterior descending artery
1243;left anterior descending  n ( % );"C0205386;C0441998;C1547177";FALSE;2098;left anterior descending n
1244;anterior ( n  % );C0205094;FALSE;1243;anterior n
1244;anterior { % );C0205094;FALSE;1243;anterior
1244;non - anterior;"C0205094;C1518422";FALSE;1243;non anterior
1244;not anterior;"C0205094;C1518422";FALSE;1243;not anterior
1236;fatty acid composition;"C0015684;C0486616;C1555710";NA;NA;fatty acid composition
1235;therapy - fatigue ( facit - f  $nmbr$ - $nmbr$ );"C0015672;C0039798;C0087111;C1363945;C3272505;C3463815;C4050243;C4554645";NA;NA;therapy fatigue facit f $nmbr$ $nmbr$
1235;facit - f;C3272505;NA;NA;facit f
1234;bempedoic acid ( n = $nmbr$ );C3659310;NA;NA;bempedoic acid n $nmbr$
1234;bempedoic;NA;NA;NA;bempedoic
1233;cad and abi < $nmbr$ - $nmbr$ §;"C1328319;C1504769;C2239547;C3813548;C3888326;C4284121";NA;NA;cad and abi $nmbr$ $nmbr$
1233;baseline abi  affected limb;"C0015385;C0168634;C0392760;C1314939;C1328319;C1442488;C3888326";NA;NA;baseline abi affected limb
1233;ankle / brachial index;"C1328319;C3888326";NA;NA;ankle brachial index
1233;ankle - brachial index £ $nmbr$ . $nmbr$;"C1328319;C3888326";NA;NA;ankle brachial index $nmbr$ $nmbr$
1233;ankle - brachial index < $nmbr$ . $nmbr$ — no . ( % );"C1328319;C3888326";NA;NA;ankle brachial index $nmbr$ $nmbr$ no
1233;ankle - brachial index < $nmbr$ . $nmbr$;"C1328319;C3888326";NA;NA;ankle brachial index $nmbr$ $nmbr$
1233;abi > $nmbr$ . $nmbr$;"C1328319;C3888326";NA;NA;abi $nmbr$ $nmbr$
1233;abi < $nmbr$ . $nmbr$;"C1328319;C3888326";NA;NA;abi $nmbr$ $nmbr$
1233;abi # $nmbr$ . $nmbr$;"C1328319;C3888326";NA;NA;abi $nmbr$ $nmbr$
1233;abi;"C1328319;C3888326";NA;NA;abi
1232;perindopril - indapamide;C1273169;NA;NA;perindopril indapamide
1232;pctindopnl - indapamide ( n = $nmbr$ );C0021186;NA;NA;pctindopnl indapamide n $nmbr$
1231;lce — l - dopa / carbidopa / entacapone  lc — l - dopa / carbidopa  pd — parkinson disease  updrs — rating scale  adl — activities of daily living  pdq - $nmbr$ — parkinson disease questionnaire .;"C0001288;C0030567;C0034394;C0165921;C0353697;C0441655;C0681889;C1420005;C1423759;C1521736;C3273355;C3639721;C4552744";NA;NA;lce l dopa carbidopa entacapone lc l dopa carbidopa pd parkinson disease updrs rating scale adl activities of daily living pdq $nmbr$ parkinson disease questionnaire
1231;l - dopa / carbidopa - l - dopa / carbidopa / entacapone;"C0165921;C0353697";NA;NA;l dopa carbidopa l dopa carbidopa entacapone
1231;entacapone;C0165921;NA;NA;entacapone
1230;pdq - $nmbr$;NA;NA;NA;pdq $nmbr$
1230;paod;NA;NA;NA;paod
1230;mean duration of pd  yr;"C0439234;C0444504;C0449238;C2347634;C2348143;C2926735;C4553228;C4553229";NA;NA;mean duration of pd yr
1230;duration of procedure;C2346509;NA;NA;duration of procedure
1230;duration of pd  y;"C0449238;C2926735;C4553228;C4553229";NA;NA;duration of pd y
1230;duration of paod ( years )  mean ± sd;"C0439234;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735";NA;NA;duration of paod years mean sd
1229;dihydropyridine;"C0012315;C0220821";NA;NA;dihydropyridine
1228;dipyridamole alone;"C0012582;C0205171;C0439044;C0679994";NA;NA;dipyridamole alone
1228;dipyridamole;C0012582;NA;NA;dipyridamole
1227;without dyspnoea;"C0013404;C1963100";NA;NA;without dyspnoea
1227;with dyspnoea;"C0013404;C1963100";NA;NA;with dyspnoea
1227;no dyspnoea ( n = $nmbr$ );"C0013404;C1963100";NA;NA;no dyspnoea n $nmbr$
1227;mmrc dyspnea scale score : t : t;"C0013404;C1963100;C3826977;C4049715";NA;NA;mmrc dyspnea scale score t t
1227;mmrc dyspnea scale  n ( % );"C0013404;C0175659;C0349674;C1947916;C1963100;C3826977";NA;NA;mmrc dyspnea scale n
1227;dyspnoea ( n = $nmbr$ );"C0013404;C1963100";NA;NA;dyspnoea n $nmbr$
1227;dyspnea t;"C0013404;C1963100";NA;NA;dyspnea t
1227;dyspnea  frequent / continuous;"C0013404;C0332183;C0549178;C1963100";NA;NA;dyspnea frequent continuous
1227;dyspnea  % ( frequent / continuous );"C0013404;C0332183;C0549178;C1963100";NA;NA;dyspnea frequent continuous
1227;dyspnea;"C0013404;C1963100";NA;NA;dyspnea
1227;clopidogrel dyspnoea vs no dyspnoea *;"C0013404;C0070166;C1963100";NA;NA;clopidogrel dyspnoea vs no dyspnoea
1227;cangrelor dyspnoea vs no dyspnoea *;"C0013404;C1121991;C1963100";NA;NA;cangrelor dyspnoea vs no dyspnoea
1226;pnd;"C1417807;C1956415;C4552608";NA;NA;pnd
1226;paroxysmal nocturnal dyspnea;C1956415;NA;NA;paroxysmal nocturnal dyspnea
1225;rivaroxaban plus aspirin ( n = $nmbr$ ) $nmbr$ . $nmbr$ ± $nmbr$ . $nmbr$;"C0004057;C0332287;C1739768";NA;NA;rivaroxaban plus aspirin n $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
1225;rivaroxaban plus aspirin ( n = $nmbr$ );"C0004057;C0332287;C1739768";NA;NA;rivaroxaban plus aspirin n $nmbr$
1225;rivaroxaban plus aspirin ( $nmbr$ % cl );"C0004057;C0332287;C0596019;C1739768";NA;NA;rivaroxaban plus aspirin $nmbr$ cl
1225;rivaroxaban plus;C1739768;NA;NA;rivaroxaban plus
1225;rivaroxaban + aspirin;"C0004057;C1739768";NA;NA;rivaroxaban aspirin
1225;rivaroxaban +;C1739768;NA;NA;rivaroxaban
1225;rivaroxaban ( n   = $nmbr$ );C1739768;NA;NA;rivaroxaban n $nmbr$
1225;rivaroxaban ( n = $nmbr$ );C1739768;NA;NA;rivaroxaban n $nmbr$
1225;rivaroxaban $nmbr$ mg;"C0024671;C0026410;C0439269;C1739768;C1960952;C2346927;C4321396;C4521761";NA;NA;rivaroxaban $nmbr$ mg
1225;rivaroxaban;C1739768;NA;NA;rivaroxaban
1225;low - dose rivaroxaban plus aspirin ( n = $nmbr$ );"C0332287;C1739768;C2608320";NA;NA;low dose rivaroxaban plus aspirin n $nmbr$
1225;low - dose rivaroxaban + aspirin group;"C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C1739768;C2608320";NA;NA;low dose rivaroxaban aspirin group
1225;low - dose rivaroxaban + aspirin ( n / n );"C1739768;C2608320";NA;NA;low dose rivaroxaban aspirin n n
1224;apixaban vs . placebo;"C0032042;C1696465;C1706408;C1831808";NA;NA;apixaban vs placebo
1224;apixaban dose ( or matching placebo );"C0032042;C0150103;C0178602;C0869039;C1114758;C1696465;C1706408;C1708943;C1831808";NA;NA;apixaban dose or matching placebo
1224;apixaban ( n = $nmbr$ );C1831808;NA;NA;apixaban n $nmbr$
1224;apixaban;C1831808;NA;NA;apixaban
1223;tolvaptan ( n = $nmbr$ );C1176308;NA;NA;tolvaptan n $nmbr$
1223;tolvaptan;C1176308;NA;NA;tolvaptan
1223;placebo tolvaptan ( $nmbr$ mg ) ( n $nmbr$ $nmbr$ ) ( n $nmbr$ $nmbr$ );"C0024671;C0026410;C0032042;C0439269;C1176308;C1696465;C1706408;C1960952;C2346927;C4321396;C4521761";NA;NA;placebo tolvaptan $nmbr$ mg n $nmbr$ $nmbr$ n $nmbr$ $nmbr$
1222;fluvastatin ( n = $nmbr$ );C0082608;NA;NA;fluvastatin n $nmbr$
1222;fluvastatin $nmbr$ mg;"C0024671;C0026410;C0082608;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;fluvastatin $nmbr$ mg
1221;plasma lipoproteins  mmol / l;"C0023820;C0032105;C1532563;C1550098;C4521445";NA;NA;plasma lipoproteins mmol l
1220;hr with edoxaban ( $nmbr$ % ci );"C0008107;C2975435;C3259781";NA;NA;hr with edoxaban $nmbr$ ci
1220;higher dose edoxaban regimen;"C0205250;C2348331;C2975435";NA;NA;higher dose edoxaban regimen
1220;edoxaban n = $nmbr$ n / n ( % );C2975435;NA;NA;edoxaban n $nmbr$ n n
1220;edoxaban n = $nmbr$;C2975435;NA;NA;edoxaban n $nmbr$
1207;losartan;C0126174;NA;NA;losartan
1221;plasma creatine  mg / dl;"C0010286;C0032105;C0439269;C1550098;C4521445";FALSE; 952;plasma creatine mg dl
1221;plasma triglyceride — mg / dl;"C0032105;C0041004;C0439269;C1550098;C4521445";FALSE; 368;plasma triglyceride mg dl
1229;non - dihydropyridine ccbs;"C0006684;C0012315;C0220821;C1518422";FALSE; 704;non dihydropyridine ccbs
1234;zoledronic acid;C0257685;FALSE;2092;zoledronic acid
1234;zoledronic acid arm;"C0257685;C0446516;C3715044;C4553528";FALSE;2092;zoledronic acid arm
1234;zoledronic acid ( n = $nmbr$ );C0257685;FALSE;2092;zoledronic acid n $nmbr$
1234;baseline mean serum uric acid  pmol / l ( sd );"C0168634;C0439284;C0444504;C0455272;C0700634;C1442488;C2347634;C2348143;C2699239";FALSE;2093;baseline mean serum uric acid pmol l sd
1234;serum uric acid  n;"C0455272;C0700634";FALSE;2093;serum uric acid n
1235;paci;C1165245;FALSE;2094;paci
1235;paci ( n = $nmbr$ );C1165245;FALSE;2094;paci n $nmbr$
1235;taci;"C0666480;C1425349;C4284230";FALSE;2094;taci
1236;thromboaspiration;NA;FALSE;2095;thromboaspiration
1237;a mini - mental state examination  omega - $nmbr$ fatty acids vs placebo;"C0015684;C0032042;C0451306;C1696465;C1706408;C1719844";FALSE; -10;a mini mental state examination omega $nmbr$ fatty acids vs placebo
1220;edoxaban n / n  rate ( % );"C0871208;C1521828;C2975435";NA;NA;edoxaban n n rate
1220;edoxaban ( n = $nmbr$ );C2975435;NA;NA;edoxaban n $nmbr$
1220;edoxaban;C2975435;NA;NA;edoxaban
1219;doxazosin group;"C0114873;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429";NA;NA;doxazosin group
1219;doxazosin;C0114873;NA;NA;doxazosin
1218;endovascular — no . ( % );C0524425;NA;NA;endovascular no
1218;endovascular;C0524425;NA;NA;endovascular
1217;ventricular tachycardia or fibrillation;"C0042514;C0232197;C0344428;C1963247;C4554446";NA;NA;ventricular tachycardia or fibrillation
1217;ventricular tachyarrhythmias;C3827656;NA;NA;ventricular tachyarrhythmias
1216;lacunar infarction  n ( % );C0333559;NA;NA;lacunar infarction n
1216;lacunar;"C0241970;C1459585";NA;NA;lacunar
1214;patients with microvascular complications  n ( % );"C0009566;C0030705;C0443258;C1171258";NA;NA;patients with microvascular complications n
1214;microvascular complicationsb;C0443258;NA;NA;microvascular complicationsb
1214;microvascular complications  n ( % ) ’;"C0009566;C0443258;C1171258";NA;NA;microvascular complications n
1213;revascularization in $nmbr$ days;"C0439228;C0581603";NA;NA;revascularization in $nmbr$ days
1213;revascularization during index hospitalization  %;"C0019993;C0581603;C0600653;C0918012;C1552854;C1637833;C2986546";NA;NA;revascularization during index hospitalization
1213;revascularization;C0581603;NA;NA;revascularization
1213;revascularisation  n ( % );C0581603;NA;NA;revascularisation n
1213;prior revascularization ( n = $nmbr$  $nmbr$ );"C0332152;C0581603;C2826257";NA;NA;prior revascularization n $nmbr$ $nmbr$
1213;prior revascularization ( % );"C0332152;C0581603;C2826257";NA;NA;prior revascularization
1213;prior revascularization;"C0332152;C0581603;C2826257";NA;NA;prior revascularization
1213;peripheral arterial revascularization;"C0003842;C0205100;C0221464;C0581603";NA;NA;peripheral arterial revascularization
1213;no revascularisation;C0581603;NA;NA;no revascularisation
1213;no prior revascularization ( n = $nmbr$  $nmbr$ );"C0332152;C0581603;C2826257";NA;NA;no prior revascularization n $nmbr$ $nmbr$
1213;arterial revascularization;"C0003842;C0221464;C0581603";NA;NA;arterial revascularization
1213;any revascularization;C0581603;NA;NA;any revascularization
1213;any peripheral revascularization;"C0205100;C0581603";NA;NA;any peripheral revascularization
1213;$nmbr$ days urgent revascularization;"C0439228;C0439609;C0581603;C3272275";NA;NA;$nmbr$ days urgent revascularization
1212;with rehospitalization  urgent coronary revascularization;"C0439609;C0877341;C3272275";NA;NA;with rehospitalization urgent coronary revascularization
1212;urgent revascularizati on;"C0439609;C3272275";NA;NA;urgent revascularizati on
1212;urgent coronary revascularization;"C0439609;C0877341;C3272275";NA;NA;urgent coronary revascularization
1212;cvd / mi / stroke / urgent coronary revascularization;"C0007222;C0038454;C0439609;C0877341;C3272275;C3810814;C4554100";NA;NA;cvd mi stroke urgent coronary revascularization
1211;forearm fracture;C1305215;NA;NA;forearm fracture
1211;forearm;C0016536;NA;NA;forearm
1211;distal forearm;C0588203;NA;NA;distal forearm
   7;p - value for trend across categories;"C0683312;C1521798;C1709380;C4554533";NA;NA;p value for trend across categories
1210;affected body - surface area > $nmbr$ % — no . { % );"C0005902;C0205148;C0392760;C1314939;C1879646";NA;NA;affected body surface area $nmbr$ no
1209;irbesartan ( n = $nmbr$ );C0288171;NA;NA;irbesartan n $nmbr$
1209;irbesartan;C0288171;NA;NA;irbesartan
1208;other - candesartan;C0717550;NA;NA;other candesartan
1208;candesartan group ( n = $nmbr$ );"C0441848;C0717550";NA;NA;candesartan group n $nmbr$
1208;candesartan $nmbr$ / $nmbr$;C0717550;NA;NA;candesartan $nmbr$ $nmbr$
1208;candesartan;C0717550;NA;NA;candesartan
1207;p ( losartan versus placebo );"C0032042;C0126174;C0369773;C1696465;C1706408;C2603361";NA;NA;p losartan versus placebo
1207;losartan plus placebo ( n = $nmbr$ );"C0032042;C0126174;C0332287;C1696465;C1706408";NA;NA;losartan plus placebo n $nmbr$
1207;losartan n = $nmbr$;C0126174;NA;NA;losartan n $nmbr$
1207;losartan + placebo;"C0032042;C0126174;C1696465;C1706408";NA;NA;losartan placebo
1207;losartan ( n = $nmbr$ );C0126174;NA;NA;losartan n $nmbr$
1207;losartan ( n = $nmbr$  $nmbr$ );C0126174;NA;NA;losartan n $nmbr$ $nmbr$
1207;losartan  n / n ( % );C0126174;NA;NA;losartan n n
1209;olmesartan along with diuretic ( n - $nmbr$ );"C0012798;C1098320";FALSE;2087;olmesartan along with diuretic n $nmbr$
1209;olmesartan ( n = $nmbr$ );C1098320;FALSE;2087;olmesartan n $nmbr$
1210;colonic area involved;"C0009368;C0017446;C0205146;C1314939";FALSE;2088;colonic area involved
1210;intestinal area involved  n ( % ) $;"C0017446;C0021853;C0205146;C0369718;C0441922;C1314939";FALSE;2088;intestinal area involved n $
1210;involved intestinal area  n ( % );"C0021853;C1879646";FALSE;2088;involved intestinal area n
1210;median fecal calprotectin — mg / kg gi areas involved — no . ( % );"C0015733;C0205146;C0439272;C0549183;C0876920;C0950624;C1314939;C1335798;C1366582;C1708130;C2347635;C2348144;C2939193;C3539617;C4050121;C4319729";FALSE; 780;median fecal calprotectin mg kg gi areas involved no
1210;areas;"C0205146;C4319729";FALSE; -10;areas
1211;korea;C0022771;FALSE;2089;korea
1211;korean;C1556095;FALSE;2089;korean
1211;vora;NA;FALSE; -10;vora
1213;urgent revascularisation due to unstable angina;"C0002965;C0439609;C0581603;C0678226;C3272275";FALSE;1212;urgent revascularisation due to unstable angina
1213;with revascularisation;C0581603;FALSE;1212;with revascularisation
1213;• urgent coronaiy revascularization > $nmbr$ days;"C0439228;C0439609;C0581603;C3272275";FALSE;1212;urgent coronaiy revascularization $nmbr$ days
1215;glomerular;"C0022663;C0268731";FALSE; -10;glomerular
1215;estimated glomerular filtration rate < $nmbr$;C3811844;FALSE; 592;estimated glomerular filtration rate $nmbr$
1215;estimated glomerular filtration rate  n ( % );C3811844;FALSE; 592;estimated glomerular filtration rate n
1215;estimated glomerular filtration rate - ml / min / $nmbr$ . $nmbr$ m $nmbr$ tt;"C0369637;C0439445;C0441923;C1452561;C3811844;C4554543";FALSE; 592;estimated glomerular filtration rate ml min $nmbr$ $nmbr$ m $nmbr$ tt
1215;estimated glomerular filtration rate  ml / min / $nmbr$ . $nmbr$ m $nmbr$  mean ( sd ) §;"C0369637;C0439445;C0441923;C0444504;C2347634;C2348143;C2699239;C3811844";FALSE; 592;estimated glomerular filtration rate ml min $nmbr$ $nmbr$ m $nmbr$ mean sd
1215;estimated glomerular filtration rate  ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C3811844";FALSE; 592;estimated glomerular filtration rate ml min $nmbr$ $nmbr$ m $nmbr$
1215;estimated glomerular filtration rate — ml / min / $nmbr$ . $nmbr$ m ^;"C0369637;C0439445;C0441923;C3811844";FALSE; 592;estimated glomerular filtration rate ml min $nmbr$ $nmbr$ m
1215;estimated glomerular filtration rate - ml / min  median ( iqr ) ';"C0439445;C0549183;C0876920;C2347635;C2348144;C2939193;C3811844";FALSE; 592;estimated glomerular filtration rate ml min median iqr
1215;estimated glomerular filtration rate §;C3811844;FALSE; 592;estimated glomerular filtration rate
1215;estimated glomerular filtration rate | |;C3811844;FALSE; 592;estimated glomerular filtration rate
1215;estimated glomerular filtration rate ^;C3811844;FALSE; 592;estimated glomerular filtration rate
1218;rv and pulmonary vascular;"C0035190;C0459963;C1508661;C3889272";FALSE;2090;rv and pulmonary vascular
1210;agea;NA;FALSE; -10;agea
1207;adjusted $nmbr$ risk reduction losartan vs placebo ( $nmbr$ % cl );"C0032042;C0126174;C0456081;C0596019;C1137094;C1696465;C1706408";NA;NA;adjusted $nmbr$ risk reduction losartan vs placebo $nmbr$ cl
1206;valsartan n / n;C0216784;NA;NA;valsartan n n
1206;valsartan / hctz ( n = $nmbr$ );"C0020261;C0216784";NA;NA;valsartan hctz n $nmbr$
1206;valsartan / hctz  n / n ( % );"C0020261;C0216784";NA;NA;valsartan hctz n n
1206;valsartan / hctz;"C0020261;C0216784";NA;NA;valsartan hctz
1206;valsartan ( n = $nmbr$ );C0216784;NA;NA;valsartan n $nmbr$
1206;valsartan  n / n ( % );C0216784;NA;NA;valsartan n n
1206;valsartan  n ( % );C0216784;NA;NA;valsartan n
1206;valsartan;C0216784;NA;NA;valsartan
1206;hazard ratio ( $nmbr$ % cl ) valsartan vs . placebo;"C0032042;C0216784;C0596019;C1696465;C1706408;C2985465";NA;NA;hazard ratio $nmbr$ cl valsartan vs placebo
1205;telmisartan group ( n = $nmbr$ );"C0248719;C0441848";NA;NA;telmisartan group n $nmbr$
1205;telmisartan ( n = $nmbr$ );C0248719;NA;NA;telmisartan n $nmbr$
1205;telmisartan ( n = $nmbr$  $nmbr$ );C0248719;NA;NA;telmisartan n $nmbr$ $nmbr$
1205;telmisartan;C0248719;NA;NA;telmisartan
1205;randomization to placebo or telmisartan;"C0032042;C0034656;C0248719;C1696465;C1706408";NA;NA;randomization to placebo or telmisartan
1204;any dynamic st - segment shift;"C0333051;C0429029;C0729333;C2347509";NA;NA;any dynamic st segment shift
1203;self - reported descent  n ( % );"C0205386;C0369718;C0441922;C0680043;C0681906;C2700446";NA;NA;self reported descent n
1203;descent;"C0205386;C0680043";NA;NA;descent
1202;requiring assistance;"C0018896;C1269765";NA;NA;requiring assistance
1202;events requiring assistance;"C0018896;C0441471;C1269765;C3541888";NA;NA;events requiring assistance
1202;$nmbr$ = help needed  still independent;"C0027552;C0085862;C0686904;C1269765;C1290940;C1299583;C1552861";NA;NA;$nmbr$ help needed still independent
1201;fixed triple ( n = $nmbr$ );"C0205174;C0443218;C2827483;C3714578";NA;NA;fixed triple n $nmbr$
1201;adhere;C3714578;NA;NA;adhere
1200;verifynow pru - defined hpr ( % patients );"C0030705;C1337105;C1704788;C3539106";NA;NA;verifynow pru defined hpr patients
1200;vasp pri - defined hpr ( % patients );"C0030705;C0034044;C0255567;C1337105;C1421428;C1704788;C1826843;C3539106;C3539761;C3539762";NA;NA;vasp pri defined hpr patients
1200;other defined;"C1704788;C3539106";NA;NA;other defined
1200;lta ( max response to $nmbr$ pm adp ) defined hpr ( % patients );"C0030266;C0030705;C0523452;C1337105;C1704788;C2611142;C3539106;C4049155";NA;NA;lta max response to $nmbr$ pm adp defined hpr patients
1199;none or diet;"C0012155;C0012159;C1519433;C2983588;C3668949";NA;NA;none or diet
1199;hr is < $nmbr$ if pravastatin is better than diet alone;"C0012155;C0012159;C0085542;C0205171;C0332272;C0439044;C0679994;C1519433;C2983588;C3668949;C4522046";NA;NA;hr is $nmbr$ if pravastatin is better than diet alone
1199;diet plus pravastatin group ( n = $nmbr$ );"C0012155;C0012159;C0085542;C0332287;C0441848;C1519433;C2983588;C3668949";NA;NA;diet plus pravastatin group n $nmbr$
1199;diet only;"C0012155;C0012159;C0205171;C1519433;C1720467;C2983588;C3668949";NA;NA;diet only
1199;diet group ( n = $nmbr$ );"C0012155;C0012159;C0441848;C1519433;C2983588;C3668949";NA;NA;diet group n $nmbr$
1199;diet group;"C0012155;C0012159;C0441833;C0687744;C1257890;C1519433;C1519504;C1705428;C1705429;C2983588;C3668949";NA;NA;diet group
1199;diet diet + pravastatin;"C0012155;C0012159;C0085542;C1519433;C2983588;C3668949";NA;NA;diet diet pravastatin
1199;diet and exercise;"C0012155;C0012159;C0015259;C1519433;C1522704;C2983588;C3668949";NA;NA;diet and exercise
1199;diet alone;"C0012155;C0012159;C0205171;C0439044;C0679994;C1519433;C2983588;C3668949";NA;NA;diet alone
1199;diet - i - pravastatin ( n = $nmbr$ );"C0012155;C0012159;C0021966;C0085542;C0221138;C1519433;C2983588;C3668949";NA;NA;diet i pravastatin n $nmbr$
1199;diet + pravastatin group;"C0012155;C0012159;C0085542;C0441833;C0687744;C1257890;C1519433;C1519504;C1705428;C1705429;C2983588;C3668949";NA;NA;diet pravastatin group
1199;diet + pravastatin ( n = $nmbr$ );"C0012155;C0012159;C0085542;C1519433;C2983588;C3668949";NA;NA;diet pravastatin n $nmbr$
1199;diet + pravastatin $nmbr$ / $nmbr$ ( $nmbr$ . $nmbr$ );"C0012155;C0012159;C0085542;C1519433;C2983588;C3668949";NA;NA;diet pravastatin $nmbr$ $nmbr$ $nmbr$ $nmbr$
1199;diet + pravastatin;"C0012155;C0012159;C0085542;C1519433;C2983588;C3668949";NA;NA;diet pravastatin
1199;diet ( n 二 $nmbr$ );"C0012155;C0012159;C1519433;C2983588;C3668949";NA;NA;diet n $nmbr$
1199;diet ( n = $nmbr$ );"C0012155;C0012159;C1519433;C2983588;C3668949";NA;NA;diet n $nmbr$
1199;diet $nmbr$ / $nmbr$ ( $nmbr$ . $nmbr$ );"C0012155;C0012159;C1519433;C2983588;C3668949";NA;NA;diet $nmbr$ $nmbr$ $nmbr$ $nmbr$
1199;diet;"C0012155;C0012159;C1519433;C2983588;C3668949";NA;NA;diet
1198;safety variable;"C0036043;C0439828;C1705187;C4553760";NA;NA;safety variable
1198;safety : non - cabg - related bleeding;"C0010055;C0019080;C0036043;C0439849;C0445223;C1518422;C1705187";NA;NA;safety non cabg related bleeding
1198;safety    n   ( % ) b;"C0036043;C1705187";NA;NA;safety n b
1198;safety  %;"C0036043;C1705187";NA;NA;safety
1198;primary safety outcome -;"C0036043;C0205225;C0439612;C0439631;C1274040;C1705187";NA;NA;primary safety outcome
1197;spirometry;C0037981;NA;NA;spirometry
1197;spirometric values at baseline;"C0037981;C0042295;C0168634;C0183441;C1442488";NA;NA;spirometric values at baseline
1197;baseline spirometry;"C0037981;C0168634;C1442488";NA;NA;baseline spirometry
1196;left atrial diameter : < $nmbr$ mm ( n = $nmbr$ );"C0225860;C0225861;C1301886;C4330985;C4554674";NA;NA;left atrial diameter $nmbr$ mm n $nmbr$
1196;left atrial diameter  mm ( sd );"C0225860;C0225861;C1301886;C2699239;C4330985;C4554674";NA;NA;left atrial diameter mm sd
1196;left atrial diameter;"C0225860;C0225861;C1301886";NA;NA;left atrial diameter
1196;left atrial anteroposterior diameter — mm;"C0225860;C0225861;C1301886;C4330985;C4554674";NA;NA;left atrial anteroposterior diameter mm
1195;mod / sev exacerbation rates;"C0011860;C0439793;C0458216;C0871208;C1521828;C2983285;C4086268";NA;NA;mod sev exacerbation rates
1195;mod / sev exacerbation rate;"C0011860;C0439793;C0458216;C0871208;C1521828;C2983285;C4086268";NA;NA;mod sev exacerbation rate
1194;sample size ( n );C0242618;NA;NA;sample size n
1194;sample size  n ( % ) by treatment;"C0037793;C0039798;C0087111;C0242618;C0456389;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;sample size n by treatment
1194;sample size  n;C0242618;NA;NA;sample size n
1194;sample size;C0242618;NA;NA;sample size
1193;us site;"C0205145;C1515974;C2825164";NA;NA;us site
1193;u . s . sites;"C0041703;C0205145";NA;NA;u s sites
1193;u . s . site;"C0041703;C0205145;C1515974;C2825164";NA;NA;u s site
1193;sites;C0205145;NA;NA;sites
1193;site;"C0205145;C1515974;C2825164";NA;NA;site
1193;fractures ( site not specified );"C0016658;C0205145;C0205369;C1515974;C1518422;C2825164";NA;NA;fractures site not specified
1193;disease site — no . of patients ( % ) |;"C0012634;C0030705;C0205145;C1515974;C2825164";NA;NA;disease site no of patients
1123;rca  n ( % );NA;NA;NA;rca n
1195;diabetes type ii  n ( % );C0011860;FALSE;2081;diabetes type ii n
1196;degree of stenosis  % of diameter;"C1301886;C4034225";FALSE;2082;degree of stenosis of diameter
1203;african descent;"C0027567;C0205386;C0680043";FALSE;2083;african descent
1204;legend;C2729544;FALSE; -10;legend
1206;sacubitril / valsartan;C4033631;FALSE;2084;sacubitril valsartan
1206;amlodipine and valsartan;"C0051696;C0216784";FALSE;2085;amlodipine and valsartan
1207;atenolol - losartan;"C0004147;C0126174";FALSE;2086;atenolol losartan
1207;adjusted hr losartan vs atenolol *;"C0004147;C0126174;C0456081";FALSE;2086;adjusted hr losartan vs atenolol
1193;internal carotid artery sites;"C0007276;C0205145";FALSE;2199;internal carotid artery sites
1193;disease site — no . ( % ) ^;"C0012634;C0205145;C1515974;C2825164";NA;NA;disease site no
1018;variable;"C0439828;C4553760";NA;NA;variable
1193;disease site  n [ % ];"C0012634;C0205145;C1515974;C2825164";NA;NA;disease site n
1193;critical site;"C0205145;C1511545;C1515974;C2825164";NA;NA;critical site
1193;any site;"C0205145;C1515974;C2825164";NA;NA;any site
1192;platelet  $nmbr$ / l;C0456525;NA;NA;platelet $nmbr$ l
1191;use of antiplatelet agents — no . / total no . ( % );"C0085826;C0439175;C0439810;C1524063";NA;NA;use of antiplatelet agents no total no
1191;use of antiplatelet agents ^;"C0085826;C1524063";NA;NA;use of antiplatelet agents
1191;use of antiplatelet agents  n ( % );"C0085826;C1524063";NA;NA;use of antiplatelet agents n
1191;previous use of antiplatelet drugs;"C0085826;C0205156;C1524063;C1552607;C2963157";NA;NA;previous use of antiplatelet drugs
1191;previous chronic use of antiplatelet drugs;"C0085826;C0205156;C0205191;C1524063;C1552607;C2963157";NA;NA;previous chronic use of antiplatelet drugs
1191;other antiplatelet agent 一 no . ( % );C0085826;NA;NA;other antiplatelet agent no
1191;aspirin orother antiplatelet drug;"C0004057;C0013227;C0085826;C1254351";NA;NA;aspirin orother antiplatelet drug
1191;aspirin or other antiplatelet drug;"C0004057;C0085826";NA;NA;aspirin or other antiplatelet drug
1191;asa or antiplatelet agent;"C0004057;C0085826;C3853627";NA;NA;asa or antiplatelet agent
1191;antiplateletsa;NA;NA;NA;antiplateletsa
1191;antiplatelets agents;C0085826;NA;NA;antiplatelets agents
1191;antiplatelets  any;NA;NA;NA;antiplatelets any
1191;antiplatelet drugs;"C0085826;C2963157";NA;NA;antiplatelet drugs
1191;antiplatelet drug;C0085826;NA;NA;antiplatelet drug
1191;antiplatelet agents ( % );C0085826;NA;NA;antiplatelet agents
1191;antiplatelet agents;C0085826;NA;NA;antiplatelet agents
1191;antiplatelet agent n ( % );C0085826;NA;NA;antiplatelet agent n
1191;antiplatelet agent;C0085826;NA;NA;antiplatelet agent
1191;> $nmbr$ . $nmbr$ mg / liter antiplatelet agents;"C0024671;C0026410;C0085826;C0439269;C0475211;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ $nmbr$ mg liter antiplatelet agents
1190;placebo / open - label abatacept;"C0032042;C1619966;C1696465;C1706408;C1709323";NA;NA;placebo open label abatacept
1190;placebo - abatacept $nmbr$ / $nmbr$ - abatacept $nmbr$ / $nmbr$;"C0032042;C1619966;C1696465;C1706408";NA;NA;placebo abatacept $nmbr$ $nmbr$ abatacept $nmbr$ $nmbr$
1190;abatacept ‡;C1619966;NA;NA;abatacept
1190;abatacept ~ $nmbr$ mg / kg ( n = $nmbr$ );"C0439272;C1619966";NA;NA;abatacept $nmbr$ mg kg n $nmbr$
1190;abatacept plus mtx ( n = $nmbr$ );"C0025677;C1417487;C1619966";NA;NA;abatacept plus mtx n $nmbr$
1190;abatacept monotherapy ( n = $nmbr$ );C1619966;NA;NA;abatacept monotherapy n $nmbr$
1190;abatacept / open - label abatacept;"C1619966;C1709323";NA;NA;abatacept open label abatacept
1190;abatacept ( n = $nmbr$ * );C1619966;NA;NA;abatacept n $nmbr$
1190;abatacept $nmbr$ mg / kg ( n = $nmbr$ );"C0439272;C1619966";NA;NA;abatacept $nmbr$ mg kg n $nmbr$
1190;abatacept $nmbr$ / — $nmbr$ mg / kg ( n = $nmbr$ );"C0439272;C1619966";NA;NA;abatacept $nmbr$ $nmbr$ mg kg n $nmbr$
1190;abatacept $nmbr$ / $nmbr$ ( n = $nmbr$ );C1619966;NA;NA;abatacept $nmbr$ $nmbr$ n $nmbr$
1190;abatacept;C1619966;NA;NA;abatacept
1189;intravenous study drug administered — no . ( % );"C0013175;C0348016;C0557651;C0683092;C1521801;C2603343";NA;NA;intravenous study drug administered no
1189;intravenous ( n = $nmbr$ );C0348016;NA;NA;intravenous n $nmbr$
1187;parameters at baseline;"C0168634;C0449381;C1442488";NA;NA;parameters at baseline
1187;parameters;C0449381;NA;NA;parameters
1187;other lipid parameters;"C0023779;C0449381";NA;NA;other lipid parameters
1187;lipid parameters;"C0023779;C0449381";NA;NA;lipid parameters
1187;hemodynamic parameters at baseline in the patients enrolled in the hemodynamic substudy;"C0019010;C0030705;C0168634;C0449381;C1442488;C4281788;C4684790";NA;NA;hemodynamic parameters at baseline in the patients enrolled in the hemodynamic substudy
1187;glycaemic parameters;"C0005802;C0449381";NA;NA;glycaemic parameters
1187;biometric parameters;"C0005544;C0449381;C2718322";NA;NA;biometric parameters
1186;parameter mean ± s . d .;"C0444504;C0549193;C1704769;C2347634;C2348143;C2350001";NA;NA;parameter mean s d
1186;parameter at baseline;"C0168634;C0549193;C1442488;C1704769;C2350001";NA;NA;parameter at baseline
1186;parameter / variable;"C0439828;C0549193;C1704769;C2350001;C4553760";NA;NA;parameter variable
1186;parameter ( mg / dl );"C0439269;C0549193;C1704769;C2350001";NA;NA;parameter mg dl
1186;parameter  n ( % );"C0549193;C1704769;C2350001";NA;NA;parameter n
1186;parameter  % ( $nmbr$ % ci );"C0008107;C0549193;C1704769;C2350001;C3259781";NA;NA;parameter $nmbr$ ci
1186;parameter;"C0549193;C1704769;C2350001";NA;NA;parameter
1186;efficacy parameter;"C0549193;C1280519;C1704769;C1707887;C2350001";NA;NA;efficacy parameter
1186;baseline parameter;"C0168634;C0549193;C1442488;C1704769;C2350001";NA;NA;baseline parameter
1186;$nmbr$ parameter;"C0549193;C1704769;C2350001";NA;NA;$nmbr$ parameter
1185;placebo - linagliptin;"C0032042;C1696465;C1706408;C2746078";NA;NA;placebo linagliptin
1185;linagliptin ( n z $nmbr$ );C2746078;NA;NA;linagliptin n z $nmbr$
1185;linagliptin ( n = $nmbr$ ) ';C2746078;NA;NA;linagliptin n $nmbr$
1185;linagliptin ( n = $nmbr$ );C2746078;NA;NA;linagliptin n $nmbr$
1185;linagliptin  patients with events / total patients;"C0030705;C0439175;C0439810;C0441471;C2746078;C3541888";NA;NA;linagliptin patients with events total patients
1185;linagliptin;C2746078;NA;NA;linagliptin
1185;incidence rate difference  linagliptin - placebo ( $nmbr$ % cl );"C0032042;C0596019;C1696465;C1705241;C1705242;C1706408;C1708485;C2746078";NA;NA;incidence rate difference linagliptin placebo $nmbr$ cl
1185;comparator - linagliptin;"C1707454;C2746078;C4553389;C4553390";NA;NA;comparator linagliptin
1184;sitagliptin ± oad;C1565750;NA;NA;sitagliptin oad
1184;sitagliptin no . / total no .;"C0439175;C0439810;C1565750";NA;NA;sitagliptin no total no
1184;sitagliptin n = $nmbr$;C1565750;NA;NA;sitagliptin n $nmbr$
1184;sitagliptin ( n = $nmbr$ );C1565750;NA;NA;sitagliptin n $nmbr$
1184;sitagliptin $nmbr$ mg n = $nmbr$;"C0024671;C0026410;C0439269;C1565750;C1960952;C2346927;C4321396;C4521761";NA;NA;sitagliptin $nmbr$ mg n $nmbr$
1192;aspirin or other antiplatelet agent;"C0004057;C0085826";FALSE;1191;aspirin or other antiplatelet agent
1189;intravenous anticoagulant during hospitalisation *;"C0003280;C0019993;C0348016;C0848112;C3536711";FALSE;2070;intravenous anticoagulant during hospitalisation
1189;intravenous anticoagulant during hospitalization;"C0003280;C0019993;C0348016;C0848112;C3536711";FALSE;2070;intravenous anticoagulant during hospitalization
1189;intravenous vasoactive drugs  % y;"C0683092;C1980011";FALSE;2071;intravenous vasoactive drugs y
1189;intravenous vasodilators ( % );C0443081;FALSE;2071;intravenous vasodilators
1189;intravenous dobutamine;"C0012963;C0348016";FALSE;2072;intravenous dobutamine
1188;treatment with antiplatelet drugs;C3469597;FALSE;2073;treatment with antiplatelet drugs
1188;with antiplatelets;NA;FALSE;2073;with antiplatelets
1188;without antiplatelets;NA;FALSE;2073;without antiplatelets
1188;antidiabetes drug usage [ % ( n ) ];C0242510;FALSE; 995;antidiabetes drug usage n
1188;drug - related teaes;"C0013227;C0439849;C0445223;C1254351";FALSE;  47;drug related teaes
1188;drug - related teaes *;"C0013227;C0439849;C0445223;C1254351";FALSE;  47;drug related teaes
1188;drug - related teaes $nmbr$;"C0013227;C0439849;C0445223;C1254351";FALSE;  47;drug related teaes $nmbr$
1188;nsteacs;NA;FALSE;  47;nsteacs
1192;other $nmbr$;NA;FALSE; -10;other $nmbr$
1193;carotid bulb sites;"C0007281;C0205145";FALSE;1547;carotid bulb sites
1193;common carotid artery sites;"C0007272;C0162859;C0205145";FALSE;2198;common carotid artery sites
1193;$nmbr$ carotid artery sites;"C0007272;C0162859;C0205145";FALSE;1547;$nmbr$ carotid artery sites
1184;sitagliptin $nmbr$ $nmbr$ . $nmbr$ 士 $nmbr$ . $nmbr$ $nmbr$ - h postprandial plasma glucose ( ppg ) ( mmol / l );"C0202042;C0376674;C0455280;C1418888;C1565750;C2827804";NA;NA;sitagliptin $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ h postprandial plasma glucose ppg mmol l
1184;sitagliptin $nmbr$;C1565750;NA;NA;sitagliptin $nmbr$
1184;sitagliptin;C1565750;NA;NA;sitagliptin
1184;canagliflozin $nmbr$ mg vs sitagliptin $nmbr$ mg;"C0024671;C0026410;C0439269;C1565750;C1960952;C2346927;C2974540;C4321396;C4521761";NA;NA;canagliflozin $nmbr$ mg vs sitagliptin $nmbr$ mg
1183;with alogliptin $nmbr$ mg ( n $nmbr$ $nmbr$ );"C0024671;C0026410;C0439269;C1958126;C1960952;C2346927;C4321396;C4521761";NA;NA;with alogliptin $nmbr$ mg n $nmbr$ $nmbr$
1183;with alogliptin $nmbr$ mg;"C0024671;C0026410;C0439269;C1958126;C1960952;C2346927;C4321396;C4521761";NA;NA;with alogliptin $nmbr$ mg
1183;with alogliptin $nmbr$ . $nmbr$ mg ( n $nmbr$ $nmbr$ );"C0024671;C0026410;C0439269;C1958126;C1960952;C2346927;C4321396;C4521761";NA;NA;with alogliptin $nmbr$ $nmbr$ mg n $nmbr$ $nmbr$
1183;with alogliptin $nmbr$ . $nmbr$ mg;"C0024671;C0026410;C0439269;C1958126;C1960952;C2346927;C4321396;C4521761";NA;NA;with alogliptin $nmbr$ $nmbr$ mg
1183;alogliptin ( n = $nmbr$ );C1958126;NA;NA;alogliptin n $nmbr$
1183;alogliptin  n ( % );C1958126;NA;NA;alogliptin n
1183;alogliptin;C1958126;NA;NA;alogliptin
1183;allogliptin;NA;NA;NA;allogliptin
1182;empagllflozln;NA;NA;NA;empagllflozln
1182;empagllflozin;NA;NA;NA;empagllflozin
1182;empagliflozin n with event / n;"C0441471;C3490348;C4019010";NA;NA;empagliflozin n with event n
1182;empagliflozin ( n   =   $nmbr$ );C3490348;NA;NA;empagliflozin n $nmbr$
1182;empagliflozin ( n = $nmbr$ ) $nmbr$ . $nmbr$ ± $nmbr$ . $nmbr$;C3490348;NA;NA;empagliflozin n $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
1182;empagliflozin ( n = $nmbr$ );C3490348;NA;NA;empagliflozin n $nmbr$
1182;empagliflozin $nmbr$ mg / day ( n = $nmbr$ );"C0439422;C3490348";NA;NA;empagliflozin $nmbr$ mg day n $nmbr$
1182;empagliflozin $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C3490348;C4321396;C4521761";NA;NA;empagliflozin $nmbr$ mg n $nmbr$
1182;empagliflozin $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C3490348;C4321396;C4521761";NA;NA;empagliflozin $nmbr$ mg
1182;empagliflozin;C3490348;NA;NA;empagliflozin
1182;$nmbr$ mg empagliflozin;"C0024671;C0026410;C0439269;C1960952;C2346927;C3490348;C4321396;C4521761";NA;NA;$nmbr$ mg empagliflozin
1181;canagliflozin dose;"C0178602;C0869039;C1114758;C2974540";NA;NA;canagliflozin dose
1181;canagliflozin ( n = $nmbr$ );C2974540;NA;NA;canagliflozin n $nmbr$
1181;canagliflozin;C2974540;NA;NA;canagliflozin
1181;canagiiflozin;NA;NA;NA;canagiiflozin
1180;ertugliflozin $nmbr$   mg ( n   =   $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C4079805;C4321396;C4521761";NA;NA;ertugliflozin $nmbr$ mg n $nmbr$
1180;ertugliflozin $nmbr$   mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C4079805;C4321396;C4521761";NA;NA;ertugliflozin $nmbr$ mg
1180;ertugliflozin $nmbr$ mg vs placebo / glirneplride;"C0024671;C0026410;C0032042;C0439269;C1696465;C1706408;C1960952;C2346927;C4079805;C4321396;C4521761";NA;NA;ertugliflozin $nmbr$ mg vs placebo glirneplride
1180;ertugliflozin $nmbr$ mg vs placebo / glinepiride;"C0024671;C0026410;C0032042;C0439269;C1696465;C1706408;C1960952;C2346927;C4079805;C4321396;C4521761";NA;NA;ertugliflozin $nmbr$ mg vs placebo glinepiride
1180;ertugliflozin $nmbr$ mg vs placebo / glimepiride;"C0024671;C0026410;C0032042;C0061323;C0439269;C1696465;C1706408;C1960952;C2346927;C4079805;C4321396;C4521761";NA;NA;ertugliflozin $nmbr$ mg vs placebo glimepiride
1180;ertugliflozin $nmbr$ mg vs placebo / giimepiride;"C0024671;C0026410;C0032042;C0439269;C1696465;C1706408;C1960952;C2346927;C4079805;C4321396;C4521761";NA;NA;ertugliflozin $nmbr$ mg vs placebo giimepiride
1180;ertugliflozin $nmbr$ mg ( n   =   $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C4079805;C4321396;C4521761";NA;NA;ertugliflozin $nmbr$ mg n $nmbr$
1180;ertugliflozin $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C4079805;C4321396;C4521761";NA;NA;ertugliflozin $nmbr$ mg n $nmbr$
1180;ertugliflozin $nmbr$ mg ( n $nmbr$ $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C4079805;C4321396;C4521761";NA;NA;ertugliflozin $nmbr$ mg n $nmbr$ $nmbr$
1180;ertugliflozin $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C4079805;C4321396;C4521761";NA;NA;ertugliflozin $nmbr$ mg
1180;ertugliflozin;C4079805;NA;NA;ertugliflozin
1179;hemoglobin level  %;"C0019029;C1314664";FALSE;1177;hemoglobin level
1179;hemoglobin concentration — g / liter;"C0019029;C0086045;C0439267;C0475211;C1314664;C1318517;C1319312;C1446561;C3827302";FALSE;1177;hemoglobin concentration g liter
1180;dapagliflozint;NA;FALSE;2066;dapagliflozint
1180;dapagliflozin ( n = $nmbr$ );C2353951;FALSE;2066;dapagliflozin n $nmbr$
1180;dapagliflozin  n *;C2353951;FALSE;2066;dapagliflozin n
1180;dapaglifloiin  n *;NA;FALSE;2066;dapaglifloiin n
1180;sotagliflozin;C3896939;FALSE;2067;sotagliflozin
1180;sotagliflozin $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C3896939;C4321396;C4521761";FALSE;2067;sotagliflozin $nmbr$ mg n $nmbr$
1180;sotagliflozin ( n = $nmbr$ );C3896939;FALSE;2067;sotagliflozin n $nmbr$
1183;vildagliptin ( n = $nmbr$ );C1570906;FALSE;2068;vildagliptin n $nmbr$
1183;vildagliptin $nmbr$ mg qd;"C0024671;C0026410;C0332173;C0439269;C1570906;C1960952;C2346927;C4321396;C4521761";FALSE;2068;vildagliptin $nmbr$ mg qd
1183;vildagliptin $nmbr$ mg qd n = $nmbr$;"C0024671;C0026410;C0332173;C0439269;C1570906;C1960952;C2346927;C4321396;C4521761";FALSE;2068;vildagliptin $nmbr$ mg qd n $nmbr$
1183;vildagliptin $nmbr$ mg daily;"C0024671;C0026410;C0332173;C0439269;C1570906;C1960952;C2346927;C4321396;C4521761";FALSE;2068;vildagliptin $nmbr$ mg daily
1183;vildagliptin $nmbr$ mg bid;"C0024671;C0026410;C0439269;C1570906;C1960952;C2346927;C4321396;C4521761";FALSE;2068;vildagliptin $nmbr$ mg bid
1183;vildagliptin;C1570906;FALSE;2068;vildagliptin
1183;saxagiiptin;NA;FALSE;2069;saxagiiptin
1183;saxagliptin ( % );C1611934;FALSE;2069;saxagliptin
1183;saxagliptin;C1611934;FALSE;2069;saxagliptin
1183;saxagliptin $nmbr$ mg ( n = $nmbr$  $nmbr$ );"C0024671;C0026410;C0439269;C1611934;C1960952;C2346927;C4321396;C4521761";FALSE;2069;saxagliptin $nmbr$ mg n $nmbr$ $nmbr$
1183;saxagliptin $nmbr$ mg;"C0024671;C0026410;C0439269;C1611934;C1960952;C2346927;C4321396;C4521761";FALSE;2069;saxagliptin $nmbr$ mg
1183;saxagliptin $nmbr$ mg ( n z $nmbr$ );"C0024671;C0026410;C0439269;C1611934;C1960952;C2346927;C4321396;C4521761";FALSE;2069;saxagliptin $nmbr$ mg n z $nmbr$
1183;saxagliptin $nmbr$ . $nmbr$ mg;"C0024671;C0026410;C0439269;C1611934;C1960952;C2346927;C4321396;C4521761";FALSE;2069;saxagliptin $nmbr$ $nmbr$ mg
1183;saxagliptin $nmbr$ . $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1611934;C1960952;C2346927;C4321396;C4521761";FALSE;2069;saxagliptin $nmbr$ $nmbr$ mg n $nmbr$
1183;saxagliptin $nmbr$ . $nmbr$ mg ( n = $nmbr$  $nmbr$ );"C0024671;C0026410;C0439269;C1611934;C1960952;C2346927;C4321396;C4521761";FALSE;2069;saxagliptin $nmbr$ $nmbr$ mg n $nmbr$ $nmbr$
1183;saxagliptin $nmbr$ . $nmbr$ mg ( n z $nmbr$ );"C0024671;C0026410;C0439269;C1611934;C1960952;C2346927;C4321396;C4521761";FALSE;2069;saxagliptin $nmbr$ $nmbr$ mg n z $nmbr$
1183;saxagliptin ( n = $nmbr$ );C1611934;FALSE;2069;saxagliptin n $nmbr$
1183;saxagliptin ( n = $nmbr$  $nmbr$ );C1611934;FALSE;2069;saxagliptin n $nmbr$ $nmbr$
1179;ct  calcitonin  cv  cardiovascular  egfr  estimated glomerular filtration rate  hbalc  glycated hemoglobin  h $nmbr$  histamine $nmbr$  iqr  interquartile range  n  number of patients  sd  standard deviation .;"C0006668;C0007226;C0017654;C0019588;C0033727;C0062408;C0369286;C0441932;C0564385;C0750572;C0871420;C1561549;C1711350;C1739039;C2360800;C2699239;C3538987;C3666909;C3811844;C3812682;C3887460;C4048877;C4318503;C4528284";NA;NA;ct calcitonin cv cardiovascular egfr estimated glomerular filtration rate hbalc glycated hemoglobin h $nmbr$ histamine $nmbr$ iqr interquartile range n number of patients sd standard deviation
1177;hemoglobin category;"C0019046;C0683312;C3889287";NA;NA;hemoglobin category
1177;hemoglobin aj ^ ( % );"C0004486;C0019046;C0230613";NA;NA;hemoglobin aj
1177;hemoglobin ( g / l );"C0019046;C0439267;C0439294;C0456615;C0635222";NA;NA;hemoglobin g l
1177;hemoglobin  mg / dl;"C0019046;C0439269";NA;NA;hemoglobin mg dl
1177;hemoglobin  g / l;"C0019046;C0439267;C0439294;C0456615;C0635222";NA;NA;hemoglobin g l
1177;hemoglobin;C0019046;NA;NA;hemoglobin
1177;haemoglobin ( mg / dl );"C0019046;C0439269";NA;NA;haemoglobin mg dl
1177;haemoglobin ( g / l );"C0019046;C0439267;C0439294;C0456615;C0635222";NA;NA;haemoglobin g l
1177;haemoglobin  mg / dl;"C0019046;C0439269";NA;NA;haemoglobin mg dl
1177;baseline hemoglobin aj ^ values;"C0004486;C0019046;C0042295;C0168634;C0230613;C1442488";NA;NA;baseline hemoglobin aj values
1139;tender joint count ( n / $nmbr$ );C0451530;NA;NA;tender joint count n $nmbr$
1176;patients with glycated hemoglobin > $nmbr$ . $nmbr$ % and > $nmbr$ episode ofdiabetic ketoacidosis *;"C0017853;C0030705;C1859860";NA;NA;patients with glycated hemoglobin $nmbr$ $nmbr$ and $nmbr$ episode ofdiabetic ketoacidosis
1176;mean glycated hemoglobin reduction during characteristic follow - up ( $nmbr$ % ci ) percent;"C0017853;C0439165;C0444504;C0520870;C0589120;C1521970;C1522577;C1704685;C2347634;C2348143;C3274571";NA;NA;mean glycated hemoglobin reduction during characteristic follow up $nmbr$ ci percent
1176;glycosylated hemoglobin  %;C0017853;NA;NA;glycosylated hemoglobin
1176;glycated hemoglobin — % -;C0017853;NA;NA;glycated hemoglobin
1176;glycated hemoglobin — %;C0017853;NA;NA;glycated hemoglobin
1176;glycated hemoglobin | |;C0017853;NA;NA;glycated hemoglobin
1176;glycated hemoglobin < median;"C0017853;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;glycated hemoglobin median
1176;glycated hemoglobin - % ’;C0017853;NA;NA;glycated hemoglobin
1176;glycated hemoglobin ( % );C0017853;NA;NA;glycated hemoglobin
1176;glycated hemoglobin  standardized level — %;"C0017853;C0441889;C0456079;C1547707;C2946261";NA;NA;glycated hemoglobin standardized level
1176;glycated hemoglobin  median ( iqr );"C0017853;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;glycated hemoglobin median iqr
1176;glycated hemoglobin  %  mean ( sd );"C0017853;C0444504;C2347634;C2348143;C2699239";NA;NA;glycated hemoglobin mean sd
1176;glycated hemoglobin  %;C0017853;NA;NA;glycated hemoglobin
1176;glycated hemoglobin;C0017853;NA;NA;glycated hemoglobin
1176;glycated haemoglobin ( % );C0017853;NA;NA;glycated haemoglobin
1176;glycated haemoglobin  %;C0017853;NA;NA;glycated haemoglobin
1176;baseline glycated hemoglobin ( % );"C0017853;C0168634;C1442488";NA;NA;baseline glycated hemoglobin
1174;modmy al randcnxzaton;C0202311;NA;NA;modmy al randcnxzaton
1174;iglar dose at randomization ( u / day );"C0034656;C0178602;C0456683;C0869039;C1114758";NA;NA;iglar dose at randomization u day
1174;iglar;NA;NA;NA;iglar
1174;ali;NA;NA;NA;ali
1173;patients randomly assigned;"C0030705;C1516050;C1552601";NA;NA;patients randomly assigned
1173;indzgly;NA;NA;NA;indzgly
1173;all randomly assigned;"C1516050;C1552601";NA;NA;all randomly assigned
1172;enalapril + aliskiren dm = $nmbr$ non - dm = $nmbr$;"C0011816;C0014025;C1120110;C1518422;C3250443";NA;NA;enalapril aliskiren dm $nmbr$ non dm $nmbr$
1172;aliskiren dm = $nmbr$ non - dm = $nmbr$;"C0011816;C1120110;C1518422;C3250443";NA;NA;aliskiren dm $nmbr$ non dm $nmbr$
1172;aliskiren / valsartan ( n = $nmbr$ );C2733073;NA;NA;aliskiren valsartan n $nmbr$
1172;aliskiren ( n = $nmbr$ );C1120110;NA;NA;aliskiren n $nmbr$
1172;aliskiren ( dm - vs . dm + );"C0011816;C1120110;C3250443";NA;NA;aliskiren dm vs dm
1172;aliskiren;C1120110;NA;NA;aliskiren
1171;adamantane derivatives;C3653470;NA;NA;adamantane derivatives
1170;dilatative  n ( % );"C0002940;C0012359;C0700124;C1322279";NA;NA;dilatative n
1170;dilatative;"C0002940;C0012359;C0700124;C1322279";NA;NA;dilatative
1169;elective surgery;C0206058;NA;NA;elective surgery
1169;elective procedure;C0747973;NA;NA;elective procedure
1168;normotensive ( n = $nmbr$ );C2712122;NA;NA;normotensive n $nmbr$
1167;non - extensive;"C0205231;C1518422";NA;NA;non extensive
1167;extensive  n ( % );C0205231;NA;NA;extensive n
1167;extensive;C0205231;NA;NA;extensive
1167;extensive colitis;"C0009319;C0205231;C1963084";FALSE;2063;extensive colitis
1167;extensive colitis  n;"C0009319;C0205231;C1963084";FALSE;2063;extensive colitis n
1167;extensive colitis or pancolitis;"C0009319;C0205231;C0868908;C1963084";FALSE;2063;extensive colitis or pancolitis
1167;no extensive colitis  n;"C0009319;C0205231;C1963084";FALSE;2063;no extensive colitis n
1167;extensive colitisy;C0205231;FALSE;2063;extensive colitisy
1167;extenswe;NA;FALSE; -10;extenswe
1168;anti - hypertensive treatment history  n ( % );"C0019664;C0019665;C0039798;C0087111;C0262512;C0262926;C0432633;C0857121;C1522326;C1533734;C1705169;C1705255;C2004062;C3538994;C3887704";FALSE;1579;anti hypertensive treatment history n
1168;use of anti - hypertensive agents  n ( % ) *;"C0432633;C0450442;C0857121;C1254351;C1521826;C1524063";FALSE;1579;use of anti hypertensive agents n
1168;hypertensive;C0857121;FALSE;1364;hypertensive
1168;hypertensive  n ( % );C0857121;FALSE;1364;hypertensive n
1169;elective peripheral revascularization;"C0205100;C0206058;C0439608;C0581603";FALSE;2064;elective peripheral revascularization
1170;mycophenolate ( any derivative );"C0883242;C1527240";FALSE; 304;mycophenolate any derivative
1171;sulphonamides  urea derivatives;"C0038760;C0041942;C0243072";FALSE;2065;sulphonamides urea derivatives
1175;glycated hemoglobin level;C0202054;FALSE;1176;glycated hemoglobin level
1175;glycated hemoglobin  nonstandardized level — %;C0202054;FALSE;1176;glycated hemoglobin nonstandardized level
1175;glycohemoglobin  %;"C0202054;C0696092";FALSE;1176;glycohemoglobin
1175;glycohemoglobin  %  mean ( sd );"C0202054;C0444504;C0696092;C2347634;C2348143;C2699239";FALSE;1176;glycohemoglobin mean sd
1177;glyeated haemoglobin;C0019046;FALSE;1176;glyeated haemoglobin
1178;for baseline hemoglobin < $nmbr$ g $nmbr$ ';"C0168634;C1319312;C1442488";FALSE;1177;for baseline hemoglobin $nmbr$ g $nmbr$
1178;hemoglobin  g $nmbr$ $nmbr$;C1319312;FALSE;1177;hemoglobin g $nmbr$ $nmbr$
1178;for baseline hemoglobin $nmbr$ g $nmbr$ ’;"C0168634;C1319312;C1442488";FALSE;1177;for baseline hemoglobin $nmbr$ g $nmbr$
1178;hemoglobin  g / dlf;C1319312;FALSE;1177;hemoglobin g dlf
1178;hemoglobin ( g r $nmbr$ );"C0205090;C0684010;C1319312;C2603358";FALSE;1177;hemoglobin g r $nmbr$
1178;hemoglobin ( g $nmbr$ ! );C1319312;FALSE;1177;hemoglobin g $nmbr$
1179;glycated hemoglobin  n ( % );"C0062408;C3666909";FALSE;1176;glycated hemoglobin n
1179;hemoglobin a $nmbr$ c;"C0019020;C3889898";FALSE;1176;hemoglobin a $nmbr$ c
1179;hemoglobin - a $nmbr$ c ( % ) ' • ■ * *;"C0019020;C3889898";FALSE;1176;hemoglobin a $nmbr$ c
1179;hemoglobin a $nmbr$ c ( % );"C0019020;C3889898";FALSE;1176;hemoglobin a $nmbr$ c
1179;hemoglobin a $nmbr$ c  %;"C0019020;C3889898";FALSE;1176;hemoglobin a $nmbr$ c
1165;ezetimibe  n ( % );C1142985;NA;NA;ezetimibe n
1165;ezetimibe;C1142985;NA;NA;ezetimibe
1164;sensitive responders ( n = $nmbr$ );"C0020517;C0332324;C1522640";NA;NA;sensitive responders n $nmbr$
1164;sensitive responder ( n = $nmbr$ );"C0020517;C0332324;C1522640";NA;NA;sensitive responder n $nmbr$
1164;sensitive;"C0020517;C0332324;C1522640";NA;NA;sensitive
1164;hypersensitivity  n ( % );"C0020517;C0520946";NA;NA;hypersensitivity n
1164;highly sensitive responders ( n = $nmbr$ );C0439822;NA;NA;highly sensitive responders n $nmbr$
1164;highly sensitive responder ( n = $nmbr$ );C0439822;NA;NA;highly sensitive responder n $nmbr$
1164;highly sensitive;C0439822;NA;NA;highly sensitive
1163;troponin positive ( n = $nmbr$ );"C0041199;C0439178;C1446409;C1514241;C2825490;C3812269";NA;NA;troponin positive n $nmbr$
1163;shared epitope  a % positive;"C0003316;C0237876;C0439178;C1446409;C1514241;C1522138;C2825490;C3812269";NA;NA;shared epitope a positive
1163;positive vs . negative;"C0205160;C0439178;C1446409;C1513916;C1514241;C2825415;C2825490;C2825491;C3812269;C3853545";NA;NA;positive vs negative
1163;positive troponin i or t  no . ( % );"C0077401;C0439178;C1446409;C1514241;C2603360;C2825490;C3812269";NA;NA;positive troponin i or t no
1163;positive ctnl ( n = $nmbr$ );"C0439178;C1446409;C1514241;C2825490;C3812269";NA;NA;positive ctnl n $nmbr$
1163;positive atopic status;"C0392707;C0439178;C0449438;C1446409;C1514241;C2825490;C3812269";NA;NA;positive atopic status
1163;positive;"C0439178;C1446409;C1514241;C2825490;C3812269";NA;NA;positive
1163;low complement / anti - dsdna positive ( n = $nmbr$ );"C0012854;C0311474;C0432633;C0439178;C1446409;C1514241;C2825490;C3812269;C3897137";NA;NA;low complement anti dsdna positive n $nmbr$
1163;hla - b $nmbr$ positive at baseline  n ( % );"C0019737;C0168634;C0439178;C0550853;C1415561;C1442488;C1446409;C1514241;C2825490;C3812269";NA;NA;hla b $nmbr$ positive at baseline n
1163;hla - b $nmbr$ positive  n ( % );"C0439178;C1426226;C1446409;C1514241;C2825490;C3812269";NA;NA;hla b $nmbr$ positive n
1163;anti - dsdna positive;"C0439178;C0741099;C1446409;C1514241;C2825490;C3812269";NA;NA;anti dsdna positive
1163;angina or positive stress test;"C0002962;C0015260;C0439178;C1446409;C1514241;C2825490;C3494508;C3812269";NA;NA;angina or positive stress test
1163;age is > $nmbr$ vrs  significant ecg changes  and positive biomarkers;"C0001779;C0005516;C0237881;C0439178;C0458261;C0750502;C0855329;C1446409;C1514241;C1546944;C2825490;C3273608;C3812269";NA;NA;age is $nmbr$ vrs significant ecg changes and positive biomarkers
1163;* * positive stress test;"C0015260;C0439178;C1446409;C1514241;C2825490;C3494508;C3812269";NA;NA;positive stress test
1162;furosemide equivalent  mg / kg;"C0016860;C0205163;C0439185;C0439272";NA;NA;furosemide equivalent mg kg
1162;furosemide;C0016860;NA;NA;furosemide
1161;glucosamine + chondroitin sulfate ( n = $nmbr$ );"C0008454;C0008466;C0017718;C0017720;C0038720;C0474702;C0475337;C0876712;C3536965";NA;NA;glucosamine chondroitin sulfate n $nmbr$
1161;glucosamine ( n = $nmbr$ );C0017718;NA;NA;glucosamine n $nmbr$
1161;glucosamine;C0017718;NA;NA;glucosamine
1160;bumetanide;C0006376;NA;NA;bumetanide
1160;budesonide — no . ( % );C0054201;NA;NA;budesonide no
1160;budesonide { symptom days a week );"C0054201;C0332174;C0439228;C0439230;C1457887;C3854129";NA;NA;budesonide symptom days a week
1160;budesonide mmx $nmbr$ mg  ( n = $nmbr$ );"C0024671;C0026410;C0054201;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;budesonide mmx $nmbr$ mg n $nmbr$
1160;budesonide ( symptom days a week );"C0054201;C0332174;C0439228;C0439230;C1457887;C3854129";NA;NA;budesonide symptom days a week
1160;budesonide ( n = $nmbr$ );C0054201;NA;NA;budesonide n $nmbr$
1160;budesonide $nmbr$ ^ g ( n = $nmbr$ );"C0054201;C0439267";NA;NA;budesonide $nmbr$ g n $nmbr$
1160;budesonide  n ( % );C0054201;NA;NA;budesonide n
1160;budesonide;C0054201;NA;NA;budesonide
1159;budesonide - formoterol ( n = $nmbr$ );C1276807;NA;NA;budesonide formoterol n $nmbr$
1159;budesonide - formoterol $nmbr$ ^ g + $nmbr$ . $nmbr$ ^ g ( n = $nmbr$ );"C1276807;C1319635";NA;NA;budesonide formoterol $nmbr$ g $nmbr$ $nmbr$ g n $nmbr$
1159;budesonide - formoterol $nmbr$ + $nmbr$ . $nmbr$ ^ g ( n = $nmbr$ );"C0439267;C1276807";NA;NA;budesonide formoterol $nmbr$ $nmbr$ $nmbr$ g n $nmbr$
1159;budesonide - budesonide / formoterol;C1276807;NA;NA;budesonide budesonide formoterol
 -10;leflunomide;C0063041;NA;NA;leflunomide
1157;glinide 一 no . ( % );C2266929;NA;NA;glinide no
1157;glinide;C2266929;NA;NA;glinide
1123;rca;NA;NA;NA;rca
1165;statin + ezetimibe { n = $nmbr$  $nmbr$ );"C0360714;C1142985";FALSE;1862;statin ezetimibe n $nmbr$ $nmbr$
1165;statin or ezetimibe;"C0360714;C1142985";FALSE;1862;statin or ezetimibe
1165;statins / ezetimibe;"C0360714;C1142985";FALSE;1862;statins ezetimibe
1165;statin with ezetimibe;"C0360714;C1142985";FALSE;1862;statin with ezetimibe
1156;nateglinide and repaglinide;"C0246689;C0903898";FALSE;2047;nateglinide and repaglinide
1156;nateglinide n / n;C0903898;FALSE;2047;nateglinide n n
1156;nateglinide ( n = $nmbr$ );C0903898;FALSE;2047;nateglinide n $nmbr$
1157;flecainide;C0016229;FALSE;2048;flecainide
1161;lacosamide;C0893761;FALSE;2049;lacosamide
1162;torsemide;C0076840;FALSE;2050;torsemide
1163;rheumatoid factor and acpa positive;"C0035448;C0201660;C0439178;C1446409;C1514241;C1525410;C1706063;C2825490;C3812269";FALSE;2059;rheumatoid factor and acpa positive
1163;rheumatoid factor or acpa positive  or both;"C0035448;C0201660;C0439178;C1446409;C1514241;C1525410;C1706063;C2825490;C3812269";FALSE;2059;rheumatoid factor or acpa positive or both
1163;acpa positive;"C0439178;C1446409;C1514241;C1525410;C1706063;C2825490;C3812269";FALSE;2051;acpa positive
1163;acpa positive  %;"C0439178;C1446409;C1514241;C1525410;C1706063;C2825490;C3812269";FALSE;2051;acpa positive
1163;acpa positive  n ( % );"C0439178;C1446409;C1514241;C1525410;C1706063;C2825490;C3812269";FALSE;2051;acpa positive n
1163;anticyclic citrullinated peptide positive ^  n ( % );"C0439178;C1320283;C1446409;C1514241;C2825490;C3812269";FALSE; 360;anticyclic citrullinated peptide positive n
1163;anti - ccp positive;"C0439178;C1446409;C1514241;C2825490;C3812269;C4318437";FALSE; 360;anti ccp positive
1163;anti - ccp positive ( > $nmbr$ u / ml )  n ( % );"C0432633;C0439178;C0439340;C1446409;C1514241;C1525410;C1704514;C1880521;C2825490;C2945590;C3812269";FALSE; 360;anti ccp positive $nmbr$ u ml n
1163;rf or acpa positive;"C0035448;C0201660;C0439178;C0748398;C1446409;C1514241;C1525410;C1547111;C1706063;C2825490;C3812269";FALSE;2059;rf or acpa positive
1163;rheumatoid factor positive;"C0035448;C0201660;C0439178;C1446409;C1514241;C2825490;C3812269";FALSE;2060;rheumatoid factor positive
1163;rheumatoid factor positive §  n ( % );"C0035448;C0201660;C0439178;C1446409;C1514241;C2825490;C3812269";FALSE;2060;rheumatoid factor positive n
1163;gad positive — no . ( % ) ^;"C0270549;C0439178;C1414925;C1446409;C1514241;C2825490;C3812269";FALSE;2061;gad positive no
1163;anti - gad positive ( n = $nmbr$ );"C0270549;C0432633;C0439178;C1414925;C1446409;C1514241;C2825490;C3812269";FALSE;2061;anti gad positive n $nmbr$
1163;anti - gad positive;"C0270549;C0439178;C1414925;C1446409;C1514241;C2825490;C3812269";FALSE;2061;anti gad positive
1163;positive for rheumatoid factor  anti - cyclic citrullinated peptide antibodies  or both — % ff;"C0003241;C0035448;C0201660;C0439178;C0439596;C0741132;C1320283;C1446409;C1511572;C1514241;C2825490;C3812269;C4505301;C4554348";FALSE;2062;positive for rheumatoid factor anti cyclic citrullinated peptide antibodies or both ff
1156;meglitinides ( glinides );"C0065880;C1579432;C3537178";NA;NA;meglitinides glinides
1156;meglitinide;C0065880;NA;NA;meglitinide
1155;placebo + glimepiride;"C0032042;C0061323;C1696465;C1706408";NA;NA;placebo glimepiride
1155;glimepiride;C0061323;NA;NA;glimepiride
1154;fasting c - peptide ( nmol / l ) c;"C0006558;C0015663;C0439282";NA;NA;fasting c peptide nmol l c
1154;c peptide  nmol / l * ';"C0006558;C0439282";NA;NA;c peptide nmol l
1154;c - peptide tx difference vs pbo  median change from baseline ( se ) $nmbr$;"C0006558;C0031962;C0036919;C0041403;C0168634;C0392747;C0443172;C0549183;C0876920;C1442488;C1705241;C1705242;C2347635;C2348144;C2939193;C4319952";NA;NA;c peptide tx difference vs pbo median change from baseline se $nmbr$
1154;c - peptide;C0006558;NA;NA;c peptide
1153;glucagon - like peptide - $nmbr$ receptor agonist;"C0014361;C4543206";NA;NA;glucagon like peptide $nmbr$ receptor agonist
1153;glucagon - like peptide - $nmbr$ agonist;"C0014361;C2987634";NA;NA;glucagon like peptide $nmbr$ agonist
1152;b - blockers at baseline;"C0168634;C1442488";NA;NA;b blockers at baseline
1152;( $nmbr$ - blockers;NA;NA;NA;$nmbr$ blockers
1151;lc  n = $nmbr$;NA;NA;NA;lc n $nmbr$
1150;muscle twitching;"C0015644;C0231530";NA;NA;muscle twitching
1150;muscle spasms;C0037763;NA;NA;muscle spasms
1149;val / hctz ( n = $nmbr$ );"C0020261;C0042285;C0523975";NA;NA;val hctz n $nmbr$
1149;v alsartan / hctz  n ( % );C0020261;NA;NA;v alsartan hctz n
1149;v / hctz ( n = $nmbr$ );C0020261;NA;NA;v hctz n $nmbr$
1149;v / hctz;C0020261;NA;NA;v hctz
1149;telmisartan / amlodipine - telmisartan / amlodipine / hydrochlorothiazide;"C0020261;C0051696;C0939233;C2733369";NA;NA;telmisartan amlodipine telmisartan amlodipine hydrochlorothiazide
1149;om $nmbr$ mg / hctz $nmbr$ mg ( n = $nmbr$ );"C0020261;C0028971;C1319635;C1705272";NA;NA;om $nmbr$ mg hctz $nmbr$ mg n $nmbr$
1149;om $nmbr$ mg / hctz $nmbr$ mg;"C0020261;C0028971;C1319635;C1705272";NA;NA;om $nmbr$ mg hctz $nmbr$ mg
1149;om $nmbr$ mg + aml $nmbr$ mg + hctz $nmbr$ mg;"C0020261;C0023465;C0023467;C0028971;C1319635;C1705272";NA;NA;om $nmbr$ mg aml $nmbr$ mg hctz $nmbr$ mg
1149;om $nmbr$ / aml $nmbr$ / hctz $nmbr$ mg;"C0020261;C0023465;C0023467;C0024671;C0026410;C0028971;C0439269;C1705272;C1960952;C2346927;C4321396;C4521761";NA;NA;om $nmbr$ aml $nmbr$ hctz $nmbr$ mg
1149;om $nmbr$ / aml $nmbr$ / hctz $nmbr$ . $nmbr$ mg *;"C0020261;C0023465;C0023467;C0024671;C0026410;C0028971;C0439269;C1705272;C1960952;C2346927;C4321396;C4521761";NA;NA;om $nmbr$ aml $nmbr$ hctz $nmbr$ $nmbr$ mg
1149;om $nmbr$ / aml $nmbr$ / hctz $nmbr$ . $nmbr$ mg;"C0020261;C0023465;C0023467;C0024671;C0026410;C0028971;C0439269;C1705272;C1960952;C2346927;C4321396;C4521761";NA;NA;om $nmbr$ aml $nmbr$ hctz $nmbr$ $nmbr$ mg
1149;olmesartan medoxomil $nmbr$ mg / hctz $nmbr$ . $nmbr$ mg ( n = $nmbr$ );"C0020261;C0386393;C1319635";NA;NA;olmesartan medoxomil $nmbr$ mg hctz $nmbr$ $nmbr$ mg n $nmbr$
1149;olmesartan $nmbr$ - olmesartan $nmbr$ / hydrochlorothiazide $nmbr$ . $nmbr$;"C0020261;C1098320";NA;NA;olmesartan $nmbr$ olmesartan $nmbr$ hydrochlorothiazide $nmbr$ $nmbr$
1149;hydrochlorothiazide;C0020261;NA;NA;hydrochlorothiazide
1149;hydochlorothiazide ( n = $nmbr$ );NA;NA;NA;hydochlorothiazide n $nmbr$
1149;hctz = hydrochlorothiazide . * based on wilcoxon $nmbr$ - sample rank - sum tests for age and body mass index  t tests for systolic and diastolic blood and ' / $nmbr$ tests for categorical variables . t data were missing for some patients .;"C0001779;C0005767;C0005768;C0005893;C0012000;C0020261;C0022885;C0030705;C0039155;C0039593;C0229664;C0242931;C0370003;C0392366;C0439828;C0456984;C0578022;C0871472;C1305855;C1515051;C1515976;C1527178;C1551393;C1705492;C1705938;C2347026;C3272743;C3831328;C4318744;C4684582";NA;NA;hctz hydrochlorothiazide based on wilcoxon $nmbr$ sample rank sum tests for age and body mass index t tests for systolic and diastolic blood and $nmbr$ tests for categorical variables t data were missing for some patients
   7;p - value for trend *;"C1521798;C1709380;C4554533";NA;NA;p value for trend
   7;p - value for interaction *;"C1704675;C1709380";NA;NA;p value for interaction
   7;p - value for interaction $nmbr$ :;"C1704675;C1709380";NA;NA;p value for interaction $nmbr$
1149;hctz = hydrochlorothiazide . * based on a ' / _ $nmbr$ test  t data were missing for some patients .;"C0020261;C0022885;C0030705;C0039593;C0242356;C0392366;C0456984;C0993637;C1515976;C1551393;C1705492;C3272743;C3831328;C4318744";NA;NA;hctz hydrochlorothiazide based on a _ $nmbr$ test t data were missing for some patients
1149;hctz - hydrochlorothiazide . * data were missing for some patients .;"C0020261;C0030705;C1511726;C1551393;C1705492;C3245479;C3272743;C3714741";NA;NA;hctz hydrochlorothiazide data were missing for some patients
1149;hctz * ( n = $nmbr$ );C0020261;NA;NA;hctz n $nmbr$
1149;hctz *;C0020261;NA;NA;hctz
1149;hctz;C0020261;NA;NA;hctz
1149;aml / hctz ( n = $nmbr$ );"C0020261;C0023465;C0023467";NA;NA;aml hctz n $nmbr$
1149;aml $nmbr$ mg / hctz $nmbr$ mg;"C0020261;C0023465;C0023467;C1319635";NA;NA;aml $nmbr$ mg hctz $nmbr$ mg
1149;aml $nmbr$ mg + hctz $nmbr$ mg ( n = $nmbr$ );"C0020261;C0023465;C0023467;C1319635";NA;NA;aml $nmbr$ mg hctz $nmbr$ mg n $nmbr$
1149;aml $nmbr$ mg + hctz $nmbr$ mg;"C0020261;C0023465;C0023467;C1319635";NA;NA;aml $nmbr$ mg hctz $nmbr$ mg
1148;coping;C0009967;NA;NA;coping
1147;smoking history — no . ( % );C1519384;NA;NA;smoking history no
1147;smoking history ( ever );"C1519384;C3887636";NA;NA;smoking history ever
1147;smoking history    n   ( % );C1519384;NA;NA;smoking history n
1147;smoking history  r ( % );"C0205090;C0684010;C1519384;C2603358";NA;NA;smoking history r
1147;smoking history  n ( % );C1519384;NA;NA;smoking history n
1147;smoking history;C1519384;NA;NA;smoking history
1147;history of smoking;C1519384;NA;NA;history of smoking
1146;walking;"C0080331;C4283795;C4321241;C4321242";NA;NA;walking
1146;some walking;"C0080331;C4283795;C4321241;C4321242";NA;NA;some walking
1146;physical activity ( hours walking / wk );"C0015259;C0026606;C0080331;C0332174;C0439227;C0439230;C4283795;C4321241;C4321242";NA;NA;physical activity hours walking wk
1145;other or missing data;C4684714;NA;NA;other or missing data
1145;missing data — no . / total no . ( % );"C0439175;C0439810;C4684714";NA;NA;missing data no total no
1145;missing data;C4684714;NA;NA;missing data
1144;unknown or missing;"C0439673;C1551393;C1705492;C3272743;C3541433;C4050014";NA;NA;unknown or missing
1144;unknown / missing;"C0439673;C1551393;C1705492;C3272743;C3541433;C4050014";NA;NA;unknown missing
1144;other / missing;"C1551393;C1705492;C3272743";NA;NA;other missing
1144;missing hb at yr $nmbr$;"C0019046;C0439234;C1551393;C1705492;C3272743";NA;NA;missing hb at yr $nmbr$
1144;missing *;"C1551393;C1705492;C3272743";NA;NA;missing
1144;missing  n ( % ) a;"C1551393;C1705492;C3272743";NA;NA;missing n a
1144;missing;"C1551393;C1705492;C3272743";NA;NA;missing
1148;morning;C0332170;FALSE;2043;morning
1150;nsclc;C0007131;FALSE;2044;nsclc
1151;baseline hbalc > $nmbr$ % to < $nmbr$ %;"C0168634;C1442488";FALSE;1176;baseline hbalc $nmbr$ to $nmbr$
1151;hbalc > $nmbr$ %;NA;FALSE;1176;hbalc $nmbr$
1151;baseline ldl - c > $nmbr$ . $nmbr$ to < $nmbr$ . $nmbr$ mmol / lc;"C0168634;C0439190;C1442488";FALSE;1068;baseline ldl c $nmbr$ $nmbr$ to $nmbr$ $nmbr$ mmol lc
1151;baseline ldl - c $nmbr$ . $nmbr$ to < $nmbr$ . $nmbr$ mmol / lc;"C0168634;C0439190;C1442488";FALSE;1068;baseline ldl c $nmbr$ $nmbr$ to $nmbr$ $nmbr$ mmol lc
1152;hscrp;NA;FALSE; 286;hscrp
1152;hscrp at baseline;"C0168634;C1442488";FALSE; 286;hscrp at baseline
1155;eduglinozin $nmbr$ mg vs placebo / glimepiride;"C0024671;C0026410;C0032042;C0061323;C0439269;C1696465;C1706408;C1960952;C2346927;C4321396;C4521761";FALSE;2045;eduglinozin $nmbr$ mg vs placebo glimepiride
1155;glipizide;C0017642;FALSE;2046;glipizide
1155;glipizide ( n = $nmbr$ );C0017642;FALSE;2046;glipizide n $nmbr$
1144;data missing or no drug given;"C0013227;C1254351;C1442162;C1511726;C1550718;C1551393;C1705492;C1947971;C3244317;C3245479;C3272743;C3714741";NA;NA;data missing or no drug given
1144;data missing;"C1511726;C1551393;C1705492;C3245479;C3272743;C3714741";NA;NA;data missing
1143;fibrinolysist;NA;NA;NA;fibrinolysist
1143;fibrinolysis ( n = $nmbr$ );"C0016017;C1305868";NA;NA;fibrinolysis n $nmbr$
1142;fibrinogen ( pmol / l ) c;"C0016006;C0439284;C1167394;C2587184;C3540039";NA;NA;fibrinogen pmol l c
1142;fibrinogen  g / l;"C0016006;C0439294;C0456615;C1167394;C2587184;C3540039";NA;NA;fibrinogen g l
1142;fibrinogen;"C0016006;C1167394;C2587184;C3540039";NA;NA;fibrinogen
1141;inclusion findings ( % );"C0007637;C1512693;C2607943;C2926606;C3539655";NA;NA;inclusion findings
1141;additional radiographic findings at week $nmbr$;"C0332174;C0439230;C0444708;C1524062;C2607943;C2926606;C3539655";NA;NA;additional radiographic findings at week $nmbr$
1140;swollen joints ( $nmbr$ - joint count )  mean ± sd;"C0444504;C0451521;C2347634;C2348143;C2699239";NA;NA;swollen joints $nmbr$ joint count mean sd
1140;swollen joint count of $nmbr$ joints;C0451521;NA;NA;swollen joint count of $nmbr$ joints
1140;swollen joint count ( range $nmbr$ - $nmbr$ joints );"C0451521;C1514721;C2348147;C3542016";NA;NA;swollen joint count range $nmbr$ $nmbr$ joints
1140;swollen joint count ( n / $nmbr$ );C0451521;NA;NA;swollen joint count n $nmbr$
1140;swollen joint count ( $nmbr$ — $nmbr$  per swollen joint );C0451521;NA;NA;swollen joint count $nmbr$ $nmbr$ per swollen joint
1140;swollen joint count ( $nmbr$ – $nmbr$ joints )  mean ( sd );"C0444504;C0451521;C2347634;C2348143;C2699239";NA;NA;swollen joint count $nmbr$ $nmbr$ joints mean sd
1140;swollen joint count ( $nmbr$ joints )  mean ( sd ) ’;"C0444504;C0451521;C2347634;C2348143;C2699239";NA;NA;swollen joint count $nmbr$ joints mean sd
1140;swollen joint count ( $nmbr$ joints )  mean ( sd );"C0444504;C0451521;C2347634;C2348143;C2699239";NA;NA;swollen joint count $nmbr$ joints mean sd
1140;swollen joint count ( $nmbr$ joints );C0451521;NA;NA;swollen joint count $nmbr$ joints
1140;swollen joint count ( $nmbr$ - $nmbr$ possible joints );"C0332149;C0451521;C1705910;C2362652";NA;NA;swollen joint count $nmbr$ $nmbr$ possible joints
1140;swollen joint count ( $nmbr$ - $nmbr$ joints );C0451521;NA;NA;swollen joint count $nmbr$ $nmbr$ joints
1140;swollen joint count ( $nmbr$ - $nmbr$ );C0451521;NA;NA;swollen joint count $nmbr$ $nmbr$
1140;swollen joint count ( $nmbr$ )  mean ( sd );"C0444504;C0451521;C2347634;C2348143;C2699239";NA;NA;swollen joint count $nmbr$ mean sd
1140;swollen joint count  of $nmbr$;C0451521;NA;NA;swollen joint count of $nmbr$
1140;swollen joint count;C0451521;NA;NA;swollen joint count
1140;swollen - joint count ( of $nmbr$ joints assessed ) — no .;"C0451521;C1516048";NA;NA;swollen joint count of $nmbr$ joints assessed no
1140;swollen - joint count ( of $nmbr$ joints );C0451521;NA;NA;swollen joint count of $nmbr$ joints
1140;swollen - joint count  of $nmbr$ joints examined;"C0332128;C0451521";NA;NA;swollen joint count of $nmbr$ joints examined
1140;mean ( sd ) swollen joint count *;"C0444504;C0451521;C2347634;C2348143;C2699239";NA;NA;mean sd swollen joint count
1139;tender joints ( $nmbr$ - joint count )  mean ± sd;"C0444504;C0451530;C2347634;C2348143;C2699239";NA;NA;tender joints $nmbr$ joint count mean sd
1139;tender joint count of $nmbr$ joints;C0451530;NA;NA;tender joint count of $nmbr$ joints
1139;tender joint count ( range $nmbr$ - $nmbr$ joints );"C0451530;C1514721;C2348147;C3542016";NA;NA;tender joint count range $nmbr$ $nmbr$ joints
1139;tender joint count ( $nmbr$ – $nmbr$ joints )  mean ( sd );"C0444504;C0451530;C2347634;C2348143;C2699239";NA;NA;tender joint count $nmbr$ $nmbr$ joints mean sd
1139;tender joint count ( $nmbr$ joints )  mean ( sd ) ’;"C0444504;C0451530;C2347634;C2348143;C2699239";NA;NA;tender joint count $nmbr$ joints mean sd
1139;tender joint count ( $nmbr$ joints )  mean ( sd );"C0444504;C0451530;C2347634;C2348143;C2699239";NA;NA;tender joint count $nmbr$ joints mean sd
1139;tender joint count ( $nmbr$ joints );C0451530;NA;NA;tender joint count $nmbr$ joints
1139;tender joint count ( $nmbr$ - $nmbr$ joints );C0451530;NA;NA;tender joint count $nmbr$ $nmbr$ joints
1139;tender joint count ( $nmbr$ - $nmbr$ );C0451530;NA;NA;tender joint count $nmbr$ $nmbr$
1139;tender joint count ( $nmbr$ - $nmbr$  per tender joint );C0451530;NA;NA;tender joint count $nmbr$ $nmbr$ per tender joint
1139;tender joint count ( $nmbr$ )  mean ( sd );"C0444504;C0451530;C2347634;C2348143;C2699239";NA;NA;tender joint count $nmbr$ mean sd
1139;tender joint count  of $nmbr$;C0451530;NA;NA;tender joint count of $nmbr$
1139;tender joint count;C0451530;NA;NA;tender joint count
1139;tender - joint count ( of $nmbr$ joints );C0451530;NA;NA;tender joint count of $nmbr$ joints
1139;tender - joint count  of $nmbr$ joints examined;"C0332128;C0451530";NA;NA;tender joint count of $nmbr$ joints examined
1139;mean ( sd ) tender joint count *;"C0444504;C0451530;C2347634;C2348143;C2699239";NA;NA;mean sd tender joint count
1138;tender and swollen joints — mean no . : :;"C0152031;C0234234;C0444504;C2347634;C2348143";NA;NA;tender and swollen joints mean no
1138;joint swelling  effusion  or both on clinical examination — no . ( % );"C0013604;C0013687;C0031809;C0038999;C0152031;C1253936;C1963136;C2317432;C4554335";NA;NA;joint swelling effusion or both on clinical examination no
1138;joint swelling  effusion  or both on clinical examination;"C0013604;C0013687;C0031809;C0038999;C0152031;C1253936;C1963136;C2317432;C4554335";NA;NA;joint swelling effusion or both on clinical examination
1138;joint swelling;C0152031;NA;NA;joint swelling
1143;post - fibrinolysis angioplasty ( n = $nmbr$ );"C0016017;C0162577;C0687676;C1305868;C1548817;C1704687;C3469826";FALSE;1722;post fibrinolysis angioplasty n $nmbr$
1137;tjc ( / $nmbr$ joints );"C0022417;C0392905";FALSE;1139;tjc $nmbr$ joints
1137;tjc ( $nmbr$ joints );"C0022417;C0392905";FALSE;1139;tjc $nmbr$ joints
1137;tjc ( $nmbr$ joints )  mean ( sd );"C0022417;C0392905;C0444504;C2347634;C2348143;C2699239";FALSE;1139;tjc $nmbr$ joints mean sd
1138;swollen joints > $nmbr$  n ( % );C0152031;FALSE;1140;swollen joints $nmbr$ n
1141;ecg findings;C0438154;FALSE;1129;ecg findings
1141;ecg findings at baseline — no . ( % );"C0168634;C0438154;C1442488";FALSE;1129;ecg findings at baseline no
1141;electrocardiographic findings at randomization;"C0034656;C0438154";FALSE;1129;electrocardiographic findings at randomization
1141;electrocardiographic findings — no . ( % );C0438154;FALSE;1129;electrocardiographic findings no
1141;angiographic findings | |;"C0002978;C2607943;C2926606;C3539655";FALSE;1723;angiographic findings
1136;patients with end point;"C0030705;C2349179;C2826544";NA;NA;patients with end point
1136;other prespecified end points;C2349179;NA;NA;other prespecified end points
1136;other end points;C2349179;NA;NA;other end points
1136;mean change in radiographic end points;"C0392747;C0443172;C0444504;C0444708;C1705241;C2347634;C2348143;C2349179;C4319952";NA;NA;mean change in radiographic end points
1136;main accord endpoint;"C0205225;C0680240;C1542147;C2349179;C2826544";NA;NA;main accord endpoint
1136;endpoints;C2349179;NA;NA;endpoints
1136;endpointc;NA;NA;NA;endpointc
1136;endpoint rate;"C0871208;C1521828;C2349179;C2826544";NA;NA;endpoint rate
1136;endpoint *;"C2349179;C2826544";NA;NA;endpoint
1136;endpoint;"C2349179;C2826544";NA;NA;endpoint
1136;end points;C2349179;NA;NA;end points
1136;end point;"C2349179;C2826544";NA;NA;end point
1136;end - point ( sd );"C2349179;C2699239;C2826544";NA;NA;end point sd
1136;combined end points;"C0205195;C2349179";NA;NA;combined end points
1136;combined end point;"C0205195;C2349179;C2826544";NA;NA;combined end point
1136;additional endpoints;"C1524062;C2349179";NA;NA;additional endpoints
1135;oct center point thickness  pm;"C0030266;C0205099;C1280412;C1552961;C2347617;C3714763;C3810851;C3828732;C4049155";NA;NA;oct center point thickness pm
1135;mean change from baseline  % ‐ points;"C0168634;C0392747;C0443172;C0444504;C1442488;C1552961;C1705241;C2347617;C2347634;C2348143;C3714763;C4319952";NA;NA;mean change from baseline points
1135;( points );"C1552961;C2347617;C3714763";NA;NA;points
1134;time point;C2348792;NA;NA;time point
1134;pint;"C0560012;C3811619;C3890014;C3890556";NA;NA;pint
1134;p value ( vs . previous time point );"C0205156;C1552607;C1709380;C2348792";NA;NA;p value vs previous time point
1133;post erior - anterior spine;"C0037949;C0205094;C0687676;C1704687;C2752558;C3469826";NA;NA;post erior anterior spine
1132;£ $nmbr$ m b ' m in;C1709500;NA;NA;$nmbr$ m b m in
1132;ppci in - $nmbr$;NA;NA;NA;ppci in $nmbr$
1132;pain in extremity;"C0030196;C4553007";NA;NA;pain in extremity
1132;in - h;"C0033727;C0369286;C0441932;C0564385;C4528284";NA;NA;in h
1131;“ on ” without troublesome dyskinesia;C0013384;NA;NA;on without troublesome dyskinesia
1131;“ on ” with troublesome dyskinesia;C0013384;NA;NA;on with troublesome dyskinesia
1131;absolute time spent “ on ” without troublesome dyskinesia  h / day;"C0013384;C0033727;C0332173;C0369286;C0439228;C0439505;C0439546;C0441932;C0564385;C0680968;C4528284";NA;NA;absolute time spent on without troublesome dyskinesia h day
1131;absolute time spent “ on ” with troublesome dyskinesia  h / day;"C0013384;C0033727;C0332173;C0369286;C0439228;C0439505;C0439546;C0441932;C0564385;C0680968;C4528284";NA;NA;absolute time spent on with troublesome dyskinesia h day
1130;etoricoxib dose;"C0178602;C0869039;C0972314;C1114758";NA;NA;etoricoxib dose
1130;etoricoxib ( n = $nmbr$ );C0972314;NA;NA;etoricoxib n $nmbr$
1130;etoricoxib ( n = $nmbr$ $nmbr$ );C0972314;NA;NA;etoricoxib n $nmbr$ $nmbr$
1130;etoricoxib ( n = $nmbr$  $nmbr$ );C0972314;NA;NA;etoricoxib n $nmbr$ $nmbr$
1130;etoricoxib $nmbr$ mg n = $nmbr$ n ( % );"C0024671;C0026410;C0439269;C0972314;C1960952;C2346927;C4321396;C4521761";NA;NA;etoricoxib $nmbr$ mg n $nmbr$ n
1130;etoricoxib $nmbr$ mg ( n $nmbr$ $nmbr$ )  . . n . . . ( . % . . ) . . . . . . . . . . . . .;"C0024671;C0026410;C0439269;C0972314;C1960952;C2346927;C4321396;C4521761";NA;NA;etoricoxib $nmbr$ mg n $nmbr$ $nmbr$ n
1130;etoricoxib $nmbr$ mg ( n $nmbr$ $nmbr$ )  . . n . . . ( . % . . ) . . . . . . . . . . . .;"C0024671;C0026410;C0439269;C0972314;C1960952;C2346927;C4321396;C4521761";NA;NA;etoricoxib $nmbr$ mg n $nmbr$ $nmbr$ n
   7;p - value for interaction $nmbr$ . $nmbr$;"C1704675;C1709380";NA;NA;p value for interaction $nmbr$ $nmbr$
1130;etoricoxib $nmbr$ mg ( n $nmbr$ $nmbr$ )  . . . n . . . ( . % . . ) . . . . . . . . . . .;"C0024671;C0026410;C0439269;C0972314;C1960952;C2346927;C4321396;C4521761";NA;NA;etoricoxib $nmbr$ mg n $nmbr$ $nmbr$ n
1130;etoricoxib $nmbr$ mg ( n $nmbr$ $nmbr$ )  . . . n . . ( . % . . ) . . . . . . . . . . . .;"C0024671;C0026410;C0439269;C0972314;C1960952;C2346927;C4321396;C4521761";NA;NA;etoricoxib $nmbr$ mg n $nmbr$ $nmbr$ n
1130;etoricoxib $nmbr$ mg ( n $nmbr$ $nmbr$ )  . . . n . . ( . % . . ) . . . . . . . . . . .;"C0024671;C0026410;C0439269;C0972314;C1960952;C2346927;C4321396;C4521761";NA;NA;etoricoxib $nmbr$ mg n $nmbr$ $nmbr$ n
1130;etoricoxib $nmbr$ mg  n = $nmbr$  n ( % );"C0024671;C0026410;C0439269;C0972314;C1960952;C2346927;C4321396;C4521761";NA;NA;etoricoxib $nmbr$ mg n $nmbr$ n
1130;etoricoxib;C0972314;NA;NA;etoricoxib
1129;electrocardiography;"C0013798;C1623258";NA;NA;electrocardiography
1129;electrocardiograph results  no . ( % );"C0013798;C0180600;C1274040;C1546471;C1623258;C2825142";NA;NA;electrocardiograph results no
1129;electrocardiogram;"C0013798;C1547122;C1623258";NA;NA;electrocardiogram
1129;ecg abnormality ( resting )  %;"C0035253;C1512899;C1623258;C1704258";NA;NA;ecg abnormality resting
1129;ecg;C1623258;NA;NA;ecg
1128;uc [ gemini $nmbr$ ] ‘;NA;NA;NA;uc gemini $nmbr$
1128;uc;NA;NA;NA;uc
1128;surgical technique;C0683469;NA;NA;surgical technique
1128;other uc - related gi surgical procedure;"C0439849;C0445223;C0543467;C1708130;C3539617;C4050121";NA;NA;other uc related gi surgical procedure
1127;mean bdi focal score ( sd );"C0006448;C0205234;C0451022;C2699239;C3533236;C3714938;C3889415";NA;NA;mean bdi focal score sd
1127;focal;C0205234;NA;NA;focal
1127;bdi focal score $nmbr$;"C0006448;C0205234;C0449820;C0451022;C3714938;C3889415;C4050231";NA;NA;bdi focal score $nmbr$
1127;bdi focal score;"C0006448;C0205234;C0449820;C0451022;C3714938;C3889415;C4050231";NA;NA;bdi focal score
1127;> $nmbr$ % focal seizure frequency responders;"C0149775;C0205234;C0376249;C0439603;C0751495;C0871396;C1561548;C1705502;C3898838;C4321352";NA;NA;$nmbr$ focal seizure frequency responders
 -10;atypical absence;C0595948;NA;NA;atypical absence
1125;topical prescription;"C0033080;C0332237;C1521941";NA;NA;topical prescription
1125;topical non - prescription;"C0033080;C0332237;C1518422;C1521941";NA;NA;topical non prescription
1125;topical;C0332237;NA;NA;topical
 -10;puerto rican;C0034043;NA;NA;puerto rican
1129;lvh by electrocardiogram;"C0013798;C0149721;C1547122;C1623258";FALSE;1496;lvh by electrocardiogram
1130;celecoxib;C0538927;FALSE;2033;celecoxib
1130;celecoxib ( n = $nmbr$ );C0538927;FALSE;2033;celecoxib n $nmbr$
1130;rofecoxib;C0762662;FALSE;2034;rofecoxib
1130;valdecoxib;C0913246;FALSE;2034;valdecoxib
1131;ocn;"C1412791;C2347392";FALSE; -10;ocn
1132;in - stent restenosis;C3272317;FALSE;2035;in stent restenosis
1132;in - stent restenosis of des;"C0011702;C3272317;C4551552";FALSE;2035;in stent restenosis of des
1132;dactylitis in > $nmbr$ digit;C3863761;FALSE; 492;dactylitis in $nmbr$ digit
1132;dapaglifloz . in  n;NA;FALSE;2036;dapaglifloz in n
1133;spine;"C0037949;C2752558";FALSE;2037;spine
1133;spine *;"C0037949;C2752558";FALSE;2037;spine
1136;bleeding end points;"C0019080;C2349179";FALSE;2038;bleeding end points
1136;coronary endpoint;"C0018787;C2349179;C2826544";FALSE;2039;coronary endpoint
1136;coronary end point;"C0018787;C2349179;C2826544";FALSE;2039;coronary end point
1136;all randomized coronary end point;"C0018787;C0034656;C2349179;C2826544;C3815594";FALSE;2039;all randomized coronary end point
1137;sjc ( / $nmbr$ joints );"C0022417;C0392905";FALSE;1140;sjc $nmbr$ joints
1137;sjc ( $nmbr$ joints );"C0022417;C0392905";FALSE;1140;sjc $nmbr$ joints
1137;sjc ( $nmbr$ joints )  mean ( sd );"C0022417;C0392905;C0444504;C2347634;C2348143;C2699239";FALSE;1140;sjc $nmbr$ joints mean sd
1123;$nmbr$ degree of ica stenosis 丰;"C0201519;C4034225";NA;NA;$nmbr$ degree of ica stenosis
1122;primary / key efficacy endpoint;"C1280519;C1707887;C1709665;C2349179;C2826544";NA;NA;primary key efficacy endpoint
1122;peripheral limb vascular efficacy;"C0015385;C0150936;C0947487;C1280519;C1707887";NA;NA;peripheral limb vascular efficacy
1122;overall efficacy;"C0282416;C1280519;C1561607;C1707887";NA;NA;overall efficacy
1122;efficacy variable;"C0439828;C1280519;C1707887;C4553760";NA;NA;efficacy variable
1122;efficacy endpoints *;"C1280519;C1707887;C2349179";NA;NA;efficacy endpoints
1122;efficacy endpoint;"C1280519;C1707887;C2349179;C2826544";NA;NA;efficacy endpoint
1122;efficacy end points;"C1280519;C1707887;C2349179";NA;NA;efficacy end points
1122;efficacy and safety : net adverse clinical events *;"C0036043;C0205210;C0877248;C1280519;C1456447;C1705187;C1705413;C1707887;C3853572;C3887809;C3890893";NA;NA;efficacy and safety net adverse clinical events
1122;efficacy    n   ( % ) a;"C1280519;C1707887";NA;NA;efficacy n a
1122;efficacy;"C1280519;C1707887";NA;NA;efficacy
1122;combined efficacy and safety endpoint;"C0036043;C0205195;C1280519;C1705187;C1707887;C2349179;C2826544";NA;NA;combined efficacy and safety endpoint
 -10;colesevelam ( n = $nmbr$ );C0541155;NA;NA;colesevelam n $nmbr$
1120;the american college of rheumatology ) .;"C0035452;C0557806;C0596070";NA;NA;the american college of rheumatology
1120;some college / tech;"C0557806;C1826596";NA;NA;some college tech
1120;some college;C0557806;NA;NA;some college
1119;volume change  mm ^;"C0392747;C0443172;C0449468;C1690016;C1705102;C1705241;C2700258;C4319952;C4330985;C4554674";NA;NA;volume change mm
1119;voided volume  ml;"C0042034;C0439526;C0449468;C1552835;C1690016;C1705102;C1705224;C2700258;C3887665";NA;NA;voided volume ml
1119;normalized volume measures;"C0079809;C0242485;C0449468;C1690016;C1705102;C1879489;C1882115;C2700258";NA;NA;normalized volume measures
1119;median change in atheroma volume  %;"C0264956;C0392747;C0443172;C0449468;C0549183;C0876920;C1690016;C1705102;C1705241;C2347635;C2348144;C2700258;C2939193;C4319952";NA;NA;median change in atheroma volume
1118;pulse pressure ( mmhg );"C0439475;C0949236";NA;NA;pulse pressure mmhg
1118;pulse pressure ( mm hg );"C0439475;C0949236";NA;NA;pulse pressure mm hg
1118;pulse pressure;C0949236;NA;NA;pulse pressure
1118;mean pulse pressure  mmhg ( s . d . ) “;"C0232117;C0391850;C0444504;C0445074;C0949236;C1947910;C2347155;C2347634;C2348143";NA;NA;mean pulse pressure mmhg s d
1117;sitting pulse  bpma;"C0232117;C0277814;C0391850;C1947910;C2584297;C4050224";NA;NA;sitting pulse bpma
1117;pulse — beats / min;"C0232117;C0391850;C0702093;C1524029;C1947910;C3813700";NA;NA;pulse beats min
1117;pulse ( beats / min ) cholesterol ( mmol / l );"C0008377;C0232117;C0391850;C1947910;C2827896";NA;NA;pulse beats min cholesterol mmol l
1117;pulse  beats / min;"C0232117;C0391850;C0702093;C1524029;C1947910;C3813700";NA;NA;pulse beats min
1116;quality of life;"C0034380;C0518214";NA;NA;quality of life
1116;qol due to urinary symptoms;"C0426359;C0518214;C0678226";NA;NA;qol due to urinary symptoms
1116;qol;C0518214;NA;NA;qol
1116;mean ipss qol ( sd );"C0444504;C0518214;C1019118;C1998280;C2347634;C2348143;C2699239;C2827405;C3811063";NA;NA;mean ipss qol sd
1116;ipss qol ( ls;"C0023668;C0518214;C1019118;C1998280;C2827405;C3811063";NA;NA;ipss qol ls
1116;ipss qol;"C0518214;C1019118;C1998280;C2827405;C3811063";NA;NA;ipss qol
1116;disease and quality - of - life scores  mean ( sd );"C0012634;C0034380;C0444504;C0449820;C0518214;C2347634;C2348143;C2699239;C4050231";NA;NA;disease and quality of life scores mean sd
1116;disease and quality - of - life scores;"C0012634;C0034380;C0449820;C0518214;C4050231";NA;NA;disease and quality of life scores
   7;p - value for interaction;"C1704675;C1709380";NA;NA;p value for interaction
1116;baseline disease and quality - of - life scores;"C0012634;C0034380;C0168634;C0449820;C0518214;C1442488;C4050231";NA;NA;baseline disease and quality of life scores
1115;humerus fracture;C0020162;NA;NA;humerus fracture
1114;pelvic fractures;C0149531;NA;NA;pelvic fractures
1114;hip fracture only;"C0019557;C0149531;C0205171;C1720467;C4552776";NA;NA;hip fracture only
1114;hip fracture + > $nmbr$;"C0019557;C0149531;C4552776";NA;NA;hip fracture $nmbr$
1114;hip fracture;"C0019557;C0149531;C4552776";NA;NA;hip fracture
1113;tibia fracture;C0040185;NA;NA;tibia fracture
1107;race / ethnicity  %;"C0015031;C0034510;C0243103;C1706779;C3853635";NA;NA;race ethnicity
1118;pollent < $nmbr$;NA;FALSE;1906;pollent $nmbr$
1113;vertebral fracture and / or t score - $nmbr$ . $nmbr$;"C0080179;C3854607";FALSE;2023;vertebral fracture and or t score $nmbr$ $nmbr$
1113;spinal fractures;"C0080179;C0518450";FALSE;1038;spinal fractures
1115;fractures;C0016658;FALSE;2026;fractures
1115;fracture history ( predefined )  n ( % );"C0016658;C0019664;C0019665;C0262512;C0262926;C0369718;C0441922;C1705255;C2004062";FALSE;2026;fracture history predefined n
1115;fracture;C0016658;FALSE;2026;fracture
1115;bone fracture;C0016658;FALSE;2026;bone fracture
1115;bone fracture due to fall;"C0016658;C0085639;C0238715;C0678226;C4553726";FALSE;2026;bone fracture due to fall
1115;nonvertebral fracture;C0016658;FALSE;2026;nonvertebral fracture
1115;nonvertebral fractures;C0016658;FALSE;2026;nonvertebral fractures
1115;prior clinical fracture ( since age $nmbr$ );"C0001779;C0016658;C0205210;C0332152;C2826257";FALSE;2026;prior clinical fracture since age $nmbr$
1115;prior nonvertebral fracture;"C0016658;C0332152;C2826257";FALSE;2026;prior nonvertebral fracture
1055;atenoioi ( n = $nmbr$ );NA;NA;NA;atenoioi n $nmbr$
1115;prior nonvertebral fracture at age > $nmbr$ years;"C0016658;C0332152;C1510829;C2826257";FALSE;2026;prior nonvertebral fracture at age $nmbr$ years
1115;d non - vertebral fragility fractures ( fas );"C0016658;C0073187;C0302113;C0332173;C0549207;C1518422;C4484261";FALSE;2026;d non vertebral fragility fractures fas
1115;c clinical fractures ( fas );"C0016658;C0205210";FALSE;2026;c clinical fractures fas
1115;e major non - vertebral fragility fractures ( fas );"C0016658;C0205082;C0205164;C0302113;C0549207;C1518422;C4318856;C4521762";FALSE;2026;e major non vertebral fragility fractures fas
1115;hip + other nonvertebral fractures;"C0016658;C0019552;C0022122;C1505163;C3538851;C4284725";FALSE;2026;hip other nonvertebral fractures
1115;no fracture history;"C0016658;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";FALSE;2026;no fracture history
1115;femur fracture;C0015802;FALSE;2027;femur fracture
1115;thoracic cage fractures;"C0016658;C0222762";FALSE;2028;thoracic cage fractures
1115;hand fracture;C0435632;FALSE;2027;hand fracture
1115;foot fracture;C0272774;FALSE;2027;foot fracture
1115;radius fracture;C0034628;FALSE;2028;radius fracture
1115;skull  and facial bone fractures;"C0015455;C0016658;C0037303;C2951888";FALSE;2028;skull and facial bone fractures
1115;wrist fracture;"C0435630;C4553927";FALSE;2029;wrist fracture
1115;fas;NA;FALSE; -10;fas
1119;contrast volume > $nmbr$ ( ml );"C0009924;C0439526;C0449468;C1690016;C1705102;C1705224;C1979874;C2700258;C3887665";FALSE;2030;contrast volume $nmbr$ ml
1119;contrast volume > $nmbr$ ml;"C0009924;C0439526;C0449468;C1690016;C1705102;C1705224;C1979874;C2700258;C3887665";FALSE;2030;contrast volume $nmbr$ ml
1112;stratification factors;C1514984;NA;NA;stratification factors
1111;temporary factors;"C0205374;C1521761;C1548539;C2827422;C3245481";NA;NA;temporary factors
1111;risk factor for venous thromboembolism  no . ( % );"C1521761;C2827422;C3495424;C3496592";NA;NA;risk factor for venous thromboembolism no
1111;hospital factor # $nmbr$;"C0019994;C1510665;C1521761;C2827422";NA;NA;hospital factor $nmbr$
1111;factors that confer a;"C1521761;C2827422";NA;NA;factors that confer a
1111;factor at baseline;"C0168634;C1442488;C1521761;C2827422";NA;NA;factor at baseline
1111;factor *;"C1521761;C2827422";NA;NA;factor
1111;factor;"C1521761;C2827422";NA;NA;factor
1111;baseline factor;"C0168634;C1442488;C1521761;C2827422";NA;NA;baseline factor
1110;patient characteristic;"C0030705;C1521970";NA;NA;patient characteristic
1110;medical characteristics;"C0199168;C0205476;C1521970";NA;NA;medical characteristics
1110;feature;"C1521970;C1706388;C2346469;C2348519";NA;NA;feature
1110;e ( characteristic n;C1521970;NA;NA;e characteristic n
1110;demographic characteristic;"C0011298;C1521970";NA;NA;demographic characteristic
1110;characteristics of pulmonary embolism at inclusion;"C0007637;C0034065;C1512693;C1521970";NA;NA;characteristics of pulmonary embolism at inclusion
1110;characteristics *;C1521970;NA;NA;characteristics
1110;characteristics;C1521970;NA;NA;characteristics
1110;characteristic †;C1521970;NA;NA;characteristic
1110;characteristic at baseline;"C0168634;C1442488;C1521970";NA;NA;characteristic at baseline
1110;characteristic ^;C1521970;NA;NA;characteristic
1110;characteristic *;C1521970;NA;NA;characteristic
1110;characteristic ( a );C1521970;NA;NA;characteristic a
1110;characteristic  no . ( % );C1521970;NA;NA;characteristic no
1110;characteristic;C1521970;NA;NA;characteristic
1110;baseline feature;"C0168634;C1442488;C1521970;C1706388;C2346469;C2348519";NA;NA;baseline feature
1110;baseline characteristic;"C0168634;C1442488;C1521970";NA;NA;baseline characteristic
1110;anthropometric characteristics;"C0003188;C1521970";NA;NA;anthropometric characteristics
1108;macce ( % ) abciximab placebo;"C0032042;C0288672;C1696465;C1706408";NA;NA;macce abciximab placebo
1108;macce ( % );NA;NA;NA;macce
1108;macce;NA;NA;NA;macce
1107;white race — no . { % ) t;"C0007457;C0034510;C0043157;C0220938;C1706779;C2603360;C3853635";NA;NA;white race no t
1107;racec  n ( % );C4287599;NA;NA;racec n
1107;race — no . { % ) - i -;"C0021966;C0034510;C0221138;C1706779;C3853635";NA;NA;race no i
1107;race — no . { % ) ' i ';"C0021966;C0034510;C0221138;C1706779;C3853635";NA;NA;race no i
1107;race — no . / total no . ( % ) f;"C0016327;C0034510;C0439175;C0439810;C1706779;C3853635";NA;NA;race no total no f
1107;race — no . ( % ) 卞;"C0034510;C1706779;C3853635";NA;NA;race no
1107;race — no . ( % ) |;"C0034510;C1706779;C3853635";NA;NA;race no
1107;race — no . ( % ) f;"C0016327;C0034510;C1706779;C3853635";NA;NA;race no f
1107;race — no . ( % ) : t;"C0034510;C1706779;C2603360;C3853635";NA;NA;race no t
1107;race — no . ( % ) : c;"C0034510;C1706779;C3853635";NA;NA;race no c
1107;race — no . ( % ) ' (;"C0034510;C1706779;C3853635";NA;NA;race no
1107;race — no . ( % );"C0034510;C1706779;C3853635";NA;NA;race no
1107;race §;"C0034510;C1706779;C3853635";NA;NA;race
1107;race white;"C0007457;C0034510;C0043157;C0220938;C1706779;C3853635";NA;NA;race white
1107;race or ethnic group — no . ( % ) : t;"C0015031;C0034510;C1706779;C1879937;C2603360;C3853635";NA;NA;race or ethnic group no t
1107;race or ethnic group  no . ( % );"C0015031;C0034510;C1706779;C1879937;C3853635";NA;NA;race or ethnic group no
1107;race or ethnic background — no . ( % ) f;"C0015031;C0016327;C0034510;C1706779;C3853635";NA;NA;race or ethnic background no f
1107;race nonwhitet;"C0034510;C1706779;C3853635";NA;NA;race nonwhitet
1107;race n ( % );"C0034510;C1706779;C3853635";NA;NA;race n
1107;race : white;"C0007457;C0034510;C0043157;C0220938;C1706779;C3853635";NA;NA;race white
1107;race : non - white;"C0007457;C0034510;C0043157;C0220938;C1518422;C1706779;C3853635";NA;NA;race non white
1107;race :;"C0034510;C1706779;C3853635";NA;NA;race
1107;race / ethnicity chinese;"C0008120;C0015031;C0034510;C0152035;C0243103;C1706779;C3853635";NA;NA;race ethnicity chinese
1107;race / ethnicity  zz ( % );"C0015031;C0034510;C0243103;C1706779;C2347310;C3853635";NA;NA;race ethnicity zz
1099;years with gout;"C0018099;C0439234";NA;NA;years with gout
1109;mace +;"C0349381;C0949745;C1445339";FALSE; 414;mace
1109;mae;"C0286540;C4085238";FALSE; 414;mae
1109;$nmbr$ - point mace;"C0349381;C0949745;C1445339;C1552961;C2347617;C3714763";FALSE; 414;$nmbr$ point mace
1109;mace category  n ( % ) [ ir ];"C0022065;C0022071;C0349381;C0683312;C0949745;C1445339;C1448132;C3889287";FALSE; 414;mace category n ir
1109;$nmbr$ - polnt mace;"C0349381;C0949745;C1445339";FALSE; 414;$nmbr$ polnt mace
1109;primary mace endpoint;"C0349381;C0949745;C1445339;C2986535";FALSE; 414;primary mace endpoint
1109;primary outcome ( $nmbr$ - point mace );"C0205225;C0349381;C0439612;C0439631;C0949745;C1274040;C1445339;C1552961;C2347617;C3714763";FALSE; 414;primary outcome $nmbr$ point mace
1109;secondary mace endpoint;"C0349381;C0949745;C1445339;C4528314";FALSE; 414;secondary mace endpoint
1109;three - point mace;"C0205449;C0349381;C0949745;C1445339;C1552961;C2347617;C3714763";FALSE; 414;three point mace
1110;characteristic age;"C0001779;C1521970";FALSE;2015;characteristic age
1110;characteristic age — yr;"C0001779;C0439234;C1521970";FALSE;2015;characteristic age yr
1110;infarct characteristics;"C0021308;C1521970";FALSE;2016;infarct characteristics
1110;surgical technique post - randomisation characteristic * *;"C0034656;C0683469;C0687676;C1521970;C1704687;C3469826";FALSE;2017;surgical technique post randomisation characteristic
1110;angiographic characteristics  no . ( % );"C0002978;C1521970";FALSE;2018;angiographic characteristics no
1110;angiographic features;"C0002978;C1521970;C1706388;C2346469;C2348519";FALSE;2018;angiographic features
1112;factor v leiden ( % );"C0380964;C0584960;C1414509;C3542419";FALSE;2019;factor v leiden
1054;lleocolon;NA;NA;NA;lleocolon
1112;factor v leiden or prothrombin mutation;"C0380964;C0584960;C1414509;C1610621;C3542419";FALSE;2019;factor v leiden or prothrombin mutation
1112;stratification factor : menopausal status  n ( % );"C1513126;C1514984";FALSE;2020;stratification factor menopausal status n
1112;factor xa inhibitor;"C2825027;C4553708";FALSE;2021;factor xa inhibitor
1112;predictive factor;C0683956;FALSE;2022;predictive factor
1113;prevalent vertebral fracture;"C0033105;C0080179;C0220900";FALSE;2023;prevalent vertebral fracture
1113;prevalent vertebral fracture status;"C0033105;C0080179;C0220900;C0449438";FALSE;2023;prevalent vertebral fracture status
1113;prevalent vertebral fracture  n ( % );"C0033105;C0080179;C0220900";FALSE;2023;prevalent vertebral fracture n
1113;number of prevalent vertebral fractures;"C0033105;C0080179;C0220900;C0237753;C0449788";FALSE;2023;number of prevalent vertebral fractures
1113;clinical vertebral fractures;"C0080179;C0205210";FALSE;2023;clinical vertebral fractures
1113;ankle fracture;"C0159877;C4552974";FALSE;2024;ankle fracture
1113;patella fracture;C0159849;FALSE;2025;patella fracture
1113;clavicle fracture;C0159658;FALSE;2024;clavicle fracture
1113;fibula fracture;C0149699;FALSE;2024;fibula fracture
1107;race / ethnicity;"C0015031;C0034510;C0243103;C1706779;C3853635";NA;NA;race ethnicity
1107;race - white ( n = $nmbr$  $nmbr$ );"C0007457;C0034510;C0043157;C0220938;C1706779;C3853635";NA;NA;race white n $nmbr$ $nmbr$
1107;race - non - white ( n = $nmbr$  $nmbr$ );"C0007457;C0034510;C0043157;C0220938;C1518422;C1706779;C3853635";NA;NA;race non white n $nmbr$ $nmbr$
1107;race - no . ( % );"C0034510;C1706779;C3853635";NA;NA;race no
1107;race - n ( % );"C0034510;C1706779;C3853635";NA;NA;race n
1107;race *;"C0034510;C1706779;C3853635";NA;NA;race
1107;race ( white  n [ % ] );"C0007457;C0034510;C0043157;C0220938;C1706779;C3853635";NA;NA;race white n
1107;race ( p = o - $nmbr$ );"C0034510;C1706779;C3853635";NA;NA;race p o $nmbr$
1107;race ( non - white ) ( % );"C0007457;C0034510;C0043157;C0220938;C1518422;C1706779;C3853635";NA;NA;race non white
1107;race ( % white );"C0007457;C0034510;C0043157;C0220938;C1706779;C3853635";NA;NA;race white
1107;race ( % ) white;"C0007457;C0034510;C0043157;C0220938;C1706779;C3853635";NA;NA;race white
1107;race ( % ) *;"C0034510;C1706779;C3853635";NA;NA;race
1107;race ( % ) ) ';"C0034510;C1706779;C3853635";NA;NA;race
1107;race ( % ) $;"C0034510;C1706779;C3853635";NA;NA;race $
1107;race ( % );"C0034510;C1706779;C3853635";NA;NA;race
1107;race $nmbr$;"C0034510;C1706779;C3853635";NA;NA;race $nmbr$
1107;race    n   ( % );"C0034510;C1706779;C3853635";NA;NA;race n
1107;race  zz ( % );"C0034510;C1706779;C2347310;C3853635";NA;NA;race zz
1107;race  white ( % );"C0007457;C0034510;C0043157;C0220938;C1706779;C3853635";NA;NA;race white
1107;race  white    n   ( % );"C0007457;C0034510;C0043157;C0220938;C1706779;C3853635";NA;NA;race white n
1107;race  white  n ( % );"C0007457;C0034510;C0043157;C0220938;C1706779;C3853635";NA;NA;race white n
1107;race  nonwhite;"C0034510;C1706779;C3853635";NA;NA;race nonwhite
1107;race  no . / total ( % );"C0034510;C0439175;C0439810;C1706779;C3853635";NA;NA;race no total
1107;race  no . ( % ) c;"C0034510;C1706779;C3853635";NA;NA;race no c
1107;race  no . ( % ) b;"C0034510;C1706779;C3853635";NA;NA;race no b
1107;race  no . ( % ) *;"C0034510;C1706779;C3853635";NA;NA;race no
1107;race  no . ( % );"C0034510;C1706779;C3853635";NA;NA;race no
1107;race  n ( % ];"C0034510;C1706779;C3853635";NA;NA;race n
1107;race  n ( % ) ’;"C0034510;C1706779;C3853635";NA;NA;race n
1107;race  n ( % ) y;"C0034510;C1706779;C3853635";NA;NA;race n y
1107;race  n ( % ) white;"C0007457;C0034510;C0043157;C0220938;C1706779;C3853635";NA;NA;race n white
1107;race  n ( % ) t;"C0034510;C1706779;C3853635";NA;NA;race n t
1107;race  n ( % ) b;"C0034510;C1706779;C3853635";NA;NA;race n b
1107;race  n ( % ) a;"C0034510;C1706779;C3853635";NA;NA;race n a
1107;race  n ( % ) :;"C0034510;C1706779;C3853635";NA;NA;race n
1107;race  n ( % ) +;"C0034510;C1706779;C3853635";NA;NA;race n
1107;race  n ( % ) *;"C0034510;C1706779;C3853635";NA;NA;race n
1107;race  n ( % );"C0034510;C1706779;C3853635";NA;NA;race n
1107;race  asian  n ( % );"C0034510;C0078988;C1706779;C3853635";NA;NA;race asian n
1107;race  * ’ n ( % );"C0034510;C1706779;C3853635";NA;NA;race n
1107;race  % white;"C0007457;C0034510;C0043157;C0220938;C1706779;C3853635";NA;NA;race white
1107;race  % of patients;"C0030705;C0034510;C1706779;C3853635";NA;NA;race of patients
1107;race  %;"C0034510;C1706779;C3853635";NA;NA;race
1107;race;"C0034510;C1706779;C3853635";NA;NA;race
1107;other race  n ( % );"C0034510;C1706779;C3853635";NA;NA;other race n
1107;other race;"C0034510;C1706779;C3853635";NA;NA;other race
1107;nonblack race — no . ( % ) f;"C0016327;C0034510;C1706779;C3853635";NA;NA;nonblack race no f
1107;nonblack race — no . ( % ) - j -;"C0034510;C1706779;C3853635";NA;NA;nonblack race no j
1107;$ race was determined by the investigator during the patient ' s interview .;"C0034510;C0035173;C0521095;C0683518;C1706779;C3853635";NA;NA;$ race was determined by the investigator during the patient s interview
1106;number and % of participants with events  and incidence rate per $nmbr$ person - year;"C0027361;C0237753;C0439234;C0439508;C0441471;C0449788;C0679646;C1708485;C2347489;C3541888";NA;NA;number and of participants with events and incidence rate per $nmbr$ person year
1106;no . ( % ) with event [ incidence rate per $nmbr$ patient - y ];"C0030705;C0441471;C1708485;C4019010";NA;NA;no with event incidence rate per $nmbr$ patient y
1106;incidence rate *;C1708485;NA;NA;incidence rate
1106;incidence rate ( per $nmbr$ person - yr );"C0027361;C0439234;C1708485;C2347489";NA;NA;incidence rate per $nmbr$ person yr
1106;incidence rate ( n ) a;C1708485;NA;NA;incidence rate n a
1106;incidence rate ( n );C1708485;NA;NA;incidence rate n
1106;incidence rate;C1708485;NA;NA;incidence rate
1106;$nmbr$ - y incidence rate ( se ) per $nmbr$ participants;"C0036919;C0679646;C1708485";NA;NA;$nmbr$ y incidence rate se per $nmbr$ participants
1105;preoperative heart rate ( beats per minute );"C0018810;C0439385;C0445204";NA;NA;preoperative heart rate beats per minute
1105;heart rate — bpm;C0018810;NA;NA;heart rate bpm
1105;heart rate ( bpm ) *;C0018810;NA;NA;heart rate bpm
1105;heart rate ( bpm );C0018810;NA;NA;heart rate bpm
1105;heart rate ( bpm $nmbr$ ) *  * *;C0018810;NA;NA;heart rate bpm $nmbr$
1105;heart rate ( beats per minute );"C0018810;C0439385";NA;NA;heart rate beats per minute
1105;heart rate ( beats per min );"C0018810;C0439385";NA;NA;heart rate beats per min
1105;heart rate ( b . p . m . );"C0018810;C0369637;C0441923";NA;NA;heart rate b p m
1105;heart rate  beats per minute;"C0018810;C0439385";NA;NA;heart rate beats per minute
1105;heart rate  beats per min;"C0018810;C0439385";NA;NA;heart rate beats per min
1105;heart rate;C0018810;NA;NA;heart rate
1105;baseline heart rate ( beats / min );"C0018810;C0168634;C0702093;C1442488;C1524029;C3813700";NA;NA;baseline heart rate beats min
1105;baseline heart rate;"C0018810;C0168634;C1442488";NA;NA;baseline heart rate
1104;rales  n ( % );"C0034642;C0240859";NA;NA;rales n
1104;rales  ( % );"C0034642;C0240859";NA;NA;rales
1104;rales;"C0034642;C0240859";NA;NA;rales
1104;pulmonary rales  n ( % );C0034642;NA;NA;pulmonary rales n
1104;pulmonary rales;C0034642;NA;NA;pulmonary rales
1103;rate per $nmbr$ patient - years;"C0030705;C0439234;C0871208;C1521828";FALSE;2009;rate per $nmbr$ patient years
1103;rates;"C0871208;C1521828";FALSE;2009;rates
1103;rates per $nmbr$ patient - years;"C0030705;C0439234;C0871208;C1521828";FALSE;2009;rates per $nmbr$ patient years
1103;vhd event rate / year ( n );"C0439234;C0439508;C0441471;C0871208;C1521828;C4019010";FALSE;2011;vhd event rate year n
1103;w event ( rate );"C0441471;C0871208;C1521828;C4019010";FALSE;2011;w event rate
1104;ramus;C3538818;FALSE;2013;ramus
1107;female  n ( % ) race  n ( % );"C0034510;C0043210;C0086287;C1705497;C1705498;C1706779;C3853635";FALSE;2014;female n race n
1107;female race / ethnicity;"C0015031;C0034510;C0043210;C0086287;C0243103;C1705497;C1705498;C1706779;C3853635";FALSE;2014;female race ethnicity
1103;rate of sares;"C0871208;C1521828";NA;NA;rate of sares
1103;ranotazine vs . placebo km failure rate;"C0032042;C0231174;C0680095;C0871208;C1521828;C1696465;C1706408;C3887676";NA;NA;ranotazine vs placebo km failure rate
1103;k ( rate );"C0597277;C0871208;C1521828;C1708601";NA;NA;k rate
1103;health - care use rate ( peryear );"C0814514;C0871208;C1521828";NA;NA;health care use rate peryear
1103;> $nmbr$ % responder rate  n ( % );"C0871208;C1521828";NA;NA;$nmbr$ responder rate n
1103;* rate is number of events per $nmbr$ patient - years of follow - up . fthe p value for number of patients from log - rank  for total number of hospitalizations from permutation test . ^ by treatment comparing the;"C0022885;C0030705;C0039593;C0039798;C0087111;C0392366;C0439175;C0439234;C0439810;C0456984;C0589120;C0667477;C0699794;C0871208;C1515976;C1521828;C1522326;C1522577;C1533734;C1704685;C1705169;C1707455;C1708728;C1709380;C1882348;C2360800;C2986775;C3274571;C3538994;C3831328;C3887704;C4086639;C4318744;C4330837";NA;NA;rate is number of events per $nmbr$ patient years of follow up fthe p value for number of patients from log rank for total number of hospitalizations from permutation test by treatment comparing the
1102;respiratory rate ( breaths / min );"C0231832;C0439386;C0489258";NA;NA;respiratory rate breaths min
1102;respiratory rate  breaths / min;"C0231832;C0439386;C0489258";NA;NA;respiratory rate breaths min
1101;raee;NA;NA;NA;raee
1100;racey  z;NA;NA;NA;racey z
1100;racea;NA;NA;NA;racea
1099;赛 $nmbr$ years;C0439234;NA;NA;$nmbr$ years
1099;〉 $nmbr$ years;C0439234;NA;NA;$nmbr$ years
1099;■ $nmbr$ years;C0439234;NA;NA;$nmbr$ years
1099;≥ $nmbr$ years;C0439234;NA;NA;$nmbr$ years
1099;≥ $nmbr$ to < $nmbr$ years;C0439234;NA;NA;$nmbr$ to $nmbr$ years
1099;≥ $nmbr$ . $nmbr$ years;C0439234;NA;NA;$nmbr$ $nmbr$ years
1099;≥ $nmbr$ . $nmbr$ to < $nmbr$ . $nmbr$ years;C0439234;NA;NA;$nmbr$ $nmbr$ to $nmbr$ $nmbr$ years
1099;≤ $nmbr$   year;"C0439234;C0439508";NA;NA;$nmbr$ year
1099;≤ $nmbr$ years;C0439234;NA;NA;$nmbr$ years
1099;» $nmbr$ yr;C0439234;NA;NA;$nmbr$ yr
1099;» $nmbr$ years;C0439234;NA;NA;$nmbr$ years
1099;£ $nmbr$ yr;C0439234;NA;NA;$nmbr$ yr
1099;£ $nmbr$ years;C0439234;NA;NA;$nmbr$ years
1099;£ $nmbr$ to < $nmbr$ years;C0439234;NA;NA;$nmbr$ to $nmbr$ years
1099;years with gouty arthritis;"C0003868;C0439234";NA;NA;years with gouty arthritis
1099;years with gout  mean ± sd;"C0018099;C0439234;C0444504;C2347634;C2348143;C2699239";NA;NA;years with gout mean sd
1100;racea white;"C0007457;C0043157;C0220938";FALSE;2004;racea white
1101;glomerular filtration rate §;"C0017654;C1561549";FALSE; 592;glomerular filtration rate
1101;glomerular filtration rate ( ml / min / $nmbr$ . $nmbr$ ma;"C0017654;C0024443;C0439445;C1561549;C3887485";FALSE; 592;glomerular filtration rate ml min $nmbr$ $nmbr$ ma
1102;breakfastb;NA;FALSE; -10;breakfastb
1103;adjusted exacerbation rate ( per patient peryear );"C0030705;C0456081;C0871208;C1521828;C4086268";FALSE;2005;adjusted exacerbation rate per patient peryear
1103;exacerbation rate in the previous year ( range );"C0205156;C0439234;C0439508;C0871208;C1514721;C1521828;C1552607;C2348147;C3542016;C4086268";FALSE;2006;exacerbation rate in the previous year range
1103;exacerbation rate per year;"C0439234;C0439508;C0871208;C1521828;C4086268";FALSE;2006;exacerbation rate per year
1103;event rate ( % / year );"C0439234;C0439508;C0441471;C0871208;C1521828;C4019010";FALSE;2007;event rate year
1103;event rate ( % / vr );"C0441471;C0871208;C1521828;C3476815;C4019010";FALSE;2007;event rate vr
1103;event rates per $nmbr$ patient - years ( $nmbr$ % ci );"C0008107;C0030705;C0439234;C0441471;C0871208;C1521828;C3259781;C4019010";FALSE;2007;event rates per $nmbr$ patient years $nmbr$ ci
1103;event rates  %;"C0441471;C0871208;C1521828;C4019010";FALSE;2007;event rates
1103;event rate ( per $nmbr$;"C0441471;C0871208;C1521828;C4019010";FALSE;2007;event rate per $nmbr$
1103;event rate ( % ) of primary endpoints;"C0441471;C0871208;C1521828;C2986535;C4019010";FALSE;2007;event rate of primary endpoints
1103;event rate;"C0441471;C0871208;C1521828;C4019010";FALSE;2007;event rate
1103;kaplan - meier rates  %;"C0871208;C1521828";FALSE;2008;kaplan meier rates
1103;kaplan - meier rates  % i i;"C0021966;C0221138;C0871208;C1521828";FALSE;2008;kaplan meier rates i i
1103;km event rate ( % );"C0441471;C0871208;C1521828;C3887676;C4019010";FALSE;2008;km event rate
1103;km rates { % ) p / s;"C0234833;C0722388;C0871208;C1521828;C3887676";FALSE;2008;km rates p s
1103;km rate ( % );"C0871208;C1521828;C3887676";FALSE;2008;km rate
1103;km rates { % ) e / s;"C0871208;C1521828;C3887676";FALSE;2008;km rates e s
1103;n event ( rate );"C0369718;C0441471;C0441922;C0871208;C1521828;C4019010";FALSE;2008;n event rate
1103;$nmbr$ - y kaplan - meier rate ( $nmbr$ % ci );"C0008107;C0871208;C1521828;C3259781";FALSE;2008;$nmbr$ y kaplan meier rate $nmbr$ ci
1103;$nmbr$ yr . km rate;"C0439234;C0871208;C1521828;C3887676";FALSE;2008;$nmbr$ yr km rate
1103;$nmbr$ - yr rate / $nmbr$ participants;"C0439234;C0679646;C0871208;C1521828";FALSE;2008;$nmbr$ yr rate $nmbr$ participants
1103;n ( $nmbr$ yr km event rate  % );"C0369718;C0439234;C0441471;C0441922;C0871208;C1521828;C3887676;C4019010";FALSE;2008;n $nmbr$ yr km event rate
1103;no . of events ( rate );"C0441471;C0871208;C1521828;C3541888";FALSE;2008;no of events rate
1103;no vhd event rate / year ( n );"C0439234;C0439508;C0441471;C0871208;C1521828;C4019010";FALSE;2008;no vhd event rate year n
1103;overal event rate;"C0441471;C0871208;C1521828;C4019010";FALSE;2008;overal event rate
1103;overall event rate;"C0282416;C0441471;C0871208;C1521828;C1561607;C4019010";FALSE;2008;overall event rate
1103;crude rate;"C0871208;C1521828";FALSE;2009;crude rate
1103;rate *;"C0871208;C1521828";FALSE;2009;rate
1103;rate;"C0871208;C1521828";FALSE;2009;rate
1103;rate difference ( events / year );"C0439234;C0439508;C0441471;C0871208;C1521828;C1705241;C1705242;C3541888";FALSE;2009;rate difference events year
1103;rate in all participants  % / y;"C0679646;C0871208;C1521828";FALSE;2009;rate in all participants y
1103;rate * ( n );"C0871208;C1521828";FALSE;2009;rate n
1103;rate / $nmbr$ patient - years;"C0030705;C0439234;C0871208;C1521828";FALSE;2009;rate $nmbr$ patient years
1103;rate / $nmbr$ pyo;"C0033809;C0871208;C1521828";FALSE;2009;rate $nmbr$ pyo
1103;rate ( % per year );"C0439234;C0439508;C0871208;C1521828";FALSE;2009;rate per year
1103;rate  % / y;"C0871208;C1521828";FALSE;2009;rate y
1103;rate ( % / year );"C0439234;C0439508;C0871208;C1521828";FALSE;2009;rate year
1103;rate of non - progression ( defined as cfb in mtss £ $nmbr$ . $nmbr$ )  n / n ( % ) *;"C0009002;C0871208;C1521828;C1704788;C1824728;C3539106;C3839460";FALSE;2010;rate of non progression defined as cfb in mtss $nmbr$ $nmbr$ n n
1103;rate of non - progression ( defined as cfb in mtss £ $nmbr$ )  n / n ( % ) *;"C0009002;C0871208;C1521828;C1704788;C1824728;C3539106;C3839460";FALSE;2010;rate of non progression defined as cfb in mtss $nmbr$ n n
1103;filtration rate $nmbr$ - $nmbr$;"C0016107;C0871208;C1521828";FALSE; 592;filtration rate $nmbr$ $nmbr$
1103;baseline monthly pos seizure rate;"C0036572;C0168634;C0332177;C0871208;C1262869;C1442488;C1521828;C1959629;C3496112;C3496399;C4553401";FALSE;2012;baseline monthly pos seizure rate
1099;years since symptom onset;"C0439234;C4086878";NA;NA;years since symptom onset
1099;years since pd diagnosis  mean ± sd;"C0011900;C0439234;C0444504;C1704338;C1704656;C2347634;C2348143;C2699239;C4553228;C4553229";NA;NA;years since pd diagnosis mean sd
1099;years since pah diagnosis;"C0011900;C0030123;C0439234;C1704338;C1704656;C3203102;C4284467";NA;NA;years since pah diagnosis
1099;years since menopause;"C0025320;C0439234;C0567312";NA;NA;years since menopause
1099;years since diagnosis  mean;"C0011900;C0439234;C0444504;C1704338;C1704656;C2347634;C2348143";NA;NA;years since diagnosis mean
1099;years since diagnosis;"C0011900;C0439234;C1704338;C1704656";NA;NA;years since diagnosis
1099;years of follow - up  mean ( sd ) [ maximum ];"C0439234;C0444504;C0589120;C0806909;C1522577;C1552615;C1704685;C2347634;C2348143;C2699239;C2826546;C3274571";NA;NA;years of follow up mean sd maximum
1099;years of education  mean ( sd );"C0013621;C0013622;C0013658;C0039401;C0439234;C0444504;C2347634;C2348143;C2699239";NA;NA;years of education mean sd
1099;years duration oa;"C0029408;C0439234;C0449238;C2926735;C3887876";NA;NA;years duration oa
1099;years [ range ];"C0439234;C1514721;C2348147;C3542016";NA;NA;years range
1099;years );C0439234;NA;NA;years
1099;years  n ( % ) smoking  n ( % ) current;"C0037369;C0439234;C0453996;C0521116;C1705970;C1881674";NA;NA;years n smoking n current
1099;years;C0439234;NA;NA;years
1099;year from randomization;"C0034656;C0439234;C0439508";NA;NA;year from randomization
1099;year - $nmbr$;"C0439234;C0439508";NA;NA;year $nmbr$
1099;year $nmbr$;"C0439234;C0439508";NA;NA;year $nmbr$
1099;year  n ( % );"C0439234;C0439508";NA;NA;year n
1099;x $nmbr$ years;C0439234;NA;NA;x $nmbr$ years
1099;women > $nmbr$ years;"C0043210;C0439234";NA;NA;women $nmbr$ years
1099;women < $nmbr$ years;"C0043210;C0439234";NA;NA;women $nmbr$ years
1099;vorapaxar placebo $nmbr$ - yr . km % rate;"C0032042;C0439234;C0871208;C1521828;C1696465;C1706408;C2974521;C3887676";NA;NA;vorapaxar placebo $nmbr$ yr km rate
1099;vorapaxar placebo $nmbr$ - yr %;"C0032042;C0439234;C1696465;C1706408;C2974521";NA;NA;vorapaxar placebo $nmbr$ yr
1099;ukpds $nmbr$ - year risk score > $nmbr$ %;"C0035647;C0439234;C0439508;C0449820;C4050231;C4552904";NA;NA;ukpds $nmbr$ year risk score $nmbr$
1099;ukpds $nmbr$ - year risk score < $nmbr$ %;"C0035647;C0439234;C0439508;C0449820;C4050231;C4552904";NA;NA;ukpds $nmbr$ year risk score $nmbr$
1099;type $nmbr$ diabetes duration  years;"C0439234;C0449238;C1320657;C2926735";NA;NA;type $nmbr$ diabetes duration years
1099;type $nmbr$ diabetes duration  mean ( sd )  years;"C0439234;C0444504;C0449238;C1320657;C2347634;C2348143;C2699239;C2926735";NA;NA;type $nmbr$ diabetes duration mean sd years
1099;time since start of fit  years ( meanisd );"C0036572;C0040223;C0439234;C0439659;C1711239;C2349186;C3541383;C4048158;C4553125";NA;NA;time since start of fit years meanisd
1099;time since start insulin ( years );"C0021641;C0040223;C0439234;C0439659;C1533581;C1579433;C1711239;C3541383;C3714501";NA;NA;time since start insulin years
1099;time since rheumatoid arthritis diagnosis  years;"C0003873;C0011900;C0040223;C0439234;C1704338;C1704656;C3541383";NA;NA;time since rheumatoid arthritis diagnosis years
1099;time since psoriasis diagnosis  years $nmbr$;"C0011900;C0033860;C0040223;C0439234;C1704338;C1704656;C3541383";NA;NA;time since psoriasis diagnosis years $nmbr$
1099;time since psa diagnosis ( years )  mean ( sd );"C0011900;C0040223;C0439234;C0444504;C1704338;C1704656;C2347634;C2348143;C2699239;C3541383;C3810537;C3813209";NA;NA;time since psa diagnosis years mean sd
1099;time since pah diagnosisc ( years );"C0030123;C0040223;C0439234;C3203102;C3541383;C4284467";NA;NA;time since pah diagnosisc years
1099;time since first copd diagnosis ( years );"C0011900;C0024117;C0040223;C0205435;C0439234;C1279901;C1412502;C1704338;C1704656;C3541383;C3714496";NA;NA;time since first copd diagnosis years
1099;time since epilepsy diagnosis ( years );"C0011900;C0014544;C0040223;C0439234;C1704338;C1704656;C3541383";NA;NA;time since epilepsy diagnosis years
1099;time since diagnosis of sle  years;"C0011900;C0024141;C0040223;C0439234;C1704338;C1704656;C3541383";NA;NA;time since diagnosis of sle years
1099;time since diagnosis of psa ( years )  mean ( sd );"C0011900;C0040223;C0439234;C0444504;C1704338;C1704656;C2347634;C2348143;C2699239;C3541383;C3810537;C3813209";NA;NA;time since diagnosis of psa years mean sd
1099;time since diagnosis of pah years #;"C0011900;C0030123;C0040223;C0439234;C1704338;C1704656;C3203102;C3541383;C4284467";NA;NA;time since diagnosis of pah years
   7;p - value for;C1709380;NA;NA;p value for
   7;p - value * ' ';C1709380;NA;NA;p value
1099;time since diagnosis of osteoarthritis — yr;"C0011900;C0029408;C0040223;C0439234;C1704338;C1704656;C3541383";NA;NA;time since diagnosis of osteoarthritis yr
1099;time since diagnosis of ln  years;"C0011900;C0040223;C0439234;C0861352;C1428884;C1704338;C1704656;C3541383;C3714709";NA;NA;time since diagnosis of ln years
1099;time since diagnosis of diabetes ( years ) ( median  iqr );"C0011847;C0011849;C0011900;C0040223;C0439234;C0549183;C0876920;C1704338;C1704656;C2347635;C2348144;C2939193;C3541383";NA;NA;time since diagnosis of diabetes years median iqr
1099;time since diagnosis of copd  years;"C0011900;C0024117;C0040223;C0439234;C1412502;C1704338;C1704656;C3541383;C3714496";NA;NA;time since diagnosis of copd years
1099;time since diagnosis  years;"C0011900;C0040223;C0439234;C1704338;C1704656;C3541383";NA;NA;time since diagnosis years
1099;time since bph diagnosis ( years );"C0005001;C0011900;C0040223;C0439234;C1704272;C1704338;C1704656;C3541383";NA;NA;time since bph diagnosis years
1099;time since as diagnosis ( years )  mean   ±   sd;"C0011900;C0040223;C0439234;C0444504;C1704338;C1704656;C2347634;C2348143;C2699239;C3541383";NA;NA;time since as diagnosis years mean sd
1099;ticagrelor $nmbr$ mg $nmbr$ yr km %;"C0024671;C0026410;C0439234;C0439269;C1960952;C1999375;C2346927;C3887676;C4321396;C4521761";NA;NA;ticagrelor $nmbr$ mg $nmbr$ yr km
1099;t $nmbr$ dm duration ( years );"C0011816;C0439234;C0449238;C2603360;C2926735;C3250443";NA;NA;t $nmbr$ dm duration years
1099;t $nmbr$ d duration  years;"C0439234;C0449238;C2603360;C2926735";NA;NA;t $nmbr$ d duration years
1099;surgical repair of vsd or pda > $nmbr$ - year duration;"C0013274;C0018818;C0226047;C0374711;C0439234;C0439508;C0449238;C2926735;C4282128";NA;NA;surgical repair of vsd or pda $nmbr$ year duration
1099;standard care slope lsm ± se ( mm / year );"C0036919;C0439234;C0439508;C0807955;C1442989;C1947933;C2828392;C4330985;C4554674";NA;NA;standard care slope lsm se mm year
1099;ss years;"C0439234;C2699257;C3891295;C4551874";NA;NA;ss years
1099;smoking index — pack - yr §;"C0037369;C0439234;C0453996;C0600653;C0918012;C1552854;C1637833;C1881674;C1968515;C2825051;C2828395;C2986546";NA;NA;smoking index pack yr
1099;smoking history ( pack - yr );"C0439234;C1519384;C1968515;C2825051;C2828395";NA;NA;smoking history pack yr
1099;s $nmbr$ years ( n = $nmbr$ );"C0439234;C2986823";NA;NA;s $nmbr$ years n $nmbr$
1099;s $nmbr$ years;"C0439234;C0565930;C2603362";NA;NA;s $nmbr$ years
1099;recurrent infections ( > $nmbr$ per year );"C0239998;C0439234;C0439508";NA;NA;recurrent infections $nmbr$ per year
1099;ra duration ( years )  mean ( s . e . );"C0439234;C0444504;C0449238;C2347634;C2348143;C2926735;C3538806;C4048756";NA;NA;ra duration years mean s e
1099;psoriasis duration ( years )  mean ( sd );"C0033860;C0439234;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735";NA;NA;psoriasis duration years mean sd
1099;psoriasis duration  years;"C0033860;C0439234;C0449238;C2926735";NA;NA;psoriasis duration years
1099;psoriasis duration  mean ± sd  years;"C0033860;C0439234;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735";NA;NA;psoriasis duration mean sd years
1099;psa duration ( years )  mean ( sd );"C0439234;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735;C3810537;C3813209";NA;NA;psa duration years mean sd
1099;psa duration ( years );"C0439234;C0449238;C2926735;C3810537;C3813209";NA;NA;psa duration years
1099;psa duration  years;"C0439234;C0449238;C2926735;C3810537;C3813209";NA;NA;psa duration years
1099;prior years taking warfarin;"C0043031;C0332152;C0439234;C1515187;C2826257";NA;NA;prior years taking warfarin
1099;person - years;"C0027361;C0439234;C2347489";NA;NA;person years
1099;< $nmbr$ years;C0439234;NA;NA;$nmbr$ years
1099;persistent anemia bsl hb < $nmbr$ g i - $nmbr$  yr $nmbr$ < $nmbr$ g i $nmbr$;"C0019046;C0021966;C0221138;C0439234;C0741008;C1319635;C1549954";NA;NA;persistent anemia bsl hb $nmbr$ g i $nmbr$ yr $nmbr$ $nmbr$ g i $nmbr$
1012;at weeks $nmbr$ and $nmbr$;C0439230;NA;NA;at weeks $nmbr$ and $nmbr$
1099;percentage with disease duration < $nmbr$ years;"C0439165;C0439234;C0872146;C1549488;C1561533";NA;NA;percentage with disease duration $nmbr$ years
1099;patients with an event per $nmbr$ patient - years;"C0030705;C0439234;C0441471;C4019010";NA;NA;patients with an event per $nmbr$ patient years
1099;patients per $nmbr$ patient - years;"C0030705;C0439234";NA;NA;patients per $nmbr$ patient years
1099;patient years;"C0030705;C0439234";NA;NA;patient years
1099;patient - years ) hr ( unadjusted );"C0030705;C0439234;C1439367";NA;NA;patient years hr unadjusted
1099;participants with an event per $nmbr$ patient - years;"C0030705;C0439234;C0441471;C0679646;C4019010";NA;NA;participants with an event per $nmbr$ patient years
1099;p value ( aged > $nmbr$ vs . < $nmbr$ years );"C0001779;C0001792;C0439234;C1709380;C1999167";NA;NA;p value aged $nmbr$ vs $nmbr$ years
1099;older than $nmbr$ years;"C0439234;C0580836";NA;NA;older than $nmbr$ years
1099;of t $nmbr$ dm ( years );"C0011816;C0439234;C2603360;C3250443";NA;NA;of t $nmbr$ dm years
1099;number ol ( % ) patients > $nmbr$ years;"C0030705;C0237753;C0439234;C0449788";NA;NA;number ol patients $nmbr$ years
1099;number of patients > $nmbr$ years ( % );"C0439234;C2360800";NA;NA;number of patients $nmbr$ years
1099;number of hospitalizations in last year prior to baseline;"C0168634;C0332152;C0439234;C0439508;C1442488;C1517741;C4086639";NA;NA;number of hospitalizations in last year prior to baseline
1099;number of copd exacerbations in the previous year    n   ( % );"C0205156;C0237753;C0439234;C0439508;C0449788;C0740304;C1552607";NA;NA;number of copd exacerbations in the previous year n
1099;number of copd exacerbations in the previous year  n ( % );"C0205156;C0237753;C0439234;C0439508;C0449788;C0740304;C1552607";NA;NA;number of copd exacerbations in the previous year n
1099;number of clinically significant asthma exacerbations in last year prior to baseline;"C0168634;C0237753;C0237881;C0332152;C0349790;C0439234;C0439508;C0449788;C0750502;C1442488;C1517741;C1546944";NA;NA;number of clinically significant asthma exacerbations in last year prior to baseline
1099;number of ( % ) patients > $nmbr$ years;"C0439234;C2360800";NA;NA;number of patients $nmbr$ years
1099;no . of participants per $nmbr$ patient - yr;"C0030705;C0439234;C0679646";NA;NA;no of participants per $nmbr$ patient yr
1099;no . of pack - yr;"C0439234;C1968515;C2825051;C2828395";NA;NA;no of pack yr
1099;no . of events / patients % / yr;"C0030705;C0439234;C0441471;C3541888";NA;NA;no of events patients yr
1099;no . of cardiovascular events ( cardiovascular events / $nmbr$ person - years );"C0027361;C0439234;C1320716;C2347489";NA;NA;no of cardiovascular events cardiovascular events $nmbr$ person years
1099;no . / $nmbr$ person - yr;"C0027361;C0439234;C2347489";NA;NA;no $nmbr$ person yr
1099;necessitating hospitalization in previous year — no . ( % );"C0019993;C0205156;C0439234;C0439508;C1552607";NA;NA;necessitating hospitalization in previous year no
1099;n / n ( % / yr );"C0369718;C0439234;C0441922";NA;NA;n n yr
1099;myocardial infarction / cabg / pci < $nmbr$ years;"C0010055;C0027051;C0428953;C0439234;C2926063;C3810814;C4049621;C4552959";NA;NA;myocardial infarction cabg pci $nmbr$ years
1099;median duration of symptoms ( range )  yr;"C0436359;C0439234;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016";NA;NA;median duration of symptoms range yr
1099;median disease duration — yr;"C0439234;C0549183;C0872146;C0876920;C2347635;C2348144;C2939193";NA;NA;median disease duration yr
1099;median ( q $nmbr$ : q $nmbr$ ) duration of insulin use  years;"C0021641;C0439234;C0549183;C0876920;C1533581;C1579433;C1881378;C2347635;C2348144;C2826775;C2939193;C3714501";NA;NA;median q $nmbr$ q $nmbr$ duration of insulin use years
1099;median ( q $nmbr$ : q $nmbr$ ) duration of diabetes  years;"C0011847;C0011849;C0439234;C0449238;C0549183;C0876920;C2347635;C2348144;C2926735;C2939193";NA;NA;median q $nmbr$ q $nmbr$ duration of diabetes years
1099;median ( interquartile range ) — yr;"C0439234;C0549183;C0876920;C1711350;C2347635;C2348144;C2939193";NA;NA;median interquartile range yr
1099;mean — yr age group — no . ( % );"C0027362;C0439234;C0444504;C2347634;C2348001;C2348143";NA;NA;mean yr age group no
1099;mean — yr;"C0439234;C0444504;C2347634;C2348143";NA;NA;mean yr
1099;mean ± sd ( yr );"C0439234;C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd yr
1099;mean ± s . d . duration of diabetes  years;"C0011847;C0011849;C0439234;C0444504;C0449238;C2347634;C2348143;C2926735";NA;NA;mean s d duration of diabetes years
1099;mean years since menopause;"C0025320;C0439234;C0444504;C0567312;C2347634;C2348143";NA;NA;mean years since menopause
   7;p - value *;C1709380;NA;NA;p value
1099;mean time since diagnosis ( years );"C0011900;C0040223;C0439234;C0444504;C1704338;C1704656;C2347634;C2348143;C3541383";NA;NA;mean time since diagnosis years
1099;mean duration offollow - up ( years ) *;"C0439234;C0444504;C0449238;C2347634;C2348143;C2926735";NA;NA;mean duration offollow up years
1099;mean duration of disease  years;"C0439234;C0444504;C0872146;C2347634;C2348143";NA;NA;mean duration of disease years
1099;mean ( sd ) [ range ] duration of epilepsy  years;"C0014544;C0439234;C0444504;C0449238;C1514721;C2347634;C2348143;C2348147;C2699239;C2926735;C3542016";NA;NA;mean sd range duration of epilepsy years
1099;mean $nmbr$ - year cvd risk *;"C0007222;C0035647;C0439234;C0439508;C0444504;C2347634;C2348143;C4552904";NA;NA;mean $nmbr$ year cvd risk
1099;less than $nmbr$ year;"C0439092;C0439234;C0439508";NA;NA;less than $nmbr$ year
1099;interval of > $nmbr$ yr since diagnosis of type $nmbr$ diabetes — no . ( % );"C0011847;C0011849;C0011900;C0439234;C1272706;C1320657;C1550351;C1552654;C1552713;C1704338;C1704656";NA;NA;interval of $nmbr$ yr since diagnosis of type $nmbr$ diabetes no
1099;interquartile range — yr;"C0439234;C1711350";NA;NA;interquartile range yr
1099;insulin glargine slope lsm ± se ( mm / year );"C0036919;C0439234;C0439508;C0807955;C0907402;C4330985;C4554674";NA;NA;insulin glargine slope lsm se mm year
1099;history of falls in year before randomization;"C0034656;C0439234;C0439508;C1561668;C2919132";NA;NA;history of falls in year before randomization
1099;history of clinical fracture ( > $nmbr$ years old );"C0205210;C0439234;C0580836;C1272071";NA;NA;history of clinical fracture $nmbr$ years old
1099;heart failure $nmbr$ yr before admission;"C0018801;C0018802;C0184666;C0439234;C0809949;C4554158";NA;NA;heart failure $nmbr$ yr before admission
1099;framingham $nmbr$ - year cv risk score;"C0035647;C0439234;C0439508;C0449820;C3166866;C3538987;C4048877;C4050231;C4318503;C4552904";NA;NA;framingham $nmbr$ year cv risk score
1099;formal education  years;"C0439234;C0681344";NA;NA;formal education years
1099;follow - up in - trial at $nmbr$ yr;"C0008976;C0439234;C0589120;C1522577;C1704685;C3274571";NA;NA;follow up in trial at $nmbr$ yr
1099;first year *;"C0205435;C0439234;C0439508;C1279901";NA;NA;first year
1099;eze / simva - $nmbr$ yr km rale ( % );"C0034642;C0439234;C3887676";NA;NA;eze simva $nmbr$ yr km rale
1099;incidence [ n / n ( rate per $nmbr$ person - years ) ];"C0027361;C0439234;C1708485;C2347489";FALSE;1998;incidence n n rate per $nmbr$ person years
1099;incidence  $nmbr$ person - year;"C0021149;C0027361;C0220856;C0439234;C0439508;C2347489";FALSE;1998;incidence $nmbr$ person year
1099;incidence rate no . ( / $nmbr$ person - years );"C0027361;C0439234;C1708485;C2347489";FALSE;1998;incidence rate no $nmbr$ person years
1099;incidence rate per $nmbr$ person - years;"C0027361;C0439234;C1708485;C2347489";FALSE;1998;incidence rate per $nmbr$ person years
1099;incidence rate per $nmbr$ person years;"C0027361;C0439234;C1708485;C2347489";FALSE;1998;incidence rate per $nmbr$ person years
1099;known duration of diabetes  yr;"C0011847;C0011849;C0205309;C0439234;C0449238;C2926735";FALSE;1988;known duration of diabetes yr
1099;evenls per $nmbr$  $nmbr$ palienl - years;C0439234;NA;NA;evenls per $nmbr$ $nmbr$ palienl years
1099;elderly ( > $nmbr$ years );"C0001792;C0439234;C1999167";NA;NA;elderly $nmbr$ years
1099;ed > $nmbr$ yr  no . ( % );"C0439234;C3538926";NA;NA;ed $nmbr$ yr no
1099;duration — yr;"C0439234;C0449238;C2926735";NA;NA;duration yr
1099;duration since diagnosis ( years );"C0011900;C0439234;C0449238;C1704338;C1704656;C2926735";NA;NA;duration since diagnosis years
1099;duration of t $nmbr$ d ( years );"C0439234;C0449238;C2926735";NA;NA;duration of t $nmbr$ d years
1099;duration of rat  years;"C0034693;C0034721;C0439234;C0449238;C2926735";NA;NA;duration of rat years
1099;difference ( glargine - standard care ) lsm ± se ( mm / year );"C0036919;C0439234;C0439508;C0907402;C1442989;C1705241;C1705242;C1947933;C2828392;C4330985;C4554674";NA;NA;difference glargine standard care lsm se mm year
1012;at week $nmbr$;"C0332174;C0439230";NA;NA;at week $nmbr$
1099;diagnosis — yr;"C0011900;C0439234;C1704338;C1704656";NA;NA;diagnosis yr
1099;diagnosis ( years );"C0011900;C0439234;C1704338;C1704656";NA;NA;diagnosis years
1099;cv event  years;"C0439234;C0441471;C3538987;C4019010;C4048877;C4318503";NA;NA;cv event years
1099;copd duration  mean ( sd )  yr *;"C0024117;C0439234;C0444504;C0449238;C1412502;C2347634;C2348143;C2699239;C2926735;C3714496";NA;NA;copd duration mean sd yr
1099;characteristic age mean ± sd — yr;"C0001779;C0439234;C0444504;C1521970;C2347634;C2348143;C2699239";NA;NA;characteristic age mean sd yr
1099;< $nmbr$ year;"C0439234;C0439508";NA;NA;$nmbr$ year
1099;copd exacerbations during the previous year;"C0205156;C0439234;C0439508;C0740304;C1552607";FALSE;1987;copd exacerbations during the previous year
1099;diabetes duration  median ( iqr )  years;"C0011847;C0011849;C0439234;C0449238;C0549183;C0876920;C2347635;C2348144;C2926735;C2939193";FALSE;1988;diabetes duration median iqr years
1099;diabetes duration  years ^;"C0011847;C0011849;C0439234;C0449238;C2926735";FALSE;1988;diabetes duration years
1099;duration of diabetes < $nmbr$ years;"C0011847;C0011849;C0439234;C0449238;C2926735";FALSE;1988;duration of diabetes $nmbr$ years
1099;duration of diabetes > $nmbr$ years;"C0011847;C0011849;C0439234;C0449238;C2926735";FALSE;1988;duration of diabetes $nmbr$ years
1099;duration of diabetes  years;"C0011847;C0011849;C0439234;C0449238;C2926735";FALSE;1988;duration of diabetes years
1099;duration of diabetes ( years );"C0011847;C0011849;C0439234;C0449238;C2926735";FALSE;1988;duration of diabetes years
1099;duration of diabetes  years  mean ( sd );"C0011847;C0011849;C0439234;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735";FALSE;1988;duration of diabetes years mean sd
1099;duration of diabetes ( years )  mean ( sd );"C0011847;C0011849;C0439234;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735";FALSE;1988;duration of diabetes years mean sd
1099;duration of diabetes  years  median ( iqr );"C0011847;C0011849;C0439234;C0449238;C0549183;C0876920;C2347635;C2348144;C2926735;C2939193";FALSE;1988;duration of diabetes years median iqr
1099;duration of diabetes ( years ) t;"C0011847;C0011849;C0439234;C0449238;C2926735";FALSE;1988;duration of diabetes years t
1099;duration of diabetes — yr;"C0011847;C0011849;C0439234;C0449238;C2926735";FALSE;1988;duration of diabetes yr
1099;duration ofdiabetes — yr;"C0439234;C0449238;C2926735";FALSE;1988;duration ofdiabetes yr
1099;disease duration  median ( range ) years;"C0439234;C0549183;C0872146;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016";FALSE;1989;disease duration median range years
1099;disease duration $nmbr$ to b $nmbr$ years ( n = $nmbr$ );"C0439234;C0872146";FALSE;1989;disease duration $nmbr$ to b $nmbr$ years n $nmbr$
1099;disease duration > $nmbr$ years ( n = $nmbr$ );"C0439234;C0872146";FALSE;1989;disease duration $nmbr$ years n $nmbr$
1099;disease duration  years;"C0439234;C0872146";FALSE;1989;disease duration years
1099;disease duration ( years );"C0439234;C0872146";FALSE;1989;disease duration years
1099;disease duration  years : median ( range );"C0439234;C0549183;C0872146;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016";FALSE;1989;disease duration years median range
1099;duration > $nmbr$ to < $nmbr$ years  n ( % );"C0439234;C0449238;C2926735";FALSE;1989;duration $nmbr$ to $nmbr$ years n
1099;duration < $nmbr$ year  n ( % );"C0439234;C0439508;C0449238;C2926735";FALSE;1989;duration $nmbr$ year n
1099;duration > $nmbr$ years  n ( % );"C0439234;C0449238;C2926735";FALSE;1989;duration $nmbr$ years n
1099;duration of disease  years;"C0439234;C0872146";FALSE;1989;duration of disease years
1099;duration of as  years;"C0439234;C0449238;C2926735";FALSE;1989;duration of as years
1099;duration of disease ( years );"C0439234;C0872146";FALSE;1989;duration of disease years
1099;education in years  mean;"C0013621;C0013622;C0013658;C0039401;C0439234;C0444504;C2347634;C2348143";FALSE;1990;education in years mean
1099;education in years  mean ( sd );"C0013621;C0013622;C0013658;C0039401;C0439234;C0444504;C2347634;C2348143;C2699239";FALSE;1990;education in years mean sd
1099;education  mean ( sd ) years;"C0013621;C0013622;C0013658;C0039401;C0439234;C0444504;C2347634;C2348143;C2699239";FALSE;1990;education mean sd years
1099;education $nmbr$ - $nmbr$ years;"C0013621;C0013622;C0013658;C0039401;C0439234";FALSE;1990;education $nmbr$ $nmbr$ years
1099;education > $nmbr$ years;"C0013621;C0013622;C0013658;C0039401;C0439234";FALSE;1990;education $nmbr$ years
1099;education ( years );"C0013621;C0013622;C0013658;C0039401;C0439234";FALSE;1990;education years
1099;education  years  mean ( sd );"C0013621;C0013622;C0013658;C0039401;C0439234;C0444504;C2347634;C2348143;C2699239";FALSE;1990;education years mean sd
1099;exacerbation in previous year;"C0205156;C0439234;C0439508;C1552607;C4086268";FALSE;1991;exacerbation in previous year
1099;duration alendronate use  years ( meanisd );"C0042153;C0102118;C0439234;C0449238;C0457083;C1947944;C2926735";FALSE;1992;duration alendronate use years meanisd
1099;duration of coronary artery disease — yr;"C0018787;C0439234;C0449238;C0852949;C2926735";FALSE;1992;duration of coronary artery disease yr
1099;duration of epilepsy  mean ( sd )  years;"C0014544;C0439234;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735";FALSE;1993;duration of epilepsy mean sd years
1099;duration of epilepsy  years;"C0014544;C0439234;C0449238;C2926735";FALSE;1993;duration of epilepsy years
1099;duration of epilepsy  years  mean ( sd );"C0014544;C0439234;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735";FALSE;1993;duration of epilepsy years mean sd
1099;duration of heart failure ( years );"C0018801;C0018802;C0439234;C0449238;C2926735;C4554158";FALSE;1994;duration of heart failure years
1099;duration of hypercholesterolemia  mean ± sd ( years );"C0020443;C0439234;C0444504;C0449238;C1522133;C2347634;C2348143;C2699239;C2926735";FALSE;1995;duration of hypercholesterolemia mean sd years
1099;duration of hypercholesterolemia ( yr );"C0020443;C0439234;C0449238;C1522133;C2926735";FALSE;1995;duration of hypercholesterolemia yr
1099;duration of psoriasis  years;"C0033860;C0439234;C0449238;C2926735";FALSE;1996;duration of psoriasis years
1099;duration of psoriasis ( years )  mean ( sd );"C0033860;C0439234;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735";FALSE;1996;duration of psoriasis years mean sd
1099;duration of ra  mean ± sd years;"C0439234;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735;C3538806;C4048756";FALSE;1997;duration of ra mean sd years
1099;duration of rheumatoid arthritis  year;"C0003873;C0439234;C0439508;C0449238;C2926735";FALSE;1997;duration of rheumatoid arthritis year
1099;dm duration  years;"C0011816;C0439234;C0449238;C2926735;C3250443";FALSE;1988;dm duration years
1099;bsl  baseline  cl  confidence interval  esrd  end - stage renal disease  hb  hemoglobin  hr  hazard ratio  k ( rate )  # of events per $nmbr$ patient - years of follow - up  yr  year . multivariate cox model with hemoglobin category and baseline urinary albumimcreatinine ratio  serum albumin  serum creatinine  and hemoglobin as covariates .;"C0009667;C0019046;C0022661;C0030705;C0036773;C0042027;C0168634;C0201976;C0229671;C0439234;C0441471;C0456603;C0589120;C0596019;C0597277;C0600061;C0683312;C0728877;C0871208;C1442488;C1521828;C1522577;C1524119;C1546774;C1547037;C1549954;C1550100;C1565830;C1704685;C1708601;C2362049;C2985465;C3161035;C3274571;C3274659;C3541888;C3714583;C3853906;C3889287";NA;NA;bsl baseline cl confidence interval esrd end stage renal disease hb hemoglobin hr hazard ratio k rate of events per $nmbr$ patient years of follow up yr year multivariate cox model with hemoglobin category and baseline urinary albumimcreatinine ratio serum albumin serum creatinine and hemoglobin as covariates
1099;baseline to year $nmbr$;"C0168634;C0439234;C0439508;C1442488";NA;NA;baseline to year $nmbr$
1099;baseline if have $nmbr$ yr follow - up *;"C0168634;C0439234;C0589120;C1442488;C1522577;C1704685;C3274571";NA;NA;baseline if have $nmbr$ yr follow up
1099;at $nmbr$ years;C0439234;NA;NA;at $nmbr$ years
1099;asthma duration ( sd )  years;"C0004096;C0439234;C0449238;C2699239;C2926735;C2984299";NA;NA;asthma duration sd years
1099;aspirin group ( n = $nmbr$ $nmbr$ ) ( $nmbr$ $nmbr$ person years );"C0004057;C0027361;C0439234;C0441848;C2347489";NA;NA;aspirin group n $nmbr$ $nmbr$ $nmbr$ $nmbr$ person years
1099;ard per $nmbr$ $nmbr$ patient - years ( $nmbr$ % ci );"C0008107;C0030705;C0439234;C1817569;C1826411;C3259781";NA;NA;ard per $nmbr$ $nmbr$ patient years $nmbr$ ci
1099;ard ( $nmbr$ % cl ) per $nmbr$ patient - years;"C0030705;C0439234;C0596019;C1817569;C1826411";NA;NA;ard $nmbr$ cl per $nmbr$ patient years
1012;at six weeks;"C0205452;C0439230";NA;NA;at six weeks
1099;all - cause mortality at $nmbr$ year;"C0015127;C0026565;C0026566;C0439234;C0439508;C0444868;C1524003;C3539085";NA;NA;all cause mortality at $nmbr$ year
1099;all - cause mortality ( per $nmbr$ person - years );"C0015127;C0026565;C0026566;C0027361;C0439234;C0444868;C1524003;C2347489;C3539085";NA;NA;all cause mortality per $nmbr$ person years
1099;age at menopause ( yr );"C0439234;C1625754;C1629609";NA;NA;age at menopause yr
1099;age at asthma diagnosis years;"C0004096;C0439234;C1828181;C2984299;C3173302";NA;NA;age at asthma diagnosis years
1099;age  yr  mean ( sd );"C0001779;C0439234;C0444504;C2347634;C2348143;C2699239";NA;NA;age yr mean sd
1099;a $nmbr$ years;C0439234;NA;NA;a $nmbr$ years
1099;> year $nmbr$;"C0439234;C0439508";NA;NA;year $nmbr$
1099;> l $nmbr$ years;"C0439234;C0439394;C1706495;C3642217";NA;NA;l $nmbr$ years
1099;> is years;C0439234;NA;NA;is years
1099;> = medan ( $nmbr$ year - old );"C0439234;C0439508;C0580836";NA;NA;medan $nmbr$ year old
1099;> = $nmbr$ yr;C0439234;NA;NA;$nmbr$ yr
1099;> = $nmbr$ years and < $nmbr$ years;C0439234;NA;NA;$nmbr$ years and $nmbr$ years
1099;> = $nmbr$ years ( placebo n = $nmbr$  $nmbr$  saxagliptin n = $nmbr$  $nmbr$ );"C0032042;C0439234;C1611934;C1696465;C1706408";NA;NA;$nmbr$ years placebo n $nmbr$ $nmbr$ saxagliptin n $nmbr$ $nmbr$
1099;> = $nmbr$ years ( n = $nmbr$ );C0439234;NA;NA;$nmbr$ years n $nmbr$
1099;> = $nmbr$ years;C0439234;NA;NA;$nmbr$ years
1099;> = $nmbr$ yea ' s;NA;NA;NA;$nmbr$ yea s
1099;> $nmbr$   years;C0439234;NA;NA;$nmbr$ years
1099;> $nmbr$ yr — no . { % );C0439234;NA;NA;$nmbr$ yr no
1099;> $nmbr$ yr — no . ( % );C0439234;NA;NA;$nmbr$ yr no
1099;> $nmbr$ yr — %;C0439234;NA;NA;$nmbr$ yr
1099;> $nmbr$ yr warfarin experience;"C0043031;C0237607;C0439234;C0596545";NA;NA;$nmbr$ yr warfarin experience
1099;> $nmbr$ yr since menopause;"C0025320;C0439234;C0567312";NA;NA;$nmbr$ yr since menopause
1099;> $nmbr$ yr from the united states;"C0041703;C0439234";NA;NA;$nmbr$ yr from the united states
1099;> $nmbr$ yr ( n = $nmbr$ );C0439234;NA;NA;$nmbr$ yr n $nmbr$
1099;> $nmbr$ yr ( % );C0439234;NA;NA;$nmbr$ yr
1099;> $nmbr$ yr  n ( % );C0439234;NA;NA;$nmbr$ yr n
1099;> $nmbr$ yr;C0439234;NA;NA;$nmbr$ yr
1099;> $nmbr$ yearstos is years;C0439234;NA;NA;$nmbr$ yearstos is years
1099;> $nmbr$ years vs .   ≤   $nmbr$ years;C0439234;NA;NA;$nmbr$ years vs $nmbr$ years
1099;> $nmbr$ years to < $nmbr$ years ( n = $nmbr$ );C0439234;NA;NA;$nmbr$ years to $nmbr$ years n $nmbr$
1099;> $nmbr$ years to < $nmbr$ years;C0439234;NA;NA;$nmbr$ years to $nmbr$ years
1099;> $nmbr$ years simva ( „ = $nmbr$ };C0439234;NA;NA;$nmbr$ years simva $nmbr$
1099;> $nmbr$ years simva ( n = $nmbr$ );C0439234;NA;NA;$nmbr$ years simva n $nmbr$
1099;> $nmbr$ years simva;C0439234;NA;NA;$nmbr$ years simva
1099;> $nmbr$ years old;"C0439234;C0580836";NA;NA;$nmbr$ years old
1099;> $nmbr$ years n z $nmbr$;C0439234;NA;NA;$nmbr$ years n z $nmbr$
1099;> $nmbr$ years eze / simva baseline ldl - c;"C0168634;C0439234;C1442488";NA;NA;$nmbr$ years eze simva baseline ldl c
1099;> $nmbr$ years eze / simva ( „ = $nmbr$ };C0439234;NA;NA;$nmbr$ years eze simva $nmbr$
1099;> $nmbr$ years eze / simva ( n = $nmbr$ );C0439234;NA;NA;$nmbr$ years eze simva n $nmbr$
1099;> $nmbr$ years education;"C0013621;C0013622;C0013658;C0039401;C0439234";NA;NA;$nmbr$ years education
1099;> $nmbr$ years ( n = $nmbr$ );C0439234;NA;NA;$nmbr$ years n $nmbr$
1099;> $nmbr$ years ( % );C0439234;NA;NA;$nmbr$ years
1099;> $nmbr$ years $nmbr$ / $nmbr$ ( $nmbr$ . $nmbr$ );C0439234;NA;NA;$nmbr$ years $nmbr$ $nmbr$ $nmbr$ $nmbr$
1099;> $nmbr$ years  n ( % );C0439234;NA;NA;$nmbr$ years n
1099;> $nmbr$ years;C0439234;NA;NA;$nmbr$ years
1099;> $nmbr$ year;"C0439234;C0439508";NA;NA;$nmbr$ year
1099;> $nmbr$ to   ≤   $nmbr$ years vs .   ≤   $nmbr$ years;C0439234;NA;NA;$nmbr$ to $nmbr$ years vs $nmbr$ years
1099;> $nmbr$ to < = $nmbr$ years  n ( % );C0439234;NA;NA;$nmbr$ to $nmbr$ years n
1099;> $nmbr$ to < $nmbr$ yr;C0439234;NA;NA;$nmbr$ to $nmbr$ yr
1099;> $nmbr$ to < $nmbr$ years;C0439234;NA;NA;$nmbr$ to $nmbr$ years
1099;> $nmbr$ to $nmbr$   years;C0439234;NA;NA;$nmbr$ to $nmbr$ years
1099;> $nmbr$ to $nmbr$ years;C0439234;NA;NA;$nmbr$ to $nmbr$ years
1099;> $nmbr$ and < $nmbr$ years;C0439234;NA;NA;$nmbr$ and $nmbr$ years
1099;> $nmbr$ - < $nmbr$ years;C0439234;NA;NA;$nmbr$ $nmbr$ years
1099;> $nmbr$ - $nmbr$ yr;C0439234;NA;NA;$nmbr$ $nmbr$ yr
1099;> $nmbr$ - $nmbr$ years;C0439234;NA;NA;$nmbr$ $nmbr$ years
1099;< median ( $nmbr$ year - old );"C0439234;C0439508;C0549183;C0580836;C0876920;C2347635;C2348144;C2939193";NA;NA;median $nmbr$ year old
1099;< l $nmbr$ years;"C0439234;C0439394;C1706495;C3642217";NA;NA;l $nmbr$ years
1099;< = $nmbr$ yr;C0439234;NA;NA;$nmbr$ yr
1099;< = $nmbr$ year  n ( % );"C0439234;C0439508";NA;NA;$nmbr$ year n
1099;< $nmbr$ yr — no . ( % );C0439234;NA;NA;$nmbr$ yr no
1099;< $nmbr$ yr since menopause;"C0025320;C0439234;C0567312";NA;NA;$nmbr$ yr since menopause
1099;< $nmbr$ yr of education — no . ( % );"C0013621;C0013622;C0013658;C0039401;C0439234";NA;NA;$nmbr$ yr of education no
1099;< $nmbr$ yr ( n = $nmbr$ );C0439234;NA;NA;$nmbr$ yr n $nmbr$
1099;< $nmbr$ yr;C0439234;NA;NA;$nmbr$ yr
1099;< $nmbr$ years simva ( n = $nmbr$ };C0439234;NA;NA;$nmbr$ years simva n $nmbr$
1099;< $nmbr$ years simva ( n = $nmbr$ );C0439234;NA;NA;$nmbr$ years simva n $nmbr$
1099;< $nmbr$ years simva;C0439234;NA;NA;$nmbr$ years simva
1099;< $nmbr$ years n z $nmbr$;C0439234;NA;NA;$nmbr$ years n z $nmbr$
1099;< $nmbr$ years eze / simva ( n = $nmbr$ };C0439234;NA;NA;$nmbr$ years eze simva n $nmbr$
1099;< $nmbr$ years eze / simva ( n = $nmbr$ );C0439234;NA;NA;$nmbr$ years eze simva n $nmbr$
1099;< $nmbr$ years eze / simva;C0439234;NA;NA;$nmbr$ years eze simva
1099;< $nmbr$ years ( placebo n = $nmbr$  $nmbr$  saxagliptin n = $nmbr$  $nmbr$ );"C0032042;C0439234;C1611934;C1696465;C1706408";NA;NA;$nmbr$ years placebo n $nmbr$ $nmbr$ saxagliptin n $nmbr$ $nmbr$
1099;< $nmbr$ years ( n = $nmbr$ );C0439234;NA;NA;$nmbr$ years n $nmbr$
1099;< $nmbr$ years ( % );C0439234;NA;NA;$nmbr$ years
1099;< $nmbr$ years  n ( % );C0439234;NA;NA;$nmbr$ years n
1099;% / year;"C0439234;C0439508";NA;NA;year
1099;$nmbr$ — < $nmbr$ years;C0439234;NA;NA;$nmbr$ $nmbr$ years
1099;$nmbr$ — $nmbr$ years;C0439234;NA;NA;$nmbr$ $nmbr$ years
1099;$nmbr$ yr km % ( n );"C0439234;C3887676";NA;NA;$nmbr$ yr km n
1099;$nmbr$ yr;C0439234;NA;NA;$nmbr$ yr
1099;$nmbr$ years or older;"C0439234;C0580836";NA;NA;$nmbr$ years or older
1099;$nmbr$ years ( n = $nmbr$ );C0439234;NA;NA;$nmbr$ years n $nmbr$
1099;$nmbr$ years  n ( % );C0439234;NA;NA;$nmbr$ years n
1099;$nmbr$ years;C0439234;NA;NA;$nmbr$ years
1099;$nmbr$ year or more;"C0205172;C0439234;C0439508";NA;NA;$nmbr$ year or more
1099;$nmbr$ to < $nmbr$ yr — no . { % );C0439234;NA;NA;$nmbr$ to $nmbr$ yr no
1099;$nmbr$ to < $nmbr$ yr — no . ( % );C0439234;NA;NA;$nmbr$ to $nmbr$ yr no
1099;$nmbr$ to < $nmbr$ yr;C0439234;NA;NA;$nmbr$ to $nmbr$ yr
1099;$nmbr$ to < $nmbr$ years;C0439234;NA;NA;$nmbr$ to $nmbr$ years
1099;$nmbr$ to $nmbr$ yr;C0439234;NA;NA;$nmbr$ to $nmbr$ yr
1099;$nmbr$ to $nmbr$ years;C0439234;NA;NA;$nmbr$ to $nmbr$ years
1099;$nmbr$ moto < $nmbr$ yr  n ( % );C0439234;NA;NA;$nmbr$ moto $nmbr$ yr n
1099;$nmbr$ mo to $nmbr$ yr;"C0026544;C0332177;C0439234";NA;NA;$nmbr$ mo to $nmbr$ yr
1099;$nmbr$ e $nmbr$ years;C0439234;NA;NA;$nmbr$ e $nmbr$ years
1099;$nmbr$ = $nmbr$ yr — no . ( % );C0439234;NA;NA;$nmbr$ $nmbr$ yr no
1099;$nmbr$ - yr km mortality rate;"C0026565;C0205848;C0439234;C3887676";NA;NA;$nmbr$ yr km mortality rate
1099;$nmbr$ - yr %;C0439234;NA;NA;$nmbr$ yr
1099;$nmbr$ - year risk of chd  % # < $nmbr$ . $nmbr$;"C0439234;C0439508;C1282512";NA;NA;$nmbr$ year risk of chd $nmbr$ $nmbr$
1099;$nmbr$ - year risk of chd  % #;"C0439234;C0439508;C1282512";NA;NA;$nmbr$ year risk of chd
1099;$nmbr$ - year risk for chd;"C0439234;C0439508;C1282512";NA;NA;$nmbr$ year risk for chd
1099;$nmbr$ - year predicted risk ( % ) of;"C0035647;C0439234;C0439508;C0681842;C1882327;C4552904";NA;NA;$nmbr$ year predicted risk of
1099;$nmbr$ - year mortality;"C0026565;C0026566;C0439234;C0439508";NA;NA;$nmbr$ year mortality
1099;$nmbr$ - year km %;"C0439234;C0439508;C3887676";NA;NA;$nmbr$ year km
1099;$nmbr$ - year framingham chd risk ( % ) $nmbr$ mean / sd );"C0439234;C0439508;C0444504;C1282512;C2347634;C2348143;C2699239;C3166866";NA;NA;$nmbr$ year framingham chd risk $nmbr$ mean sd
1099;$nmbr$ - year framingham chd risk  %;"C0439234;C0439508;C1282512;C3166866";NA;NA;$nmbr$ year framingham chd risk
1099;$nmbr$ - year framingham chd risk;"C0439234;C0439508;C1282512;C3166866";NA;NA;$nmbr$ year framingham chd risk
1099;$nmbr$ - < $nmbr$ years;C0439234;NA;NA;$nmbr$ $nmbr$ years
1099;$nmbr$ - $nmbr$ yr — no . ( % );C0439234;NA;NA;$nmbr$ $nmbr$ yr no
1099;$nmbr$ - $nmbr$ yr ( % );C0439234;NA;NA;$nmbr$ $nmbr$ yr
1099;$nmbr$ - $nmbr$ yr;C0439234;NA;NA;$nmbr$ $nmbr$ yr
1099;$nmbr$ - $nmbr$ years;C0439234;NA;NA;$nmbr$ $nmbr$ years
1099;$nmbr$ $nmbr$ years  n ( % );C0439234;NA;NA;$nmbr$ $nmbr$ years n
1099;$ $nmbr$ years ( n = $nmbr$ );C0439234;NA;NA;$ $nmbr$ years n $nmbr$
1099;$ $nmbr$ years;C0439234;NA;NA;$ $nmbr$ years
1099;$ $nmbr$ and  $nmbr$ years;C0439234;NA;NA;$ $nmbr$ and $nmbr$ years
1099;# $nmbr$ year;"C0439234;C0439508";NA;NA;$nmbr$ year
1098;teaes of special interest;"C0205555;C0543488";NA;NA;teaes of special interest
1098;special interest categories;"C0205555;C0543488;C0683312";NA;NA;special interest categories
1098;social interaction;C0037420;NA;NA;social interaction
1098;interact !;NA;NA;NA;interact
1097;interval from symptom onset to qualifying ecg obtained in the er — hr;"C1272706;C1301820;C1514624;C1552654;C1552713;C1623258;C3810541;C3811131;C4086878";NA;NA;interval from symptom onset to qualifying ecg obtained in the er hr
1097;interval from onset of symptoms;"C1272706;C1552654;C1552713;C4086878";NA;NA;interval from onset of symptoms
1097;interval between clinical evaluation and initiation oftreatment — no . ( % );"C0205210;C0589507;C1158830;C1261322;C1272706;C1552654;C1552713;C1704686;C2826267;C4084924";NA;NA;interval between clinical evaluation and initiation oftreatment no
1097;interval between clinical evaluation and initiation of treatment — no . ( % );"C0039798;C0087111;C0205210;C0589507;C1158830;C1261322;C1272706;C1522326;C1533734;C1552654;C1552713;C1704686;C1705169;C2826267;C3538994;C3887704;C4084924";NA;NA;interval between clinical evaluation and initiation of treatment no
1096;long - acting  intermediate / long - acting + fast - acting;"C0015663;C0079613;C0205103;C0205166;C0456962;C1550465;C1704930;C1706317;C1869853;C2827755;C2985769;C3889971;C3890007;C4048375";NA;NA;long acting intermediate long acting fast acting
1096;intermediate / long - acting + fast - acting;"C0015663;C0079613;C0205103;C0205166;C0456962;C1550465;C1704930;C1706317;C1869853;C2827755;C2985769;C3889971;C3890007;C4048375";NA;NA;intermediate long acting fast acting
1096;intermediate - acting;"C0205103;C1550465;C2827755;C3889971";NA;NA;intermediate acting
1096;intermediate ( $nmbr$ - $nmbr$ );"C0205103;C1550465;C2827755;C3889971";NA;NA;intermediate $nmbr$ $nmbr$
1096;intermediate ( $nmbr$ ) ( n = $nmbr$  $nmbr$  $nmbr$ % );"C0205103;C1550465;C2827755;C3889971";NA;NA;intermediate $nmbr$ n $nmbr$ $nmbr$ $nmbr$
1096;intermediate ( $nmbr$ )  %;"C0205103;C1550465;C2827755;C3889971";NA;NA;intermediate $nmbr$
1096;intermediate;"C0205103;C1550465;C2827755;C3889971";NA;NA;intermediate
1095;nintedanib ( n   =   $nmbr$ );C2930789;NA;NA;nintedanib n $nmbr$
1095;nintedanib ( n = $nmbr$ );C2930789;NA;NA;nintedanib n $nmbr$
1094;previous intolerance of infliximab  n ( % ) *;"C0205156;C0231199;C0666743;C1552607;C1744706;C2355652";NA;NA;previous intolerance of infliximab n
1094;patients with previous loss of response to and intolerance of infliximab *;"C0030705;C0205156;C0231199;C0666743;C0871261;C1517945;C1552607;C1704632;C1706817;C1744706;C2355652;C2911692";NA;NA;patients with previous loss of response to and intolerance of infliximab
1094;patients with previous intolerance of infliximab;"C0030705;C0205156;C0231199;C0666743;C1552607;C1744706;C2355652";NA;NA;patients with previous intolerance of infliximab
1094;inadequate response or intolerance to > $nmbr$ anti - tnfdrug;"C0205412;C0231199;C0439856;C0871261;C1704632;C1706817;C1744706;C2355652;C2911692";NA;NA;inadequate response or intolerance to $nmbr$ anti tnfdrug
1093;infections and infestations;"C0851341;C3714514";NA;NA;infections and infestations
1093;infections;C3714514;NA;NA;infections
1093;infected  n ( % ) a;C0439663;NA;NA;infected n a
1093;injection - site reaction  n ( % );"C0151735;C4551923";FALSE;1983;injection site reaction n
1097;hazard ratio ( $nmbr$ % confi dence interval );"C1272706;C1552654;C1552713;C2985465";FALSE; 975;hazard ratio $nmbr$ confi dence interval
1094;intolerance;"C0231199;C1744706;C2355652";FALSE;1984;intolerance
1095;maintenance dose;C3714445;FALSE;1985;maintenance dose
1095;ics dose of stable maintenance treatment ( μ g ) ∗  †;"C0039798;C0087111;C0178602;C0205360;C0439267;C0814469;C0815320;C0869039;C1114758;C1522326;C1533734;C1547311;C1705169;C3538994;C3714445;C3887704;C4551720";FALSE;1348;ics dose of stable maintenance treatment g
1096;p - inter;"C0205103;C0369773;C1548610;C2603361";FALSE;1986;p inter
1096;inter p - value;"C0205103;C1548610;C1709380";FALSE;1986;inter p value
1096;inter .;"C0205103;C1548610";FALSE; -10;inter
1094;statin intolerance $nmbr$  n ( % );"C0231199;C0360714;C1744706;C2355652";FALSE;1999;statin intolerance $nmbr$ n
1096;p value ( inter );"C0205103;C1548610;C1709380";FALSE;1986;p value inter
1096;p for inter - act;"C0079613;C0205103;C0369773;C1548610;C1704930;C1869853;C2603361;C3890007;C4048375";FALSE;1986;p for inter act
1096;p inter;"C0205103;C0369773;C1548610;C2603361";FALSE;1986;p inter
1093;acute infection without septic shock;"C0036983;C0275518";NA;NA;acute infection without septic shock
1092;( incl . uncertain );"C0087130;C0268281;C1418854;C4085655";NA;NA;incl uncertain
1091;st - segment depression or t - wave inversion on ecg;"C0021943;C0021945;C0429104;C0520887;C0520888;C1623258;C1705687;C2349984";NA;NA;st segment depression or t wave inversion on ecg
1091;st - depression and t - wave inversion;"C0520887;C0520888";NA;NA;st depression and t wave inversion
1091;major st depression or t - wave inversion;"C0036056;C0041696;C0205082;C0205164;C0520887;C0520888;C1269683;C3272372;C4318856;C4521762";NA;NA;major st depression or t wave inversion
1090;patients with fingernail involvement;"C0030705;C0222001;C1314939";NA;NA;patients with fingernail involvement
1090;organ system involvement  no . ( % );"C0460002;C1314939";NA;NA;organ system involvement no
1090;no ststm;NA;NA;NA;no ststm
1090;no . fingernails;C0222001;NA;NA;no fingernails
1090;no . ( % ) of patients with fingernail involvement;"C0030705;C0222001;C1314939";NA;NA;no of patients with fingernail involvement
1089;specific risk of bleeding ^;"C0205369;C1552740;C3251812";NA;NA;specific risk of bleeding
1089;risk of bleeding;C3251812;NA;NA;risk of bleeding
1088;life - threatening bleeding  disabling stroke  and death;"C0011065;C0019080;C0038454;C1306577;C1546953;C2826244;C3537125;C4082313;C4552775;C4554100";NA;NA;life threatening bleeding disabling stroke and death
1088;life - threatening bleed;"C0019080;C1546953;C2826244;C3537125";NA;NA;life threatening bleed
1088;life - threatening;"C1546953;C2826244;C3537125";NA;NA;life threatening
1087;undetermined etiology  n ( % );C0478157;NA;NA;undetermined etiology n
1087;undetermined etiology;C0478157;NA;NA;undetermined etiology
1086;undetermined;"C0205258;C3536725;C4082977";NA;NA;undetermined
1086;patients who received indeterminate results on test for antibodies to infliximabt;"C0003241;C0030705;C0205258;C0456984;C1514756";NA;NA;patients who received indeterminate results on test for antibodies to infliximabt
1086;indeterminate nfs - $nmbr$ . $nmbr$ < nfs < $nmbr$ . $nmbr$ ! n = $nmbr$ );"C0205258;C1513839";NA;NA;indeterminate nfs $nmbr$ $nmbr$ nfs $nmbr$ $nmbr$ n $nmbr$
1086;indeterminate ! !;C0205258;NA;NA;indeterminate
1085;generalized;C0205246;NA;NA;generalized
1085;general andthoracic epidural;"C0205246;C0228134;C0812144;C3812897;C3891294;C4521767";NA;NA;general andthoracic epidural
1085;general alone;"C0205171;C0205246;C0439044;C0679994;C3812897;C3891294;C4521767";NA;NA;general alone
1085;general allergic events;"C0205246;C0441471;C0700624;C3541888;C3812897;C3891294;C4521767";NA;NA;general allergic events
1085;general;"C0205246;C3812897;C3891294;C4521767";NA;NA;general
1084;gene / chr / snp;"C0017337;C0043459;C0752046;C1527094;C1861559;C3890034;C4050175";NA;NA;gene chr snp
1084;gene;C0017337;NA;NA;gene
1083;gertder;NA;NA;NA;gertder
1083;gender n ( % );"C0079399;C1522384";NA;NA;gender n
1083;gender female;"C0043210;C0079399;C0086287;C1522384;C1705497;C1705498";NA;NA;gender female
1083;gender [ n ( % ) ];"C0079399;C1522384";NA;NA;gender n
1083;gender :;"C0079399;C1522384";NA;NA;gender
1083;gender - n ( % );"C0079399;C1522384";NA;NA;gender n
1083;gender ( m / f )  ( % );"C0079399;C1306057;C1522384";NA;NA;gender m f
1083;gender    n   ( % );"C0079399;C1522384";NA;NA;gender n
1083;gender  no . ( % );"C0079399;C1522384";NA;NA;gender no
1083;gender  n ( % ];"C0079399;C1522384";NA;NA;gender n
1083;gender  n ( % );"C0079399;C1522384";NA;NA;gender n
1083;gender  female  n ( % );"C0043210;C0079399;C0086287;C1522384;C1705497;C1705498";NA;NA;gender female n
1083;gender  % of patients;"C0030705;C0079399;C1522384";NA;NA;gender of patients
1083;gender  %;"C0079399;C1522384";NA;NA;gender
1083;gender;"C0079399;C1522384";NA;NA;gender
1083;gendar;NA;NA;NA;gendar
1083;eze / simva gender;"C0079399;C1522384";NA;NA;eze simva gender
1083;> $nmbr$  n ( % ) gender  n ( % );"C0079399;C0369718;C0441922;C1522384";NA;NA;$nmbr$ n gender n
1081;p  net difference;"C0369773;C1456447;C1705241;C1705242;C2603361;C3853572;C3887809;C3890893";NA;NA;p net difference
1081;net ep $nmbr$;"C1456447;C1880476;C3853572;C3887809;C3890893;C4321526";NA;NA;net ep $nmbr$
1081;net composite;"C0205199;C1456447;C1547335;C3853572;C3887809;C3890893";NA;NA;net composite
1081;net clinical benefit *;"C1456447;C3853572;C3887809;C3890893;C4684590";NA;NA;net clinical benefit
1080;knees ( n );C0022742;NA;NA;knees n
1080;knee;"C0022742;C0022745;C1963703";NA;NA;knee
1079;new des ( n = $nmbr$ );"C0011702;C0205314;C4551552";NA;NA;new des n $nmbr$
1078;odds ratio;C0028873;NA;NA;odds ratio
1078;estimated response rate and odds ratio;"C0028873;C0237629;C0750572";NA;NA;estimated response rate and odds ratio
1078;estimated odds ratio;"C0028873;C0750572";NA;NA;estimated odds ratio
1077;fdc $nmbr$ / $nmbr$   μ g ( n   =   $nmbr$ );"C0340427;C0439267;C1413520;C3539652";NA;NA;fdc $nmbr$ $nmbr$ g n $nmbr$
1076;ada impaired fasting glucose;"C1060325;C1272092;C3811629";NA;NA;ada impaired fasting glucose
1076;ada $nmbr$ / $nmbr$ n [ $nmbr$;"C1060325;C3811629";NA;NA;ada $nmbr$ $nmbr$ n $nmbr$
1076;ada $nmbr$ / $nmbr$ ( n [ $nmbr$ );"C1060325;C3811629";NA;NA;ada $nmbr$ $nmbr$ n $nmbr$
1076;ada  yes;"C1060325;C1549445;C1705108;C1710701;C3811629";NA;NA;ada yes
1076;ada  no;"C1060325;C3811629";NA;NA;ada no
1075;adas — cog score;"C0449820;C3539026;C4050231";NA;NA;adas cog score
1075;adas - cog score *;"C0449820;C3539026;C4050231";NA;NA;adas cog score
1075;adas - cog;C3539026;NA;NA;adas cog
1074;gaviscon da ( n = $nmbr$ );"C0011318;C0061146;C3668815";NA;NA;gaviscon da n $nmbr$
1063;> $nmbr$ aes leading to discontinuation;"C0332152;C0457454;C1412268;C1444662;C1522538;C2699274;C4552847";NA;NA;$nmbr$ aes leading to discontinuation
1079;new or worsentna neohrodathv;C0205314;FALSE;1718;new or worsentna neohrodathv
1079;new or worsenina neohrodathv;C0205314;FALSE;1718;new or worsenina neohrodathv
1087;stroke of undetermined cause;"C0015127;C0038454;C1524003";FALSE;1762;stroke of undetermined cause
1077;fluticasone propionate / salmeterol fdc;"C0340427;C1413520;C1622832;C3539652";FALSE;1978;fluticasone propionate salmeterol fdc
1080;below - knee popliteal;"C0022742;C0022745;C0442037;C0542339;C1552829;C1963703";FALSE;1979;below knee popliteal
1082;tender;C0234234;FALSE;1980;tender
1091;symmetric t - wave inversions;"C0332516;C0520888;C2699744";FALSE;1981;symmetric t wave inversions
1087;undeterminedc;NA;FALSE; -10;undeterminedc
1091;symmetric t wave inversions;"C0332516;C0520888;C2699744";FALSE;1981;symmetric t wave inversions
1089;noirecerving;NA;FALSE; -10;noirecerving
1089;noliecervrig;NA;FALSE; -10;noliecervrig
1091;t - wave inversion;C0520888;FALSE;1981;t wave inversion
1091;t wave inversion;C0520888;FALSE;1981;t wave inversion
1091;inversion;"C0021943;C0021945;C1705687;C2349984";FALSE; -10;inversion
1092;uncerlain;NA;FALSE;1982;uncerlain
1092;uncertain;"C0087130;C4085655";FALSE;1982;uncertain
1092;ischemic stroke ( incl . uncertain );"C0087130;C0948008;C4085655";FALSE;1762;ischemic stroke incl uncertain
1081;net adverse clinical events at day $nmbr$;"C0205210;C0332173;C0439228;C0439505;C0877248;C1456447;C1705413;C3853572;C3887809;C3890893";FALSE;  47;net adverse clinical events at day $nmbr$
1082;number of tender joints ( $nmbr$ assessed );"C0234234;C0449813;C1516048";FALSE;1139;number of tender joints $nmbr$ assessed
1082;number of tender joints ( $nmbr$ - $nmbr$ );"C0234234;C0449813";FALSE;1139;number of tender joints $nmbr$ $nmbr$
1074;abbreviations : da  disc area  e - etdrs  electronic early treatment diabetic retinopathy study  iop  intraocular pressure  oct  optical coherence tomography .;"C0000723;C0011318;C0011884;C0013850;C0017446;C0021888;C0180459;C0205146;C0920367;C1547561;C1556138;C1705370;C2348299;C3161471;C3668815;C4281784";NA;NA;abbreviations da disc area e etdrs electronic early treatment diabetic retinopathy study iop intraocular pressure oct optical coherence tomography
1074;> $nmbr$ da of capillary nonperfusion in the eyec;"C0006901;C0011318;C0935624;C3668815";NA;NA;$nmbr$ da of capillary nonperfusion in the eyec
1073;vdz n = \ $nmbr$;NA;NA;NA;vdz n \ $nmbr$
1073;vdz n = $nmbr$;NA;NA;NA;vdz n $nmbr$
1073;vdz / vdz [ n = $nmbr$ ];NA;NA;NA;vdz vdz n $nmbr$
1073;vdz / pbo [ n = $nmbr$ ];C0031962;NA;NA;vdz pbo n $nmbr$
1071;albumin ( mg / dl );"C0001924;C0439269";NA;NA;albumin mg dl
1071;albumin  g / dl;"C0001924;C0439267";NA;NA;albumin g dl
1070;adcs - adl score *;"C0449820;C3641947;C4050231";NA;NA;adcs adl score
1070;adcs - adl;C3641947;NA;NA;adcs adl
1068;ldl : hdl ratio;C0428621;NA;NA;ldl hdl ratio
1068;ldl / hdl cholesterol ratio  mean ( sd ) §;"C0008377;C0428621;C0444504;C2347634;C2348143;C2699239";NA;NA;ldl hdl cholesterol ratio mean sd
1068;ldl - to - hdl cholesterol ratio  mean ( sd );"C0008377;C0428621;C0444504;C1171408;C2347634;C2348143;C2699239";NA;NA;ldl to hdl cholesterol ratio mean sd
1068;ldl - csmedian;NA;NA;NA;ldl csmedian
1068;ldl - c > median;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;ldl c median
1068;ldl - c : hdl - c ratio;C0428621;NA;NA;ldl c hdl c ratio
1068;ldl - c / hdl - c ratio  mean ( sd );"C0428621;C0444504;C2347634;C2348143;C2699239";NA;NA;ldl c hdl c ratio mean sd
1068;ldl - c / hdl - c ratio;C0428621;NA;NA;ldl c hdl c ratio
1068;ldl - c ( median  iqr )  mg / dl;"C0439269;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;ldl c median iqr mg dl
1068;ldl - c;NA;NA;NA;ldl c
1068;lcl;C3658298;NA;NA;lcl
1066;vldl cholesterol;"C0023826;C0523560";NA;NA;vldl cholesterol
1066;vldl - c;C0523560;NA;NA;vldl c
1066;vldl;C0523560;NA;NA;vldl
1065;inconsistent fao ( n [ $nmbr$ );"C0016457;C0442809";NA;NA;inconsistent fao n $nmbr$
1065;$nmbr$ - $nmbr$ fo - $nmbr$ - o - q ^ i;"C0021966;C0221138";NA;NA;$nmbr$ $nmbr$ fo $nmbr$ o q i
1065;$nmbr$ - $nmbr$ fo - $nmbr$ $nmbr$ - $nmbr$ ^;NA;NA;NA;$nmbr$ $nmbr$ fo $nmbr$ $nmbr$ $nmbr$
1065;$nmbr$ $nmbr$ fo $nmbr$ - $nmbr$ $nmbr$ );NA;NA;NA;$nmbr$ $nmbr$ fo $nmbr$ $nmbr$ $nmbr$
1064;metrex modified intention - to - treat population with an eosinophilic phenotypey;"C0032659;C0087111;C0162425;C0333930;C0392747;C1257890;C1283828;C1292734;C1522326;C3889737";NA;NA;metrex modified intention to treat population with an eosinophilic phenotypey
1064;metreo modified intention - to - treat population §;"C0032659;C0087111;C0162425;C0392747;C1257890;C1283828;C1292734;C1522326;C3889737";NA;NA;metreo modified intention to treat population
1064;ization — no . ( % );NA;NA;NA;ization no
1054;ileum or colon;"C0009368;C0020885;C3888384";NA;NA;ileum or colon
1064;individual intended study duration — no . ( % );"C0027361;C0237401;C0489652;C1283828;C1551357";NA;NA;individual intended study duration no
1063;no prior pci;"C0332152;C2826257;C4049621";NA;NA;no prior pci
1063;no . of prior bdmards;"C0332152;C2826257";NA;NA;no of prior bdmards
1063;leading to discontinuation;"C0332152;C0457454;C1444662;C1522538;C4552847";NA;NA;leading to discontinuation
1063;> $nmbr$ b ( $nmbr$ b to $nmbr$ a );NA;NA;NA;$nmbr$ b $nmbr$ b to $nmbr$ a
1066;serum ldl cholesterol;C0428474;FALSE;1068;serum ldl cholesterol
1064;intent - to - treatb;"C0162425;C1283828;C1550453";FALSE;1975;intent to treatb
1066;ratio of ldl to hdl cholesterol;"C0023822;C0392885;C0456603;C1547037";FALSE;1068;ratio of ldl to hdl cholesterol
1063;adverse events leading to premature treatment discontinuation;"C0039798;C0087111;C0151526;C0205252;C0332152;C0457454;C0877248;C1444662;C1522326;C1522538;C1533734;C1705169;C1705413;C3538994;C3887704;C4018905;C4552847";FALSE;1974;adverse events leading to premature treatment discontinuation
1064;intent - to - treat population;"C0032659;C0087111;C0162425;C1257890;C1283828;C1292734;C1522326;C1550453";FALSE;1975;intent to treat population
1064;intention to treat;"C0040363;C0041260;C0087111;C0162425;C1283828;C1292734;C1522326;C1883351";FALSE;1975;intention to treat
1064;intent - to - treat population  n ( % );"C0032659;C0087111;C0162425;C1257890;C1283828;C1292734;C1522326;C1550453";FALSE;1975;intent to treat population n
1067;ldu - c;NA;FALSE; -10;ldu c
1069;ldl - c ( calculated ) *;"C0444686;C1441506";FALSE;1068;ldl c calculated
1067;baseline fc - ldl - c;"C0168634;C1442488;C2983605";FALSE;1068;baseline fc ldl c
1067;ldlc;C1416822;FALSE;1068;ldlc
1067;baseline ldlc level ( n = $nmbr$  $nmbr$ ) > $nmbr$ . $nmbr$ mgzdl;"C0168634;C0441889;C0456079;C1416822;C1442488;C1547707;C2946261";FALSE;1068;baseline ldlc level n $nmbr$ $nmbr$ $nmbr$ $nmbr$ mgzdl
1069;fc - ldl - c  friedewald - calculated;"C0444686;C1441506;C2983605";FALSE;1068;fc ldl c friedewald calculated
1070;adl subscale ( range  $nmbr$ - $nmbr$ ) *;"C0001288;C1420005;C1514721;C2348147;C3542016";FALSE;1976;adl subscale range $nmbr$ $nmbr$
1070;adl;"C0001288;C1420005";FALSE;1976;adl
1071;ldl - c  mmol / l ( mg / dl );"C3642216;C3898312";FALSE;1068;ldl c mmol l mg dl
1071;hdl - c  mmol / l ( mg / dl );"C3642216;C3715113;C3898312";FALSE;1977;hdl c mmol l mg dl
1071;tg  mmol / l [ mg / dl ];"C0337445;C3642216;C3898312";FALSE;1977;tg mmol l mg dl
1071;fpg  mmol / l ( mg / dl );"C3642216;C3898312";FALSE;1977;fpg mmol l mg dl
1072;eze / simva  $nmbr$ / $nmbr$ mg + feno  $nmbr$ mg dn = $nmbr$ ) ';"C1319635;C1333964;C1707618";FALSE; 803;eze simva $nmbr$ $nmbr$ mg feno $nmbr$ mg dn $nmbr$
1072;feno  $nmbr$ dn = $nmbr$ );"C1333964;C1707618";FALSE; 803;feno $nmbr$ dn $nmbr$
1063;< $nmbr$ — no . { % );NA;NA;NA;$nmbr$ no
1063;- $nmbr$ . $nmbr$ to - $nmbr$ cm;NA;NA;NA;$nmbr$ $nmbr$ to $nmbr$ cm
1063;$nmbr$ to < $nmbr$ ( n z $nmbr$ );"C0369718;C0441922";NA;NA;$nmbr$ to $nmbr$ n z $nmbr$
1063;$nmbr$ to < $nmbr$ ( n = $nmbr$ );"C0369718;C0441922";NA;NA;$nmbr$ to $nmbr$ n $nmbr$
1063;$ $nmbr$ to  $nmbr$ ( n = $nmbr$ );"C0369718;C0441922";NA;NA;$ $nmbr$ to $nmbr$ n $nmbr$
1062;some;NA;NA;NA;some
1062;geographic distribution - no . ( % );C0681686;NA;NA;geographic distribution no
1062;edss stratification . no . ( % );"C0451246;C1514983;C3887783";NA;NA;edss stratification no
1062;edss stratification  no . ( % );"C0451246;C1514983;C3887783";NA;NA;edss stratification no
1062;$nmbr$ = some restrictions  no help needed;"C0027552;C0443288;C0686904;C1269765;C1552861";NA;NA;$nmbr$ some restrictions no help needed
1061;use of other medications — no . ( % );C0240320;NA;NA;use of other medications no
1061;other  no . ( % );NA;NA;NA;other no
1061;no immomtedion;NA;NA;NA;no immomtedion
1061;no hemoconcentration hemoconcentration;"C0549409;C0854379";NA;NA;no hemoconcentration hemoconcentration
1061;> $nmbr$ y  no . ( % );NA;NA;NA;$nmbr$ y no
1060;region 一 no . ( % );"C0017446;C0205147";NA;NA;region no
1060;region — no . { % );"C0017446;C0205147";NA;NA;region no
1060;region — no . ( % );"C0017446;C0205147";NA;NA;region no
1060;region - no . ( % );"C0017446;C0205147";NA;NA;region no
1060;region  no . / total ( % );"C0017446;C0205147;C0439175;C0439810";NA;NA;region no total
1060;region  no . ( % ) c;"C0017446;C0205147";NA;NA;region no c
1060;region  no . ( % );"C0017446;C0205147";NA;NA;region no
1060;previous antiarrhythmic treatment — no . ( % );"C0003195;C0039798;C0087111;C0205156;C1522326;C1533734;C1552607;C1705169;C3537142;C3538994;C3887704";NA;NA;previous antiarrhythmic treatment no
1060;other ® region — no . ( % );"C0017446;C0205147";NA;NA;other region no
1060;no treatment or antihistamines only;"C0019590;C0039798;C0087111;C0205171;C1522326;C1533734;C1705169;C1720467;C3538994;C3887704";NA;NA;no treatment or antihistamines only
1060;no ?;NA;NA;NA;no
1060;no .;NA;NA;NA;no
1060;geographic region — no . ( % );C0017446;NA;NA;geographic region no
1060;enrollment by region  no . ( % );"C0017446;C0205147;C1516879;C1696073;C3888021";NA;NA;enrollment by region no
1059;primary end point  no . of events / total no . ( % );"C0439175;C0439810;C0441471;C2986535;C3541888";NA;NA;primary end point no of events total no
1059;no . of events / total no . ( % );"C0439175;C0439810;C0441471;C3541888";NA;NA;no of events total no
1059;no . of events / total no . $nmbr$ % );"C0439175;C0439810;C0441471;C3541888";NA;NA;no of events total no $nmbr$
1059;no . of events / total;"C0439175;C0439810;C0441471;C3541888";NA;NA;no of events total
1059;no . of events;"C0441471;C3541888";NA;NA;no of events
1059;no . of;NA;NA;NA;no of
1059;no . evenls;NA;NA;NA;no evenls
1059;management of event — no . ( % );"C0001554;C0376636;C0441471;C1273870;C3273539;C4019010";NA;NA;management of event no
1059;< $nmbr$ — no . ( % );NA;NA;NA;$nmbr$ no
1059;$nmbr$ no . of events;"C0441471;C3541888";NA;NA;$nmbr$ no of events
   7;p - value ( vs placebo );"C0032042;C1696465;C1706408;C1709380";NA;NA;p value vs placebo
   7;p - value ( trend );"C1521798;C1709380;C4554533";NA;NA;p value trend
1058;eo severity by la classification at baseline ( baseline of the healing study )  n ( % );"C0043240;C0168634;C0205249;C0332120;C0439793;C0522510;C0557651;C1442488;C1881447;C2603343";NA;NA;eo severity by la classification at baseline baseline of the healing study n
1058;eo;C0332120;NA;NA;eo
1057;low renin ( pra < $nmbr$ . $nmbr$ ng / ml / h ) ( n = $nmbr$ );"C0633231;C0855389;C1141951;C1419788;C1533072;C3274822;C3669212;C4050009;C4283900";NA;NA;low renin pra $nmbr$ $nmbr$ ng ml h n $nmbr$
1057;lo ( lo - lo );"C0206579;C1232424";NA;NA;lo lo lo
1057;$nmbr$ . $nmbr$ ( lo . i );"C0021966;C0206579;C0221138;C1232424";NA;NA;$nmbr$ $nmbr$ lo i
1057;$nmbr$ . $nmbr$ ( lo - $nmbr$ . $nmbr$ );"C0206579;C1232424";NA;NA;$nmbr$ $nmbr$ lo $nmbr$ $nmbr$
1056;wml load at follow - up mri stratified by baseline severity of wml load;"C0024485;C0168634;C0205363;C0439793;C0522510;C0589120;C1442488;C1522577;C1550025;C1704685;C1704782;C1708715;C1824234;C3274571;C3890166";NA;NA;wml load at follow up mri stratified by baseline severity of wml load
1056;wml load at follow - up mri;"C0024485;C0589120;C1522577;C1550025;C1704685;C1704782;C1708715;C1824234;C3274571;C3890166";NA;NA;wml load at follow up mri
1056;wml load at baseline mri;"C0024485;C0168634;C1442488;C1550025;C1704782;C1708715;C1824234;C3890166";NA;NA;wml load at baseline mri
1056;late load;"C0205087;C1550025;C1704782;C1708715";NA;NA;late load
1056;early load;"C1279919;C1550025;C1704782;C1708715";NA;NA;early load
1055;atenolol n = $nmbr$ no . ( % );C0004147;NA;NA;atenolol n $nmbr$ no
1055;atenolol n = $nmbr$;C0004147;NA;NA;atenolol n $nmbr$
1055;atenolol *;C0004147;NA;NA;atenolol
1055;atenolol ( « = $nmbr$ $nmbr$ );C0004147;NA;NA;atenolol $nmbr$ $nmbr$
1055;atenolol ( no . = $nmbr$ );C0004147;NA;NA;atenolol no $nmbr$
1055;atenolol ( n = $nmbr$ );C0004147;NA;NA;atenolol n $nmbr$
1055;atenolol ( n = $nmbr$  $nmbr$ );C0004147;NA;NA;atenolol n $nmbr$ $nmbr$
1055;atenolol;C0004147;NA;NA;atenolol
1054;ileum and colon  n ( % );"C0009368;C0020885;C3888384";NA;NA;ileum and colon n
1054;ileum and colon  ' n ( % );"C0009368;C0020885;C3888384";NA;NA;ileum and colon n
1054;ileum and colon;"C0009368;C0020885;C3888384";NA;NA;ileum and colon
1054;ileocolonic ( both ileum and colon );"C0009368;C0020885;C3888384";NA;NA;ileocolonic both ileum and colon
1054;ileocolon;NA;NA;NA;ileocolon
1055;carvedilol;C0054836;FALSE;1972;carvedilol
1055;carvedilol  % ( n );C0054836;FALSE;1972;carvedilol n
1061;history of amputation — no . ( % );"C0002688;C0019664;C0019665;C0262512;C0262926;C0332840;C1546539;C1705255;C2004062";FALSE;1973;history of amputation no
1061;amputation — no . ( % );"C0002688;C0332840;C1546539";FALSE;1973;amputation no
1061;history of amputation  no . ( % );"C0002688;C0019664;C0019665;C0262512;C0262926;C0332840;C1546539;C1705255;C2004062";FALSE;1973;history of amputation no
1053;history of alcohol use;"C0551571;C0552479";NA;NA;history of alcohol use
1053;current alcohol  n ( % );"C0001962;C0001975;C0521116;C1705970";NA;NA;current alcohol n
1053;alcohol usef  n ( % );"C0001962;C0001975";NA;NA;alcohol usef n
1053;alcohol useb;"C0001962;C0001975";NA;NA;alcohol useb
1053;alcohol abuse;"C0085762;C4050601";NA;NA;alcohol abuse
1053;alcohol ^;"C0001962;C0001975";NA;NA;alcohol
1053;alcohol > $nmbr$ / wk;"C0001962;C0001975;C0332174;C0439230";NA;NA;alcohol $nmbr$ wk
1053;alcohol < = $nmbr$ / wk;"C0001962;C0001975;C0332174;C0439230";NA;NA;alcohol $nmbr$ wk
1053;alcohol;"C0001962;C0001975";NA;NA;alcohol
1051;previously untreated isolated systolic hypertension;"C0332155;C0745133";NA;NA;previously untreated isolated systolic hypertension
1051;isolated systolic hypertension ⁎;C0745133;NA;NA;isolated systolic hypertension
1051;isolated systolic hypertension ^;C0745133;NA;NA;isolated systolic hypertension
1051;isolated systolic hypertension  n ( ' % >;C0745133;NA;NA;isolated systolic hypertension n
1051;isolated systolic hypertension  n ( % ) “;C0745133;NA;NA;isolated systolic hypertension n
1051;isolated systolic hypertension;C0745133;NA;NA;isolated systolic hypertension
1049;perfusion defectsatinclusion;"C0031001;C4281794";NA;NA;perfusion defectsatinclusion
1049;no reperfusion;"C0035124;C0684253";NA;NA;no reperfusion
1049;acute reperfusion;"C0035124;C0205178;C0684253";NA;NA;acute reperfusion
1048;symptomatic hypotension with sbp < $nmbr$ mm   hg;"C0020649;C0085805;C0231220;C0439475;C3163620";NA;NA;symptomatic hypotension with sbp $nmbr$ mm hg
1048;symptomatic hypotension ( sbp < $nmbr$ mmhg );"C0020649;C0085805;C0231220;C0439475;C3163620";NA;NA;symptomatic hypotension sbp $nmbr$ mmhg
1048;symptomatic hypotension;"C0020649;C0231220;C3163620";NA;NA;symptomatic hypotension
1048;orthostatic hypotension;C0020651;NA;NA;orthostatic hypotension
1048;hypotension  n ( % );"C0020649;C3163620";NA;NA;hypotension n
1048;hypotension;"C0020649;C3163620";NA;NA;hypotension
1047;proportions  n ( % );C1709707;NA;NA;proportions n
1047;proportion of responders n / n ( % );C1709707;NA;NA;proportion of responders n n
1047;proportion of > = $nmbr$ % responder rates;"C0871208;C1521828;C1709707";NA;NA;proportion of $nmbr$ responder rates
1047;proportion;C1709707;NA;NA;proportion
1047;propafenone;C0033429;NA;NA;propafenone
1047;mean proportion ( % );"C0444504;C1709707;C2347634;C2348143";NA;NA;mean proportion
1047;estimated proportions ( % ) and odds ratios;"C0028873;C0750572;C1709707";NA;NA;estimated proportions and odds ratios
1046;patients with radiographic erosion  n / n ( % );"C0030705;C0333307;C0444708;C1880549;C1959609;C3887524";NA;NA;patients with radiographic erosion n n
1046;erosion score ( $nmbr$ – $nmbr$ scale );"C0175659;C0333307;C0349674;C0449820;C1880549;C1947916;C1959609;C3887524;C4050231";NA;NA;erosion score $nmbr$ $nmbr$ scale
1046;erosion score ( $nmbr$ - $nmbr$ );"C0333307;C0449820;C1880549;C1959609;C3887524;C4050231";NA;NA;erosion score $nmbr$ $nmbr$
1046;erosion score;"C0333307;C0449820;C1880549;C1959609;C3887524;C4050231";NA;NA;erosion score
1046;erosion  mean ± sd;"C0333307;C0444504;C1880549;C1959609;C2347634;C2348143;C2699239;C3887524";NA;NA;erosion mean sd
1046;erosion;"C0333307;C1880549;C1959609;C3887524";NA;NA;erosion
1046;change in erosion score ( mean );"C0333307;C0392747;C0443172;C1705241;C1880549;C1959609;C3533236;C3887524;C4319952";NA;NA;change in erosion score mean
1046;baseline erosion;"C0168634;C0333307;C1442488;C1880549;C1959609;C3887524";NA;NA;baseline erosion
1046;> $nmbr$ erosion  n ( % );"C0333307;C1880549;C1959609;C3887524";NA;NA;$nmbr$ erosion n
1045;prior diagnosis - no . ( % );C0332132;NA;NA;prior diagnosis no
1045;previous hypersensitivity reaction — no . ( % );"C0020517;C0205156;C1552607";NA;NA;previous hypersensitivity reaction no
1045;previous events  no . ( % );"C0205156;C0441471;C1552607;C3541888";NA;NA;previous events no
1045;previous diagnosis;C0332132;NA;NA;previous diagnosis
1045;previous antiparkinson medication  no . ( % );"C0003405;C0205156;C1552607";NA;NA;previous antiparkinson medication no
1045;no previous diagnosis of diabetes mellitus;"C0011849;C0332132";NA;NA;no previous diagnosis of diabetes mellitus
1045;no . of previous csdmards  n ( % );"C0205156;C1552607";NA;NA;no of previous csdmards n
1045;no . of previous biologic dmards — no . ( % );"C0205156;C1552607;C4055380";NA;NA;no of previous biologic dmards no
1045;no . *;NA;NA;NA;no
1044;smoking status ( previous ) ( n );"C0205156;C1519386;C1552607";NA;NA;smoking status previous n
1044;previous vascular disease;"C0042373;C0205156;C1552607";NA;NA;previous vascular disease
1044;previous use of niacin or niaspan §;"C0027996;C0205156;C1142562;C1161310;C1524063;C1552607";NA;NA;previous use of niacin or niaspan
1044;previous use of amiodarone;"C0002598;C0205156;C1524063;C1552607";NA;NA;previous use of amiodarone
1044;previous treatment failure — no . ( % ) § * *;"C0162643;C0205156;C0235828;C0521983;C1547544;C1552607";NA;NA;previous treatment failure no
1044;previous therapy;"C0039798;C0087111;C0205156;C1363945;C1552607";NA;NA;previous therapy
1044;previous therapies  n ( % );"C0087111;C0205156;C1552607";NA;NA;previous therapies n
1044;previous systemic treatment  n ( % );"C0205156;C0678812;C1552607";NA;NA;previous systemic treatment n
1044;previous statin use;"C0042153;C0205156;C0360714;C0457083;C1552607;C1947944";NA;NA;previous statin use
1044;previous segments resection ( s ) *;"C0205156;C1552607;C2987624";NA;NA;previous segments resection s
1044;previous segmental resection — no . ( % );"C0205156;C1552607;C2987624";NA;NA;previous segmental resection no
1044;previous revascularization;"C0205156;C0581603;C1552607";NA;NA;previous revascularization
1044;previous pde $nmbr$ inhibitors;"C0031638;C0205156;C1552607";NA;NA;previous pde $nmbr$ inhibitors
1050;hypertensiont;NA;FALSE;1364;hypertensiont
1054;all of the colon;"C0009368;C3888384";FALSE;1971;all of the colon
1052;alcohol > $nmbr$ drinks per week;"C0332174;C0439230;C0556297";FALSE;1053;alcohol $nmbr$ drinks per week
1044;previous tnf - antagonist use  n ( % );"C0042153;C0205156;C0231491;C0457083;C1448177;C1552607;C1947944";FALSE;2391;previous tnf antagonist use n
1044;reason for discontinuation of previous tnfa inhibitor;"C0205156;C0392360;C0457454;C1444662;C1448177;C1552607;C1710304;C1999216;C4552847";FALSE;2392;reason for discontinuation of previous tnfa inhibitor
1044;severe episodes in previous year — no . / patient;"C0030705;C0205082;C0205156;C0332189;C0439234;C0439508;C1552607;C4050465;C4050466";FALSE;2393;severe episodes in previous year no patient
1044;previous use of systemic steroids for ciu / csu;"C0205156;C0205373;C0281991;C0578870;C1552607";FALSE;2396;previous use of systemic steroids for ciu csu
1044;previous use of systemic steroids  n ( % );"C0205156;C0205373;C0281991;C1552607";FALSE;2396;previous use of systemic steroids n
1044;previous receipt of therapy against tnf - a — no . ( % );"C0039798;C0087111;C0205156;C1363945;C1448177;C1552607;C1710304";FALSE;2398;previous receipt of therapy against tnf a no
1044;previous vte;"C0205156;C0630906;C1552607";FALSE;2399;previous vte
1044;previous venous thromboembolism — no . ( % );"C0205156;C1552607;C1861172";FALSE;2399;previous venous thromboembolism no
1044;previous vte n ( % );"C0205156;C0630906;C1552607";FALSE;2399;previous vte n
1044;previous vte  n ( % );"C0205156;C0630906;C1552607";FALSE;2399;previous vte n
1044;previous vte — no . ( % );"C0205156;C0630906;C1552607";FALSE;2399;previous vte no
1044;previous pci or cabg;"C0010055;C0205156;C1552607;C4049621";FALSE;1661;previous pci or cabg
1044;yes previous revascularization;"C0205156;C0581603;C1549445;C1552607;C1705108;C1710701";FALSE;1661;yes previous revascularization
1044;previous htn  n ( % );"C0020538;C0205156;C1552607";NA;NA;previous htn n
1044;previous chronic kidney disease;"C0205156;C1552607;C1561643;C4553188";NA;NA;previous chronic kidney disease
1044;previous cancerc;"C0205156;C1552607";NA;NA;previous cancerc
1044;previous analgesic products n ( % );"C0002771;C0205156;C1552607";NA;NA;previous analgesic products n
1044;previous ami  n ( % );"C0205156;C1552607;C4319936";NA;NA;previous ami n
1044;previous ami;"C0205156;C1552607;C4319936";NA;NA;previous ami
1044;previous $nmbr$ ari use;"C0042153;C0205156;C0457083;C1412533;C1552607;C1947944;C4521376";NA;NA;previous $nmbr$ ari use
1044;previous $nmbr$ - ari use ( % );"C0042153;C0205156;C0457083;C1412533;C1552607;C1947944;C4521376";NA;NA;previous $nmbr$ ari use
1044;previous;"C0205156;C1552607";NA;NA;previous
1044;no previous dmard therapy;"C0039798;C0087111;C0205156;C0242708;C1363945;C1552607";NA;NA;no previous dmard therapy
1044;> $nmbr$ in previous;"C0205156;C1552607";NA;NA;$nmbr$ in previous
1043;postmenopausal and no ht;"C0018510;C0232970;C0677607";NA;NA;postmenopausal and no ht
1043;postmenopausal and current ht;"C0018510;C0232970;C0521116;C0677607;C1705970";NA;NA;postmenopausal and current ht
1043;poslmenopausal  no ht;"C0018510;C0677607";NA;NA;poslmenopausal no ht
1043;poslmenopausal  ht;"C0018510;C0677607";NA;NA;poslmenopausal ht
1043;menopause and ht;"C0018510;C0025320;C0567312;C0677607";NA;NA;menopause and ht
1043;menopause and hrt;"C0025320;C0282402;C0567312";NA;NA;menopause and hrt
1042;premenopausal  %;C0279752;NA;NA;premenopausal
1042;premenopausal;C0279752;NA;NA;premenopausal
1042;menopausal status and hormone therapy use premenopausal;"C0042153;C0279025;C0279752;C0457083;C1513126;C1947944";NA;NA;menopausal status and hormone therapy use premenopausal
1042;female : premenopausal;"C0043210;C0086287;C0279752;C1705497;C1705498";NA;NA;female premenopausal
1041;postmenopausal hormone use;"C0019932;C0042153;C0232970;C0457083;C1947944;C4521914";NA;NA;postmenopausal hormone use
1041;postmenopausal ( % );C0232970;NA;NA;postmenopausal
1041;postmenopausal  never or past hormone therapy use;"C0042153;C0232970;C0279025;C0457083;C1444637;C1947944;C2003901;C4284302";NA;NA;postmenopausal never or past hormone therapy use
1041;postmenopausal;C0232970;NA;NA;postmenopausal
1041;post - menopausal ( a );C0232970;NA;NA;post menopausal a
1041;peri - or postmenopausal;"C0232970;C0347985";NA;NA;peri or postmenopausal
1041;female participants who are ≥ $nmbr$ years postmenopausal;"C0043210;C0086287;C0232970;C0439234;C0679646;C1705497;C1705498";NA;NA;female participants who are $nmbr$ years postmenopausal
1041;female : ≥ $nmbr$ years postmenopausal;"C0043210;C0086287;C0232970;C0439234;C1705497;C1705498";NA;NA;female $nmbr$ years postmenopausal
1041;female : perimenopausal or < $nmbr$ years postmenopausal;"C0043210;C0086287;C0232970;C0439234;C0849668;C1705497;C1705498;C3839366";NA;NA;female perimenopausal or $nmbr$ years postmenopausal
 -10;personal relationships;C1552027;NA;NA;personal relationships
1039;perianal or anus;"C0003461;C0442158";NA;NA;perianal or anus
1039;perianal gi tract;"C0017189;C0442158";NA;NA;perianal gi tract
1039;perianal  n ( % );C0442158;NA;NA;perianal n
1038;new vertebral fracture at $nmbr$ months;"C0080179;C0205314;C0439231";NA;NA;new vertebral fracture at $nmbr$ months
1038;new or worsening vertebral fracture at $nmbr$ months;"C0080179;C0205314;C0332271;C0439231;C1457868;C1546960";NA;NA;new or worsening vertebral fracture at $nmbr$ months
1038;b pooled new and worsened vertebral fractures ( mfas );"C0080179;C0205314;C1457868;C1549796;C1549980;C1709595;C2349200;C4084902;C4522255";NA;NA;b pooled new and worsened vertebral fractures mfas
1038;a new vertebral fractures ( mfas );"C0080179;C0205314;C1549796;C1549980";NA;NA;a new vertebral fractures mfas
1037;male patients *;C0150904;NA;NA;male patients
1037;male patients  n ( % );C0150904;NA;NA;male patients n
1028;apolipoprotein b;C0003593;NA;NA;apolipoprotein b
1044;previous heart failure — no . ( % );"C0018801;C0018802;C0205156;C1552607;C4554158";FALSE;  12;previous heart failure no
1044;previous heart failure;"C0018801;C0018802;C0205156;C1552607;C4554158";FALSE;  12;previous heart failure
1044;previous cabg surgery;"C0010055;C0038894;C0038895;C0205156;C0543467;C1274039;C1552607";FALSE; 389;previous cabg surgery
1038;mfns ( n = $nmbr$ );NA;FALSE; -10;mfns n $nmbr$
1044;cardioversion in previous $nmbr$ wk;"C0013778;C0205156;C0332174;C0439230;C1552607";FALSE;2386;cardioversion in previous $nmbr$ wk
1037;femaie;NA;FALSE;1970;femaie
1037;female patients ^;C0150905;FALSE;1970;female patients
1037;female sex  n ( % of patients );"C0009253;C0030705;C0036864;C0043210;C0079399;C0086287;C0150831;C0150905;C0804628;C1314687;C1522384;C1705497;C1705498";FALSE;1970;female sex n of patients
1044;previous anti - tnf therapy  n [ % ];"C0205156;C0279936;C0432633;C1552607";FALSE;2387;previous anti tnf therapy n
1044;previous cabg;"C0010055;C0205156;C1552607";FALSE; 389;previous cabg
1044;previous cabg  n ( % );"C0010055;C0205156;C1552607";FALSE; 389;previous cabg n
1044;previous infliximab therapy | |;"C0205156;C1552607;C4076075";FALSE;2387;previous infliximab therapy
1044;previous chf;"C0018802;C0205156;C1552607";FALSE;2388;previous chf
1044;previous chf — no . ( % );"C0018802;C0205156;C1552607";FALSE;2388;previous chf no
1044;previous chf  n ( % );"C0018802;C0205156;C1552607";FALSE;2388;previous chf n
1044;previous diabetes;"C0011847;C0011849;C0205156;C1552607";FALSE;2389;previous diabetes
1044;previous diabetes mellitus;"C0011849;C0205156;C1552607";FALSE;2389;previous diabetes mellitus
1044;previous myocardiaunfarction;"C0205156;C1552607";FALSE;2390;previous myocardiaunfarction
1044;previous cardiovascular disease !;"C0007222;C0205156;C1552607";FALSE;2390;previous cardiovascular disease
1044;previous infarction ( % of group );"C0021308;C0205156;C0441833;C0687744;C1257890;C1519504;C1552607;C1705428;C1705429";FALSE;2390;previous infarction of group
1044;previous dmards use  n ( % );"C0042153;C0205156;C0242708;C0369718;C0441922;C0457083;C1552607;C1947944";FALSE;2391;previous dmards use n
1044;previous bdmard received;"C0205156;C1514756;C1552607";FALSE;2391;previous bdmard received
1044;exacerbations in the previous year;"C0205156;C0439234;C0439508;C1552607;C4086268";FALSE;2393;exacerbations in the previous year
1044;moderate or severe exacerbations in the previous year ( range );"C0205081;C0205082;C0205156;C0439234;C0439508;C1514721;C1552607;C1881878;C2348147;C3542016;C4049705;C4049706;C4050465;C4050466;C4085643;C4086268;C4321335";FALSE;2394;moderate or severe exacerbations in the previous year range
1044;hospitalization in previous year with management of heart failure;"C0001554;C0018801;C0018802;C0019993;C0205156;C0376636;C0439234;C0439508;C1273870;C1552607;C3273539;C4554158";FALSE;2395;hospitalization in previous year with management of heart failure
1044;previous episode of heart failure;"C0018801;C0018802;C0205156;C0332189;C1552607;C4554158";FALSE;2395;previous episode of heart failure
1044;no . of previous venous thromboembolic events;"C0205156;C1552607;C1861172;C1997614;C3160733";FALSE;2399;no of previous venous thromboembolic events
1044;number of previous tnfa inhibitors;"C0205156;C0237753;C0243077;C0449788;C1448177;C1552607;C1710304";FALSE;2398;number of previous tnfa inhibitors
1044;> $nmbr$ previous venous thromboembolisms ( % );"C0205156;C1552607;C1997614";FALSE;2399;$nmbr$ previous venous thromboembolisms
1044;previous pci;"C0205156;C1552607;C4049621";FALSE;1661;previous pci
1044;previous pci  n ( % );"C0205156;C1552607;C4049621";FALSE;1661;previous pci n
1044;previous pci / cabg  n ( % );"C0010055;C0205156;C1552607;C4049621";FALSE;1661;previous pci cabg n
1035;worldwide black patients;"C0005680;C0027567;C0030705;C0085756;C0439541";NA;NA;worldwide black patients
1035;vents / patients;C0030705;NA;NA;vents patients
1035;u . s . black patients;"C0005680;C0027567;C0030705;C0041703;C0085756;C0439541";NA;NA;u s black patients
1035;remaining patients;"C0030705;C1527428";NA;NA;remaining patients
1035;randomised patients ( n );C0030705;NA;NA;randomised patients n
1035;race  white  n ( % of patients );"C0007457;C0030705;C0034510;C0043157;C0220938;C1706779;C3853635";NA;NA;race white n of patients
1035;proportion of patients who achieved acr $nmbr$ n / n ( % );"C0030705;C1412134;C1515941;C1709707";NA;NA;proportion of patients who achieved acr $nmbr$ n n
1035;previous bowel resection performed — no . of patients ( % );"C0030705;C0205156;C0741614;C0884358;C1552607";NA;NA;previous bowel resection performed no of patients
1035;previous acute hypersensitivity reaction to infliximab — no . of patients ( % );"C0030705;C0205156;C0413234;C0666743;C1552607";NA;NA;previous acute hypersensitivity reaction to infliximab no of patients
1035;percentage patients reaching target;"C0030705;C0439165;C1521840;C1549488;C1561533;C2584321;C2986546";NA;NA;percentage patients reaching target
1035;percent of patients;"C0030705;C0439165";NA;NA;percent of patients
1035;patients without prevalent kidney disease at baseline;"C0022646;C0030705;C0168634;C0227665;C0683921;C1442488";NA;NA;patients without prevalent kidney disease at baseline
1035;patients without diabetesb;C0030705;NA;NA;patients without diabetesb
1035;patients without;C0030705;NA;NA;patients without
1035;patients with uncomplicated events ( p = o - $nmbr$ 十 );"C0030705;C0441471;C0443334;C3541888";NA;NA;patients with uncomplicated events p o $nmbr$
1035;patients with uncomplicated events;"C0030705;C0441471;C0443334;C3541888";NA;NA;patients with uncomplicated events
1035;patients with pulmonary embolism;"C0030705;C0034065";NA;NA;patients with pulmonary embolism
1035;patients with prior dmard use  n ( % ) a;"C0030705;C0042153;C0242708;C0332152;C0457083;C1947944;C2826257";NA;NA;patients with prior dmard use n a
1035;patients with prevalent kidney disease at baseline;"C0022646;C0030705;C0168634;C0227665;C0683921;C1442488";NA;NA;patients with prevalent kidney disease at baseline
1035;patients with pneumonia event  n ( % ) #;"C0030705;C0032285;C0441471;C4019010";NA;NA;patients with pneumonia event n
1035;patients with perianal fistulae  n [ % ];"C0030705;C0267561";NA;NA;patients with perianal fistulae n
1035;patients with nail psoriasis ( mnapsi > $nmbr$ );"C0030705;C0406322";NA;NA;patients with nail psoriasis mnapsi $nmbr$
1035;patients with level > $nmbr$ pg / ml;"C0030705;C0439297;C0441889;C0456079;C1547707;C2946261";NA;NA;patients with level $nmbr$ pg ml
1035;patients with improvement $ $nmbr$ . $nmbr$;"C0030705;C2986411";NA;NA;patients with improvement $ $nmbr$ $nmbr$
1035;patients with event / patients analyzed;"C0030705;C0441471;C0936012;C4019010";NA;NA;patients with event patients analyzed
1035;patients with event / patients analysed;"C0030705;C0441471;C4019010";NA;NA;patients with event patients analysed
1035;patients with event / analyzed;"C0030705;C0441471;C0936012;C4019010";NA;NA;patients with event analyzed
1035;patients with event ( n  % );"C0030705;C0441471;C4019010";NA;NA;patients with event n
1035;patients with endpoin t  n ( % );"C0030705;C2986835";NA;NA;patients with endpoin t n
1035;patients with diabetic nephropathy;"C0011881;C0030705;C1442864";NA;NA;patients with diabetic nephropathy
1035;patients with diabetesb;C0030705;NA;NA;patients with diabetesb
1035;patients with at least one concomitant disease | |;"C0030705;C0205447;C0243087";NA;NA;patients with at least one concomitant disease
1035;patients with at least one concomitant disease *;"C0030705;C0205447;C0243087";NA;NA;patients with at least one concomitant disease
1035;patients with any clinical event;"C0030705;C0205210;C0441471;C4019010";NA;NA;patients with any clinical event
1035;patients with any clinical;"C0030705;C0205210";NA;NA;patients with any clinical
1035;patients with > $nmbr$ co - aeds;"C0030705;C0180309;C3245499";NA;NA;patients with $nmbr$ co aeds
1035;patients with $nmbr$ co - aeds;"C0030705;C0180309;C3245499";NA;NA;patients with $nmbr$ co aeds
1035;patients with $nmbr$ co - aed;"C0030705;C0887457;C3245499";NA;NA;patients with $nmbr$ co aed
1035;patients who used insulin pump;"C0030705;C1140609;C1273517";NA;NA;patients who used insulin pump
1035;patients who had ulcerations at;"C0030705;C0041582";NA;NA;patients who had ulcerations at
1035;patients who did not use insulin pump;"C0030705;C0042153;C0457083;C1140609;C1518422;C1947944";NA;NA;patients who did not use insulin pump
1035;patients treated with statins ( n = $nmbr$ );"C0030705;C0332293;C0360714";NA;NA;patients treated with statins n $nmbr$
1035;patients treated with atenoloi ( n = $nmbr$ );"C0030705;C0332293";NA;NA;patients treated with atenoloi n $nmbr$
1035;patients receiving immunotherapy  no . ( % );"C0005525;C0021083;C0030705;C1514756";NA;NA;patients receiving immunotherapy no
1035;patients receiving immunosuppressive agents at baseline;"C0021081;C0030705;C0168634;C1442488;C1514756";NA;NA;patients receiving immunosuppressive agents at baseline
1035;patients receiving enl  no . ( % );"C0030705;C1514756";NA;NA;patients receiving enl no
1035;patients randomised  n;"C0030705;C0369718;C0441922";NA;NA;patients randomised n
1035;patients not treated with statins ( n = $nmbr$ );"C0030705;C0332293;C0360714;C1518422";NA;NA;patients not treated with statins n $nmbr$
1035;patients not receiving immunosuppressive agents at baseline;"C0021081;C0030705;C0168634;C1442488;C1514756;C1518422";NA;NA;patients not receiving immunosuppressive agents at baseline
1035;patients n;C0030705;NA;NA;patients n
1035;patients assessed;"C0030705;C1516048";NA;NA;patients assessed
1035;patients > $nmbr$ y *;C0030705;NA;NA;patients $nmbr$ y
1035;patients > $nmbr$ y;C0030705;NA;NA;patients $nmbr$ y
1035;patients > $nmbr$ %;C0030705;NA;NA;patients $nmbr$
1035;patients < $nmbr$ y *;C0030705;NA;NA;patients $nmbr$ y
1035;patients < $nmbr$ y;C0030705;NA;NA;patients $nmbr$ y
1035;patients < $nmbr$ %;C0030705;NA;NA;patients $nmbr$
1035;patients / events n;"C0030705;C0441471;C3541888";NA;NA;patients events n
1035;patients ( n );C0030705;NA;NA;patients n
1035;patients    n   ( % );C0030705;NA;NA;patients n
1035;patients  no .;C0030705;NA;NA;patients no
1035;patients  n / n ( % ) a;C0030705;NA;NA;patients n n a
1035;patients  n ( % );C0030705;NA;NA;patients n
1035;patients  n;C0030705;NA;NA;patients n
1035;patients;C0030705;NA;NA;patients
1035;patient presentation;"C0030705;C0449450";NA;NA;patient presentation
1035;patient;C0030705;NA;NA;patient
1035;of patients;C0030705;NA;NA;of patients
1035;obese patients  ! n ( % );"C0028754;C0030705";NA;NA;obese patients n
1035;nyha class ( when patient was last in stable condition before admission )  %;"C0030705;C0184666;C0677946;C0809949;C1517741;C1882083;C3538874";NA;NA;nyha class when patient was last in stable condition before admission
1035;nyha class ( when patient was last in stable condition;"C0030705;C0677946;C1517741;C1882083;C3538874";NA;NA;nyha class when patient was last in stable condition
1035;number of events / patients;"C0030705;C0441471;C2360800;C3541888;C4330837";NA;NA;number of events patients
1035;no . patients with;C0030705;NA;NA;no patients with
1035;no . patients ( % );C0030705;NA;NA;no patients
1035;no . of patients with events ( % );"C0030705;C0441471;C3541888";NA;NA;no of patients with events
1035;no . of patients with as;C0030705;NA;NA;no of patients with as
1035;no . of patients ( % );C0030705;NA;NA;no of patients
1035;no . of patients;C0030705;NA;NA;no of patients
1035;patients with dactylitisa;C0030705;FALSE; 492;patients with dactylitisa
1035;patients with digits with dactylitis  n ( % );"C0030705;C0239161;C0582802";FALSE; 492;patients with digits with dactylitis n
1035;no . of hospitalised patients;C0030705;NA;NA;no of hospitalised patients
1035;n ( % of patients );"C0030705;C0369718;C0441922";NA;NA;n of patients
1035;male sex — no . of patients ( % );"C0030705;C0086582";NA;NA;male sex no of patients
1035;laba use  % patients;"C0030705;C0042153;C0457083;C1947944";NA;NA;laba use patients
1035;itt patients  n ( % );C0030705;NA;NA;itt patients n
1035;intensive control ( n = $nmbr$ ) no . of patients ( percent );"C0030705;C0162425;C0243148;C0439165;C0522510;C1283828;C1550141;C1550453;C1882979;C2587213;C3274648;C4553389";NA;NA;intensive control n $nmbr$ no of patients percent
1035;for patients using personal cgm;"C0030705;C1519021;C1524063";NA;NA;for patients using personal cgm
1035;for patients not using personal cgm;"C0030705;C1518422;C1519021;C1524063";NA;NA;for patients not using personal cgm
1035;all randomized patients ( range );"C0030705;C0034656;C1514721;C2348147;C3542016;C3815594";NA;NA;all randomized patients range
1035;all randomized patients;"C0030705;C0034656;C3815594";NA;NA;all randomized patients
1035;all patients with opg n - $nmbr$;"C0030705;C1262886;C1336645;C1412836;C1710303";NA;NA;all patients with opg n $nmbr$
1035;all patients with fistulas ( n = $nmbr$ );"C0016169;C0030705";NA;NA;all patients with fistulas n $nmbr$
1035;all patients n = $nmbr$ $nmbr$;C0030705;NA;NA;all patients n $nmbr$ $nmbr$
1035;all patients n = $nmbr$;C0030705;NA;NA;all patients n $nmbr$
1035;all patients ( « = $nmbr$ $nmbr$ );C0030705;NA;NA;all patients $nmbr$ $nmbr$
1035;all patients ( p = $nmbr$ . $nmbr$ );C0030705;NA;NA;all patients p $nmbr$ $nmbr$
1035;all patients ( p < $nmbr$ . $nmbr$ );C0030705;NA;NA;all patients p $nmbr$ $nmbr$
1035;all patients ( n   =   $nmbr$ ) b;C0030705;NA;NA;all patients n $nmbr$ b
1035;all patients ( n = $nmbr$ );C0030705;NA;NA;all patients n $nmbr$
1035;all patients ( n = $nmbr$  $nmbr$ );C0030705;NA;NA;all patients n $nmbr$ $nmbr$
1035;all patients ( n $nmbr$ $nmbr$ );C0030705;NA;NA;all patients n $nmbr$ $nmbr$
1035;all patients  n =;C0030705;NA;NA;all patients n
1035;all patients;C0030705;NA;NA;all patients
1035;all mn - na ï ve patients;"C0026327;C0026405;C0030705;C0042469;C0597484;C1272460;C1546968;C1879645;C3714652;C4049872;C4285072;C4321495;C4552882";NA;NA;all mn na ve patients
1035;> $nmbr$ %  n ( % of patients );"C0030705;C0369718;C0441922";NA;NA;$nmbr$ n of patients
1035;( $nmbr$ patients );C0030705;NA;NA;$nmbr$ patients
1035;( $nmbr$ . $nmbr$ % )  values were not collected for $nmbr$ patients ( $nmbr$ . $nmbr$ % ) who were enrolled;"C0030705;C0042295;C1516695;C1516698;C1518422;C4684790";NA;NA;$nmbr$ $nmbr$ values were not collected for $nmbr$ patients $nmbr$ $nmbr$ who were enrolled
1035;% patients with no progression;"C0030705;C0242656;C0449258";NA;NA;patients with no progression
1035;% patients;C0030705;NA;NA;patients
1035;% of patients $nmbr$ . $nmbr$ $nmbr$ . $nmbr$;C0030705;NA;NA;of patients $nmbr$ $nmbr$ $nmbr$ $nmbr$
1035;$nmbr$ %  n ( % of patients );"C0030705;C0369718;C0441922";NA;NA;$nmbr$ n of patients
 -10;philippines;C0031529;NA;NA;philippines
1033;total no . of events / total no . of participants;"C0439175;C0439810;C0441471;C0679646;C3541888";NA;NA;total no of events total no of participants
1033;total no . of events / participants;"C0439175;C0439810;C0441471;C0679646;C3541888";NA;NA;total no of events participants
1033;total no . of events ( % of participants ) / total no . of participants;"C0439175;C0439810;C0441471;C0679646;C3541888";NA;NA;total no of events of participants total no of participants
1033;peri - operative cabg participants :;"C0010055;C0347985;C0679646;C1882154";NA;NA;peri operative cabg participants
1033;participants without hf at baseline;"C0018488;C0168634;C0679646;C1313497;C1442488;C1538440;C3273279";NA;NA;participants without hf at baseline
1033;participants with hf at baseline;"C0018488;C0168634;C0679646;C1313497;C1442488;C1538440;C3273279";NA;NA;participants with hf at baseline
1033;participants n;C0679646;NA;NA;participants n
1033;participants at baseline  n;"C0168634;C0679646;C1442488";NA;NA;participants at baseline n
1033;participants  no . ( % );C0679646;NA;NA;participants no
1033;participants  n;C0679646;NA;NA;participants n
1033;participants;C0679646;NA;NA;participants
1033;normal cognitive function ( spmsq < $nmbr$ ) . n - $nmbr$ . $nmbr$ n ( % ) participants with the event of interest;"C0009240;C0392335;C0441471;C0679646;C1276356;C4019010;C4050130";NA;NA;normal cognitive function spmsq $nmbr$ n $nmbr$ $nmbr$ n participants with the event of interest
1033;nonblack participants;C0679646;NA;NA;nonblack participants
1033;no . of participants with events ( % );"C0441471;C0679646;C3541888";NA;NA;no of participants with events
1033;no . of participants ( % );C0679646;NA;NA;no of participants
1033;no . of participants;C0679646;NA;NA;no of participants
1033;no . ( % ) of participants;C0679646;NA;NA;no of participants
1033;n participants;"C0369718;C0441922;C0679646";NA;NA;n participants
1033;impaired cognitive function ( spmsq > $nmbr$ ) . n - $nmbr$ n ( % ) participants with the event of interest;"C0009240;C0221099;C0392335;C0441471;C0543488;C0679646;C4019010;C4050130";NA;NA;impaired cognitive function spmsq $nmbr$ n $nmbr$ n participants with the event of interest
1033;characteristics no . of participants;"C0679646;C1521970";NA;NA;characteristics no of participants
1033;all participants ^ ^ ( n = $nmbr$ / $nmbr$ );C0679646;NA;NA;all participants n $nmbr$ $nmbr$
1033;all participants * ( n = $nmbr$ / $nmbr$ );C0679646;NA;NA;all participants n $nmbr$ $nmbr$
1033;all participants ( n = $nmbr$ );C0679646;NA;NA;all participants n $nmbr$
1033;all participants  mm hg : sbp  mean ( sd );"C0085805;C0439475;C0444504;C0679646;C2347634;C2348143;C2699239";NA;NA;all participants mm hg sbp mean sd
1033;all participants;C0679646;NA;NA;all participants
1033;$nmbr$ % participants;C0679646;NA;NA;$nmbr$ participants
1032;multivitamins;"C0301532;C3714835";NA;NA;multivitamins
1032;multivitamin use yes;"C0042153;C0301532;C0457083;C1549445;C1705108;C1710701;C1947944";NA;NA;multivitamin use yes
1032;multivitamin use ( current );"C0042153;C0301532;C0457083;C0521116;C1705970;C1947944";NA;NA;multivitamin use current
1032;multivitamin use;"C0042153;C0301532;C0457083;C1947944";NA;NA;multivitamin use
1031;sustain $nmbr$ : semaglutide vs . placebo;"C0032042;C0443318;C1696465;C1706408;C2732140;C3885068";NA;NA;sustain $nmbr$ semaglutide vs placebo
1031;sustain $nmbr$ : semaglutide vs . iglar;"C0443318;C2732140;C3885068";NA;NA;sustain $nmbr$ semaglutide vs iglar
1031;sustain $nmbr$;"C0443318;C2732140";NA;NA;sustain $nmbr$
1031;sustain;"C0443318;C2732140";NA;NA;sustain
1031;octave sustain;"C0443318;C2732140";NA;NA;octave sustain
1030;mean lixi dose ± sd ( lg / day );"C0023128;C0178602;C0332173;C0439228;C0439505;C0444504;C0694651;C0869039;C1114758;C2347634;C2348143;C2699239";NA;NA;mean lixi dose sd lg day
1030;mean ( s . d . ) ldl particle size  nm;"C0203634;C0312860;C0444504;C2347634;C2348143;C3641256;C3890923";NA;NA;mean s d ldl particle size nm
1030;lixi;NA;NA;NA;lixi
1030;ldi - b > $nmbr$ ( n = $nmbr$ );NA;NA;NA;ldi b $nmbr$ n $nmbr$
1030;ldi $nmbr$;NA;NA;NA;ldi $nmbr$
1030;ldi  mean [ sd ] b;"C0444504;C2347634;C2348143;C2699239";NA;NA;ldi mean sd b
1030;ldi  mean ( sd ) a;"C0444504;C2347634;C2348143;C2699239";NA;NA;ldi mean sd a
1029;napsit;NA;NA;NA;napsit
1029;mnapsi  mean [ sd ] d;"C0444504;C2347634;C2348143;C2699239";NA;NA;mnapsi mean sd d
1029;mnapsi  mean ( sd );"C0444504;C2347634;C2348143;C2699239";NA;NA;mnapsi mean sd
1029;mnapsi;NA;NA;NA;mnapsi
1029;basfi *;NA;NA;NA;basfi
1029;basfi  mean ( sd );"C0444504;C2347634;C2348143;C2699239";NA;NA;basfi mean sd
1028;apolipoprotein b tx difference vs pbo  ls mean % change from baseline ( se );"C0003593;C0023668;C0031962;C0036919;C0041403;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C1705242;C2347634;C2348143;C4319952";NA;NA;apolipoprotein b tx difference vs pbo ls mean change from baseline se
1028;apolipoprotein b ^;C0003593;NA;NA;apolipoprotein b
1028;apolipoprotein a - i *;"C0085201;C1677784";NA;NA;apolipoprotein a i
1028;apolipoprotein a - i;"C0085201;C1677784";NA;NA;apolipoprotein a i
1028;apolipoprotein a $nmbr$ ( g / l );"C0003592;C0439294;C0456615;C0523508";NA;NA;apolipoprotein a $nmbr$ g l
1028;apolipoprotein a;"C0003592;C0523508";NA;NA;apolipoprotein a
1028;apolipoprotein;C0003591;NA;NA;apolipoprotein
1028;apolipoproiein b ( mij / $nmbr$ );NA;NA;NA;apolipoproiein b mij $nmbr$
1028;apolipoproiein a $nmbr$ ( tng / $nmbr$ );NA;NA;NA;apolipoproiein a $nmbr$ tng $nmbr$
1027;periostin ( ng / ml );"C0219433;C0439275;C1424662;C3812270";NA;NA;periostin ng ml
1027;periostin;"C0219433;C1424662;C3812270";NA;NA;periostin
1027;low periostin subgroup (  $nmbr$ ng / ml ) ( n = $nmbr$ );"C0205251;C0219433;C0439275;C1079230;C1424662;C1515021;C1550472;C3812270;C3890211;C4048187;C4321351;C4522223";NA;NA;low periostin subgroup $nmbr$ ng ml n $nmbr$
1026;ulcerative colitis;C0009324;NA;NA;ulcerative colitis
1026;mouth ulceration;C0149745;NA;NA;mouth ulceration
1026;concomitant medications for ulcerative colitis — no . ( % );"C0009324;C0013227;C0521115;C0802604;C2598133;C4284232";NA;NA;concomitant medications for ulcerative colitis no
1026;any ulcerative colitis medication;"C0009324;C0013227;C3244316;C4284232";NA;NA;any ulcerative colitis medication
1025;penetrating no . of resections  n ( % );"C0015252;C0205321";NA;NA;penetrating no of resections n
1025;penetrating disease  %;"C0012634;C0205321";NA;NA;penetrating disease
1025;penetrating;C0205321;NA;NA;penetrating
1024;monitoring treatment;"C0039798;C0087111;C0150369;C1283169;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;monitoring treatment
1024;monitoring group ( n = $nmbr$ );"C0150369;C0441848;C1283169";NA;NA;monitoring group n $nmbr$
1024;monitoring ( n = $nmbr$ );"C0150369;C1283169";NA;NA;monitoring n $nmbr$
1023;vomiting;"C0042963;C1963281;C3898969;C4084766;C4084767;C4084768;C4084769";NA;NA;vomiting
1023;nausea and / or vomiting adverse events;"C0027497;C0042963;C0877248;C1705413;C1963179;C1963281;C2984057;C3829611;C3898969;C4084766;C4084767;C4084768;C4084769;C4084796;C4085222;C4085661;C4085862;C4255480;C4552888;C4552889;C4553767";NA;NA;nausea and or vomiting adverse events
1022;use of concomitant lipid - lowering treatment;"C0023779;C0039798;C0087111;C0441994;C0521115;C1522326;C1524063;C1533734;C1705169;C2003888;C3538994;C3887704";NA;NA;use of concomitant lipid lowering treatment
1022;remodeling;NA;NA;NA;remodeling
1022;prior urate lowering therapies  n ( % );"C0441994;C0729829;C0935936;C1514463;C2003888";NA;NA;prior urate lowering therapies n
1022;lipid lowering medication use;"C0023779;C0240320;C0441994;C2003888";NA;NA;lipid lowering medication use
1022;lipid lowering;"C0023779;C0441994;C2003888";NA;NA;lipid lowering
1022;lipid - lowering;"C0023779;C0441994;C2003888";NA;NA;lipid lowering
1022;glucose - lowering drug;"C0013227;C0017725;C0441994;C1254351;C2003888";NA;NA;glucose lowering drug
1021;stratum i;"C0021966;C0221138";NA;NA;stratum i
1021;revive i;"C0021966;C0221138";NA;NA;revive i
1021;previous pde $nmbr$ - i therapy  no . ( % );"C0021966;C0039798;C0087111;C0205156;C0221138;C1363945;C1552607";NA;NA;previous pde $nmbr$ i therapy no
1021;pre - bronchodilator fev i ( l );"C0021966;C0221138;C2599602;C3714541";NA;NA;pre bronchodilator fev i l
1021;pde - $nmbr$ i monotherapy;"C0021966;C0221138";NA;NA;pde $nmbr$ i monotherapy
1021;pde - $nmbr$ i;"C0021966;C0221138";NA;NA;pde $nmbr$ i
1021;other ' i ';"C0021966;C0221138";NA;NA;other i
1021;lvef — no . ( % )  i;"C0021966;C0221138;C0428772;C0488728";NA;NA;lvef no i
1021;infliiimab i;"C0021966;C0221138";NA;NA;infliiimab i
1021;i u - uj;"C0021966;C0221138;C0439148";NA;NA;i u uj
1021;i idl cholesterol ( mg / dl );"C0021966;C0123167;C0221138;C0439269;C0523559;C0619865";NA;NA;i idl cholesterol mg dl
1021;i amiodarone;"C0002598;C0021966;C0221138";NA;NA;i amiodarone
1021;i . $nmbr$ i ( $nmbr$ . $nmbr$ - i . $nmbr$ );"C0021966;C0221138";NA;NA;i $nmbr$ i $nmbr$ $nmbr$ i $nmbr$
1021;i . $nmbr$ ( $nmbr$ . $nmbr$ - i . $nmbr$ );"C0021966;C0221138";NA;NA;i $nmbr$ $nmbr$ $nmbr$ i $nmbr$
1021;i - ^ w « - i - $nmbr$;"C0021966;C0221138";NA;NA;i w i $nmbr$
1021;i ( $nmbr$ . i );"C0021966;C0221138";NA;NA;i $nmbr$ i
1021;i % $nmbr$;"C0021966;C0221138";NA;NA;i $nmbr$
1021;i $nmbr$ ± i $nmbr$;"C0021966;C0221138";NA;NA;i $nmbr$ i $nmbr$
1021;i $nmbr$ ± $nmbr$ i;"C0021966;C0221138";NA;NA;i $nmbr$ $nmbr$ i
1021;i $nmbr$ i ± i $nmbr$;"C0021966;C0221138";NA;NA;i $nmbr$ i i $nmbr$
1021;i $nmbr$ i ( i $nmbr$ . $nmbr$ );"C0021966;C0221138";NA;NA;i $nmbr$ i i $nmbr$ $nmbr$
1021;i $nmbr$ i $nmbr$ ± $nmbr$;"C0021966;C0221138";NA;NA;i $nmbr$ i $nmbr$ $nmbr$
1021;i $nmbr$ i;"C0021966;C0221138";NA;NA;i $nmbr$ i
1021;i $nmbr$ . $nmbr$ vs $nmbr$ . $nmbr$;"C0021966;C0221138";NA;NA;i $nmbr$ $nmbr$ vs $nmbr$ $nmbr$
1021;i $nmbr$ ( i $nmbr$ . i );"C0021966;C0221138";NA;NA;i $nmbr$ i $nmbr$ i
1021;i $nmbr$ ( i $nmbr$ . $nmbr$ );"C0021966;C0221138";NA;NA;i $nmbr$ i $nmbr$ $nmbr$
1021;i;"C0021966;C0221138";NA;NA;i
1021;ffa / i;"C0015688;C0021966;C0221138";NA;NA;ffa i
1021;dual i extension - end of trial hba $nmbr$ c;"C0008976;C0019016;C0021966;C0205173;C0221138;C0231448;C0444930;C1554184;C1825777;C1880641;C2746065;C3538758";NA;NA;dual i extension end of trial hba $nmbr$ c
1021;dual i extension;"C0021966;C0205173;C0221138;C0231448;C1554184;C1880641";NA;NA;dual i extension
1021;antithrombotic ! i;"C0021966;C0221138";NA;NA;antithrombotic i
1021;albumin - to - creatinine ratio ' i  /;"C0021966;C0221138;C0486293;C1318293";NA;NA;albumin to creatinine ratio i
1021;> i;"C0021966;C0221138";NA;NA;i
1021;- f $nmbr$ . $nmbr$ ( - i - $nmbr$ . $nmbr$ );"C0016327;C0021966;C0221138";NA;NA;f $nmbr$ $nmbr$ i $nmbr$ $nmbr$
1021;- b - i —;"C0021966;C0221138";NA;NA;b i
1021;- b - i -;"C0021966;C0221138";NA;NA;b i
1021;$nmbr$ — — bh — i;"C0004684;C0004952;C0021966;C0221138;C1412800;C2986890;C4284594;C4321407";NA;NA;$nmbr$ bh i
1021;$nmbr$ tq - fi ' i;"C0021966;C0221138;C3555502;C4050619";NA;NA;$nmbr$ tq fi i
1021;$nmbr$ t i;"C0021966;C0221138;C2603360";NA;NA;$nmbr$ t i
1021;$nmbr$ i $nmbr$ ( $nmbr$ i . $nmbr$ );"C0021966;C0221138";NA;NA;$nmbr$ i $nmbr$ $nmbr$ i $nmbr$
1021;$nmbr$ . i $nmbr$ ( $nmbr$ . $nmbr$ i - $nmbr$ . $nmbr$ );"C0021966;C0221138";NA;NA;$nmbr$ i $nmbr$ $nmbr$ $nmbr$ i $nmbr$ $nmbr$
1021;$nmbr$ . $nmbr$ to . $nmbr$ . i . iot;"C0006196;C0021966;C0221138";NA;NA;$nmbr$ $nmbr$ to $nmbr$ i iot
1021;$nmbr$ . $nmbr$ i $nmbr$ . $nmbr$ ( n = $nmbr$ ) a;"C0021966;C0221138";NA;NA;$nmbr$ $nmbr$ i $nmbr$ $nmbr$ n $nmbr$ a
1021;$nmbr$ . $nmbr$ i $nmbr$ . $nmbr$ ( n = $nmbr$ );"C0021966;C0221138";NA;NA;$nmbr$ $nmbr$ i $nmbr$ $nmbr$ n $nmbr$
1021;$nmbr$ . $nmbr$ ( i $nmbr$ . s );"C0021966;C0221138";NA;NA;$nmbr$ $nmbr$ i $nmbr$ s
1021;$nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ - $nmbr$ . i $nmbr$ i );"C0021966;C0221138";NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ i $nmbr$ i
1021;$nmbr$ - i;"C0021966;C0221138";NA;NA;$nmbr$ i
1021;$nmbr$ ( $nmbr$ i . i );"C0021966;C0221138";NA;NA;$nmbr$ $nmbr$ i i
1020;trial completers;C0008976;NA;NA;trial completers
1020;trial $nmbr$;C0008976;NA;NA;trial $nmbr$
1020;trial;C0008976;NA;NA;trial
1020;time in trial;"C0008976;C0040223;C0150312;C0332285;C1707101;C3541383";NA;NA;time in trial
1020;pooled trials * n = $nmbr$;"C0008976;C1709595;C2349200;C4522255";NA;NA;pooled trials n $nmbr$
1020;non - trial treatment during hospital stay;"C0008976;C0039798;C0087111;C1518422;C1522326;C1533734;C1705169;C3489408;C3538994;C3887704";NA;NA;non trial treatment during hospital stay
1020;non - trial p blocker;"C0008976;C1518422";NA;NA;non trial p blocker
1009;arial flutter or fibrillation;"C0016385;C0232197;C2242390";NA;NA;arial flutter or fibrillation
1020;no in - trial stroke n = $nmbr$  $nmbr$;"C0008976;C0038454;C0150312;C0332285;C1707101;C4554100";NA;NA;no in trial stroke n $nmbr$ $nmbr$
1020;lipid trial participantss;"C0008976;C0023779";NA;NA;lipid trial participantss
1020;lipid trial participantsk;"C0008976;C0023779";NA;NA;lipid trial participantsk
1020;end of trial;"C0008976;C0444930;C2746065";NA;NA;end of trial
1020;enact - $nmbr$ trial rerandomization to natalizumab ( n = $nmbr$ );"C0008976;C1172734";NA;NA;enact $nmbr$ trial rerandomization to natalizumab n $nmbr$
1020;enact - $nmbr$ trial;C0008976;NA;NA;enact $nmbr$ trial
1020;dual iv - end of trial hba $nmbr$ c;"C0008976;C0019016;C0205173;C0444930;C0444972;C1554184;C1825777;C2746065;C3538758";NA;NA;dual iv end of trial hba $nmbr$ c
1020;dual ii - end of trial hba $nmbr$ c;"C0008976;C0019016;C0205173;C0444930;C0444967;C1554184;C1825777;C2746065;C3538758";NA;NA;dual ii end of trial hba $nmbr$ c
1020;completed trial;"C0008976;C0205197;C3854010";NA;NA;completed trial
1020;all trials;C0008976;NA;NA;all trials
1019;ure;NA;NA;NA;ure
1019;pre - specified trial endpoints;"C0008976;C2349179;C2826245";NA;NA;pre specified trial endpoints
1019;cure trial;"C0008976;C1880198";NA;NA;cure trial
1018;variables .;C0439828;NA;NA;variables
1018;variables *;C0439828;NA;NA;variables
1018;variables $nmbr$;C0439828;NA;NA;variables $nmbr$
1018;variables;C0439828;NA;NA;variables
1018;variable ' ! ';"C0439828;C4553760";NA;NA;variable
1018;values were calculated using t tests for continuous variables and chi - square;"C0042295;C0439828;C0444686;C0549178;C0871472;C1441506;C1524063;C1552646";NA;NA;values were calculated using t tests for continuous variables and chi square
1018;stratification variables;"C0439828;C1514983";NA;NA;stratification variables
1018;diary variables  mean ( sd );"C0376660;C0439828;C0444504;C2347634;C2348143;C2699239";NA;NA;diary variables mean sd
1018;continuous variables  mean ( sd ) ^;"C0439828;C0444504;C0549178;C2347634;C2348143;C2699239";NA;NA;continuous variables mean sd
1018;continuous variables  mean ( sd );"C0439828;C0444504;C0549178;C2347634;C2348143;C2699239";NA;NA;continuous variables mean sd
1018;categorical variables . no . ( % ) * ’;"C0439828;C0683312;C3889287";NA;NA;categorical variables no
1018;categorical variables;"C0439828;C0683312;C3889287";NA;NA;categorical variables
1018;baseline variable;"C0168634;C0439828;C1442488;C4553760";NA;NA;baseline variable
1018;adjusted for all baseline variables and interaction between acei and baseline upb;"C0168634;C0439828;C0456081;C1442488;C1704675";NA;NA;adjusted for all baseline variables and interaction between acei and baseline upb
1018;adjusted for all baseline variables $nmbr$;"C0168634;C0439828;C0456081;C1442488";NA;NA;adjusted for all baseline variables $nmbr$
1018;action tested is between the continuous variable and treatment .;"C0039798;C0087111;C0392366;C0439828;C0441472;C0549178;C1522326;C1533734;C1705169;C3266814;C3538994;C3887704;C4553760";NA;NA;action tested is between the continuous variable and treatment
1017;quintile ( n );C1508496;NA;NA;quintile n
1017;quintile $nmbr$ ( $nmbr$ . $nmbr$ % - $nmbr$ . $nmbr$ % ) ( n = $nmbr$ );C1508496;NA;NA;quintile $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ n $nmbr$
1017;quintile  range  mg / dl;"C0439269;C1508496;C1514721;C2348147;C3542016";NA;NA;quintile range mg dl
1017;quicki;NA;NA;NA;quicki
1016;suit quartile $nmbr$ ( b $nmbr$ . $nmbr$ nmol / mmol ) ( n = $nmbr$ );"C1532564;C1533073;C2828255";NA;NA;suit quartile $nmbr$ b $nmbr$ $nmbr$ nmol mmol n $nmbr$
1016;suit quartile $nmbr$ ( > $nmbr$ . $nmbr$ nmol / mmol ) ( n = $nmbr$ );"C1532564;C1533073;C2828255";NA;NA;suit quartile $nmbr$ $nmbr$ $nmbr$ nmol mmol n $nmbr$
1016;suit quartile $nmbr$ ( > $nmbr$ . $nmbr$ - < $nmbr$ . $nmbr$ nmol / mmol ) ( n = $nmbr$ );"C1532564;C1533073;C2828255";NA;NA;suit quartile $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ nmol mmol n $nmbr$
1016;estradiol quartiles;"C0014912;C2828255";NA;NA;estradiol quartiles
1015;teriparatide n / n ( % );C0070093;NA;NA;teriparatide n n
1015;teriparatide ( n   =   $nmbr$ );C0070093;NA;NA;teriparatide n $nmbr$
1015;interquartile range height — cm;"C0489786;C1711350";NA;NA;interquartile range height cm
1015;interquartile range;C1711350;NA;NA;interquartile range
1015;bmi = body mass index  bnp = brain natriuretic peptide  dbp = diastolic blood pressure  gfr = glomerular filtration rate  hr = heart rate  iqr = interquartile range  kccq = kansas city cardiomyopathy questionnaire  n = number  nt = n - terminal  nyha = new york heart association  sbp = systolic blood pressure;"C0004083;C0005767;C0005768;C0005823;C0012000;C0017654;C0018787;C0018810;C0027976;C0033095;C0039155;C0054015;C0085805;C0205088;C0229664;C0237753;C0332126;C0439849;C0449788;C0460139;C0536221;C0596306;C0699792;C1095989;C1271104;C1272641;C1275491;C1305855;C1306345;C1417808;C1424601;C1449832;C1561549;C1705314;C1705315;C1711350;C2982014;C3476086;C3476798;C3813197;C3889152;C4050156;C4281799;C4283901;C4284008;C4284038";NA;NA;bmi body mass index bnp brain natriuretic peptide dbp diastolic blood pressure gfr glomerular filtration rate hr heart rate iqr interquartile range kccq kansas city cardiomyopathy questionnaire n number nt n terminal nyha new york heart association sbp systolic blood pressure
1015;* interquartile range;C1711350;NA;NA;interquartile range
1015;( interquartile range ) ( mm );"C1711350;C4330985;C4554674";NA;NA;interquartile range mm
1014;sleeping problems in the past $nmbr$ weeks ( % );"C0700201;C2987125";NA;NA;sleeping problems in the past $nmbr$ weeks
1014;restriction in normal activities in the past $nmbr$ weeks;"C0443288;C2987125;C4697852";NA;NA;restriction in normal activities in the past $nmbr$ weeks
1014;night - time awakenings in past $nmbr$ weeks prior to baseline;"C0168634;C0860510;C1442488;C2987125";NA;NA;night time awakenings in past $nmbr$ weeks prior to baseline
1014;night - time awakenings in past $nmbr$ weeks ( sd ) *;"C0860510;C2699239;C2987125";NA;NA;night time awakenings in past $nmbr$ weeks sd
1014;angina ( past $nmbr$ weeks );"C0002962;C2987125";NA;NA;angina past $nmbr$ weeks
1013;weekly iss {;"C0332174;C1740819;C1845118";NA;NA;weekly iss
1013;weekly iss $nmbr$;"C0332174;C1740819;C1845118";NA;NA;weekly iss $nmbr$
1013;weekly;C0332174;NA;NA;weekly
1013;patients with weekly iss mid response  n ( % ) v;"C0030705;C0332174;C0871261;C1704632;C1706817;C1740819;C1845118;C2911692";NA;NA;patients with weekly iss mid response n v
1013;median ( $nmbr$ % ci ) time to weekly iss mid response up to week $nmbr$ ( wk ) f;"C0008107;C0016327;C0034746;C0332174;C0439230;C0549183;C0876920;C1740819;C1845118;C2347635;C2348144;C2939193;C3259781";NA;NA;median $nmbr$ ci time to weekly iss mid response up to week $nmbr$ wk f
1013;change from baseline to week $nmbr$ in weekly iss;"C0168634;C0332174;C0392747;C0439230;C0443172;C1442488;C1705241;C1740819;C1845118;C4319952";NA;NA;change from baseline to week $nmbr$ in weekly iss
1013;baseline weekly iss;"C0168634;C0332174;C1442488;C1740819;C1845118";NA;NA;baseline weekly iss
1012;weeks;C0439230;NA;NA;weeks
1012;week   $nmbr$;"C0332174;C0439230";NA;NA;week $nmbr$
1012;week and;"C0332174;C0439230";NA;NA;week and
1012;week - $nmbr$ changea;"C0332174;C0439230;C4349366";NA;NA;week $nmbr$ changea
1012;week $nmbr$ — mg / liter ^;"C0024671;C0026410;C0332174;C0439230;C0439269;C0475211;C1960952;C2346927;C4321396;C4521761";NA;NA;week $nmbr$ mg liter
1012;week $nmbr$ — mg / liter;"C0024671;C0026410;C0332174;C0439230;C0439269;C0475211;C1960952;C2346927;C4321396;C4521761";NA;NA;week $nmbr$ mg liter
1012;week $nmbr$ responders  ( n = $nmbr$ );"C0332174;C0439230";NA;NA;week $nmbr$ responders n $nmbr$
1012;week $nmbr$ overall population;"C0032659;C0282416;C0332174;C0439230;C1257890;C1561607";NA;NA;week $nmbr$ overall population
1012;week $nmbr$ outcomes;"C0332174;C0439230;C1274040";NA;NA;week $nmbr$ outcomes
1012;week $nmbr$ outcome;"C0332174;C0439230;C1274040";NA;NA;week $nmbr$ outcome
1012;week $nmbr$ crp;"C0332174;C0439230;C3890735;C4048285";NA;NA;week $nmbr$ crp
1012;week $nmbr$ a;"C0332174;C0439230";NA;NA;week $nmbr$ a
1012;week $nmbr$ / et;"C0040028;C0332174;C0439230";NA;NA;week $nmbr$ et
1012;week $nmbr$ - baseline;"C0168634;C0332174;C0439230;C1442488";NA;NA;week $nmbr$ baseline
1012;week $nmbr$ * ’ ’;"C0332174;C0439230";NA;NA;week $nmbr$
1012;week $nmbr$ *;"C0332174;C0439230";NA;NA;week $nmbr$
1012;week $nmbr$ ( non - ee responders );"C0332174;C0439230;C1518422";NA;NA;week $nmbr$ non ee responders
1012;week $nmbr$ ( mmol / l );"C0332174;C0439230;C1532563";NA;NA;week $nmbr$ mmol l
1012;week $nmbr$ ( itt population );"C0032659;C0332174;C0439230;C1257890";NA;NA;week $nmbr$ itt population
1012;week $nmbr$ ( geometric mean  cv );"C0332174;C0439230;C2986759;C3538987;C4048877;C4318503";NA;NA;week $nmbr$ geometric mean cv
1012;week $nmbr$ ( before ee );"C0332174;C0439230";NA;NA;week $nmbr$ before ee
1012;week $nmbr$ % of patients;"C0030705;C0332174;C0439230";NA;NA;week $nmbr$ of patients
1012;week $nmbr$  % ( n ) §;"C0332174;C0439230";NA;NA;week $nmbr$ n
1012;week $nmbr$  % ( n ) j;"C0332174;C0439230";NA;NA;week $nmbr$ n j
1012;week $nmbr$  % ( n ) ^;"C0332174;C0439230";NA;NA;week $nmbr$ n
1012;week $nmbr$  % ( n ) * *;"C0332174;C0439230";NA;NA;week $nmbr$ n
1012;week $nmbr$  % ( n ) $nmbr$;"C0332174;C0439230";NA;NA;week $nmbr$ n $nmbr$
1012;week $nmbr$  % ( n ) #;"C0332174;C0439230";NA;NA;week $nmbr$ n
1012;week $nmbr$  % ( n );"C0332174;C0439230";NA;NA;week $nmbr$ n
1012;week $nmbr$;"C0332174;C0439230";NA;NA;week $nmbr$
1012;week;"C0332174;C0439230";NA;NA;week
1012;apob ( week $nmbr$ );"C0003593;C0332174;C0439230;C3252643";NA;NA;apob week $nmbr$
1012;acr $nmbr$ week $nmbr$ responders  ( n = $nmbr$ );"C0332174;C0439230;C1412134;C1515941";NA;NA;acr $nmbr$ week $nmbr$ responders n $nmbr$
1012;> $nmbr$ weeks;C0439230;NA;NA;$nmbr$ weeks
1012;> $nmbr$ servings / wk ( n = $nmbr$ );"C0332174;C0439230;C1519269";NA;NA;$nmbr$ servings wk n $nmbr$
1012;> $nmbr$ / week;"C0332174;C0439230";NA;NA;$nmbr$ week
1012;> $nmbr$ - $nmbr$ mg / week;"C0024671;C0026410;C0332174;C0439230;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ $nmbr$ mg week
1012;treated patients with baseline and $nmbr$ post - baseline ef ﬁ cacy measurement  bp value for treatment group comparison ( proactive intervention vs usual care ) was calculated based on a $nmbr$ - sample t test for continuous variables and chi - square test for categorical variables  cbp values were measured at baseline ( week $nmbr$ )  whereas information on all of the other variables listed was collected during screening . abbreviations : bmi  body mass index  bp  blood pressure  chd  coronary heart disease  crucial  cluster randomized usual care vs caduet investigation assessing long - term - risk  dbp  diastolic blood pressure  dm  diabetes mellitus  hdl - c  high - density lipoprotein cholesterol  ldl - c  low - density lipoprotein cholesterol  sd  standard deviation  sbp  systolic blood pressure  tc  total cholesterol  tg  triglyceride .;"C0000723;C0005823;C0008041;C0011849;C0012641;C0018787;C0023822;C0030705;C0034656;C0035647;C0037623;C0039411;C0039798;C0040642;C0041004;C0041405;C0041698;C0042295;C0065055;C0085805;C0087111;C0168634;C0184661;C0201950;C0205251;C0220825;C0220908;C0220909;C0237403;C0242485;C0280604;C0332174;C0332293;C0370003;C0374505;C0428883;C0439230;C0439828;C0441833;C0443252;C0444686;C0444706;C0488055;C0543421;C0549178;C0683312;C0687676;C0687744;C0745732;C0871420;C0871470;C0871472;C0886296;C1149372;C1257890;C1261322;C1273869;C1305855;C1306620;C1330119;C1415692;C1419788;C1441506;C1442488;C1516048;C1516695;C1516698;C1519504;C1522326;C1522609;C1527178;C1533716;C1533734;C1550472;C1552578;C1698960;C1704687;C1705169;C1705428;C1705429;C1705938;C1705981;C1707455;C1708288;C1710031;C1710032;C1710477;C1824670;C1947933;C2347026;C2348164;C2699239;C2986530;C3272378;C3272447;C3274822;C3469826;C3538928;C3538994;C3539643;C3541902;C3542407;C3815594;C3887704;C3887980;C3889287;C3890211;C4048187;C4318478;C4321351;C4522122;C4522223;C4552904";NA;NA;treated patients with baseline and $nmbr$ post baseline ef cacy measurement bp value for treatment group comparison proactive intervention vs usual care was calculated based on a $nmbr$ sample t test for continuous variables and chi square test for categorical variables cbp values were measured at baseline week $nmbr$ whereas information on all of the other variables listed was collected during screening abbreviations bmi body mass index bp blood pressure chd coronary heart disease crucial cluster randomized usual care vs caduet investigation assessing long term risk dbp diastolic blood pressure dm diabetes mellitus hdl c high density lipoprotein cholesterol ldl c low density lipoprotein cholesterol sd standard deviation sbp systolic blood pressure tc total cholesterol tg triglyceride
1012;total cholesterol ( week $nmbr$ );"C0201950;C0332174;C0439230;C0543421";NA;NA;total cholesterol week $nmbr$
1012;tdi total score ( week $nmbr$;"C0205976;C0332174;C0439230;C2674784;C2964552;C3714807";NA;NA;tdi total score week $nmbr$
1012;tcz - sc $nmbr$ mg every other week ( n = $nmbr$ );"C0024671;C0026410;C0282380;C0332174;C0439230;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;tcz sc $nmbr$ mg every other week n $nmbr$
1012;sgrq total score ( week;"C0332174;C0439230;C2964552";NA;NA;sgrq total score week
1012;responders of three - item end point at $nmbr$ weeks *;"C0205449;C0439230;C1551338;C2349179;C2826544;C4554251";NA;NA;responders of three item end point at $nmbr$ weeks
   7;p - value ( overall );"C0282416;C1561607;C1709380";NA;NA;p value overall
   7;p - value ( lnteraction );C1709380;NA;NA;p value lnteraction
1012;received an oral aha within $nmbr$ weeks prior to screening;"C0050451;C0220908;C0220909;C0439230;C0442027;C0772110;C1514756;C1698960;C1710031;C1710032;C1710477;C2348164;C4521986";NA;NA;received an oral aha within $nmbr$ weeks prior to screening
1012;ratio to baseline in eosinophil count at week $nmbr$  geometric mean ( se on loge scale ) cells / ll;"C0007584;C0007634;C0036919;C0168634;C0175659;C0200638;C0332174;C0349674;C0439230;C0456603;C0750879;C1442488;C1547037;C1947916;C2697934;C2986759";NA;NA;ratio to baseline in eosinophil count at week $nmbr$ geometric mean se on loge scale cells ll
1012;randomized  double - blind reversal phase ( baseline = week $nmbr$ );"C0013072;C0034656;C0168634;C0205390;C0332174;C0439230;C0443290;C1442488;C1710475;C3815594";NA;NA;randomized double blind reversal phase baseline week $nmbr$
1012;randomised patients with basdai assessment at baseline and week $nmbr$  n;"C0168634;C0332174;C0439230;C0679830;C1442488;C1998004";NA;NA;randomised patients with basdai assessment at baseline and week $nmbr$ n
1012;pt baseline ( week $nmbr$ );"C0032743;C0168634;C0332174;C0439230;C0699718;C1442488";NA;NA;pt baseline week $nmbr$
1012;proportion of patients in corticosteroid - free clinical remission at week $nmbr$;"C0001617;C0030705;C0205210;C0332174;C0332296;C0439230;C0544452;C0687702;C1709707;C1880497;C1996904;C3536709";NA;NA;proportion of patients in corticosteroid free clinical remission at week $nmbr$
1012;percent change from baseline at week $nmbr$;"C0332174;C0439230;C3272907";NA;NA;percent change from baseline at week $nmbr$
1012;patients with dactylitis at week $nmbr$  n ( % );"C0030705;C0239161;C0332174;C0439230";NA;NA;patients with dactylitis at week $nmbr$ n
1012;pasi # $nmbr$ at week $nmbr$;"C0332174;C0439230;C4528685";NA;NA;pasi $nmbr$ at week $nmbr$
1012;p $nmbr$ min twice / week;"C0332174;C0369773;C0439230;C0702093;C1524029;C1720725;C1948050;C2603361;C3813700";NA;NA;p $nmbr$ min twice week
1012;open - label phase ( baseline = week $nmbr$ );"C0168634;C0205390;C0332174;C0439230;C1442488;C1709323;C1710475";NA;NA;open label phase baseline week $nmbr$
1012;night - time awakenings / week;"C0332174;C0439230;C0860510";NA;NA;night time awakenings week
1012;mtx ≥ $nmbr$ mg / week;"C0024671;C0025677;C0026410;C0332174;C0439230;C0439269;C1417487;C1960952;C2346927;C4321396;C4521761";NA;NA;mtx $nmbr$ mg week
1012;mtx £ $nmbr$ mg / week;"C0024671;C0025677;C0026410;C0332174;C0439230;C0439269;C1417487;C1960952;C2346927;C4321396;C4521761";NA;NA;mtx $nmbr$ mg week
1012;mtx sio mg / week;"C0024671;C0025677;C0026410;C0332174;C0439230;C0439269;C1039355;C1417487;C1960952;C2346927;C4321396;C4521761";NA;NA;mtx sio mg week
1012;mtx exposure ( mg / week );"C0024671;C0025677;C0026410;C0274281;C0332157;C0332174;C0439230;C0439269;C1417487;C1960952;C2346927;C4321396;C4521761";NA;NA;mtx exposure mg week
1012;ixekizumab every $nmbr$ weeks ( n = $nmbr$ );"C0439230;C3489764";NA;NA;ixekizumab every $nmbr$ weeks n $nmbr$
1012;habitual fish intake : < $nmbr$ servings / wk ( n = $nmbr$ );"C0205353;C0332174;C0439230;C0556216;C1519269";NA;NA;habitual fish intake $nmbr$ servings wk n $nmbr$
1012;evaluable for acr $nmbr$ at week $nmbr$  n;"C0332174;C0439230;C1412134;C1515941;C1516986";NA;NA;evaluable for acr $nmbr$ at week $nmbr$ n
1012;endpoint week $nmbr$;"C0332174;C0439230;C2349179;C2826544";NA;NA;endpoint week $nmbr$
1012;dose ratio at week $nmbr$ ( $nmbr$ % cl );"C0178602;C0332174;C0439230;C0456603;C0596019;C0869039;C1114758;C1547037";NA;NA;dose ratio at week $nmbr$ $nmbr$ cl
1012;disease activity outcomes ( itt population ) week $nmbr$;"C0032659;C0205177;C0332174;C0439167;C0439230;C0441655;C0679250;C1257890;C1274040;C1292728;C1561536;C3542417;C3668946;C4049938;C4049939";NA;NA;disease activity outcomes itt population week $nmbr$
1012;db baseline ( week $nmbr$ );"C0168634;C0332174;C0439230;C1418892;C1442488";NA;NA;db baseline week $nmbr$
1012;daytime symptoms more than twice per week;"C0332169;C0332174;C0439230;C0683368;C1457887;C1720725;C1948050";NA;NA;daytime symptoms more than twice per week
1012;concomitant use of nsaids to week $nmbr$;"C0003211;C0332174;C0439230;C0521115;C1524063";NA;NA;concomitant use of nsaids to week $nmbr$
1012;complete clinical response at week $nmbr$;"C0205197;C0332174;C0439230;C3853530;C4055223;C4283785";NA;NA;complete clinical response at week $nmbr$
1012;clinical efficacy at week $nmbr$;"C0087113;C0332174;C0439230";NA;NA;clinical efficacy at week $nmbr$
1012;change to   week $nmbr$;"C0332174;C0392747;C0439230;C0443172;C1705241;C4319952";NA;NA;change to week $nmbr$
 996;diabetics ( n = $nmbr$ );C0241863;NA;NA;diabetics n $nmbr$
1012;ldl particle size ( week $nmbr$ );"C0332174;C0439230;C3641256";FALSE;1068;ldl particle size week $nmbr$
1012;change to week $nmbr$ *;"C0332174;C0392747;C0439230;C0443172;C1705241;C4319952";NA;NA;change to week $nmbr$
1012;change to week $nmbr$;"C0332174;C0392747;C0439230;C0443172;C1705241;C4319952";NA;NA;change to week $nmbr$
1012;change in fev $nmbr$ at week $nmbr$;"C0332174;C0392747;C0439230;C0443172;C1705241;C3714541;C4319952";NA;NA;change in fev $nmbr$ at week $nmbr$
1012;change from baseline to week $nmbr$ in weekly size of largest hive score;"C0042109;C0168634;C0221232;C0332174;C0392747;C0439230;C0443172;C0443228;C0449820;C0456389;C1442488;C1705241;C4050231;C4319952";NA;NA;change from baseline to week $nmbr$ in weekly size of largest hive score
1012;change from baseline to week $nmbr$ in dlqi scorez;"C0168634;C0332174;C0392747;C0439230;C0443172;C1442488;C1705241;C3899393;C4319952";NA;NA;change from baseline to week $nmbr$ in dlqi scorez
1012;change from baseline to week $nmbr$;"C0168634;C0332174;C0392747;C0439230;C0443172;C1442488;C1705241;C4319952";NA;NA;change from baseline to week $nmbr$
1012;cfb at week $nmbr$;"C0009002;C0332174;C0439230;C1824728";NA;NA;cfb at week $nmbr$
1012;calculated ldl cholesterol ( week $nmbr$ );"C0023824;C0202117;C0332174;C0439230;C0444686;C1441506";NA;NA;calculated ldl cholesterol week $nmbr$
1012;< $nmbr$ weeks;C0439230;NA;NA;$nmbr$ weeks
1012;< $nmbr$ week;"C0332174;C0439230";NA;NA;$nmbr$ week
1012;- - week $nmbr$ - -;"C0332174;C0439230";NA;NA;week $nmbr$
1012;( week );"C0332174;C0439230";NA;NA;week
1012;% change from baseline to week $nmbr$;"C0168634;C0332174;C0392747;C0439230;C0443172;C1442488;C1705241;C4319952";NA;NA;change from baseline to week $nmbr$
1012;$nmbr$ wk;"C0332174;C0439230";NA;NA;$nmbr$ wk
1012;$nmbr$ week to $nmbr$ month;"C0332174;C0332177;C0439230;C0439231";NA;NA;$nmbr$ week to $nmbr$ month
1012;$nmbr$ week;"C0332174;C0439230";NA;NA;$nmbr$ week
1012;$nmbr$ min twice / week;"C0332174;C0439230;C0702093;C1524029;C1720725;C1948050;C3813700";NA;NA;$nmbr$ min twice week
1012;$nmbr$ / week ( n = $nmbr$ );"C0332174;C0439230";NA;NA;$nmbr$ week n $nmbr$
1012;$nmbr$ / week;"C0332174;C0439230";NA;NA;$nmbr$ week
1012;$nmbr$ - wk kaplan - meier rate  %;"C0332174;C0439230;C0871208;C1521828";NA;NA;$nmbr$ wk kaplan meier rate
1012;$nmbr$ - $nmbr$ / week ( n = $nmbr$ ) $nmbr$ - $nmbr$ / week ( n = $nmbr$ );"C0332174;C0439230";NA;NA;$nmbr$ $nmbr$ week n $nmbr$ $nmbr$ $nmbr$ week n $nmbr$
1012;$nmbr$ - $nmbr$ / week ( n = $nmbr$ );"C0332174;C0439230";NA;NA;$nmbr$ $nmbr$ week n $nmbr$
1012;$nmbr$ - $nmbr$ / week;"C0332174;C0439230";NA;NA;$nmbr$ $nmbr$ week
1011;parenteral anticoagulation;"C0003281;C0030547;C2917212;C2919015;C3537050;C4522267";NA;NA;parenteral anticoagulation
1011;intended duration of anticoagulation;"C0003281;C0449238;C1283828;C1551357;C2917212;C2919015;C2926735;C3537050";NA;NA;intended duration of anticoagulation
1011;antimalarial;"C0003374;C3536844;C4552582";NA;NA;antimalarial
1010;rvalue for interaction;C1704675;NA;NA;rvalue for interaction
1010;rvalue;NA;NA;NA;rvalue
1010;pvaluefor interaction $nmbr$ - $nmbr$;C1704675;NA;NA;pvaluefor interaction $nmbr$ $nmbr$
1010;interaction p - valuef;C1704675;NA;NA;interaction p valuef
1010;interaction j $nmbr$ - valuet;C1704675;NA;NA;interaction j $nmbr$ valuet
1010;interaction : treatment by psoriasis p valueb;"C1704675;C3258078";NA;NA;interaction treatment by psoriasis p valueb
1009;type of atrial fibrillation — no . / total no . ( % );"C0004238;C0332307;C0344434;C0439175;C0439810;C1547052;C1963067";NA;NA;type of atrial fibrillation no total no
1009;type of atrial fibrillation - n ( % );"C0004238;C0332307;C0344434;C1547052;C1963067";NA;NA;type of atrial fibrillation n
1009;type of atrial fibrillation ( n = $nmbr$ $nmbr$ );"C0004238;C0332307;C0344434;C1547052;C1963067";NA;NA;type of atrial fibrillation n $nmbr$ $nmbr$
1009;type of atrial fibrillation ( % );"C0004238;C0332307;C0344434;C1547052;C1963067";NA;NA;type of atrial fibrillation
1009;type of atrial fibrillation  no . / total no . ( % );"C0004238;C0332307;C0344434;C0439175;C0439810;C1547052;C1963067";NA;NA;type of atrial fibrillation no total no
1009;type of atrial fibrillation  n ( % );"C0004238;C0332307;C0344434;C1547052;C1963067";NA;NA;type of atrial fibrillation n
1009;type of atrial fibrillation;"C0004238;C0332307;C0344434;C1547052;C1963067";NA;NA;type of atrial fibrillation
1009;rate of atrial fibrillation;"C0004238;C0344434;C0871208;C1521828;C1963067";NA;NA;rate of atrial fibrillation
1009;no atrial fibrillation;"C0004238;C0344434;C1963067";NA;NA;no atrial fibrillation
1009;history of atrial fibrillation / flutter  ( % );"C0016385;C0232197;C0729790;C1998417;C2242390";NA;NA;history of atrial fibrillation flutter
1009;history of atrial fibrillation / flutter;"C0016385;C0232197;C0729790;C1998417;C2242390";NA;NA;history of atrial fibrillation flutter
1009;first episode of atrial fibrillation ( vs . recurrent episode ) — no . ( % ) f;"C0004238;C0016327;C0205435;C0332189;C0344434;C0443287;C1279901;C1963067";NA;NA;first episode of atrial fibrillation vs recurrent episode no f
1009;fibrillation / flutter );"C0016385;C0232197;C2242390";NA;NA;fibrillation flutter
1009;ecg atrial fibrillation  n ( % );"C0004238;C0344434;C1623258;C1963067";NA;NA;ecg atrial fibrillation n
1009;duration of last qualifying episode of atrial fibrillation > $nmbr$ days;"C0004238;C0332189;C0344434;C0439228;C0449238;C1514624;C1963067;C2926735";NA;NA;duration of last qualifying episode of atrial fibrillation $nmbr$ days
1009;current atrial fibrillation or flutter on ecg;"C0004238;C0016385;C0344434;C0521116;C1623258;C1705970;C1963067;C2242390";NA;NA;current atrial fibrillation or flutter on ecg
1009;atrial flutter / fibrillation;C0155709;NA;NA;atrial flutter fibrillation
1009;atrial flutter;"C0004239;C0344423;C1963068";NA;NA;atrial flutter
1009;atrial fibrillation — no . / total no . ( % );"C0004238;C0344434;C0439175;C0439810;C1963067";NA;NA;atrial fibrillation no total no
1009;atrial fibrillation — no . ( % );"C0004238;C0344434;C1963067";NA;NA;atrial fibrillation no
1009;atrial fibrillation type  n ( % );"C0004238;C0332307;C0344434;C1547052;C1963067";NA;NA;atrial fibrillation type n
1009;atrial fibrillation pattern;"C0004238;C0344434;C0449774;C1963067";NA;NA;atrial fibrillation pattern
1009;atrial fibrillation or flutter — no . ( % );"C0004238;C0016385;C0344434;C1963067;C2242390";NA;NA;atrial fibrillation or flutter no
1009;atrial fibrillation or flutter ( ecg ) §;"C0004238;C0016385;C0344434;C1623258;C1963067;C2242390";NA;NA;atrial fibrillation or flutter ecg
1009;atrial fibrillation or flutter;"C0004238;C0016385;C0344434;C1963067;C2242390";NA;NA;atrial fibrillation or flutter
1009;atrial fibrillation onset;"C0004238;C0206132;C0332162;C0344434;C1963067";NA;NA;atrial fibrillation onset
1009;atrial fibrillation alone );"C0004238;C0205171;C0344434;C0439044;C0679994;C1963067";NA;NA;atrial fibrillation alone
1009;atrial fibrillation / flutter  n ( % );C0155709;NA;NA;atrial fibrillation flutter n
1009;atrial fibrillation / flutter;C0155709;NA;NA;atrial fibrillation flutter
1009;atrial fibrillation / atrial flutter  %;C0155709;NA;NA;atrial fibrillation atrial flutter
1009;atrial fibrillation . no . ( % );"C0004238;C0344434;C1963067";NA;NA;atrial fibrillation no
1009;atrial fibrillation ( % );"C0004238;C0344434;C1963067";NA;NA;atrial fibrillation
1009;atrial fibrillation !;"C0004238;C0344434;C1963067";NA;NA;atrial fibrillation
1009;atrial fibrillation    n   ( % );"C0004238;C0344434;C1963067";NA;NA;atrial fibrillation n
1009;atrial fibrillation  n ( % );"C0004238;C0344434;C1963067";NA;NA;atrial fibrillation n
1009;atrial fibrillation  %;"C0004238;C0344434;C1963067";NA;NA;atrial fibrillation
1009;atrial fibrillation;"C0004238;C0344434;C1963067";NA;NA;atrial fibrillation
1009;af or atrial flutter 卞;"C0004239;C0344423;C0344434;C1963068;C4049859";NA;NA;af or atrial flutter
1009;af or atrial flutter !;"C0004239;C0344423;C0344434;C1963068;C4049859";NA;NA;af or atrial flutter
1009;> $nmbr$ episodes of atrial fibrillation in previous $nmbr$ mo;"C0004238;C0026544;C0205156;C0332177;C0332189;C0344434;C1552607;C1963067";NA;NA;$nmbr$ episodes of atrial fibrillation in previous $nmbr$ mo
1008;naive ( n = $nmbr$ );NA;NA;NA;naive n $nmbr$
1008;iv inotropic drug;C1971835;NA;NA;iv inotropic drug
1008;drug naive;"C0013227;C1254351";NA;NA;drug naive
1007;serum k + level and drug treatment;"C0150270;C0302353;C0441889;C0456079;C1547707;C2946261;C3469597";NA;NA;serum k level and drug treatment
1007;on drug treatment ( % );"C0150270;C3469597";NA;NA;on drug treatment
1007;days of study - drug administration ( % ) * * $nmbr$ day;"C0150270;C2826182;C3469597";NA;NA;days of study drug administration $nmbr$ day
1007;concomitant drug treatment;"C0150270;C0521115;C3469597";NA;NA;concomitant drug treatment
1007;administration of study drug ( % );"C0001554;C0013175;C0013227;C0150270;C0262754;C0557651;C1254351;C1533734;C2603343;C3161471;C3469597";NA;NA;administration of study drug
1006;stool frequency subscore;"C0015733;C0183622;C0376249;C0439603;C0871396;C1561548;C1705502;C3898838;C4321352";NA;NA;stool frequency subscore
1006;sotalol;C0037707;NA;NA;sotalol
1006;socalone ( n = $nmbr$ );NA;NA;NA;socalone n $nmbr$
1005;symbol digit score;"C0449820;C0582802;C0679214;C1698987;C3241971;C4050231";NA;NA;symbol digit score
1005;digit symbol substitution;"C0582802;C0679214;C1555721;C1698987;C1706204;C3241971";NA;NA;digit symbol substitution
1005;b digit symbol substitution  insulin glargine vs standard care;"C0291665;C0582802;C0679214;C0907402;C1442989;C1555721;C1698987;C1706204;C1947933;C2828392;C3241971";NA;NA;b digit symbol substitution insulin glargine vs standard care
1004;total sample = $nmbr$ ( % );"C0370003;C0439175;C0439810;C2347026";NA;NA;total sample $nmbr$
1004;sample sizea;"C0370003;C2347026";NA;NA;sample sizea
1004;no . of events / sample size i i;"C0021966;C0221138;C0370003;C0441471;C0456389;C2347026;C3541888";NA;NA;no of events sample size i i
1004;no . of events / sample size;"C0370003;C0441471;C0456389;C2347026;C3541888";NA;NA;no of events sample size
1004;atwo ‐ sample t ‐ test .;"C0370003;C0871472;C2347026";NA;NA;atwo sample t test
1003;stable angina — no . ( % );C0340288;NA;NA;stable angina no
1003;stable angina ( n = $nmbr$  $nmbr$ );C0340288;NA;NA;stable angina n $nmbr$ $nmbr$
1003;stable angina ( n - $nmbr$  $nmbr$ );C0340288;NA;NA;stable angina n $nmbr$ $nmbr$
1003;stable angina  n ( % );C0340288;NA;NA;stable angina n
1003;stable angina;C0340288;NA;NA;stable angina
1003;rankin scale ≥ $nmbr$;C0451405;NA;NA;rankin scale $nmbr$
1003;histor y of stable angina;C0340288;NA;NA;histor y of stable angina
1003;chronic stable angina;C0340288;NA;NA;chronic stable angina
1002;• unstable angina;C0002965;NA;NA;unstable angina
1002;• hospitalization for unstable angina;"C0002965;C0019993";NA;NA;hospitalization for unstable angina
1002;urgent revascularization because of unstable angina;"C0002965;C0439609;C0581603;C3272275";NA;NA;urgent revascularization because of unstable angina
1002;unstableangina;NA;NA;NA;unstableangina
1002;unstable anginat;"C0443343;C1883468";NA;NA;unstable anginat
1002;unstable anginad;"C0443343;C1883468";NA;NA;unstable anginad
1002;unstable angina §;C0002965;NA;NA;unstable angina
1002;unstable angina requiring hospitalization;"C0002965;C0019993";NA;NA;unstable angina requiring hospitalization
1002;unstable angina > $nmbr$ mo ago;"C0002965;C0026544;C0332177";NA;NA;unstable angina $nmbr$ mo ago
1002;unstable angina *;C0002965;NA;NA;unstable angina
1002;unstable angina  n ( % );C0002965;NA;NA;unstable angina n
1002;unstable;"C0443343;C1883468";NA;NA;unstable
1002;uncodable;NA;NA;NA;uncodable
1002;hospitalization for unstable angina;"C0002965;C0019993";NA;NA;hospitalization for unstable angina
1002;histor y of unstable angina;C0002965;NA;NA;histor y of unstable angina
1002;cvd  mi  stroke  or recurrent ischemia - urgent revascularization  or hospitalization for unstable angina;"C0002965;C0007222;C0019993;C0022116;C0038454;C0439609;C0581603;C1455761;C2945760;C3272275;C3810814;C4321499;C4554100";NA;NA;cvd mi stroke or recurrent ischemia urgent revascularization or hospitalization for unstable angina
1002;* * * unstable angina;C0002965;NA;NA;unstable angina
1001;probable stent thrombosis;"C0033204;C0332148;C3897493";NA;NA;probable stent thrombosis
1001;probable;"C0033204;C0332148";NA;NA;probable
1001;heritable;C0439660;NA;NA;heritable
1000;octi & mate $nmbr$;"C0682323;C1260875";NA;NA;octi mate $nmbr$
1000;octi;NA;NA;NA;octi
1000;mate !;"C0682323;C1260875";NA;NA;mate
1000;mate;"C0682323;C1260875";NA;NA;mate
1000;companion : wake - up stroke;"C0031268;C0038454;C0335343;C0682323;C1170730;C4554100";NA;NA;companion wake up stroke
1000;companion : $nmbr$ - $nmbr$ hours;"C0031268;C0335343;C0439227;C0682323";NA;NA;companion $nmbr$ $nmbr$ hours
 999;empty;C1880497;NA;NA;empty
 999;corticosteroid - free remissioni;"C0001617;C0332296;C1880497;C1996904;C3536709";NA;NA;corticosteroid free remissioni
 998;romania;C0035826;NA;NA;romania
 998;iief - ef domain score  visit $nmbr$ y;"C0449820;C0545082;C1512346;C1880389;C1883221;C2826704;C3541951;C3641331;C4050231";NA;NA;iief ef domain score visit $nmbr$ y
 998;iief - ef domain score  visit $nmbr$ * *;"C0449820;C0545082;C1512346;C1880389;C1883221;C2826704;C3541951;C3641331;C4050231";NA;NA;iief ef domain score visit $nmbr$
 998;ef domain;"C1880389;C1883221;C3541951";NA;NA;ef domain
 998;coumadin;C0699129;NA;NA;coumadin
 998;bilag a  b or c domain score  n ( % );"C0449820;C1440044;C1880389;C1883221;C3541951;C3845933;C4050231";NA;NA;bilag a b or c domain score n
 997;other combination;"C0205195;C1947911;C3811910";NA;NA;other combination
 997;medication taken alone or in combination;"C0013227;C0205171;C0205195;C0439044;C0679994;C1883727;C1947911;C3244316;C3811910;C4284232";NA;NA;medication taken alone or in combination
 997;continuation ( n = $nmbr$ );NA;NA;NA;continuation n $nmbr$
 997;continuation;NA;NA;NA;continuation
 997;combined trials;"C0008976;C0205195";NA;NA;combined trials
 997;combined statin and other lipid - lowering agent use;"C0042153;C0086440;C0205195;C0360714;C0457083;C1947944";NA;NA;combined statin and other lipid lowering agent use
 997;combined n = $nmbr$;C0205195;NA;NA;combined n $nmbr$
 997;combined macro + micro;"C0085672;C0205195;C1553035;C2984010;C3811161;C4049106";NA;NA;combined macro micro
 997;combined insulin / oral hypoglycaemic agent use;"C0205195;C0240016;C0359086";NA;NA;combined insulin oral hypoglycaemic agent use
 997;combined fatal / nonfatal outcomes;"C0205195;C0206277";NA;NA;combined fatal nonfatal outcomes
 997;combined cvd;"C0007222;C0205195";NA;NA;combined cvd
 997;combined ( n = $nmbr$ );C0205195;NA;NA;combined n $nmbr$
 997;combined $nmbr$ - year cvd;"C0007222;C0205195;C0439234;C0439508";NA;NA;combined $nmbr$ year cvd
 997;combined;C0205195;NA;NA;combined
 997;combinationf;NA;NA;NA;combinationf
 997;combination - facilitated pci ( n = $nmbr$ );"C0205195;C1947911;C3811910;C4049621";NA;NA;combination facilitated pci n $nmbr$
 997;combination - facilitated pci ( % );"C0205195;C1947911;C3811910;C4049621";NA;NA;combination facilitated pci
 997;combination ( n = $nmbr$ );"C0205195;C1947911;C3811910";NA;NA;combination n $nmbr$
 997;combination;"C0205195;C1947911;C3811910";NA;NA;combination
 996;total ! by baseline diabetic status;"C0168634;C0241863;C0439175;C0439810;C0449438;C1442488";NA;NA;total by baseline diabetic status
 996;non - diabetics ( n = $nmbr$ );"C0241863;C1518422";NA;NA;non diabetics n $nmbr$
 996;non - diabetics;"C0241863;C1518422";NA;NA;non diabetics
 996;non - diabetic subjects  n = $nmbr$;"C0241863;C0681850;C1518422;C1550501;C1706203;C2349001;C2697811";NA;NA;non diabetic subjects n $nmbr$
 996;non - diabetic patients;"C0241863;C1829939";NA;NA;non diabetic patients
 996;non - diabetic ( n = $nmbr$ );"C0241863;C1518422";NA;NA;non diabetic n $nmbr$
 996;non - diabetic;"C0241863;C1518422";NA;NA;non diabetic
 996;diabetics;C0241863;NA;NA;diabetics
 996;diabeticb;NA;NA;NA;diabeticb
 996;diabetic treatments !;"C0087111;C0241863";NA;NA;diabetic treatments
 996;diabetic therapy use  n ( % ) * no therapy;"C0039798;C0042153;C0087111;C0241863;C0457083;C1363945;C1947944";NA;NA;diabetic therapy use n no therapy
 996;diabetic status  n ( % );"C0241863;C0449438";NA;NA;diabetic status n
 996;diabetic status;"C0241863;C0449438";NA;NA;diabetic status
 996;diabetic patients;"C0030705;C0241863";NA;NA;diabetic patients
 996;diabetic participants !;"C0241863;C0679646";NA;NA;diabetic participants
 996;diabetic participants;"C0241863;C0679646";NA;NA;diabetic participants
 996;diabetic no;C0241863;NA;NA;diabetic no
 996;diabetic ( no );C0241863;NA;NA;diabetic no
 996;diabetic $nmbr$;C0241863;NA;NA;diabetic $nmbr$
 996;diabetic  n ( % );C0241863;NA;NA;diabetic n
 996;diabetic;C0241863;NA;NA;diabetic
 996;by gfr stratum tor diabetic participants  ml / min per $nmbr$ . $nmbr$ m ’ §;"C0017654;C0076836;C0241863;C0369637;C0439445;C0441923;C0679646;C1199517;C1419603;C1424601;C3539732";NA;NA;by gfr stratum tor diabetic participants ml min per $nmbr$ $nmbr$ m
 996;by gfr stratum for diabetic participants  mt / min per $nmbr$ . $nmbr$ m ’ §;"C0017654;C0241863;C0369637;C0441923;C0679646;C0702093;C1424601;C1524029;C3813700";NA;NA;by gfr stratum for diabetic participants mt min per $nmbr$ $nmbr$ m
 996;by baseline diabetic status;"C0168634;C0241863;C0449438;C1442488";NA;NA;by baseline diabetic status
 996;brandomization was stratified by diabetic status .;"C0205363;C0241863;C0449438";NA;NA;brandomization was stratified by diabetic status
 995;previous oral antidiabetic medication use  n ( % );"C0205156;C0935929;C1527415;C1552607";NA;NA;previous oral antidiabetic medication use n
 995;no oral antidiabetic medication;"C0175795;C0442027;C0935929;C4521986";NA;NA;no oral antidiabetic medication
 995;no antidiabetic drug;C0935929;NA;NA;no antidiabetic drug
 968;charm;C0849759;NA;NA;charm
 995;insulin + oral antidiabetic medication ( s );"C0021641;C0175795;C0442027;C0935929;C1533581;C1579433;C3714501;C4521986";NA;NA;insulin oral antidiabetic medication s
 995;duration of oral antidiabetic treatment  y  mean ( sd );"C0442027;C0444504;C0444921;C0935929;C2347634;C2348143;C2699239;C4521986";NA;NA;duration of oral antidiabetic treatment y mean sd
 995;antidiabetic medications;C0935929;NA;NA;antidiabetic medications
 995;antidiabetic medication | |;C0935929;NA;NA;antidiabetic medication
 995;antidiabetic medication;C0935929;NA;NA;antidiabetic medication
 995;antidiabetic drug ‘ i “ j ‘;"C0021966;C0221138;C0935929";NA;NA;antidiabetic drug i j
 995;antidiabetic drug;C0935929;NA;NA;antidiabetic drug
 995;antidiabetic agents;C0935929;NA;NA;antidiabetic agents
 995;antidiabetic agent;C0935929;NA;NA;antidiabetic agent
 995;antidiabetic;C0935929;NA;NA;antidiabetic
 995;> $nmbr$ oral antidiabetic medication;"C0175795;C0442027;C0935929;C4521986";NA;NA;$nmbr$ oral antidiabetic medication
 995;$nmbr$ oral antidiabetic medication;"C0175795;C0442027;C0935929;C4521986";NA;NA;$nmbr$ oral antidiabetic medication
 994;acitretin;C0050559;NA;NA;acitretin
 993;thiazide diuretics;C0012802;NA;NA;thiazide diuretics
 993;thiazide diuretic *;"C0012802;C3536861";NA;NA;thiazide diuretic
 993;thiazide diuretic;"C0012802;C3536861";NA;NA;thiazide diuretic
 993;loop or thiazide diuretic ^;"C0012802;C0445022;C3536861";NA;NA;loop or thiazide diuretic
 993;loop or thiazide diuretic : ! :;"C0012802;C0445022;C3536861";NA;NA;loop or thiazide diuretic
 993;loop or thiazide diuretic #;"C0012802;C0445022;C3536861";NA;NA;loop or thiazide diuretic
 993;loop or thiazide diuretic;"C0012802;C0445022;C3536861";NA;NA;loop or thiazide diuretic
 993;diuretic thiazide;C0012802;NA;NA;diuretic thiazide
 993;any thiazide diuretic;"C0012802;C3536861";NA;NA;any thiazide diuretic
 992;randomly assigned to diuretic;"C0012798;C1516050;C1552601";NA;NA;randomly assigned to diuretic
 992;other diuretic;C0012798;NA;NA;other diuretic
 992;no - diuretics group ( n = $nmbr$ );"C0012798;C0441848";NA;NA;no diuretics group n $nmbr$
 992;diuretics group ( n = $nmbr$ );"C0012798;C0441848";NA;NA;diuretics group n $nmbr$
 992;diuretics ^;C0012798;NA;NA;diuretics
 992;diuretics * *;C0012798;NA;NA;diuretics
 992;diuretics ( % );C0012798;NA;NA;diuretics
 992;diuretics  n ( % );C0012798;NA;NA;diuretics n
 992;diuretics  %;C0012798;NA;NA;diuretics
 992;diuretics;C0012798;NA;NA;diuretics
 992;diureticff;NA;NA;NA;diureticff
 992;diuretic use at baseline;"C0012798;C0042153;C0168634;C0457083;C1442488;C1947944";NA;NA;diuretic use at baseline
 992;diuretic use;"C0012798;C0042153;C0457083;C1947944";NA;NA;diuretic use
 992;diuretic n ( % );C0012798;NA;NA;diuretic n
 992;diuretic drugs ( excluding antialdosterone );"C0012798;C0013227;C0332196;C2828389;C3687832";NA;NA;diuretic drugs excluding antialdosterone
 992;diuretic drugs  n ( % );"C0012798;C0013227;C3687832";NA;NA;diuretic drugs n
 992;diuretic drugs;"C0012798;C0013227;C3687832";NA;NA;diuretic drugs
 992;diuretic agents ( excluding antialdosterone );"C0012798;C0332196;C0450442;C1254351;C1521826;C2828389";NA;NA;diuretic agents excluding antialdosterone
 992;diuretic agents;"C0012798;C0450442;C1254351;C1521826";NA;NA;diuretic agents
 992;diuretic agent;"C0012798;C0450442;C1254351;C1521826";NA;NA;diuretic agent
 992;diuretic ( any );C0012798;NA;NA;diuretic any
 992;diuretic;C0012798;NA;NA;diuretic
 992;diurciic;NA;NA;NA;diurciic
 992;cluster $nmbr$ : reversible  no diuretic ( n = $nmbr$ );"C0012798;C0205343;C1555715;C1704332";NA;NA;cluster $nmbr$ reversible no diuretic n $nmbr$
 992;cluster $nmbr$ : diuretic ( n = $nmbr$ );"C0012798;C1555715;C1704332";NA;NA;cluster $nmbr$ diuretic n $nmbr$
 992;baseiine diuretic;C0012798;NA;NA;baseiine diuretic
 991;use of loop diuretics  n ( % );"C0354100;C1524063";NA;NA;use of loop diuretics n
 991;use of loop diuretics;"C0354100;C1524063";NA;NA;use of loop diuretics
 991;total intravenous loop diuretics  mg;"C0024671;C0026410;C0348016;C0354100;C0439175;C0439269;C0439810;C1960952;C2346927;C4321396;C4521761";NA;NA;total intravenous loop diuretics mg
 991;loop diureties;C0445022;NA;NA;loop diureties
 991;loop diuretics;C0354100;NA;NA;loop diuretics
 991;loop diuretic use;"C0042153;C0354100;C0457083;C1947944;C3536704";NA;NA;loop diuretic use
 991;loop diuretic;"C0354100;C3536704";NA;NA;loop diuretic
 991;intravenous loop diuretics !;"C0348016;C0354100";NA;NA;intravenous loop diuretics
 990;digital clubbing  n ( % );"C0009080;C0149651";NA;NA;digital clubbing n
 989;previous use of digoxin;"C0012265;C0205156;C1524063;C1552607";NA;NA;previous use of digoxin
 989;previous digoxin use ( % );"C0012265;C0042153;C0205156;C0457083;C1552607;C1947944";NA;NA;previous digoxin use
 989;previous digoxin use;"C0012265;C0042153;C0205156;C0457083;C1552607;C1947944";NA;NA;previous digoxin use
 989;no digoxin scd  no . ( % / y );C0012265;NA;NA;no digoxin scd no y
 989;no digoxin n = $nmbr$ $nmbr$ ( $nmbr$ % );C0012265;NA;NA;no digoxin n $nmbr$ $nmbr$ $nmbr$
 989;digoxin or digitalis preparations;"C0012265;C0304520";NA;NA;digoxin or digitalis preparations
 989;digoxin or digitalis preparation;"C0012265;C0304520";NA;NA;digoxin or digitalis preparation
 989;digoxin n = $nmbr$ ( $nmbr$ % );C0012265;NA;NA;digoxin n $nmbr$ $nmbr$
 989;digoxin n ( % );C0012265;NA;NA;digoxin n
 989;digoxin at enrollment;"C0012265;C1516879;C1696073;C3888021";NA;NA;digoxin at enrollment
 989;digoxin  n ( % );C0012265;NA;NA;digoxin n
 989;digoxin  ( % );C0012265;NA;NA;digoxin
 989;digoxin  % ( n );C0012265;NA;NA;digoxin n
 989;digoxin  %;C0012265;NA;NA;digoxin
 991;diureties;NA;FALSE;2312;diureties
 994;potassium - sparing diuretic;"C0304490;C3536751";FALSE;1966;potassium sparing diuretic
 989;digoxin;C0012265;NA;NA;digoxin
 988;item;"C1551338;C4554251";NA;NA;item
 988;fasting free fatty acids ( ^ mol / liter );"C0015663;C0015688;C0347982";NA;NA;fasting free fatty acids mol liter
 988;> $nmbr$ ^ mol / liter — no . ( % );C0347982;NA;NA;$nmbr$ mol liter no
 987;serum creatinine — pmol / liter;"C0201976;C0439192;C0475211;C0600061";NA;NA;serum creatinine pmol liter
 987;free fatty acids — mmol / liter;"C0015688;C0439190;C0475211";NA;NA;free fatty acids mmol liter
 987;> $nmbr$ / tmol / liter — no . ( % );C0475211;NA;NA;$nmbr$ tmol liter no
 987;> $nmbr$ . $nmbr$ pmol / liter hscrp level;"C0439192;C0441889;C0456079;C0475211;C1547707;C2946261";NA;NA;$nmbr$ $nmbr$ pmol liter hscrp level
 987;> $nmbr$ . $nmbr$ pmol / liter;"C0439192;C0475211";NA;NA;$nmbr$ $nmbr$ pmol liter
 987;> $nmbr$ . $nmbr$ mmol / liter;"C0439190;C0475211";NA;NA;$nmbr$ $nmbr$ mmol liter
 987;< $nmbr$ . $nmbr$ pmol / liter;"C0439192;C0475211";NA;NA;$nmbr$ $nmbr$ pmol liter
 987;< $nmbr$ . $nmbr$ mmol / liter triglyceride level;"C0428475;C0439190;C0475211";NA;NA;$nmbr$ $nmbr$ mmol liter triglyceride level
 987;< $nmbr$ . $nmbr$ mmol / liter;"C0439190;C0475211";NA;NA;$nmbr$ $nmbr$ mmol liter
 986;d - dimer levelsatinclusion;C0060323;NA;NA;d dimer levelsatinclusion
 986;d - dimer ( ng / ml );"C0060323;C0439275";NA;NA;d dimer ng ml
 985;other / mixed ( n = $nmbr$ );"C0205430;C3160715";NA;NA;other mixed n $nmbr$
 985;mixed hispanic;"C0086409;C0205430;C3160715";NA;NA;mixed hispanic
 985;mixed ( n = $nmbr$ );"C0205430;C3160715";NA;NA;mixed n $nmbr$
 985;mixed ( itt ) ( n = $nmbr$ );"C0205430;C3160715";NA;NA;mixed itt n $nmbr$
 985;mixed;"C0205430;C3160715";NA;NA;mixed
 985;lisrs;NA;NA;NA;lisrs
 985;ixeq $nmbr$ w  n = $nmbr$;NA;NA;NA;ixeq $nmbr$ w n $nmbr$
 985;insulin lispro mix $nmbr$ / lispro mix $nmbr$ - insulin glargine / insulin lispro;"C0205430;C0293359;C0907402;C1421951;C1720722;C4553942";NA;NA;insulin lispro mix $nmbr$ lispro mix $nmbr$ insulin glargine insulin lispro
 985;insulin lispro mix $nmbr$;"C0205430;C0293359;C1421951;C1720722;C4553942";NA;NA;insulin lispro mix $nmbr$
 984;planned conservative therapy subgroup;"C0459914;C1079230;C1301732;C1515021";NA;NA;planned conservative therapy subgroup
 968;chajdsj - vasc > $nmbr$;NA;NA;NA;chajdsj vasc $nmbr$
 984;observation;"C0302523;C0700325;C1964257;C3889687";NA;NA;observation
 984;conservative;NA;NA;NA;conservative
 983;naire can range from $nmbr$ to $nmbr$ for the alternative disability portion and from $nmbr$ to $nmbr$ for the pain portion . scores for the medical outcomes;"C0030193;C0040363;C0041260;C0199168;C0205476;C0231170;C0449719;C0449820;C0518090;C1274040;C1514721;C1523987;C1883351;C1962977;C2348147;C2984058;C3542016;C4050231;C4085210;C4085211;C4085212;C4553004;C4554132";NA;NA;naire can range from $nmbr$ to $nmbr$ for the alternative disability portion and from $nmbr$ to $nmbr$ for the pain portion scores for the medical outcomes
 983;alternative disability;"C0231170;C1523987";NA;NA;alternative disability
 982;obstructive subscore;C0549186;NA;NA;obstructive subscore
 982;chronic obstructive pulmonary;"C0024109;C0205191;C0549186;C2707265;C2709248;C4522268";NA;NA;chronic obstructive pulmonary
 981;strategy;C0679199;NA;NA;strategy
 981;rerapamil - sr strategy ( n = $nmbr$ );"C0679199;C0753208;C1709991;C3813610;C3890900;C3891546";NA;NA;rerapamil sr strategy n $nmbr$
 981;planned treatment strategy;"C0599880;C0679199";NA;NA;planned treatment strategy
 981;intent of conservative strategy  %;"C0162425;C0679199;C1283828;C1550453";NA;NA;intent of conservative strategy
 981;conservative strategy ( n = $nmbr$  $nmbr$ );C0679199;NA;NA;conservative strategy n $nmbr$ $nmbr$
 981;atenolol strategy ( n = $nmbr$ );"C0004147;C0679199";NA;NA;atenolol strategy n $nmbr$
 981;atenolol strategy ( n = $nmbr$  $nmbr$ );"C0004147;C0679199";NA;NA;atenolol strategy n $nmbr$ $nmbr$
 981;atenolol strategy;"C0004147;C0679199";NA;NA;atenolol strategy
 980;stating;"C1301808;C1442792;C3148680";NA;NA;stating
 980;state;"C1301808;C1442792;C3148680";NA;NA;state
 980;ipeated - measures state examinatioi;"C0079809;C1301808;C1442792;C1879489;C3148680";NA;NA;ipeated measures state examinatioi
 980;disease characteristics  n ( % )  unless otherwise stated;"C0599878;C1301808;C1442792";NA;NA;disease characteristics n unless otherwise stated
 979;laboratory measurements;C0681902;NA;NA;laboratory measurements
 979;laboratory examination;C0260877;NA;NA;laboratory examination
 979;clinical and laboratory measurements;"C0205210;C0681902";NA;NA;clinical and laboratory measurements
 979;catscorecategory  n ( % );NA;NA;NA;catscorecategory n
 978;symptom onset to arrival in catheterization laboratory;"C0007430;C0022877;C1555577;C1706079;C3244292;C4086878;C4283904";NA;NA;symptom onset to arrival in catheterization laboratory
 978;randomization to arrival in catheterization laboratory;"C0007430;C0022877;C0034656;C1555577;C1706079;C3244292;C4283904";NA;NA;randomization to arrival in catheterization laboratory
 978;laboratory variables at baseline;"C0022877;C0168634;C0439828;C1442488;C3244292;C4283904";NA;NA;laboratory variables at baseline
 978;laboratory variables;"C0022877;C0439828;C3244292;C4283904";NA;NA;laboratory variables
 978;laboratory values at admission ( median and iqr );"C0022877;C0042295;C0184666;C0549183;C0809949;C0876920;C2347635;C2348144;C2939193;C3244292;C4283904";NA;NA;laboratory values at admission median and iqr
 978;laboratory values;"C0022877;C0042295;C3244292;C4283904";NA;NA;laboratory values
 978;laboratory measures;"C0022877;C0079809;C0242485;C1879489;C3244292;C4283904";NA;NA;laboratory measures
 978;laboratory evaluations;"C0022877;C0220825;C3244292;C4283904";NA;NA;laboratory evaluations
 978;laboratory determinations;"C0022877;C0680730;C3244292;C4283904";NA;NA;laboratory determinations
 978;dbp > $nmbr$ or sbp > $nmbr$ mm hg laboratory determinations;"C0022877;C0085805;C0439475;C0536221;C0680730;C3244292;C3813197;C4281799;C4283904";NA;NA;dbp $nmbr$ or sbp $nmbr$ mm hg laboratory determinations
 978;catheterization laboratory in center;"C0007430;C0022877;C0205099;C3244292;C4283904;C4534362";NA;NA;catheterization laboratory in center
 978;catheterization laboratory in;"C0007430;C0022877;C3244292;C4283904";NA;NA;catheterization laboratory in
 978;baseline laboratory values  median ( iqr ) d;"C0022877;C0042295;C0168634;C0549183;C0876920;C1442488;C2347635;C2348144;C2939193;C3244292;C4283904";NA;NA;baseline laboratory values median iqr d
 977;inspiratory capacity ( l );"C0021610;C0802663";NA;NA;inspiratory capacity l
 977;chronic respiratory failure;C0264492;NA;NA;chronic respiratory failure
 977;acute respiratory insufficiency;C0865850;NA;NA;acute respiratory insufficiency
 976;respiratory medication ( % );C0418986;NA;NA;respiratory medication
 976;previous medication for respiratory disease — no . ( % );"C0012634;C0013227;C0035204;C0035242;C0205156;C0418986;C1552607;C3244316;C4284232";NA;NA;previous medication for respiratory disease no
 976;( b ) concomitant respiratory medications [ n ( % ) ];"C0418986;C0521115";NA;NA;b concomitant respiratory medications n
 975;unadjusted hazard ratio ( $nmbr$ % cl );"C0596019;C1439367;C2985465";NA;NA;unadjusted hazard ratio $nmbr$ cl
 975;unadjusted hazard ratio ( $nmbr$ % ci );"C0008107;C1439367;C2985465;C3259781";NA;NA;unadjusted hazard ratio $nmbr$ ci
 987;serum potassium — mmol / liter;"C0302353;C0439190;C0475211;C0543465";FALSE;1959;serum potassium mmol liter
 987;serum potassium 一 mmol / liter;"C0302353;C0439190;C0475211;C0543465";FALSE;1959;serum potassium mmol liter
 987;fasting blood glucose — mmol / liter;"C0428568;C0439190;C0475211;C1261430";FALSE;1960;fasting blood glucose mmol liter
 987;serum cholesterol — mmol / liter;"C0439190;C0475211;C0587184";FALSE;1501;serum cholesterol mmol liter
 987;serum sodium — mmol / liter;"C0439190;C0475211;C0523891";FALSE;1379;serum sodium mmol liter
 987;fasting plasma glucose — mmol / liter;"C0015663;C0202042;C0439190;C0455280;C0475211";FALSE;1960;fasting plasma glucose mmol liter
 975;selexipag vs placebo hazard ratio ( $nmbr$ % cl );"C0032042;C0596019;C1696465;C1706408;C2000145;C2985465";NA;NA;selexipag vs placebo hazard ratio $nmbr$ cl
 975;hazard ratio with low ( $nmbr$ % cl );"C0205251;C0596019;C1550472;C2985465;C3890211;C4048187;C4321351;C4522223";NA;NA;hazard ratio with low $nmbr$ cl
 975;hazard ratio with high ( $nmbr$ % cl );"C0205250;C0596019;C1299351;C2700149;C2985465;C3887512;C3889660;C4321237;C4522209";NA;NA;hazard ratio with high $nmbr$ cl
 975;hazard ratio with;C2985465;NA;NA;hazard ratio with
 975;hazard ratio vs . placebo;"C0032042;C1696465;C1706408;C2985465";NA;NA;hazard ratio vs placebo
 975;hazard ratio for event ( $nmbr$ % ci );"C0008107;C0441471;C2985465;C3259781;C4019010";NA;NA;hazard ratio for event $nmbr$ ci
 975;hazard ratio and $nmbr$ % confidence interval;"C0009667;C2985465";NA;NA;hazard ratio and $nmbr$ confidence interval
 975;hazard ratio [ $nmbr$ % cl ];"C0596019;C2985465";NA;NA;hazard ratio $nmbr$ cl
 975;hazard ratio [ $nmbr$ % ci ];"C0008107;C2985465;C3259781";NA;NA;hazard ratio $nmbr$ ci
 975;hazard ratio * ( and $nmbr$ % ci );"C0008107;C2985465;C3259781";NA;NA;hazard ratio and $nmbr$ ci
 975;hazard ratio ( $nmbr$ % confidence interval ) *;"C0009667;C2985465";NA;NA;hazard ratio $nmbr$ confidence interval
 975;hazard ratio ( $nmbr$ % confidence interval );"C0009667;C2985465";NA;NA;hazard ratio $nmbr$ confidence interval
 975;hazard ratio ( $nmbr$ % cl ];"C0596019;C2985465";NA;NA;hazard ratio $nmbr$ cl
 975;hazard ratio ( $nmbr$ % cl ) nateglinide vs . placebo;"C0032042;C0596019;C0903898;C1696465;C1706408;C2985465";NA;NA;hazard ratio $nmbr$ cl nateglinide vs placebo
 975;hazard ratio ( $nmbr$ % cl ) *;"C0596019;C2985465";NA;NA;hazard ratio $nmbr$ cl
 975;hazard ratio ( $nmbr$ % cl ) $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ );"C0596019;C2985465";NA;NA;hazard ratio $nmbr$ cl $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 975;hazard ratio ( $nmbr$ % cl );"C0596019;C2985465";NA;NA;hazard ratio $nmbr$ cl
 975;hazard ratio ( $nmbr$ % ci ) vs . placebo;"C0008107;C0032042;C1696465;C1706408;C2985465;C3259781";NA;NA;hazard ratio $nmbr$ ci vs placebo
 975;hazard ratio ( $nmbr$ % ci ) for adjudicated type $nmbr$ diabetes;"C0008107;C1320657;C2985465;C3259781";NA;NA;hazard ratio $nmbr$ ci for adjudicated type $nmbr$ diabetes
 975;hazard ratio ( $nmbr$ % ci ) - j -;"C0008107;C2985465;C3259781";NA;NA;hazard ratio $nmbr$ ci j
 975;hazard ratio ( $nmbr$ % ci ) *;"C0008107;C2985465;C3259781";NA;NA;hazard ratio $nmbr$ ci
 975;hazard ratio ( $nmbr$ % c;C2985465;NA;NA;hazard ratio $nmbr$ c
 975;hazard ratio $nmbr$ );C2985465;NA;NA;hazard ratio $nmbr$
 975;hazard ratio $nmbr$;C2985465;NA;NA;hazard ratio $nmbr$
 975;hazard ratio  umec / vi vs . tio ( $nmbr$ % ci );"C0008107;C0205999;C2985465;C3259781";NA;NA;hazard ratio umec vi vs tio $nmbr$ ci
 975;hazard ratio;C2985465;NA;NA;hazard ratio
 975;hazard . ratio . ( $nmbr$ % ci ) . . . . . . . . . .;"C0008107;C2985465;C3259781";NA;NA;hazard ratio $nmbr$ ci
 975;genotype - specific treatment effect hazard ratio ( $nmbr$ % ci );"C0008107;C0017431;C0205369;C1518681;C1552740;C2985465;C3259781";NA;NA;genotype specific treatment effect hazard ratio $nmbr$ ci
 975;adjusted ⁎ hazard ratio ( $nmbr$ % ci );"C0008107;C0456081;C2985465;C3259781";NA;NA;adjusted hazard ratio $nmbr$ ci
 975;adjusted hazard ratio ≠ ( $nmbr$ % ci );"C0008107;C0456081;C2985465;C3259781";NA;NA;adjusted hazard ratio $nmbr$ ci
 975;adjusted hazard ratio ‡ ( $nmbr$ % ci );"C0008107;C0456081;C2985465;C3259781";NA;NA;adjusted hazard ratio $nmbr$ ci
 975;adjusted hazard ratio § ( $nmbr$ % ci );"C0008107;C0456081;C2985465;C3259781";NA;NA;adjusted hazard ratio $nmbr$ ci
 975;adjusted hazard ratio *;"C0456081;C2985465";NA;NA;adjusted hazard ratio
 975;adjusted hazard ratio ( $nmbr$ % cl ) *;"C0456081;C0596019;C2985465";NA;NA;adjusted hazard ratio $nmbr$ cl
 975;adjusted hazard ratio ( $nmbr$ % ci ) †;"C0008107;C0456081;C2985465;C3259781";NA;NA;adjusted hazard ratio $nmbr$ ci
 975;adiusted hazard ratio *;C2985465;NA;NA;adiusted hazard ratio
 974;ratet n ( % );NA;NA;NA;ratet n
 974;ratet ( $nmbr$ % cl );C0596019;NA;NA;ratet $nmbr$ cl
 974;ratet;NA;NA;NA;ratet
 974;odds ratio and $nmbr$ % cl;"C0028873;C0596019";NA;NA;odds ratio and $nmbr$ cl
 974;odds ratio adj ( $nmbr$ % cl );"C0001552;C0028873;C0596019;C2826286";NA;NA;odds ratio adj $nmbr$ cl
 974;odds ratio ( $nmbr$ % cl );"C0028873;C0596019";NA;NA;odds ratio $nmbr$ cl
 973;waisthip ratio;"C0205682;C0456603;C1547037";NA;NA;waisthip ratio
 973;ratio;"C0456603;C1547037";NA;NA;ratio
 973;rate ratio { $nmbr$ % cl );"C0456603;C0596019;C0871208;C1521828;C1547037";NA;NA;rate ratio $nmbr$ cl
 973;rate ratio mepo / pbo ( $nmbr$ % ci );"C0008107;C0031962;C0456603;C0871208;C1521828;C1547037;C3259781";NA;NA;rate ratio mepo pbo $nmbr$ ci
 973;rate ratio ( $nmbr$ % cl );"C0456603;C0596019;C0871208;C1521828;C1547037";NA;NA;rate ratio $nmbr$ cl
 973;rate ratio ( $nmbr$ % ci );"C0008107;C0456603;C0871208;C1521828;C1547037;C3259781";NA;NA;rate ratio $nmbr$ ci
 973;rate ratio;"C0456603;C0871208;C1521828;C1547037";NA;NA;rate ratio
 973;pepsinogen i / ii ratio;"C0030915;C0456603;C0523817;C1547037";NA;NA;pepsinogen i ii ratio
 973;iglarlixi ( n   =   $nmbr$ );NA;NA;NA;iglarlixi n $nmbr$
 973;iglarlixi ( fixed - ratio combination );"C0205195;C0443218;C0456603;C1547037;C1947911;C2827483;C3714578;C3811910";NA;NA;iglarlixi fixed ratio combination
 973;iglarlixi;NA;NA;NA;iglarlixi
 973;hzard ratio;"C0456603;C1547037";NA;NA;hzard ratio
 973;hscrp ( post - baseline / baseline ratio )  ls mean   ±   se;"C0023668;C0036919;C0168634;C0444504;C0456603;C0687676;C1442488;C1547037;C1704687;C2347634;C2348143;C3469826";NA;NA;hscrp post baseline baseline ratio ls mean se
 973;e / a ratio;"C0456603;C1547037";NA;NA;e a ratio
 973;cardiothoracic ratio > $nmbr$ . $nmbr$;"C0456603;C1547037;C4055270";NA;NA;cardiothoracic ratio $nmbr$ $nmbr$
 973;cardiothoracic ratio;"C0456603;C1547037;C4055270";NA;NA;cardiothoracic ratio
 972;multiple ( $nmbr$ + ) chd risk;"C0439064;C1282512";NA;NA;multiple $nmbr$ chd risk
 972;chda;NA;NA;NA;chda
 972;chd risk equivalents  n ( % );"C0439185;C1282512;C4049980";NA;NA;chd risk equivalents n
 970;repaired chd;"C0205340;C0280604;C3542407";NA;NA;repaired chd
 970;other chd;"C0280604;C3542407";NA;NA;other chd
 971;vhd;NA;FALSE; -10;vhd
 971;c  right - sided vhd ( n = $nmbr$ );"C0205090;C0444532";FALSE; -10;c right sided vhd n $nmbr$
 970;no chd simva ( „ = $nmbr$ );"C0280604;C3542407";NA;NA;no chd simva $nmbr$
 970;no chd simva ( n = $nmbr$ ];"C0280604;C3542407";NA;NA;no chd simva n $nmbr$
 970;no chd simva;"C0280604;C3542407";NA;NA;no chd simva
 970;no chd eze / simva ( n = $nmbr$ );"C0280604;C3542407";NA;NA;no chd eze simva n $nmbr$
 970;no chd eze / simva $nmbr$ = $nmbr$ };"C0280604;C3542407";NA;NA;no chd eze simva $nmbr$ $nmbr$
 970;no chd eze / simva;"C0280604;C3542407";NA;NA;no chd eze simva
 970;no chd at baseline;"C0168634;C0280604;C1442488;C3542407";NA;NA;no chd at baseline
 970;no chd;"C0280604;C3542407";NA;NA;no chd
 970;known chd;"C0205309;C0280604;C3542407";NA;NA;known chd
 970;history ot chd  n ( % );"C0019664;C0019665;C0262512;C0262926;C0280604;C1318464;C1418208;C1705255;C1705587;C2004062;C3542407";NA;NA;history ot chd n
 970;history ol chd at baselines;"C0019664;C0019665;C0168634;C0262512;C0262926;C0280604;C1705255;C2004062;C3542407";NA;NA;history ol chd at baselines
 970;history of chd at baseline §;"C0019664;C0019665;C0168634;C0262512;C0262926;C0280604;C1442488;C1705255;C2004062;C3542407";NA;NA;history of chd at baseline
 970;history of chd at baseline d  g;"C0019664;C0019665;C0168634;C0262512;C0262926;C0280604;C0439267;C1442488;C1705255;C2004062;C3542407";NA;NA;history of chd at baseline d g
 970;history of chd at baseline  no . ( % );"C0019664;C0019665;C0168634;C0262512;C0262926;C0280604;C1442488;C1705255;C2004062;C3542407";NA;NA;history of chd at baseline no
 970;history of chd at baseline;"C0019664;C0019665;C0168634;C0262512;C0262926;C0280604;C1442488;C1705255;C2004062;C3542407";NA;NA;history of chd at baseline
 970;history of chd  n ( % );"C0019664;C0019665;C0262512;C0262926;C0280604;C1705255;C2004062;C3542407";NA;NA;history of chd n
 970;history of chd;"C0019664;C0019665;C0262512;C0262926;C0280604;C1705255;C2004062;C3542407";NA;NA;history of chd
 970;history chd;"C0019664;C0019665;C0262512;C0262926;C0280604;C1705255;C2004062;C3542407";NA;NA;history chd
 970;family history ot chd  n ( % );"C0241889;C0280604;C1318464;C1418208;C1705587;C3542407";NA;NA;family history ot chd n
 970;combined chd;"C0205195;C0280604;C3542407";NA;NA;combined chd
 970;chd status §;"C0280604;C0449438;C3542407";NA;NA;chd status
 970;chd status;"C0280604;C0449438;C3542407";NA;NA;chd status
 970;chd simva ( „ = $nmbr$ );"C0280604;C3542407";NA;NA;chd simva $nmbr$
 970;chd simva $nmbr$ = $nmbr$ ];"C0280604;C3542407";NA;NA;chd simva $nmbr$ $nmbr$
 970;chd simva;"C0280604;C3542407";NA;NA;chd simva
 970;chd risk - no . ( % );"C0035647;C0280604;C3542407;C4552904";NA;NA;chd risk no
 970;chd history  n ( % );"C0019664;C0019665;C0262512;C0262926;C0280604;C1705255;C2004062;C3542407";NA;NA;chd history n
 970;chd eze / simva ( „ = $nmbr$ );"C0280604;C3542407";NA;NA;chd eze simva $nmbr$
 970;chd eze / simva ( n = $nmbr$ ];"C0280604;C3542407";NA;NA;chd eze simva n $nmbr$
 970;chd eze / simva;"C0280604;C3542407";NA;NA;chd eze simva
 970;chd disease death;"C0011065;C0012634;C0280604;C1306577;C3542407;C4082313;C4552775";NA;NA;chd disease death
 970;chd deaths;"C0011065;C0280604;C1306577;C3542407";NA;NA;chd deaths
 970;chd death;"C0011065;C0280604;C1306577;C3542407;C4082313;C4552775";NA;NA;chd death
 970;chd at baseline;"C0168634;C0280604;C1442488;C3542407";NA;NA;chd at baseline
 970;chd + cl all;"C0280604;C0596019;C3542407";NA;NA;chd cl all
 970;chd *  n ( % );"C0280604;C3542407";NA;NA;chd n
 970;chd  total;"C0280604;C0439175;C0439810;C3542407";NA;NA;chd total
 970;chd  n ( % );"C0280604;C3542407";NA;NA;chd n
 970;chd;"C0280604;C3542407";NA;NA;chd
 970;> $nmbr$ mg / dl chd status;"C0280604;C0439269;C0449438;C3542407";NA;NA;$nmbr$ mg dl chd status
 970;* p < $nmbr$ . $nmbr$ for between - treatment difference with same dose of simvastatin for entire cohort data are expressed as least squares mean ± standard error simva = simvastatin  eze = ezetimibe  chd = coronary heart disease;"C0009247;C0012634;C0018787;C0023189;C0039798;C0074554;C0087111;C0178602;C0280604;C0369773;C0439751;C0444504;C0444667;C0445247;C0599755;C0869039;C1114758;C1142985;C1511726;C1522326;C1533734;C1705169;C1705241;C1705242;C1710181;C2347634;C2348143;C2603361;C3245479;C3538994;C3542407;C3714741;C3887704";NA;NA;p $nmbr$ $nmbr$ for between treatment difference with same dose of simvastatin for entire cohort data are expressed as least squares mean standard error simva simvastatin eze ezetimibe chd coronary heart disease
 969;chlor;C0308648;NA;NA;chlor
 969;chl;C0019829;NA;NA;chl
 969;aml vs . chl;"C0019829;C0023465;C0023467";NA;NA;aml vs chl
 968;chajdsj - vasc $nmbr$ - $nmbr$;NA;NA;NA;chajdsj vasc $nmbr$ $nmbr$
 968;chajdsa - vasc $nmbr$ - $nmbr$;NA;NA;NA;chajdsa vasc $nmbr$ $nmbr$
 968;cha $nmbr$ ds $nmbr$ vasc score ( % );"C0449820;C1420648;C3714751;C4050231";NA;NA;cha $nmbr$ ds $nmbr$ vasc score
 968;cha $nmbr$ ds $nmbr$ vasc score;"C0449820;C1420648;C3714751;C4050231";NA;NA;cha $nmbr$ ds $nmbr$ vasc score
 968;cha $nmbr$ ds $nmbr$ - vasc score ( median  iqr );"C0449820;C0549183;C0876920;C1420648;C2347635;C2348144;C2939193;C3714751;C4050231";NA;NA;cha $nmbr$ ds $nmbr$ vasc score median iqr
 968;cha $nmbr$ ds $nmbr$ - vasc score    n   ( % );"C0449820;C1420648;C3714751;C4050231";NA;NA;cha $nmbr$ ds $nmbr$ vasc score n
 968;cha $nmbr$ ds $nmbr$ - vasc score  mean ± sd;"C0444504;C0449820;C1420648;C2347634;C2348143;C2699239;C3714751;C4050231";NA;NA;cha $nmbr$ ds $nmbr$ vasc score mean sd
 968;cha $nmbr$ ds $nmbr$ - vasc score;"C0449820;C1420648;C3714751;C4050231";NA;NA;cha $nmbr$ ds $nmbr$ vasc score
 968;cha $nmbr$ ds $nmbr$ - vasc > $nmbr$;"C1420648;C3714751";NA;NA;cha $nmbr$ ds $nmbr$ vasc $nmbr$
 968;cha $nmbr$ ds $nmbr$ - vasc < $nmbr$;"C1420648;C3714751";NA;NA;cha $nmbr$ ds $nmbr$ vasc $nmbr$
 968;cha $nmbr$ ds $nmbr$ - vasc $nmbr$ - $nmbr$;"C1420648;C3714751";NA;NA;cha $nmbr$ ds $nmbr$ vasc $nmbr$ $nmbr$
 968;cha $nmbr$ ds $nmbr$ - vasc $nmbr$ $nmbr$;"C1420648;C3714751";NA;NA;cha $nmbr$ ds $nmbr$ vasc $nmbr$ $nmbr$
 968;cha $nmbr$ ds $nmbr$ - vasc $ $nmbr$;"C1420648;C3714751";NA;NA;cha $nmbr$ ds $nmbr$ vasc $ $nmbr$
 968;cha $nmbr$ ds $nmbr$ - vasc # $nmbr$;"C1420648;C3714751";NA;NA;cha $nmbr$ ds $nmbr$ vasc $nmbr$
 968;cha $nmbr$ ds $nmbr$ - vasc  mean ± sd;"C0444504;C1420648;C2347634;C2348143;C2699239;C3714751";NA;NA;cha $nmbr$ ds $nmbr$ vasc mean sd
 968;cha $nmbr$ ds $nmbr$ - vasc;"C1420648;C3714751";NA;NA;cha $nmbr$ ds $nmbr$ vasc
 968;baseline cha $nmbr$ ds $nmbr$ - vascb  c;"C0168634;C1420648;C1442488;C3714751";NA;NA;baseline cha $nmbr$ ds $nmbr$ vascb c
 967;without ckd ( $nmbr$ );C1561643;NA;NA;without ckd $nmbr$
 967;with ckd standard ( n = $nmbr$ );"C1442989;C1561643;C2828392";NA;NA;with ckd standard n $nmbr$
 967;with ckd intensive ( n = $nmbr$ );"C0162425;C0522510;C1283828;C1550453;C1561643";NA;NA;with ckd intensive n $nmbr$
 967;with ckd ( $nmbr$ );C1561643;NA;NA;with ckd $nmbr$
 967;stage > $nmbr$ chronic kidney disease ( % );"C0205390;C1300072;C1306673;C1561643;C4553188";NA;NA;stage $nmbr$ chronic kidney disease
 967;no moderate ckd;"C0205081;C1561643;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;no moderate ckd
 967;no ckd rate ( # events );"C0441471;C0871208;C1521828;C1561643;C3541888";NA;NA;no ckd rate events
 967;no ckd n;C1561643;NA;NA;no ckd n
 967;no ckd ( % );C1561643;NA;NA;no ckd
 967;no ckd;C1561643;NA;NA;no ckd
 967;no - ckd standard ( n = $nmbr$ );"C1442989;C1561643;C2828392";NA;NA;no ckd standard n $nmbr$
 967;no - ckd intensive ( n = $nmbr$ );"C0162425;C0522510;C1283828;C1550453;C1561643";NA;NA;no ckd intensive n $nmbr$
 967;moderate ckd at randomization;"C0034656;C0205081;C1561643;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate ckd at randomization
 967;moderate ckd;"C0205081;C1561643;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate ckd
 967;gfr ( ckd - epi );"C0017654;C0162734;C1424601;C1561643;C4281721";NA;NA;gfr ckd epi
 967;cvd  ckd;"C0007222;C1561643";NA;NA;cvd ckd
 967;ckdc  n ( % );NA;NA;NA;ckdc n
 960;p blockers;"C0369773;C2603361";NA;NA;p blockers
 967;ckd rate ( # events );"C0441471;C0871208;C1521828;C1561643;C3541888";NA;NA;ckd rate events
 967;ckd prognosis by kdigo ' ';"C0033325;C1561643;C3854082";NA;NA;ckd prognosis by kdigo
 967;ckd n;C1561643;NA;NA;ckd n
 967;ckd at baseline;"C0168634;C1442488;C1561643";NA;NA;ckd at baseline
 967;ckd *;C1561643;NA;NA;ckd
 967;ckd  n ( % ) t;C1561643;NA;NA;ckd n t
 967;ckd;C1561643;NA;NA;ckd
 967;chronic renal insufficiency  %;"C0403447;C1561643";NA;NA;chronic renal insufficiency
 967;chronic renal insufficiency;"C0403447;C1561643";NA;NA;chronic renal insufficiency
 967;chronic renal failure  n ( % );"C0022661;C1561643;C2316810";NA;NA;chronic renal failure n
 967;chronic renal failure;"C0022661;C1561643;C2316810";NA;NA;chronic renal failure
 967;chronic renal disease — no . ( % );"C0022661;C1561643";NA;NA;chronic renal disease no
 967;chronic renal disease;"C0022661;C1561643";NA;NA;chronic renal disease
 967;chronic kidney disease †;"C1561643;C4553188";NA;NA;chronic kidney disease
 967;chronic kidney disease ( % );"C1561643;C4553188";NA;NA;chronic kidney disease
 967;chronic kidney disease  no . ( % ) t;"C1561643;C2603360;C4553188";NA;NA;chronic kidney disease no t
 967;chronic kidney disease  n ( % );"C1561643;C4553188";NA;NA;chronic kidney disease n
 967;chronic kidney disease;"C1561643;C4553188";NA;NA;chronic kidney disease
 967;change from baseline stage $nmbr$ ckd;"C0168634;C0597205;C0679846;C1442488;C1561643";NA;NA;change from baseline stage $nmbr$ ckd
 967;baseline - ckd - epi;"C0162734;C0168634;C1442488;C1561643;C4281721";NA;NA;baseline ckd epi
 966;non - black race and ss > $nmbr$ ( n = $nmbr$ vs $nmbr$ );"C0005680;C1518422;C2699257;C3891295;C4551874";NA;NA;non black race and ss $nmbr$ n $nmbr$ vs $nmbr$
 966;non - black race and ss < $nmbr$ ( n = $nmbr$ vs $nmbr$ );"C0005680;C1518422;C2699257;C3891295;C4551874";NA;NA;non black race and ss $nmbr$ n $nmbr$ vs $nmbr$
 966;non - black race ( n = $nmbr$ vs $nmbr$ );"C0005680;C1518422";NA;NA;non black race n $nmbr$ vs $nmbr$
 966;non - black;"C0005680;C0027567;C0085756;C0439541;C1518422";NA;NA;non black
 966;blaic > $nmbr$ . $nmbr$ %;NA;NA;NA;blaic $nmbr$ $nmbr$
 966;blaic < $nmbr$ . $nmbr$ %;NA;NA;NA;blaic $nmbr$ $nmbr$
 966;blaek / afriean - ameriean;NA;NA;NA;blaek afriean ameriean
 966;blaek;NA;NA;NA;blaek
 966;black race — no . / total no . ( % ) f;"C0005680;C0016327;C0027567;C0034510;C0085756;C0439175;C0439541;C0439810;C1706779;C3853635";NA;NA;black race no total no f
 966;black race and ss > $nmbr$ ( n = $nmbr$ vs $nmbr$ );"C0005680;C2699257;C3891295;C4551874";NA;NA;black race and ss $nmbr$ n $nmbr$ vs $nmbr$
 966;black race and ss < $nmbr$ ( n = $nmbr$ vs $nmbr$ ) ■ -;"C0005680;C2699257;C3891295;C4551874";NA;NA;black race and ss $nmbr$ n $nmbr$ vs $nmbr$
 966;black race ( n = $nmbr$ vs $nmbr$ );C0005680;NA;NA;black race n $nmbr$ vs $nmbr$
 966;black race  n ( % );C0005680;NA;NA;black race n
 966;black race;C0005680;NA;NA;black race
 966;black and other;"C0005680;C0027567;C0085756;C0439541";NA;NA;black and other
 966;black / african;C0337824;NA;NA;black african
 966;black /;"C0005680;C0027567;C0085756;C0439541";NA;NA;black
 966;black ( n = $nmbr$ );"C0005680;C0027567;C0085756;C0439541";NA;NA;black n $nmbr$
 966;$nmbr$ fe black *;"C0005680;C0027567;C0085756;C0439541;C3848561";NA;NA;$nmbr$ fe black
 965;locf );C2825507;NA;NA;locf
 965;left bundle - branch block;"C0023211;C0344420;C2828132";NA;NA;left bundle branch block
 965;bundle branch block;"C0006384;C1879286";NA;NA;bundle branch block
 965;$nmbr$ locf );C2825507;NA;NA;$nmbr$ locf
 964;patients receiving lcz  no . ( % );"C0030705;C1514756";NA;NA;patients receiving lcz no
 964;lcz $nmbr$ treatment  n ( % );"C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;lcz $nmbr$ treatment n
 964;lcz $nmbr$ ( n = $nmbr$ );NA;NA;NA;lcz $nmbr$ n $nmbr$
 964;lcz $nmbr$;NA;NA;NA;lcz $nmbr$
 964;lce  n = $nmbr$;"C1423759;C3273355";NA;NA;lce n $nmbr$
 963;β - blocker;NA;NA;NA;blocker
 963;| ? > - blocker ( n  % );NA;NA;NA;blocker n
 963;| ? ) - blocker  %;NA;NA;NA;blocker
 963;renin - angiotensin - aldosterone system blocker;C0086907;NA;NA;renin angiotensin aldosterone system blocker
 963;b - blockers;NA;NA;NA;b blockers
 963;angiotensin receptor blocker yes;"C0034787;C1549445;C1622222;C1705108;C1710701";NA;NA;angiotensin receptor blocker yes
 963;angiotensin receptor blocker and / or ace;"C0034787;C1452534;C1622222;C4284014";NA;NA;angiotensin receptor blocker and or ace
 963;angiotensin receptor blocker;"C0034787;C1622222";NA;NA;angiotensin receptor blocker
 963;angiotensin - receptor blocker;"C0034787;C1622222";NA;NA;angiotensin receptor blocker
 963;angiotensin - converting enzyme or angiotensin receptor blocker;"C0022709;C0034787;C1452534;C1622222";NA;NA;angiotensin converting enzyme or angiotensin receptor blocker
 963;angiotensin - converting enzyme inhibitor or angiotensin receptor blocker use ( mitt population );"C0003015;C0032659;C0034787;C0042153;C0457083;C1257890;C1622222;C1947944;C2757044;C3536837;C4541021";NA;NA;angiotensin converting enzyme inhibitor or angiotensin receptor blocker use mitt population
 963;angiotensin - converting enzyme inhibitor or angiotensin receptor blocker;"C0003015;C0034787;C1622222;C2757044;C3536837;C4541021";NA;NA;angiotensin converting enzyme inhibitor or angiotensin receptor blocker
 963;angiotensin - converting - enzyme inhibitor or angiotensin - receptor blocker §;"C0003015;C0034787;C1622222;C2757044;C3536837;C4541021";NA;NA;angiotensin converting enzyme inhibitor or angiotensin receptor blocker
 963;aldosterone blockers;C0002006;NA;NA;aldosterone blockers
 963;aldosterone blocker  %;C0002006;NA;NA;aldosterone blocker
 963;aldosterone blocker;C0002006;NA;NA;aldosterone blocker
 963;ace - i or angiotensin receptor blocker;"C0021966;C0034787;C0221138;C1452534;C1622222;C4284014";NA;NA;ace i or angiotensin receptor blocker
 963;/ $nmbr$ - blocker;NA;NA;NA;$nmbr$ blocker
 963;( i - blocker;"C0021966;C0221138";NA;NA;i blocker
 963;( a blocker;NA;NA;NA;a blocker
 963;( $nmbr$ - blocker;NA;NA;NA;$nmbr$ blocker
 963;$nmbr$ blocker before admission;"C0184666;C0809949";NA;NA;$nmbr$ blocker before admission
 962;receptor blockers  n ( % ) baseline lipid and apolipoprotein levels;"C0003591;C0023779;C0168634;C0441889;C0597357;C1442488";NA;NA;receptor blockers n baseline lipid and apolipoprotein levels
 962;receptor blockers  n ( % );C0597357;NA;NA;receptor blockers n
 962;receptor blockers;C0597357;NA;NA;receptor blockers
 962;receptor blocker;C0597357;NA;NA;receptor blocker
 962;angiotensin - converting enzyme inhibitors / angiotensin receptor blockers;"C0003015;C0597357;C2757044";NA;NA;angiotensin converting enzyme inhibitors angiotensin receptor blockers
 962;and either an ace inhibitor or angiotension receptor blocker;"C0003015;C0597357;C3844638;C4541021";NA;NA;and either an ace inhibitor or angiotension receptor blocker
 962;$nmbr$ blockers;NA;NA;NA;$nmbr$ blockers
 962;$nmbr$ - blockers;NA;NA;NA;$nmbr$ blockers
 961;no . previous alpha - blocker use;"C0001641;C0042153;C0205156;C0457083;C1552607;C1947944";NA;NA;no previous alpha blocker use
 961;alpha blockers;C0001641;NA;NA;alpha blockers
 961;alpha - blockers;C0001641;NA;NA;alpha blockers
 961;alpha - blocker;C0001641;NA;NA;alpha blocker
 961;alpha $nmbr$ blockers;C0001641;NA;NA;alpha $nmbr$ blockers
 961;a - blockers;NA;NA;NA;a blockers
 960;β - blockers;NA;NA;NA;blockers
 960;without p blockers;"C0369773;C2603361";NA;NA;without p blockers
 960;with p blockers;"C0369773;C2603361";NA;NA;with p blockers
 960;randomly assigned to calcium channel blocker;"C0006684;C1516050;C1552601;C3536851;C4521885";NA;NA;randomly assigned to calcium channel blocker
 960;p blockers ( % );"C0369773;C2603361";NA;NA;p blockers
 960;p blocker *;"C0369773;C2603361";NA;NA;p blocker
 960;p - blockers ( % );"C0369773;C2603361";NA;NA;p blockers
 960;p - blockers  n ( % );"C0369773;C2603361";NA;NA;p blockers n
 960;p - blockers;"C0369773;C2603361";NA;NA;p blockers
 960;p - blocker yes;"C0369773;C1549445;C1705108;C1710701;C2603361";NA;NA;p blocker yes
 960;p - blocker ( % );"C0369773;C2603361";NA;NA;p blocker
 960;j $nmbr$ - blocker  % ( n );NA;NA;NA;j $nmbr$ blocker n
 960;apo  apolipoprotein  dm  diabetes mellitus  hdl - c  high - density lipoprotein cholesterol  ldl - c  low - density lipoprotein cholesterol  tc  total cholesterol  tg  triglycerides . * includes agents acting on the renin - angiotensin system  beta blocking agents  calcium channel blockers  and diuretics . † median values [ standard deviation for medians calculated by ( q $nmbr$ q $nmbr$ ) / $nmbr$ . $nmbr$ ] . § includes cardiac glycosides  antiarrhythmics class i and iii  vasodilators used in cardiac diseases and other cardiac preparations . ‡ expressed as g / l .;"C0001645;C0003195;C0003591;C0003594;C0006684;C0008377;C0011849;C0012634;C0012798;C0017977;C0018787;C0023821;C0023824;C0035096;C0039411;C0040642;C0041004;C0041405;C0041698;C0042295;C0042402;C0079613;C0201950;C0202117;C0332257;C0428473;C0439070;C0439294;C0441885;C0444686;C0450442;C0456615;C0543421;C0549183;C0871420;C0876920;C1254351;C1273517;C1319793;C1441506;C1521826;C1521827;C1522601;C1552866;C1704930;C1705160;C1824670;C1869853;C2347635;C2348144;C2698967;C2700399;C2757014;C2939193;C2984247;C3272447;C3541930;C3715113;C3812761;C3890007;C4048375;C4522122";NA;NA;apo apolipoprotein dm diabetes mellitus hdl c high density lipoprotein cholesterol ldl c low density lipoprotein cholesterol tc total cholesterol tg triglycerides includes agents acting on the renin angiotensin system beta blocking agents calcium channel blockers and diuretics median values standard deviation for medians calculated by q $nmbr$ q $nmbr$ $nmbr$ $nmbr$ includes cardiac glycosides antiarrhythmics class i and iii vasodilators used in cardiac diseases and other cardiac preparations expressed as g l
 960;( e - blocker;NA;NA;NA;e blocker
 960;( : > blockers;NA;NA;NA;blockers
 959;β ‐ blocker;NA;NA;NA;blocker
 959;β blockers;NA;NA;NA;blockers
 959;β blocker;NA;NA;NA;blocker
 959;without beta blocker;C0001645;NA;NA;without beta blocker
 959;with beta blocker;C0001645;NA;NA;with beta blocker
 959;use of beta - blockers;"C0001645;C1524063";NA;NA;use of beta blockers
 959;use of beta - blocker;"C0001645;C1524063";NA;NA;use of beta blocker
 959;peri - op beta - blockers : no ( n = $nmbr$ );"C0001645;C0347985;C0369718;C0441922";NA;NA;peri op beta blockers no n $nmbr$
 959;no betablocker use;"C0001645;C0042153;C0457083;C1947944";NA;NA;no betablocker use
 959;blocker;NA;NA;NA;blocker
 959;betablocker use;"C0001645;C0042153;C0457083;C1947944";NA;NA;betablocker use
 959;betablocker;C0001645;NA;NA;betablocker
 959;beta blockers;C0001645;NA;NA;beta blockers
 959;beta blocker users;"C0001645;C1706077";NA;NA;beta blocker users
 959;beta blocker use ( % );"C0001645;C0042153;C0457083;C1947944";NA;NA;beta blocker use
 959;beta blocker use;"C0001645;C0042153;C0457083;C1947944";NA;NA;beta blocker use
 959;beta blocker  n ( % );C0001645;NA;NA;beta blocker n
 959;beta blocker  %;C0001645;NA;NA;beta blocker
 959;beta blocker;C0001645;NA;NA;beta blocker
 959;beta - blockers through hospital discharge or day $nmbr$ — %;"C0001645;C0332173;C0439228;C0439505;C0586003";NA;NA;beta blockers through hospital discharge or day $nmbr$
 959;beta - blockers ( all )  n ( % );"C0001645;C0369718;C0441922";NA;NA;beta blockers all n
 959;beta - blockers  n ( % );C0001645;NA;NA;beta blockers n
 959;beta - blockers  ( % );C0001645;NA;NA;beta blockers
 959;beta - blockers;C0001645;NA;NA;beta blockers
 959;beta - blocker — no . / total no . ( % );"C0001645;C0439175;C0439810";NA;NA;beta blocker no total no
 959;beta - blocker use at randomization;"C0001645;C0034656;C0042153;C0457083;C1947944";NA;NA;beta blocker use at randomization
 959;beta - blocker use at baseline;"C0001645;C0042153;C0168634;C0457083;C1442488;C1947944";NA;NA;beta blocker use at baseline
 959;beta - blocker use;"C0001645;C0042153;C0457083;C1947944";NA;NA;beta blocker use
 959;beta - blocker n ( % );C0001645;NA;NA;beta blocker n
 959;beta - blocker at last follow - up |;"C0001645;C0589120;C1522577;C1704685;C3274571";NA;NA;beta blocker at last follow up
 959;beta - blocker at enrollment;"C0001645;C1516879;C1696073;C3888021";NA;NA;beta blocker at enrollment
 959;beta - blocker ( except sotalol );"C0001645;C0037707";NA;NA;beta blocker except sotalol
 959;beta - blocker % target dose;"C0001645;C0178602;C0869039;C1114758;C1521840;C2986546";NA;NA;beta blocker target dose
 959;beta - blocker !;C0001645;NA;NA;beta blocker
 959;beta - blocker  %;C0001645;NA;NA;beta blocker
 959;beta - blocker;C0001645;NA;NA;beta blocker
 959;beta - adrenergic blocker;"C0001645;C2757061;C3536830";NA;NA;beta adrenergic blocker
 959;b - blockers  n ( % );NA;NA;NA;b blockers n
 958;tdi e ' ( septal ) ( cm / sec );"C0205976;C0439392;C0442004;C2674784;C3714807";NA;NA;tdi e septal cm sec
 958;ae ' ( per cm / s );"C0439392;C3887670";NA;NA;ae per cm s
 957;om $nmbr$ /;"C0028971;C1705272";NA;NA;om $nmbr$
 957;new om;"C0028971;C0205314;C1705272";NA;NA;new om
 957;- ° - $nmbr$  wom -;NA;NA;NA;$nmbr$ wom
 956;triglycerides  mmolt $nmbr$ ( gm * );"C0017480;C0041004;C3854019";NA;NA;triglycerides mmolt $nmbr$ gm
 956;lgm ( n = $nmbr$ );NA;NA;NA;lgm n $nmbr$
 956;im on ] y;NA;NA;NA;im on y
 956;igm ( n = $nmbr$ );C1706005;NA;NA;igm n $nmbr$
 956;igm;NA;NA;NA;igm
 956;gm;"C0017480;C3854019";NA;NA;gm
 956;bmi : body mass index  dbp : diastolic blood pressure  gm : geometric mean  sbp : systolic blood pressure . the analysis was based on observed data without imputation on missing values . asubgroup of patients in whom $nmbr$ h urine was collected ( see materials and methods section ) .;"C0002778;C0017480;C0025663;C0025664;C0030705;C0033727;C0039155;C0042036;C0042037;C0042295;C0042789;C0085805;C0152060;C0369286;C0428883;C0428886;C0441932;C0444504;C0449829;C0449851;C0488053;C0488055;C0520510;C0564385;C0700320;C0871470;C0936012;C1305855;C1306620;C1441672;C1511726;C1516695;C1516698;C1522472;C1524024;C1527178;C1551393;C1552923;C1705191;C1705492;C1705938;C1947903;C2347634;C2348143;C2699638;C2963137;C3245479;C3272743;C3714523;C3714741;C3854019;C4528284";NA;NA;bmi body mass index dbp diastolic blood pressure gm geometric mean sbp systolic blood pressure the analysis was based on observed data without imputation on missing values asubgroup of patients in whom $nmbr$ h urine was collected see materials and methods section
 956;( gm );"C0017480;C3854019";NA;NA;gm
 955;without t $nmbr$ dm n = $nmbr$;"C0011816;C2986835;C3250443";NA;NA;without t $nmbr$ dm n $nmbr$
 955;without dm ( n = $nmbr$ i $nmbr$ * );"C0011816;C0021966;C0221138;C0369718;C0441922;C3250443";NA;NA;without dm n $nmbr$ i $nmbr$
 955;without dm;"C0011816;C3250443";NA;NA;without dm
 796;smoking status  n ( % );C1519386;NA;NA;smoking status n
 960;calcium - channel blocker;"C0006684;C3536851;C4521885";FALSE;1884;calcium channel blocker
 960;calcium - channel blocker *;"C0006684;C3536851;C4521885";FALSE;1884;calcium channel blocker
 960;calcium - channel blocker ( ratelowering );"C0006684;C3536851;C4521885";FALSE;1884;calcium channel blocker ratelowering
 960;calcium - channel blockers;"C0006684;C2757014";FALSE;1884;calcium channel blockers
 960;calcium - channel blockers ( % );"C0006684;C2757014";FALSE;1884;calcium channel blockers
 960;calcium channel blockers;"C0006684;C2757014";FALSE;1884;calcium channel blockers
 960;calcium channel blockers  n ( % );"C0006684;C2757014";FALSE;1884;calcium channel blockers n
 960;caleium ehannel bloekers ( ccb );C0006684;FALSE;1884;caleium ehannel bloekers ccb
 960;dihydropyridine calcium - channel blocker;C2945601;FALSE;1884;dihydropyridine calcium channel blocker
 955;with t $nmbr$ dm n = $nmbr$;"C0011816;C2986835;C3250443";NA;NA;with t $nmbr$ dm n $nmbr$
 955;with dm;"C0011816;C3250443";NA;NA;with dm
 955;t $nmbr$ dm;"C0011816;C2603360;C3250443";NA;NA;t $nmbr$ dm
 955;prior dm;"C0011816;C0332152;C2826257;C3250443";NA;NA;prior dm
 955;previous mi and t $nmbr$ dm;"C0011816;C0205156;C1552607;C2603360;C3250443;C3810814";NA;NA;previous mi and t $nmbr$ dm
 955;previous dm  n ( % );"C0011816;C0205156;C1552607;C3250443";NA;NA;previous dm n
 955;previous dm;"C0011816;C0205156;C1552607;C3250443";NA;NA;previous dm
 955;patients without dm ( n = $nmbr$ );"C0011816;C0030705;C3250443";NA;NA;patients without dm n $nmbr$
 955;patients without dm ( n = $nmbr$  $nmbr$ );"C0011816;C0030705;C3250443";NA;NA;patients without dm n $nmbr$ $nmbr$
 955;patients with possible new dm at randomization ( fpg > $nmbr$ - $nmbr$ );"C0011816;C0030705;C0034656;C0205314;C0332149;C1705910;C2362652;C3250443";NA;NA;patients with possible new dm at randomization fpg $nmbr$ $nmbr$
 955;patients with dm vs . patients without dm;"C0011816;C0030705;C3250443";NA;NA;patients with dm vs patients without dm
 955;patients with dm ( n = $nmbr$ );"C0011816;C0030705;C3250443";NA;NA;patients with dm n $nmbr$
 955;p value for dm vs . no dm;"C0011816;C3250443;C4086240";NA;NA;p value for dm vs no dm
 955;oral anti - dm drug status  no . ( % );"C0011816;C0029167;C0175795;C0304289;C0449438;C3250443";NA;NA;oral anti dm drug status no
 955;non - insulin treated dm;"C0011816;C0021641;C1518422;C1522326;C1533581;C1579433;C3250443;C3714501";NA;NA;non insulin treated dm
 955;non - dm;"C0011816;C1518422;C3250443";NA;NA;non dm
 955;no prior dm;"C0011816;C0332152;C2826257;C3250443";NA;NA;no prior dm
 955;no dm ( n = $nmbr$ );"C0011816;C3250443";NA;NA;no dm n $nmbr$
 955;no dm ( n = $nmbr$  $nmbr$ );"C0011816;C3250443";NA;NA;no dm n $nmbr$ $nmbr$
 955;no dm;"C0011816;C3250443";NA;NA;no dm
 955;new dm;"C0011816;C0205314;C3250443";NA;NA;new dm
 955;neither t $nmbr$ dm nor mets;"C0011816;C0812270;C1705694;C2603360;C2939420;C3250443";NA;NA;neither t $nmbr$ dm nor mets
 955;mets w / o t $nmbr$ dm;"C0011816;C0812270;C1705694;C2939420;C3250443";NA;NA;mets w o t $nmbr$ dm
 955;dm or diabetic complications;"C0011816;C0342257;C3250443";NA;NA;dm or diabetic complications
 955;dm or ckd *;"C0011816;C1561643;C3250443";NA;NA;dm or ckd
 955;dm medication  n ( % ) c;"C0011816;C0013227;C3244316;C3250443;C4284232";NA;NA;dm medication n c
 955;dm ( n = $nmbr$ );"C0011816;C3250443";NA;NA;dm n $nmbr$
 955;dm ( n = $nmbr$  $nmbr$ );"C0011816;C3250443";NA;NA;dm n $nmbr$ $nmbr$
 955;dm  n ( % );"C0011816;C3250443";NA;NA;dm n
 955;dm;"C0011816;C3250443";NA;NA;dm
 955;diff_measure ( dm added this as table had multiple headings );"C0011816;C0039224;C0079809;C0242485;C0439064;C1524062;C1706074;C3250443";NA;NA;diff_measure dm added this as table had multiple headings
 955;concomitant oral anti - dm drugs  no . ( % ) a;"C0011816;C0029167;C0175795;C0304289;C0521115;C3250443";NA;NA;concomitant oral anti dm drugs no a
 954;pm  n ( % );"C0030266;C4049155";NA;NA;pm n
 954;hr ( bpm );NA;NA;NA;hr bpm
 954;hr  bpm ( sd );C2699239;NA;NA;hr bpm sd
 954;hr  bpm;NA;NA;NA;hr bpm
 954;csf a ( $nmbr$ ( pm );"C0030266;C3540512;C3889436;C4049155";NA;NA;csf a $nmbr$ pm
 954;> $nmbr$ bpm ( n = $nmbr$ l $nmbr$ );NA;NA;NA;$nmbr$ bpm n $nmbr$ l $nmbr$
 954;> $nmbr$ . $nmbr$ bpm;NA;NA;NA;$nmbr$ $nmbr$ bpm
 953;serum albumin concentration  g / l;"C0001924;C0036773;C0086045;C0229671;C0439294;C0456615;C0486291;C0683149;C0728877;C1446561;C1546774;C1550100;C3827302";NA;NA;serum albumin concentration g l
 953;serum albumin  g / l;"C0036773;C0439294;C0456615;C0728877";NA;NA;serum albumin g l
 953;serum albumin  g / dl;"C0036773;C0439267;C0728877";NA;NA;serum albumin g dl
 953;serum albumin  g $nmbr$ $nmbr$;"C0036773;C0439267;C0728877";NA;NA;serum albumin g $nmbr$ $nmbr$
 953;serms;C0732611;NA;NA;serms
 952;serum creatinine — mg / dl §;"C0201976;C0439269;C0600061";NA;NA;serum creatinine mg dl
 952;serum creatinine — mg / dl | |;"C0201976;C0439269;C0600061";NA;NA;serum creatinine mg dl
 952;serum creatinine — mg / dl;"C0201976;C0439269;C0600061";NA;NA;serum creatinine mg dl
 952;serum creatinine level;C0600061;NA;NA;serum creatinine level
 952;serum creatinine > $nmbr$ pmol / l . n ( % ) |;"C0201976;C0439284;C0600061";NA;NA;serum creatinine $nmbr$ pmol l n
 952;serum creatinine > $nmbr$ mmol / l  n ( % );"C0201976;C0600061;C1532563";NA;NA;serum creatinine $nmbr$ mmol l n
 952;serum creatinine > $nmbr$ / xmol / l  n ( % ) | |;"C0201976;C0600061";NA;NA;serum creatinine $nmbr$ xmol l n
 952;serum creatinine . mg / dl;"C0201976;C0439269;C0600061";NA;NA;serum creatinine mg dl
 952;serum creatinine - mean ( sd  n );"C0201976;C0444504;C0600061;C2347634;C2348143;C2699239";NA;NA;serum creatinine mean sd n
 952;serum creatinine ( pmol / l )  mean ( sd );"C0201976;C0439284;C0444504;C0600061;C2347634;C2348143;C2699239";NA;NA;serum creatinine pmol l mean sd
 952;serum creatinine ( mmol / l );"C0201976;C0600061;C1532563";NA;NA;serum creatinine mmol l
 952;serum creatinine ( mg / dl );"C0201976;C0439269;C0600061";NA;NA;serum creatinine mg dl
 952;serum creatinine ( gmol / );"C0201976;C0600061";NA;NA;serum creatinine gmol
 952;serum creatinine  ≥ $nmbr$ . $nmbr$ mg / dl;"C0201976;C0439269;C0600061";NA;NA;serum creatinine $nmbr$ $nmbr$ mg dl
 952;serum creatinine  μ mol / l;"C0201976;C0347982;C0600061";NA;NA;serum creatinine mol l
 952;serum creatinine  mg / dl  mean ( sd );"C0201976;C0439269;C0444504;C0600061;C2347634;C2348143;C2699239";NA;NA;serum creatinine mg dl mean sd
 952;serum creatinine  mg / dl;"C0201976;C0439269;C0600061";NA;NA;serum creatinine mg dl
 952;serum creatinine  mean ( sd ) mg / dl;"C0201976;C0439269;C0444504;C0600061;C2347634;C2348143;C2699239";NA;NA;serum creatinine mean sd mg dl
 952;serum creatinine  mean ( sd )  pmol / l;"C0201976;C0439284;C0444504;C0600061;C2347634;C2348143;C2699239";NA;NA;serum creatinine mean sd pmol l
 952;serum creatinine  mean ( sd )  mg / dl;"C0201976;C0439269;C0444504;C0600061;C2347634;C2348143;C2699239";NA;NA;serum creatinine mean sd mg dl
 952;serum creatinine  limo $nmbr$ $nmbr$;"C0201976;C0600061";NA;NA;serum creatinine limo $nmbr$ $nmbr$
 952;serum creatinine  gmol / l |;"C0201976;C0600061";NA;NA;serum creatinine gmol l
 952;serum creatinine  gmol / ' l  mean ( sd );"C0201976;C0444504;C0600061;C2347634;C2348143;C2699239";NA;NA;serum creatinine gmol l mean sd
 952;serum creatinine  ^ mol / l;"C0201976;C0347982;C0600061";NA;NA;serum creatinine mol l
 952;serum creatinine  / xmol / l | |;"C0201976;C0600061";NA;NA;serum creatinine xmol l
 952;serum creatinine;"C0201976;C0600061";NA;NA;serum creatinine
 952;second serum creatinine;"C0201976;C0205436;C0457385;C0565930;C0600061;C1561503;C1705190";NA;NA;second serum creatinine
 952;preoperative serum creatinine > $nmbr$ pmol / l;"C0201976;C0439284;C0445204;C0600061";NA;NA;preoperative serum creatinine $nmbr$ pmol l
 952;mean serum creatinine  mg / dl;"C0201976;C0439269;C0444504;C0600061;C2347634;C2348143";NA;NA;mean serum creatinine mg dl
 952;increase in serum creatinine;"C0201976;C0442805;C0600061";NA;NA;increase in serum creatinine
 952;first serum creatinine;"C0201976;C0205435;C0600061;C1279901";NA;NA;first serum creatinine
 952;doubling of serum creatinine;"C0201976;C0205173;C0600061;C1705764";NA;NA;doubling of serum creatinine
 952;composite endpoint of doubling of serum creatinine  esrd;"C0022661;C0035078;C0201976;C0205173;C0205199;C0600061;C1547335;C1705764;C2316810;C2349179;C2826544";NA;NA;composite endpoint of doubling of serum creatinine esrd
 952;acute increase in serum creatinine;"C0010294;C0201976;C0205178;C0442805;C0600061;C1546542;C1561535";NA;NA;acute increase in serum creatinine
 951;serum values ^;"C0042295;C0229671;C1546774;C1550100";NA;NA;serum values
 951;serum values;"C0042295;C0229671;C1546774;C1550100";NA;NA;serum values
 951;serum trap - $nmbr$ b ( u / liter );"C0184047;C0229671;C0439148;C0475211;C1336677;C1546774;C1550100;C1566918;C1706005;C1710330;C3887583";NA;NA;serum trap $nmbr$ b u liter
 951;serum pepsinogen i / iit;"C0077923;C0229671;C0523816;C1546774;C1550100";NA;NA;serum pepsinogen i iit
 951;serum p $nmbr$ np ( ^ g / liter );"C0065827;C0229671;C0439267;C0475211;C1546774;C1550100;C1706141;C3887659";NA;NA;serum p $nmbr$ np g liter
 951;serum n - propeptide of type $nmbr$ collagen;"C0009325;C0229671;C0332307;C1546774;C1547052;C1550100;C1709708;C1875696";NA;NA;serum n propeptide of type $nmbr$ collagen
 951;serum gastrint  pg / ml;"C0229671;C0439297;C1546774;C1550100";NA;NA;serum gastrint pg ml
 951;serum ctx i ( ng / ml );"C0229671;C0439275;C0631180;C1546774;C1550100";NA;NA;serum ctx i ng ml
 951;serum ctx - $nmbr$  ng / ml  median ( iqr );"C0010377;C0229671;C0439275;C0549183;C0631180;C0876920;C1546774;C1550100;C2347635;C2348144;C2939193;C3539598";NA;NA;serum ctx $nmbr$ ng ml median iqr
 951;serum ctx ( ng / ml );"C0010377;C0229671;C0439275;C0631180;C1546774;C1550100;C3539598";NA;NA;serum ctx ng ml
 951;serum c - terminal telopeptide of;"C0229671;C1546774;C1550100;C1707271";NA;NA;serum c terminal telopeptide of
 951;serum bone - specific alkaline;"C0205369;C0229671;C0262950;C1546774;C1550100;C1552740;C1979842";NA;NA;serum bone specific alkaline
 951;serum $nmbr$ - hydroxyvitamin d  ng / ml;"C0020337;C0229671;C0439275;C1546774;C1550100";NA;NA;serum $nmbr$ hydroxyvitamin d ng ml
 951;serum;"C0229671;C1546774;C1550100";NA;NA;serum
 951;patients with serum $nmbr$ ( oh ) d ≥   $nmbr$ . $nmbr$ and <   $nmbr$   ng / ml    n / n   ( % );"C0030705;C0220853;C0229671;C0439275;C1546774;C1550100";NA;NA;patients with serum $nmbr$ oh d $nmbr$ $nmbr$ and $nmbr$ ng ml n n
 951;median serum periostin ( ng / ml ) t;"C0219433;C0229671;C0439275;C0549183;C0876920;C1424662;C1546774;C1550100;C2347635;C2348144;C2939193;C3812270";NA;NA;median serum periostin ng ml t
 951;mean total serum psa;"C0229671;C0444504;C1546774;C1550100;C2347634;C2348143;C2986589";NA;NA;mean total serum psa
 951;mean total serum ige ( sd )  iu / ml;"C0229671;C0439175;C0439458;C0439810;C0444504;C1546774;C1550100;C2347634;C2348143;C2699239";NA;NA;mean total serum ige sd iu ml
 950;two arm;"C0205448;C0446516;C3715044;C4553528";NA;NA;two arm
 950;treatment arm ( zoledronate ) ( % );"C0392938;C1522541";NA;NA;treatment arm zoledronate
 950;treatment arm;C1522541;NA;NA;treatment arm
 950;three arm;"C0205449;C0446516;C3715044;C4553528";NA;NA;three arm
 950;s arm;"C0446516;C0565930;C2603362;C3715044;C4553528";NA;NA;s arm
 950;by treatment arm;C1522541;NA;NA;by treatment arm
 950;arm;"C0446516;C3715044;C4553528";NA;NA;arm
 949;short term ^;C0443303;NA;NA;short term
 949;short term ( n = $nmbr$ ) +;C0443303;NA;NA;short term n $nmbr$
 949;preferred term  %;"C1709637;C2347664";NA;NA;preferred term
 948;evolocumab ( n = $nmbr$ );C3529352;NA;NA;evolocumab n $nmbr$
 948;evolocumab ( $nmbr$ mg );"C0024671;C0026410;C0439269;C1960952;C2346927;C3529352;C4321396;C4521761";NA;NA;evolocumab $nmbr$ mg
 948;evolocumab $nmbr$ mg monthly ( n = $nmbr$ );"C0024671;C0026410;C0332177;C0439269;C1960952;C2346927;C3529352;C4321396;C4521761";NA;NA;evolocumab $nmbr$ mg monthly n $nmbr$
   7;p - value ( interaction ) ≠;"C1704675;C1709380";NA;NA;p value interaction
 948;evolocumab $nmbr$ mg every $nmbr$ weeks ( n = $nmbr$ );"C0024671;C0026410;C0439230;C0439269;C1960952;C2346927;C3529352;C4321396;C4521761";NA;NA;evolocumab $nmbr$ mg every $nmbr$ weeks n $nmbr$
 948;evolocumab;C3529352;NA;NA;evolocumab
 948;alirocumab n = $nmbr$;C3491162;NA;NA;alirocumab n $nmbr$
 948;alirocumab ( n = $nmbr$ );C3491162;NA;NA;alirocumab n $nmbr$
 948;alirocumab $nmbr$ mg q $nmbr$ w;"C0024671;C0026410;C0439269;C1960952;C2346927;C3491162;C4321396;C4521761";NA;NA;alirocumab $nmbr$ mg q $nmbr$ w
 948;alirocumab $nmbr$ / $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C3491162;C4321396;C4521761";NA;NA;alirocumab $nmbr$ $nmbr$ mg
 948;alirocumab;C3491162;NA;NA;alirocumab
 948;aiirocumab ( n = $nmbr$ );NA;NA;NA;aiirocumab n $nmbr$
 948;aiirocumab;NA;NA;NA;aiirocumab
 947;veflonzumao;NA;NA;NA;veflonzumao
 947;resllzumab;NA;NA;NA;resllzumab
 947;reslizumab ( n = $nmbr$ );C1869620;NA;NA;reslizumab n $nmbr$
 947;reslizumab $nmbr$ . $nmbr$   mg / kg ( n   = $nmbr$ );"C0439272;C1869620";NA;NA;reslizumab $nmbr$ $nmbr$ mg kg n $nmbr$
 947;reslizumab $nmbr$ . $nmbr$ mg / kg ( n = $nmbr$ );"C0439272;C1869620";NA;NA;reslizumab $nmbr$ $nmbr$ mg kg n $nmbr$
 947;reslizumab;C1869620;NA;NA;reslizumab
 947;benralizumab q $nmbr$ w ( n = $nmbr$ );C2982078;NA;NA;benralizumab q $nmbr$ w n $nmbr$
 947;benralizumab q $nmbr$ w ( n - $nmbr$ );C2982078;NA;NA;benralizumab q $nmbr$ w n $nmbr$
 947;benralizumab $nmbr$ mg q $nmbr$ w ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C2982078;C4321396;C4521761";NA;NA;benralizumab $nmbr$ mg q $nmbr$ w n $nmbr$
 947;benralizumab $nmbr$ mg q $nmbr$ w;"C0024671;C0026410;C0439269;C1960952;C2346927;C2982078;C4321396;C4521761";NA;NA;benralizumab $nmbr$ mg q $nmbr$ w
 947;benralizumab;C2982078;NA;NA;benralizumab
 947;b reslizumab $nmbr$ . $nmbr$ mg / kg n / n;"C0439272;C1869620";NA;NA;b reslizumab $nmbr$ $nmbr$ mg kg n n
 947;b . benralizumab $nmbr$ mg q $nmbr$ w;"C0024671;C0026410;C0439269;C1960952;C2346927;C2982078;C4321396;C4521761";NA;NA;b benralizumab $nmbr$ mg q $nmbr$ w
 947;a reslizumab $nmbr$ . $nmbr$ mg / kg n / n;"C0439272;C1869620";NA;NA;a reslizumab $nmbr$ $nmbr$ mg kg n n
 946;rituximab ( $nmbr$ x $nmbr$ mg ) + mtx ( n = $nmbr$ );"C0024671;C0025677;C0026410;C0393022;C0439269;C1417487;C1960952;C2346927;C4321396;C4521761";NA;NA;rituximab $nmbr$ x $nmbr$ mg mtx n $nmbr$
 946;rituximab ( $nmbr$ x $nmbr$ mg ) + mtx;"C0024671;C0025677;C0026410;C0393022;C0439269;C1417487;C1960952;C2346927;C4321396;C4521761";NA;NA;rituximab $nmbr$ x $nmbr$ mg mtx
 946;rituximab  n = $nmbr$;C0393022;NA;NA;rituximab n $nmbr$
 946;rituximab;C0393022;NA;NA;rituximab
 -10;jejunum;C0022378;NA;NA;jejunum
 944;secukinumab $nmbr$   mg ( n   =   $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C3179547;C4321396;C4521761";NA;NA;secukinumab $nmbr$ mg n $nmbr$
 847;lisinopril;C0065374;NA;NA;lisinopril
 944;secukinumab $nmbr$ mg ( n $nmbr$ $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C3179547;C4321396;C4521761";NA;NA;secukinumab $nmbr$ mg n $nmbr$ $nmbr$
 944;secukinumab  $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C3179547;C4321396;C4521761";NA;NA;secukinumab $nmbr$ mg n $nmbr$
 944;secukinumab;C3179547;NA;NA;secukinumab
 944;placebo secukinumab $nmbr$ mg;"C0024671;C0026410;C0032042;C0439269;C1696465;C1706408;C1960952;C2346927;C3179547;C4321396;C4521761";NA;NA;placebo secukinumab $nmbr$ mg
 944;any secukinumab ( n   = $nmbr$ );C3179547;NA;NA;any secukinumab n $nmbr$
 943;vedolizumab n = $nmbr$;C2742797;NA;NA;vedolizumab n $nmbr$
 943;vedolizumab cohort $nmbr$ ( n = $nmbr$ );"C0009247;C0599755;C2742797";NA;NA;vedolizumab cohort $nmbr$ n $nmbr$
 943;vedolizumab;C2742797;NA;NA;vedolizumab
 943;mepolizumab group;"C0441833;C0687744;C0969324;C1257890;C1519504;C1705428;C1705429";NA;NA;mepolizumab group
 943;mepolizumab;C0969324;NA;NA;mepolizumab
 943;evomab + soc;NA;NA;NA;evomab soc
 943;evomab ( n = $nmbr$ );NA;NA;NA;evomab n $nmbr$
 943;evomab;NA;NA;NA;evomab
 943;denosumab ( n = $nmbr$ ) n ( % );C1690432;NA;NA;denosumab n $nmbr$ n
 943;denosumab ( n = $nmbr$ );C1690432;NA;NA;denosumab n $nmbr$
 943;denosumab;C1690432;NA;NA;denosumab
 942;dupilumab $nmbr$;C3660996;NA;NA;dupilumab $nmbr$
 942;both adalimumab groups ( n = $nmbr$ ) no baseline cd - related antibiotic use;"C0003232;C0007928;C0034283;C0042153;C0168634;C0369718;C0439849;C0441833;C0441922;C0445223;C0457083;C0687744;C1122087;C1257890;C1442488;C1519504;C1552839;C1705428;C1705429;C1947944;C4552032";NA;NA;both adalimumab groups n $nmbr$ no baseline cd related antibiotic use
 942;both adalimumab groups ( n = $nmbr$ );"C0369718;C0441833;C0441922;C0687744;C1122087;C1257890;C1519504;C1552839;C1705428;C1705429";NA;NA;both adalimumab groups n $nmbr$
 942;adalimumab group ( n = $nmbr$ ) t;"C0036669;C1122087";NA;NA;adalimumab group n $nmbr$ t
 942;adalimumab croup  n / n ( % );"C0010380;C1122087";NA;NA;adalimumab croup n n
 942;adalimumab ( n = $nmbr$ );C1122087;NA;NA;adalimumab n $nmbr$
 942;adalimumab;C1122087;NA;NA;adalimumab
 941;golimumab combined ( n = $nmbr$ );"C0205195;C2353893";NA;NA;golimumab combined n $nmbr$
 796;smoking status;C1519386;NA;NA;smoking status
 941;golimumab $nmbr$ mg / $nmbr$ mgt;"C0024671;C0026410;C0439269;C1960952;C2346927;C2353893;C4321396;C4521761";NA;NA;golimumab $nmbr$ mg $nmbr$ mgt
 941;golimumab $nmbr$ mg ( n = $nmbr$ ) †;"C0024671;C0026410;C0439269;C1960952;C2346927;C2353893;C4321396;C4521761";NA;NA;golimumab $nmbr$ mg n $nmbr$
 941;golimumab $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C2353893;C4321396;C4521761";NA;NA;golimumab $nmbr$ mg n $nmbr$
 941;golimumab $nmbr$ / $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C2353893;C4321396;C4521761";NA;NA;golimumab $nmbr$ $nmbr$ mg
 941;golimumab;C2353893;NA;NA;golimumab
 941;combined golimumab groups;"C0205195;C0441833;C0687744;C1257890;C1519504;C1552839;C1705428;C1705429;C2353893";NA;NA;combined golimumab groups
 940;prior therapy with omalizumab : yes;"C0966225;C1514463;C1549445;C1705108;C1710701";NA;NA;prior therapy with omalizumab yes
 940;omalizumab ( lsm );C0966225;NA;NA;omalizumab lsm
 940;omalizumab;C0966225;NA;NA;omalizumab
 939;death due to renal failure ®;"C0011065;C0035078;C0678226;C1306577;C1963154;C4082313;C4552775";NA;NA;death due to renal failure
 939;death due to renal failure or sustained esrd;"C0011065;C0022661;C0035078;C0443318;C0678226;C1306577;C1963154;C2316810;C4082313;C4552775";NA;NA;death due to renal failure or sustained esrd
 938;primary renal endpoint or death;"C0011065;C0022646;C1306577;C2986535;C4082313;C4552775";NA;NA;primary renal endpoint or death
 938;primary renal endpoint;"C0022646;C2986535";NA;NA;primary renal endpoint
 937;severe renal impairment;"C0205082;C1565489;C4050465;C4050466";NA;NA;severe renal impairment
 937;renal impairment *;C1565489;NA;NA;renal impairment
 937;renal impairment  n ( % );C1565489;NA;NA;renal impairment n
 937;renal impairment;C1565489;NA;NA;renal impairment
 937;renal dysfunction;"C1565489;C3279454";NA;NA;renal dysfunction
 937;non - endstage renal dysfunction *;"C0205088;C1518422;C1565489;C3279454";NA;NA;non endstage renal dysfunction
 937;non - end - stage renal dysfunction;"C0205088;C1518422;C1565489;C3279454";NA;NA;non end stage renal dysfunction
 937;no renal dysfunction;"C1565489;C3279454";NA;NA;no renal dysfunction
 937;moderate renal impairment  n ( % ) *;"C0205081;C1565489;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate renal impairment n
 937;moderate renal impairment;"C0205081;C1565489;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate renal impairment
 937;mild to moderate renal impairment *;"C1299392;C1565489";NA;NA;mild to moderate renal impairment
 937;level of renal impairment ';"C0441889;C0456079;C1547707;C1565489;C2946261";NA;NA;level of renal impairment
 937;level of renal impairment;"C0441889;C0456079;C1547707;C1565489;C2946261";NA;NA;level of renal impairment
 937;impaired renal function †;C1565489;NA;NA;impaired renal function
 937;impaired renal function §;C1565489;NA;NA;impaired renal function
 937;history of impaired renal function  no . ( % );"C0019664;C0019665;C0262512;C0262926;C1565489;C1705255;C2004062";NA;NA;history of impaired renal function no
 937;history of impaired renal function;"C0019664;C0019665;C0262512;C0262926;C1565489;C1705255;C2004062";NA;NA;history of impaired renal function
 936;medal;C0524670;NA;NA;medal
 936;beyond popliteal pedal;"C0016504;C0442037;C0687080";NA;NA;beyond popliteal pedal
 935;wegu;NA;NA;NA;wegu
 935;emotional well - being;"C2984554;C3641833";NA;NA;emotional well being
 934;peripheral artery revascularization without amputation;"C0002688;C0332840;C0489868;C0581603;C1546539";NA;NA;peripheral artery revascularization without amputation
 934;peripheral artery diseasef;C0489868;NA;NA;peripheral artery diseasef
 934;peripheral artery diseaseb;C0489868;NA;NA;peripheral artery diseaseb
 934;peripheral artery disease 一 no . ( % );"C1704436;C4025272";NA;NA;peripheral artery disease no
 934;peripheral artery disease — no . ( % );"C1704436;C4025272";NA;NA;peripheral artery disease no
 934;peripheral artery disease details;"C1522508;C1561567;C1704436;C4025272";NA;NA;peripheral artery disease details
 934;peripheral artery disease - -;"C1704436;C4025272";NA;NA;peripheral artery disease
 934;peripheral artery disease *;"C1704436;C4025272";NA;NA;peripheral artery disease
 934;peripheral artery disease;"C1704436;C4025272";NA;NA;peripheral artery disease
 934;peripheral artery;C0489868;NA;NA;peripheral artery
 934;peripheral arterial stenosis;C4025272;NA;NA;peripheral arterial stenosis
 934;peripheral - artery stenosis;C4025272;NA;NA;peripheral artery stenosis
 934;peripheral - artery disease — no . ( % );"C1704436;C4025272";NA;NA;peripheral artery disease no
 934;peripheral - artery disease ( % );"C1704436;C4025272";NA;NA;peripheral artery disease
 934;peripheral - artery disease;"C1704436;C4025272";NA;NA;peripheral artery disease
 934;only peripheral artery disease;"C0205171;C1704436;C1720467;C4025272";NA;NA;only peripheral artery disease
 934;history of peripheral artery disease — no . { % );"C0489868;C0683519;C0730226;C0850708;C0944983";NA;NA;history of peripheral artery disease no
 934;history of peripheral artery disease;"C0489868;C0683519;C0730226;C0850708;C0944983";NA;NA;history of peripheral artery disease
 934;baseline peripheral artery disease;"C0168634;C1442488;C1704436;C4025272";NA;NA;baseline peripheral artery disease
 933;qualifying peripheral arterial disease;"C0085096;C1514624;C1704436";NA;NA;qualifying peripheral arterial disease
 933;prior peripheral arterial disease;"C0085096;C0332152;C1704436;C2826257";NA;NA;prior peripheral arterial disease
 938;renal impairmentf;C0022646;FALSE; 937;renal impairmentf
 938;renal impairmentt;C0022646;FALSE; 937;renal impairmentt
 938;renal functiona;C0022646;FALSE;1532;renal functiona
 938;renal functionb;C0022646;FALSE;1532;renal functionb
 938;renal functionc  n ( % );C0022646;FALSE;1532;renal functionc n
 939;renal insufficiency;"C0035078;C1565489";FALSE; 937;renal insufficiency
 939;renal failure;"C0035078;C1963154";FALSE; 937;renal failure
 939;renal insufficiency *;"C0035078;C1565489";FALSE; 937;renal insufficiency
 939;renal insufficiency / failure;"C0035078;C0231174;C0231179;C0680095;C1565489;C1963154";FALSE; 937;renal insufficiency failure
 939;renal insufficiency $nmbr$;"C0035078;C1565489";FALSE; 937;renal insufficiency $nmbr$
 939;renal insufficiency — no . ( % );"C0035078;C1565489";FALSE; 937;renal insufficiency no
 939;renal insufficiency or failure;"C0035078;C0231174;C0680095;C1565489";FALSE; 937;renal insufficiency or failure
 938;renal;C0022646;FALSE;1951;renal
 938;renal events;"C0022646;C0441471;C3541888";FALSE;1951;renal events
 938;renal parameters;"C0022646;C0449381";FALSE;1951;renal parameters
 940;tocilizumab;C1609165;FALSE;2295;tocilizumab
 940;tocilizumab ( n = $nmbr$ );C1609165;FALSE;2295;tocilizumab n $nmbr$
 933;peripheral vascular disease  n ( % );C0085096;NA;NA;peripheral vascular disease n
 933;peripheral vascular disease;C0085096;NA;NA;peripheral vascular disease
 933;peripheral artery occlusive disease ( stage $nmbr$ / $nmbr$ / $nmbr$ / $nmbr$ / $nmbr$ );"C0205390;C1300072;C1306673;C1306889";NA;NA;peripheral artery occlusive disease stage $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 933;peripheral artery occlusive disease;C1306889;NA;NA;peripheral artery occlusive disease
 933;peripheral arterial disease — no . ( % ) §;"C0085096;C1704436";NA;NA;peripheral arterial disease no
 933;peripheral arterial disease — no . ( % );"C0085096;C1704436";NA;NA;peripheral arterial disease no
 933;peripheral arterial disease §;"C0085096;C1704436";NA;NA;peripheral arterial disease
 933;peripheral arterial disease ( n = $nmbr$ $nmbr$ );"C0085096;C1704436";NA;NA;peripheral arterial disease n $nmbr$ $nmbr$
 933;peripheral arterial disease  n ( % );"C0085096;C1704436";NA;NA;peripheral arterial disease n
 933;peripheral arterial disease;"C0085096;C1704436";NA;NA;peripheral arterial disease
 933;cerebrovascular or peripheral arterial disease    n   ( % );"C0085096;C1704436;C1880018";NA;NA;cerebrovascular or peripheral arterial disease n
 933;cerebrovascular or peripheral arterial disease  n ( % );"C0085096;C1704436;C1880018";NA;NA;cerebrovascular or peripheral arterial disease n
 933;cerebrovascular or peripheral arterial disease;"C0085096;C1704436;C1880018";NA;NA;cerebrovascular or peripheral arterial disease
 933;any peripheral arterial disease;"C0085096;C1704436";NA;NA;any peripheral arterial disease
 933;any established peripheral arterial disease;"C0085096;C0443211;C1272684;C1704436";NA;NA;any established peripheral arterial disease
 932;urgent peripheral revascularization;"C0205100;C0439609;C0581603;C3272275";NA;NA;urgent peripheral revascularization
 932;peripheral vasodilators;C0724804;NA;NA;peripheral vasodilators
 932;peripheral revascularization ( n = $nmbr$ );"C0205100;C0581603";NA;NA;peripheral revascularization n $nmbr$
 932;peripheral revascularization;"C0205100;C0581603";NA;NA;peripheral revascularization
 932;peripheral revascularisation;"C0205100;C0581603";NA;NA;peripheral revascularisation
 932;peripheral;C0205100;NA;NA;peripheral
 932;no peripheral revascularization ( n = $nmbr$  $nmbr$ );"C0205100;C0581603";NA;NA;no peripheral revascularization n $nmbr$ $nmbr$
 932;history of peripheral vascular disease;C1881056;NA;NA;history of peripheral vascular disease
 931;lateral;C0205093;NA;NA;lateral
 931;bilateral disease ( % ) ' j ' ' j ';C1511113;NA;NA;bilateral disease j j
 930;vilanterol  n = $nmbr$;C2935023;NA;NA;vilanterol n $nmbr$
 930;fluticasone furoate and vilanterol ( n = $nmbr$ );"C1948374;C2935023";NA;NA;fluticasone furoate and vilanterol n $nmbr$
 929;intracerebral;C0442111;NA;NA;intracerebral
 929;chd plus cerebral infarction;"C0007785;C0280604;C3542407";NA;NA;chd plus cerebral infarction
 929;chd + cerebral infarction;"C0007785;C0280604;C3542407";NA;NA;chd cerebral infarction
 929;cerebral thrombosis;"C0079102;C0151945;C0795687";NA;NA;cerebral thrombosis
 929;cerebral ischemia;"C0007785;C0917798";NA;NA;cerebral ischemia
 929;cerebral infarction;C0007785;NA;NA;cerebral infarction
 929;cerebral hemorrhage;C2937358;NA;NA;cerebral hemorrhage
 929;cerebral embolism;C0007780;NA;NA;cerebral embolism
 929;cerebral;NA;NA;NA;cerebral
 928;northamerica;NA;NA;NA;northamerica
 928;nonvertebral;NA;NA;NA;nonvertebral
 928;morphometric vertebral;"C0200760;C0549207";NA;NA;morphometric vertebral
 928;hip + nonvertebral + vertebral;"C0019552;C0022122;C0549207;C1505163;C3538851;C4284725";NA;NA;hip nonvertebral vertebral
 927;neuraxial anaesthesia;"C0002903;C0002912;C0002930;C3714787;C4049933";NA;NA;neuraxial anaesthesia
 927;neuraxial alonee;C3714787;NA;NA;neuraxial alonee
 927;central nervous system;"C3540014;C3714787";NA;NA;central nervous system
 926;treatment after randomization  in the single - dummy phase — days ];"C0034656;C0037179;C0039798;C0087111;C0087136;C0205171;C0205390;C0439228;C1522326;C1533734;C1705169;C1710475;C3538994;C3887704";NA;NA;treatment after randomization in the single dummy phase days
 926;thienopyridine alone;"C0205171;C0439044;C0679994;C1120149";NA;NA;thienopyridine alone
 926;single;"C0037179;C0087136;C0205171";NA;NA;single
 926;rivaroxaban alone ( n = $nmbr$ ) $nmbr$ . $nmbr$ ± $nmbr$ . $nmbr$;"C0205171;C0439044;C0679994;C1739768";NA;NA;rivaroxaban alone n $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 926;rivaroxaban alone ( n = $nmbr$ );"C0205171;C0439044;C0679994;C1739768";NA;NA;rivaroxaban alone n $nmbr$
 926;previous ics alone;"C0205156;C0205171;C0439044;C0679994;C0815320;C1552607;C4551720";NA;NA;previous ics alone
 926;pci alone ( n = $nmbr$ );"C0205171;C0439044;C0679994;C4049621";NA;NA;pci alone n $nmbr$
 926;metformin alone;"C0025598;C0205171;C0439044;C0679994";NA;NA;metformin alone
 926;lived alone;"C0205171;C0439044;C0679994;C1548795;C1634625;C2982691";NA;NA;lived alone
 926;ics alone;"C0205171;C0439044;C0679994;C0815320;C4551720";NA;NA;ics alone
 926;heparin alone ( n = $nmbr$ );"C0019134;C0205171;C0439044;C0679994;C0770546";NA;NA;heparin alone n $nmbr$
 926;fluticasone alone ( n = $nmbr$ );"C0082607;C0205171;C0439044;C0679994";NA;NA;fluticasone alone n $nmbr$
 926;bivalirudin alone ( n = $nmbr$ );"C0168273;C0205171;C0439044;C0679994";NA;NA;bivalirudin alone n $nmbr$
 926;basal alone;"C0205112;C0205171;C0439044;C0679994";NA;NA;basal alone
 926;alone;"C0205171;C0439044;C0679994";NA;NA;alone
 926;$nmbr$ ( except for female alone );"C0043210;C0086287;C0205171;C0439044;C0679994;C1705497;C1705498";NA;NA;$nmbr$ except for female alone
 925;unfractionated only;"C0205171;C1720467";NA;NA;unfractionated only
 925;unfractionated heparin only;"C0019134;C0205171;C1720467;C2825026";NA;NA;unfractionated heparin only
 925;type of surgery cabg only;"C0010055;C0038894;C0038895;C0205171;C0332307;C0543467;C1274039;C1547052;C1720467";NA;NA;type of surgery cabg only
 925;t - wave inversion only;"C0205171;C0520888;C1720467";NA;NA;t wave inversion only
 925;statin only ( n = $nmbr$  $nmbr$ );"C0205171;C0360714;C1720467";NA;NA;statin only n $nmbr$ $nmbr$
 925;statin only  n ( % );"C0205171;C0360714;C1720467";NA;NA;statin only n
 925;statin only;"C0205171;C0360714;C1720467";NA;NA;statin only
 925;st - depression only;"C0205171;C0520887;C1720467";NA;NA;st depression only
 925;pulmonary embolism only;"C0034065;C0205171;C1720467";NA;NA;pulmonary embolism only
 925;ptca only;"C0205171;C1720467;C2936173";NA;NA;ptca only
 925;previous lev only;"C0023556;C0205156;C0205171;C1552607;C1720467";NA;NA;previous lev only
 925;previous labd only;"C0205156;C0205171;C0396059;C1552607;C1720467";NA;NA;previous labd only
 925;pioglitazone only;"C0071097;C0205171;C1720467";NA;NA;pioglitazone only
 925;oral hypoglycemic drugs only;"C0205171;C0359086;C1720467";NA;NA;oral hypoglycemic drugs only
 925;oral hypoglycaemics only;"C0205171;C0359086;C1720467";NA;NA;oral hypoglycaemics only
 925;oad only;"C0205171;C1720467";NA;NA;oad only
 925;monotherapy $nmbr$;NA;NA;NA;monotherapy $nmbr$
 925;metformin only;"C0025598;C0205171;C1720467";NA;NA;metformin only
 925;medical management only — no . { % );"C0001554;C0199168;C0205171;C0205476;C0376636;C1273870;C1720467;C3273539";NA;NA;medical management only no
 925;medical management only;"C0001554;C0199168;C0205171;C0205476;C0376636;C1273870;C1720467;C3273539";NA;NA;medical management only
 925;lieum only  n ( % );"C0205171;C1720467";NA;NA;lieum only n
 925;legs only;"C0205171;C1140621;C1720467";NA;NA;legs only
 925;lama ( only monotherapy );"C0205171;C0999593;C1416775;C1720467";NA;NA;lama only monotherapy
 925;laba ( only monotherapy );"C0205171;C1720467";NA;NA;laba only monotherapy
 925;jbs - $nmbr$ secondary prevention only $nmbr$;"C0175692;C0205171;C0679699;C0795841;C1416527;C1720467";NA;NA;jbs $nmbr$ secondary prevention only $nmbr$
 925;jbs - $nmbr$ primary prevention only $nmbr$;"C0033144;C0175692;C0205171;C0795841;C1416527;C1720467";NA;NA;jbs $nmbr$ primary prevention only $nmbr$
 925;immunosuppressants and antimalarials only;"C0003374;C0021081;C0205171;C1720467";NA;NA;immunosuppressants and antimalarials only
 925;sulphonylureas only;"C0038766;C0205171;C1720467";FALSE; 752;sulphonylureas only
 925;image only;"C0205171;C1704254;C1704922;C1720467;C3542466";NA;NA;image only
 925;handihaler only  n;"C0205171;C1720467";NA;NA;handihaler only n
 925;enoxaparin only;"C0205171;C0206460;C1720467";NA;NA;enoxaparin only
 925;depressed only;"C0205171;C0344315;C0549249;C1720467";NA;NA;depressed only
 925;class v only;"C0205171;C0457166;C1720467;C1880098";NA;NA;class v only
 925;cabg only;"C0010055;C0205171;C1720467";NA;NA;cabg only
 925;basal only;"C0205112;C0205171;C1720467";NA;NA;basal only
 925;antimalarials only;"C0003374;C0205171;C1720467";NA;NA;antimalarials only
 925;$nmbr$ ( only $nmbr$ distal );"C0205108;C0205171;C1720467;C4522154";NA;NA;$nmbr$ only $nmbr$ distal
 924;range ed etiology ( n );"C0015127;C1314792;C1514721;C1524003;C2348147;C3538926;C3542016";NA;NA;range ed etiology n
 924;pah origin / cause;"C0015127;C1418251;C1524003";NA;NA;pah origin cause
 924;pah etiology :;"C0015127;C0030123;C1314792;C1524003;C3203102;C4284467";NA;NA;pah etiology
 924;pah etiology;"C0015127;C0030123;C1314792;C1524003;C3203102;C4284467";NA;NA;pah etiology
 924;other determined etiology;"C0015127;C0521095;C1314792;C1524003";NA;NA;other determined etiology
 924;other cause  n ( % );"C0015127;C1524003";NA;NA;other cause n
 924;other cause;"C0015127;C1524003";NA;NA;other cause
 924;non - ischaemic aetiology;"C0015127;C0475224;C1314792;C1518422;C1524003";NA;NA;non ischaemic aetiology
 924;neohrodathv . and all - cause mortalitv;"C0015127;C1524003";NA;NA;neohrodathv and all cause mortalitv
 924;main etiology of heart failure;"C0015127;C0018801;C0018802;C0205225;C1314792;C1524003;C1542147;C4554158";NA;NA;main etiology of heart failure
 924;ischemic heart failure etiology;"C0015127;C0018801;C0018802;C0475224;C1314792;C1524003;C4554158";NA;NA;ischemic heart failure etiology
 924;ischemic etiology ( % );"C0015127;C0475224;C1314792;C1524003";NA;NA;ischemic etiology
 924;ischemic etiology  %;"C0015127;C0475224;C1314792;C1524003";NA;NA;ischemic etiology
 924;ischemic etiology;"C0015127;C0475224;C1314792;C1524003";NA;NA;ischemic etiology
 924;ischemic aetiology  n ( % );"C0015127;C0475224;C1314792;C1524003";NA;NA;ischemic aetiology n
 924;ischemic aetiology;"C0015127;C0475224;C1314792;C1524003";NA;NA;ischemic aetiology
 924;ischaemic etiology n ( % );"C0015127;C0475224;C1314792;C1524003";NA;NA;ischaemic etiology n
 924;ischaemic aetiology;"C0015127;C0475224;C1314792;C1524003";NA;NA;ischaemic aetiology
 924;etiology ( % );"C0015127;C1314792;C1524003";NA;NA;etiology
 924;etiology    n   ( % );"C0015127;C1314792;C1524003";NA;NA;etiology n
 924;etiology  n ( % );"C0015127;C1314792;C1524003";NA;NA;etiology n
 924;etiology;"C0015127;C1314792;C1524003";NA;NA;etiology
 924;ed etiology  no . ( % );"C0015127;C1314792;C1524003;C3538926";NA;NA;ed etiology no
 924;diabetes etiology;"C0011847;C0011849;C0015127;C1314792;C1524003";NA;NA;diabetes etiology
 924;combined major macrovascular events  neohrodathv . and all - cause mortalitv ■;"C0015127;C0205082;C0205164;C0205195;C0441471;C1524003;C3541888;C4318856;C4521762";NA;NA;combined major macrovascular events neohrodathv and all cause mortalitv
 924;any cause;"C0015127;C1524003";NA;NA;any cause
 924;all randomized all - cause mortality or hospitalization for worsening hf ^;"C0015127;C0018488;C0019993;C0026565;C0026566;C0034656;C0332271;C0444868;C1313497;C1457868;C1524003;C1538440;C1546960;C3273279;C3539085;C3815594";NA;NA;all randomized all cause mortality or hospitalization for worsening hf
 924;all randomized all - cause mortality;"C0015127;C0026565;C0026566;C0034656;C0444868;C1524003;C3539085;C3815594";NA;NA;all randomized all cause mortality
 924;all cause mortality;"C0015127;C0026565;C0026566;C0444868;C1524003;C3539085";NA;NA;all cause mortality
 924;all - cause mortality or hf hospitalization ^;"C0015127;C0018488;C0019993;C0026565;C0026566;C0444868;C1313497;C1524003;C1538440;C3273279;C3539085";NA;NA;all cause mortality or hf hospitalization
 924;all - cause mortality or hf hospitalization;"C0015127;C0018488;C0019993;C0026565;C0026566;C0444868;C1313497;C1524003;C1538440;C3273279;C3539085";NA;NA;all cause mortality or hf hospitalization
 924;all - cause mortality ( no . of events );"C0015127;C0026565;C0026566;C0441471;C0444868;C1524003;C3539085;C3541888";NA;NA;all cause mortality no of events
 924;all - cause mortality ( n = $nmbr$ );"C0015127;C0026565;C0026566;C0444868;C1524003;C3539085";NA;NA;all cause mortality n $nmbr$
 924;all - cause mortality;"C0015127;C0026565;C0026566;C0444868;C1524003;C3539085";NA;NA;all cause mortality
 924;all - cause mortalitv;"C0015127;C1524003";NA;NA;all cause mortalitv
 924;all - cause hospitalization;"C0015127;C0019993;C1524003";NA;NA;all cause hospitalization
 924;all - cause;"C0015127;C1524003";NA;NA;all cause
 924;aetiology of pah;"C0015127;C0030123;C1314792;C1524003;C3203102;C4284467";NA;NA;aetiology of pah
 924;aetiology;"C0015127;C1314792;C1524003";NA;NA;aetiology
 924;acute stroke of other determined cause;"C0015127;C0521095;C0751956;C1524003";NA;NA;acute stroke of other determined cause
 923;six - minute walk distance  m;"C0012751;C0369637;C0441923;C3900196";NA;NA;six minute walk distance m
 923;rate ( ml / min / $nmbr$ . $nmbr$ m $nmbr$ );"C0369637;C0439445;C0441923;C0871208;C1521828";NA;NA;rate ml min $nmbr$ $nmbr$ m $nmbr$
 923;mean — ml / min / $nmbr$ . $nmbr$ m $nmbr$ level — no . ( % );"C0369637;C0439445;C0441889;C0441923;C0444504;C0456079;C1547707;C2347634;C2348143;C2946261";NA;NA;mean ml min $nmbr$ $nmbr$ m $nmbr$ level no
 923;mab;"C0003250;C0369637";NA;NA;mab
 923;m o nito ring treatment;"C0039798;C0087111;C0369637;C0441923;C0521164;C1260969;C1522326;C1533734;C1705169;C1882954;C3538994;C3887704";NA;NA;m o nito ring treatment
 923;m being;"C0369637;C0441923";NA;NA;m being
 923;m;"C0369637;C0441923";NA;NA;m
 923;k - m % n;"C0369637;C0441923;C0597277;C1708601";NA;NA;k m n
 923;k - m %;"C0369637;C0441923;C0597277;C1708601";NA;NA;k m
 923;glomerular filtration rate  $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0017654;C0369637;C0439445;C0441923;C1561549";NA;NA;glomerular filtration rate $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 923;estimated glomerular filtration rate < $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C3811844";NA;NA;estimated glomerular filtration rate $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$
 923;estimated glomerular filtration rate < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ — no . / total no . ( % ) §;"C0369637;C0439175;C0439445;C0439810;C0441923;C3811844";NA;NA;estimated glomerular filtration rate $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ no total no
 923;estimated glomerular filtration rate < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ : i : §;"C0021966;C0023806;C0221138;C0369637;C0439445;C0441923;C0702093;C1524029;C3811844;C3813700";NA;NA;estimated glomerular filtration rate $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ i
 923;estimated glomerular filtration rate ( ml / min / $nmbr$ . $nmbr$ m $nmbr$ );"C0369637;C0439445;C0441923;C3811844";NA;NA;estimated glomerular filtration rate ml min $nmbr$ $nmbr$ m $nmbr$
 923;estimated glomerular filtration rate ( mdrd )  ml · min $nmbr$ · $nmbr$ . $nmbr$ m $nmbr$ *;"C0369637;C0439445;C0441923;C3811844;C3839656";NA;NA;estimated glomerular filtration rate mdrd ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$
 923;estimated glomerular filtration rate ( mdrd )  ml · min $nmbr$ · $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C3811844;C3839656";NA;NA;estimated glomerular filtration rate mdrd ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$
 923;estimated glomerular filtration rate ( mdrd )  ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C3811844;C3839656";NA;NA;estimated glomerular filtration rate mdrd ml min $nmbr$ $nmbr$ m $nmbr$
 831;hip circumference — cm;C0562350;NA;NA;hip circumference cm
 923;estimated glomerular filtration rate  ml / min per $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C3811844";NA;NA;estimated glomerular filtration rate ml min per $nmbr$ $nmbr$ m $nmbr$
 923;death or $nmbr$ mwd decrease > $nmbr$ m;"C0011065;C0369637;C0392756;C0441923;C0547047;C1306577;C4082313;C4552775";NA;NA;death or $nmbr$ mwd decrease $nmbr$ m
 923;baseline mwd  m;"C0168634;C0369637;C0441923;C1442488";NA;NA;baseline mwd m
 923;baseline $nmbr$ - min walk distance m;"C0168634;C0369637;C0429886;C0441923;C0702093;C1442488;C1524029;C3813700";NA;NA;baseline $nmbr$ min walk distance m
 923;azl - m / cld ( n = $nmbr$ );"C0369637;C0441923";NA;NA;azl m cld n $nmbr$
 923;azl - m + hctz ( n = $nmbr$ );"C0020261;C0369637;C0441923";NA;NA;azl m hctz n $nmbr$
 923;azl - m + cldb;"C0369637;C0441923";NA;NA;azl m cldb
 923;azl - m $nmbr$ mg + cld $nmbr$ mg;"C0369637;C0441923;C1319635";NA;NA;azl m $nmbr$ mg cld $nmbr$ mg
 923;azl - m $nmbr$ mg $nmbr$ - cld $nmbr$ mg ( n = l $nmbr$ );"C0369637;C0441923;C2827881";NA;NA;azl m $nmbr$ mg $nmbr$ cld $nmbr$ mg n l $nmbr$
 923;azl - m;"C0369637;C0441923";NA;NA;azl m
 923;> $nmbr$ to < $nmbr$ iiil / iiim / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0441923";NA;NA;$nmbr$ to $nmbr$ iiil iiim $nmbr$ $nmbr$ m $nmbr$
 923;> $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ — no . ( % );"C0369637;C0439445;C0441923";NA;NA;$nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ no
 923;> $nmbr$ . $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923";NA;NA;$nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 923;< $nmbr$ ml / min / $nmbr$ . $nmbr$ m ^ — no . { % );"C0369637;C0439445;C0441923";NA;NA;$nmbr$ ml min $nmbr$ $nmbr$ m no
 923;< $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ — no . ( % );"C0369637;C0439445;C0441923";NA;NA;$nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ no
 923;< $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ nt - pro - bnp;"C0369637;C0439445;C0441923;C0669479;C0754710";NA;NA;$nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ nt pro bnp
 923;< $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$  n ( % );"C0369637;C0439445;C0441923";NA;NA;$nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ n
 923;. $nmbr$ . $nmbr$ ml / s / m $nmbr$ ( $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ )  n ( % );"C0369637;C0439445;C0441923";NA;NA;$nmbr$ $nmbr$ ml s m $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ n
 923;$nmbr$ to < $nmbr$ m um in;"C0369637;C0441923";NA;NA;$nmbr$ to $nmbr$ m um in
 923;$nmbr$ mwt ( m );"C0369637;C0441923";NA;NA;$nmbr$ mwt m
 923;$nmbr$ mwd decrease > $nmbr$ m;"C0369637;C0392756;C0441923;C0547047";NA;NA;$nmbr$ mwd decrease $nmbr$ m
 923;$nmbr$ mwd  m;"C0369637;C0441923";NA;NA;$nmbr$ mwd m
 923;$nmbr$ mw distance  m;"C0012751;C0024548;C0026385;C0369637;C0441923;C0556966";NA;NA;$nmbr$ mw distance m
 923;$nmbr$ - minute walk distance — m;"C0369637;C0429886;C0439232;C0441923;C0700321;C0702093;C1282918;C2347166";NA;NA;$nmbr$ minute walk distance m
 923;$nmbr$ - min walk distance ( m );"C0369637;C0429886;C0441923;C0702093;C1524029;C3813700";NA;NA;$nmbr$ min walk distance m
 922;method of identification ofstenosis ( % );C1301921;NA;NA;method of identification ofstenosis
 922;mestizos;C0682082;NA;NA;mestizos
 921;without mets;"C0812270;C1705694;C2939420";NA;NA;without mets
 921;with mets;"C0812270;C1705694;C2939420";NA;NA;with mets
 921;presence of mets ( % ) a;"C0150312;C0392148;C0812270;C1705694;C2939420;C3854307";NA;NA;presence of mets a
 921;presence of mets;"C0150312;C0392148;C0812270;C1705694;C2939420;C3854307";NA;NA;presence of mets
 921;non - mets;"C0812270;C1518422;C1705694;C2939420";NA;NA;non mets
 921;no dysglycaemia or mets pbo ( n = $nmbr$ ) vs evomab ( n = $nmbr$ );"C0031962;C0812270;C1705694;C1960636;C2939420";NA;NA;no dysglycaemia or mets pbo n $nmbr$ vs evomab n $nmbr$
 921;no dysglycaemia or mets;"C0812270;C1705694;C1960636;C2939420";NA;NA;no dysglycaemia or mets
 921;mets  n ( % );"C0812270;C1705694;C2939420";NA;NA;mets n
 921;mets;"C0812270;C1705694;C2939420";NA;NA;mets
 921;i without mets ( n = $nmbr$ );"C0021966;C0221138;C0812270;C1705694;C2939420";NA;NA;i without mets n $nmbr$
 921;i with mets ( n = $nmbr$ );"C0021966;C0221138;C0812270;C1705694;C2939420";NA;NA;i with mets n $nmbr$
 921;dysglycaemia or mets;"C0812270;C1705694;C1960636;C2939420";NA;NA;dysglycaemia or mets
 920;height in meters .;"C0441074;C0489786";NA;NA;height in meters
 920;> = $nmbr$ meters;C0441074;NA;NA;$nmbr$ meters
 920;< $nmbr$ meters;C0441074;NA;NA;$nmbr$ meters
 919;neither ics nor laba;"C0815320;C4551720";NA;NA;neither ics nor laba
 919;neither;NA;NA;NA;neither
 918;jugular venous distention > $nmbr$ cm;C0425687;NA;NA;jugular venous distention $nmbr$ cm
 918;jugular venous distension  n ( % );C0425687;NA;NA;jugular venous distension n
 917;venous graft;"C0042449;C0181074;C0332835;C0348013;C1961139";NA;NA;venous graft
 917;venous;"C0042449;C0348013";NA;NA;venous
 916;sirius;NA;NA;NA;sirius
 916;serious teaes;C0205404;NA;NA;serious teaes
 916;serious infections;"C0205404;C3714514";NA;NA;serious infections
 916;serious decline in kidney function *;"C0205404;C0232804";NA;NA;serious decline in kidney function
 916;serious decline in kidney function $nmbr$;"C0205404;C0232804";NA;NA;serious decline in kidney function $nmbr$
 916;serious aes;"C0205404;C1412268;C2699274";NA;NA;serious aes
 916;serious ae;"C0205404;C3887670";NA;NA;serious ae
 916;serious;C0205404;NA;NA;serious
 916;any serious teaes;C0205404;NA;NA;any serious teaes
 916;any serious ae  n ( % );"C0205404;C3887670";NA;NA;any serious ae n
 916;> $nmbr$ serious aes;"C0205404;C1412268;C2699274";NA;NA;$nmbr$ serious aes
 915;stent thrombosis arc definite / probable;"C0033204;C0332148;C0439544;C1704787;C3897493";NA;NA;stent thrombosis arc definite probable
 915;disseminated tuberculosis;C0152915;NA;NA;disseminated tuberculosis
 915;definite stent thrombosis;"C0439544;C1704787;C3897493";NA;NA;definite stent thrombosis
 915;definite / probable stent thrombosis;"C0033204;C0332148;C0439544;C1704787;C3897493";NA;NA;definite probable stent thrombosis
 915;definite;"C0439544;C1704787";NA;NA;definite
 914;patients without clinically evident vascular disease;"C0030705;C0042373;C3887511";NA;NA;patients without clinically evident vascular disease
 914;patients with clinically evident vascular disease;"C0030705;C0042373;C3887511";NA;NA;patients with clinically evident vascular disease
 914;clinically evident vascular disease;"C0042373;C3887511";NA;NA;clinically evident vascular disease
 913;very severe n z $nmbr$;"C3641272;C4050419";NA;NA;very severe n z $nmbr$
 913;very severe ( itt ) ( n = $nmbr$ );"C3641272;C4050419";NA;NA;very severe itt n $nmbr$
 913;very severe;"C3641272;C4050419";NA;NA;very severe
 913;severe or very severe smoking status;"C0205082;C1519386;C3641272;C4050419;C4050465;C4050466";NA;NA;severe or very severe smoking status
 913;severe or very severe;"C0205082;C3641272;C4050419;C4050465;C4050466";NA;NA;severe or very severe
 913;$nmbr$ - $nmbr$ ( very severe );"C3641272;C4050419";NA;NA;$nmbr$ $nmbr$ very severe
 912;prior or new diabetes;"C0011847;C0011849;C0205314;C0332152;C2826257";NA;NA;prior or new diabetes
 912;prior gestational diabetes;"C0085207;C0332152;C2826257";NA;NA;prior gestational diabetes
 912;prior diabetes;"C0011847;C0011849;C0332152;C2826257";NA;NA;prior diabetes
 912;diabetese;NA;NA;NA;diabetese
 912;diabetesc;NA;NA;NA;diabetesc
 912;comorbid diseasesa diabetesb;C0009488;NA;NA;comorbid diseasesa diabetesb
 910;prediabeticb;NA;NA;NA;prediabeticb
 910;prediabetese;NA;NA;NA;prediabetese
 910;prediabetes — no . ( % ) $nmbr$;C0362046;NA;NA;prediabetes no $nmbr$
 910;prediabetes  n ( % );C0362046;NA;NA;prediabetes n
 910;prediabetes  %;C0362046;NA;NA;prediabetes
 910;pre – diabetes mellitus  n = $nmbr$;C0362046;NA;NA;pre diabetes mellitus n $nmbr$
 910;pre – diabetes mellitus;C0362046;NA;NA;pre diabetes mellitus
 910;ifg / prediabetes ^;"C0362046;C1334085;C1708411";NA;NA;ifg prediabetes
 913;very severe copd;"C0024117;C1412502;C3641272;C3714496;C4050419";FALSE;1836;very severe copd
 914;evidence or thombus  n ( % );C3887511;FALSE; -10;evidence or thombus n
 918;venous insufficiency;C0042485;FALSE;1949;venous insufficiency
 911;progression to diabetes;C1735364;FALSE; 907;progression to diabetes
 625;baseline tophusa;"C0168634;C1442488";NA;NA;baseline tophusa
 917;history of recurrent venous thromboembolism;"C0042449;C0348013;C0455533;C1455761;C2945760";FALSE;2399;history of recurrent venous thromboembolism
 911;amputation due to diabetes — no . ( % );"C0598284;C0678226";FALSE; 909;amputation due to diabetes no
 911;diabetesf;NA;FALSE; 909;diabetesf
 910;baseline prediabetes;"C0168634;C0362046;C1442488";NA;NA;baseline prediabetes
 909;without diabetes;"C0011847;C0011849";NA;NA;without diabetes
 909;with diabetes;"C0011847;C0011849";NA;NA;with diabetes
 909;undiagnosed diabetes mellitus  n = $nmbr$;"C0011849;C1408353";NA;NA;undiagnosed diabetes mellitus n $nmbr$
 909;undiagnosed diabetes mellitus;"C0011849;C1408353";NA;NA;undiagnosed diabetes mellitus
 909;undiagnosed diabetes ( n = $nmbr$ );"C0011847;C0011849;C1408353";NA;NA;undiagnosed diabetes n $nmbr$
 909;time since diagnosis of type $nmbr$ diabetes;"C0011847;C0011849;C0011900;C0040223;C1320657;C1550351;C1704338;C1704656;C3541383";NA;NA;time since diagnosis of type $nmbr$ diabetes
 909;time since diagnosis of diabetes — no . ( % );"C0011847;C0011849;C0011900;C0040223;C1704338;C1704656;C3541383";NA;NA;time since diagnosis of diabetes no
 909;time since diagnosis of diabetes  n ( % );"C0011847;C0011849;C0011900;C0040223;C1704338;C1704656;C3541383";NA;NA;time since diagnosis of diabetes n
 909;time since diagnosis of diabetes;"C0011847;C0011849;C0011900;C0040223;C1704338;C1704656;C3541383";NA;NA;time since diagnosis of diabetes
 909;short ( < $nmbr$ years ) duration of diabetes;"C0011847;C0011849;C0439234;C0439593";NA;NA;short $nmbr$ years duration of diabetes
 909;reported diabetes mellitus;"C0011849;C0684224;C0700287;C4319718";NA;NA;reported diabetes mellitus
 909;postbaseline new - onset diabetes - n ( % );"C0011847;C0011849;C0746890";NA;NA;postbaseline new onset diabetes n
 909;people without diabetes n = $nmbr$;"C0011847;C0011849;C0027361";NA;NA;people without diabetes n $nmbr$
 909;people with diabetes n = $nmbr$;"C0011847;C0011849;C0027361";NA;NA;people with diabetes n $nmbr$
 909;patients without diabetes mellitus ( n = $nmbr$ );"C0011849;C0030705";NA;NA;patients without diabetes mellitus n $nmbr$
 909;patients without diabetes;"C0011847;C0011849;C0030705";NA;NA;patients without diabetes
 909;patients with diabetes mellitus ( n = $nmbr$ );"C0011849;C0030705";NA;NA;patients with diabetes mellitus n $nmbr$
 909;patients with diabetes mellitus;"C0011849;C0030705";NA;NA;patients with diabetes mellitus
 909;patients with diabetes;"C0011847;C0011849;C0030705";NA;NA;patients with diabetes
 909;other ( % ) diabetes ( interaction : p = $nmbr$ . $nmbr$ );"C0011847;C0011849;C1704675";NA;NA;other diabetes interaction p $nmbr$ $nmbr$
 909;non - diabetes;"C0011847;C0011849;C1518422";NA;NA;non diabetes
 909;no diabetes mellitus;C0011849;NA;NA;no diabetes mellitus
 909;no diabetes ( p = . o $nmbr$ );"C0011847;C0011849";NA;NA;no diabetes p o $nmbr$
 909;no diabetes ( p = . $nmbr$ );"C0011847;C0011849";NA;NA;no diabetes p $nmbr$
 909;no diabetes ( n = $nmbr$  $nmbr$ );"C0011847;C0011849";NA;NA;no diabetes n $nmbr$ $nmbr$
 909;no diabetes ( n - $nmbr$  $nmbr$ );"C0011847;C0011849";NA;NA;no diabetes n $nmbr$ $nmbr$
 909;no diabetes;"C0011847;C0011849";NA;NA;no diabetes
 909;new diabetes — no . ( % );"C0011847;C0011849;C0205314";NA;NA;new diabetes no
 909;new diabetes;"C0011847;C0011849;C0205314";NA;NA;new diabetes
 909;new - onset diabetes §;"C0011847;C0011849;C0746890";NA;NA;new onset diabetes
 909;new - onset diabetes;"C0011847;C0011849;C0746890";NA;NA;new onset diabetes
 909;n o diabetes;"C0011847;C0011849;C0369718;C0441922";NA;NA;n o diabetes
 909;mellitus;NA;NA;NA;mellitus
 909;median duration of diabetes ( yr );"C0011847;C0011849;C0439234;C0449238;C0549183;C0876920;C2347635;C2348144;C2926735;C2939193";NA;NA;median duration of diabetes yr
 909;long ( i $nmbr$ years ) duration of diabetes;"C0011847;C0011849;C0021966;C0221138;C0439234;C0439591";NA;NA;long i $nmbr$ years duration of diabetes
 909;long ( > $nmbr$ years ) duration of diabetes;"C0011847;C0011849;C0439234;C0439591";NA;NA;long $nmbr$ years duration of diabetes
 909;laboratory values in patients with history of diabetes;"C0011847;C0011849;C0019664;C0019665;C0022877;C0030705;C0042295;C0262512;C0262926;C1705255;C2004062;C3244292;C4283904";NA;NA;laboratory values in patients with history of diabetes
 909;individuals without diabetes  n = $nmbr$  $nmbr$;"C0011847;C0011849;C0027361;C0237401";NA;NA;individuals without diabetes n $nmbr$ $nmbr$
 909;individuals with t $nmbr$ dm ( scale diabetes );"C0011816;C0011847;C0011849;C0027361;C0175659;C0237401;C0349674;C1947916;C3250443";NA;NA;individuals with t $nmbr$ dm scale diabetes
 909;individuals with diabetes  n = $nmbr$;"C0011847;C0011849;C0027361;C0237401";NA;NA;individuals with diabetes n $nmbr$
 909;hx of diabetes  n ( % );"C0011847;C0011849;C0262926;C3814444";NA;NA;hx of diabetes n
 909;history of diabetes requiring drugs;"C0011847;C0011849;C0019664;C0019665;C0020616;C0262512;C0262926;C1553893;C1705255;C2004062";NA;NA;history of diabetes requiring drugs
 909;history of diabetes :;"C0011847;C0011849;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";NA;NA;history of diabetes
 909;history of diabetes - n ( % );"C0011847;C0011849;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";NA;NA;history of diabetes n
 909;history of diabetes ( n = $nmbr$ );"C0011847;C0011849;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";NA;NA;history of diabetes n $nmbr$
 909;history of diabetes ( a );"C0011847;C0011849;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";NA;NA;history of diabetes a
 909;high risk of diabetes;"C0011847;C0011849;C0332167";NA;NA;high risk of diabetes
 909;duration of diabetes — yr ^;"C0011847;C0011849;C0439234;C0449238;C2926735";NA;NA;duration of diabetes yr
 909;duration of diabetes microvascular disease — no . ( % );"C0011847;C0011849;C0443258;C0872146";NA;NA;duration of diabetes microvascular disease no
 909;duration of diabetes mellitus  y  mean ( sd ) §;"C0011849;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735";NA;NA;duration of diabetes mellitus y mean sd
 909;duration of diabetes mellitus  y;"C0011849;C0449238;C2926735";NA;NA;duration of diabetes mellitus y
 909;duration of diabetes mellitus  median ( iqr )  y;"C0011849;C0449238;C0549183;C0876920;C2347635;C2348144;C2926735;C2939193";NA;NA;duration of diabetes mellitus median iqr y
 909;duration of diabetes mellitus;"C0011849;C0449238;C2926735";NA;NA;duration of diabetes mellitus
 909;duration of diabetes by tertiles;"C0011847;C0011849;C0449238;C2926735";NA;NA;duration of diabetes by tertiles
 909;duration of diabetes < $nmbr$ yrs;"C0011847;C0011849;C0449238;C2926735";NA;NA;duration of diabetes $nmbr$ yrs
 909;duration of diabetes ( years )  mean  ( sd );"C0011847;C0011849;C0439234;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735";NA;NA;duration of diabetes years mean sd
 909;duration of diabetes ( y );"C0011847;C0011849;C0449238;C2926735";NA;NA;duration of diabetes y
 909;duration of diabetes ( months );"C0011847;C0011849;C0439231;C0449238;C2926735";NA;NA;duration of diabetes months
 909;duration of diabetes  yrs;"C0011847;C0011849;C0449238;C2926735";NA;NA;duration of diabetes yrs
 909;duration of diabetes  y  mean ( sd );"C0011847;C0011849;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735";NA;NA;duration of diabetes y mean sd
 909;duration of diabetes  y;"C0011847;C0011849;C0449238;C2926735";NA;NA;duration of diabetes y
 909;duration of diabetes  median ( iqr );"C0011847;C0011849;C0449238;C0549183;C0876920;C2347635;C2348144;C2926735;C2939193";NA;NA;duration of diabetes median iqr
 909;duration of diabetes  mean ( sd )  y;"C0011847;C0011849;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735";NA;NA;duration of diabetes mean sd y
 909;duration of diabetes;"C0011847;C0011849;C0449238;C2926735";NA;NA;duration of diabetes
 909;drugs used in diabetes  n ( % );"C0011847;C0011849;C0013227;C1273517;C3687832";NA;NA;drugs used in diabetes n
 909;drugs used in diabetes;"C0011847;C0011849;C0013227;C1273517;C3687832";NA;NA;drugs used in diabetes
 909;diagnosis of diabetes  n ( % );"C0011847;C0011849;C0011900;C1704338;C1704656";NA;NA;diagnosis of diabetes n
 909;diagnosed diabetes ( n = $nmbr$ );"C0011847;C0011849;C0011900";NA;NA;diagnosed diabetes n $nmbr$
 909;diabetesz;NA;NA;NA;diabetesz
 909;diabetes — no . ( % );"C0011847;C0011849";NA;NA;diabetes no
 909;diabetes | |;"C0011847;C0011849";NA;NA;diabetes
 902;education — no . ( % );"C0013621;C0013622;C0013658;C0039401";NA;NA;education no
 909;diabetes with target organ disease *;"C0011847;C0011849;C0012634;C0178784;C1521840;C2986546";NA;NA;diabetes with target organ disease
 909;diabetes treatment;"C0011847;C0011849;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;diabetes treatment
 909;diabetes t;"C0011847;C0011849";NA;NA;diabetes t
 707;all bleeding;C0019080;NA;NA;all bleeding
 909;diabetes present $nmbr$ ( $nmbr$ . $nmbr$ );"C0011847;C0011849;C0150312;C0449450";NA;NA;diabetes present $nmbr$ $nmbr$ $nmbr$
 909;diabetes n ( % );"C0011847;C0011849";NA;NA;diabetes n
 909;diabetes mellitust;"C0011847;C0011849";NA;NA;diabetes mellitust
 909;diabetes mellitus 一 no . ( % );C0011849;NA;NA;diabetes mellitus no
 909;diabetes mellitus — no . / total no . ( % );"C0011849;C0439175;C0439810";NA;NA;diabetes mellitus no total no
 909;diabetes mellitus — no . ( % );C0011849;NA;NA;diabetes mellitus no
 909;diabetes mellitus n = $nmbr$  $nmbr$;C0011849;NA;NA;diabetes mellitus n $nmbr$ $nmbr$
 909;diabetes mellitus duration ( sd )  y;"C0011849;C0449238;C2699239;C2926735";NA;NA;diabetes mellitus duration sd y
 909;diabetes mellitus duration  y ( sd );"C0011849;C0449238;C2699239;C2926735";NA;NA;diabetes mellitus duration y sd
 909;diabetes mellitus duration  y;"C0011849;C0449238;C2926735";NA;NA;diabetes mellitus duration y
 909;diabetes mellitus [ n ( % ) ];C0011849;NA;NA;diabetes mellitus n
 909;diabetes mellitus :;C0011849;NA;NA;diabetes mellitus
 909;diabetes mellitus ( % );C0011849;NA;NA;diabetes mellitus
 909;diabetes mellitus !;C0011849;NA;NA;diabetes mellitus
 909;diabetes mellitus  § n ( % );C0011849;NA;NA;diabetes mellitus n
 909;diabetes mellitus  no . / total no . ( % );"C0011849;C0439175;C0439810";NA;NA;diabetes mellitus no total no
 909;diabetes mellitus  no . ( % );C0011849;NA;NA;diabetes mellitus no
 909;diabetes mellitus  n = $nmbr$;C0011849;NA;NA;diabetes mellitus n $nmbr$
 909;diabetes mellitus  n / n ( % );C0011849;NA;NA;diabetes mellitus n n
 909;diabetes mellitus  n ( % );C0011849;NA;NA;diabetes mellitus n
 909;diabetes mellitus  ( % );C0011849;NA;NA;diabetes mellitus
 909;diabetes mellitus  %;C0011849;NA;NA;diabetes mellitus
 909;diabetes mellitus;C0011849;NA;NA;diabetes mellitus
 909;diabetes melitus;"C0011847;C0011849";NA;NA;diabetes melitus
 909;diabetes history  mean ( sd )  years;"C0011847;C0011849;C0019664;C0019665;C0262512;C0262926;C0439234;C0444504;C1705255;C2004062;C2347634;C2348143;C2699239";NA;NA;diabetes history mean sd years
 909;diabetes durationa < median;"C0011847;C0011849;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;diabetes durationa median
 909;diabetes duration subgroups;"C0011847;C0011849;C0449238;C1079230;C2926735";NA;NA;diabetes duration subgroups
 909;diabetes duration mean ± sd;"C0011847;C0011849;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735";NA;NA;diabetes duration mean sd
 909;diabetes duration ( years );"C0011847;C0011849;C0439234;C0449238;C2926735";NA;NA;diabetes duration years
 909;diabetes duration ( y );"C0011847;C0011849;C0449238;C2926735";NA;NA;diabetes duration y
   7;p - value ( anova );"C0753802;C1709380";NA;NA;p value anova
 909;diabetes duration ( known )  % of patients;"C0011847;C0011849;C0030705;C0205309;C0449238;C2926735";NA;NA;diabetes duration known of patients
 909;diabetes duration  years ( mean ± sd );"C0011847;C0011849;C0439234;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735";NA;NA;diabetes duration years mean sd
 909;diabetes duration  years;"C0011847;C0011849;C0439234;C0449238;C2926735";NA;NA;diabetes duration years
 909;diabetes duration  ycars “;"C0011847;C0011849;C0449238;C2926735";NA;NA;diabetes duration ycars
 909;diabetes duration  y;"C0011847;C0011849;C0449238;C2926735";NA;NA;diabetes duration y
 909;diabetes duration  n ( % );"C0011847;C0011849;C0449238;C2926735";NA;NA;diabetes duration n
 909;diabetes duration;"C0011847;C0011849;C0449238;C2926735";NA;NA;diabetes duration
 909;diabetes classificationa;"C0011847;C0011849";NA;NA;diabetes classificationa
 909;diabetes at randomization;"C0011847;C0011849;C0034656";NA;NA;diabetes at randomization
 909;diabetes and untreated hypertension;"C0011847;C0011849;C0745134";NA;NA;diabetes and untreated hypertension
 909;diabetes and currently on an oral hypoglycaemic agent orinsulin;"C0011847;C0011849;C0359086;C0521116";NA;NA;diabetes and currently on an oral hypoglycaemic agent orinsulin
 909;diabetes absent $nmbr$ ( $nmbr$ . $nmbr$ );"C0011847;C0011849;C0332197;C4285062";NA;NA;diabetes absent $nmbr$ $nmbr$ $nmbr$
 909;diabetes ^;"C0011847;C0011849";NA;NA;diabetes
 909;diabetes - related medication use    n   ( % );"C0011847;C0011849;C0240320;C0439849;C0445223";NA;NA;diabetes related medication use n
 909;diabetes *;"C0011847;C0011849";NA;NA;diabetes
 909;diabetes ( p = . oo $nmbr$ );"C0011847;C0011849";NA;NA;diabetes p oo $nmbr$
 909;diabetes ( p = . o $nmbr$ );"C0011847;C0011849";NA;NA;diabetes p o $nmbr$
 909;diabetes ( p = . $nmbr$ );"C0011847;C0011849";NA;NA;diabetes p $nmbr$
 909;diabetes ( n [ % ] ) *;"C0011847;C0011849";NA;NA;diabetes n
 909;diabetes ( n = $nmbr$ );"C0011847;C0011849";NA;NA;diabetes n $nmbr$
 909;diabetes ( n - $nmbr$  $nmbr$ );"C0011847;C0011849";NA;NA;diabetes n $nmbr$ $nmbr$
 909;diabetes ( % );"C0011847;C0011849";NA;NA;diabetes
 909;diabetes $nmbr$ ( % );"C0011847;C0011849";NA;NA;diabetes $nmbr$
 909;diabetes $nmbr$;"C0011847;C0011849";NA;NA;diabetes $nmbr$
 909;diabetes  no . ( % ) c;"C0011847;C0011849";NA;NA;diabetes no c
 909;diabetes  no . ( % );"C0011847;C0011849";NA;NA;diabetes no
 909;diabetes  n ( % );"C0011847;C0011849";NA;NA;diabetes n
 909;diabetes  * n ( % );"C0011847;C0011849";NA;NA;diabetes n
 909;diabetes  %;"C0011847;C0011849";NA;NA;diabetes
 909;diabetes;"C0011847;C0011849";NA;NA;diabetes
 909;dabetes;NA;NA;NA;dabetes
 909;current cvd / diabetes  n ( % );"C0007222;C0011847;C0011849;C0521116;C1705970";NA;NA;current cvd diabetes n
 909;all without diabetes ( n = $nmbr$ );"C0011847;C0011849";NA;NA;all without diabetes n $nmbr$
 909;all with diabetes ( n = $nmbr$ );"C0011847;C0011849";NA;NA;all with diabetes n $nmbr$
 909;( scale diabetes );"C0011847;C0011849;C0175659;C0349674;C1947916";NA;NA;scale diabetes
 -10;dizziness;"C0012833;C0042571;C1963093;C4084788;C4085547;C4085548;C4085549;C4553830";NA;NA;dizziness
 907;years since diagnosis of type $nmbr$ diabetes  n ( % );"C0011847;C0011849;C0011900;C0439234;C1320657;C1550351;C1704338;C1704656";NA;NA;years since diagnosis of type $nmbr$ diabetes n
 907;type $nmbr$ diabetes 一 no . ( % );C1320657;NA;NA;type $nmbr$ diabetes no
 907;type $nmbr$ diabetes — no . { % ) §;C1320657;NA;NA;type $nmbr$ diabetes no
 907;type $nmbr$ diabetes — no . ( % ) §;C1320657;NA;NA;type $nmbr$ diabetes no
 907;type $nmbr$ diabetes — no . ( % );C1320657;NA;NA;type $nmbr$ diabetes no
 907;type $nmbr$ diabetes mellitusa;C1320657;NA;NA;type $nmbr$ diabetes mellitusa
 907;type $nmbr$ diabetes mellitus ’;C1320657;NA;NA;type $nmbr$ diabetes mellitus
 907;type $nmbr$ diabetes mellitus ' $nmbr$ ';C1320657;NA;NA;type $nmbr$ diabetes mellitus $nmbr$
 907;type $nmbr$ diabetes mellitus  n ( % );C1320657;NA;NA;type $nmbr$ diabetes mellitus n
 907;type $nmbr$ diabetes mellitus;C1320657;NA;NA;type $nmbr$ diabetes mellitus
 907;type $nmbr$ diabetes meiiitus;C1320657;NA;NA;type $nmbr$ diabetes meiiitus
 907;type $nmbr$ diabetes history  n ( % );"C0019664;C0019665;C0262512;C0262926;C1320657;C1705255;C2004062";NA;NA;type $nmbr$ diabetes history n
 907;type $nmbr$ diabetes . n ( % );C1320657;NA;NA;type $nmbr$ diabetes n
 907;type $nmbr$ diabetes *;C1320657;NA;NA;type $nmbr$ diabetes
 907;type $nmbr$ diabetes ( n = $nmbr$  $nmbr$ );C1320657;NA;NA;type $nmbr$ diabetes n $nmbr$ $nmbr$
 907;type $nmbr$ diabetes  no . ( % );C1320657;NA;NA;type $nmbr$ diabetes no
 907;type $nmbr$ diabetes  n ( % ) d;C1320657;NA;NA;type $nmbr$ diabetes n d
 907;type $nmbr$ diabetes  n ( % );C1320657;NA;NA;type $nmbr$ diabetes n
 907;type $nmbr$ diabetes;C1320657;NA;NA;type $nmbr$ diabetes
 902;education level;"C0013621;C0013658";NA;NA;education level
 617;without metabolic syndrome;C0524620;NA;NA;without metabolic syndrome
 907;time since diagnosis of type $nmbr$ diabetes mellitus;"C0011900;C0040223;C1320657;C1704338;C1704656;C3541383";NA;NA;time since diagnosis of type $nmbr$ diabetes mellitus
 907;time since diagnosis of type $nmbr$ diabetes - no . ( % );"C0011847;C0011849;C0011900;C0040223;C1320657;C1550351;C1704338;C1704656;C3541383";NA;NA;time since diagnosis of type $nmbr$ diabetes no
 907;no type $nmbr$ diabetes ( n = $nmbr$  $nmbr$ );C1320657;NA;NA;no type $nmbr$ diabetes n $nmbr$ $nmbr$
 907;known duration of type $nmbr$ diabetes ( years );"C0205309;C0439234;C0449238;C1320657;C2926735";NA;NA;known duration of type $nmbr$ diabetes years
 907;known duration of type $nmbr$ diabetes;"C0205309;C0449238;C1320657;C2926735";NA;NA;known duration of type $nmbr$ diabetes
 907;duration of type $nmbr$ diabetes mellitus ( years );"C0439234;C0449238;C1320657;C2926735";NA;NA;duration of type $nmbr$ diabetes mellitus years
 907;duration of type $nmbr$ diabetes mellitus  years;"C0439234;C0449238;C1320657;C2926735";NA;NA;duration of type $nmbr$ diabetes mellitus years
 907;duration of type $nmbr$ diabetes categories  n ( % );"C1320657;C1547660";NA;NA;duration of type $nmbr$ diabetes categories n
 907;duration of type $nmbr$ diabetes ( years );"C0439234;C0449238;C1320657;C2926735";NA;NA;duration of type $nmbr$ diabetes years
 907;duration of type $nmbr$ diabetes  years;"C0439234;C0449238;C1320657;C2926735";NA;NA;duration of type $nmbr$ diabetes years
 907;duration of type $nmbr$ diabetes;"C0449238;C1320657;C2926735";NA;NA;duration of type $nmbr$ diabetes
 907;diabetes mellitus ( type $nmbr$ or $nmbr$ );C1320657;NA;NA;diabetes mellitus type $nmbr$ or $nmbr$
 907;diabetes mellitus ( type $nmbr$ )  n ( % );C1320657;NA;NA;diabetes mellitus type $nmbr$ n
 906;option;"C1518601;C1550456";NA;NA;option
 906;location of disease  n ( % );"C0012634;C0450429;C1515974;C4284930;C4284931";NA;NA;location of disease n
 906;location of crohn ' s disease  %;"C0010346;C0450429;C1515974;C4284930;C4284931";NA;NA;location of crohn s disease
 906;location  n ( % );"C0450429;C1515974;C4284930;C4284931";NA;NA;location n
 906;location;"C0450429;C1515974;C4284930;C4284931";NA;NA;location
 906;lesion location;"C0221198;C0450429;C1515974;C1546698;C4284930;C4284931";NA;NA;lesion location
 906;geographical location  n ( % );C4545686;NA;NA;geographical location n
 906;ethnicity  location;"C0015031;C0243103;C0450429;C1515974;C4284930;C4284931";NA;NA;ethnicity location
 906;disease location ( % ) *;"C0012634;C0450429;C1515974;C4284930;C4284931";NA;NA;disease location
 906;disease location  %;"C0012634;C0450429;C1515974;C4284930;C4284931";NA;NA;disease location
 906;discontinu - ation;NA;NA;NA;discontinu ation
 905;omega $nmbr$ allocation;"C1706778;C1719844";NA;NA;omega $nmbr$ allocation
 905;n - $nmbr$ allocation;"C0369718;C0441922;C1706778";NA;NA;n $nmbr$ allocation
 904;uplift ® population;"C0032659;C1257890";NA;NA;uplift population
 904;subpopulation;C1257890;NA;NA;subpopulation
 904;safety population  n ( % );"C0032659;C0036043;C1257890;C1705187";NA;NA;safety population n
 904;safety population;"C0032659;C0036043;C1257890;C1705187";NA;NA;safety population
 904;populations :;"C0032659;C1257890";NA;NA;populations
 904;population;"C0032659;C1257890";NA;NA;population
 904;patient population;"C0030705;C0032659;C1257890";NA;NA;patient population
 904;overall pea population;"C0030738;C0032659;C0069964;C0070939;C0282416;C1257890;C1262903;C1561607;C3257529";NA;NA;overall pea population
 904;overall freedom population ( n = $nmbr$ );"C0016694;C0032659;C0282416;C1257890;C1561607";NA;NA;overall freedom population n $nmbr$
 904;open - label population;"C0032659;C1257890;C1709323";NA;NA;open label population
 904;indian subpopulation;"C1257890;C1524069";NA;NA;indian subpopulation
 904;global trial population;"C0008976;C0032659;C0205246;C1257890;C2348867";NA;NA;global trial population
 904;full population;"C0032659;C0443225;C1257890";NA;NA;full population
 904;d population;"C0032659;C0073187;C0332173;C1257890;C4484261";NA;NA;d population
 904;ctd population subgroup;"C0032659;C1079230;C1257890;C1335071;C1442905;C1515021";NA;NA;ctd population subgroup
 904;boost intensify premix i ( global patient population );"C0021966;C0030705;C0032659;C0205246;C0221138;C1257890;C1511253;C1874596;C2348867";NA;NA;boost intensify premix i global patient population
 904;boost intensify all ( pan - asian patient population );"C0030705;C0032659;C0078988;C0085999;C1257890;C1511253;C1874596;C3887654";NA;NA;boost intensify all pan asian patient population
 904;^ ≥ $nmbr$ % incidence in any treatment group in the overall safety population .;"C0021149;C0032659;C0036043;C0220856;C0282416;C0374505;C1257890;C1561607;C1705187";NA;NA;$nmbr$ incidence in any treatment group in the overall safety population
 903;uc disease duration ( y );C0872146;NA;NA;uc disease duration y
 903;mean disease duration  years;"C0439234;C0444504;C0872146;C2347634;C2348143";NA;NA;mean disease duration years
 903;mean disease duration  y ( sd );"C0444504;C0872146;C2347634;C2348143;C2699239";NA;NA;mean disease duration y sd
 903;mean ( sd ) disease duration  years;"C0439234;C0444504;C0872146;C2347634;C2348143;C2699239";NA;NA;mean sd disease duration years
 903;duration of disease — yr ^ mean;"C0439234;C0444504;C0872146;C2347634;C2348143";NA;NA;duration of disease yr mean
 903;duration of disease — yr : t;"C0439234;C0872146";NA;NA;duration of disease yr t
 903;duration of disease — yr;"C0439234;C0872146";NA;NA;duration of disease yr
 903;duration of disease since;C0872146;NA;NA;duration of disease since
 903;duration of disease before baseline;"C0168634;C0872146;C1442488";NA;NA;duration of disease before baseline
 903;duration of disease ( yr );"C0439234;C0872146";NA;NA;duration of disease yr
 903;duration of disease ( y )  median ( min  max };"C0549183;C0702093;C0872146;C0876920;C1524029;C2347635;C2348144;C2939193;C3813700";NA;NA;duration of disease y median min max
 903;duration of disease  y;C0872146;NA;NA;duration of disease y
 903;duration of disease  n ( % );C0872146;NA;NA;duration of disease n
 903;duration of disease  median;"C0549183;C0872146;C0876920;C2347635;C2348144;C2939193";NA;NA;duration of disease median
 903;disease duration b $nmbr$ years ( n = $nmbr$ );"C0439234;C0872146";NA;NA;disease duration b $nmbr$ years n $nmbr$
 903;disease duration [ year ]  mean ± sda;"C0276477;C0439234;C0439508;C0444504;C0872146;C1428349;C1553165;C2347634;C2348143";NA;NA;disease duration year mean sda
 903;disease duration > $nmbr$ years  $nmbr$ [ % ] disease activity ‘ s;"C0205177;C0439167;C0439234;C0441655;C0449238;C0872146;C1292728;C1561536;C2926735;C3668946;C4049938;C4049939";NA;NA;disease duration $nmbr$ years $nmbr$ disease activity s
 903;disease duration : < baseline mean;"C0168634;C0444504;C0872146;C1442488;C2347634;C2348143";NA;NA;disease duration baseline mean
 903;disease duration ( yr )  mean ± sd;"C0439234;C0444504;C0872146;C2347634;C2348143;C2699239";NA;NA;disease duration yr mean sd
 903;disease duration ( yr );"C0439234;C0872146";NA;NA;disease duration yr
 903;disease duration ( y )  median ( m / n  max );"C0369637;C0441923;C0549183;C0872146;C0876920;C2347635;C2348144;C2939193";NA;NA;disease duration y median m n max
 903;disease duration  year ( median );"C0439234;C0439508;C0549183;C0872146;C0876920;C2347635;C2348144;C2939193";NA;NA;disease duration year median
 903;disease duration  y  mean ± sd;"C0444504;C0872146;C2347634;C2348143;C2699239";NA;NA;disease duration y mean sd
 903;disease duration  y;C0872146;NA;NA;disease duration y
 906;infarct location;"C0021308;C0450429;C1515974;C4284930;C4284931";FALSE;1948;infarct location
 906;location of infarction — no . ( % ) §;"C0021308;C0450429;C1515974;C4284930;C4284931";FALSE;1948;location of infarction no
 906;location of ml;"C0439526;C0450429;C1515974;C1705224;C3887665;C4284930;C4284931";FALSE;1948;location of ml
 903;disease duration  mean yr ( sd );"C0439234;C0444504;C0872146;C2347634;C2348143;C2699239";NA;NA;disease duration mean yr sd
 903;disease duration  mean [ sd ] years;"C0439234;C0444504;C0872146;C2347634;C2348143;C2699239";NA;NA;disease duration mean sd years
 903;disease duration;C0872146;NA;NA;disease duration
 903;disease characteristics duration of psoriatic arthritis — yr;"C0003872;C0439234;C0449238;C0599878;C0872146;C1521970;C2926735";NA;NA;disease characteristics duration of psoriatic arthritis yr
 902;years of education *;"C0013621;C0013622;C0013658;C0039401;C0439234";NA;NA;years of education
 902;education > $nmbr$ yr ( % );"C0013621;C0013622;C0013658;C0039401;C0439234";NA;NA;education $nmbr$ yr
 902;education > $nmbr$ y;"C0013621;C0013622;C0013658;C0039401";NA;NA;education $nmbr$ y
 902;education < $nmbr$ y;"C0013621;C0013622;C0013658;C0039401";NA;NA;education $nmbr$ y
 902;education *;"C0013621;C0013622;C0013658;C0039401";NA;NA;education
 902;education ( % );"C0013621;C0013622;C0013658;C0039401";NA;NA;education
 902;education $nmbr$ to $nmbr$ y;"C0013621;C0013622;C0013658;C0039401";NA;NA;education $nmbr$ to $nmbr$ y
 902;education  yrs  mean ( sd );"C0013621;C0013622;C0013658;C0039401;C0444504;C2347634;C2348143;C2699239";NA;NA;education yrs mean sd
 902;education  y  mean ( sd );"C0013621;C0013622;C0013658;C0039401;C0444504;C2347634;C2348143;C2699239";NA;NA;education y mean sd
 902;education  y;"C0013621;C0013622;C0013658;C0039401";NA;NA;education y
 902;education  mean ( sd )  ya;"C0013621;C0013622;C0013658;C0039401;C0444504;C2347634;C2348143;C2699239";NA;NA;education mean sd ya
 902;education  mean ( sd )  y;"C0013621;C0013622;C0013658;C0039401;C0444504;C2347634;C2348143;C2699239";NA;NA;education mean sd y
 902;education;"C0013621;C0013622;C0013658;C0039401";NA;NA;education
 902;age of completion of highest education  years ( sd );"C0013621;C0013622;C0013658;C0039401;C0205197;C1510829;C1522410;C1554962;C2699239";NA;NA;age of completion of highest education years sd
 901;t $nmbr$ dm duration  y;"C0011816;C0449238;C2603360;C2926735;C3250443";NA;NA;t $nmbr$ dm duration y
 901;symptom duration  months;"C0439231;C0449238;C1457887;C2926735;C3854129";NA;NA;symptom duration months
 901;symptom duration;"C0449238;C1457887;C2926735;C3854129";NA;NA;symptom duration
 901;ra symptom duration — year;"C0439234;C0439508;C0449238;C1457887;C2926735;C3538806;C3854129;C4048756";NA;NA;ra symptom duration year
 901;ra symptom duration < $nmbr$ months — number ( % );"C0237753;C0439231;C0449238;C0449788;C1457887;C2926735;C3538806;C3854129;C4048756";NA;NA;ra symptom duration $nmbr$ months number
 901;ra duration ( months ) *;"C0439231;C0449238;C2926735;C3538806;C4048756";NA;NA;ra duration months
 901;pci duration in min ( median  iqr );"C0449238;C0549183;C0702093;C0876920;C1524029;C2347635;C2348144;C2926735;C2939193;C3813700;C4049621";NA;NA;pci duration in min median iqr
 901;pci duration;"C0449238;C2926735;C4049621";NA;NA;pci duration
 901;median crohn ' s disease duration  y ( range );"C0010346;C0449238;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2926735;C2939193;C3542016";NA;NA;median crohn s disease duration y range
 901;mean ( sd ) duration of t $nmbr$ dm  y;"C0011816;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735;C3250443";NA;NA;mean sd duration of t $nmbr$ dm y
 901;mean ( s . d . ) duration of t $nmbr$ dm  years;"C0011816;C0439234;C0444504;C0449238;C2347634;C2348143;C2926735;C3250443";NA;NA;mean s d duration of t $nmbr$ dm years
 901;known duration of t $nmbr$ dm  y;"C0011816;C0205309;C0449238;C2926735;C3250443";NA;NA;known duration of t $nmbr$ dm y
 901;known duration;"C0205309;C0449238;C2926735";NA;NA;known duration
 901;extended - duration enoxaparin ( n = $nmbr$ );"C0206460;C0231448;C0231449;C0439792;C0449238;C2926735";NA;NA;extended duration enoxaparin n $nmbr$
 901;extended - duration enoxaparin  n / n ( % );"C0206460;C0231448;C0231449;C0439792;C0449238;C2926735";NA;NA;extended duration enoxaparin n n
 901;duration of ulcerative colitis;"C0009324;C0449238;C2926735";NA;NA;duration of ulcerative colitis
 901;duration of t $nmbr$ dm > $nmbr$ years;"C0011816;C0439234;C0449238;C2926735;C3250443";NA;NA;duration of t $nmbr$ dm $nmbr$ years
 901;duration of t $nmbr$ dm < $nmbr$ years;"C0011816;C0439234;C0449238;C2926735;C3250443";NA;NA;duration of t $nmbr$ dm $nmbr$ years
 901;duration of t $nmbr$ dm ( years );"C0011816;C0439234;C0449238;C2926735;C3250443";NA;NA;duration of t $nmbr$ dm years
 901;duration of t $nmbr$ dm ( % );"C0011816;C0449238;C2926735;C3250443";NA;NA;duration of t $nmbr$ dm
 901;duration of t $nmbr$ dm  years;"C0011816;C0439234;C0449238;C2926735;C3250443";NA;NA;duration of t $nmbr$ dm years
 901;duration of t $nmbr$ dm  y;"C0011816;C0449238;C2926735;C3250443";NA;NA;duration of t $nmbr$ dm y
 901;duration of t $nmbr$ dm;"C0011816;C0449238;C2926735;C3250443";NA;NA;duration of t $nmbr$ dm
 901;duration of t $nmbr$ d  y;"C0449238;C2926735";NA;NA;duration of t $nmbr$ d y
 901;duration of study - drug infusion;"C0392877;C0449238;C0557651;C2603343;C2926735";NA;NA;duration of study drug infusion
 901;duration of ra ( years );"C0439234;C0449238;C2926735;C3538806;C4048756";NA;NA;duration of ra years
 901;duration of ra ( time from symptom onset )  years;"C0040223;C0439234;C0449238;C2926735;C3538806;C3541383;C4048756;C4086878";NA;NA;duration of ra time from symptom onset years
 901;duration of ra;"C0449238;C2926735;C3538806;C4048756";NA;NA;duration of ra
 901;duration of pci — min;"C0449238;C0702093;C1524029;C2926735;C3813700;C4049621";NA;NA;duration of pci min
 901;duration of pci ( min )  median;"C0449238;C0549183;C0702093;C0876920;C1524029;C2347635;C2348144;C2926735;C2939193;C3813700;C4049621";NA;NA;duration of pci min median
 901;duration of pci  min;"C0449238;C0702093;C1524029;C2926735;C3813700;C4049621";NA;NA;duration of pci min
 901;duration of morning;"C0332170;C0449238;C2926735";NA;NA;duration of morning
 901;duration of dm - years;"C0011816;C0439234;C0449238;C2926735;C3250443";NA;NA;duration of dm years
 901;duration of chf ( months );"C0018802;C0439231;C0449238;C2926735";NA;NA;duration of chf months
 901;duration of assigned regimen before surgery post - randomisation characteristic * *;"C0034656;C0038894;C0038895;C0040808;C0449238;C0543467;C0687676;C1274039;C1516050;C1521970;C1552601;C1704687;C2926735;C2945654;C3469826";NA;NA;duration of assigned regimen before surgery post randomisation characteristic
 901;duration of assigned regimen before surgery post - randomisation characteristic *;"C0034656;C0038894;C0038895;C0040808;C0449238;C0543467;C0687676;C1274039;C1516050;C1521970;C1552601;C1704687;C2926735;C2945654;C3469826";NA;NA;duration of assigned regimen before surgery post randomisation characteristic
 901;duration of assigned regimen before surgery;"C0038894;C0038895;C0040808;C0449238;C0543467;C1274039;C1516050;C1552601;C2926735;C2945654";NA;NA;duration of assigned regimen before surgery
 901;duration of;"C0449238;C2926735";NA;NA;duration of
 901;duration;"C0449238;C2926735";NA;NA;duration
 901;dm duration;"C0011816;C0449238;C2926735;C3250443";NA;NA;dm duration
 901;crohn ' s disease duration;"C0010346;C0449238;C2926735";NA;NA;crohn s disease duration
 901;cornell voltage - duration product ( mmxmsec ) *;"C0449238;C0598352;C1514468;C1704444;C2926735";NA;NA;cornell voltage duration product mmxmsec
 901;af duration  n ( % );"C0344434;C0449238;C2926735;C4049859";NA;NA;af duration n
 900;severe exacerbations  itt population  n ( % );"C0032659;C0205082;C1257890;C4050465;C4050466;C4086268";NA;NA;severe exacerbations itt population n
 900;moderate / severe exacerbations  itt population  n ( % );"C0032659;C0205081;C0205082;C1257890;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4086268;C4321335";NA;NA;moderate severe exacerbations itt population n
 900;mitt population ( n = $nmbr$ );"C0032659;C1257890";NA;NA;mitt population n $nmbr$
 900;mitt population;"C0032659;C1257890";NA;NA;mitt population
 900;joint damage outcomes ( mitt population );"C0010957;C0022417;C0032659;C0392905;C1257890;C1274040;C1706309;C1883709";NA;NA;joint damage outcomes mitt population
 900;itt population  n;"C0032659;C1257890";NA;NA;itt population n
 900;itt population;"C0032659;C1257890";NA;NA;itt population
 900;itt;NA;NA;NA;itt
 900;asian itt population total ( n = $nmbr$ );"C0032659;C0078988;C0439175;C0439810;C1257890";NA;NA;asian itt population total n $nmbr$
 899;infarct localization  n ( % );"C0021308;C0475264;C1744691";NA;NA;infarct localization n
 899;infarct localization;"C0021308;C0475264;C1744691";NA;NA;infarct localization
 899;infarct localisation;"C0021308;C0475264;C1744691";NA;NA;infarct localisation
 898;medication effects;C1319171;NA;NA;medication effects
 897;cardiovascular medications  %;C0007220;NA;NA;cardiovascular medications
 897;cardiovascular medications;C0007220;NA;NA;cardiovascular medications
 897;cardiovascular medication usage;"C0007220;C0457083";NA;NA;cardiovascular medication usage
 617;with metabolic syndrome;C0524620;NA;NA;with metabolic syndrome
 897;baseline concomitant cardiovascular medications;"C0007220;C0168634;C0521115;C1442488";NA;NA;baseline concomitant cardiovascular medications
 897;baseline cardiovascular medications  n ( % );"C0007220;C0168634;C1442488";NA;NA;baseline cardiovascular medications n
 897;baseline cardiovascular medication  c n ( % );"C0007220;C0168634;C1442488";NA;NA;baseline cardiovascular medication c n
 897;baseline cardiovascular medication;"C0007220;C0168634;C1442488";NA;NA;baseline cardiovascular medication
 897;antihypertensive  antianginal  and other cardiovascular medications;"C0003364;C0007220;C1874267;C3537168";NA;NA;antihypertensive antianginal and other cardiovascular medications
 896;laboratory investigations;"C0022877;C1261322;C3244292;C4283904";NA;NA;laboratory investigations
 896;investigations;C1261322;NA;NA;investigations
 896;additional investigations;C2359834;NA;NA;additional investigations
 895;prior amputation;"C0002688;C0332152;C0332840;C1546539;C2826257";NA;NA;prior amputation
 895;major amputations at week $nmbr$;"C0002688;C0205082;C0205164;C0332174;C0439230;C4318856;C4521762";NA;NA;major amputations at week $nmbr$
 895;amputations  n ( % );C0002688;NA;NA;amputations n
 895;amputation;"C0002688;C0332840;C1546539";NA;NA;amputation
 894;• ml without st - segment elevation;"C0439526;C0520886;C1705224;C3887665";NA;NA;ml without st segment elevation
 894;• ml with st - segment elevation;"C0439526;C0520886;C1705224;C3887665";NA;NA;ml with st segment elevation
 894;st - segment elevation mi;"C0520886;C3810814";NA;NA;st segment elevation mi
 894;non - st - segment elevation mi;"C0520886;C1518422;C3810814";NA;NA;non st segment elevation mi
 894;non - st - segment elevation acs;"C0520886;C0742343;C1518422;C4318612";NA;NA;non st segment elevation acs
 894;non - st - segment elevation;"C0520886;C1518422";NA;NA;non st segment elevation
 894;non - st - elevation ml;"C0439526;C0520886;C1518422;C1705224;C3887665";NA;NA;non st elevation ml
 894;ml without st - segment elevation !;"C0439526;C0520886;C1705224;C3887665";NA;NA;ml without st segment elevation
 894;ml with st - segment elevation;"C0439526;C0520886;C1705224;C3887665";NA;NA;ml with st segment elevation
 893;lm bifurcation treated;"C0184906;C1261082;C1522326;C1551056;C3146289";NA;NA;lm bifurcation treated
 893;lm bifurcation not treated;"C0184906;C1261082;C1518422;C1522326;C1551056;C3146289";NA;NA;lm bifurcation not treated
 893;bifurcation per lesion ‡;"C0184906;C0221198;C1546698;C3146289";NA;NA;bifurcation per lesion
 893;bifurcation lesion with side branch ≥ $nmbr$ . $nmbr$ mm stented;"C0038257;C0184906;C0205384;C0221198;C0441987;C1253959;C1546698;C1881507;C2700383;C2826234;C3146289;C4330985;C4554674";NA;NA;bifurcation lesion with side branch $nmbr$ $nmbr$ mm stented
 893;bifurcation lesion with side branch $ $nmbr$ . $nmbr$ mm stented;"C0038257;C0184906;C0205384;C0221198;C0441987;C1253959;C1546698;C1881507;C2700383;C2826234;C3146289;C4330985;C4554674";NA;NA;bifurcation lesion with side branch $ $nmbr$ $nmbr$ mm stented
 893;bifurcation lesion;"C0184906;C0221198;C1546698;C3146289";NA;NA;bifurcation lesion
 893;bifurcation  n ( % );"C0184906;C3146289";NA;NA;bifurcation n
 893;bifurcation;"C0184906;C3146289";NA;NA;bifurcation
 892;score distribution : < $nmbr$;"C0449820;C0520511;C1704711;C4050231";NA;NA;score distribution $nmbr$
 892;score distribution :;"C0449820;C0520511;C1704711;C4050231";NA;NA;score distribution
 892;distribution — no . { % );"C0520511;C1704711";NA;NA;distribution no
 892;distribution — no . ( % );"C0520511;C1704711";NA;NA;distribution no
 892;distribution time;"C0040223;C0520511;C1704711;C3541383";NA;NA;distribution time
 892;distribution of metformin dose at randomization  n ( % );"C0025598;C0034656;C0178602;C0520511;C0869039;C1114758;C1704711";NA;NA;distribution of metformin dose at randomization n
 892;bmi distribution  n ( % );"C0520511;C0578022;C1704711";NA;NA;bmi distribution n
 892;a $nmbr$ c distribution ( % );"C0520511;C1704711";NA;NA;a $nmbr$ c distribution
 891;one or more copd exacerbations ( n / n [ % ] );"C0205172;C0205447;C0740304";NA;NA;one or more copd exacerbations n n
 891;copd exacerbation : no;C0740304;NA;NA;copd exacerbation no
 890;mean number of clinically significant asthma exacerbations †;"C0237753;C0237881;C0349790;C0444504;C0449788;C0750502;C1546944;C2347634;C2348143";NA;NA;mean number of clinically significant asthma exacerbations
 890;asthma exacerbations;C0349790;NA;NA;asthma exacerbations
 889;s $nmbr$ exacerbations;"C0565930;C2603362;C4086268";NA;NA;s $nmbr$ exacerbations
 889;patients with > $nmbr$ exacerbations resulting in hospital admission;"C0030705;C0184666;C0678226;C4086268";NA;NA;patients with $nmbr$ exacerbations resulting in hospital admission
 889;patients with > $nmbr$ exacerbations resulting in emergency department visit;"C0030705;C0332294;C0545082;C0553618;C0562508;C1512346;C1704729;C2826704;C4086268";NA;NA;patients with $nmbr$ exacerbations resulting in emergency department visit
 889;patients with > $nmbr$ exacerbations resulting in ed visit;"C0030705;C0332294;C0545082;C1512346;C2826704;C3538926;C4086268";NA;NA;patients with $nmbr$ exacerbations resulting in ed visit
 889;patients with > $nmbr$ exacerbation in previous $nmbr$ months;"C0030705;C0205156;C0439231;C1552607;C4086268";NA;NA;patients with $nmbr$ exacerbation in previous $nmbr$ months
 889;patients having exacerbation;"C0030705;C4086268";NA;NA;patients having exacerbation
 889;p ) atients with > $nmbr$ exacerbations resulting in emergency department visit;"C0332294;C0369773;C0545082;C0553618;C0562508;C1512346;C1704729;C2603361;C2826704;C4086268";NA;NA;p atients with $nmbr$ exacerbations resulting in emergency department visit
 889;number of patients with exacerbations in the previous $nmbr$ months  n ( % );"C0205156;C0439231;C1552607;C2360800;C4086268";NA;NA;number of patients with exacerbations in the previous $nmbr$ months n
 889;number of exacerbations in the past $nmbr$ months;"C0237753;C0449788;C4086268;C4331910";NA;NA;number of exacerbations in the past $nmbr$ months
 889;number of exacerbations in the last $nmbr$ months  mean ± sd;"C0237753;C0444504;C0449788;C2347634;C2348143;C2699239;C4086268;C4331910";NA;NA;number of exacerbations in the last $nmbr$ months mean sd
 889;number of exacerbations in the last $nmbr$ months;"C0237753;C0449788;C4086268;C4331910";NA;NA;number of exacerbations in the last $nmbr$ months
 889;number of exacerbations in previous $nmbr$   months;"C0205156;C0237753;C0439231;C0449788;C1552607;C4086268";NA;NA;number of exacerbations in previous $nmbr$ months
 889;number of exacerbations in previous $nmbr$ months;"C0205156;C0237753;C0439231;C0449788;C1552607;C4086268";NA;NA;number of exacerbations in previous $nmbr$ months
 889;number of exacerbations in last $nmbr$ months;"C0237753;C0449788;C4086268;C4331910";NA;NA;number of exacerbations in last $nmbr$ months
 889;number of exacerbations $nmbr$ months before randomisation;"C0034656;C0237753;C0439231;C0449788;C4086268";NA;NA;number of exacerbations $nmbr$ months before randomisation
 889;number of exacerbations;"C0237753;C0449788;C4086268";NA;NA;number of exacerbations
 889;number of exacerbation in the previous $nmbr$ months  n ( % );"C0205156;C0237753;C0439231;C0449788;C1552607;C4086268";NA;NA;number of exacerbation in the previous $nmbr$ months n
 889;hospitalized for an exacerbation;"C0701159;C4086268";NA;NA;hospitalized for an exacerbation
 707;all bleed;C0019080;NA;NA;all bleed
 894;time from randomization to pci ( st - elevation mi )  min;"C0034656;C0040223;C0520886;C0702093;C1524029;C3541383;C3810814;C3813700;C4049621";FALSE;1945;time from randomization to pci st elevation mi min
 898;cardiac medications at discharge  %;"C0018787;C0806915;C1522601";FALSE; 897;cardiac medications at discharge
 898;medications at discharge;C0806915;FALSE;1946;medications at discharge
 899;symptomatic localization - related;"C0231220;C0439849;C0445223;C0475264;C1744691";FALSE;1947;symptomatic localization related
 889;hospitalized exacerbation rates;"C0701159;C0871208;C1521828;C4086268";NA;NA;hospitalized exacerbation rates
 889;exacerbations in the past $nmbr$ months n;"C4086268;C4331910";NA;NA;exacerbations in the past $nmbr$ months n
 889;exacerbations;C4086268;NA;NA;exacerbations
 889;exacerbation historyh  n ( % );C4086268;NA;NA;exacerbation historyh n
 889;> $nmbr$ exacerbations;C4086268;NA;NA;$nmbr$ exacerbations
 889;> $nmbr$ exacerbation in prev $nmbr$ m ( n = $nmbr$ );"C0369637;C0441923;C1552852;C4086268";NA;NA;$nmbr$ exacerbation in prev $nmbr$ m n $nmbr$
 889;$nmbr$ exacerbations;C4086268;NA;NA;$nmbr$ exacerbations
 889;$nmbr$ exacerbation in prev $nmbr$ m ( n = $nmbr$ );"C0369637;C0441923;C1552852;C4086268";NA;NA;$nmbr$ exacerbation in prev $nmbr$ m n $nmbr$
 889;$nmbr$ exacerbation;C4086268;NA;NA;$nmbr$ exacerbation
 889;$ $nmbr$ exacerbations;C4086268;NA;NA;$ $nmbr$ exacerbations
 888;| interactior $nmbr$ p;NA;NA;NA;interactior $nmbr$ p
 888;time to randomisation [ hours ] ( interaction : p = $nmbr$ . $nmbr$ );"C0034656;C0040223;C0439227;C1704675;C3541383";NA;NA;time to randomisation hours interaction p $nmbr$ $nmbr$
 888;pinteraction = $nmbr$ . $nmbr$;NA;NA;NA;pinteraction $nmbr$ $nmbr$
 888;pinteraction;NA;NA;NA;pinteraction
 888;pfor interaction;"C1151635;C1704675";NA;NA;pfor interaction
 888;p   values for interaction;"C1704675;C1709380";NA;NA;p values for interaction
 888;p value for interaction - dosage with dabigatran  $nmbr$ mg;"C0024671;C0026410;C0178602;C0439269;C1704675;C1709380;C1960952;C2346927;C2348066;C2986497;C4321396;C4521761";NA;NA;p value for interaction dosage with dabigatran $nmbr$ mg
 888;p value for interaction  dosage with dabigatran  $nmbr$ mg;"C0024671;C0026410;C0178602;C0439269;C1704675;C1709380;C1960952;C2346927;C2348066;C2986497;C4321396;C4521761";NA;NA;p value for interaction dosage with dabigatran $nmbr$ mg
 888;p vaiue ( interaction );"C0369773;C1704675;C2603361";NA;NA;p vaiue interaction
 888;p lace of randomization ( interaction : p = $nmbr$ . $nmbr$ );"C0034656;C0280109;C0369773;C0453991;C1704675;C2603361";NA;NA;p lace of randomization interaction p $nmbr$ $nmbr$
 888;p interaction women vs men;"C0025266;C0043210;C0369773;C1704675;C2603361";NA;NA;p interaction women vs men
 888;p interaction = $nmbr$ . $nmbr$;"C0369773;C1704675;C2603361";NA;NA;p interaction $nmbr$ $nmbr$
 888;p interaction;"C0369773;C1704675;C2603361";NA;NA;p interaction
 888;p for interaction between rhtn and no rhtn and treatmenta;"C0369773;C1704675;C2603361";NA;NA;p for interaction between rhtn and no rhtn and treatmenta
 888;p for interaction *;"C0369773;C1704675;C2603361";NA;NA;p for interaction
 888;p for interaction;"C0369773;C1704675;C2603361";NA;NA;p for interaction
 888;p : interaction;"C0369773;C1704675;C2603361";NA;NA;p interaction
 888;p / interaction;"C0369773;C1704675;C2603361";NA;NA;p interaction
 888;p . interaction;"C0369773;C1704675;C2603361";NA;NA;p interaction
 888;p - interaction;"C0369773;C1704675;C2603361";NA;NA;p interaction
 888;p $nmbr$ interaction;"C0369773;C1704675;C2603361";NA;NA;p $nmbr$ interaction
 888;p  interaction !;"C0369773;C1704675;C2603361";NA;NA;p interaction
 888;lue for interaction;C1704675;NA;NA;lue for interaction
 888;interactior p - value;C1709380;NA;NA;interactior p value
 888;interaction pf;"C1704675;C3815179";NA;NA;interaction pf
 888;interaction p vaiue;C1704675;NA;NA;interaction p vaiue
 888;interaction p = $nmbr$ . $nmbr$;C1704675;NA;NA;interaction p $nmbr$ $nmbr$
 888;interaction p - vaiue;C1704675;NA;NA;interaction p vaiue
 888;interaction p;C1704675;NA;NA;interaction p
 888;interaction - p;C1704675;NA;NA;interaction p
 888;interaction $nmbr$;C1704675;NA;NA;interaction $nmbr$
 888;interaction;C1704675;NA;NA;interaction
 888;egfr_p_interaction;"C1704675;C1739039;C3811844;C3812682";NA;NA;egfr_p_interaction
 888;/ ’ interaction;C1704675;NA;NA;interaction
 887;section $nmbr$ c;"C0152060;C0700320;C1522472;C1552923;C1705191;C3714523";NA;NA;section $nmbr$ c
 887;section $nmbr$ b;"C0152060;C0700320;C1522472;C1552923;C1705191;C3714523";NA;NA;section $nmbr$ b
 887;section $nmbr$ a;"C0152060;C0700320;C1522472;C1552923;C1705191;C3714523";NA;NA;section $nmbr$ a
 887;method of assessing ejection fraction;"C0025663;C0302131;C0336969;C0449851;C0812388;C0871511;C1264633;C1516048";NA;NA;method of assessing ejection fraction
 887;fraction ( % );"C1264633;C1554103";NA;NA;fraction
 887;ejection fraction group;"C0441833;C0489482;C0687744;C1257890;C1519504;C1705428;C1705429;C2700378";NA;NA;ejection fraction group
 887;ejection fraction category;"C0489482;C0683312;C2700378;C3889287";NA;NA;ejection fraction category
 887;ejection fraction based on local reading;"C0034754;C0205276;C0489482;C1527178;C1705179;C1705938;C2700378;C4284139";NA;NA;ejection fraction based on local reading
 887;ejection fraction : < $nmbr$ % ( n = $nmbr$ );"C0489482;C2700378";NA;NA;ejection fraction $nmbr$ n $nmbr$
 887;ejection fraction *;"C0489482;C2700378";NA;NA;ejection fraction
 887;ejection fraction ( % );"C0489482;C2700378";NA;NA;ejection fraction
 887;ejection fraction  percent ( sd );"C0439165;C0489482;C2699239;C2700378";NA;NA;ejection fraction percent sd
 887;ejection fraction  % nyha class  n ( % );"C0489482;C1882083;C2700378";NA;NA;ejection fraction nyha class n
 887;ejection fraction  %;"C0489482;C2700378";NA;NA;ejection fraction
 887;ejection fraction;"C0489482;C2700378";NA;NA;ejection fraction
 886;rosuvastatin   n   =   $nmbr$;C0965129;NA;NA;rosuvastatin n $nmbr$
 886;rosuvastatin of patients ( rate );"C0030705;C0871208;C0965129;C1521828";NA;NA;rosuvastatin of patients rate
 886;rosuvastatin n = $nmbr$;C0965129;NA;NA;rosuvastatin n $nmbr$
 886;rosuvastatin n ( rate ) *;"C0871208;C0965129;C1521828";NA;NA;rosuvastatin n rate
 886;rosuvastatin n ( rate ) $nmbr$;"C0871208;C0965129;C1521828";NA;NA;rosuvastatin n rate $nmbr$
 886;rosuvastatin n ( rate );"C0871208;C0965129;C1521828";NA;NA;rosuvastatin n rate
 886;rosuvastatin events / patients ( % );"C0030705;C0441471;C0965129;C3541888";NA;NA;rosuvastatin events patients
 886;rosuvastatin + fenofibric acid;"C0060179;C0965129";NA;NA;rosuvastatin fenofibric acid
 886;rosuvastatin +;C0965129;NA;NA;rosuvastatin
 886;rosuvastatin ( n = $nmbr$ . $nmbr$ );C0965129;NA;NA;rosuvastatin n $nmbr$ $nmbr$
 886;rosuvastatin ( n = $nmbr$ );C0965129;NA;NA;rosuvastatin n $nmbr$
 886;rosuvastatin ( n = $nmbr$  $nmbr$ );C0965129;NA;NA;rosuvastatin n $nmbr$ $nmbr$
 886;rosuvastatin $nmbr$ mg;"C0024671;C0026410;C0439269;C0965129;C1960952;C2346927;C4321396;C4521761";NA;NA;rosuvastatin $nmbr$ mg
 886;rosuvastatin $nmbr$ - $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C0965129;C1960952;C2346927;C4321396;C4521761";NA;NA;rosuvastatin $nmbr$ $nmbr$ mg n $nmbr$
 886;rosuvastatin  n ( rate );"C0871208;C0965129;C1521828";NA;NA;rosuvastatin n rate
 886;rosuvastatin  n ( % );C0965129;NA;NA;rosuvastatin n
 886;rosuvastatin  events / patients ( % );"C0030705;C0441471;C0965129;C3541888";NA;NA;rosuvastatin events patients
 886;rosuvastatin;C0965129;NA;NA;rosuvastatin
 886;rosuva  rosuvastatin  sd  standard deviation  t $nmbr$ dm  type $nmbr$ diabetes mellitus .;"C0011816;C0011849;C0332307;C0871420;C0965129;C1320657;C1547052;C2699239;C3250443";NA;NA;rosuva rosuvastatin sd standard deviation t $nmbr$ dm type $nmbr$ diabetes mellitus
 886;i rosuvastatin ( n = $nmbr$ );"C0021966;C0221138;C0965129";NA;NA;i rosuvastatin n $nmbr$
 886;dose of rosuvastatin;"C0178602;C0869039;C0965129;C1114758";NA;NA;dose of rosuvastatin
 886;crosuvastatin + fenofibric acid vs . rosuvastatin monotherapy .;"C0060179;C0965129";NA;NA;crosuvastatin fenofibric acid vs rosuvastatin monotherapy
 886;copd - rosuvastatin ( n = $nmbr$ );"C0024117;C0965129;C1412502;C3714496";NA;NA;copd rosuvastatin n $nmbr$
 886;copd - rosuvastatin ( $nmbr$ pt ) n . ( % );"C0024117;C0032743;C0699718;C0965129;C1412502;C3714496";NA;NA;copd rosuvastatin $nmbr$ pt n
 886;$nmbr$ mg  rosuvastatin $nmbr$ mg .;"C0965129;C1319635";NA;NA;$nmbr$ mg rosuvastatin $nmbr$ mg
 885;z\tonastaiin;NA;NA;NA;z\tonastaiin
 885;dose of atorvastatin;"C0178602;C0286651;C0869039;C1114758";NA;NA;dose of atorvastatin
 885;concomitant atorvastatin dose  mg;"C0024671;C0026410;C0178602;C0286651;C0439269;C0521115;C0869039;C1114758;C1960952;C2346927;C4321396;C4521761";NA;NA;concomitant atorvastatin dose mg
 873;pooled simvastatin factorial studies;"C0074554;C1709595;C2349200;C2826344;C4522255";NA;NA;pooled simvastatin factorial studies
 873;placebo / simvastatin;"C0032042;C0074554;C1696465;C1706408";NA;NA;placebo simvastatin
 873;placebo + $nmbr$ mg / d of simvastatin;"C0032042;C0074554;C0439422;C1696465;C1706408";NA;NA;placebo $nmbr$ mg d of simvastatin
 872;use of statins;"C0360714;C1524063";NA;NA;use of statins
 872;use of statin at any follow - up visit ( % );"C0360714;C0589121;C1524063";NA;NA;use of statin at any follow up visit
 872;treatment with statins;"C0039798;C0087111;C0360714;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;treatment with statins
 872;statins 一 no . ( % );C0360714;NA;NA;statins no
 872;statins  no . ( % );C0360714;NA;NA;statins no
 872;statins  n ( % );C0360714;NA;NA;statins n
 872;statins;C0360714;NA;NA;statins
 872;statin without other llt;"C0360714;C2347090";NA;NA;statin without other llt
 885;atv  atorvastatin  ldl - c  low - density lipoprotein cholesterol . * p - values pertain to treatment - by - stratum interaction test for stratum or treatment - by - subgroup interaction test for subgroups . ' multiplicity adjustments were not applied to this predefined subgroup analysis of ldl - c goal attainment   [ expressed as number of patients reaching ldl - c goal at week $nmbr$ / number of patients above goal at baseline  ^ treatment stratum was defined by intake of atv $nmbr$ or $nmbr$ mg .;"C0018017;C0022885;C0023824;C0024671;C0026410;C0039593;C0039798;C0087111;C0168634;C0210243;C0237455;C0286651;C0332174;C0376209;C0392366;C0439230;C0439269;C0449822;C0456081;C0456984;C0674679;C0680230;C1079230;C1145759;C1334862;C1442488;C1512806;C1515021;C1515976;C1518422;C1522326;C1533734;C1571704;C1704675;C1704788;C1705169;C1709380;C1960952;C2346927;C2360800;C2584321;C2945673;C2986480;C3538994;C3539106;C3831328;C3887704;C4048755;C4318744;C4321396;C4521761";NA;NA;atv atorvastatin ldl c low density lipoprotein cholesterol p values pertain to treatment by stratum interaction test for stratum or treatment by subgroup interaction test for subgroups multiplicity adjustments were not applied to this predefined subgroup analysis of ldl c goal attainment expressed as number of patients reaching ldl c goal at week $nmbr$ number of patients above goal at baseline treatment stratum was defined by intake of atv $nmbr$ or $nmbr$ mg
 885;atorvastatinb;NA;NA;NA;atorvastatinb
 885;atorvastatin { n = $nmbr$  $nmbr$ );C0286651;NA;NA;atorvastatin n $nmbr$ $nmbr$
 885;atorvastatin monotherapy ( n = $nmbr$ * );C0286651;NA;NA;atorvastatin monotherapy n $nmbr$
 885;atorvastatin factorial study;"C0286651;C2826344";NA;NA;atorvastatin factorial study
 885;atorvastatin dose;"C0178602;C0286651;C0869039;C1114758";NA;NA;atorvastatin dose
 885;atorvastatin ( n = $nmbr$  $nmbr$ );C0286651;NA;NA;atorvastatin n $nmbr$ $nmbr$
 885;atorvastatin $nmbr$ mg + ezetimibe $nmbr$ mg ( n = $nmbr$ );"C0286651;C1142985;C1319635";NA;NA;atorvastatin $nmbr$ mg ezetimibe $nmbr$ mg n $nmbr$
 885;atorvastatin $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0286651;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;atorvastatin $nmbr$ mg n $nmbr$
 885;atorvastatin $nmbr$ mg ( n = $nmbr$  $nmbr$ );"C0024671;C0026410;C0286651;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;atorvastatin $nmbr$ mg n $nmbr$ $nmbr$
 885;atorvastatin $nmbr$ mg;"C0024671;C0026410;C0286651;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;atorvastatin $nmbr$ mg
 885;atorvastatin  n ( % );C0286651;NA;NA;atorvastatin n
 885;atorvastatin;C0286651;NA;NA;atorvastatin
 885;aiorvasiaiin;NA;NA;NA;aiorvasiaiin
 884;metastatic disease;"C0027627;C2939419;C2939420";NA;NA;metastatic disease
 884;metastatic;"C0036525;C1522484;C4085632";NA;NA;metastatic
 884;epistaxis;"C0014591;C4554627";NA;NA;epistaxis
 883;prosthetic;NA;NA;NA;prosthetic
 883;alprostadil n / n %;C0002335;NA;NA;alprostadil n n
 883;alprostadil n / n;C0002335;NA;NA;alprostadil n n
 883;alprostadil ( n = $nmbr$ );C0002335;NA;NA;alprostadil n $nmbr$
 882;i moderate  $nmbr$ mg of pravastatin ( n = $nmbr$ );"C0021966;C0024671;C0026410;C0085542;C0205081;C0221138;C0439269;C1881878;C1960952;C2346927;C4049705;C4049706;C4085643;C4321335;C4321396;C4521761";NA;NA;i moderate $nmbr$ mg of pravastatin n $nmbr$
 882;clow - potency stratum : simvastatin $nmbr$ mg  pravastatin $nmbr$ mg  fluvastatin $nmbr$ mg  atorvastatin $nmbr$ mg  high - potency stratum : simvastatin $nmbr$ mg  atorvastatin;"C0074554;C0082608;C0085542;C0205250;C0286651;C1299351;C1319635;C2700149;C2985073;C3245505;C3887512;C3889660;C4321237;C4522209";NA;NA;clow potency stratum simvastatin $nmbr$ mg pravastatin $nmbr$ mg fluvastatin $nmbr$ mg atorvastatin $nmbr$ mg high potency stratum simvastatin $nmbr$ mg atorvastatin
 881;migraine with aura;C0154723;NA;NA;migraine with aura
 880;without revascularsation;NA;NA;NA;without revascularsation
 880;without ( n = $nmbr$ $nmbr$ );"C0369718;C0441922";NA;NA;without n $nmbr$ $nmbr$
 879;withdrew consent;"C1511481;C1554192;C2349954;C2923685";NA;NA;withdrew consent
 879;withdrawals  n / n ( % );"C1710677;C2349954;C2825032;C3812880;C4049634";NA;NA;withdrawals n n
 878;with an sfua;NA;NA;NA;with an sfua
 878;with ( n = $nmbr$ );"C0369718;C0441922";NA;NA;with n $nmbr$
 878;patients with specific disease characteris -;"C0205369;C0683521;C1552740";NA;NA;patients with specific disease characteris
 878;patients with remission;C1277626;NA;NA;patients with remission
 877;treated with atenolol ( n = $nmbr$ );"C0004147;C0332293";NA;NA;treated with atenolol n $nmbr$
 876;without an sfua;NA;NA;NA;without an sfua
 876;or ( itt ) ( n = $nmbr$ );NA;NA;NA;or itt n $nmbr$
 876;associated with hiv infection;"C0019693;C0332281";NA;NA;associated with hiv infection
 876;associated with drug or toxin exposure;"C0013227;C0040537;C0332281;C1254351";NA;NA;associated with drug or toxin exposure
 876;associated with drug / toxin;"C0013221;C0332281";NA;NA;associated with drug toxin
 876;associated with ctd;"C0332281;C1335071;C1442905";NA;NA;associated with ctd
 876;associated with corrected - congenital shunts;"C0009678;C0205202;C0232180;C0332281;C0542331;C1442858;C1744681";NA;NA;associated with corrected congenital shunts
 876;associated with corrected;"C0205202;C0332281";NA;NA;associated with corrected
 876;associated with an atrial septal defect;"C0018817;C0332281";NA;NA;associated with an atrial septal defect
 875;regular alcohol consumption per week  no . ( % );"C0001948;C0205272;C0332174;C0439230";NA;NA;regular alcohol consumption per week no
 875;no alcohol consumption  on average;"C0001948;C1510992;C2825518";NA;NA;no alcohol consumption on average
 875;drinking  n ( % );"C0001948;C0684271";NA;NA;drinking n
 875;drinking;"C0001948;C0684271";NA;NA;drinking
 875;current weekly alcohol use ( % );"C0001948;C0332174;C0521116;C1705970";NA;NA;current weekly alcohol use
 875;current alcohol use  n ( % );"C0001948;C0521116;C1705970";NA;NA;current alcohol use n
 875;alcohol use ( > $nmbr$ drink / wk );"C0001948;C0042153;C0332174;C0439230;C0452428;C0457083;C0556297;C1947944";NA;NA;alcohol use $nmbr$ drink wk
 875;alcohol use ( % );C0001948;NA;NA;alcohol use
 875;alcohol use ( %  > $nmbr$ / day );"C0001948;C0332173;C0439228;C0439505";NA;NA;alcohol use $nmbr$ day
 875;alcohol use  n ( % );C0001948;NA;NA;alcohol use n
 875;alcohol use;C0001948;NA;NA;alcohol use
 875;alcohol intake never / rarely;"C0001948;C0522498;C2003901";NA;NA;alcohol intake never rarely
 875;alcohol intake ( a );C0001948;NA;NA;alcohol intake a
 875;alcohol intake ( + ) ( % );C0001948;NA;NA;alcohol intake
 875;alcohol intake  drinks / week;"C0001948;C0332174;C0439230;C0452428";NA;NA;alcohol intake drinks week
 875;alcohol intake;C0001948;NA;NA;alcohol intake
 875;alcohol consumption at baseline;"C0001948;C0168634;C1442488";NA;NA;alcohol consumption at baseline
 875;alcohol consumption > once weekly;"C0001948;C0558293";NA;NA;alcohol consumption once weekly
 875;alcohol consumption *;C0001948;NA;NA;alcohol consumption
 875;alcohol consumption ( yes ) ( n );"C0001948;C1549445;C1705108;C1710701";NA;NA;alcohol consumption yes n
 875;alcohol consumption ( % ) < $nmbr$ drink / dav;"C0001948;C0009830;C0452428;C0556297;C1947907";NA;NA;alcohol consumption $nmbr$ drink dav
 875;alcohol consumption ( % );C0001948;NA;NA;alcohol consumption
 875;alcohol consumption !;C0001948;NA;NA;alcohol consumption
 625;baseline vfx;"C0168634;C1442488";NA;NA;baseline vfx
 882;atorvastatin - pravastatin;"C0085542;C0286651";FALSE; 885;atorvastatin pravastatin
 877;patients treated with losartan ( n = $nmbr$ );"C0030705;C0126174;C0332293";FALSE;1939;patients treated with losartan n $nmbr$
 877;treated with losartan ( n = $nmbr$ );"C0126174;C0332293";FALSE;1939;treated with losartan n $nmbr$
 877;table $nmbr$ . characteristics of patients treated with losartan and atenolol *;"C0004147;C0039224;C0126174;C0332293;C0815172;C1706074";FALSE;1939;table $nmbr$ characteristics of patients treated with losartan and atenolol
 877;treated with laba  %;C0332293;FALSE;1508;treated with laba
 881;epilepsy with grand mal seizures on awakening;"C0014549;C0494475;C1720052";FALSE;1940;epilepsy with grand mal seizures on awakening
 880;migraine without aura;C0338480;FALSE;1941;migraine without aura
 883;benign prostatic hyperplasia;C1704272;FALSE;1942;benign prostatic hyperplasia
 875;alcohol consumption  no . ( % );C0001948;NA;NA;alcohol consumption no
 875;alcohol consumption  n ( % );C0001948;NA;NA;alcohol consumption n
 875;alcohol consumption;C0001948;NA;NA;alcohol consumption
 875;alcohol  % with > $nmbr$ drink / d;"C0001948;C0556297";NA;NA;alcohol with $nmbr$ drink d
 874;sildenafil ( n = $nmbr$ );C0529793;NA;NA;sildenafil n $nmbr$
 865;not hispanic;C1518424;NA;NA;not hispanic
 872;statin with other llt;"C0360714;C2347090";NA;NA;statin with other llt
 872;statin with niacin;"C0027996;C0360714;C1142562";NA;NA;statin with niacin
 872;statin use at baseline;"C0042153;C0168634;C0360714;C0457083;C1442488;C1947944";NA;NA;statin use at baseline
 872;statin use  n ( % );"C0042153;C0360714;C0457083;C1947944";NA;NA;statin use n
 872;statin usage;"C0360714;C0457083";NA;NA;statin usage
 872;statin treatment;"C0039798;C0087111;C0360714;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;statin treatment
 872;statin potency stratum  n ( % );"C0360714;C3245505";NA;NA;statin potency stratum n
 872;statin medication;"C0013227;C0360714;C3244316;C4284232";NA;NA;statin medication
 872;statin intolerant *;"C0231200;C0360714";NA;NA;statin intolerant
 872;statin during admission;"C0184666;C0360714;C0809949";NA;NA;statin during admission
 872;statin alone;"C0205171;C0360714;C0439044;C0679994";NA;NA;statin alone
 872;statin + er niacin ( n = $nmbr$ );"C0027996;C0360714;C1142562;C3810541;C3811131";NA;NA;statin er niacin n $nmbr$
 872;statin ( s );C0360714;NA;NA;statin s
 872;statin ( n = $nmbr$ );C0360714;NA;NA;statin n $nmbr$
 872;statin ( n - $nmbr$ );C0360714;NA;NA;statin n $nmbr$
 872;statin ( % );C0360714;NA;NA;statin
 872;statin  n ( % );C0360714;NA;NA;statin n
 872;statin  % ( n );C0360714;NA;NA;statin n
 872;statin;C0360714;NA;NA;statin
 872;stalin;NA;NA;NA;stalin
 872;prevention )  n ( % ) patients on llt ( other than statin )  n ( % );"C0030705;C0199176;C0360714;C1706420;C2347090;C2700409";NA;NA;prevention n patients on llt other than statin n
 872;peri - op statins : no ( n = $nmbr$ );"C0347985;C0360714;C0369718;C0441922";NA;NA;peri op statins no n $nmbr$
 872;patients receiving statin;"C0030705;C0360714;C1514756";NA;NA;patients receiving statin
 872;patients not receiving statin;"C0030705;C0360714;C1514756;C1518422";NA;NA;patients not receiving statin
 872;non high dose statin ( n = $nmbr$  $nmbr$ );"C0360714;C0444956;C1518422";NA;NA;non high dose statin n $nmbr$ $nmbr$
 872;non - statin ( n = $nmbr$ );"C0360714;C1518422";NA;NA;non statin n $nmbr$
 872;no statin during admission;"C0184666;C0360714;C0809949";NA;NA;no statin during admission
 872;no statin ( + / - llt );"C0360714;C2347090";NA;NA;no statin llt
 872;no statin;C0360714;NA;NA;no statin
 872;moderate - intensity statin use;"C0042153;C0360714;C0457083;C1947944;C4081855";NA;NA;moderate intensity statin use
 872;moderate - intensity statin;"C0360714;C4081855";NA;NA;moderate intensity statin
 872;ltt other than statin;C0360714;NA;NA;ltt other than statin
 872;llv wlalil $nmbr$ statin;C0360714;NA;NA;llv wlalil $nmbr$ statin
 872;history of statin use;"C0019664;C0019665;C0262512;C0262926;C0360714;C1524063;C1705255;C2004062";NA;NA;history of statin use
 872;high - dose statin pretreatment ( n = $nmbr$ );"C0360714;C0444956;C1550147;C2709094;C3539075;C3539076";NA;NA;high dose statin pretreatment n $nmbr$
 872;eze + statin n = $nmbr$;C0360714;NA;NA;eze statin n $nmbr$
 872;eze + statin;C0360714;NA;NA;eze statin
 872;baseline statin use;"C0042153;C0168634;C0360714;C0457083;C1442488;C1947944";NA;NA;baseline statin use
 872;baseiine statin;C0360714;NA;NA;baseiine statin
 872;any statin versus no statin at randomization;"C0034656;C0360714";NA;NA;any statin versus no statin at randomization
 872;any statin ( with / without llt );"C0360714;C2347090";NA;NA;any statin with without llt
 872;any statin;C0360714;NA;NA;any statin
 872;all patients on maximally tolerated statin ± other llt;"C0030705;C0360714;C2347090";NA;NA;all patients on maximally tolerated statin other llt
 872;a . overall and subgroups bv statin potency - -;"C0085166;C0282416;C0360714;C1079230;C1511278;C1561607;C3245505";NA;NA;a overall and subgroups bv statin potency
 871;niacini;NA;NA;NA;niacini
 871;niacin + statin;"C0027996;C0360714;C1142562";NA;NA;niacin statin
 871;niacin ( n = $nmbr$ );"C0027996;C1142562";NA;NA;niacin n $nmbr$
 871;niacin  n ( % );"C0027996;C1142562";NA;NA;niacin n
 871;niacin;"C0027996;C1142562";NA;NA;niacin
 870;histamine - $nmbr$ - receptor antagonist;"C0019590;C4521896";NA;NA;histamine $nmbr$ receptor antagonist
 870;anti - histamines;C0019590;NA;NA;anti histamines
 869;vitamin e;"C0042874;C3714803";NA;NA;vitamin e
 869;randomized to receive vitamin e;"C0034656;C0040363;C0041260;C0042874;C1514756;C1883351;C3714803;C3815594";NA;NA;randomized to receive vitamin e
 869;i vitamin e ( n = $nmbr$ );"C0021966;C0042874;C0042890;C0221138;C0683454;C3714803";NA;NA;i vitamin e n $nmbr$
 869;i vitamin e;"C0021966;C0042874;C0042890;C0221138;C0683454;C3714803";NA;NA;i vitamin e
 869;$nmbr$ vitamin e ( n = $nmbr$ $nmbr$ );"C0042874;C3714803";NA;NA;$nmbr$ vitamin e n $nmbr$ $nmbr$
 869;$nmbr$ vitamin e;"C0042874;C3714803";NA;NA;$nmbr$ vitamin e
 868;vitamin k antagonists;C3653316;NA;NA;vitamin k antagonists
 868;vitamin k antagonist naive;"C1096489;C2267235";NA;NA;vitamin k antagonist naive
 873;simvastatin $nmbr$ mg ( n = $nmbr$  $nmbr$ );"C0024671;C0026410;C0074554;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;1840;simvastatin $nmbr$ mg n $nmbr$ $nmbr$
 873;simvastatin ( n = $nmbr$ );C0074554;FALSE;1840;simvastatin n $nmbr$
 873;simvastatin ( n = $nmbr$  $nmbr$ );C0074554;FALSE;1840;simvastatin n $nmbr$ $nmbr$
 873;simvastatin ( n = $nmbr$ . $nmbr$ );C0074554;FALSE;1840;simvastatin n $nmbr$ $nmbr$
 873;atorvastatin $nmbr$ mg and simvastatin $nmbr$ - $nmbr$ mg ( zi = $nmbr$ );"C0024671;C0026410;C0043476;C0074554;C0286651;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;1840;atorvastatin $nmbr$ mg and simvastatin $nmbr$ $nmbr$ mg zi $nmbr$
 873;exetimibe / simvastatin;C0074554;FALSE;1840;exetimibe simvastatin
 873;patients on atorvastatin  rosuvastatin  or simvastatin at;"C0030705;C0074554;C0286651;C0965129";FALSE;1840;patients on atorvastatin rosuvastatin or simvastatin at
 871;extended - release niacin plus statin ( n = $nmbr$ );"C0027996;C0332287;C0360714;C1142562;C1707968";FALSE; 872;extended release niacin plus statin n $nmbr$
 870;rivastigmine;C0649350;FALSE;1937;rivastigmine
 870;rivastigmine ( n = $nmbr$ );C0649350;FALSE;1937;rivastigmine n $nmbr$
 874;solifenacin ( n = $nmbr$ );C1099677;FALSE;1938;solifenacin n $nmbr$
 868;vitamin k antagonist experiencedk ( n = $nmbr$ $nmbr$ );"C1096489;C2267235";NA;NA;vitamin k antagonist experiencedk n $nmbr$ $nmbr$
 868;vitamin k antagonist experienced  n ( % );"C0237607;C0369718;C0441922;C0596545;C1096489;C2267235";NA;NA;vitamin k antagonist experienced n
 868;vitamin k antagonist ( e . g . warfarin / coumarol );"C0043031;C1096489;C2267235";NA;NA;vitamin k antagonist e g warfarin coumarol
 868;vitamin k antagonist;"C1096489;C2267235";NA;NA;vitamin k antagonist
 868;previous use of vitamin k antagonist for > $nmbr$ days — no . ( % );"C0205156;C0439228;C1096489;C1524063;C1552607;C2267235";NA;NA;previous use of vitamin k antagonist for $nmbr$ days no
 867;vitamins;"C0042890;C3540032;C3714649";NA;NA;vitamins
 867;other plain vitamin preparations;C0042890;NA;NA;other plain vitamin preparations
 866;vitamin d §;"C0014695;C0042866;C2936842;C3537249;C3714503";NA;NA;vitamin d
 866;serum vitamin d ( nmol / l );"C0014695;C0042866;C0229671;C0439282;C1546774;C1550100;C2936842;C3537249;C3714503";NA;NA;serum vitamin d nmol l
 866;daily dose of vitamin d ( iu / day );"C0014695;C0042866;C0439465;C2348070;C2936842;C3537249;C3714503";NA;NA;daily dose of vitamin d iu day
 866;baseline vitamin - d;"C0014695;C0042866;C0168634;C1442488;C2936842;C3537249;C3714503";NA;NA;baseline vitamin d
 866;$nmbr$ ( oh ) vitamin d ( ng / ml );"C0014695;C0042866;C0220853;C0439275;C2936842;C3537249;C3714503";NA;NA;$nmbr$ oh vitamin d ng ml
 865;white not of hispanic origin;"C0007457;C0043157;C0079946;C0086409;C0220938;C0439659;C1518422;C1518424;C1550512";NA;NA;white not of hispanic origin
 865;not hispanic or latino ( n — $nmbr$ );"C0086528;C1518424";NA;NA;not hispanic or latino n $nmbr$
 865;not hispanic or latino ( n = $nmbr$ );"C0086528;C1518424";NA;NA;not hispanic or latino n $nmbr$
 865;not hispanic or latino;"C0086528;C1518424";NA;NA;not hispanic or latino
 865;not hispanic / latino ( n = $nmbr$  $nmbr$ );"C0086528;C1518424";NA;NA;not hispanic latino n $nmbr$ $nmbr$
 865;not hispanic / latino;"C0086528;C1518424";NA;NA;not hispanic latino
 865;non - hispanic or latino;"C0086528;C1518424";NA;NA;non hispanic or latino
 865;non - hispanic and latino;"C0086528;C1518424";NA;NA;non hispanic and latino
 865;non - hispanic / latino;"C0086528;C1518424";NA;NA;non hispanic latino
 865;non - hispanic  non - latino;"C0086528;C1518424";NA;NA;non hispanic non latino
 865;non - hispanic;C1518424;NA;NA;non hispanic
 865;hispanic — no . ( % );C0086409;NA;NA;hispanic no
 865;hispanic or non - hispanic ethnic group — no . ( % ) f;"C0015031;C0016327;C0086409;C1518424;C1879937";NA;NA;hispanic or non hispanic ethnic group no f
 865;hispanic ethnic group — no . { % ) ’ i ';"C0015031;C0021966;C0086409;C0221138;C1879937";NA;NA;hispanic ethnic group no i
 865;hispanic ethnic group — no . / total no . ( % ) ‘ j ‘;"C0015031;C0086409;C0439175;C0439810;C1879937";NA;NA;hispanic ethnic group no total no j
 865;hispanic ethnic group — no . ( % ) f;"C0015031;C0016327;C0086409;C1879937";NA;NA;hispanic ethnic group no f
 865;hispanic ethnic group — no . ( % ) : t;"C0015031;C0086409;C1879937;C2603360";NA;NA;hispanic ethnic group no t
 865;hispanic ethnic group  n ( % );"C0015031;C0086409;C0441848;C0680174";NA;NA;hispanic ethnic group n
 865;hispanic / non - hispanic;"C0086409;C1518422";NA;NA;hispanic non hispanic
 865;hispanic ( n = $nmbr$ l $nmbr$ );C0086409;NA;NA;hispanic n $nmbr$ l $nmbr$
 865;hispanic ( n = $nmbr$ );C0086409;NA;NA;hispanic n $nmbr$
 865;hispanic  n ( % );C0086409;NA;NA;hispanic n
 865;hispanic;C0086409;NA;NA;hispanic
 865;ethnicity  not hispanic / latino    n   ( % );"C0015031;C0086528;C0243103;C1518424";NA;NA;ethnicity not hispanic latino n
 865;black hispanic - n ( % );"C1533017;C1533018";NA;NA;black hispanic n
 865;black hispanic;"C1533017;C1533018";NA;NA;black hispanic
 865;black  non - hispanic;"C0005680;C0027567;C0085756;C0439541;C1518422;C1518424;C1533017;C1533018";NA;NA;black non hispanic
 865;biack non - hispanic;C1518424;NA;NA;biack non hispanic
 865;biack hispanic;C0086409;NA;NA;biack hispanic
 865;biack;NA;NA;NA;biack
 865;american hispanic ( n   = $nmbr$ );"C0086409;C0596070";NA;NA;american hispanic n $nmbr$
 864;unfractionated heparin — no . ( % );"C0019134;C2825026";NA;NA;unfractionated heparin no
 864;unfractionated heparin within $nmbr$ hr before randomization — no . / total no . ( % );"C0019134;C0034656;C0439175;C0439810;C2825026";NA;NA;unfractionated heparin within $nmbr$ hr before randomization no total no
 864;unfractionated heparin before randomisation;"C0019134;C0034656;C2825026";NA;NA;unfractionated heparin before randomisation
 864;unfractionated heparin ( n = $nmbr$ );"C0019134;C2825026";NA;NA;unfractionated heparin n $nmbr$
 864;unfractionated heparin ( n = $nmbr$  $nmbr$ );"C0019134;C2825026";NA;NA;unfractionated heparin n $nmbr$ $nmbr$
 864;unfractionated heparin;"C0019134;C2825026";NA;NA;unfractionated heparin
 864;non - pci intravenous unfractionated heparin;"C0354566;C1518422;C4049621";NA;NA;non pci intravenous unfractionated heparin
 864;neither unfractionated heparin nor low - molecular - weight heparin;"C0019134;C0019139;C2825026;C3536766";NA;NA;neither unfractionated heparin nor low molecular weight heparin
 864;intravenous heparin;C0354566;NA;NA;intravenous heparin
 864;both unfractionated heparin and low - molecular - weight heparin;"C0019134;C0019139;C2825026;C3536766";NA;NA;both unfractionated heparin and low molecular weight heparin
 863;neither uh or lmw heparin;"C0019134;C0770546";NA;NA;neither uh or lmw heparin
 863;initial heparin treatment duration on or after randomization;"C0019134;C0034656;C0205265;C0444921;C0770546;C1279901;C1555582;C1705685;C3259042";NA;NA;initial heparin treatment duration on or after randomization
 863;initial heparin treatment duration;"C0019134;C0205265;C0444921;C0770546;C1279901;C1555582;C1705685;C3259042";NA;NA;initial heparin treatment duration
 863;heparin plus gpi ( n = $nmbr$  $nmbr$ );"C0019134;C0332287;C0770546;C1415351";NA;NA;heparin plus gpi n $nmbr$ $nmbr$
 863;heparin plus a gpi ( n = $nmbr$ );"C0019134;C0770546;C1415351";NA;NA;heparin plus a gpi n $nmbr$
 863;heparin only;"C0019134;C0205171;C0770546;C1720467";NA;NA;heparin only
 863;heparin dose regimen;"C0019134;C0770546;C2348331";NA;NA;heparin dose regimen
 863;heparin;"C0019134;C0770546";NA;NA;heparin
 863;bivalirudin - heparin plus gpi;"C0019134;C0168273;C0770546;C1415351";NA;NA;bivalirudin heparin plus gpi
 863;additional heparin;"C0019134;C0770546;C1524062";NA;NA;additional heparin
 863;> = $nmbr$ day s initial heparin treatment duration;"C0019134;C0205265;C0332173;C0439228;C0439505;C0444921;C0770546;C1279901;C1555582;C1705685;C3259042";NA;NA;$nmbr$ day s initial heparin treatment duration
 863;> = $nmbr$ ^ initial heparin treatment duration;"C0019134;C0205265;C0444921;C0770546;C1279901;C1555582;C1705685;C3259042";NA;NA;$nmbr$ initial heparin treatment duration
 862;unfractionated heparin or enoxaparin plus glycoprotein iib / iiia inhibitors ( n = $nmbr$ );"C0016011;C0019134;C0206460;C0243077;C0332287;C2825026";NA;NA;unfractionated heparin or enoxaparin plus glycoprotein iib iiia inhibitors n $nmbr$
 862;enoxaparin / vka n / n ( % ) $nmbr$ / $nmbr$ ( $nmbr$ . $nmbr$ );C0206460;NA;NA;enoxaparin vka n n $nmbr$ $nmbr$ $nmbr$ $nmbr$
 862;enoxaparin / vka;C0206460;NA;NA;enoxaparin vka
 862;enoxaparin ( n = $nmbr$ );C0206460;NA;NA;enoxaparin n $nmbr$
 862;enoxaparin ( n = $nmbr$  $nmbr$ );C0206460;NA;NA;enoxaparin n $nmbr$ $nmbr$
 862;enoxaparin $nmbr$ mg ( n = $nmbr$  $nmbr$ );"C0024671;C0026410;C0206460;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;enoxaparin $nmbr$ mg n $nmbr$ $nmbr$
 862;enoxaparin;C0206460;NA;NA;enoxaparin
 861;nyhaiiioriv;NA;NA;NA;nyhaiiioriv
 860;no nadroparin ( n = $nmbr$ );C0206232;NA;NA;no nadroparin n $nmbr$
 860;nadroparin vs control;"C0206232;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389";NA;NA;nadroparin vs control
 860;nadroparin ( n = $nmbr$ );C0206232;NA;NA;nadroparin n $nmbr$
 860;nadroparin;C0206232;NA;NA;nadroparin
 623;thrombophilia;C0398623;NA;NA;thrombophilia
 860;dalteparin ( n = $nmbr$ );C0206461;FALSE;1933;dalteparin n $nmbr$
 862;semuloparin ( n = $nmbr$ );C2700104;FALSE;1934;semuloparin n $nmbr$
 864;unfractionated;NA;FALSE;1935;unfractionated
 868;vitamin c;"C0003968;C2349136;C3714687;C4522080";FALSE;1936;vitamin c
 859;total time of fondaparinux treatment before;"C0039798;C0040223;C0087111;C0439175;C0439810;C1098510;C1522326;C1533734;C1705169;C3538994;C3541383;C3887704";NA;NA;total time of fondaparinux treatment before
 859;heparins and fondaparinux;"C0019134;C1098510";NA;NA;heparins and fondaparinux
 859;heparin  fondaparinux or brvalirudin use between - oex event;"C0019134;C0042153;C0441471;C0457083;C0770546;C1098510;C1947944;C4019010";NA;NA;heparin fondaparinux or brvalirudin use between oex event
 859;fondaparinux — no . ( % );C1098510;NA;NA;fondaparinux no
 859;fondaparinux ( n = $nmbr$ );C1098510;NA;NA;fondaparinux n $nmbr$
 859;fondaparinux ( n = $nmbr$  $nmbr$ );C1098510;NA;NA;fondaparinux n $nmbr$ $nmbr$
 859;fondaparinux;C1098510;NA;NA;fondaparinux
 859;commercially available fondaparinux;"C0470187;C1098510";NA;NA;commercially available fondaparinux
 858;warfarin naive;C0043031;NA;NA;warfarin naive
 858;warfarin n = $nmbr$ n / n ( % );C0043031;NA;NA;warfarin n $nmbr$ n n
 858;warfarin n = $nmbr$;C0043031;NA;NA;warfarin n $nmbr$
 858;warfarin n / n  rate ( % );"C0043031;C0871208;C1521828";NA;NA;warfarin n n rate
 858;warfarin group ( n = $nmbr$ );"C0043031;C0441848";NA;NA;warfarin group n $nmbr$
 858;warfarin group;"C0043031;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429";NA;NA;warfarin group
 858;warfarin at enrollment;"C0043031;C1516879;C1696073;C3888021";NA;NA;warfarin at enrollment
 858;warfarin ( s $nmbr$ % cl );"C0043031;C0596019";NA;NA;warfarin s $nmbr$ cl
 858;warfarin ( n = $nmbr$ )  n ( % / y );C0043031;NA;NA;warfarin n $nmbr$ n y
 858;warfarin ( n = $nmbr$ );C0043031;NA;NA;warfarin n $nmbr$
 858;warfarin ( n - $nmbr$  $nmbr$ );C0043031;NA;NA;warfarin n $nmbr$ $nmbr$
 858;warfarin ( % );C0043031;NA;NA;warfarin
 858;warfarin % ( n / n );C0043031;NA;NA;warfarin n n
 858;warfarin  no . ( % );C0043031;NA;NA;warfarin no
 858;warfarin;C0043031;NA;NA;warfarin
 858;warf;C0043031;NA;NA;warf
 858;vs . warfarin;C0043031;NA;NA;vs warfarin
 847;lisinopril ( n = $nmbr$ );C0065374;NA;NA;lisinopril n $nmbr$
 858;ttr ( warfarin arm only );"C0032923;C0043031;C0205171;C0446516;C1421224;C1720467;C3715044;C4553528";NA;NA;ttr warfarin arm only
 858;re - cover $nmbr$ warfarin;"C0043031;C0180153;C0556581;C1999244;C2986904;C3888055";NA;NA;re cover $nmbr$ warfarin
 858;previous warfarin use  no . ( % );"C0042153;C0043031;C0205156;C0457083;C1552607;C1947944";NA;NA;previous warfarin use no
 858;previous transient ischaemic attack / ischaemic stroke previous warfarin use;"C0007787;C0038454;C0042153;C0043031;C0205156;C0457083;C0917805;C1552607;C1947944;C4554100";NA;NA;previous transient ischaemic attack ischaemic stroke previous warfarin use
 858;median time in therapeutic range for warfarin recipients  %;"C0040223;C0043031;C0087111;C0302350;C0460097;C0549183;C0876920;C1554109;C1709854;C2347635;C2348144;C2939193;C3541383";NA;NA;median time in therapeutic range for warfarin recipients
 858;low - dose edoxaban vs warfarin;"C0043031;C0445550;C1708745;C2975435";NA;NA;low dose edoxaban vs warfarin
 858;ld edoxaban vs warfarin;"C0043031;C0694649;C2975435";NA;NA;ld edoxaban vs warfarin
 858;hr vs . warfarin ( $nmbr$ % ci );"C0008107;C0043031;C3259781";NA;NA;hr vs warfarin $nmbr$ ci
 858;edoxaban warfarin;"C0043031;C2975435";NA;NA;edoxaban warfarin
 858;edoxaban vs . warfarin;"C0043031;C2975435";NA;NA;edoxaban vs warfarin
 858;d $nmbr$ vs warfarin rr ( $nmbr$ % ci  p value );"C0008107;C0043031;C0073187;C0332173;C1709380;C3259781;C4484261;C4554402";NA;NA;d $nmbr$ vs warfarin rr $nmbr$ ci p value
 858;d $nmbr$ vs warfarin;"C0043031;C0073187;C0332173;C4484261";NA;NA;d $nmbr$ vs warfarin
 857;tofacitinib $nmbr$ mg two times a day;"C0024671;C0026410;C0332173;C0439228;C0439269;C0439505;C1948050;C1960952;C2346927;C2930696;C4321396;C4521761";NA;NA;tofacitinib $nmbr$ mg two times a day
 857;tofacitinib $nmbr$ mg bid [ n = $nmbr$ |;"C0024671;C0026410;C0439269;C1960952;C2346927;C2930696;C4321396;C4521761";NA;NA;tofacitinib $nmbr$ mg bid n $nmbr$
 857;tofacitinib $nmbr$ mg bid ( n   = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C2930696;C4321396;C4521761";NA;NA;tofacitinib $nmbr$ mg bid n $nmbr$
 857;tofacitinib $nmbr$ mg bid ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C2930696;C4321396;C4521761";NA;NA;tofacitinib $nmbr$ mg bid n $nmbr$
 857;tofacitinib $nmbr$ mg bid;"C0024671;C0026410;C0439269;C1960952;C2346927;C2930696;C4321396;C4521761";NA;NA;tofacitinib $nmbr$ mg bid
 857;tofacitinib  $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C2930696;C4321396;C4521761";NA;NA;tofacitinib $nmbr$ mg n $nmbr$
 857;tofacitinib;C2930696;NA;NA;tofacitinib
 856;anacetrapib ( n = $nmbr$ );C2604745;NA;NA;anacetrapib n $nmbr$
 856;anacetrapib ( n = $nmbr$  $nmbr$ );C2604745;NA;NA;anacetrapib n $nmbr$ $nmbr$
 856;anacetrapib $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C2604745;C4321396;C4521761";NA;NA;anacetrapib $nmbr$ mg n $nmbr$
 856;anacetrapib $nmbr$ mg ( n - $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C2604745;C4321396;C4521761";NA;NA;anacetrapib $nmbr$ mg n $nmbr$
 856;anacetrapib $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C2604745;C4321396;C4521761";NA;NA;anacetrapib $nmbr$ mg
 855;tadalafil $nmbr$ mg n = $nmbr$;"C0024671;C0026410;C0439269;C1176316;C1960952;C2346927;C4321396;C4521761";NA;NA;tadalafil $nmbr$ mg n $nmbr$
 855;tadalafil $nmbr$ mg mean change ( sd );"C0024671;C0026410;C0392747;C0439269;C0443172;C0444504;C1176316;C1705241;C1960952;C2346927;C2347634;C2348143;C2699239;C4319952;C4321396;C4521761";NA;NA;tadalafil $nmbr$ mg mean change sd
 855;tadalafil $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1176316;C1960952;C2346927;C4321396;C4521761";NA;NA;tadalafil $nmbr$ mg n $nmbr$
 855;tadalafil $nmbr$ mg;"C0024671;C0026410;C0439269;C1176316;C1960952;C2346927;C4321396;C4521761";NA;NA;tadalafil $nmbr$ mg
 855;tadalafil $nmbr$ . $nmbr$ mg n = $nmbr$;"C0024671;C0026410;C0439269;C1176316;C1960952;C2346927;C4321396;C4521761";NA;NA;tadalafil $nmbr$ $nmbr$ mg n $nmbr$
 855;tadalafil $nmbr$ . $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1176316;C1960952;C2346927;C4321396;C4521761";NA;NA;tadalafil $nmbr$ $nmbr$ mg n $nmbr$
 855;tadalafil $nmbr$ . $nmbr$ mg;"C0024671;C0026410;C0439269;C1176316;C1960952;C2346927;C4321396;C4521761";NA;NA;tadalafil $nmbr$ $nmbr$ mg
 855;tadalafil;C1176316;NA;NA;tadalafil
 854;tnl ultrapositive > $nmbr$ . $nmbr$ pg / l  $nmbr$ = $nmbr$;"C0439278;C1540071";NA;NA;tnl ultrapositive $nmbr$ $nmbr$ pg l $nmbr$ $nmbr$
 854;ag + gg;"C0002037;C0017454;C0018370;C0051080;C0152305;C3888235";NA;NA;ag gg
 854;ag;"C0002037;C0051080;C0152305;C3888235";NA;NA;ag
 853;sal ( n   = $nmbr$  $nmbr$ );"C0036140;C0037494;C0206136";NA;NA;sal n $nmbr$ $nmbr$
 853;sal ( n = $nmbr$ );"C0036140;C0037494;C0206136";NA;NA;sal n $nmbr$
 853;sal $nmbr$ pg ( n = $nmbr$ );"C0030827;C0036140;C0037494;C0072225;C0206136;C1266240";NA;NA;sal $nmbr$ pg n $nmbr$
 853;sal $nmbr$ mg;"C0024671;C0026410;C0036140;C0037494;C0206136;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;sal $nmbr$ mg
 853;fp / sal $nmbr$ / $nmbr$ pg ( n = $nmbr$ );"C0016704;C0030827;C0036140;C0037494;C0072225;C0206136;C1266240;C1419068;C1419906;C3541238;C3541412";NA;NA;fp sal $nmbr$ $nmbr$ pg n $nmbr$
 852;rvw;NA;NA;NA;rvw
 852;row §;"C1552840;C1552846";NA;NA;row
 852;row * n = $nmbr$;"C1552840;C1552846";NA;NA;row n $nmbr$
 852;row;"C1552840;C1552846";NA;NA;row
 852;analysis compared with the pretreatment condition ( baseline )  n  ldl = low - density lipoprotein  csf = cerebrospinal fluid .;"C0002778;C0007806;C0012634;C0023823;C0168634;C0348080;C0936012;C1442488;C1524024;C1550147;C1705253;C1707455;C2709094;C3539075;C3539076;C3864998";NA;NA;analysis compared with the pretreatment condition baseline n ldl low density lipoprotein csf cerebrospinal fluid
 851;scale — cognitive portion  ldl — low -;"C0175659;C0205251;C0349674;C0449719;C1516691;C1550472;C1947916;C3890211;C4048187;C4321351;C4522223";NA;NA;scale cognitive portion ldl low
 851;periostin low;"C0205251;C0219433;C1424662;C1550472;C3812270;C3890211;C4048187;C4321351;C4522223";NA;NA;periostin low
 851;patients with low ( < $nmbr$ mg / dl ) c $nmbr$;"C0030705;C0205251;C0439269;C1550472;C3890211;C4048187;C4321351;C4522223";NA;NA;patients with low $nmbr$ mg dl c $nmbr$
 851;nfs < - $nmbr$ . $nmbr$ ( low );"C0205251;C1550472;C1555018;C3890211;C4048187;C4321351;C4522223";NA;NA;nfs $nmbr$ $nmbr$ low
 851;moderate / low;"C0205081;C0205251;C1550472;C1881878;C3890211;C4048187;C4049705;C4049706;C4085643;C4321335;C4321351;C4522223";NA;NA;moderate low
 851;low ’;"C0205251;C1550472;C3890211;C4048187;C4321351;C4522223";NA;NA;low
 851;low { < $nmbr$ % );"C0205251;C1550472;C3890211;C4048187;C4321351;C4522223";NA;NA;low $nmbr$
 851;low trs : $nmbr$ - $nmbr$ ( n = $nmbr$  $nmbr$ );"C0205251;C0266427;C0968917;C1150746;C1550472;C3890211;C4048187;C4321351;C4522223";NA;NA;low trs $nmbr$ $nmbr$ n $nmbr$ $nmbr$
 851;low subgroup;"C0205251;C1079230;C1515021;C1550472;C3890211;C4048187;C4321351;C4522223";NA;NA;low subgroup
 851;low potencyc;"C0205251;C1550472;C3890211;C4048187;C4321351;C4522223";NA;NA;low potencyc
 851;low perceived social support only;"C0030971;C0037438;C0205171;C0205251;C0748877;C1540833;C1550472;C1720467;C3669642;C3890211;C4048187;C4321351;C4522223";NA;NA;low perceived social support only
 851;low or moderate;"C0205081;C0205251;C1550472;C1881878;C3890211;C4048187;C4049705;C4049706;C4085643;C4321335;C4321351;C4522223";NA;NA;low or moderate
 851;low normal ( n = $nmbr$ );"C0205251;C0205307;C0231683;C0439166;C1550472;C2347086;C3890211;C4048187;C4321351;C4522223;C4553972";NA;NA;low normal n $nmbr$
 851;low nfs nfs < - $nmbr$ . $nmbr$ ( n = $nmbr$ );"C0205251;C1513839;C1550472;C3890211;C4048187;C4321351;C4522223";NA;NA;low nfs nfs $nmbr$ $nmbr$ n $nmbr$
 851;low nafld fibrosis score ( nfs < - $nmbr$ . $nmbr$ );"C0205251;C0400966;C1550472;C1555018;C1954436;C1954437;C3890211;C4048187;C4321351;C4522223";NA;NA;low nafld fibrosis score nfs $nmbr$ $nmbr$
 851;low feno subgroup (  $nmbr$ . $nmbr$ ppb ) ( n = $nmbr$ );"C0205251;C1079230;C1415800;C1515021;C1550472;C3890211;C4048187;C4321351;C4522223";NA;NA;low feno subgroup $nmbr$ $nmbr$ ppb n $nmbr$
 851;low eosinophil subgroup (  $nmbr$ / ml ) ( n = $nmbr$ );"C0014467;C0205251;C0439526;C1079230;C1515021;C1550472;C1705224;C3887665;C3890211;C4048187;C4321351;C4522223";NA;NA;low eosinophil subgroup $nmbr$ ml n $nmbr$
 851;low c $nmbr$ / c $nmbr$ and anti - dsdna;"C0012854;C0205251;C0311474;C1550472;C3890211;C4048187;C4321351;C4522223";NA;NA;low c $nmbr$ c $nmbr$ and anti dsdna
 851;low c $nmbr$ ( < $nmbr$ mg / dl )  %;"C0205251;C0439269;C1550472;C3890211;C4048187;C4321351;C4522223";NA;NA;low c $nmbr$ $nmbr$ mg dl
 851;low c $nmbr$ ( < $nmbr$ . $nmbr$ g / l );"C0205251;C0439294;C0456615;C1550472;C3890211;C4048187;C4321351;C4522223";NA;NA;low c $nmbr$ $nmbr$ $nmbr$ g l
 851;low - molecular - weight only;"C0026385;C0041667;C0205171;C0205251;C1521991;C1550472;C1720467;C3890211;C4048187;C4321351;C4522223";NA;NA;low molecular weight only
 851;low - molecular - weight;"C0026385;C0041667;C0205251;C1521991;C1550472;C3890211;C4048187;C4321351;C4522223";NA;NA;low molecular weight
 851;low - ceiling diuretic;"C0012798;C0205251;C1550472;C3890211;C4048187;C4321351;C4522223";NA;NA;low ceiling diuretic
 851;low ( no risk factor );"C0035648;C0205251;C1550472;C3890211;C4048187;C4321351;C4522223";NA;NA;low no risk factor
 851;low ( n = $nmbr$ );"C0205251;C1550472;C3890211;C4048187;C4321351;C4522223";NA;NA;low n $nmbr$
 851;low ( > $nmbr$ . $nmbr$ and < $nmbr$ );"C0205251;C1550472;C3890211;C4048187;C4321351;C4522223";NA;NA;low $nmbr$ $nmbr$ and $nmbr$
 851;low ( < $nmbr$ % ) baseline hbalc;"C0168634;C0205251;C1442488;C1550472;C3890211;C4048187;C4321351;C4522223";NA;NA;low $nmbr$ baseline hbalc
 851;low ( < $nmbr$ % ) baseline hba $nmbr$ c;"C0019016;C0168634;C0205251;C1442488;C1550472;C1825777;C3538758;C3890211;C4048187;C4321351;C4522223";NA;NA;low $nmbr$ baseline hba $nmbr$ c
 851;low ( < $nmbr$ % );"C0205251;C1550472;C3890211;C4048187;C4321351;C4522223";NA;NA;low $nmbr$
 851;low ( $nmbr$ - $nmbr$ ) ( n = $nmbr$  $nmbr$  $nmbr$ % );"C0205251;C1550472;C3890211;C4048187;C4321351;C4522223";NA;NA;low $nmbr$ $nmbr$ n $nmbr$ $nmbr$ $nmbr$
 851;low ( $nmbr$ - $nmbr$ )  %;"C0205251;C1550472;C3890211;C4048187;C4321351;C4522223";NA;NA;low $nmbr$ $nmbr$
 851;low ( $nmbr$ - $nmbr$ );"C0205251;C1550472;C3890211;C4048187;C4321351;C4522223";NA;NA;low $nmbr$ $nmbr$
 851;low  %;"C0205251;C1550472;C3890211;C4048187;C4321351;C4522223";NA;NA;low
 851;low;"C0205251;C1550472;C3890211;C4048187;C4321351;C4522223";NA;NA;low
 851;fgf - $nmbr$ low / egfr > $nmbr$;"C0016026;C0205251;C0919505;C1550472;C1739039;C3811844;C3812682;C3890211;C4048187;C4321351;C4522223";NA;NA;fgf $nmbr$ low egfr $nmbr$
 851;fgf - $nmbr$ low / egfr < $nmbr$;"C0016026;C0205251;C0919505;C1550472;C1739039;C3811844;C3812682;C3890211;C4048187;C4321351;C4522223";NA;NA;fgf $nmbr$ low egfr $nmbr$
 851;fgf - $nmbr$ low / > $nmbr$ elevated biomarkers;"C0005516;C0016026;C0205250;C0205251;C0919505;C1550472;C3163633;C3890211;C4048187;C4321351;C4522223";NA;NA;fgf $nmbr$ low $nmbr$ elevated biomarkers
 851;fgf - $nmbr$ low / < $nmbr$ elevated biomarkers;"C0005516;C0016026;C0205250;C0205251;C0919505;C1550472;C3163633;C3890211;C4048187;C4321351;C4522223";NA;NA;fgf $nmbr$ low $nmbr$ elevated biomarkers
 851;eosinophil low;"C0014467;C0205251;C1550472;C3890211;C4048187;C4321351;C4522223";NA;NA;eosinophil low
 851;depressed and low perceived social support;"C0030971;C0037438;C0205251;C0344315;C0549249;C0748877;C1540833;C1550472;C3669642;C3890211;C4048187;C4321351;C4522223";NA;NA;depressed and low perceived social support
 851;bl updrs : low;"C0005918;C0006413;C0205251;C1550472;C1552663;C2827109;C3639721;C3890211;C4048187;C4321351;C4522223";NA;NA;bl updrs low
 851;biomarker low;"C0005516;C0205251;C1550472;C3890211;C4048187;C4321351;C4522223";NA;NA;biomarker low
 851;$nmbr$ low ( n = $nmbr$ );"C0205251;C1550472;C3890211;C4048187;C4321351;C4522223";NA;NA;$nmbr$ low n $nmbr$
 850;igelow ( n = $nmbr$  $nmbr$ );NA;NA;NA;igelow n $nmbr$ $nmbr$
 850;igelow ( < i $nmbr$ ku / l  n = i  $nmbr$ );"C0021966;C0221138;C0369718;C0439340;C0441922";NA;NA;igelow i $nmbr$ ku l n i $nmbr$
 850;igelow ( < $nmbr$ ku / l  n = $nmbr$  $nmbr$ );C0439340;NA;NA;igelow $nmbr$ ku l n $nmbr$ $nmbr$
 849;eosinophils £ $nmbr$ % ( n = $nmbr$ );"C0014467;C0200638";NA;NA;eosinophils $nmbr$ n $nmbr$
 849;eosinophils £ $nmbr$ % ( itt ) ( n = $nmbr$ );"C0014467;C0200638";NA;NA;eosinophils $nmbr$ itt n $nmbr$
 849;eosinophils > $nmbr$ . $nmbr$ x $nmbr$ ^ ^ ( itt ) ( n = $nmbr$ );"C0014467;C0200638";NA;NA;eosinophils $nmbr$ $nmbr$ x $nmbr$ itt n $nmbr$
 849;eosinophils > $nmbr$ . $nmbr$ x $nmbr$ * $nmbr$ ( n = $nmbr$ );"C0014467;C0200638";NA;NA;eosinophils $nmbr$ $nmbr$ x $nmbr$ $nmbr$ n $nmbr$
 849;eosinophils > $nmbr$ . $nmbr$ x $nmbr$ ' ^ ( itt ) ( n = $nmbr$ );"C0014467;C0200638";NA;NA;eosinophils $nmbr$ $nmbr$ x $nmbr$ itt n $nmbr$
 849;eosinophils > $nmbr$ . $nmbr$ x $nmbr$ ' ' $nmbr$ ( itt ) ( n = $nmbr$ );"C0014467;C0200638";NA;NA;eosinophils $nmbr$ $nmbr$ x $nmbr$ $nmbr$ itt n $nmbr$
 849;eosinophils > $nmbr$ % ( n = $nmbr$ );"C0014467;C0200638";NA;NA;eosinophils $nmbr$ n $nmbr$
 849;eosinophils > $nmbr$ % ( itt ) ( n = $nmbr$ );"C0014467;C0200638";NA;NA;eosinophils $nmbr$ itt n $nmbr$
 849;eosinophils > $nmbr$ $nmbr$ x $nmbr$ * $nmbr$ / $nmbr$ ( n = $nmbr$ );"C0014467;C0200638";NA;NA;eosinophils $nmbr$ $nmbr$ x $nmbr$ $nmbr$ $nmbr$ n $nmbr$
 849;eosinophils < $nmbr$ . $nmbr$ x $nmbr$ * $nmbr$ ( n = $nmbr$ );"C0014467;C0200638";NA;NA;eosinophils $nmbr$ $nmbr$ x $nmbr$ $nmbr$ n $nmbr$
 849;eosinophils < $nmbr$ . $nmbr$ x $nmbr$ * $nmbr$ ( itt ) ( n = $nmbr$ );"C0014467;C0200638";NA;NA;eosinophils $nmbr$ $nmbr$ x $nmbr$ $nmbr$ itt n $nmbr$
 849;eosinophils < $nmbr$ . $nmbr$ x $nmbr$ ' ' $nmbr$ ( n = $nmbr$ );"C0014467;C0200638";NA;NA;eosinophils $nmbr$ $nmbr$ x $nmbr$ $nmbr$ n $nmbr$
 849;eosinophils < $nmbr$ . $nmbr$ x $nmbr$ ' ' $nmbr$ ( itt ) ( n = $nmbr$ );"C0014467;C0200638";NA;NA;eosinophils $nmbr$ $nmbr$ x $nmbr$ $nmbr$ itt n $nmbr$
 849;eosinophils < $nmbr$ % ( n = $nmbr$ );"C0014467;C0200638";NA;NA;eosinophils $nmbr$ n $nmbr$
 849;eosinophils < $nmbr$ % ( itt ) ( n = $nmbr$ );"C0014467;C0200638";NA;NA;eosinophils $nmbr$ itt n $nmbr$
 849;eosinophils < $nmbr$ $nmbr$ x $nmbr$ * $nmbr$ / l ( n = $nmbr$ );"C0014467;C0200638";NA;NA;eosinophils $nmbr$ $nmbr$ x $nmbr$ $nmbr$ l n $nmbr$
 849;eosinophils $nmbr$ . $nmbr$ x $nmbr$ ' ' $nmbr$ ( n = $nmbr$ );"C0014467;C0200638";NA;NA;eosinophils $nmbr$ $nmbr$ x $nmbr$ $nmbr$ n $nmbr$
 849;eosinophils $nmbr$ % ( n - $nmbr$ );"C0014467;C0200638";NA;NA;eosinophils $nmbr$ n $nmbr$
 849;eosinophils $nmbr$ % ( itt ) ( n = $nmbr$ );"C0014467;C0200638";NA;NA;eosinophils $nmbr$ itt n $nmbr$
 849;eosinophils;"C0014467;C0200638";NA;NA;eosinophils
 849;calima japandhigh - dosage ics / laba and baseline blood eosinophils > $nmbr$ cells / ml ( n = $nmbr$ ) y;"C0014467;C0168634;C0178602;C0815320;C1442488;C2699156;C2986497;C4551720";NA;NA;calima japandhigh dosage ics laba and baseline blood eosinophils $nmbr$ cells ml n $nmbr$ y
 849;blood eosinophils count;"C0014467;C0750480;C1705566";NA;NA;blood eosinophils count
 849;blood eosinophils  mean ( range )  cells / mlb;"C0005773;C0007584;C0007634;C0014467;C0200638;C0444504;C1514721;C2347634;C2348143;C2348147;C3542016";NA;NA;blood eosinophils mean range cells mlb
 849;blood eosinophils  cells / ml;"C0014467;C2699156";NA;NA;blood eosinophils cells ml
 849;blood eosinophil proportion ( % );"C0014467;C1709707";NA;NA;blood eosinophil proportion
 849;blood eosinophil count  geometric mean ( sd loge scale ) cells / ll;"C0007584;C0007634;C0014467;C0175659;C0349674;C0750480;C1705566;C1947916;C2697934;C2699239;C2986759";NA;NA;blood eosinophil count geometric mean sd loge scale cells ll
 849;blood eosinophil;C0014467;NA;NA;blood eosinophil
 848;median blood eosinophil count  cells per pla;"C0200638;C0456170;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median blood eosinophil count cells per pla
 848;local eosinophil count [ cells / µ l ]  median ( range );"C0200638;C0205276;C0347983;C0549183;C0750879;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016";NA;NA;local eosinophil count cells l median range
 848;local eosinophil count [ cells / ml ]  median ( range );"C0200638;C0205276;C0549183;C0750879;C0876920;C1514721;C2347635;C2348144;C2348147;C2699156;C2939193;C3542016";NA;NA;local eosinophil count cells ml median range
 848;local eosinophil count;"C0200638;C0205276;C0750879";NA;NA;local eosinophil count
 848;eosinophil count;"C0200638;C0750879";NA;NA;eosinophil count
 848;blood eosinophil count — cells / mm ’;"C0005773;C0200638;C0750879;C4330985;C4554674";NA;NA;blood eosinophil count cells mm
 848;blood eosinophil count cells / mm $nmbr$ no .;"C0005773;C0200638;C0750879;C4330985;C4554674";NA;NA;blood eosinophil count cells mm $nmbr$ no
 848;blood eosinophil count > $nmbr$ / mm $nmbr$ at screening — no . ( % );"C0200638;C0750879;C1511226;C4330985;C4554674";NA;NA;blood eosinophil count $nmbr$ mm $nmbr$ at screening no
 848;blood eosinophil count ( $nmbr$ cells per l );C0200638;NA;NA;blood eosinophil count $nmbr$ cells per l
 847;ii lisinopril i;"C0021966;C0065374;C0221138;C1710602;C4082587";NA;NA;ii lisinopril i
 847;i lisinopril ( n = $nmbr$ );"C0021966;C0065374;C0221138";NA;NA;i lisinopril n $nmbr$
 847;$nmbr$ lisinopril;C0065374;NA;NA;$nmbr$ lisinopril
 846;killip class — no . / total no . ( % ) i;"C0021966;C0221138;C0439175;C0439810;C1881332";NA;NA;killip class no total no i
 846;killip class — no . ( % ) i;"C0021966;C0221138;C1881332";NA;NA;killip class no i
 846;killip class lll - iv;"C1261077;C2697847";NA;NA;killip class lll iv
 846;killip class iv at randomization;"C0034656;C2697847";NA;NA;killip class iv at randomization
 846;killip class i — no . ( % );C2697844;NA;NA;killip class i no
 846;killip class at admission — no . / total no . ( % );"C0184666;C0439175;C0439810;C0809949;C1881332";NA;NA;killip class at admission no total no
 846;killip class > ii ( % );C2697845;NA;NA;killip class ii
 846;killip class > i  %;C2697844;NA;NA;killip class i
 846;killip class > $nmbr$  no . ( % );C1881332;NA;NA;killip class $nmbr$ no
 846;killip class *;C1881332;NA;NA;killip class
 846;killip class ( interaction : p = $nmbr$ . $nmbr$ );"C1704675;C1881332";NA;NA;killip class interaction p $nmbr$ $nmbr$
 846;killip class $nmbr$ / $nmbr$;C1881332;NA;NA;killip class $nmbr$ $nmbr$
 846;killip class $nmbr$;C1881332;NA;NA;killip class $nmbr$
 846;killip class  n ( % ) i;"C0021966;C0221138;C0369718;C0441922;C1881332";NA;NA;killip class n i
 846;killip class  n ( % );C1881332;NA;NA;killip class n
 846;killip class;C1881332;NA;NA;killip class
 846;baseline killip class;"C0168634;C1442488;C1881332";NA;NA;baseline killip class
 846;< $nmbr$ baseline killip class;"C0168634;C1442488;C1881332";NA;NA;$nmbr$ baseline killip class
 845;who functional class ii / iii;"C0205245;C0439070;C0441886;C0441887;C0542341;C1705160;C1710602;C2698968;C2698969;C2700217;C4082587";NA;NA;who functional class ii iii
 845;iorii ( n z $nmbr$ );NA;NA;NA;iorii n z $nmbr$
 845;iiiv;NA;NA;NA;iiiv
 845;class iii;"C0441887;C2698969";NA;NA;class iii
 845;class ii ( b - blockers );"C0441886;C2698968";NA;NA;class ii b blockers
 845;class ii;"C0441886;C2698968";NA;NA;class ii
 845;class > ii;"C0441886;C2698968";NA;NA;class ii
 845;> ii;NA;NA;NA;ii
 845;> $nmbr$ : obese class iii;C1319441;NA;NA;$nmbr$ obese class iii
 845;$nmbr$ - $nmbr$ . $nmbr$ : obese class ii;C3853263;NA;NA;$nmbr$ $nmbr$ $nmbr$ obese class ii
 844;diastolic fmmhff ' );C0012000;NA;NA;diastolic fmmhff
 844;diastolic  treated at baseline;"C0012000;C0168634;C1442488;C1522326";NA;NA;diastolic treated at baseline
 844;diastolic  total;"C0012000;C0439175;C0439810";NA;NA;diastolic total
 844;diastolic;C0012000;NA;NA;diastolic
 843;idiopathica;NA;NA;NA;idiopathica
 843;idiopathic / familial;"C0015576;C0241888;C0332240";NA;NA;idiopathic familial
 843;idiopathic;C0332240;NA;NA;idiopathic
 842;diastolic bp ( mmhg ) *;"C0428883;C0439475";NA;NA;diastolic bp mmhg
 842;diastolic bp ( mmhg );"C0428883;C0439475";NA;NA;diastolic bp mmhg
 842;diastolic bp ( mm hg );"C0428883;C0439475";NA;NA;diastolic bp mm hg
 842;diastolic bp  mmhg ( sd );"C0428883;C0439475;C2699239";NA;NA;diastolic bp mmhg sd
 842;diastolic bp  mmhg;"C0428883;C0439475";NA;NA;diastolic bp mmhg
 842;diastolic bp  mm   hg  mean ( sd );"C0012000;C0428883;C0439475;C0444504;C0488053;C2347634;C2348143;C2699239";NA;NA;diastolic bp mm hg mean sd
 842;diastolic bp  mm hg  mean ( sd );"C0012000;C0428883;C0439475;C0444504;C0488053;C2347634;C2348143;C2699239";NA;NA;diastolic bp mm hg mean sd
 842;diastolic bp  mm hg;"C0428883;C0439475";NA;NA;diastolic bp mm hg
 842;diastolic bp;C0428883;NA;NA;diastolic bp
 842;diastolic blood pressure subgroups;"C0428883;C1079230;C1305849";NA;NA;diastolic blood pressure subgroups
 842;diastolic blood pressure ( mm hg ) medications;"C0013227;C0428883;C0439475;C0802604;C1305849;C2598133;C4284232";NA;NA;diastolic blood pressure mm hg medications
 842;diastolic blood pressure ( mm hg );"C0428883;C0439475;C1305849";NA;NA;diastolic blood pressure mm hg
 842;diastolic blood pressure  mm hq;"C0428883;C1305849;C4330985;C4554674";NA;NA;diastolic blood pressure mm hq
 842;diastolic blood pressure  mm hg  median ( range );"C0428883;C0439475;C0549183;C0876920;C1305849;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016";NA;NA;diastolic blood pressure mm hg median range
 842;diastolic blood pressure  mm hg;"C0428883;C0439475;C1305849";NA;NA;diastolic blood pressure mm hg
 842;diastolic blood pressure  and lp ( a );"C0065058;C0428883;C1305849;C1439335;C4553379";NA;NA;diastolic blood pressure and lp a
 842;diastolic blood pressure;"C0428883;C1305849";NA;NA;diastolic blood pressure
 841;time since diagnosis of t $nmbr$ dm  y  n ( % );"C0011816;C0011900;C0040223;C1704338;C1704656;C3250443;C3541383";NA;NA;time since diagnosis of t $nmbr$ dm y n
 841;time since diagnosis of t $nmbr$ dm;"C0011816;C0011900;C0040223;C1704338;C1704656;C3250443;C3541383";NA;NA;time since diagnosis of t $nmbr$ dm
 841;time since diagnosis of pah — yrf;"C0011900;C0030123;C0040223;C1704338;C1704656;C3203102;C3541383;C4284467";NA;NA;time since diagnosis of pah yrf
 841;time since diagnosis of diabetesa  n ( % );"C0011900;C0040223;C1704338;C1704656;C3541383";NA;NA;time since diagnosis of diabetesa n
 841;time since diagnosis of ciu / csuf ( y );"C0011900;C0040223;C0578870;C1704338;C1704656;C3541383";NA;NA;time since diagnosis of ciu csuf y
 824;recurrent hf;"C0018488;C1313497;C1455761;C1538440;C2945760;C3273279";FALSE;  12;recurrent hf
 841;time since diagnosis of ciu / csu ( years ) $nmbr$;"C0011900;C0040223;C0439234;C0578870;C1704338;C1704656;C3541383";NA;NA;time since diagnosis of ciu csu years $nmbr$
 841;since diagnosis;"C0011900;C1704338;C1704656";NA;NA;since diagnosis
 841;qualifying diagnosis;"C0011900;C1514624;C1704338;C1704656";NA;NA;qualifying diagnosis
 841;presenting history or diagnosis — no . ( % );"C0011900;C0019664;C0019665;C0262512;C0262926;C0449450;C1704338;C1704656;C1705255;C2004062";NA;NA;presenting history or diagnosis no
 841;presenting diagnosis;"C0011900;C0449450;C1704338;C1704656";NA;NA;presenting diagnosis
 841;predominant cardiac diagnosis — no . ( % );"C0011900;C0018787;C1522601;C1542147;C1704338;C1704656";NA;NA;predominant cardiac diagnosis no
 841;inclusion diagnosis;"C0007637;C0011900;C1512693;C1704338;C1704656";NA;NA;inclusion diagnosis
 841;first diagnosed;"C0011900;C0205435;C1279901";NA;NA;first diagnosed
 841;diagnosis of hefh  n ( % );"C0011900;C1704338;C1704656";NA;NA;diagnosis of hefh n
 841;diagnosis of allergic rhinitis;"C0011900;C1334103;C1704338;C1704656;C2607914;C4552864";NA;NA;diagnosis of allergic rhinitis
 841;diagnosis at presentation — no . ( % );"C0011900;C0449450;C1704338;C1704656";NA;NA;diagnosis at presentation no
 841;diagnosis at presentation;"C0011900;C0449450;C1704338;C1704656";NA;NA;diagnosis at presentation
 841;diagnosed  y;C0011900;NA;NA;diagnosed y
 841;age when diabetes first diagnosed — yr;"C0001779;C0011847;C0011849;C0011900;C0205435;C0439234;C1279901";NA;NA;age when diabetes first diagnosed yr
 841;af first diagnosis > $nmbr$ years  n ( % );"C0011900;C0205435;C0344434;C0439234;C1279901;C1704338;C1704656;C4049859";NA;NA;af first diagnosis $nmbr$ years n
 840;with highest bwa;"C0006041;C1522410";NA;NA;with highest bwa
 840;highest killip classiciation pre - pci;"C0332152;C0740175;C1522410;C2257086;C3669034;C4049621";NA;NA;highest killip classiciation pre pci
 840;highest;C1522410;NA;NA;highest
 839;cv death or first hhf;"C0011065;C0205435;C1279901;C1306577;C3538987;C4048877;C4082313;C4318503;C4552775";NA;NA;cv death or first hhf
 838;less than high school;"C0439092;C0599395;C0683862;C0870649";NA;NA;less than high school
 838;high - school graduate or ged;"C0870649;C1549971;C1880947";NA;NA;high school graduate or ged
 838;high - school graduate;"C0870649;C1549971";NA;NA;high school graduate
 837;very high risk;"C0035647;C0332167;C0442804;C0442824;C2984081;C3272283;C4050568;C4319571;C4321397;C4552904";NA;NA;very high risk
 837;qualifying high - risk features — %;"C0332167;C1514624;C1521970;C1706388;C2346469;C2348519;C3272283;C4050568;C4319571";NA;NA;qualifying high risk features
 837;moderately high risk without atherosclerotic vascular disease *;"C0004153;C0205081;C0332167;C1881878;C3272283;C4050568;C4085643;C4319571;C4321491";NA;NA;moderately high risk without atherosclerotic vascular disease
 837;moderately high risk;"C0205081;C0332167;C1881878;C3272283;C4050568;C4085643;C4319571;C4321491";NA;NA;moderately high risk
 837;higher risk ( n = $nmbr$ );"C0332167;C3272283;C4050568;C4319571";NA;NA;higher risk n $nmbr$
 837;high risk without atherosclerotic vascular disease +;"C0004153;C0332167;C3272283;C4050568;C4319571";NA;NA;high risk without atherosclerotic vascular disease
 837;high risk for diabetes *;"C0011847;C0011849;C0205250;C0332167;C1171304;C1299351;C2700149;C3272283;C3887512;C3889660;C4050568;C4319571;C4321237;C4522209";NA;NA;high risk for diabetes
 837;high risk and fewer symptoms ( group c );"C0205388;C0332167;C0441837;C0683368;C1457887;C3272283;C4050568;C4319571";NA;NA;high risk and fewer symptoms group c
 837;high risk *  %;"C0332167;C3272283;C4050568;C4319571";NA;NA;high risk
 837;high risk ( ri ≥ $nmbr$ );"C0035487;C0332167;C1826843;C3272283;C4050568;C4319571";NA;NA;high risk ri $nmbr$
 837;high risk ( receiving treatment for ) :;"C0039798;C0087111;C0332167;C1514756;C1522326;C1533734;C1705169;C3272283;C3538994;C3887704;C4050568;C4319571";NA;NA;high risk receiving treatment for
 837;high risk ( n $nmbr$ $nmbr$ );"C0332167;C3272283;C4050568;C4319571";NA;NA;high risk n $nmbr$ $nmbr$
 837;high risk ( ? ics );"C0332167;C0815320;C3272283;C4050568;C4319571;C4551720";NA;NA;high risk ics
 837;high risk ( > $nmbr$ );"C0332167;C3272283;C4050568;C4319571";NA;NA;high risk $nmbr$
 837;high risk ( - ics );"C0332167;C0815320;C3272283;C4050568;C4319571;C4551720";NA;NA;high risk ics
 837;high risk ( $nmbr$ - $nmbr$ );"C0332167;C3272283;C4050568;C4319571";NA;NA;high risk $nmbr$ $nmbr$
 837;high risk;"C0332167;C3272283;C4050568;C4319571";NA;NA;high risk
 837;high fracture risk stratum;"C0016658;C0332167;C3272283;C4050568;C4319571";NA;NA;high fracture risk stratum
 837;high cv risk;"C0332167;C3272283;C3538987;C4048877;C4050568;C4318503;C4319571";NA;NA;high cv risk
 837;high cardiovascular risk  n ( % ) ^;"C0007226;C0332167;C3272283;C3887460;C4050568;C4319571";NA;NA;high cardiovascular risk n
 837;high - risk cvd  n ( % );"C0007222;C0332167;C3272283;C4050568;C4319571";NA;NA;high risk cvd n
 837;high - risk criterion;"C0243161;C0332167;C3272283;C4050568;C4319571";NA;NA;high risk criterion
 837;high - risk clinical features;"C0332167;C0683325;C3272283;C4050568;C4319571";NA;NA;high risk clinical features
 837;high - risk;"C0332167;C3272283;C4050568;C4319571";NA;NA;high risk
 837;high ( > $nmbr$ risk factor );"C0035648;C0205250;C0332167;C1299351;C1521761;C2700149;C2827422;C3272283;C3887512;C3889660;C4050568;C4319571;C4321237;C4522209";NA;NA;high $nmbr$ risk factor
 837;group d ( high risk  more symptoms )  n ( % );"C0332167;C0441848;C0683368;C1457887;C3272283;C4050568;C4319571";NA;NA;group d high risk more symptoms n
 837;> $nmbr$ ( high risk );"C0332167;C3272283;C4050568;C4319571";NA;NA;$nmbr$ high risk
 837;$nmbr$ or $nmbr$ high cardiovascular risk categories;"C0007226;C0332167;C0683312;C3272283;C3887460;C4050568;C4319571";NA;NA;$nmbr$ or $nmbr$ high cardiovascular risk categories
 837;$nmbr$ or $nmbr$ high - risk categories;"C0332167;C0683312;C3272283;C4050568;C4319571";NA;NA;$nmbr$ or $nmbr$ high risk categories
 836;high intensity;C4081854;NA;NA;high intensity
 835;high density lipoprotein ( mg / dl );"C0023821;C0439269";NA;NA;high density lipoprotein mg dl
 835;high - density lipoprotein ];C0023821;NA;NA;high density lipoprotein
 835;high - density lipoprotein  mg / dl;"C0023821;C0439269";NA;NA;high density lipoprotein mg dl
 835;high - density lipoprotein;C0023821;NA;NA;high density lipoprotein
 834;total aim ‐ high study;"C0205250;C0439175;C0439810;C0557651;C1299351;C1947946;C2603343;C2700149;C2744535;C2948600;C3540471;C3540472;C3887512;C3889660;C3890193;C4321237;C4522209";NA;NA;total aim high study
 834;periostin high;"C0205250;C0219433;C1299351;C1424662;C2700149;C3812270;C3887512;C3889660;C4321237;C4522209";NA;NA;periostin high
 834;p - value low vs . high nfs ^;"C0205250;C0205251;C1299351;C1550472;C1555018;C1709380;C2700149;C3887512;C3889660;C3890211;C4048187;C4321237;C4321351;C4522209;C4522223";NA;NA;p value low vs high nfs
 834;nfs > $nmbr$ . $nmbr$ ( high );"C0205250;C1299351;C1555018;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;nfs $nmbr$ $nmbr$ high
 834;ige high ( > $nmbr$ ku / l  n = $nmbr$  $nmbr$ );"C0205250;C0439340;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;ige high $nmbr$ ku l n $nmbr$ $nmbr$
 834;highjj;NA;NA;NA;highjj
 834;high vs . normalc;"C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;high vs normalc
 821;hdl - c ( mmol / l );"C1532563;C3715113";NA;NA;hdl c mmol l
 839;first hhf;"C0205435;C1279901";FALSE;1929;first hhf
 839;hhf ( n = $nmbr$ );NA;FALSE;1929;hhf n $nmbr$
 834;high vs . normalb;"C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;high vs normalb
 834;high tt > $nmbr$ . $nmbr$ ( n = $nmbr$ );"C0205250;C1299351;C1452561;C2700149;C3887512;C3889660;C4321237;C4522209;C4554543";NA;NA;high tt $nmbr$ $nmbr$ n $nmbr$
 834;high trs : $nmbr$ - $nmbr$ ( n = $nmbr$  $nmbr$ );"C0205250;C0266427;C0968917;C1150746;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;high trs $nmbr$ $nmbr$ n $nmbr$ $nmbr$
 834;high titre ( > $nmbr$ times of uln )  n ( % );"C0040223;C0205250;C0475208;C1299351;C1519815;C1632851;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;high titre $nmbr$ times of uln n
 834;high subgroup;"C0205250;C1079230;C1299351;C1515021;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;high subgroup
 834;high potencyc;"C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;high potencyc
 834;high periostin subgroup ( > $nmbr$ ng / ml ) ( n = $nmbr$ );"C0205250;C0219433;C0439275;C1079230;C1299351;C1424662;C1515021;C2700149;C3812270;C3887512;C3889660;C4321237;C4522209";NA;NA;high periostin subgroup $nmbr$ ng ml n $nmbr$
 834;high on - treatment platelet reactivity *;"C0005821;C0039798;C0087111;C0205250;C0443286;C1299351;C1522326;C1533734;C1705169;C2700149;C3538994;C3887512;C3887704;C3889660;C4321237;C4522209";NA;NA;high on treatment platelet reactivity
 834;high nfs nfs > $nmbr$ . $nmbr$ ( n = $nmbr$ );"C0205250;C1299351;C1513839;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;high nfs nfs $nmbr$ $nmbr$ n $nmbr$
 834;high nafld fibrosis score ( nfs > $nmbr$ . $nmbr$ );"C0205250;C0400966;C1299351;C1555018;C1954436;C1954437;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;high nafld fibrosis score nfs $nmbr$ $nmbr$
 834;high microalbuminuria to macroalbuminuria ( n = $nmbr$ );"C0205250;C0730345;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;high microalbuminuria to macroalbuminuria n $nmbr$
 834;high crp or esr;"C0205250;C1299351;C2700149;C3811131;C3887512;C3889660;C3890735;C4048285;C4321237;C4522209";NA;NA;high crp or esr
 834;high crp and esr;"C0205250;C1299351;C2700149;C3811131;C3887512;C3889660;C3890735;C4048285;C4321237;C4522209";NA;NA;high crp and esr
 834;high - dosage ics plus laba with baseline blood eosinophils a $nmbr$ cells per pl ( n = $nmbr$ );"C0005773;C0007584;C0007634;C0014467;C0168634;C0178602;C0200638;C0205250;C0815320;C1299351;C1442488;C2700149;C2986497;C3887512;C3889660;C3897966;C4049765;C4321237;C4522209;C4551720";NA;NA;high dosage ics plus laba with baseline blood eosinophils a $nmbr$ cells per pl n $nmbr$
 834;high - dosage ics plus laba with baseline blood eosinophils > $nmbr$ cells per pl ( n = $nmbr$ );"C0005773;C0007584;C0007634;C0014467;C0168634;C0178602;C0200638;C0205250;C0815320;C1299351;C1442488;C2700149;C2986497;C3887512;C3889660;C3897966;C4049765;C4321237;C4522209;C4551720";NA;NA;high dosage ics plus laba with baseline blood eosinophils $nmbr$ cells per pl n $nmbr$
 834;high - dosage ics plus laba with baseline blood eosinophils < $nmbr$ cells per pl ( n = $nmbr$ );"C0005773;C0007584;C0007634;C0014467;C0168634;C0178602;C0200638;C0205250;C0815320;C1299351;C1442488;C2700149;C2986497;C3887512;C3889660;C3897966;C4049765;C4321237;C4522209;C4551720";NA;NA;high dosage ics plus laba with baseline blood eosinophils $nmbr$ cells per pl n $nmbr$
 834;high *;"C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;high
 824;hf hosp .;"C0018488;C1313497;C1538440;C3273279";FALSE;  12;hf hosp
 834;high ( n = $nmbr$ );"C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;high n $nmbr$
 834;high ( i $nmbr$ % ) baseline hba $nmbr$ c;"C0019016;C0021966;C0168634;C0205250;C0221138;C1299351;C1442488;C1825777;C2700149;C3538758;C3887512;C3889660;C4321237;C4522209";NA;NA;high i $nmbr$ baseline hba $nmbr$ c
 834;high ( >   uln and   ≤   $nmbr$ xuln ) ( n   =   $nmbr$ );"C0205250;C1299351;C1519815;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;high uln and $nmbr$ xuln n $nmbr$
 834;high ( > uln );"C0205250;C1299351;C1519815;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;high uln
 834;high ( > $nmbr$ . $nmbr$ u / ml );"C0205250;C0439340;C1299351;C1880521;C2700149;C2945590;C3887512;C3889660;C4321237;C4522209";NA;NA;high $nmbr$ $nmbr$ u ml
 834;high ( > $nmbr$ ) ( n = $nmbr$  $nmbr$  $nmbr$ % );"C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;high $nmbr$ n $nmbr$ $nmbr$ $nmbr$
 834;high ( > $nmbr$ )  %;"C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;high $nmbr$
 834;high ( > $nmbr$ );"C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;high $nmbr$
 834;high ( > $nmbr$ % ) baseline hbalc;"C0168634;C0205250;C1299351;C1442488;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;high $nmbr$ baseline hbalc
 834;high ( > $nmbr$ % );"C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;high $nmbr$
 834;high ( $nmbr$ - $nmbr$ );"C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;high $nmbr$ $nmbr$
 834;high ( $nmbr$ % );"C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;high $nmbr$
 834;high  %;"C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;high
 834;high;"C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;high
 834;fgf - $nmbr$ high / egfr > $nmbr$;"C0016026;C0205250;C0919505;C1299351;C1739039;C2700149;C3811844;C3812682;C3887512;C3889660;C4321237;C4522209";NA;NA;fgf $nmbr$ high egfr $nmbr$
 834;fgf - $nmbr$ high / egfr < $nmbr$;"C0016026;C0205250;C0919505;C1299351;C1739039;C2700149;C3811844;C3812682;C3887512;C3889660;C4321237;C4522209";NA;NA;fgf $nmbr$ high egfr $nmbr$
 834;fgf - $nmbr$ high / > $nmbr$ elevated biomarkers;"C0005516;C0016026;C0205250;C0919505;C1299351;C2700149;C3163633;C3887512;C3889660;C4321237;C4522209";NA;NA;fgf $nmbr$ high $nmbr$ elevated biomarkers
 834;fgf - $nmbr$ high / < $nmbr$ elevated biomarkers;"C0005516;C0016026;C0205250;C0919505;C1299351;C2700149;C3163633;C3887512;C3889660;C4321237;C4522209";NA;NA;fgf $nmbr$ high $nmbr$ elevated biomarkers
 834;eosinophil high;"C0014467;C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;eosinophil high
 834;education  high school or higher;"C0205250;C0683862";NA;NA;education high school or higher
 834;college degree or higher;"C0205250;C0441889;C0449286;C0542560;C0557806;C2348088";NA;NA;college degree or higher
 834;bl updrs : high;"C0005918;C0006413;C0205250;C1299351;C1552663;C2700149;C2827109;C3639721;C3887512;C3889660;C4321237;C4522209";NA;NA;bl updrs high
 834;biomarker high ( periostin > $nmbr$ ng / ml or blood eosinophils > $nmbr$ cells per pl )  na;"C0005516;C0005773;C0007584;C0007634;C0014467;C0200638;C0205250;C0219433;C0439275;C0597484;C1272460;C1299351;C1424662;C1546968;C1879645;C2700149;C3812270;C3887512;C3889660;C3897966;C4049765;C4049872;C4321237;C4522209;C4552882";NA;NA;biomarker high periostin $nmbr$ ng ml or blood eosinophils $nmbr$ cells per pl na
 834;biomarker high;"C0005516;C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;biomarker high
 833;hscrp §;NA;NA;NA;hscrp
 833;hcru ( a );NA;NA;NA;hcru a
 833;elevated hscrp > $nmbr$ mg / l  n ( % );"C0205250;C0439268;C3163633";NA;NA;elevated hscrp $nmbr$ mg l n
 833;elevated hscrp;"C0205250;C3163633";NA;NA;elevated hscrp
 832;white  n ( % ) medical history  n ( % );"C0007457;C0043157;C0220938;C0262926;C1704706";NA;NA;white n medical history n
 832;vascular history  %;"C0005847;C0019664;C0019665;C0262512;C0262926;C1558950;C1705255;C1801960;C2004062";NA;NA;vascular history
 832;uc history;"C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";NA;NA;uc history
 832;selective vascular history;"C0005847;C0019664;C0019665;C0036576;C0262512;C0262926;C1558950;C1705255;C1707391;C1801960;C2004062";NA;NA;selective vascular history
 832;seizure history  n ( % );"C0019664;C0019665;C0036572;C0262512;C0262926;C1705255;C1959629;C2004062;C4553401";NA;NA;seizure history n
 832;risk factors and medical history;"C0035648;C0262926;C1553898;C1704706";NA;NA;risk factors and medical history
 832;revascularization history;"C0019664;C0019665;C0262512;C0262926;C0581603;C1705255;C2004062";NA;NA;revascularization history
 832;prior treatment history $nmbr$;"C0019664;C0019665;C0262512;C0262926;C1514463;C1705255;C2004062";NA;NA;prior treatment history $nmbr$
 832;history of stroke *;"C0019664;C0019665;C0038454;C0262512;C0262926;C1705255;C2004062;C4554100";NA;NA;history of stroke
 832;plus – minus values are means ± sd . cabg denotes coronary - artery by - pass graft  ptca percutaneous transluminal coronary angioplasty  and ace angiotensin - converting enzyme . hypertension and diabetes were de - fined by clinical history . a more complete list of base - line characteristics is given in rubins et al . $nmbr$ † nitrates includes all preparations except as - needed nitroglycerin . ‡ any antianginal drug includes any nitrate ( as defined above )  calcium - channel blocker  or beta - blocker . § the body - mass index is the weight in kilograms divided by the square of the height in meters . ¶ to convert values for cholesterol to millimoles per liter  multiply by $nmbr$ . $nmbr$ . to convert values for triglycerides to millimoles per liter  multiply by $nmbr$ . $nmbr$ .;"C0001645;C0005893;C0005910;C0006448;C0006539;C0006684;C0008377;C0010055;C0011198;C0011847;C0011849;C0013227;C0017480;C0017887;C0019664;C0019665;C0020538;C0022709;C0028125;C0030125;C0040028;C0040363;C0041004;C0041260;C0042295;C0043100;C0181074;C0202311;C0205042;C0205120;C0205172;C0205197;C0205210;C0205232;C0252873;C0262512;C0262926;C0332257;C0332288;C0332835;C0332849;C0439190;C0439209;C0441074;C0475211;C0489786;C0578022;C0687757;C0699857;C0745732;C0885378;C1254351;C1305855;C1305866;C1442162;C1452534;C1521827;C1532563;C1550718;C1552595;C1552866;C1704788;C1704970;C1705104;C1705255;C1719797;C1820373;C1874267;C1879745;C1883351;C1883728;C1947971;C1961139;C1963138;C2004062;C2699239;C2700399;C2828386;C2911648;C2936173;C3244317;C3272378;C3536851;C3537168;C3539106;C3541240;C3812761;C3848573;C3853530;C3854028;C4283785;C4284014;C4321248;C4521885;C4522126;C4684572";NA;NA;plus minus values are means sd cabg denotes coronary artery by pass graft ptca percutaneous transluminal coronary angioplasty and ace angiotensin converting enzyme hypertension and diabetes were de fined by clinical history a more complete list of base line characteristics is given in rubins et al $nmbr$ nitrates includes all preparations except as needed nitroglycerin any antianginal drug includes any nitrate as defined above calcium channel blocker or beta blocker the body mass index is the weight in kilograms divided by the square of the height in meters to convert values for cholesterol to millimoles per liter multiply by $nmbr$ $nmbr$ to convert values for triglycerides to millimoles per liter multiply by $nmbr$ $nmbr$
 832;parental history of mii;"C0019664;C0019665;C0030551;C0262512;C0262926;C1705255;C2004062";NA;NA;parental history of mii
 832;parental history of mi before age $nmbr$ y;"C0001779;C0019664;C0019665;C0030551;C0262512;C0262926;C1705255;C2004062;C3810814";NA;NA;parental history of mi before age $nmbr$ y
 832;other medical history — no . / total no . ( % );"C0262926;C0439175;C0439810;C1704706";NA;NA;other medical history no total no
 832;other medical history — no . ( % );"C0262926;C1704706";NA;NA;other medical history no
 832;other medical history  no . ( % );"C0262926;C1704706";NA;NA;other medical history no
 832;oad history  years;"C0019664;C0019665;C0262512;C0262926;C0439234;C1705255;C2004062";NA;NA;oad history years
 832;no history of paroxysmal af;"C0019664;C0019665;C0235480;C0262512;C0262926;C1705255;C2004062";NA;NA;no history of paroxysmal af
 832;no history of mi ( n = $nmbr$  $nmbr$ );"C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C3810814";NA;NA;no history of mi n $nmbr$ $nmbr$
 832;no history of hf;"C0018488;C0019664;C0019665;C0262512;C0262926;C1313497;C1538440;C1705255;C2004062;C3273279";NA;NA;no history of hf
 832;no history of diabetes ( n = $nmbr$ );"C0011847;C0011849;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";NA;NA;no history of diabetes n $nmbr$
 832;no history of chf;"C0018802;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";NA;NA;no history of chf
 832;no history of bowel resections;"C0019664;C0019665;C0262512;C0262926;C0741614;C1705255;C2004062";NA;NA;no history of bowel resections
 832;no history of af;"C0019664;C0019665;C0262512;C0262926;C0344434;C1705255;C2004062;C4049859";NA;NA;no history of af
 832;medical history — no . / total no . ( % );"C0262926;C0439175;C0439810;C1704706";NA;NA;medical history no total no
 832;medical history — no . ( % );"C0262926;C1704706";NA;NA;medical history no
 832;medical history — %;"C0262926;C1704706";NA;NA;medical history
 832;medical history of diabetic retinopathy §;"C0011884;C0262926";NA;NA;medical history of diabetic retinopathy
 832;medical history before index acute coronary syndrome — no . { % );"C0262926;C0600653;C0918012;C0948089;C1552854;C1637833;C1704706;C2986546";NA;NA;medical history before index acute coronary syndrome no
 832;medical history at randomization — no . ( % );"C0034656;C0262926;C1704706";NA;NA;medical history at randomization no
 832;medical history and risk factors — no . ( % );"C0035648;C0262926;C1553898;C1704706";NA;NA;medical history and risk factors no
 832;medical history and risk factors ( % );"C0035648;C0262926;C1553898;C1704706";NA;NA;medical history and risk factors
 832;medical history and risk factors  no . / total ( % ) *;"C0035648;C0262926;C0439175;C0439810;C1553898;C1704706";NA;NA;medical history and risk factors no total
 832;medical history and risk factors;"C0035648;C0262926;C1553898;C1704706";NA;NA;medical history and risk factors
 832;medical history . no . ( % );"C0262926;C1704706";NA;NA;medical history no
 832;medical history ( % );"C0262926;C1704706";NA;NA;medical history
 832;medical history    n   ( % );"C0262926;C1704706";NA;NA;medical history n
 832;medical history  no . ( % );"C0262926;C1704706";NA;NA;medical history no
 832;medical history  n ( % );"C0262926;C1704706";NA;NA;medical history n
 832;medical history;"C0262926;C1704706";NA;NA;medical history
 832;hx cabg;"C0010055;C0262926;C3814444";NA;NA;hx cabg
 832;htn hx;"C0020538;C0262926;C3814444";NA;NA;htn hx
 832;history pci;"C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C4049621";NA;NA;history pci
 832;history ol mi or stroke;"C0019664;C0019665;C0038454;C0262512;C0262926;C1705255;C2004062;C3810814;C4554100";NA;NA;history ol mi or stroke
 832;history of vte * *;"C0019664;C0019665;C0262512;C0262926;C0630906;C1705255;C2004062";NA;NA;history of vte
 832;history of vte;"C0019664;C0019665;C0262512;C0262926;C0630906;C1705255;C2004062";NA;NA;history of vte
 832;history of venous;"C0019664;C0019665;C0042449;C0262512;C0262926;C0348013;C1705255;C2004062";NA;NA;history of venous
 832;history of upper gi events ( perforations  ulcers and bleeding ) n ( % );"C0019080;C0019664;C0019665;C0041582;C0203057;C0262512;C0262926;C0441471;C0549099;C1705255;C2004062;C3541888";NA;NA;history of upper gi events perforations ulcers and bleeding n
 832;history of upper;"C0019664;C0019665;C0262512;C0262926;C1282910;C1705255;C2004062";NA;NA;history of upper
 832;history of tia or stroke;"C0007787;C0019664;C0019665;C0038454;C0262512;C0262926;C0917805;C1054154;C1705255;C2004062;C4554100";NA;NA;history of tia or stroke
 832;history of tia  n ( % );"C0007787;C0019664;C0019665;C0262512;C0262926;C0917805;C1054154;C1705255;C2004062";NA;NA;history of tia n
 832;history of strokea;"C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";NA;NA;history of strokea
 832;history of stroke †;"C0019664;C0019665;C0038454;C0262512;C0262926;C1705255;C2004062;C4554100";NA;NA;history of stroke
 832;history of stroke or transient ischemic attack;"C0007787;C0019664;C0019665;C0038454;C0262512;C0262926;C0917805;C1705255;C2004062;C4554100";NA;NA;history of stroke or transient ischemic attack
 832;history of stroke or tia - n ( % );"C0007787;C0019664;C0019665;C0038454;C0262512;C0262926;C0917805;C1054154;C1705255;C2004062;C4554100";NA;NA;history of stroke or tia n
 832;history of stroke or tia;"C0007787;C0019664;C0019665;C0038454;C0262512;C0262926;C0917805;C1054154;C1705255;C2004062;C4554100";NA;NA;history of stroke or tia
 832;history of stroke at baseline;"C0019664;C0019665;C0038454;C0168634;C0262512;C0262926;C1442488;C1705255;C2004062;C4554100";NA;NA;history of stroke at baseline
 832;history of stroke / see / tia  n ( % );"C0007787;C0019664;C0019665;C0038454;C0042789;C0262512;C0262926;C0917805;C1054154;C1705255;C1947903;C2004062;C4554100";NA;NA;history of stroke see tia n
 832;history of stroke / see / tia;"C0007787;C0019664;C0019665;C0038454;C0042789;C0262512;C0262926;C0917805;C1054154;C1705255;C1947903;C2004062;C4554100";NA;NA;history of stroke see tia
 832;history of stroke * *;"C0019664;C0019665;C0038454;C0262512;C0262926;C1705255;C2004062;C4554100";NA;NA;history of stroke
 814;α - glucosidase inhibitor;C1512211;NA;NA;glucosidase inhibitor
 832;pci history;"C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C4049621";FALSE;1661;pci history
 832;history of stroke ( % );"C0019664;C0019665;C0038454;C0262512;C0262926;C1705255;C2004062;C4554100";NA;NA;history of stroke
 832;history of stroke $nmbr$;"C0019664;C0019665;C0038454;C0262512;C0262926;C1705255;C2004062;C4554100";NA;NA;history of stroke $nmbr$
 832;history of stroke  n ( % );"C0019664;C0019665;C0038454;C0262512;C0262926;C1705255;C2004062;C4554100";NA;NA;history of stroke n
 832;history of stroke;"C0019664;C0019665;C0038454;C0262512;C0262926;C1705255;C2004062;C4554100";NA;NA;history of stroke
 832;history of second prior mi  n ( % );"C0019664;C0019665;C0205436;C0262512;C0262926;C0332152;C0457385;C0565930;C1561503;C1705190;C1705255;C2004062;C2826257;C3810814";NA;NA;history of second prior mi n
 832;history of parental myocardial;"C0019664;C0019665;C0027061;C0030551;C0262512;C0262926;C1522564;C1705255;C2004062";NA;NA;history of parental myocardial
 832;history of pad;"C0019664;C0019665;C0182158;C0262512;C0262926;C0332568;C1705255;C2004062;C3540603;C3669270;C3814046;C4319657";NA;NA;history of pad
 832;history of oxygen use - yes  n ( % );"C0019664;C0019665;C0030054;C0262512;C0262926;C1524063;C1549445;C1705108;C1705255;C1710701;C2004062";NA;NA;history of oxygen use yes n
 832;history of or current cardiac disorders  %;"C0018799;C0019664;C0019665;C0262512;C0262926;C0521116;C1705255;C1705970;C2004062";NA;NA;history of or current cardiac disorders
 832;history of non - hemor - rhagic stroke;"C0019664;C0019665;C0038454;C0262512;C0262926;C1518422;C1705255;C2004062;C4554100";NA;NA;history of non hemor rhagic stroke
 832;history of nicotine use;"C0019664;C0019665;C0028040;C0262512;C0262926;C1524063;C1705255;C2004062";NA;NA;history of nicotine use
 832;history of more than $nmbr$ prior mi ( % );"C0019664;C0019665;C0262512;C0262926;C0332152;C1705255;C2004062;C2826257;C3810814";NA;NA;history of more than $nmbr$ prior mi
 832;history of ml or stroke;"C0019664;C0019665;C0038454;C0262512;C0262926;C0439526;C1705224;C1705255;C2004062;C3887665;C4554100";NA;NA;history of ml or stroke
 832;history of ml or ischemic stroke;"C0019664;C0019665;C0262512;C0262926;C0439526;C0948008;C1705224;C1705255;C2004062;C3887665";NA;NA;history of ml or ischemic stroke
 832;history of mi or stroke history of coronary;"C0018787;C0019664;C0019665;C0038454;C0262512;C0262926;C1705255;C2004062;C3810814;C4554100";NA;NA;history of mi or stroke history of coronary
 832;history of mi or stroke d;"C0019664;C0019665;C0038454;C0262512;C0262926;C1705255;C2004062;C3810814;C4554100";NA;NA;history of mi or stroke d
 832;history of mi or stroke  no . ( % );"C0019664;C0019665;C0038454;C0262512;C0262926;C1705255;C2004062;C3810814;C4554100";NA;NA;history of mi or stroke no
 832;history of mi or stroke  n ( % );"C0019664;C0019665;C0038454;C0262512;C0262926;C1705255;C2004062;C3810814;C4554100";NA;NA;history of mi or stroke n
 832;history of mi or stroke;"C0019664;C0019665;C0038454;C0262512;C0262926;C1705255;C2004062;C3810814;C4554100";NA;NA;history of mi or stroke
 832;history of mi ( n = $nmbr$  $nmbr$ );"C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C3810814";NA;NA;history of mi n $nmbr$ $nmbr$
 832;history of mi  n ( % );"C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C3810814";NA;NA;history of mi n
 832;history of mi;"C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C3810814";NA;NA;history of mi
 832;history of major bleeding;"C0019080;C0019664;C0019665;C0205082;C0205164;C0262512;C0262926;C1705255;C2004062;C4318856;C4521762";NA;NA;history of major bleeding
 718;permanent;C0205355;NA;NA;permanent
 832;history of macroalbuminuriat  n ( % );"C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";NA;NA;history of macroalbuminuriat n
 832;history of ischemic stroke;"C0019664;C0019665;C0262512;C0262926;C0948008;C1705255;C2004062";NA;NA;history of ischemic stroke
 832;history of htn  %;"C0019664;C0019665;C0020538;C0262512;C0262926;C1705255;C2004062";NA;NA;history of htn
 832;history of high cholesterol ( a ) $nmbr$;"C0019664;C0019665;C0020443;C0262512;C0262926;C1522133;C1705255;C2004062";NA;NA;history of high cholesterol a $nmbr$
 832;history of hf;"C0018488;C0019664;C0019665;C0262512;C0262926;C1313497;C1538440;C1705255;C2004062;C3273279";NA;NA;history of hf
 832;history of h pylori eradication *;"C0019664;C0019665;C0079488;C0262512;C0262926;C1705255;C2004062";NA;NA;history of h pylori eradication
 832;history of extra - intestinal manifestations of ibd;"C0019664;C0019665;C0021853;C0262512;C0262926;C1280464;C1705255;C1883702;C2004062";NA;NA;history of extra intestinal manifestations of ibd
 832;history of dyslipidemia;"C0019664;C0019665;C0242339;C0262512;C0262926;C1705255;C2004062";NA;NA;history of dyslipidemia
 832;history of dyslipidaemia;"C0019664;C0019665;C0242339;C0262512;C0262926;C1705255;C2004062";NA;NA;history of dyslipidaemia
 832;history of diabetes { p = $nmbr$ * $nmbr$ );"C0011847;C0011849;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";NA;NA;history of diabetes p $nmbr$ $nmbr$
 832;history of diabetes nyha class;"C0011847;C0011849;C0019664;C0019665;C0262512;C0262926;C1705255;C1882083;C2004062";NA;NA;history of diabetes nyha class
 832;history of diabetes ( % );"C0011847;C0011849;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";NA;NA;history of diabetes
 832;history of diabetes;"C0011847;C0011849;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";NA;NA;history of diabetes
 832;history of cvd  n ( % );"C0007222;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";NA;NA;history of cvd n
 832;history of cvd;"C0007222;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";NA;NA;history of cvd
 832;history of coronary revascularization d;"C0019664;C0019665;C0262512;C0262926;C0877341;C1705255;C2004062";NA;NA;history of coronary revascularization d
 832;history of coronary revascularization;"C0019664;C0019665;C0262512;C0262926;C0877341;C1705255;C2004062";NA;NA;history of coronary revascularization
 832;history of coronary;"C0018787;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";NA;NA;history of coronary
 832;history of copd;"C0019664;C0019665;C0024117;C0262512;C0262926;C1412502;C1705255;C2004062;C3714496";NA;NA;history of copd
 832;history of chronic hf;"C0018488;C0019664;C0019665;C0205191;C0262512;C0262926;C1313497;C1538440;C1705255;C2004062;C3273279";NA;NA;history of chronic hf
 832;history of chf - n ( % );"C0018802;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";NA;NA;history of chf n
 832;history of chf  nyha class ii or iii — no . ( % );"C0018802;C0019664;C0019665;C0262512;C0262926;C0439070;C1705160;C1705255;C1882085;C2004062";NA;NA;history of chf nyha class ii or iii no
 832;history of chf  n ( % );"C0018802;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";NA;NA;history of chf n
 832;history of chf;"C0018802;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";NA;NA;history of chf
 832;history of cardiovascular events;"C0019664;C0019665;C0262512;C0262926;C0441471;C1320716;C1705255;C1880008;C2004062;C3541888";NA;NA;history of cardiovascular events
 832;history of cad / mi;"C0019664;C0019665;C0262512;C0262926;C1504769;C1705255;C2004062;C2239547;C3810814;C3813548;C4284121";NA;NA;history of cad mi
 832;history of cad;"C0019664;C0019665;C0262512;C0262926;C1504769;C1705255;C2004062;C2239547;C3813548;C4284121";NA;NA;history of cad
 814;pde $nmbr$ inhibitors;C0031638;NA;NA;pde $nmbr$ inhibitors
 832;history of omalizumab treatment;"C0019664;C0019665;C0039798;C0087111;C0262512;C0262926;C0966225;C1522326;C1533734;C1705169;C1705255;C2004062;C3538994;C3887704";FALSE; 940;history of omalizumab treatment
 832;history of pci;"C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C4049621";FALSE;1661;history of pci
 832;history of pci  n ( % );"C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C4049621";FALSE;1661;history of pci n
 832;history of pci with stenting;"C0019664;C0019665;C0038257;C0262512;C0262926;C1705255;C2004062;C2348535;C4049621";FALSE;1661;history of pci with stenting
 832;history of bowel resections  n ( % );"C0019664;C0019665;C0262512;C0262926;C0741614;C1705255;C2004062";NA;NA;history of bowel resections n
 832;history of atrial arrhythmia  n ( % );"C0019664;C0019665;C0085611;C0262512;C0262926;C1705255;C2004062";NA;NA;history of atrial arrhythmia n
 832;history of amputation  n ( % );"C0002688;C0019664;C0019665;C0262512;C0262926;C0332840;C1546539;C1705255;C2004062";NA;NA;history of amputation n
 832;history of amputation;"C0002688;C0019664;C0019665;C0262512;C0262926;C0332840;C1546539;C1705255;C2004062";NA;NA;history of amputation
 832;history of af;"C0019664;C0019665;C0262512;C0262926;C0344434;C1705255;C2004062;C4049859";NA;NA;history of af
 832;history of > $nmbr$ previous vte ( excluding index event );"C0019664;C0019665;C0205156;C0262512;C0262926;C0332196;C0441471;C0600653;C0630906;C0918012;C1552607;C1552854;C1637833;C1705255;C2004062;C2828389;C2986546;C4019010";NA;NA;history of $nmbr$ previous vte excluding index event
 832;history of ( % );"C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";NA;NA;history of
 832;history mi or stroke;"C0019664;C0019665;C0038454;C0262512;C0262926;C1705255;C2004062;C3810814;C4554100";NA;NA;history mi or stroke
 832;history coronary revascularization;"C0019664;C0019665;C0262512;C0262926;C0877341;C1705255;C2004062";NA;NA;history coronary revascularization
 832;history coronary;"C0018787;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";NA;NA;history coronary
 832;history congestive heart failure;"C0018802;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";NA;NA;history congestive heart failure
 832;history ( pack - years );"C0019664;C0019665;C0262512;C0262926;C1277691;C1705255;C2004062";NA;NA;history pack years
 832;history  pack - years;"C0019664;C0019665;C0262512;C0262926;C1277691;C1705255;C2004062";NA;NA;history pack years
 832;history;"C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";NA;NA;history
 832;diabetic history ( years ) x;"C0019664;C0019665;C0241863;C0262512;C0262926;C0439234;C1705255;C2004062";NA;NA;diabetic history years x
 832;copd history yrs;"C0019664;C0019665;C0024117;C0262512;C0262926;C1412502;C1705255;C2004062;C3714496";NA;NA;copd history yrs
 832;copd exacerbation history  n ( % );"C0019664;C0019665;C0262512;C0262926;C0740304;C1705255;C2004062";NA;NA;copd exacerbation history n
 832;clinical history — no . ( % );"C0019664;C0019665;C0205210;C0262512;C0262926;C1705255;C2004062";NA;NA;clinical history no
 832;clinical history  no . ( % );"C0019664;C0019665;C0205210;C0262512;C0262926;C1705255;C2004062";NA;NA;clinical history no
 832;clinical history  n ( % );"C0019664;C0019665;C0205210;C0262512;C0262926;C1705255;C2004062";NA;NA;clinical history n
 832;clinical history;"C0019664;C0019665;C0205210;C0262512;C0262926;C1705255;C2004062";NA;NA;clinical history
 832;chf history;"C0018802;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";NA;NA;chf history
 832;cardiovascular risk factors and medical history;"C0262926;C0850624;C1704706";NA;NA;cardiovascular risk factors and medical history
 832;cardiac history  %;"C0018787;C0019664;C0019665;C0262512;C0262926;C1522601;C1705255;C2004062";NA;NA;cardiac history
 832;cardiac history;"C0018787;C0019664;C0019665;C0262512;C0262926;C1522601;C1705255;C2004062";NA;NA;cardiac history
 832;cad history and risk factors  n ( % );"C0019664;C0019665;C0035648;C0262512;C0262926;C1504769;C1553898;C1705255;C2004062;C2239547;C3813548;C4284121";NA;NA;cad history and risk factors n
 832;baseline copd exacerbation history  * n ( % );"C0019664;C0019665;C0168634;C0262512;C0262926;C0740304;C1442488;C1705255;C2004062";NA;NA;baseline copd exacerbation history n
 832;any cvd history ( % );"C0007222;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";NA;NA;any cvd history
 831;hiv;"C0019682;C0019699";NA;NA;hiv
 830;waist - to - hip  male;"C0019552;C0022122;C0086582;C0230097;C1505163;C1706180;C1706428;C1706429;C3538851;C4284725";NA;NA;waist to hip male
 830;total hip or knee replacement;"C0019552;C0022122;C0086511;C0439175;C0439810;C1505163;C3538851;C4284725";NA;NA;total hip or knee replacement
 830;total hip bmi ) t - score;"C0019552;C0022122;C0578022;C1505163;C2964552;C3538851;C4284725";NA;NA;total hip bmi t score
 830;total hip bmd t - score;"C0019552;C0022122;C1505163;C2964552;C3538851;C4284725";NA;NA;total hip bmd t score
 830;total - hip bmd t - score;"C0019552;C0022122;C1505163;C2964552;C3538851;C4284725";NA;NA;total hip bmd t score
 830;hip + $nmbr$ vertebral fractures;"C0019552;C0019557;C0022122;C0080179;C0549207;C1505163;C3538851;C4284725";NA;NA;hip $nmbr$ vertebral fractures
 830;hip  femur;"C0015811;C0019552;C0022122;C1505163;C3538851;C4284725";NA;NA;hip femur
 830;hip;"C0019552;C0022122;C1505163;C3538851;C4284725";NA;NA;hip
 -10;hub;"C0063034;C1414372;C1708389";NA;NA;hub
 828;aspirin < $nmbr$ hours;"C0004057;C0439227";NA;NA;aspirin $nmbr$ hours
 828;$nmbr$ - hour postload glucose;"C0017725;C0439227;C0564385";NA;NA;$nmbr$ hour postload glucose
 828;$nmbr$ - $nmbr$ hours;C0439227;NA;NA;$nmbr$ $nmbr$ hours
 827;use of medication from randomization through $nmbr$ hr — no . / total no . ( % );"C0013227;C0034656;C0439175;C0439810;C1524063;C3244316;C4284232";NA;NA;use of medication from randomization through $nmbr$ hr no total no
 827;hr ( b . p . m . );"C0369637;C0441923";NA;NA;hr b p m
 827;hr ( adjusteda );NA;NA;NA;hr adjusteda
 827;> $nmbr$ hr;NA;NA;NA;$nmbr$ hr
 827;$nmbr$ hr prandial glucose ' * ’;"C0017725;C1998602;C4553624";NA;NA;$nmbr$ hr prandial glucose
 827;$nmbr$ - $nmbr$ hr;NA;NA;NA;$nmbr$ $nmbr$ hr
 825;hr $nmbr$ . $nmbr$;NA;NA;NA;hr $nmbr$ $nmbr$
 825;hr;NA;NA;NA;hr
 825;hc;"C0020268;C0262499;C1413512";NA;NA;hc
 825;duration of infusion — hr;"C0449238;C0574032;C1827465;C2926735";NA;NA;duration of infusion hr
 825;duration of infusion during medical management — hr;"C0001554;C0199168;C0205476;C0376636;C0449238;C0574032;C1273870;C1827465;C2926735;C3273539";NA;NA;duration of infusion during medical management hr
 825;duration of infusion before pci — hr;"C0449238;C0574032;C1827465;C2926735;C4049621";NA;NA;duration of infusion before pci hr
 825;duration of infusion before cabg — hr;"C0010055;C0449238;C0574032;C1827465;C2926735";NA;NA;duration of infusion before cabg hr
 825;duration of infusion after pci — hr;"C0449238;C0574032;C1827465;C2926735;C4049621";NA;NA;duration of infusion after pci hr
 825;duration of clopidogrel pretreatment — hr median;"C0070166;C0449238;C0549183;C0876920;C1550147;C2347635;C2348144;C2709094;C2926735;C2939193;C3539075;C3539076";NA;NA;duration of clopidogrel pretreatment hr median
 825;direction of hr;C0449738;NA;NA;direction of hr
 826;< $nmbr$ hr;NA;FALSE; 298;$nmbr$ hr
 832;atherosclerotic vascular disease history †;"C0004153;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";FALSE;1698;atherosclerotic vascular disease history
 832;atherosclerotic vascular disease history  n ( % ) t;"C0004153;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";FALSE;1698;atherosclerotic vascular disease history n t
 828;$nmbr$ - hour madbp  mm hg;"C0439227;C0439475;C0564385";FALSE;  15;$nmbr$ hour madbp mm hg
 828;$nmbr$ - hour masbp  mm hg;"C0439227;C0439475;C0564385";FALSE;  15;$nmbr$ hour masbp mm hg
 824;recurrent hf hospitalization;"C0018488;C0019993;C1313497;C1455761;C1538440;C2945760;C3273279";FALSE;  12;recurrent hf hospitalization
 824;stroke / m l / hf hospitalization;"C0018488;C0019993;C0038454;C0456616;C1313497;C1538440;C3273279;C4554100";FALSE;  12;stroke m l hf hospitalization
 824;without hx of hf;"C0018488;C0262926;C1313497;C1538440;C3273279;C3814444";FALSE;  12;without hx of hf
 832;all participants history of cabg;"C0010055;C0019664;C0019665;C0262512;C0262926;C0679646;C1705255;C2004062";FALSE; 389;all participants history of cabg
 823;hl 土 $nmbr$ . $nmbr$;"C1453952;C4085347";NA;NA;hl $nmbr$ $nmbr$
 821;total cholesterol / hdl - c;"C0023822;C0201950;C0439175;C0439810;C0543421;C3715113";NA;NA;total cholesterol hdl c
 821;total c / hdl - c ratio * *;"C0439175;C0439810;C0456603;C1547037;C3715113";NA;NA;total c hdl c ratio
 821;total - c : hdl - c;"C0439175;C0439810;C3715113";NA;NA;total c hdl c
 821;ratio of ldl to hdl;"C0456603;C1547037;C3715113";NA;NA;ratio of ldl to hdl
 821;non - hdl choleslerol;"C1518422;C3715113";NA;NA;non hdl choleslerol
 821;non - hdl - c in $nmbr$ classes;"C0456387;C1518422;C1518526;C1705943;C3715113;C4019422";NA;NA;non hdl c in $nmbr$ classes
 821;non - hdl - c / hdl - c;"C1518422;C3715113";NA;NA;non hdl c hdl c
 821;non - hdl - c *;"C1518422;C3715113";NA;NA;non hdl c
 821;non - hdl - c ( mmol / l );"C1518422;C1532563;C3715113";NA;NA;non hdl c mmol l
 821;non - hdl - c ( mmol / l  mean );"C0444504;C1518422;C1532563;C2347634;C2348143;C3715113";NA;NA;non hdl c mmol l mean
 821;non - hdl - c  mmol / l  mean ( sd );"C0444504;C1518422;C1532563;C2347634;C2348143;C2699239;C3715113";NA;NA;non hdl c mmol l mean sd
 821;non - hdl - c  mmol / l;"C1518422;C1532563;C3715113";NA;NA;non hdl c mmol l
 821;non - hdl - c  mean ( sd )  rng / dl;"C0444504;C1518422;C2347634;C2348143;C2699239;C3642216;C3715113";NA;NA;non hdl c mean sd rng dl
 821;non - hdl - c  mean ( sd );"C0444504;C1518422;C2347634;C2348143;C2699239;C3715113";NA;NA;non hdl c mean sd
 821;non - hdl - c;"C1518422;C3715113";NA;NA;non hdl c
 821;non - hdl;"C1518422;C3715113";NA;NA;non hdl
 821;ldl - c : hdl - c;C3715113;NA;NA;ldl c hdl c
 821;ldl - c / hdl - cx;C3715113;NA;NA;ldl c hdl cx
 821;ldl - c / hdl - c;C3715113;NA;NA;ldl c hdl c
 821;hdl — male;"C0086582;C1706180;C1706428;C1706429;C3715113";NA;NA;hdl male
 821;hdl — female;"C0043210;C0086287;C1705497;C1705498;C3715113";NA;NA;hdl female
 821;hdl choleslerol;C3715113;NA;NA;hdl choleslerol
 821;hdl - cy;"C0010622;C0332298;C2239193;C3715113";NA;NA;hdl cy
 821;hdl - cd;"C0007928;C0034283;C3715113;C4552032";NA;NA;hdl cd
 821;hdl - c at baseline .;"C0168634;C1442488;C3715113";NA;NA;hdl c at baseline
 823;elevated non - hdl cholesterol;"C0205250;C0729627;C1535899;C3163633";FALSE; 821;elevated non hdl cholesterol
 823;low hdl - c;C0151691;FALSE; 821;low hdl c
 823;low hdl cholesterol * |;C0151691;FALSE; 821;low hdl cholesterol
 823;non - hdl cholesterol / apob ( ratio );"C0003593;C0456603;C0729627;C1518422;C1535899;C1547037;C2938854;C3252643";FALSE; 821;non hdl cholesterol apob ratio
 823;non - hdl cholesterol j;"C0729627;C1535899";FALSE; 821;non hdl cholesterol j
 823;non - hdl cholesterol ( mg / dl );"C0439269;C0729627;C1535899";FALSE; 821;non hdl cholesterol mg dl
 823;non - hdl cholesterol ( mmol / l );"C0729627;C1532563;C1535899";FALSE; 821;non hdl cholesterol mmol l
 823;non - hdl cholesterol ( week $nmbr$ );"C0332174;C0439230;C0729627;C1535899";FALSE; 821;non hdl cholesterol week $nmbr$
 823;reduced hdl cholesterol;C0151691;FALSE; 821;reduced hdl cholesterol
 824;cardiovascular death or hospitalized hf;"C0007226;C0011065;C0018488;C0701159;C1306577;C1313497;C1538440;C3273279;C3887460;C4082313;C4552775";FALSE;  12;cardiovascular death or hospitalized hf
 824;clinical features of hf;"C0018488;C0683325;C1313497;C1538440;C3273279";FALSE;  12;clinical features of hf
 824;all ~ cause mort / hf hosp .;"C0015127;C0018488;C1313497;C1524003;C1538440;C3273279;C3815322";FALSE;  12;all cause mort hf hosp
 824;enrolment through hf;"C0018488;C1313497;C1516879;C1538440;C1696073;C3273279;C3888021";FALSE;  12;enrolment through hf
 824;duration of hf  y;"C0018488;C0449238;C1313497;C1538440;C2926735;C3273279";FALSE;  12;duration of hf y
 824;heart failure ( hf )  ( % );"C0018488;C0018801;C0018802;C1313497;C1538440;C3273279;C4554158";FALSE;  12;heart failure hf
 824;hf;"C0018488;C1313497;C1538440;C3273279";FALSE;  12;hf
 824;hf cause;"C0015127;C0018488;C1313497;C1524003;C1538440;C3273279";FALSE;  12;hf cause
 824;hf duration  y  n ( % );"C0018488;C0449238;C1313497;C1538440;C2926735;C3273279";FALSE;  12;hf duration y n
 824;hf hospitalisation;"C0018488;C0019993;C1313497;C1538440;C3273279";FALSE;  12;hf hospitalisation
 824;hf hospitalization n;"C0018488;C0019993;C1313497;C1538440;C3273279";FALSE;  12;hf hospitalization n
 824;hf  lvd  or both;"C0018488;C1313497;C1538440;C3273279";FALSE;  12;hf lvd or both
 824;hf signs and symptoms;"C0018488;C0220912;C0220913;C0311392;C0683368;C1313497;C1457887;C1538440;C3273279";FALSE;  12;hf signs and symptoms
 824;hf symptomatic improvement;"C0018488;C0231220;C1313497;C1538440;C2986411;C3273279";FALSE;  12;hf symptomatic improvement
 824;hf symptom unchanged;"C0018488;C0442739;C1313497;C1457887;C1538440;C2346711;C3273279;C3854129";FALSE;  12;hf symptom unchanged
 824;hf symptoms and signs;"C0018488;C0220912;C0220913;C0311392;C0683368;C1313497;C1457887;C1538440;C3273279";FALSE;  12;hf symptoms and signs
 824;history of hf hospitalization;"C0018488;C0551577;C1313497;C1538440;C3273279";FALSE;  12;history of hf hospitalization
 824;hf  total;"C0018488;C0439175;C0439810;C1313497;C1538440;C3273279";FALSE;  12;hf total
 824;hosp . for hf;"C0018488;C1313497;C1538440;C3273279";FALSE;  12;hosp for hf
 824;hospitalization for hf previous year  ( % );"C0018488;C0019993;C0205156;C0439234;C0439508;C1313497;C1538440;C1552607;C3273279";FALSE;  12;hospitalization for hf previous year
 824;hospitalized hf;"C0018488;C0701159;C1313497;C1538440;C3273279";FALSE;  12;hospitalized hf
 824;hospitalized hf !;"C0018488;C0701159;C1313497;C1538440;C3273279";FALSE;  12;hospitalized hf
 824;hosp . worsening hf;"C0018488;C0332271;C1313497;C1457868;C1538440;C1546960;C3273279";FALSE;  12;hosp worsening hf
 824;ischemic hf etiology;"C0015127;C0018488;C0475224;C1313497;C1314792;C1524003;C1538440;C3273279";FALSE;  12;ischemic hf etiology
 824;ischemic hf  % ( n );"C0018488;C0475224;C1313497;C1538440;C3273279";FALSE;  12;ischemic hf n
 824;new hf medication;"C0013227;C0018488;C0205314;C1313497;C1538440;C3244316;C3273279;C4284232";FALSE;  12;new hf medication
 824;no hx of hf ( n = $nmbr$ );"C0018488;C0262926;C1313497;C1538440;C3273279;C3814444";FALSE;  12;no hx of hf n $nmbr$
 824;no prior hf hospitalization ( n   = $nmbr$  $nmbr$ );"C0018488;C0019993;C0332152;C1313497;C1538440;C2826257;C3273279";FALSE;  12;no prior hf hospitalization n $nmbr$ $nmbr$
 824;no prior hf n = $nmbr$;"C0018488;C0332152;C1313497;C1538440;C2826257;C3273279";FALSE;  12;no prior hf n $nmbr$
 824;no prior hf ( n = $nmbr$  $nmbr$ );"C0018488;C0332152;C1313497;C1538440;C2826257;C3273279";FALSE;  12;no prior hf n $nmbr$ $nmbr$
 824;pharmacological therapy for hf;"C0013217;C0018488;C1313497;C1538440;C3273279";FALSE;  12;pharmacological therapy for hf
 824;previous hf;"C0018488;C0205156;C1313497;C1538440;C1552607;C3273279";FALSE;  12;previous hf
 824;previous hf hospitalization  n ( % );"C0018488;C0019993;C0205156;C1313497;C1538440;C1552607;C3273279";FALSE;  12;previous hf hospitalization n
 824;prior hf n = $nmbr$;"C0018488;C0332152;C1313497;C1538440;C2826257;C3273279";FALSE;  12;prior hf n $nmbr$
 824;prior hf ( n = $nmbr$  $nmbr$ );"C0018488;C0332152;C1313497;C1538440;C2826257;C3273279";FALSE;  12;prior hf n $nmbr$ $nmbr$
 821;hdl - c  mmol / l  mean ( sd );"C0444504;C1532563;C2347634;C2348143;C2699239;C3715113";NA;NA;hdl c mmol l mean sd
 821;hdl - c  mmol / l;"C1532563;C3715113";NA;NA;hdl c mmol l
 821;hdl - c;C3715113;NA;NA;hdl c
 821;hdl *;C3715113;NA;NA;hdl
 821;hdl ( mmol / l );"C1532563;C3715113";NA;NA;hdl mmol l
 821;hdl $nmbr$ - c;C3715113;NA;NA;hdl $nmbr$ c
 821;hdl $nmbr$;C3715113;NA;NA;hdl $nmbr$
 821;hdl;C3715113;NA;NA;hdl
 821;baseline non - hdl - ca;"C0168634;C1442488;C1518422;C3715113;C3887642";NA;NA;baseline non hdl ca
 821;baseline hdl - c in $nmbr$ classes;"C0168634;C0456387;C1442488;C1518526;C1705943;C3715113;C4019422";NA;NA;baseline hdl c in $nmbr$ classes
 821;baseline hdl - c;"C0168634;C1442488;C3715113";NA;NA;baseline hdl c
 820;with highest hba $nmbr$ cc;"C0008318;C0019016;C1522410;C1825777;C3538758;C3538933";NA;NA;with highest hba $nmbr$ cc
 820;week $nmbr$ hba $nmbr$ c  mean ( s . e . );"C0019016;C0332174;C0439230;C0444504;C1825777;C2347634;C2348143;C3538758";NA;NA;week $nmbr$ hba $nmbr$ c mean s e
 820;subpopulation analyses according to baseline hba $nmbr$ c;"C0002778;C0019016;C0168634;C0441837;C0680240;C0936012;C1442488;C1524024;C1825777;C3538758";NA;NA;subpopulation analyses according to baseline hba $nmbr$ c
 820;subgroup analysis : change from baseline in hba $nmbr$ c at week $nmbr$ per baseline hba $nmbr$ c category;"C0019016;C0168634;C0332174;C0392747;C0439230;C0443172;C0683312;C1442488;C1705241;C1825777;C2986480;C3538758;C3889287;C4319952";NA;NA;subgroup analysis change from baseline in hba $nmbr$ c at week $nmbr$ per baseline hba $nmbr$ c category
 820;screening hba $nmbr$ c ( % );"C0019016;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C1825777;C2348164;C3538758";NA;NA;screening hba $nmbr$ c
 820;qualifying hba $nmbr$ c ( % );"C0019016;C1514624;C1825777;C3538758";NA;NA;qualifying hba $nmbr$ c
 820;proportion ( $nmbr$ % ci ) adjusted for baseline hba $nmbr$ c  %;"C0008107;C0019016;C0168634;C0456081;C1442488;C1709707;C1825777;C3259781;C3538758";NA;NA;proportion $nmbr$ ci adjusted for baseline hba $nmbr$ c
 820;mean ± s . d . hba $nmbr$ c;"C0019016;C0444504;C1825777;C2347634;C2348143;C3538758";NA;NA;mean s d hba $nmbr$ c
 820;mean hba $nmbr$ c ± s . d .  %;"C0019016;C0444504;C1825777;C2347634;C2348143;C3538758";NA;NA;mean hba $nmbr$ c s d
 820;mean hba $nmbr$ c  %;"C0019016;C0444504;C1825777;C2347634;C2348143;C3538758";NA;NA;mean hba $nmbr$ c
 820;mean ( sd ) hba $nmbr$ c level  %;"C0019016;C0441889;C0444504;C0456079;C1547707;C1825777;C2347634;C2348143;C2699239;C2946261;C3538758";NA;NA;mean sd hba $nmbr$ c level
 820;mean ( s . d . ) baseline hba $nmbr$ c  %;"C0019016;C0168634;C0444504;C1442488;C1825777;C2347634;C2348143;C3538758";NA;NA;mean s d baseline hba $nmbr$ c
 820;hba „ ( % );"C0019016;C1825777;C3538758";NA;NA;hba
 820;hba ] c ( mmol / mol );"C0019016;C1825777;C3538758;C3829066";NA;NA;hba c mmol mol
 820;hba $nmbr$ ca  % ( mmol / mol );"C0019016;C1825777;C3538758;C3829066;C3887642";NA;NA;hba $nmbr$ ca mmol mol
 820;hba $nmbr$ c ≤ $nmbr$ . $nmbr$ % without gi adverse reactions;"C0019016;C0559546;C1708130;C1825777;C3538758;C3539617;C4050121";NA;NA;hba $nmbr$ c $nmbr$ $nmbr$ without gi adverse reactions
 820;hba $nmbr$ c ≤ $nmbr$ . $nmbr$ %;"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c $nmbr$ $nmbr$
 820;hba $nmbr$ c   baseline ( % );"C0019016;C0168634;C1442488;C1825777;C3538758";NA;NA;hba $nmbr$ c baseline
 820;hba $nmbr$ c   at randomization;"C0019016;C0034656;C1825777;C3538758";NA;NA;hba $nmbr$ c at randomization
 820;hba $nmbr$ c   ( mmol / mol );"C0019016;C1825777;C3538758;C3829066";NA;NA;hba $nmbr$ c mmol mol
 820;hba $nmbr$ c   ( % );"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c
 820;hba $nmbr$ c subgroups;"C0019016;C1079230;C1825777;C3538758";NA;NA;hba $nmbr$ c subgroups
 820;hba $nmbr$ c strata;"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c strata
 820;hba $nmbr$ c levels;"C0019016;C0441889;C1825777;C3538758";NA;NA;hba $nmbr$ c levels
 820;hba $nmbr$ c in patients with baseline hba $nmbr$ c < $nmbr$ % ( < $nmbr$ mmol / l )  % [ mmol / mol ]  la  n baseline ( sd ) adjusted mean change ( $nmbr$ % ci ) placebo - subtracted change ( se );"C0008107;C0019016;C0023031;C0023749;C0027960;C0030705;C0032042;C0036919;C0168634;C0230347;C0324740;C0392747;C0439189;C0443172;C0444504;C0456081;C1442488;C1456781;C1696465;C1705241;C1706408;C1719767;C1824986;C1825777;C1960955;C2346906;C2347634;C2348143;C2348589;C2699239;C3259781;C3538758;C3665593;C4319952;C4553351";NA;NA;hba $nmbr$ c in patients with baseline hba $nmbr$ c $nmbr$ $nmbr$ mmol l mmol mol la n baseline sd adjusted mean change $nmbr$ ci placebo subtracted change se
 820;hba $nmbr$ c distribution at baseline  n ( % );"C0019016;C0168634;C0520511;C1442488;C1704711;C1825777;C3538758";NA;NA;hba $nmbr$ c distribution at baseline n
 820;hba $nmbr$ c distribution at baseline;"C0019016;C0168634;C0520511;C1442488;C1704711;C1825777;C3538758";NA;NA;hba $nmbr$ c distribution at baseline
 820;hba $nmbr$ c distribution;"C0019016;C0520511;C1704711;C1825777;C3538758";NA;NA;hba $nmbr$ c distribution
 820;hba $nmbr$ c category  n ( % );"C0019016;C0683312;C1825777;C3538758;C3889287";NA;NA;hba $nmbr$ c category n
 617;the metabolic syndrome ^;C0524620;NA;NA;the metabolic syndrome
 820;hba $nmbr$ c category;"C0019016;C0683312;C1825777;C3538758;C3889287";NA;NA;hba $nmbr$ c category
 820;hba $nmbr$ c categories  n ( % );"C0019016;C0683312;C1825777;C3538758";NA;NA;hba $nmbr$ c categories n
 820;hba $nmbr$ c at week $nmbr$;"C0019016;C0332174;C0439230;C1825777;C3538758";NA;NA;hba $nmbr$ c at week $nmbr$
 820;hba $nmbr$ c at baseline :;"C0019016;C0168634;C1442488;C1825777;C3538758";NA;NA;hba $nmbr$ c at baseline
 820;hba $nmbr$ c at baseline  %;"C0019016;C0168634;C1442488;C1825777;C3538758";NA;NA;hba $nmbr$ c at baseline
 820;hba $nmbr$ c at baseline;"C0019016;C0168634;C1442488;C1825777;C3538758";NA;NA;hba $nmbr$ c at baseline
 820;hba $nmbr$ c at $nmbr$ weeks *;"C0019016;C0439230;C1825777;C3538758";NA;NA;hba $nmbr$ c at $nmbr$ weeks
 820;hba $nmbr$ c \n;"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c \n
 820;hba $nmbr$ c > = $nmbr$ %;"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c $nmbr$
 820;hba $nmbr$ c > $nmbr$ · $nmbr$ %;"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c $nmbr$ $nmbr$
 820;hba $nmbr$ c > $nmbr$ . $nmbr$ %;"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c $nmbr$ $nmbr$
 820;hba $nmbr$ c > $nmbr$ % level;"C0019016;C0441889;C0456079;C1547707;C1825777;C2946261;C3538758";NA;NA;hba $nmbr$ c $nmbr$ level
 820;hba $nmbr$ c > $nmbr$ % ( n $nmbr$ $nmbr$ );"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c $nmbr$ n $nmbr$ $nmbr$
 820;hba $nmbr$ c > $nmbr$ %;"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c $nmbr$
 820;hba $nmbr$ c < = $nmbr$ % ( n $nmbr$ $nmbr$ );"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c $nmbr$ n $nmbr$ $nmbr$
 820;hba $nmbr$ c < = $nmbr$ %;"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c $nmbr$
 820;hba $nmbr$ c < $nmbr$ . $nmbr$ %;"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c $nmbr$ $nmbr$
 820;hba $nmbr$ c < $nmbr$ % level;"C0019016;C0441889;C0456079;C1547707;C1825777;C2946261;C3538758";NA;NA;hba $nmbr$ c $nmbr$ level
 820;hba $nmbr$ c < $nmbr$ % ( n - $nmbr$ );"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c $nmbr$ n $nmbr$
 820;hba $nmbr$ c < $nmbr$ %;"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c $nmbr$
 820;hba $nmbr$ c ( sd )  %;"C0019016;C1825777;C2699239;C3538758";NA;NA;hba $nmbr$ c sd
 820;hba $nmbr$ c ( n );"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c n
 820;hba $nmbr$ c ( mmol / mol );"C0019016;C1825777;C3538758;C3829066";NA;NA;hba $nmbr$ c mmol mol
 820;hba $nmbr$ c ( change from baseline );"C0019016;C0168634;C0392747;C0443172;C1442488;C1705241;C1825777;C3538758;C4319952";NA;NA;hba $nmbr$ c change from baseline
 820;hba $nmbr$ c ( % patients < $nmbr$ . $nmbr$ % );"C0019016;C0030705;C1825777;C3538758";NA;NA;hba $nmbr$ c patients $nmbr$ $nmbr$
 820;hemoglobin a    ( % );C0019016;FALSE;2074;hemoglobin a
 820;hba $nmbr$ c ( % ) *;"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c
 820;hba $nmbr$ c ( % )  mean ( sd );"C0019016;C0444504;C1825777;C2347634;C2348143;C2699239;C3538758";NA;NA;hba $nmbr$ c mean sd
 820;hba $nmbr$ c ( % );"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c
 820;hba $nmbr$ c % ( range );"C0019016;C1514721;C1825777;C2348147;C3538758;C3542016";NA;NA;hba $nmbr$ c range
 820;hba $nmbr$ c $nmbr$ weeks;"C0019016;C0439230;C1825777;C3538758";NA;NA;hba $nmbr$ c $nmbr$ weeks
 820;hba $nmbr$ c $nmbr$ - < = $nmbr$ %;"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c $nmbr$ $nmbr$
 820;hba $nmbr$ c $nmbr$ % - < $nmbr$ % ( n - $nmbr$ );"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c $nmbr$ $nmbr$ n $nmbr$
 820;hba $nmbr$ c $ $nmbr$ . $nmbr$ % ( $nmbr$ mmol / mol );"C0019016;C1825777;C3538758;C3829066";NA;NA;hba $nmbr$ c $ $nmbr$ $nmbr$ $nmbr$ mmol mol
 820;hba $nmbr$ c  n;"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c n
 820;hba $nmbr$ c  mmol / mole;"C0019016;C1825777;C3538758;C3829066";NA;NA;hba $nmbr$ c mmol mole
 820;hba $nmbr$ c  mmol / mold;"C0019016;C0369241;C0439190;C1825777;C3538758";NA;NA;hba $nmbr$ c mmol mold
 820;hba $nmbr$ c  mmol / mol;"C0019016;C1825777;C3538758;C3829066";NA;NA;hba $nmbr$ c mmol mol
 820;hba $nmbr$ c  median ( sd )  %;"C0019016;C0549183;C0876920;C1825777;C2347635;C2348144;C2699239;C2939193;C3538758";NA;NA;hba $nmbr$ c median sd
 820;hba $nmbr$ c  mean = sd  %;"C0019016;C0444504;C1825777;C2347634;C2348143;C2699239;C3538758";NA;NA;hba $nmbr$ c mean sd
 820;hba $nmbr$ c  mean ( sd )  % [ mmol / mol ];"C0019016;C0444504;C1825777;C2347634;C2348143;C2699239;C3538758;C3829066";NA;NA;hba $nmbr$ c mean sd mmol mol
 820;hba $nmbr$ c  mean ( sd )  %;"C0019016;C0444504;C1825777;C2347634;C2348143;C2699239;C3538758";NA;NA;hba $nmbr$ c mean sd
 820;hba $nmbr$ c  mean ( sd );"C0019016;C0444504;C1825777;C2347634;C2348143;C2699239;C3538758";NA;NA;hba $nmbr$ c mean sd
 820;hba $nmbr$ c  baseline mean hba $nmbr$ c  % ( sd );"C0019016;C0168634;C0444504;C1442488;C1825777;C2347634;C2348143;C2699239;C3538758";NA;NA;hba $nmbr$ c baseline mean hba $nmbr$ c sd
 820;hba $nmbr$ c  > $nmbr$ . $nmbr$;"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c $nmbr$ $nmbr$
 820;hba $nmbr$ c  < $nmbr$ . $nmbr$;"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c $nmbr$ $nmbr$
 820;hba $nmbr$ c  ( % );"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c
 820;hba $nmbr$ c  % §;"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c
 820;hba $nmbr$ c  % d;"C0012358;C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c d
 820;hba $nmbr$ c  % *;"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c
 820;hba $nmbr$ c  % ( sd );"C0019016;C1825777;C2699239;C3538758";NA;NA;hba $nmbr$ c sd
 820;hba $nmbr$ c  % ( mean ± sd ) [ range ];"C0019016;C0444504;C1514721;C1825777;C2347634;C2348143;C2348147;C2699239;C3538758;C3542016";NA;NA;hba $nmbr$ c mean sd range
 820;hba $nmbr$ c  % ( mean $nmbr$ sd );"C0019016;C0444504;C1825777;C2347634;C2348143;C2699239;C3538758";NA;NA;hba $nmbr$ c mean $nmbr$ sd
 820;hba $nmbr$ c  %  n ( % ) b;"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c n b
 820;hba $nmbr$ c  %  mean ± sd;"C0019016;C0444504;C1825777;C2347634;C2348143;C2699239;C3538758";NA;NA;hba $nmbr$ c mean sd
 820;hba $nmbr$ c  %  mean ( sd ) b;"C0019016;C0444504;C1825777;C2347634;C2348143;C2699239;C3538758";NA;NA;hba $nmbr$ c mean sd b
 820;hba $nmbr$ c  %  mean ( sd );"C0019016;C0444504;C1825777;C2347634;C2348143;C2699239;C3538758";NA;NA;hba $nmbr$ c mean sd
 820;hba $nmbr$ c  %;"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c
 820;hba $nmbr$ c  $nmbr$ . $nmbr$ – $nmbr$ . $nmbr$;"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c $nmbr$ $nmbr$ $nmbr$ $nmbr$
 820;hba $nmbr$ c;"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c
 820;hba  c ( % );"C0019016;C1825777;C3538758";NA;NA;hba c
 820;hba  % $nmbr$ c;"C0019016;C1825777;C3538758";NA;NA;hba $nmbr$ c
 820;hba   ( % );"C0019016;C1825777;C3538758";NA;NA;hba
 820;change from baseline in hba $nmbr$ c ( % );"C0019016;C0168634;C0392747;C0443172;C1442488;C1705241;C1825777;C3538758;C4319952";NA;NA;change from baseline in hba $nmbr$ c
 820;baseline hba ^ c;"C0019016;C0168634;C1442488;C1825777;C3538758";NA;NA;baseline hba c
 820;baseline hba $nmbr$ c in $nmbr$ classes;"C0019016;C0168634;C0456387;C1442488;C1518526;C1705943;C1825777;C3538758;C4019422";NA;NA;baseline hba $nmbr$ c in $nmbr$ classes
 820;baseline hba $nmbr$ c concentration;"C0019016;C0086045;C0168634;C1442488;C1446561;C1825777;C3538758;C3827302";NA;NA;baseline hba $nmbr$ c concentration
 820;baseline hba $nmbr$ c ^;"C0019016;C0168634;C1442488;C1825777;C3538758";NA;NA;baseline hba $nmbr$ c
 820;baseline hba $nmbr$ c > $nmbr$ . $nmbr$ %;"C0019016;C0168634;C1442488;C1825777;C3538758";NA;NA;baseline hba $nmbr$ c $nmbr$ $nmbr$
 820;baseline hba $nmbr$ c < $nmbr$ . $nmbr$ %;"C0019016;C0168634;C1442488;C1825777;C3538758";NA;NA;baseline hba $nmbr$ c $nmbr$ $nmbr$
 820;baseline hba $nmbr$ c ( % );"C0019016;C0168634;C1442488;C1825777;C3538758";NA;NA;baseline hba $nmbr$ c
 820;baseline hba $nmbr$ c  n ( % );"C0019016;C0168634;C1442488;C1825777;C3538758";NA;NA;baseline hba $nmbr$ c n
 820;baseline hba $nmbr$ c  mean ( s . e . );"C0019016;C0168634;C0444504;C1442488;C1825777;C2347634;C2348143;C3538758";NA;NA;baseline hba $nmbr$ c mean s e
 820;baseline hba $nmbr$ c  %;"C0019016;C0168634;C1442488;C1825777;C3538758";NA;NA;baseline hba $nmbr$ c
 820;baseline hba $nmbr$ c;"C0019016;C0168634;C1442488;C1825777;C3538758";NA;NA;baseline hba $nmbr$ c
 820;any hba $nmbr$ c;"C0019016;C1825777;C3538758";NA;NA;any hba $nmbr$ c
 820;% hba $nmbr$ c ( mmol / mol );"C0019016;C1825777;C3538758;C3829066";NA;NA;hba $nmbr$ c mmol mol
 820;$nmbr$ % < hba $nmbr$ c < = $nmbr$ % ( n $nmbr$ $nmbr$ );"C0019016;C1825777;C3538758";NA;NA;$nmbr$ hba $nmbr$ c $nmbr$ n $nmbr$ $nmbr$
 820;$nmbr$ % < hba $nmbr$ c < = $nmbr$ %;"C0019016;C1825777;C3538758";NA;NA;$nmbr$ hba $nmbr$ c $nmbr$
 -10;bisphosphonates;"C0012544;C3541401";NA;NA;bisphosphonates
 818;isolated impaired glucose tolerance — no .;"C0205409;C0271650;C1548221";NA;NA;isolated impaired glucose tolerance no
 818;isolated igt;"C0205409;C1548221";NA;NA;isolated igt
 817;vasodilator therapy;"C0039798;C0042402;C0087111;C1363945;C3537240";NA;NA;vasodilator therapy
 817;vasodilator;"C0042402;C3537240";NA;NA;vasodilator
 817;other vasodilators §;C0042402;NA;NA;other vasodilators
 817;other vasodilator;"C0042402;C3537240";NA;NA;other vasodilator
 817;iv vasodilator;"C0022326;C0042402;C3537240;C4265176";NA;NA;iv vasodilator
 817;both iv vasodilator and inotrope;"C0022326;C0042402;C1258199;C3537240;C4265176";NA;NA;both iv vasodilator and inotrope
 816;non - ischaemic dilated cardiomyopathy;"C1518422;C1960867";NA;NA;non ischaemic dilated cardiomyopathy
 816;ischaemic dilated cardiomyopathy;C1960867;NA;NA;ischaemic dilated cardiomyopathy
 816;hypertrophic cardiomyopathy;"C0007194;C4551472";NA;NA;hypertrophic cardiomyopathy
 816;dilated cardiomyopathy;"C0007193;C2984282";NA;NA;dilated cardiomyopathy
 816;combined cardiac failure  cardiomyopathy or other cardiac disorders;"C0018799;C0018801;C0018802;C0205195;C0878544";NA;NA;combined cardiac failure cardiomyopathy or other cardiac disorders
 816;cardiomyopathy;C0878544;NA;NA;cardiomyopathy
 815;rhabdomyolysis or myopathy;"C0026848;C0035410;C4552660";NA;NA;rhabdomyolysis or myopathy
 815;rhabdomyolysis ( n = $nmbr$ );"C0035410;C4552660";NA;NA;rhabdomyolysis n $nmbr$
 815;rhabdomyolysis  myopathy  or myalgia with ck elevation > $nmbr$ x uln;"C0009212;C0010287;C0026848;C0035410;C0231528;C0439775;C0702240;C1519815;C1872855;C4552646;C4552660";NA;NA;rhabdomyolysis myopathy or myalgia with ck elevation $nmbr$ x uln
 815;rhabdomyolysis  myopathy  or elevated creatine phosphokinase > $nmbr$ x upper limit of normal ( n = $nmbr$ );"C0010286;C0026848;C0035410;C0205250;C1427255;C1519815;C3163633;C4552660";NA;NA;rhabdomyolysis myopathy or elevated creatine phosphokinase $nmbr$ x upper limit of normal n $nmbr$
 815;rhabdomyolysis;"C0035410;C4552660";NA;NA;rhabdomyolysis
 818;isolated upper gastrointestinal disease behavior  n ( % );"C0004927;C0205409;C0810300;C1548221;C2707008";FALSE;1927;isolated upper gastrointestinal disease behavior n
 818;isolated pulmonary embolism;"C0034065;C0205409;C1548221";FALSE; 630;isolated pulmonary embolism
 814;pde $nmbr$ inhibitor monotherapy;C0031638;NA;NA;pde $nmbr$ inhibitor monotherapy
 814;monoamine oxidase b inhibitors;"C2917290;C3653412";NA;NA;monoamine oxidase b inhibitors
 814;era and pde $nmbr$ inhibitors;"C0031638;C1521863;C3495919";NA;NA;era and pde $nmbr$ inhibitors
 814;a - glucosidase inhibitors ' $nmbr$;C1512211;NA;NA;a glucosidase inhibitors $nmbr$
 814;a - glucosidase inhibitors;C1512211;NA;NA;a glucosidase inhibitors
 814;a - glucosidase inhibitor;C1512211;NA;NA;a glucosidase inhibitor
 813;sglt - $nmbr$ inhibitors ^;C3665045;NA;NA;sglt $nmbr$ inhibitors
 813;renin inhibitors;"C2917241;C3653375";NA;NA;renin inhibitors
 813;renin inhibitor ( e . g . aliskerin );"C1960108;C3537174;C4521920";NA;NA;renin inhibitor e g aliskerin
 813;renin inhibitor;"C1960108;C3537174;C4521920";NA;NA;renin inhibitor
 813;renin - angiotensin inhibitors;"C0003018;C2917241;C3653375;C4521302";NA;NA;renin angiotensin inhibitors
 813;platelet aggregation inhibitors excluding heparin;"C0019134;C0032177;C0332196;C0770546;C2828389";NA;NA;platelet aggregation inhibitors excluding heparin
 813;platelet aggregation inhibitors  n ( % );C0032177;NA;NA;platelet aggregation inhibitors n
 812;renin – angiotensin system inhibitor;"C0035096;C1999216;C2984247";NA;NA;renin angiotensin system inhibitor
 812;renin - angiotensin system inhibitor use;"C0035096;C0042153;C0457083;C1947944;C1999216;C2984247";NA;NA;renin angiotensin system inhibitor use
 812;raas inhibitor use;"C0042153;C0457083;C1947944;C1999216";NA;NA;raas inhibitor use
 812;raas inhibitor;C1999216;NA;NA;raas inhibitor
 812;p $nmbr$ y $nmbr$ inhibitor maintenance;"C0024501;C0369773;C1999216;C2603361";NA;NA;p $nmbr$ y $nmbr$ inhibitor maintenance
 812;p $nmbr$ y $nmbr$ inhibitor loading dos;"C0369773;C1428722;C1708715;C1999216;C2603361";NA;NA;p $nmbr$ y $nmbr$ inhibitor loading dos
 812;p $nmbr$ y $nmbr$ inhibitor;"C0369773;C1999216;C2603361";NA;NA;p $nmbr$ y $nmbr$ inhibitor
 812;other sglt - $nmbr$ inhibitor;C1999216;NA;NA;other sglt $nmbr$ inhibitor
 812;inhibitor;C1999216;NA;NA;inhibitor
 812;gpifo ' llia inhibitor use before angography;"C0042153;C0457083;C1947944;C1999216";NA;NA;gpifo llia inhibitor use before angography
 812;gpifeellla inhibitor use before angography;"C0042153;C0457083;C1947944;C1999216";NA;NA;gpifeellla inhibitor use before angography
 811;use of ace inhibitor;"C0003015;C1524063;C4541021";NA;NA;use of ace inhibitor
 811;current use of an ace inhibitor;"C0003015;C0521116;C1524063;C1705970;C4541021";NA;NA;current use of an ace inhibitor
 811;angiotensin - converting enzyme inhibitors ^;"C0003015;C2757044";NA;NA;angiotensin converting enzyme inhibitors
 811;angiotensin - converting enzyme inhibitors;"C0003015;C2757044";NA;NA;angiotensin converting enzyme inhibitors
 811;angiotensin - converting enzyme inhibitor / angiotensin receptor blocker;"C0003015;C0597357;C2757044;C3536837;C4541021";NA;NA;angiotensin converting enzyme inhibitor angiotensin receptor blocker
 811;angiotensin - converting enzyme inhibitor;"C0003015;C2757044;C3536837;C4541021";NA;NA;angiotensin converting enzyme inhibitor
 811;angiotensin - converting - enzyme inhibitor or angiotensin -;"C0003015;C0003018;C2757044;C3536837;C4521302;C4541021";NA;NA;angiotensin converting enzyme inhibitor or angiotensin
 811;angiotensin - converting - enzyme inhibitor;"C0003015;C2757044;C3536837;C4541021";NA;NA;angiotensin converting enzyme inhibitor
 811;ace inhibitors through hospital discharge or day $nmbr$ — %;"C0003015;C0332173;C0439228;C0439505;C0586003";NA;NA;ace inhibitors through hospital discharge or day $nmbr$
 811;ace inhibitors / sartans;"C0003015;C1563745";NA;NA;ace inhibitors sartans
 811;ace inhibitors;C0003015;NA;NA;ace inhibitors
 811;ace inhibitor — no . ( % );"C0003015;C4541021";NA;NA;ace inhibitor no
 811;ace inhibitor use ( % );"C0003015;C0042153;C0457083;C1947944;C4541021";NA;NA;ace inhibitor use
 811;ace inhibitor or arb use;"C0003015;C0042153;C0457083;C1947944;C3888198;C4541021";NA;NA;ace inhibitor or arb use
 811;ace inhibitor or angiotensin ii receptor;"C0003011;C0003015;C4541021";NA;NA;ace inhibitor or angiotensin ii receptor
 811;ace inhibitor or angiotensin - receptor blocker — no . / total no . ( % );"C0003015;C0034787;C0439175;C0439810;C1622222;C4541021";NA;NA;ace inhibitor or angiotensin receptor blocker no total no
 811;ace inhibitor monotherapy;"C0003015;C4541021";NA;NA;ace inhibitor monotherapy
 811;ace inhibitor  n ( % );"C0003015;C4541021";NA;NA;ace inhibitor n
 811;ace inhibitor  %;"C0003015;C4541021";NA;NA;ace inhibitor
 811;ace inhibitor;"C0003015;C4541021";NA;NA;ace inhibitor
 811;ace - inhibitors  n ( % );C0003015;NA;NA;ace inhibitors n
 811;ace - inhibitors;C0003015;NA;NA;ace inhibitors
 811;ace - inhibitor use;"C0003015;C0042153;C0457083;C1947944;C4541021";NA;NA;ace inhibitor use
 810;p - gp inhibitor;C3898062;NA;NA;p gp inhibitor
 810;gp llb / llla inhibitors;"C0243077;C1705010;C3811116";NA;NA;gp llb llla inhibitors
 809;tnf inhibitors;"C0243077;C1448177";NA;NA;tnf inhibitors
 809;raas inhibitors;C0243077;NA;NA;raas inhibitors
 809;non - tnf inhibitors;"C0243077;C1448177;C1518422";NA;NA;non tnf inhibitors
 809;no . of previous tne inhibitors;"C0205156;C0243077;C1552607;C3896585";NA;NA;no of previous tne inhibitors
 808;no ilb / iiia inhibitors;"C0243077;C4697913";NA;NA;no ilb iiia inhibitors
 808;ilb / iiia inhibitors;"C0243077;C4697913";NA;NA;ilb iiia inhibitors
 808;ijb ^;NA;NA;NA;ijb
 808;gpiib / iiia receptor inhibitor;"C0016011;C0597357;C1999216";NA;NA;gpiib iiia receptor inhibitor
 808;gpiib - iiia inhibitors;"C0016011;C0243077";NA;NA;gpiib iiia inhibitors
 808;gp iib / iiia inhibitors;"C0016011;C0243077";NA;NA;gp iib iiia inhibitors
 808;gp iib / iiia inhibitor used;"C0016011;C1273517;C1999216";NA;NA;gp iib iiia inhibitor used
 808;gp iib / iiia inhibitor before pci — no . ( % );"C0016011;C1999216;C4049621";NA;NA;gp iib iiia inhibitor before pci no
 808;glycoprotein iib / iiia inhibitort;C0016011;NA;NA;glycoprotein iib iiia inhibitort
 808;glycoprotein iib / iiia inhibitors;"C0016011;C0243077";NA;NA;glycoprotein iib iiia inhibitors
 808;glycoprotein iib / iiia inhibitor;"C0016011;C1999216";NA;NA;glycoprotein iib iiia inhibitor
 808;bail ‐ out use of glycoprotein iib / iiia inhibitors;"C0016011;C0175673;C0243077;C1524063";NA;NA;bail out use of glycoprotein iib iiia inhibitors
 807;potent phosphorylated glycoprotein inhibitor use;"C0017968;C0042153;C0457083;C1947944;C1999216;C3245505";NA;NA;potent phosphorylated glycoprotein inhibitor use
 807;glycoprotein iib / iiiareceptorinhibitor;C0017968;NA;NA;glycoprotein iib iiiareceptorinhibitor
 806;received first loading dose;"C0205435;C1279901;C1514756;C3714444";NA;NA;received first loading dose
 806;no ipst ( n = $nmbr$  $nmbr$ );NA;NA;NA;no ipst n $nmbr$ $nmbr$
 806;no ipst;NA;NA;NA;no ipst
 806;missing data initial diagnosis — no .;"C0011900;C0205265;C1279901;C1555582;C1704338;C1704656;C1705685;C4684714";NA;NA;missing data initial diagnosis no
 806;ipst ( n = $nmbr$ );NA;NA;NA;ipst n $nmbr$
 806;ipst;NA;NA;NA;ipst
 806;initial timi flow grade $nmbr$;"C0205265;C0441800;C0919553;C1279901;C1555582;C1705685;C3244287;C3272266";NA;NA;initial timi flow grade $nmbr$
 806;initial timi flow;"C0205265;C1279901;C1555582;C1705685;C3272266";NA;NA;initial timi flow
 806;initial heparin — no . ( % ) §;"C0019134;C0205265;C0770546;C1279901;C1555582;C1705685";NA;NA;initial heparin no
 806;initial diagnosis — no . ( % );"C0011900;C0205265;C1279901;C1555582;C1704338;C1704656;C1705685";NA;NA;initial diagnosis no
 806;first loading dose;"C0205435;C1279901;C3714444";NA;NA;first loading dose
 806;first - recorded event  no . ( and % ) of patients;"C0030705;C0034869;C0205435;C0441471;C1279901;C3853788;C4019010";NA;NA;first recorded event no and of patients
 806;first - generation stentt;"C0079411;C0205435;C1279901;C3146294";NA;NA;first generation stentt
 806;first ( n = $nmbr$ );"C0205435;C1279901";NA;NA;first n $nmbr$
 806;criterion reached first  n ( % );"C0205435;C0243161;C1279901;C2584321;C4321250";NA;NA;criterion reached first n
 806;components of the first cid;"C0205435;C0449432;C1279901;C1707433";NA;NA;components of the first cid
 805;micral test result;"C0456984;C0587081";NA;NA;micral test result
 805;labs at randomization;"C0034656;C0587081";NA;NA;labs at randomization
 805;laboratory findings;C0587081;NA;NA;laboratory findings
 805;> $nmbr$ microg / l;NA;NA;NA;$nmbr$ microg l
 805;< $nmbr$ microg / l;NA;NA;NA;$nmbr$ microg l
 804;tirofiban ( n = $nmbr$ );C0247025;NA;NA;tirofiban n $nmbr$
 804;irofiban;NA;NA;NA;irofiban
 804;heparin ± tirofiban ( n = $nmbr$ );"C0019134;C0247025;C0770546";NA;NA;heparin tirofiban n $nmbr$
 804;heparin plus tirofiban ( n = $nmbr$ );"C0019134;C0247025;C0332287;C0770546";NA;NA;heparin plus tirofiban n $nmbr$
 804;heparin + tirofiban ( n = $nmbr$ );"C0019134;C0247025;C0770546";NA;NA;heparin tirofiban n $nmbr$
 803;simvastatin $nmbr$ mg plus fenofibrate $nmbr$ mg ( n = $nmbr$ /;"C0033228;C0074554;C0332287;C1319635";NA;NA;simvastatin $nmbr$ mg plus fenofibrate $nmbr$ mg n $nmbr$
 803;fenofibrate ( n = $nmbr$ );C0033228;NA;NA;fenofibrate n $nmbr$
 802;non - fibrin - specific;"C0015982;C0205370";NA;NA;non fibrin specific
 802;fibrin - specilic;C0015982;NA;NA;fibrin specilic
 802;fibrin - specific;"C0015982;C0205369;C1552740";NA;NA;fibrin specific
 801;minority;C0026192;NA;NA;minority
 801;ethnic minority group — no . ( % );"C0015031;C0026192;C0680174;C1879937";NA;NA;ethnic minority group no
 800;evening mealb;C0587117;NA;NA;evening mealb
 800;evening;C0587117;NA;NA;evening
 799;selexipag patients / events n;"C0030705;C0441471;C2000145;C3541888";NA;NA;selexipag patients events n
 799;selexipag ( n = $nmbr$ );C2000145;NA;NA;selexipag n $nmbr$
 799;selexipag;C2000145;NA;NA;selexipag
 798;theophylline use at screening;"C0220908;C0220909;C0241361;C1698960;C1710031;C1710032;C1710477;C2348164";NA;NA;theophylline use at screening
 798;screening visit;"C0220908;C0220909;C0545082;C1512346;C1698960;C1710031;C1710032;C1710477;C2348164;C2826704";NA;NA;screening visit
 798;screening and baseline lung function characteristics;"C0035245;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C4684572";NA;NA;screening and baseline lung function characteristics
 798;screening ( visit $nmbr$ );"C0220908;C0220909;C0545082;C1512346;C1698960;C1710031;C1710032;C1710477;C2348164;C2826704";NA;NA;screening visit $nmbr$
 798;screening  l;"C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164";NA;NA;screening l
 798;screening;"C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164";NA;NA;screening
 798;risk factor ( predefined ) for falling at screening  n ( % );"C0000921;C0035648;C0085639;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164";NA;NA;risk factor predefined for falling at screening n
 798;pre - bronchodilator screening;"C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C2599602";NA;NA;pre bronchodilator screening
 798;post - bronchodilator screening;"C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C2599594";NA;NA;post bronchodilator screening
 798;post - bronchodilator fev $nmbr$ at screening;"C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C2599594;C3714541";NA;NA;post bronchodilator fev $nmbr$ at screening
 798;patients with > $nmbr$ exacerbation requiring er visit or admission to hospital in the $nmbr$ months before screening;"C0184666;C0220908;C0220909;C0439231;C1512346;C1698960;C1710031;C1710032;C1710477;C2348164;C3810541;C3811131;C4086268";NA;NA;patients with $nmbr$ exacerbation requiring er visit or admission to hospital in the $nmbr$ months before screening
 798;patients with > $nmbr$ exacerbation requiring admission to hospital in the $nmbr$ months before screening;"C0019994;C0030673;C0220908;C0220909;C0439231;C1510665;C1698960;C1710031;C1710032;C1710477;C2348164;C4086268";NA;NA;patients with $nmbr$ exacerbation requiring admission to hospital in the $nmbr$ months before screening
 798;oad at screening  n ( % );"C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164";NA;NA;oad at screening n
 798;modified rankin scale at screening  $nmbr$ - $nmbr$;"C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C2984908;C3854213";NA;NA;modified rankin scale at screening $nmbr$ $nmbr$
 798;mean blood pressure at screening visit ( mm hg );"C0220908;C0220909;C0428886;C0439475;C0488053;C0545082;C1512346;C1698960;C1710031;C1710032;C1710477;C2348164;C2826704";NA;NA;mean blood pressure at screening visit mm hg
 798;lama use at screening  n ( % );"C0042153;C0220908;C0220909;C0457083;C0999593;C1416775;C1698960;C1710031;C1710032;C1710477;C1947944;C2348164";NA;NA;lama use at screening n
 798;lama use at screening;"C0042153;C0220908;C0220909;C0457083;C0999593;C1416775;C1698960;C1710031;C1710032;C1710477;C1947944;C2348164";NA;NA;lama use at screening
 798;laba use at screening  n ( % );"C0042153;C0220908;C0220909;C0457083;C1698960;C1710031;C1710032;C1710477;C1947944;C2348164";NA;NA;laba use at screening n
 798;laba use at screening;"C0042153;C0220908;C0220909;C0457083;C1698960;C1710031;C1710032;C1710477;C1947944;C2348164";NA;NA;laba use at screening
 798;fev $nmbr$   at screening ∗;"C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C3714541";NA;NA;fev $nmbr$ at screening
 798;devices for heart failure at screening visit;"C0018787;C0018801;C0018802;C0025078;C0025080;C0220819;C0220908;C0220909;C0231174;C0545082;C0680095;C0699733;C1512346;C1698960;C1710031;C1710032;C1710477;C2024216;C2348164;C2826704;C4554158";NA;NA;devices for heart failure at screening visit
 798;current smoker  n ( % ) post - bronchodilator screening;"C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C2599594;C3173209;C3241966";NA;NA;current smoker n post bronchodilator screening
 798;at screening;"C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164";NA;NA;at screening
 798;aspirin use before screening — no . { % );"C0004057;C0042153;C0220908;C0220909;C0457083;C1698960;C1710031;C1710032;C1710477;C1947944;C2348164";NA;NA;aspirin use before screening no
 798;> $nmbr$ per pl in $nmbr$ months before screening;"C0220908;C0220909;C0439231;C1698960;C1710031;C1710032;C1710477;C2348164;C3897966;C4049765";NA;NA;$nmbr$ per pl in $nmbr$ months before screening
 798;> $nmbr$ per pl at screening;"C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C3897966;C4049765";NA;NA;$nmbr$ per pl at screening
 617;syndrome  n ( % );C0039082;NA;NA;syndrome n
 798;> $nmbr$ at screening;"C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164";NA;NA;$nmbr$ at screening
 797;smokingb;NA;NA;NA;smokingb
 797;smoking habit  n ( % );C4505437;NA;NA;smoking habit n
 797;current cigarette smoking  no . ( % );"C0239059;C0521116;C0700219;C1705970";NA;NA;current cigarette smoking no
 797;current cigarette smoking;"C0239059;C0521116;C0700219;C1705970";NA;NA;current cigarette smoking
 797;cigarette smoking in the past year;"C0239059;C0700219;C4086728";NA;NA;cigarette smoking in the past year
 797;cigarette smoking  n ( % );"C0239059;C0700219";NA;NA;cigarette smoking n
 797;cigarette smoking;"C0239059;C0700219";NA;NA;cigarette smoking
 796;smoking status — no . { % );C1519386;NA;NA;smoking status no
 796;smoking status — no . ( % );C1519386;NA;NA;smoking status no
 796;smoking status at screening  n ( % );"C0037369;C0220908;C0220909;C0421330;C0453996;C1519386;C1698960;C1710031;C1710032;C1710477;C1881674;C2348164";NA;NA;smoking status at screening n
 796;smoking status at screening;"C0037369;C0220908;C0220909;C0421330;C0453996;C1519386;C1698960;C1710031;C1710032;C1710477;C1881674;C2348164";NA;NA;smoking status at screening
 796;smoking status . no . ( % );C1519386;NA;NA;smoking status no
 796;smoking status *;C1519386;NA;NA;smoking status
 796;smoking status ( ongoing ) ( n );"C0549178;C1519386";NA;NA;smoking status ongoing n
 796;smoking status ( % );C1519386;NA;NA;smoking status
 796;smoking status  no . ( % );C1519386;NA;NA;smoking status no
 796;smoking status  n [ % ] ®;C1519386;NA;NA;smoking status n
 796;smoking status  n ( % ) *;C1519386;NA;NA;smoking status n
 798;laba - inhaled glucocorticoid use at screening;"C0004048;C0017710;C0042153;C0220908;C0220909;C0457083;C1698960;C1710031;C1710032;C1710477;C1947944;C2348164";FALSE;2182;laba inhaled glucocorticoid use at screening
 796;cigarette smoking status;"C0239059;C0449438;C0677453;C0700219;C1519386;C1704760;C3890423";NA;NA;cigarette smoking status
 796;cigarette - smoking status — no . ( % );"C0239059;C0449438;C0677453;C0700219;C1519386;C1704760;C3890423";NA;NA;cigarette smoking status no
 796;cigarette - smoking status ( % );"C0239059;C0449438;C0677453;C0700219;C1519386;C1704760;C3890423";NA;NA;cigarette smoking status
 796;baseline smoking status;"C0168634;C1442488;C1519386";NA;NA;baseline smoking status
 -10;streptokinase;C0038418;NA;NA;streptokinase
 794;use of compression stockings  no . ( % );"C0038348;C1524063";NA;NA;use of compression stockings no
 794;compression stockings;C0038348;NA;NA;compression stockings
 793;no clinical or lesion rfs for st;"C0036056;C0205210;C0221198;C0341703;C1546698;C3272372";NA;NA;no clinical or lesion rfs for st
 793;durable clinical responseg;C0205210;NA;NA;durable clinical responseg
 793;durable clinical remissionh;C0205210;NA;NA;durable clinical remissionh
 793;clinical responsed;C0205210;NA;NA;clinical responsed
 793;clinical remissione;C0205210;NA;NA;clinical remissione
 793;clinical or lesion rf for st;"C0035448;C0036056;C0201660;C0205210;C0221198;C0748398;C1546698;C1547111;C3272372";NA;NA;clinical or lesion rf for st
 793;clinical details;"C0205210;C1522508";NA;NA;clinical details
 793;clinical criteria $nmbr$;"C0205210;C0243161";NA;NA;clinical criteria $nmbr$
 793;clinical and patient - reported characteristics at baseline and randomization;"C0034656;C0205210;C0588446;C4684572";NA;NA;clinical and patient reported characteristics at baseline and randomization
 793;clinical;C0205210;NA;NA;clinical
 793;any clinical or lesion rf for st;"C0035448;C0036056;C0201660;C0205210;C0221198;C0748398;C1546698;C1547111;C3272372";NA;NA;any clinical or lesion rf for st
 792;non - cortical;"C0001613;C0007776;C0022655;C1518422";NA;NA;non cortical
 792;cortical only;"C0001613;C0007776;C0022655;C0205171;C1720467";NA;NA;cortical only
 791;clinical endpoint;C2347784;NA;NA;clinical endpoint
 791;clinical dementia rating score;C4304227;NA;NA;clinical dementia rating score
 790;clinical presentation of vte at initial diagnosis — no . ( % );"C0011900;C0205265;C0630906;C1279901;C1555582;C1704338;C1704656;C1705685;C2708283";NA;NA;clinical presentation of vte at initial diagnosis no
 790;clinical presentation;C2708283;NA;NA;clinical presentation
 789;selected clinical characteristics — no . / total no . ( % );"C0439175;C0439810;C0683325;C1707391";NA;NA;selected clinical characteristics no total no
 789;selected clinical characteristics  n ( % );"C0683325;C1707391";NA;NA;selected clinical characteristics n
 789;selected clinical characteristics;"C0683325;C1707391";NA;NA;selected clinical characteristics
 789;other clinical characteristics;C0683325;NA;NA;other clinical characteristics
 789;demographics and clinical characteristics;"C0011298;C0683325;C1704791";NA;NA;demographics and clinical characteristics
 789;clinical characteristics ( % );C0683325;NA;NA;clinical characteristics
 789;clinical characteristics  n ( % );C0683325;NA;NA;clinical characteristics n
 789;clinical characteristics;C0683325;NA;NA;clinical characteristics
 788;timi clinically significant;"C0237881;C0750502;C1546944";NA;NA;timi clinically significant
 788;significant worsening in kccq clinical;"C0205210;C0237881;C0332271;C0750502;C1457868;C1546944;C1546960;C3476798";NA;NA;significant worsening in kccq clinical
 787;women ethnic origin;"C0015031;C0043210";NA;NA;women ethnic origin
 787;white ethnicity;"C0007457;C0015031;C0043157;C0220938;C0243103";NA;NA;white ethnicity
 787;white ethnic origin;"C0007457;C0015031;C0043157;C0220938";NA;NA;white ethnic origin
 787;while ethnic origin;C0015031;NA;NA;while ethnic origin
 787;sex ( male ) ethnic origin;"C0015031;C0086582";NA;NA;sex male ethnic origin
 787;race or ethnicity  n ( % );"C0015031;C0034510;C0243103;C1706779;C3853635";NA;NA;race or ethnicity n
 787;race or ethnicity;"C0015031;C0034510;C0243103;C1706779;C3853635";NA;NA;race or ethnicity
 787;race or ethnic origin;"C0015031;C0034510;C1706779;C3853635";NA;NA;race or ethnic origin
 787;race or ethnic group — no . { % ) ■ ' ( white;"C0007457;C0015031;C0034510;C0043157;C0220938;C1706779;C1879937;C3853635";NA;NA;race or ethnic group no white
 787;race or ethnic group — no . f;"C0015031;C0016327;C0034510;C1706779;C1879937;C3853635";NA;NA;race or ethnic group no f
 787;race or ethnic group — no . / total no . ( % ) f;"C0015031;C0016327;C0034510;C0439175;C0439810;C1706779;C1879937;C3853635";NA;NA;race or ethnic group no total no f
 787;race or ethnic group — no . ( % ) f;"C0015031;C0016327;C0034510;C1706779;C1879937;C3853635";NA;NA;race or ethnic group no f
 787;race or ethnic group ( % ) f;"C0015031;C0016327;C0034510;C0441840;C0680174;C1706779;C1879937;C3853635";NA;NA;race or ethnic group f
 787;race or ethnic group ( % );"C0015031;C0034510;C1706779;C1879937;C3853635";NA;NA;race or ethnic group
 787;race or ethnic group  n ( % ) *;"C0015031;C0034510;C0441848;C0680174;C1706779;C3853635";NA;NA;race or ethnic group n
 787;race or ethnic group;"C0015031;C0034510;C1706779;C1879937;C3853635";NA;NA;race or ethnic group
 787;race / ethnicity white;"C0007457;C0015031;C0034510;C0043157;C0220938;C0243103;C1706779;C3853635";NA;NA;race ethnicity white
 787;race / ethnicity n ( % );"C0015031;C0034510;C0243103;C1706779;C3853635";NA;NA;race ethnicity n
 787;race / ethnicity  no . ( % ) *;"C0015031;C0034510;C0243103;C1706779;C3853635";NA;NA;race ethnicity no
 787;race / ethnicity  no . ( % );"C0015031;C0034510;C0243103;C1706779;C3853635";NA;NA;race ethnicity no
 787;race / ethnicity  n ( % );"C0015031;C0034510;C0243103;C1706779;C3853635";NA;NA;race ethnicity n
 787;race / ethnicity  % white non - hispanic;"C0007457;C0015031;C0034510;C0043157;C0220938;C0243103;C1518422;C1518424;C1533020;C1533021;C1706779;C3853635";NA;NA;race ethnicity white non hispanic
 787;othery ethnicity  n ( % ) *;"C0015031;C0243103";NA;NA;othery ethnicity n
 787;othery ethnicity  n ( % );"C0015031;C0243103";NA;NA;othery ethnicity n
 787;male sex ( % ) race or ethnic group ( % ) f;"C0015031;C0016327;C0034510;C0086582;C0441840;C0680174;C1706779;C1879937;C3853635";NA;NA;male sex race or ethnic group f
 787;hispanic ethnicity  n ( % );"C0015031;C0086409;C0243103";NA;NA;hispanic ethnicity n
 787;hispanic ethnicity;"C0015031;C0086409;C0243103";NA;NA;hispanic ethnicity
 787;hispanic / latino ethnicity  n ( % );"C0015031;C0086409;C0086528;C0243103";NA;NA;hispanic latino ethnicity n
 787;hispanic / latino ethnicity;"C0015031;C0086409;C0086528;C0243103";NA;NA;hispanic latino ethnicity
 787;ethnieity;NA;NA;NA;ethnieity
 787;ethnicity t;"C0015031;C0243103";NA;NA;ethnicity t
 787;ethnicity - no . ( % );"C0015031;C0243103";NA;NA;ethnicity no
 787;ethnicity - - hispanic or latino;"C0015031;C0086409;C0086528;C0243103";NA;NA;ethnicity hispanic or latino
 787;ethnicity ( % );"C0015031;C0243103";NA;NA;ethnicity
 787;ethnicity $nmbr$ ';"C0015031;C0243103";NA;NA;ethnicity $nmbr$
 787;ethnicity  no . ( % );"C0015031;C0243103";NA;NA;ethnicity no
 787;ethnicity  n ( % ) b;"C0015031;C0243103";NA;NA;ethnicity n b
 787;ethnicity  n ( % ) :;"C0015031;C0243103";NA;NA;ethnicity n
 787;ethnicity  n ( % ) *;"C0015031;C0243103";NA;NA;ethnicity n
 787;ethnicity  n ( % );"C0015031;C0243103";NA;NA;ethnicity n
 787;ethnicity  hispanic / latino  n ( % );"C0015031;C0086409;C0086528;C0243103";NA;NA;ethnicity hispanic latino n
 787;ethnicity  %;"C0015031;C0243103";NA;NA;ethnicity
 787;ethnicity;"C0015031;C0243103";NA;NA;ethnicity
 787;ethnic origin white;"C0007457;C0015031;C0043157;C0220938";NA;NA;ethnic origin white
 787;ethnic origin *;C0015031;NA;NA;ethnic origin
 787;ethnic origin  n ( % );C0015031;NA;NA;ethnic origin n
 787;ethnic origin;C0015031;NA;NA;ethnic origin
 787;ethnic group — no . ( % ) ';"C0015031;C1879937";NA;NA;ethnic group no
 787;ethnic group ( % );"C0015031;C1879937";NA;NA;ethnic group
 787;ethnic group;"C0015031;C1879937";NA;NA;ethnic group
 787;ethnic background;C0015031;NA;NA;ethnic background
 787;age  mean ( sd )  y ethnicity  no . ( % );"C0001779;C0015031;C0243103;C0444504;C2347634;C2348143;C2699239";NA;NA;age mean sd y ethnicity no
   7;p - value ( ancova treatment difference ) a;"C0039798;C0087111;C0814908;C1522326;C1533734;C1705169;C1705241;C1705242;C1709380;C3538994;C3887704";NA;NA;p value ancova treatment difference a
   7;p - value $nmbr$;C1709380;NA;NA;p value $nmbr$
   7;p - value;C1709380;NA;NA;p value
 787;* plus - minus values are means 士 sd . race or ethnic group was self - determined . the body - mass index is the weight in kilograms divided by;"C0005893;C0005910;C0015031;C0034510;C0036595;C0042295;C0043100;C0332288;C0332849;C0439209;C0578022;C1305855;C1305866;C1704970;C1705104;C1706779;C1879937;C2699239;C3853635";NA;NA;plus minus values are means sd race or ethnic group was self determined the body mass index is the weight in kilograms divided by
 786;urti;NA;NA;NA;urti
 786;single vessel coronary artery disease †;C0581374;NA;NA;single vessel coronary artery disease
 786;single vessel coronary artery disease *;C0581374;NA;NA;single vessel coronary artery disease
 786;single vessel coronary artery disease $nmbr$;C0581374;NA;NA;single vessel coronary artery disease $nmbr$
 786;multi - vessel coronary artery disease;C1299432;NA;NA;multi vessel coronary artery disease
 786;ischemic coronary artery disease;C0852149;NA;NA;ischemic coronary artery disease
 786;history of coronary artery disease — no . { % );C1881055;NA;NA;history of coronary artery disease no
 786;history of coronary artery disease - n ( % );C1881055;NA;NA;history of coronary artery disease n
 786;history of coronary artery disease;C1881055;NA;NA;history of coronary artery disease
 786;coronar y artery disease;C0852949;NA;NA;coronar y artery disease
 786;coronaiy artery disease;C0852949;NA;NA;coronaiy artery disease
 785;non - lad artery;"C0003842;C0226004;C1518422";NA;NA;non lad artery
 785;lad artery;"C0003842;C0226004";NA;NA;lad artery
 785;imaged artery;"C0003842;C0226004;C1704254;C1704922;C3542466";NA;NA;imaged artery
 784;carrier ( n = $nmbr$ );"C0007294;C0560175;C1325398;C1706209;C3273162";NA;NA;carrier n $nmbr$
 784;apolipoprotein e carrier;"C0003595;C0007294;C0560175;C1325398;C1706209;C3273162";NA;NA;apolipoprotein e carrier
 784;apoe   ε $nmbr$ carrier;"C0003595;C0007294;C0523511;C0560175;C1325398;C1412481;C1706209;C3273162";NA;NA;apoe $nmbr$ carrier
 784;apoe e $nmbr$ carriers  no . ( % );"C0003595;C0007294;C0523511;C1412481";NA;NA;apoe e $nmbr$ carriers no
 784;ala carriers;"C0007294;C0523459;C3888236";NA;NA;ala carriers
 783;prevalence of each metabolic syndrome criterion;"C0033105;C0220900;C0243161;C0524620";NA;NA;prevalence of each metabolic syndrome criterion
 783;entry criteria ( % );"C0243161;C1705654";NA;NA;entry criteria
 783;entry criteria;"C0243161;C1705654";NA;NA;entry criteria
 783;cv entry criteria;"C0243161;C1705654;C3538987;C4048877;C4318503";NA;NA;cv entry criteria
 783;criterion;C0243161;NA;NA;criterion
 783;by who / simon broome criteria;"C0243161;C0443058";NA;NA;by who simon broome criteria
 782;total  adjusted weight of $nmbr$ . $nmbr$ for gastrointestinal bleeding;"C0005910;C0017181;C0043100;C0439175;C0439810;C0456081;C1305866;C1705104";NA;NA;total adjusted weight of $nmbr$ $nmbr$ for gastrointestinal bleeding
 782;gastrointestinal bleeding;C0017181;NA;NA;gastrointestinal bleeding
 782;gastroenteritis;C0017160;NA;NA;gastroenteritis
 781;upper gastrointestinal tract;C3203348;NA;NA;upper gastrointestinal tract
 781;upper gastrointestinal;C3203348;NA;NA;upper gastrointestinal
 781;history of upper gastrointestinal event;"C0019664;C0019665;C0262512;C0262926;C0441471;C1705255;C2004062;C3203348;C4019010";NA;NA;history of upper gastrointestinal event
 780;fecal calprotectin — pg / g * *;"C0015733;C0950624;C1335798;C1366582;C1638318";NA;NA;fecal calprotectin pg g
 779;angiotensin receptor blockers;"C0521942;C0815017";NA;NA;angiotensin receptor blockers
 779;angiotensin receptor;"C0034787;C1622222";NA;NA;angiotensin receptor
 779;angiotensin receptive blocker;"C0003018;C0544683;C4521302";NA;NA;angiotensin receptive blocker
 779;angiotensin ll - receptor blocker;"C0003018;C0597357;C4521302";NA;NA;angiotensin ll receptor blocker
 779;angiotensin ll - receptor antagonist — no . ( % );"C0003018;C4521302;C4543207";NA;NA;angiotensin ll receptor antagonist no
 779;angiotensin il - receptor blocker;"C0003018;C0020898;C0021764;C0022271;C0034787;C1149183;C1622222;C4521302";NA;NA;angiotensin il receptor blocker
 779;angiotensin ii receptor blockers;"C0521942;C2757003";NA;NA;angiotensin ii receptor blockers
 779;angiotensin ii receptor blocker;"C0521942;C3536793";NA;NA;angiotensin ii receptor blocker
 779;angiotensin - receptor;"C0034787;C1622222";NA;NA;angiotensin receptor
 778;urticaria;"C0042109;C1559188";NA;NA;urticaria
 778;other / multiracial;C1881928;NA;NA;other multiracial
 778;multiracial or other;C1881928;NA;NA;multiracial or other
 778;multiracial  n ( % );C1881928;NA;NA;multiracial n
 778;multiracial;C1881928;NA;NA;multiracial
 777;prior exposure to levetiracetam;"C0274281;C0332152;C0332157;C0377265;C2826257;C3693636";NA;NA;prior exposure to levetiracetam
 777;levetiracetam;"C0377265;C3693636";NA;NA;levetiracetam
 776;bivalirudin used during pci;"C0168273;C1273517;C4049621";NA;NA;bivalirudin used during pci
 776;bivalirudin used;"C0168273;C1273517";NA;NA;bivalirudin used
 776;bivalirudin plus glycoprotein iib / iiia inhibitors ( n = $nmbr$ );"C0016011;C0168273;C0243077";NA;NA;bivalirudin plus glycoprotein iib iiia inhibitors n $nmbr$
 776;bivalirudin only;"C0168273;C0205171;C1720467";NA;NA;bivalirudin only
 776;bivalirudin ( n = $nmbr$ );C0168273;NA;NA;bivalirudin n $nmbr$
 776;bivalirudin ( n = $nmbr$  $nmbr$ );C0168273;NA;NA;bivalirudin n $nmbr$ $nmbr$
 776;bivalirudin;C0168273;NA;NA;bivalirudin
 775;re - cover $nmbr$ dabigatran;"C0180153;C0556581;C1999244;C2348066;C2986904;C3888055";NA;NA;re cover $nmbr$ dabigatran
 775;hazard ratio with dabigatran  $nmbr$ mg ( $nmbr$ % cl );"C0024671;C0026410;C0439269;C0596019;C1960952;C2346927;C2348066;C2985465;C4321396;C4521761";NA;NA;hazard ratio with dabigatran $nmbr$ mg $nmbr$ cl
 775;favors dabigatran;"C0309049;C2348066";NA;NA;favors dabigatran
 775;factors dabigatran event incidence / n;"C0021149;C0220856;C0441471;C1521761;C2348066;C2827422;C4019010";NA;NA;factors dabigatran event incidence n
 775;factors dabigatran;"C1521761;C2348066;C2827422";NA;NA;factors dabigatran
 775;dabigatran ( n = $nmbr$ );C2348066;NA;NA;dabigatran n $nmbr$
 607;ambulatory sbp  n;"C0085805;C0439841";NA;NA;ambulatory sbp n
 775;dabigatran  $nmbr$ mg twice daily;"C0024671;C0026410;C0439269;C0585361;C1960952;C2346927;C2348066;C4321396;C4521761";NA;NA;dabigatran $nmbr$ mg twice daily
 775;dabigatran;C2348066;NA;NA;dabigatran
 775;$nmbr$ mg dabigatran ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C2348066;C4321396;C4521761";NA;NA;$nmbr$ mg dabigatran n $nmbr$
 775;$nmbr$ mg dabigatran;"C0024671;C0026410;C0439269;C1960952;C2346927;C2348066;C4321396;C4521761";NA;NA;$nmbr$ mg dabigatran
 774;placebo - ideglira;"C0032042;C1696465;C1706408;C4308663";NA;NA;placebo ideglira
 774;ideglira - ideg - lira;"C1555441;C4308663";NA;NA;ideglira ideg lira
 774;ideglira - ideg;C4308663;NA;NA;ideglira ideg
 774;ideglira;C4308663;NA;NA;ideglira
 774;ideg;NA;NA;NA;ideg
 773;cgi - s  n ( % ) z :;C4526016;NA;NA;cgi s n z
 773;bpearson ' s chi ‐ square test .;C0008041;NA;NA;bpearson s chi square test
 772;china / tjapan;C0008115;NA;NA;china tjapan
 772;china / japan;"C0008115;C0022341";NA;NA;china japan
 772;china;C0008115;NA;NA;china
 780;vasoprotectives;C0304533;FALSE;2316;vasoprotectives
 779;angiogenesis;"C0302600;C1519670";FALSE; -10;angiogenesis
 779;angiotensin -;"C0003018;C4521302";FALSE; -10;angiotensin
 779;ace inhibitors or angiotensin receptor blockers;"C0003015;C0521942;C0815017";FALSE; 811;ace inhibitors or angiotensin receptor blockers
 771;mean ( ± sd ) change from;"C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C2699239;C4319952";NA;NA;mean sd change from
 771;mean ( sd ) change from pre - to post - bronchodilator fevi  ml;"C0332152;C0439526;C0444504;C0687676;C0740175;C1704687;C1705224;C2257086;C2347634;C2348143;C2599594;C2599602;C2699239;C3469826;C3481639;C3669034;C3887665";NA;NA;mean sd change from pre to post bronchodilator fevi ml
 771;mean ( sd ) change from pre - to post - bronchodilator fev $nmbr$  l;"C0332152;C0392747;C0443172;C0444504;C0687676;C0740175;C1704687;C1705241;C2257086;C2347634;C2348143;C2599594;C2599602;C2699239;C3469826;C3669034;C3714541;C4319952";NA;NA;mean sd change from pre to post bronchodilator fev $nmbr$ l
 771;change from pre - to;"C0332152;C0392747;C0443172;C0740175;C1705241;C2257086;C3669034;C4319952";NA;NA;change from pre to
 770;chinese subgroup;"C0008120;C0152035;C1079230;C1515021";NA;NA;chinese subgroup
 770;chinese;"C0008120;C0152035";NA;NA;chinese
 769;prior congestive heart failure yes;"C0018802;C0332152;C1549445;C1705108;C1710701;C2826257";NA;NA;prior congestive heart failure yes
 769;prior congestive heart failure;"C0018802;C0332152;C2826257";NA;NA;prior congestive heart failure
 769;prior chf  %;"C0018802;C0332152;C2826257";NA;NA;prior chf
 769;prior chf;"C0018802;C0332152;C2826257";NA;NA;prior chf
 769;first hospitalization for chf or cv death;"C0011065;C0018802;C0019993;C0205435;C1279901;C1306577;C3538987;C4048877;C4082313;C4318503;C4552775";NA;NA;first hospitalization for chf or cv death
 769;chf on losartan ( % );"C0018802;C0126174";NA;NA;chf on losartan
 769;chf ( % );C0018802;NA;NA;chf
 769;chf;C0018802;NA;NA;chf
 768;pulmonary congestion ( cxr );"C0006888;C0039985;C0242073";NA;NA;pulmonary congestion cxr
 768;chest x - ray;C0039985;NA;NA;chest x ray
 767;total psa ‐ modified shs;"C0392747;C2986589;C3889737";NA;NA;total psa modified shs
 767;second primary ( estimated change in total updrs score from baseline to wk $nmbr$ );"C0168634;C0205225;C0205436;C0332174;C0392747;C0439175;C0439230;C0439612;C0439631;C0439810;C0443172;C0449820;C0457385;C0565930;C0750572;C1442488;C1561503;C1705190;C1705241;C3639721;C4050231;C4319952";NA;NA;second primary estimated change in total updrs score from baseline to wk $nmbr$
 767;retinal severity change;"C0035298;C0392747;C0439793;C0443172;C0522510;C1705241;C4319952";NA;NA;retinal severity change
 767;rec . ischemia due to ecg changes;"C0022116;C0392747;C0443172;C0678226;C1424025;C1623258;C1705241;C2606415;C4319952;C4321499";NA;NA;rec ischemia due to ecg changes
 767;percent change;"C0392747;C0439165;C0443172;C1705241;C4319952";NA;NA;percent change
 767;patients with enthesitis at week $nmbr$ radiographic progression § change from baseline to week $nmbr$ in psa - modified total shs score;"C0030705;C0168634;C0242656;C0332174;C0392747;C0439175;C0439230;C0439810;C0443172;C0444708;C0449258;C0449820;C1282952;C1442488;C1705241;C3810537;C3813209;C3889737;C4050231;C4319952";NA;NA;patients with enthesitis at week $nmbr$ radiographic progression change from baseline to week $nmbr$ in psa modified total shs score
 767;patients with change from baseline in total psa ‐ modified shs ≤ $nmbr$;"C0030705;C0168634;C0392747;C0443172;C1442488;C1705241;C2986589;C3889737;C4319952";NA;NA;patients with change from baseline in total psa modified shs $nmbr$
 767;pain vas  mean change from baselined;"C0042815;C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C4319952";NA;NA;pain vas mean change from baselined
 767;pain vas  mean change from baselinea;"C0042815;C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C4319952";NA;NA;pain vas mean change from baselinea
 767;nominal change;"C0392747;C0443172;C1705241;C4319952";NA;NA;nominal change
 767;no incident dm or change in fg > $nmbr$;"C0011816;C0016703;C0392747;C0439214;C0443172;C1551358;C1705241;C2348814;C3250443;C4319952";NA;NA;no incident dm or change in fg $nmbr$
 767;no change;"C0392747;C0443172;C1705241;C4319952";NA;NA;no change
 767;modified total sharp score * *;"C0392747;C1444775;C1539835;C2964552;C3889737;C3890003";NA;NA;modified total sharp score
 767;modified total sharp score;"C0392747;C1444775;C1539835;C2964552;C3889737;C3890003";NA;NA;modified total sharp score
 767;modified has - bled score  mean ± sd;"C0019080;C0392747;C0444504;C0449820;C2347634;C2348143;C2699239;C3889737;C4050231";NA;NA;modified has bled score mean sd
 767;modified has - bled > $nmbr$;"C0019080;C0392747;C3889737";NA;NA;modified has bled $nmbr$
 767;modified has - bled < $nmbr$;"C0019080;C0392747;C3889737";NA;NA;modified has bled $nmbr$
 767;modified has - bled $ $nmbr$;"C0019080;C0392747;C3889737";NA;NA;modified has bled $ $nmbr$
 767;modified has - bled;"C0019080;C0392747;C3889737";NA;NA;modified has bled
 767;mean change in sgrq;"C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C4319952";NA;NA;mean change in sgrq
 767;mean change in fev $nmbr$;"C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C3714541;C4319952";NA;NA;mean change in fev $nmbr$
 767;mean change in acq score;"C0392747;C0443172;C1705241;C2919686;C3533236;C4319952";NA;NA;mean change in acq score
 767;mean change from baseline in the number of;"C0168634;C0237753;C0392747;C0443172;C0444504;C0449788;C1442488;C1705241;C2347634;C2348143;C4319952";NA;NA;mean change from baseline in the number of
 767;mean change from baseline in fev $nmbr$ % predicted  % ( sd ) *;"C0168634;C0392747;C0443172;C0444504;C0681842;C1442488;C1705241;C1882327;C2347634;C2348143;C2699239;C3714541;C4319952";NA;NA;mean change from baseline in fev $nmbr$ predicted sd
 767;mean change from baseline bp at week $nmbr$;"C0168634;C0332174;C0392747;C0439230;C0443172;C0444504;C0488053;C1268766;C1442488;C1705241;C2347634;C2348143;C4319952";NA;NA;mean change from baseline bp at week $nmbr$
 767;mean change at week $nmbr$;"C0332174;C0392747;C0439230;C0443172;C0444504;C1705241;C2347634;C2348143;C4319952";NA;NA;mean change at week $nmbr$
 767;mean change;"C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C4319952";NA;NA;mean change
 767;mean - sd change in pre - bronchodilator fev $nmbr$  l;"C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C2599602;C2699239;C3714541;C4319952";NA;NA;mean sd change in pre bronchodilator fev $nmbr$ l
 767;mean % change in fn bmd;"C0392747;C0443172;C0444504;C1570610;C1705241;C2347634;C2348143;C4319952";NA;NA;mean change in fn bmd
 767;lyear mean change from baseline;"C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C4319952";NA;NA;lyear mean change from baseline
 767;ls mean change from baseline ( se );"C0023668;C0036919;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C4319952";NA;NA;ls mean change from baseline se
 767;ls mean change from baseline $nmbr$;"C0023668;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C4319952";NA;NA;ls mean change from baseline $nmbr$
 767;ls mean change from baseline;"C0023668;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C4319952";NA;NA;ls mean change from baseline
 767;low - density lipoprotein cholesterol tx difference vs pbo  ls mean % change from baseline ( se );"C0023668;C0023824;C0031962;C0036919;C0041403;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C1705242;C2347634;C2348143;C4319952";NA;NA;low density lipoprotein cholesterol tx difference vs pbo ls mean change from baseline se
 767;lipoprotein ( a ) tx difference vs pbo  ls mean % change from baseline ( se );"C0023668;C0031962;C0036919;C0041403;C0065058;C0125953;C0168634;C0392747;C0443172;C0444504;C1096202;C1439335;C1442488;C1705241;C1705242;C2347634;C2348143;C4319952";NA;NA;lipoprotein a tx difference vs pbo ls mean change from baseline se
 767;incident dm or change in;"C0011816;C0392747;C0443172;C1551358;C1705241;C3250443;C4319952";NA;NA;incident dm or change in
 767;high - density lipoprotein cholesterol tx difference vs pbo  ls mean % change from baseline ( se );"C0023668;C0023822;C0031962;C0036919;C0041403;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C1705242;C2347634;C2348143;C4319952";NA;NA;high density lipoprotein cholesterol tx difference vs pbo ls mean change from baseline se
 767;fasting plasma glucose ( change from baseline );"C0168634;C0392747;C0443172;C0583513;C1442488;C1705241;C4319952";NA;NA;fasting plasma glucose change from baseline
 767;ecg changes ( % ) t;"C0392747;C0443172;C1623258;C1705241;C2603360;C4319952";NA;NA;ecg changes t
 767;due to ecg changes;"C0392747;C0443172;C1623258;C1705241;C4319952";NA;NA;due to ecg changes
 767;changes in shs;"C0392747;C0443172";NA;NA;changes in shs
 767;changes in serum creatinine  pmol / l;"C0201976;C0392747;C0439284;C0443172;C0600061";NA;NA;changes in serum creatinine pmol l
 767;change to week $nmbr$ * ’ ’;"C0332174;C0392747;C0439230;C0443172;C1705241;C4319952";NA;NA;change to week $nmbr$
 767;change in tc;"C0039411;C0040642;C0041405;C0041698;C0392747;C0443172;C1705241;C1824670;C3272447;C4319952;C4522122";NA;NA;change in tc
 767;change in retinal pathology;"C0030664;C0035298;C0205469;C0392747;C0443172;C0677042;C1705241;C4319952";NA;NA;change in retinal pathology
 767;change in psa ‐ modified shs  baseline to week $nmbr$;"C0168634;C0332174;C0392747;C0439230;C0443172;C1442488;C1705241;C3810537;C3813209;C3889737;C4319952";NA;NA;change in psa modified shs baseline to week $nmbr$
 767;change in nt - probnp at $nmbr$;"C0392747;C0443172;C0669479;C0754710;C1705241;C4319952";NA;NA;change in nt probnp at $nmbr$
 767;change in mtss ( mean );"C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C4319952";NA;NA;change in mtss mean
 767;change in ldl ‐ c;"C0392747;C0443172;C1705241;C4319952";NA;NA;change in ldl c
 767;change in hdl ‐ c;"C0392747;C0443172;C1705241;C3715113;C4319952";NA;NA;change in hdl c
 767;change in hbalc after $nmbr$ weeks etd ( $nmbr$ % cl );"C0392747;C0439230;C0443172;C0596019;C1180255;C1705241;C4319952";NA;NA;change in hbalc after $nmbr$ weeks etd $nmbr$ cl
 767;change in das $nmbr$ > $nmbr$ . $nmbr$;"C0051767;C0057671;C0392747;C0443172;C1705241;C4319952";NA;NA;change in das $nmbr$ $nmbr$ $nmbr$
 767;change in das $nmbr$ - esr ( mean ) i physical function outcomes week $nmbr$;"C0021966;C0051767;C0057671;C0221138;C0332174;C0392747;C0439230;C0443172;C0444504;C0516981;C1274040;C1705241;C2347634;C2348143;C3811131;C4049916;C4319952";NA;NA;change in das $nmbr$ esr mean i physical function outcomes week $nmbr$
 767;change from baseline in sgrq;"C0168634;C0392747;C0443172;C1442488;C1705241;C4319952";NA;NA;change from baseline in sgrq
 767;change from baseline in fevj ( mb );"C0024853;C0168634;C0392747;C0443172;C1442488;C1705241;C4319952";NA;NA;change from baseline in fevj mb
 767;change from baseline in acq - $nmbr$ score;"C0168634;C0392747;C0443172;C0449820;C1442488;C1705241;C2919686;C4050231;C4319952";NA;NA;change from baseline in acq $nmbr$ score
 767;change from baseline in acq - $nmbr$;"C0168634;C0392747;C0443172;C1442488;C1705241;C2919686;C4319952";NA;NA;change from baseline in acq $nmbr$
 767;change from baseline in;"C0168634;C0392747;C0443172;C1442488;C1705241;C4319952";NA;NA;change from baseline in
 767;change from baseline at week $nmbr$;"C0168634;C0332174;C0392747;C0439230;C0443172;C1442488;C1705241;C4319952";NA;NA;change from baseline at week $nmbr$
 767;change from baseline;"C0168634;C0392747;C0443172;C1442488;C1705241;C4319952";NA;NA;change from baseline
 767;change from;"C0392747;C0443172;C1705241;C4319952";NA;NA;change from
 767;change at week $nmbr$;"C0332174;C0392747;C0439230;C0443172;C1705241;C4319952";NA;NA;change at week $nmbr$
 767;change $nmbr$;"C0392747;C0443172;C1705241;C4319952";NA;NA;change $nmbr$
 767;change;"C0392747;C0443172;C1705241;C4319952";NA;NA;change
 767;body weight ( change from baseline );"C0005911;C0168634;C0392747;C0443172;C1303013;C1442488;C1705241;C4319952";NA;NA;body weight change from baseline
 767;before a change to the enrollment form was implemented in august $nmbr$ . bnp;"C0054015;C0348078;C0376315;C0392747;C0443172;C1095989;C1417808;C1516879;C1522492;C1696073;C1705241;C2982014;C3831448;C3888021;C4255237;C4319952;C4520547";NA;NA;before a change to the enrollment form was implemented in august $nmbr$ bnp
 767;basdai  mean change from baseline;"C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C1998004;C2347634;C2348143;C4319952";NA;NA;basdai mean change from baseline
 767;at c change ( % ) *;"C0392747;C0443172;C1705241;C4319952";NA;NA;at c change
 767;% change from baseline  mean ( s . e . );"C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C4319952";NA;NA;change from baseline mean s e
 767;% change from baseline;"C0168634;C0392747;C0443172;C1442488;C1705241;C4319952";NA;NA;change from baseline
 767;% change ( meantse );"C0392747;C0443172;C1705241;C4319952";NA;NA;change meantse
 767;% change ( meanlse );"C0392747;C0443172;C1705241;C4319952";NA;NA;change meanlse
 767;% change;"C0392747;C0443172;C1705241;C4319952";NA;NA;change
 767;$nmbr$ year mean change from baseline;"C0168634;C0392747;C0439234;C0439508;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C4319952";NA;NA;$nmbr$ year mean change from baseline
 766;charlson comorbidity index  mean ( sd );"C0444504;C2347634;C2348143;C2699239;C4546361";NA;NA;charlson comorbidity index mean sd
 766;charlson comorbidity index;C4546361;NA;NA;charlson comorbidity index
 766;charlson comobility score  n ( % );"C0449820;C4050231";NA;NA;charlson comobility score n
 766;charlson;NA;NA;NA;charlson
 765;comorbidity  no . ( % );C0009488;NA;NA;comorbidity no
 765;comorbidities other than diabetes;"C0009488;C0011847;C0011849";NA;NA;comorbidities other than diabetes
 765;comorbidities ( % );C0009488;NA;NA;comorbidities
 765;comorbidities  no . ( % );C0009488;NA;NA;comorbidities no
 765;comorbidities  n ( % ) a;C0009488;NA;NA;comorbidities n a
 765;comorbidities  %;C0009488;NA;NA;comorbidities
 765;comorbidities;C0009488;NA;NA;comorbidities
 765;comorbidites  n ( % );NA;NA;NA;comorbidites n
 765;comorbid illnesses;"C0009488;C0221423";NA;NA;comorbid illnesses
 765;comorbid conditionsb;C0009488;NA;NA;comorbid conditionsb
 765;co - morbidities  n ( % );C0009488;NA;NA;co morbidities n
 765;co - morbidities  a n ( % );"C0009488;C0369718;C0441922";NA;NA;co morbidities a n
 765;co - morbidities;C0009488;NA;NA;co morbidities
 764;prior exposure to carbamazepine;"C0006949;C0006950;C0274281;C0332152;C0332157;C0682993;C2826257";NA;NA;prior exposure to carbamazepine
 764;cbz - naive;C0006949;NA;NA;cbz naive
 764;cbz - exposed;"C0006949;C0332157";NA;NA;cbz exposed
 764;carbamazepine;"C0006949;C0006950;C0682993";NA;NA;carbamazepine
 763;native latin;C0302891;NA;NA;native latin
 763;american ‐ indian / alaska native;"C0002460;C0682125";NA;NA;american indian alaska native
 763;american indian or alaskan native;"C0002460;C0238611;C0302891";NA;NA;american indian or alaskan native
 763;american indian or alaska native  :;"C0002460;C0682125";NA;NA;american indian or alaska native
 763;american indian or alaska native;"C0002460;C0682125";NA;NA;american indian or alaska native
 763;american indian / alaskan native  n ( % );"C0002460;C0238611;C0302891;C0886378;C1524069";NA;NA;american indian alaskan native n
 763;american indian / alaskan native;"C0002460;C0238611;C0302891";NA;NA;american indian alaskan native
 763;american indian / alaska native;"C0002460;C0682125";NA;NA;american indian alaska native
 763;alaska native;C0682125;NA;NA;alaska native
 762;pharmaco - invasive n = $nmbr$;"C0205281;C1334278";NA;NA;pharmaco invasive n $nmbr$
 762;pharmaco - invasive ( n = $nmbr$ );"C0205281;C1334278";NA;NA;pharmaco invasive n $nmbr$
 762;invasive;"C0205281;C1334278";NA;NA;invasive
 762;intent of early invasive strategy  %;"C0162425;C0205281;C0679199;C1279919;C1283828;C1334278;C1550453";NA;NA;intent of early invasive strategy
 762;early invasive strategy ( n = $nmbr$  $nmbr$ );"C0205281;C0679199;C1279919;C1334278";NA;NA;early invasive strategy n $nmbr$ $nmbr$
 762;early invasive *;"C0205281;C1279919;C1334278";NA;NA;early invasive
 762;early invasive $nmbr$;"C0205281;C1279919;C1334278";NA;NA;early invasive $nmbr$
 -10;oxidative stress;C0242606;NA;NA;oxidative stress
 760;relative wall thickness;"C0080103;C0205345;C0677535;C1280412;C1547039";NA;NA;relative wall thickness
 760;relative decrease > $nmbr$ %;"C0080103;C0205345;C0392756;C0547047;C1547039";NA;NA;relative decrease $nmbr$
 759;sustain $nmbr$ : semaglutide vs . exenatide er $nmbr$ . $nmbr$ mg;"C0024671;C0026410;C0167117;C0439269;C0443318;C1960952;C2346927;C2732140;C3810541;C3811131;C3885068;C4321396;C4521761";NA;NA;sustain $nmbr$ semaglutide vs exenatide er $nmbr$ $nmbr$ mg
 759;lixisenatide ( n = $nmbr$ o );C2973895;NA;NA;lixisenatide n $nmbr$ o
 759;lixisenatide ( n = $nmbr$ );C2973895;NA;NA;lixisenatide n $nmbr$
 759;lixisenatide;C2973895;NA;NA;lixisenatide
 759;exenatide ± oad;C0167117;NA;NA;exenatide oad
 759;exenatide no . of events / total no . ( % );"C0167117;C0439175;C0439810;C0441471;C3541888";NA;NA;exenatide no of events total no
 759;exenatide n = $nmbr$;C0167117;NA;NA;exenatide n $nmbr$
 759;exenatide lar;"C0167117;C1419115;C3814448";NA;NA;exenatide lar
 759;exenatide er;"C0167117;C3810541;C3811131";NA;NA;exenatide er
 759;exenatide;C0167117;NA;NA;exenatide
 757;timi ≥ $nmbr$ and spoke and time ≤ $nmbr$ h;"C0033727;C0040223;C0369286;C0441932;C0564385;C3541383;C4528284";NA;NA;timi $nmbr$ and spoke and time $nmbr$ h
 757;timi ≥ $nmbr$ and spoke;NA;NA;NA;timi $nmbr$ and spoke
 757;time to first sare * ( % );"C0040223;C0205435;C1279901;C3541383";NA;NA;time to first sare
 757;time to first morbidity / mortality event up to the end of the treatment periodd;"C0026538;C0026565;C0026566;C0039798;C0040223;C0087111;C0205435;C0220880;C0441471;C0444930;C0547043;C1279901;C1522326;C1533734;C1705169;C2746065;C3538994;C3541383;C3887704;C4019010";NA;NA;time to first morbidity mortality event up to the end of the treatment periodd
 757;time to first exacerbation;"C0040223;C0205435;C1279901;C3541383;C4086268";NA;NA;time to first exacerbation
 757;time since primary diagnosis;"C0040223;C0332137;C0801658;C3541383";NA;NA;time since primary diagnosis
 757;time since most recent myocardial;"C0027061;C0040223;C0332185;C1522564;C3541383";NA;NA;time since most recent myocardial
 757;time since first luts ( years );"C0040223;C0205435;C0439234;C0574785;C1279901;C3541383";NA;NA;time since first luts years
 757;time since cabg;"C0010055;C0040223;C3541383";NA;NA;time since cabg
 757;time since asthma diagnosis years;"C0004096;C0011900;C0040223;C0439234;C1704338;C1704656;C2984299;C3541383";NA;NA;time since asthma diagnosis years
 757;time since asthma diagnosis [ years ]  median ( range );"C0004096;C0011900;C0040223;C0439234;C0549183;C0876920;C1514721;C1704338;C1704656;C2347635;C2348144;C2348147;C2939193;C2984299;C3541383;C3542016";NA;NA;time since asthma diagnosis years median range
 757;time since asthma diagnosis ( years );"C0004096;C0011900;C0040223;C0439234;C1704338;C1704656;C2984299;C3541383";NA;NA;time since asthma diagnosis years
 757;time since asthma;"C0004096;C0040223;C2984299;C3541383";NA;NA;time since asthma
 757;time in therapeutic range before inclusion;"C0007637;C0040223;C0087111;C0302350;C0460097;C1512693;C1554109;C3541383";NA;NA;time in therapeutic range before inclusion
 757;time in therapeutic range  median ( iqr )  %;"C0040223;C0087111;C0302350;C0460097;C0549183;C0876920;C1554109;C2347635;C2348144;C2939193;C3541383";NA;NA;time in therapeutic range median iqr
 757;time in therapeutic range;"C0040223;C0087111;C0302350;C0460097;C1554109;C3541383";NA;NA;time in therapeutic range
 757;time from randomization to cabg — hr;"C0010055;C0034656;C0040223;C3541383";NA;NA;time from randomization to cabg hr
 757;time from qualifying mi  yrs;"C0040223;C1514624;C3541383;C3810814";NA;NA;time from qualifying mi yrs
 757;time from qualifying mi  %;"C0040223;C1514624;C3541383;C3810814";NA;NA;time from qualifying mi
 757;time from most recent qualifying;"C0040223;C0332185;C1514624;C3541383";NA;NA;time from most recent qualifying
 757;time from first eval;"C0040223;C0205435;C1279901;C1707957;C2698624;C3541383";NA;NA;time from first eval
 757;time ( sec ) *;"C0040223;C0565930;C3541383";NA;NA;time sec
 757;spoke;NA;NA;NA;spoke
 757;percentage of time in therapeutic inr range  mean ( sd );"C0040223;C0439165;C0444504;C0460097;C0525032;C1549488;C1561533;C1704538;C2347634;C2348143;C2699239;C3541383";NA;NA;percentage of time in therapeutic inr range mean sd
 757;percent work time missed due to asthma;"C0004096;C0040223;C0043227;C0439165;C0678226;C1705492;C2984299;C3541383";NA;NA;percent work time missed due to asthma
 757;percent of the time that inr was in the therapeutic range;"C0040223;C0439165;C0460097;C0525032;C1704538;C3541383";NA;NA;percent of the time that inr was in the therapeutic range
 757;mean time to first oral dose postsurgeryh  hr;"C0040223;C0178602;C0205435;C0442027;C0444504;C0869039;C1114758;C1279901;C2347634;C2348143;C3541383;C4521986";NA;NA;mean time to first oral dose postsurgeryh hr
 757;mean time since asthma;"C0004096;C0040223;C0444504;C2347634;C2348143;C2984299;C3541383";NA;NA;mean time since asthma
 757;ecg at time of qualifying symptoms;"C0040223;C0683368;C1457887;C1514624;C1623258;C3541383";NA;NA;ecg at time of qualifying symptoms
 757;at any time;"C0040223;C3541383";NA;NA;at any time
 756;time since last dose of;C0946444;NA;NA;time since last dose of
 756;time intervals  h;"C0033727;C0369286;C0441932;C0564385;C0872291;C4528284";NA;NA;time intervals h
 756;time intervals;C0872291;NA;NA;time intervals
 756;time from last dose of p $nmbr$ y $nmbr$ inhibitor  days;"C0439228;C0946444;C1999216";NA;NA;time from last dose of p $nmbr$ y $nmbr$ inhibitor days
 755;tpm - naive;C0076829;NA;NA;tpm naive
 755;tpm - exposed;"C0076829;C0332157";NA;NA;tpm exposed
 755;topiramate;C0076829;NA;NA;topiramate
 755;assigned to topiramate;"C0040363;C0041260;C0076829;C1516050;C1552601;C1883351";NA;NA;assigned to topiramate
 754;womac stiffness score;"C0427008;C0449820;C4050231";NA;NA;womac stiffness score
 754;stiffness subscale;C0427008;NA;NA;stiffness subscale
 754;question $nmbr$ ( morning stiffness since arising );"C0332284;C0457086;C1522634;C4019053;C4318616";NA;NA;question $nmbr$ morning stiffness since arising
 754;question $nmbr$ ( length of morning stiffness since arising );"C0332284;C0457086;C1444754;C1522634;C1706316;C4019053;C4318616";NA;NA;question $nmbr$ length of morning stiffness since arising
 753;voiding subscore;"C0042034;C4067975";NA;NA;voiding subscore
 753;rectal bleeding subscore {;"C0018932;C0267596";NA;NA;rectal bleeding subscore
 753;rectal bleeding subscore;"C0018932;C0267596";NA;NA;rectal bleeding subscore
 753;mean ipss  voiding subscore ( sd );"C0042034;C0444504;C1019118;C1998280;C2347634;C2348143;C2699239;C2827405;C3811063;C4067975";NA;NA;mean ipss voiding subscore sd
 753;irritative subscore;"C0441723;C1706307;C2700617";NA;NA;irritative subscore
 753;ipss voiding subscore;"C0042034;C1019118;C1998280;C2827405;C3811063;C4067975";NA;NA;ipss voiding subscore
 752;sulphonylureas;C0038766;NA;NA;sulphonylureas
 752;sulphonylurea;"C0038766;C3536898";NA;NA;sulphonylurea
 752;sulfonylureasb;NA;NA;NA;sulfonylureasb
 752;sulfonylureas;"C0038766;C3653359";NA;NA;sulfonylureas
 752;sulfonylureaa;NA;NA;NA;sulfonylureaa
 752;sulfonylurea — no . ( % );"C0038766;C3536898";NA;NA;sulfonylurea no
 752;sulfonylurea use at baseline;"C0038766;C0042153;C0168634;C0457083;C1442488;C1947944;C3536898";NA;NA;sulfonylurea use at baseline
 752;sulfonylurea derivatives;C0038766;NA;NA;sulfonylurea derivatives
 752;sulfonylurea based;"C0038766;C1527178;C1705938;C3536898";NA;NA;sulfonylurea based
 752;sulfonylurea;"C0038766;C3536898";NA;NA;sulfonylurea
 752;other sulfonylurea 一 no . ( % );"C0038766;C3536898";NA;NA;other sulfonylurea no
 752;on sulfonylurea;"C0038766;C3536898";NA;NA;on sulfonylurea
 752;non - sulfonylurea secretagogues;"C0038766;C1518422;C3536898;C4704833";NA;NA;non sulfonylurea secretagogues
 752;insulin + sulphonylureas;"C0021641;C0038766;C1533581;C1579433;C3714501";NA;NA;insulin sulphonylureas
 752;insulin + metformin + sulphonylureas;"C0021641;C0025598;C0038766;C1533581;C1579433;C3714501";NA;NA;insulin metformin sulphonylureas
 752;duration of sulphonylurea use ( months )  mean ± s . d .;"C0038766;C0439231;C0444504;C1881378;C2347634;C2348143;C2826775;C3536898";NA;NA;duration of sulphonylurea use months mean s d
 752;any sulfonylurea;"C0038766;C3536898";NA;NA;any sulfonylurea
 751;st george ' s respiratory questionnaire total score !;"C0439175;C0439810;C3472502";NA;NA;st george s respiratory questionnaire total score
 751;score on st . george ' s respiratory questionnaire ^ ^;C3472502;NA;NA;score on st george s respiratory questionnaire
 751;score on asthma control questionnaire * *;C4706265;NA;NA;score on asthma control questionnaire
 750;mean aqlq total score t;"C0439175;C0439810;C0444504;C2347634;C2348143;C2964552;C3533236;C4055434";NA;NA;mean aqlq total score t
 752;metformin + sulphonylureas;"C0025598;C0038766";FALSE;2253;metformin sulphonylureas
 750;aqlq ( s ) + $nmbr$ scorets;C4055434;NA;NA;aqlq s $nmbr$ scorets
 749;physical component score ( pcs );"C0449432;C1705248;C1864389;C1882368;C4483112";NA;NA;physical component score pcs
 749;pcs score ( $nmbr$ – $nmbr$ scale );"C0175659;C0349674;C0449820;C1864389;C1882368;C1947916;C4050231";NA;NA;pcs score $nmbr$ $nmbr$ scale
 749;pcs score;"C0449820;C1864389;C1882368;C4050231";NA;NA;pcs score
 749;lithe;NA;NA;NA;lithe
 749;iwqol - lite physical score ( arbitrary units );"C0439183;C4483112";NA;NA;iwqol lite physical score arbitrary units
 748;— $nmbr$ . $nmbr$ < fn t - score < — $nmbr$ . $nmbr$;"C0449820;C1570610;C4050231";NA;NA;$nmbr$ $nmbr$ fn t score $nmbr$ $nmbr$
 748;— $nmbr$ . $nmbr$ < fn t - score;"C0449820;C1570610;C4050231";NA;NA;$nmbr$ $nmbr$ fn t score
 748;womac score;"C0449820;C4050231";NA;NA;womac score
 748;womac function score;"C0031843;C0449820;C0542341;C0700205;C1705273;C4050231";NA;NA;womac function score
 748;vadas score *;"C0449820;C4050231";NA;NA;vadas score
 748;updrs score;"C0449820;C3639721;C4050231";NA;NA;updrs score
 748;target nail napsi score ( $nmbr$ – $nmbr$ scale );"C0027342;C0175659;C0349674;C0449820;C1432728;C1521840;C1947916;C2986546;C3538766;C4050231";NA;NA;target nail napsi score $nmbr$ $nmbr$ scale
 748;stroke risk score;"C0449820;C1277291;C4050231";NA;NA;stroke risk score
 748;st - segment deviation timi risk score  %;"C0012727;C0035647;C0036056;C0205419;C0429029;C0429066;C0441635;C0449820;C1114722;C1116089;C1705236;C3272372;C4050231;C4552904";NA;NA;st segment deviation timi risk score
 748;sss score;"C0037052;C0449820;C0723181;C4050231";NA;NA;sss score
 748;significant worsening in kccq clinical score ( ≥ $nmbr$ ) at $nmbr$ mo †;"C0026544;C0332177;C0332271;C0449820;C1457868;C1546960;C2826293;C3476798;C4050231";NA;NA;significant worsening in kccq clinical score $nmbr$ at $nmbr$ mo
 748;shs ( $nmbr$ - $nmbr$  per $nmbr$ score );"C0449820;C4050231";NA;NA;shs $nmbr$ $nmbr$ per $nmbr$ score
 748;score 一 no . ( % );"C0449820;C4050231";NA;NA;score no
 748;score of > $nmbr$ . $nmbr$ — %;"C0449820;C4050231";NA;NA;score of $nmbr$ $nmbr$
 748;score of $ $nmbr$  no . ( % );"C0449820;C4050231";NA;NA;score of $ $nmbr$ no
 748;score of # $nmbr$  no . ( % );"C0449820;C4050231";NA;NA;score of $nmbr$ no
 748;score > $nmbr$ . $nmbr$;"C0449820;C4050231";NA;NA;score $nmbr$ $nmbr$
 748;score > $nmbr$ %  % of patients;"C0030705;C0449820;C4050231";NA;NA;score $nmbr$ of patients
 748;score $nmbr$ . $nmbr$;"C0449820;C4050231";NA;NA;score $nmbr$ $nmbr$
 748;score $nmbr$ - $nmbr$;"C0449820;C4050231";NA;NA;score $nmbr$ $nmbr$
 748;score  no . ( % );"C0449820;C4050231";NA;NA;score no
 748;score  %;"C0449820;C4050231";NA;NA;score
 748;score;"C0449820;C4050231";NA;NA;score
 748;schwab & england score;"C0014282;C0449820;C4050231";NA;NA;schwab england score
 748;rope score * *;"C0449820;C1563164;C4050231";NA;NA;rope score
 748;rope score;"C0449820;C1563164;C4050231";NA;NA;rope score
 748;rentrop score;"C0449820;C4050231";NA;NA;rentrop score
 748;patients with mild pain ( womac pain score  $nmbr$ - $nmbr$ );"C0030705;C0278138;C0449820;C0582148;C2945599;C4050231;C4522280";NA;NA;patients with mild pain womac pain score $nmbr$ $nmbr$
 748;nvf at flex baseline - $nmbr$ < flex fn t - score;"C0168634;C0449820;C1442488;C1570610;C4050231";NA;NA;nvf at flex baseline $nmbr$ flex fn t score
 748;npi - $nmbr$ score *;"C0449820;C1412208;C1549728;C3539727;C4050231";NA;NA;npi $nmbr$ score
 748;normalized womac score;"C0449820;C1882115;C4050231";NA;NA;normalized womac score
 748;nihss score;"C0449820;C1697238;C4050231";NA;NA;nihss score
 748;napsi score ( $nmbr$ - $nmbr$ ) of target fingernail;"C0222001;C0449820;C1521840;C2986546;C4050231";NA;NA;napsi score $nmbr$ $nmbr$ of target fingernail
 748;midas score;"C0449820;C1309950;C1423498;C4049617;C4050231";NA;NA;midas score
 748;mhis score;"C0449820;C4050231";NA;NA;mhis score
 748;mcs score ( $nmbr$ – $nmbr$ scale );"C0175659;C0349674;C0449820;C1947916;C4050231";NA;NA;mcs score $nmbr$ $nmbr$ scale
 748;mcs score;"C0449820;C4050231";NA;NA;mcs score
 748;ls t - score < — $nmbr$ . $nmbr$;"C0023668;C0449820;C4050231";NA;NA;ls t score $nmbr$ $nmbr$
 748;leeds enthesitis index ^ score > $nmbr$ — no . { % );"C0449820;C0451148;C4050231";NA;NA;leeds enthesitis index score $nmbr$ no
 748;kccq score;"C0449820;C3476798;C4050231";NA;NA;kccq score
 748;karnofsky score 竺 $nmbr$;"C0206065;C0449820;C4050231";NA;NA;karnofsky score $nmbr$
 748;karnofsky score < $nmbr$;"C0206065;C0449820;C4050231";NA;NA;karnofsky score $nmbr$
 748;ibdq score |;"C0449820;C4050231";NA;NA;ibdq score
 748;ibdq score  mean ( sd );"C0444504;C0449820;C2347634;C2348143;C2699239;C4050231";NA;NA;ibdq score mean sd
 748;hit - $nmbr$ score;"C0272285;C0332159;C0449820;C1708373;C4050231";NA;NA;hit $nmbr$ score
 748;gds score *;"C0449820;C0451184;C1149049;C1418244;C4050231";NA;NA;gds score
 748;fn t - score < — $nmbr$ . $nmbr$;"C0449820;C1570610;C4050231";NA;NA;fn t score $nmbr$ $nmbr$
 748;fn t - score < = - $nmbr$ . $nmbr$ ( % );"C0449820;C1570610;C4050231";NA;NA;fn t score $nmbr$ $nmbr$
 748;flex fn f - score < - $nmbr$ . $nmbr$;"C0016327;C0449820;C1570610;C4050231";NA;NA;flex fn f score $nmbr$ $nmbr$
 748;flex baseline bmd t - score at femoral neck ( meanisd );"C0015815;C0168634;C0449820;C1442488;C4050231";NA;NA;flex baseline bmd t score at femoral neck meanisd
   7;p ' value;C1709380;NA;NA;p value
   7;nteraction p value;C1709380;NA;NA;nteraction p value
 748;timi risk score > $nmbr$  %;"C0035647;C0449820;C4050231;C4552904";FALSE;2052;timi risk score $nmbr$
 748;timi risk score — no . ( % ) : t;"C0035647;C0449820;C2603360;C4050231;C4552904";FALSE;2052;timi risk score no t
 748;timi risk score — no . / total no . ( % ) f;"C0016327;C0035647;C0439175;C0439810;C0449820;C4050231;C4552904";FALSE;2052;timi risk score no total no f
 748;tim $nmbr$ nsk score;"C0449820;C1313407;C3541335;C3711667;C3827754;C3890185;C4050231;C4319633";FALSE;2052;tim $nmbr$ nsk score
 748;tlmi risk score;"C0035647;C0449820;C4050231;C4552904";FALSE;2052;tlmi risk score
 748;timi score;"C0449820;C4050231";FALSE;2052;timi score
 748;score on modified rankin scale ( ' % / ';"C0449820;C2984908;C3854213;C4050231";FALSE;2053;score on modified rankin scale
 748;score on modified rankin scale — no . ( % ) §;"C0449820;C2984908;C3854213;C4050231";FALSE;2053;score on modified rankin scale no
 748;modified rankin scale score;"C0449820;C2984908;C3854213;C4050231";FALSE;2054;modified rankin scale score
 748;modified rankin score;"C0392747;C0449820;C3889737;C4050231";FALSE;2054;modified rankin score
 748;joint space narrowing score;"C0449820;C1859695;C4050231";FALSE;2055;joint space narrowing score
 748;joint space narrowing score  mean ( sd );"C0444504;C0449820;C1859695;C2347634;C2348143;C2699239;C4050231";FALSE;2055;joint space narrowing score mean sd
 748;jsn score;"C0449820;C4050231";FALSE;2055;jsn score
 748;jsn score  mean $nmbr$ sd;"C0444504;C0449820;C2347634;C2348143;C2699239;C4050231";FALSE;2055;jsn score mean $nmbr$ sd
 748;jsn score ( $nmbr$ – $nmbr$ scale );"C0175659;C0349674;C0449820;C1947916;C4050231";FALSE;2055;jsn score $nmbr$ $nmbr$ scale
 748;weekly number of hives score {;"C0042109;C0237753;C0332174;C0449788;C0449820;C4050231";FALSE;2058;weekly number of hives score
 748;weekly number of hives score $nmbr$;"C0042109;C0237753;C0332174;C0449788;C0449820;C4050231";FALSE;2058;weekly number of hives score $nmbr$
 748;weekly size of largest hives score {;"C0042109;C0332174;C0443228;C0449820;C0456389;C4050231";FALSE;2058;weekly size of largest hives score
 748;first primary ( change in updrs score / wk  wk $nmbr$ - $nmbr$ );"C0205225;C0205435;C0332174;C0392747;C0439230;C0439612;C0439631;C0443172;C0449820;C1279901;C1705241;C3639721;C4050231;C4319952";NA;NA;first primary change in updrs score wk wk $nmbr$ $nmbr$
 748;femoral neck t - score;"C0015815;C0449820;C4050231";NA;NA;femoral neck t score
 748;femoral neck bmd t - score;"C0015815;C0449820;C4050231";NA;NA;femoral neck bmd t score
 748;facit - f score;"C0449820;C3272505;C4050231";NA;NA;facit f score
 748;edss score;"C0449820;C0451246;C3887783;C4050231";NA;NA;edss score
 748;crohn ' s disease activity index score ];"C0449820;C0451071;C4050231";NA;NA;crohn s disease activity index score
 748;chf score ( u );"C0018802;C0439148;C0449820;C4050231";NA;NA;chf score u
 748;change from baseline to week $nmbr$ in weekly no . of hives score;"C0042109;C0168634;C0332174;C0392747;C0439230;C0443172;C0449820;C1442488;C1705241;C4050231;C4319952";NA;NA;change from baseline to week $nmbr$ in weekly no of hives score
 748;change from baseline in aqlq { s ) score;"C0168634;C0392747;C0443172;C0449820;C1442488;C1705241;C4050231;C4055434;C4319952";NA;NA;change from baseline in aqlq s score
 748;cha $nmbr$ s $nmbr$ score;"C0449820;C1420648;C4050231";NA;NA;cha $nmbr$ s $nmbr$ score
 748;ccq score § §;"C0449820;C4050231";NA;NA;ccq score
 748;cadillac score;"C0449820;C4050231";NA;NA;cadillac score
 748;bii score;"C0449820;C1413059;C4050231";NA;NA;bii score
 748;baseline nihss score ( % ) #;"C0168634;C0449820;C1442488;C1697238;C4050231";NA;NA;baseline nihss score
 748;baseline nihss score  median ( range );"C0168634;C0449820;C0549183;C0876920;C1442488;C1514721;C1697238;C2347635;C2348144;C2348147;C2939193;C3542016;C4050231";NA;NA;baseline nihss score median range
 748;baseline dyspnea index score;"C0449820;C1511069;C4050231";NA;NA;baseline dyspnea index score
 748;baseline bmd t score at femoral neck;"C0015815;C0168634;C0449820;C1442488;C4050231";NA;NA;baseline bmd t score at femoral neck
 748;admission grace score;"C0184666;C0449820;C0809949;C4050231";NA;NA;admission grace score
 748;accp score;"C0449820;C4050231";NA;NA;accp score
 748;abbreviations : ace  angiotensin - converting enzyme  iqr  interquartile range  ml  myocardial infarction . si conversion : to convert creatinine clearance to ml / s  multiply by $nmbr$ . $nmbr$ . * data are expressed as no . / total ( % ) unless otherwise specified . festimated using cockroft - gault equation . tthe timi risk score was used to categorize patients at low ( $nmbr$ - $nmbr$ )  intermediate ( $nmbr$ - $nmbr$ )  and high ( $nmbr$ - $nmbr$ ) risk . $nmbr$;"C0000723;C0021308;C0022709;C0027061;C0030705;C0035647;C0040363;C0041260;C0205103;C0205250;C0205251;C0205369;C0439175;C0439390;C0439526;C0439810;C0439836;C0449820;C0552449;C0812399;C0871968;C1273517;C1299351;C1511726;C1514721;C1522564;C1524063;C1550465;C1550472;C1705224;C1719797;C1883351;C2348147;C2700149;C2827755;C2911648;C3245479;C3542016;C3714741;C3887512;C3887665;C3889660;C3889971;C3890211;C4048187;C4050231;C4321237;C4321351;C4522209;C4522223;C4552904";NA;NA;abbreviations ace angiotensin converting enzyme iqr interquartile range ml myocardial infarction si conversion to convert creatinine clearance to ml s multiply by $nmbr$ $nmbr$ data are expressed as no total unless otherwise specified festimated using cockroft gault equation tthe timi risk score was used to categorize patients at low $nmbr$ $nmbr$ intermediate $nmbr$ $nmbr$ and high $nmbr$ $nmbr$ risk $nmbr$
 748;- $nmbr$ < flex fn f - score;"C0016327;C0449820;C1570610;C4050231";NA;NA;$nmbr$ flex fn f score
 748;- $nmbr$ . $nmbr$ < ls t - score < — $nmbr$ . $nmbr$;"C0023668;C0449820;C4050231";NA;NA;$nmbr$ $nmbr$ ls t score $nmbr$ $nmbr$
 748;- $nmbr$ . $nmbr$ < ls t - score;"C0023668;C0449820;C4050231";NA;NA;$nmbr$ $nmbr$ ls t score
 748;- $nmbr$ . $nmbr$ < flex fn f - score < - $nmbr$;"C0016327;C0449820;C1570610;C4050231";NA;NA;$nmbr$ $nmbr$ flex fn f score $nmbr$
 747;target vessel diameter;"C0449618;C1301886";NA;NA;target vessel diameter
 747;target vessel;C0449618;NA;NA;target vessel
 747;target - vessel revascularization;"C0449618;C0581603";NA;NA;target vessel revascularization
 747;number of target vessels;"C0237753;C0449618;C0449788";NA;NA;number of target vessels
 747;no . of target vessels;C0449618;NA;NA;no of target vessels
 747;large vessel;C0225990;NA;NA;large vessel
 746;two - vessel disease;C0581375;NA;NA;two vessel disease
 746;triple - vessel disease  n ( % );C0856738;NA;NA;triple vessel disease n
 746;three - vessel disease;C3272265;NA;NA;three vessel disease
 746;small vessel;C0225988;NA;NA;small vessel
 745;vessels with stenosis > $nmbr$ %;C0679403;NA;NA;vessels with stenosis $nmbr$
 745;stented vessels;C0183521;NA;NA;stented vessels
 745;stented vessel;C0183521;NA;NA;stented vessel
 745;non - stenotic vessels  n ( % );"C0679403;C1518422";NA;NA;non stenotic vessels n
 745;> $nmbr$ vessels with > $nmbr$ % stenosis;C0679403;NA;NA;$nmbr$ vessels with $nmbr$ stenosis
 744;variable_level;"C0439828;C0441889;C0456079;C1547707;C2946261;C4553760";NA;NA;variable_level
 744;troponin level;"C0041199;C0441889;C0456079;C1547707;C2946261";NA;NA;troponin level
 744;risk factors and immobility level  n ( % );"C0035648;C0231441;C0441889;C0456079;C1547707;C1553898;C2946261";NA;NA;risk factors and immobility level n
 744;no active cancer center - level inr percent time;"C0040223;C0205177;C0439165;C0441889;C0456079;C0525032;C1513817;C1547707;C1704538;C2946261;C3541383;C3853793;C3888249";NA;NA;no active cancer center level inr percent time
 744;mean — mm hg level — no . ( % );"C0439475;C0441889;C0444504;C0456079;C1547707;C2347634;C2348143;C2946261";NA;NA;mean mm hg level no
 744;level — no . ( % );"C0441889;C0456079;C1547707;C2946261";NA;NA;level no
 744;level $nmbr$ immobility § | |;"C0231441;C0441889;C0456079;C1547707;C2946261";NA;NA;level $nmbr$ immobility
 744;level $nmbr$ immobility ^;"C0231441;C0441889;C0456079;C1547707;C2946261";NA;NA;level $nmbr$ immobility
 744;level $nmbr$;"C0441889;C0456079;C1547707;C2946261";NA;NA;level $nmbr$
 744;hscrp level;"C0441889;C0456079;C1547707;C2946261";NA;NA;hscrp level
 744;geometric anti - dsdna antibody binding level;"C0441889;C0449829;C0456079;C1145667;C1167622;C1547707;C2355607;C2746079;C2946261";NA;NA;geometric anti dsdna antibody binding level
 744;european quality of life - $nmbr$ dimensions - $nmbr$ level ( eq - $nmbr$ d );"C0034380;C0205163;C0239307;C0439185;C0439534;C0441889;C0456079;C0518214;C1535514;C1547707;C2946261";NA;NA;european quality of life $nmbr$ dimensions $nmbr$ level eq $nmbr$ d
 744;elevated natriuretic peptide level ( n = $nmbr$ );"C0205250;C0441889;C0456079;C1144709;C1547707;C2709270;C2946261;C3163633;C3537020";NA;NA;elevated natriuretic peptide level n $nmbr$
 744;characteristic_level;"C0441889;C0456079;C1521970;C1547707;C2946261";NA;NA;characteristic_level
 744;center level ttr;"C0032923;C0205099;C0441889;C0456079;C1421224;C1547707;C2946261;C3810851";NA;NA;center level ttr
 744;cardiac troponin t level > $nmbr$ . $nmbr$ pg / l;"C0439278;C0441889;C0456079;C1547707;C2946261;C3538889";NA;NA;cardiac troponin t level $nmbr$ $nmbr$ pg l
 744;cardiac troponin t level  median ( iqr )  pg / l;"C0439278;C0441889;C0456079;C0549183;C0876920;C1547707;C2347635;C2348144;C2939193;C2946261;C3538889";NA;NA;cardiac troponin t level median iqr pg l
 743;vessel treated  n;"C0005847;C0369718;C0441922;C1522326";NA;NA;vessel treated n
 743;vascular territory # $nmbr$;"C0005847;C1301808;C1558950;C1801960;C2983136";NA;NA;vascular territory $nmbr$
 743;vascular intervention;"C0005847;C0184661;C0886296;C1273869;C1558950;C1801960";NA;NA;vascular intervention
 743;vascular disordersb;"C0005847;C1558950;C1801960";NA;NA;vascular disordersb
 748;crusade bleeding score;"C0019080;C0449820;C4050231";FALSE;2056;crusade bleeding score
 748;aqlq score;"C0449820;C4050231;C4055434";FALSE;2057;aqlq score
 748;aqlq score  mean;"C0444504;C0449820;C2347634;C2348143;C4050231;C4055434";FALSE;2057;aqlq score mean
 748;aqlq ( si + $nmbr$ score ’;"C0449820;C4050231;C4055434";FALSE;2057;aqlq si $nmbr$ score
 516;inferior mi *  %;"C0340305;C3542426";NA;NA;inferior mi
 743;vascular accidents  n ( % );"C0000924;C0005847;C1558950;C1801960";NA;NA;vascular accidents n
 743;vascular access site †;"C0005847;C0205145;C0589360;C0750138;C1515974;C1558950;C1801960;C2825164";NA;NA;vascular access site
 743;vascular;"C0005847;C1558950;C1801960";NA;NA;vascular
 743;urgent vascular hospitalization;"C0005847;C0019993;C0439609;C1558950;C1801960;C3272275";NA;NA;urgent vascular hospitalization
 743;treated vessel ( s );"C0005847;C1522326";NA;NA;treated vessel s
 743;treated vessel !;"C0005847;C1522326";NA;NA;treated vessel
 743;treated vessel;"C0005847;C1522326";NA;NA;treated vessel
 743;timi flow grade $nmbr$ of mi culprit vessel pre ‐ pci;"C0005847;C0332152;C0441800;C0740175;C0919553;C2257086;C3244287;C3272266;C3669034;C3810814;C4049621";NA;NA;timi flow grade $nmbr$ of mi culprit vessel pre pci
 743;single vessel coronary artery diseasea;"C0005847;C0265903";NA;NA;single vessel coronary artery diseasea
 743;restenotic vessel;"C0005847;C0333186";NA;NA;restenotic vessel
 743;number of vessels treated  index pci;"C0005847;C0237753;C0449788;C0600653;C0918012;C1522326;C1552854;C1637833;C2986546;C4049621";NA;NA;number of vessels treated index pci
 743;number of treated vessels ( per patient );"C0005847;C0030705;C0237753;C0449788;C1522326";NA;NA;number of treated vessels per patient
 743;number of treated vessels;"C0005847;C0237753;C0449788;C1522326";NA;NA;number of treated vessels
 743;number of diseased vessels  mean ( sd );"C0005847;C0237753;C0444504;C0449788;C2347634;C2348143;C2699239";NA;NA;number of diseased vessels mean sd
 743;no culprit vessel identified;"C0005847;C0205396;C1550043";NA;NA;no culprit vessel identified
 743;no . of vessels treated;"C0005847;C1522326";NA;NA;no of vessels treated
 743;no . of vessels;C0005847;NA;NA;no of vessels
 743;no . of treated vessels;"C0005847;C1522326";NA;NA;no of treated vessels
 743;multi vessel ( or left main );"C0005847;C0205091;C0205225;C0439064;C0443246;C1542147;C1552822;C3266262";NA;NA;multi vessel or left main
 743;more than $nmbr$ vessels stented;"C0005847;C0038257;C0205172";NA;NA;more than $nmbr$ vessels stented
 743;cvd / mi / stroke / revascularization / urgent vascular hospitalization;"C0005847;C0007222;C0019993;C0038454;C0439609;C0581603;C1558950;C1801960;C3272275;C3810814;C4554100";NA;NA;cvd mi stroke revascularization urgent vascular hospitalization
 743;culprit vessel;C0005847;NA;NA;culprit vessel
 743;any vascular diasease;"C0005847;C1558950;C1801960";NA;NA;any vascular diasease
 743;any vascular *   efficacy;"C0005847;C1280519;C1558950;C1707887;C1801960";NA;NA;any vascular efficacy
 743;> $nmbr$ vessels treated;"C0005847;C1522326";NA;NA;$nmbr$ vessels treated
 743;> $nmbr$ diseased vessels;C0005847;NA;NA;$nmbr$ diseased vessels
 743;$nmbr$ vessels or left main;"C0005847;C0205091;C0205225;C0443246;C1542147;C1552822";NA;NA;$nmbr$ vessels or left main
 743;$nmbr$ vessels;C0005847;NA;NA;$nmbr$ vessels
 743;$nmbr$ vessel;C0005847;NA;NA;$nmbr$ vessel
 742;tnfi and other bdmardst  n ( % );NA;NA;NA;tnfi and other bdmardst n
 742;otherx;NA;NA;NA;otherx
 742;otherd;NA;NA;NA;otherd
 742;other { n = $nmbr$ );"C0369718;C0441922";NA;NA;other n $nmbr$
 742;other vasculars;NA;NA;NA;other vasculars
 742;other vascular disease ( cvd or pad )  %;"C0007222;C0042373;C0182158;C0332568;C3540603;C3669270;C3814046;C4319657";NA;NA;other vascular disease cvd or pad
 742;other vascular disease;C0042373;NA;NA;other vascular disease
 742;other n ( % );"C0369718;C0441922";NA;NA;other n
 742;other * ( n = $nmbr$ );"C0369718;C0441922";NA;NA;other n $nmbr$
 742;other ( n — $nmbr$ );"C0369718;C0441922";NA;NA;other n $nmbr$
 742;other ( n   = $nmbr$ );"C0369718;C0441922";NA;NA;other n $nmbr$
 742;other ( n = $nmbr$ );"C0369718;C0441922";NA;NA;other n $nmbr$
 742;other ( n = $nmbr$  $nmbr$ ];"C0369718;C0441922";NA;NA;other n $nmbr$ $nmbr$
 742;other ( n = $nmbr$  $nmbr$ );"C0369718;C0441922";NA;NA;other n $nmbr$ $nmbr$
 742;other ( n  % );"C0369718;C0441922";NA;NA;other n
 742;other  n ( % );"C0369718;C0441922";NA;NA;other n
 742;extensive disease other;C0849867;NA;NA;extensive disease other
 742;dpi ( other than diskus )  n;C1553480;NA;NA;dpi other than diskus n
 742;all other;NA;NA;NA;all other
 741;othersc;NA;NA;NA;othersc
 741;others  n ( % );"C1955473;C3539125";NA;NA;others n
 741;others;"C1955473;C3539125";NA;NA;others
 741;otherc;NA;NA;NA;otherc
 741;all others eteed for $nmbr$ mg edoxaban dose at;"C1955473;C2975435;C3539125;C4086581";NA;NA;all others eteed for $nmbr$ mg edoxaban dose at
 741;all others  n ( % );"C1955473;C3539125";NA;NA;all others n
 741;all others;"C1955473;C3539125";NA;NA;all others
 740;otherz;NA;NA;NA;otherz
 740;otherf;NA;NA;NA;otherf
 740;other osteoporosis medication;"C0013227;C0029456;C3244316;C4284232;C4554622";NA;NA;other osteoporosis medication
 740;other medication usage;"C0013227;C0457083;C3244316;C4284232";NA;NA;other medication usage
 740;other glucose - lowering drugs;"C0013227;C0017725;C0441994;C2003888;C3687832";NA;NA;other glucose lowering drugs
 740;other drugs — no . ( % );"C0013227;C3687832";NA;NA;other drugs no
 740;other drugs;"C0013227;C3687832";NA;NA;other drugs
 740;other * ’;NA;NA;NA;other
 740;any other antihyperglycaemic drugs;"C0013227;C0020616;C3687832";NA;NA;any other antihyperglycaemic drugs
 739;upper tertile : > $nmbr$ . $nmbr$;C1282910;NA;NA;upper tertile $nmbr$ $nmbr$
 739;upper;C1282910;NA;NA;upper
 739;none of the above;"C1282910;C1552828";NA;NA;none of the above
 739;history of upper gl events ( perforations  ulcers  bleeding )  n ( % );"C0018229;C0019080;C0019664;C0019665;C0041582;C0262512;C0262926;C0369718;C0441471;C0441922;C0549099;C1282910;C1423073;C1427674;C1705255;C2004062;C3541888";NA;NA;history of upper gl events perforations ulcers bleeding n
 739;any of the above;"C1282910;C1552828";NA;NA;any of the above
 739;all of the above;"C1282910;C1552828";NA;NA;all of the above
 738;one - vessel disease;C3275121;NA;NA;one vessel disease
 738;noneh;NA;NA;NA;noneh
 738;none 一 no . ( % );NA;NA;NA;none no
 738;none ( n = $nmbr$ );"C0369718;C0441922";NA;NA;none n $nmbr$
 738;none;NA;NA;NA;none
 737;one vessel;"C0005847;C0205447";NA;NA;one vessel
 737;one tnfi and;C0205447;NA;NA;one tnfi and
 737;one tnfi *;C0205447;NA;NA;one tnfi
 737;one of the above;C0205447;NA;NA;one of the above
 737;one lesion;"C0205447;C0221198;C1546698";NA;NA;one lesion
 736;time since psa onset  mean years ( sd );"C0040223;C0206132;C0332162;C0439234;C0444504;C2347634;C2348143;C2699239;C3541383;C3810537;C3813209";NA;NA;time since psa onset mean years sd
 736;time since onset ( h );"C0033727;C0040223;C0206132;C0332162;C0369286;C0441932;C0564385;C3541383;C4528284";NA;NA;time since onset h
 736;since onset;"C0206132;C0332162";NA;NA;since onset
 736;onset of chest pain;"C0024902;C0206132;C0332162";NA;NA;onset of chest pain
 736;onset $nmbr$ [ $nmbr$ ];"C0206132;C0332162";NA;NA;onset $nmbr$ $nmbr$
 736;age of onset < $nmbr$ years ( n = $nmbr$ );"C0206132;C0439234;C3175530";NA;NA;age of onset $nmbr$ years n $nmbr$
 736;age of onset $nmbr$ years ( n = $nmbr$ );"C0206132;C0439234;C3175530";NA;NA;age of onset $nmbr$ years n $nmbr$
 736;age of onset;"C0206132;C3175530";NA;NA;age of onset
 736;age of asthma onset  years;"C0004096;C0206132;C0439234;C2984299;C3175530";NA;NA;age of asthma onset years
 736;age at onset  y;"C0206132;C3870509";NA;NA;age at onset y
 736;age at disease onset  years *;"C0012634;C0206132;C0439234;C3870509";NA;NA;age at disease onset years
 736;age at disease onset  n ( % ) *;"C0012634;C0206132;C3870509";NA;NA;age at disease onset n
 735;lower - target group ( n = $nmbr$ );"C0441848;C0441994;C1521840;C1548802;C2003888;C2986546";NA;NA;lower target group n $nmbr$
   7;multivariate p - value;C1709380;NA;NA;multivariate p value
 735;higher - target group ( n = $nmbr$ );"C0205250;C0441848;C1521840;C2986546";NA;NA;higher target group n $nmbr$
 508;total n;"C0439175;C0439810";NA;NA;total n
 735;average daily dose ( % of target ) *;"C1510992;C1521840;C2348070;C2825518;C2986546";NA;NA;average daily dose of target
 735;( % of target ) ∗;"C1521840;C2986546";NA;NA;of target
 734;suit index  nmol / mmol;"C0600653;C0918012;C1532564;C1533073;C1552854;C1637833;C2986546";NA;NA;suit index nmol mmol
 734;qualifying index event as pe;"C0070939;C0441471;C0600653;C0918012;C1514624;C1552854;C1637833;C1880476;C2986546;C4019010;C4284304";NA;NA;qualifying index event as pe
 734;nternational index of;"C0600653;C0918012;C1552854;C1637833;C2986546";NA;NA;nternational index of
 734;mean slicc damage index score ± sd;"C0010957;C0600653;C0918012;C1552854;C1637833;C1883709;C2699239;C2986546;C3533236";NA;NA;mean slicc damage index score sd
 734;mean preoperative abpi of the index;"C0444504;C0445204;C0600653;C0918012;C1552854;C1637833;C2347634;C2348143;C2986546";NA;NA;mean preoperative abpi of the index
 734;mass index;"C0577559;C0577573;C0600653;C0918012;C1096155;C1306372;C1552854;C1637833;C2986546;C3152252;C3539882;C4283905";NA;NA;mass index
 734;lv mass index ( g / m $nmbr$ - $nmbr$ );"C0455825;C0456715;C0600653;C0918012;C1552854;C1637833;C2986546";NA;NA;lv mass index g m $nmbr$ $nmbr$
 734;labs at the index acs event;"C0441471;C0587081;C0600653;C0742343;C0918012;C1552854;C1637833;C2986546;C4019010;C4318612";NA;NA;labs at the index acs event
 734;interval after index event;"C0441471;C0600653;C0918012;C1272706;C1552654;C1552713;C1552854;C1637833;C2986546;C4019010";NA;NA;interval after index event
 734;insulinogenic index ( dinsulino_ $nmbr$ o min / dglucoseo - $nmbr$ o min );"C0600653;C0702093;C0918012;C1524029;C1552854;C1637833;C2986546;C3813700";NA;NA;insulinogenic index dinsulino_ $nmbr$ o min dglucoseo $nmbr$ o min
 734;indication for index procedure;"C0600653;C0918012;C1552854;C1637833;C2315323;C2986546";NA;NA;indication for index procedure
 734;index pe : event during;"C0070939;C0441471;C0600653;C0918012;C1552854;C1637833;C1880476;C2986546;C4019010;C4284304";NA;NA;index pe event during
 734;index mi ( n - $nmbr$  $nmbr$ );"C0600653;C0918012;C1552854;C1637833;C2986546;C3810814";NA;NA;index mi n $nmbr$ $nmbr$
 734;index inclusion acute coronary syndrome;"C0007637;C0600653;C0918012;C0948089;C1512693;C1552854;C1637833;C2986546";NA;NA;index inclusion acute coronary syndrome
 734;index event subtype;"C0441471;C0449560;C0600653;C0918012;C1552854;C1637833;C2986546;C4019010";NA;NA;index event subtype
 734;index event  %;"C0441471;C0600653;C0918012;C1552854;C1637833;C2986546;C4019010";NA;NA;index event
 734;index diagnosis;"C0011900;C0600653;C0918012;C1552854;C1637833;C1704338;C1704656;C2986546";NA;NA;index diagnosis
 734;index acute coronary syndrome — no . { % );"C0600653;C0918012;C0948089;C1552854;C1637833;C2986546";NA;NA;index acute coronary syndrome no
 734;extent of index event;"C0439792;C0441471;C0600653;C0918012;C1552854;C1637833;C2986546;C4019010";NA;NA;extent of index event
 734;extent of index dvt ' ( n  % of dvt patients ' );"C0030705;C0149871;C0439792;C0600653;C0918012;C1552854;C1637833;C2926618;C2986546;C3899446";NA;NA;extent of index dvt n of dvt patients
 734;disposition index;"C0600653;C0743223;C0918012;C1552854;C1637833;C1705555;C2986546";NA;NA;disposition index
 734;des type at index procedure;"C0011702;C0455713;C0600653;C0918012;C1552854;C1637833;C2986546;C4551552";NA;NA;des type at index procedure
 734;coronary angiography during the index hospitalization;"C0002978;C0019993;C0085532;C0428776;C0600653;C0918012;C1548829;C1552854;C1637833;C2986546";NA;NA;coronary angiography during the index hospitalization
 734;cornell index  pv;"C0030840;C0032463;C0600653;C0918012;C1552854;C1637833;C2986546";NA;NA;cornell index pv
 734;composite physiologic index §;"C0205199;C0205463;C0600653;C0918012;C1547335;C1552854;C1637833;C2986546";NA;NA;composite physiologic index
 734;clinical indication at the index procedure  n ( % );"C0205210;C0600653;C0918012;C1552854;C1637833;C2315323;C2347896;C2986546";NA;NA;clinical indication at the index procedure n
 734;classification of index venous thromboembolism — no . ( % );"C0008902;C0008903;C0600653;C0678229;C0918012;C1552854;C1637833;C1997614;C2986546";NA;NA;classification of index venous thromboembolism no
 734;charlson index ( % );"C0600653;C0918012;C1552854;C1637833;C2986546";NA;NA;charlson index
 734;at index event;"C0441471;C0600653;C0918012;C1552854;C1637833;C2986546;C4019010";NA;NA;at index event
 734;at index acs event;"C0441471;C0600653;C0742343;C0918012;C1552854;C1637833;C2986546;C4019010;C4318612";NA;NA;at index acs event
 734;angiography during index hospitalization;"C0002978;C0019993;C0600653;C0918012;C1552854;C1637833;C2986546";NA;NA;angiography during index hospitalization
 733;reversible to bronchodilator  b %;"C0006280;C0205343";NA;NA;reversible to bronchodilator b
 733;reversible to albuterolc  d  n ( % );C0205343;NA;NA;reversible to albuterolc d n
 733;reversible ( % );C0205343;NA;NA;reversible
 733;reversible;C0205343;NA;NA;reversible
 733;nonreversible;NA;NA;NA;nonreversible
 733;non - reversible ( % );"C0205343;C1518422";NA;NA;non reversible
 733;cluster $nmbr$ : not reversible  no diuretic ( n = $nmbr$ );"C0012798;C0205343;C1518422;C1555715;C1704332";NA;NA;cluster $nmbr$ not reversible no diuretic n $nmbr$
 733;associated with transient or reversible risk factor;"C0035648;C0040704;C0205343;C0205374;C0332281";NA;NA;associated with transient or reversible risk factor
 732;measured at home with automated device;"C0025080;C0205554;C0444706;C0699733;C3541902;C4534363";NA;NA;measured at home with automated device
 732;measured at clinic visit with usual device;"C0008952;C0025080;C0444706;C0699733;C3538928;C3541902";NA;NA;measured at clinic visit with usual device
 732;measured at clinic visit with automated device §;"C0008952;C0025080;C0205554;C0444706;C0699733;C3541902";NA;NA;measured at clinic visit with automated device
 732;devices;"C0025080;C0220819;C0699733";NA;NA;devices
 732;device group ( n = $nmbr$ );"C0025080;C0441848;C0699733";NA;NA;device group n $nmbr$
 731;recervng;NA;NA;NA;recervng
 731;recervini };NA;NA;NA;recervini
 731;received pci;"C1514756;C4049621";NA;NA;received pci
 731;received $nmbr$ prior biologic therapy  n;"C0278947;C1514756";NA;NA;received $nmbr$ prior biologic therapy n
 731;received $nmbr$ prior biologic therapies  n;"C0278947;C1514756";NA;NA;received $nmbr$ prior biologic therapies n
 731;patients who received positive results on test for antibodies to infliximabt;"C0003241;C0030705;C1335447;C1514756";NA;NA;patients who received positive results on test for antibodies to infliximabt
 731;patients who received negative results on test for antibodies to infliximabt;"C0003241;C0030705;C1334932;C1514756";NA;NA;patients who received negative results on test for antibodies to infliximabt
 731;patients who received $nmbr$ or $nmbr$ drugs;"C0013227;C0030705;C1514756;C3687832";NA;NA;patients who received $nmbr$ or $nmbr$ drugs
 731;patients who received $nmbr$ drug;"C0013227;C0030705;C1254351;C1514756";NA;NA;patients who received $nmbr$ drug
 731;patients receiving mtx  n =;"C0025677;C0030705;C1417487;C1514756";NA;NA;patients receiving mtx n
 731;patients receiving mtx;"C0025677;C0030705;C1417487;C1514756";NA;NA;patients receiving mtx
 731;patients not receiving mtx  n =;"C0025677;C0030705;C1417487;C1514756;C1518422";NA;NA;patients not receiving mtx n
 731;not receiving;"C1514756;C1518422";NA;NA;not receiving
 730;seizure reduction from baseline;"C0036572;C0168634;C0301630;C0392756;C1293152;C1442488;C1959629;C4551656;C4553401";NA;NA;seizure reduction from baseline
 730;reduction of hba $nmbr$ c from baseline ≥ $nmbr$ . $nmbr$ %;"C0019016;C0168634;C0301630;C0392756;C1293152;C1442488;C1825777;C3538758;C4551656";NA;NA;reduction of hba $nmbr$ c from baseline $nmbr$ $nmbr$
 730;reduction in odds %;"C0301630;C0392756;C1293152;C4551656";NA;NA;reduction in odds
 734;pci for index mi ( % );"C0600653;C0918012;C1552854;C1637833;C2986546;C3810814;C4049621";FALSE;1661;pci for index mi
 731;received antihypertensive within last $nmbr$ days  n ( % );"C0003364;C0439228;C1514756";FALSE;1579;received antihypertensive within last $nmbr$ days n
 730;rate reduction ( % );"C0301630;C0392756;C0871208;C1293152;C1521828;C4551656";NA;NA;rate reduction
 730;osteoprotegerin decreased;"C0205216;C0392756;C0442797;C0538161;C1308614;C1336645";NA;NA;osteoprotegerin decreased
 730;ocs reduced / stopped;"C0392756;C1272691";NA;NA;ocs reduced stopped
 730;% reduction;"C0301630;C0392756;C1293152;C4551656";NA;NA;reduction
 481;age > $nmbr$ years  %;C1510829;NA;NA;age $nmbr$ years
 730;$nmbr$ ‐ point reduction in selena – sledai score  %;"C0301630;C0392756;C0449820;C0451528;C1293152;C1552961;C2347617;C3714763;C4050231;C4551656";NA;NA;$nmbr$ point reduction in selena sledai score
 -10;= cerebrospinal fluid .;"C0007806;C0007807";NA;NA;cerebrospinal fluid
 728;without cerebrovascular disease;C0007820;NA;NA;without cerebrovascular disease
 728;with cerebrovascular disease;C0007820;NA;NA;with cerebrovascular disease
 728;stroke or cerebrovascular disease;"C0007820;C0038454;C4554100";NA;NA;stroke or cerebrovascular disease
 728;prior cerebrovascular disease;"C0007820;C0332152;C2826257";NA;NA;prior cerebrovascular disease
 728;only cerebrovascular disease;"C0007820;C0205171;C1720467";NA;NA;only cerebrovascular disease
 728;ischemic cerebrovascular disease  n ( % );"C0007820;C0475224";NA;NA;ischemic cerebrovascular disease n
 728;cerebrovascular disorders  n ( % );C0007820;NA;NA;cerebrovascular disorders n
 728;cerebrovascular disease n ( % );C0007820;NA;NA;cerebrovascular disease n
 728;cerebrovascular disease  n ( % );C0007820;NA;NA;cerebrovascular disease n
 728;cerebrovascular disease  %;C0007820;NA;NA;cerebrovascular disease
 728;cerebrovascular disease;C0007820;NA;NA;cerebrovascular disease
 728;cerebral vascular disease;C0007820;NA;NA;cerebral vascular disease
 727;sri ‐ $nmbr$ response rate  %;"C0237629;C1420401";NA;NA;sri $nmbr$ response rate
 727;n ( % ) responders;"C0369718;C0441922";NA;NA;n responders
 727;all responders  ( n = $nmbr$ );NA;NA;NA;all responders n $nmbr$
 726;trough fvc response ( l ) !;"C0444506;C0871261;C1704632;C1706817;C2911692;C3714541";NA;NA;trough fvc response l
 726;trough fvc response ( l );"C0444506;C0871261;C1704632;C1706817;C2911692;C3714541";NA;NA;trough fvc response l
 726;trough fev | response ( l );"C0444506;C0871261;C1704632;C1706817;C2911692;C3714541";NA;NA;trough fev response l
 726;trough fev $nmbr$   response;"C0444506;C0871261;C1704632;C1706817;C2911692;C3714541";NA;NA;trough fev $nmbr$ response
 726;trough fev  response ( l ) i;"C0021966;C0221138;C0444506;C0871261;C1704632;C1706817;C2911692;C3714541";NA;NA;trough fev response l i
 726;stratum $nmbr$ : inadequate response or intolerance to > $nmbr$ bdmards of same moa or > $nmbr$ of multiple moa;"C0205412;C0231199;C0439064;C0439856;C0445247;C0871261;C1704632;C1706817;C1744706;C2355652;C2911692;C4551881";NA;NA;stratum $nmbr$ inadequate response or intolerance to $nmbr$ bdmards of same moa or $nmbr$ of multiple moa
 726;stratum $nmbr$ : inadequate response or intolerance to $nmbr$ - $nmbr$ bdmards of same moa;"C0205412;C0231199;C0439856;C0445247;C0871261;C1704632;C1706817;C1744706;C2355652;C2911692;C4551881";NA;NA;stratum $nmbr$ inadequate response or intolerance to $nmbr$ $nmbr$ bdmards of same moa
 726;sri response  %;"C0871261;C1420401;C1704632;C1706817;C2911692";NA;NA;sri response
 726;previous loss of response to infliximab  n ( % ) *;"C0205156;C0666743;C0871261;C1517945;C1552607;C1704632;C1706817;C2911692";NA;NA;previous loss of response to infliximab n
 726;previous loss of response to and intolerance of infliximab  n ( % ) *;"C0205156;C0231199;C0666743;C0871261;C1517945;C1552607;C1704632;C1706817;C1744706;C2355652;C2911692";NA;NA;previous loss of response to and intolerance of infliximab n
 726;peak fev $nmbr$ ( $nmbr$ - $nmbr$ h )   response;"C0033727;C0369286;C0441932;C0444505;C0564385;C0871261;C1704632;C1706817;C2911692;C3714541;C4528284";NA;NA;peak fev $nmbr$ $nmbr$ $nmbr$ h response
 726;patients with previous loss of response to infliximab;"C0030705;C0205156;C0666743;C0871261;C1517945;C1552607;C1704632;C1706817;C2911692";NA;NA;patients with previous loss of response to infliximab
 726;pasi response by baseline weight  no . / total no . ( % ) * pasi $nmbr$;"C0439175;C0439810;C0871261;C1303013;C1704632;C1706817;C2911692;C4528685";NA;NA;pasi response by baseline weight no total no pasi $nmbr$
 726;pasi $nmbr$ response };"C0871261;C1704632;C1706817;C2911692;C4528685";NA;NA;pasi $nmbr$ response
 726;omeract - oarsi response;"C0871261;C1704632;C1706817;C2911692";NA;NA;omeract oarsi response
 726;loss of response ‘ s;"C0871261;C1517945;C1704632;C1706817;C2911692";NA;NA;loss of response s
 726;loss of response ®;"C0871261;C1517945;C1704632;C1706817;C2911692";NA;NA;loss of response
 726;loss of response : ! : : ! :;"C0871261;C1517945;C1704632;C1706817;C2911692";NA;NA;loss of response
 726;loss of response;"C0871261;C1517945;C1704632;C1706817;C2911692";NA;NA;loss of response
 726;inadequate response / intolerance to prior therapy  %;"C0039798;C0087111;C0205412;C0231199;C0332152;C0439856;C0871261;C1363945;C1704632;C1706817;C1744706;C2355652;C2911692";NA;NA;inadequate response intolerance to prior therapy
 726;inadequate response ' ’ ';"C0205412;C0439856;C0871261;C1704632;C1706817;C2911692";NA;NA;inadequate response
 726;inadequate response ' ^;"C0205412;C0439856;C0871261;C1704632;C1706817;C2911692";NA;NA;inadequate response
 726;inadequate response;"C0205412;C0439856;C0871261;C1704632;C1706817;C2911692";NA;NA;inadequate response
 726;eular good response;"C0205170;C0871261;C1704632;C1706817;C2911692";NA;NA;eular good response
 726;bronchodilator response  ml;"C0006280;C0439526;C0871261;C1704632;C1705224;C1706817;C2911692;C3887665";NA;NA;bronchodilator response ml
 725;medical treatment  n ( % );C0679624;NA;NA;medical treatment n
 725;medical treatment;C0679624;NA;NA;medical treatment
 725;hypertension requiring treatment;C0578998;NA;NA;hypertension requiring treatment
 725;hypertension requiring medical treatment;"C0020538;C0679624;C1963138";NA;NA;hypertension requiring medical treatment
 725;hypertension  receiving treatment  n ( % );"C0578998;C1514756";NA;NA;hypertension receiving treatment n
 725;conventional treatment ( n = $nmbr$ );C2945704;NA;NA;conventional treatment n $nmbr$
 725;conventional treatment;C2945704;NA;NA;conventional treatment
 724;≥ $nmbr$ teae;NA;NA;NA;$nmbr$ teae
 724;abbreviations :   teae  treatment - emergent adverse event  gly  glycopyrrolate inhalation solution  bid  twice daily .;"C0000723;C0017890;C0017970;C0523677;C0585361;C1154181;C4684800";NA;NA;abbreviations teae treatment emergent adverse event gly glycopyrrolate inhalation solution bid twice daily
 723;naive : no;NA;NA;NA;naive no
 723;naive ( no treatment for current flare );"C1517205;C2827774;C3540542";NA;NA;naive no treatment for current flare
 723;active treatment;C1704532;NA;NA;active treatment
 722;transient st elevation;"C0040704;C0205374;C0520886";NA;NA;transient st elevation
 722;transient;"C0040704;C0205374";NA;NA;transient
 722;prior transient ischaemic;"C0040704;C0205374;C0332152;C0475224;C2826257";NA;NA;prior transient ischaemic
 721;prevalent cvd;"C0007222;C0033105;C0220900";NA;NA;prevalent cvd
 721;fracture status prevalent vertebral fractured;"C0016658;C0033105;C0220900;C0449438;C0549207;C4554413";NA;NA;fracture status prevalent vertebral fractured
 720;sufficient;C0205410;NA;NA;sufficient
 720;j $nmbr$ coefficient;C1707429;NA;NA;j $nmbr$ coefficient
 720;coefficient;C1707429;NA;NA;coefficient
 719;persistent wrf ( n = $nmbr$ );"C0205322;C0332996";NA;NA;persistent wrf n $nmbr$
 719;persistent or paroxysmal;"C0205311;C0205322;C0332996";NA;NA;persistent or paroxysmal
 719;persistent faol ( n [ $nmbr$ );"C0205322;C0332996";NA;NA;persistent faol n $nmbr$
 719;persistent faod ( n [ $nmbr$ );"C0205322;C0332996";NA;NA;persistent faod n $nmbr$
 719;persistent af  n ( % );"C0205322;C0332996;C0344434;C4049859";NA;NA;persistent af n
 719;persistent af;"C0205322;C0332996;C0344434;C4049859";NA;NA;persistent af
 719;persistent *;"C0205322;C0332996";NA;NA;persistent
 719;persistent ( n  % );"C0205322;C0332996";NA;NA;persistent n
 719;persistent  n ( % );"C0205322;C0332996";NA;NA;persistent n
 719;persistent;"C0205322;C0332996";NA;NA;persistent
 719;persisent;NA;NA;NA;persisent
 719;no persistent wrf ( n = $nmbr$  $nmbr$ );"C0205322;C0332996";NA;NA;no persistent wrf n $nmbr$ $nmbr$
 719;long - standing persistent;"C0205166;C0205322;C0231472;C0332996;C1706317";NA;NA;long standing persistent
 718;persistent or permanent immobilization;"C0020944;C0205322;C0205355;C0332996;C4048292";NA;NA;persistent or permanent immobilization
 718;persistent / permanent;"C0205322;C0205355;C0332996";NA;NA;persistent permanent
 718;permanent users  n;"C0205355;C1706077";NA;NA;permanent users n
 718;permanent users;"C0205355;C1706077";NA;NA;permanent users
 718;permanent af;"C0205355;C0344434;C4049859";NA;NA;permanent af
 718;permanent ( n  % );C0205355;NA;NA;permanent n
 718;permanent  n ( % );C0205355;NA;NA;permanent n
 717;treatment throughout study;"C1521826;C3161471";NA;NA;treatment throughout study
 717;study treatment — no . / total no . ( % );"C0439175;C0439810;C1521826";NA;NA;study treatment no total no
 717;study treatment;C1521826;NA;NA;study treatment
 717;standard treatment ( n - $nmbr$ );C4684780;NA;NA;standard treatment n $nmbr$
 717;prior treatment status;"C0332152;C0449438;C0749659;C1514463;C2826257";NA;NA;prior treatment status
 717;previously failed anti - tnf treatment  no . ( % );"C0039798;C0087111;C0231175;C1448177;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;previously failed anti tnf treatment no
 717;previously;NA;NA;NA;previously
 717;previous treatment in the healing study  n ( % );"C0043240;C0205156;C0205249;C1521826;C1552607;C3161471";NA;NA;previous treatment in the healing study n
 717;prestudy treatment status;C0749659;NA;NA;prestudy treatment status
 717;continued treatment study;"C0549178;C3161471";NA;NA;continued treatment study
 716;treatment satisfaction;C3476649;NA;NA;treatment satisfaction
 716;rank based on treatment   =   placebo;"C0032042;C0667477;C0699794;C1527178;C1696465;C1705938;C1706408;C4684449";NA;NA;rank based on treatment placebo
 716;planned treatment duration  n ( % );C4528394;NA;NA;planned treatment duration n
 716;past treatment for paod;C2945691;NA;NA;past treatment for paod
 716;on - treatment;C4684449;NA;NA;on treatment
 716;methotrexate treatment !;C0746573;NA;NA;methotrexate treatment
 715;with laba  n ( % ) pretreatment;"C1550147;C2709094;C3539075;C3539076";NA;NA;with laba n pretreatment
 715;pretreatment hdl - c;"C1550147;C2709094;C3539075;C3539076;C3715113";NA;NA;pretreatment hdl c
 715;pre - treatment [ n ( % ) ] c;"C1550147;C2709094;C3539075;C3539076";NA;NA;pre treatment n c
 715;no pretreatment;"C1550147;C2709094;C3539075;C3539076";NA;NA;no pretreatment
 714;bb after randomisation;"C0004739;C0034656;C0332297";NA;NA;bb after randomisation
 714;bb;"C0004739;C0332297";NA;NA;bb
 714;acei / arb and bb after randomisation;"C0004739;C0034656;C0332297;C3888198";NA;NA;acei arb and bb after randomisation
 714;- < — ■ bb — - ►;"C0004739;C0332297";NA;NA;bb
 713;subjects stratified by baseline pra;"C0168634;C0205363;C0633231;C0681850;C1141951;C1419788;C1442488;C1550501;C1706203;C2349001;C2697811;C3274822;C3669212;C4283900";NA;NA;subjects stratified by baseline pra
 713;stratified by;C0205363;NA;NA;stratified by
 711;trough seated hr ( bpm ) a;"C0277814;C0444506;C1283233";NA;NA;trough seated hr bpm a
 711;seated sbp  n;"C0085805;C0277814;C1283233";NA;NA;seated sbp n
 710;obesity t;"C0028754;C1963185";NA;NA;obesity t
 710;obesity * ( bm $nmbr$ > $nmbr$ kg / m $nmbr$ );"C0006416;C0028754;C1532718;C1963185";NA;NA;obesity bm $nmbr$ $nmbr$ kg m $nmbr$
 710;obesity *;"C0028754;C1963185";NA;NA;obesity
 710;obesity ( % ) §;"C0028754;C1963185";NA;NA;obesity
 710;obesity  % *;"C0028754;C1963185";NA;NA;obesity
 710;obesity;"C0028754;C1963185";NA;NA;obesity
 710;obese ( > $nmbr$ kg / m $nmbr$ ) b;"C0028754;C1532718";NA;NA;obese $nmbr$ kg m $nmbr$ b
 710;obese ( > $nmbr$ kg / m $nmbr$ );"C0028754;C1532718";NA;NA;obese $nmbr$ kg m $nmbr$
 710;obese;C0028754;NA;NA;obese
 710;> $nmbr$  obesity class $nmbr$;"C0028754;C0456387;C1518526;C1705943;C1963185";NA;NA;$nmbr$ obesity class $nmbr$
 710;( scale obesity and prediabetes );"C0028754;C0175659;C0349674;C0362046;C1947916;C1963185";NA;NA;scale obesity and prediabetes
 710;$nmbr$ - $nmbr$ - $nmbr$  obesity class $nmbr$;"C0028754;C0456387;C1518526;C1705943;C1963185";NA;NA;$nmbr$ $nmbr$ $nmbr$ obesity class $nmbr$
 709;volumetric bmd by qct;"C0412669;C0445383";NA;NA;volumetric bmd by qct
 709;lost bmd;"C0745777;C3815882";NA;NA;lost bmd
 709;gained bmd;C1517378;NA;NA;gained bmd
 708;form / bud;"C0348078;C0376315;C1522492;C2700462;C2945744;C4255237";NA;NA;form bud
 708;bud / fm $nmbr$ / $nmbr$ atg n = ^ $nmbr$;"C2700462;C2945744;C3540627;C3815109";NA;NA;bud fm $nmbr$ $nmbr$ atg n $nmbr$
 708;bud $nmbr$ ptg n = $nmbr$;"C0039512;C1418830;C2700462;C2945744";NA;NA;bud $nmbr$ ptg n $nmbr$
 707;timi - defined bleeding;"C0019080;C1704788;C3539106";NA;NA;timi defined bleeding
 707;primary + gusto severe bleeding;"C0019080;C0205082;C0205225;C0439612;C0439631;C4050465;C4050466";NA;NA;primary gusto severe bleeding
 707;primary + gusto moderate or severe bleeding;"C0019080;C0205081;C0205082;C0205225;C0439612;C0439631;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335";NA;NA;primary gusto moderate or severe bleeding
 707;has - bled score ’;"C0019080;C0449820;C4050231";NA;NA;has bled score
 707;has - bled score > $nmbr$;"C0019080;C0449820;C4050231";NA;NA;has bled score $nmbr$
 707;has - bled score;"C0019080;C0449820;C4050231";NA;NA;has bled score
 707;has - bled > $nmbr$;C0019080;NA;NA;has bled $nmbr$
 707;has - bled $nmbr$ - $nmbr$;C0019080;NA;NA;has bled $nmbr$ $nmbr$
 707;gusto severe bleed;"C0019080;C0205082;C4050465;C4050466";NA;NA;gusto severe bleed
 707;gusto moderate / severe bleed;"C0019080;C0205081;C0205082;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335";NA;NA;gusto moderate severe bleed
 707;gusto - defined bleeding;"C0019080;C1704788;C3539106";NA;NA;gusto defined bleeding
 707;gusto - bleeding severe / moderate;"C0019080;C1299393";NA;NA;gusto bleeding severe moderate
 707;fatal bleeding;"C0019080;C1302234;C1705232";NA;NA;fatal bleeding
 707;fatal bleed;"C0019080;C1302234;C1705232";NA;NA;fatal bleed
 707;bleeding outcomes;"C0019080;C1274040";NA;NA;bleeding outcomes
 707;bleeding events during the entire study;"C0019080;C0439751;C0441471;C0444667;C0557651;C2603343;C3541888";NA;NA;bleeding events during the entire study
 707;bleeding events during first $nmbr$ days of treatmen;"C0019080;C0205435;C0439228;C0441471;C1279901;C3541888";NA;NA;bleeding events during first $nmbr$ days of treatmen
 707;bleeding;C0019080;NA;NA;bleeding
 707;any timi bleeding;C0019080;NA;NA;any timi bleeding
 707;any overt bleed;C0019080;NA;NA;any overt bleed
 707;any gusto bleeding;C0019080;NA;NA;any gusto bleeding
 707;any bleeding;C0019080;NA;NA;any bleeding
 712;heart rate > $nmbr$ bpm;C0018810;FALSE;1105;heart rate $nmbr$ bpm
 712;heart rate ( sd )  bpm;"C0018810;C2699239";FALSE;1105;heart rate sd bpm
 712;heart rate ( sd )  bpm blood pressure  mm hg;"C0005823;C0018810;C0439475;C1271104;C1272641;C2699239";FALSE;1105;heart rate sd bpm blood pressure mm hg
 712;pulse rate ( bpm );C0232117;FALSE;1105;pulse rate bpm
 712;pulse rate  bpm ( mean $nmbr$ h )  mean ( sd ) *;"C0033727;C0232117;C0369286;C0441932;C0444504;C0564385;C2347634;C2348143;C2699239;C4528284";FALSE;1105;pulse rate bpm mean $nmbr$ h mean sd
 712;pulse rate ( mean $nmbr$ h )  bpm *;"C0033727;C0232117;C0369286;C0441932;C0444504;C0564385;C2347634;C2348143;C4528284";FALSE;1105;pulse rate mean $nmbr$ h bpm
 712;< $nmbr$ bpm ( n = $nmbr$ );NA;FALSE;1105;$nmbr$ bpm n $nmbr$
 712;≥ $nmbr$ bpm ( n = $nmbr$ );NA;FALSE;1105;$nmbr$ bpm n $nmbr$
 712;> $nmbr$ bpm ( n = $nmbr$ );NA;FALSE;1105;$nmbr$ bpm n $nmbr$
 712;< $nmbr$ . $nmbr$ bpm;NA;FALSE;1105;$nmbr$ $nmbr$ bpm
 707;acuity - defined bleeding;"C0019080;C0750509;C1704788;C3539106";NA;NA;acuity defined bleeding
 706;cyclo;C1172566;NA;NA;cyclo
 706;crcl < $nmbr$;C1846718;NA;NA;crcl $nmbr$
 706;crcl $nmbr$ - $nmbr$;C1846718;NA;NA;crcl $nmbr$ $nmbr$
 706;crci > $nmbr$ - < $nmbr$;NA;NA;NA;crci $nmbr$ $nmbr$
 706;crci > $nmbr$;NA;NA;NA;crci $nmbr$
 706;admission crcl;"C0184666;C0809949;C1846718";NA;NA;admission crcl
 706;> $nmbr$ years or < $nmbr$ crcl  n ( % );"C0439234;C1846718";NA;NA;$nmbr$ years or $nmbr$ crcl n
 706;> $nmbr$ crcl;C1846718;NA;NA;$nmbr$ crcl
 706;< $nmbr$ crcl  n ( % );C1846718;NA;NA;$nmbr$ crcl n
 706;< $nmbr$ crcl;C1846718;NA;NA;$nmbr$ crcl
 706;$nmbr$ - $nmbr$ crcl;C1846718;NA;NA;$nmbr$ $nmbr$ crcl
 705;rs $nmbr$ ( cc ) & rs $nmbr$;"C0008318;C0035970;C3538933;C3714753;C3813325";NA;NA;rs $nmbr$ cc rs $nmbr$
 705;cc;"C0008318;C3538933";NA;NA;cc
 704;olmesartan along with ccb ( n - $nmbr$ );"C0006684;C1098320";NA;NA;olmesartan along with ccb n $nmbr$
 704;olmesartan / ccb - olmesartan / diuretic;"C0006684;C0012798;C1098320";NA;NA;olmesartan ccb olmesartan diuretic
 704;dihydropyridine ccbs;"C0006684;C0012315;C0220821";NA;NA;dihydropyridine ccbs
 704;ccbs  ( % );C0006684;NA;NA;ccbs
 704;ccb;C0006684;NA;NA;ccb
 704;baseiine ccb;C0006684;NA;NA;baseiine ccb
 704;arb = angiotensin ii receptor blocker  ccb;"C0006684;C0521942;C3536793;C3888198";NA;NA;arb angiotensin ii receptor blocker ccb
 704;arb - arb / ccb;"C0006684;C3888198";NA;NA;arb arb ccb
 704;arb + ccb ( n = $nmbr$ );"C0006684;C3888198";NA;NA;arb ccb n $nmbr$
 703;women  > $nmbr$ cm;C0043210;NA;NA;women $nmbr$ cm
 703;women  < $nmbr$ cm;C0043210;NA;NA;women $nmbr$ cm
 703;wc ( cm );"C0013123;C2825512";NA;NA;wc cm
 703;mean wall thickness ( cm );"C0677535;C4054557";NA;NA;mean wall thickness cm
 703;< - $nmbr$ . $nmbr$ cm;NA;NA;NA;$nmbr$ $nmbr$ cm
 702;waist ( cm );C0230097;NA;NA;waist cm
 702;pulmonary vascular resistance  dyne • s • cm $nmbr$;"C0308914;C0456261;C0488644;C0600130";NA;NA;pulmonary vascular resistance dyne s cm $nmbr$
 701;mean bmd ( = sd )  g / cm $nmbr$;"C0439267;C0444504;C2347634;C2348143;C2699239";NA;NA;mean bmd sd g cm $nmbr$
 701;mean ( sd ) bmd in g / cm $nmbr$;"C0439267;C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd bmd in g cm $nmbr$
 701;flex baseline bmd  mean ( sd )  g / cm $nmbr$;"C0168634;C0439267;C0444504;C1442488;C2347634;C2348143;C2699239";NA;NA;flex baseline bmd mean sd g cm $nmbr$
 701;flex baseline bmd  g / cm ^ ( meanisd );"C0168634;C0439267;C1442488";NA;NA;flex baseline bmd g cm meanisd
 701;femoral neck bmd ( g / cm $nmbr$ );"C0015815;C0439267";NA;NA;femoral neck bmd g cm $nmbr$
 701;femoral neck ( n = $nmbr$  $nmbr$ ) bmd ( g / cm $nmbr$ ) ( sd );"C0015815;C0439267;C2699239";NA;NA;femoral neck n $nmbr$ $nmbr$ bmd g cm $nmbr$ sd
 701;cm;NA;NA;NA;cm
 701;bone mineral density ( g / cm $nmbr$ )  mean ( sd );"C0005938;C0177804;C0439267;C0444504;C2347634;C2348143;C2699239";NA;NA;bone mineral density g cm $nmbr$ mean sd
 701;> - $nmbr$ cm;NA;NA;NA;$nmbr$ cm
 701;> $nmbr$ cm;NA;NA;NA;$nmbr$ cm
 701;> $nmbr$ - $nmbr$ cm;NA;NA;NA;$nmbr$ $nmbr$ cm
 701;< $nmbr$ cm;NA;NA;NA;$nmbr$ cm
 701;( cm );NA;NA;NA;cm
 700;urine p / cr;"C0042036;C0042037;C0201975;C2963137;C3539604;C3711669;C4084730;C4553336;C4553337";NA;NA;urine p cr
 700;steroid - free cr - $nmbr$;"C0038317;C0201975;C0332296;C1880497;C1996904;C3539604;C3711669;C4084730;C4553336;C4553337";NA;NA;steroid free cr $nmbr$
 700;crpnonr ?;NA;NA;NA;crpnonr
 700;cr imputation ( random . ) ( n = $nmbr$ );"C0034656;C0201975;C0439605;C2699638;C3539604;C3711669;C4084730;C4553336;C4553337";NA;NA;cr imputation random n $nmbr$
 700;cr + mh + crpnorr;"C0026514;C0201975;C2930980;C3539604;C3711669;C4084730;C4553336;C4553337";NA;NA;cr mh crpnorr
 700;cr + crpnorr;"C0201975;C3539604;C3711669;C4084730;C4553336;C4553337";NA;NA;cr crpnorr
 700;albuminuria < $nmbr$ gram / gram cr;"C0001925;C0201975;C1319635;C3539604;C3711669;C4084730;C4553336;C4553337";NA;NA;albuminuria $nmbr$ gram gram cr
 699;prior surgery for cd  n [ % ];"C0007928;C0034283;C0455610;C4552032";NA;NA;prior surgery for cd n
 699;prior surgery for cd  n ( % );"C0007928;C0034283;C0455610;C4552032";NA;NA;prior surgery for cd n
 699;patients with eligible ses - cd score;"C0007928;C0030705;C0034283;C0449820;C1548635;C4050231;C4552032";NA;NA;patients with eligible ses cd score
 699;cd duration  y;"C0007928;C0034283;C0449238;C2926735;C4552032";NA;NA;cd duration y
 699;cd complications;"C0007928;C0009566;C0034283;C1171258;C4552032";NA;NA;cd complications
 699;cd [ gemini $nmbr$ ] * ’;"C0007928;C0034283;C4552032";NA;NA;cd gemini $nmbr$
 698;prior cad;"C0332152;C1504769;C2239547;C2826257;C3813548;C4284121";NA;NA;prior cad
 698;previous cad  n ( % );"C0205156;C1504769;C1552607;C2239547;C3813548;C4284121";NA;NA;previous cad n
 698;previous cad;"C0205156;C1504769;C1552607;C2239547;C3813548;C4284121";NA;NA;previous cad
 698;premature cad among family members;"C0086282;C0151526;C0205252;C1504769;C2239547;C3813548;C4018905;C4284121";NA;NA;premature cad among family members
 698;no cad / mi;"C1504769;C2239547;C3810814;C3813548;C4284121";NA;NA;no cad mi
 698;multivessel cad ( % );"C1504769;C2239547;C3813548;C4284121";NA;NA;multivessel cad
 698;multivessel cad  n ( % );"C1504769;C2239547;C3813548;C4284121";NA;NA;multivessel cad n
 698;mi or cad;"C1504769;C2239547;C3810814;C3813548;C4284121";NA;NA;mi or cad
 698;family history of cad;"C0241889;C1504769;C2239547;C3813548;C4284121";NA;NA;family history of cad
 698;familv historv of cad;"C1504769;C2239547;C3813548;C4284121";NA;NA;familv historv of cad
 698;cad death;"C0011065;C1306577;C1504769;C2239547;C3813548;C4082313;C4284121;C4552775";NA;NA;cad death
 699;chads $nmbr$ < $nmbr$;"C0007928;C1413373";FALSE;2128;chads $nmbr$ $nmbr$
 699;chads $nmbr$ risk factors  n ( % );"C0007928;C0035648;C1413373;C1553898";FALSE;2128;chads $nmbr$ risk factors n
 699;chads - $nmbr$ score;"C0007928;C0449820;C1413373;C4050231";FALSE;2128;chads $nmbr$ score
 699;chads $nmbr$ score;"C0007928;C0449820;C1413373;C4050231";FALSE;2128;chads $nmbr$ score
 699;chads $nmbr$ score *;"C0007928;C0449820;C1413373;C4050231";FALSE;2128;chads $nmbr$ score
 699;chads $nmbr$ scoref;"C0007928;C1413373";FALSE;2128;chads $nmbr$ scoref
 699;chads $nmbr$ score  n ( % );"C0007928;C0369718;C0441922;C0449820;C1413373;C4050231";FALSE;2128;chads $nmbr$ score n
 699;chads $nmbr$ score > $nmbr$;"C0007928;C0449820;C1413373;C4050231";FALSE;2128;chads $nmbr$ score $nmbr$
 699;chads $nmbr$ score $nmbr$;"C0007928;C0449820;C1413373;C4050231";FALSE;2128;chads $nmbr$ score $nmbr$
 699;chads $nmbr$ score $nmbr$ - $nmbr$  n ( % );"C0007928;C0369718;C0441922;C0449820;C1413373;C4050231";FALSE;2128;chads $nmbr$ score $nmbr$ $nmbr$ n
 699;chads $nmbr$ scoret;"C0007928;C1413373";FALSE;2128;chads $nmbr$ scoret
 699;chads $nmbr$   score    n   ( % );"C0007928;C0369718;C0441922;C0449820;C1413373;C4050231";FALSE;2128;chads $nmbr$ score n
 699;chads score;"C0007928;C0449820;C1413373;C4050231";FALSE;2128;chads score
 699;chads score  n ( % );"C0007928;C0369718;C0441922;C0449820;C1413373;C4050231";FALSE;2128;chads score n
 699;baseline chads $nmbr$ a  c;"C0007928;C0168634;C1413373;C1442488";FALSE;2128;baseline chads $nmbr$ a c
 699;> $nmbr$ ( n  % ) chads $nmbr$ score;"C0007928;C0369718;C0441922;C0449820;C1413373;C4050231";FALSE;2128;$nmbr$ n chads $nmbr$ score
 698;cad and / or crvd ( % );"C1504769;C2239547;C3813548;C4284121";NA;NA;cad and or crvd
 698;cad *;"C1504769;C2239547;C3813548;C4284121";NA;NA;cad
 698;cad;"C1504769;C2239547;C3813548;C4284121";NA;NA;cad
 697;mean cdai score ( sd );"C0444504;C0449820;C0683448;C1413248;C2347634;C2348143;C2699239;C3273706;C4050231";NA;NA;mean cdai score sd
 697;mean cdai score;"C0444504;C0449820;C0683448;C1413248;C2347634;C2348143;C3273706;C4050231";NA;NA;mean cdai score
 697;mean ( sd ) cdai *;"C0444504;C0683448;C1413248;C2347634;C2348143;C2699239;C3273706";NA;NA;mean sd cdai
 697;cdai §;"C0683448;C1413248;C3273706";NA;NA;cdai
 697;cdai score §;"C0449820;C0683448;C1413248;C3273706;C4050231";NA;NA;cdai score
 697;cdai score < $nmbr$;"C0449820;C0683448;C1413248;C3273706;C4050231";NA;NA;cdai score $nmbr$
 697;cdai score  median ( min  max );"C0449820;C0549183;C0683448;C0702093;C0876920;C1413248;C1524029;C2347635;C2348144;C2939193;C3273706;C3813700;C4050231";NA;NA;cdai score median min max
 697;cdai score  mean ± sda;"C0276477;C0444504;C0449820;C0683448;C1413248;C1428349;C1553165;C2347634;C2348143;C3273706;C4050231";NA;NA;cdai score mean sda
 697;cdai score  mean ( s . d . );"C0444504;C0449820;C0683448;C1413248;C2347634;C2348143;C3273706;C4050231";NA;NA;cdai score mean s d
 697;cdai score;"C0449820;C0683448;C1413248;C3273706;C4050231";NA;NA;cdai score
 697;cdai > $nmbr$  n [ % ];"C0683448;C1413248;C3273706";NA;NA;cdai $nmbr$ n
 697;cdai < $nmbr$ t;"C0683448;C1413248;C3273706";NA;NA;cdai $nmbr$ t
 697;cdai < $nmbr$ . $nmbr$ *;"C0683448;C1413248;C3273706";NA;NA;cdai $nmbr$ $nmbr$
 697;cdai ( $nmbr$ - $nmbr$ );"C0683448;C1413248;C3273706";NA;NA;cdai $nmbr$ $nmbr$
 697;cdai  mean [ sd ];"C0444504;C0683448;C1413248;C2347634;C2348143;C2699239;C3273706";NA;NA;cdai mean sd
 697;cdai  mean ( sd );"C0444504;C0683448;C1413248;C2347634;C2348143;C2699239;C3273706";NA;NA;cdai mean sd
 697;cdai;"C0683448;C1413248;C3273706";NA;NA;cdai
 697;baseline cdai score  mean ( sd );"C0168634;C0444504;C0449820;C0683448;C1413248;C1442488;C2347634;C2348143;C2699239;C3273706;C4050231";NA;NA;baseline cdai score mean sd
 697;baseline cdai score  mean ( s . d . );"C0168634;C0444504;C0449820;C0683448;C1413248;C1442488;C2347634;C2348143;C3273706;C4050231";NA;NA;baseline cdai score mean s d
 697;baseline cdai  mean ( sd );"C0168634;C0444504;C0683448;C1413248;C1442488;C2347634;C2348143;C2699239;C3273706";NA;NA;baseline cdai mean sd
 697;baseline cdai;"C0168634;C0683448;C1413248;C1442488;C3273706";NA;NA;baseline cdai
 697;a decrease of > $nmbr$ points in the cdai score;"C0392756;C0449820;C0547047;C0683448;C1413248;C2924612;C3273706;C4050231";NA;NA;a decrease of $nmbr$ points in the cdai score
 696;cdr - sob;"C0013404;C4521843";NA;NA;cdr sob
 696;baseline cdr - sb ( n   = $nmbr$ + $nmbr$ );"C0038111;C0168634;C1442488;C3811240;C4521843";NA;NA;baseline cdr sb n $nmbr$ $nmbr$
 695;oam;NA;NA;NA;oam
 695;no oam;NA;NA;NA;no oam
 695;atm - locus;"C1708726;C3711796";NA;NA;atm locus
 695;atm - locm;C3711796;NA;NA;atm locm
 695;am △ 士 s . e .;"C3813124;C3890196;C4520798";NA;NA;am s e
 695;acm;"C0001143;C1549040";NA;NA;acm
 694;total asthma symptom score :;"C0004096;C2984299;C3533163";NA;NA;total asthma symptom score
 694;total asthma symptom score  mean ± sdz;"C0004096;C0444504;C2347634;C2348143;C2984299;C3533163";NA;NA;total asthma symptom score mean sdz
 694;total asthma symptom score  mean ± sd ‡;"C0004096;C0444504;C2347634;C2348143;C2699239;C2984299;C3533163";NA;NA;total asthma symptom score mean sd
 694;total asthma symptom score;"C0004096;C2984299;C3533163";NA;NA;total asthma symptom score
 694;percent overall work impairment due to asthma;"C0004096;C0043227;C0221099;C0282416;C0439165;C0678226;C0684336;C1561607;C2984299";NA;NA;percent overall work impairment due to asthma
 694;percent impairment while working due to asthma;"C0004096;C0043227;C0221099;C0439165;C0678226;C0684336;C2984299";NA;NA;percent impairment while working due to asthma
 694;percent activity impairment due to asthma;"C0004096;C0221099;C0439167;C0678226;C0684336;C2984299";NA;NA;percent activity impairment due to asthma
 694;newly diagnosed asthma ( n );"C0004096;C0011900;C0750546;C2984299";NA;NA;newly diagnosed asthma n
 694;median ( range ) duration of asthma ( years );"C0004096;C0439234;C0449238;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2926735;C2939193;C2984299;C3542016";NA;NA;median range duration of asthma years
 694;median ( range ) duration of asthma ( y );"C0004096;C0449238;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2926735;C2939193;C2984299;C3542016";NA;NA;median range duration of asthma y
 694;hospitalized for asthma  n ( % ) *;"C0004096;C0701159;C2984299";NA;NA;hospitalized for asthma n
 694;duration of asthma — yr;"C0004096;C0439234;C0449238;C2926735;C2984299";NA;NA;duration of asthma yr
 694;duration of asthma > $nmbr$ years;"C0004096;C0439234;C0449238;C2926735;C2984299";NA;NA;duration of asthma $nmbr$ years
 694;duration of asthma ( years );"C0004096;C0439234;C0449238;C2926735;C2984299";NA;NA;duration of asthma years
 694;duration of asthma  years;"C0004096;C0439234;C0449238;C2926735;C2984299";NA;NA;duration of asthma years
 694;duration of asthma  y;"C0004096;C0449238;C2926735;C2984299";NA;NA;duration of asthma y
 694;duration of asthma;"C0004096;C0449238;C2926735;C2984299";NA;NA;duration of asthma
 694;asthma population ( n = $nmbr$ );"C0004096;C0032659;C1257890;C2984299";NA;NA;asthma population n $nmbr$
 694;asthma;"C0004096;C2984299";NA;NA;asthma
 693;noncomplex anatomy ( n - $nmbr$  $nmbr$ );"C0002808;C0700276;C1384516";NA;NA;noncomplex anatomy n $nmbr$ $nmbr$
 693;complex anatomy ( n - $nmbr$  $nmbr$ );"C0002808;C0439855;C0700276;C1384516;C1704241";NA;NA;complex anatomy n $nmbr$ $nmbr$
 693;anatomy;"C0002808;C0700276;C1384516";NA;NA;anatomy
 692;treatments at randomisation;"C0034656;C0087111";NA;NA;treatments at randomisation
 692;treatmentofpulmonary embolismpriorto randomization;C0034656;NA;NA;treatmentofpulmonary embolismpriorto randomization
 692;treatment randomization;"C0034656;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;treatment randomization
 692;treatment at randomization — no . ( % );"C0034656;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;treatment at randomization no
 692;treatment at randomization;"C0034656;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;treatment at randomization
 692;treatment at randomisation;"C0034656;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;treatment at randomisation
 692;to randomization;C0034656;NA;NA;to randomization
 692;time to randomization from symptom onset;"C0034656;C0040223;C3541383;C4086878";NA;NA;time to randomization from symptom onset
 692;time to randomization;"C0034656;C0040223;C3541383";NA;NA;time to randomization
 692;time to randomisation from symptom onset ( h );"C0033727;C0034656;C0040223;C0369286;C0441932;C0564385;C3541383;C4086878;C4528284";NA;NA;time to randomisation from symptom onset h
 692;time since randomization;"C0034656;C0040223;C3541383";NA;NA;time since randomization
 692;time of randomization ( interaction : p = $nmbr$ . $nmbr$ );"C0034656;C0040223;C1704675;C3541383";NA;NA;time of randomization interaction p $nmbr$ $nmbr$
 692;time of randomization;"C0034656;C0040223;C3541383";NA;NA;time of randomization
 692;time from symptom onset to randomization;"C0034656;C0040223;C0449244;C1457887;C3541383;C3854129;C4086878";NA;NA;time from symptom onset to randomization
 692;time from randomization to pci — hr;"C0034656;C0040223;C3541383;C4049621";NA;NA;time from randomization to pci hr
 692;time from qualifying event to randomization;"C0034656;C0040223;C0441471;C1514624;C3541383;C4019010";NA;NA;time from qualifying event to randomization
 692;time from presentation to randomization — hr;"C0034656;C0040223;C0449450;C3541383";NA;NA;time from presentation to randomization hr
 692;time from longest event to randomisation;"C0034656;C0040223;C0441471;C1522425;C3541383;C4019010";NA;NA;time from longest event to randomisation
 692;time from hospitalization to randomization — hr;"C0019993;C0034656;C0040223;C3541383";NA;NA;time from hospitalization to randomization hr
 396;all patientsb;NA;NA;NA;all patientsb
 692;thienopyridine at randomization;"C0034656;C1120149";NA;NA;thienopyridine at randomization
 692;symptom onset to randomization;"C0034656;C4086878";NA;NA;symptom onset to randomization
 692;symptom onset - to - randomization;"C0034656;C4086878";NA;NA;symptom onset to randomization
 692;renal function at randomization;"C0034656;C0232804";NA;NA;renal function at randomization
 692;randomized treatments  n ( % );"C0034656;C0087111;C3815594";NA;NA;randomized treatments n
 692;randomized to receiveaspirin;"C0034656;C3815594";NA;NA;randomized to receiveaspirin
 692;randomized to aspirin use;"C0004057;C0034656;C0042153;C0457083;C1947944;C3815594";NA;NA;randomized to aspirin use
 692;randomized patients;"C0030705;C0034656;C3815594";NA;NA;randomized patients
 692;randomized < $nmbr$ hr after presentation — %;"C0034656;C0449450;C3815594";NA;NA;randomized $nmbr$ hr after presentation
 692;randomized;"C0034656;C3815594";NA;NA;randomized
 692;randomize;NA;NA;NA;randomize
 692;randomization );C0034656;NA;NA;randomization
 692;randomization  n ( % );C0034656;NA;NA;randomization n
 692;randomization;C0034656;NA;NA;randomization
 692;randomisation scheme;"C0034656;C1519193";NA;NA;randomisation scheme
 692;randomisation;C0034656;NA;NA;randomisation
 692;radiographic characteristics at baseline and randomization;"C0034656;C0444708;C4684572";NA;NA;radiographic characteristics at baseline and randomization
 692;patients randomized  no .;"C0030705;C0034656;C3815594";NA;NA;patients randomized no
 692;patients randomized  n;"C0030705;C0034656;C0369718;C0441922;C3815594";NA;NA;patients randomized n
 692;patients randomized;"C0030705;C0034656;C3815594";NA;NA;patients randomized
 692;participants randomized;"C0034656;C0679646;C3815594";NA;NA;participants randomized
 692;parenteral anticoagulalion before randomization;"C0030547;C0034656;C4522267";NA;NA;parenteral anticoagulalion before randomization
 692;other llt at randomization;"C0034656;C2347090";NA;NA;other llt at randomization
 692;on oac at time of randomisation  n ( % );"C0034656;C0040223;C3541383";NA;NA;on oac at time of randomisation n
 692;number randomized;"C0034656;C0237753;C0449788;C3815594";NA;NA;number randomized
 692;number of patients randomized;"C0034656;C2360800;C3815594";NA;NA;number of patients randomized
 692;no . randomized;"C0034656;C3815594";NA;NA;no randomized
 692;nihss at randomization  $nmbr$ - $nmbr$;"C0034656;C1697238";NA;NA;nihss at randomization $nmbr$ $nmbr$
 692;nihss at randomization;"C0034656;C1697238";NA;NA;nihss at randomization
 692;medications at timing of randomization  n ( % );"C0034656;C2359859";NA;NA;medications at timing of randomization n
 692;malignancy at randomization;"C0006826;C0034656;C1306459;C4282132";NA;NA;malignancy at randomization
 692;mafcaiancy at randorrtzaton;NA;NA;NA;mafcaiancy at randorrtzaton
 692;llt other than statin at randomization;"C0034656;C0360714;C2347090";NA;NA;llt other than statin at randomization
 692;heparin at randomization;"C0019134;C0034656;C0770546";NA;NA;heparin at randomization
 692;edoxaban at randomization  n ( % );"C0034656;C2975435";NA;NA;edoxaban at randomization n
 692;coronary revascularization $nmbr$ days after randomization;"C0034656;C0439228;C0877341";NA;NA;coronary revascularization $nmbr$ days after randomization
 692;concomitant treatments at randomization;"C0034656;C0087111;C0521115";NA;NA;concomitant treatments at randomization
 692;at randomization;C0034656;NA;NA;at randomization
 692;asastoppedat randomization  n;C0034656;NA;NA;asastoppedat randomization n
 692;all randomized women;"C0034656;C0043210;C3815594";NA;NA;all randomized women
 692;all randomized;"C0034656;C3815594";NA;NA;all randomized
 692;- [ the null hypothesis is that there are no differences among subgroups  for age and time since randomization  the inter -;"C0001779;C0034656;C0040223;C0205103;C1079230;C1548610;C1705241;C1705242;C3541383;C4684719";NA;NA;the null hypothesis is that there are no differences among subgroups for age and time since randomization the inter
 691;peripheral edema;C0085649;NA;NA;peripheral edema
 691;eczema;"C0013595;C4553957";NA;NA;eczema
 691;ankle edema;C0235439;NA;NA;ankle edema
 690;physical exam oedema;"C0013604;C0031809;C1717255";NA;NA;physical exam oedema
 690;edema peripheral;"C0013604;C0205100;C1717255";NA;NA;edema peripheral
 690;edema  peripheral;"C0013604;C0205100;C1717255";NA;NA;edema peripheral
 690;edema  n ( % );"C0013604;C1717255";NA;NA;edema n
 690;edema  ( % );"C0013604;C1717255";NA;NA;edema
 690;edema  % z;"C0013604;C1717255";NA;NA;edema z
 689;proportion of angioedema - free days from week $nmbr$ to week $nmbr$ x;"C0002994;C0332174;C0332296;C0439228;C0439230;C1709707;C1880497;C1996904";NA;NA;proportion of angioedema free days from week $nmbr$ to week $nmbr$ x
 689;angioedema ( adjudicated )  n ( % );C0002994;NA;NA;angioedema adjudicated n
 688;pnorcabg;NA;NA;NA;pnorcabg
 688;normal renal function;C0232805;NA;NA;normal renal function
 688;normal cognitive;C2712133;NA;NA;normal cognitive
 687;very high vs . normal;"C0205307;C0231683;C0439166;C0442804;C2347086;C4321397;C4553972";NA;NA;very high vs normal
 687;size of left atrium normal — no . ( % ) £;"C0205307;C0225860;C0231683;C0439166;C0456389;C2347086;C4553972";NA;NA;size of left atrium normal no
 687;serum mg > $nmbr$ . $nmbr$ mmol / l ( normal mg / hvpermagnesemia );"C0205307;C0229671;C0231683;C0439166;C0439190;C1546774;C1550100;C2347086;C2827881;C4553972";NA;NA;serum mg $nmbr$ $nmbr$ mmol l normal mg hvpermagnesemia
 687;percent of predicted normal value;"C0205307;C0231683;C0439166;C1882327;C2347086;C4553972";NA;NA;percent of predicted normal value
 687;normal troponin;"C0041199;C0205307;C0231683;C0439166;C2347086;C4553972";NA;NA;normal troponin
 687;normal study termination;"C0205307;C0231683;C0439166;C0557651;C1549081;C1692758;C2347086;C2603343;C4553972";NA;NA;normal study termination
 687;normal responders ( n = $nmbr$ );"C0205307;C0231683;C0439166;C2347086;C4553972";NA;NA;normal responders n $nmbr$
 687;normal responder ( n = $nmbr$ );"C0205307;C0231683;C0439166;C2347086;C4553972";NA;NA;normal responder n $nmbr$
 687;normal responder;"C0205307;C0231683;C0439166;C2347086;C4553972";NA;NA;normal responder
 687;normal left ventricular ejection fraction — no . ( % ) j;"C0205091;C0205307;C0231683;C0428772;C0439166;C0443246;C0488728;C1535947;C1552822;C2347086;C4553972";NA;NA;normal left ventricular ejection fraction no j
 687;normal hscrp;"C0205307;C0231683;C0439166;C2347086;C4553972";NA;NA;normal hscrp
 687;normal hba $nmbr$ c  n = $nmbr$;"C0019016;C0205307;C0231683;C0439166;C1825777;C2347086;C3538758;C4553972";NA;NA;normal hba $nmbr$ c n $nmbr$
 687;normal fasting glucose level ( n = $nmbr$ );"C0015663;C0202045;C0205307;C0231683;C0439166;C0522082;C2347086;C4553972";NA;NA;normal fasting glucose level n $nmbr$
 687;normal crp and;"C0205307;C0231683;C0439166;C2347086;C3890735;C4048285;C4553972";NA;NA;normal crp and
 687;normal baseline crp;"C0168634;C0205307;C0231683;C0439166;C1442488;C2347086;C3890735;C4048285;C4553972";NA;NA;normal baseline crp
 687;normal albuminuria ( uacr < $nmbr$ );"C0001925;C0205307;C0231683;C0439166;C2347086;C4553972";NA;NA;normal albuminuria uacr $nmbr$
 687;normal > $nmbr$ - $nmbr$;"C0205307;C0231683;C0439166;C2347086;C4553972";NA;NA;normal $nmbr$ $nmbr$
 687;normal - high renin ( pra > $nmbr$ . $nmbr$ ng / ml / h ) ( n = $nmbr$ );"C0205307;C0231683;C0439166;C0633231;C0855390;C1141951;C1419788;C1533072;C2347086;C3274822;C3669212;C4050009;C4283900;C4553972";NA;NA;normal high renin pra $nmbr$ $nmbr$ ng ml h n $nmbr$
 687;normal ( ≥ $nmbr$ ml · min − $nmbr$ · $nmbr$ . $nmbr$ m − $nmbr$ )  n ( % );"C0205307;C0231683;C0369637;C0439166;C0439445;C0441923;C2347086;C4553972";NA;NA;normal $nmbr$ ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$ n
 687;normal ( > $nmbr$ mlvmin per $nmbr$ . $nmbr$ m $nmbr$ );"C0205307;C0231683;C0369637;C0439166;C0441923;C2347086;C4553972";NA;NA;normal $nmbr$ mlvmin per $nmbr$ $nmbr$ m $nmbr$
 687;normal ( > $nmbr$ ml / min );"C0205307;C0231683;C0439166;C0439445;C2347086;C4553972";NA;NA;normal $nmbr$ ml min
 687;normal ( > $nmbr$ );"C0205307;C0231683;C0439166;C2347086;C4553972";NA;NA;normal $nmbr$
 687;normal ( < $nmbr$ . $nmbr$ u / ml );"C0205307;C0231683;C0439166;C0439340;C1880521;C2347086;C2945590;C4553972";NA;NA;normal $nmbr$ $nmbr$ u ml
 692;aspirin dose at randomization;"C0034656;C4696290";FALSE;1366;aspirin dose at randomization
 687;normal  < $nmbr$;"C0205307;C0231683;C0439166;C2347086;C4553972";NA;NA;normal $nmbr$
 687;normal;"C0205307;C0231683;C0439166;C2347086;C4553972";NA;NA;normal
 687;mild dysfunction or normal;"C0205307;C0231683;C0439166;C2347086;C3274775;C4553972";NA;NA;mild dysfunction or normal
 687;medium normal ( n = $nmbr$ );"C0009458;C0205307;C0231683;C0439166;C0439536;C1705217;C2347086;C3244283;C4085196;C4522282;C4522283;C4553972";NA;NA;medium normal n $nmbr$
 687;lowest normal ( n = $nmbr$ );"C0205307;C0231683;C0439166;C1708760;C2347086;C4553972";NA;NA;lowest normal n $nmbr$
 687;high normal ( n = $nmbr$ );"C0205250;C0205307;C0231683;C0439166;C1299351;C2347086;C2700149;C3887512;C3889660;C4321237;C4522209;C4553972";NA;NA;high normal n $nmbr$
 686;prior ml or abnormal angiogram;"C0002978;C0205161;C0332152;C0439526;C1548816;C1705224;C2347472;C2699333;C2826257;C3887665;C3891555;C4255126";NA;NA;prior ml or abnormal angiogram
 686;previous ml or abnormal angiogram;"C0002978;C0205156;C0205161;C0439526;C1548816;C1552607;C1705224;C2347472;C2699333;C3887665;C3891555;C4255126";NA;NA;previous ml or abnormal angiogram
 686;abnormal angiogram;"C0002978;C0205161;C1548816;C2347472;C2699333;C3891555;C4255126";NA;NA;abnormal angiogram
 686;abnormal;"C0205161;C2347472;C2699333";NA;NA;abnormal
 685;biguanides ¶;"C0005382;C0360396;C3540012";NA;NA;biguanides
 685;biguanides ( metformin );"C0005382;C0025598;C0360396;C3540012";NA;NA;biguanides metformin
 685;biguanides;"C0005382;C0360396;C3540012";NA;NA;biguanides
 670;( $ $nmbr$ mg / dl [ $nmbr$ . $nmbr$ mmol / l ] );"C0439269;C1532563";NA;NA;$ $nmbr$ mg dl $nmbr$ $nmbr$ mmol l
 685;biguanide use at baseline;"C0005382;C0042153;C0168634;C0457083;C1442488;C1947944;C3537187;C4317165";NA;NA;biguanide use at baseline
 685;biguanide ( metformin );"C0005382;C0025598;C3537187;C4317165";NA;NA;biguanide metformin
 685;biguanide;"C0005382;C3537187;C4317165";NA;NA;biguanide
 684;prior migraine *;"C0149931;C0332152;C2826257";NA;NA;prior migraine
 684;prior migraine;"C0149931;C0332152;C2826257";NA;NA;prior migraine
 684;migraine — no . ( % ) $;C0149931;NA;NA;migraine no $
 684;migraine severity score;"C0149931;C0457451";NA;NA;migraine severity score
 684;migraine occurrence ( days / month );"C0149931;C0243132;C0556971;C1554210;C2745955";NA;NA;migraine occurrence days month
 683;≥ $nmbr$ . $nmbr$ % and ≤ $nmbr$ . $nmbr$ %;NA;NA;NA;$nmbr$ $nmbr$ and $nmbr$ $nmbr$
 683;rankin grade;"C0441800;C0919553;C3244287";NA;NA;rankin grade
 683;nerd grade;"C0441800;C0919553;C3244287";NA;NA;nerd grade
 683;nerd;NA;NA;NA;nerd
 683;modi fied la grade *;"C0023031;C0023749;C0230347;C0342276;C0441800;C0919553;C2346906;C3244287;C4553351";NA;NA;modi fied la grade
 683;mmrc grade  n ( % );"C0441800;C0919553;C3244287;C3826977";NA;NA;mmrc grade n
 683;mmrc grade;"C0441800;C0919553;C3244287;C3826977";NA;NA;mmrc grade
 683;mean mmrc grade  units ( sd );"C0439148;C0441800;C0444504;C0919553;C1519795;C2347634;C2348143;C2699239;C3244287;C3826977;C3853603";NA;NA;mean mmrc grade units sd
 683;la grade a  n ( % ) f;"C0016327;C0023031;C0023749;C0230347;C0369718;C0441800;C0441922;C0919553;C2346906;C3244287;C4553351";NA;NA;la grade a n f
 683;kellgren and lawrence radiographic reading grade $nmbr$ — no . ( % );"C0034754;C0441800;C0444708;C0919553;C1705179;C3244287;C4284139";NA;NA;kellgren and lawrence radiographic reading grade $nmbr$ no
 683;grade > $nmbr$;"C0441800;C0919553;C3244287";NA;NA;grade $nmbr$
 683;grade $nmbr$;"C0441800;C0919553;C3244287";NA;NA;grade $nmbr$
 683;gold grade $nmbr$;"C0018026;C0441800;C0919553;C1304897;C3244287";NA;NA;gold grade $nmbr$
 683;dyspnoea - mmrc grade  n ( % );"C0013404;C0441800;C0919553;C1963100;C3244287;C3826977";NA;NA;dyspnoea mmrc grade n
 683;dyspnea – mmrc grade  n ( % );"C0013404;C0441800;C0919553;C1963100;C3244287;C3826977";NA;NA;dyspnea mmrc grade n
 683;baseline los angeles grade of eo  n ( % );"C0024015;C0168634;C0332120;C0441800;C0919553;C1442488;C3244287";NA;NA;baseline los angeles grade of eo n
 682;screening prebronchodilator fev $nmbr$  l;"C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C2599602;C3714541";NA;NA;screening prebronchodilator fev $nmbr$ l
 682;prebronchodilator fevj ( % predicted );"C0681842;C1882327;C2599602";NA;NA;prebronchodilator fevj predicted
 682;prebronchodilator fev $nmbr$;"C2599602;C3714541";NA;NA;prebronchodilator fev $nmbr$
 682;prebronchodilator;C2599602;NA;NA;prebronchodilator
 682;pre - bronchodilator screening fev $nmbr$ ml;"C0220908;C0220909;C0439526;C1698960;C1705224;C1710031;C1710032;C1710477;C2348164;C2599602;C3714541;C3887665";NA;NA;pre bronchodilator screening fev $nmbr$ ml
 682;pre - bronchodilator fvc ’ % pred;"C0032952;C0044955;C2599602;C3714541";NA;NA;pre bronchodilator fvc pred
 682;pre - bronchodilator fvc ( l );"C2599602;C3714541";NA;NA;pre bronchodilator fvc l
 682;pre - bronchodilator fevr l;"C1708033;C2599602";NA;NA;pre bronchodilator fevr l
 682;pre - bronchodilator fevr % pred;"C0032952;C0044955;C1708033;C2599602";NA;NA;pre bronchodilator fevr pred
 682;pre - bronchodilator fevj;C2599602;NA;NA;pre bronchodilator fevj
 682;pre - bronchodilator fev ^ ( l );"C2599602;C3714541";NA;NA;pre bronchodilator fev l
 682;pre - bronchodilator fev $nmbr$ ( l );"C2599602;C3714541";NA;NA;pre bronchodilator fev $nmbr$ l
 682;pre - bronchodilator fev $nmbr$ ( % predicted normal );"C0205307;C0231683;C0439166;C0681842;C1882327;C2347086;C2599602;C3714541;C4553972";NA;NA;pre bronchodilator fev $nmbr$ predicted normal
 682;pre - bronchodilator fev  ( l );"C2599602;C3714541";NA;NA;pre bronchodilator fev l
 682;pre - bronchodilator fev  % predicted;"C0681842;C1882327;C2599602;C3714541";NA;NA;pre bronchodilator fev predicted
 682;pre - bronchodilator fef $nmbr$ . $nmbr$ ( ml / s ) baseline blood eosinophil count;"C0005767;C0005768;C0014467;C0168634;C0200638;C0229664;C0439390;C0750480;C0750879;C1442488;C1705566;C2599602";NA;NA;pre bronchodilator fef $nmbr$ $nmbr$ ml s baseline blood eosinophil count
 682;pre - bronchodilator;C2599602;NA;NA;pre bronchodilator
 682;percentage of predicted pre - bronchodilator fev ^;"C0439165;C0681842;C1549488;C1561533;C1882327;C2599602;C3714541";NA;NA;percentage of predicted pre bronchodilator fev
 682;fvc pre - bronchodilator;"C2599602;C3714541";NA;NA;fvc pre bronchodilator
 682;fev $nmbr$ pre - bronchodilator ( % predicted normal )  mean ( sd ) c  d;"C0012358;C0205307;C0231683;C0439166;C0444504;C0681842;C1882327;C2347086;C2347634;C2348143;C2599602;C2699239;C3714541;C4553972";NA;NA;fev $nmbr$ pre bronchodilator predicted normal mean sd c d
 682;fev $nmbr$ pre - bronchodilator;"C2599602;C3714541";NA;NA;fev $nmbr$ pre bronchodilator
 682;fev $nmbr$ ( l ) pre - bronchodilator;"C2599602;C3714541";NA;NA;fev $nmbr$ l pre bronchodilator
 682;baseline pre - bronchodilator fev $nmbr$  l;"C0168634;C1442488;C2599602;C3714541";NA;NA;baseline pre bronchodilator fev $nmbr$ l
 682;a prebronchodilator fevl ( % predicted );"C0681842;C1882327;C2599602";NA;NA;a prebronchodilator fevl predicted
 682;% predicted pre - bronchodilator fev $nmbr$  % *;"C0681842;C1882327;C2599602;C3714541";NA;NA;predicted pre bronchodilator fev $nmbr$
 681;before bronchodilation — liters §;"C0475211;C1371299;C3537072";NA;NA;before bronchodilation liters
 681;before bronchodilation;"C1371299;C3537072";NA;NA;before bronchodilation
 681;after bronchodilation;"C1371299;C3537072";NA;NA;after bronchodilation
 680;postbronchodilator lung function at screening;"C0035245;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C2599594";NA;NA;postbronchodilator lung function at screening
 680;postbronchodilator fev $nmbr$  % predicted;"C0681842;C1882327;C2599594;C3714541";NA;NA;postbronchodilator fev $nmbr$ predicted
 680;postbronchodilator $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ );C2599594;NA;NA;postbronchodilator $nmbr$ $nmbr$ $nmbr$ $nmbr$
 680;postbronchodilator;C2599594;NA;NA;postbronchodilator
 680;post - bronchodilator screening fev $nmbr$ ml;"C0220908;C0220909;C0439526;C1698960;C1705224;C1710031;C1710032;C1710477;C2348164;C2599594;C3714541;C3887665";NA;NA;post bronchodilator screening fev $nmbr$ ml
 680;post - bronchodilator ratio of fev $nmbr$ to fvc — %;"C0456603;C1547037;C2599594;C3714541";NA;NA;post bronchodilator ratio of fev $nmbr$ to fvc
 680;post - bronchodilator fvc ( l ) a;"C2599594;C3714541";NA;NA;post bronchodilator fvc l a
 683;adverse events ( any grade );"C0441800;C0877248;C0919553;C1705413;C3244287";FALSE;  47;adverse events any grade
 680;post - bronchodilator fevx ( l );C2599594;NA;NA;post bronchodilator fevx l
 680;post - bronchodilator fev $nmbr$ — liters;"C0475211;C2599594;C3714541";NA;NA;post bronchodilator fev $nmbr$ liters
 680;post - bronchodilator fev $nmbr$ — % of predicted value;"C0681842;C1522609;C1882327;C2599594;C3714541";NA;NA;post bronchodilator fev $nmbr$ of predicted value
 680;post - bronchodilator fev $nmbr$ ml;"C0439526;C1705224;C2599594;C3714541;C3887665";NA;NA;post bronchodilator fev $nmbr$ ml
 680;post - bronchodilator fev $nmbr$ / fvc ( % ) a;"C2599594;C3714541";NA;NA;post bronchodilator fev $nmbr$ fvc a
 680;post - bronchodilator fev $nmbr$ / fvc  %;"C2599594;C3714541";NA;NA;post bronchodilator fev $nmbr$ fvc
 680;post - bronchodilator fev $nmbr$ ( l ) a;"C2599594;C3714541";NA;NA;post bronchodilator fev $nmbr$ l a
 680;post - bronchodilator fev $nmbr$ ( l ) *;"C2599594;C3714541";NA;NA;post bronchodilator fev $nmbr$ l
 680;post - bronchodilator fev $nmbr$ ( l );"C2599594;C3714541";NA;NA;post bronchodilator fev $nmbr$ l
 680;post - bronchodilator fev $nmbr$ ( % predicted normal ) a;"C0205307;C0231683;C0439166;C0681842;C1882327;C2347086;C2599594;C3714541;C4553972";NA;NA;post bronchodilator fev $nmbr$ predicted normal a
 680;post - bronchodilator fev $nmbr$ ( % predicted * );"C0681842;C1882327;C2599594;C3714541";NA;NA;post bronchodilator fev $nmbr$ predicted
 680;post - bronchodilator fev $nmbr$ % predictedb;"C2599594;C3714541";NA;NA;post bronchodilator fev $nmbr$ predictedb
 680;post - bronchodilator fev $nmbr$  l *;"C2599594;C3714541";NA;NA;post bronchodilator fev $nmbr$ l
 680;post - bronchodilator fev $nmbr$  l;"C2599594;C3714541";NA;NA;post bronchodilator fev $nmbr$ l
 680;post - bronchodilator fev $nmbr$  % predicted of normal value;"C0086715;C0681842;C1882327;C2599594;C3714541";NA;NA;post bronchodilator fev $nmbr$ predicted of normal value
 680;post - bronchodilator fev $nmbr$  % predicted  mean ( sd );"C0444504;C0681842;C1882327;C2347634;C2348143;C2599594;C2699239;C3714541";NA;NA;post bronchodilator fev $nmbr$ predicted mean sd
 680;post - bronchodilator fev $nmbr$  % predicted;"C0681842;C1882327;C2599594;C3714541";NA;NA;post bronchodilator fev $nmbr$ predicted
 680;post - bronchodilator fev  / fvc;"C2599594;C3714541";NA;NA;post bronchodilator fev fvc
 680;post - bronchodilator fev  ( l );"C2599594;C3714541";NA;NA;post bronchodilator fev l
 680;post - bronchodilator fev  % predicted;"C0681842;C1882327;C2599594;C3714541";NA;NA;post bronchodilator fev predicted
 680;post - bronchodilator fev   % predicted;"C0681842;C1882327;C2599594;C3714541";NA;NA;post bronchodilator fev predicted
 680;post - bronchodilator;C2599594;NA;NA;post bronchodilator
 680;fvc post - bronchodilator;"C2599594;C3714541";NA;NA;fvc post bronchodilator
 680;fev $nmbr$ post - bronchodilator  % predicted normal;"C0205307;C0231683;C0439166;C0681842;C1882327;C2347086;C2599594;C3714541;C4553972";NA;NA;fev $nmbr$ post bronchodilator predicted normal
 680;baseline post - bronchodilator fev $nmbr$   ( sd )  ml;"C0168634;C0439526;C1442488;C1705224;C2599594;C2699239;C3714541;C3887665";NA;NA;baseline post bronchodilator fev $nmbr$ sd ml
 680;baseline post - bronchodilator % predicted fev  > $nmbr$ % and prior ics use;"C0042153;C0168634;C0332152;C0457083;C0681842;C0815320;C1442488;C1882327;C1947944;C2599594;C2826257;C3714541;C4551720";NA;NA;baseline post bronchodilator predicted fev $nmbr$ and prior ics use
 680;baseline post - bronchodilator % predicted fev  < $nmbr$ %;"C0168634;C0681842;C1442488;C1882327;C2599594;C3714541";NA;NA;baseline post bronchodilator predicted fev $nmbr$
 680;% predicted post - bronchodilator fev $nmbr$  mean ( sd )  l;"C0444504;C0681842;C1882327;C2347634;C2348143;C2599594;C2699239;C3714541";NA;NA;predicted post bronchodilator fev $nmbr$ mean sd l
 679;nebivolol ( n = $nmbr$ );C0068475;NA;NA;nebivolol n $nmbr$
 679;metoprolol group ( n = $nmbr$ );"C0025859;C0441848";NA;NA;metoprolol group n $nmbr$
 679;metoprolol ( n = $nmbr$ $nmbr$ );C0025859;NA;NA;metoprolol n $nmbr$ $nmbr$
 678;study protocol;"C1507394;C2348563;C2599718";NA;NA;study protocol
 677;location of treatment center;"C0039798;C0087111;C0205099;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;location of treatment center
 677;centre;"C0205099;C3810851";NA;NA;centre
 677;central eosinophil count ( cells per pl ) t;"C0007584;C0007634;C0200638;C0205099;C0750879;C1879652;C3897966;C4049765";NA;NA;central eosinophil count cells per pl t
 677;central eosinophil count ( cells per pl );"C0007584;C0007634;C0200638;C0205099;C0750879;C1879652;C3897966;C4049765";NA;NA;central eosinophil count cells per pl
 677;central eosinophil count;"C0200638;C0205099;C0750879;C1879652";NA;NA;central eosinophil count
 677;central / eastern;"C0205099;C1707877;C1879652";NA;NA;central eastern
 677;center location;C0205099;NA;NA;center location
 677;center - level ihr percent time in therapeutic range for warfarin subjects;"C0040223;C0043031;C0087111;C0205099;C0302350;C0439165;C0441889;C0456079;C0460097;C0681850;C1547707;C1550501;C1554109;C1706203;C2349001;C2697811;C2946261;C3541383;C3810851";NA;NA;center level ihr percent time in therapeutic range for warfarin subjects
 677;center;"C0205099;C3810851";NA;NA;center
 676;ldl - c concentration;"C0086045;C1446561;C3827302";NA;NA;ldl c concentration
 676;hdlc - concentration;"C0086045;C1446561;C1704429;C3827302";NA;NA;hdlc concentration
 676;geometric c $nmbr$ concentration  mg / dl;"C0086045;C0439269;C0449829;C1446561;C3827302";NA;NA;geometric c $nmbr$ concentration mg dl
 676;crp concentration > $nmbr$ . $nmbr$ mg / dl ( $nmbr$ mg / l )  n ( % );"C0086045;C1446561;C2827881;C3642216;C3827302;C3890735;C4048285";NA;NA;crp concentration $nmbr$ $nmbr$ mg dl $nmbr$ mg l n
 676;blood leucocyte concentration ( $nmbr$ cells per l );"C0023516;C0086045;C0347983;C0427728;C0699870;C1313904;C1446561;C3827302";NA;NA;blood leucocyte concentration $nmbr$ cells per l
 676;blood eosinophil concentration  $nmbr$ cells per l;"C0014467;C0086045;C0347983;C0427728;C0699870;C1313904;C1446561;C3827302";NA;NA;blood eosinophil concentration $nmbr$ cells per l
 675;rhythm - control group ( n = $nmbr$ );"C0243148;C0441848;C0871269;C1523018;C1550141;C1882979;C2587213;C3274648;C3828331;C4553389";NA;NA;rhythm control group n $nmbr$
 675;proportion ( % ) of individuals • control alirocumab;"C0027361;C0237401;C0243148;C1550141;C1709707;C1882979;C2587213;C3274648;C3491162;C4553389";NA;NA;proportion of individuals control alirocumab
 675;good control ( < $nmbr$ );"C0205170;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389";NA;NA;good control $nmbr$
 675;glycaemic control ( hba $nmbr$ c )  n ( % );"C0005802;C0019016;C0243148;C1550141;C1825777;C1882979;C2587213;C3274648;C3538758;C4553389";NA;NA;glycaemic control hba $nmbr$ c n
 675;fair control ( $nmbr$ - $nmbr$ . $nmbr$ );"C0243148;C1550141;C1882979;C2587213;C2911689;C3274648;C4553389";NA;NA;fair control $nmbr$ $nmbr$ $nmbr$
 675;controls ( n = $nmbr$ );"C0243148;C0369718;C0441922;C1550141;C1882979;C2587213;C3274648;C4553389";NA;NA;controls n $nmbr$
 675;controlled : acq - $nmbr$ < $nmbr$ . $nmbr$;"C2587213;C2911690;C2919686";NA;NA;controlled acq $nmbr$ $nmbr$ $nmbr$
 675;controlled $nmbr$ — no . ( % );"C2587213;C2911690";NA;NA;controlled $nmbr$ no
 675;controlled;"C2587213;C2911690";NA;NA;controlled
 675;controlld;NA;NA;NA;controlld
 675;control of sitting bp at week $nmbr$;"C0037623;C0243148;C0277814;C0332174;C0439230;C1415692;C1550141;C1708288;C1882979;C2584297;C2587213;C3274648;C4050224;C4318478;C4553389";NA;NA;control of sitting bp at week $nmbr$
 675;control n = $nmbr$;"C0243148;C1550141;C1882979;C2587213;C3274648;C4553389";NA;NA;control n $nmbr$
 675;control group ( n = $nmbr$ );"C0243148;C0441848;C1550141;C1882979;C2587213;C3274648;C4553389";NA;NA;control group n $nmbr$
 675;control baseline ( n - $nmbr$ );"C0168634;C0243148;C1442488;C1550141;C1882979;C2587213;C3274648;C4553389";NA;NA;control baseline n $nmbr$
 675;control = warfarin;"C0043031;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389";NA;NA;control warfarin
 675;control ( nz $nmbr$ );"C0027978;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389";NA;NA;control nz $nmbr$
 675;control ( n z $nmbr$ );"C0243148;C1550141;C1882979;C2587213;C3274648;C4553389";NA;NA;control n z $nmbr$
 675;control ( n = $nmbr$ );"C0243148;C1550141;C1882979;C2587213;C3274648;C4553389";NA;NA;control n $nmbr$
 359;xanthines;"C0043318;C3541955";NA;NA;xanthines
 678;original dabigatran protocol;"C0205313;C0442711;C1507394;C1522729;C2347409;C2348066;C2348563;C2599718;C3715209;C4282383";FALSE; 775;original dabigatran protocol
 675;control ( n - $nmbr$ );"C0243148;C1550141;C1882979;C2587213;C3274648;C4553389";NA;NA;control n $nmbr$
 675;control $nmbr$ months ( n - $nmbr$ );"C0243148;C0439231;C1550141;C1882979;C2587213;C3274648;C4553389";NA;NA;control $nmbr$ months n $nmbr$
 675;control;"C0243148;C1550141;C1882979;C2587213;C3274648;C4553389";NA;NA;control
 675;bp control;"C0037623;C0243148;C1415692;C1550141;C1708288;C1882979;C2587213;C3274648;C4318478;C4553389";NA;NA;bp control
 675;blood pressure control *;"C0005823;C0243148;C1271104;C1272641;C1550141;C1882979;C2587213;C3274648;C4553389";NA;NA;blood pressure control
 675;blood pressure control;"C0005823;C0243148;C1271104;C1272641;C1550141;C1882979;C2587213;C3274648;C4553389";NA;NA;blood pressure control
 675;baseline glycemic control;"C0005802;C0168634;C0243148;C1442488;C1550141;C1882979;C2587213;C3274648;C4553389";NA;NA;baseline glycemic control
 675;asthma control;"C0004096;C0243148;C1550141;C1882979;C2587213;C2984299;C3274648;C4553389";NA;NA;asthma control
 675;asthma - control status at randomization — no . ( % );"C0004096;C0034656;C0243148;C0449438;C1550141;C1882979;C2587213;C2984299;C3274648;C4553389";NA;NA;asthma control status at randomization no
 675;active - control study;"C0243148;C0557651;C1550141;C1706449;C1882979;C2347179;C2587213;C2603343;C3274648;C4553389";NA;NA;active control study
 675;( % ) control ( $nmbr$ );"C0243148;C1550141;C1882979;C2587213;C3274648;C4553389";NA;NA;control $nmbr$
 675;% asthma control days {  #;"C0004096;C0243148;C0439228;C1550141;C1882979;C2587213;C2984299;C3274648;C4553389";NA;NA;asthma control days
 674;tertile $nmbr$ ( > $nmbr$ . $nmbr$ pg / ml ) n - $nmbr$;C0439297;NA;NA;tertile $nmbr$ $nmbr$ $nmbr$ pg ml n $nmbr$
 481;age > $nmbr$ years;C1510829;NA;NA;age $nmbr$ years
 674;tertile $nmbr$ ( $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ pg / ml ) n = $nmbr$;C0439297;NA;NA;tertile $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ pg ml n $nmbr$
 674;tertile $nmbr$;NA;NA;NA;tertile $nmbr$
 674;terrible;C3827840;NA;NA;terrible
 674;terlile $nmbr$;NA;NA;NA;terlile $nmbr$
 673;terminal ileum;C0227327;NA;NA;terminal ileum
 673;disease location / type : terminal ileum;"C0227327;C0450429;C0457464;C1515974;C4284930;C4284931";NA;NA;disease location type terminal ileum
 673;$nmbr$ rrmnl );NA;NA;NA;$nmbr$ rrmnl
 672;western europe and israel;"C0022271;C0043129";NA;NA;western europe and israel
 672;lymphocytes  $nmbr$ / + il;"C0020898;C0021764;C0022271;C0024264;C4018897";NA;NA;lymphocytes $nmbr$ il
 672;israel;C0022271;NA;NA;israel
 672;il - $nmbr$ ( pg / ml );"C0020898;C0021764;C0022271;C0439297";NA;NA;il $nmbr$ pg ml
 672;il - $nmbr$  ng / l;"C0020898;C0021764;C0022271;C0439297";NA;NA;il $nmbr$ ng l
 672;il - $nmbr$;"C0020898;C0021764;C0022271";NA;NA;il $nmbr$
 672;canakinumab  $nmbr$ month on - treatment il - $nmbr$ above the median value ( ≥ $nmbr$ . $nmbr$ ng / l ) ( n   =   $nmbr$ );"C0020898;C0021764;C0022271;C0039798;C0087111;C0332177;C0439231;C0439297;C0549183;C0876920;C1522326;C1522609;C1533734;C1705169;C2347635;C2348144;C2718773;C2939193;C3538994;C3887704";NA;NA;canakinumab $nmbr$ month on treatment il $nmbr$ above the median value $nmbr$ $nmbr$ ng l n $nmbr$
 671;ppg  mmol / l;"C1418888;C1532563";NA;NA;ppg mmol l
 671;phosphorus  mmol $nmbr$ $nmbr$;"C0031705;C0080014;C0439190;C3714498";NA;NA;phosphorus mmol $nmbr$ $nmbr$
 671;fpg ( mmol / $nmbr$ );C0439190;NA;NA;fpg mmol $nmbr$
 671;fpg  mmol / la;"C0023031;C0023749;C0230347;C0439190;C2346906;C4553351";NA;NA;fpg mmol la
 671;> $nmbr$ . $nmbr$ to < $nmbr$ . $nmbr$ mu / l - mmol / l;"C0439190;C0439342";NA;NA;$nmbr$ $nmbr$ to $nmbr$ $nmbr$ mu l mmol l
 671;> $nmbr$ . $nmbr$ to < $nmbr$ . $nmbr$ mu / l $ mmol / l;"C0439190;C0439342";NA;NA;$nmbr$ $nmbr$ to $nmbr$ $nmbr$ mu l $ mmol l
 671;> $nmbr$ . $nmbr$ mu / l - mmol / l;"C0439190;C0439342";NA;NA;$nmbr$ $nmbr$ mu l mmol l
 671;> $nmbr$ . $nmbr$ mu / l $ mmol / l;"C0439190;C0439342";NA;NA;$nmbr$ $nmbr$ mu l $ mmol l
 671;< $nmbr$ . $nmbr$ mu / l - mmol / l;"C0439190;C0439342";NA;NA;$nmbr$ $nmbr$ mu l mmol l
 671;< $nmbr$ . $nmbr$ mu / l $ mmol / l;"C0439190;C0439342";NA;NA;$nmbr$ $nmbr$ mu l $ mmol l
 671;( mu / l $ mmol / l ) b;"C0439190;C0439342";NA;NA;mu l $ mmol l b
 671;$nmbr$ - hour ppg  mmol / l;"C0439227;C0564385;C1418888;C1532563";NA;NA;$nmbr$ hour ppg mmol l
 671;$nmbr$ - h ppg ( mmol / l ) *;"C1418888;C2827804";NA;NA;$nmbr$ h ppg mmol l
 671;$nmbr$ - h ppg ( mmol / l );"C1418888;C2827804";NA;NA;$nmbr$ h ppg mmol l
 671;$nmbr$ - h pmg ( mmol / l );C2827804;NA;NA;$nmbr$ h pmg mmol l
 671;$nmbr$ - h pmg  mmol / l ( mean ± sd );"C0444504;C2347634;C2348143;C2699239;C2827804";NA;NA;$nmbr$ h pmg mmol l mean sd
 670;£ $nmbr$ . $nmbr$ mmol / l;C1532563;NA;NA;$nmbr$ $nmbr$ mmol l
 670;women : < $nmbr$ mg / dl ( < $nmbr$ . $nmbr$ mmol / l );"C0043210;C0439269;C1532563";NA;NA;women $nmbr$ mg dl $nmbr$ $nmbr$ mmol l
 670;triacylglycerol  mmol / l  mean ( sd );"C0041004;C0444504;C1532563;C2347634;C2348143;C2699239";NA;NA;triacylglycerol mmol l mean sd
 670;tertile of total cholesterol at baseline  mean ( sd )  mmol / l;"C0168634;C0201950;C0444504;C0543421;C1442488;C1532563;C2347634;C2348143;C2699239";NA;NA;tertile of total cholesterol at baseline mean sd mmol l
 670;sitagliptin $nmbr$ $nmbr$ . $nmbr$ 士 $nmbr$ . $nmbr$ fasting plasma glucose ( fpg ) ( mmol / l );"C0015663;C0202042;C0455280;C1532563;C1565750";NA;NA;sitagliptin $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ fasting plasma glucose fpg mmol l
 670;serum phosphate  mmol / l;"C0036820;C1532563";NA;NA;serum phosphate mmol l
 670;serum mg < $nmbr$ . $nmbr$ mmol / l ( hypomagnesemia );"C0024671;C0026410;C0151723;C0229671;C0439190;C0439268;C0439269;C1532563;C1546774;C1550100;C1960952;C2346927;C4321396;C4521761;C4552839";NA;NA;serum mg $nmbr$ $nmbr$ mmol l hypomagnesemia
 670;serum hdl cholesterol ( mmol / l )  mean ( sd );"C0428472;C0444504;C1532563;C2347634;C2348143;C2699239";NA;NA;serum hdl cholesterol mmol l mean sd
 670;serum glucose ( mmol / l );"C0202041;C1532563;C3534430";NA;NA;serum glucose mmol l
 670;serum calcium  mmol / l;"C0036785;C0728876;C1532563";NA;NA;serum calcium mmol l
 670;phosphate ( mmol / l );"C0031603;C0031701;C1532563;C1601799";NA;NA;phosphate mmol l
 670;mmol / l [ n ];C1532563;NA;NA;mmol l n
 670;mmol / l );C1532563;NA;NA;mmol l
 670;mmol / l;C1532563;NA;NA;mmol l
 670;mg / dl fpg ( mmol / l );"C0439269;C1532563";NA;NA;mg dl fpg mmol l
 670;mean fpg  mmol / l;"C0444504;C1532563;C2347634;C2348143";NA;NA;mean fpg mmol l
 670;mean change ‘ s in fasting blood glucose [ mg / dl ( mmol / l ) ];"C0392747;C0428568;C0443172;C0444504;C1261430;C1532563;C1705241;C2347634;C2348143;C2827883;C3642216;C4319952";NA;NA;mean change s in fasting blood glucose mg dl mmol l
 670;mean ( s . d . ) baseline fpg  mmol / l;"C0168634;C0444504;C1442488;C1532563;C2347634;C2348143";NA;NA;mean s d baseline fpg mmol l
 670;mdg ( mmol / l );"C0024443;C1417239;C1532563;C2986643";NA;NA;mdg mmol l
 670;lipoprotein ( a ) ( mmol / l );"C0065058;C0125953;C1096202;C1439335;C1532563";NA;NA;lipoprotein a mmol l
 359;xanthine;"C0043314;C0043318";NA;NA;xanthine
 670;serum potassium : < $nmbr$ . $nmbr$ mmol / l ( n = $nmbr$ );"C0302353;C0543465;C1532563";FALSE;1959;serum potassium $nmbr$ $nmbr$ mmol l n $nmbr$
 670;serum total cholesterol ( mmol / l )  mean ( sd );"C0444504;C0587184;C1287371;C1532563;C2347634;C2348143;C2699239";FALSE;1504;serum total cholesterol mmol l mean sd
 670;serum potassium  mean ( sd ) mmol / l;"C0302353;C0444504;C0543465;C1532563;C2347634;C2348143;C2699239";FALSE;1959;serum potassium mean sd mmol l
 670;serum potassium  > $nmbr$ . $nmbr$ mmol / l;"C0302353;C0543465;C1532563";FALSE;1959;serum potassium $nmbr$ $nmbr$ mmol l
 670;potassium at admission  mmol / l - $nmbr$;"C0032821;C0184666;C0202194;C0304475;C0597277;C0809949;C1532563;C3714637";FALSE;1959;potassium at admission mmol l $nmbr$
 670;serum biochemistry potassium  mmol / l;"C0005477;C0302353;C0543465;C1532563";FALSE;1371;serum biochemistry potassium mmol l
 670;haemoglobin ( mmol / l );"C0019046;C0439190;C0635222;C1532563";NA;NA;haemoglobin mmol l
 670;glucose  mmol / l;"C0017725;C1532563";NA;NA;glucose mmol l
 670;fc > $nmbr$ mg / dl ( > _ $nmbr$ . $nmbr$ mmol / l ) or history of diabetes;"C0011847;C0011849;C0019664;C0019665;C0262512;C0262926;C0439269;C1532563;C1705255;C2004062;C2983605";NA;NA;fc $nmbr$ mg dl _ $nmbr$ $nmbr$ mmol l or history of diabetes
 670;change  mg / dl ( mmol / l );"C0392747;C0439269;C0443172;C1532563;C1705241;C4319952";NA;NA;change mg dl mmol l
 670;bun  mmol / l;C1532563;NA;NA;bun mmol l
 670;baseline normoglycaemia ( fpg < $nmbr$ . $nmbr$ mmol / l ) - n;"C0168634;C0580545;C1442488;C1532563";NA;NA;baseline normoglycaemia fpg $nmbr$ $nmbr$ mmol l n
 670;baseline lipids  mean ± sd ( mmol / l );"C0023779;C0168634;C0444504;C1442488;C1532563;C2347634;C2348143;C2699239";NA;NA;baseline lipids mean sd mmol l
 670;baseline lipid parameters  mg / dl  mmol / l or g / l;"C0023779;C0168634;C0439269;C0439294;C0449381;C0456615;C1442488;C1532563";NA;NA;baseline lipid parameters mg dl mmol l or g l
 670;baseline ( mmol / l );"C0168634;C1442488;C1532563";NA;NA;baseline mmol l
 670;[ $nmbr$ . $nmbr$ mmol / l ] );C1532563;NA;NA;$nmbr$ $nmbr$ mmol l
 670;> $nmbr$ mmol / l;C1532563;NA;NA;$nmbr$ mmol l
 670;> $nmbr$ mg / dl ( > $nmbr$ . $nmbr$ mmol / l ) + +;"C0439269;C1532563";NA;NA;$nmbr$ mg dl $nmbr$ $nmbr$ mmol l
 670;> $nmbr$ . $nmbr$ mmol / l ( n = $nmbr$ );C1532563;NA;NA;$nmbr$ $nmbr$ mmol l n $nmbr$
 670;> $nmbr$ . $nmbr$ mmol / l;C1532563;NA;NA;$nmbr$ $nmbr$ mmol l
 670;> $nmbr$ - $nmbr$ mmol / l;C1532563;NA;NA;$nmbr$ $nmbr$ mmol l
 670;> $nmbr$ + $nmbr$ mmol / l;C1532563;NA;NA;$nmbr$ $nmbr$ mmol l
 670;> $nmbr$ ' $nmbr$ mmol / l;C1532563;NA;NA;$nmbr$ $nmbr$ mmol l
 670;< $nmbr$ mmol / l;C1532563;NA;NA;$nmbr$ mmol l
 670;< $nmbr$ mg / dl ( < $nmbr$ . $nmbr$ mmol / l );"C0439269;C1532563";NA;NA;$nmbr$ mg dl $nmbr$ $nmbr$ mmol l
 670;< $nmbr$ . $nmbr$ mmol / l;C1532563;NA;NA;$nmbr$ $nmbr$ mmol l
 670;< $nmbr$ - $nmbr$ mmol / l;C1532563;NA;NA;$nmbr$ $nmbr$ mmol l
 670;( mmol / l ];C1532563;NA;NA;mmol l
 670;( mmol / l );C1532563;NA;NA;mmol l
 670;( < $nmbr$ . $nmbr$ mmol / l );C1532563;NA;NA;$nmbr$ $nmbr$ mmol l
 670;$nmbr$ st tertile ( < = $nmbr$ mg / dl [ < = $nmbr$ . $nmbr$ mmol / l ] ) b;"C0036056;C0439269;C1532563;C3272372";NA;NA;$nmbr$ st tertile $nmbr$ mg dl $nmbr$ $nmbr$ mmol l b
 670;$nmbr$ nd tertile ( > $nmbr$ to < = $nmbr$ mg / dl [ > $nmbr$ . $nmbr$ to < = $nmbr$ . $nmbr$ mmol / l ] ) c;"C0439269;C1532563";NA;NA;$nmbr$ nd tertile $nmbr$ to $nmbr$ mg dl $nmbr$ $nmbr$ to $nmbr$ $nmbr$ mmol l c
 670;$nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ mmol / l;C1532563;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ mmol l
 670;$nmbr$ - $nmbr$ mmol / l;C1532563;NA;NA;$nmbr$ $nmbr$ mmol l
 669;unbound pcsk $nmbr$ ( nmol / l );C0439282;NA;NA;unbound pcsk $nmbr$ nmol l
 669;testosterone level ( nmol / l );"C0428412;C0439282;C0523912";NA;NA;testosterone level nmol l
 359;methylxanthines;C0066447;NA;NA;methylxanthines
 670;ldl cholesterol  mmol / l  mean ( sd ) §;"C0023824;C0202117;C0444504;C1532563;C2347634;C2348143;C2699239";FALSE;1068;ldl cholesterol mmol l mean sd
 670;ldl cholesterol  mmol / l  mean ± sd;"C0023824;C0202117;C0444504;C1532563;C2347634;C2348143;C2699239";FALSE;1068;ldl cholesterol mmol l mean sd
 670;ldl cholesterol ( mmol / l )  mean ( sd );"C0023824;C0202117;C0444504;C1532563;C2347634;C2348143;C2699239";FALSE;1068;ldl cholesterol mmol l mean sd
 670;ldl cholesterol ( mmol / l ) ( median  iqr );"C0023824;C0202117;C0549183;C0876920;C1532563;C2347635;C2348144;C2939193";FALSE;1068;ldl cholesterol mmol l median iqr
 670;ldl - c   *   ( mmol / l );C1532563;FALSE;1068;ldl c mmol l
 670;ldl ( mmol / l );C1532563;FALSE;1068;ldl mmol l
 670;ldl - c < $nmbr$ . $nmbr$ mmol / l;C1532563;FALSE;1068;ldl c $nmbr$ $nmbr$ mmol l
 670;ldl - c < $nmbr$ mg / dl ( $nmbr$ . $nmbr$ mmol / l );"C0439269;C1532563";FALSE;1068;ldl c $nmbr$ mg dl $nmbr$ $nmbr$ mmol l
 670;ldl - c  mmol / l ( sd );"C1532563;C2699239";FALSE;1068;ldl c mmol l sd
 670;ldl - c ( mmol / l  mean );"C0444504;C1532563;C2347634;C2348143";FALSE;1068;ldl c mmol l mean
 670;ldl - c  mmol / l  mean ( sd );"C0444504;C1532563;C2347634;C2348143;C2699239";FALSE;1068;ldl c mmol l mean sd
 670;ldl - c * ( mmol / l );C1532563;FALSE;1068;ldl c mmol l
 670;ldl - c ( mmol / l );C1532563;FALSE;1068;ldl c mmol l
 670;ldl - c  mmol / l;C1532563;FALSE;1068;ldl c mmol l
 670;ldl cholesterol > $nmbr$ - $nmbr$ mmol / l;"C0023824;C0202117;C1532563";FALSE;1068;ldl cholesterol $nmbr$ $nmbr$ mmol l
 670;ldl cholesterol < $nmbr$ - $nmbr$ mmol / l;"C0023824;C0202117;C1532563";FALSE;1068;ldl cholesterol $nmbr$ $nmbr$ mmol l
 670;ldl cholesterol  mmol / l 丰;"C0023824;C0202117;C1532563";FALSE;1068;ldl cholesterol mmol l
 670;fasting plasma glucose ( mmol / l );"C0015663;C0202042;C0455280;C1532563";FALSE;1960;fasting plasma glucose mmol l
 670;fasting serum glucose  mmol / l  median ( q $nmbr$  q $nmbr$ );"C0015663;C0202041;C0549183;C0876920;C1532563;C2347635;C2348144;C2939193;C3534430";FALSE;1960;fasting serum glucose mmol l median q $nmbr$ q $nmbr$
 670;fbg  mmol / l;C1532563;FALSE;1960;fbg mmol l
 670;fpg  median ( q $nmbr$  q $nmbr$ )  mmol / l;"C0549183;C0876920;C1532563;C2347635;C2348144;C2939193";FALSE;1960;fpg median q $nmbr$ q $nmbr$ mmol l
 670;fpg  mean ( sd )  mmol / l;"C0444504;C1532563;C2347634;C2348143;C2699239";FALSE;1960;fpg mean sd mmol l
 670;fpg  median ( ql  q $nmbr$ )  mmol / l;"C0549183;C0876920;C1532563;C2347635;C2348144;C2939193";FALSE;1960;fpg median ql q $nmbr$ mmol l
 670;fpg  mmol / l;C1532563;FALSE;1960;fpg mmol l
 670;fpg  ( mmol / l );C1532563;FALSE;1960;fpg mmol l
 670;fpg  mg / dl ( mmol / l );"C0439269;C1532563";FALSE;1960;fpg mg dl mmol l
 670;fpg  mmol / l ( mean ± sd );"C0444504;C1532563;C2347634;C2348143;C2699239";FALSE;1960;fpg mmol l mean sd
 670;fpg ( mmol / l );C1532563;FALSE;1960;fpg mmol l
 670;fpg  mmol / l  mean ( sd );"C0444504;C1532563;C2347634;C2348143;C2699239";FALSE;1960;fpg mmol l mean sd
 670;fpg ( mmol / l )  mean ( sd );"C0444504;C1532563;C2347634;C2348143;C2699239";FALSE;1960;fpg mmol l mean sd
 670;fpg ( mmol / l )  mean ( sd ) 、;"C0444504;C1532563;C2347634;C2348143;C2699239";FALSE;1960;fpg mmol l mean sd
 670;fpg ( range ) ( mmol / l );"C1514721;C1532563;C2348147;C3542016";FALSE;1960;fpg range mmol l
 670;f - plasma glucose  mmol / l;"C0016327;C0202042;C0455280;C1532563";FALSE;1960;f plasma glucose mmol l
 670;free fatty acids ( mmol / l );"C0015688;C1532563";FALSE;1961;free fatty acids mmol l
 670;ffa ( mmol / l );"C0015688;C1532563";FALSE;1961;ffa mmol l
 670;k  mmol / l;"C0597277;C1532563;C1708601";FALSE;1959;k mmol l
 670;k ( mmol / l );"C0597277;C1532563;C1708601";FALSE;1959;k mmol l
 670;admission k  mmol / l;"C0184666;C0597277;C0809949;C1532563;C1708601";FALSE;1959;admission k mmol l
 670;hdl - c ( mmol / l  mean );"C0444504;C1532563;C2347634;C2348143;C3715113";FALSE; 821;hdl c mmol l mean
 670;hdl - c > $nmbr$ mg / dl ( $nmbr$ . $nmbr$ mmol / l );"C0439269;C1532563;C3715113";FALSE; 821;hdl c $nmbr$ mg dl $nmbr$ $nmbr$ mmol l
 670;high - density lipoprotein cholesterol  mean ( sd )  mmol / l;"C0023822;C0444504;C1532563;C2347634;C2348143;C2699239";FALSE; 821;high density lipoprotein cholesterol mean sd mmol l
 670;elevated serum potassium  > $nmbr$ . $nmbr$ mmol / l;"C0553704;C1532563";FALSE;1371;elevated serum potassium $nmbr$ $nmbr$ mmol l
 670;hyperkalaemia ( serum potassium > $nmbr$ . $nmbr$ mmol / l );"C0020461;C0302353;C0543465;C1532563;C4552983";FALSE;1371;hyperkalaemia serum potassium $nmbr$ $nmbr$ mmol l
 669;testosterone ( tt ) ( nmol / l );"C0039601;C0439282;C1452561;C4554543";NA;NA;testosterone tt nmol l
 669;testosterone ( nmol / l );"C0039601;C0439282";NA;NA;testosterone nmol l
 669;hscrp ( nmol / l );C0439282;NA;NA;hscrp nmol l
 669;crp  nmol / l  median ( range );"C0439282;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016;C3890735;C4048285";NA;NA;crp nmol l median range
 669;cholesterol ( nmol / l );"C0008377;C0439282";NA;NA;cholesterol nmol l
 668;≥   $nmbr$   mmol / mol ( $nmbr$ . $nmbr$ % )    n   ( % );C3829066;NA;NA;$nmbr$ mmol mol $nmbr$ $nmbr$ n
 668;≥ $nmbr$ . $nmbr$ % ( ≥ $nmbr$ mmol / mol );C3829066;NA;NA;$nmbr$ $nmbr$ $nmbr$ mmol mol
 668;≤   $nmbr$   mmol / mol ( $nmbr$ . $nmbr$ % )    n   ( % );C3829066;NA;NA;$nmbr$ mmol mol $nmbr$ $nmbr$ n
 668;mmol / mol;C3829066;NA;NA;mmol mol
 668;mean hba $nmbr$ c  mmol / mol †;"C0019016;C0444504;C1825777;C2347634;C2348143;C3538758;C3829066";NA;NA;mean hba $nmbr$ c mmol mol
 668;ls mean ( $nmbr$ % ci )  mmol / mol;"C0008107;C0023668;C0444504;C2347634;C2348143;C3259781;C3829066";NA;NA;ls mean $nmbr$ ci mmol mol
 668;alc ( mmol / mol );"C1424945;C3811058;C3829066";NA;NA;alc mmol mol
 668;a $nmbr$ c ( mmol / mol );C3829066;NA;NA;a $nmbr$ c mmol mol
 668;a $nmbr$ c  % ( mmol / mol );C3829066;NA;NA;a $nmbr$ c mmol mol
 668;>   $nmbr$ – <   $nmbr$   mmol / mol ( $nmbr$ . $nmbr$ – $nmbr$ . $nmbr$ % )    n   ( % );C3829066;NA;NA;$nmbr$ $nmbr$ mmol mol $nmbr$ $nmbr$ $nmbr$ $nmbr$ n
 668;> = $nmbr$ . $nmbr$ % ( > = $nmbr$ mmol / mol );C3829066;NA;NA;$nmbr$ $nmbr$ $nmbr$ mmol mol
 668;> = $nmbr$ % and < $nmbr$ % ( > = $nmbr$ and < $nmbr$ mmol / mol );C3829066;NA;NA;$nmbr$ and $nmbr$ $nmbr$ and $nmbr$ mmol mol
 668;> = $nmbr$ % ( $nmbr$ mmol / mol );C3829066;NA;NA;$nmbr$ $nmbr$ mmol mol
 668;> $nmbr$ % ( > $nmbr$ mmol / mol );C3829066;NA;NA;$nmbr$ $nmbr$ mmol mol
 668;< $nmbr$ . $nmbr$ % ( < $nmbr$ mmol / mol );C3829066;NA;NA;$nmbr$ $nmbr$ $nmbr$ mmol mol
 668;< $nmbr$ . $nmbr$ % ( $nmbr$ mmol / mol );C3829066;NA;NA;$nmbr$ $nmbr$ $nmbr$ mmol mol
 668;< $nmbr$ % ( < $nmbr$ mmol / mol );C3829066;NA;NA;$nmbr$ $nmbr$ mmol mol
 668;< $nmbr$ % ( $nmbr$ mmol / mol );C3829066;NA;NA;$nmbr$ $nmbr$ mmol mol
 667;trigl yeerides * ( m mol / l );"C0027960;C0324740;C0347982;C0369637;C0439189;C0441923;C0456616;C1456781;C1824986;C3665593";NA;NA;trigl yeerides m mol l
 667;serum creatinine  弘 mol 儿 | |;"C0027960;C0201976;C0324740;C0439189;C0600061;C1456781;C1824986;C3665593";NA;NA;serum creatinine mol
 667;epa ( mol % );"C0027960;C0324740;C0439189;C1456781;C1824986;C3665593";NA;NA;epa mol
 667;epa  mol %;"C0027960;C0324740;C0439189;C1456781;C1824986;C3665593";NA;NA;epa mol
 666;fpi  m - u / ml ( pmol / l );"C0369637;C0439192;C0439284;C0439340;C0441923;C0456616;C1880521;C2945590";NA;NA;fpi m u ml pmol l
 635;hbak < median;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;hbak median
 666;fpi  gu / ml ( pmol / l );"C0120446;C0439192;C0439284;C0439526;C1635169;C1705224;C3887515;C3887665";NA;NA;fpi gu ml pmol l
 666;estradiol ( pmol / l );"C0014912;C0439284";NA;NA;estradiol pmol l
 666;estradiol ( e $nmbr$ ) ( pmol / l );"C0014912;C0439284";NA;NA;estradiol e $nmbr$ pmol l
 666;$nmbr$ rd : $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ pmol / l;"C0439284;C0694666;C4553350";NA;NA;$nmbr$ rd $nmbr$ $nmbr$ $nmbr$ $nmbr$ pmol l
 666;$nmbr$ nd : $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ pmol / l;C0439284;NA;NA;$nmbr$ nd $nmbr$ $nmbr$ $nmbr$ $nmbr$ pmol l
 665;fasting proinsulin ( pmol / l );"C0015663;C0033362;C0439284;C3813208";NA;NA;fasting proinsulin pmol l
 665;$nmbr$ - h postprandial proinsulin ( pmol / l );"C0033362;C0376674;C2827799;C3813208";NA;NA;$nmbr$ h postprandial proinsulin pmol l
 664;el  n ( % );"C1416870;C1447747;C1823249;C3811107;C3811848;C3815598";NA;NA;el n
 664;( $nmbr$ % ell ' ll  * non - hdl - c;"C1427925;C1518422;C3273466;C3715113";NA;NA;$nmbr$ ell ll non hdl c
 664;( $nmbr$ % ell ' ll;"C1427925;C3273466";NA;NA;$nmbr$ ell ll
 664;$nmbr$ ± ll;NA;NA;NA;$nmbr$ ll
 663;ll $nmbr$ ( $nmbr$ );NA;NA;NA;ll $nmbr$ $nmbr$
 663;l / ll;"C0439394;C1706495;C3642217";NA;NA;l ll
 663;insulin glargine ( n = $nmbr$ ll );C0907402;NA;NA;insulin glargine n $nmbr$ ll
 663;- $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ ) * ll;NA;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ ll
 662;ll ( $nmbr$ );NA;NA;NA;ll $nmbr$
 662;eosinophils ( cells / ll ) inclusion criteria  n ( % );"C0682547;C1512693";NA;NA;eosinophils cells ll inclusion criteria n
 662;eosinophil count ( cells / microlitre );"C0200638;C0439378;C0750879";NA;NA;eosinophil count cells microlitre
 662;> $nmbr$ cells / ul;C0439378;NA;NA;$nmbr$ cells ul
 662;< $nmbr$ cells / ul $nmbr$ $nmbr$;C0439378;NA;NA;$nmbr$ cells ul $nmbr$ $nmbr$
 661;squamous cell carcinoma;"C0007137;C1302853";NA;NA;squamous cell carcinoma
 661;dynamic measure of β - cell function ( ϕ s ) ( change from baseline ) – assessed for mmtt subset only;"C0007613;C0079809;C0168634;C0205171;C0242485;C0392747;C0443172;C0729333;C1442488;C1515021;C1516048;C1705241;C1720467;C4319952";NA;NA;dynamic measure of cell function s change from baseline assessed for mmtt subset only
 661;^ $nmbr$ - cell function — % §;C0007613;NA;NA;$nmbr$ cell function
 660;ill -;C0231218;NA;NA;ill
 660;all noncompleters;NA;NA;NA;all noncompleters
 660;all completers ( n $nmbr$ $nmbr$ );NA;NA;NA;all completers n $nmbr$ $nmbr$
 660;all completers;NA;NA;NA;all completers
 660;< $nmbr$ . $nmbr$ tng > cll;C0023434;NA;NA;$nmbr$ $nmbr$ tng cll
 659;white blood cell count  cellsx $nmbr$;"C0023508;C0427512";NA;NA;white blood cell count cellsx $nmbr$
 668;hbajc ( mmol / mol ) mean ± sd;"C0444504;C2347634;C2348143;C2699239;C3829066";FALSE; 820;hbajc mmol mol mean sd
 668;hbaj ( - ( %  mmol / mol );C3829066;FALSE; 820;hbaj mmol mol
 668;hbalc a $nmbr$ mmol / mol ( > $nmbr$ . $nmbr$ % ) ( n = $nmbr$ / $nmbr$ );C3829066;FALSE; 820;hbalc a $nmbr$ mmol mol $nmbr$ $nmbr$ n $nmbr$ $nmbr$
 668;hbalc < $nmbr$ mmol / mol ( < $nmbr$ . $nmbr$ % ) at week $nmbr$;"C0332174;C0439230;C3829066";FALSE; 820;hbalc $nmbr$ mmol mol $nmbr$ $nmbr$ at week $nmbr$
 668;hbalc < $nmbr$ mmol / mol ( < $nmbr$ . $nmbr$ % ) ( n = $nmbr$ / $nmbr$ );C3829066;FALSE; 820;hbalc $nmbr$ mmol mol $nmbr$ $nmbr$ n $nmbr$ $nmbr$
 668;hba $nmbr$ c  ( mmol / mol );"C0019016;C1825777;C3538758;C3829066";FALSE; 820;hba $nmbr$ c mmol mol
 668;hba $nmbr$ c  % [ mmol / mol ];"C0019016;C1825777;C3538758;C3829066";FALSE; 820;hba $nmbr$ c mmol mol
 668;hba $nmbr$ c  mmol / mol ( mean );"C0019016;C0444504;C1825777;C2347634;C2348143;C3538758;C3829066";FALSE; 820;hba $nmbr$ c mmol mol mean
 668;hba $nmbr$ c  mmol / mol  mean ( sd );"C0019016;C0444504;C1825777;C2347634;C2348143;C2699239;C3538758;C3829066";FALSE; 820;hba $nmbr$ c mmol mol mean sd
 668;hba $nmbr$ c  mmol / mol  median ( q $nmbr$  q $nmbr$ );"C0019016;C0549183;C0876920;C1825777;C2347635;C2348144;C2939193;C3538758;C3829066";FALSE; 820;hba $nmbr$ c mmol mol median q $nmbr$ q $nmbr$
 668;hba $nmbr$ c ( mmol / mol [ se ] );"C0019016;C0036919;C1825777;C3538758;C3829066";FALSE; 820;hba $nmbr$ c mmol mol se
 668;hba $nmbr$ c $nmbr$ . $nmbr$ to < $nmbr$ . $nmbr$ % ( $nmbr$ - $nmbr$ mmol / mol );"C0019016;C1825777;C3538758;C3829066";FALSE; 820;hba $nmbr$ c $nmbr$ $nmbr$ to $nmbr$ $nmbr$ $nmbr$ $nmbr$ mmol mol
 668;hba $nmbr$ c ( sd )  mmol / mol;"C0019016;C1825777;C2699239;C3538758;C3829066";FALSE; 820;hba $nmbr$ c sd mmol mol
 659;white - cell count — x $nmbr$ _ $nmbr$ / liter;"C0023508;C0427512;C0475211";NA;NA;white cell count x $nmbr$ _ $nmbr$ liter
 659;blood leukocyte count ( $nmbr$ cells per l );"C0023508;C0023516;C0347983;C0427512";NA;NA;blood leukocyte count $nmbr$ cells per l
 658;ucl;NA;NA;NA;ucl
 658;treatment difference ( $nmbr$ % cl );"C0039798;C0087111;C0596019;C1522326;C1533734;C1705169;C1705241;C1705242;C3538994;C3887704";NA;NA;treatment difference $nmbr$ cl
 658;treatment difference % ( $nmbr$ % cl );"C0039798;C0087111;C0596019;C1522326;C1533734;C1705169;C1705241;C1705242;C3538994;C3887704";NA;NA;treatment difference $nmbr$ cl
 658;risk reduction ( $nmbr$ % cl );"C0596019;C1137094";NA;NA;risk reduction $nmbr$ cl
 658;risk ratio [ $nmbr$ % cl ];"C0028873;C0242492;C0596019";NA;NA;risk ratio $nmbr$ cl
 658;relative risk ® ( $nmbr$ % cl );"C0242492;C0596019";NA;NA;relative risk $nmbr$ cl
 658;relative risk ® ' ( $nmbr$ % cl );"C0242492;C0596019";NA;NA;relative risk $nmbr$ cl
 658;relative risk vs . placebo ( $nmbr$ % cl );"C0032042;C0242492;C0596019;C1696465;C1706408";NA;NA;relative risk vs placebo $nmbr$ cl
 658;relative risk reduction ( $nmbr$ % cl ) percent;"C0080103;C0205345;C0242492;C0301630;C0392756;C0439165;C0596019;C1137094;C1293152;C1547039;C4551656";NA;NA;relative risk reduction $nmbr$ cl percent
 658;relative risk reduction ( $nmbr$ % cl );"C0080103;C0205345;C0242492;C0301630;C0392756;C0596019;C1137094;C1293152;C1547039;C4551656";NA;NA;relative risk reduction $nmbr$ cl
 658;relative risk * ( $nmbr$ % cl );"C0242492;C0596019";NA;NA;relative risk $nmbr$ cl
 658;relative risk ( $nmbr$ % cl );"C0242492;C0596019";NA;NA;relative risk $nmbr$ cl
 658;ratio of hrs ( $nmbr$ % cl )  p for sex interaction;"C0009253;C0036864;C0079399;C0456603;C0596019;C0804628;C1314687;C1522384;C1547037;C1568891;C1704675";NA;NA;ratio of hrs $nmbr$ cl p for sex interaction
 658;pre - specified hr ( $nmbr$ % cl );"C0596019;C2826245";NA;NA;pre specified hr $nmbr$ cl
 658;p ( $nmbr$ % cl );"C0369773;C0596019;C2603361";NA;NA;p $nmbr$ cl
 658;overall hr ( $nmbr$ % cl );"C0282416;C0596019;C1561607";NA;NA;overall hr $nmbr$ cl
 658;orc ( $nmbr$ % cl );"C0596019;C1167125";NA;NA;orc $nmbr$ cl
 658;oradj ( $nmbr$ % cl );C0596019;NA;NA;oradj $nmbr$ cl
 658;or [ $nmbr$ % cl ];C0596019;NA;NA;or $nmbr$ cl
 658;or ( $nmbr$ % cl ) = $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ . $nmbr$ . $nmbr$ );C0596019;NA;NA;or $nmbr$ cl $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 658;or ( $nmbr$ % cl ) = $nmbr$ . $nmbr$ ( $nmbr$ $nmbr$ . $nmbr$ . $nmbr$ );C0596019;NA;NA;or $nmbr$ cl $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 658;or ( $nmbr$ % cl ) = $nmbr$ $nmbr$ ( $nmbr$ . $nmbr$ . $nmbr$ $nmbr$ );C0596019;NA;NA;or $nmbr$ cl $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 658;or ( $nmbr$ % cl ) = $nmbr$ $nmbr$ ( $nmbr$ . $nmbr$  $nmbr$ $nmbr$ );C0596019;NA;NA;or $nmbr$ cl $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 658;or ( $nmbr$ % cl );C0596019;NA;NA;or $nmbr$ cl
 658;or  $nmbr$ . $nmbr$ ( $nmbr$ % cl  $nmbr$ . $nmbr$ — $nmbr$  $nmbr$ );C0596019;NA;NA;or $nmbr$ $nmbr$ $nmbr$ cl $nmbr$ $nmbr$ $nmbr$ $nmbr$
 658;or  $nmbr$ . $nmbr$ ( $nmbr$ % cl  $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ );C0596019;NA;NA;or $nmbr$ $nmbr$ $nmbr$ cl $nmbr$ $nmbr$ $nmbr$ $nmbr$
 658;north america hr ( $nmbr$ % cl );"C0028405;C0596019";NA;NA;north america hr $nmbr$ cl
 658;mean difference ( $nmbr$ % cl );"C0444504;C0596019;C1705241;C1705242;C2347634;C2348143";NA;NA;mean difference $nmbr$ cl
 658;lsm difference ( $nmbr$ % cl );"C0596019;C1705241;C1705242";NA;NA;lsm difference $nmbr$ cl
 658;lsm ( $nmbr$ % cl );C0596019;NA;NA;lsm $nmbr$ cl
 658;ls mean difference ( $nmbr$ % cl );"C0023668;C0444504;C0596019;C1705241;C1705242;C2347634;C2348143";NA;NA;ls mean difference $nmbr$ cl
 658;ls - mean difference ® ( $nmbr$ % cl );"C0023668;C0444504;C0596019;C1705241;C1705242;C2347634;C2348143";NA;NA;ls mean difference $nmbr$ cl
 658;least - squares mean difference ( $nmbr$ % cl );"C0023189;C0444504;C0596019;C1705241;C1705242;C2347634;C2348143";NA;NA;least squares mean difference $nmbr$ cl
 658;laba or lama ’ versus ind / gly lsm difference ( $nmbr$ % cl );"C0017890;C0523677;C0596019;C0999593;C1416775;C1705241;C1705242;C4049864";NA;NA;laba or lama versus ind gly lsm difference $nmbr$ cl
 658;hr : $nmbr$ . $nmbr$ ( $nmbr$ % cl : $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ ) p = $nmbr$ . $nmbr$;C0596019;NA;NA;hr $nmbr$ $nmbr$ $nmbr$ cl $nmbr$ $nmbr$ $nmbr$ $nmbr$ p $nmbr$ $nmbr$
 658;hr ( $nmbr$ % cl ) pvalue;C0596019;NA;NA;hr $nmbr$ cl pvalue
 658;hr ( $nmbr$ % cl ) = $nmbr$ . $nmbr$ b ( $nmbr$  $nmbr$ . $nmbr$ );C0596019;NA;NA;hr $nmbr$ cl $nmbr$ $nmbr$ b $nmbr$ $nmbr$ $nmbr$
 658;hr ( $nmbr$ % cl ) = $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$  $nmbr$ $nmbr$ );C0596019;NA;NA;hr $nmbr$ cl $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 658;hr ( $nmbr$ % cl ) = $nmbr$ . $nmbr$ ( $nmbr$ $nmbr$  $nmbr$ . $nmbr$ );C0596019;NA;NA;hr $nmbr$ cl $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 658;hr ( $nmbr$ % cl ) = $nmbr$ $nmbr$ ( $nmbr$ . $nmbr$ . $nmbr$  $nmbr$ );C0596019;NA;NA;hr $nmbr$ cl $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 658;hr ( $nmbr$ % cl );C0596019;NA;NA;hr $nmbr$ cl
 658;hr $nmbr$ and $nmbr$ % cl;C0596019;NA;NA;hr $nmbr$ and $nmbr$ cl
 658;hr $nmbr$ . $nmbr$ ( $nmbr$ % cl $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ ) p = $nmbr$ . $nmbr$ *;C0596019;NA;NA;hr $nmbr$ $nmbr$ $nmbr$ cl $nmbr$ $nmbr$ $nmbr$ $nmbr$ p $nmbr$ $nmbr$
 658;hr $nmbr$ - $nmbr$ ( $nmbr$ % cl $nmbr$ - $nmbr$ - $nmbr$ - $nmbr$ );C0596019;NA;NA;hr $nmbr$ $nmbr$ $nmbr$ cl $nmbr$ $nmbr$ $nmbr$ $nmbr$
 658;hr $nmbr$ - $nmbr$ ( $nmbr$ % cl $nmbr$ - $nmbr$ - $nmbr$ );C0596019;NA;NA;hr $nmbr$ $nmbr$ $nmbr$ cl $nmbr$ $nmbr$ $nmbr$
 658;hr $nmbr$ % cl;C0596019;NA;NA;hr $nmbr$ cl
 658;hr  $nmbr$ % cl;C0596019;NA;NA;hr $nmbr$ cl
 658;hazard ratio or difference $nmbr$ * ( $nmbr$ % cl ) p - value;"C0596019;C1705241;C1705242;C1709380;C2985465";NA;NA;hazard ratio or difference $nmbr$ $nmbr$ cl p value
 658;hazard ratio or difference $nmbr$ ( $nmbr$ % cl ) p - value;"C0596019;C1705241;C1705242;C1709380;C2985465";NA;NA;hazard ratio or difference $nmbr$ $nmbr$ cl p value
 658;estimated mean $nmbr$ % cl;"C0444504;C0596019;C0750572;C2347634;C2348143";NA;NA;estimated mean $nmbr$ cl
 658;estimate ( $nmbr$ % cl );"C0596019;C0750572";NA;NA;estimate $nmbr$ cl
 658;difference in ls mean $nmbr$ ( $nmbr$ % cl );"C0023668;C0444504;C0596019;C1705241;C1705242;C2347634;C2348143";NA;NA;difference in ls mean $nmbr$ $nmbr$ cl
 658;difference ( $nmbr$ % cl );"C0596019;C1705241;C1705242";NA;NA;difference $nmbr$ cl
 658;cl - $nmbr$ ];C0596019;NA;NA;cl $nmbr$
 658;cl $nmbr$ %;C0596019;NA;NA;cl $nmbr$
 658;change in pav  mean ( $nmbr$ % cl )  %;"C0058890;C0392747;C0443172;C0444504;C0596019;C1705241;C2347634;C2348143;C4319952";NA;NA;change in pav mean $nmbr$ cl
   7;multivariable or ( $nmbr$ % ci )  p value *;"C0008107;C1709380;C3259781";NA;NA;multivariable or $nmbr$ ci p value
   7;interaction p value 中;"C1704675;C1709380";NA;NA;interaction p value
   7;interaction p value ∗;"C1704675;C1709380";NA;NA;interaction p value
   7;interaction p value §;"C1704675;C1709380";NA;NA;interaction p value
   7;interaction p value *;"C1704675;C1709380";NA;NA;interaction p value
 658;bsl  baseline  cl  confidence interval  esrd  end - stage renal disease  hb  hemoglobin  k ( rate )  # of events per $nmbr$ patient - years of follow - up  rrr  relative risk reduction  yr  year . ^ treatment effect of losartan versus placebo . interaction test between treatment group and hemoglobin group ( < $nmbr$ or > $nmbr$ g i - $nmbr$ ) . cmultivariate cox model with baseline log urinary albumimcreatinine ratio  serum albumin  serum creatinine  and hemoglobin as covariates . dmultivariate cox model with baseline log urinary albumimcreatinine ratio  serum albumin  serum creatinine  and hemoglobin and change in hemoglobin at year $nmbr$ as covariates .;"C0001924;C0009667;C0010294;C0019046;C0022661;C0022885;C0030705;C0032042;C0036773;C0039593;C0042027;C0080103;C0086706;C0126174;C0168634;C0201976;C0205345;C0229671;C0237455;C0242492;C0301630;C0374505;C0392366;C0392747;C0392756;C0439234;C0439508;C0441471;C0441833;C0443172;C0455271;C0456603;C0456984;C0486293;C0589120;C0596019;C0597277;C0600061;C0687744;C0728877;C0871208;C1137094;C1257890;C1293152;C1318330;C1442488;C1515976;C1518681;C1519504;C1521828;C1522577;C1524119;C1546774;C1547037;C1547039;C1549954;C1550100;C1561535;C1565830;C1626828;C1696465;C1704675;C1704685;C1705241;C1705428;C1705429;C1706408;C1708601;C1708728;C2986775;C3161035;C3274571;C3274659;C3541888;C3714583;C3831328;C3853906;C4281686;C4318744;C4319952;C4551656";NA;NA;bsl baseline cl confidence interval esrd end stage renal disease hb hemoglobin k rate of events per $nmbr$ patient years of follow up rrr relative risk reduction yr year treatment effect of losartan versus placebo interaction test between treatment group and hemoglobin group $nmbr$ or $nmbr$ g i $nmbr$ cmultivariate cox model with baseline log urinary albumimcreatinine ratio serum albumin serum creatinine and hemoglobin as covariates dmultivariate cox model with baseline log urinary albumimcreatinine ratio serum albumin serum creatinine and hemoglobin and change in hemoglobin at year $nmbr$ as covariates
 658;adjusted or ( $nmbr$ % cl );"C0456081;C0596019";NA;NA;adjusted or $nmbr$ cl
 658;adjusted hr * ( $nmbr$ % cl ) pvalue;"C0456081;C0596019";NA;NA;adjusted hr $nmbr$ cl pvalue
 658;adjusted hr ( enl vs lcz ) ( $nmbr$ % cl );"C0456081;C0596019";NA;NA;adjusted hr enl vs lcz $nmbr$ cl
 658;adjusted hr ( $nmbr$ % cl );"C0456081;C0596019";NA;NA;adjusted hr $nmbr$ cl
 658;adjusted $nmbr$ or ( $nmbr$ % cl );"C0456081;C0596019";NA;NA;adjusted $nmbr$ or $nmbr$ cl
 658;adj . hr ( $nmbr$ % cl ) a;"C0001552;C0596019;C2826286";NA;NA;adj hr $nmbr$ cl a
 658;[ $nmbr$ % cl ];C0596019;NA;NA;$nmbr$ cl
 658;( %  $nmbr$ % cl );C0596019;NA;NA;$nmbr$ cl
 658;( $nmbr$ % cl ) interaction;"C0596019;C1704675";NA;NA;$nmbr$ cl interaction
 658;( $nmbr$ % cl );C0596019;NA;NA;$nmbr$ cl
 658;% risk reduction ( $nmbr$ % cl );"C0596019;C1137094";NA;NA;risk reduction $nmbr$ cl
 658;$nmbr$ cl );C0596019;NA;NA;$nmbr$ cl
 658;$nmbr$ ( $nmbr$ cl );C0596019;NA;NA;$nmbr$ $nmbr$ cl
 658;$nmbr$ % cl;C0596019;NA;NA;$nmbr$ cl
 657;kl $nmbr$ ( % );"C1366480;C1416656;C1704887";NA;NA;kl $nmbr$
 657;hmgcoa rl;"C0047420;C1419337;C3539667";NA;NA;hmgcoa rl
 656;cox bsl onlyc;"C1549954;C1565830";NA;NA;cox bsl onlyc
 656;cox bsl + yr $nmbr$ hbd;"C0439234;C1549954;C1565830";NA;NA;cox bsl yr $nmbr$ hbd
 655;diabetes bl;"C0005918;C0006413;C0011847;C0011849;C1552663;C2827109";NA;NA;diabetes bl
 655;bl mean ( cm );"C0005918;C0006413;C0444504;C1552663;C2347634;C2348143;C2827109";NA;NA;bl mean cm
 655;bl h / y : unilateral;"C0005918;C0006413;C0033727;C0205092;C0369286;C0441932;C0564385;C1552663;C2827109;C4528284";NA;NA;bl h y unilateral
 655;bl h / y : bilateral;"C0005918;C0006413;C0033727;C0238767;C0369286;C0441932;C0564385;C1552663;C2827109;C4528284";NA;NA;bl h y bilateral
 655;bl bml > $nmbr$ kg / m ^;"C0005918;C0006413;C1532718;C1552663;C2827109";NA;NA;bl bml $nmbr$ kg m
 655;bl bml > $nmbr$ ke / m ^;"C0005918;C0006413;C0022558;C0369637;C0441923;C1552663;C2827109";NA;NA;bl bml $nmbr$ ke m
 655;bl bml < $nmbr$ kg / m ^;"C0005918;C0006413;C1532718;C1552663;C2827109";NA;NA;bl bml $nmbr$ kg m
 655;bl bmioo kg / m ^;"C0005918;C0006413;C1532718;C1552663;C2827109";NA;NA;bl bmioo kg m
 655;bl alc < $nmbr$ . $nmbr$ %;"C0005918;C0006413;C1424945;C1552663;C2827109;C3811058";NA;NA;bl alc $nmbr$ $nmbr$
 655;bl;"C0005918;C0006413;C1552663;C2827109";NA;NA;bl
 655;\bl - sc n / n;"C0005918;C0006413;C0282380;C1552663;C2827109";NA;NA;\bl sc n n
 -10;caribbean;"C0043122;C0206155;C1331005";NA;NA;caribbean
 653;cardiogenic shock during first $nmbr$ hr after randomization;"C0034656;C0036980;C0205435;C1279901";NA;NA;cardiogenic shock during first $nmbr$ hr after randomization
 653;cardiogenic shock;C0036980;NA;NA;cardiogenic shock
 652;nonischemic cardiomyopathy — no . ( % );C0878544;NA;NA;nonischemic cardiomyopathy no
 652;nonischemic cardiomyopathy;C0878544;NA;NA;nonischemic cardiomyopathy
 652;nonischemic;NA;NA;NA;nonischemic
 652;non - ischaemic cardiomyopathy;"C0349782;C1518422";NA;NA;non ischaemic cardiomyopathy
 652;ischemic cardiomyopathy;C0349782;NA;NA;ischemic cardiomyopathy
 652;ischaemic cardiomyopathy;C0349782;NA;NA;ischaemic cardiomyopathy
 651;other cardiovascular risk factors;C0850624;NA;NA;other cardiovascular risk factors
 651;nonglycemic cardiovascular risk factors;C0850624;NA;NA;nonglycemic cardiovascular risk factors
 651;major cerebrovascular;"C0205082;C0205164;C1880018;C4318856;C4521762";NA;NA;major cerebrovascular
 651;cerebrovascular;C1880018;NA;NA;cerebrovascular
 651;cardiovascular risk factors — no . { % );C0850624;NA;NA;cardiovascular risk factors no
 651;cardiovascular risk factors — no . / total no . ( % );"C0439175;C0439810;C0850624";NA;NA;cardiovascular risk factors no total no
 651;cardiovascular risk factors and history — no . ( % );"C0019664;C0019665;C0262512;C0262926;C0850624;C1705255;C2004062";NA;NA;cardiovascular risk factors and history no
 625;baseline therapy;"C0039798;C0087111;C0168634;C1363945;C1442488";NA;NA;baseline therapy
 651;cardiovascular risk factors and history ( % );"C0019664;C0019665;C0262512;C0262926;C0850624;C1705255;C2004062";NA;NA;cardiovascular risk factors and history
 651;cardiovascular risk factors and history;"C0019664;C0019665;C0262512;C0262926;C0850624;C1705255;C2004062";NA;NA;cardiovascular risk factors and history
 651;cardiovascular risk factors alone ( n = $nmbr$ );"C0205171;C0439044;C0679994;C0850624";NA;NA;cardiovascular risk factors alone n $nmbr$
 651;cardiovascular risk factors  no . ( % );C0850624;NA;NA;cardiovascular risk factors no
 651;cardiovascular risk factors  n ( % );C0850624;NA;NA;cardiovascular risk factors n
 651;cardiovascular risk factors;C0850624;NA;NA;cardiovascular risk factors
 651;cardiovascular risk factor — no . { % );C0850624;NA;NA;cardiovascular risk factor no
 651;at least two cardiovascular risk factors;"C0205448;C0850624";NA;NA;at least two cardiovascular risk factors
 650;cardiovascular history 一 no . ( % );C1880008;NA;NA;cardiovascular history no
 650;cardiovascular history — no . / total no . ( % );"C0439175;C0439810;C1880008";NA;NA;cardiovascular history no total no
 650;cardiovascular history — no . ( % );C1880008;NA;NA;cardiovascular history no
 650;cardiovascular history;C1880008;NA;NA;cardiovascular history
 649;secondary cardiovascular endpoint;"C0007226;C3887460;C4528314";NA;NA;secondary cardiovascular endpoint
 649;primary cardiovascular endpoint;"C0007226;C2986535;C3887460";NA;NA;primary cardiovascular endpoint
 649;previous history of cardiovascular events;"C0007226;C2004062;C3887460";NA;NA;previous history of cardiovascular events
 649;no . of predictors of cardiovascular risk;"C0007226;C0035647;C2698872;C3887460;C4552904";NA;NA;no of predictors of cardiovascular risk
 649;extended cardiovascular endpoint;"C0007226;C0231448;C0231449;C0439792;C2349179;C2826544;C3887460";NA;NA;extended cardiovascular endpoint
 649;death from cardiovascular causes;"C0007226;C0007465;C3887460";NA;NA;death from cardiovascular causes
 649;core cardiovascular endpoint;"C0007226;C0444669;C1167518;C1706352;C1882467;C2349179;C2826544;C3274653;C3887460";NA;NA;core cardiovascular endpoint
 649;cardiovascular status;"C0007226;C0449438;C3887460";NA;NA;cardiovascular status
 649;cardiovascular risk  n ( % );"C0007226;C0035647;C3887460;C4552904";NA;NA;cardiovascular risk n
 649;cardiovascular risk;"C0007226;C0035647;C3887460;C4552904";NA;NA;cardiovascular risk
 649;cardiovascular hospitalization;"C0007226;C0019993;C3887460";NA;NA;cardiovascular hospitalization
 649;cardiovascular hospitalisation §;"C0007226;C0019993;C3887460";NA;NA;cardiovascular hospitalisation
 649;cardiovascular and respiratory;"C0007226;C0521346;C1546767;C3887460";NA;NA;cardiovascular and respiratory
 649;cardiovascular and oral hypoglycemic drugs - no . ( % );"C0007226;C0359086;C3887460";NA;NA;cardiovascular and oral hypoglycemic drugs no
 649;cardiovascular;"C0007226;C3887460";NA;NA;cardiovascular
 649;any cardiovascular diseased;"C0007226;C3887460";NA;NA;any cardiovascular diseased
 649;all cardiovascular;"C0007226;C3887460";NA;NA;all cardiovascular
 649;* per $nmbr$ participant years . composite of first occurrence death ( all cause )  nonfatal ml  or nonfatal stroke . cardiovascular death excluding those classified as “ unable to determine . ”;"C0007226;C0008902;C0011065;C0015127;C0038454;C0040363;C0041260;C0205199;C0205435;C0243132;C0332196;C0439234;C0439526;C0566415;C0679646;C1279901;C1299582;C1306577;C1524003;C1547335;C1554210;C1705224;C1883351;C2698741;C2745955;C2828389;C3887460;C3887665;C4048706;C4082313;C4321405;C4552775;C4554048;C4554100";NA;NA;per $nmbr$ participant years composite of first occurrence death all cause nonfatal ml or nonfatal stroke cardiovascular death excluding those classified as unable to determine
 648;concomitant cardiovascular therapy — no . ( % );"C0007226;C0521115;C0587038;C1707479;C3887460";NA;NA;concomitant cardiovascular therapy no
 648;concomitant cardiovascular therapy ( taken > $nmbr$ days );"C0007226;C0439228;C0521115;C0587038;C1707479;C1883727;C3887460";NA;NA;concomitant cardiovascular therapy taken $nmbr$ days
 648;concomitant cardiovascular therapy;"C0007226;C0521115;C0587038;C1707479;C3887460";NA;NA;concomitant cardiovascular therapy
 648;concomitant cardiovascular therapies — no . ( % );"C0007226;C0521115;C0587038;C1707479;C3887460";NA;NA;concomitant cardiovascular therapies no
 648;cardiovascular therapies — no . { % );C0587038;NA;NA;cardiovascular therapies no
 647;prior myocardial infarction 一 no . ( % );C0155668;NA;NA;prior myocardial infarction no
 647;prior myocardial infarction — no . { % );C0155668;NA;NA;prior myocardial infarction no
 647;prior myocardial infarction — no . / total no . ( % );"C0155668;C0439175;C0439810";NA;NA;prior myocardial infarction no total no
 647;prior myocardial infarction — no . ( % );C0155668;NA;NA;prior myocardial infarction no
 647;prior myocardial infarction yes;"C0155668;C1549445;C1705108;C1710701";NA;NA;prior myocardial infarction yes
 647;prior myocardial infarction ( % );C0155668;NA;NA;prior myocardial infarction
 647;prior myocardial infarction  no . / total no . ( % );"C0155668;C0439175;C0439810";NA;NA;prior myocardial infarction no total no
 647;prior myocardial infarction  n ( % );C0155668;NA;NA;prior myocardial infarction n
 647;prior myocardial infarction  %;C0155668;NA;NA;prior myocardial infarction
 647;prior myocardial infarction;C0155668;NA;NA;prior myocardial infarction
 647;cardioembolic infarction  n ( % );C0021308;NA;NA;cardioembolic infarction n
 647;cardioembolic;NA;NA;NA;cardioembolic
 647;anterior myocardial infarction — no . / total no . ( % );"C0340293;C0439175;C0439810";NA;NA;anterior myocardial infarction no total no
 647;anterior myocardial infarction — no . ( % );C0340293;NA;NA;anterior myocardial infarction no
 647;angina class iii or iv prior myocardial infarction;"C0022326;C0155668;C0264677;C4265176";NA;NA;angina class iii or iv prior myocardial infarction
 647;> $nmbr$ prior myocardial infarction — no . ( % );C0155668;NA;NA;$nmbr$ prior myocardial infarction no
 646;years since myocardial infarction;"C0027051;C0428953;C0439234;C2926063;C3810814;C4552959";NA;NA;years since myocardial infarction
 646;type of myocardial infarction — no . ( % );"C0027051;C0332307;C0428953;C1547052;C2926063;C3810814;C4552959";NA;NA;type of myocardial infarction no
 646;time from qualifying myocardial infarction;"C0027051;C0040223;C0428953;C1514624;C2926063;C3541383;C3810814;C4552959";NA;NA;time from qualifying myocardial infarction
 646;suspected myocardial infarction;"C0027051;C0332147;C0428953;C0750491;C2926063;C3810814;C4552959";NA;NA;suspected myocardial infarction
 646;qualifying myocardial infarction;"C0027051;C0428953;C1514624;C2926063;C3810814;C4552959";NA;NA;qualifying myocardial infarction
 646;previous stroke yes ( n  % ) previous myocardial infarction;"C0027051;C0205156;C0428953;C1552607;C2926063;C3810814;C3841753;C4552959";NA;NA;previous stroke yes n previous myocardial infarction
 646;previous myocardial infarction — no . ( % );"C0027051;C0205156;C0428953;C1552607;C2926063;C3810814;C4552959";NA;NA;previous myocardial infarction no
 646;previous myocardial infarction ( % );"C0027051;C0205156;C0428953;C1552607;C2926063;C3810814;C4552959";NA;NA;previous myocardial infarction
 646;previous myocardial infarction  no . ( % );"C0027051;C0205156;C0428953;C1552607;C2926063;C3810814;C4552959";NA;NA;previous myocardial infarction no
 646;previous myocardial infarction  n ( % );"C0027051;C0205156;C0428953;C1552607;C2926063;C3810814;C4552959";NA;NA;previous myocardial infarction n
 646;previous myocardial infarction;"C0027051;C0205156;C0428953;C1552607;C2926063;C3810814;C4552959";NA;NA;previous myocardial infarction
 646;nonfatal myocardial infarction ®;"C0027051;C0428953;C2926063;C3810814;C4552959";NA;NA;nonfatal myocardial infarction
 646;nonfatal myocardial infarction;"C0027051;C0428953;C2926063;C3810814;C4552959";NA;NA;nonfatal myocardial infarction
 646;non - fatal myocardial infarction;"C0027051;C0428953;C1302234;C1518422;C1705232;C2926063;C3810814;C4552959";NA;NA;non fatal myocardial infarction
 646;no previous myocardial infarction $nmbr$ / $nmbr$;"C0027051;C0205156;C0428953;C1552607;C2926063;C3810814;C4552959";NA;NA;no previous myocardial infarction $nmbr$ $nmbr$
 646;no previous myocardial infarction;"C0027051;C0205156;C0428953;C1552607;C2926063;C3810814;C4552959";NA;NA;no previous myocardial infarction
 646;no myocardial infarction at presentation ( n = $nmbr$ );"C0027051;C0428953;C0449450;C2926063;C3810814;C4552959";NA;NA;no myocardial infarction at presentation n $nmbr$
 646;myocardial infarction — no . ( % );"C0027051;C0428953;C2926063;C3810814;C4552959";NA;NA;myocardial infarction no
 646;myocardial infarction §;"C0027051;C0428953;C2926063;C3810814;C4552959";NA;NA;myocardial infarction
 625;baseline tava;"C0168634;C1442488";NA;NA;baseline tava
 646;myocardial infarction within the previous $nmbr$ yr;"C0027051;C0205156;C0428953;C0439234;C1552607;C2926063;C3810814;C4552959";NA;NA;myocardial infarction within the previous $nmbr$ yr
 646;myocardial infarction n ( % );"C0027051;C0428953;C2926063;C3810814;C4552959";NA;NA;myocardial infarction n
 646;myocardial infarction at presentation ( n = $nmbr$ );"C0027051;C0428953;C0449450;C2926063;C3810814;C4552959";NA;NA;myocardial infarction at presentation n $nmbr$
 646;myocardial infarction :;"C0027051;C0428953;C2926063;C3810814;C4552959";NA;NA;myocardial infarction
 646;myocardial infarction / cabg / pci;"C0010055;C0027051;C0428953;C2926063;C3810814;C4049621;C4552959";NA;NA;myocardial infarction cabg pci
 646;myocardial infarction ( % );"C0027051;C0428953;C2926063;C3810814;C4552959";NA;NA;myocardial infarction
 646;myocardial infarction  n ( % );"C0027051;C0428953;C2926063;C3810814;C4552959";NA;NA;myocardial infarction n
 646;myocardial infarction  ( % );"C0027051;C0428953;C2926063;C3810814;C4552959";NA;NA;myocardial infarction
 646;myocardial infarction;"C0027051;C0428953;C2926063;C3810814;C4552959";NA;NA;myocardial infarction
 646;investigator - determined myocardial infarction;"C0027051;C0035173;C0428953;C2926063;C3810814;C4552959";NA;NA;investigator determined myocardial infarction
 646;histor y of myocardial infarction;"C0027051;C0428953;C2926063;C3810814;C4552959";NA;NA;histor y of myocardial infarction
 646;fatal myocardial infarction;"C0027051;C0428953;C1302234;C1705232;C2926063;C3810814;C4552959";NA;NA;fatal myocardial infarction
 646;cardiovasculardeath / myocardial infarction / stroke;"C0027051;C0038454;C0428953;C2926063;C3810814;C4552959;C4554100";NA;NA;cardiovasculardeath myocardial infarction stroke
 646;cardiovasculardeath;NA;NA;NA;cardiovasculardeath
 646;cardiovascular death or nonfatal myocardial infarction;"C0007226;C0011065;C0027051;C0428953;C1306577;C2926063;C3810814;C3887460;C4082313;C4552775;C4552959";NA;NA;cardiovascular death or nonfatal myocardial infarction
 646;cardiovascular death  nonfatal myocardial infarction  nonfatal stroke;"C0011065;C0027051;C0428953;C1306577;C2926063;C3810814;C4082313;C4552775;C4552959";NA;NA;cardiovascular death nonfatal myocardial infarction nonfatal stroke
 646;b . myocardial infarction;"C0027051;C0428953;C2926063;C3810814;C4552959";NA;NA;b myocardial infarction
 645;sudden cardiac death §;C0085298;NA;NA;sudden cardiac death
 645;noncardiovascular death;"C0011065;C1306577;C4082313;C4552775";NA;NA;noncardiovascular death
 645;noncardiovascular;NA;NA;NA;noncardiovascular
 645;cardiac death;C0376297;NA;NA;cardiac death
   7;interaction p value $nmbr$ . $nmbr$;"C1704675;C1709380";NA;NA;interaction p value $nmbr$ $nmbr$
 644;cardiac therapy §;C3654025;NA;NA;cardiac therapy
 644;cardiac therapy  n ( % ) d;C3654025;NA;NA;cardiac therapy n d
 644;cardiac therapy;C3654025;NA;NA;cardiac therapy
 643;rvfac ( % );NA;NA;NA;rvfac
 643;elevation of cardiac biomarker levels — no . / total no . ( % );"C0439175;C0439775;C0439810;C0441889;C0702240;C1271630";NA;NA;elevation of cardiac biomarker levels no total no
 643;cardiac procedure :;C1279986;NA;NA;cardiac procedure
 643;cardiac biomarker status !;"C0005516;C0018787;C0449438;C0449442;C1271630;C1522601;C1999091;C2735302";NA;NA;cardiac biomarker status
 643;cardiac biomarker elevation;"C0439775;C0702240;C1271630";NA;NA;cardiac biomarker elevation
 643;cardiac biomarker  n ( % );C1271630;NA;NA;cardiac biomarker n
 643;arvfac ( per $nmbr$ % );NA;NA;NA;arvfac per $nmbr$
 643;aborted cardiac arrest;"C0018790;C1550015;C1609614;C4085625;C4318470;C4553105";NA;NA;aborted cardiac arrest
 -10;phenobarbital;C0031412;NA;NA;phenobarbital
 641;reinfarction;NA;NA;NA;reinfarction
 641;prior myocardial intarction;"C0027061;C0332152;C1522564;C2826257";NA;NA;prior myocardial intarction
 641;parental history of myocardial infarction before age $nmbr$ y yes;"C0001779;C0030551;C1275835;C1549445;C1705108;C1710701";NA;NA;parental history of myocardial infarction before age $nmbr$ y yes
 641;parental history of myocardial infarction before age $nmbr$ y;"C0001779;C0030551;C1275835";NA;NA;parental history of myocardial infarction before age $nmbr$ y
 641;parental history of myocardial infarction before $nmbr$ yr of age ( % );"C0001779;C0030551;C0439234;C1275835";NA;NA;parental history of myocardial infarction before $nmbr$ yr of age
 641;history of myocardial infarction ( % );C1275835;NA;NA;history of myocardial infarction
 641;history of myocardial infarction  n ( % );C1275835;NA;NA;history of myocardial infarction n
 641;history of myocardial infarction;C1275835;NA;NA;history of myocardial infarction
 641;history myocardial infarction;"C0155668;C1275835";NA;NA;history myocardial infarction
 641;fatal or nonlatal myocardial inlarctlon;"C0027061;C1302234;C1522564;C1705232";NA;NA;fatal or nonlatal myocardial inlarctlon
 640;useofmedical therapyathospitaldischarge;NA;NA;NA;useofmedical therapyathospitaldischarge
 640;stenting plus medical therapy ( n = $nmbr$ );"C0038257;C0418981;C2348535";NA;NA;stenting plus medical therapy n $nmbr$
 640;stent plus medical therapy;"C0038257;C0418981";NA;NA;stent plus medical therapy
 640;medical therapy only ( n = $nmbr$ );"C0205171;C0418981;C1720467";NA;NA;medical therapy only n $nmbr$
 640;medical therapy only;"C0205171;C0418981;C1720467";NA;NA;medical therapy only
 640;medical therapy before admission;"C0184666;C0418981;C0809949";NA;NA;medical therapy before admission
 640;medical therapy alone;"C0205171;C0418981;C0439044;C0679994";NA;NA;medical therapy alone
 640;medical therapy ( n = $nmbr$ );C0418981;NA;NA;medical therapy n $nmbr$
 640;medical therapy;C0418981;NA;NA;medical therapy
 640;medical therapies;C0418981;NA;NA;medical therapies
 639;medical historv;"C0199168;C0205476";NA;NA;medical historv
 639;first medical contact — no . ( % ) §;"C0199168;C0205435;C0205476;C0332158;C0337611;C1279901;C1705415;C3812666";NA;NA;first medical contact no
 639;first medical contact;"C0199168;C0205435;C0205476;C0332158;C0337611;C1279901;C1705415;C3812666";NA;NA;first medical contact
 638;minimal important change threshold ( improvement ) a;"C0449864;C2986411;C3845594;C3898777;C4084912";NA;NA;minimal important change threshold improvement a
 638;medically important infectionsa;"C3898777;C4084912";NA;NA;medically important infectionsa
 637;indian ( indian subcontinent );C0454693;NA;NA;indian indian subcontinent
 637;indian ( american ) or alaska native;"C0596070;C0682125;C1524069";NA;NA;indian american or alaska native
 637;indian;C1524069;NA;NA;indian
 637;american indian or native alaskan;"C0002460;C0682125";NA;NA;american indian or native alaskan
 637;american indian or alaskan;"C0002460;C0238611";NA;NA;american indian or alaskan
 637;american indian or alaska;"C0001905;C0002460";NA;NA;american indian or alaska
 637;american indian or;C0002460;NA;NA;american indian or
 637;american indian / native alaskan;"C0002460;C0682125";NA;NA;american indian native alaskan
 637;american indian /;C0002460;NA;NA;american indian
 637;american indian  alaskan native  or aboriginal canadian;"C0002460;C0238611;C0238884;C0302891;C0935542";NA;NA;american indian alaskan native or aboriginal canadian
 637;american indian;C0002460;NA;NA;american indian
 636;rarertd antocagibtcn before andorrtzafon;NA;NA;NA;rarertd antocagibtcn before andorrtzafon
 636;indomethacin;C0021246;NA;NA;indomethacin
 635;≤ median;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median
 635;£ median ( $nmbr$ . $nmbr$ );"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median $nmbr$ $nmbr$
 635;£ median ( $nmbr$ );"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median $nmbr$
 635;£ median;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median
 635;years since mi ( median;"C0439234;C0549183;C0876920;C2347635;C2348144;C2939193;C3810814";NA;NA;years since mi median
 635;wt  second  median;"C0205436;C0457385;C0549183;C0565930;C0876920;C1561503;C1705190;C1883559;C2347635;C2348144;C2700323;C2939193";NA;NA;wt second median
 635;waisvhip > = median;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;waisvhip median
 635;waist / hip < median;"C0019552;C0022122;C0230097;C0549183;C0876920;C1505163;C2347635;C2348144;C2939193;C3538851;C4284725";NA;NA;waist hip median
 635;urine acr > = median;"C0042036;C0042037;C0549183;C0876920;C1412134;C1515941;C2347635;C2348144;C2939193;C2963137";NA;NA;urine acr median
 635;urine acr < median;"C0042036;C0042037;C0549183;C0876920;C1412134;C1515941;C2347635;C2348144;C2939193;C2963137";NA;NA;urine acr median
 635;urinary albumin / creatinine ratio  median mg / g ( range );"C0455271;C0549183;C0876920;C1300563;C1318330;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016";NA;NA;urinary albumin creatinine ratio median mg g range
 635;triglycerides  median ( range );"C0041004;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016";NA;NA;triglycerides median range
 635;triglycerides  median ( q $nmbr$ : q $nmbr$ );"C0041004;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;triglycerides median q $nmbr$ q $nmbr$
 635;total ige levelx ( iu / ml )  median ( range );"C0439175;C0439458;C0439810;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016";NA;NA;total ige levelx iu ml median range
 635;total cholesterol ( median  iqr )  mg / dl;"C0201950;C0439269;C0543421;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;total cholesterol median iqr mg dl
 635;tngtycerides a median;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;tngtycerides a median
 635;tngtycerides < median;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;tngtycerides median
 635;tngtycendes a median;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;tngtycendes a median
 635;tnglycendes < median;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;tnglycendes median
 635;time to end - of - study ivus  median ( iqr )  days;"C0439548;C0444930;C0549183;C0557651;C0876920;C1456025;C2347635;C2348144;C2603343;C2746065;C2939193";NA;NA;time to end of study ivus median iqr days
 635;time from symptom onset of ra  years  median;"C0439234;C0549183;C0876920;C1320528;C2347635;C2348144;C2939193;C3538806;C4048756";NA;NA;time from symptom onset of ra years median
 635;time from study drug administration to coronary revascularization  median ( iqr )  h;"C0013175;C0033727;C0040227;C0150270;C0206209;C0369286;C0441932;C0549183;C0564385;C0876920;C0877341;C2347635;C2348144;C2349982;C2939193;C3469597;C4528284";NA;NA;time from study drug administration to coronary revascularization median iqr h
 635;time from ra diagnosis  years  median;"C0011900;C0549183;C0556970;C0876920;C1704338;C1704656;C2347635;C2348144;C2939193;C3538806;C4048756";NA;NA;time from ra diagnosis years median
 635;time from hospital admission to pci  h  median ( q $nmbr$  q $nmbr$ );"C0019994;C0033727;C0040223;C0369286;C0441932;C0549183;C0564385;C0876920;C1510665;C1959907;C2347635;C2348144;C2939193;C3541383;C4049621;C4528284";NA;NA;time from hospital admission to pci h median q $nmbr$ q $nmbr$
 635;time from  median ( iqr )  h;"C0033727;C0040223;C0369286;C0441932;C0549183;C0564385;C0876920;C2347635;C2348144;C2939193;C3541383;C4528284";NA;NA;time from median iqr h
 635;tg ( mmol / l  median );"C0337445;C0549183;C0876920;C1532563;C2347635;C2348144;C2939193";NA;NA;tg mmol l median
 635;tg  mmol / l ( mg / dl ) [ median ];"C0337445;C0549183;C0876920;C2347635;C2348144;C2939193;C3642216;C3898312";NA;NA;tg mmol l mg dl median
 635;tg  median ( sdy rng / cjl;"C0337445;C0549183;C0876920;C1424906;C2347635;C2348144;C2939193";NA;NA;tg median sdy rng cjl
 635;tg  median ( interquartile range );"C0337445;C0549183;C0876920;C1711350;C2347635;C2348144;C2939193";NA;NA;tg median interquartile range
 635;systolic blood pressure  mm hg  median ( range );"C0439475;C0488055;C0549183;C0871470;C0876920;C1306620;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016";NA;NA;systolic blood pressure mm hg median range
 635;score on nih stroke scale — median ( iqr );"C0449820;C0549183;C0876920;C1697238;C2347635;C2348144;C2939193;C3484372;C4050231";NA;NA;score on nih stroke scale median iqr
 635;score on modified rankin scale — median ( iqr );"C0449820;C0549183;C0876920;C2347635;C2348144;C2939193;C2984908;C3854213;C4050231";NA;NA;score on modified rankin scale median iqr
 635;score on modified mini - mental state examination — median ( iqr );"C0549183;C0876920;C2347635;C2348144;C2939193;C4304091";NA;NA;score on modified mini mental state examination median iqr
 635;score improvement  baseline to week $nmbr$  median ( iqr );"C0168634;C0332174;C0439230;C0449820;C0549183;C0876920;C1442488;C2347635;C2348144;C2939193;C2986411;C4050231";NA;NA;score improvement baseline to week $nmbr$ median iqr
 635;sbp indicates systolic blood pressure  dbp  diastolic blood pressure  aa  arachidonic acid  epa  eicosapentaenoic acid . values for age  bmi  total cholesterol  ldl cholesterol  hdl cholesterol  sbp  dbp  aa  epa  and epa / aa ratio represent the mean values represent the median ( interquartile range ) . p values are for the differences between the no epa and epa groups .;"C0000545;C0003695;C0042295;C0085805;C0282379;C0428883;C0439175;C0439632;C0439810;C0441833;C0444504;C0456603;C0488055;C0536221;C0549183;C0578022;C0687744;C0871470;C0876920;C1235746;C1257890;C1306620;C1519504;C1547037;C1552839;C1705241;C1705242;C1705428;C1705429;C1709380;C1711350;C1882141;C1882932;C2316832;C2347634;C2347635;C2348143;C2348144;C2699193;C2939193;C3813197;C4281799;C4554792";NA;NA;sbp indicates systolic blood pressure dbp diastolic blood pressure aa arachidonic acid epa eicosapentaenoic acid values for age bmi total cholesterol ldl cholesterol hdl cholesterol sbp dbp aa epa and epa aa ratio represent the mean values represent the median interquartile range p values are for the differences between the no epa and epa groups
 635;sbp > median ( n = $nmbr$ );"C0085805;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;sbp median n $nmbr$
 635;sbp < median ( n = $nmbr$ o $nmbr$ );"C0085805;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;sbp median n $nmbr$ o $nmbr$
 635;sbp ( mm hg )  median ( iqr );"C0085805;C0439475;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;sbp mm hg median iqr
 635;s median;"C0549183;C0565930;C0876920;C2347635;C2348144;C2603362;C2939193";NA;NA;s median
 635;pulse pressure ( median $nmbr$ . $nmbr$ ];"C0549183;C0876920;C0949236;C2347635;C2348144;C2939193";NA;NA;pulse pressure median $nmbr$ $nmbr$
 635;percent improvement  baseline to week $nmbr$  median ( iqr );"C0168634;C0332174;C0439165;C0439230;C0549183;C0876920;C1442488;C2347635;C2348144;C2939193;C2986411";NA;NA;percent improvement baseline to week $nmbr$ median iqr
 635;pasi  median ( range ) * *;"C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016;C4528685";NA;NA;pasi median range
 635;number of visits  median;"C0549183;C0876920;C1549755;C2347635;C2348144;C2939193";NA;NA;number of visits median
 635;nt - probnp  median pg / ml;"C0439297;C0549183;C0669479;C0754710;C0876920;C2347635;C2348144;C2939193";NA;NA;nt probnp median pg ml
 635;nt - probnp  median ( iqr )  pg / ml;"C0439297;C0549183;C0669479;C0754710;C0876920;C2347635;C2348144;C2939193";NA;NA;nt probnp median iqr pg ml
 635;non - high density lipoprotein ( mg / dl ) - baseline - > = median ( n = $nmbr$  $nmbr$ );"C0168634;C0439269;C0549183;C0876920;C1442488;C1535899;C2347635;C2348144;C2939193";NA;NA;non high density lipoprotein mg dl baseline median n $nmbr$ $nmbr$
 635;non - high density lipoprotein ( mg / dl ) - baseline - < median ( n = $nmbr$  $nmbr$ );"C0168634;C0439269;C0549183;C0876920;C1442488;C1535899;C2347635;C2348144;C2939193";NA;NA;non high density lipoprotein mg dl baseline median n $nmbr$ $nmbr$
 635;msfc timed $nmbr$ - foot walk test  median seconds;"C0016504;C0347981;C0392761;C0457385;C0549183;C0876920;C2346504;C2347635;C2348144;C2348613;C2348704;C2939193;C4277740";NA;NA;msfc timed $nmbr$ foot walk test median seconds
 635;months from mi — median ( iqr );"C0439231;C0549183;C0876920;C2347635;C2348144;C2939193;C3810814";NA;NA;months from mi median iqr
 635;minutes from symptom onset to prehospital ecg  median ( iqr );"C0439232;C0549183;C0700321;C0702093;C0876920;C1282918;C1623258;C2347166;C2347635;C2348144;C2939193;C4086878";NA;NA;minutes from symptom onset to prehospital ecg median iqr
 635;minutes from prehospital ecg to pci  median ( iqr );"C0439232;C0549183;C0700321;C0702093;C0876920;C1282918;C1623258;C2347166;C2347635;C2348144;C2939193;C4049621";NA;NA;minutes from prehospital ecg to pci median iqr
 635;minutes from pre - pci angiography to post - pci angiography  median ( iqr );"C0002978;C0332152;C0439232;C0549183;C0687676;C0700321;C0702093;C0740175;C0876920;C1282918;C1704687;C2257086;C2347166;C2347635;C2348144;C2939193;C3469826;C3669034;C4049621";NA;NA;minutes from pre pci angiography to post pci angiography median iqr
 635;medians ( iqr );C0549183;NA;NA;medians iqr
 635;median — yr;"C0439234;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median yr
 635;median — vr;"C0549183;C0876920;C2347635;C2348144;C2939193;C3476815";NA;NA;median vr
 635;median §;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median
 635;median time to event ( weeks );"C0040223;C0439230;C0441471;C0549183;C0876920;C2347635;C2348144;C2939193;C3541383;C4019010";NA;NA;median time to event weeks
 635;median time since diagnosis * ( range )  yr;"C0011900;C0040223;C0439234;C0549183;C0876920;C1514721;C1704338;C1704656;C2347635;C2348144;C2348147;C2939193;C3541383;C3542016";NA;NA;median time since diagnosis range yr
 635;median time delay ( interquartile range ) — min;"C0522486;C0549183;C0702093;C0876920;C1524029;C1711350;C2347635;C2348144;C2939193;C3813700";NA;NA;median time delay interquartile range min
 635;median seconds;"C0457385;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median seconds
 635;median of jsw;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median of jsw
 635;median nt - probnp ( iqr ) – pg / ml;"C0439297;C0549183;C0669479;C0754710;C0876920;C2347635;C2348144;C2939193";NA;NA;median nt probnp iqr pg ml
 635;median n - terminal probnp ( iqr ) — pg / ml;"C0439297;C0549183;C0669479;C0876920;C2347635;C2348144;C2939193";NA;NA;median n terminal probnp iqr pg ml
 635;median feno  ppba;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median feno ppba
 635;median egfr ( interquartile range );"C0549183;C0876920;C1711350;C1739039;C2347635;C2348144;C2939193;C3811844;C3812682";NA;NA;median egfr interquartile range
 635;median duration oftype $nmbr$ diabetes ( iqr ) — yr;"C0011847;C0011849;C0439234;C0449238;C0549183;C0876920;C2347635;C2348144;C2926735;C2939193";NA;NA;median duration oftype $nmbr$ diabetes iqr yr
 635;median delay ( h ) §;"C0033727;C0205421;C0369286;C0441932;C0549183;C0564385;C0876920;C2347635;C2348144;C2939193;C4528284";NA;NA;median delay h
 635;median daily dose - iu ™;"C0049272;C0439453;C0549183;C0694756;C0876920;C2347635;C2348070;C2348144;C2939193";NA;NA;median daily dose iu
 635;median change  %;"C0392747;C0443172;C0549183;C0876920;C1705241;C2347635;C2348144;C2939193;C4319952";NA;NA;median change
   7;interaction p value !;"C1704675;C1709380";NA;NA;interaction p value
 635;median ( range ) total ige level ( iuml ~ ’ ) $nmbr$;"C0439175;C0439810;C0441889;C0456079;C0549183;C0876920;C1514721;C1547707;C2347635;C2348144;C2348147;C2939193;C2946261;C3542016";NA;NA;median range total ige level iuml $nmbr$
 635;median ( range );"C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016";NA;NA;median range
 635;median ( q $nmbr$ – q $nmbr$ );"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median q $nmbr$ q $nmbr$
 635;median ( q $nmbr$ : q $nmbr$ ) total daily insulin dose $nmbr$;"C0021641;C0549183;C0876920;C1533581;C1579433;C2347635;C2348070;C2348144;C2939193;C3714501";NA;NA;median q $nmbr$ q $nmbr$ total daily insulin dose $nmbr$
 635;median ( q $nmbr$ : q $nmbr$ ) tgs;"C0549183;C0876920;C1156212;C1537574;C2347635;C2348144;C2939193";NA;NA;median q $nmbr$ q $nmbr$ tgs
 635;median ( q $nmbr$ : q $nmbr$ ) lp ( a )  mg / dl;"C0065058;C0439269;C0549183;C0876920;C1439335;C2347635;C2348144;C2939193;C4553379";NA;NA;median q $nmbr$ q $nmbr$ lp a mg dl
 635;median ( q $nmbr$ : q $nmbr$ );"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median q $nmbr$ q $nmbr$
 342;esrd;"C0022661;C0035078;C2316810";NA;NA;esrd
 635;median albumin / creatinine ratio ( g / mg );"C0024671;C0026410;C0439267;C0439269;C0486293;C0549183;C0876920;C1318293;C1960952;C2346927;C2347635;C2348144;C2939193;C4321396;C4521761";FALSE;1902;median albumin creatinine ratio g mg
 635;median cardiac troponin t ( iqr ) — pg / ml;"C0439297;C0549183;C0876920;C2347635;C2348144;C2939193;C3538889";FALSE;1903;median cardiac troponin t iqr pg ml
 635;median c - reactive protein — mg / dl ^;"C0006560;C0439269;C0549183;C0876920;C1413716;C2347635;C2348144;C2939193;C4048285";FALSE; 286;median c reactive protein mg dl
 635;median ( q $nmbr$  q $nmbr$ );"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median q $nmbr$ q $nmbr$
 635;median ( iqr ) — yr;"C0439234;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median iqr yr
 635;median ( iqr ) cholesterol;"C0008377;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median iqr cholesterol
 635;median ( iqr ) change from baseline to week $nmbr$ in psa - modified total shs score;"C0168634;C0332174;C0392747;C0439175;C0439230;C0439810;C0443172;C0449820;C0549183;C0876920;C1442488;C1705241;C2347635;C2348144;C2939193;C3810537;C3813209;C3889737;C4050231;C4319952";NA;NA;median iqr change from baseline to week $nmbr$ in psa modified total shs score
 635;median ( iqr ) age  years;"C0549183;C0876920;C1510829;C2347635;C2348144;C2939193";NA;NA;median iqr age years
 635;median ( iqr ) admission data;"C0184666;C0549183;C0809949;C0876920;C1511726;C2347635;C2348144;C2939193;C3245479;C3714741";NA;NA;median iqr admission data
 635;median ( iqr )  h;"C0033727;C0369286;C0441932;C0549183;C0564385;C0876920;C2347635;C2348144;C2939193;C4528284";NA;NA;median iqr h
 635;median ( iqr );"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median iqr
 635;median ( iq range );"C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016";NA;NA;median iq range
 635;median ( interquartile range );"C0549183;C0876920;C1711350;C2347635;C2348144;C2939193";NA;NA;median interquartile range
 635;median  y ( range );"C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016";NA;NA;median y range
 635;median  range;"C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016";NA;NA;median range
 635;median  ml;"C0439526;C0549183;C0876920;C1705224;C2347635;C2348144;C2939193;C3887665";NA;NA;median ml
 635;median  mg / dl;"C0439269;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median mg dl
 635;median  iqr );"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median iqr
 635;median  iqr;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median iqr
 635;median;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median
 635;mean age  y  median ( range );"C0001779;C0444504;C0549183;C0876920;C1514721;C2347634;C2347635;C2348143;C2348144;C2348147;C2939193;C3542016";NA;NA;mean age y median range
 635;maximum cimt < median;"C0549183;C0806909;C0876920;C1552615;C2347635;C2348144;C2826546;C2939193";NA;NA;maximum cimt median
 635;lvef  %  median ( iqr );"C0428772;C0488728;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;lvef median iqr
 635;lp ( a )  mg / dl  median ( q $nmbr$ : q $nmbr$ );"C0065058;C0439269;C0549183;C0876920;C1439335;C2347635;C2348144;C2939193;C4553379";NA;NA;lp a mg dl median q $nmbr$ q $nmbr$
 635;lp ( a )  median ( q $nmbr$ : q $nmbr$ );"C0065058;C0549183;C0876920;C1439335;C2347635;C2348144;C2939193;C4553379";NA;NA;lp a median q $nmbr$ q $nmbr$
 635;less than the median;"C0439092;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;less than the median
 635;less than median;"C0439092;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;less than median
 635;laboratory values at randomization ( median and iqr );"C0022877;C0034656;C0042295;C0549183;C0876920;C2347635;C2348144;C2939193;C3244292;C4283904";NA;NA;laboratory values at randomization median and iqr
 635;laboratory parameters  median ( iqr );"C0022877;C0449381;C0549183;C0876920;C2347635;C2348144;C2939193;C3244292;C4283904";NA;NA;laboratory parameters median iqr
 635;index event to randomization  median ( iqr )  h;"C0033727;C0034656;C0369286;C0441471;C0441932;C0549183;C0564385;C0600653;C0876920;C0918012;C1552854;C1637833;C2347635;C2348144;C2939193;C2986546;C4019010;C4528284";NA;NA;index event to randomization median iqr h
 635;ige ( ku / l )  median ( range ) c;"C0439340;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016";NA;NA;ige ku l median range c
 635;hscrp ( mg / l )  median ( min – max );"C0439420;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;hscrp mg l median min max
 635;hscrp  mg / l  median ( min – max );"C0439420;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;hscrp mg l median min max
 635;hscrp  median ( min  max )  mg / l;"C0549183;C0876920;C2347635;C2348144;C2827895;C2939193";NA;NA;hscrp median min max mg l
 635;homa_ir  median ( q $nmbr$  q $nmbr$ )  % / $nmbr$;"C0022065;C0022071;C0549183;C0876920;C1448132;C2347635;C2348144;C2939193";NA;NA;homa_ir median q $nmbr$ q $nmbr$ $nmbr$
 635;homa_ % b tx difference vs pbo  median change from baseline ( se ) $nmbr$;"C0031962;C0036919;C0041403;C0168634;C0392747;C0443172;C0549183;C0876920;C1442488;C1705241;C1705242;C2347635;C2348144;C2939193;C4319952";NA;NA;homa_ b tx difference vs pbo median change from baseline se $nmbr$
 635;homa_ % b  median ( q $nmbr$  q $nmbr$ )  %;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;homa_ b median q $nmbr$ q $nmbr$
 635;hbak > median;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;hbak median
 481;age > $nmbr$ ( years ) t;C1510829;NA;NA;age $nmbr$ years t
 635;hba < median;"C0019016;C0549183;C0876920;C1825777;C2347635;C2348144;C2939193;C3538758";NA;NA;hba median
 635;fasting tgs  median ( q $nmbr$ : q $nmbr$ );"C0015663;C0549183;C0876920;C1156212;C1537574;C2347635;C2348144;C2939193";NA;NA;fasting tgs median q $nmbr$ q $nmbr$
 342;erd *  n ( % );NA;NA;NA;erd n
 635;fasting plasma glucose in mmol / l ( median ( q $nmbr$  q $nmbr$ ) [ n ] );"C0549183;C0583513;C0876920;C1532563;C2347635;C2348144;C2939193";FALSE;1896;fasting plasma glucose in mmol l median q $nmbr$ q $nmbr$ n
 635;hba $nmbr$ c in % ( median ( q $nmbr$  q $nmbr$ ) [ n ] );"C0019016;C0549183;C0876920;C1825777;C2347635;C2348144;C2939193;C3538758";FALSE;1897;hba $nmbr$ c in median q $nmbr$ q $nmbr$ n
 635;hba $nmbr$ c ( % ) ( median ( iqr );"C0019016;C0549183;C0876920;C1825777;C2347635;C2348144;C2939193;C3538758";FALSE;1897;hba $nmbr$ c median iqr
 635;hbalca median;"C0549183;C0876920;C2347635;C2348144;C2939193";FALSE;1897;hbalca median
 635;hbalc in %  median ( iqr );"C0549183;C0876920;C2347635;C2348144;C2939193";FALSE;1897;hbalc in median iqr
 635;hbalc < median;"C0549183;C0876920;C2347635;C2348144;C2939193";FALSE;1897;hbalc median
 635;hbalc > median;"C0549183;C0876920;C2347635;C2348144;C2939193";FALSE;1897;hbalc median
 635;heart rate ( median $nmbr$ . $nmbr$ };"C0018810;C0549183;C0876920;C2347635;C2348144;C2939193";FALSE;1898;heart rate median $nmbr$ $nmbr$
 635;insulin dose ( iu / day )  median;"C0366513;C0439465;C0549183;C0876920;C2347635;C2348144;C2939193";FALSE;1899;insulin dose iu day median
 635;insulin  median ( ql  q $nmbr$ )  pmol / l;"C0021641;C0439284;C0549183;C0876920;C1533581;C1579433;C2347635;C2348144;C2939193;C3714501";FALSE;1899;insulin median ql q $nmbr$ pmol l
 635;insulin  median ( q $nmbr$  q $nmbr$ )  pmol / l;"C0021641;C0439284;C0549183;C0876920;C1533581;C1579433;C2347635;C2348144;C2939193;C3714501";FALSE;1899;insulin median q $nmbr$ q $nmbr$ pmol l
 635;length of stent < median;"C0449462;C0549183;C0876920;C2347635;C2348144;C2939193";FALSE;1900;length of stent median
 635;length of stent > median;"C0449462;C0549183;C0876920;C2347635;C2348144;C2939193";FALSE;1900;length of stent median
 635;duration from hospital admission to pci  h ( median  iqr );"C0019994;C0033727;C0369286;C0441932;C0449238;C0549183;C0564385;C0876920;C1510665;C1959907;C2347635;C2348144;C2926735;C2939193;C4049621;C4528284";NA;NA;duration from hospital admission to pci h median iqr
 635;difference  % median;"C0549183;C0876920;C1705241;C1705242;C2347635;C2348144;C2939193";NA;NA;difference median
 635;data represent number of patients ( % ) or mean ( standard deviation )  unless otherwise indicated . a self - reported information . bc physician - diagnosed diabetes or fasting plasma glucose ≥ $nmbr$ mg / dl or hemoglobin a $nmbr$ c ≥ $nmbr$ . $nmbr$ % . d physician - diagnosed hypertension or systolic blood pressure ≥ $nmbr$ mmhg or diastolic blood pressure ≥ $nmbr$ mmhg . median ( interquartile range ) . ldl  low - density lipoprotein  hdl  high - density lipoprotein  tg  triglyceride .;"C0006041;C0011847;C0011849;C0011900;C0015663;C0019020;C0020538;C0023820;C0031831;C0062152;C0073187;C0178587;C0202042;C0205251;C0332173;C0337445;C0428883;C0439269;C0439475;C0444504;C0455280;C0488055;C0549183;C0681906;C0804815;C0871420;C0871470;C0876920;C1305849;C1306620;C1442989;C1444656;C1511726;C1533716;C1550472;C1711350;C1828170;C1882932;C1963138;C2347634;C2347635;C2348143;C2348144;C2360800;C2700446;C2828392;C2939193;C2984916;C3245479;C3714741;C3889898;C3890211;C4048187;C4321351;C4484261;C4522223";NA;NA;data represent number of patients or mean standard deviation unless otherwise indicated a self reported information bc physician diagnosed diabetes or fasting plasma glucose $nmbr$ mg dl or hemoglobin a $nmbr$ c $nmbr$ $nmbr$ d physician diagnosed hypertension or systolic blood pressure $nmbr$ mmhg or diastolic blood pressure $nmbr$ mmhg median interquartile range ldl low density lipoprotein hdl high density lipoprotein tg triglyceride
 635;clinical variables  median ( iqr );"C0205210;C0439828;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;clinical variables median iqr
 635;change from baseline  median ( iqr );"C0168634;C0392747;C0443172;C0549183;C0876920;C1442488;C1705241;C2347635;C2348144;C2939193;C4319952";NA;NA;change from baseline median iqr
 635;below median;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;below median
 635;baseline total pcsk $nmbr$ level by median;"C0168634;C0439175;C0439810;C0441889;C0456079;C0549183;C0876920;C1442488;C1547707;C2347635;C2348144;C2939193;C2946261";NA;NA;baseline total pcsk $nmbr$ level by median
 635;baseline tg  ( mg / dl )  median ( iqr );"C0168634;C0337445;C0439269;C0549183;C0876920;C1442488;C2347635;C2348144;C2939193";NA;NA;baseline tg mg dl median iqr
 635;baseline tav - > = median ( n = $nmbr$  $nmbr$ );"C0168634;C0279686;C0549183;C0876920;C1442488;C2347635;C2348144;C2939193";NA;NA;baseline tav median n $nmbr$ $nmbr$
 635;baseline tav - < median ( n = $nmbr$  $nmbr$ );"C0168634;C0279686;C0549183;C0876920;C1442488;C2347635;C2348144;C2939193";NA;NA;baseline tav median n $nmbr$ $nmbr$
 635;baseline scales  median ( range );"C0168634;C0175659;C0222045;C0349674;C0549183;C0876920;C1442488;C1514721;C1947916;C2347635;C2348144;C2348147;C2939193;C3542016";NA;NA;baseline scales median range
 635;baseline pav - > = median ( n = $nmbr$  $nmbr$ );"C0058890;C0168634;C0549183;C0876920;C1442488;C2347635;C2348144;C2939193";NA;NA;baseline pav median n $nmbr$ $nmbr$
 635;baseline pav - < median ( n = $nmbr$  $nmbr$ );"C0058890;C0168634;C0549183;C0876920;C1442488;C2347635;C2348144;C2939193";NA;NA;baseline pav median n $nmbr$ $nmbr$
 635;baseline median [ mg / l ];"C0168634;C0439268;C0549183;C0876920;C1442488;C2347635;C2348144;C2939193";NA;NA;baseline median mg l
 635;baseline median ( iq range );"C0168634;C0549183;C0876920;C1442488;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016";NA;NA;baseline median iq range
 635;baseline median  mg / dl;"C0168634;C0439269;C0549183;C0876920;C1442488;C2347635;C2348144;C2939193";NA;NA;baseline median mg dl
 635;baseline median;"C0168634;C0549183;C0876920;C1442488;C2347635;C2348144;C2939193";NA;NA;baseline median
 635;baseline free pcsk $nmbr$ level by median;"C0168634;C0332296;C0441889;C0456079;C0549183;C0876920;C1442488;C1547707;C1880497;C1996904;C2347635;C2348144;C2939193;C2946261";NA;NA;baseline free pcsk $nmbr$ level by median
 635;at or above the median;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;at or above the median
 635;at or above median;"C0549183;C0876920;C1282910;C1552828;C2347635;C2348144;C2939193";NA;NA;at or above median
 635;a median;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;a median
 635;a $nmbr$ c > = median;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;a $nmbr$ c median
 635;a $nmbr$ c < median;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;a $nmbr$ c median
 635;a $nmbr$ c < $nmbr$ . $nmbr$ % ( median );"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;a $nmbr$ c $nmbr$ $nmbr$ median
 635;a $nmbr$ = $nmbr$ . $nmbr$ % ( median );"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;a $nmbr$ $nmbr$ $nmbr$ median
 635;^ median > median;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median median
 635;^ median;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median
 625;baseline vertebral fracture;"C0080179;C0168634;C1442488";NA;NA;baseline vertebral fracture
 635;age ( median [ iqr ] )  y;"C0001779;C0549183;C0876920;C2347635;C2348144;C2939193";FALSE;1890;age median iqr y
 635;age  median ( iqr )  years;"C0549183;C0876920;C1510829;C2347635;C2348144;C2939193";FALSE;1890;age median iqr years
 635;age - years  median ( iqr );"C0549183;C0876920;C1510829;C2347635;C2348144;C2939193";FALSE;1890;age years median iqr
 635;bmi ( kg / m $nmbr$ ) [ median ( $nmbr$ th to $nmbr$ th percentile ) ];"C0039725;C0039738;C0549183;C0876920;C1420718;C1532718;C2347635;C2348144;C2923536;C2939193;C4282123;C4285344";FALSE;1891;bmi kg m $nmbr$ median $nmbr$ th to $nmbr$ th percentile
 635;bmi * ( kg / m $nmbr$ )  median ( q $nmbr$  q $nmbr$ );"C0549183;C0578022;C0876920;C1532718;C2347635;C2348144;C2939193";FALSE;1891;bmi kg m $nmbr$ median q $nmbr$ q $nmbr$
 635;bmi  median ( sd )  kg / m $nmbr$;"C0549183;C0578022;C0876920;C1532718;C2347635;C2348144;C2699239;C2939193";FALSE;1891;bmi median sd kg m $nmbr$
 635;c - peptide  median ( q $nmbr$  q $nmbr$ )  nmol / l;"C0006558;C0439282;C0549183;C0876920;C2347635;C2348144;C2939193";FALSE;1892;c peptide median q $nmbr$ q $nmbr$ nmol l
 635;c - peptide  median ( ql  q $nmbr$ )  nmol / l;"C0006558;C0439282;C0549183;C0876920;C2347635;C2348144;C2939193";FALSE;1892;c peptide median ql q $nmbr$ nmol l
 625;baseline albumin : < $nmbr$;"C0001924;C0168634;C1442488";NA;NA;baseline albumin $nmbr$
 635;dactylitis score at baseline  median ( iqr ) week $nmbr$;"C0168634;C0239161;C0332174;C0439230;C0449820;C0549183;C0876920;C1442488;C2347635;C2348144;C2939193;C4050231";FALSE; 492;dactylitis score at baseline median iqr week $nmbr$
 635;c - reactive protein  median ( iqr )  mg / l;"C0006560;C0439268;C0549183;C0876920;C1413716;C2347635;C2348144;C2939193;C4048285";FALSE; 286;c reactive protein median iqr mg l
 635;c - reactive protein  median ( q $nmbr$  q $nmbr$ );"C0006560;C0549183;C0876920;C1413716;C2347635;C2348144;C2939193;C4048285";FALSE; 286;c reactive protein median q $nmbr$ q $nmbr$
 635;crp median ( se )  rng / l;"C0036919;C0549183;C0876920;C2347635;C2348144;C2939193;C3890735;C4048285";FALSE; 286;crp median se rng l
 635;crp ( mg / l ) [ b ]  median ( min - max );"C0439420;C0549183;C0876920;C2347635;C2348144;C2939193;C3890735;C4048285";FALSE; 286;crp mg l b median min max
 635;crp [ mg / l ]  median;"C0439268;C0549183;C0876920;C2347635;C2348144;C2939193;C3890735;C4048285";FALSE; 286;crp mg l median
 635;> median ( $nmbr$ mm );"C0549183;C0876920;C2347635;C2348144;C2939193;C4330985;C4554674";NA;NA;median $nmbr$ mm
 635;> median ( $nmbr$ kg );"C0022718;C0439209;C0549183;C0876920;C2347635;C2348144;C2939193;C4054209";NA;NA;median $nmbr$ kg
 635;> median ( $nmbr$ . $nmbr$ years ) — number / n ( % );"C0237753;C0439234;C0449788;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median $nmbr$ $nmbr$ years number n
 635;> median ( $nmbr$ . $nmbr$ ) — number / n ( % );"C0237753;C0449788;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median $nmbr$ $nmbr$ number n
 635;> median ( $nmbr$ . $nmbr$ );"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median $nmbr$ $nmbr$
 635;> median ( $nmbr$ ) — number / n ( % );"C0237753;C0449788;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median $nmbr$ number n
 635;> median ( $nmbr$ );"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median $nmbr$
 635;> median ( $nmbr$ % );"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median $nmbr$
 635;> median $nmbr$ . $nmbr$;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median $nmbr$ $nmbr$
 635;> median;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median
 635;> = median;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median
 635;< median { $nmbr$ days );"C0439228;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median $nmbr$ days
 635;< median ( $nmbr$ kg );"C0022718;C0439209;C0549183;C0876920;C2347635;C2348144;C2939193;C4054209";NA;NA;median $nmbr$ kg
 635;< median ( $nmbr$ . $nmbr$ years ) — number / n ( % );"C0237753;C0439234;C0449788;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median $nmbr$ $nmbr$ years number n
 635;< median ( $nmbr$ . $nmbr$ ) — number / n ( % );"C0237753;C0449788;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median $nmbr$ $nmbr$ number n
 635;< median ( $nmbr$ . $nmbr$ );"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median $nmbr$ $nmbr$
 635;< median ( $nmbr$ ) — number / n ( % );"C0237753;C0449788;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median $nmbr$ number n
 635;< median $nmbr$ . $nmbr$;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median $nmbr$ $nmbr$
 635;< median;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median
 635;- median tg ( iqr );"C0337445;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median tg iqr
 635;- median pulse pressure ( mm hg ) ( iqr );"C0439475;C0549183;C0876920;C0949236;C2347635;C2348144;C2939193";NA;NA;median pulse pressure mm hg iqr
 635;* data reported as n ( % ) or median ( quartiles $nmbr$  $nmbr$ ) .;"C0549183;C0684224;C0700287;C0876920;C1511726;C2347635;C2348144;C2828255;C2939193;C3245479;C3714741;C4319718";NA;NA;data reported as n or median quartiles $nmbr$ $nmbr$
 635;( median  h );"C0033727;C0369286;C0441932;C0549183;C0564385;C0876920;C2347635;C2348144;C2939193;C4528284";NA;NA;median h
 635;& median;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median
 635;% change ( median  q $nmbr$  q $nmbr$ );"C0392747;C0443172;C0549183;C0876920;C1705241;C2347635;C2348144;C2939193;C4319952";NA;NA;change median q $nmbr$ q $nmbr$
 634;no . of days to homa - ir testing — median ( iqr );"C0022065;C0022071;C0039593;C0392366;C0439228;C0549183;C0876920;C1448132;C2347635;C2348144;C2939193";NA;NA;no of days to homa ir testing median iqr
 634;homa > median;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;homa median
 634;homa . ir  median ( ql  q $nmbr$ )  % / $nmbr$;"C0022065;C0022071;C0549183;C0876920;C1448132;C2347635;C2348144;C2939193";NA;NA;homa ir median ql q $nmbr$ $nmbr$
 634;homa . % b  median ( ql  q $nmbr$ )  %;"C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;homa b median ql q $nmbr$
 634;homa - p;NA;NA;NA;homa p
 634;homa - ir  median ( q $nmbr$  q $nmbr$ );"C0022065;C0022071;C0549183;C0876920;C1448132;C2347635;C2348144;C2939193";NA;NA;homa ir median q $nmbr$ q $nmbr$
 634;homa - b;NA;NA;NA;homa b
 634;homa;NA;NA;NA;homa
 633;zotarolimust;NA;NA;NA;zotarolimust
 633;zotarolimus - eluting;C1700035;NA;NA;zotarolimus eluting
 633;zotarolimus;C1700035;NA;NA;zotarolimus
 633;sirolimus eluting stent;"C0038257;C0072980";NA;NA;sirolimus eluting stent
 633;sirolimus - eluting stent use  n ( % );"C0038257;C0042153;C0072980;C0457083;C1947944";NA;NA;sirolimus eluting stent use n
 633;sirolimus - eluting;C0072980;NA;NA;sirolimus eluting
 633;sirolimus;C0072980;NA;NA;sirolimus
 633;everolimus - eluting;C0541315;NA;NA;everolimus eluting
 633;everolimus;C0541315;NA;NA;everolimus
 632;c $nmbr$ e $nmbr$ fab bolus ( n = $nmbr$ );"C1186706;C1511237;C1705509;C3812160";NA;NA;c $nmbr$ e $nmbr$ fab bolus n $nmbr$
 632;c $nmbr$ e $nmbr$ fab bolus;"C1186706;C1511237;C1705509;C3812160";NA;NA;c $nmbr$ e $nmbr$ fab bolus
 632;bolus of heparin given;"C0019134;C0770546;C1186706;C1442162;C1511237;C1550718;C1705509;C1947971;C3244317;C3812160";NA;NA;bolus of heparin given
 632;bolus and corrections;"C1186706;C1511237;C1705509;C1705565;C1947976;C3812160";NA;NA;bolus and corrections
 632;bolus alone;"C0205171;C0439044;C0679994;C1186706;C1511237;C1705509;C3812160";NA;NA;bolus alone
 632;bolus administered — no . ( % );"C1186706;C1511237;C1521801;C1705509;C3812160";NA;NA;bolus administered no
 632;bolus;"C1186706;C1511237;C1705509;C3812160";NA;NA;bolus
 632;basal plus bolus;"C0205112;C0332287;C1186706;C1511237;C1705509;C3812160";NA;NA;basal plus bolus
 631;systemic embolism;"C0013922;C0205373;C1704212";NA;NA;systemic embolism
 631;peripheral embolism;"C0013922;C0205100;C1704212";NA;NA;peripheral embolism
 631;non cns embolism;"C0013922;C1518422;C1704212;C3714787";NA;NA;non cns embolism
 631;embolism;"C0013922;C1704212";NA;NA;embolism
 631;cns systemic embolism;"C0013922;C0205373;C1704212;C3714787";NA;NA;cns systemic embolism
 630;pulmonary embolism ± deep vein thrombosis;"C0034065;C0149871;C0226514;C0852030";NA;NA;pulmonary embolism deep vein thrombosis
 630;pulmonary embolism;C0034065;NA;NA;pulmonary embolism
 630;previous deep - vein thrombosis or pulmonary embolism;"C0034065;C0149871;C0205156;C1552607";NA;NA;previous deep vein thrombosis or pulmonary embolism
 630;neither deep - vein thrombosis nor pulmonary embolism §;"C0034065;C0149871";NA;NA;neither deep vein thrombosis nor pulmonary embolism
 630;neither deep - vein thrombosis nor pulmonary embolism ^;"C0034065;C0149871";NA;NA;neither deep vein thrombosis nor pulmonary embolism
 630;deep - vein thrombosis or pulmonary embolism — no . ( % );"C0034065;C0149871";NA;NA;deep vein thrombosis or pulmonary embolism no
 630;both deep - vein thrombosis and pulmonary embolism;"C0034065;C0149871";NA;NA;both deep vein thrombosis and pulmonary embolism
 629;metabolism and nutrition;"C0025519;C0025520;C0028707;C0392209;C0518896;C1442959";NA;NA;metabolism and nutrition
 629;glucose metabolism;C0596620;NA;NA;glucose metabolism
 625;mean change from baseline in acq overall score ( sd ) *;"C0168634;C0282416;C0392747;C0443172;C0444504;C0449820;C1442488;C1561607;C1705241;C2347634;C2348143;C2699239;C2919686;C4050231;C4319952";NA;NA;mean change from baseline in acq overall score sd
 625;mean change from baseline  %;"C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C4319952";NA;NA;mean change from baseline
 629;data are reported as percentage or mean ± standard deviation  unless otherwise indicated . ng  normoglycemia  igm  impaired glucose metabolism  ldl  low - density lipoprotein  hdl  high - density lipoprotein  fpg  fasting plasma glucose . a median ( interquartile range ) . ‡ p < $nmbr$ . $nmbr$ vs . non - epa . § p < $nmbr$ . $nmbr$ vs . non - epa;"C0015663;C0017725;C0017887;C0023820;C0023821;C0028074;C0178587;C0202042;C0205251;C0221099;C0439165;C0444504;C0455280;C0549183;C0580545;C0596620;C0684224;C0700287;C0871420;C0876920;C1154908;C1442989;C1444656;C1511726;C1518422;C1549488;C1550472;C1561533;C1706005;C1711350;C1828170;C2347634;C2347635;C2348143;C2348144;C2828392;C2939193;C3245479;C3714741;C3890211;C4048187;C4319718;C4321351;C4522223";NA;NA;data are reported as percentage or mean standard deviation unless otherwise indicated ng normoglycemia igm impaired glucose metabolism ldl low density lipoprotein hdl high density lipoprotein fpg fasting plasma glucose a median interquartile range p $nmbr$ $nmbr$ vs non epa p $nmbr$ $nmbr$ vs non epa
 628;undetermined  other  or cardioembolism;"C0205258;C3536725;C4082977";NA;NA;undetermined other or cardioembolism
 628;cardioembolism;NA;NA;NA;cardioembolism
 627;table $nmbr$ . selected baseline characteristics of the study patients . *;"C0030705;C0039224;C0168634;C0557651;C1442488;C1568011;C1706074;C1707391;C2603343;C4684572";NA;NA;table $nmbr$ selected baseline characteristics of the study patients
 625;baseline uric acid;"C0041980;C0168634;C1442488";NA;NA;baseline uric acid
 627;p < $nmbr$ . $nmbr$ ) between the study groups in any of the baseline characteristics . ace;"C0369773;C0441849;C0557651;C0681848;C1452534;C1959644;C2603343;C2603361;C4284014;C4684572";NA;NA;p $nmbr$ $nmbr$ between the study groups in any of the baseline characteristics ace
 627;no baseline characteristics;C4684572;NA;NA;no baseline characteristics
 627;endpoint / baselinec;"C2349179;C2826544";NA;NA;endpoint baselinec
 627;endpoint / baseline;"C0168634;C1442488;C2349179;C2826544";NA;NA;endpoint baseline
 627;baselinec;NA;NA;NA;baselinec
 627;baseline characteristics;C4684572;NA;NA;baseline characteristics
 626;weight at baseline;C1303013;NA;NA;weight at baseline
 626;baseline body weight quartile;"C1303013;C2828255";NA;NA;baseline body weight quartile
 625;without hypertension at baseline to hypertension;"C0020538;C0168634;C1442488;C1963138";NA;NA;without hypertension at baseline to hypertension
 625;without baseline vertebral fracture;"C0080179;C0168634;C1442488";NA;NA;without baseline vertebral fracture
 625;with baseline vertebral fracture;"C0080179;C0168634;C1442488";NA;NA;with baseline vertebral fracture
 625;vertebral fractures at baseline;"C0080179;C0168634;C1442488";NA;NA;vertebral fractures at baseline
 625;using alendronate at baseline ( % );"C0102118;C0168634;C1442488;C1524063";NA;NA;using alendronate at baseline
 625;use at baseline  n;"C0042153;C0168634;C0457083;C1442488;C1947944";NA;NA;use at baseline n
 625;use at baseline;"C0042153;C0168634;C0457083;C1442488;C1947944";NA;NA;use at baseline
 625;uas $nmbr$ {;NA;NA;NA;uas $nmbr$
 625;triglycerides at baseline;"C0041004;C0168634;C1442488";NA;NA;triglycerides at baseline
 625;treated at baseline;"C0168634;C1442488;C1522326";NA;NA;treated at baseline
 625;thienopyridine at baseline;"C0168634;C1120149;C1442488";NA;NA;thienopyridine at baseline
 625;systolic  treated at baseline;"C0039155;C0168634;C1442488;C1522326";NA;NA;systolic treated at baseline
 625;supine after $nmbr$ minutes change from baseline;"C0038846;C0168634;C0392747;C0439232;C0443172;C0700321;C0702093;C1282918;C1442488;C1705241;C2347166;C4319952";NA;NA;supine after $nmbr$ minutes change from baseline
 625;standing after $nmbr$ minutes change from baseline;"C0168634;C0231472;C0392747;C0439232;C0443172;C0700321;C0702093;C1282918;C1442488;C1705241;C2347166;C4319952";NA;NA;standing after $nmbr$ minutes change from baseline
 625;standing after $nmbr$ minute change from baseline;"C0168634;C0231472;C0392747;C0439232;C0443172;C0700321;C0702093;C1282918;C1442488;C1705241;C2347166;C4319952";NA;NA;standing after $nmbr$ minute change from baseline
 625;selected baseline medications;"C0013227;C0168634;C0802604;C1442488;C1707391;C2598133;C4284232";NA;NA;selected baseline medications
 625;seizure types reported during baseline  n ( % ) a;"C0036572;C0168634;C0332307;C0684224;C0700287;C1442488;C1959629;C4319718;C4553401";NA;NA;seizure types reported during baseline n a
 625;seizure types reported during baseline  b n ( % );"C0036572;C0168634;C0332307;C0684224;C0700287;C1442488;C1959629;C4319718;C4553401";NA;NA;seizure types reported during baseline b n
 625;respiratory medication taken at baseline  n ( % );"C0168634;C0418986;C1442488;C1883727";NA;NA;respiratory medication taken at baseline n
 625;remission by : baseline duration of steroid;"C0038317;C0168634;C0814126;C1442488";NA;NA;remission by baseline duration of steroid
 625;randomised patients with > $nmbr$ % bsa psoriasis skin involvement at baseline;"C0030705;C0033860;C0168634;C0444099;C1123023;C1314939;C1442488;C4520765";NA;NA;randomised patients with $nmbr$ bsa psoriasis skin involvement at baseline
 625;radiographic progression based on change from baseline > sdc;"C0168634;C0242656;C0392747;C0443172;C0444708;C0449258;C1419891;C1442488;C1527178;C1705241;C1705938;C3273112;C4319952";NA;NA;radiographic progression based on change from baseline sdc
 625;ppi use at baseline;"C0042153;C0168634;C0358591;C0457083;C0871125;C1442488;C1947944;C3811894";NA;NA;ppi use at baseline
 625;planned thienopyridine at baseline;"C0168634;C1120149;C1301732;C1442488";NA;NA;planned thienopyridine at baseline
 625;percent atheroma volume at baseline;"C0168634;C0264956;C1442488;C1690016;C3887614";NA;NA;percent atheroma volume at baseline
 625;patients without syndesmophytes at baseline;"C0030705;C0168634;C0221690;C1442488";NA;NA;patients without syndesmophytes at baseline
 625;patients with syndesmophytes at baseline;"C0030705;C0168634;C0221690;C1442488";NA;NA;patients with syndesmophytes at baseline
 625;pah therapy at baseline;"C0030123;C0039798;C0087111;C0168634;C1363945;C1442488;C3203102;C4284467";NA;NA;pah therapy at baseline
 625;one at baseline;"C0168634;C0205447;C1442488";NA;NA;one at baseline
 625;on steroid at baseline;"C0038317;C0168634;C1442488";NA;NA;on steroid at baseline
 625;on statins at baseline;"C0168634;C0360714;C1442488";NA;NA;on statins at baseline
 625;ocs at baseline;"C0168634;C1442488";NA;NA;ocs at baseline
 625;normonatremic ( > $nmbr$ meq / l ) at baseline;"C0168634;C0439375;C1442488";NA;NA;normonatremic $nmbr$ meq l at baseline
 625;none at baseline;"C0168634;C1442488";NA;NA;none at baseline
 625;non - smokers ( at baseline );"C0168634;C0337672;C1442488;C4554605";NA;NA;non smokers at baseline
 625;no new jsn among patients with ≥ $nmbr$ uninvolved joint at baseline ¶;"C0022417;C0030705;C0168634;C0205314;C0205429;C0392905;C1442488;C1706309";NA;NA;no new jsn among patients with $nmbr$ uninvolved joint at baseline
 625;no new erosions among patients with ≥ $nmbr$ uninvolved joint at baseline ¶;"C0022417;C0030705;C0168634;C0205314;C0205429;C0333307;C0392905;C1442488;C1706309;C1959609";NA;NA;no new erosions among patients with $nmbr$ uninvolved joint at baseline
 625;no immunosuppressive agents at baseline;"C0021081;C0168634;C1442488";NA;NA;no immunosuppressive agents at baseline
 625;no hospitalization in the past $nmbr$ months prior to baseline ( ref );"C0019993;C0168634;C1425988;C1442488;C4331910";NA;NA;no hospitalization in the past $nmbr$ months prior to baseline ref
 625;no aspirin at baseline;"C0004057;C0168634;C1442488";NA;NA;no aspirin at baseline
 625;nihss at baseline;"C0168634;C1442488;C1697238";NA;NA;nihss at baseline
 625;mmrc at baseline;"C0168634;C1442488;C3826977";NA;NA;mmrc at baseline
 625;microalbuminuria at baseline ( $nmbr$ % of patients treated );"C0030705;C0168634;C0730345;C1442488;C1522326";NA;NA;microalbuminuria at baseline $nmbr$ of patients treated
 625;methotrexate use at baseline;"C0025677;C0042153;C0168634;C0457083;C1442488;C1947944";NA;NA;methotrexate use at baseline
 625;methotrexate dose at baseline;"C0025677;C0168634;C0178602;C0869039;C1114758;C1442488";NA;NA;methotrexate dose at baseline
 625;mental activities updrs subscore ( baseline )  mean ( sd );"C0168634;C0229992;C0441655;C0444504;C1442488;C2347634;C2348143;C2699239;C3639721";NA;NA;mental activities updrs subscore baseline mean sd
 625;memantine use at baseline  no . ( % );"C0025242;C0042153;C0168634;C0457083;C1442488;C1947944";NA;NA;memantine use at baseline no
 625;medication use at baseline — no . ( % );"C0168634;C0240320;C1442488";NA;NA;medication use at baseline no
 625;medication use at baseline - n ( % );"C0168634;C0240320;C1442488";NA;NA;medication use at baseline n
 625;medication use at baseline  n ( % );"C0168634;C0240320;C1442488";NA;NA;medication use at baseline n
 625;medication in use at the baseline;"C0013227;C0042153;C0150312;C0168634;C0332285;C0457083;C1442488;C1707101;C1947944;C3244316;C4284232";NA;NA;medication in use at the baseline
 625;mean baseline ucdai score;"C0168634;C0444504;C0449820;C1442488;C2347634;C2348143;C4050231";NA;NA;mean baseline ucdai score
 625;mean baseline nasal congestion score;"C0027424;C0168634;C1442488;C3533236;C4554631";NA;NA;mean baseline nasal congestion score
 625;mean baseline ldl - c ( mmol / l );"C0168634;C0444504;C1442488;C1532563;C2347634;C2348143";NA;NA;mean baseline ldl c mmol l
 625;mean baseline ei score;"C0022067;C0168634;C0444504;C0449820;C1414370;C1442488;C2347634;C2348143;C2348481;C4050231";NA;NA;mean baseline ei score
 625;mean baseline ( n );"C0168634;C0444504;C1442488;C2347634;C2348143";NA;NA;mean baseline n
 625;mean arterial pressure  baseline;"C0168634;C0428886;C1442488";NA;NA;mean arterial pressure baseline
 625;macroalbuminuria at baseline ( $nmbr$ % of patients treated );"C0030705;C0168634;C1442488;C1522326";NA;NA;macroalbuminuria at baseline $nmbr$ of patients treated
 625;low - dose aspirin use at baseline yes;"C0042153;C0168634;C0457083;C1442488;C1549445;C1705108;C1710701;C1947944;C2608320";NA;NA;low dose aspirin use at baseline yes
 625;level of thyroperoxidase antibody at baseline;"C0021965;C0168634;C0428536;C0441889;C0456079;C0487652;C1318460;C1364508;C1429427;C1442488;C1547707;C2946261;C3272921";NA;NA;level of thyroperoxidase antibody at baseline
 625;ldl cholesterol at baseline ( mmol / l ) * ldl cholesterol at screening;"C0023824;C0168634;C0202117;C0220908;C0220909;C1442488;C1532563;C1698960;C1710031;C1710032;C1710477;C2348164";NA;NA;ldl cholesterol at baseline mmol l ldl cholesterol at screening
 625;ldl - c in mmol / l ( baseline : mean ( sd ) [ n ]  wk $nmbr$ and change : mean ( se ) [ n ] );"C0036919;C0168634;C0332174;C0392747;C0439230;C0443172;C0444504;C1442488;C1532563;C1705241;C2347634;C2348143;C2699239;C4319952";NA;NA;ldl c in mmol l baseline mean sd n wk $nmbr$ and change mean se n
 625;ldl - c at baseline :;"C0168634;C1442488";NA;NA;ldl c at baseline
 625;killip at baseline;"C0168634;C1442488";NA;NA;killip at baseline
 625;intensified baseline ( n - $nmbr$ );"C0168634;C1442488";NA;NA;intensified baseline n $nmbr$
 625;in remission at maintenance study baseline;"C0024501;C0168634;C0544452;C0557651;C0687702;C1442488;C2603343";NA;NA;in remission at maintenance study baseline
 625;improvement from baseline ≥   $nmbr$;"C0168634;C1442488;C2986411";NA;NA;improvement from baseline $nmbr$
 625;immunosuppressive agents at baseline;"C0021081;C0168634;C1442488";NA;NA;immunosuppressive agents at baseline
 625;icsusers atbaseline  n ( % );NA;NA;NA;icsusers atbaseline n
 625;ics use at baseline : yes;"C0042153;C0168634;C0457083;C0815320;C1442488;C1549445;C1705108;C1710701;C1947944;C4551720";NA;NA;ics use at baseline yes
 625;ics use at baseline  n ( % );"C0042153;C0168634;C0457083;C0815320;C1442488;C1947944;C4551720";NA;NA;ics use at baseline n
 625;ics use at baseline;"C0042153;C0168634;C0457083;C0815320;C1442488;C1947944;C4551720";NA;NA;ics use at baseline
 625;hyponatremic ( < $nmbr$ meq / l ) at baseline;"C0168634;C0439375;C0857122;C1442488";NA;NA;hyponatremic $nmbr$ meq l at baseline
 625;hypertension severity at baseline  n ( % );"C0168634;C1442488;C4013784";NA;NA;hypertension severity at baseline n
 625;hypertension at baseline;"C0020538;C0168634;C1442488;C1963138";NA;NA;hypertension at baseline
 625;hospitalization in the past $nmbr$ months prior to baseline;"C0019993;C0168634;C1442488;C4331910";NA;NA;hospitalization in the past $nmbr$ months prior to baseline
 625;heart - rate group at baseline;"C0018810;C0168634;C0441833;C0687744;C1257890;C1442488;C1519504;C1705428;C1705429";NA;NA;heart rate group at baseline
 625;flex baseline bmd t score;"C0168634;C0449820;C1442488;C4050231";NA;NA;flex baseline bmd t score
 625;femoral neck f - score at flex baseline;"C0015815;C0016327;C0168634;C0449820;C1442488;C4050231";NA;NA;femoral neck f score at flex baseline
 625;fbg baseline;"C0168634;C1442488";NA;NA;fbg baseline
 625;draining cutaneous fistula at baseline  n ( % );"C0013103;C0168634;C0180499;C0423772;C1442488;C4265177";NA;NA;draining cutaneous fistula at baseline n
 625;dmard at baseline;"C0168634;C0242708;C1442488";NA;NA;dmard at baseline
 625;difference $nmbr$ years - baseline *;"C0168634;C0439234;C1442488;C1705241;C1705242";NA;NA;difference $nmbr$ years baseline
 625;difference $nmbr$ years - baseline;"C0168634;C0439234;C1442488;C1705241;C1705242";NA;NA;difference $nmbr$ years baseline
 625;diabetic retinopathy at baseline;"C0011884;C0168634;C1442488";NA;NA;diabetic retinopathy at baseline
 625;diabetes duration at baseline;"C0011847;C0011849;C0168634;C0449238;C1442488;C2926735";NA;NA;diabetes duration at baseline
 625;diabetes at baseline;"C0011847;C0011849;C0168634;C1442488";NA;NA;diabetes at baseline
 625;csdmard use at baseline ^;"C0042153;C0168634;C0457083;C1442488;C1947944";NA;NA;csdmard use at baseline
 625;crohn ' s disease - related medication at baseline  n ( % );"C0010346;C0013227;C0168634;C0439849;C0445223;C1442488;C3244316;C4284232";NA;NA;crohn s disease related medication at baseline n
 625;creatinine > $nmbr$ x baseline;"C0010294;C0168634;C1442488;C1561535";NA;NA;creatinine $nmbr$ x baseline
 625;creatinine > $nmbr$ . $nmbr$ x baseline and above uln;"C0010294;C0168634;C1282910;C1442488;C1519815;C1552828;C1561535";NA;NA;creatinine $nmbr$ $nmbr$ x baseline and above uln
 625;conventional synthetic dmard use at baseline;"C0042153;C0168634;C0242708;C0439858;C0457083;C1442488;C1883254;C1947944";NA;NA;conventional synthetic dmard use at baseline
 625;concentrations at baseline;"C0086045;C0168634;C1442488";NA;NA;concentrations at baseline
 625;common study baseline;"C0168634;C0205214;C0557651;C1442488;C1522138;C2603343;C3245511";NA;NA;common study baseline
 625;coiticosieroids at baseline;"C0168634;C1442488";NA;NA;coiticosieroids at baseline
 625;changes at baseline;"C0168634;C0392747;C0443172;C1442488";NA;NA;changes at baseline
 625;change in psa ‐ modified shs  baseline to week $nmbr$ ‡;"C0168634;C0332174;C0392747;C0439230;C0443172;C1442488;C1705241;C3810537;C3813209;C3889737;C4319952";NA;NA;change in psa modified shs baseline to week $nmbr$
 625;change in femoral neck bmd from fit baseline to flex baseline;"C0015815;C0036572;C0168634;C0392747;C0443172;C1442488;C1705241;C2349186;C4048158;C4319952;C4553125";NA;NA;change in femoral neck bmd from fit baseline to flex baseline
 625;change from baseline to week $nmbr$ in uas $nmbr$;"C0168634;C0332174;C0392747;C0439230;C0443172;C1442488;C1705241;C4319952";NA;NA;change from baseline to week $nmbr$ in uas $nmbr$
 625;change from baseline to eos  uu / ml;"C0168634;C0392747;C0439342;C0443172;C1442488;C1623465;C1705241;C1861303;C4319952";NA;NA;change from baseline to eos uu ml
 625;change from baseline in pre - bd;"C0005126;C0168634;C0332152;C0392747;C0443172;C0740175;C1442488;C1705241;C2257086;C2344255;C3669034;C4050145;C4319952";NA;NA;change from baseline in pre bd
 625;change from baseline in post - bd;"C0005126;C0168634;C0392747;C0443172;C0687676;C1442488;C1704687;C1705241;C2344255;C3469826;C4050145;C4319952";NA;NA;change from baseline in post bd
 625;change from baseline *;"C0168634;C0392747;C0443172;C1442488;C1705241;C4319952";NA;NA;change from baseline
 625;change from baseline ( % );"C0168634;C0392747;C0443172;C1442488;C1705241;C4319952";NA;NA;change from baseline
 625;change from baseline  adjusted mean ( $nmbr$ % ci )  %;"C0008107;C0168634;C0392747;C0443172;C0444504;C0456081;C1442488;C1705241;C2347634;C2348143;C3259781;C4319952";NA;NA;change from baseline adjusted mean $nmbr$ ci
 625;change from baseline  adjusted mean ( $nmbr$ % ci );"C0008107;C0168634;C0392747;C0443172;C0444504;C0456081;C1442488;C1705241;C2347634;C2348143;C3259781;C4319952";NA;NA;change from baseline adjusted mean $nmbr$ ci
 625;biomarkers at baseline;"C0005516;C0168634;C1442488";NA;NA;biomarkers at baseline
 625;baselineb;NA;NA;NA;baselineb
 625;baseline upgr > $nmbr$ gm / gm ( $nmbr$ mg / mmole );"C0017480;C0168634;C0567349;C1442488;C2348885;C3854019";NA;NA;baseline upgr $nmbr$ gm gm $nmbr$ mg mmole
 625;baseline upgr  mg / mmole ( n = $nmbr$  $nmbr$  $nmbr$ );"C0168634;C0567349;C1442488;C2348885";NA;NA;baseline upgr mg mmole n $nmbr$ $nmbr$ $nmbr$
 625;baseline uas $nmbr$;"C0168634;C1442488";NA;NA;baseline uas $nmbr$
 625;baseline trl - c by quintiles;"C0168634;C1442488;C1508496";NA;NA;baseline trl c by quintiles
 625;baseline triglycerides by quintiles;"C0041004;C0168634;C1442488;C1508496";NA;NA;baseline triglycerides by quintiles
 625;baseline triglycerides;"C0041004;C0168634;C1442488";NA;NA;baseline triglycerides
 625;baseline treatments  n ( % ) a;"C0087111;C0168634;C1442488";NA;NA;baseline treatments n a
 625;baseline total pcsk $nmbr$ level;"C0168634;C0439175;C0439810;C0441889;C0456079;C1442488;C1547707;C2946261";NA;NA;baseline total pcsk $nmbr$ level
 625;baseline t - score at femoral neck  n ( % );"C0015815;C0168634;C0449820;C1442488;C4050231";NA;NA;baseline t score at femoral neck n
 625;baseline steroids;"C0038317;C0168634;C1442488";NA;NA;baseline steroids
 625;baseline sitosterol / lathosterol;"C0037215;C0064673;C0168634;C0220914;C1442488";NA;NA;baseline sitosterol lathosterol
 625;baseline sitosterol / cholesterol;"C0008377;C0037215;C0168634;C0220914;C1442488";NA;NA;baseline sitosterol cholesterol
 625;baseline sitosterol;"C0037215;C0168634;C0220914;C1442488";NA;NA;baseline sitosterol
 625;baseline shs ( $nmbr$ - $nmbr$ );"C0168634;C1442488";NA;NA;baseline shs $nmbr$ $nmbr$
 625;baseline sgrq score;"C0168634;C0449820;C1442488;C4050231";NA;NA;baseline sgrq score
 625;baseline serum k +  meq / l;"C0168634;C0302353;C0439375;C1442488";NA;NA;baseline serum k meq l
 625;baseline serum calcium level  n ( % );"C0036785;C0168634;C0728876;C1442488";NA;NA;baseline serum calcium level n
 625;baseline rst - segment elevation  mm;"C0168634;C0439775;C0441635;C0702240;C1425219;C1442488;C4330985;C4554674";NA;NA;baseline rst segment elevation mm
 625;baseline rst - segment;"C0168634;C0441635;C1425219;C1442488";NA;NA;baseline rst segment
 625;baseline ptga;"C0168634;C1442488";NA;NA;baseline ptga
 625;baseline pos frequency per $nmbr$ days;"C0168634;C0585290;C1262869;C1442488;C3496112;C3496399";NA;NA;baseline pos frequency per $nmbr$ days
 625;baseline pfd  m;"C0016065;C0168634;C0369637;C0441923;C1442488;C1839454;C2827389;C3889643";NA;NA;baseline pfd m
 625;baseline pcsi < $nmbr$ a;"C0168634;C1442488";NA;NA;baseline pcsi $nmbr$ a
 625;baseline pava;"C0135567;C0168634;C1442488";NA;NA;baseline pava
 625;baseline of induction )  n ( % );"C0168634;C0205263;C0857127;C1442488";NA;NA;baseline of induction n
 625;baseline of induction;"C0168634;C0205263;C0857127;C1442488";NA;NA;baseline of induction
 625;baseline nihss;"C0168634;C1442488;C1697238";NA;NA;baseline nihss
 625;baseline nih stroke scale — no . ( % ) ^;"C0168634;C1442488;C1697238;C3484372";NA;NA;baseline nih stroke scale no
 625;baseline medications ( % );"C0013227;C0168634;C0802604;C1442488;C2598133;C4284232";NA;NA;baseline medications
 625;baseline medications  n ( % );"C0013227;C0168634;C0802604;C1442488;C2598133;C4284232";NA;NA;baseline medications n
 625;baseline medication;"C0013227;C0168634;C1442488;C3244316;C4284232";NA;NA;baseline medication
 625;baseline medical therapy  n ( % );"C0168634;C0418981;C1442488";NA;NA;baseline medical therapy n
 625;baseline medical therapy;"C0168634;C0418981;C1442488";NA;NA;baseline medical therapy
 625;baseline measurements;"C0168634;C0242485;C1442488";NA;NA;baseline measurements
 625;baseline mean 士 sd;"C0168634;C0444504;C1442488;C2347634;C2348143;C2699239";NA;NA;baseline mean sd
 625;baseline mean mtss;"C0168634;C0444504;C1442488;C2347634;C2348143";NA;NA;baseline mean mtss
 625;baseline mean;"C0168634;C0444504;C1442488;C2347634;C2348143";NA;NA;baseline mean
 625;baseline mdrd egfr > $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0168634;C0369637;C0439445;C0441923;C1442488;C1739039;C3811844;C3812682;C3839656";NA;NA;baseline mdrd egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 625;baseline mdrd egfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0168634;C0369637;C0439445;C0441923;C1442488;C1739039;C3811844;C3812682;C3839656";NA;NA;baseline mdrd egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 625;baseline hstni;"C0168634;C1442488";NA;NA;baseline hstni
 625;baseline glycated;"C0168634;C1442488;C3666909";NA;NA;baseline glycated
 625;baseline free pcsk $nmbr$ level;"C0168634;C0332296;C0441889;C0456079;C1442488;C1547707;C1880497;C1996904;C2946261";NA;NA;baseline free pcsk $nmbr$ level
 625;baseline fecal caicrctectin;"C0015733;C0168634;C1442488";NA;NA;baseline fecal caicrctectin
 625;baseline ezetimibe usec;"C0168634;C0439224;C1142985;C1442488";NA;NA;baseline ezetimibe usec
 625;baseline ecro < $nmbr$ mumin;"C0168634;C1442488";NA;NA;baseline ecro $nmbr$ mumin
 625;baseline ecrcl k $nmbr$ to < $nmbr$ ml / min;"C0168634;C0439445;C0597277;C1442488;C1708601";NA;NA;baseline ecrcl k $nmbr$ to $nmbr$ ml min
 625;baseline ecrcl $nmbr$ $nmbr$ ml / min;"C0168634;C0439445;C1442488";NA;NA;baseline ecrcl $nmbr$ $nmbr$ ml min
 625;baseline ecrcl;"C0168634;C1442488";NA;NA;baseline ecrcl
 625;baseline ecg with lvh  n ( % );"C0168634;C0232306;C1442488";NA;NA;baseline ecg with lvh n
 625;baseline dmard use  n ( % );"C0042153;C0168634;C0242708;C0457083;C1442488;C1947944";NA;NA;baseline dmard use n
 625;baseline dlco . mmol kpa - ’ -;"C0168634;C0263428;C0439190;C0439474;C1442488;C1516251";NA;NA;baseline dlco mmol kpa
 625;baseline dipeptidyl peptidase $nmbr$;"C0022709;C0168634;C1442488";NA;NA;baseline dipeptidyl peptidase $nmbr$
 625;baseline demographics;"C0011298;C0168634;C1442488;C1704791";NA;NA;baseline demographics
 625;baseline hbalc;"C0168634;C1442488";FALSE;2188;baseline hbalc
 625;baseline hbalc ^;"C0168634;C1442488";FALSE;2188;baseline hbalc
 625;baseline hbalc < $nmbr$ . $nmbr$ % ( $nmbr$ mmol / mol ) $nmbr$;"C0168634;C1442488;C3829066";FALSE;2188;baseline hbalc $nmbr$ $nmbr$ $nmbr$ mmol mol $nmbr$
 625;baseline hbalc > $nmbr$ . $nmbr$ % ( $nmbr$ mmol / mol ) $nmbr$;"C0168634;C1442488;C3829066";FALSE;2188;baseline hbalc $nmbr$ $nmbr$ $nmbr$ mmol mol $nmbr$
 625;baseline hb $nmbr$ g i $nmbr$ n = $nmbr$;"C0062408;C0086706;C0168634;C1442488";FALSE;2188;baseline hb $nmbr$ g i $nmbr$ n $nmbr$
 625;baseline hb < $nmbr$ g $nmbr$ $nmbr$ n = $nmbr$;"C0062408;C0168634;C0439267;C1442488";FALSE;2188;baseline hb $nmbr$ g $nmbr$ $nmbr$ n $nmbr$
 625;baseline ldl - c;"C0168634;C1442488";FALSE;2189;baseline ldl c
 625;baseline ldl - c :;"C0168634;C1442488";FALSE;2189;baseline ldl c
 625;baseline ldl - c strata  n ( ° / o );"C0168634;C1442488";FALSE;2189;baseline ldl c strata n o
 625;baseline lipid and apolipoprotein levels;"C0003591;C0023779;C0168634;C0441889;C1442488";FALSE;2190;baseline lipid and apolipoprotein levels
 625;baseline lipid and lipoprotein values;"C0023779;C0023820;C0042295;C0168634;C1442488";FALSE;2190;baseline lipid and lipoprotein values
 625;baseline lipid / lipoprotein values;"C0042295;C0168634;C0443602;C1442488";FALSE;2190;baseline lipid lipoprotein values
 625;baseline lipid therapy;"C0023779;C0039798;C0087111;C0168634;C1363945;C1442488";FALSE;2190;baseline lipid therapy
 625;baseline diabetes mellitus therapy  n ( % );"C0168634;C0948092;C1442488";FALSE;2191;baseline diabetes mellitus therapy n
 625;baseline diabetes;"C0011847;C0011849;C0168634;C1442488";FALSE;2191;baseline diabetes
 625;baseline das $nmbr$  mean ( s . e . );"C0051767;C0057671;C0168634;C0444504;C1442488;C2347634;C2348143";NA;NA;baseline das $nmbr$ mean s e
 625;baseline dad ( n   = $nmbr$ + $nmbr$ );"C0168634;C1442488;C3641946";NA;NA;baseline dad n $nmbr$ $nmbr$
 625;baseline cv treatment  n ( % ) y;"C0039798;C0087111;C0168634;C1442488;C1522326;C1533734;C1705169;C3538987;C3538994;C3887704;C4048877;C4318503";NA;NA;baseline cv treatment n y
 625;baseline cv treatment;"C0039798;C0087111;C0168634;C1442488;C1522326;C1533734;C1705169;C3538987;C3538994;C3887704;C4048877;C4318503";NA;NA;baseline cv treatment
 625;baseline crohn ' s disease medications;"C0010346;C0013227;C0168634;C0802604;C1442488;C2598133;C4284232";NA;NA;baseline crohn s disease medications
 625;baseline creatinine clearance;"C0168634;C0812399;C1442488";NA;NA;baseline creatinine clearance
 625;baseline creatinine  median ( range ) mg / dl;"C0010294;C0168634;C0439269;C0549183;C0876920;C1442488;C1514721;C1561535;C2347635;C2348144;C2348147;C2939193;C3542016";NA;NA;baseline creatinine median range mg dl
 625;baseline concentration;"C0086045;C0168634;C1442488;C1446561;C3827302";NA;NA;baseline concentration
 625;baseline cardiovascular assessment;"C0007226;C0168634;C0846600;C1442488;C3887460;C4684571";NA;NA;baseline cardiovascular assessment
 625;baseline cardiac biomarkers elevated;"C0168634;C0205250;C1442488;C2735101;C2735102;C3163633";NA;NA;baseline cardiac biomarkers elevated
 625;baseline cardiac biomarkers;"C0168634;C1442488;C2735101;C2735102";NA;NA;baseline cardiac biomarkers
 625;baseline bp  mean ( sd ) *;"C0168634;C0488053;C1442488;C2699239";NA;NA;baseline bp mean sd
 625;baseline bnp concentration ( pg / ml );"C0054015;C0086045;C0168634;C0439297;C1095989;C1417808;C1442488;C1446561;C2982014;C3827302";NA;NA;baseline bnp concentration pg ml
 625;baseline basfi;"C0168634;C1442488";NA;NA;baseline basfi
 625;baseline albuminuria;"C0001925;C0168634;C1442488";NA;NA;baseline albuminuria
 625;baseline adas - cog $nmbr$;"C0168634;C1442488;C3539026";NA;NA;baseline adas cog $nmbr$
 625;baseline acq - $nmbr$ score;"C0168634;C0449820;C1442488;C2919686;C4050231";NA;NA;baseline acq $nmbr$ score
 625;baseline a $nmbr$ c ( % );"C0168634;C1442488";NA;NA;baseline a $nmbr$ c
 625;baseline - adjusted hr;"C0168634;C0456081;C1442488";NA;NA;baseline adjusted hr
 625;baseline - - mdrd;"C0168634;C1442488;C3839656";NA;NA;baseline mdrd
 625;baseline ( sd );"C0168634;C1442488;C2699239";NA;NA;baseline sd
 625;baseline ( n );"C0168634;C1442488";NA;NA;baseline n
 625;baseline % bsa involvement;"C0168634;C1314939;C1442488";NA;NA;baseline bsa involvement
 625;baseline $nmbr$ - mlnute walk distance :;"C0168634;C0429886;C1442488";NA;NA;baseline $nmbr$ mlnute walk distance
 625;baseline $nmbr$ - h ppg;"C0033727;C0168634;C0369286;C0441932;C0564385;C1418888;C1442488;C4528284";NA;NA;baseline $nmbr$ h ppg
 625;baseline  no . ( % );"C0168634;C1442488";NA;NA;baseline no
 625;baseline  % ( n );"C0168634;C1442488";NA;NA;baseline n
 625;baseline;"C0168634;C1442488";NA;NA;baseline
 625;available baseline blood specimen n;"C0168634;C0178913;C0470187;C1442488";NA;NA;available baseline blood specimen n
 625;at baseline — no . ( % );"C0168634;C1442488";NA;NA;at baseline no
 625;at baseline;"C0168634;C1442488";NA;NA;at baseline
 625;asthma control test score at baseline;"C0168634;C1442488;C2733224";NA;NA;asthma control test score at baseline
 625;antihyperglycaemic medication at baseline;"C0013227;C0020616;C0168634;C1442488;C3244316;C4284232";NA;NA;antihyperglycaemic medication at baseline
 625;antiepileptic drug type at baseline;"C0003299;C0168634;C0332307;C0457591;C1442488;C1547052;C3537002";NA;NA;antiepileptic drug type at baseline
 625;antibody binding level at baseline;"C0168634;C0428536;C0441889;C0456079;C1145667;C1149306;C1167622;C1442488;C1547707;C2946261";NA;NA;antibody binding level at baseline
 625;adjusted mean change from baseline ( $nmbr$ % ci )  % [ mmol / mol ];"C0008107;C0168634;C0392747;C0439190;C0443172;C0444504;C0456081;C0948922;C1442488;C1705241;C2347634;C2348143;C3259781;C3829066;C4319952";NA;NA;adjusted mean change from baseline $nmbr$ ci mmol mol
 625;adjusted mean change from baseline;"C0168634;C0392747;C0443172;C0444504;C0456081;C1442488;C1705241;C2347634;C2348143;C4319952";NA;NA;adjusted mean change from baseline
 625;adjusted change from baseline mean ( s . e . );"C0168634;C0392747;C0443172;C0444504;C0456081;C1442488;C1705241;C2347634;C2348143;C4319952";NA;NA;adjusted change from baseline mean s e
 625;adjusted change from baseline;"C0168634;C0392747;C0443172;C0456081;C1442488;C1705241;C4319952";NA;NA;adjusted change from baseline
   7;interaction p value;"C1704675;C1709380";NA;NA;interaction p value
 625;activities of daily living updrs subscore ( baseline )  mean ( sd );"C0001288;C0168634;C0444504;C1442488;C2347634;C2348143;C2699239;C3639721;C4050548";NA;NA;activities of daily living updrs subscore baseline mean sd
 625;abdominal or perianal fistula at baseline  n ( % );"C0000726;C0168634;C0267561;C1442488";NA;NA;abdominal or perianal fistula at baseline n
 625;abbreviations : acei  angiotensin - converting enzyme inhibitor  arb  angiotensin receptor blocker  bpm  beats per minute  ccb  calcium channel blocker  msdbp  mean sitting diastolic blood pressure  mssbp  mean sitting systolic blood pressure . values are no . ( % ) unless otherwise indicated . amean ± sd . bmore severe  > $nmbr$ and < $nmbr$ mm hg / > $nmbr$ and < $nmbr$ mm hg  less severe  > $nmbr$ and < $nmbr$ mm hg / > $nmbr$ and < $nmbr$ mm hg . blood pressure at baseline is with monotherapy ( ie  before switch to amlodipine / valsar - tan therapy ) .;"C0000723;C0003015;C0005767;C0005768;C0005823;C0006684;C0014122;C0022067;C0025424;C0039798;C0040363;C0041260;C0042295;C0051696;C0087111;C0168634;C0205082;C0229664;C0277814;C0302595;C0332152;C0428257;C0439092;C0439385;C0439453;C0439475;C0443150;C0444504;C0488055;C0547044;C0597357;C0871470;C1271104;C1272641;C1306620;C1319894;C1363945;C1442488;C1444656;C1537110;C1705850;C1707719;C1881173;C1883351;C2347108;C2347109;C2347634;C2348143;C2348272;C2584297;C2699239;C2757044;C3275241;C3536837;C3536851;C3888198;C4050224;C4050465;C4050466;C4330985;C4521885;C4541021;C4554371;C4554674";NA;NA;abbreviations acei angiotensin converting enzyme inhibitor arb angiotensin receptor blocker bpm beats per minute ccb calcium channel blocker msdbp mean sitting diastolic blood pressure mssbp mean sitting systolic blood pressure values are no unless otherwise indicated amean sd bmore severe $nmbr$ and $nmbr$ mm hg $nmbr$ and $nmbr$ mm hg less severe $nmbr$ and $nmbr$ mm hg $nmbr$ and $nmbr$ mm hg blood pressure at baseline is with monotherapy ie before switch to amlodipine valsar tan therapy
 625;a from baselineb;NA;NA;NA;a from baselineb
 625;a from baseline;"C0168634;C1442488";NA;NA;a from baseline
 625;a $nmbr$ c at baseline ≥ $nmbr$ . $nmbr$ %;"C0168634;C1442488";NA;NA;a $nmbr$ c at baseline $nmbr$ $nmbr$
 625;a $nmbr$ c at baseline < $nmbr$ . $nmbr$ %;"C0168634;C1442488";NA;NA;a $nmbr$ c at baseline $nmbr$ $nmbr$
 625;> $nmbr$ years baseline ldl - c;"C0168634;C0439234;C1442488";NA;NA;$nmbr$ years baseline ldl c
 625;> $nmbr$ med at baseline cardiac disorder *;"C0018799;C0168634;C1442488;C4321267";NA;NA;$nmbr$ med at baseline cardiac disorder
 625;> $nmbr$ % blood eosinophils at baseline;"C0014467;C0168634;C1442488";NA;NA;$nmbr$ blood eosinophils at baseline
 625;< $nmbr$ % blood eosinophils at baseline;"C0014467;C0168634;C1442488";NA;NA;$nmbr$ blood eosinophils at baseline
 625;( baseline );"C0168634;C1442488";NA;NA;baseline
 625;$nmbr$ med at baseline;"C0168634;C1442488;C4321267";NA;NA;$nmbr$ med at baseline
 625;$nmbr$ baseline mean;"C0168634;C0444504;C1442488;C2347634;C2348143";NA;NA;$nmbr$ baseline mean
 624;thrombocytopenia;"C0040034;C0392386";NA;NA;thrombocytopenia
 624;profound thrombocytopenia ( < $nmbr$ x $nmbr$ / l );"C0040034;C0392386;C0439808";NA;NA;profound thrombocytopenia $nmbr$ x $nmbr$ l
 624;moderate thrombocytopenia ( < $nmbr$ x $nmbr$ / l );"C0040034;C0205081;C0392386;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate thrombocytopenia $nmbr$ x $nmbr$ l
 624;mild thrombocytopenia ( < $nmbr$ x $nmbr$ / l );C1856453;NA;NA;mild thrombocytopenia $nmbr$ x $nmbr$ l
 623;thrombophilia  no . ( % ) e;C0398623;NA;NA;thrombophilia no e
 625;baseline anti - hyperglycemic medications;"C0013227;C0168634;C0802604;C1442488;C2598133;C4284232";FALSE;  33;baseline anti hyperglycemic medications
 623;known thrombophilia — no . ( % );"C0205309;C0398623";NA;NA;known thrombophilia no
 623;known thrombophilia;"C0205309;C0398623";NA;NA;known thrombophilia
 622;stent thrombosis or mi;"C3810814;C3897493";NA;NA;stent thrombosis or mi
 622;stent thrombosis - related mi;"C0439849;C0445223;C3810814;C3897493";NA;NA;stent thrombosis related mi
 622;stent thrombosis *;C3897493;NA;NA;stent thrombosis
 622;stent thrombosis;C3897493;NA;NA;stent thrombosis
 622;non stent thrombosis - related mi;"C0439849;C0445223;C1518422;C3810814;C3897493";NA;NA;non stent thrombosis related mi
 622;definite acute stent thrombosis;"C0205178;C0439544;C1704787;C3897493";NA;NA;definite acute stent thrombosis
 622;death or stent thrombosis;"C0011065;C1306577;C3897493;C4082313;C4552775";NA;NA;death or stent thrombosis
 622;death / q - ml / stent thrombosis;"C0011065;C0439526;C1306577;C1705224;C3887665;C3897493;C4082313;C4552775";NA;NA;death q ml stent thrombosis
 622;composite of death / mi / stro ke / urgent revasc / definit e acute stent thrombosis;"C0011065;C0022558;C0155626;C0205199;C0378365;C0439609;C1306577;C1547335;C3272275;C3897493;C4082313;C4552775";NA;NA;composite of death mi stro ke urgent revasc definit e acute stent thrombosis
 622;acute stent thrombosis ( definite or probable );"C0033204;C0205178;C0332148;C0439544;C1704787;C3897493";NA;NA;acute stent thrombosis definite or probable
 622;acute stent thrombosis;"C0205178;C3897493";NA;NA;acute stent thrombosis
 621;use of pci or thrombolysis within one day of randomization;"C0034656;C0520997;C1524063;C3844320;C4049621";NA;NA;use of pci or thrombolysis within one day of randomization
 621;thrombolysis;C0520997;NA;NA;thrombolysis
 621;pci / thrombolysis at randomization;"C0034656;C0520997;C4049621";NA;NA;pci thrombolysis at randomization
 620;treatment with open - label perindopril;"C0136123;C3640652";NA;NA;treatment with open label perindopril
 620;trandolapril ( n = $nmbr$ );C0076891;NA;NA;trandolapril n $nmbr$
 620;trandolapril;C0076891;NA;NA;trandolapril
 620;perindopril;C0136123;NA;NA;perindopril
 619;phenytoin;"C0031507;C0202454";NA;NA;phenytoin
 619;outcome and metabolizer phenotype;"C0031437;C1274040;C1285572";NA;NA;outcome and metabolizer phenotype
 619;metabolizer phenotype ( % ) §;"C0031437;C1285572";NA;NA;metabolizer phenotype
 618;genotyping;C1285573;NA;NA;genotyping
 618;by genotyping;C1285573;NA;NA;by genotyping
 617;specific syndromes;"C0039082;C0205369;C1552740;C1558916";NA;NA;specific syndromes
 617;participants without metabolic syndrome;"C0524620;C0679646";NA;NA;participants without metabolic syndrome
 617;participants with metabolic syndrome;"C0524620;C0679646";NA;NA;participants with metabolic syndrome
 617;nonmetabolic syndrome ( n = $nmbr$ );C0039082;NA;NA;nonmetabolic syndrome n $nmbr$
 617;no metabolic syndrome;C0524620;NA;NA;no metabolic syndrome
 617;ncep atp - iii metabolic syndrome features  n ( % );"C0369718;C0439070;C0441922;C0524620;C1521970;C1705160;C1706388;C2346469;C2348519;C2744579;C4552600";NA;NA;ncep atp iii metabolic syndrome features n
 617;metabolic syndromeb;"C0311400;C1524026;C2707259";NA;NA;metabolic syndromeb
 617;metabolic syndrome — no . ( % ) ^;C0524620;NA;NA;metabolic syndrome no
 617;metabolic syndrome — no . ( % ) $nmbr$;C0524620;NA;NA;metabolic syndrome no $nmbr$
 617;metabolic syndrome — no . ( % ) !;C0524620;NA;NA;metabolic syndrome no
 617;metabolic syndrome w / o t $nmbr$ dm;"C0011816;C0524620;C3250443";NA;NA;metabolic syndrome w o t $nmbr$ dm
 617;metabolic syndrome visit $nmbr$ low - density lipoprotein cholesterol strata;"C0023824;C0524620;C0545082;C1512346;C2826704";NA;NA;metabolic syndrome visit $nmbr$ low density lipoprotein cholesterol strata
 617;metabolic syndrome characteristics  n ( % );"C0524620;C1521970";NA;NA;metabolic syndrome characteristics n
 617;metabolic syndrome * n = $nmbr$;C0524620;NA;NA;metabolic syndrome n $nmbr$
 617;metabolic syndrome *;C0524620;NA;NA;metabolic syndrome
 617;metabolic syndrome ( n = $nmbr$ );C0524620;NA;NA;metabolic syndrome n $nmbr$
 617;metabolic syndrome ( > $nmbr$ of $nmbr$ characteristics );"C0524620;C1521970";NA;NA;metabolic syndrome $nmbr$ of $nmbr$ characteristics
 617;metabolic syndrome ( % ) b;C0524620;NA;NA;metabolic syndrome b
 617;metabolic syndrome ( % );C0524620;NA;NA;metabolic syndrome
 617;metabolic syndrome $nmbr$ *;C0524620;NA;NA;metabolic syndrome $nmbr$
 617;metabolic syndrome  n / n ( % ) *;C0524620;NA;NA;metabolic syndrome n n
 617;metabolic syndrome  n ( % );C0524620;NA;NA;metabolic syndrome n
 617;metabolic syndrome  ! n ( % );C0524620;NA;NA;metabolic syndrome n
 617;metabolic syndrome;C0524620;NA;NA;metabolic syndrome
 617;high - density lipoprotein cholesterol metabolic syndrome  patients were to;"C0023822;C0030705;C0040363;C0041260;C0524620;C1883351";NA;NA;high density lipoprotein cholesterol metabolic syndrome patients were to
   7;interaction p - value *;"C1704675;C1709380";NA;NA;interaction p value
   7;interaction p - value $nmbr$;"C1704675;C1709380";NA;NA;interaction p value $nmbr$
 617;changes ( a ) in metabolic syndrome parameters hdl cholesterol;"C0392747;C0443172;C0449381;C0524620;C1705241;C2357172;C4319952";NA;NA;changes a in metabolic syndrome parameters hdl cholesterol
 617;cardiovascular metabolic syndrome risk lactors;"C0007226;C0035647;C0524620;C3887460;C4552904";NA;NA;cardiovascular metabolic syndrome risk lactors
 617;cardiometabolic syndrome  ^ n ( % );C0039082;NA;NA;cardiometabolic syndrome n
 616;syncope — no . ( % );"C0039070;C3541349;C4554644";NA;NA;syncope no
 616;syncope;"C0039070;C3541349;C4554644";NA;NA;syncope
 615;systolic bp at baseline :;"C0168634;C0871470;C1442488";NA;NA;systolic bp at baseline
 615;systolic bp;C0871470;NA;NA;systolic bp
 615;systolic blood pressure subgroups;"C0488055;C0871470;C1079230;C1306620";NA;NA;systolic blood pressure subgroups
 615;systolic blood pressure ^;"C0488055;C0871470;C1306620";NA;NA;systolic blood pressure
 615;systolic blood pressure ( mmhg );"C0439475;C0488055;C0871470;C1306620";NA;NA;systolic blood pressure mmhg
 615;systolic blood pressure ( median $nmbr$ . $nmbr$ );"C0488055;C0549183;C0871470;C0876920;C1306620;C2347635;C2348144;C2939193";NA;NA;systolic blood pressure median $nmbr$ $nmbr$
 615;systolic blood pressure  mmhg;"C0439475;C0488055;C0871470;C1306620";NA;NA;systolic blood pressure mmhg
 615;systolic blood pressure  mm hq;"C0488055;C0871470;C1306620;C4330985;C4554674";NA;NA;systolic blood pressure mm hq
 615;systolic blood pressure;"C0488055;C0871470;C1306620";NA;NA;systolic blood pressure
 615;nonglycemic cardiovascular risk factors systolic blood pressure — mmhg;"C0439475;C0488055;C0850624;C0871470;C1306620";NA;NA;nonglycemic cardiovascular risk factors systolic blood pressure mmhg
 615;baseline systolic bp;"C0168634;C0871470;C1442488";NA;NA;baseline systolic bp
 614;mean systolic pressure gradient;"C0039155;C4687744";NA;NA;mean systolic pressure gradient
 613;systemic symptoms;"C0205373;C0683368;C1457887";NA;NA;systemic symptoms
 613;symptoms and feelings;"C0683368;C1457887;C1527305";NA;NA;symptoms and feelings
 613;symptoms;"C0683368;C1457887";NA;NA;symptoms
 613;symptom bother;"C1457887;C3854129";NA;NA;symptom bother
 613;symptom - free days in the past $nmbr$ weeks ( % );"C0332296;C0439228;C0677547;C1444637;C1457887;C1880497;C1996904;C2987125;C3854129;C4284302";NA;NA;symptom free days in the past $nmbr$ weeks
 613;presenting signs and symptoms;"C0220912;C0220913;C0311392;C0449450;C0683368;C1457887";NA;NA;presenting signs and symptoms
 613;placebo ( symptom days a week );"C0032042;C0332174;C0439228;C0439230;C1457887;C1696465;C1706408;C3854129";NA;NA;placebo symptom days a week
 613;number of symptom days per week;"C0237753;C0332174;C0439228;C0439230;C0449788;C1457887;C3854129";NA;NA;number of symptom days per week
 613;nocturnal symptoms in past week;"C0240526;C0683368;C1457887;C2987125";NA;NA;nocturnal symptoms in past week
 613;no symptoms;"C0683368;C1457887";NA;NA;no symptoms
 613;no . of ' signs or symptoms of chff;"C0220912;C0220913;C0311392;C0683368;C1457887";NA;NA;no of signs or symptoms of chff
 614;peak systolic pressure gradient;"C0039155;C4687747";FALSE;1919;peak systolic pressure gradient
 613;days with asthma symptoms / week;"C0004096;C0677547;C0683368;C1457887;C2984299";NA;NA;days with asthma symptoms week
 613;class i or no symptoms;"C0441885;C0683368;C1319793;C1457887;C2698967";NA;NA;class i or no symptoms
 613;class $nmbr$ or no symptoms;"C0456387;C0683368;C1457887;C1518526;C1705943";NA;NA;class $nmbr$ or no symptoms
 613;baseline symptom days perweek;"C0168634;C0439228;C1442488;C1457887;C3854129";NA;NA;baseline symptom days perweek
 613;asthma symptoms in the past $nmbr$ weeks;"C0004096;C0683368;C1457887;C2984299;C2987125";NA;NA;asthma symptoms in the past $nmbr$ weeks
 613;> $nmbr$ symptom days per week;"C0677547;C1457887;C3854129";NA;NA;$nmbr$ symptom days per week
 613;$nmbr$ to $nmbr$ symptom days per week;"C0677547;C1457887;C3854129";NA;NA;$nmbr$ to $nmbr$ symptom days per week
 613;$nmbr$ = no symptoms;"C0683368;C1457887";NA;NA;$nmbr$ no symptoms
 613;$nmbr$ = minor symptoms  no limitations;"C0026193;C0205165;C0449295;C0683368;C1457887";NA;NA;$nmbr$ minor symptoms no limitations
 612;symptom onset to hospitalization;"C0019993;C4086878";NA;NA;symptom onset to hospitalization
 612;symptom onset to hospital arrival  median ( iqr )  h;"C0019994;C0033727;C0369286;C0441932;C0549183;C0564385;C0876920;C1510665;C1555577;C1706079;C2347635;C2348144;C2939193;C4086878;C4528284";NA;NA;symptom onset to hospital arrival median iqr h
 612;symptom onset to hospital arrival  hours;"C0019994;C0439227;C1510665;C1555577;C1706079;C4086878";NA;NA;symptom onset to hospital arrival hours
 612;symptom onset to hospital admission;"C0184666;C4086878";NA;NA;symptom onset to hospital admission
 612;symptom onset - to -;C4086878;NA;NA;symptom onset to
 612;symptom onset;C4086878;NA;NA;symptom onset
 611;symptomaticb;NA;NA;NA;symptomaticb
 611;symptomatic remissionb n / n ( % );C0231220;NA;NA;symptomatic remissionb n n
 611;symptomatic padt;C0231220;NA;NA;symptomatic padt
 611;symptomatic pad;"C0182158;C0231220;C0332568;C3540603;C3669270;C3814046;C4319657";NA;NA;symptomatic pad
 611;symptomatic hypoglycaemia;"C0020615;C0231220;C4553659";NA;NA;symptomatic hypoglycaemia
 611;symptomatic deep - vein thrombosis;"C0149871;C0231220";NA;NA;symptomatic deep vein thrombosis
 611;symptomatic;C0231220;NA;NA;symptomatic
 611;history of symptomatic;"C0019664;C0019665;C0231220;C0262512;C0262926;C1705255;C2004062";NA;NA;history of symptomatic
 610;dpp ‐ $nmbr$ inhibitors;"C0243077;C1414174";NA;NA;dpp $nmbr$ inhibitors
 610;dpp - $nmbr$ inhibitors;"C0243077;C1414174";NA;NA;dpp $nmbr$ inhibitors
 610;dpp - $nmbr$ inhibitor therapy;"C0039798;C0087111;C1363945;C1414174;C1999216";NA;NA;dpp $nmbr$ inhibitor therapy
 610;dpp - $nmbr$ inhibitor;"C1414174;C1999216";NA;NA;dpp $nmbr$ inhibitor
 610;dpp - $nmbr$;C1414174;NA;NA;dpp $nmbr$
 609;cyp $nmbr$ a $nmbr$ inhibitors;"C0243077;C1418793;C2634343";NA;NA;cyp $nmbr$ a $nmbr$ inhibitors
 609;cyp $nmbr$ a $nmbr$;"C1418793;C2634343";NA;NA;cyp $nmbr$ a $nmbr$
 608;treatment with any bp lowering drugs;"C0037623;C0441994;C1415692;C1708288;C2003888;C3469597;C4318478";NA;NA;treatment with any bp lowering drugs
 608;syst . bp ( mmhg );"C0037623;C0439475;C1415692;C1708288;C4318478";NA;NA;syst bp mmhg
 608;patientswith bp $ $nmbr$ / $nmbr$ mmhg ( abpm ) at baseline  nt;"C0037623;C0168634;C0332126;C0439475;C1415692;C1442488;C1449832;C1708288;C3889152;C4050156;C4283901;C4284038;C4318478";NA;NA;patientswith bp $ $nmbr$ $nmbr$ mmhg abpm at baseline nt
 608;patientswith bp  $nmbr$ / $nmbr$ mmhg ( abpm ) at baseline  n §;"C0037623;C0168634;C0439475;C1415692;C1442488;C1708288;C4318478";NA;NA;patientswith bp $nmbr$ $nmbr$ mmhg abpm at baseline n
 608;patients with bp $ $nmbr$ / $nmbr$ mmhg ( abpm ) at baseline  nt;"C0030705;C0037623;C0168634;C0332126;C0439475;C1415692;C1442488;C1449832;C1708288;C3889152;C4050156;C4283901;C4284038;C4318478";NA;NA;patients with bp $ $nmbr$ $nmbr$ mmhg abpm at baseline nt
 608;other bp drug;"C0013227;C0037623;C1254351;C1415692;C1708288;C4318478";NA;NA;other bp drug
 608;on bp medication  n ( % );"C0013227;C0037623;C1415692;C1708288;C3244316;C4284232;C4318478";NA;NA;on bp medication n
 608;intensive bp lowering  < $nmbr$ mm hg ( n = $nmbr$ );"C0037623;C0162425;C0439475;C0441994;C0522510;C1283828;C1415692;C1550453;C1708288;C2003888;C4318478";NA;NA;intensive bp lowering $nmbr$ mm hg n $nmbr$
 608;hba $nmbr$ c < $nmbr$ . $nmbr$ %  bp < $nmbr$ / $nmbr$ mm hg  ldl - c < $nmbr$ mg / dl;"C0019016;C0037623;C0439269;C0439475;C1415692;C1708288;C1825777;C3538758;C4318478";NA;NA;hba $nmbr$ c $nmbr$ $nmbr$ bp $nmbr$ $nmbr$ mm hg ldl c $nmbr$ mg dl
 608;bp variable  mm hg;"C0037623;C0439475;C0439828;C1415692;C1708288;C4318478;C4553760";NA;NA;bp variable mm hg
 608;bp in pre - treated patients;"C0030705;C0037623;C0332152;C0740175;C1415692;C1522326;C1708288;C2257086;C3669034;C4318478";NA;NA;bp in pre treated patients
 608;bp goal at week $nmbr$;"C0018017;C0037623;C0332174;C0439230;C1415692;C1571704;C1708288;C4318478";NA;NA;bp goal at week $nmbr$
 608;bp goal  no . ( % );"C0018017;C0037623;C1415692;C1571704;C1708288;C4318478";NA;NA;bp goal no
 608;bp component ( mm hg );"C0037623;C0439475;C0449432;C1415692;C1705248;C1708288;C4318478";NA;NA;bp component mm hg
 608;bp and fasting glucose results;"C0015663;C0017725;C0037623;C1274040;C1415692;C1546471;C1708288;C2825142;C4318478";NA;NA;bp and fasting glucose results
 608;bp < $nmbr$ / $nmbr$  n ( % );"C0037623;C1415692;C1708288;C4318478";NA;NA;bp $nmbr$ $nmbr$ n
 608;bp - lowering treatments  n ( % );"C0037623;C0087111;C0441994;C1415692;C1708288;C2003888;C4318478";NA;NA;bp lowering treatments n
 608;bp - lowering treatment ( n = $nmbr$ );"C0037623;C0039798;C0087111;C0441994;C1415692;C1522326;C1533734;C1705169;C1708288;C2003888;C3538994;C3887704;C4318478";NA;NA;bp lowering treatment n $nmbr$
 608;any bp - lowering agents ^;"C0037623;C0441994;C0450442;C1254351;C1415692;C1521826;C1708288;C2003888;C4318478";NA;NA;any bp lowering agents
 607;trough seated sbp ( mmhg ) a;"C0085805;C0277814;C0439475;C0444506;C1283233";NA;NA;trough seated sbp mmhg a
 607;seated sbp at $nmbr$ weeks  mmhg + * *;"C0085805;C0277814;C0439230;C0439475;C1283233";NA;NA;seated sbp at $nmbr$ weeks mmhg
 607;seated sbp at $nmbr$ weeks  mmhg +;"C0085805;C0277814;C0439230;C0439475;C1283233";NA;NA;seated sbp at $nmbr$ weeks mmhg
 607;sd of sbp;"C0085805;C2699239";NA;NA;sd of sbp
 607;sbp ≥ $nmbr$ mmhg;"C0085805;C0439475";NA;NA;sbp $nmbr$ mmhg
 607;sbp during the follow - up period ( mmhg );"C0085805;C0439475;C0439531;C0589120;C1522577;C1704685;C1948053;C3274571";NA;NA;sbp during the follow up period mmhg
 607;sbp > $nmbr$ mmhg or dbp > $nmbr$ mmhg;"C0085805;C0439475;C0536221;C3813197;C4281799";NA;NA;sbp $nmbr$ mmhg or dbp $nmbr$ mmhg
 607;sbp > $nmbr$ mmhg n = $nmbr$;"C0085805;C0439475";NA;NA;sbp $nmbr$ mmhg n $nmbr$
 607;sbp > $nmbr$ mmhg and / or dbp > $nmbr$ mmhg;"C0085805;C0439475;C0536221;C3813197;C4281799";NA;NA;sbp $nmbr$ mmhg and or dbp $nmbr$ mmhg
 607;sbp > $nmbr$ mmhg;"C0085805;C0439475";NA;NA;sbp $nmbr$ mmhg
 607;sbp > $nmbr$ mm hg and / or dbp > $nmbr$ mm hg $nmbr$ / $nmbr$;"C0085805;C0439475;C0536221;C3813197;C4281799";NA;NA;sbp $nmbr$ mm hg and or dbp $nmbr$ mm hg $nmbr$ $nmbr$
 607;sbp < $nmbr$ mmhg n = $nmbr$;"C0085805;C0439475";NA;NA;sbp $nmbr$ mmhg n $nmbr$
 607;sbp < $nmbr$ mmhg and dbp < $nmbr$ mmhg;"C0085805;C0439475;C0536221;C3813197;C4281799";NA;NA;sbp $nmbr$ mmhg and dbp $nmbr$ mmhg
 607;sbp < $nmbr$ mmhg;"C0085805;C0439475";NA;NA;sbp $nmbr$ mmhg
 607;sbp < $nmbr$ mm hg and dbp < $nmbr$ mm hg $nmbr$ / $nmbr$;"C0085805;C0439475;C0536221;C3813197;C4281799";NA;NA;sbp $nmbr$ mm hg and dbp $nmbr$ mm hg $nmbr$ $nmbr$
 607;sbp / dbp ( mmhg );"C0085805;C0439475;C0536221;C3813197;C4281799";NA;NA;sbp dbp mmhg
 607;sbp / dbp $ $nmbr$ / $ $nmbr$ mmhg;"C0085805;C0439475;C0536221;C3813197;C4281799";NA;NA;sbp dbp $ $nmbr$ $ $nmbr$ mmhg
 607;sbp . mean ( sd ) mm hg;"C0085805;C0439475;C0444504;C2347634;C2348143;C2699239";NA;NA;sbp mean sd mm hg
 607;sbp ( sd )  mm   hg;"C0085805;C0439475;C2699239";NA;NA;sbp sd mm hg
 607;sbp ( sd );"C0085805;C2699239";NA;NA;sbp sd
 607;sbp ( office measurement )  mmhg;"C0085805;C0242485;C0439475;C0442603";NA;NA;sbp office measurement mmhg
 607;sbp ( mmhg ) < $nmbr$;"C0085805;C0439475";NA;NA;sbp mmhg $nmbr$
 607;sbp ( mmhg ) *;"C0085805;C0439475";NA;NA;sbp mmhg
 607;sbp ( mmhg );"C0085805;C0439475";NA;NA;sbp mmhg
 607;sbp ( mm hg );"C0085805;C0439475";NA;NA;sbp mm hg
 330;other / multiple;C0439064;NA;NA;other multiple
 607;sbp ( mean over $nmbr$ h )  mmhg;"C0033727;C0085805;C0369286;C0439475;C0441932;C0444504;C0564385;C2347634;C2348143;C4528284";NA;NA;sbp mean over $nmbr$ h mmhg
 607;sbp  systolic blood pressure  sd  standard deviation  dbp  diastolic blood pressure  b . p . m .  beats per minute  mi  myocardial infarction  tia  transient ischaemic attack .;"C0007787;C0027051;C0085805;C0369637;C0428883;C0439385;C0441923;C0488055;C0871420;C0871470;C1306620;C2699239";NA;NA;sbp systolic blood pressure sd standard deviation dbp diastolic blood pressure b p m beats per minute mi myocardial infarction tia transient ischaemic attack
 607;sbp  mmhg;"C0085805;C0439475";NA;NA;sbp mmhg
 607;sbp  mm   hg ( sd );"C0085805;C0439475;C2699239";NA;NA;sbp mm hg sd
 607;sbp  mm   hg;"C0085805;C0439475";NA;NA;sbp mm hg
 607;sbp  mm hg ( office measurement )  mean ( sd );"C0085805;C0242485;C0439475;C0442603;C0444504;C2347634;C2348143;C2699239";NA;NA;sbp mm hg office measurement mean sd
 607;sbp  mean ( sd ) mm hg;"C0085805;C0439475;C0444504;C2347634;C2348143;C2699239";NA;NA;sbp mean sd mm hg
 607;sbp  mean ( sd )  mm hg;"C0085805;C0439475;C0444504;C2347634;C2348143;C2699239";NA;NA;sbp mean sd mm hg
 607;sbp  last;"C0085805;C1517741";NA;NA;sbp last
 607;sbp;C0085805;NA;NA;sbp
 607;nighttime mean sbp ( abpm ) at week $nmbr$  mmhg;"C0085805;C0240526;C0332174;C0439230;C0439475;C0444504;C2347634;C2348143";NA;NA;nighttime mean sbp abpm at week $nmbr$ mmhg
 607;mean sitting sbp ( mmhg );"C0085805;C0277814;C0439475;C0444504;C2347634;C2348143;C2584297;C4050224";NA;NA;mean sitting sbp mmhg
 607;mean change in sbp from baseline  mmhg  mean ( sd );"C0085805;C0168634;C0392747;C0439475;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C2699239;C4319952";NA;NA;mean change in sbp from baseline mmhg mean sd
 607;daytime mean sbp ( abpm ) at week $nmbr$  mmhg;"C0085805;C0332169;C0332174;C0439230;C0439475;C0444504;C2347634;C2348143";NA;NA;daytime mean sbp abpm at week $nmbr$ mmhg
 607;change in sbp;"C0085805;C0392747;C0443172;C1705241;C4319952";NA;NA;change in sbp
 607;change from baseline in mean $nmbr$ - h sbp  mmhg;"C0033727;C0085805;C0168634;C0369286;C0392747;C0439475;C0441932;C0443172;C0444504;C0564385;C1442488;C1705241;C2347634;C2348143;C4319952;C4528284";NA;NA;change from baseline in mean $nmbr$ h sbp mmhg
 607;baseline sbp  mean ± sd  mm hg;"C0085805;C0168634;C0439475;C0444504;C1442488;C2347634;C2348143;C2699239";NA;NA;baseline sbp mean sd mm hg
 607;baseline mean seated sbp  mm hg ( sd );"C0085805;C0168634;C0277814;C0439475;C0444504;C1283233;C1442488;C2347634;C2348143;C2699239";NA;NA;baseline mean seated sbp mm hg sd
 607;baseline mean ambulatory sbp  mm hg ( sd ) *;"C0085805;C0168634;C0439475;C0439841;C0444504;C1442488;C2347634;C2348143;C2699239";NA;NA;baseline mean ambulatory sbp mm hg sd
 607;$nmbr$ < sbp < $nmbr$ mmhg n = $nmbr$;"C0085805;C0439475";NA;NA;$nmbr$ sbp $nmbr$ mmhg n $nmbr$
 606;tbp;NA;NA;NA;tbp
 606;sbp at baseline;"C0085805;C0168634;C1442488";NA;NA;sbp at baseline
 606;sbp  baseline;"C0085805;C0168634;C1442488";NA;NA;sbp baseline
 606;nbp;NA;NA;NA;nbp
 606;baseline tbp;"C0168634;C1442488";NA;NA;baseline tbp
 606;baseline sbp { p = o - $nmbr$ );"C0085805;C0168634;C1442488";NA;NA;baseline sbp p o $nmbr$
 606;baseline sbp;"C0085805;C0168634;C1442488";NA;NA;baseline sbp
 606;baseline nbp;"C0168634;C1442488";NA;NA;baseline nbp
 606;baseline $nmbr$ - hour mean sbp  mm hg;"C0085805;C0168634;C0439227;C0439475;C0444504;C0564385;C1442488;C2347634;C2348143";NA;NA;baseline $nmbr$ hour mean sbp mm hg
 606;adjusted for all baseline variables  interaction between acei and baseline up  and declines in sbp and up;"C0085805;C0168634;C0439828;C0456081;C1442488;C1704675";NA;NA;adjusted for all baseline variables interaction between acei and baseline up and declines in sbp and up
 605;visit $nmbr$ dbp  mm hg;"C0439475;C0536221;C0545082;C1512346;C2826704;C3813197;C4281799";NA;NA;visit $nmbr$ dbp mm hg
 605;trough seated dbp ( mmhg ) a;"C0277814;C0439475;C0444506;C0536221;C1283233;C3813197;C4281799";NA;NA;trough seated dbp mmhg a
 605;seated dbp  mean ( sd )  mmhg;"C0277814;C0439475;C0444504;C0536221;C1283233;C2347634;C2348143;C2699239;C3813197;C4281799";NA;NA;seated dbp mean sd mmhg
 605;sbp / dbp mean;"C0085805;C0444504;C0536221;C2347634;C2348143;C3813197;C4281799";NA;NA;sbp dbp mean
 605;mean sitting dbp ( mmhg );"C0277814;C0439475;C0444504;C0536221;C2347634;C2348143;C2584297;C3813197;C4050224;C4281799";NA;NA;mean sitting dbp mmhg
 605;mean $nmbr$ - h dbp +;"C0033727;C0369286;C0441932;C0444504;C0536221;C0564385;C2347634;C2348143;C3813197;C4281799;C4528284";NA;NA;mean $nmbr$ h dbp
 605;dbp ≥ $nmbr$ mmhg;"C0439475;C0536221;C3813197;C4281799";NA;NA;dbp $nmbr$ mmhg
 605;dbp mm hg;"C0439475;C0536221;C3813197;C4281799";NA;NA;dbp mm hg
 605;dbp during the follow - up period ( mmhg );"C0439475;C0439531;C0536221;C0589120;C1522577;C1704685;C1948053;C3274571;C3813197;C4281799";NA;NA;dbp during the follow up period mmhg
 605;dbp < $nmbr$ mmhg;"C0439475;C0536221;C3813197;C4281799";NA;NA;dbp $nmbr$ mmhg
 605;dbp . mean ( sd ) mm hg;"C0439475;C0444504;C0536221;C2347634;C2348143;C2699239;C3813197;C4281799";NA;NA;dbp mean sd mm hg
 605;dbp ( sd )  mm   hg;"C0439475;C0536221;C2699239;C3813197;C4281799";NA;NA;dbp sd mm hg
 605;dbp ( sd );"C0536221;C2699239;C3813197;C4281799";NA;NA;dbp sd
 605;dbp ( office measurement )  mmhg;"C0242485;C0439475;C0442603;C0536221;C3813197;C4281799";NA;NA;dbp office measurement mmhg
 605;dbp ( mmhg )  mean ( sd );"C0439475;C0444504;C0536221;C2347634;C2348143;C2699239;C3813197;C4281799";NA;NA;dbp mmhg mean sd
 605;dbp ( mmhg );"C0439475;C0536221;C3813197;C4281799";NA;NA;dbp mmhg
 605;dbp ( mmghg )  mean ( sd );"C0444504;C0536221;C2347634;C2348143;C2699239;C3813197;C4281799";NA;NA;dbp mmghg mean sd
 605;dbp ( mm hg )  median ( iqr );"C0439475;C0536221;C0549183;C0876920;C2347635;C2348144;C2939193;C3813197;C4281799";NA;NA;dbp mm hg median iqr
 605;dbp ( mm hg );"C0439475;C0536221;C3813197;C4281799";NA;NA;dbp mm hg
 605;dbp ( mean over $nmbr$ h )  mmhg;"C0033727;C0369286;C0439475;C0441932;C0444504;C0536221;C0564385;C2347634;C2348143;C3813197;C4281799;C4528284";NA;NA;dbp mean over $nmbr$ h mmhg
 605;dbp  mmhg;"C0439475;C0536221;C3813197;C4281799";NA;NA;dbp mmhg
 605;dbp  mm   hg ( sd );"C0439475;C0536221;C2699239;C3813197;C4281799";NA;NA;dbp mm hg sd
 605;dbp  mm   hg;"C0439475;C0536221;C3813197;C4281799";NA;NA;dbp mm hg
 605;dbp  mm hg ( office measurement )  mean ( sd );"C0242485;C0439475;C0442603;C0444504;C0536221;C2347634;C2348143;C2699239;C3813197;C4281799";NA;NA;dbp mm hg office measurement mean sd
 605;dbp  mm hg ( mean $nmbr$ h )  mean ( sd );"C0025424;C0428257;C0444504;C0456680;C0536221;C2347108;C2347109;C2347634;C2348143;C2348272;C2699239;C3813197;C4281799";NA;NA;dbp mm hg mean $nmbr$ h mean sd
 605;dbp  mm hg  mean ± sdc;"C0439475;C0444504;C0536221;C1419891;C2347634;C2348143;C3273112;C3813197;C4281799";NA;NA;dbp mm hg mean sdc
 605;dbp  mm hg;"C0439475;C0536221;C3813197;C4281799";NA;NA;dbp mm hg
 605;dbp  mean ± sd ( mmhg );"C0439475;C0444504;C0536221;C2347634;C2348143;C2699239;C3813197;C4281799";NA;NA;dbp mean sd mmhg
 605;dbp  mean ( sd ) mm hg;"C0439475;C0444504;C0536221;C2347634;C2348143;C2699239;C3813197;C4281799";NA;NA;dbp mean sd mm hg
 605;dbp  mean ( sd )  mmhg;"C0439475;C0444504;C0536221;C2347634;C2348143;C2699239;C3813197;C4281799";NA;NA;dbp mean sd mmhg
 605;dbp  mean ( sd )  mm hg glycaemic parameters;"C0005802;C0439475;C0444504;C0449381;C0536221;C2347634;C2348143;C2699239;C3813197;C4281799";NA;NA;dbp mean sd mm hg glycaemic parameters
 605;dbp  mean ( sd )  mm hg;"C0439475;C0444504;C0536221;C2347634;C2348143;C2699239;C3813197;C4281799";NA;NA;dbp mean sd mm hg
 605;dbp  mean ( sd );"C0444504;C0536221;C2347634;C2348143;C2699239;C3813197;C4281799";NA;NA;dbp mean sd
 605;dbp;"C0536221;C3813197;C4281799";NA;NA;dbp
 605;change from baseline in mean $nmbr$ - h dbp  mmhg;"C0033727;C0168634;C0369286;C0392747;C0439475;C0441932;C0443172;C0444504;C0536221;C0564385;C1442488;C1705241;C2347634;C2348143;C3813197;C4281799;C4319952;C4528284";NA;NA;change from baseline in mean $nmbr$ h dbp mmhg
 605;baseline sitting dbp  * mm hg;"C0168634;C0277814;C0439475;C0536221;C1442488;C2584297;C3813197;C4050224;C4281799";NA;NA;baseline sitting dbp mm hg
 605;baseline dbp ( mm hg );"C0168634;C0439475;C0536221;C1442488;C3813197;C4281799";NA;NA;baseline dbp mm hg
 605;baseline dbp  mean ± sd  mm hg;"C0168634;C0439475;C0444504;C0536221;C1442488;C2347634;C2348143;C2699239;C3813197;C4281799";NA;NA;baseline dbp mean sd mm hg
 605;baseline dbp;"C0168634;C0536221;C1442488;C3813197;C4281799";NA;NA;baseline dbp
 604;type of treatment  n ( % );C0455708;NA;NA;type of treatment n
 604;type of intervention;C3274412;NA;NA;type of intervention
 604;type of index event — no . ( % );"C0600653;C0918012;C1552854;C1561488;C1637833;C2986546";NA;NA;type of index event no
 604;type of hospitalization;C3177060;NA;NA;type of hospitalization
 604;type of event — no . ( % );C1561488;NA;NA;type of event no
 604;type of event :;C1561488;NA;NA;type of event
 604;type of event;C1561488;NA;NA;type of event
 604;initial type of heparin treatment received;"C0019134;C0205265;C0455708;C0770546;C1279901;C1514756;C1555582;C1705685";NA;NA;initial type of heparin treatment received
 604;hope ( n = $nmbr$ );C0392347;NA;NA;hope n $nmbr$
 603;type of stent at index procedure;"C0038257;C0184661;C0332307;C0600653;C0918012;C1547052;C1552854;C1637833;C2700391;C2986546;C3274430;C3539779";NA;NA;type of stent at index procedure
 603;type of lipid - lowering regimen;"C0023779;C0040808;C0332307;C0441994;C1547052;C2003888;C2945654";NA;NA;type of lipid lowering regimen
 603;type of hospital care;"C0259945;C0332307;C1547052";NA;NA;type of hospital care
 603;type of end point;"C0332307;C1547052;C2349179;C2826544";NA;NA;type of end point
 603;type of des at index procedure;"C0011702;C0184661;C0332307;C0600653;C0918012;C1547052;C1552854;C1637833;C2700391;C2986546;C3274430;C3539779;C4551552";NA;NA;type of des at index procedure
 603;type of des;"C0011702;C0332307;C1547052;C4551552";NA;NA;type of des
 603;type of af  n ( % );"C0332307;C0344434;C1547052;C4049859";NA;NA;type of af n
 603;type of af;"C0332307;C0344434;C1547052;C4049859";NA;NA;type of af
 603;type / no . of valves repaired / replaced mitral;"C0184252;C0205340;C0332307;C0559956;C0746591;C1186983;C1299987;C1547052";NA;NA;type no of valves repaired replaced mitral
 603;type $nmbr$  n ( % );"C0332307;C1547052";NA;NA;type $nmbr$ n
 603;type;"C0332307;C1547052";NA;NA;type
 603;stent type implanted;"C0021102;C0038257;C0332307;C1547052;C2828363";NA;NA;stent type implanted
 603;stent type;"C0038257;C0332307;C1547052";NA;NA;stent type
 334;> $nmbr$ enroll;NA;NA;NA;$nmbr$ enroll
 603;predominant type of heparin;"C0019134;C0332307;C0770546;C1542147;C1547052";NA;NA;predominant type of heparin
 603;phosphodiesterase type $nmbr$ inhibitors;"C0031638;C0332307;C1547052;C1656262;C3539996";NA;NA;phosphodiesterase type $nmbr$ inhibitors
 603;outcome type;"C0332307;C1274040;C1547052";NA;NA;outcome type
 603;des type;"C0011702;C0332307;C1547052;C4551552";NA;NA;des type
 603;cardiac surgery type;"C0018821;C0332307;C0524727;C1547052";NA;NA;cardiac surgery type
 603;af type — no . ( % );"C0332307;C0344434;C1547052;C4049859";NA;NA;af type no
 603;af type;"C0332307;C0344434;C1547052;C4049859";NA;NA;af type
 603;acs type;"C0332307;C0742343;C1547052;C4318612";NA;NA;acs type
 603;> $nmbr$ type;"C0332307;C1547052";NA;NA;$nmbr$ type
 603;> $nmbr$ des type;"C0011702;C0332307;C1547052;C4551552";NA;NA;$nmbr$ des type
 602;known prothrombotic genotype;"C0017431;C0205309";NA;NA;known prothrombotic genotype
 602;haplotype;C0018591;NA;NA;haplotype
 602;gentype;NA;NA;NA;gentype
 602;genotype;C0017431;NA;NA;genotype
 601;eastern european;C0239309;NA;NA;eastern european
 601;eastern europe and africa;"C0001737;C0015177";NA;NA;eastern europe and africa
 601;eastern europe ( n   = $nmbr$  $nmbr$ );C0015177;NA;NA;eastern europe n $nmbr$ $nmbr$
 601;eastern europe ( n = $nmbr$ );C0015177;NA;NA;eastern europe n $nmbr$
 601;eastern europe ( % );C0015177;NA;NA;eastern europe
 601;eastern europe  africa;"C0001737;C0001741;C0015176;C0015177";NA;NA;eastern europe africa
 601;eastern europe;C0015177;NA;NA;eastern europe
 601;central and eastern europe;"C0015177;C0205099;C1879652";NA;NA;central and eastern europe
 600;western friroce;C1705493;NA;NA;western friroce
 600;western;C1705493;NA;NA;western
 600;west europe;"C0015176;C1705493";NA;NA;west europe
 599;western europe plus other;"C0043129;C0332287";NA;NA;western europe plus other
 599;western europe and other;C0043129;NA;NA;western europe and other
 599;western europe and lebanon;"C0023190;C0043129";NA;NA;western europe and lebanon
 599;western europe ( n   = $nmbr$  $nmbr$ );C0043129;NA;NA;western europe n $nmbr$ $nmbr$
 599;western europe ( n = $nmbr$ );C0043129;NA;NA;western europe n $nmbr$
 599;western europe ( including south africa );"C0037712;C0043129;C0332257";NA;NA;western europe including south africa
 599;western europe ( % );C0043129;NA;NA;western europe
 599;western europe  australia  new zealand  middle east;"C0026068;C0043129;C4289954";NA;NA;western europe australia new zealand middle east
 599;western europe  australia  new zealand  and middle east;"C0026068;C0043129;C4289954";NA;NA;western europe australia new zealand and middle east
 599;western europe  australia  new zealand;"C0043129;C4289954";NA;NA;western europe australia new zealand
 599;western europe;C0043129;NA;NA;western europe
 598;without previous surgery;"C0038894;C0038895;C0205156;C0543467;C1274039;C1552607";NA;NA;without previous surgery
 598;with previous surgery;"C0038894;C0038895;C0205156;C0543467;C1274039;C1552607";NA;NA;with previous surgery
 598;valve surgery  n ( % );"C0038894;C0038895;C0184252;C0543467;C1186983;C1274039;C1704414;C3888056";NA;NA;valve surgery n
 598;type of surgery cabg;"C0010055;C0038894;C0038895;C0332307;C0543467;C1274039;C1547052";NA;NA;type of surgery cabg
 598;type of surgery;"C0038894;C0038895;C0332307;C0543467;C1274039;C1547052";NA;NA;type of surgery
 598;surgery;"C0038894;C0038895;C0543467;C1274039";NA;NA;surgery
 598;recent surgery or trauma;"C0038894;C0038895;C0043251;C0332185;C0543467;C1274039;C1510467;C3263723;C3714660;C4049136";NA;NA;recent surgery or trauma
 598;prior pci or cabg surgery;"C0010055;C0038894;C0038895;C0332152;C0543467;C1274039;C2826257;C4049621";NA;NA;prior pci or cabg surgery
 598;planned valve surgery  n ( % );"C0038894;C0038895;C0184252;C0543467;C1186983;C1274039;C1301732;C1704414;C3888056";NA;NA;planned valve surgery n
 598;operative procedure;"C0543467;C0677612";NA;NA;operative procedure
 598;no previous cd related surgery $nmbr$;"C0007928;C0034283;C0038894;C0038895;C0205156;C0439849;C0445223;C0543467;C1274039;C1552607;C4552032";NA;NA;no previous cd related surgery $nmbr$
 598;interventional or surgical procedures;"C0184661;C0543467;C3274035";NA;NA;interventional or surgical procedures
 598;diuretic — no . ( % ) surgery;"C0012798;C0038894;C0038895;C0543467;C1274039";NA;NA;diuretic no surgery
 598;crohn ’ s disease related surgery;"C0010346;C0038894;C0038895;C0439849;C0445223;C0543467;C1274039";NA;NA;crohn s disease related surgery
 598;cardiac valve surgery : no ( n = $nmbr$ );"C0018821;C0018826;C0038894;C0038895;C0184252;C0369718;C0441922;C0524727;C0543467;C1186983;C1274039;C1704414;C3888056";NA;NA;cardiac valve surgery no n $nmbr$
 597;study eye characteristics;"C0015392;C0700042;C1568011";NA;NA;study eye characteristics
 597;microvascular eye diseased;"C0015392;C0443258;C0700042";NA;NA;microvascular eye diseased
 306;men  n ( % ) *;C0025266;FALSE;1842;men n
 603;type of concomitant statin by daily dose - no . ( % );"C0332307;C0360714;C0521115;C1547052;C2348070";FALSE; 872;type of concomitant statin by daily dose no
 603;type of concomitant statin by daily dose;"C0332307;C0360714;C0521115;C1547052;C2348070";FALSE; 872;type of concomitant statin by daily dose
 598;cabg surgery;"C0010055;C0038894;C0038895;C0543467;C1274039";FALSE; 389;cabg surgery
 596;major diabetic eye disease  n ( % );"C0205082;C0205164;C0342245;C4318856;C4521762";NA;NA;major diabetic eye disease n
 596;diabetic eye disease;C0342245;NA;NA;diabetic eye disease
 595;edge ii;"C0205154;C1710602;C2697523;C4082587";NA;NA;edge ii
 595;edge;"C0205154;C2697523";NA;NA;edge
 594;sertraline;"C0074393;C0524265";NA;NA;sertraline
 594;postbaseline binding antibodies;"C0003241;C1145667;C1167622";NA;NA;postbaseline binding antibodies
 594;femoralneck t - scorebybaselinevfxstatus;NA;NA;NA;femoralneck t scorebybaselinevfxstatus
 593;postprandial indices;"C0376674;C4033634";NA;NA;postprandial indices
 593;$nmbr$ - h postprandial c - peptide ( ng / ml );"C0006558;C0376674;C2827809";NA;NA;$nmbr$ h postprandial c peptide ng ml
 592;treatment by egfr stage;"C0815181;C1739039;C3811844;C3812682";NA;NA;treatment by egfr stage
 592;sustained decrease of > $nmbr$ % in egfr ®;"C0392756;C0443318;C0547047;C1739039;C3811844;C3812682";NA;NA;sustained decrease of $nmbr$ in egfr
 592;stage $nmbr$ ckd egfr > $nmbr$ ml / ( n = $nmbr$ );"C0205390;C0439526;C1300072;C1306673;C1561643;C1705224;C1739039;C3811844;C3812682;C3887665";NA;NA;stage $nmbr$ ckd egfr $nmbr$ ml n $nmbr$
 592;normal or increased egfr;"C0205217;C0205307;C0231683;C0439166;C0442805;C1739039;C2347086;C3811844;C3812682;C4553972";NA;NA;normal or increased egfr
 592;normal egfr ( $nmbr$ < egfr < $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$ ) at baseline to high egfr ( > $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$ );"C0168634;C0205250;C0205307;C0231683;C0369637;C0439166;C0439445;C0441923;C1299351;C1442488;C1739039;C2347086;C2700149;C3811844;C3812682;C3887512;C3889660;C4321237;C4522209;C4553972";NA;NA;normal egfr $nmbr$ egfr $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$ at baseline to high egfr $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$
 592;normal ( egfr ≥ $nmbr$ )  n ( % );"C0205307;C0231683;C0439166;C1739039;C2347086;C3811844;C3812682;C4553972";NA;NA;normal egfr $nmbr$ n
 592;normal ( egfr > $nmbr$ );"C0205307;C0231683;C0439166;C1739039;C2347086;C3811844;C3812682;C4553972";NA;NA;normal egfr $nmbr$
 592;moderate impairment ( egfr $nmbr$ – $nmbr$ )  n ( % );"C0205081;C0221099;C0684336;C1739039;C1881878;C3811844;C3812682;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate impairment egfr $nmbr$ $nmbr$ n
 592;moderate impairment ( egfr $nmbr$ - $nmbr$ ml / min / m ^ );"C0205081;C0221099;C0369637;C0439445;C0441923;C0684336;C1739039;C1881878;C3811844;C3812682;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate impairment egfr $nmbr$ $nmbr$ ml min m
 592;moderate impairment ( egfr $nmbr$ - $nmbr$ );"C0205081;C0221099;C0684336;C1739039;C1881878;C3811844;C3812682;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate impairment egfr $nmbr$ $nmbr$
 592;moderate / severe reduction in egfr;"C0205081;C0205082;C0301630;C0392756;C1293152;C1739039;C1881878;C3811844;C3812682;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335;C4551656";NA;NA;moderate severe reduction in egfr
 334;< $nmbr$ enroll;NA;NA;NA;$nmbr$ enroll
 592;mild reduction in egfr;"C0301630;C0392756;C1293152;C1739039;C2945599;C3811844;C3812682;C4551656";NA;NA;mild reduction in egfr
 592;mdrd egfr geometric mean ( cv % )  a  b ml /;"C0439526;C1705224;C1739039;C2986759;C3538987;C3811844;C3812682;C3839656;C3887665;C4048877;C4318503";NA;NA;mdrd egfr geometric mean cv a b ml
 592;estimated glomerular filtration rate — no . ( % );C3811844;NA;NA;estimated glomerular filtration rate no
 592;estimated glomerular filtration rate - no . ( % ) : :;C3811844;NA;NA;estimated glomerular filtration rate no
 592;estimated glomerular filtration rate;C3811844;NA;NA;estimated glomerular filtration rate
 592;egfr ≥ $nmbr$ ml / min per $nmbr$ · $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";NA;NA;egfr $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$
 592;egfr ≥ $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ ( n = $nmbr$ );"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";NA;NA;egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ n $nmbr$
 592;egfr ≥ $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";NA;NA;egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 592;egfr ‡ ( ml / min per $nmbr$ · $nmbr$ m $nmbr$ );"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";NA;NA;egfr ml min per $nmbr$ $nmbr$ m $nmbr$
 592;egfr   ≥ $nmbr$   ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";NA;NA;egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 592;egfr   < $nmbr$   ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";NA;NA;egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 592;egfr using cg / mdrd formulae  % of patients;"C0012164;C0030705;C0043444;C0489829;C1524063;C1567075;C1705501;C1739039;C3540479;C3811844;C3812682;C3839656";NA;NA;egfr using cg mdrd formulae of patients
 592;egfr s $nmbr$ o ml / min / $nmbr$ . $nmbr$ m ^;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";NA;NA;egfr s $nmbr$ o ml min $nmbr$ $nmbr$ m
 592;egfr s $nmbr$ ml / min / $nmbr$ . $nmbr$ m ^;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";NA;NA;egfr s $nmbr$ ml min $nmbr$ $nmbr$ m
 592;egfr category ( ml / min / $nmbr$ . $nmbr$ m $nmbr$ )  n ( % );"C0369637;C0439445;C0441923;C0683312;C1739039;C3811844;C3812682;C3889287";NA;NA;egfr category ml min $nmbr$ $nmbr$ m $nmbr$ n
 592;egfr category  n ( % );"C0683312;C1739039;C3811844;C3812682;C3889287";NA;NA;egfr category n
 592;egfr category;"C0683312;C1739039;C3811844;C3812682;C3889287";NA;NA;egfr category
 592;egfr and albuminuria;"C0001925;C1739039;C3811844;C3812682";NA;NA;egfr and albuminuria
  28;abbreviations : ace  angiotensin - converting enzyme  bmi  body mass index ( calculated as weight in kilograms divided by height in meters squared )  dm  diabetes mellitus  hba $nmbr$ c  hemoglobin a $nmbr$ c  hmg - coa  $nmbr$ - hydroxy - $nmbr$ - methylglutaryl coenzyme a . asome subjects took more than $nmbr$ oral anti - dm drug in addition to metformin  and thus the total number of concomitant oral anti - dm drugs in the columns exceed the “ n ” values in the colesevelam hydrochloride and placebo group headings . bsulfonylureas include chlorpropamide  glibenclamide  glimepiride  glipizide  and tolazamide . cthiazolidinediones include pioglitazone  pioglitazone hydrochloride  rosiglitazone  and rosiglitazone maleate . d - glucosidase inhibitors include acarbose or miglitol .;"C0000723;C0005910;C0008287;C0009226;C0011816;C0011849;C0013227;C0017628;C0017642;C0019016;C0019046;C0022709;C0025598;C0029167;C0032042;C0040372;C0042295;C0043100;C0050393;C0061323;C0066535;C0073187;C0175795;C0205120;C0205172;C0289313;C0304289;C0332173;C0332257;C0332287;C0332849;C0369718;C0439209;C0441074;C0441833;C0441922;C0442027;C0444686;C0489786;C0521115;C0541154;C0681850;C0687744;C0700307;C0795660;C0872972;C1185738;C1254351;C1257890;C1305855;C1305866;C1441506;C1512211;C1515187;C1519504;C1550501;C1552595;C1552866;C1696465;C1705104;C1705428;C1705429;C1706132;C1706203;C1706408;C1825777;C2349001;C2697811;C2700399;C3250443;C3538758;C4288115;C4484261;C4521986;C4553328";FALSE; -10;abbreviations ace angiotensin converting enzyme bmi body mass index calculated as weight in kilograms divided by height in meters squared dm diabetes mellitus hba $nmbr$ c hemoglobin a $nmbr$ c hmg coa $nmbr$ hydroxy $nmbr$ methylglutaryl coenzyme a asome subjects took more than $nmbr$ oral anti dm drug in addition to metformin and thus the total number of concomitant oral anti dm drugs in the columns exceed the n values in the colesevelam hydrochloride and placebo group headings bsulfonylureas include chlorpropamide glibenclamide glimepiride glipizide and tolazamide cthiazolidinediones include pioglitazone pioglitazone hydrochloride rosiglitazone and rosiglitazone maleate d glucosidase inhibitors include acarbose or miglitol
 592;egfr > $nmbr$ ml / min per $nmbr$ ^ $nmbr$ m ';"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";NA;NA;egfr $nmbr$ ml min per $nmbr$ $nmbr$ m
 592;egfr > $nmbr$ ml / min / $nmbr$ . $nmbr$ m ^;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";NA;NA;egfr $nmbr$ ml min $nmbr$ $nmbr$ m
  64;no rest angina;"C0002965;C0152172";FALSE;  65;no rest angina
 592;egfr > $nmbr$  n ( % );"C1739039;C3811844;C3812682";NA;NA;egfr $nmbr$ n
 592;egfr > $nmbr$;"C1739039;C3811844;C3812682";NA;NA;egfr $nmbr$
  64;rec . ischemia due worsening angina;"C0002965;C0022116;C0678226;C1424025;C2606415;C3146286;C4321499";FALSE;  65;rec ischemia due worsening angina
   7;interaction p - value;"C1704675;C1709380";NA;NA;interaction p value
  64;rest angina past $nmbr$ h;"C0002965;C0033727;C0152172;C0369286;C0441932;C0564385;C1444637;C4284302;C4528284";FALSE;  65;rest angina past $nmbr$ h
  79;data are expressed as n / total ( % ) unless otherwise specified . systeme international unit conversion : to convert creatinine clearance to ml / s  multiply by $nmbr$ . $nmbr$ . * estimated with cockroft - gault equation;"C0040363;C0041260;C0205369;C0439175;C0439390;C0439453;C0439810;C0439836;C0552449;C0750572;C0812399;C1511726;C1719797;C1883351;C2911648;C3245479;C3714741";FALSE; -10;data are expressed as n total unless otherwise specified systeme international unit conversion to convert creatinine clearance to ml s multiply by $nmbr$ $nmbr$ estimated with cockroft gault equation
 588;other individual and exploratory end points;"C0027361;C0237401;C2349179";NA;NA;other individual and exploratory end points
 588;normoglycaemic individuals  n ( % );"C0027361;C0237401;C0580545";NA;NA;normoglycaemic individuals n
  97;component . for all instruments  higher scores indicate more severe disease . ara denotes american rheumatism association ( now called;"C0004083;C0009326;C0035435;C0205172;C0205250;C0325983;C0439849;C0449432;C0449820;C0596070;C0596306;C0679006;C0699792;C1705248;C1836348;C1947967;C1948052;C2316832;C3890184;C4282437;C4321455;C4551823";FALSE; -10;component for all instruments higher scores indicate more severe disease ara denotes american rheumatism association now called
 134;$nmbr$ . $nmbr$ % vs . $nmbr$ . $nmbr$ %;NA;FALSE; -10;$nmbr$ $nmbr$ vs $nmbr$ $nmbr$
 134;> $nmbr$   vs .   ≤   $nmbr$;NA;FALSE; -10;$nmbr$ vs $nmbr$
 106;b . i . d .  twice daily  cat  copd assessment test  copd  chronic obstructive pulmonary disease  fev $nmbr$    forced expiratory volume in $nmbr$   s  fvc  forced vital capacity  gold  global initiative for chronic obstructive lung disease  ics  inhaled corticosteroid  mcid  minimum clinically important difference  mmrc  modified medical research council  o . d .  once daily  sd  standard deviation  sgrq - c  st . george ’ s respiratory questionnaire for copd;"C0001617;C0004048;C0007450;C0016529;C0018026;C0024115;C0024117;C0034394;C0079816;C0152277;C0205191;C0205246;C0325090;C0332173;C0392747;C0424093;C0521346;C0524517;C0549186;C0585361;C0815320;C0871420;C1304897;C1306036;C1412502;C1443200;C1546767;C1551807;C1553316;C2348867;C2699239;C3536709;C3665481;C3714496;C3714541;C3826872;C3826977;C3889737;C4050461;C4277733;C4284282;C4551720";FALSE; -10;b i d twice daily cat copd assessment test copd chronic obstructive pulmonary disease fev $nmbr$ forced expiratory volume in $nmbr$ s fvc forced vital capacity gold global initiative for chronic obstructive lung disease ics inhaled corticosteroid mcid minimum clinically important difference mmrc modified medical research council o d once daily sd standard deviation sgrq c st george s respiratory questionnaire for copd
 123;rs $nmbr$;"C0035970;C3714753;C3813325";FALSE; -10;rs $nmbr$
 123;e - rs total scoreb;"C0035970;C0439175;C0439810;C3714753;C3813325";FALSE; -10;e rs total scoreb
 123;rs $nmbr$ ( aa ) & rs $nmbr$;"C0035970;C0282379;C1235746;C1882141;C3714753;C3813325;C4554792";FALSE; -10;rs $nmbr$ aa rs $nmbr$
 123;rs $nmbr$ ( ac ) & rs $nmbr$;"C0001246;C0003354;C0035970;C1412573;C2000891;C3539770;C3714753;C3813325";FALSE; -10;rs $nmbr$ ac rs $nmbr$
 123;rs $nmbr$ & rs $nmbr$;"C0035970;C3714753;C3813325";FALSE; -10;rs $nmbr$ rs $nmbr$
 123;rs - breathlessnessb;"C0035970;C3714753;C3813325";FALSE; -10;rs breathlessnessb
  31;p value *  placebo group p value *  hyponatremia normonatremic group  tolvaptan vs hyponatremic vs placebo;"C0020625;C0032042;C0441833;C0687744;C0857122;C1176308;C1257890;C1519504;C1696465;C1705428;C1705429;C1706408;C1709380;C4553967";FALSE; -10;p value placebo group p value hyponatremia normonatremic group tolvaptan vs hyponatremic vs placebo
 592;egfr < $nmbr$ ml / min per $nmbr$ · $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";NA;NA;egfr $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$
 592;egfr < $nmbr$ ml / min per $nmbr$ ^ $nmbr$ m ';"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";NA;NA;egfr $nmbr$ ml min per $nmbr$ $nmbr$ m
 559;ra - beam;"C0338248;C2347880;C3538806;C4048756;C4521565";NA;NA;ra beam
 592;egfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m ^;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";NA;NA;egfr $nmbr$ ml min $nmbr$ $nmbr$ m
 592;egfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ ( n = $nmbr$ );"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";NA;NA;egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ n $nmbr$
 592;egfr < $nmbr$ . $nmbr$ ( vs egfr > $nmbr$ );"C1739039;C3811844;C3812682";NA;NA;egfr $nmbr$ $nmbr$ vs egfr $nmbr$
 592;egfr < $nmbr$  n ( % );"C1739039;C3811844;C3812682";NA;NA;egfr $nmbr$ n
 592;egfr < $nmbr$;"C1739039;C3811844;C3812682";NA;NA;egfr $nmbr$
 592;egfr -;"C1739039;C3811844;C3812682";NA;NA;egfr
 592;egfr ( mumin / $nmbr$ . $nmbr$ m $nmbr$ );"C0369637;C0441923;C1739039;C3811844;C3812682";NA;NA;egfr mumin $nmbr$ $nmbr$ m $nmbr$
 592;egfr ( ml / min per $nmbr$ · $nmbr$ m $nmbr$ );"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";NA;NA;egfr ml min per $nmbr$ $nmbr$ m $nmbr$
 592;egfr ( ml / min per $nmbr$ ^ $nmbr$ m ' );"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";NA;NA;egfr ml min per $nmbr$ $nmbr$ m
 592;egfr ( ml / min per $nmbr$ . $nmbr$ m $nmbr$ );"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";NA;NA;egfr ml min per $nmbr$ $nmbr$ m $nmbr$
 592;egfr ( ml / min per $nmbr$ - $nmbr$ m ’ );"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";NA;NA;egfr ml min per $nmbr$ $nmbr$ m
 592;egfr ( ml / min per $nmbr$ - $nmbr$ m ^ );"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";NA;NA;egfr ml min per $nmbr$ $nmbr$ m
 592;egfr ( ml / min per $nmbr$ - $nmbr$ kg / m ^ );"C0369637;C0439402;C0441923;C1739039;C3811844;C3812682";NA;NA;egfr ml min per $nmbr$ $nmbr$ kg m
 592;egfr ( ml / min per $nmbr$ + $nmbr$ m ”;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";NA;NA;egfr ml min per $nmbr$ $nmbr$ m
 592;egfr ( mdrd )  n ( % );"C1739039;C3811844;C3812682;C3839656";NA;NA;egfr mdrd n
 592;egfr $nmbr$ ml / min / $nmbr$ . $nmbr$ m ^;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";NA;NA;egfr $nmbr$ ml min $nmbr$ $nmbr$ m
 592;egfr $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ ( vs egfr > $nmbr$ );"C1739039;C3811844;C3812682";NA;NA;egfr $nmbr$ $nmbr$ $nmbr$ $nmbr$ vs egfr $nmbr$
 592;egfr $nmbr$ - $nmbr$;"C1739039;C3811844;C3812682";NA;NA;egfr $nmbr$ $nmbr$
 592;egfr  n ( % ) normal ( egfr > $nmbr$ ml / min / em ^ );"C0205307;C0231683;C0439166;C0439445;C1739039;C2347086;C3811844;C3812682;C4553972";NA;NA;egfr n normal egfr $nmbr$ ml min em
 592;egfr  ml • mn ' • $nmbr$ . $nmbr$ m $nmbr$;"C0026327;C0026405;C0369637;C0439526;C0441923;C1705224;C1739039;C3811844;C3812682;C3887665;C4285072";NA;NA;egfr ml mn $nmbr$ $nmbr$ m $nmbr$
 592;egfr  ml / min per $nmbr$ · $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";NA;NA;egfr ml min per $nmbr$ $nmbr$ m $nmbr$
 592;egfr  ml / min per $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";NA;NA;egfr ml min per $nmbr$ $nmbr$ m $nmbr$
 592;egfr  ml / min / $nmbr$ . $nmbr$   m $nmbr$;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";NA;NA;egfr ml min $nmbr$ $nmbr$ m $nmbr$
 592;egfr  ml / min / $nmbr$ . $nmbr$ m ^;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";NA;NA;egfr ml min $nmbr$ $nmbr$ m
 592;egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$  ‡;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";NA;NA;egfr ml min $nmbr$ $nmbr$ m $nmbr$
 592;egfr  $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$  n ( % );"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";NA;NA;egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ n
 592;egfr;"C1739039;C3811844;C3812682";NA;NA;egfr
 592;ckd ( egfr < $nmbr$ b );"C1561643;C1739039;C3811844;C3812682";NA;NA;ckd egfr $nmbr$ b
 592;ckd ( egfr < $nmbr$ )  n ( % );"C1561643;C1739039;C3811844;C3812682";NA;NA;ckd egfr $nmbr$ n
 592;bp = blood pressure  egfr = estimated glomerular filtration rate ( men : $nmbr$ en : $nmbr$ x cr $nmbr$ . $nmbr$ x age $nmbr$ . $nmbr$ x $nmbr$ . $nmbr$ )  hdl = high - density lipoprotein .;"C0001779;C0005823;C0014908;C0017654;C0023821;C0025266;C0201975;C0750572;C1417861;C1561549;C1739039;C2987294;C3539604;C3711669;C3811844;C3812682;C3889152;C4084730;C4553336;C4553337";NA;NA;bp blood pressure egfr estimated glomerular filtration rate men $nmbr$ en $nmbr$ x cr $nmbr$ $nmbr$ x age $nmbr$ $nmbr$ x $nmbr$ $nmbr$ hdl high density lipoprotein
 592;baseline egfr ≥ $nmbr$ to < $nmbr$;"C0168634;C1442488;C1739039;C3811844;C3812682";NA;NA;baseline egfr $nmbr$ to $nmbr$
 592;baseline egfr < $nmbr$;"C0168634;C1442488;C1739039;C3811844;C3812682";NA;NA;baseline egfr $nmbr$
 592;baseline egfr ( ml / min per $nmbr$ « $nmbr$ m ’ );"C0168634;C0369637;C0439445;C0441923;C1442488;C1739039;C3811844;C3812682";NA;NA;baseline egfr ml min per $nmbr$ $nmbr$ m
 592;baseline egfr  ml / min / $nmbr$ . $nmbr$   m $nmbr$;"C0168634;C0369637;C0439445;C0441923;C1442488;C1739039;C3811844;C3812682";NA;NA;baseline egfr ml min $nmbr$ $nmbr$ m $nmbr$
 592;baseline egfr;"C0168634;C1442488;C1739039;C3811844;C3812682";NA;NA;baseline egfr
 592;baseline ckd egfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0168634;C0369637;C0439445;C0441923;C1442488;C1561643;C1739039;C3811844;C3812682";NA;NA;baseline ckd egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 592;$nmbr$ — em;NA;NA;NA;$nmbr$ em
 -10;inguinal hernia repair;C0021446;NA;NA;inguinal hernia repair
 590;hiatus hernia;C3489393;NA;NA;hiatus hernia
 590;hiatal hernia ( yes ) ( n );"C1549445;C1705108;C1710701;C3489393";NA;NA;hiatal hernia yes n
 590;esophageal hiatal hernia *;C3489393;NA;NA;esophageal hiatal hernia
 589;previous pneumonia;"C0032285;C0205156;C1552607";NA;NA;previous pneumonia
 589;pneumonia;C0032285;NA;NA;pneumonia
 589;bacterial pneumonia;C0004626;NA;NA;bacterial pneumonia
 588;teaes in a $nmbr$ % of individuals;"C0027361;C0237401";NA;NA;teaes in a $nmbr$ of individuals
 588;no . ( % ) of individuals *;"C0027361;C0237401";NA;NA;no of individuals
 588;individuals with type $nmbr$ diabetes  n ( % );"C0027361;C0237401;C1320657";NA;NA;individuals with type $nmbr$ diabetes n
 588;individuals with prediabetes;"C0027361;C0237401;C0362046";NA;NA;individuals with prediabetes
 588;individuals with pre - diabetes  n ( % );"C0027361;C0237401;C0362046";NA;NA;individuals with pre diabetes n
 588;individuals with normoglycaemia;"C0027361;C0237401;C0580545";NA;NA;individuals with normoglycaemia
 588;individual endpoints;"C0027361;C0237401;C2349179";NA;NA;individual endpoints
 587;smi :;NA;NA;NA;smi
 587;meddra smq;C1140263;NA;NA;meddra smq
 587;intended durat - sm of antccagubficn;"C0036154;C1283828;C1551357;C4553627";NA;NA;intended durat sm of antccagubficn
 586;simva n = $nmbr$ n ( % );NA;NA;NA;simva n $nmbr$ n
 586;simva ( „ = $nmbr$ };NA;NA;NA;simva $nmbr$
 586;simva ( n = $nmbr$ );NA;NA;NA;simva n $nmbr$
 586;simva ( % );NA;NA;NA;simva
 586;simva;NA;NA;NA;simva
 586;male simva ( „ = $nmbr$ };"C0086582;C1706180;C1706428;C1706429";NA;NA;male simva $nmbr$
 586;male simva ( n = $nmbr$ );"C0086582;C1706180;C1706428;C1706429";NA;NA;male simva n $nmbr$
 586;male simva;"C0086582;C1706180;C1706428;C1706429";NA;NA;male simva
 586;male eze / simva ( „ = $nmbr$ };"C0086582;C1706180;C1706428;C1706429";NA;NA;male eze simva $nmbr$
 586;male eze / simva ( n = $nmbr$ );"C0086582;C1706180;C1706428;C1706429";NA;NA;male eze simva n $nmbr$
 586;male eze / simva;"C0086582;C1706180;C1706428;C1706429";NA;NA;male eze simva
 586;female simva ( „ = $nmbr$ };"C0043210;C0086287;C1705497;C1705498";NA;NA;female simva $nmbr$
 586;female simva ( n = $nmbr$ );"C0043210;C0086287;C1705497;C1705498";NA;NA;female simva n $nmbr$
 586;female simva;"C0043210;C0086287;C1705497;C1705498";NA;NA;female simva
 586;female eze / simva;"C0043210;C0086287;C1705497;C1705498";NA;NA;female eze simva
 586;caucasian simva;"C0007457;C0043157";NA;NA;caucasian simva
 585;subdural / epidural;"C0038541;C0228134;C0812144";NA;NA;subdural epidural
 585;structural heart disease — no . ( % ) f;"C0016327;C1290384";NA;NA;structural heart disease no f
 585;structural heart disease §;C1290384;NA;NA;structural heart disease
 585;structural heart disease;C1290384;NA;NA;structural heart disease
 585;structural;C0678594;NA;NA;structural
 584;salbutamol  %;C0001927;NA;NA;salbutamol
 584;post - salbutamol fev $nmbr$ / fvcb  mean ( sd );"C0001927;C0444504;C0687676;C1704687;C2347634;C2348143;C2699239;C3469826;C3714541";NA;NA;post salbutamol fev $nmbr$ fvcb mean sd
 538;intertrochanteric;C0745355;NA;NA;intertrochanteric
 584;post - salbutamol fev $nmbr$ ( l ) b  mean ( sd );"C0001927;C0444504;C0687676;C1704687;C2347634;C2348143;C2699239;C3469826;C3714541";NA;NA;post salbutamol fev $nmbr$ l b mean sd
 584;fev $nmbr$  litres ( post - salbutamol )  mean ( sd );"C0001927;C0444504;C0475211;C0687676;C1704687;C2347634;C2348143;C2699239;C3469826;C3714541";NA;NA;fev $nmbr$ litres post salbutamol mean sd
 583;variable demographic characteristics;"C0439828;C0683970;C4553760";NA;NA;variable demographic characteristics
 583;demographic features;C0683970;NA;NA;demographic features
 583;demographic feature;C0683970;NA;NA;demographic feature
 583;demographic data;C4684639;NA;NA;demographic data
 583;demographic characteristics  mean ± sd unless otherwise indicated;"C0444504;C0683970;C1444656;C2347634;C2348143;C2699239";NA;NA;demographic characteristics mean sd unless otherwise indicated
 583;demographic characteristics  mean ( sd )  unless otherwise stated;"C0444504;C0683970;C1301808;C1442792;C2347634;C2348143;C2699239";NA;NA;demographic characteristics mean sd unless otherwise stated
 583;demographic characteristics;C0683970;NA;NA;demographic characteristics
 582;patient demographics age — yr;"C0011298;C0439234;C1704791;C4698447";NA;NA;patient demographics age yr
 582;demography;C0011298;NA;NA;demography
 582;demographics age ( years );"C0011298;C1510829;C1704791";NA;NA;demographics age years
 582;demographics age  years  mean ( sd );"C0011298;C0444504;C1510829;C1704791;C2347634;C2348143;C2699239";NA;NA;demographics age years mean sd
 582;demographics;"C0011298;C1704791";NA;NA;demographics
 582;demographic variable;"C0011298;C0439828;C4553760";NA;NA;demographic variable
 582;demographic factors;"C0011292;C0011298";NA;NA;demographic factors
 582;demographic and medical variables;"C0011298;C0199168;C0205476;C0439828";NA;NA;demographic and medical variables
 582;demographic and clinical characteristics;"C0011298;C0683325";NA;NA;demographic and clinical characteristics
 582;demographic and clinical;"C0011298;C0205210";NA;NA;demographic and clinical
 582;demographic $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ );C0011298;NA;NA;demographic $nmbr$ $nmbr$ $nmbr$ $nmbr$
 582;demographic;C0011298;NA;NA;demographic
 582;( a ) demographics;"C0011298;C1704791";NA;NA;a demographics
 581;• hemorrhagic stroke;C0553692;NA;NA;hemorrhagic stroke
 581;subarachnoid hemorrhage;C0038525;NA;NA;subarachnoid hemorrhage
 581;prior non - haemorrhagic stroke;"C0332152;C0553692;C1518422;C2826257";NA;NA;prior non haemorrhagic stroke
 581;primary hemorrhagic stroke;"C0205225;C0439612;C0439631;C0553692";NA;NA;primary hemorrhagic stroke
 581;non ‐ haemorrhagic stroke — no . ( % );"C0038454;C0333275;C1518422;C4554100";NA;NA;non haemorrhagic stroke no
 581;ischemic stroke without hemorrhagic conversior;"C0333275;C0475224;C0553692;C0948008";NA;NA;ischemic stroke without hemorrhagic conversior
 581;hemorrhagic stroke ( n = $nmbr$ );C0553692;NA;NA;hemorrhagic stroke n $nmbr$
 581;hemorrhagic stroke;C0553692;NA;NA;hemorrhagic stroke
 581;hemorrhagic;C0333275;NA;NA;hemorrhagic
 581;haemorrhagic stroke — no . ( % );C0553692;NA;NA;haemorrhagic stroke no
 581;haemorrhagic stroke;C0553692;NA;NA;haemorrhagic stroke
 581;haemorrhagic;C0333275;NA;NA;haemorrhagic
 580;south asian;C1519427;NA;NA;south asian
 580;south asia;"C0037723;C1519427";NA;NA;south asia
 580;south american;C0425359;NA;NA;south american
 580;south america ( n = $nmbr$ );C0037713;NA;NA;south america n $nmbr$
 580;south america ( % );C0037713;NA;NA;south america
 580;south america;C0037713;NA;NA;south america
 580;south africa / south america;"C0001737;C0002454;C0037712;C0037713";NA;NA;south africa south america
 580;south africa;C0037712;NA;NA;south africa
 580;south ! central america;"C0007674;C0037713;C0205099;C1710133;C1879652";NA;NA;south central america
 580;latin america or south africa;"C0023122;C0037712";NA;NA;latin america or south africa
 580;central or south america;"C0037713;C0205099;C1879652";NA;NA;central or south america
 580;central and south america and mexico;"C0025885;C0037713;C0205099;C1879652";NA;NA;central and south america and mexico
 580;central and south america;"C0037713;C0205099;C1879652";NA;NA;central and south america
 580;central america and south america;"C0007674;C0037713";NA;NA;central america and south america
 580;central / south america and mexico;"C0007674;C0025885;C0037713;C0205099;C1710133;C1879652";NA;NA;central south america and mexico
 580;central / south america;"C0007674;C0037713;C0205099;C1710133;C1879652";NA;NA;central south america
 579;north ameriea;C1709269;NA;NA;north ameriea
 579;north american;"C0425358;C2700615";NA;NA;north american
 579;north;C1709269;NA;NA;north
 579;< $nmbr$ nwrrtn;NA;NA;NA;$nmbr$ nwrrtn
 578;grip strength > = median;"C0429271;C0549183;C0876920;C2347635;C2348144;C2598165;C2939193";NA;NA;grip strength median
 578;grip strength < meidan;"C0429271;C2598165";NA;NA;grip strength meidan
 577;health state index score  uk algorithm;"C0002045;C0041700;C0449820;C0600653;C0683314;C0918012;C1552854;C1553907;C1637833;C2986546;C4050231";NA;NA;health state index score uk algorithm
 577;algorithm $nmbr$;"C0002045;C1553907";NA;NA;algorithm $nmbr$
 576;tertile $nmbr$ index pci performed;"C0600653;C0884358;C0918012;C1552854;C1637833;C2986546;C4049621";NA;NA;tertile $nmbr$ index pci performed
 576;resection performed — no . { % );"C0015252;C0728940;C0884358";NA;NA;resection performed no
 576;resection performed  %;"C0015252;C0728940;C0884358";NA;NA;resection performed
 576;pci performed;"C0884358;C4049621";NA;NA;pci performed
 576;index pci performed;"C0600653;C0884358;C0918012;C1552854;C1637833;C2986546;C4049621";NA;NA;index pci performed
 575;thienopyridine drug at start of open - label period;"C0439531;C1120149;C1709323;C1948053;C2348346";NA;NA;thienopyridine drug at start of open label period
 575;study period fatal pe;"C0070939;C0439531;C0557651;C1302234;C1705232;C1880476;C1948053;C2603343;C4284304";NA;NA;study period fatal pe
 575;placebo ‐ controlled period;"C0439531;C1706408;C1948053";NA;NA;placebo controlled period
 575;period i;"C0021966;C0221138;C0439531;C1948053";NA;NA;period i
 575;overall study period;"C0282416;C0439531;C0557651;C1561607;C1948053;C2603343";NA;NA;overall study period
 575;during overall study period;"C0282416;C0439531;C0557651;C1561607;C1948053;C2603343";NA;NA;during overall study period
 575;- recurrent vte during overall study period;"C0282416;C0439531;C0557651;C0630906;C1455761;C1561607;C1948053;C2603343;C2945760";NA;NA;recurrent vte during overall study period
 574;prior treatment — no . ( % );C1514463;NA;NA;prior treatment no
 574;prior treatment — %;C1514463;NA;NA;prior treatment
 574;prior treatment;C1514463;NA;NA;prior treatment
 574;prior tnfi treatment;C1514463;NA;NA;prior tnfi treatment
 574;prior tnf antagonist treatment - no;"C0231491;C1448177;C1514463";NA;NA;prior tnf antagonist treatment no
 574;prior therapy  %;C1514463;NA;NA;prior therapy
 574;prior ms treatment with ifn - beta or glatiramer acetate . no . ( % );"C0015980;C0289884;C1514463;C2349943;C3539704;C3713294";NA;NA;prior ms treatment with ifn beta or glatiramer acetate no
 574;prior ms treatment with ifn - beta or;"C0015980;C1514463;C2349943;C3539704;C3713294";NA;NA;prior ms treatment with ifn beta or
 574;prior lipid - modifying therapy;"C0023779;C0392747;C1514463";NA;NA;prior lipid modifying therapy
 574;prior lev treatment    n   ( % );"C0023556;C1514463";NA;NA;prior lev treatment n
 574;prior lev treatment;"C0023556;C1514463";NA;NA;prior lev treatment
 574;prior anti - tnf treatment;"C1448177;C1514463";NA;NA;prior anti tnf treatment
 574;no prior ms therapies;"C1514463;C2349943;C3539704;C3713294";NA;NA;no prior ms therapies
 573;negative for helicobacter pylori — no . / total no . ( % );"C0439175;C0439810;C4688581";NA;NA;negative for helicobacter pylori no total no
 573;helicobacter pylori infection ( + ) ( n );C0850666;NA;NA;helicobacter pylori infection n
 573;helicobacter pylori - negative  n ( % );C4688581;NA;NA;helicobacter pylori negative n
 573;h pylori serology *;"C0036745;C0079488;C0220911;C0455278";NA;NA;h pylori serology
 573;h . pylori infection;C0850666;NA;NA;h pylori infection
 537;nitratesf;NA;NA;NA;nitratesf
 333;diet controlled or no;C0743195;NA;NA;diet controlled or no
 572;pulmonary medications ( % );"C0013227;C0024109;C0802604;C2598133;C2707265;C2709248;C4284232;C4522268";NA;NA;pulmonary medications
 572;pulmonary medication during baseline ! ';"C0013227;C0024109;C0168634;C1442488;C2707265;C2709248;C3244316;C4284232;C4522268";NA;NA;pulmonary medication during baseline
 572;pulmonary embolismb  n / n ( % );"C0024109;C2707265;C2709248;C4522268";NA;NA;pulmonary embolismb n n
 572;pulmonary embolisma  n / n ( % );"C0024109;C2707265;C2709248;C4522268";NA;NA;pulmonary embolisma n n
 572;proportion taking pulmonary medications ( % ) b;"C0013227;C0024109;C0802604;C1515187;C1709707;C2598133;C2707265;C2709248;C4284232;C4522268";NA;NA;proportion taking pulmonary medications b
 572;fvc ( l ) proportion taking pulmonary medications ( % ) b;"C0013227;C0024109;C0802604;C1515187;C1709707;C2598133;C2707265;C2709248;C3714541;C4284232;C4522268";NA;NA;fvc l proportion taking pulmonary medications b
 572;baseline pulmonary medications;"C0013227;C0024109;C0168634;C0802604;C1442488;C2598133;C2707265;C2709248;C4284232;C4522268";NA;NA;baseline pulmonary medications
 572;baseline pulmonary medication  n ( % );"C0013227;C0024109;C0168634;C1442488;C2707265;C2709248;C3244316;C4284232;C4522268";NA;NA;baseline pulmonary medication n
 572;baseline pulmonary medication  b n ( % );"C0013227;C0024109;C0168634;C1442488;C2707265;C2709248;C3244316;C4284232;C4522268";NA;NA;baseline pulmonary medication b n
 572;baseline pulmonary medication;"C0013227;C0024109;C0168634;C1442488;C2707265;C2709248;C3244316;C4284232;C4522268";NA;NA;baseline pulmonary medication
 572;any pulmonary medication  n ( % );"C0013227;C0024109;C2707265;C2709248;C3244316;C4284232;C4522268";NA;NA;any pulmonary medication n
 572;any pulmonary medication;"C0013227;C0024109;C2707265;C2709248;C3244316;C4284232;C4522268";NA;NA;any pulmonary medication
 571;sleep;C0037313;NA;NA;sleep
 571;on step - $nmbr$ drug  %;"C0013227;C1254351;C1261552;C1704379;C1705117;C2825408;C3814463";NA;NA;on step $nmbr$ drug
 571;. $nmbr$ step or incident vitrectomy or photocoagulation;"C0023694;C0042903;C1261552;C1328010;C1551358;C1704379;C1705117;C2825408;C3814463";NA;NA;$nmbr$ step or incident vitrectomy or photocoagulation
 571;$nmbr$ step;"C1261552;C1704379;C1705117;C2825408;C3814463";NA;NA;$nmbr$ step
 571;$nmbr$ or $nmbr$ step;"C1261552;C1704379;C1705117;C2825408;C3814463";NA;NA;$nmbr$ or $nmbr$ step
 570;stemi ( % );"C1536220;C3538872";NA;NA;stemi
 570;stemi;"C1536220;C3538872";NA;NA;stemi
 570;st - segment — elevation myocardial infarction;C1536220;NA;NA;st segment elevation myocardial infarction
 570;st - segment elevation myocardial infarction;C1536220;NA;NA;st segment elevation myocardial infarction
 570;st - segment - elevation myocardial infarction — no . ( % );C1536220;NA;NA;st segment elevation myocardial infarction no
 570;st - elevation myocardial infarction;"C1536220;C3538872";NA;NA;st elevation myocardial infarction
 570;qualifying mi : stemi;"C1514624;C1536220;C3538872;C3810814";NA;NA;qualifying mi stemi
 570;prior stemi;"C0332152;C1536220;C2826257;C3538872";NA;NA;prior stemi
 570;no prior stemi;"C0332152;C1536220;C2826257;C3538872";NA;NA;no prior stemi
 570;myocardial infarction without st - segment elevation — no . ( % );C1536220;NA;NA;myocardial infarction without st segment elevation no
 569;without stent;C0038257;NA;NA;without stent
 569;with stent ^ l;C0038257;NA;NA;with stent l
 569;with stent;C0038257;NA;NA;with stent
 569;with any stent;C0038257;NA;NA;with any stent
 569;vein graft stented;"C0038257;C0042449;C0181074;C0332835;C1961139";NA;NA;vein graft stented
 569;vein bypass stented;"C0038257;C0042449;C0741847";NA;NA;vein bypass stented
 569;vein bypass graft stented;"C0038257;C0398147";NA;NA;vein bypass graft stented
 569;stent plus placebo;"C0032042;C0038257;C0332287;C1696465;C1706408";NA;NA;stent plus placebo
 569;stent plus abciximab;"C0038257;C0288672;C0332287";NA;NA;stent plus abciximab
 569;stent length per lesion  mm;"C0038257;C0221198;C1444754;C1546698;C1706316;C4330985;C4554674";NA;NA;stent length per lesion mm
 569;stent group ( n = $nmbr$ );"C0038257;C0441848";NA;NA;stent group n $nmbr$
 569;stent diameter < $nmbr$ mm;"C0038257;C1301886;C4330985;C4554674";NA;NA;stent diameter $nmbr$ mm
 569;stent diameter $ $nmbr$ mm;"C0038257;C1301886;C4330985;C4554674";NA;NA;stent diameter $ $nmbr$ mm
 569;stent / abciximab - stent / placebo;"C0032042;C0038257;C0288672;C1696465;C1706408";NA;NA;stent abciximab stent placebo
 569;stent ( n = $nmbr$ );C0038257;NA;NA;stent n $nmbr$
 569;stent;C0038257;NA;NA;stent
 569;prior stent;"C0038257;C0332152;C2826257";NA;NA;prior stent
 569;previous stenting ( % previous pci );"C0038257;C0205156;C1552607;C2348535;C4049621";NA;NA;previous stenting previous pci
 569;other stent;C0038257;NA;NA;other stent
 569;number stent > $nmbr$;"C0038257;C0237753;C0449788";NA;NA;number stent $nmbr$
 569;number of stents implanted;"C0021102;C0038257;C0237753;C0449788;C2828363";NA;NA;number of stents implanted
 569;number of stents ( per patient );"C0030705;C0038257;C0237753;C0449788";NA;NA;number of stents per patient
 569;number of stents;"C0038257;C0237753;C0449788";NA;NA;number of stents
 569;number of stent = l or $nmbr$ or $nmbr$;"C0038257;C0237753;C0449788";NA;NA;number of stent l or $nmbr$ or $nmbr$
 569;number of stent = $nmbr$;"C0038257;C0237753;C0449788";NA;NA;number of stent $nmbr$
 569;no . of stents;C0038257;NA;NA;no of stents
 569;multivessel stenting;"C0038257;C2348535";NA;NA;multivessel stenting
 569;minimum stent diameter;"C0038257;C4054490";NA;NA;minimum stent diameter
 549;pre - menopausal with hormone replacement;"C0206158;C0282402";NA;NA;pre menopausal with hormone replacement
 569;mean total stent length per lesion  mm ( sd ) ‡;"C0038257;C0221198;C0439175;C0439810;C0444504;C1444754;C1546698;C1706316;C2347634;C2348143;C2699239;C4330985;C4554674";NA;NA;mean total stent length per lesion mm sd
 569;coronary angioplasty or stenting;"C0002997;C0038257;C0190211;C2348535";NA;NA;coronary angioplasty or stenting
 569;biolimus a $nmbr$ - eluting stent ¶;C0038257;NA;NA;biolimus a $nmbr$ eluting stent
 568;subgroup sex;"C0009253;C0036864;C0079399;C0804628;C1079230;C1314687;C1515021;C1522384";NA;NA;subgroup sex
 568;sexy;"C0009253;C0036864;C0079399;C0804628;C1314687;C1522384";NA;NA;sexy
 568;sex — no . / total no . ( % );"C0009253;C0036864;C0079399;C0439175;C0439810;C0804628;C1314687;C1522384";NA;NA;sex no total no
 568;sex — no . ( % );"C0009253;C0036864;C0079399;C0804628;C1314687;C1522384";NA;NA;sex no
 568;sex m / f;"C0009253;C0036864;C0079399;C0804628;C1306057;C1314687;C1522384";NA;NA;sex m f
 568;sex :;"C0009253;C0036864;C0079399;C0804628;C1314687;C1522384";NA;NA;sex
 568;sex ( women  n [ % ] );"C0009253;C0036864;C0043210;C0079399;C0804628;C1314687;C1522384";NA;NA;sex women n
 568;sex ( p = $nmbr$ );"C0009253;C0036864;C0079399;C0804628;C1314687;C1522384";NA;NA;sex p $nmbr$
 568;sex ( no . );"C0009253;C0036864;C0079399;C0804628;C1314687;C1522384";NA;NA;sex no
 568;sex ( interaction : p = $nmbr$ . $nmbr$ );"C0009253;C0036864;C0079399;C0804628;C1314687;C1522384;C1704675";NA;NA;sex interaction p $nmbr$ $nmbr$
 568;sex ( % );"C0009253;C0036864;C0079399;C0804628;C1314687;C1522384";NA;NA;sex
 568;sex  no . ( % ) male;"C0009253;C0036864;C0079399;C0086582;C0804628;C1314687;C1522384;C1706180;C1706428;C1706429";NA;NA;sex no male
 568;sex  no . ( % );"C0009253;C0036864;C0079399;C0804628;C1314687;C1522384";NA;NA;sex no
 568;sex  no  ( % );"C0009253;C0036864;C0079399;C0804628;C1314687;C1522384";NA;NA;sex no
 568;sex  n ( % ) b;"C0009253;C0036864;C0079399;C0804628;C1314687;C1522384";NA;NA;sex n b
 568;sex  n ( % ) *;"C0009253;C0036864;C0079399;C0804628;C1314687;C1522384";NA;NA;sex n
 568;sex  n ( % );"C0009253;C0036864;C0079399;C0804628;C1314687;C1522384";NA;NA;sex n
 568;sex  %;"C0009253;C0036864;C0079399;C0804628;C1314687;C1522384";NA;NA;sex
 568;sex;"C0009253;C0036864;C0079399;C0804628;C1314687;C1522384";NA;NA;sex
 568;p interaction ( rx arm * sex );"C0009253;C0036864;C0079399;C0369773;C0446516;C0804628;C1314687;C1425688;C1521941;C1522384;C1704675;C2603361;C2709207;C3715044;C4553528";NA;NA;p interaction rx arm sex
 568;intercourse satisfac -;C0009253;NA;NA;intercourse satisfac
 568;assigned treatment by sex interaction;"C0009253;C0036864;C0039798;C0079399;C0087111;C0804628;C1314687;C1516050;C1522326;C1522384;C1533734;C1552601;C1704675;C1705169;C3538994;C3887704";NA;NA;assigned treatment by sex interaction
 568;> $nmbr$ yrs sex :;"C0009253;C0036864;C0079399;C0804628;C1314687;C1522384";NA;NA;$nmbr$ yrs sex
 568;> $nmbr$ yr sex;"C0009253;C0036864;C0079399;C0439234;C0804628;C1314687;C1522384";NA;NA;$nmbr$ yr sex
 567;week $nmbr$ mean ( se );"C0036919;C0332174;C0439230;C0444504;C2347634;C2348143";NA;NA;week $nmbr$ mean se
 567;triglycerides tx difference vs pbo  ls mean % change from baseline ( se );"C0023668;C0031962;C0036919;C0041004;C0041403;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C1705242;C2347634;C2348143;C4319952";NA;NA;triglycerides tx difference vs pbo ls mean change from baseline se
 567;sesbp;NA;NA;NA;sesbp
 567;sedbp;NA;NA;NA;sedbp
 567;se;C0036919;NA;NA;se
 567;modified se - adl scale;"C0001288;C0036919;C0175659;C0349674;C0392747;C1420005;C1947916;C3889737";NA;NA;modified se adl scale
 567;mean ± se ) bii ( ls mean ± se );"C0023668;C0036919;C0444504;C1413059;C2347634;C2348143";NA;NA;mean se bii ls mean se
 567;mean ± se;"C0036919;C0444504;C2347634;C2348143";NA;NA;mean se
 567;mean change  % ( se );"C0036919;C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C4319952";NA;NA;mean change se
 567;mean ( se ) trough l;"C0036919;C0444504;C0444506;C2347634;C2348143";NA;NA;mean se trough l
 567;mean ( se ) trough  l;"C0036919;C0444504;C0444506;C2347634;C2348143";NA;NA;mean se trough l
 567;mean ( se ) auc ^ p l;"C0036919;C0376690;C0444504;C2347634;C2348143";NA;NA;mean se auc p l
 567;mean ( se ) auc $nmbr$ - $nmbr$  l;"C0036919;C0376690;C0444504;C2347634;C2348143";NA;NA;mean se auc $nmbr$ $nmbr$ l
 567;mean ( se ) $nmbr$ - year rates per $nmbr$ population;"C0036919;C0439234;C0439508;C0871208;C1521828;C2347634";NA;NA;mean se $nmbr$ year rates per $nmbr$ population
 567;mean ( se );"C0036919;C0444504;C2347634;C2348143";NA;NA;mean se
 567;ls mean ± se;"C0023668;C0036919;C0444504;C2347634;C2348143";NA;NA;ls mean se
 567;ls mean difference ( se );"C0023668;C0036919;C0444504;C1705241;C1705242;C2347634;C2348143";NA;NA;ls mean difference se
 567;ls mean change from baseline ( se )  %;"C0023668;C0036919;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C4319952";NA;NA;ls mean change from baseline se
 567;ls mean change from baseline  ml ( se ) a;"C0023668;C0036919;C0168634;C0392747;C0439526;C0443172;C0444504;C1442488;C1705224;C1705241;C2347634;C2348143;C3887665;C4319952";NA;NA;ls mean change from baseline ml se a
 567;ls mean change ( se );"C0023668;C0036919;C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C4319952";NA;NA;ls mean change se
 567;ls mean ( se );"C0023668;C0036919;C0444504;C2347634;C2348143";NA;NA;ls mean se
 567;ls mean % change from baseline _ se;"C0023668;C0036919;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C4319952";NA;NA;ls mean change from baseline _ se
 567;ipss ( ls mean ± se );"C0023668;C0036919;C0444504;C1019118;C1998280;C2347634;C2348143;C2827405;C3811063";NA;NA;ipss ls mean se
 567;in ibdq total score at week $nmbr$  mean [ se ];"C0036919;C0332174;C0439175;C0439230;C0439810;C0444504;C2347634;C2348143;C2964552;C3533236";NA;NA;in ibdq total score at week $nmbr$ mean se
 567;in - trial and post - trial $nmbr$ - year rates per $nmbr$ ( se ) total events / number at risk;"C0008976;C0036919;C0150312;C0332285;C0439175;C0439234;C0439508;C0439810;C0441471;C0687676;C0871208;C1264674;C1444641;C1521828;C1704687;C1707101;C3469826;C3541888;C4288115";NA;NA;in trial and post trial $nmbr$ year rates per $nmbr$ se total events number at risk
 567;hscrp  exp ls mean change ± se ‡;"C0023668;C0036919;C0392747;C0443172;C0444504;C1417055;C1705241;C2347634;C2348143;C4319952";NA;NA;hscrp exp ls mean change se
 567;homajr tx difference vs pbo  median change from baseline ( se ) $nmbr$ lipid parameters;"C0031962;C0036919;C0041403;C0168634;C0449381;C0549183;C0876920;C1158406;C1442488;C1705241;C1705242;C2347635;C2348144;C2939193";NA;NA;homajr tx difference vs pbo median change from baseline se $nmbr$ lipid parameters
 567;homa_ir tx difference vs pbo  median change from baseline ( se ) $nmbr$;"C0022065;C0022071;C0031962;C0036919;C0041403;C0168634;C0392747;C0443172;C0549183;C0876920;C1442488;C1448132;C1705241;C1705242;C2347635;C2348144;C2939193;C4319952";NA;NA;homa_ir tx difference vs pbo median change from baseline se $nmbr$
 567;fev $nmbr$ at week $nmbr$  mean ml ( se ) difference mepo - pbo ( $nmbr$ % ci );"C0031962;C0036919;C0332174;C0439230;C0444504;C1705241;C1705242;C2347634;C2348025;C2348143;C3714541";NA;NA;fev $nmbr$ at week $nmbr$ mean ml se difference mepo pbo $nmbr$ ci
 567;difference ( se );"C0036919;C1705241;C1705242";NA;NA;difference se
 567;daytime nasal symptoms score change from baseline  mean ± se;"C0036919;C0168634;C0231918;C0332169;C0392747;C0443172;C0444504;C0449820;C1442488;C1705241;C2347634;C2348143;C4050231;C4319952";NA;NA;daytime nasal symptoms score change from baseline mean se
 567;das $nmbr$ - crp  ls mean change from baseline ( se ) §;"C0023668;C0036919;C0051767;C0057671;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C3890735;C4048285;C4319952";NA;NA;das $nmbr$ crp ls mean change from baseline se
 567;cwt  mean ( se )  mm;"C0036919;C0444504;C2347634;C2348143;C4330985;C4554674";NA;NA;cwt mean se mm
 567;change in sesbp  ls mean ( se );"C0023668;C0036919;C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C4319952";NA;NA;change in sesbp ls mean se
 567;change in sedbp  ls mean ( se );"C0023668;C0036919;C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C4319952";NA;NA;change in sedbp ls mean se
 567;change from baseline in morning pef during weeks $nmbr$ - $nmbr$  mean l / min ( se );"C0030771;C0036919;C0168634;C0332170;C0392747;C0439230;C0443172;C0444504;C0702093;C1442488;C1518922;C1524029;C1542834;C1705241;C2347634;C2348143;C3813700;C4319952";NA;NA;change from baseline in morning pef during weeks $nmbr$ $nmbr$ mean l min se
 567;baseline mean ( se );"C0036919;C0168634;C0444504;C1442488;C2347634;C2348143";NA;NA;baseline mean se
 567;baseline insulin dose ( u = kg ) [ lsm ( se ) ];"C0036919;C0168634;C0366513;C1300561;C1442488";NA;NA;baseline insulin dose u kg lsm se
 567;baseline a $nmbr$ c ( % ) [ lsm ( se ) ];"C0036919;C0168634;C1442488";NA;NA;baseline a $nmbr$ c lsm se
 567;basdai  ls mean change from baseline   ±   se;"C0023668;C0036919;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C1998004;C2347634;C2348143;C4319952";NA;NA;basdai ls mean change from baseline se
 567;asqol  ls mean change ± se;"C0023668;C0036919;C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C4319952";NA;NA;asqol ls mean change se
 567;asqol  ls mean change from baseline   ±   se;"C0023668;C0036919;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C4319952";NA;NA;asqol ls mean change from baseline se
 567;adjusted ∗   mean ( se ) ( ml );"C0036919;C0439526;C0444504;C0456081;C1705224;C2347634;C2348143;C3887665";NA;NA;adjusted mean se ml
 567;adjusted mean change from baseline ( se );"C0036919;C0168634;C0392747;C0443172;C0444504;C0456081;C1442488;C1705241;C2347634;C2348143;C4319952";NA;NA;adjusted mean change from baseline se
 567;adjusted mean _ se change from baseline;"C0036919;C0168634;C0392747;C0443172;C0444504;C0456081;C1442488;C1705241;C2347634;C2348143;C4319952";NA;NA;adjusted mean _ se change from baseline
 567;adjusted mean ( se ) fevi auco_ $nmbr$  ml;"C0036919;C0429706;C0439526;C0444504;C0456081;C0849974;C1561566;C1705224;C2347634;C2348143;C3887665;C4528367";NA;NA;adjusted mean se fevi auco_ $nmbr$ ml
 567;( se ] tf total - c;"C0036919;C0439175;C0439810;C4048299;C4048587";NA;NA;se tf total c
 567;( se ] tf hdl - c;"C0036919;C3715113;C4048299;C4048587";NA;NA;se tf hdl c
 567;( se ] tf;"C0036919;C4048299;C4048587";NA;NA;se tf
 567;( se ] t *;C0036919;NA;NA;se t
 567;( se ] t;C0036919;NA;NA;se t
 567;( se ] +;C0036919;NA;NA;se
 567;( se ) t *;C0036919;NA;NA;se t
 567;( se );C0036919;NA;NA;se
 567;% change from baseline ls means ( se );"C0023668;C0036919;C0168634;C0392747;C0443172;C1442488;C1704970;C1705241;C4319952";NA;NA;change from baseline ls means se
 567;% change ( mean ± se );"C0036919;C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C4319952";NA;NA;change mean se
 567;% ( se );C0036919;NA;NA;se
 567;$nmbr$ - y rate per $nmbr$ persons ( se )  n;"C0027361;C0036919;C0871208;C1521828";NA;NA;$nmbr$ y rate per $nmbr$ persons se n
 566;screening  mean ( sd ) morning pef  mean;"C0030771;C0220908;C0220909;C0332170;C0444504;C1518922;C1542834;C1698960;C1710031;C1710032;C1710477;C2347634;C2348143;C2348164;C2699239";NA;NA;screening mean sd morning pef mean
 566;pm pef ( sd )  l / min;"C0030266;C0030771;C0702093;C1518922;C1524029;C1542834;C2699239;C3813700;C4049155";NA;NA;pm pef sd l min
 566;pef !;"C0030771;C1518922;C1542834";NA;NA;pef
 566;am pef ( sd )  l / min;"C0030771;C0702093;C1518922;C1524029;C1542834;C2699239;C3813700";NA;NA;am pef sd l min
 565;aortic stenosis  n ( % );C0003507;NA;NA;aortic stenosis n
 565;aortic stenosis;C0003507;NA;NA;aortic stenosis
 565;> $nmbr$ y pathogenesis  n ( % );"C0543483;C0699748";NA;NA;$nmbr$ y pathogenesis n
 564;osteoporosis drug;"C0013227;C0029456;C1254351;C4554622";NA;NA;osteoporosis drug
 564;osteoporosis;"C0029456;C4554622";NA;NA;osteoporosis
 -10;exercise category ( % );C3669314;NA;NA;exercise category
 562;t - score categories lumbar spineb;"C0024090;C0683312;C3854607";NA;NA;t score categories lumbar spineb
 562;racial category *;"C0034510;C0683312;C1706779;C3669213;C3853635;C3889287";NA;NA;racial category
 562;racial category;"C0034510;C0683312;C1706779;C3669213;C3853635;C3889287";NA;NA;racial category
 562;qmax category  n ( % ) :;"C0683312;C3889287";NA;NA;qmax category n
 562;p value within category;"C0683312;C1709380;C3889287";NA;NA;p value within category
 562;mean ± sd age ( y ) mean bmi category ( % );"C0001779;C0444504;C0578022;C0683312;C2347634;C2348143;C2699239;C3889287";NA;NA;mean sd age y mean bmi category
 562;key : fc = fasting glucose  bp = * this category did not include ar have $nmbr$ of the indicated charac;"C0015663;C0017725;C0037623;C0332257;C0683312;C1415692;C1436327;C1444656;C1518422;C1552866;C1708288;C2700399;C2983605;C2986463;C3884535;C3889287;C4318478;C4521369";NA;NA;key fc fasting glucose bp this category did not include ar have $nmbr$ of the indicated charac
 562;interaction between treatment and baseline bmi category;"C0039798;C0087111;C0168634;C0578022;C0683312;C1442488;C1522326;C1533734;C1704675;C1705169;C3538994;C3887704;C3889287";NA;NA;interaction between treatment and baseline bmi category
 562;glycatedhemoglobin category  %;"C0683312;C3889287";NA;NA;glycatedhemoglobin category
 562;entry category;"C0683312;C1705654;C3889287";NA;NA;entry category
 562;dysglycemic categories  n ( % );"C0683312;C1960636";NA;NA;dysglycemic categories n
 562;creatine clearance category $nmbr$ to < $nmbr$ ml / min $nmbr$ / $nmbr$;"C0373595;C0439445;C0683312;C3889287";NA;NA;creatine clearance category $nmbr$ to $nmbr$ ml min $nmbr$ $nmbr$
 562;creatine clearance category;"C0373595;C0683312;C3889287";NA;NA;creatine clearance category
 562;category $nmbr$ and $nmbr$;"C0683312;C3889287";NA;NA;category $nmbr$ and $nmbr$
 562;category $nmbr$;"C0683312;C3889287";NA;NA;category $nmbr$
 562;category;"C0683312;C3889287";NA;NA;category
 562;cardiovascular disease risk category;"C0683312;C1113685;C3889287";NA;NA;cardiovascular disease risk category
 562;background csdmard category;"C0683312;C1706907;C3889287";NA;NA;background csdmard category
 562;age category >;"C0001779;C0683312;C3889287";NA;NA;age category
 562;age category ( years )  n ( % );"C0683312;C1510829;C3889287";NA;NA;age category years n
 562;age category ( % );"C0001779;C0683312;C3889287";NA;NA;age category
 562;age category  n ( % ) < $nmbr$ years;"C0683312;C1510829;C3889287";NA;NA;age category n $nmbr$ years
 562;age category  n ( % ) :;"C0001779;C0683312;C3889287";NA;NA;age category n
 562;age category  n ( % );"C0001779;C0683312;C3889287";NA;NA;age category n
 562;age category;"C0001779;C0683312;C3889287";NA;NA;age category
 562;/ \ge category;"C0683312;C1292300;C3538705;C3889287";NA;NA;\ge category
 561;severity ofhypertension [ n ( % ) ] b;"C0439793;C0522510";NA;NA;severity ofhypertension n b
 561;severity of hypertensionb;"C0439793;C0522510";NA;NA;severity of hypertensionb
 561;severity of heartburnb;"C0439793;C0522510";NA;NA;severity of heartburnb
 561;severity of copda  airflow limitation  n ( % );"C0231999;C0439793;C0443288;C0449295;C0522510";NA;NA;severity of copda airflow limitation n
 561;severity of copd  airflow limitation  n ( % );"C0024117;C0231999;C0439793;C0443288;C0449295;C0522510;C1412502;C3714496";NA;NA;severity of copd airflow limitation n
 561;severity of airflow obstruction;"C0028778;C0231999;C0439793;C0522510;C1882136";NA;NA;severity of airflow obstruction
 561;severity of airflow limitation;"C0231999;C0439793;C0443288;C0449295;C0522510";NA;NA;severity of airflow limitation
 561;severity n ( % );"C0439793;C0522510";NA;NA;severity n
 561;severity;"C0439793;C0522510";NA;NA;severity
 561;nocturnal heartburn severity;"C0018834;C0240526;C0439793;C0522510";NA;NA;nocturnal heartburn severity
 565;carotid stenosis;C0007282;FALSE;2196;carotid stenosis
 565;carotid artery stenosis  n ( % );C0007282;FALSE;2196;carotid artery stenosis n
 565;extracranial carotid stenosis  n ( % );"C0007282;C0580586";FALSE;2196;extracranial carotid stenosis n
 561;morning stiffness severity  $nmbr$ - $nmbr$ scale;"C0175659;C0349674;C0439793;C0457086;C0522510;C1947916";NA;NA;morning stiffness severity $nmbr$ $nmbr$ scale
 561;lowzmedium intensity;C0522510;NA;NA;lowzmedium intensity
 561;lntensityd;NA;NA;NA;lntensityd
 561;intensive therapy ( n = $nmbr$ );"C0039798;C0087111;C0162425;C0522510;C1283828;C1363945;C1550453";NA;NA;intensive therapy n $nmbr$
 561;intensive glycemia lowering;"C0005802;C0162425;C0441994;C0522510;C1283828;C1550453;C2003888";NA;NA;intensive glycemia lowering
 561;intensive control;"C0162425;C0243148;C0522510;C1283828;C1550141;C1550453;C1882979;C2587213;C3274648;C4553389";NA;NA;intensive control
 561;intensive blood glucose control;"C0162425;C0522510;C1283828;C1550453;C3267174";NA;NA;intensive blood glucose control
 561;intensive ( n = $nmbr$ );"C0162425;C0522510;C1283828;C1550453";NA;NA;intensive n $nmbr$
 561;intensity $nmbr$;C0522510;NA;NA;intensity $nmbr$
 561;intense physical activity;"C0015259;C0026606;C0522510";NA;NA;intense physical activity
 561;intense;C0522510;NA;NA;intense
 561;hypertension severity;"C0020538;C0439793;C0522510;C1963138";NA;NA;hypertension severity
 561;heartburn severity during the run - in periodt;"C0018834;C0439793;C0522510;C3274438";NA;NA;heartburn severity during the run in periodt
 561;ed severity * *  n ( % ) :;"C0439793;C0522510;C3538926";NA;NA;ed severity n
 561;ed severity  no . ( % ) a;"C0439793;C0522510;C3538926";NA;NA;ed severity no a
 561;data presented as mean   ±   sd  unless otherwise specified    acopd severity is based on the gold $nmbr$ criteria [ $nmbr$ ]  gold $nmbr$ [ $nmbr$ ]    bon a scale of $nmbr$ – $nmbr$  with higher scores indicating worse health status  the mcid is a change of $nmbr$   units  on a scale of $nmbr$ – $nmbr$  with higher scores indicating more severe dyspnea  on a scale of $nmbr$ – $nmbr$  with higher scores indicating worse health status;"C0018026;C0018759;C0175659;C0205172;C0205250;C0205369;C0243161;C0332271;C0349674;C0392747;C0439148;C0439793;C0443172;C0444504;C0449450;C0449820;C0522510;C1279889;C1304897;C1457868;C1511726;C1519795;C1527178;C1552041;C1705241;C1705938;C1947916;C2080700;C2347634;C2348143;C2699239;C2986536;C3245479;C3714741;C3853603;C4319952";NA;NA;data presented as mean sd unless otherwise specified acopd severity is based on the gold $nmbr$ criteria $nmbr$ gold $nmbr$ $nmbr$ bon a scale of $nmbr$ $nmbr$ with higher scores indicating worse health status the mcid is a change of $nmbr$ units on a scale of $nmbr$ $nmbr$ with higher scores indicating more severe dyspnea on a scale of $nmbr$ $nmbr$ with higher scores indicating worse health status
 561;baseline statin intensity;"C0168634;C0360714;C0522510;C1442488";NA;NA;baseline statin intensity
 561;baseline ed severity * * :;"C0168634;C0439793;C0522510;C1442488;C3538926";NA;NA;baseline ed severity
 561;any severity;"C0439793;C0522510";NA;NA;any severity
 560;hrg;"C1437978;C1705020";NA;NA;hrg
 560;hmg - coa reductase inhibitors;"C0360714;C2756999;C3539119";NA;NA;hmg coa reductase inhibitors
 333;diet - controlled ( % );C0743195;NA;NA;diet controlled
 559;beam   <   $nmbr$   mg / dl at week $nmbr$  n ( % );"C0332174;C0338248;C0439230;C0439269;C2347880;C4521565";NA;NA;beam $nmbr$ mg dl at week $nmbr$ n
 558;menopausal status and hormone therapy use;"C0042153;C0279025;C0457083;C1513126;C1947944";NA;NA;menopausal status and hormone therapy use
 558;hormone therapy use;"C0042153;C0279025;C0457083;C1947944";NA;NA;hormone therapy use
 558;hormone therapy;C0279025;NA;NA;hormone therapy
 558;hormonal therapy — no . ( % );C0279025;NA;NA;hormonal therapy no
 558;baseline use of hormone therapy ( % );"C0168634;C0279025;C1442488;C1524063";NA;NA;baseline use of hormone therapy
 556;no diuretic therapy;C0948575;NA;NA;no diuretic therapy
 556;diuretic therapy;C0948575;NA;NA;diuretic therapy
 556;diabetes therapy at baseline ( alone or in combination );"C0168634;C0205171;C0205195;C0439044;C0679994;C1442488;C1947911;C3274787;C3539002;C3811910";NA;NA;diabetes therapy at baseline alone or in combination
 556;diabetes therapy  n ( % );"C3274787;C3539002";NA;NA;diabetes therapy n
 556;diabetes therapy;"C3274787;C3539002";NA;NA;diabetes therapy
 555;estrogen therapy;C0279494;NA;NA;estrogen therapy
 555;anticoagulant therapy;C0150457;NA;NA;anticoagulant therapy
 554;pharmacotherapy;"C0013216;C0013217";NA;NA;pharmacotherapy
 554;other drug therapy  n ( % );"C0013216;C0013217";NA;NA;other drug therapy n
 554;macroalbuminuria — no . ( % ) drug therapy — no . ( % );"C0013216;C0013217";NA;NA;macroalbuminuria no drug therapy no
 554;drug therapy  no . ( % );"C0013216;C0013217";NA;NA;drug therapy no
 554;drug therapy  n ( % );"C0013216;C0013217";NA;NA;drug therapy n
 554;drug therapy;"C0013216;C0013217";NA;NA;drug therapy
 553;statin monotherapy;C0360714;NA;NA;statin monotherapy
 553;phototherapy previous systemic treatment  n ( % );"C0031765;C0205156;C0678812;C1552607";NA;NA;phototherapy previous systemic treatment n
 553;phototherapy;C0031765;NA;NA;phototherapy
 553;monotherapy;NA;NA;NA;monotherapy
 553;metforminmonotherapy;NA;NA;NA;metforminmonotherapy
 553;glulisine monotherapy;NA;NA;NA;glulisine monotherapy
 552;treatment stratum ^ :;"C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;treatment stratum
 552;treated lesions ‡;"C0221198;C1522326";NA;NA;treated lesions
 552;treated;C1522326;NA;NA;treated
 552;stratum;NA;NA;NA;stratum
 552;patients treated for > $nmbr$ weeks ( % );"C0030705;C0439230;C1522326";NA;NA;patients treated for $nmbr$ weeks
 552;patients treated and operated  n ( % );"C0030705;C1522326;C3242339";NA;NA;patients treated and operated n
 552;patients treated;"C0030705;C1522326";NA;NA;patients treated
 552;patients ( treated set * )  n;"C0030705;C0036849;C1442518;C1522326;C1705195";NA;NA;patients treated set n
 552;not treated;"C1518422;C1522326";NA;NA;not treated
 552;normoalbuminuria at baseline ( $nmbr$ % of patients treated );"C0030705;C0168634;C1442488;C1522326";NA;NA;normoalbuminuria at baseline $nmbr$ of patients treated
 552;no . of treated lesions;"C0221198;C1522326";NA;NA;no of treated lesions
 552;lesions treated per patient;"C0030705;C0221198;C1522326";NA;NA;lesions treated per patient
 552;coronary artery treated  no . ( % );"C0205042;C1522326";NA;NA;coronary artery treated no
 551;untreated at baseline;"C0168634;C0332155;C1442488";NA;NA;untreated at baseline
 551;untreated;C0332155;NA;NA;untreated
 550;pvaluefor trend;"C1521798;C4554533";NA;NA;pvaluefor trend
 550;pfor trend;"C1151635;C1521798;C4554533";NA;NA;pfor trend
 550;p trend;"C0369773;C1521798;C2603361;C4554533";NA;NA;p trend
 550;p j $nmbr$ * trend;"C1518835;C1521798;C4554533";NA;NA;p j $nmbr$ trend
 550;p for trend -;"C0369773;C1521798;C2603361;C4554533";NA;NA;p for trend
 550;p for trend;"C0369773;C1521798;C2603361;C4554533";NA;NA;p for trend
 550;heterogeneity or trend p vaiue;"C0019409;C0242960;C1521798;C4554533";NA;NA;heterogeneity or trend p vaiue
 549;use of hormone replacement therapy ( a );"C0282402;C1524063";NA;NA;use of hormone replacement therapy a
 549;pre - menopausal without hormone replacement;"C0206158;C0282402";NA;NA;pre menopausal without hormone replacement
 561;intensity of statin therapy;"C0522510;C1278454";FALSE; 872;intensity of statin therapy
 561;intensity of statin therapy at baseline — no . { % );"C0168634;C0522510;C1278454;C1442488";FALSE; 872;intensity of statin therapy at baseline no
 557;anti - hypertensive therapy;C0585941;FALSE;1579;anti hypertensive therapy
 557;antihypertensive therapy;C0585941;FALSE;1579;antihypertensive therapy
 557;antihypertensive therapy  n ( % );C0585941;FALSE;1579;antihypertensive therapy n
 557;number of antihypertensive medications used  n ( % ) no antihypertensive therapy;"C0003364;C0369718;C0441922;C0585941;C1273517;C1718138";FALSE;1579;number of antihypertensive medications used n no antihypertensive therapy
 549;postmenopausal and no hrt;"C0232970;C0282402";NA;NA;postmenopausal and no hrt
 549;postmenopausal and current hrt;"C0232970;C0282402;C0521116;C1705970";NA;NA;postmenopausal and current hrt
 549;postmenopausal  no hrt;"C0232970;C0282402";NA;NA;postmenopausal no hrt
 549;postmenopausal  current hrt;"C0232970;C0282402;C0521116;C1705970";NA;NA;postmenopausal current hrt
 549;hrt use;"C0042153;C0282402;C0457083;C1947944";NA;NA;hrt use
 549;hrt;C0282402;NA;NA;hrt
 549;hormone replacement therapy use;"C0042153;C0282402;C0457083;C1947944";NA;NA;hormone replacement therapy use
 549;hormone replacement therapy;C0282402;NA;NA;hormone replacement therapy
 549;hormone replacement ! !;C0282402;NA;NA;hormone replacement
 549;hormone replacement;C0282402;NA;NA;hormone replacement
 548;itherchdt;NA;NA;NA;itherchdt
 548;atherectomy;C0162513;NA;NA;atherectomy
 548;> $nmbr$ or incident vitrectomy or photocoagulation;"C0023694;C0042903;C1328010;C1551358";NA;NA;$nmbr$ or incident vitrectomy or photocoagulation
 547;rarely;C0522498;NA;NA;rarely
 547;none or seldom;C0522498;NA;NA;none or seldom
 547;never / rarely;"C0522498;C2003901";NA;NA;never rarely
 546;stratum ii;"C1710602;C4082587";NA;NA;stratum ii
 546;stratum *;NA;NA;NA;stratum
 546;stratum  n ( % );NA;NA;NA;stratum n
 546;randomization stratum;C0034656;NA;NA;randomization stratum
 545;moderatex;NA;NA;NA;moderatex
 545;fibrate;NA;NA;NA;fibrate
 544;risk factors and diabetes status ( % );"C0035648;C1317301;C1553898";NA;NA;risk factors and diabetes status
 544;polyvascular disease * and type $nmbr$ diabetes status;"C0012634;C0332307;C0449438;C1317301;C1320657;C1547052";NA;NA;polyvascular disease and type $nmbr$ diabetes status
 544;diabetes status  no . ( % );C1317301;NA;NA;diabetes status no
 544;diabetes status  n ( % );C1317301;NA;NA;diabetes status n
 544;diabetes status;C1317301;NA;NA;diabetes status
 544;diabetes mellitus status;C1317301;NA;NA;diabetes mellitus status
 544;biomarker status;C0449442;NA;NA;biomarker status
 543;ugt induction status : per aeda  n ( % );"C0205263;C0449438;C0857127;C1420188;C4284131";NA;NA;ugt induction status per aeda n
 543;status ( spmsq > $nmbr$;C0449438;NA;NA;status spmsq $nmbr$
 543;status ( spmsq < $nmbr$;C0449438;NA;NA;status spmsq $nmbr$
 543;smokinq status;C0449438;NA;NA;smokinq status
 543;other glucose status;"C0017725;C0449438";NA;NA;other glucose status
 543;lev status  n ( % );"C0023556;C0449438";NA;NA;lev status n
 543;lev status;"C0023556;C0449438";NA;NA;lev status
 543;hormonal status;"C0449438;C0458083";NA;NA;hormonal status
 543;h . pylori status  n ( % );"C0079488;C0449438";NA;NA;h pylori status n
 543;frailty status;"C0424594;C0449438";NA;NA;frailty status
 543;emotional status;"C0013987;C0449438;C0849912";NA;NA;emotional status
 543;cortteosterom relrsclory status;C0449438;NA;NA;cortteosterom relrsclory status
 543;angina status — no . ( % );"C0002962;C0449438";NA;NA;angina status no
 543;aha status at screeningb  n ( % );"C0050451;C0449438;C0772110";NA;NA;aha status at screeningb n
 543;aed inducer status;"C0449438;C0887457;C3898767";NA;NA;aed inducer status
 542;stage iii;C0441771;NA;NA;stage iii
 542;stage ii;C0441767;NA;NA;stage ii
 542;stage $nmbr$ b : egfr > = $nmbr$ and < $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441781;C0441923;C1739039;C3811844;C3812682";NA;NA;stage $nmbr$ b egfr $nmbr$ and $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$
 542;stage $nmbr$ b : > = $nmbr$ and < $nmbr$;C0441781;NA;NA;stage $nmbr$ b $nmbr$ and $nmbr$
 542;stage $nmbr$ b : $nmbr$ - $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441781;C0441923";NA;NA;stage $nmbr$ b $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 542;stage $nmbr$ b;C0441781;NA;NA;stage $nmbr$ b
 542;gold stage iii;"C0018026;C0441771;C1304897";NA;NA;gold stage iii
 542;gold stage ii;"C0018026;C0441767;C1304897";NA;NA;gold stage ii
 541;years modified hoehn and yahr stage  n ( % );"C0205390;C0392747;C0439234;C1300072;C1306673;C3889737";NA;NA;years modified hoehn and yahr stage n
 541;stage of pda;"C0013274;C0205390;C0226047;C1300072;C1306673;C4282128";NA;NA;stage of pda
 541;stage iv;"C0022326;C0205390;C1300072;C1306673;C4265176";NA;NA;stage iv
 541;stage $nmbr$ a ckd cohort ( secondary analysis );"C0027627;C0086027;C0175668;C0205390;C0205436;C1300072;C1306673;C1561643";NA;NA;stage $nmbr$ a ckd cohort secondary analysis
 541;stage $nmbr$ a ckd cohort ( post hoc analysis excluding metformin users );"C0025598;C0086027;C0205390;C0332196;C0687676;C1300072;C1306673;C1561643;C1704687;C1706077;C2828389;C3469826";NA;NA;stage $nmbr$ a ckd cohort post hoc analysis excluding metformin users
 541;stage $nmbr$ a : egfr > = $nmbr$ and < $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$;"C0205390;C0369637;C0439445;C0441923;C1300072;C1306673;C1739039;C3811844;C3812682";NA;NA;stage $nmbr$ a egfr $nmbr$ and $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$
 541;stage $nmbr$ a : > = $nmbr$ and < $nmbr$;"C0205390;C1300072;C1306673";NA;NA;stage $nmbr$ a $nmbr$ and $nmbr$
 541;stage $nmbr$ a : $nmbr$ - $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0205390;C0369637;C0439445;C0441923;C1300072;C1306673";NA;NA;stage $nmbr$ a $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 541;stage $nmbr$ a;"C0205390;C1300072;C1306673";NA;NA;stage $nmbr$ a
 541;stage $nmbr$ : > = $nmbr$;"C0205390;C1300072;C1306673";NA;NA;stage $nmbr$ $nmbr$
 541;stage $nmbr$ : < $nmbr$;"C0205390;C1300072;C1306673";NA;NA;stage $nmbr$ $nmbr$
 541;stage $nmbr$ ( four - variable modification of diet in kidney disease );"C0022658;C0086153;C0205390;C0205450;C0439828;C1300072;C1306673;C3671772;C4553760";NA;NA;stage $nmbr$ four variable modification of diet in kidney disease
 541;stage $nmbr$ ( cockcroft - gault );"C0205390;C1300072;C1306673";NA;NA;stage $nmbr$ cockcroft gault
 541;stage $nmbr$;"C0205390;C1300072;C1306673";NA;NA;stage $nmbr$
 541;retinopathy ( stage $nmbr$ / $nmbr$ / $nmbr$ / $nmbr$ );"C0035309;C0205390;C1300072;C1306673;C1962966";NA;NA;retinopathy stage $nmbr$ $nmbr$ $nmbr$ $nmbr$
 541;nkf stage;"C0205390;C1300072;C1306673";NA;NA;nkf stage
 541;hoehn and yahr stage ( range  $nmbr$ - $nmbr$ );"C0205390;C1300072;C1306673;C1514721;C2348147;C3542016";NA;NA;hoehn and yahr stage range $nmbr$ $nmbr$
 541;hoehn and yahr stage ( baseline )  mean ( sd );"C0168634;C0205390;C0444504;C1300072;C1306673;C1442488;C2347634;C2348143;C2699239";NA;NA;hoehn and yahr stage baseline mean sd
 541;hoehn and yahr stage;"C0205390;C1300072;C1306673";NA;NA;hoehn and yahr stage
 541;hoehn & yahr stage ( “ on ” )  n ( % );"C0205390;C1300072;C1306673";NA;NA;hoehn yahr stage on n
 541;hoehn & yahr stage ( “ off ” )  n ( % );"C0205390;C1300072;C1306673";NA;NA;hoehn yahr stage off n
 541;hoehn & yahr stage;"C0205390;C1300072;C1306673";NA;NA;hoehn yahr stage
 541;gold stage — no . ( % ) * *;"C0018026;C0205390;C1300072;C1304897;C1306673";NA;NA;gold stage no
 541;gold stage iv;"C0018026;C0022326;C0205390;C1300072;C1304897;C1306673;C4265176";NA;NA;gold stage iv
 541;gold stage [ n ( % ) ];"C0018026;C0205390;C1300072;C1304897;C1306673";NA;NA;gold stage n
 541;gold stage ( % ) f;"C0016327;C0018026;C0205390;C1300072;C1304897;C1306673";NA;NA;gold stage f
 541;gold stage #;"C0018026;C0205390;C1300072;C1304897;C1306673";NA;NA;gold stage
 541;gold stage  nf * ( % );"C0018026;C0205390;C1300072;C1304897;C1306673";NA;NA;gold stage nf
 541;gold stage  n ( % );"C0018026;C0205390;C1300072;C1304897;C1306673";NA;NA;gold stage n
 541;gold stage  %;"C0018026;C0205390;C1300072;C1304897;C1306673";NA;NA;gold stage
 541;gold stage;"C0018026;C0205390;C1300072;C1304897;C1306673";NA;NA;gold stage
 541;estimated gfr renal function stage;"C0017654;C0205390;C0232804;C0750572;C1300072;C1306673;C1424601";NA;NA;estimated gfr renal function stage
 541;copd severity stage ( gold );"C0018026;C0024117;C0205390;C0439793;C0522510;C1300072;C1304897;C1306673;C1412502;C3714496";NA;NA;copd severity stage gold
 541;copd severity ( gold stage );"C0018026;C0024117;C0205390;C0439793;C0522510;C1300072;C1304897;C1306673;C1412502;C3714496";NA;NA;copd severity gold stage
 541;ckd stages;"C1306673;C1561643";NA;NA;ckd stages
 541;ckd stage $nmbr$ ( % );"C0205390;C1300072;C1306673;C1561643";NA;NA;ckd stage $nmbr$
 541;ckd stage $nmbr$;"C0205390;C1300072;C1306673;C1561643";NA;NA;ckd stage $nmbr$
 540;total vdh - s score ( $nmbr$ - $nmbr$ ) ( n );C2964552;NA;NA;total vdh s score $nmbr$ $nmbr$ n
 540;total vdh - s score;C2964552;NA;NA;total vdh s score
 540;total sgrq mean total score ( sd );"C0439175;C0439810;C0444504;C2347634;C2348143;C2699239;C2964552;C3533236";NA;NA;total sgrq mean total score sd
 540;total score §;C2964552;NA;NA;total score
 540;total score on the sgrq - c  i;"C0021966;C0221138;C2964552;C3826872";NA;NA;total score on the sgrq c i
 540;total score > $nmbr$;C2964552;NA;NA;total score $nmbr$
 540;total score < $nmbr$;C2964552;NA;NA;total score $nmbr$
 540;total score ( $nmbr$ – $nmbr$ scale );"C0175659;C0349674;C1947916;C2964552";NA;NA;total score $nmbr$ $nmbr$ scale
 540;total score;C2964552;NA;NA;total score
 540;total feet score;"C0016504;C0347981;C2964552";NA;NA;total feet score
 540;source;"C0449416;C1705919;C4521696";NA;NA;source
 540;sgrq total score * *;C2964552;NA;NA;sgrq total score
 540;sgrq total score * ( units );"C0439148;C1519795;C2964552;C3853603";NA;NA;sgrq total score units
 540;sgrq total score ( units ) : ! :;"C0439148;C1519795;C2964552;C3853603";NA;NA;sgrq total score units
 540;sgrq total score ( units );"C0439148;C1519795;C2964552;C3853603";NA;NA;sgrq total score units
 540;sgrq total score $nmbr$;C2964552;NA;NA;sgrq total score $nmbr$
 540;sgrq total score  units;"C0439148;C1519795;C2964552;C3853603";NA;NA;sgrq total score units
 540;sgrq total score;C2964552;NA;NA;sgrq total score
 540;sgrq responder ( % );NA;NA;NA;sgrq responder
 540;selena - sledai total score;"C0451528;C2964552";NA;NA;selena sledai total score
 540;mean sgrq total score ( sd );"C0439175;C0439810;C0444504;C2347634;C2348143;C2699239;C2964552;C3533236";NA;NA;mean sgrq total score sd
 540;mean sgrq total score;"C0439175;C0439810;C0444504;C2347634;C2348143;C2964552;C3533236";NA;NA;mean sgrq total score
 540;iwqol - lite total score ( arbitrary units ) #;"C0439183;C2964552";NA;NA;iwqol lite total score arbitrary units
 540;eacit - e total score ) |;C2964552;NA;NA;eacit e total score
 540;ccq total score;C2964552;NA;NA;ccq total score
 540;c $nmbr$ - unit sgrq total score increase;"C0439148;C0439453;C0442805;C1509845;C1519795;C1704753;C1880519;C2964552;C3853603";NA;NA;c $nmbr$ unit sgrq total score increase
 540;bdi total score ( baseline );"C0006448;C0168634;C0451022;C1442488;C2964552;C3714938;C3889415";NA;NA;bdi total score baseline
 540;baseline sgrq total score;"C0168634;C1442488;C2964552";NA;NA;baseline sgrq total score
 540;acq - $nmbr$ total score ∗;"C2919686;C2964552";NA;NA;acq $nmbr$ total score
 540;( total ses - cd score at;"C0007928;C0034283;C2964552;C4552032";NA;NA;total ses cd score at
 539;storage subscore;"C0337174;C1698986;C1753314";NA;NA;storage subscore
 539;stomach;"C0038351;C3714551";NA;NA;stomach
 539;mean ipss  storage sub - score ( sd );"C0337174;C0542339;C1019118;C1264637;C1698986;C1753314;C1998280;C2699239;C2827405;C3533236;C3811063";NA;NA;mean ipss storage sub score sd
 539;ipss storage subscore;"C0337174;C1019118;C1698986;C1753314;C1998280;C2827405;C3811063";NA;NA;ipss storage subscore
 538;trochanter;C0162370;NA;NA;trochanter
 538;subtrochanteric;NA;NA;NA;subtrochanteric
 537;nitrates ( oral or topical );"C0028125;C0332237;C0442027;C0699857;C3848573;C4521986";NA;NA;nitrates oral or topical
 537;nitrates ( % );"C0028125;C0699857;C3848573";NA;NA;nitrates
 537;nitrates  n ( % );"C0028125;C0369718;C0441922;C0699857;C3848573";NA;NA;nitrates n
 537;nitrates  ( % );"C0028125;C0699857;C3848573";NA;NA;nitrates
 537;nitrates;"C0028125;C0699857;C3848573";NA;NA;nitrates
 537;nitrate — no . ( % );"C0028125;C0699857;C3848573";NA;NA;nitrate no
 537;nitrate use;"C0028125;C0042153;C0457083;C0699857;C1947944;C3848573";NA;NA;nitrate use
 537;nitrate ( oral or intravenous );"C0028125;C0348016;C0442027;C0699857;C3848573;C4521986";NA;NA;nitrate oral or intravenous
 537;nitrate;"C0028125;C0699857;C3848573";NA;NA;nitrate
 537;iv nitrates;"C0022326;C0028125;C0699857;C3848573;C4265176";NA;NA;iv nitrates
 537;intravenous nitrates;"C0028125;C0348016";NA;NA;intravenous nitrates
 536;no estimate;C0750572;NA;NA;no estimate
 536;estimated glomerular filtration;"C0232809;C0750572";NA;NA;estimated glomerular filtration
 536;estimated gfr;"C0017654;C0750572;C1424601";NA;NA;estimated gfr
 536;estimate;C0750572;NA;NA;estimate
 536;combined estimated gfr and albuminuria status;"C0001925;C0017654;C0205195;C0449438;C0750572;C1424601";NA;NA;combined estimated gfr and albuminuria status
 536;baseline estimated gfr;"C0017654;C0168634;C0750572;C1424601;C1442488";NA;NA;baseline estimated gfr
 536;< $nmbr$ . $nmbr$ mmol / liter estimated gfr;"C0017654;C0439190;C0475211;C0750572;C1424601";NA;NA;$nmbr$ $nmbr$ mmol liter estimated gfr
 535;used;C1273517;NA;NA;used
 535;spacer use during the study;"C0221874;C0869040";NA;NA;spacer use during the study
 535;gpi used during pci;"C1273517;C1415351;C4049621";NA;NA;gpi used during pci
 535;acei use;"C0042153;C0457083;C1947944";NA;NA;acei use
 535;acei  n ( % );NA;NA;NA;acei n
 534;user;"C1548600;C1706077";NA;NA;user
 534;nonuser;NA;NA;NA;nonuser
 534;non - user $nmbr$;"C1518422;C1548600;C1706077";NA;NA;non user $nmbr$
 534;low - dose corticosteroid user;"C0001617;C0445550;C1548600;C1706077;C1708745;C3536709";NA;NA;low dose corticosteroid user
 534;laba users;C1706077;NA;NA;laba users
 534;laba non - users;"C1518422;C1706077";NA;NA;laba non users
 534;dmard user;"C0242708;C1548600;C1706077";NA;NA;dmard user
 534;bivariate frailty model ( statin users vs non - users );"C0360714;C0424594;C1518422;C1706077;C3161035;C3274659;C3714583;C3853906";NA;NA;bivariate frailty model statin users vs non users
 534;biologics user;"C0005515;C0005522;C1548600;C1706077;C4553887";NA;NA;biologics user
 533;western eu  australia  new zealand;"C0015179;C0027978;C0043128;C0324547;C1705493;C3665627;C4289954";NA;NA;western eu australia new zealand
 533;european union;C0015179;NA;NA;european union
 533;eu;"C0015179;C3665627";NA;NA;eu
 533;eastern eu;"C0015179;C1707877;C3665627";NA;NA;eastern eu
 -10;environmental stimuli;C0450025;NA;NA;environmental stimuli
 531;timi flow ‡;C3272266;NA;NA;timi flow
 531;final timi flow grade post - ppci;"C0205088;C0441800;C0687676;C0919553;C1546485;C1704687;C3244287;C3272266;C3469826;C3853528";NA;NA;final timi flow grade post ppci
 531;final timi flow grade < $nmbr$;"C0205088;C0441800;C0919553;C1546485;C3244287;C3272266;C3853528";NA;NA;final timi flow grade $nmbr$
 531;final timi flow;"C0205088;C1546485;C3272266;C3853528";NA;NA;final timi flow
 530;timi ≥ $nmbr$;NA;NA;NA;timi $nmbr$
 530;timi major / minor bleeding;"C0019080;C4441842";NA;NA;timi major minor bleeding
 530;timi major / minor;C4441842;NA;NA;timi major minor
 530;timi - bleeding major / minor;"C0019080;C4441842";NA;NA;timi bleeding major minor
 540;baseline ibdq total score  mean;"C0168634;C0444504;C1442488;C2347634;C2348143;C2964552";FALSE;2313;baseline ibdq total score mean
 540;ibdq total score;C2964552;FALSE;2313;ibdq total score
 529;qualifying nstemi  n ( % );"C1514624;C3537184;C4255010";NA;NA;qualifying nstemi n
 529;nstemi ( n = $nmbr$  $nmbr$ );"C3537184;C4255010";NA;NA;nstemi n $nmbr$ $nmbr$
 529;nstemi ( % );"C3537184;C4255010";NA;NA;nstemi
 529;nstemi;"C3537184;C4255010";NA;NA;nstemi
 529;nste - mi;"C3537184;C4255010";NA;NA;nste mi
 529;non — st - segment — elevation myocardial infarction;"C0441635;C1518422;C1536220;C1536221;C1536222;C3537184;C4255010";NA;NA;non st segment elevation myocardial infarction
 529;non - stemi;C3537184;NA;NA;non stemi
 529;non - st - segment elevation myocardial infarction;"C0441635;C1518422;C1536220;C1536221;C1536222;C3537184;C4255010";NA;NA;non st segment elevation myocardial infarction
 529;non - st - elevation myocardial infarction;"C1536221;C1536222;C3537184;C4255010";NA;NA;non st elevation myocardial infarction
 528;moderate decrease ( $nmbr$ - < $nmbr$ mlymin per $nmbr$ . $nmbr$ m $nmbr$ );"C0205081;C0369637;C0392756;C0441923;C0547047;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate decrease $nmbr$ $nmbr$ mlymin per $nmbr$ $nmbr$ m $nmbr$
 528;lvmi ( $nmbr$;NA;NA;NA;lvmi $nmbr$
 528;alvmi ( per g / m $nmbr$ );C0456715;NA;NA;alvmi per g m $nmbr$
 528;> $nmbr$ mlymin;NA;NA;NA;$nmbr$ mlymin
 528;< $nmbr$ mlymin;NA;NA;NA;$nmbr$ mlymin
 528;< $nmbr$ mlmin ) $nmbr$;NA;NA;NA;$nmbr$ mlmin $nmbr$
 528;$nmbr$ - < $nmbr$ mvmin;NA;NA;NA;$nmbr$ $nmbr$ mvmin
 527;overall dlqi score $nmbr$;"C0282416;C0449820;C1561607;C3899393;C4050231";NA;NA;overall dlqi score $nmbr$
 527;overall dlqi score;"C0282416;C0449820;C1561607;C3899393;C4050231";NA;NA;overall dlqi score
 527;mean dlqi score ( $nmbr$ % ci );"C0008107;C0444504;C0449820;C2347634;C2348143;C3259781;C3899393;C4050231";NA;NA;mean dlqi score $nmbr$ ci
 527;dlqi §;C3899393;NA;NA;dlqi
 527;dlqi score;"C0449820;C3899393;C4050231";NA;NA;dlqi score
 527;dlqi improvement from baseline to week $nmbr$;"C0168634;C0332174;C0439230;C1442488;C2986411;C3899393";NA;NA;dlqi improvement from baseline to week $nmbr$
 527;dlqi ( $nmbr$ - $nmbr$ )  mean ( sd );"C0444504;C2347634;C2348143;C2699239;C3899393";NA;NA;dlqi $nmbr$ $nmbr$ mean sd
 527;dlqi  $nmbr$ - $nmbr$ *;C3899393;NA;NA;dlqi $nmbr$ $nmbr$
 527;dlqi;C3899393;NA;NA;dlqi
 527;baseline dlqi  mean ( sd );"C0168634;C0444504;C1442488;C2347634;C2348143;C2699239;C3899393";NA;NA;baseline dlqi mean sd
 526;patients with enthesitis ( lei > $nmbr$ );"C0023401;C0030705;C0428209;C1282952";NA;NA;patients with enthesitis lei $nmbr$
 526;li $nmbr$ ( $nmbr$ . $nmbr$ );"C0023617;C3495095";NA;NA;li $nmbr$ $nmbr$ $nmbr$
 526;lei > $nmbr$ ( n = $nmbr$ );"C0023401;C0428209";NA;NA;lei $nmbr$ n $nmbr$
 526;lei $nmbr$;"C0023401;C0428209";NA;NA;lei $nmbr$
 526;lei  mean [ sd ] c;"C0023401;C0428209;C0444504;C2347634;C2348143;C2699239";NA;NA;lei mean sd c
 526;lei  mean ( sd );"C0023401;C0428209;C0444504;C2347634;C2348143;C2699239";NA;NA;lei mean sd
 525;no gi bleed;"C0019080;C1708130;C3539617;C4050121";NA;NA;no gi bleed
 525;gi bleed;"C0019080;C1708130;C3539617;C4050121";NA;NA;gi bleed
 525;$nmbr$ - gi;"C1708130;C3539617;C4050121";NA;NA;$nmbr$ gi
 524;who fc iii symptoms at baseline;"C0168634;C0439070;C0683368;C1442488;C1457887;C1705160;C2983605";NA;NA;who fc iii symptoms at baseline
 524;updrs total ( ii + iii );"C0439070;C0439175;C0439810;C1705160;C1710602;C3639721;C4082587";NA;NA;updrs total ii iii
 524;ncep atp iii risk factors;"C0035648;C0439070;C1553898;C1705160;C2744579;C4552600";NA;NA;ncep atp iii risk factors
 524;killip class ii  iii  or iv — %;"C0022326;C0439070;C1705160;C1710602;C2697845;C2697846;C4082587;C4265176";NA;NA;killip class ii iii or iv
 524;iii ( n z $nmbr$ );"C0439070;C1705160";NA;NA;iii n z $nmbr$
 524;iii ( $nmbr$ );"C0439070;C1705160";NA;NA;iii $nmbr$
 524;iii;"C0439070;C1705160";NA;NA;iii
 524;ii or iii;"C0439070;C1705160";NA;NA;ii or iii
 524;ii / iii;"C0439070;C1705160;C1710602;C4082587";NA;NA;ii iii
 524;ii - iii;"C0439070;C1705160;C1710602;C4082587";NA;NA;ii iii
 524;class iii / iii - v;"C0439070;C0457166;C1705160;C1880098";NA;NA;class iii iii v
 524;class i or iii aad use in $nmbr$ months before enrollment;"C0042153;C0439070;C0439231;C0441885;C0457083;C1319793;C1516879;C1696073;C1705160;C1947944;C2698967;C3888021";NA;NA;class i or iii aad use in $nmbr$ months before enrollment
 524;$nmbr$ ii ( $nmbr$ . $nmbr$ );NA;NA;NA;$nmbr$ ii $nmbr$ $nmbr$
 523;re - cover ii;"C0180153;C0556581;C1999244;C2986904;C3888055";NA;NA;re cover ii
 523;re - cover / re - cover ii;"C0180153;C0556581;C1999244;C2986904;C3888055";NA;NA;re cover re cover ii
 523;ii = $nmbr$;NA;NA;NA;ii $nmbr$
 523;ii $nmbr$ ( i $nmbr$ . $nmbr$ );"C0021966;C0221138;C1710602;C4082587";NA;NA;ii $nmbr$ i $nmbr$ $nmbr$
 523;i or ii;"C0021966;C0221138";NA;NA;i or ii
 523;i & ii : fev $nmbr$ > $nmbr$ % predicted;"C0021966;C0221138;C0681842;C1710602;C1882327;C3714541;C4082587";NA;NA;i ii fev $nmbr$ $nmbr$ predicted
 523;i $nmbr$ ± $nmbr$ ii;"C0021966;C0221138;C1710602;C4082587";NA;NA;i $nmbr$ $nmbr$ ii
 523;enrolled from re - cover ii study — no . ( % );"C0180153;C0556581;C0557651;C1999244;C2603343;C2986904;C3888055;C4684790";NA;NA;enrolled from re cover ii study no
 523;asteria i / ii;"C0021966;C0221138;C1093020;C1710602;C4082587";NA;NA;asteria i ii
 523;$nmbr$ . i ± ii . $nmbr$;"C0021966;C0221138;C1710602;C4082587";NA;NA;$nmbr$ i ii $nmbr$
 523;$nmbr$ . $nmbr$ ± ii . $nmbr$;NA;NA;NA;$nmbr$ $nmbr$ ii $nmbr$
 522;ii . $nmbr$ ( $nmbr$ . $nmbr$ ) $nmbr$;NA;NA;NA;ii $nmbr$ $nmbr$ $nmbr$ $nmbr$
 522;ii $nmbr$ ± $nmbr$;NA;NA;NA;ii $nmbr$ $nmbr$
 521;who fc ii symptoms at baselinef;"C0683368;C1457887;C1710602;C2983605;C4082587";NA;NA;who fc ii symptoms at baselinef
 521;who fc ii symptoms at baseline $nmbr$;"C0168634;C0683368;C1442488;C1457887;C1710602;C2983605;C4082587";NA;NA;who fc ii symptoms at baseline $nmbr$
 521;who fc ii symptoms at baseline;"C0168634;C0683368;C1442488;C1457887;C1710602;C2983605;C4082587";NA;NA;who fc ii symptoms at baseline
 521;updrs  part ii ( adl );"C0001288;C0449719;C1420005;C1709471;C1710602;C3639721;C4082587";NA;NA;updrs part ii adl
 521;sr ii b $nmbr$ - cjl $nmbr$;"C0753208;C1709991;C1710602;C3813610;C3890900;C3891546;C4082587";NA;NA;sr ii b $nmbr$ cjl $nmbr$
 521;revive ii;NA;NA;NA;revive ii
 521;period ii;"C0439531;C1710602;C1948053;C4082587";NA;NA;period ii
 521;lor ii;"C1416897;C1416899;C1710602;C2986770;C4082587";NA;NA;lor ii
 521;ii lisinopril;"C0065374;C1710602;C4082587";NA;NA;ii lisinopril
 521;ii chiorthaiidone amiodipine;"C1710602;C4082587";NA;NA;ii chiorthaiidone amiodipine
 521;ii ( n = $nmbr$ );"C1710602;C4082587";NA;NA;ii n $nmbr$
 521;ii $nmbr$ amlodipine - lisinopril - chlorthalidone chlorthalidone;"C0008294;C0051696;C0065374;C1710602;C4082587";NA;NA;ii $nmbr$ amlodipine lisinopril chlorthalidone chlorthalidone
 521;ii $nmbr$ ( ii . $nmbr$ );"C1710602;C4082587";NA;NA;ii $nmbr$ ii $nmbr$
 521;ii;NA;NA;NA;ii
 521;i / ii;"C0021966;C0221138;C1710602;C4082587";NA;NA;i ii
 521;europe ii;"C0015176;C1710602;C4082587";NA;NA;europe ii
 521;dual ii;"C0205173;C1554184;C1710602;C4082587";NA;NA;dual ii
 521;> o - $nmbr$ - ii;"C0483204;C1710602;C4082587";NA;NA;o $nmbr$ ii
 520;xi = ° - ° $nmbr$;C1720296;NA;NA;xi $nmbr$
 520;xi = oo  p = o - $nmbr$;C1720296;NA;NA;xi oo p o $nmbr$
 520;xi = o - $nmbr$  p = o - $nmbr$;C1720296;NA;NA;xi o $nmbr$ p o $nmbr$
 520;xi = l ’ $nmbr$  p = $nmbr$ - $nmbr$;C1720296;NA;NA;xi l $nmbr$ p $nmbr$ $nmbr$
 520;xi = $nmbr$ . $nmbr$;C1720296;NA;NA;xi $nmbr$ $nmbr$
 520;xi = $nmbr$ - l  p = $nmbr$ - $nmbr$;C1720296;NA;NA;xi $nmbr$ l p $nmbr$ $nmbr$
 520;xi = $nmbr$ - $nmbr$  p = o - l;C1720296;NA;NA;xi $nmbr$ $nmbr$ p o l
 520;xi = $nmbr$ - $nmbr$  p = $nmbr$ - l;C1720296;NA;NA;xi $nmbr$ $nmbr$ p $nmbr$ l
 520;xi = $nmbr$ - $nmbr$  p = $nmbr$ - $nmbr$;C1720296;NA;NA;xi $nmbr$ $nmbr$ p $nmbr$ $nmbr$
 520;xi = $nmbr$ - $nmbr$  p = $nmbr$;C1720296;NA;NA;xi $nmbr$ $nmbr$ p $nmbr$
 520;xi = $nmbr$ - $nmbr$;C1720296;NA;NA;xi $nmbr$ $nmbr$
 520;xi = $nmbr$;C1720296;NA;NA;xi $nmbr$
 519;unadjusted or ( $nmbr$ % ci ) p value;"C0008107;C1439367;C1709380;C3259781";NA;NA;unadjusted or $nmbr$ ci p value
 519;treatment difference ( $nmbr$ % ci );"C0008107;C0039798;C0087111;C1522326;C1533734;C1705169;C1705241;C1705242;C3259781;C3538994;C3887704";NA;NA;treatment difference $nmbr$ ci
 519;treatment diff . vs tio ( $nmbr$ % ci );"C0008107;C0039798;C0087111;C1522326;C1533734;C1705169;C3259781;C3538994;C3887704";NA;NA;treatment diff vs tio $nmbr$ ci
 519;stratified hazard ratio ( $nmbr$ % ci );"C0008107;C0205363;C2985465;C3259781";NA;NA;stratified hazard ratio $nmbr$ ci
 519;relative risk { $nmbr$ % ci );"C0008107;C0242492;C3259781";NA;NA;relative risk $nmbr$ ci
 519;relative risk ( $nmbr$ % ci ) ofprimary end point;"C0008107;C0242492;C2349179;C2826544;C3259781";NA;NA;relative risk $nmbr$ ci ofprimary end point
 519;relative risk ( $nmbr$ % ci );"C0008107;C0242492;C3259781";NA;NA;relative risk $nmbr$ ci
 519;ratio of hrs ( $nmbr$ % ci )  p for sex interaction;"C0008107;C0009253;C0036864;C0079399;C0456603;C0804628;C1314687;C1522384;C1547037;C1568891;C1704675;C3259781";NA;NA;ratio of hrs $nmbr$ ci p for sex interaction
 519;ratio mepo / pbo ( $nmbr$ % ci );"C0008107;C0031962;C0456603;C1547037;C3259781";NA;NA;ratio mepo pbo $nmbr$ ci
 519;ratio ( $nmbr$ % ci ) *;"C0008107;C0456603;C1547037;C3259781";NA;NA;ratio $nmbr$ ci
 519;rate estimate ( $nmbr$ % ci );"C0008107;C0750572;C0871208;C1521828;C3259781";NA;NA;rate estimate $nmbr$ ci
 519;r | r ' ' ' ( $nmbr$ % ci );"C0008107;C0205090;C0684010;C2603358;C3259781";NA;NA;r r $nmbr$ ci
 519;r elative risk ( $nmbr$ % ci );"C0008107;C0035647;C0205090;C0233492;C0684010;C2603358;C3259781;C4552904";NA;NA;r elative risk $nmbr$ ci
 519;placebo - adjusted mean difference in % hba $nmbr$ c ( $nmbr$ % ci  [ p value ] );"C0008107;C0019016;C0032042;C0444504;C0456081;C1696465;C1705241;C1705242;C1706408;C1709380;C1825777;C2347634;C2348143;C3259781;C3538758";NA;NA;placebo adjusted mean difference in hba $nmbr$ c $nmbr$ ci p value
 519;pav  mean ( $nmbr$ % ci );"C0008107;C0058890;C0444504;C2347634;C2348143;C3259781";NA;NA;pav mean $nmbr$ ci
 519;oradj ( $nmbr$ % ci );"C0008107;C3259781";NA;NA;oradj $nmbr$ ci
 519;or 、 ( $nmbr$ % ci );"C0008107;C3259781";NA;NA;or $nmbr$ ci
 519;or [ $nmbr$ % ci ];"C0008107;C3259781";NA;NA;or $nmbr$ ci
 519;or ( $nmbr$ % ci ) a;"C0008107;C3259781";NA;NA;or $nmbr$ ci a
 519;or ( $nmbr$ % ci );"C0008107;C3259781";NA;NA;or $nmbr$ ci
 519;or $nmbr$ % ci;"C0008107;C3259781";NA;NA;or $nmbr$ ci
 519;odds ‐ ratio ( $nmbr$ % ci );"C0008107;C0028873;C3259781";NA;NA;odds ratio $nmbr$ ci
 519;odds ratios ( $nmbr$ % ci );"C0008107;C0028873;C3259781";NA;NA;odds ratios $nmbr$ ci
 519;odds ratio versus placebo ( $nmbr$ % ci );"C0008107;C0028873;C0032042;C1696465;C1706408;C3259781";NA;NA;odds ratio versus placebo $nmbr$ ci
 519;odds ratio ( $nmbr$ % ci );"C0008107;C0028873;C3259781";NA;NA;odds ratio $nmbr$ ci
 519;mmrm estimates  ls mean ( se )  [ $nmbr$ % ci ];"C0008107;C0023668;C0036919;C0444504;C0750572;C2347634;C2348143;C3259781";NA;NA;mmrm estimates ls mean se $nmbr$ ci
 519;median time to first exacerbation ( months [ $nmbr$ % ci ] );"C0008107;C0205435;C0549183;C0556969;C0876920;C1279901;C2347635;C2348144;C2939193;C3259781;C4086268";NA;NA;median time to first exacerbation months $nmbr$ ci
 519;mean sf $nmbr$ score ( $nmbr$ % ci );"C0008107;C0037712;C3259781;C3533236";NA;NA;mean sf $nmbr$ score $nmbr$ ci
 519;mean pasi score ( $nmbr$ % ci );"C0008107;C3259781;C3533236;C4528685";NA;NA;mean pasi score $nmbr$ ci
 519;mean number of exacerbations ( per patient - year [ $nmbr$ % ci ] );"C0008107;C0030705;C0237753;C0439234;C0439508;C0444504;C0449788;C2347634;C2348143;C3259781;C4086268";NA;NA;mean number of exacerbations per patient year $nmbr$ ci
 519;mean ham - d score ( $nmbr$ % ci );"C0008107;C1570167;C3259781;C3533236;C3853311";NA;NA;mean ham d score $nmbr$ ci
 519;mean eq - $nmbr$ d response ( $nmbr$ % ci );"C0008107;C0205163;C0439185;C0444504;C0871261;C1704632;C1706817;C2347634;C2348143;C2911692;C3259781";NA;NA;mean eq $nmbr$ d response $nmbr$ ci
 519;adjusted or ( $nmbr$ % ci ) b;"C0008107;C0456081;C3259781";NA;NA;adjusted or $nmbr$ ci b
 332;uncontrolled on oad ( s );C0205318;NA;NA;uncontrolled on oad s
 519;mean ( $nmbr$ % ci ) change from $nmbr$ . $nmbr$ to $nmbr$ . $nmbr$ mg  % ‐ points;"C0008107;C0024671;C0026410;C0392747;C0439269;C0443172;C0444504;C1552961;C1705241;C1960952;C2346927;C2347617;C2347634;C2348143;C3259781;C3714763;C4319952;C4321396;C4521761";NA;NA;mean $nmbr$ ci change from $nmbr$ $nmbr$ to $nmbr$ $nmbr$ mg points
 519;mean ( $nmbr$ % ci ) change from $nmbr$ . $nmbr$ to $nmbr$ . $nmbr$ mg  %;"C0008107;C0024671;C0026410;C0392747;C0439269;C0443172;C0444504;C1705241;C1960952;C2346927;C2347634;C2348143;C3259781;C4319952;C4321396;C4521761";NA;NA;mean $nmbr$ ci change from $nmbr$ $nmbr$ to $nmbr$ $nmbr$ mg
 519;lsms difference ( $nmbr$ % ci ) $nmbr$;"C0008107;C1705241;C1705242;C3259781";NA;NA;lsms difference $nmbr$ ci $nmbr$
 519;lsm ( $nmbr$ % ci );"C0008107;C3259781";NA;NA;lsm $nmbr$ ci
 519;ls means difference ( $nmbr$ % ci ) a;"C0008107;C0023668;C1704970;C1705241;C1705242;C3259781";NA;NA;ls means difference $nmbr$ ci a
 519;ls means difference ( $nmbr$ % ci ) $nmbr$;"C0008107;C0023668;C1704970;C1705241;C1705242;C3259781";NA;NA;ls means difference $nmbr$ ci $nmbr$
 519;ls mean treatment difference ( $nmbr$ % ci );"C0008107;C0023668;C0039798;C0087111;C0444504;C1522326;C1533734;C1705169;C1705241;C1705242;C2347634;C2348143;C3259781;C3538994;C3887704";NA;NA;ls mean treatment difference $nmbr$ ci
 519;ls mean difference ( $nmbr$ % ci );"C0008107;C0023668;C0444504;C1705241;C1705242;C2347634;C2348143;C3259781";NA;NA;ls mean difference $nmbr$ ci
 519;ls mean ( $nmbr$ % ci ) a;"C0008107;C0023668;C0444504;C2347634;C2348143;C3259781";NA;NA;ls mean $nmbr$ ci a
 519;ls mean ( $nmbr$ % ci )  %;"C0008107;C0023668;C0444504;C2347634;C2348143;C3259781";NA;NA;ls mean $nmbr$ ci
 519;ls mean ( $nmbr$ % ci );"C0008107;C0023668;C0444504;C2347634;C2348143;C3259781";NA;NA;ls mean $nmbr$ ci
 519;ls - mean difference between treatment groups ( $nmbr$ % ci );"C0008107;C0023668;C0039798;C0087111;C0374505;C0444504;C1522326;C1533734;C1705169;C1705241;C1705242;C2347634;C2348143;C3259781;C3538994;C3887704";NA;NA;ls mean difference between treatment groups $nmbr$ ci
 519;ls - mean change from baseline ( $nmbr$ % ci );"C0008107;C0023668;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C3259781;C4319952";NA;NA;ls mean change from baseline $nmbr$ ci
 519;ls - mean between - group difference ( $nmbr$ % ci );"C0008107;C0023668;C1705241;C1705242;C2347634;C3259781";NA;NA;ls mean between group difference $nmbr$ ci
 519;least squares mean between - treatment difference ( $nmbr$ % ci );"C0008107;C0023189;C0039798;C0087111;C0444504;C1522326;C1533734;C1705169;C1705241;C1705242;C2347634;C2348143;C3259781;C3538994;C3887704";NA;NA;least squares mean between treatment difference $nmbr$ ci
 519;least - squares mean difference ( $nmbr$ % ci ) *;"C0008107;C0023189;C0444504;C1705241;C1705242;C2347634;C2348143;C3259781";NA;NA;least squares mean difference $nmbr$ ci
 519;hradjusted ( $nmbr$ % ci ) b;"C0008107;C3259781";NA;NA;hradjusted $nmbr$ ci b
 519;hradj ( $nmbr$ % ci );"C0008107;C3259781";NA;NA;hradj $nmbr$ ci
 519;hr [ $nmbr$ % ci );"C0008107;C3259781";NA;NA;hr $nmbr$ ci
 519;hr ( $nmbr$ s % ci );"C0008107;C3259781";NA;NA;hr $nmbr$ s ci
 519;hr ( $nmbr$ % ci ) p   value;"C0008107;C1709380;C3259781";NA;NA;hr $nmbr$ ci p value
 519;hr ( $nmbr$ % ci ) p value for interaction *;"C0008107;C1704675;C1709380;C3259781";NA;NA;hr $nmbr$ ci p value for interaction
 519;hr  ( $nmbr$ % ci );"C0008107;C3259781";NA;NA;hr $nmbr$ ci
 519;heart failure  ci  confidence interval .;"C0008107;C0009667;C0018801;C0018802;C3259781;C4554158";NA;NA;heart failure ci confidence interval
 519;hazard ratio for cardiovascular death  stroke  or myocardial infarction ( $nmbr$ % ci );"C0008107;C0011065;C0027051;C0428953;C1306577;C2926063;C2985465;C3259781;C3810814;C4082313;C4552775;C4552959";NA;NA;hazard ratio for cardiovascular death stroke or myocardial infarction $nmbr$ ci
 519;hazard ratio * ( $nmbr$ % ci );"C0008107;C2985465;C3259781";NA;NA;hazard ratio $nmbr$ ci
 519;hazard ratio ( $nmbr$ % ci ) $nmbr$ with vs . without psoriasis;"C0008107;C0033860;C2985465;C3259781";NA;NA;hazard ratio $nmbr$ ci $nmbr$ with vs without psoriasis
 519;hazard ratio ( $nmbr$ % ci );"C0008107;C2985465;C3259781";NA;NA;hazard ratio $nmbr$ ci
 519;harzard ratio ( $nmbr$ % ci );"C0008107;C0456603;C1547037;C3259781";NA;NA;harzard ratio $nmbr$ ci
 519;harzar ratio ( $nmbr$ % ci );"C0008107;C0456603;C1547037;C3259781";NA;NA;harzar ratio $nmbr$ ci
 519;from baseline ( $nmbr$ % ci );"C0008107;C0168634;C1442488;C3259781";NA;NA;from baseline $nmbr$ ci
 519;etr : $nmbr$ . $nmbr$ [ $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ ] $nmbr$ % ci  p     =   $nmbr$ . $nmbr$;"C0008107;C3259781";NA;NA;etr $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ ci p $nmbr$ $nmbr$
 519;etd : − $nmbr$ . $nmbr$ [ − $nmbr$ . $nmbr$  − $nmbr$ . $nmbr$ ] $nmbr$ % ci  p     <   $nmbr$ . $nmbr$;"C0008107;C1180255;C3259781";NA;NA;etd $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ ci p $nmbr$ $nmbr$
 519;etd : − $nmbr$ . $nmbr$ [ − $nmbr$ . $nmbr$  − $nmbr$ . $nmbr$ ] $nmbr$ % ci  p     <   $nmbr$ . $nmbr$;"C0008107;C1180255;C3259781";NA;NA;etd $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ ci p $nmbr$ $nmbr$
 519;etd : − $nmbr$ . $nmbr$ [ − $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ ] $nmbr$ % ci  p     =   $nmbr$ . $nmbr$;"C0008107;C1180255;C3259781";NA;NA;etd $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ ci p $nmbr$ $nmbr$
 519;etd ( % ) [ $nmbr$ % ci ];"C0008107;C1180255;C3259781";NA;NA;etd $nmbr$ ci
 519;etd ( $nmbr$ % ci );"C0008107;C1180255;C3259781";NA;NA;etd $nmbr$ ci
 519;estimated difference ( $nmbr$ % ci );"C0008107;C0750572;C1705241;C1705242;C3259781";NA;NA;estimated difference $nmbr$ ci
 519;estimate ( $nmbr$ % ci );"C0008107;C0750572;C3259781";NA;NA;estimate $nmbr$ ci
 519;difference in ls means ( $nmbr$ % ci ) versus placebo;"C0008107;C0023668;C0032042;C1696465;C1704970;C1705241;C1705242;C1706408;C3259781";NA;NA;difference in ls means $nmbr$ ci versus placebo
 519;difference in ls means ( $nmbr$ % ci ) a;"C0008107;C0023668;C1704970;C1705241;C1705242;C3259781";NA;NA;difference in ls means $nmbr$ ci a
 519;difference in ls means ( $nmbr$ % ci ) $nmbr$;"C0008107;C0023668;C1704970;C1705241;C1705242;C3259781";NA;NA;difference in ls means $nmbr$ ci $nmbr$
 519;difference in ls means ( $nmbr$ % ci );"C0008107;C0023668;C1704970;C1705241;C1705242;C3259781";NA;NA;difference in ls means $nmbr$ ci
 519;difference in ls mean vs placebo ( $nmbr$ % ci )  mmol / mol;"C0008107;C0023668;C0032042;C0444504;C1696465;C1705241;C1705242;C1706408;C2347634;C2348143;C3259781;C3829066";NA;NA;difference in ls mean vs placebo $nmbr$ ci mmol mol
 519;difference in ls mean vs placebo ( $nmbr$ % ci )  %;"C0008107;C0023668;C0032042;C0444504;C1696465;C1705241;C1705242;C1706408;C2347634;C2348143;C3259781";NA;NA;difference in ls mean vs placebo $nmbr$ ci
 519;difference ( $nmbr$ % ci ) *;"C0008107;C1705241;C1705242;C3259781";NA;NA;difference $nmbr$ ci
 519;difference ( $nmbr$ % ci  p value );"C0008107;C1705241;C1705242;C1709380;C3259781";NA;NA;difference $nmbr$ ci p value
 519;d ( $nmbr$ % ci );"C0008107;C0073187;C0332173;C3259781;C4484261";NA;NA;d $nmbr$ ci
 519;coronary syndrome . ci = confidence interval  hr = hazard ratio .;"C0008107;C0009667;C0018787;C0039082;C2985465;C3259781";NA;NA;coronary syndrome ci confidence interval hr hazard ratio
 519;cochranemantelehaenszel ( repeated $nmbr$ . $nmbr$ % ci ) c;"C0008107;C0205341;C3259781";NA;NA;cochranemantelehaenszel repeated $nmbr$ $nmbr$ ci c
 519;ci = confidence interval  na = not applicable or not analyzed .;"C0008107;C0009667;C0597484;C0936012;C1272460;C1518422;C1546968;C1879645;C3259781;C4049872;C4552882";NA;NA;ci confidence interval na not applicable or not analyzed
 519;ci - aki risk score;"C0008107;C0022660;C0035647;C0330978;C0449820;C3259781;C4050231;C4552904";NA;NA;ci aki risk score
 519;atorvastatin ls means difference $nmbr$ mg ( $nmbr$ % ci ) a ( n = $nmbr$ );"C0008107;C0023668;C0024671;C0026410;C0286651;C0369718;C0439269;C0441922;C1704970;C1705241;C1705242;C1960952;C2346927;C3259781;C4321396;C4521761";NA;NA;atorvastatin ls means difference $nmbr$ mg $nmbr$ ci a n $nmbr$
 519;annt or bnnh ( $nmbr$ % ci );"C0008107;C3259781";NA;NA;annt or bnnh $nmbr$ ci
 519;adjusted rate of pneumonia events ( per patient - year )  mean ( $nmbr$ % ci );"C0008107;C0030705;C0032285;C0439234;C0439508;C0441471;C0444504;C0456081;C0871208;C1521828;C2347634;C2348143;C3259781;C3541888";NA;NA;adjusted rate of pneumonia events per patient year mean $nmbr$ ci
 519;adjusted rate of hospitalized pneumonia events ( per patient - year )  mean ( $nmbr$ % ci );"C0008107;C0030705;C0032285;C0439234;C0439508;C0441471;C0444504;C0456081;C0701159;C0871208;C1521828;C2347634;C2348143;C3259781;C3541888";NA;NA;adjusted rate of hospitalized pneumonia events per patient year mean $nmbr$ ci
 519;adjusted or ( $nmbr$ % ci ) c;"C0008107;C0456081;C3259781";NA;NA;adjusted or $nmbr$ ci c
 519;adjusted modelc hr  $nmbr$ % ci  p value;"C0008107;C0456081;C1709380;C3259781";NA;NA;adjusted modelc hr $nmbr$ ci p value
 519;adjusted mean ± se ( $nmbr$ % ci );"C0008107;C0036919;C0444504;C0456081;C2347634;C2348143;C3259781";NA;NA;adjusted mean se $nmbr$ ci
 519;adjusted mean difference ( $nmbr$ % ci );"C0008107;C0444504;C0456081;C1705241;C1705242;C2347634;C2348143;C3259781";NA;NA;adjusted mean difference $nmbr$ ci
 519;adjusted hr * ( $nmbr$ % ci );"C0008107;C0456081;C3259781";NA;NA;adjusted hr $nmbr$ ci
 519;adjusted hr ( $nmbr$ % ci ) * comparing idm with bl;"C0005918;C0006413;C0008107;C0270221;C0456081;C1552663;C1707455;C2827109;C3259781";NA;NA;adjusted hr $nmbr$ ci comparing idm with bl
 519;adjusted hr ( $nmbr$ % ci ) * compared with no diabetes at bl or at year $nmbr$;"C0005918;C0006413;C0008107;C0011847;C0011849;C0439234;C0439508;C0456081;C1552663;C1707455;C2827109;C3259781";NA;NA;adjusted hr $nmbr$ ci compared with no diabetes at bl or at year $nmbr$
 519;adjusted hr ( $nmbr$ % ci );"C0008107;C0456081;C3259781";NA;NA;adjusted hr $nmbr$ ci
 519;adjusted hr  $nmbr$ % ci;"C0008107;C0456081;C3259781";NA;NA;adjusted hr $nmbr$ ci
 519;adjusted * or ( $nmbr$ % ci ) p value;"C0008107;C0456081;C1709380;C3259781";NA;NA;adjusted or $nmbr$ ci p value
 519;[ $nmbr$ % ci ] *;"C0008107;C3259781";NA;NA;$nmbr$ ci
 519;- $nmbr$ . $nmbr$ ( $nmbr$ % ci : - $nmbr$ . $nmbr$  - $nmbr$ . $nmbr$  n = $nmbr$ ) a - $nmbr$ . $nmbr$ %  * p = $nmbr$ . $nmbr$;"C0008107;C3259781";NA;NA;$nmbr$ $nmbr$ $nmbr$ ci $nmbr$ $nmbr$ $nmbr$ $nmbr$ n $nmbr$ a $nmbr$ $nmbr$ p $nmbr$ $nmbr$
 519;- $nmbr$ . $nmbr$ ( $nmbr$ % ci : - $nmbr$ . $nmbr$  - $nmbr$ . $nmbr$  n = $nmbr$ ) * p = $nmbr$ . $nmbr$;"C0008107;C3259781";NA;NA;$nmbr$ $nmbr$ $nmbr$ ci $nmbr$ $nmbr$ $nmbr$ $nmbr$ n $nmbr$ p $nmbr$ $nmbr$
 519;- $nmbr$ . $nmbr$ ( $nmbr$ % ci : - $nmbr$ . $nmbr$  - $nmbr$ . $nmbr$  n = $nmbr$ );"C0008107;C3259781";NA;NA;$nmbr$ $nmbr$ $nmbr$ ci $nmbr$ $nmbr$ $nmbr$ $nmbr$ n $nmbr$
 519;* ci denotes confidence interval .;"C0008107;C0009667;C3259781";NA;NA;ci denotes confidence interval
 519;( mean difference  $nmbr$ % ci );"C0008107;C0444504;C1705241;C1705242;C2347634;C2348143;C3259781";NA;NA;mean difference $nmbr$ ci
 519;( mean change  $nmbr$ % ci );"C0008107;C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C3259781;C4319952";NA;NA;mean change $nmbr$ ci
 519;( mean % difference  $nmbr$ % ci );"C0008107;C0444504;C1705241;C1705242;C2347634;C2348143;C3259781";NA;NA;mean difference $nmbr$ ci
 519;( mean % change  $nmbr$ % ci );"C0008107;C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C3259781;C4319952";NA;NA;mean change $nmbr$ ci
 519;( ci ) b;"C0008107;C3259781";NA;NA;ci b
 519;( $nmbr$ % ci ] h;"C0008107;C0033727;C0369286;C0441932;C0564385;C3259781;C4528284";NA;NA;$nmbr$ ci h
 519;( $nmbr$ % ci ] $nmbr$;"C0008107;C3259781";NA;NA;$nmbr$ ci $nmbr$
 519;( $nmbr$ % ci ) p value;"C0008107;C1709380;C3259781";NA;NA;$nmbr$ ci p value
 519;( $nmbr$ % ci ) c;"C0008107;C3259781";NA;NA;$nmbr$ ci c
 519;( $nmbr$ % ci ) b;"C0008107;C3259781";NA;NA;$nmbr$ ci b
 519;( $nmbr$ % ci ) a;"C0008107;C3259781";NA;NA;$nmbr$ ci a
 519;( $nmbr$ % ci );"C0008107;C3259781";NA;NA;$nmbr$ ci
 519;% difference  $nmbr$ % ci );"C0008107;C1705241;C1705242;C3259781";NA;NA;difference $nmbr$ ci
 519;% change  $nmbr$ % ci );"C0008107;C0392747;C0443172;C1705241;C3259781;C4319952";NA;NA;change $nmbr$ ci
 519;% ( $nmbr$ % ci );"C0008107;C3259781";NA;NA;$nmbr$ ci
 519;$nmbr$ . $nmbr$ ( $nmbr$ % ci : $nmbr$ . $nmbr$  $nmbr$ . $nmbr$  n = $nmbr$ );"C0008107;C3259781";NA;NA;$nmbr$ $nmbr$ $nmbr$ ci $nmbr$ $nmbr$ $nmbr$ $nmbr$ n $nmbr$
 519;$nmbr$ . $nmbr$ ( $nmbr$ % ci $nmbr$ . $nmbr$ to $nmbr$ . $nmbr$ ) p = $nmbr$ . $nmbr$;"C0008107;C3259781";NA;NA;$nmbr$ $nmbr$ $nmbr$ ci $nmbr$ $nmbr$ to $nmbr$ $nmbr$ p $nmbr$ $nmbr$
 519;$nmbr$ . $nmbr$ ( $nmbr$ % ci $nmbr$ . $nmbr$ to $nmbr$ . $nmbr$ );"C0008107;C3259781";NA;NA;$nmbr$ $nmbr$ $nmbr$ ci $nmbr$ $nmbr$ to $nmbr$ $nmbr$
 514;network;"C0150775;C1513822;C1705739;C1882071";NA;NA;network
 519;$nmbr$ . $nmbr$ $nmbr$ % ci : $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ p = $nmbr$ . $nmbr$;"C0008107;C3259781";NA;NA;$nmbr$ $nmbr$ $nmbr$ ci $nmbr$ $nmbr$ $nmbr$ $nmbr$ p $nmbr$ $nmbr$
 519;$nmbr$ % ci $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$;"C0008107;C3259781";NA;NA;$nmbr$ ci $nmbr$ $nmbr$ $nmbr$ $nmbr$
 519;$nmbr$ % ci $nmbr$;"C0008107;C3259781";NA;NA;$nmbr$ ci $nmbr$
 519;$nmbr$ % ci;"C0008107;C3259781";NA;NA;$nmbr$ ci
 518;mdi / hfa  n;"C0015458;C0993596;C1839839;C4049613";NA;NA;mdi hfa n
 518;mdi;"C0993596;C1839839;C4049613";NA;NA;mdi
 518;gp mdi;"C0993596;C1705010;C1839839;C3811116;C4049613";NA;NA;gp mdi
 518;gff mdi;"C0993596;C1839839;C4049613";NA;NA;gff mdi
 518;ff mdi;"C0993596;C1839839;C4049613;C4554348";NA;NA;ff mdi
 517;mri substudy ( n = $nmbr$ );"C0024485;C1824234;C3890166";NA;NA;mri substudy n $nmbr$
 517;criteria for subcortical vad ( by mri )  %;"C0024485;C0077973;C0243161;C0815275;C1824234;C3890166";NA;NA;criteria for subcortical vad by mri
 516;• ii : death from coronary heart disease  nonfatal mi  coronary revascularization > $nmbr$ days;"C0011065;C0018799;C0439228;C0545743;C0581603;C1306577;C1710602;C3810814;C4082313;C4082587;C4552775";NA;NA;ii death from coronary heart disease nonfatal mi coronary revascularization $nmbr$ days
 516;• any mi;C3810814;NA;NA;any mi
 516;type of mi ( % );"C0332307;C1547052;C3810814";NA;NA;type of mi
 516;type of mi;"C0332307;C1547052;C3810814";NA;NA;type of mi
 516;time from randomization to pci ( non - st - elevation mi )  h;"C0033727;C0034656;C0040223;C0369286;C0441932;C0520886;C0564385;C1518422;C3541383;C3810814;C4049621;C4528284";NA;NA;time from randomization to pci non st elevation mi h
 516;second prior mi;"C0205436;C0332152;C0457385;C0565930;C1561503;C1705190;C2826257;C3810814";NA;NA;second prior mi
 516;qualifying mi type;"C0332307;C1514624;C1547052;C3810814";NA;NA;qualifying mi type
 516;qualifying mi < $nmbr$ yrs prior;"C0332152;C1514624;C2826257;C3810814";NA;NA;qualifying mi $nmbr$ yrs prior
 516;qualifying mi $ $nmbr$ yrs prior;"C0332152;C1514624;C2826257;C3810814";NA;NA;qualifying mi $ $nmbr$ yrs prior
 516;qmi;NA;NA;NA;qmi
 516;pvaluefor any mi versus no mi;C3810814;NA;NA;pvaluefor any mi versus no mi
 516;prior mi within $nmbr$ y  no . ( % );"C0332152;C2826257;C3810814";NA;NA;prior mi within $nmbr$ y no
 516;prior mi n = $nmbr$;"C0332152;C2826257;C3810814";NA;NA;prior mi n $nmbr$
 516;prior mi diagnosis :;"C0332132;C3810814";NA;NA;prior mi diagnosis
 516;prior mi ( n = $nmbr$  $nmbr$ );"C0332152;C2826257;C3810814";NA;NA;prior mi n $nmbr$ $nmbr$
 516;prior mi ( n - $nmbr$  $nmbr$ );"C0332152;C2826257;C3810814";NA;NA;prior mi n $nmbr$ $nmbr$
 516;prior mi  n / n ( % );"C0332152;C2826257;C3810814";NA;NA;prior mi n n
 516;prior mi  %;"C0332152;C2826257;C3810814";NA;NA;prior mi
 516;prior mi;"C0332152;C2826257;C3810814";NA;NA;prior mi
 516;prior history of mi or ischaemic stroke;"C0019664;C0019665;C0262512;C0262926;C0332152;C0948008;C1705255;C2004062;C2826257;C3810814";NA;NA;prior history of mi or ischaemic stroke
 516;previous mi — no . ( % );"C0205156;C1552607;C3810814";NA;NA;previous mi no
 516;previous mi ( % );"C0205156;C1552607;C3810814";NA;NA;previous mi
 516;previous mi  n ( % );"C0205156;C1552607;C3810814";NA;NA;previous mi n
 516;previous mi  %;"C0205156;C1552607;C3810814";NA;NA;previous mi
 516;previous mi;"C0205156;C1552607;C3810814";NA;NA;previous mi
 516;nonfatal mi ( n = $nmbr$ );C3810814;NA;NA;nonfatal mi n $nmbr$
 516;non - st — elevation mi;"C0520886;C1518422;C3810814";NA;NA;non st elevation mi
 516;non - st - elevation mi;"C0520886;C1518422;C3810814";NA;NA;non st elevation mi
 516;nocad / mi;C3810814;NA;NA;nocad mi
 516;no prior mi n = $nmbr$;"C0332152;C2826257;C3810814";NA;NA;no prior mi n $nmbr$
 516;no prior mi ( n = $nmbr$  $nmbr$ );"C0332152;C2826257;C3810814";NA;NA;no prior mi n $nmbr$ $nmbr$
 516;no prior mi;"C0332152;C2826257;C3810814";NA;NA;no prior mi
 516;no mi ( n - $nmbr$  $nmbr$ );C3810814;NA;NA;no mi n $nmbr$ $nmbr$
 516;no mi;C3810814;NA;NA;no mi
 516;mi — no . ( % );C3810814;NA;NA;mi no
 516;mi *;C3810814;NA;NA;mi
 516;mi  n ( % );C3810814;NA;NA;mi n
 516;mi;C3810814;NA;NA;mi
 516;mhi;NA;NA;NA;mhi
 516;large mi;"C0549177;C3810814";NA;NA;large mi
 516;history of second prior mi;"C0019664;C0019665;C0205436;C0262512;C0262926;C0332152;C0457385;C0565930;C1561503;C1705190;C1705255;C2004062;C2826257;C3810814";NA;NA;history of second prior mi
 516;fatal / nonfatal mi ( excluding silent mi );"C0332196;C0443304;C1302234;C1705232;C2828389;C3810814;C3816734";NA;NA;fatal nonfatal mi excluding silent mi
 516;death  large mi;"C0011065;C0549177;C1306577;C3810814;C4082313;C4552775";NA;NA;death large mi
 516;cvd or mi;"C0007222;C3810814";NA;NA;cvd or mi
 516;cvd  mi  stroke  or recurrent ischemia - urgent revascularization;"C0007222;C0022116;C0038454;C0439609;C0581603;C1455761;C2945760;C3272275;C3810814;C4321499;C4554100";NA;NA;cvd mi stroke or recurrent ischemia urgent revascularization
 516;cvd  mi  or stroke;"C0007222;C0038454;C3810814;C4554100";NA;NA;cvd mi or stroke
 516;cardiovascular death or nonfatal mi ( excluding silent mi );"C0007226;C0011065;C0332196;C0443304;C1306577;C2828389;C3810814;C3816734;C3887460;C4082313;C4552775";NA;NA;cardiovascular death or nonfatal mi excluding silent mi
 516;cardiovascular death  nonfatal mi ( excluding silent mi )  or stroke;"C0007226;C0011065;C0038454;C0332196;C0443304;C1306577;C2828389;C3810814;C3816734;C3887460;C4082313;C4552775;C4554100";NA;NA;cardiovascular death nonfatal mi excluding silent mi or stroke
 516;any mi ( n - $nmbr$  $nmbr$ );C3810814;NA;NA;any mi n $nmbr$ $nmbr$
 516;any mi;C3810814;NA;NA;any mi
 516;anterior mi;C3536746;NA;NA;anterior mi
 516;: mi  previous pci and chronic obstructive pulmonary disease .;"C0024117;C0205156;C1552607;C3810814;C4049621";NA;NA;mi previous pci and chronic obstructive pulmonary disease
 515;vi – $nmbr$ % ( $nmbr$ % ci – $nmbr$ – $nmbr$ % );"C0008107;C0205999;C3259781";NA;NA;vi $nmbr$ $nmbr$ ci $nmbr$ $nmbr$
 515;vi - $nmbr$ % ( - $nmbr$ %  $nmbr$ % );C0205999;NA;NA;vi $nmbr$ $nmbr$ $nmbr$
 515;vi $nmbr$   µ g;"C0205999;C0439267";NA;NA;vi $nmbr$ g
 515;vi $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0205999;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;vi $nmbr$ mg n $nmbr$
 515;vi $nmbr$ % ( - $nmbr$ %  $nmbr$ % );C0205999;NA;NA;vi $nmbr$ $nmbr$ $nmbr$
 515;vi $nmbr$ % ( $nmbr$ % ci – $nmbr$ – $nmbr$ % );"C0008107;C0205999;C3259781";NA;NA;vi $nmbr$ $nmbr$ ci $nmbr$ $nmbr$
 515;vi $nmbr$ % ( $nmbr$ % ci $nmbr$ – $nmbr$ % );"C0008107;C0205999;C3259781";NA;NA;vi $nmbr$ $nmbr$ ci $nmbr$ $nmbr$
 515;umec / vi $nmbr$ . $nmbr$ / $nmbr$ ( n $nmbr$ $nmbr$ );C0205999;NA;NA;umec vi $nmbr$ $nmbr$ $nmbr$ n $nmbr$ $nmbr$
 515;umec / vi $nmbr$ . $nmbr$ / $nmbr$;C0205999;NA;NA;umec vi $nmbr$ $nmbr$ $nmbr$
 515;ff / vi – $nmbr$ % ( $nmbr$ % ci – $nmbr$ – $nmbr$ % );"C0008107;C0205999;C3259781;C4554348";NA;NA;ff vi $nmbr$ $nmbr$ ci $nmbr$ $nmbr$
 515;ff / vi ( n   =   $nmbr$ );"C0205999;C4554348";NA;NA;ff vi n $nmbr$
 515;ff / vi $nmbr$ mg / $nmbr$ mg ( n = $nmbr$ );"C0205999;C1319635;C4554348";NA;NA;ff vi $nmbr$ mg $nmbr$ mg n $nmbr$
 515;ff / vi $nmbr$ / $nmbr$   µ g;"C0205999;C0439267;C4554348";NA;NA;ff vi $nmbr$ $nmbr$ g
 515;ff / vi $nmbr$ / $nmbr$ pg od;"C0030827;C0072225;C0205999;C0229089;C0439164;C1266240;C1512019;C3273373;C3665488;C4554348";NA;NA;ff vi $nmbr$ $nmbr$ pg od
 515;ff / vi $nmbr$ . $nmbr$;"C0205999;C4554348";NA;NA;ff vi $nmbr$ $nmbr$
 515;ff / vi $nmbr$ % ( - $nmbr$ %  $nmbr$ % );"C0205999;C4554348";NA;NA;ff vi $nmbr$ $nmbr$ $nmbr$
 515;ff / vi $nmbr$ % ( $nmbr$ % ci $nmbr$ – $nmbr$ % );"C0008107;C0205999;C3259781;C4554348";NA;NA;ff vi $nmbr$ $nmbr$ ci $nmbr$ $nmbr$
 515;favors ff / vi favors placebo;"C0032042;C0205999;C0309049;C1696465;C1706408;C4554348";NA;NA;favors ff vi favors placebo
 515;$nmbr$ . $nmbr$ % vi . $nmbr$ . $nmbr$ %;C0205999;NA;NA;$nmbr$ $nmbr$ vi $nmbr$ $nmbr$
 515;$nmbr$ . $nmbr$ % vi  $nmbr$ . $nmbr$ %;C0205999;NA;NA;$nmbr$ $nmbr$ vi $nmbr$ $nmbr$
 514;work and school;"C0036375;C0043227";NA;NA;work and school
 513;never took alendronate;"C0102118;C1515187;C2003901";NA;NA;never took alendronate
 513;- $nmbr$ - $nmbr$ ( - $nmbr$ - $nmbr$ too $nmbr$ );NA;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ too $nmbr$
 512;transfemoral;NA;NA;NA;transfemoral
 512;femoral neckc;C0015811;NA;NA;femoral neckc
 512;femoral access — no . / total no . ( % );"C0015811;C0439175;C0439810;C0444454;C1554204";NA;NA;femoral access no total no
 512;femoral access;"C0015811;C0444454;C1554204";NA;NA;femoral access
 512;femoral;C0015811;NA;NA;femoral
 512;catheter site — femoral;"C0015811;C0449652";NA;NA;catheter site femoral
 511;t - score at femoral neck;"C0015815;C3854607";NA;NA;t score at femoral neck
 511;mean femoral neck t score;"C0015815;C3533236";NA;NA;mean femoral neck t score
 511;femoral neck;C0015815;NA;NA;femoral neck
 511;at femoral neck  mean ( sd );"C0015815;C0444504;C2347634;C2348143;C2699239";NA;NA;at femoral neck mean sd
 510;total study population ( n = $nmbr$ );"C0439175;C0439810;C0557651;C2348561;C2603343;C3258257";NA;NA;total study population n $nmbr$
 510;total study population ( n = $nmbr$  $nmbr$ );"C0439175;C0439810;C0557651;C2348561;C2603343;C3258257";NA;NA;total study population n $nmbr$ $nmbr$
 510;total study population;"C0439175;C0439810;C0557651;C2348561;C2603343;C3258257";NA;NA;total study population
 510;total study itt population ( n = $nmbr$ );"C0439175;C0439810;C0557651;C2348561;C2603343;C3258257";NA;NA;total study itt population n $nmbr$
 510;total population n;C3258257;NA;NA;total population n
 510;total population ( n = $nmbr$ );C3258257;NA;NA;total population n $nmbr$
 510;total population;C3258257;NA;NA;total population
 510;total ho population ( n = $nmbr$ );"C0019905;C1832110;C3258257;C3889614";NA;NA;total ho population n $nmbr$
 510;total carmelina population;C3258257;NA;NA;total carmelina population
 509;total no . $nmbr$;"C0439175;C0439810";NA;NA;total no $nmbr$
 509;total gadolinium - enhancing lesion count . no . ( % );"C0439175;C0439810;C0750480;C1333400;C1705566";NA;NA;total gadolinium enhancing lesion count no
 509;total gadolinium - enhancing lesion count  no . ( % );"C0439175;C0439810;C0750480;C1333400;C1705566";NA;NA;total gadolinium enhancing lesion count no
 509;no . ( % ) *;NA;NA;NA;no
 509;no *;NA;NA;NA;no
 509;cardiac - biomarker status 一 no . / total no . ( % ) $;"C0005516;C0018787;C0439175;C0439810;C0449438;C0449442;C1271630;C1522601;C1999091;C2735302";NA;NA;cardiac biomarker status no total no $
 509;cardiac - biomarker status — no . / total no . ( % ) $;"C0005516;C0018787;C0439175;C0439810;C0449438;C0449442;C1271630;C1522601;C1999091;C2735302";NA;NA;cardiac biomarker status no total no $
 509;$nmbr$ - $nmbr$  no . / totalno . ( % );NA;NA;NA;$nmbr$ $nmbr$ no totalno
 508;v total ( n = $nmbr$ );"C0439175;C0439810";NA;NA;v total n $nmbr$
 508;treated with pci — no . / total no . ( % );"C0332293;C0439175;C0439810;C4049621";NA;NA;treated with pci no total no
 508;total sgrq score;"C0439175;C0439810;C0449820;C4050231";NA;NA;total sgrq score
 508;total resolution of nail psoriasisd;"C0027342;C0439175;C0439810;C1432728;C1514893;C1706463;C2699488;C3538766";NA;NA;total resolution of nail psoriasisd
 508;total resolution of enthesitisc;"C0439175;C0439810;C1514893;C1706463;C2699488";NA;NA;total resolution of enthesitisc
 508;total resolution of dactylitisb;"C0439175;C0439810;C1514893;C1706463;C2699488";NA;NA;total resolution of dactylitisb
 508;total randomized  n;"C0034656;C0439175;C0439810;C3815594";NA;NA;total randomized n
 508;total randomized;"C0034656;C0439175;C0439810;C3815594";NA;NA;total randomized
 508;total randomised ( n );"C0439175;C0439810";NA;NA;total randomised n
 508;total patients n = $nmbr$;"C0030705;C0439175;C0439810";NA;NA;total patients n $nmbr$
 508;total patients  n;"C0030705;C0439175;C0439810";NA;NA;total patients n
 508;total patients;"C0030705;C0439175;C0439810";NA;NA;total patients
 508;total number of patients;"C0439175;C0439810;C2360800";NA;NA;total number of patients
 508;total number of events / participants;"C0439175;C0439810;C0679646;C4330837";NA;NA;total number of events participants
 508;total no . of patients;"C0030705;C0439175;C0439810";NA;NA;total no of patients
 508;total no .;"C0439175;C0439810";NA;NA;total no
 508;total n   =   $nmbr$;"C0439175;C0439810";NA;NA;total n $nmbr$
 508;total n = $nmbr$ n ( % );"C0439175;C0439810";NA;NA;total n $nmbr$ n
 508;total n = $nmbr$;"C0439175;C0439810";NA;NA;total n $nmbr$
 508;total n $nmbr$;"C0439175;C0439810";NA;NA;total n $nmbr$
 508;total mortality all;"C0026565;C0026566;C0439175;C0439810";NA;NA;total mortality all
 508;total mortality;"C0026565;C0026566;C0439175;C0439810";NA;NA;total mortality
 508;total invasive cancer;"C0439175;C0439810;C0677898";NA;NA;total invasive cancer
 508;total ige — lu / ml;"C0439175;C0439810;C2697941";NA;NA;total ige lu ml
 508;total ige  geometric;"C0439175;C0439810;C0449829";NA;NA;total ige geometric
 508;total hipc;"C0439175;C0439810";NA;NA;total hipc
 508;total hip bmd ( g / cm $nmbr$ );"C0019552;C0022122;C0439175;C0439267;C0439810;C1505163;C3538851;C4284725";NA;NA;total hip bmd g cm $nmbr$
 508;total hip ( n = $nmbr$  $nmbr$ ) bmd ( g / cm $nmbr$ ) ( sd );"C0019552;C0022122;C0439175;C0439267;C0439810;C1505163;C2699239;C3538851;C4284725";NA;NA;total hip n $nmbr$ $nmbr$ bmd g cm $nmbr$ sd
 508;total hip;"C0019552;C0022122;C0439175;C0439810;C1505163;C3538851;C4284725";NA;NA;total hip
 508;total haq  $nmbr$ - $nmbr$;"C0102923;C0439175;C0439810;C0451208";NA;NA;total haq $nmbr$ $nmbr$
 508;total deaths  n;"C0011065;C0439175;C0439810;C1306577";NA;NA;total deaths n
 508;total deaths;"C0011065;C0439175;C0439810;C1306577";NA;NA;total deaths
 508;total death;"C0011065;C0439175;C0439810;C1306577;C4082313;C4552775";NA;NA;total death
 508;total c;"C0439175;C0439810";NA;NA;total c
 508;total antihypertensive use;"C0003364;C0042153;C0439175;C0439810;C0457083;C1947944";NA;NA;total antihypertensive use
 508;total > atients;"C0439175;C0439810";NA;NA;total atients
 508;total - c;"C0439175;C0439810";NA;NA;total c
 508;total *;"C0439175;C0439810";NA;NA;total
 508;total ( v = $nmbr$  $nmbr$ );"C0439175;C0439810";NA;NA;total v $nmbr$ $nmbr$
 508;total ( n   =   $nmbr$ );"C0439175;C0439810";NA;NA;total n $nmbr$
 508;total ( n   = $nmbr$ );"C0439175;C0439810";NA;NA;total n $nmbr$
 508;total ( n [ $nmbr$ );"C0439175;C0439810";NA;NA;total n $nmbr$
 508;total ( n = $nmbr$ );"C0439175;C0439810";NA;NA;total n $nmbr$
 508;total ( n = $nmbr$ $nmbr$ );"C0439175;C0439810";NA;NA;total n $nmbr$ $nmbr$
 508;total ( n = $nmbr$  $nmbr$ ) - -;"C0439175;C0439810";NA;NA;total n $nmbr$ $nmbr$
 508;total ( n = $nmbr$  $nmbr$ );"C0439175;C0439810";NA;NA;total n $nmbr$ $nmbr$
 508;total ( n );"C0439175;C0439810";NA;NA;total n
 508;total ( n $nmbr$ $nmbr$ );"C0439175;C0439810";NA;NA;total n $nmbr$ $nmbr$
 508;total $nmbr$;"C0439175;C0439810";NA;NA;total $nmbr$
 508;total !;"C0439175;C0439810";NA;NA;total
 508;total  n = $nmbr$ $nmbr$;"C0439175;C0439810";NA;NA;total n $nmbr$ $nmbr$
 508;total  n = $nmbr$;"C0439175;C0439810";NA;NA;total n $nmbr$
 508;total;"C0439175;C0439810";NA;NA;total
 508;totai mortaiity;NA;NA;NA;totai mortaiity
 508;tiotropium salmeterol no . of patients / total no .;"C0030705;C0073992;C0213771;C0439175;C0439810";NA;NA;tiotropium salmeterol no of patients total no
 508;statin — no . / total no . ( % );"C0360714;C0439175;C0439810";NA;NA;statin no total no
 508;standardized total hip bmd ( g / cm $nmbr$ );"C0019552;C0022122;C0439175;C0439267;C0439810;C1505163;C3538851;C4284725";NA;NA;standardized total hip bmd g cm $nmbr$
 508;sgrq - c total scoreb;"C0439175;C0439810;C3826872";NA;NA;sgrq c total scoreb
 508;previous cabg ( % total );"C0010055;C0205156;C0439175;C0439810;C1552607";NA;NA;previous cabg total
 509;antiplatelet — no . ( % );NA;FALSE;1191;antiplatelet no
 508;patients total no .;"C0030705;C0439175;C0439810";NA;NA;patients total no
 508;patients  no . / total no . ( % );"C0030705;C0439175;C0439810";NA;NA;patients no total no
 508;oral study drug administered — no . / total no . ( % );"C0013175;C0439175;C0439810;C0442027;C1521801;C4521986";NA;NA;oral study drug administered no total no
 508;oral contraceptive pills — no . / total no . ( % );"C0009905;C0009906;C0029151;C0439175;C0439810";NA;NA;oral contraceptive pills no total no
 508;of patients meeting criterion / total no . of patients;"C0030705;C0243161;C0439175;C0439810;C0556656";NA;NA;of patients meeting criterion total no of patients
 508;o total randomized;"C0034656;C0439175;C0439810;C0483204;C3815594";NA;NA;o total randomized
 508;nsaid use — no . / total no . ( % );"C0003211;C0042153;C0439175;C0439810;C0457083;C1947944;C3536840";NA;NA;nsaid use no total no
 508;normoalbuminuria — no . / total no . ( % );"C0439175;C0439810";NA;NA;normoalbuminuria no total no
 508;no . of patients / total no . ( % );"C0030705;C0439175;C0439810";NA;NA;no of patients total no
 508;no . of panents . total no . $nmbr$ % );"C0439175;C0439810";NA;NA;no of panents total no $nmbr$
 508;no . / total no . ( % ) t;"C0439175;C0439810;C2603360";NA;NA;no total no t
 508;no . / total no . ( % );"C0439175;C0439810";NA;NA;no total no
 508;no . / total 	 no . ( % );"C0439175;C0439810";NA;NA;no total no
 508;no . / total;"C0439175;C0439810";NA;NA;no total
 508;medications in use at baseline — no . / total no . ( % );"C0013227;C0042153;C0150312;C0168634;C0332285;C0439175;C0439810;C0457083;C0802604;C1442488;C1707101;C1947944;C2598133;C4284232";NA;NA;medications in use at baseline no total no
 508;medications at study entry — no . / total no . ( % );"C0013175;C0439175;C0439810;C1705654";NA;NA;medications at study entry no total no
 508;medical therapy before randomization — no . / total no . ( % );"C0034656;C0418981;C0439175;C0439810";NA;NA;medical therapy before randomization no total no
 508;managed medically — no . / total no . ( % );"C0439175;C0439810;C1273870";NA;NA;managed medically no total no
 508;macroalbuminuria — no . / total no . ( % );"C0439175;C0439810";NA;NA;macroalbuminuria no total no
 508;long - term treatment with aspirin — no . / total no . ( % );"C0004057;C0023977;C0439175;C0439810";NA;NA;long term treatment with aspirin no total no
 508;infusion administered — no . / total no . ( % );"C0439175;C0439810;C0574032;C1521801;C1827465";NA;NA;infusion administered no total no
 508;history of gi bleeding or ulcer — no . / total no . ( % );"C0017181;C0019664;C0019665;C0041582;C0262512;C0262926;C0439175;C0439810;C1705255;C2004062;C3887532";NA;NA;history of gi bleeding or ulcer no total no
 508;gastrointestinal area involved — no . / total no . ( % );"C0017446;C0205146;C0439175;C0439810;C0521362;C1314939";NA;NA;gastrointestinal area involved no total no
   7;interaction : treatment by psoriasis p value $nmbr$;"C1704675;C1709380;C3258078";NA;NA;interaction treatment by psoriasis p value $nmbr$
 508;elevation of troponin levels — no . / total no . ( % );"C0041199;C0439175;C0439775;C0439810;C0441889;C0702240";NA;NA;elevation of troponin levels no total no
 508;diuretic — no . / total no . ( % );"C0012798;C0439175;C0439810";NA;NA;diuretic no total no
 508;current alcohol use — no . / total no . ( % );"C0001962;C0001975;C0042153;C0439175;C0439810;C0457083;C0521116;C1705970;C1947944";NA;NA;current alcohol use no total no
 508;colectomy ( partial or total );"C0009274;C0439175;C0439810;C0728938;C1550516";NA;NA;colectomy partial or total
 508;category — no . / total no . ( % );"C0439175;C0439810;C0683312;C3889287";NA;NA;category no total no
 508;between - treatment comparison of percentage change from baseline in total hip bmd;"C0019552;C0022122;C0168634;C0439165;C0439175;C0439810;C1299575;C1442488;C1505163;C1549488;C1561533;C1707455;C3538851;C4284725";NA;NA;between treatment comparison of percentage change from baseline in total hip bmd
 508;angiographic complications  site - reported — no . / total no . ( % );"C0002978;C0009566;C0205145;C0439175;C0439810;C0684224;C0700287;C1171258;C1515974;C2825164;C4319718";NA;NA;angiographic complications site reported no total no
 508;administration of study - drug bolus — no . / total no . ( % );"C0001554;C0013175;C0013227;C0150270;C0262754;C0439175;C0439810;C0557651;C1186706;C1254351;C1511237;C1533734;C1705509;C2603343;C3161471;C3469597;C3812160";NA;NA;administration of study drug bolus no total no
 508;$nmbr$ — no . / total no . ( % );"C0439175;C0439810";NA;NA;$nmbr$ no total no
 508;$nmbr$ or $nmbr$ — no . / total no . ( % );"C0439175;C0439810";NA;NA;$nmbr$ or $nmbr$ no total no
 508;$nmbr$ or $nmbr$  no . / total no . ( % );"C0439175;C0439810";NA;NA;$nmbr$ or $nmbr$ no total no
 508;$nmbr$ - $nmbr$ — no . / total no . ( % );"C0439175;C0439810";NA;NA;$nmbr$ $nmbr$ no total no
 508;$nmbr$  no . / total no . ( % );"C0439175;C0439810";NA;NA;$nmbr$ no total no
 507;• death from cv causes  major coronary event  or nonfatal stroke;"C0011065;C0015127;C0038454;C0205082;C0205164;C0741923;C1306577;C1314792;C1524003;C3538987;C4048877;C4082313;C4318503;C4318856;C4521762;C4552775;C4554100";NA;NA;death from cv causes major coronary event or nonfatal stroke
 507;stroke non - fatal;"C0038454;C1302234;C1518422;C1705232;C4554100";NA;NA;stroke non fatal
 507;stroke ( fatal / nonfatal );"C0038454;C1302234;C1705232;C4554100";NA;NA;stroke fatal nonfatal
 507;stroke  fatal and nonfatal;"C0038454;C1302234;C1705232;C4554100";NA;NA;stroke fatal and nonfatal
 507;nonfatal stroke ®;"C0038454;C4554100";NA;NA;nonfatal stroke
 507;nonfatal stroke ( n = $nmbr$ );"C0038454;C4554100";NA;NA;nonfatal stroke n $nmbr$
 507;nonfatal stroke;"C0038454;C4554100";NA;NA;nonfatal stroke
 507;nonfatal;NA;NA;NA;nonfatal
 507;nondisabling  nonfatal stroke;"C0038454;C4554100";NA;NA;nondisabling nonfatal stroke
 507;non - fatal stroke;"C0038454;C1302234;C1518422;C1705232;C4554100";NA;NA;non fatal stroke
 507;in - trial nonfatal or fatal stroke n = $nmbr$  $nmbr$;"C0008976;C0038454;C0150312;C0332285;C1302234;C1705232;C1707101;C4554100";NA;NA;in trial nonfatal or fatal stroke n $nmbr$ $nmbr$
 507;fatal stroke;"C0038454;C1302234;C1705232;C4554100";NA;NA;fatal stroke
 507;fatal or nonlatal stroke;"C0038454;C1302234;C1705232;C4554100";NA;NA;fatal or nonlatal stroke
 507;fatal or nonfatal stroke;"C0038454;C1302234;C1705232;C4554100";NA;NA;fatal or nonfatal stroke
 507;fatal or non - fatal stroke;"C0038454;C1302234;C1518422;C1705232;C4554100";NA;NA;fatal or non fatal stroke
 507;fatal and nonfatal stroke;"C0038454;C1302234;C1705232;C4554100";NA;NA;fatal and nonfatal stroke
 507;fatal / nonfatal stroke  n ( % );"C0038454;C1302234;C1705232;C4554100";NA;NA;fatal nonfatal stroke n
 507;fatal / nonfatal stroke;"C0038454;C1302234;C1705232;C4554100";NA;NA;fatal nonfatal stroke
 507;fatal & nonfatal hospitalized stroke;"C0038454;C0701159;C1302234;C1705232;C4554100";NA;NA;fatal nonfatal hospitalized stroke
 506;role physical;"C0031809;C0035820;C0205485;C1509143;C1705810;C3871154";NA;NA;role physical
 506;role emotional;"C0013987;C0035820;C0849912;C1705810;C3871154";NA;NA;role emotional
 506;physical role;"C0031809;C0035820;C0205485;C1509143;C1705810;C3871154";NA;NA;physical role
 506;emotional role;"C0013987;C0035820;C0849912;C1705810;C3871154";NA;NA;emotional role
 505;neutropenia;"C0023530;C0027947;C0853697";NA;NA;neutropenia
 505;leukopenia;"C0023530;C0750394";NA;NA;leukopenia
 505;europa ( n = $nmbr$ l $nmbr$ );C0242751;NA;NA;europa n $nmbr$ l $nmbr$
 505;eastern and central europe;"C0682369;C1707877";NA;NA;eastern and central europe
 505;central europe;C0682369;NA;NA;central europe
 505;central / eastern europe and russia hr ( $nmbr$ % cl );"C0015177;C0035970;C0205099;C0596019;C0682369;C1707877;C1879652";NA;NA;central eastern europe and russia hr $nmbr$ cl
 505;central / eastern europe / russia;"C0015177;C0035970;C0205099;C0682369;C1707877;C1879652";NA;NA;central eastern europe russia
 504;white / european;"C0007457;C0043157;C0220938;C0239307;C1535514";NA;NA;white european
 504;non - european trial;"C0008976;C0239307;C1518422;C1535514";NA;NA;non european trial
 504;non - european;"C0239307;C1518422;C1535514";NA;NA;non european
 504;european trial;"C0008976;C0239307;C1535514";NA;NA;european trial
 504;european subcategories;"C0239307;C1515010;C1535514";NA;NA;european subcategories
 504;european;"C0239307;C1535514";NA;NA;european
 503;prior pacemaker  n ( % );"C0030163;C0332152;C0810633;C1546728;C2826257;C3275122;C3853703";NA;NA;prior pacemaker n
 503;pacemaker — no . ( % );"C0030163;C0810633;C1546728;C3275122;C3853703";NA;NA;pacemaker no
 503;pacemaker  n ( % );"C0030163;C0810633;C1546728;C3275122;C3853703";NA;NA;pacemaker n
 503;pacemaker  ( % );"C0030163;C0810633;C1546728;C3275122;C3853703";NA;NA;pacemaker
 503;pacemaker;"C0030163;C0810633;C1546728;C3275122;C3853703";NA;NA;pacemaker
 503;cardiac pacemaker — no . ( % );"C0030163;C0037189";NA;NA;cardiac pacemaker no
 503;biventricular pacemaker;C1719274;NA;NA;biventricular pacemaker
 502;paracetamol;C0000970;NA;NA;paracetamol
 502;acetaminophen;"C0000970;C2917659";NA;NA;acetaminophen
 501;study drug loading days ( actual ) : $nmbr$ ( n = $nmbr$ );"C0013175;C0237400;C0439228;C1708715";NA;NA;study drug loading days actual $nmbr$ n $nmbr$
 501;actual ( l );C0237400;NA;NA;actual l
 500;paclitaxel - eluting stent use  n ( % );"C0038257;C0042153;C0144576;C0457083;C1947944";NA;NA;paclitaxel eluting stent use n
 500;paclitaxel - eluting;C0144576;NA;NA;paclitaxel eluting
 500;paclitaxel;C0144576;NA;NA;paclitaxel
 499;with long - acting j $nmbr$ - agonists;"C0079613;C0205166;C0243192;C1704930;C1706317;C1869853;C2987634;C3890007;C4048375";NA;NA;with long acting j $nmbr$ agonists
 499;short - acting b $nmbr$ - agonists;"C0079613;C0243192;C1282927;C1704930;C1806781;C1869853;C2350002;C2987634;C3890007;C4048375";NA;NA;short acting b $nmbr$ agonists
 499;short - acting;"C0079613;C1282927;C1704930;C1806781;C1869853;C2350002;C3890007;C4048375";NA;NA;short acting
 499;peak procedural act — sec;"C0025664;C0079613;C0184661;C0444505;C0565930;C1704930;C1869853;C2700391;C3274430;C3538935;C3539779;C3890007;C4048375";NA;NA;peak procedural act sec
 499;long acting nitratef;"C0079613;C0205166;C1704930;C1706317;C1869853;C3890007;C4048375";NA;NA;long acting nitratef
 499;long - acting or short - acting nitrates;"C0028125;C0079613;C0205166;C1282927;C1704930;C1706317;C1806781;C1869853;C2350002;C3890007;C4048375";NA;NA;long acting or short acting nitrates
 499;long - acting nitrates;"C0028125;C0079613;C0205166;C1704930;C1706317;C1869853;C3890007;C4048375";NA;NA;long acting nitrates
 499;long - acting nitrate agents;"C0028125;C0079613;C0205166;C0450442;C0699857;C1254351;C1521826;C1704930;C1706317;C1869853;C3848573;C3890007;C4048375";NA;NA;long acting nitrate agents
 499;long - acting nitrate;"C0028125;C0079613;C0205166;C0699857;C1704930;C1706317;C1869853;C3848573;C3890007;C4048375";NA;NA;long acting nitrate
   7;heterogeneity p value;"C0019409;C0242960;C1709380";NA;NA;heterogeneity p value
 499;long - acting bronchodilator use at screening;"C0006280;C0042153;C0079613;C0205166;C0220908;C0220909;C0457083;C1698960;C1704930;C1706317;C1710031;C1710032;C1710477;C1869853;C1947944;C2348164;C3890007;C4048375";NA;NA;long acting bronchodilator use at screening
 499;long - acting b $nmbr$ - agonists;"C0079613;C0205166;C0243192;C1704930;C1706317;C1869853;C2987634;C3890007;C4048375";NA;NA;long acting b $nmbr$ agonists
 499;long - acting ^;"C0079613;C0205166;C1704930;C1706317;C1869853;C3890007;C4048375";NA;NA;long acting
 499;long - acting;"C0079613;C0205166;C1704930;C1706317;C1869853;C3890007;C4048375";NA;NA;long acting
 499;b - agonists ( short - acting ) a;"C0079613;C0243192;C1282927;C1704930;C1806781;C1869853;C2350002;C2987634;C3890007;C4048375";NA;NA;b agonists short acting a
 499;b - agonists ( long - acting ) a;"C0079613;C0205166;C0243192;C1704930;C1706317;C1869853;C2987634;C3890007;C4048375";NA;NA;b agonists long acting a
 499;anti - cholinergics ( short - acting ) a;"C0079613;C0242896;C1282927;C1704930;C1806781;C1869853;C2350002;C3890007;C4048375";NA;NA;anti cholinergics short acting a
 499;anti - cholinergics ( long - acting );"C0079613;C0205166;C0242896;C1704930;C1706317;C1869853;C3890007;C4048375";NA;NA;anti cholinergics long acting
 499;act total score ≥   $nmbr$;"C0079613;C1704930;C1869853;C2964552;C3890007;C4048375";NA;NA;act total score $nmbr$
 499;act total score   ≥   $nmbr$ and / or improvement from baseline   ≥   $nmbr$;"C0079613;C0168634;C1442488;C1704930;C1869853;C2964552;C2986411;C3890007;C4048375";NA;NA;act total score $nmbr$ and or improvement from baseline $nmbr$
 499;act . $nmbr$;"C0079613;C1704930;C1869853;C3890007;C4048375";NA;NA;act $nmbr$
 499;act - $nmbr$;"C0079613;C1704930;C1869853;C3890007;C4048375";NA;NA;act $nmbr$
 -10;centrally acting sympathomimetics;C3653511;NA;NA;centrally acting sympathomimetics
 497;sexually active with female;"C0043210;C0086287;C0241028;C1705497;C1705498";NA;NA;sexually active with female
 497;sexually active $nmbr$ ( % );C0241028;NA;NA;sexually active $nmbr$
 497;sexually active;C0241028;NA;NA;sexually active
 496;reason for enrollment in active a — no . ( % );"C0150312;C0205177;C0332285;C0392360;C1516879;C1696073;C1707101;C3853793;C3888021;C3888249";NA;NA;reason for enrollment in active a no
 496;reason for enrollment in active a;"C0150312;C0205177;C0332285;C0392360;C1516879;C1696073;C1707101;C3853793;C3888021;C3888249";NA;NA;reason for enrollment in active a
 496;randomized to active yitamin e;"C0034656;C0205177;C3815594;C3853793;C3888249";NA;NA;randomized to active yitamin e
 496;alive ( n = $nmbr$ );"C2584946;C4551704";NA;NA;alive n $nmbr$
 496;active smoking;"C0037369;C0205177;C0453996;C1881674;C3853793;C3888249";NA;NA;active smoking
 496;active pso wi $nmbr$ bsa > $nmbr$ %  n ( . % y;"C0043193;C0205177;C1520135;C3853793;C3888249";NA;NA;active pso wi $nmbr$ bsa $nmbr$ n y
 496;active comparatorb;"C0205177;C3853793;C3888249";NA;NA;active comparatorb
 496;active canakinumab ( n   =   $nmbr$  $nmbr$ );"C0205177;C2718773;C3853793;C3888249";NA;NA;active canakinumab n $nmbr$ $nmbr$
 496;active a;"C0205177;C3853793;C3888249";NA;NA;active a
 496;active ( n = $nmbr$ );"C0205177;C3853793;C3888249";NA;NA;active n $nmbr$
 496;active;"C0205177;C3853793;C3888249";NA;NA;active
 -10;any acuity bleeding;C0333276;NA;NA;any acuity bleeding
 494;selena - sledai activity  n ( % );"C0205177;C0439167;C0441655;C0451528;C1561536;C3668946;C4049938;C4049939";NA;NA;selena sledai activity n
 494;activity limitation;"C0205177;C0439167;C0441655;C0443288;C0449295;C1561536;C3668946;C4049938;C4049939";NA;NA;activity limitation
 494;activity ( range $nmbr$ - $nmbr$ )  mean ± sd;"C0205177;C0439167;C0441655;C0444504;C1514721;C1561536;C2347634;C2348143;C2348147;C2699239;C3542016;C3668946;C4049938;C4049939";NA;NA;activity range $nmbr$ $nmbr$ mean sd
 494;activity;"C0205177;C0439167;C0441655;C1561536;C3668946;C4049938;C4049939";NA;NA;activity
 493;catheter access site;"C0085590;C0444454;C0449652;C0589360;C1554204";NA;NA;catheter access site
 493;arterial access site;C3272298;NA;NA;arterial access site
 493;arterial access;"C0003842;C0221464;C0444454;C1554204";NA;NA;arterial access
 493;arteriai access;"C0444454;C1554204";NA;NA;arteriai access
 493;access site;C0589360;NA;NA;access site
 492;randomised patients with dactylitis at baseline;"C0030705;C0168634;C0239161;C1442488";NA;NA;randomised patients with dactylitis at baseline
 492;patients with dactylitis at baseline  no .;"C0030705;C0168634;C0239161;C1442488";NA;NA;patients with dactylitis at baseline no
 492;patients with dactylitis  no . ( % );"C0030705;C0239161";NA;NA;patients with dactylitis no
 492;patients with dactylitis;"C0030705;C0239161";NA;NA;patients with dactylitis
 492;dactylitis severity score ) score > $nmbr$ — no . { % );"C0239161;C0449820;C0457451;C4050231";NA;NA;dactylitis severity score score $nmbr$ no
 492;dactylitis score ( $nmbr$ – $nmbr$ scale );"C0175659;C0239161;C0349674;C0449820;C1947916;C4050231";NA;NA;dactylitis score $nmbr$ $nmbr$ scale
 492;dactylitis score ( $nmbr$ - $nmbr$ )  mean ( sd );"C0239161;C0444504;C0449820;C2347634;C2348143;C2699239;C4050231";NA;NA;dactylitis score $nmbr$ $nmbr$ mean sd
 492;dactylitis score ( $nmbr$ - $nmbr$ );"C0239161;C0449820;C4050231";NA;NA;dactylitis score $nmbr$ $nmbr$
 492;dactylitis score;"C0239161;C0449820;C4050231";NA;NA;dactylitis score
 492;dactylitis  n ( % );C0239161;NA;NA;dactylitis n
 492;dactylitis  % #;C0239161;NA;NA;dactylitis
 492;dactylitis;C0239161;NA;NA;dactylitis
 492;% improvement in dactylitis score at week $nmbr$  n;"C0239161;C0332174;C0439230;C0449820;C2986411;C4050231";NA;NA;improvement in dactylitis score at week $nmbr$ n
 491;patient global assessment of disease;"C0012634;C4054229";NA;NA;patient global assessment of disease
 491;patient assessment of pain ( $nmbr$ - $nmbr$ cm  vas );"C0042815;C0679830";NA;NA;patient assessment of pain $nmbr$ $nmbr$ cm vas
 491;patient assessment of disease activity  mm;"C0679830;C1292728;C4330985;C4554674";NA;NA;patient assessment of disease activity mm
 491;patient assessment of arthritis pain  mm;"C0679830;C4317006;C4330985;C4554674";NA;NA;patient assessment of arthritis pain mm
 491;patient ' s global assessment of response to therapy score;"C0039798;C0087111;C0449820;C0871261;C1363945;C1704632;C1706817;C2911692;C4050231;C4054229";NA;NA;patient s global assessment of response to therapy score
 491;patient ' s global assessment of disease status score;"C0449820;C3176928;C4050231;C4054229";NA;NA;patient s global assessment of disease status score
 491;patient ' s global assessment of disease;"C0012634;C4054229";NA;NA;patient s global assessment of disease
 491;patient ' s global assessment of;C4054229;NA;NA;patient s global assessment of
 491;patient ' s global assessment !;C4054229;NA;NA;patient s global assessment
 491;patient ' s global assessment;C4054229;NA;NA;patient s global assessment
 491;patient ' s assessment of pain ( $nmbr$ - $nmbr$ vas );"C0042815;C0679830";NA;NA;patient s assessment of pain $nmbr$ $nmbr$ vas
 490;patients with measurement;"C0030705;C0242485";NA;NA;patients with measurement
 490;measurements;C0242485;NA;NA;measurements
 490;* determined by investigator to be possibly  probably or definitely related to study drug tmyopathy defined as cpk > $nmbr$ x uln with associated muscle symptoms with no other plausible etiology ^ consecutive defined as two or more measurements at least one week apart or one measurement < $nmbr$ days after the last dose of study drug ( presumed consecutive ) § two patients had incomplete data to assess chd status simva = simvastatin  eze = ezetimibe  ae = adverse event  alt = alanine aminotransferase  ast = aspartate aminotransferase  cpk = creatine phosphokinase  uln = upper limit of normal;"C0010287;C0013175;C0015127;C0026845;C0030705;C0035173;C0040363;C0041260;C0074554;C0178602;C0205172;C0205448;C0242485;C0280604;C0332281;C0439849;C0445223;C0449438;C0521095;C0683368;C0750492;C0805162;C0869039;C0877248;C1114758;C1142985;C1266129;C1314792;C1415181;C1442452;C1457887;C1516048;C1519815;C1524003;C1704788;C1707491;C1883351;C2362652;C3242203;C3539106;C3542407;C3844320;C3887670;C3891303;C4083049;C4553172";NA;NA;determined by investigator to be possibly probably or definitely related to study drug tmyopathy defined as cpk $nmbr$ x uln with associated muscle symptoms with no other plausible etiology consecutive defined as two or more measurements at least one week apart or one measurement $nmbr$ days after the last dose of study drug presumed consecutive two patients had incomplete data to assess chd status simva simvastatin eze ezetimibe ae adverse event alt alanine aminotransferase ast aspartate aminotransferase cpk creatine phosphokinase uln upper limit of normal
 489;preamendment;C1548596;NA;NA;preamendment
 489;postamendment;NA;NA;NA;postamendment
 489;before amendment ( % );"C0680532;C2346732";NA;NA;before amendment
 489;before amendment;"C0680532;C2346732";NA;NA;before amendment
 489;after amendment ( % );"C0680532;C2346732";NA;NA;after amendment
 489;after amendment;"C0680532;C2346732";NA;NA;after amendment
 488;temporal data and management strategy;"C0001554;C0376636;C0442043;C0679199;C1273870;C1511726;C2362314;C3245479;C3273539;C3714741";NA;NA;temporal data and management strategy
 488;primary management strategy;"C0001554;C0205225;C0376636;C0439612;C0439631;C0679199;C1273870;C3273539";NA;NA;primary management strategy
 488;management distribution medical treatment;"C0001554;C0030677;C0199168;C0205476;C0376636;C0520511;C0679624;C1273870;C1704711;C3273539";NA;NA;management distribution medical treatment
 488;management distribution;"C0001554;C0376636;C0520511;C1273870;C1704711;C3273539";NA;NA;management distribution
 488;acs management  no . ( % );"C0001554;C0376636;C0742343;C1273870;C3273539;C4318612";NA;NA;acs management no
 487;types of fibrinolytic agent;"C0016018;C0332307";NA;NA;types of fibrinolytic agent
 487;thrombolytic agents;C0016018;NA;NA;thrombolytic agents
 487;inotropic agent;C0304509;NA;NA;inotropic agent
 487;fibrinolytic agent given;"C0016018;C1442162;C1550718;C1947971;C3244317";NA;NA;fibrinolytic agent given
 487;fibrinolytic agent before randomisation;"C0016018;C0034656";NA;NA;fibrinolytic agent before randomisation
 486;use of antiarrhythmic agent;"C0003195;C0301380;C1524063";NA;NA;use of antiarrhythmic agent
 486;class $nmbr$ antiarrhythmic agents;"C0003195;C0301380;C0456387;C1518526;C1705943";NA;NA;class $nmbr$ antiarrhythmic agents
 486;antiarrhythmic agent;"C0003195;C0301380";NA;NA;antiarrhythmic agent
 486;aget  y;NA;NA;NA;aget y
 485;hypertension absent;"C0020538;C0332197;C1963138;C4285062";NA;NA;hypertension absent
 485;factor absent;"C0332197;C1521761;C2827422;C4285062";NA;NA;factor absent
 485;dm absent;"C0011816;C0332197;C3250443;C4285062";NA;NA;dm absent
 485;absent ( < $nmbr$ mg / dl );"C0332197;C0439269;C4285062";NA;NA;absent $nmbr$ mg dl
 485;absent;"C0332197;C4285062";NA;NA;absent
 485;absence;"C0332197;C1689985";NA;NA;absence
 484;three or more agents;"C0205172;C0205449;C0450442;C1254351;C1521826";NA;NA;three or more agents
 484;ras agents;"C0034678;C0450442;C0525678;C1254351;C1521826";NA;NA;ras agents
 484;oral agents use;"C0042153;C0442027;C0450442;C0457083;C1254351;C1521826;C1947944;C4521986";NA;NA;oral agents use
 484;oral agents;"C0442027;C0450442;C1254351;C1521826;C4521986";NA;NA;oral agents
 484;oral agent and / or insulin therapy;"C0021641;C0039798;C0087111;C0442027;C0450442;C1254351;C1363945;C1521826;C1533581;C1579433;C3714501;C4521986";NA;NA;oral agent and or insulin therapy
 484;oral agent;"C0442027;C0450442;C1254351;C1521826;C4521986";NA;NA;oral agent
 484;number of agents;"C0237753;C0449788;C0450442;C1254351;C1521826";NA;NA;number of agents
 484;no . of agents;"C0450442;C1254351;C1521826";NA;NA;no of agents
 484;ipah / fpah / drug and toxin;"C0013227;C0040549;C0152171;C1254351;C1419079;C4522020";NA;NA;ipah fpah drug and toxin
 484;drug and insulint;"C0013227;C1254351";NA;NA;drug and insulint
 484;conventional agents *;"C0439858;C0450442;C1254351;C1521826";NA;NA;conventional agents
 484;anyantianginal agent;"C0450442;C1254351;C1521826";NA;NA;anyantianginal agent
 484;antialdosterone agents;"C0450442;C1254351;C1521826";NA;NA;antialdosterone agents
 484;anti ‐ platelet agents  n ( % );"C0005821;C0432633;C0450442;C1254351;C1521826";NA;NA;anti platelet agents n
 484;> $nmbr$ oral agents;"C0442027;C0450442;C1254351;C1521826;C4521986";NA;NA;$nmbr$ oral agents
 484;> $nmbr$ and < $nmbr$;NA;NA;NA;$nmbr$ and $nmbr$
 483;age at diagnosis s $nmbr$ years;"C0439234;C1828181;C3173302";NA;NA;age at diagnosis s $nmbr$ years
 483;age at diagnosis of sle  years;"C0024141;C0439234;C1828181;C3173302";NA;NA;age at diagnosis of sle years
 483;age at diagnosis of ln  years;"C0439234;C0861352;C1428884;C1828181;C3173302;C3714709";NA;NA;age at diagnosis of ln years
 483;age at diagnosis < $nmbr$ years;"C0439234;C1828181;C3173302";NA;NA;age at diagnosis $nmbr$ years
 483;age at diagnosis  y;"C1828181;C3173302";NA;NA;age at diagnosis y
 482;p between age groups;"C0001779;C0027362;C0369773;C0441849;C1959644;C2603361";NA;NA;p between age groups
 482;age groups;C0027362;NA;NA;age groups
 481;subjects $ $nmbr$ years of age  n ( % );"C0681850;C1510829;C1550501;C1706203;C2349001;C2697811";NA;NA;subjects $ $nmbr$ years of age n
 481;subjects  $nmbr$ years of age  n ( % );"C0681850;C1510829;C1550501;C1706203;C2349001;C2697811";NA;NA;subjects $nmbr$ years of age n
 479;$nmbr$ . $nmbr$  range $nmbr$ - $nmbr$;"C1514721;C2348147;C3542016";NA;NA;$nmbr$ $nmbr$ range $nmbr$ $nmbr$
 484;antihyperglycemic oral agent therapy;"C0020616;C0039798;C0087111;C0442027;C0450442;C1254351;C1363945;C1521826;C4521986";FALSE;  33;antihyperglycemic oral agent therapy
 484;oral diabetic agent;"C0241863;C0442027;C0450442;C1254351;C1521826;C4521986";FALSE;  33;oral diabetic agent
 481;patients ' characteristics age ( years )  mean + sd;"C0444504;C0815172;C1510829;C2347634;C2348143;C2699239";NA;NA;patients characteristics age years mean sd
 481;median age  years ( iqr );"C0549183;C0876920;C1510829;C2347635;C2348144;C2939193";NA;NA;median age years iqr
 481;mean ± s . d . age  years;"C0444504;C1510829;C2347634;C2348143";NA;NA;mean s d age years
 481;mean age ± sd ( years );"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;mean age sd years
 481;mean age ± s . d .  years;"C0444504;C1510829;C2347634;C2348143";NA;NA;mean age s d years
 481;mean age ( years ) race;"C0034510;C0444504;C1510829;C1706779;C2347634;C2348143;C3853635";NA;NA;mean age years race
 481;mean age ( years ) ( s . d . );"C0444504;C1510829;C2347634;C2348143";NA;NA;mean age years s d
 481;mean age ( years );"C0444504;C1510829;C2347634;C2348143";NA;NA;mean age years
 481;mean age ( years  sd );"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;mean age years sd
 481;mean age ( sd )  years;"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;mean age sd years
 481;mean age  years ± sd;"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;mean age years sd
 481;mean age  years ( range );"C0444504;C1510829;C1514721;C2347634;C2348143;C2348147;C3542016";NA;NA;mean age years range
 481;mean age  years ( $nmbr$ % ci );"C0008107;C0444504;C1510829;C2347634;C2348143;C3259781";NA;NA;mean age years $nmbr$ ci
 481;mean age  years;"C0444504;C1510829;C2347634;C2348143";NA;NA;mean age years
 481;mean ( s . d . ) age  years;"C0444504;C1510829;C2347634;C2348143";NA;NA;mean s d age years
 481;i $nmbr$ years of age;"C0021966;C0221138;C1510829";NA;NA;i $nmbr$ years of age
 481;age ≥ $nmbr$ years and bmi ≥ $nmbr$ kg / m $nmbr$;"C0578022;C1510829;C1532718";NA;NA;age $nmbr$ years and bmi $nmbr$ kg m $nmbr$
 481;age ≥ $nmbr$ years and bmi < $nmbr$ kg / m $nmbr$;"C0578022;C1510829;C1532718";NA;NA;age $nmbr$ years and bmi $nmbr$ kg m $nmbr$
 481;age ≥ $nmbr$ years  n ( % );C1510829;NA;NA;age $nmbr$ years n
 481;age ≥ $nmbr$ years;C1510829;NA;NA;age $nmbr$ years
 481;age £ $nmbr$ years ( itt ) ( n = $nmbr$ );C1510829;NA;NA;age $nmbr$ years itt n $nmbr$
 481;age years geographic region;"C0017446;C1510829";NA;NA;age years geographic region
 481;age years;C1510829;NA;NA;age years
 481;age s $nmbr$ years ( n = $nmbr$  $nmbr$ );C1510829;NA;NA;age s $nmbr$ years n $nmbr$ $nmbr$
 481;age range ( years );"C1510829;C1514721;C2348147;C3542016";NA;NA;age range years
 481;age range  years;"C1510829;C1514721;C2348147;C3542016";NA;NA;age range years
 481;age mean age  years sex;"C0009253;C0036864;C0079399;C0444504;C0804628;C1314687;C1510829;C1522384;C2347634;C2348143";NA;NA;age mean age years sex
 481;age in years  mean ( sd );"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;age in years mean sd
 481;age in years  mean;"C0444504;C1510829;C2347634;C2348143";NA;NA;age in years mean
 481;age in years;C1510829;NA;NA;age in years
 481;age group ( ≥ $nmbr$ years ) — no . ( % );"C0027362;C0439234;C0441833;C0687744;C1257890;C1510829;C1519504;C1705428;C1705429;C2348001";NA;NA;age group $nmbr$ years no
 481;age groiro : < $nmbr$ years;C1510829;NA;NA;age groiro $nmbr$ years
 481;age distribution  years  n ( % );"C0001782;C0439234;C0520511;C1510829;C1704711";NA;NA;age distribution years n
 481;age distribution  n ( % );C0001782;NA;NA;age distribution n
 481;age distribution;C0001782;NA;NA;age distribution
 481;age categories ( y )  n ( % );C2916832;NA;NA;age categories y n
 481;age categories  n ( % );C2916832;NA;NA;age categories n
 481;age categories;C2916832;NA;NA;age categories
 481;age at randomization ( years );"C0034656;C1510829";NA;NA;age at randomization years
 481;age at entry ( years );"C1510829;C1705654";NA;NA;age at entry years
 481;age at enrolment  years;"C1510829;C1516879;C1696073;C3888021";NA;NA;age at enrolment years
 481;age at enrollment ( years );"C1510829;C1516879;C1696073;C3888021";NA;NA;age at enrollment years
 481;age at baseline years;"C0168634;C1442488;C1510829";NA;NA;age at baseline years
 481;age at baseline ( years );"C0168634;C1442488;C1510829";NA;NA;age at baseline years
 481;age [ years ] ( interaction : p = $nmbr$ . $nmbr$ );"C1510829;C1704675";NA;NA;age years interaction p $nmbr$ $nmbr$
 481;age [ years ]  median ( range );"C0549183;C0876920;C1510829;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016";NA;NA;age years median range
 481;age [ years ];C1510829;NA;NA;age years
 481;age > = $nmbr$ years old;"C0580836;C1510829";NA;NA;age $nmbr$ years old
 481;age > = $nmbr$ years;C1510829;NA;NA;age $nmbr$ years
 481;age > $nmbr$ years ( n = $nmbr$ );C1510829;NA;NA;age $nmbr$ years n $nmbr$
 481;age > $nmbr$ years ( median );"C0549183;C0876920;C1510829;C2347635;C2348144;C2939193";NA;NA;age $nmbr$ years median
 481;age > $nmbr$ years ( itt ) ( n = $nmbr$ );C1510829;NA;NA;age $nmbr$ years itt n $nmbr$
 481;age > $nmbr$ years $nmbr$;C1510829;NA;NA;age $nmbr$ years $nmbr$
 481;age > $nmbr$ years  n ( % );C1510829;NA;NA;age $nmbr$ years n
 481;age < $nmbr$ years — no . ( % );C1510829;NA;NA;age $nmbr$ years no
 481;age < $nmbr$ years old;"C0580836;C1510829";NA;NA;age $nmbr$ years old
 481;age < $nmbr$ years and bmi ≥ $nmbr$ kg / m $nmbr$;"C0578022;C1510829;C1532718";NA;NA;age $nmbr$ years and bmi $nmbr$ kg m $nmbr$
 481;age < $nmbr$ years and bmi < $nmbr$ kg / m $nmbr$;"C0578022;C1510829;C1532718";NA;NA;age $nmbr$ years and bmi $nmbr$ kg m $nmbr$
 481;age < $nmbr$ years ( n = $nmbr$ );C1510829;NA;NA;age $nmbr$ years n $nmbr$
 481;age < $nmbr$ years ( n = $nmbr$  $nmbr$ );C1510829;NA;NA;age $nmbr$ years n $nmbr$ $nmbr$
 481;age < $nmbr$ years ( n =;C1510829;NA;NA;age $nmbr$ years n
 481;age < $nmbr$ years ( median );"C0549183;C0876920;C1510829;C2347635;C2348144;C2939193";NA;NA;age $nmbr$ years median
 481;age < $nmbr$ years ( itt ) ( n = $nmbr$ );C1510829;NA;NA;age $nmbr$ years itt n $nmbr$
 481;age < $nmbr$ years $nmbr$;C1510829;NA;NA;age $nmbr$ years $nmbr$
 481;age < $nmbr$ years  n ( % );C1510829;NA;NA;age $nmbr$ years n
 481;age < $nmbr$ years;C1510829;NA;NA;age $nmbr$ years
 481;age : > $nmbr$ years;C1510829;NA;NA;age $nmbr$ years
 481;age : < $nmbr$ years ( n = $nmbr$ );C1510829;NA;NA;age $nmbr$ years n $nmbr$
 481;age : < $nmbr$ years;C1510829;NA;NA;age $nmbr$ years
 481;age . years;C1510829;NA;NA;age years
 481;age - years;C1510829;NA;NA;age years
 481;age - mean ( sd ) years;"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;age mean sd years
 481;age ( years ) a;C1510829;NA;NA;age years a
 481;age ( years ) [ median ( $nmbr$ th to $nmbr$ th percentile ) ];"C0039725;C0039738;C0549183;C0876920;C1264641;C1420718;C1510829;C2347635;C2348144;C2939193;C4282123;C4285344";NA;NA;age years median $nmbr$ th to $nmbr$ th percentile
 481;age ( years ) : mean ± sd;"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;age years mean sd
 481;age ( years ) : > $nmbr$;C1510829;NA;NA;age years $nmbr$
 481;age ( years ) : < $nmbr$;C1510829;NA;NA;age years $nmbr$
 481;age ( years ) : $nmbr$ - < $nmbr$;C1510829;NA;NA;age years $nmbr$ $nmbr$
 481;age ( years ) :;C1510829;NA;NA;age years
 481;age ( years ) - mean ± sd;"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;age years mean sd
 481;age ( years ) - > = median ( n = $nmbr$  $nmbr$ );"C0549183;C0876920;C1510829;C2347635;C2348144;C2939193";NA;NA;age years median n $nmbr$ $nmbr$
 481;age ( years ) - < median ( n = $nmbr$  $nmbr$ );"C0549183;C0876920;C1510829;C2347635;C2348144;C2939193";NA;NA;age years median n $nmbr$ $nmbr$
 481;age ( years ) +;C1510829;NA;NA;age years
 481;age ( years ) *;C1510829;NA;NA;age years
 481;age ( years ) ( mean ± sd );"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;age years mean sd
 481;age ( years ) ( mean  sd );"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;age years mean sd
 481;age ( years )  median ( range );"C0549183;C0876920;C1510829;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016";NA;NA;age years median range
 481;age ( years )  mean   ±   sd;"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;age years mean sd
 481;age ( years )  mean ± sd;"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;age years mean sd
 481;age ( years )  mean ± s . d .;"C0444504;C1510829;C2347634;C2348143";NA;NA;age years mean s d
 481;age ( years )  mean _ sd;"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;age years mean _ sd
 481;age ( years )  mean ( sd );"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;age years mean sd
 481;age ( years )  mean ( s . d . );"C0444504;C1510829;C2347634;C2348143";NA;NA;age years mean s d
 481;age ( years );C1510829;NA;NA;age years
 481;age ( years ( s . d . ) );C1510829;NA;NA;age years s d
 481;age ( years  sd );"C1510829;C2699239";NA;NA;age years sd
 481;age ( range ) ( years );"C1510829;C1514721;C2348147;C3542016";NA;NA;age range years
 481;age ( per $nmbr$ years );C1510829;NA;NA;age per $nmbr$ years
 481;age ( median  years );"C0549183;C0876920;C1510829;C2347635;C2348144;C2939193";NA;NA;age median years
 481;age $nmbr$ years or more;"C0205172;C1510829";NA;NA;age $nmbr$ years or more
 481;age $nmbr$ years ( n = $nmbr$ );C1510829;NA;NA;age $nmbr$ years n $nmbr$
 481;age $nmbr$ years;C1510829;NA;NA;age $nmbr$ years
 481;age $nmbr$ - $nmbr$ years ( n = $nmbr$ );C1510829;NA;NA;age $nmbr$ $nmbr$ years n $nmbr$
 481;age $nmbr$ - $nmbr$ years ( itt ) ( n = $nmbr$ );C1510829;NA;NA;age $nmbr$ $nmbr$ years itt n $nmbr$
 481;age $nmbr$ + years;C1510829;NA;NA;age $nmbr$ years
 481;age $ $nmbr$ years § *;C1510829;NA;NA;age $ $nmbr$ years
 481;age  years “;C1510829;NA;NA;age years
 481;age  years mean ± sd;"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;age years mean sd
 481;age  years mean ( sd );"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;age years mean sd
 481;age  years mean ( s . d . );"C0444504;C1510829;C2347634;C2348143";NA;NA;age years mean s d
 481;age  years geographical distribution of patients;"C0030705;C0681686;C1510829";NA;NA;age years geographical distribution of patients
 481;age  years ^;C1510829;NA;NA;age years
 481;age  years : median ( range );"C0549183;C0876920;C1510829;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016";NA;NA;age years median range
 481;age  years *;C1510829;NA;NA;age years
 481;age  years ( sd );"C1510829;C2699239";NA;NA;age years sd
 481;age  years ( mean ± sd );"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;age years mean sd
 481;age  years ( mean _ + sd ) sex  n ( % ) :;"C0009253;C0036864;C0079399;C0444504;C0804628;C1314687;C1510829;C1522384;C2347634;C2348143;C2699239";NA;NA;age years mean _ sd sex n
 481;age  years ( mean = sd );"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;age years mean sd
 481;age  years ( mean $nmbr$ sd );"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;age years mean $nmbr$ sd
 481;age  years $nmbr$ ';C1510829;NA;NA;age years $nmbr$
 481;age  years  mean ± sd;"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;age years mean sd
 481;age  years  mean ( sd );"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;age years mean sd
 481;age  years  mean ( range );"C0444504;C1510829;C1514721;C2347634;C2348143;C2348147;C3542016";NA;NA;age years mean range
 481;age  years;C1510829;NA;NA;age years
 481;age  median years;"C0549183;C0876920;C1510829;C2347635;C2348144;C2939193";NA;NA;age median years
 481;age  median ( range ) ( years );"C0549183;C0876920;C1510829;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016";NA;NA;age median range years
 481;age  mean ± sd  years;"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;age mean sd years
 481;age  mean years ( sd );"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;age mean years sd
 481;age  mean = sd  years;"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;age mean sd years
 481;age  mean ( sd ) years  n ( % );"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;age mean sd years n
 481;age  mean ( sd ) years;"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;age mean sd years
 481;age  mean ( sd ) ( years );"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;age mean sd years
 481;age  mean ( sd )  years;"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;age mean sd years
 481;age  mean ( range ) years;"C0444504;C1510829;C1514721;C2347634;C2348143;C2348147;C3542016";NA;NA;age mean range years
 481;age  mean  years ( ± sd );"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;age mean years sd
 481;age  ( years );C1510829;NA;NA;age years
 481;age  $nmbr$ years;C1510829;NA;NA;age $nmbr$ years
 481;> $nmbr$ years of age  n ( % );C1510829;NA;NA;$nmbr$ years of age n
 481;> $nmbr$ years of age;C1510829;NA;NA;$nmbr$ years of age
 481;< $nmbr$ years of age;C1510829;NA;NA;$nmbr$ years of age
 480;x cr $nmbr$ . $nmbr$ x age;"C0001779;C0201975;C3539604;C3711669;C4084730;C4553336;C4553337";NA;NA;x cr $nmbr$ $nmbr$ x age
 480;unstable angina age;"C0001779;C0002965";NA;NA;unstable angina age
 480;patients aged > $nmbr$ y  no  ( ss );"C0001779;C0001792;C0030705;C1999167;C2699257;C3891295;C4551874";NA;NA;patients aged $nmbr$ y no ss
 480;p value for interaction ( age continuous );"C0001779;C0549178;C1704675;C1709380";NA;NA;p value for interaction age continuous
 480;min - max age;"C0001779;C0702093;C1524029;C3813700";NA;NA;min max age
 480;median age — yr §;"C0001779;C0439234;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median age yr
 480;median age — yr;"C0001779;C0439234;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median age yr
 480;median age [ interquartile range ] — yr;"C0001779;C0439234;C0549183;C0876920;C1711350;C2347635;C2348144;C2939193";NA;NA;median age interquartile range yr
 480;median age ( $nmbr$ %  $nmbr$ % )  y;"C0001779;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median age $nmbr$ $nmbr$ y
 480;mean age 士 s . d .  year;"C0001779;C0439234;C0439508;C0444504;C2347634;C2348143";NA;NA;mean age s d year
 480;mean age — yr ( range );"C0001779;C0439234;C0444504;C1514721;C2347634;C2348143;C2348147;C3542016";NA;NA;mean age yr range
 480;mean age — yr;"C0001779;C0439234;C0444504;C2347634;C2348143";NA;NA;mean age yr
 480;mean age ± s . d .  year;"C0001779;C0439234;C0439508;C0444504;C2347634;C2348143";NA;NA;mean age s d year
 480;mean age ( yrs );"C0001779;C0444504;C2347634;C2348143";NA;NA;mean age yrs
 480;mean age ( yr );"C0001779;C0439234;C0444504;C2347634;C2348143";NA;NA;mean age yr
 480;mean age ( y );"C0001779;C0444504;C2347634;C2348143";NA;NA;mean age y
 480;mean age ( sd )  yr;"C0001779;C0439234;C0444504;C2347634;C2348143;C2699239";NA;NA;mean age sd yr
 480;mean age ( sd )  y;"C0001779;C0444504;C2347634;C2348143;C2699239";NA;NA;mean age sd y
 480;mean age ( range ) — yr;"C0001779;C0439234;C0444504;C1514721;C2347634;C2348143;C2348147;C3542016";NA;NA;mean age range yr
 480;mean age  yrs;"C0001779;C0444504;C2347634;C2348143";NA;NA;mean age yrs
 480;mean age  y : ( range );"C0001779;C0444504;C1514721;C2347634;C2348143;C2348147;C3542016";NA;NA;mean age y range
 480;mean age  y ( range );"C0001779;C0444504;C1514721;C2347634;C2348143;C2348147;C3542016";NA;NA;mean age y range
 480;mean age  y;"C0001779;C0444504;C2347634;C2348143";NA;NA;mean age y
 480;mean ( sd ) age  yr;"C0001779;C0439234;C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd age yr
 480;mean ( sd ) age  y race  n ( % ) *;"C0001779;C0034510;C0444504;C1706779;C2347634;C2348143;C2699239;C3853635";NA;NA;mean sd age y race n
 480;mean ( sd ) age  y;"C0001779;C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd age y
 480;low - trauma fracture since age $nmbr$  n ( % );"C0001779;C0521170";NA;NA;low trauma fracture since age $nmbr$ n
 480;infarction before age $nmbr$ ( a );"C0001779;C0021308";NA;NA;infarction before age $nmbr$ a
 480;family history of myocardial infarction prior to age $nmbr$  %;"C0001779;C0455406";NA;NA;family history of myocardial infarction prior to age $nmbr$
 480;established cvd / chronic kidney disease ( age > $nmbr$ ) ^ * ’;"C0001779;C0007222;C0443211;C1272684;C1561643;C4553188";NA;NA;established cvd chronic kidney disease age $nmbr$
 480;established cvd ( age > $nmbr$ );"C0001779;C0007222;C0443211;C1272684";NA;NA;established cvd age $nmbr$
 480;cvd risk factors ( age > $nmbr$ ) ^ “ ^;"C0001779;C0001783;C0007222;C0035647;C0035648;C1553898;C4552904";NA;NA;cvd risk factors age $nmbr$
 480;cvd risk factors ( age > $nmbr$ );"C0001779;C0001783;C0007222;C0035647;C0035648;C1553898;C4552904";NA;NA;cvd risk factors age $nmbr$
 480;baseline age;"C0001779;C0168634;C1442488";NA;NA;baseline age
 480;average age ( year );"C0001779;C0439234;C0439508;C1510992;C2825518";NA;NA;average age year
 480;aged $nmbr$ y or older  n ( % );"C0001779;C0001792;C0580836;C1999167";NA;NA;aged $nmbr$ y or older n
 480;ageadj;NA;NA;NA;ageadj
 480;age\\yr;"C0001779;C0439234";NA;NA;age\\yr
 480;age — yrf;C0001779;NA;NA;age yrf
 480;age — yr race — no . ( % ) f;"C0001779;C0016327;C0034510;C0439234;C1706779;C3853635";NA;NA;age yr race no f
 480;age — yr;"C0001779;C0439234";NA;NA;age yr
 480;age — year ( median );"C0001779;C0439234;C0439508;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;age year median
 480;age — y £;C0001779;NA;NA;age y
 480;age — y  meantsd;C0001779;NA;NA;age y meantsd
 480;age   ≥ $nmbr$   y  n ( % );C0001779;NA;NA;age $nmbr$ y n
 480;age £ $nmbr$;C0001779;NA;NA;age $nmbr$
 480;age yrs;C0001779;NA;NA;age yrs
 480;age yr  range;"C0001779;C0439234;C1514721;C2348147;C3542016";NA;NA;age yr range
 480;age y  median ( range );"C0001779;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016";NA;NA;age y median range
 480;age subgroups;"C0001779;C1079230";NA;NA;age subgroups
 480;age subgroup  y;"C0001779;C1079230;C1515021";NA;NA;age subgroup y
 480;age s * $nmbr$ yr;"C0001779;C0439234";NA;NA;age s $nmbr$ yr
 480;age s $nmbr$;C0001779;NA;NA;age s $nmbr$
 480;age range  y;"C0001779;C1514721;C2348147;C3542016";NA;NA;age range y
 480;age range;"C0001779;C1514721;C2348147;C3542016";NA;NA;age range
 480;age mean ( yrs ± sd );"C0001779;C0444504;C2347634;C2348143;C2699239";NA;NA;age mean yrs sd
 480;age groups  n ( % );"C0001779;C0441848";NA;NA;age groups n
 480;age group ( y );"C0001779;C0441858";NA;NA;age group y
 480;age group  n ( % );"C0001779;C0441848";NA;NA;age group n
 480;age b $nmbr$ y ( n = $nmbr$ );C0001779;NA;NA;age b $nmbr$ y n $nmbr$
 480;age at time of first seizure;"C0001779;C0036572;C0040223;C0205435;C1279901;C1959629;C3541383;C4553401";NA;NA;age at time of first seizure
 480;age at screening;"C0001779;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164";NA;NA;age at screening
 480;age at randomization;"C0001779;C0034656";NA;NA;age at randomization
 480;age at randomisation;"C0001779;C0034656";NA;NA;age at randomisation
 480;age at lipid randomization ( y );"C0001779;C0034656;C0065033";NA;NA;age at lipid randomization y
 480;age at completion of highest level of;"C0001779;C0205197;C1554962;C4321237";NA;NA;age at completion of highest level of
 480;age a $nmbr$;C0001779;NA;NA;age a $nmbr$
 480;age ^ $nmbr$;C0001779;NA;NA;age $nmbr$
 480;age [ year ]  mean ± sda;"C0001779;C0276477;C0439234;C0439508;C0444504;C1428349;C1553165;C2347634;C2348143";NA;NA;age year mean sda
 480;age > = $nmbr$ yrs;C0001779;NA;NA;age $nmbr$ yrs
 480;age > = $nmbr$;C0001779;NA;NA;age $nmbr$
 480;age > : $nmbr$;C0001779;NA;NA;age $nmbr$
 480;age > $nmbr$ yrs *;C0001779;NA;NA;age $nmbr$ yrs
 480;age > $nmbr$ yrs  %;C0001779;NA;NA;age $nmbr$ yrs
 480;age > $nmbr$ yrs;C0001779;NA;NA;age $nmbr$ yrs
 480;age > $nmbr$ yr 十;"C0001779;C0439234";NA;NA;age $nmbr$ yr
 480;age > $nmbr$ yr — no . ( % );"C0001779;C0439234";NA;NA;age $nmbr$ yr no
 480;age > $nmbr$ yr and st - segment changes;"C0001779;C0232326;C0439234";NA;NA;age $nmbr$ yr and st segment changes
 480;age > $nmbr$ yr and elevated biomarkers;"C0001779;C0005516;C0205250;C0439234;C3163633";NA;NA;age $nmbr$ yr and elevated biomarkers
 480;age > $nmbr$ yr ( % );"C0001779;C0439234";NA;NA;age $nmbr$ yr
 480;age > $nmbr$ yr  elevated biomarkers  and st - segment changes;"C0001779;C0005516;C0205250;C0232326;C0439234;C3163633";NA;NA;age $nmbr$ yr elevated biomarkers and st segment changes
 480;age > $nmbr$ yr;"C0001779;C0439234";NA;NA;age $nmbr$ yr
 480;age > $nmbr$ y * *;C0001779;NA;NA;age $nmbr$ y
 480;age > $nmbr$ y *;C0001779;NA;NA;age $nmbr$ y
 480;age > $nmbr$ y ( n = $nmbr$ );C0001779;NA;NA;age $nmbr$ y n $nmbr$
 480;age > $nmbr$ y ( % );C0001779;NA;NA;age $nmbr$ y
 480;age > $nmbr$ y  n / n ( % );C0001779;NA;NA;age $nmbr$ y n n
 480;age > $nmbr$ y  n ( % );C0001779;NA;NA;age $nmbr$ y n
 480;age > $nmbr$ y  %;C0001779;NA;NA;age $nmbr$ y
 480;age > $nmbr$ y;C0001779;NA;NA;age $nmbr$ y
 480;age > $nmbr$ vears n = $nmbr$;C0001779;NA;NA;age $nmbr$ vears n $nmbr$
 480;age > $nmbr$  y;C0001779;NA;NA;age $nmbr$ y
 480;age > $nmbr$  %;C0001779;NA;NA;age $nmbr$
 480;age > $nmbr$;C0001779;NA;NA;age $nmbr$
 480;age >;C0001779;NA;NA;age
 480;age < $nmbr$ yrs;C0001779;NA;NA;age $nmbr$ yrs
 480;age < $nmbr$ yr or > $nmbr$ yr;"C0001779;C0439234";NA;NA;age $nmbr$ yr or $nmbr$ yr
 480;age < $nmbr$ yr;"C0001779;C0439234";NA;NA;age $nmbr$ yr
 480;age < $nmbr$ y ( n = $nmbr$ );C0001779;NA;NA;age $nmbr$ y n $nmbr$
 480;age < $nmbr$ y;C0001779;NA;NA;age $nmbr$ y
 480;age < $nmbr$ vears n = $nmbr$;C0001779;NA;NA;age $nmbr$ vears n $nmbr$
 480;age < $nmbr$;C0001779;NA;NA;age $nmbr$
 480;age :;C0001779;NA;NA;age
 480;age . y;C0001779;NA;NA;age y
 480;age . . . . . . . . y ( n = $nmbr$ );C0001779;NA;NA;age y n $nmbr$
 480;age - interaction;"C0001779;C1704675";NA;NA;age interaction
 480;age *;C0001779;NA;NA;age
 480;age ( yrs )  mean ± sd;"C0001779;C0444504;C2347634;C2348143;C2699239";NA;NA;age yrs mean sd
 480;age ( yrs )  mean *;"C0001779;C0444504;C2347634;C2348143";NA;NA;age yrs mean
 480;age ( yrs );C0001779;NA;NA;age yrs
 480;age ( yr ) *;"C0001779;C0439234";NA;NA;age yr
 480;age ( yr )  mean ( sd ) bmd t - score  mean ( sd );"C0001779;C0439234;C2699239;C3533236";NA;NA;age yr mean sd bmd t score mean sd
 480;age ( yr )  mean ( sd );"C0001779;C0439234;C0444504;C2347634;C2348143;C2699239";NA;NA;age yr mean sd
 480;age ( yr );"C0001779;C0439234";NA;NA;age yr
 480;age ( yij;C0001779;NA;NA;age yij
 480;age ( year )  mean ± sd;"C0001779;C0439234;C0439508;C0444504;C2347634;C2348143;C2699239";NA;NA;age year mean sd
 480;age ( year );"C0001779;C0439234;C0439508";NA;NA;age year
 480;age ( y ) ∗;C0001779;NA;NA;age y
 480;age ( y ) [ mean - sd ];"C0001779;C0444504;C2347634;C2348143;C2699239";NA;NA;age y mean sd
 480;age ( y )  median ( min  max };"C0001779;C0549183;C0702093;C0876920;C1524029;C2347635;C2348144;C2939193;C3813700";NA;NA;age y median min max
 480;age ( y )  median ( min  max );"C0001779;C0549183;C0702093;C0876920;C1524029;C2347635;C2348144;C2939193;C3813700";NA;NA;age y median min max
 480;age ( y )  median ( iqr );"C0001779;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;age y median iqr
 480;age ( y )  mean ( sd );"C0001779;C0444504;C2347634;C2348143;C2699239";NA;NA;age y mean sd
 480;age ( y )  mean ( range );"C0001779;C0444504;C1514721;C2347634;C2348143;C2348147;C3542016";NA;NA;age y mean range
 480;age ( y );C0001779;NA;NA;age y
 480;age ( sd )  y;"C0001779;C2699239";NA;NA;age sd y
 480;age ( p = o - $nmbr$ );C0001779;NA;NA;age p o $nmbr$
 480;age ' ^ $nmbr$ yrs;C0001779;NA;NA;age $nmbr$ yrs
 480;age ' $nmbr$ y ( n $nmbr$ );C0001779;NA;NA;age $nmbr$ y n $nmbr$
 480;age & $nmbr$;C0001779;NA;NA;age $nmbr$
 480;age $nmbr$ y;C0001779;NA;NA;age $nmbr$ y
 480;age $nmbr$ - $nmbr$ yr  elevated biomarkers  and previous vascular;"C0001779;C0005516;C0005847;C0205156;C0205250;C0439234;C1552607;C1558950;C1801960;C3163633";NA;NA;age $nmbr$ $nmbr$ yr elevated biomarkers and previous vascular
 480;age $nmbr$ - $nmbr$ y ( n = $nmbr$ );C0001779;NA;NA;age $nmbr$ $nmbr$ y n $nmbr$
 480;age $nmbr$ - $nmbr$;C0001779;NA;NA;age $nmbr$ $nmbr$
 480;age $nmbr$ + y;C0001779;NA;NA;age $nmbr$ y
 480;age $nmbr$ +;C0001779;NA;NA;age $nmbr$
 480;age $nmbr$ * $nmbr$ yr;"C0001779;C0439234";NA;NA;age $nmbr$ $nmbr$ yr
 480;age $nmbr$ $nmbr$ y;C0001779;NA;NA;age $nmbr$ $nmbr$ y
 480;age $nmbr$;C0001779;NA;NA;age $nmbr$
 480;age $ $nmbr$ yrs;C0001779;NA;NA;age $ $nmbr$ yrs
 480;age # $nmbr$ yrs;C0001779;NA;NA;age $nmbr$ yrs
 480;age  yt;"C0001779;C1412122";NA;NA;age yt
 480;age  yrs *;C0001779;NA;NA;age yrs
 480;age  yrs ( mean ± sd );"C0001779;C0444504;C2347634;C2348143;C2699239";NA;NA;age yrs mean sd
 480;age  yrs  mean ( sd );"C0001779;C0444504;C2347634;C2348143;C2699239";NA;NA;age yrs mean sd
 480;age  yrs;C0001779;NA;NA;age yrs
 480;age  yr mean ( sd );"C0001779;C0439234;C0444504;C2347634;C2348143;C2699239";NA;NA;age yr mean sd
 480;age  yr  n ( % );"C0001779;C0439234";NA;NA;age yr n
 480;age  yr;"C0001779;C0439234";NA;NA;age yr
 480;age  yf $nmbr$ - $nmbr$;C0001779;NA;NA;age yf $nmbr$ $nmbr$
 480;age  year ( median );"C0001779;C0439234;C0439508;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;age year median
 480;age  year;"C0001779;C0439234;C0439508";NA;NA;age year
 480;age  ya;C0001779;NA;NA;age ya
 480;age  y sex  no . ( % );"C0001779;C0009253;C0036864;C0079399;C0804628;C1314687;C1522384";NA;NA;age y sex no
 480;age  y gender  n ( % );"C0001779;C0079399;C1522384";NA;NA;age y gender n
 480;age  y < $nmbr$;C0001779;NA;NA;age y $nmbr$
 480;age  y . o .;C0001779;NA;NA;age y o
 480;age  y ( sd );"C0001779;C2699239";NA;NA;age y sd
 480;age  y ( mean ± s . d . );"C0001779;C0444504;C2347634;C2348143";NA;NA;age y mean s d
 480;age  y  median ( q $nmbr$ – q $nmbr$ );"C0001779;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;age y median q $nmbr$ q $nmbr$
 480;age  y  mean ± sd;"C0001779;C0444504;C2347634;C2348143;C2699239";NA;NA;age y mean sd
 480;age  y;C0001779;NA;NA;age y
 480;age  x;C0001779;NA;NA;age x
 480;age  n ( % );C0001779;NA;NA;age n
 480;age  median ( interquartile range )  y;"C0001779;C0549183;C0876920;C1711350;C2347635;C2348144;C2939193";NA;NA;age median interquartile range y
 480;age  mean ± sd ( year );"C0001779;C0439234;C0439508;C0444504;C2347634;C2348143;C2699239";NA;NA;age mean sd year
 480;age  mean ± sd  y;"C0001779;C0444504;C2347634;C2348143;C2699239";NA;NA;age mean sd y
 480;age  mean yr ( sd );"C0001779;C0439234;C0444504;C2347634;C2348143;C2699239";NA;NA;age mean yr sd
 480;age  mean yr;"C0001779;C0439234;C0444504;C2347634;C2348143";NA;NA;age mean yr
 480;age  mean ( sd ) [ range ]  y;"C0001779;C0444504;C1514721;C2347634;C2348143;C2348147;C2699239;C3542016";NA;NA;age mean sd range y
 480;age  mean ( sd )  yrs;"C0001779;C0444504;C2347634;C2348143;C2699239";NA;NA;age mean sd yrs
 480;age  mean ( sd )  yr;"C0001779;C0439234;C0444504;C2347634;C2348143;C2699239";NA;NA;age mean sd yr
 480;age  mean ( sd )  yearsa;"C0001779;C0444504;C2347634;C2348143;C2699239";NA;NA;age mean sd yearsa
 480;age  mean ( sd )  y;"C0001779;C0444504;C2347634;C2348143;C2699239";NA;NA;age mean sd y
 480;age  mean ( s . e . );"C0001779;C0444504;C2347634;C2348143";NA;NA;age mean s e
 480;age  mean ( min - max ) ( yrs );"C0001779;C0444504;C0702093;C1524029;C2347634;C2348143;C3813700";NA;NA;age mean min max yrs
 480;age  mean  yrs ( sd );"C0001779;C0444504;C2347634;C2348143;C2699239";NA;NA;age mean yrs sd
 480;age  mean;"C0001779;C0444504;C2347634;C2348143";NA;NA;age mean
 480;age;C0001779;NA;NA;age
 480;adults ( aged   ≥ $nmbr$ y )  no . ( % );"C0001675;C0001779;C0001792;C1999167";NA;NA;adults aged $nmbr$ y no
 480;adolescents ( aged $nmbr$ - $nmbr$ y )  no . ( % );"C0001779;C0001792;C0205653;C1999167";NA;NA;adolescents aged $nmbr$ $nmbr$ y no
 480;> $nmbr$ yrs of age ( n = $nmbr$  $nmbr$ );C0001779;NA;NA;$nmbr$ yrs of age n $nmbr$ $nmbr$
 480;< $nmbr$ yrs of age ( n = $nmbr$  $nmbr$ );C0001779;NA;NA;$nmbr$ yrs of age n $nmbr$ $nmbr$
 480;( b ) age subgroups;"C0001779;C1304659";NA;NA;b age subgroups
 469;no depression;"C0011570;C0011581;C0344315;C0460137;C4049644;C4084909;C4085311;C4553827";NA;NA;no depression
 469;depression ®;"C0011570;C0011581;C0344315;C0460137;C4049644;C4084909;C4085311;C4553827";NA;NA;depression
 479;§ classes on the canadian cardiovascular society ( ccs ) scale range from i to iv;"C0007226;C0021966;C0022326;C0037455;C0175659;C0221138;C0238884;C0349674;C1514721;C1879987;C1947916;C2348147;C3542016;C3887460;C4265176";NA;NA;classes on the canadian cardiovascular society ccs scale range from i to iv
 479;total updrs score ( range  $nmbr$ — $nmbr$ ) y;"C0439175;C0439810;C0449820;C1514721;C2348147;C3542016;C3639721;C4050231";NA;NA;total updrs score range $nmbr$ $nmbr$ y
 479;total updrs score ( range  $nmbr$ - $nmbr$ ) 卞;"C0439175;C0439810;C0449820;C1514721;C2348147;C3542016;C3639721;C4050231";NA;NA;total updrs score range $nmbr$ $nmbr$
 479;total scores ( total score range : $nmbr$ - $nmbr$ );"C1514721;C2348147;C2964552;C3542016";NA;NA;total scores total score range $nmbr$ $nmbr$
 479;selena - sledai ( range u - $nmbr$ u $nmbr$ ) t;"C0439148;C0451528;C1514721;C2348147;C3542016";NA;NA;selena sledai range u $nmbr$ u $nmbr$ t
 479;seizure frequency during $nmbr$ ‐ week baseline  median ( range );"C0149775;C0168634;C0332174;C0439230;C0549183;C0876920;C1442488;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016";NA;NA;seizure frequency during $nmbr$ week baseline median range
 479;range race  n ( % );"C0034510;C1514721;C1706779;C2348147;C3542016;C3853635";NA;NA;range race n
 479;range of sbp;"C0085805;C1514721;C2348147;C3542016";NA;NA;range of sbp
 479;range;"C1514721;C2348147;C3542016";NA;NA;range
 479;motor subscale ( range  $nmbr$ - $nmbr$ );"C1513492;C1514721;C1705994;C2348147;C3542016";NA;NA;motor subscale range $nmbr$ $nmbr$
 479;median dose ( range ) b;"C0178602;C0549183;C0869039;C0876920;C1114758;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016";NA;NA;median dose range b
 479;median dose ( range ) ' ’;"C0178602;C0549183;C0869039;C0876920;C1114758;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016";NA;NA;median dose range
 479;median ( range ) treatment duration  d;"C0444921;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3259042;C3542016";NA;NA;median range treatment duration d
 479;median ( range ) duration of hospital stayi  d;"C0019994;C0449238;C0549183;C0876920;C1510665;C1514721;C2347635;C2348144;C2348147;C2926735;C2939193;C3542016";NA;NA;median range duration of hospital stayi d
 479;il - $nmbr$ range  ng / l;"C0020898;C0021764;C0022271;C0439297;C1514721;C2348147;C3542016";NA;NA;il $nmbr$ range ng l
 479;hscrp range  mg / l;"C0439268;C1514721;C2348147;C3542016";NA;NA;hscrp range mg l
 479;health assessment questionnaire ( $nmbr$ - $nmbr$ range );"C0451208;C1514721;C2348147;C3542016";NA;NA;health assessment questionnaire $nmbr$ $nmbr$ range
 479;duration of current flare  median ( range ) months ( n = $nmbr$  $nmbr$  $nmbr$ );"C0439231;C0449238;C0521116;C0549183;C0876920;C1514721;C1517205;C1705970;C2347635;C2348144;C2348147;C2926735;C2939193;C3540542;C3542016";NA;NA;duration of current flare median range months n $nmbr$ $nmbr$ $nmbr$
 479;( range );"C1514721;C2348147;C3542016";NA;NA;range
 479;$nmbr$ . $nmbr$ range $nmbr$ - $nmbr$;"C1514721;C2348147;C3542016";NA;NA;$nmbr$ $nmbr$ range $nmbr$ $nmbr$
 478;repaired s - p shunts;"C0205340;C0232180;C0542331;C1442858";NA;NA;repaired s p shunts
 478;repaired congenital shunts;"C0009678;C0205340;C0232180;C0542331;C1442858;C1744681";NA;NA;repaired congenital shunts
 478;repaired congenital shunt;"C0009678;C0205340;C0232180;C0542331;C1442858;C1744681";NA;NA;repaired congenital shunt
 478;pfo with large shunt without atrial septal aneurysm;"C0232180;C0521533;C0542331;C0549177;C1442858";NA;NA;pfo with large shunt without atrial septal aneurysm
 478;pfo with large shunt and atrial septal aneurysm;"C0232180;C0521533;C0542331;C0549177;C1442858";NA;NA;pfo with large shunt and atrial septal aneurysm
 478;large shunt;"C0232180;C0542331;C0549177;C1442858";NA;NA;large shunt
 478;congenital shunts;"C0009678;C0232180;C0542331;C1442858;C1744681";NA;NA;congenital shunts
 478;assoc  with corrected congenital shunts;"C0009678;C0205202;C0232180;C0542331;C1442858;C1744681";NA;NA;assoc with corrected congenital shunts
 477;residual perfusion defect > $nmbr$ % on lung scan  no . ( % );"C1457869;C1518040;C1609982";NA;NA;residual perfusion defect $nmbr$ on lung scan no
 477;lung infection;"C0876973;C4552950";NA;NA;lung infection
 477;lung;C0024109;NA;NA;lung
 477;lunchb;NA;NA;NA;lunchb
 477;high - probability ventilation / perfusion lung scanning;"C0024109;C0560738;C4699572";NA;NA;high probability ventilation perfusion lung scanning
 476;lung neoplasm malignant;"C0024121;C0205282";NA;NA;lung neoplasm malignant
 476;> $nmbr$ / $nmbr$ lung fields;C0225759;NA;NA;$nmbr$ $nmbr$ lung fields
 475;pool of long term ( hefh patients only ) and high fh;"C0030705;C0205171;C0205250;C0337051;C0443252;C1299351;C1509144;C1720467;C2349200;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;pool of long term hefh patients only and high fh
 475;hong kong;"C0019907;C2987742";NA;NA;hong kong
 474;total occlusion  n ( % );"C0001168;C0011382;C0028778;C0439175;C0439810;C0441597;C1110554;C1947917";NA;NA;total occlusion n
   7;heterogeneity or trend p value;"C0019409;C0242960;C1521798;C1709380;C4554533";NA;NA;heterogeneity or trend p value
 473;cardiovascular inclusion criteriat;"C0007226;C0007637;C1512693;C3887460";NA;NA;cardiovascular inclusion criteriat
 472;three or more lesions;"C0205172;C0205449;C0221198;C1546698";NA;NA;three or more lesions
 472;t $nmbr$ lesion volume  mm ';"C0221198;C0449468;C1546698;C1690016;C1705102;C2603360;C2700258;C4330985;C4554674";NA;NA;t $nmbr$ lesion volume mm
 472;t $nmbr$ lesion volume  mm $nmbr$;"C0221198;C0449468;C1546698;C1690016;C1705102;C2603360;C2700258;C4330985;C4554674";NA;NA;t $nmbr$ lesion volume mm $nmbr$
 472;stents per lesion  n;"C0038257;C0221198;C1546698";NA;NA;stents per lesion n
 472;stented lesions;"C0038257;C0221198";NA;NA;stented lesions
 472;n ( stented lesions );"C0038257;C0221198;C0369718;C0441922";NA;NA;n stented lesions
 472;more than $nmbr$ lesions per vessel;"C0005847;C0205172;C0221198;C1546698";NA;NA;more than $nmbr$ lesions per vessel
 472;mean stents per lesion ( sd ) ‡;"C0038257;C0221198;C0444504;C1546698;C2347634;C2348143;C2699239";NA;NA;mean stents per lesion sd
 472;lesions b $nmbr$ / c;"C0221198;C1546698";NA;NA;lesions b $nmbr$ c
 472;lesions;C0221198;NA;NA;lesions
 472;lesion length ≥ $nmbr$ mm;"C0221198;C1444754;C1546698;C1706316;C4330985;C4554674";NA;NA;lesion length $nmbr$ mm
 472;lesion length > $nmbr$ mm;"C0221198;C1444754;C1546698;C1706316;C4330985;C4554674";NA;NA;lesion length $nmbr$ mm
 472;lesion length $ $nmbr$ mm;"C0221198;C1444754;C1546698;C1706316;C4330985;C4554674";NA;NA;lesion length $ $nmbr$ mm
 472;lesion length  mean ( sd )  mm;"C0221198;C0444504;C1444754;C1546698;C1706316;C2347634;C2348143;C2699239;C4330985;C4554674";NA;NA;lesion length mean sd mm
 472;lesion ( s );"C0221198;C1546698";NA;NA;lesion s
 472;intervention in complex lesions;"C0221198;C1292781";NA;NA;intervention in complex lesions
 472;direct stenting per lesion ‡;"C0038257;C0221198;C0439851;C1546698;C1947931;C2348535";NA;NA;direct stenting per lesion
 472;complex lesions ^;"C0221198;C0439855;C1704241";NA;NA;complex lesions
 472;age > $nmbr$ gd lesion > $nmbr$ n = $nmbr$;"C0001779;C0221198;C1546698";NA;NA;age $nmbr$ gd lesion $nmbr$ n $nmbr$
 472;age > $nmbr$ gd lesion = $nmbr$ n = $nmbr$;"C0001779;C0221198;C1546698";NA;NA;age $nmbr$ gd lesion $nmbr$ n $nmbr$
 472;age < $nmbr$ gd lesion > $nmbr$ n = $nmbr$;"C0001779;C0221198;C1546698";NA;NA;age $nmbr$ gd lesion $nmbr$ n $nmbr$
 472;age < $nmbr$ gd lesion = $nmbr$ n = $nmbr$;"C0001779;C0221198;C1546698";NA;NA;age $nmbr$ gd lesion $nmbr$ n $nmbr$
 472;age / gd lesion;"C0001779;C0221198;C1546698";NA;NA;age gd lesion
 472;> $nmbr$ lesions per vessel;"C0005847;C0221198";NA;NA;$nmbr$ lesions per vessel
 471;regadenoson ( n = $nmbr$ );C1698215;NA;NA;regadenoson n $nmbr$
 471;regadenoson;C1698215;NA;NA;regadenoson
 470;treatment before admission ( % );"C0039798;C0087111;C0184666;C0809949;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;treatment before admission
 470;treatment after admission;"C0039798;C0087111;C0184666;C0809949;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;treatment after admission
 470;risk level at admission;"C0184666;C0809949;C2923839";NA;NA;risk level at admission
 470;before admission )  %;"C0184666;C0809949";NA;NA;before admission
 469;no st depression or elevation;"C0439775;C0520887;C0702240";NA;NA;no st depression or elevation
 428;apob;"C0003593;C3252643";FALSE; 426;apob
 469;depression ^;"C0011570;C0011581;C0344315;C0460137;C4049644;C4084909;C4085311;C4553827";NA;NA;depression
 469;depression;"C0011570;C0011581;C0344315;C0460137;C4049644;C4084909;C4085311;C4553827";NA;NA;depression
 469;antidepressant;C0003289;NA;NA;antidepressant
 468;linear regression;"C0023733;C2346679";NA;NA;linear regression
 468;aggressive ( n = $nmbr$ );"C0001807;C0580822";NA;NA;aggressive n $nmbr$
 468;aggressive ( $nmbr$ );"C0001807;C0580822";NA;NA;aggressive $nmbr$
 467;history of dyspepsia;"C0013395;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C4552968";NA;NA;history of dyspepsia
 467;dyspepsia;"C0013395;C4552968";NA;NA;dyspepsia
 466;y es;"C0013754;C0205944";FALSE; -10;y es
 469;st depression > $nmbr$ mm;"C0520887;C4330985;C4554674";FALSE;1856;st depression $nmbr$ mm
 469;st - segment depression > $nmbr$ mm — no . ( % );"C0520887;C4330985;C4554674";FALSE;1856;st segment depression $nmbr$ mm no
 470;aspirin before admission;"C0004057;C0184666;C0809949";FALSE;1366;aspirin before admission
 471;no readmission ( n = $nmbr$ );"C1548168;C4489276";FALSE;1857;no readmission n $nmbr$
 471;readmission ( n = $nmbr$ );"C1548168;C4489276";FALSE;1857;readmission n $nmbr$
 475;long - term vitamin k antagonist;"C0443252;C1096489;C2267235";FALSE; 858;long term vitamin k antagonist
 475;long - term warfarin ( n = $nmbr$ );"C0043031;C0443252";FALSE; 858;long term warfarin n $nmbr$
 475;long - term warfarin ( n - $nmbr$ );"C0043031;C0443252";FALSE; 858;long term warfarin n $nmbr$
 475;long term *;C0443252;FALSE;1858;long term
 475;long term ( n = $nmbr$ ) +;C0443252;FALSE;1858;long term n $nmbr$
 474;small - artery occlusion;"C0001168;C0011382;C0028778;C0226001;C0264995;C0441597;C0700321;C1110554;C1947917";FALSE;1859;small artery occlusion
 474;small - artery occlusion ( lacune );"C0001168;C0011382;C0028778;C0226001;C0241970;C0264995;C0441597;C0700321;C1110554;C1947917";FALSE;1859;small artery occlusion lacune
 473;inclusion criteria;C1512693;FALSE;1860;inclusion criteria
 473;inclusion criteria — no . ( % );C1512693;FALSE;1860;inclusion criteria no
 465;with des;"C0011702;C4551552";NA;NA;with des
 465;older des ( n = $nmbr$ );"C0011702;C0580836;C4551552";NA;NA;older des n $nmbr$
 465;no des;"C0011702;C4551552";NA;NA;no des
 465;des implantation for restenosis  n ( % );"C0011702;C0021107;C0029976;C0333186;C4551552";NA;NA;des implantation for restenosis n
 465;des ( % previous stenting );"C0011702;C0038257;C0205156;C1552607;C2348535;C4551552";NA;NA;des previous stenting
 465;des;"C0011702;C4551552";NA;NA;des
 464;yes  no;C1512698;NA;NA;yes no
 464;non - metsyn;C1518422;NA;NA;non metsyn
 464;metsyn;NA;NA;NA;metsyn
 464;ics use yes / no  %;"C0042153;C0457083;C0815320;C1512698;C1947944;C4551720";NA;NA;ics use yes no
 464;ics use  yes / no %;"C0042153;C0457083;C0815320;C1512698;C1947944;C4551720";NA;NA;ics use yes no
 464;ics use  yes / no  %;"C0042153;C0457083;C0815320;C1512698;C1947944;C4551720";NA;NA;ics use yes no
 464;( yes / no );C1512698;NA;NA;yes no
 463;us;NA;NA;NA;us
 463;non - us;C1518422;NA;NA;non us
 463;non - inhaled steroid use  n ( % );"C0586793;C1518422";NA;NA;non inhaled steroid use n
 463;non - black  us;"C0005680;C0027567;C0085756;C0439541;C1518422";NA;NA;non black us
 462;saphenous vein graft;C0729538;NA;NA;saphenous vein graft
 462;saphenous - vein graft;C0729538;NA;NA;saphenous vein graft
 462;graft occlusionsa;"C0181074;C0332835;C1961139";NA;NA;graft occlusionsa
 462;graft  n ( % );"C0181074;C0332835;C1961139";NA;NA;graft n
 462;graft;"C0181074;C0332835;C1961139";NA;NA;graft
 462;gait;C0016928;NA;NA;gait
 462;all grafts;"C0181074;C0332835;C1527362;C1961139";NA;NA;all grafts
 461;percentage unless otherwise noted . cabg indicates coronary artery bypass graft  lvh  left ventricular hypertrophy  nsaids  nonsteroidal antiinflammatory drugs  pvd  peripheral vascular disease  tia  transient ischemic attack . ‘ history of hypercholesterolemia or reporting use of lipid - lowering medications at baseline . thistory of or currently have elevated serum creatinine level < $nmbr$ mg / dl . tbased on participant history or review of chart .;"C0003211;C0007787;C0010055;C0013227;C0019664;C0019665;C0020443;C0023779;C0042373;C0085096;C0149721;C0168634;C0205100;C0205250;C0229671;C0262512;C0262926;C0439165;C0439269;C0441889;C0441994;C0455536;C0456079;C0521116;C0541653;C0600061;C0679646;C0700225;C0700287;C0802604;C0917805;C1054154;C1260596;C1442488;C1522133;C1524063;C1546774;C1547707;C1549488;C1550100;C1561533;C1705255;C2003888;C2004062;C2598133;C2698741;C2946261;C3163633;C3671888;C4284232;C4288581;C4521226;C4554048";NA;NA;percentage unless otherwise noted cabg indicates coronary artery bypass graft lvh left ventricular hypertrophy nsaids nonsteroidal antiinflammatory drugs pvd peripheral vascular disease tia transient ischemic attack history of hypercholesterolemia or reporting use of lipid lowering medications at baseline thistory of or currently have elevated serum creatinine level $nmbr$ mg dl tbased on participant history or review of chart
 461;granulating  n ( % ) a;NA;NA;NA;granulating n a
 460;peak creatine kinase - mb  u / l;"C0010290;C0439339;C0444505;C0523584";NA;NA;peak creatine kinase mb u l
 460;gamma glutamyltransferase  u / l;"C0017040;C0439339";NA;NA;gamma glutamyltransferase u l
 460;elevated creatine kinase mb ( > $nmbr$ u / l );"C0010290;C0024853;C0151576;C0205250;C0439339;C0523584;C3163633";NA;NA;elevated creatine kinase mb $nmbr$ u l
 460;elevated creatine kinase - mb ( > $nmbr$ u / l );"C0010290;C0024853;C0151576;C0205250;C0439339;C0523584;C3163633";NA;NA;elevated creatine kinase mb $nmbr$ u l
 460;alt ( units / l );"C0439339;C1266129;C4553172";NA;NA;alt units l
 460;alt  u / l;"C0439339;C1266129;C4553172";NA;NA;alt u l
 459;idegasp – biasp $nmbr$;NA;NA;NA;idegasp biasp $nmbr$
 459;biasp $nmbr$ bid;NA;NA;NA;biasp $nmbr$ bid
 459;biasp $nmbr$;NA;NA;NA;biasp $nmbr$
 459;ast increased;"C0205217;C0442805;C1415181;C3891303";NA;NA;ast increased
 459;ast  u / l;"C0439339;C1415181;C3891303";NA;NA;ast u l
 459;asp;"C0206293;C0206298;C1332656;C1528298;C3541260;C3890396;C4048238;C4321307;C4553371";NA;NA;asp
 458;at;NA;NA;NA;at
 457;within last $nmbr$ d;C1517741;NA;NA;within last $nmbr$ d
 457;mean arterial pressure  last;"C0428886;C1517741";NA;NA;mean arterial pressure last
 457;last infusion in the horizon - pft;"C0024119;C0053122;C0279232;C0574032;C1517741;C1827465";NA;NA;last infusion in the horizon pft
 438;no . ( % ) ';NA;NA;NA;no
 461;coronary bypass graft;C1260596;FALSE;1843;coronary bypass graft
 458;digoxin at last follow - up;"C0012265;C0589120;C1522577;C1704685;C3274571";FALSE; 989;digoxin at last follow up
 456;past or nonsmoker ( n = $nmbr$ );"C0337672;C0425293;C1444637;C4284302;C4554605";FALSE; 420;past or nonsmoker n $nmbr$
 456;past smoking;"C0037369;C0453996;C1444637;C1881674;C4284302";FALSE; 420;past smoking
 456;past smoker;"C0337664;C1444637;C4284302";FALSE; 420;past smoker
 456;past smoker  n ( % );"C0337664;C1444637;C4284302";FALSE; 420;past smoker n
 456;smoking in past yr;"C0037369;C0439234;C0453996;C1444637;C1881674;C4284302";FALSE; 420;smoking in past yr
 456;smoking past;"C0037369;C0453996;C1444637;C1881674;C4284302";FALSE; 420;smoking past
 458;ace inhibitor or arb at last follow - up;"C0003015;C0589120;C1522577;C1704685;C3274571;C3888198;C4541021";FALSE; 811;ace inhibitor or arb at last follow up
 458;arb at last follow - up;"C0589120;C1522577;C1704685;C3274571;C3888198";FALSE; 779;arb at last follow up
 458;ace inhibitor at last follow - up;"C0003015;C0589120;C1522577;C1704685;C3274571;C4541021";FALSE; 811;ace inhibitor at last follow up
 458;statin at last follow - up;"C0360714;C0589120;C1522577;C1704685;C3274571";FALSE; 872;statin at last follow up
 458;warfarin at last follow - up;"C0043031;C0589120;C1522577;C1704685;C3274571";FALSE; 858;warfarin at last follow up
 458;thiazide at last follow - up;"C0541746;C0589120;C1522577;C1704685;C3274571";FALSE; 993;thiazide at last follow up
 466;das $nmbr$ - esr remission;"C0051767;C0057671;C0544452;C0687702;C3811131";FALSE; 298;das $nmbr$ esr remission
 433;$nmbr$ to < $nmbr$ hr;NA;FALSE; -10;$nmbr$ to $nmbr$ hr
 466;das $nmbr$ - esr remission  %;"C0051767;C0057671;C0544452;C0687702;C3811131";FALSE; 298;das $nmbr$ esr remission
 466;das $nmbr$ - $nmbr$ ( esr );"C0051767;C0057671;C3811131";FALSE; 298;das $nmbr$ $nmbr$ esr
 466;das $nmbr$ - $nmbr$ ( esr ) < $nmbr$ . $nmbr$ t;"C0051767;C0057671;C3811131";FALSE; 298;das $nmbr$ $nmbr$ esr $nmbr$ $nmbr$ t
 461;bypass graft;C0185098;FALSE;2032;bypass graft
 461;arterial graft;C0450140;FALSE;2032;arterial graft
 461;bypass graft §;C0185098;FALSE;2032;bypass graft
 461;multivessel coronary - artery bypass grafting;C0010055;FALSE;2032;multivessel coronary artery bypass grafting
 466;das $nmbr$ - esr;"C0051767;C0057671;C3811131";FALSE; 298;das $nmbr$ esr
 466;das $nmbr$ ( esr );"C0051767;C0057671;C3811131";FALSE; 298;das $nmbr$ esr
 466;das $nmbr$ - esr lda;"C0051767;C0057671;C3811131;C4553195";FALSE; 298;das $nmbr$ esr lda
 466;das $nmbr$ - $nmbr$ ( esr ) $nmbr$;"C0051767;C0057671;C3811131";FALSE; 298;das $nmbr$ $nmbr$ esr $nmbr$
 466;das $nmbr$ - $nmbr$ ( esr ) < $nmbr$ . $nmbr$ *;"C0051767;C0057671;C3811131";FALSE; 298;das $nmbr$ $nmbr$ esr $nmbr$ $nmbr$
 461;prior bypass graft surgery;"C0185098;C0455610";FALSE;2032;prior bypass graft surgery
 461;need for urgent coronary - artery bypass grafting;"C0010055;C0027552;C0439609;C0686904;C3272275";FALSE;2032;need for urgent coronary artery bypass grafting
 462;graft  pci  percutaneous coronary intervention  tia  transient;"C0007787;C0040704;C0181074;C0205374;C0332835;C0917805;C1054154;C1532338;C1961139";FALSE;1661;graft pci percutaneous coronary intervention tia transient
 456;past or never;"C1444637;C2003901;C4284302";NA;NA;past or never
 456;past or current angina pectoris;"C0002962;C0521116;C1444637;C1705970;C4284302";NA;NA;past or current angina pectoris
 456;past or current;"C0521116;C1444637;C1705970;C4284302";NA;NA;past or current
 456;past only;"C0205171;C1444637;C1720467;C4284302";NA;NA;past only
 456;past cardiovascular history  no . ( % );"C0007226;C0332119;C1444637;C1880008;C3887460;C4284302";NA;NA;past cardiovascular history no
 456;past;"C1444637;C4284302";NA;NA;past
 456;never or past;"C1444637;C2003901;C4284302";NA;NA;never or past
 456;intra - abdominal abscess ( past );"C0243001;C1444637;C4284302";NA;NA;intra abdominal abscess past
 456;current / past;"C0521116;C1444637;C1705970;C4284302";NA;NA;current past
 456;bmi indicates body mass index  sbp  systolic blood pressure  dbp  lipoprotein ( a ) . ldl - c was calculated with the friedewald formula . ' hypertension and diabetes were based on physician diagnosis . ! smoker includes current and past smokers .;"C0005893;C0011847;C0011849;C0011900;C0012164;C0020538;C0031831;C0065058;C0085805;C0125953;C0332257;C0337664;C0444686;C0488055;C0489829;C0521116;C0536221;C0578022;C0804815;C0871470;C1096202;C1305855;C1306620;C1439335;C1441506;C1444637;C1527178;C1552866;C1704338;C1704656;C1705501;C1705938;C1705970;C1963138;C2700399;C3813197;C4281799;C4284302";NA;NA;bmi indicates body mass index sbp systolic blood pressure dbp lipoprotein a ldl c was calculated with the friedewald formula hypertension and diabetes were based on physician diagnosis smoker includes current and past smokers
 455;killip ciass;NA;NA;NA;killip ciass
 455;ciass i;"C0021966;C0221138";NA;NA;ciass i
 455;ccs class §;C1879987;NA;NA;ccs class
 454;others  classes i and iiic;"C0441885;C1319793;C1955473;C2698967;C3539125";NA;NA;others classes i and iiic
 454;class i;"C0441885;C1319793;C2698967";NA;NA;class i
 453;nyha_class;C1882083;NA;NA;nyha_class
 453;nyha class — no . ( % ) $;C1882083;NA;NA;nyha class no $
 453;nyha class — no . ( % );C1882083;NA;NA;nyha class no
 453;nyha class within past month — no . / total no . ( % );"C0439175;C0439810;C1882083;C4331910";NA;NA;nyha class within past month no total no
 453;nyha class not reported;"C0684224;C0700287;C1518422;C1882083;C4319718";NA;NA;nyha class not reported
 453;nyha class $nmbr$ or higher;"C0205250;C1882083";NA;NA;nyha class $nmbr$ or higher
 453;nyha class $nmbr$ - $nmbr$ : no { n = llll );"C0369718;C0441922;C1882083";NA;NA;nyha class $nmbr$ $nmbr$ no n llll
 453;nyha class  n ( % ) i;"C0021966;C0221138;C0369718;C0441922;C1882083";NA;NA;nyha class n i
 453;nyha class  n ( % );C1882083;NA;NA;nyha class n
 453;nyha class  ( % );C1882083;NA;NA;nyha class
 453;nyha class;C1882083;NA;NA;nyha class
 453;nyha chf class;"C0018802;C1882083";NA;NA;nyha chf class
 453;new york heart association congestive heart failure class;"C0018802;C1882083";NA;NA;new york heart association congestive heart failure class
 453;new york heart association class;C1882083;NA;NA;new york heart association class
 452;who functional class — no . ( % ) : c;"C0205245;C0456387;C0542341;C1518526;C1705943;C2700217";NA;NA;who functional class no c
 452;who functional class;"C0205245;C0456387;C0542341;C1518526;C1705943;C2700217";NA;NA;who functional class
 452;renal biopsy class;"C0194073;C0456387;C1518526;C1705943";NA;NA;renal biopsy class
 452;modified braunwald class;"C0392747;C0456387;C1518526;C1705943;C3889737";NA;NA;modified braunwald class
 452;modified acc or aha lesion class b $nmbr$ or c;"C0050451;C0175754;C0221198;C0282160;C0392747;C0456387;C0772110;C1518526;C1546698;C1705943;C3541413;C3889737";NA;NA;modified acc or aha lesion class b $nmbr$ or c
 452;modified acc / aha lesion class b $nmbr$ or cj;"C0007481;C0221198;C0392747;C0456387;C1518526;C1546698;C1705943;C3889737;C4072694";NA;NA;modified acc aha lesion class b $nmbr$ or cj
 452;modified acc / aha lesion class b $nmbr$ / c;"C0050451;C0101856;C0221198;C0392747;C0456387;C0772110;C1518526;C1546698;C1705943;C3889737";NA;NA;modified acc aha lesion class b $nmbr$ c
 452;modified acc - aha lesion class b $nmbr$ or c;"C0221198;C0392747;C0456387;C1518526;C1546698;C1705943;C3889737;C4072694";NA;NA;modified acc aha lesion class b $nmbr$ or c
 452;kilip class;"C0456387;C1518526;C1705943";NA;NA;kilip class
 452;heart failure ( class l - lll );"C0018801;C0018802;C0456387;C1261077;C1518526;C1705943;C4554158";NA;NA;heart failure class l lll
 452;egfr in $nmbr$ classes;"C0456387;C1518526;C1705943;C1739039;C3811844;C3812682;C4019422";NA;NA;egfr in $nmbr$ classes
 452;class ic;"C0020750;C0456387;C1518526;C1705943;C4554818";NA;NA;class ic
 452;class ia;"C0020980;C0456387;C0694634;C1518526;C1705943;C1947960";NA;NA;class ia
 452;class > $nmbr$;"C0456387;C1518526;C1705943";NA;NA;class $nmbr$
 452;class $nmbr$;"C0456387;C1518526;C1705943";NA;NA;class $nmbr$
 452;calculated ldl - c in $nmbr$ classes;"C0444686;C0456387;C1441506;C1518526;C1705943;C4019422";NA;NA;calculated ldl c in $nmbr$ classes
 452;borg dyspnea score who functional class  n ( % );"C0013404;C0205245;C0449820;C0456387;C0542341;C1518526;C1705943;C1963100;C2700217;C4050231";NA;NA;borg dyspnea score who functional class n
 452;baseline who functional class;"C0168634;C0205245;C0456387;C0542341;C1442488;C1518526;C1705943;C2700217";NA;NA;baseline who functional class
 452;baseline who function class;"C0031843;C0168634;C0456387;C0542341;C0700205;C1442488;C1518526;C1705273;C1705943";NA;NA;baseline who function class
 452;baseline trl - c in $nmbr$ classes;"C0168634;C0456387;C1442488;C1518526;C1705943;C4019422";NA;NA;baseline trl c in $nmbr$ classes
 452;baseline triglycerides in $nmbr$ classes;"C0041004;C0168634;C0456387;C1442488;C1518526;C1705943;C4019422";NA;NA;baseline triglycerides in $nmbr$ classes
 452;baseline lp ( a ) in $nmbr$ classes;"C0065058;C0168634;C0456387;C1439335;C1442488;C1518526;C1705943;C4019422;C4553379";NA;NA;baseline lp a in $nmbr$ classes
 452;ara functional class — no . ( % );"C0205245;C0325983;C0456387;C0542341;C1518526;C1705943;C2316832;C2700217;C3890184;C4282437;C4321455";NA;NA;ara functional class no
 452;ara functional class;"C0205245;C0325983;C0456387;C0542341;C1518526;C1705943;C2316832;C2700217;C3890184;C4282437;C4321455";NA;NA;ara functional class
 452;angina class at baseline;"C0002962;C0168634;C0456387;C1442488;C1518526;C1705943";NA;NA;angina class at baseline
 452;age in $nmbr$ classes;"C0001779;C0456387;C1518526;C1705943;C4019422";NA;NA;age in $nmbr$ classes
 452;acc / aha lesion class b $nmbr$ or c  n ( % );"C0221198;C0456387;C1518526;C1546698;C1705943;C4072694";NA;NA;acc aha lesion class b $nmbr$ or c n
 451;periprocedural anticoagulant;"C0003280;C0848112;C3536711";NA;NA;periprocedural anticoagulant
 438;no $nmbr$  $nmbr$;NA;NA;NA;no $nmbr$ $nmbr$
 438;no;NA;NA;NA;no
 455;baseline heart failure severity nyha class i;"C0018801;C0018802;C0168634;C0439793;C0522510;C1442488;C1882084;C4554158";FALSE; 453;baseline heart failure severity nyha class i
 455;nyha class iii / iv;C0278962;FALSE; 453;nyha class iii iv
 455;nyha class iii  % ( n );C1882086;FALSE; 453;nyha class iii n
 455;nyha class ii ( n = $nmbr$ );C1882085;FALSE; 453;nyha class ii n $nmbr$
 455;nyha class ii ( n = $nmbr$ l $nmbr$ );C1882085;FALSE; 453;nyha class ii n $nmbr$ l $nmbr$
 455;nyha class iv;C1882087;FALSE; 453;nyha class iv
 455;nyha class  n ( % ) ii;C1882085;FALSE; 453;nyha class n ii
 455;tcomparison of proportion of patients with nyha class lll / iv heart failure .;"C0018801;C0018802;C0030705;C1261077;C1709707;C1882087;C4554158";FALSE; 453;tcomparison of proportion of patients with nyha class lll iv heart failure
 455;nyha functional class iii ( % );"C0205245;C0542341;C1882086;C2700217";FALSE; 453;nyha functional class iii
 455;nyha functional class iii;"C0205245;C0542341;C1882086;C2700217";FALSE; 453;nyha functional class iii
 456;past or nonsmoker;"C0337672;C0425293;C1444637;C4284302;C4554605";FALSE; 420;past or nonsmoker
 451;aspirin or other antiplatelet or anticoagulant agent;"C0003280;C0004057";NA;NA;aspirin or other antiplatelet or anticoagulant agent
 451;any anticoagulant;"C0003280;C0848112;C3536711";NA;NA;any anticoagulant
 451;antithrombotic and anticoagulant medications;C0003280;NA;NA;antithrombotic and anticoagulant medications
 451;antiplatelets or anticoagulants;C0003280;NA;NA;antiplatelets or anticoagulants
 451;antiplatelets;NA;NA;NA;antiplatelets
 451;antiplatelet or anticoagulant;"C0003280;C0848112;C3536711";NA;NA;antiplatelet or anticoagulant
 451;antiplatelet agent or anticoagulant;"C0003280;C0085826;C0848112;C3536711";NA;NA;antiplatelet agent or anticoagulant
 451;antiplatelet;NA;NA;NA;antiplatelet
 450;other anticoagulant;"C0003280;C0848112;C3536711";NA;NA;other anticoagulant
 450;concomitant anticoagulant  antithrombotic or nsaid  n ( % );"C0003211;C0003280;C0521115;C0848112;C3536711;C3536840";NA;NA;concomitant anticoagulant antithrombotic or nsaid n
 450;anticoagulant;"C0003280;C0848112;C3536711";NA;NA;anticoagulant
 450;anti - coagulants - no . ( % );C0848112;NA;NA;anti coagulants no
 450;anti - coagulants;C0848112;NA;NA;anti coagulants
 449;piacebo ( n = $nmbr$ ) no . of participants with events ( % );"C0441471;C0679646;C3541888";NA;NA;piacebo n $nmbr$ no of participants with events
 449;piacebo;NA;NA;NA;piacebo
 449;nondiabetic participants !;C0679646;NA;NA;nondiabetic participants
 449;nondiabetic;NA;NA;NA;nondiabetic
 449;nondiabetes;NA;NA;NA;nondiabetes
 448;receiving concomitant nsaids and / or cox - $nmbr$ inhibitors;"C0003211;C0085387;C0521115;C1514756";NA;NA;receiving concomitant nsaids and or cox $nmbr$ inhibitors
 448;oads  n ( % );NA;NA;NA;oads n
 448;number of concomitant aeds  n ( % );"C0180309;C0237753;C0449788;C0521115";NA;NA;number of concomitant aeds n
 448;most common concomitant aeds  n ( % );"C0180309;C0205214;C0205393;C0521115;C1522138;C3245511";NA;NA;most common concomitant aeds n
 448;most common concomitant aeds  d n ( % );"C0180309;C0205214;C0205393;C0521115;C1522138;C3245511";NA;NA;most common concomitant aeds d n
 448;concomitant oads  n ( % );C0521115;NA;NA;concomitant oads n
 448;concomitant aedsb    n   ( % );C0521115;NA;NA;concomitant aedsb n
 448;concomitant aedsb  n ( % );C0521115;NA;NA;concomitant aedsb n
 448;concomitant aedsa;C0521115;NA;NA;concomitant aedsa
 448;concomitant aeds  n ( % );"C0180309;C0521115";NA;NA;concomitant aeds n
 448;> - $nmbr$ . $nmbr$ and < - $nmbr$ . $nmbr$;NA;NA;NA;$nmbr$ $nmbr$ and $nmbr$ $nmbr$
 448;> $nmbr$ oads;NA;NA;NA;$nmbr$ oads
 448;$nmbr$ oads;NA;NA;NA;$nmbr$ oads
 447;no concomitant antiplatelet;C0521115;NA;NA;no concomitant antiplatelet
 447;main concomitant treatments  no . ( % );"C0087111;C0205225;C0521115;C1542147";NA;NA;main concomitant treatments no
 447;concomitant drugs  %;"C0013227;C0521115;C3687832";NA;NA;concomitant drugs
 447;concomitant drugs;"C0013227;C0521115;C3687832";NA;NA;concomitant drugs
 447;concomitant drug therapies  n ( % );"C0013216;C0521115";NA;NA;concomitant drug therapies n
 447;concomitant antiplatelet;C0521115;NA;NA;concomitant antiplatelet
 447;concomitant antihyperglycaemic drugs  n ( % );"C0013227;C0020616;C0521115;C3687832";NA;NA;concomitant antihyperglycaemic drugs n
 447;concomitant;C0521115;NA;NA;concomitant
 446;use of concomitant lipid - modifying therapy;"C0023779;C0392747;C1524063;C1707479";NA;NA;use of concomitant lipid modifying therapy
 446;concomitant therapy  no . ( % );C1707479;NA;NA;concomitant therapy no
 446;concomitant therapy  n [ % ];C1707479;NA;NA;concomitant therapy n
 446;concomitant therapy;C1707479;NA;NA;concomitant therapy
 446;concomitant therapies n ( % );C1707479;NA;NA;concomitant therapies n
 446;concomitant therapies at hospital discharge;"C0586003;C1707479";NA;NA;concomitant therapies at hospital discharge
 446;concomitant lipid - modifying therapy — no . { % );"C0023779;C0392747;C1707479";NA;NA;concomitant lipid modifying therapy no
 446;baseline / concomitant therapies;"C0168634;C1442488;C1707479";NA;NA;baseline concomitant therapies
 445;tion — no . ( % );NA;NA;NA;tion no
 445;tics — no . ( % );"C0040188;C0278076;C2169806;C3889970";NA;NA;tics no
 445;no . copies gly $nmbr$ - glu $nmbr$ - $nmbr$ c;"C0068000;C1948062";NA;NA;no copies gly $nmbr$ glu $nmbr$ $nmbr$ c
 445;no ( n = $nmbr$ );"C0369718;C0441922";NA;NA;no n $nmbr$
 445;no ( n = $nmbr$  $nmbr$ );"C0369718;C0441922";NA;NA;no n $nmbr$ $nmbr$
 445;acecoumarol  no . ( % );NA;NA;NA;acecoumarol no
 445;$nmbr$ - $nmbr$ — no . ( % );NA;NA;NA;$nmbr$ $nmbr$ no
 444;inflotmas io mgluj versus piecew;"C1046794;C3146236";NA;NA;inflotmas io mgluj versus piecew
 444;$nmbr$ . $nmbr$ ( io . i );"C0021966;C0221138;C1046794;C3146236";NA;NA;$nmbr$ $nmbr$ io i
 444;$nmbr$ ( io - $nmbr$ % );"C1046794;C3146236";NA;NA;$nmbr$ io $nmbr$
 443;xho  p = o - $nmbr$;C4050013;NA;NA;xho p o $nmbr$
 443;ho active cancer;"C0006826;C0019905;C0205177;C0998265;C1306459;C1832110;C3853793;C3888249;C3889614";NA;NA;ho active cancer
 443;ho;"C0019905;C1832110;C3889614";NA;NA;ho
 442;glatiramer acetate  no . ( % );C0289884;NA;NA;glatiramer acetate no
 442;acarbose 一 no . ( % );C0050393;NA;NA;acarbose no
 442;> $nmbr$ — no . { % );NA;NA;NA;$nmbr$ no
 441;study medication — no . ( % );"C0013227;C0557651;C2603343;C3244316;C4284232";NA;NA;study medication no
 441;other — no . ( % );NA;NA;NA;other no
 441;other lipid - modifying drug 一 no . ( % );"C0013227;C0023779;C0392747;C1254351";NA;NA;other lipid modifying drug no
 441;no glucose lowering drugs;"C0013227;C0017725;C0441994;C2003888;C3687832";NA;NA;no glucose lowering drugs
 441;no . a;NA;NA;NA;no a
 441;no ( % );NA;NA;NA;no
 441;medication use — no . { % );"C0013227;C0042153;C0457083;C1947944;C3244316;C4284232";NA;NA;medication use no
 441;medication use — no . ( % ) ^ |;"C0013227;C0042153;C0457083;C1947944;C3244316;C4284232";NA;NA;medication use no
 441;medication use — no . ( % );"C0013227;C0042153;C0457083;C1947944;C3244316;C4284232";NA;NA;medication use no
 441;medication use  no . / total no . ( % );"C0013227;C0042153;C0439175;C0439810;C0457083;C1947944;C3244316;C4284232";NA;NA;medication use no total no
 440;£ $nmbr$ yo ( n = $nmbr$ );C1413296;NA;NA;$nmbr$ yo n $nmbr$
 440;sso - $nmbr$;NA;NA;NA;sso $nmbr$
 440;< $nmbr$ yo ( n = $nmbr$ );C1413296;NA;NA;$nmbr$ yo n $nmbr$
 440;- $nmbr$ . $nmbr$ ± lno ^;NA;NA;NA;$nmbr$ $nmbr$ lno
 439;no  no;NA;NA;NA;no no
 438;no ppi;"C0358591;C0871125;C3811894";NA;NA;no ppi
 439;no antihypertensive medication;C0003364;FALSE;1579;no antihypertensive medication
 440;current smoking — no . ( % );"C0037369;C0453996;C0521116;C1705970;C1881674";FALSE; 420;current smoking no
 440;current smoking — no . / total no . ( % );"C0037369;C0439175;C0439810;C0453996;C0521116;C1705970;C1881674";FALSE; 420;current smoking no total no
 440;no smoking;"C0037369;C0453996;C1881674";FALSE; 420;no smoking
 440;no smo king;"C1311076;C1364142;C1423784";FALSE; 420;no smo king
 207;≤ $nmbr$ u / kg / day;C1532634;NA;NA;$nmbr$ u kg day
 442;beta - blocker — no . ( % );C0001645;FALSE; 959;beta blocker no
 442;no beta - blocker;C0001645;FALSE; 959;no beta blocker
 442;no beta - blocker use;"C0001645;C0042153;C0457083;C1947944";FALSE; 959;no beta blocker use
 451;anticoagulant group ( n = $nmbr$ );"C0003280;C0441848;C0848112;C3536711";FALSE; 450;anticoagulant group n $nmbr$
 451;anticoagulant — no . ( % );"C0003280;C0848112;C3536711";FALSE; 450;anticoagulant no
 451;anticoagulants;C0003280;FALSE; 450;anticoagulants
 438;ppi but no aspirin;"C0004057;C0358591;C0871125;C3811894";FALSE;1366;ppi but no aspirin
 437;pio $nmbr$;"C0030800;C2347712";NA;NA;pio $nmbr$
 437;full po pulatio n;"C0443225;C0946289";NA;NA;full po pulatio n
 436;rro . $nmbr$ ( $nmbr$ . $nmbr$ . $nmbr$ . $nmbr$ );NA;NA;NA;rro $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 436;rro $nmbr$ ( $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ );NA;NA;NA;rro $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 436;pro / pro homozygotes;"C0019904;C1120626";NA;NA;pro pro homozygotes
 435;type $nmbr$ diabetes pbo ( n = $nmbr$ ) vs evomab ( n = $nmbr$ );"C0031962;C1320657";NA;NA;type $nmbr$ diabetes pbo n $nmbr$ vs evomab n $nmbr$
 435;score at week $nmbr$  mean ( se ) difference mepo - pbo ( $nmbr$ % ci );"C0008107;C0031962;C0036919;C0332174;C0439230;C1705241;C1705242;C3259781;C3533236";NA;NA;score at week $nmbr$ mean se difference mepo pbo $nmbr$ ci
 435;pbo to czp week $nmbr$ dose combined;"C0031962;C0054841;C0178602;C0205195;C0332174;C0439230;C0869039;C1114758;C1861828;C1872109";NA;NA;pbo to czp week $nmbr$ dose combined
 435;pbo n = $nmbr$;C0031962;NA;NA;pbo n $nmbr$
 435;pbo n ( % );C0031962;NA;NA;pbo n
 435;pbo / simva - $nmbr$ yr km rale ( % );"C0031962;C0034642;C0439234;C3887676";NA;NA;pbo simva $nmbr$ yr km rale
 435;pbo - sc every other week ( n = $nmbr$ );"C0031962;C0282380;C0332174;C0439230";NA;NA;pbo sc every other week n $nmbr$
 435;pbo - adjusted ls mean change ( se );"C0023668;C0031962;C0036919;C0392747;C0443172;C0444504;C0456081;C1705241;C2347634;C2348143;C4319952";NA;NA;pbo adjusted ls mean change se
 435;pbo - adjusted ls mean change;"C0023668;C0031962;C0392747;C0443172;C0444504;C0456081;C1705241;C2347634;C2348143;C4319952";NA;NA;pbo adjusted ls mean change
 435;pbo + statin n = $nmbr$;"C0031962;C0360714";NA;NA;pbo statin n $nmbr$
 435;pbo + statin $nmbr$;"C0031962;C0360714";NA;NA;pbo statin $nmbr$
 435;pbo + statin;"C0031962;C0360714";NA;NA;pbo statin
 435;pbo ( n   =   $nmbr$ );C0031962;NA;NA;pbo n $nmbr$
 435;pbo ( n = $nmbr$ ) vs;C0031962;NA;NA;pbo n $nmbr$ vs
 435;pbo ( n = $nmbr$ );C0031962;NA;NA;pbo n $nmbr$
 435;pbo ( n - $nmbr$ );C0031962;NA;NA;pbo n $nmbr$
 435;pbo ( n $nmbr$ );C0031962;NA;NA;pbo n $nmbr$
 435;pbo ( n $nmbr$ $nmbr$ );C0031962;NA;NA;pbo n $nmbr$ $nmbr$
 435;pbo  no . ( o / o ) ^ ’;"C0031962;C0483204";NA;NA;pbo no o o
 435;pbo  no . ( % ) ^;C0031962;NA;NA;pbo no
 435;pbo  n = $nmbr$;C0031962;NA;NA;pbo n $nmbr$
 435;pbo;C0031962;NA;NA;pbo
 435;neither pbo + statin eze + statin;"C0031962;C0360714";NA;NA;neither pbo statin eze statin
 435;mets pbo ( n = $nmbr$ ) vs evomab ( n = $nmbr$ );"C0031962;C0812270;C1705694;C2939420";NA;NA;mets pbo n $nmbr$ vs evomab n $nmbr$
 435;mepo ( n = $nmbr$ );NA;NA;NA;mepo n $nmbr$
 435;insulin tx difference vs pbo  median change from baseline ( se ) $nmbr$;"C0021641;C0031962;C0036919;C0041403;C0168634;C0392747;C0443172;C0549183;C0876920;C1442488;C1533581;C1579433;C1705241;C1705242;C2347635;C2348144;C2939193;C3714501;C4319952";NA;NA;insulin tx difference vs pbo median change from baseline se $nmbr$
 435;ind + pbo ( n = $nmbr$ );"C0031962;C4049864";NA;NA;ind pbo n $nmbr$
 435;ifg pbo ( n = $nmbr$ ) vs evomab ( n = $nmbr$ );"C0031962;C1334085;C1708411";NA;NA;ifg pbo n $nmbr$ vs evomab n $nmbr$
 435;fpg tx difference vs pbo  median change from baseline ( se ) $nmbr$;"C0031962;C0036919;C0041403;C0168634;C0392747;C0443172;C0549183;C0876920;C1442488;C1705241;C1705242;C2347635;C2348144;C2939193;C4319952";NA;NA;fpg tx difference vs pbo median change from baseline se $nmbr$
 435;flex pbo ®;C0031962;NA;NA;flex pbo
 435;difference vs pbo;"C0031962;C1705241;C1705242";NA;NA;difference vs pbo
 435;difference mepo - pbo ( $nmbr$ % ci );"C0008107;C0031962;C1705241;C1705242;C3259781";NA;NA;difference mepo pbo $nmbr$ ci
 435;blood pressure  pbo y patients with diabe teristics ( ncep atp i;"C0005823;C0021966;C0030705;C0031962;C0221138;C1271104;C1272641;C2744579;C4552600";NA;NA;blood pressure pbo y patients with diabe teristics ncep atp i
 434;time from symptoms onset to $nmbr$ st balloon inflation ( h );"C0021398;C0033727;C0036056;C0336867;C0369286;C0441144;C0441932;C0449244;C0564385;C0683368;C1318493;C1457887;C3272372;C4528284";NA;NA;time from symptoms onset to $nmbr$ st balloon inflation h
 434;time from symptom onset to balloon inflation;"C0021398;C0040223;C0336867;C0441144;C0449244;C1318493;C1457887;C3541383;C3854129;C4086878";NA;NA;time from symptom onset to balloon inflation
 434;time from randomisation to $nmbr$ st balloon inflation ( h );"C0021398;C0033727;C0034656;C0036056;C0040223;C0336867;C0369286;C0441144;C0441932;C0564385;C1318493;C3272372;C3541383;C4528284";NA;NA;time from randomisation to $nmbr$ st balloon inflation h
 434;time from qualifying ecg to balloon inflation;"C0021398;C0040223;C0336867;C0441144;C1318493;C1514624;C1623258;C3541383";NA;NA;time from qualifying ecg to balloon inflation
 434;o - oo $nmbr$ ( - $nmbr$ - $nmbr$ to $nmbr$ - $nmbr$ );C0483204;NA;NA;o oo $nmbr$ $nmbr$ $nmbr$ to $nmbr$ $nmbr$
 434;o $nmbr$ o ( oo $nmbr$ - o - $nmbr$ o );C0483204;NA;NA;o $nmbr$ o oo $nmbr$ o $nmbr$ o
 434;antibodies to infliximab  n ( % ) * *;C3533054;NA;NA;antibodies to infliximab n
 434;- o - oo $nmbr$ ( - $nmbr$ - $nmbr$ to $nmbr$ - $nmbr$ );C0483204;NA;NA;o oo $nmbr$ $nmbr$ $nmbr$ to $nmbr$ $nmbr$
 434;$nmbr$ - $nmbr$ ( o - $nmbr$ - $nmbr$ - oo );C0483204;NA;NA;$nmbr$ $nmbr$ o $nmbr$ $nmbr$ oo
 434;$nmbr$ ( oo $nmbr$ - o . $nmbr$ );NA;NA;NA;$nmbr$ oo $nmbr$ o $nmbr$
 433;time to treatment  h;"C0033727;C0369286;C0441932;C0564385;C3494202;C4528284";NA;NA;time to treatment h
 433;time to treatment;C3494202;NA;NA;time to treatment
 433;time to angiography — hr;"C0002978;C0040223;C3541383";NA;NA;time to angiography hr
 433;mean time to first subcutaneous injectiong  h in relation to surgery  hr;"C0033727;C0038894;C0038895;C0040223;C0205435;C0369286;C0441932;C0443315;C0444504;C0543467;C0564385;C1274039;C1279901;C2347634;C2348143;C3541383;C4528284";NA;NA;mean time to first subcutaneous injectiong h in relation to surgery hr
 433;door - to - balloon time — hr;C4296144;NA;NA;door to balloon time hr
 432;unrelated to effectiveness;"C0445356;C1280519;C1704623;C4553491";NA;NA;unrelated to effectiveness
 432;no . needed to treat ( $nmbr$ % cl ) *;"C0027552;C0040363;C0041260;C0087111;C0596019;C0686904;C1292734;C1522326;C1883351";NA;NA;no needed to treat $nmbr$ cl
 432;- $nmbr$ - $nmbr$ ( $nmbr$ % cl - $nmbr$ - $nmbr$ to - $nmbr$ - $nmbr$ );C0596019;NA;NA;$nmbr$ $nmbr$ $nmbr$ cl $nmbr$ $nmbr$ to $nmbr$ $nmbr$
 432;- $nmbr$ - $nmbr$ ( $nmbr$ % cl - $nmbr$ - $nmbr$ to $nmbr$ - $nmbr$ );C0596019;NA;NA;$nmbr$ $nmbr$ $nmbr$ cl $nmbr$ $nmbr$ to $nmbr$ $nmbr$
 432;$nmbr$ to < $nmbr$ — no . { % );NA;NA;NA;$nmbr$ to $nmbr$ no
 432;$nmbr$ to < $nmbr$ cel;"C0208736;C0346421;C0439237;C1413336";NA;NA;$nmbr$ to $nmbr$ cel
 432;$nmbr$ . $nmbr$ ( $nmbr$ % cl $nmbr$ . $nmbr$ to $nmbr$ . $nmbr$ ) p = $nmbr$ . $nmbr$;C0596019;NA;NA;$nmbr$ $nmbr$ $nmbr$ cl $nmbr$ $nmbr$ to $nmbr$ $nmbr$ p $nmbr$ $nmbr$
 432;$nmbr$ - $nmbr$ ( $nmbr$ % cl $nmbr$ - $nmbr$ to $nmbr$ - $nmbr$ );C0596019;NA;NA;$nmbr$ $nmbr$ $nmbr$ cl $nmbr$ $nmbr$ to $nmbr$ $nmbr$
 432;$nmbr$ ( $nmbr$ % cl $nmbr$ to $nmbr$ );C0596019;NA;NA;$nmbr$ $nmbr$ cl $nmbr$ to $nmbr$
 431;三 $nmbr$ to < $nmbr$;"C0040363;C0041260;C1883351";NA;NA;$nmbr$ to $nmbr$
 431;≥ $nmbr$ to < $nmbr$ %;"C0040363;C0041260;C1883351";NA;NA;$nmbr$ to $nmbr$
 431;randomized to receive aspirin yes;"C0004057;C0034656;C0040363;C0041260;C1514756;C1549445;C1705108;C1710701;C1883351;C3815594";NA;NA;randomized to receive aspirin yes
 431;randomization to end of study;"C0034656;C0040363;C0041260;C0444930;C0557651;C1883351;C2603343;C2746065";NA;NA;randomization to end of study
 431;randomised to canakinumab $nmbr$ mg;"C0024671;C0026410;C0040363;C0041260;C0439269;C1883351;C1960952;C2346927;C2718773;C4321396;C4521761";NA;NA;randomised to canakinumab $nmbr$ mg
 431;patients meeting the criteria to receive $nmbr$ mg of;"C0024671;C0026410;C0030705;C0040363;C0041260;C0243161;C0439269;C0556656;C1514756;C1883351;C1960952;C2346927;C4321396;C4521761";NA;NA;patients meeting the criteria to receive $nmbr$ mg of
 438;aspirin 一 no . ( % );C0004057;FALSE;1366;aspirin no
 438;drug therapy at admission — no . ( % ) aspirin;"C0004057;C0013216;C0013217;C0184666;C0809949";FALSE;1366;drug therapy at admission no aspirin
 431;patient ' s preference not to take vka  only reason;"C0040363;C0041260;C0205171;C0376409;C0392360;C1515187;C1518422;C1720467;C1883351";NA;NA;patient s preference not to take vka only reason
 431;patient ' s preference not to take;"C0040363;C0041260;C0376409;C1515187;C1518422;C1883351";NA;NA;patient s preference not to take
 431;method used to diagnose the incident pulmonary embolism  no . ( % );"C0011900;C0025663;C0034065;C0040363;C0041260;C0449851;C0871511;C1273517;C1551358;C1883351";NA;NA;method used to diagnose the incident pulmonary embolism no
 431;length of stay ( randomization to discharge  h );"C0012621;C0023303;C0030685;C0033727;C0034656;C0040363;C0041260;C0369286;C0441932;C0564385;C1883351;C2926602;C4528284";NA;NA;length of stay randomization to discharge h
 431;leading to study withdrawal;"C0040363;C0041260;C0332152;C0557651;C1522538;C1710677;C1883351;C2349954;C2603343;C2825032;C3812880;C4049634";NA;NA;leading to study withdrawal
 431;key : tc = triglyceride  hs - crp = ldl - c = low - density lipoprotein fc = fasting glucose  ncep atp * this category did not include ar to have > _ $nmbr$ of the indicated char least - square means  except tc an note : all treatment by subgroup;"C0015663;C0017725;C0023189;C0023823;C0036143;C0039411;C0039798;C0040363;C0040642;C0041004;C0041260;C0041405;C0041698;C0087111;C0327953;C0332257;C0683312;C1079230;C1316572;C1317574;C1436327;C1444656;C1515021;C1518422;C1522326;C1533734;C1552866;C1704970;C1705169;C1824670;C1883351;C2700399;C2744579;C2983605;C2986463;C3272447;C3538994;C3884535;C3887704;C3889287;C3890735;C4048285;C4521369;C4522122;C4552600";NA;NA;key tc triglyceride hs crp ldl c low density lipoprotein fc fasting glucose ncep atp this category did not include ar to have _ $nmbr$ of the indicated char least square means except tc an note all treatment by subgroup
 431;intention - to - treat without st - segment - elevation myocardial infarction;"C0040363;C0041260;C0087111;C0162425;C1283828;C1292734;C1522326;C1536220;C1883351";NA;NA;intention to treat without st segment elevation myocardial infarction
 431;intention - to - treat with st - segment - elevation myocardial infarction;"C0040363;C0041260;C0087111;C0162425;C1283828;C1292734;C1522326;C1536220;C1883351";NA;NA;intention to treat with st segment elevation myocardial infarction
 431;intention - to - treat;"C0040363;C0041260;C0087111;C0162425;C1283828;C1292734;C1522326;C1883351";NA;NA;intention to treat
 431;intent to use gp iib / iiia;"C0016011;C0040363;C0041260;C0042153;C0162425;C0457083;C1283828;C1550453;C1883351;C1947944";NA;NA;intent to use gp iib iiia
 431;intent to use glycoprotein iib / iiia inhibitor;"C0016011;C0040363;C0041260;C0042153;C0162425;C0457083;C1283828;C1550453;C1883351;C1947944;C1999216";NA;NA;intent to use glycoprotein iib iiia inhibitor
 431;intent to use dti;"C0040363;C0041260;C0042153;C0162425;C0457083;C1283828;C1537007;C1550453;C1883351;C1947944";NA;NA;intent to use dti
 431;intent to use direct thrombin;"C0040018;C0040363;C0041260;C0042153;C0162425;C0439851;C0457083;C1283828;C1550453;C1883351;C1947931;C1947944";NA;NA;intent to use direct thrombin
 431;first disease - progression outcome to occur §;"C0040363;C0041260;C0205435;C0242656;C0449258;C0679250;C1274040;C1279901;C1335499;C1709305;C1883351;C1947900;C2745955;C3542417;C4284875;C4552808";NA;NA;first disease progression outcome to occur
 431;duration of total exposure to study treatment  weeks;"C0039798;C0040363;C0041260;C0087111;C0439175;C0439230;C0439810;C0557651;C1522326;C1533734;C1705169;C1883351;C2603343;C2826870;C3538994;C3887704";NA;NA;duration of total exposure to study treatment weeks
 431;cough ( leading to study drug discontinuation );"C0010200;C0013175;C0040363;C0041260;C0332152;C0457454;C1444662;C1522538;C1883351;C1961131;C3274924;C4084725;C4084726;C4084727;C4552847";NA;NA;cough leading to study drug discontinuation
 431;adherence to study regimen — no . ( % ) ff;"C0040363;C0040808;C0041260;C0557651;C1510802;C1883351;C2603343;C2945654;C4554348";NA;NA;adherence to study regimen no ff
 431;adherence to study regimen — no . ( % );"C0040363;C0040808;C0041260;C0557651;C1510802;C1883351;C2603343;C2945654";NA;NA;adherence to study regimen no
 431;> - $nmbr$ . $nmbr$ to < - $nmbr$ . $nmbr$;"C0040363;C0041260;C1883351";NA;NA;$nmbr$ $nmbr$ to $nmbr$ $nmbr$
 431;> $nmbr$ to s $nmbr$ yrs;"C0040363;C0041260;C1883351";NA;NA;$nmbr$ to s $nmbr$ yrs
 431;> $nmbr$ to < $nmbr$ uln;"C0040363;C0041260;C1519815;C1883351";NA;NA;$nmbr$ to $nmbr$ uln
 431;> $nmbr$ to < $nmbr$;"C0040363;C0041260;C1883351";NA;NA;$nmbr$ to $nmbr$
 431;> $nmbr$ to $nmbr$;"C0040363;C0041260;C1883351";NA;NA;$nmbr$ to $nmbr$
 431;> $nmbr$ . $nmbr$   vs . $nmbr$ . $nmbr$ to   ≤   $nmbr$ . $nmbr$;"C0040363;C0041260;C1883351";NA;NA;$nmbr$ $nmbr$ vs $nmbr$ $nmbr$ to $nmbr$ $nmbr$
 431;> $nmbr$ . $nmbr$ to < $nmbr$ . $nmbr$ %;"C0040363;C0041260;C1883351";NA;NA;$nmbr$ $nmbr$ to $nmbr$ $nmbr$
 431;> $nmbr$ . $nmbr$ to < $nmbr$ . $nmbr$;"C0040363;C0041260;C1883351";NA;NA;$nmbr$ $nmbr$ to $nmbr$ $nmbr$
 431;> $nmbr$ % to < $nmbr$ % ( > $nmbr$ to < $nmbr$ mmol / mol );"C0040363;C0041260;C1883351;C3829066";NA;NA;$nmbr$ to $nmbr$ $nmbr$ to $nmbr$ mmol mol
 431;> $nmbr$ % to < $nmbr$ % ( > $nmbr$ to $nmbr$ mmol / mol );"C0040363;C0041260;C1883351;C3829066";NA;NA;$nmbr$ to $nmbr$ $nmbr$ to $nmbr$ mmol mol
 431;> $nmbr$ % to < $nmbr$ %;"C0040363;C0041260;C1883351";NA;NA;$nmbr$ to $nmbr$
 431;$nmbr$ to less than $nmbr$;"C0040363;C0041260;C1883351";NA;NA;$nmbr$ to less than $nmbr$
 431;$nmbr$ to < $nmbr$ mumin;NA;NA;NA;$nmbr$ to $nmbr$ mumin
 431;$nmbr$ to < $nmbr$ bpm ( n = $nmbr$ );"C0040363;C0041260;C1883351";NA;NA;$nmbr$ to $nmbr$ bpm n $nmbr$
 431;$nmbr$ to < $nmbr$ . $nmbr$ %;"C0040363;C0041260;C1883351";NA;NA;$nmbr$ to $nmbr$ $nmbr$
 431;$nmbr$ to < $nmbr$ ( % );"C0040363;C0041260;C1883351";NA;NA;$nmbr$ to $nmbr$
 431;$nmbr$ to < $nmbr$;"C0040363;C0041260;C1883351";NA;NA;$nmbr$ to $nmbr$
 431;$nmbr$ . $nmbr$ to < $nmbr$ . $nmbr$ % ( $nmbr$ to < $nmbr$ mmol / mol );"C0040363;C0041260;C1883351;C3829066";NA;NA;$nmbr$ $nmbr$ to $nmbr$ $nmbr$ $nmbr$ to $nmbr$ mmol mol
 431;$nmbr$ . $nmbr$ to $nmbr$ . $nmbr$ ( % );"C0040363;C0041260;C1883351";NA;NA;$nmbr$ $nmbr$ to $nmbr$ $nmbr$
 431;$nmbr$ . $nmbr$ to $nmbr$ . $nmbr$ %;"C0040363;C0041260;C1883351";NA;NA;$nmbr$ $nmbr$ to $nmbr$ $nmbr$
 431;$nmbr$ . $nmbr$ to $nmbr$ . $nmbr$;"C0040363;C0041260;C1883351";NA;NA;$nmbr$ $nmbr$ to $nmbr$ $nmbr$
 431;$nmbr$ $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ ) [ $nmbr$ ( $nmbr$ . $nmbr$ ) ] - $nmbr$ . $nmbr$ ( - $nmbr$ . $nmbr$ to - $nmbr$ . $nmbr$ ) [ - $nmbr$ . $nmbr$ ( - $nmbr$ . $nmbr$ to - $nmbr$ . $nmbr$ ) ] - $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ ) [ - $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ ) ];"C0040363;C0041260;C1883351";NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ to $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ to $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 431;$nmbr$ $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ ) [ $nmbr$ ( $nmbr$ . $nmbr$ ) ] - $nmbr$ . $nmbr$ ( - $nmbr$ . $nmbr$ to - $nmbr$ . $nmbr$ ) [ - $nmbr$ . $nmbr$ ( - $nmbr$ . $nmbr$ to - $nmbr$ . $nmbr$ ) ];"C0040363;C0041260;C1883351";NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ to $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ to $nmbr$ $nmbr$
 431;$nmbr$ $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ ) [ $nmbr$ ( $nmbr$ . $nmbr$ ) ] - $nmbr$ . $nmbr$ ( - $nmbr$ . $nmbr$ to $nmbr$ . $nmbr$ ) [ - $nmbr$ . $nmbr$ ( - $nmbr$ . $nmbr$ to $nmbr$ . $nmbr$ ) ];"C0040363;C0041260;C1883351";NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ to $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ to $nmbr$ $nmbr$
 431;$nmbr$ $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ ) [ $nmbr$ ( $nmbr$ . $nmbr$ ) ] $nmbr$ . $nmbr$ ( - $nmbr$ . $nmbr$ to $nmbr$ . $nmbr$ ) [ $nmbr$ . $nmbr$ ( - $nmbr$ . $nmbr$ to $nmbr$ . $nmbr$ ) ];"C0040363;C0041260;C1883351";NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ to $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ to $nmbr$ $nmbr$
 -10;two - dimensional echocardiography;C0013524;NA;NA;two dimensional echocardiography
 429;two or more at baseline;"C0168634;C0205172;C0205448;C1442488";NA;NA;two or more at baseline
 429;two or more;"C0205172;C0205448";NA;NA;two or more
 429;two of the above;C0205448;NA;NA;two of the above
 429;two lesions;"C0205448;C0221198";NA;NA;two lesions
 429;two agents;"C0205448;C0450442;C1254351;C1521826";NA;NA;two agents
 429;two - sided p - value for hetero - geneity;"C0205448;C0441987;C1709380";NA;NA;two sided p value for hetero geneity
 428;apobe;NA;FALSE; 426;apobe
 428;apob  g / l;"C0003593;C0439294;C0456615;C3252643";FALSE; 426;apob g l
 428;apob $nmbr$;"C0003593;C3252643";FALSE; 426;apob $nmbr$
 429;two or more antihypertensive medications;"C0003364;C0205172;C0205448";FALSE;1579;two or more antihypertensive medications
 420;smoking pack - years;"C0037369;C0453996;C1277691;C1881674";NA;NA;smoking pack years
 427;apob : apoa - l ratio;"C0003592;C0003593;C0456603;C0523508;C1547037;C3252643;C4553344;C4553379";NA;NA;apob apoa l ratio
 427;apob : apoa - $nmbr$ ratio;"C0003592;C0003593;C0456603;C0523508;C1547037;C3252643;C4553344;C4553379";NA;NA;apob apoa $nmbr$ ratio
 427;apob : apoa $nmbr$ ratio;"C0003592;C0003593;C0456603;C0523508;C1547037;C3252643;C4553344;C4553379";NA;NA;apob apoa $nmbr$ ratio
 427;apob : apoa $nmbr$;"C0003592;C0003593;C0523508;C3252643;C4553344;C4553379";NA;NA;apob apoa $nmbr$
 427;apoa - $nmbr$  g / l;"C0003592;C0439294;C0456615;C0523508;C4553344;C4553379";NA;NA;apoa $nmbr$ g l
 427;apo b / apo a - l ratio ( mean );"C0003592;C0444504;C0456603;C0523508;C1447574;C1547037;C2347634;C2348143;C4521365;C4553344";NA;NA;apo b apo a l ratio mean
 427;apo b / apo a - l;"C0003592;C0523508;C1447574;C4521365;C4553344";NA;NA;apo b apo a l
 427;apo a $nmbr$ ( g / l );"C0003592;C0439294;C0456615;C0523508;C4553344;C4553379";NA;NA;apo a $nmbr$ g l
 427;apo a $nmbr$  mean ( sd );"C0003592;C0444504;C0523508;C2347634;C2348143;C2699239;C4553344;C4553379";NA;NA;apo a $nmbr$ mean sd
 427;< $nmbr$ . $nmbr$ mmol / liter apob : apoa - l ratio;"C0003592;C0003593;C0456603;C0475211;C0523508;C1532563;C1547037;C3252643;C4553344;C4553379";NA;NA;$nmbr$ $nmbr$ mmol liter apob apoa l ratio
 426;apob : apoa - i ratio;"C0003593;C0085201;C0456603;C1547037;C1677784;C3252643";NA;NA;apob apoa i ratio
 426;apob : apoa - i;"C0003593;C0085201;C1677784;C3252643";NA;NA;apob apoa i
 426;apo b : apo a - i ratio;"C0003593;C0085201;C0456603;C1547037;C1677784;C3252643";NA;NA;apo b apo a i ratio
 425;week $nmbr$ mayo endoscopy subscorea;"C0014245;C0332174;C0439230;C0454788;C1077578";NA;NA;week $nmbr$ mayo endoscopy subscorea
 425;total mayo score $ | |;"C0454788;C1077578;C2964552";NA;NA;total mayo score $
 425;total mayo score;"C0454788;C1077578;C2964552";NA;NA;total mayo score
 425;partial mayo score $ | |;"C0449820;C0454788;C0728938;C1077578;C1550516;C4050231";NA;NA;partial mayo score $
 425;partial mayo score  mean ( sd );"C0444504;C0449820;C0454788;C0728938;C1077578;C1550516;C2347634;C2348143;C2699239;C4050231";NA;NA;partial mayo score mean sd
 425;partial mayo score;"C0449820;C0454788;C0728938;C1077578;C1550516;C4050231";NA;NA;partial mayo score
 425;partial mayo clinic scored;"C0002424;C0442592;C0449820;C0454788;C0728938;C1077578;C1550516";NA;NA;partial mayo clinic scored
 425;mean mayo score ( sd );"C0454788;C1077578;C2699239;C3533236";NA;NA;mean mayo score sd
 425;mayo score ( mean ± sd );"C0444504;C0449820;C0454788;C1077578;C2347634;C2348143;C2699239;C4050231";NA;NA;mayo score mean sd
 425;mayo score ( $nmbr$ - $nmbr$ );"C0449820;C0454788;C1077578;C4050231";NA;NA;mayo score $nmbr$ $nmbr$
 425;mayo score  mean ( sd );"C0444504;C0449820;C0454788;C1077578;C2347634;C2348143;C2699239;C4050231";NA;NA;mayo score mean sd
 425;mayo clinic scoreb;"C0002424;C0442592;C0454788;C1077578";NA;NA;mayo clinic scoreb
 425;mayo clinic score §;"C0002424;C0442592;C0449820;C0454788;C1077578;C4050231";NA;NA;mayo clinic score
 425;mayo clinic score  mean ± sd;"C0002424;C0442592;C0444504;C0449820;C0454788;C1077578;C2347634;C2348143;C2699239;C4050231";NA;NA;mayo clinic score mean sd
 425;mayo < $nmbr$  n;"C0454788;C1077578";NA;NA;mayo $nmbr$ n
 425;mayo $ $nmbr$  n;"C0454788;C1077578";NA;NA;mayo $ $nmbr$ n
 425;complete mayo clinic score  median ( min  max };"C0002424;C0205197;C0442592;C0449820;C0454788;C0549183;C0702093;C0725685;C0876920;C1077578;C1524029;C2347635;C2348144;C2939193;C3813700;C3853530;C4050231;C4283785";NA;NA;complete mayo clinic score median min max
 425;baseline mayo score;"C0168634;C0449820;C0454788;C1077578;C1442488;C4050231";NA;NA;baseline mayo score
 425;baseline composite mayo clinic score;"C0002424;C0168634;C0442592;C0454788;C1077578;C1442488;C4055211";NA;NA;baseline composite mayo clinic score
 423;smokers;C0337664;FALSE; 420;smokers
 423;smoker  n ( % );C0337664;FALSE; 420;smoker n
 423;smoker  ! n ( % );C0337664;FALSE; 420;smoker n
 423;smoker at baseline;"C0168634;C0337664;C1442488";FALSE; 420;smoker at baseline
 423;smoker ( % ) a;C0337664;FALSE; 420;smoker a
 423;smoker ( % );C0337664;FALSE; 420;smoker
 423;smoker  %;C0337664;FALSE; 420;smoker
 423;smoker;C0337664;FALSE; 420;smoker
 423;present smoker;"C0150312;C0337664;C0449450";FALSE; 420;present smoker
 423;noncurrent smoker;C0337664;FALSE; 420;noncurrent smoker
 423;ever - smoker;"C0337664;C3887636";FALSE; 420;ever smoker
 423;currently smoker;"C0337664;C0521116";FALSE; 420;currently smoker
 423;active smokers;"C0205177;C0337664;C3853793;C3888249";FALSE; 420;active smokers
 423;active smoker;"C0205177;C0337664;C3853793;C3888249";FALSE; 420;active smoker
 424;b includes both ex - smokers and nonsmokers .;"C0332257;C0337671;C0337672;C1552866;C2700399;C4554605;C4555205";FALSE; 420;b includes both ex smokers and nonsmokers
 424;current or former smoker;"C0337671;C0521116;C1705970";FALSE; 420;current or former smoker
 424;exsmoker;"C0337671;C4555205";FALSE; 420;exsmoker
 424;ex - smoker;"C0337671;C4555205";FALSE; 420;ex smoker
 424;ex - smoker / current;"C0337671;C0521116;C1705970;C4555205";FALSE; 420;ex smoker current
 424;ex - smoker ( n z $nmbr$ );"C0337671;C4555205";FALSE; 420;ex smoker n z $nmbr$
 424;ex - smokers;"C0337671;C4555205";FALSE; 420;ex smokers
 424;ex - smokers ( itt ) ( n = $nmbr$ );"C0337671;C4555205";FALSE; 420;ex smokers itt n $nmbr$
 424;ex - smoker / smoker  %;"C0337671;C4555205";FALSE; 420;ex smoker smoker
 424;ex - smokers $nmbr$;"C0337671;C4555205";FALSE; 420;ex smokers $nmbr$
 424;ex - smokers ( n = $nmbr$ );"C0337671;C4555205";FALSE; 420;ex smokers n $nmbr$
 424;ex - smokers : qvai $nmbr$ - sfc;"C0337671;C4521536;C4555205";FALSE; 420;ex smokers qvai $nmbr$ sfc
 424;former smoker;C0337671;FALSE; 420;former smoker
 424;former smoker  n ( % );C0337671;FALSE; 420;former smoker n
 424;former smoker ( n = $nmbr$ );C0337671;FALSE; 420;former smoker n $nmbr$
 424;former smoker ( n = $nmbr$  $nmbr$ );C0337671;FALSE; 420;former smoker n $nmbr$ $nmbr$
 424;former smoker — no . ( % );C0337671;FALSE; 420;former smoker no
 424;former smoker — no . { % );C0337671;FALSE; 420;former smoker no
 424;previous smoker;C0337671;FALSE; 420;previous smoker
 424;previous smokers;C0337671;FALSE; 420;previous smokers
 424;prior smoker;C0337671;FALSE; 420;prior smoker
 424;smoker or ex - smoker  n ( % );"C0337664;C0337671;C4555205";FALSE; 420;smoker or ex smoker n
 426;apoa - i;"C0085201;C1677784";FALSE;1852;apoa i
 426;apo a - i;"C0085201;C1677784";FALSE;1852;apo a i
 426;apo a - i  mg / dl;"C0085201;C0439269;C1677784";FALSE;1852;apo a i mg dl
 428;apo b;"C0003593;C3252643";FALSE; 426;apo b
 428;apo - b;"C0003593;C3252643";FALSE; 426;apo b
 428;apo b ( g / l );"C0003593;C0439294;C0456615;C3252643";FALSE; 426;apo b g l
 428;apo b  mean ( sd )  mg / dl;"C0003593;C0439269;C0444504;C2347634;C2348143;C2699239;C3252643";FALSE; 426;apo b mean sd mg dl
 428;apo b  mg / dl;"C0003593;C0439269;C3252643";FALSE; 426;apo b mg dl
 428;apo b ( mg / dl );"C0003593;C0439269;C3252643";FALSE; 426;apo b mg dl
 428;apo b ( mg / dl ) * *;"C0003593;C0439269;C3252643";FALSE; 426;apo b mg dl
 428;apo b ( mg / dl ) - mean ± sd;"C0003593;C0439269;C0444504;C2347634;C2348143;C2699239;C3252643";FALSE; 426;apo b mg dl mean sd
 420;smoking pack year ( years ) fl;"C0037369;C0439234;C0439508;C0453996;C1277691;C1300812;C1708024;C1881674";NA;NA;smoking pack year years fl
 420;smoking pack year ( years ) ^;"C0037369;C0439234;C0439508;C0453996;C1277691;C1881674";NA;NA;smoking pack year years
 420;smoking pack - yearsb  n ( % );"C0037369;C0453996;C1881674;C1968515;C2825051;C2828395";NA;NA;smoking pack yearsb n
 420;smoking pack - yearsa;"C0037369;C0453996;C1881674;C1968515;C2825051;C2828395";NA;NA;smoking pack yearsa
 420;smoking in the past year;"C0037369;C0453996;C1881674;C4086728";NA;NA;smoking in the past year
 420;smoking classification  n ( % );"C0008902;C0008903;C0037369;C0453996;C0678229;C1881674";NA;NA;smoking classification n
 420;smoking * ( > $nmbr$ pack - years );"C0037369;C0453996;C1277691;C1881674";NA;NA;smoking $nmbr$ pack years
 420;smoking *;"C0037369;C0453996;C1881674";NA;NA;smoking
 420;smoking ( a );"C0037369;C0453996;C1881674";NA;NA;smoking a
 420;smoking ( % ) laboratory parameters;"C0022877;C0037369;C0449381;C0453996;C1881674;C3244292;C4283904";NA;NA;smoking laboratory parameters
 420;smoking ( % );"C0037369;C0453996;C1881674";NA;NA;smoking
 420;smoking ' ! ';"C0037369;C0453996;C1881674";NA;NA;smoking
 420;smoking  n ( % );"C0037369;C0453996;C1881674";NA;NA;smoking n
 420;smoking  %;"C0037369;C0453996;C1881674";NA;NA;smoking
 420;smoking;"C0037369;C0453996;C1881674";NA;NA;smoking
 420;never smoked — no . ( % );"C0037366;C0439994;C1881674;C2003901";NA;NA;never smoked no
 420;never smoked  n ( % );"C0037366;C0439994;C1881674;C2003901";NA;NA;never smoked n
 420;never smoked;"C0037366;C0439994;C1881674;C2003901";NA;NA;never smoked
 420;currently smokes;"C0037366;C0037369;C0439994;C0521116;C1881674";NA;NA;currently smokes
 419;tnfi - na ï ve  n ( % );"C0042469;C0597484;C1272460;C1546968;C1879645;C3714652;C4049872;C4321495;C4552882";NA;NA;tnfi na ve n
 419;tnfi - na ï ve;"C0042469;C0597484;C1272460;C1546968;C1879645;C3714652;C4049872;C4321495;C4552882";NA;NA;tnfi na ve
 419;tnf - na ï ve;"C0042469;C0597484;C1272460;C1448177;C1546968;C1879645;C3714652;C4049872;C4321495;C4552882";NA;NA;tnf na ve
 419;rando . in na * *;"C0597484;C1272460;C1546968;C1879645;C4049872;C4552882";NA;NA;rando in na
 419;not rando . in na *;"C0597484;C1272460;C1518422;C1546968;C1879645;C4049872;C4552882";NA;NA;not rando in na
 419;na ï ve;"C0042469;C0597484;C1272460;C1546968;C1879645;C3714652;C4049872;C4321495;C4552882";NA;NA;na ve
 419;na ( mmol / l );"C0597484;C1272460;C1532563;C1546968;C1879645;C4049872;C4552882";NA;NA;na mmol l
 419;na;"C0597484;C1272460;C1546968;C1879645;C4049872;C4552882";NA;NA;na
 419;n / a;C1272460;NA;NA;n a
 419;n . a .;C1272460;NA;NA;n a
 419;insulin - na ' ive;"C0021641;C0597484;C1272460;C1533581;C1546968;C1579433;C1879645;C3435805;C3714501;C4049872;C4552882;C4554334";NA;NA;insulin na ive
 419;anti ‐ tnf ‐ na ï ve    n   ( % );"C0042469;C0432633;C0597484;C1272460;C1448177;C1546968;C1879645;C3714652;C4049872;C4321495;C4552882";NA;NA;anti tnf na ve n
 419;a / v ( n = $nmbr$ ) v ( n = $nmbr$ );"C0560268;C1272460;C3887614";NA;NA;a v n $nmbr$ v n $nmbr$
 419;a / v ( n = $nmbr$ );C1272460;NA;NA;a v n $nmbr$
 419;a $nmbr$ c [ n ( % ) ];C1272460;NA;NA;a $nmbr$ c n
 419;a $nmbr$ + e $nmbr$ ( n = $nmbr$ );C1272460;NA;NA;a $nmbr$ e $nmbr$ n $nmbr$
 418;neoplasia  n ( % );"C0027651;C1882062";NA;NA;neoplasia n
 418;neoplasia;"C0027651;C1882062";NA;NA;neoplasia
 418;detected during tumor evaluation;"C0027651;C0220825;C0442726;C1261322;C1511790;C1578706;C3273930";NA;NA;detected during tumor evaluation
 417;tenecteplase;C0872913;NA;NA;tenecteplase
 417;symptom onset to start of reperfusion treatment : tenecteplase or arterial sheath insertion !;"C0003842;C0021107;C0035124;C0039798;C0040363;C0041260;C0087111;C0221464;C0227952;C0439659;C0441587;C0684253;C0872913;C1512796;C1522326;C1533734;C1705169;C1883351;C1883719;C3538994;C3887704;C4086878";NA;NA;symptom onset to start of reperfusion treatment tenecteplase or arterial sheath insertion
 416;pleased;"C3829994;C4264468";NA;NA;pleased
 415;elevated vs normalb;"C0205250;C3163633";NA;NA;elevated vs normalb
 415;elevated vs . normalc;"C0205250;C3163633";NA;NA;elevated vs normalc
 415;elevated vs . normalb;"C0205250;C3163633";NA;NA;elevated vs normalb
 415;elevated cardiac markers — no . ( % ) : t;"C0205250;C1271630;C2603360;C3163633";NA;NA;elevated cardiac markers no t
 415;elevated cardiac markers;"C0205250;C1271630;C3163633";NA;NA;elevated cardiac markers
 415;elevated at wk $nmbr$ — no . ( % ) $nmbr$;"C0205250;C0332174;C0439230;C3163633";NA;NA;elevated at wk $nmbr$ no $nmbr$
 415;elevated at wk $nmbr$ — no . ( % ) !;"C0205250;C0332174;C0439230;C3163633";NA;NA;elevated at wk $nmbr$ no
 414;previous cardiovascular events;"C0205156;C1320716;C1552607";NA;NA;previous cardiovascular events
 414;previous cardiovascular event — no . ( % );"C0205156;C1320716;C1552607";NA;NA;previous cardiovascular event no
 414;previous cardiovascular event at randomization;"C0034656;C0205156;C1320716;C1552607";NA;NA;previous cardiovascular event at randomization
 414;previous cardiovascular event ( % );"C0205156;C1320716;C1552607";NA;NA;previous cardiovascular event
 414;cardiovascular events;C1320716;NA;NA;cardiovascular events
 413;recent;C0332185;NA;NA;recent
 412;with events ( % );"C0441471;C3541888";NA;NA;with events
 412;warfarin events / n ( % / y );"C0043031;C0441471;C3541888";NA;NA;warfarin events n y
 412;use of aspirin at time of qualifying event ( % );"C0004057;C0040223;C0441471;C1514624;C1524063;C3541383;C4019010";NA;NA;use of aspirin at time of qualifying event
 413;recent cardiovascular eventf;"C0007226;C0332185;C3887460";FALSE; 414;recent cardiovascular eventf
 416;elevated high - sensitivity crp — no . { % ) * *;"C0742906;C1441604";FALSE; 286;elevated high sensitivity crp no
 421;cigarette smoker;C0337667;FALSE; 420;cigarette smoker
 421;cigarette smoker *;C0337667;FALSE; 420;cigarette smoker
 421;passive smoker;C0425309;FALSE; 420;passive smoker
 421;cigarette smoker  no . ( % );C0337667;FALSE; 420;cigarette smoker no
 422;non - smoker ( n = $nmbr$  $nmbr$ );"C0337672;C0425293;C4554605";FALSE; 420;non smoker n $nmbr$ $nmbr$
 422;nonsmoker  n ( % );"C0337672;C0425293;C4554605";FALSE; 420;nonsmoker n
 422;non - smoker;"C0337672;C0425293;C4554605";FALSE; 420;non smoker
 422;$nmbr$ +  no . ( % );NA;FALSE; 420;$nmbr$ no
 422;never smoker;C0425293;FALSE; 420;never smoker
 422;current smoker 一 no . ( % );"C3173209;C3241966";FALSE; 420;current smoker no
 422;current smoker — no . / total no . ( % );"C0439175;C0439810;C3173209;C3241966";FALSE; 420;current smoker no total no
 422;current smoker — no . of patients ( % );"C0030705;C3173209;C3241966";FALSE; 420;current smoker no of patients
 422;current smoker — no . ( % );"C3173209;C3241966";FALSE; 420;current smoker no
 422;current smoker  no ( % );"C3173209;C3241966";FALSE; 420;current smoker no
 422;current smoker  no . ( % );"C3173209;C3241966";FALSE; 420;current smoker no
 422;current non - smoker;C0425311;FALSE; 420;current non smoker
 422;current nonsmoker;"C0337672;C0425293;C0521116;C1705970;C4554605";FALSE; 420;current nonsmoker
 423;> $nmbr$ kg / m $nmbr$ smokers;"C0337664;C1532718";FALSE; 420;$nmbr$ kg m $nmbr$ smokers
 414;adverse eventy;NA;FALSE;  47;adverse eventy
 412;total events  n;"C0439175;C0439810;C0441471;C3541888";NA;NA;total events n
 412;time since qualifying event;"C0040223;C0441471;C1514624;C3541383;C4019010";NA;NA;time since qualifying event
 412;qualifying symptomatic event  n ( % ) a;"C0231220;C0441471;C1514624;C4019010";NA;NA;qualifying symptomatic event n a
 412;qualifying events;"C0441471;C1514624;C3541888";NA;NA;qualifying events
 412;qualifying event — no . ( % );"C0441471;C1514624;C4019010";NA;NA;qualifying event no
 412;qualifying event;"C0441471;C1514624;C4019010";NA;NA;qualifying event
 412;procedures for index event;"C0025664;C0184661;C0441471;C0600653;C0918012;C1552854;C1637833;C2700391;C2986546;C3538935;C4019010";NA;NA;procedures for index event
 412;probability  of event %;"C0033204;C0441471;C4019010";NA;NA;probability of event
 412;prior to index event;"C0441471;C0600653;C0918012;C1552854;C1637833;C2986546;C4019010";NA;NA;prior to index event
 412;previous cerebrovascular event;"C0205156;C0441471;C1552607;C1880018;C4019010";NA;NA;previous cerebrovascular event
 344;ascvd  n ( % );C3665365;NA;NA;ascvd n
 412;presentation of index event;"C0441471;C0449450;C0600653;C0918012;C1552854;C1637833;C2986546;C4019010";NA;NA;presentation of index event
 412;pneumonia events  n;"C0032285;C0441471;C3541888";NA;NA;pneumonia events n
 412;pervious cerebrovascular event;"C0205326;C0441471;C1880018;C4019010";NA;NA;pervious cerebrovascular event
 412;pciperformed for qualifying event;"C0441471;C1514624;C4019010";NA;NA;pciperformed for qualifying event
 412;pci postindex event;"C0441471;C4019010;C4049621";NA;NA;pci postindex event
 412;pci or cabg surgery for index event;"C0010055;C0038894;C0038895;C0441471;C0543467;C0600653;C0918012;C1274039;C1552854;C1637833;C2986546;C4019010;C4049621";NA;NA;pci or cabg surgery for index event
 412;pci for index event;"C0441471;C0600653;C0918012;C1552854;C1637833;C2986546;C4019010;C4049621";NA;NA;pci for index event
 412;patients with pneumonia events  n ( % ) #;"C0030705;C0032285;C0441471;C3541888";NA;NA;patients with pneumonia events n
 412;patients with hospitalized pneumonia events  n ( % );"C0032285;C0441471;C0870668;C3541888";NA;NA;patients with hospitalized pneumonia events n
 412;patients with complicated events ( p = $nmbr$ - $nmbr$ 十 );"C0030705;C0231242;C0441471;C3541888";NA;NA;patients with complicated events p $nmbr$ $nmbr$
 412;patients with complicated events;"C0030705;C0231242;C0441471;C3541888";NA;NA;patients with complicated events
 412;other antithrombotic medication for index event — no . ( % );"C0013227;C0441471;C0600653;C0918012;C1552854;C1637833;C2986546;C3244316;C4019010;C4284232";NA;NA;other antithrombotic medication for index event no
 412;ophthalmologic events;"C0029087;C0205481;C0441471;C3541888";NA;NA;ophthalmologic events
 412;number ( % ) of patients with event;"C0441471;C2360800;C4019010";NA;NA;number of patients with event
 412;no revascularization for index acs event  no . ( % );"C0441471;C0581603;C0600653;C0742343;C0918012;C1552854;C1637833;C2986546;C4019010;C4318612";NA;NA;no revascularization for index acs event no
 412;no revascularization for index acs event;"C0441471;C0581603;C0600653;C0742343;C0918012;C1552854;C1637833;C2986546;C4019010;C4318612";NA;NA;no revascularization for index acs event
 412;no of events womenmen *;"C0441471;C3541888";NA;NA;no of events womenmen
 412;no of events / total n ( % );"C0439175;C0439810;C0441471;C3541888";NA;NA;no of events total n
 412;no . with event / total no . { % );"C0439175;C0439810;C0441471;C4019010";NA;NA;no with event total no
 412;no . of patients / no . of events ( % ) $nmbr$ / $nmbr$ ( $nmbr$ ) $nmbr$ / $nmbr$ ( $nmbr$ );"C0030705;C0441471;C3541888";NA;NA;no of patients no of events $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 412;no . of patients / no . of events;"C0030705;C0441471;C3541888";NA;NA;no of patients no of events
 412;no . of events / totol no . ( % );"C0441471;C3541888";NA;NA;no of events totol no
 412;no . of events / patients;"C0030705;C0441471;C3541888";NA;NA;no of events patients
 412;no . of events / no . of patients;"C0030705;C0441471;C3541888";NA;NA;no of events no of patients
 412;neurologicai events;"C0441471;C3541888";NA;NA;neurologicai events
 412;n events ( % );"C0369718;C0441471;C0441922;C3541888";NA;NA;n events
 412;morphine use for index event / pci;"C0242000;C0441471;C0600653;C0918012;C1552854;C1637833;C2986546;C4019010;C4049621";NA;NA;morphine use for index event pci
 412;km event ( % ) at $nmbr$ y;"C0441471;C3887676;C4019010";NA;NA;km event at $nmbr$ y
 412;index events : dvt n ( % );"C0149871;C0441471;C0600653;C0918012;C1552854;C1637833;C2926618;C2986546;C3541888;C3899446";NA;NA;index events dvt n
 412;index events;"C0441471;C0600653;C0918012;C1552854;C1637833;C2986546;C3541888";NA;NA;index events
 412;index event — no . ( % );"C0441471;C0600653;C0918012;C1552854;C1637833;C2986546;C4019010";NA;NA;index event no
 412;index event not confirmed;"C0441471;C0521093;C0600653;C0750484;C0918012;C1518422;C1552854;C1637833;C2986546;C4019010";NA;NA;index event not confirmed
 412;index event information;"C0441471;C0600653;C0918012;C1533716;C1552854;C1637833;C2986546;C4019010";NA;NA;index event information
 412;index event asymptomatic or unconfirmed;"C0231221;C0441471;C0600653;C0918012;C1547326;C1552854;C1637833;C2986546;C4019010";NA;NA;index event asymptomatic or unconfirmed
 412;index event  n / n ( % );"C0441471;C0600653;C0918012;C1552854;C1637833;C2986546;C4019010";NA;NA;index event n n
 412;index event  n ( % );"C0441471;C0600653;C0918012;C1552854;C1637833;C2986546;C4019010";NA;NA;index event n
 412;index event;"C0441471;C0600653;C0918012;C1552854;C1637833;C2986546;C4019010";NA;NA;index event
 412;in - trial $nmbr$ - year rates per $nmbr$ ( se ) total events / number at risk;"C0008976;C0036919;C0150312;C0332285;C0439175;C0439234;C0439508;C0439810;C0441471;C0871208;C1264674;C1444641;C1521828;C1707101;C3541888;C4288115";NA;NA;in trial $nmbr$ year rates per $nmbr$ se total events number at risk
 412;icosapent ethyl ( events / n ( % ) );"C0058978;C0441471;C3541888";NA;NA;icosapent ethyl events n
 412;i no . of events;"C0021966;C0221138;C0441471;C3541888";NA;NA;i no of events
 412;history of pci or cabg before index event;"C0010055;C0019664;C0019665;C0262512;C0262926;C0441471;C0600653;C0918012;C1552854;C1637833;C1705255;C2004062;C2986546;C4019010;C4049621";NA;NA;history of pci or cabg before index event
 412;history of ml before index event;"C0019664;C0019665;C0262512;C0262926;C0439526;C0441471;C0600653;C0918012;C1552854;C1637833;C1705224;C1705255;C2004062;C2986546;C3887665;C4019010";NA;NA;history of ml before index event
 412;history of chf before index event;"C0018802;C0019664;C0019665;C0262512;C0262926;C0441471;C0600653;C0918012;C1552854;C1637833;C1705255;C2004062;C2986546;C4019010";NA;NA;history of chf before index event
 412;heparin  ‘ ondaparinux or brvalirudin use between rxjex event;"C0019134;C0042153;C0441471;C0457083;C0770546;C1947944;C4019010";NA;NA;heparin ondaparinux or brvalirudin use between rxjex event
 412;gastrointestinal event;"C0441471;C0521362;C4019010";NA;NA;gastrointestinal event
 412;frequency of events;"C0376249;C0439603;C0441471;C0871396;C1561548;C1705502;C3541888;C3898838;C4321352";NA;NA;frequency of events
 412;freqency of events;"C0441471;C3541888";NA;NA;freqency of events
 412;for treatment of index event;"C0039798;C0087111;C0441471;C0600653;C0918012;C1522326;C1533734;C1552854;C1637833;C1705169;C2986546;C3538994;C3887704;C4019010";NA;NA;for treatment of index event
 412;fibrinolytic for qualifying event;"C0040044;C0441471;C1514624;C4019010";NA;NA;fibrinolytic for qualifying event
 412;events treatment ( $nmbr$ );"C0039798;C0087111;C0441471;C1522326;C1533734;C1705169;C3538994;C3541888;C3887704";NA;NA;events treatment $nmbr$
 412;events consistent with volume depletion;"C0332290;C0441471;C0546884;C3541888";NA;NA;events consistent with volume depletion
 412;events consistent with genital infection;"C0332290;C0441471;C0729552;C3541888";NA;NA;events consistent with genital infection
 412;events / statin group;"C0360714;C0441471;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C3541888";NA;NA;events statin group
 412;events / patient - year ( n );"C0030705;C0439234;C0439508;C0441471;C3541888";NA;NA;events patient year n
 412;events / n;"C0441471;C3541888";NA;NA;events n
 412;events ( % );"C0441471;C3541888";NA;NA;events
 412;events  no .;"C0441471;C3541888";NA;NA;events no
 412;events  n ( % / y );"C0441471;C3541888";NA;NA;events n y
 412;events  n ( % );"C0441471;C3541888";NA;NA;events n
 412;events;"C0441471;C3541888";NA;NA;events
 412;event { n ( % );"C0441471;C4019010";NA;NA;event n
 412;event number;"C0237753;C0441471;C0449788;C4019010";NA;NA;event number
 412;event during overall;"C0282416;C0441471;C1561607;C4019010";NA;NA;event during overall
 412;event during on -;"C0441471;C4019010";NA;NA;event during on
 412;event / total;"C0439175;C0439810;C0441471;C4019010";NA;NA;event total
 412;event ( p = $nmbr$ . $nmbr$ o + );"C0441471;C4019010";NA;NA;event p $nmbr$ $nmbr$ o
 412;event ( % );"C0441471;C4019010";NA;NA;event
 412;event  n ( % );"C0441471;C4019010";NA;NA;event n
 412;event;"C0441471;C4019010";NA;NA;event
 412;cvd events;"C0007222;C0441471;C3541888";NA;NA;cvd events
 412;cumulative events;"C0441471;C1511559;C3541888";NA;NA;cumulative events
 412;composite events;"C0205199;C0441471;C1547335;C3541888";NA;NA;composite events
 412;catheterization performed for qualifying event;"C0007430;C0441471;C0884358;C1514624;C4019010";NA;NA;catheterization performed for qualifying event
 412;biochemical events;"C0205474;C0441471;C3541888";NA;NA;biochemical events
 412;atients with event;"C0441471;C4019010";NA;NA;atients with event
 412;at qualifying event;"C0441471;C1514624;C4019010";NA;NA;at qualifying event
 412;at index event : no . ( % );"C0441471;C0600653;C0918012;C1552854;C1637833;C2986546;C4019010";NA;NA;at index event no
 412;any event;"C0441471;C4019010";NA;NA;any event
 412;antithrombotic drug use at time of event;"C0013227;C0040223;C0441471;C1254351;C1524063;C3541383;C4019010";NA;NA;antithrombotic drug use at time of event
 412;anatomical extent of qualifying event — no . ( % ) : t;"C0220784;C0439792;C0441471;C1514624;C2603360;C4019010";NA;NA;anatomical extent of qualifying event no t
 412;anatomic extent of qualifying event  n ( % . ) x;"C0220784;C0439792;C0441471;C1514624;C4019010";NA;NA;anatomic extent of qualifying event n x
 412;$nmbr$ events [ $nmbr$ . $nmbr$ ];"C0441471;C3541888";NA;NA;$nmbr$ events $nmbr$ $nmbr$
 412;$nmbr$ events;"C0441471;C3541888";NA;NA;$nmbr$ events
 411;sd = standard deviation  bmi = body mass index  ed = erectile;"C0030847;C0871420;C1305855;C2699239;C3538926";NA;NA;sd standard deviation bmi body mass index ed erectile
 411;prior ed therapy;"C1514463;C3538926";NA;NA;prior ed therapy
 411;missing ed duration ( y );"C0449238;C1551393;C1705492;C2926735;C3272743;C3538926";NA;NA;missing ed duration y
 411;educ ssy;NA;NA;NA;educ ssy
 411;educ > $nmbr$ y;NA;NA;NA;educ $nmbr$ y
 411;educ $nmbr$ - $nmbr$ y;NA;NA;NA;educ $nmbr$ $nmbr$ y
 411;edo;NA;NA;NA;edo
 411;eda  %;"C0162359;C1539327;C3539920;C3887494";NA;NA;eda
 411;ed therapy;"C0039798;C0087111;C1363945;C3538926";NA;NA;ed therapy
 411;ed duration > $nmbr$ yr  n ( % );"C0439234;C0449238;C2926735;C3538926";NA;NA;ed duration $nmbr$ yr n
 411;ed duration;"C0449238;C2926735;C3538926";NA;NA;ed duration
 411;ed characteristics;"C1521970;C3538926";NA;NA;ed characteristics
 410;time to all - cause death up to end of the study;"C0007465;C0015127;C0040223;C0444930;C0547043;C0557651;C1301931;C1524003;C2603343;C2746065;C3541383";NA;NA;time to all cause death up to end of the study
 410;study end concentration;"C0086045;C0444930;C0557651;C1446561;C2603343;C2746065;C3827302";NA;NA;study end concentration
 410;combined end poir;"C0205195;C0444930;C2746065";NA;NA;combined end poir
 409;era monotherapy;"C1521863;C3495919";NA;NA;era monotherapy
 409;era and pde - $nmbr$ i;"C0021966;C0221138;C1521863;C3495919";NA;NA;era and pde $nmbr$ i
 409;era;"C1521863;C3495919";NA;NA;era
 409;ebria;C1917247;NA;NA;ebria
 408;no epa group no . of events ( % );"C0441471;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C3541888";NA;NA;no epa group no of events
 408;epa hr events ( % );"C0441471;C3541888";NA;NA;epa hr events
 408;epa group no . of events ( % );"C0441471;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C3541888";NA;NA;epa group no of events
 408;epa ( n = $nmbr$ );NA;NA;NA;epa n $nmbr$
 408;epa;NA;NA;NA;epa
 408;empa;C2699863;NA;NA;empa
 -10;entocort ec ( n = $nmbr$ );C1170256;NA;NA;entocort ec n $nmbr$
 406;lvh on ecg;C0232306;NA;NA;lvh on ecg
 406;lvh by echo or ecg;"C0058928;C0149721;C1623258;C1655045";NA;NA;lvh by echo or ecg
 406;lvh by ecg or echocardiographyd;C0232306;NA;NA;lvh by ecg or echocardiographyd
 406;lvh by ecg or echocardiography  no ( % );"C0013516;C0232306";NA;NA;lvh by ecg or echocardiography no
 406;lvh by ecg or echo . n ( % );"C0058928;C0232306;C1655045";NA;NA;lvh by ecg or echo n
 406;lvh by ecg / echo;"C0058928;C0232306;C1655045";NA;NA;lvh by ecg echo
 406;lvh by ecg ( minnesota code );"C0009219;C0026183;C0232306;C0805701;C3889831";NA;NA;lvh by ecg minnesota code
 406;lvh by ecg;C0232306;NA;NA;lvh by ecg
 406;lv hypertrophy per ecg;C0232306;NA;NA;lv hypertrophy per ecg
 406;ecg - lvh ( sokolow - lyon );C0232306;NA;NA;ecg lvh sokolow lyon
 406;ecg - lvh ( cornell );C0232306;NA;NA;ecg lvh cornell
 405;infrequent exacerbator;C0521114;NA;NA;infrequent exacerbator
 405;influenza;"C0021400;C0021403";NA;NA;influenza
 404;frequent or continuous;"C0332183;C0549178";NA;NA;frequent or continuous
 404;frequent exacerbator;C0332183;NA;NA;frequent exacerbator
 403;insufficient;"C0205412;C0231180;C0439856";NA;NA;insufficient
 403;inadequate response ( > $nmbr$ months mmf / ggs );"C0083765;C0205412;C0209368;C0439231;C0439856;C0871261;C1704632;C1706817;C2911692;C3848524";NA;NA;inadequate response $nmbr$ months mmf ggs
 403;inadequate;"C0205412;C0439856";NA;NA;inadequate
 402;treatment effect ( hr );C1518681;NA;NA;treatment effect hr
 402;main effect baseline hormone;"C0019932;C0168634;C0205225;C1280500;C1442488;C1518681;C1542147;C2348382;C4521914";NA;NA;main effect baseline hormone
 402;effect estimate;"C0750572;C1280500;C1518681;C2348382";NA;NA;effect estimate
 402;consistency of effect;"C0332529;C1280500;C1518681;C1547017;C2348382";NA;NA;consistency of effect
 400;hemoglobin ale *;"C0019046;C0678386;C2632076";NA;NA;hemoglobin ale
 400;hemoglobin ale  %  median ( iqr );"C0019046;C0549183;C0678386;C0876920;C2347635;C2348144;C2632076;C2939193";NA;NA;hemoglobin ale median iqr
 400;hale;NA;NA;NA;hale
 400;flex aln ^;"C0729594;C2681220";NA;NA;flex aln
 400;ale < $nmbr$;"C0678386;C2632076";NA;NA;ale $nmbr$
 400;ale;"C0678386;C2632076";NA;NA;ale
 398;alpha glucosidase inhibitors;"C1299007;C2756986;C3539108";NA;NA;alpha glucosidase inhibitors
 398;alpha - glucosidase inhibitors;"C1299007;C2756986;C3539108";NA;NA;alpha glucosidase inhibitors
 397;all mis *;"C0687670;C1333208;C1412384;C3538735";NA;NA;all mis
 397;all mis;"C0687670;C1333208;C1412384;C3538735";NA;NA;all mis
 396;hba $nmbr$ c ( % ) all countries;"C0019016;C0454664;C1825777;C3538758";NA;NA;hba $nmbr$ c all countries
 396;all teaes *;NA;NA;NA;all teaes
 396;all teaes;NA;NA;NA;all teaes
 398;agi;C1299007;FALSE; -10;agi
 399;laba ';NA;FALSE;1508;laba
 399;laba alone;"C0205171;C0439044;C0679994";FALSE;1508;laba alone
 399;labd alone;"C0205171;C0396059;C0439044;C0679994";FALSE;1508;labd alone
 401;wafarin;NA;FALSE; 858;wafarin
 401;wafarin event incidence / n;"C0021149;C0220856;C0441471;C4019010";FALSE; 858;wafarin event incidence n
 412;aspirin alone group no of events / total n ( % );"C0004057;C0439175;C0439810;C0441471;C2826346;C3541888";FALSE;1366;aspirin alone group no of events total n
 396;all participantst ( n = $nmbr$ / $nmbr$ );NA;NA;NA;all participantst n $nmbr$ $nmbr$
 396;all participantsa;NA;NA;NA;all participantsa
 396;all n = $nmbr$ $nmbr$;"C0369718;C0441922";NA;NA;all n $nmbr$ $nmbr$
 396;all n = $nmbr$  $nmbr$;"C0369718;C0441922";NA;NA;all n $nmbr$ $nmbr$
 396;all n = $nmbr$;"C0369718;C0441922";NA;NA;all n $nmbr$
 396;all itt sutajects;NA;NA;NA;all itt sutajects
 396;all diabetesd;NA;NA;NA;all diabetesd
 396;all countries;C0454664;NA;NA;all countries
 396;all ( n = $nmbr$ f );"C0016327;C0369718;C0441922";NA;NA;all n $nmbr$ f
 396;all ( n = $nmbr$ * );"C0369718;C0441922";NA;NA;all n $nmbr$
 396;all ( n = $nmbr$ ) $nmbr$ . $nmbr$ ± $nmbr$ . $nmbr$;"C0369718;C0441922";NA;NA;all n $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 396;all ( n = $nmbr$ );"C0369718;C0441922";NA;NA;all n $nmbr$
 396;all ( n = $nmbr$  $nmbr$ );"C0369718;C0441922";NA;NA;all n $nmbr$ $nmbr$
 395;mean alc  %;"C0444504;C1424945;C2347634;C2348143;C3811058";NA;NA;mean alc
 395;baseline alc category;"C0168634;C0683312;C1424945;C1442488;C3811058;C3889287";NA;NA;baseline alc category
 395;baseline alc < $nmbr$ . $nmbr$ %;"C0168634;C1424945;C1442488;C3811058";NA;NA;baseline alc $nmbr$ $nmbr$
 395;alc group ( % );"C0441833;C0687744;C1257890;C1424945;C1519504;C1705428;C1705429;C3811058";NA;NA;alc group
 395;alc at weeko ( % );"C1424945;C3811058";NA;NA;alc at weeko
 395;alc at week $nmbr$ ( % );"C0332174;C0439230;C1424945;C3811058";NA;NA;alc at week $nmbr$
 395;alc > = $nmbr$ . $nmbr$ %;"C1424945;C3811058";NA;NA;alc $nmbr$ $nmbr$
 395;alc > $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ %;"C1424945;C3811058";NA;NA;alc $nmbr$ $nmbr$ $nmbr$ $nmbr$
 395;alc < $nmbr$ . $nmbr$ % at baseline  n ( % );"C0168634;C1424945;C1442488;C3811058";NA;NA;alc $nmbr$ $nmbr$ at baseline n
 395;alc < $nmbr$ . $nmbr$ %;"C1424945;C3811058";NA;NA;alc $nmbr$ $nmbr$
 395;alc ( % );"C1424945;C3811058";NA;NA;alc
 394;any;NA;NA;NA;any
 394;> $nmbr$ and < $nmbr$ %;NA;NA;NA;$nmbr$ and $nmbr$
 393;aab $nmbr$ ( % );NA;NA;NA;aab $nmbr$
 392;enrolled in the americas;"C0002454;C0596070;C4684790";NA;NA;enrolled in the americas
 392;americas * *;"C0002454;C0596070";NA;NA;americas
 392;americas ( n = $nmbr$ );"C0002454;C0596070";NA;NA;americas n $nmbr$
 392;americas  excluding us;"C0002454;C0332196;C0596070;C2828389";NA;NA;americas excluding us
 392;americas;"C0002454;C0596070";NA;NA;americas
 391;p $nmbr$ vs usual care;"C0369773;C1947933;C2603361;C3538928";NA;NA;p $nmbr$ vs usual care
 391;care use;"C0042153;C0457083;C1947933;C1947944";NA;NA;care use
 391;care;C1947933;NA;NA;care
 391;cards;"C2930619;C3275277";NA;NA;cards
 390;卞 at discharge .;"C0012621;C0030685;C2926602";NA;NA;at discharge
 390;thienopyridine at discharge;"C0012621;C0030685;C1120149;C2926602";NA;NA;thienopyridine at discharge
 390;therapy at discharge;"C0012621;C0030685;C0039798;C0087111;C1363945;C2926602";NA;NA;therapy at discharge
 390;medications during hospitalization or at discharge;"C0012621;C0013227;C0019993;C0030685;C0802604;C2598133;C2926602;C4284232";NA;NA;medications during hospitalization or at discharge
 390;discharge medication  n ( % );"C0012621;C0013227;C0030685;C2926602;C3244316;C4284232";NA;NA;discharge medication n
 390;concomitant drug therapy at discharge;"C0012621;C0013216;C0013217;C0013227;C0030685;C0039798;C0087111;C0521115;C1254351;C1363945;C1707479;C2926602;C3850077";NA;NA;concomitant drug therapy at discharge
 390;cardiac medications during indexhospitalization and / or discharge;"C0012621;C0013227;C0018787;C0030685;C0802604;C1522601;C2598133;C2926602;C4284232";NA;NA;cardiac medications during indexhospitalization and or discharge
 390;cardiac medications during index hospital stay and / or discharge;"C0012621;C0013227;C0030685;C0428776;C0802604;C2598133;C2926602;C3489408;C4284232";NA;NA;cardiac medications during index hospital stay and or discharge
 390;and / or discharge;"C0012621;C0030685;C2926602";NA;NA;and or discharge
 389;treated with cabg — no . / total no . ( % );"C0010055;C0332293;C0439175;C0439810";NA;NA;treated with cabg no total no
 389;prior coronary intervention or coronary artery bypass grafting;"C0010055;C0018787;C0184661;C0332152;C0886296;C1273869;C2826257";NA;NA;prior coronary intervention or coronary artery bypass grafting
 389;prior coronary artery bypass surgery;"C0010055;C0332152;C2826257";NA;NA;prior coronary artery bypass surgery
 389;prior coronary artery bypass grafting;"C0010055;C0332152;C2826257";NA;NA;prior coronary artery bypass grafting
 389;prior coronary artery bypass graft surgery;"C0010055;C0332152;C2826257";NA;NA;prior coronary artery bypass graft surgery
 389;prior coronary artery bypass graft;"C0010055;C0332152;C1260596;C2826257";NA;NA;prior coronary artery bypass graft
 389;prior cabg ( before index acs );"C0010055;C0332152;C0600653;C0742343;C0918012;C1552854;C1637833;C2826257;C2986546;C4318612";NA;NA;prior cabg before index acs
 389;prior cabg  %;"C0010055;C0332152;C2826257";NA;NA;prior cabg
 389;prior cabg;"C0010055;C0332152;C2826257";NA;NA;prior cabg
 389;no prior cabg;"C0010055;C0332152;C2826257";NA;NA;no prior cabg
 389;history of cabg surgery  n ( % );"C0010055;C0455610";NA;NA;history of cabg surgery n
 389;history of cabg surgery;"C0010055;C0455610";NA;NA;history of cabg surgery
 389;coronary bypass surgery;C0010055;NA;NA;coronary bypass surgery
 389;coronary bypass  n ( % );C0010055;NA;NA;coronary bypass n
 389;coronary artery bypass surgery;C0010055;NA;NA;coronary artery bypass surgery
 389;coronary artery bypass graft  n ( % );"C0010055;C1260596";NA;NA;coronary artery bypass graft n
 389;coronary artery bypass graft;"C0010055;C1260596";NA;NA;coronary artery bypass graft
 389;coronary artery bypass;C0010055;NA;NA;coronary artery bypass
 389;cabg — no . { % );C0010055;NA;NA;cabg no
 389;cabg — no . ( % );C0010055;NA;NA;cabg no
 391;usual care;"C1947933;C3538928";FALSE;1849;usual care
 391;usual care ( n = $nmbr$ a );"C1947933;C3538928";FALSE;1849;usual care n $nmbr$ a
 391;usual care ( n = $nmbr$ );"C1947933;C3538928";FALSE;1849;usual care n $nmbr$
 391;usual care ( n = $nmbr$ la );"C0023031;C0023749;C0230347;C1947933;C2346906;C3538928;C4553351";FALSE;1849;usual care n $nmbr$ la
 392;texcaps;NA;FALSE; -10;texcaps
 393;european or arab;"C0239307;C0282540;C1535514;C1561448";FALSE; 504;european or arab
 394;any oral hypoglycemic drug 一 no . ( % );C0359086;FALSE;  33;any oral hypoglycemic drug no
 394;insulin and oral hypoglycemic drugs;"C0021641;C0359086;C1533581;C1579433;C3714501";FALSE;  33;insulin and oral hypoglycemic drugs
 389;percutaneous coronary intervention or coronary artery bypass graft surgery  n ( % );"C0010055;C1532338";FALSE;1524;percutaneous coronary intervention or coronary artery bypass graft surgery n
 392;afcaps /;NA;FALSE; -10;afcaps
 293;pregnancy;C0032961;FALSE;2370;pregnancy
 389;cabg surgery by no . of vessels $nmbr$;"C0010055;C0042381;C3714645";NA;NA;cabg surgery by no of vessels $nmbr$
 389;cabg or pci;"C0010055;C4049621";NA;NA;cabg or pci
 389;cabg > $nmbr$ month ago;"C0010055;C0332177;C0439231";NA;NA;cabg $nmbr$ month ago
 389;cabg :;C0010055;NA;NA;cabg
 389;cabg ( % );C0010055;NA;NA;cabg
 389;cabg  n ( % );C0010055;NA;NA;cabg n
 389;cabg;C0010055;NA;NA;cabg
 388;race and ss at baseline;"C0034510;C0168634;C1442488;C1706779;C2699257;C3853635;C3891295;C4551874";NA;NA;race and ss at baseline
 388;> $nmbr$ . $nmbr$ % and ≤ $nmbr$ . $nmbr$ %;NA;NA;NA;$nmbr$ $nmbr$ and $nmbr$ $nmbr$
 387;avm ( n = $nmbr$ );"C0003857;C0279476";NA;NA;avm n $nmbr$
 387;avm % △ ( se );"C0003857;C0036919;C0279476";NA;NA;avm se
 386;s wave in v $nmbr$ ( mm );"C0456681;C4301968";NA;NA;s wave in v $nmbr$ mm
 385;q wave;"C0429089;C1305738";NA;NA;q wave
 385;non - q wave;"C0429089;C1305738;C1518422";NA;NA;non q wave
 385;non - q - wave myocardial infarction;"C0542269;C3537181";NA;NA;non q wave myocardial infarction
 385;non - q - wave ml;"C0429089;C0439526;C1305738;C1518422;C1705224;C3887665";NA;NA;non q wave ml
 384;intracranial hemorrhage †;"C0151699;C4554169";NA;NA;intracranial hemorrhage
 384;intracranial hemorrhage  n ( % );"C0151699;C4554169";NA;NA;intracranial hemorrhage n
 384;intracranial hemorrhage;"C0151699;C4554169";NA;NA;intracranial hemorrhage
 384;intracranial bleeding;C0151699;NA;NA;intracranial bleeding
 384;intracranial bleed;C0151699;NA;NA;intracranial bleed
 383;intrathoracic or intraperitoneal surgery;"C0038894;C0038895;C0442120;C0543467;C0595836;C1274039";NA;NA;intrathoracic or intraperitoneal surgery
 383;intraperitoneal;C0442120;NA;NA;intraperitoneal
 382;no antianginal drug;"C0013227;C1254351;C1874267;C3537168";NA;NA;no antianginal drug
 382;new anti - anginal therapy;"C1874267;C3242274;C3537168";NA;NA;new anti anginal therapy
 382;intensification of antianginal therapy;"C1511484;C1874267;C3537168";NA;NA;intensification of antianginal therapy
 382;any antianginal drug !;"C0013227;C1254351;C1874267;C3537168";NA;NA;any antianginal drug
 382;$nmbr$ antianginal drug;"C0013227;C1254351;C1874267;C3537168";NA;NA;$nmbr$ antianginal drug
 381;tachyarrhythmias  n ( % );C0080203;NA;NA;tachyarrhythmias n
 381;supraventricular tachyarrhythmias ( incl . atrial;"C0018792;C1698480;C3853833";NA;NA;supraventricular tachyarrhythmias incl atrial
 381;no . ( % ) of patients with atrial tachyarrhythmia;"C0018792;C0030705;C0080203";NA;NA;no of patients with atrial tachyarrhythmia
 380;prior arrhythmias  n ( % );"C0003811;C0332152;C2826257";NA;NA;prior arrhythmias n
 344;ascvd  b no . ( % );C3665365;NA;NA;ascvd b no
 380;cardiac arrhythmia  n ( % );"C0003811;C0264886;C1560249";NA;NA;cardiac arrhythmia n
 380;cardiac arrhythmia;"C0003811;C0264886;C1560249";NA;NA;cardiac arrhythmia
 380;arrhythmias;C0003811;NA;NA;arrhythmias
 380;arrhythmia !;C0003811;NA;NA;arrhythmia
 380;arrhythmia;C0003811;NA;NA;arrhythmia
 379;previous use of antiarrhythmic drugs;"C0003195;C0205156;C1524063;C1552607";NA;NA;previous use of antiarrhythmic drugs
 379;other antiarrhythmics ^;C0003195;NA;NA;other antiarrhythmics
 379;any prerandomization failure of an antiarrhythmic drug — no . ( % );"C0003195;C0231174;C0301380;C0680095";NA;NA;any prerandomization failure of an antiarrhythmic drug no
 379;antiarrhythmics;C0003195;NA;NA;antiarrhythmics
 379;antiarrhythmic therapy;"C0003195;C0039798;C0087111;C1363945;C3537142";NA;NA;antiarrhythmic therapy
 379;antiarrhythmic drugs    n   ( % );C0003195;NA;NA;antiarrhythmic drugs n
 379;antiarrhythmic drug;"C0003195;C0301380";NA;NA;antiarrhythmic drug
 379;antiarrhythmic;"C0003195;C3537142";NA;NA;antiarrhythmic
 379;anti arrhythmic;"C0003195;C3537142";NA;NA;anti arrhythmic
 378;arthralgia;"C0003862;C4551938";NA;NA;arthralgia
 376;patients with microalbuminuria at baseline;"C0030705;C0168634;C0730345;C1442488";NA;NA;patients with microalbuminuria at baseline
 376;or no microalbuminuria or macroalbuminuria;C0730345;NA;NA;or no microalbuminuria or macroalbuminuria
 376;normoalbuminuria or microalbuminuria;C0730345;NA;NA;normoalbuminuria or microalbuminuria
 376;microalbuminuria — no . / total no . ( % );"C0439175;C0439810;C0730345";NA;NA;microalbuminuria no total no
 376;microalbuminuria — no . ( % );C0730345;NA;NA;microalbuminuria no
 376;microalbuminuria or proteinuria;"C0033687;C0730345;C1962972;C4554346";NA;NA;microalbuminuria or proteinuria
 376;microalbuminuria or macroalbuminuria §;C0730345;NA;NA;microalbuminuria or macroalbuminuria
 376;microalbuminuria or macroalbuminuria;C0730345;NA;NA;microalbuminuria or macroalbuminuria
 376;microalbuminuria ( uacr $nmbr$ – $nmbr$ );C0730345;NA;NA;microalbuminuria uacr $nmbr$ $nmbr$
 376;microalbuminuria  n ( % );C0730345;NA;NA;microalbuminuria n
 376;microalbuminuria;C0730345;NA;NA;microalbuminuria
 376;macroalbuminuria ( uacr > $nmbr$ );NA;NA;NA;macroalbuminuria uacr $nmbr$
 376;and microalbuminuria or macroalbuminuria;C0730345;NA;NA;and microalbuminuria or macroalbuminuria
 375;progression of albuminuria;"C0001925;C0242656;C0449258";NA;NA;progression of albuminuria
 375;micro - albuminuria;"C0001925;C0085672;C1553035;C3811161;C4049106";NA;NA;micro albuminuria
 375;macro - albuminuria;"C0001925;C2984010";NA;NA;macro albuminuria
 375;any albuminuria — no . ( % );C0001925;NA;NA;any albuminuria no
 375;any albuminuria;C0001925;NA;NA;any albuminuria
 375;albuminuria_p_interaction;"C0001925;C1704675";NA;NA;albuminuria_p_interaction
 375;albuminuria progression;"C0001925;C0242656;C0449258";NA;NA;albuminuria progression
 375;albuminuria ( g / g );"C0001925;C1319635";NA;NA;albuminuria g g
 375;albuminuria;C0001925;NA;NA;albuminuria
 374;reteplase / abciximab - facilitated pci ( n = $nmbr$ );"C0256103;C0288672;C4049621";NA;NA;reteplase abciximab facilitated pci n $nmbr$
 377;history of microalbuminuria — no . ( % );C3532606;FALSE; 376;history of microalbuminuria no
 377;macroalbuminuriaf;NA;FALSE; 376;macroalbuminuriaf
 377;macroalbuminuria;NA;FALSE; 376;macroalbuminuria
 377;macroalbuminuria  n ( % );NA;FALSE; 376;macroalbuminuria n
 377;micro - or macroalbuminuria  n ( % ) §;"C0085672;C1553035;C3811161;C4049106";FALSE; 376;micro or macroalbuminuria n
 377;micro - or macroalbuminuria  no . ( % );"C0085672;C1553035;C3811161;C4049106";FALSE; 376;micro or macroalbuminuria no
 377;normoalbuminuria;NA;FALSE; 376;normoalbuminuria
 377;normoalbuminuria  no . ( % );NA;FALSE; 376;normoalbuminuria no
 377;normoalbuminuria — no . ( % );NA;FALSE; 376;normoalbuminuria no
 378;duration of rheumatoid arthritis ( years );"C0003873;C0439234;C0449238;C2926735";FALSE;1848;duration of rheumatoid arthritis years
 378;duration of rheumatoid arthritis — yr;"C0003873;C0439234;C0449238;C2926735";FALSE;1848;duration of rheumatoid arthritis yr
 378;rheumatoid arthritis;C0003873;FALSE;1848;rheumatoid arthritis
 378;arthritis mutilans;C0702102;FALSE; -10;arthritis mutilans
 378;polyarticular arthritis  no rheumatoid nodules;"C0035450;C0162323";FALSE; -10;polyarticular arthritis no rheumatoid nodules
 384;extracranial;C0580586;FALSE; -10;extracranial
 384;transradial;NA;FALSE; -10;transradial
 384;intracranial;C0524466;FALSE; -10;intracranial
 386;q wave mi;C0861151;FALSE; 385;q wave mi
 386;q - wave mi;C0861151;FALSE; 385;q wave mi
 386;death / q - wave mi / idr;"C0011065;C0861151;C1306577;C4082313;C4552775";FALSE; 385;death q wave mi idr
 388;bdmard - naive;NA;FALSE; 231;bdmard naive
 388;cdmard;NA;FALSE; 231;cdmard
 388;none ( cdmard - naive or past use at baseline );"C0042153;C0168634;C0457083;C1442488;C1444637;C1947944;C4284302";FALSE; 231;none cdmard naive or past use at baseline
 374;abciximab vs . primary;"C0205225;C0288672;C0439612;C0439631";NA;NA;abciximab vs primary
 374;abciximab no . / total ( % );"C0288672;C0439175;C0439810";NA;NA;abciximab no total
 374;abciximab - facilitated pci;"C0288672;C4049621";NA;NA;abciximab facilitated pci
 374;abciximab ( n = $nmbr$ );C0288672;NA;NA;abciximab n $nmbr$
 374;abciximab;C0288672;NA;NA;abciximab
 374;$nmbr$ abciximab ( n = $nmbr$ );C0288672;NA;NA;$nmbr$ abciximab n $nmbr$
 373;rate ratio ( lebrikizumab vs placebo  $nmbr$ % cl );"C0032042;C0456603;C0596019;C0871208;C1521828;C1547037;C1696465;C1706408;C2981360";NA;NA;rate ratio lebrikizumab vs placebo $nmbr$ cl
 373;rate difference ( lebrikizumab - placebo );"C0032042;C0871208;C1521828;C1696465;C1705241;C1705242;C1706408;C2981360";NA;NA;rate difference lebrikizumab placebo
 373;lebrikizumab ( n = $nmbr$ );C2981360;NA;NA;lebrikizumab n $nmbr$
 372;canakinumab  il - $nmbr$ top tertilec;"C0020898;C0021764;C0022271;C1704458;C2718773";NA;NA;canakinumab il $nmbr$ top tertilec
 372;canakinumab  il - $nmbr$ middle tertile;"C0020898;C0021764;C0022271;C0444598;C0549183;C1552826;C2718773";NA;NA;canakinumab il $nmbr$ middle tertile
 372;canakinumab  il - $nmbr$ lowest tertile;"C0020898;C0021764;C0022271;C1708760;C2718773";NA;NA;canakinumab il $nmbr$ lowest tertile
 372;canakinumab  $nmbr$ - month on - treatment il - $nmbr$ below the median value ( < $nmbr$ . $nmbr$ ng / l ) ( n   =   $nmbr$ );"C0020898;C0021764;C0022271;C0039798;C0087111;C0332177;C0439231;C0439297;C0549183;C0876920;C1522326;C1522609;C1533734;C1705169;C2347635;C2348144;C2718773;C2939193;C3538994;C3887704";NA;NA;canakinumab $nmbr$ month on treatment il $nmbr$ below the median value $nmbr$ $nmbr$ ng l n $nmbr$
 372;canakinumab;C2718773;NA;NA;canakinumab
 372;all canakinumab;C2718773;NA;NA;all canakinumab
 371;ustekinumab ® ( n = $nmbr$ );C1608841;NA;NA;ustekinumab n $nmbr$
 371;ustekinumab combined;"C0205195;C1608841";NA;NA;ustekinumab combined
 371;ustekinumab ' ’ ( n = $nmbr$ );C1608841;NA;NA;ustekinumab n $nmbr$
 371;ustekinumab $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1608841;C1960952;C2346927;C4321396;C4521761";NA;NA;ustekinumab $nmbr$ mg n $nmbr$
 371;ustekinumab;C1608841;NA;NA;ustekinumab
 371;ustekinu;NA;NA;NA;ustekinu
 371;usteki;NA;NA;NA;usteki
 371;uistekinumab;NA;NA;NA;uistekinumab
 370;area of retinal thickening within the grid  mean ( sd )  dab;"C0017446;C0086162;C0205146;C0444504;C1081457;C1302690;C1415284;C2347634;C2348143;C2348395;C2699239;C2825313;C4522144";NA;NA;area of retinal thickening within the grid mean sd dab
 370;area of retinal hemorrhage within the grid  mean ( sd )  dab;"C0017446;C0035317;C0086162;C0205146;C0444504;C1081457;C1415284;C2347634;C2348143;C2348395;C2699239;C2825313;C4522144";NA;NA;area of retinal hemorrhage within the grid mean sd dab
 370;area of fluorescein leakage within the grid  mean ( sd )  dab;"C0017446;C0086162;C0205146;C0444504;C1081457;C1415284;C2347634;C2348143;C2348395;C2699239;C2825313;C4476700;C4522144";NA;NA;area of fluorescein leakage within the grid mean sd dab
 370;area;"C0017446;C0205146";NA;NA;area
 369;reqion;NA;NA;NA;reqion
 369;regiont;NA;NA;NA;regiont
 369;regions  n ( % );"C0017446;C0205147";NA;NA;regions n
 344;ascvd;C3665365;NA;NA;ascvd
 369;region ofthe world;"C0017446;C0205147;C2700280";NA;NA;region ofthe world
 369;region ofenrollment — %;"C0017446;C0205147";NA;NA;region ofenrollment
 369;region of world — no . ( % );"C0017446;C0205147;C2700280";NA;NA;region of world no
 369;region of the world;"C0017446;C0205147;C2700280";NA;NA;region of the world
 369;region of residence ( p = $nmbr$ $nmbr$ );"C0017446;C0205147;C0237096";NA;NA;region of residence p $nmbr$ $nmbr$
 369;region of enrollment — no . ( % );"C0017446;C0205147;C1516879;C1696073;C3888021";NA;NA;region of enrollment no
 369;region of enrollment  no . ( % );"C0017446;C0205147;C1516879;C1696073;C3888021";NA;NA;region of enrollment no
 369;region of enrollment  n ( % ) +;"C0017446;C0205147;C1516879;C1696073;C3888021";NA;NA;region of enrollment n
 369;region of enrollment;"C0017446;C0205147;C1516879;C1696073;C3888021";NA;NA;region of enrollment
 369;region n ( % );"C0017446;C0205147";NA;NA;region n
 369;region :;"C0017446;C0205147";NA;NA;region
 369;region - n ( % );"C0017446;C0205147";NA;NA;region n
 369;region *;"C0017446;C0205147";NA;NA;region
 369;region ( us );"C0017446;C0205147";NA;NA;region us
 369;region ( pooled );"C0017446;C0205147;C1709595;C2349200;C4522255";NA;NA;region pooled
 369;region ( % );"C0017446;C0205147";NA;NA;region
 369;region    n   ( % );"C0017446;C0205147";NA;NA;region n
 369;region  n ( % ) a;"C0017446;C0205147";NA;NA;region n a
 369;region  n ( % );"C0017446;C0205147";NA;NA;region n
 369;region  latin america;"C0017446;C0023122;C0205147";NA;NA;region latin america
 369;region  europe union;"C0015179;C0017446;C0205147";NA;NA;region europe union
 369;region  %;"C0017446;C0205147";NA;NA;region
 369;region;"C0017446;C0205147";NA;NA;region
 369;p  treatment - by - region interaction;"C0017446;C0039798;C0087111;C0205147;C0369773;C1522326;C1533734;C1704675;C1705169;C2603361;C3538994;C3887704";NA;NA;p treatment by region interaction
 369;grouped region;"C0017446;C0205147;C0439745;C4319846";NA;NA;grouped region
 369;geographical region ( % );C0017446;NA;NA;geographical region
 369;geographical region  n ( % );C0017446;NA;NA;geographical region n
 369;geographical region;C0017446;NA;NA;geographical region
 369;geographic region ^;C0017446;NA;NA;geographic region
 369;geographic region - other;C0017446;NA;NA;geographic region other
 369;geographic region  n ( % );C0017446;NA;NA;geographic region n
 369;geographic region  %;C0017446;NA;NA;geographic region
 368;± standard deviation . triglyceride;"C0041004;C0871420";NA;NA;standard deviation triglyceride
 368;triglycerides — mmol / l;"C0041004;C1532563";NA;NA;triglycerides mmol l
 368;triglycerides — mg / dl | |;"C0041004;C0439269";NA;NA;triglycerides mg dl
 368;triglycerides — mg / dl ^;"C0041004;C0439269";NA;NA;triglycerides mg dl
 368;triglycerides — mg / dl;"C0041004;C0439269";NA;NA;triglycerides mg dl
 368;triglycerides > $nmbr$ mg / dl ( > $nmbr$ . $nmbr$ mmol / l );"C0041004;C0439269;C1532563";NA;NA;triglycerides $nmbr$ mg dl $nmbr$ $nmbr$ mmol l
 368;triglycerides > $nmbr$ mg / dl;"C0041004;C0439269";NA;NA;triglycerides $nmbr$ mg dl
 368;triglycerides > $nmbr$ - $nmbr$ mmol / l;"C0041004;C1532563";NA;NA;triglycerides $nmbr$ $nmbr$ mmol l
 368;triglycerides < $nmbr$ - $nmbr$ mmol / l;"C0041004;C1532563";NA;NA;triglycerides $nmbr$ $nmbr$ mmol l
 368;triglycerides - mg / dl * *;"C0041004;C0439269";NA;NA;triglycerides mg dl
 368;triglycerides * *;C0041004;NA;NA;triglycerides
 368;triglycerides * ( mg / dl );"C0041004;C0439269";NA;NA;triglycerides mg dl
 368;triglycerides *;C0041004;NA;NA;triglycerides
 368;triglycerides ( week $nmbr$ ) a;"C0041004;C0332174;C0439230";NA;NA;triglycerides week $nmbr$ a
 368;triglycerides ( mmol / l ) :;"C0041004;C1532563";NA;NA;triglycerides mmol l
 368;triglycerides ( mmol / l ) ( median  iqr );"C0041004;C0549183;C0876920;C1532563;C2347635;C2348144;C2939193";NA;NA;triglycerides mmol l median iqr
 368;triglycerides ( mmol / l )  mean ( sd );"C0041004;C0444504;C1532563;C2347634;C2348143;C2699239";NA;NA;triglycerides mmol l mean sd
 368;triglycerides ( mmol / l );"C0041004;C1532563";NA;NA;triglycerides mmol l
 368;triglycerides ( mg / dl ) * *;"C0041004;C0439269";NA;NA;triglycerides mg dl
 368;triglycerides ( mg / dl );"C0041004;C0439269";NA;NA;triglycerides mg dl
 368;triglycerides ( median  iqr )  mg / dl;"C0041004;C0439269;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;triglycerides median iqr mg dl
 372;anakinra;C0245109;FALSE; -10;anakinra
 368;triglycerides $nmbr$ nd third;"C0041004;C0205437";NA;NA;triglycerides $nmbr$ nd third
 368;triglycerides $nmbr$  d third;"C0041004;C0205437";NA;NA;triglycerides $nmbr$ d third
 368;triglycerides $ $nmbr$ mg / dl ( $nmbr$ . $nmbr$ mmol / l );"C0041004;C0439269;C1532563";NA;NA;triglycerides $ $nmbr$ mg dl $nmbr$ $nmbr$ mmol l
 368;triglycerides  mmol / l ®;"C0041004;C1532563";NA;NA;triglycerides mmol l
 368;triglycerides  mmol / l §;"C0041004;C1532563";NA;NA;triglycerides mmol l
 368;triglycerides  mmol / l  mean ± sd;"C0041004;C0444504;C1532563;C2347634;C2348143;C2699239";NA;NA;triglycerides mmol l mean sd
 368;triglycerides  mmol / l  mean ( sd );"C0041004;C0444504;C1532563;C2347634;C2348143;C2699239";NA;NA;triglycerides mmol l mean sd
 368;triglycerides  mmol / l;"C0041004;C1532563";NA;NA;triglycerides mmol l
 368;triglycerides  mg / l;"C0041004;C0439268";NA;NA;triglycerides mg l
 368;triglycerides  mg / dl ^;"C0041004;C0439269";NA;NA;triglycerides mg dl
 368;triglycerides  mg / dl  median ( q $nmbr$ : q $nmbr$ );"C0041004;C0439269;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;triglycerides mg dl median q $nmbr$ q $nmbr$
 368;triglycerides  median ( ql  q $nmbr$ )  mmol / l;"C0041004;C0549183;C0876920;C1532563;C2347635;C2348144;C2939193";NA;NA;triglycerides median ql q $nmbr$ mmol l
 368;triglycerides  median ( qi  q $nmbr$ )  mmol / l;"C0041004;C0376586;C0549183;C0876920;C1532563;C2347635;C2348144;C2939193";NA;NA;triglycerides median qi q $nmbr$ mmol l
 368;triglycerides  median ( iqr )  mg / dl;"C0041004;C0439269;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;triglycerides median iqr mg dl
 368;triglycerides  * mmol / l;"C0041004;C1532563";NA;NA;triglycerides mmol l
 368;triglycerides;C0041004;NA;NA;triglycerides
 368;triglyceride a;C0041004;NA;NA;triglyceride a
 368;triglyceride ( mmol / l ) t;"C0041004;C1532563";NA;NA;triglyceride mmol l t
 368;triglyceride ( mmol / l ) * blood pressure;"C0005823;C0041004;C1271104;C1272641;C1532563";NA;NA;triglyceride mmol l blood pressure
 368;triglyceride ( mmol / l );"C0041004;C1532563";NA;NA;triglyceride mmol l
 368;triglyceride ( mg / dl ) d;"C0041004;C0439422;C3642216";NA;NA;triglyceride mg dl d
 368;triglyceride ( mg / dl ) $nmbr$;"C0041004;C0439269";NA;NA;triglyceride mg dl $nmbr$
 368;triglyceride ( median : mg / dl ) a [ $nmbr$ - $nmbr$ percentile ];"C0041004;C0439269;C0549183;C0876920;C1264641;C2347635;C2348144;C2939193";NA;NA;triglyceride median mg dl a $nmbr$ $nmbr$ percentile
 368;triglyceride ( median  mg / dl ) - $nmbr$ [ $nmbr$ - $nmbr$ percentile |;"C0041004;C0439269;C0549183;C0876920;C1264641;C2347635;C2348144;C2939193";NA;NA;triglyceride median mg dl $nmbr$ $nmbr$ $nmbr$ percentile
 368;triglyceride  mmol / l;"C0041004;C1532563";NA;NA;triglyceride mmol l
 368;triglyceride;C0041004;NA;NA;triglyceride
 368;tg  triglycerides . * median values ( standard deviation for medians ) .;"C0041004;C0042295;C0399532;C0549183;C1442989;C2828392";NA;NA;tg triglycerides median values standard deviation for medians
 368;pretreatment triglycerides;"C0041004;C1550147;C2709094;C3539075;C3539076";NA;NA;pretreatment triglycerides
 368;median triglyceride ( mg / dl );"C0041004;C0439269;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median triglyceride mg dl
 368;fasting triglycerides — mg / dl;"C0015663;C0041004;C0439269";NA;NA;fasting triglycerides mg dl
 368;fasting triglycerides > $nmbr$ mg / dl *;"C0015663;C0041004;C0439269";NA;NA;fasting triglycerides $nmbr$ mg dl
 368;fasting triglycerides  mg / dl;"C0015663;C0041004;C0439269";NA;NA;fasting triglycerides mg dl
 368;fasting triglycerides  mean ( sd )  mg / dl;"C0015663;C0041004;C0439269;C0444504;C2347634;C2348143;C2699239";NA;NA;fasting triglycerides mean sd mg dl
 368;fasting triglycerides;"C0015663;C0041004";NA;NA;fasting triglycerides
 368;deviation  tg  triglyceride .;"C0012727;C0041004;C0205419;C1705236";NA;NA;deviation tg triglyceride
 368;baseline triglycerides > $nmbr$ mg / dl and;"C0041004;C0168634;C0439269;C1442488";NA;NA;baseline triglycerides $nmbr$ mg dl and
 368;baseline triglycerides < $nmbr$ mg / dl;"C0041004;C0168634;C0439269;C1442488";NA;NA;baseline triglycerides $nmbr$ mg dl
 368;- triglycerides;C0041004;NA;NA;triglycerides
 368;$nmbr$ . $nmbr$ mg / dl triglycerides ^;"C0041004;C0439269";NA;NA;$nmbr$ $nmbr$ mg dl triglycerides
 367;no . of previous anti - tnf drugs — no . ( % );"C0013227;C0205156;C1448177;C1552607;C3687832";NA;NA;no of previous anti tnf drugs no
 367;no . of drugs;"C0013227;C3687832";NA;NA;no of drugs
 367;lowering drugs;"C0013227;C0441994;C2003888;C3687832";NA;NA;lowering drugs
 367;lipid - modulating drug;"C0013227;C0023779;C0443264;C1254351";NA;NA;lipid modulating drug
 367;investigator - defined drug - related aes;"C0013227;C0035173;C0439849;C0445223;C1254351;C1412268;C1704788;C2699274;C3539106";NA;NA;investigator defined drug related aes
 367;immunomodulatory drugs;"C0013227;C3687832";NA;NA;immunomodulatory drugs
 367;glycemic drugs;"C0005802;C0013227;C3687832";NA;NA;glycemic drugs
 367;epilepsy drug;"C0013227;C0014544;C1254351";NA;NA;epilepsy drug
 367;drugs and toxins;"C0013227;C0040549;C3687832";NA;NA;drugs and toxins
 367;drug ‐ relateda;"C0013227;C1254351";NA;NA;drug relateda
 367;drug - relateda;"C0013227;C1254351";NA;NA;drug relateda
 367;blood glucose - lowering drugs  excluding insulin  n ( % );"C0005802;C0013227;C0017725;C0018938;C0021641;C0332196;C0441994;C1533581;C1579433;C2003888;C2828389;C3687832;C3714501";NA;NA;blood glucose lowering drugs excluding insulin n
 367;because of drug ‐ relateda   sae;"C0013227;C1254351;C1519255;C1622657;C4553214";NA;NA;because of drug relateda sae
 367;because of drug ‐ relateda   ae;"C0013227;C1254351;C3887670";NA;NA;because of drug relateda ae
 367;annanginal drugs ( $nmbr$ / l / s » $nmbr$ ) ^;"C0013227;C3687832";NA;NA;annanginal drugs $nmbr$ l s $nmbr$
 367;> $nmbr$ drug - related aes *;"C0013227;C0439849;C0445223;C1254351;C1412268;C2699274";NA;NA;$nmbr$ drug related aes
 367;> $nmbr$ drug - related;"C0013227;C0439849;C0445223;C1254351";NA;NA;$nmbr$ drug related
 367;$nmbr$ antianginal drugs;"C0013227;C1874267;C3537168;C3687832";NA;NA;$nmbr$ antianginal drugs
 366;use of medications for pah — no . ( % );"C0013227;C0030123;C0802604;C1524063;C2598133;C3203102;C4284232;C4284467";NA;NA;use of medications for pah no
 366;use of medication for pah;"C0013227;C0030123;C1524063;C3203102;C3244316;C4284232;C4284467";NA;NA;use of medication for pah
 366;use of medication at baseline — no . ( % );"C0013227;C0168634;C1442488;C1524063;C3244316;C4284232";NA;NA;use of medication at baseline no
 366;use of cardiac medication *;"C0013227;C0018787;C1522601;C1524063;C3244316;C4284232";NA;NA;use of cardiac medication
 366;systemic sle medications  n ( % );"C0013227;C0024141;C0205373;C0802604;C2598133;C4284232";NA;NA;systemic sle medications n
 366;selected medications — no . ( % );"C0013227;C0802604;C1707391;C2598133;C4284232";NA;NA;selected medications no
 366;prior medications;"C0013227;C0332152;C0802604;C2598133;C2826257;C4284232";NA;NA;prior medications
 366;previous medications  n ( % );"C0013227;C0205156;C0802604;C1552607;C2598133;C4284232";NA;NA;previous medications n
 366;patients receiving any uc medication  n ( % );"C0013227;C0030705;C1514756;C3244316;C4284232";NA;NA;patients receiving any uc medication n
 366;other medications;"C0013227;C0802604;C2598133;C4284232";NA;NA;other medications
 366;use of blood pressure lowering medication *;"C0013227;C0020649;C1524063;C3244316;C4284232";FALSE;1579;use of blood pressure lowering medication
 366;periprocedural medications;"C0013227;C0802604;C2598133;C4284232";FALSE;2267;periprocedural medications
 366;periprocedural medications  n ( % );"C0013227;C0802604;C2598133;C4284232";FALSE;2267;periprocedural medications n
 366;periprocedural medications — no . / total no .;"C0013227;C0439175;C0439810;C0802604;C2598133;C4284232";FALSE;2267;periprocedural medications no total no
 366;other lipid - lowering medication;"C0013227;C0023779;C0441994;C2003888;C3244316;C4284232";NA;NA;other lipid lowering medication
 366;op concomitant medications ( % );"C0013227;C0521115;C0802604;C2598133;C4284232";NA;NA;op concomitant medications
 366;no . of previous ciu / csu medications  mean ( median );"C0013227;C0205156;C0444504;C0549183;C0578870;C0802604;C0876920;C1552607;C2347634;C2347635;C2348143;C2348144;C2598133;C2939193;C4284232";NA;NA;no of previous ciu csu medications mean median
 366;no . of previous ciu / csu medications;"C0013227;C0205156;C0578870;C0802604;C1552607;C2598133;C4284232";NA;NA;no of previous ciu csu medications
 366;medications for crohn ' s disease taken at baseline — no . ( % );"C0010346;C0013227;C0168634;C0802604;C1442488;C1883727;C2598133;C4284232";NA;NA;medications for crohn s disease taken at baseline no
 366;medication;"C0013227;C3244316;C4284232";NA;NA;medication
 366;mean no . agents ( sd ) other medications;"C0013227;C0444504;C0450442;C0802604;C1254351;C1521826;C2347634;C2348143;C2598133;C2699239;C4284232";NA;NA;mean no agents sd other medications
 366;iop - lowering medication;"C0013227;C0441994;C0578862;C2003888;C3244316;C4284232";NA;NA;iop lowering medication
 366;concurrent medications;"C0013227;C0205420;C0802604;C2598133;C4284232";NA;NA;concurrent medications
 366;concurrent medication;"C0013227;C0205420;C3244316;C4284232";NA;NA;concurrent medication
 366;concomitant pd medications at baseline  n ( % ) c  d;"C0013227;C0168634;C0521115;C0802604;C1442488;C2598133;C4284232;C4553228;C4553229";NA;NA;concomitant pd medications at baseline n c d
 366;concomitant medication — no . ( % );"C0013227;C0521115;C3244316;C4284232";FALSE;1916;concomitant medication no
 366;concomitant medications;"C0013227;C0521115;C0802604;C2598133;C4284232";FALSE;1916;concomitant medications
 366;concomitant medications  %;"C0013227;C0521115;C0802604;C2598133;C4284232";FALSE;1916;concomitant medications
 366;concomitant medications ( % );"C0013227;C0521115;C0802604;C2598133;C4284232";FALSE;1916;concomitant medications
 366;concomitant medications after randomization;"C0013227;C0034656;C0521115;C0802604;C2598133;C4284232";FALSE;1916;concomitant medications after randomization
 366;concomitant medications at baseline;"C0013227;C0168634;C0521115;C0802604;C1442488;C2598133;C4284232";FALSE;1916;concomitant medications at baseline
 366;concomitant medications  * n ( % );"C0013227;C0521115;C0802604;C2598133;C4284232";FALSE;1916;concomitant medications n
 366;concomitant medications  n ( % );"C0013227;C0521115;C0802604;C2598133;C4284232";FALSE;1916;concomitant medications n
 366;concomitant medications  no . ( % );"C0013227;C0521115;C0802604;C2598133;C4284232";FALSE;1916;concomitant medications no
 366;concomitant medications — no . ( % );"C0013227;C0521115;C0802604;C2598133;C4284232";FALSE;1916;concomitant medications no
 366;medication at entry ( % );"C0013227;C1705654;C3244316;C4284232";FALSE;2263;medication at entry
 366;medication at randomization;"C0013227;C0034656;C3244316;C4284232";FALSE;2263;medication at randomization
 366;medication  n ( % );"C0013227;C3244316;C4284232";FALSE;2263;medication n
 366;medication $nmbr$ ( $nmbr$ . $nmbr$ );"C0013227;C3244316;C4284232";FALSE;2263;medication $nmbr$ $nmbr$ $nmbr$
 366;medication continued into double - blind treatment period;"C0013072;C0013227;C0039798;C0087111;C0439531;C0549178;C1522326;C1533734;C1705169;C1948053;C3244316;C3538994;C3887704;C4284232";FALSE;2263;medication continued into double blind treatment period
 366;medication — no . ( % );"C0013227;C3244316;C4284232";FALSE;2263;medication no
 366;medications;"C0013227;C0802604;C2598133;C4284232";FALSE;2263;medications
 366;medications ( % );"C0013227;C0802604;C2598133;C4284232";FALSE;2263;medications
 366;medications *;"C0013227;C0802604;C2598133;C4284232";FALSE;2263;medications
 366;medications at baseline  n ( % );"C0013227;C0168634;C0802604;C1442488;C2598133;C4284232";FALSE;2263;medications at baseline n
 366;medications at baselinet;"C0013227;C0802604;C2598133;C4284232";FALSE;2263;medications at baselinet
 366;medications at coronary angiography;"C0013227;C0085532;C0802604;C1548829;C2598133;C4284232";FALSE;2263;medications at coronary angiography
 366;medications at randomization;"C0013227;C0034656;C0802604;C2598133;C4284232";FALSE;2263;medications at randomization
 366;medications at the time of randomization — no . ( % );"C0013227;C0034656;C0040223;C0802604;C2598133;C3541383;C4284232";FALSE;2263;medications at the time of randomization no
 366;medications at time of randomization — no . ( % );"C0013227;C0034656;C0040223;C0802604;C2598133;C3541383;C4284232";FALSE;2263;medications at time of randomization no
 366;medications before admission;"C0013227;C0184666;C0802604;C0809949;C2598133;C4284232";FALSE;2263;medications before admission
 366;medications in use at baseline  n ( % );"C0013227;C0042153;C0150312;C0168634;C0332285;C0457083;C0802604;C1442488;C1707101;C1947944;C2598133;C4284232";FALSE;2263;medications in use at baseline n
 366;medications in use at baseline — no . ( % );"C0013227;C0042153;C0150312;C0168634;C0332285;C0457083;C0802604;C1442488;C1707101;C1947944;C2598133;C4284232";FALSE;2263;medications in use at baseline no
 366;medications  n;"C0013227;C0802604;C2598133;C4284232";FALSE;2263;medications n
 366;medications  n ( % );"C0013227;C0802604;C2598133;C4284232";FALSE;2263;medications n
 366;medications  no . ( % );"C0013227;C0802604;C2598133;C4284232";FALSE;2263;medications no
 366;medications . no . ( % );"C0013227;C0802604;C2598133;C4284232";FALSE;2263;medications no
 366;medications — no . ( % );"C0013227;C0802604;C2598133;C4284232";FALSE;2263;medications no
 366;medications — no . { % ) * *;"C0013227;C0802604;C2598133;C4284232";FALSE;2263;medications no
 366;medications  n ( % of patients );"C0013227;C0030705;C0802604;C2598133;C4284232";FALSE;2263;medications n of patients
 366;medications on admission  %;"C0013227;C0457453;C0802604;C2598133;C4284232";FALSE;2263;medications on admission
 366;medications taken at time of randomization statins;"C0013227;C0034656;C0040223;C0360714;C0802604;C1883727;C2598133;C3541383;C4284232";FALSE;2263;medications taken at time of randomization statins
 366;medications through day $nmbr$;"C0013227;C0332173;C0439228;C0439505;C0802604;C2598133;C4284232";FALSE;2263;medications through day $nmbr$
 366;medication useb;"C0013227;C3244316;C4284232";FALSE;2263;medication useb
 366;glucose - lowering medication;"C0013227;C0017725;C0441994;C2003888;C3244316;C4284232";FALSE;  33;glucose lowering medication
 366;glucose - lowering medications;"C0013227;C0017725;C0441994;C0802604;C2003888;C2598133;C4284232";FALSE;  33;glucose lowering medications
 366;lipid - lowering medication;"C0013227;C0023779;C0441994;C2003888;C3244316;C4284232";FALSE;2265;lipid lowering medication
 366;lipid - lowering medication ( % );"C0013227;C0023779;C0441994;C2003888;C3244316;C4284232";FALSE;2265;lipid lowering medication
 366;lipid - lowering medications ^;"C0013227;C0023779;C0441994;C0802604;C2003888;C2598133;C4284232";FALSE;2265;lipid lowering medications
 366;cv medication;"C0013227;C3244316;C3538987;C4048877;C4284232;C4318503";FALSE;2266;cv medication
 366;cv medication  % of patients;"C0013227;C0030705;C3244316;C3538987;C4048877;C4284232;C4318503";FALSE;2266;cv medication of patients
 366;diabetes medication;"C0011847;C0011849;C0013227;C3244316;C4284232";FALSE;  33;diabetes medication
 366;concomitant asthma medications  n ( % );"C0004096;C0013227;C0521115;C0802604;C2598133;C2984299;C4284232";NA;NA;concomitant asthma medications n
 366;comorbidities and concomitant medications;"C0009488;C0013227;C0521115;C0802604;C2598133;C4284232";NA;NA;comorbidities and concomitant medications
 366;comorbidities / concomitant medications;"C0009488;C0013227;C0521115;C0802604;C2598133;C4284232";NA;NA;comorbidities concomitant medications
 366;blood - pressure medications at randomization — no . / total no . ( % );"C0005823;C0013227;C0033095;C0034656;C0439175;C0439810;C0460139;C0802604;C0849164;C1271104;C1272641;C1306345;C2598133;C4284008;C4284232";NA;NA;blood pressure medications at randomization no total no
 366;baseline medications;"C0013227;C0168634;C0802604;C1442488;C2598133;C4284232";NA;NA;baseline medications
 366;baseline antihyperglycemic medications  n ( % );"C0013227;C0020616;C0168634;C0802604;C1442488;C2598133;C4284232";NA;NA;baseline antihyperglycemic medications n
 366;any medication;"C0013227;C3244316;C4284232";NA;NA;any medication
 366;antithrombotic medications  n ( % );"C0013227;C0802604;C2598133;C4284232";NA;NA;antithrombotic medications n
 366;antianginal medications;"C0013227;C0802604;C1874267;C2598133;C3537168;C4284232";NA;NA;antianginal medications
 366;anti - arthritic medications;"C0013227;C0802604;C2598133;C4284232";NA;NA;anti arthritic medications
 366;acute medication intake ( days / month );"C0013227;C0205178;C0556971;C1512806;C3244316;C4284232";NA;NA;acute medication intake days month
 366;> $nmbr$ glucose - lowering medication . no . ( % );"C0013227;C0017725;C0441994;C2003888;C3244316;C4284232";NA;NA;$nmbr$ glucose lowering medication no
 365;type of drug - eluting stent  n ( % );"C0038257;C0332307;C0457591;C1322815;C1547052";NA;NA;type of drug eluting stent n
 365;received drug - eluting stent;"C1322815;C1514756";NA;NA;received drug eluting stent
 365;non - drug - eluting stent;"C1322815;C1518422";NA;NA;non drug eluting stent
 365;drug eluting stent;C1322815;NA;NA;drug eluting stent
 365;drug - eluting stent — no . ( % );C1322815;NA;NA;drug eluting stent no
 365;drug - eluting stent implanted — no . ( % );"C0021102;C1322815;C2828363";NA;NA;drug eluting stent implanted no
 365;drug - eluting stent implanted ( at least one );"C0021102;C0205447;C1322815;C2828363";NA;NA;drug eluting stent implanted at least one
 365;drug - eluting stent implanted;"C0021102;C1322815;C2828363";NA;NA;drug eluting stent implanted
 365;drug - eluting stent  n ( % );C1322815;NA;NA;drug eluting stent n
 365;drug - eluting stent;C1322815;NA;NA;drug eluting stent
 365;at least one drug - eluting stent;"C0205447;C1322815";NA;NA;at least one drug eluting stent
 364;stent placement;C0522776;NA;NA;stent placement
 364;stent implanted — no . ( % );C0522776;NA;NA;stent implanted no
 364;stent implanted;C0522776;NA;NA;stent implanted
 363;not hispanie / latino;"C0086528;C1518422";NA;NA;not hispanie latino
 363;latino;C0086528;NA;NA;latino
 363;hispanie / latino;C0086528;NA;NA;hispanie latino
 363;hispanic or latino ethnic groupf;"C0015031;C0086409;C0086528;C0680174";NA;NA;hispanic or latino ethnic groupf
 363;hispanic or latino ethnic groupb;"C0015031;C0086409;C0086528;C0680174";NA;NA;hispanic or latino ethnic groupb
 363;hispanic or latino ethnic group *;"C0015031;C0086409;C0086528;C1879937";NA;NA;hispanic or latino ethnic group
 363;hispanic or latino ethnic group !;"C0015031;C0086409;C0086528;C1879937";NA;NA;hispanic or latino ethnic group
 363;hispanic or latino ( n — $nmbr$ );"C0086409;C0086528";NA;NA;hispanic or latino n $nmbr$
 363;hispanic or latino ( n = $nmbr$ );"C0086409;C0086528";NA;NA;hispanic or latino n $nmbr$
 363;hispanic or latino;"C0086409;C0086528";NA;NA;hispanic or latino
 363;hispanic / latino ( n = $nmbr$ );"C0086409;C0086528";NA;NA;hispanic latino n $nmbr$
 363;hispanic / latino;"C0086409;C0086528";NA;NA;hispanic latino
 363;ethnicitya hispanic or latino;"C0086409;C0086528";NA;NA;ethnicitya hispanic or latino
 362;tnf inhibitor;"C1448177;C1999216";NA;NA;tnf inhibitor
 362;tnf antagonist - naive ®;"C0231491;C1448177";NA;NA;tnf antagonist naive
 362;tnf antagonist - naive subgroup ( n - $nmbr$ );"C0231491;C1079230;C1448177;C1515021";NA;NA;tnf antagonist naive subgroup n $nmbr$
 362;tnf antagonist - naive ' ’;"C0231491;C1448177";NA;NA;tnf antagonist naive
 362;tnf - naivea;C1448177;NA;NA;tnf naivea
 362;tnf - naive patientsa;C1448177;NA;NA;tnf naive patientsa
 362;tnf - failurea;C1448177;NA;NA;tnf failurea
 362;prior tnf inhibitor exposure  no . ( % );"C0274281;C0332152;C0332157;C1448177;C1999216;C2826257";NA;NA;prior tnf inhibitor exposure no
 362;prior tnf inhibitor exposure;"C0274281;C0332152;C0332157;C1448177;C1999216;C2826257";NA;NA;prior tnf inhibitor exposure
 362;prior biologic therapy ( including anti - tnfs );"C0278947;C0332257;C1448177";NA;NA;prior biologic therapy including anti tnfs
 362;no prior tnf inhibitor exposure;"C0274281;C0332152;C0332157;C1448177;C1999216;C2826257";NA;NA;no prior tnf inhibitor exposure
 343;scd ( % );NA;NA;NA;scd
 343;non - lad;C1518422;NA;NA;non lad
 343;lad;NA;NA;NA;lad
 362;history of tnf antagonist treatment failure — no . ( % ) * *;"C0019664;C0019665;C0162643;C0231491;C0235828;C0262512;C0262926;C0521983;C1448177;C1547544;C1705255;C2004062";NA;NA;history of tnf antagonist treatment failure no
 362;anti - tnf agent ( s );"C0221141;C0313162;C0450442;C1254351;C1448177;C1521826";NA;NA;anti tnf agent s
 362;anti - tnf - naive patients $nmbr$;"C0030705;C1448177";NA;NA;anti tnf naive patients $nmbr$
 362;anti - tnf - naive patients;"C0030705;C1448177";NA;NA;anti tnf naive patients
 362;anti - tnf - naive  n ( % );"C0432633;C1448177";NA;NA;anti tnf naive n
 362;anti - tnf - experienced patients;"C0030705;C1448177";NA;NA;anti tnf experienced patients
 362;anti - tnf;C1448177;NA;NA;anti tnf
 361;injectable anti ‐ hyperglycaemic  n ( % );"C0432633;C1272883";NA;NA;injectable anti hyperglycaemic n
 361;anti ‐ hyperglycaemic agent  n ( % );"C0432633;C1321567";NA;NA;anti hyperglycaemic agent n
 360;anti - ccp antibody positive  n ( % );"C0432633;C0741132;C1525410;C1704514";NA;NA;anti ccp antibody positive n
 360;anti - ccp antibody positive;"C0741132;C4318437";NA;NA;anti ccp antibody positive
 360;anti - ccp antibody - positive  n ( % );"C0432633;C0741132;C1525410;C1704514";NA;NA;anti ccp antibody positive n
 360;anti - ccp antibody ( u /;"C0003241;C0003242;C0021027;C0439148;C1167408;C1525410;C1704514;C3665580;C4318437";NA;NA;anti ccp antibody u
 360;anti - ccp antibodies *;"C0003241;C1525410;C1624602;C1704514;C4318437";NA;NA;anti ccp antibodies
 359;xanthinesg;NA;NA;NA;xanthinesg
 359;xanthines $nmbr$;"C0043318;C3541955";NA;NA;xanthines $nmbr$
 359;xanthines  b   n ( % );"C0043318;C3541955";NA;NA;xanthines b n
 361;anti - anaemics;C0857322;FALSE; -10;anti anaemics
 362;naive;NA;FALSE; -10;naive
 366;concomitant medication;"C0013227;C0521115;C3244316;C4284232";FALSE;1916;concomitant medication
 366;concomitant medication  n ( % ) d;"C0013227;C0521115;C3244316;C4284232";FALSE;1916;concomitant medication n d
 366;concomitant medication ( > $nmbr$ % );"C0013227;C0521115;C3244316;C4284232";FALSE;1916;concomitant medication $nmbr$
 366;concomitant medication  no . ( % );"C0013227;C0521115;C3244316;C4284232";FALSE;1916;concomitant medication no
 366;> $nmbr$ concomitant medication;"C0013227;C0521115;C3244316;C4284232";FALSE;2263;$nmbr$ concomitant medication
 366;cardiac medications during index hospitalization;"C0013227;C0019993;C0428776;C0802604;C2598133;C4284232";FALSE;2266;cardiac medications during index hospitalization
 366;cardiac medications during index hospitalization  %;"C0013227;C0019993;C0428776;C0802604;C2598133;C4284232";FALSE;2266;cardiac medications during index hospitalization
 366;antihyperglycemic medications;"C0013227;C0020616;C0802604;C2598133;C4284232";FALSE;  33;antihyperglycemic medications
 359;current xanthine derivative use;"C0042153;C0043314;C0043318;C0457083;C0521116;C1527240;C1705970;C1947944";NA;NA;current xanthine derivative use
 358;fasting indices;"C0015663;C4033634";NA;NA;fasting indices
 358;fasting;C0015663;NA;NA;fasting
 358;fastest third;"C0015663;C0205437;C0456962;C2985769";NA;NA;fastest third
 358;elevated fasting glucose;"C0015663;C0017725;C0205250;C3163633";NA;NA;elevated fasting glucose
 357;multi - racial;"C0034510;C0439064;C1706779;C3266262;C3669213;C3853635";NA;NA;multi racial
 357;glacial $nmbr$;NA;NA;NA;glacial $nmbr$
 357;brachial;C0445456;NA;NA;brachial
 356;radial access — no . / total no . ( % );"C0439175;C0439810;C0442038;C0444454;C0920847;C1554204";NA;NA;radial access no total no
 356;radial access site;"C0442038;C0589360;C0920847";NA;NA;radial access site
 356;radial access;"C0442038;C0444454;C0920847;C1554204";NA;NA;radial access
 354;placebo * ( add on to basal insulin );"C0032042;C0650607;C1696465;C1706408;C1883712";NA;NA;placebo add on to basal insulin
 354;faster aspart   +   basal;"C0015663;C0123677;C0205112;C0456962;C2985769";NA;NA;faster aspart basal
 354;basal insulin doset;C0650607;NA;NA;basal insulin doset
 354;basal insulin dose at run - in ( u / day );"C0178602;C0205112;C0366513;C0456683;C0650607;C0869039;C1114758;C3274438";NA;NA;basal insulin dose at run in u day
 354;basal insulin analogue dose * ( coefficient;"C0178602;C0205112;C0243071;C0366513;C0650607;C0869039;C1114758;C1707429;C2825028";NA;NA;basal insulin analogue dose coefficient
 354;basal insulin analogue : insulin;"C0205112;C0243071;C0650607;C2825028";NA;NA;basal insulin analogue insulin
 354;basal insulin;C0650607;NA;NA;basal insulin
 353;no nasal polyps;C0027430;NA;NA;no nasal polyps
 353;nasal polyps at baseline : yes;"C0027430;C0168634;C1442488;C1549445;C1705108;C1710701";NA;NA;nasal polyps at baseline yes
 353;nasal polyps  n ( % );C0027430;NA;NA;nasal polyps n
 353;nasal polyps;C0027430;NA;NA;nasal polyps
 353;nasal polyposis or chronic rhinosinusitis — no . { % );"C0027430;C0149516";NA;NA;nasal polyposis or chronic rhinosinusitis no
 353;either ocs use  nasal polyps  pre - bd fvc < $nmbr$ % of predicted or age at diagnosis sl $nmbr$ years;"C0005126;C0027430;C0042153;C0332152;C0439234;C0457083;C0681842;C0740175;C1828181;C1882327;C1947944;C2257086;C2344255;C3173302;C3669034;C3714541;C3844638;C4050145";NA;NA;either ocs use nasal polyps pre bd fvc $nmbr$ of predicted or age at diagnosis sl $nmbr$ years
 352;medial - distal - diag;"C0205098;C0205108;C0348026;C4522154";NA;NA;medial distal diag
 352;distal;"C0205108;C4522154";NA;NA;distal
 351;septal anomaly — no . ( % );"C0332447;C0442004;C1704258";NA;NA;septal anomaly no
 351;e / e ' ( septal );C0442004;NA;NA;e e septal
 350;mental status ( baseline spmsq scores )  n ( % );"C0168634;C0278060;C0369718;C0441922;C0449820;C1442488;C4050231";NA;NA;mental status baseline spmsq scores n
 350;mental status;C0278060;NA;NA;mental status
 350;mental component summary;"C0229992;C0449432;C1552616;C1705248;C1706244";NA;NA;mental component summary
 350;mental component score ( mcs );"C0229992;C0449432;C0449820;C1705248;C4050231";NA;NA;mental component score mcs
 350;mental component;"C0229992;C0449432;C1705248";NA;NA;mental component
 350;mental;C0229992;NA;NA;mental
 350;mensa;NA;NA;NA;mensa
 349;dermal;"C0221928;C1522447";NA;NA;dermal
 349;dental procedure;C0011331;NA;NA;dental procedure
 348;bare metal stent  n ( % );C2825200;NA;NA;bare metal stent n
 348;bare metal stent;C2825200;NA;NA;bare metal stent
 348;bare metal;C0025552;NA;NA;bare metal
 348;bare - metal stent — no . ( % );C2825200;NA;NA;bare metal stent no
 348;bare - metal stent;C2825200;NA;NA;bare metal stent
 348;bare - metal;C0025552;NA;NA;bare metal
 348;all bare metal stents;C2825200;NA;NA;all bare metal stents
 347;≥ $nmbr$ . $nmbr$ % and < $nmbr$ . $nmbr$ %;NA;NA;NA;$nmbr$ $nmbr$ and $nmbr$ $nmbr$
 347;seronegative ( rf - ve and acpa - ve ) subgroup;"C0035448;C0042469;C0201660;C0521144;C0748398;C1079230;C1515021;C1525410;C1547111;C1706063;C3714652;C4321495";NA;NA;seronegative rf ve and acpa ve subgroup
 347;dopa and dopa derivativese;C0013023;NA;NA;dopa and dopa derivativese
 346;propionic acid derivatives;"C0033482;C0695274;C3540752";NA;NA;propionic acid derivatives
 346;ethacrynic acid;C0014963;NA;NA;ethacrynic acid
 346;ampd $nmbr$;NA;NA;NA;ampd $nmbr$
 346;acid;"C0001128;C0202406";NA;NA;acid
 345;hazard ratiof ( $nmbr$ % ci );"C0008107;C0598697;C3259781";NA;NA;hazard ratiof $nmbr$ ci
 345;hazard ratiof;C0598697;NA;NA;hazard ratiof
 345;hazard interaction;"C0598697;C1704675";NA;NA;hazard interaction
 345;hazard inleraction;C0598697;NA;NA;hazard inleraction
 345;hazard;C0598697;NA;NA;hazard
 344;other ascvd  no . ( % );C3665365;NA;NA;other ascvd no
 344;other ascvd;C3665365;NA;NA;other ascvd
 344;oascvd;NA;NA;NA;oascvd
 344;no ascvd;C3665365;NA;NA;no ascvd
 344;ascvd no prior ml;"C0332152;C0439526;C1705224;C2826257;C3665365;C3887665";NA;NA;ascvd no prior ml
 344;ascvd including tia;"C0007787;C0332257;C0917805;C1054154;C3665365";NA;NA;ascvd including tia
 344;ascvd as per protocol;"C1698058;C3665365";NA;NA;ascvd as per protocol
 344;ascvd * . n ( % );C3665365;NA;NA;ascvd n
 342;sustained esrd  death due to kidney failure  or sustained decrease of > $nmbr$ % in egfr from baseline;"C0011065;C0022661;C0035078;C0168634;C0392756;C0443318;C0547047;C0678226;C1306577;C1442488;C1739039;C2316810;C3811844;C3812682;C4082313;C4552775";NA;NA;sustained esrd death due to kidney failure or sustained decrease of $nmbr$ in egfr from baseline
 342;or esrd;"C0022661;C0035078;C2316810";NA;NA;or esrd
 342;esrd or death;"C0011065;C0022661;C0035078;C1306577;C2316810;C4082313;C4552775";NA;NA;esrd or death
 342;esrd on losartan ( % );"C0022661;C0035078;C0126174;C2316810";NA;NA;esrd on losartan
 342;esrd *;"C0022661;C0035078;C2316810";NA;NA;esrd
 342;esrd ';"C0022661;C0035078;C2316810";NA;NA;esrd
 352;distal anastomosis ( % );C0448964;FALSE;1845;distal anastomosis
 354;basal;C0205112;FALSE; -10;basal
 355;familial;"C0015576;C0241888";FALSE; -10;familial
 358;fasting glucose;"C0015663;C0017725";FALSE;1846;fasting glucose
 358;fasting glucose *;"C0015663;C0017725";FALSE;1846;fasting glucose
 358;impaired fasting glucosex;"C0015663;C0221099";FALSE;1846;impaired fasting glucosex
 358;normai fasting giucose levei ( n = $nmbr$ );C0015663;FALSE;1846;normai fasting giucose levei n $nmbr$
 358;fasting lipid levels  mmol / l;"C0015663;C0428460;C1532563";FALSE;1847;fasting lipid levels mmol l
 358;fasting lipids ( mmol / $nmbr$ );"C0015663;C0023779;C0439190";FALSE;1847;fasting lipids mmol $nmbr$
 358;fasting plasma insulin — mu / liter;"C0015663;C0028971;C0347978;C0475211;C0857690;C3714918";FALSE; 157;fasting plasma insulin mu liter
 358;faster aspart;"C0015663;C0123677;C0456962;C2985769";FALSE; 157;faster aspart
 358;faster aspart ( mealtime );"C0015663;C0123677;C0456962;C0587119;C2985769";FALSE; 157;faster aspart mealtime
 342;end - stage renal disease;"C0022661;C2316810";NA;NA;end stage renal disease
 342;composite of $nmbr$ % reduction in egfr  end - stage kidney disease  or death from renal causes;"C0007465;C0022646;C0022661;C0205199;C0301630;C0392756;C1293152;C1547335;C1739039;C2316810;C3811844;C3812682;C4551656";NA;NA;composite of $nmbr$ reduction in egfr end stage kidney disease or death from renal causes
 341;gastroduodenum;C0391900;NA;NA;gastroduodenum
 341;gastroduodenal;C0450199;NA;NA;gastroduodenal
 340;women taking estrogen;"C0014939;C0043210;C1515187;C2936882;C4542544";NA;NA;women taking estrogen
 340;no estrogen;"C0014939;C2936882;C4542544";NA;NA;no estrogen
 340;estrogens;"C0014939;C3537250;C3541386;C3714615";NA;NA;estrogens
 340;estrogen supplementation -;"C0014939;C0242297;C2936882;C4542544";NA;NA;estrogen supplementation
 340;estrogen supplementation;"C0014939;C0242297;C2936882;C4542544";NA;NA;estrogen supplementation
 340;estrogen ( ' % ? );"C0014939;C2936882;C4542544";NA;NA;estrogen
 340;estrogen;"C0014939;C2936882;C4542544";NA;NA;estrogen
 339;us site of enrollment;"C1516879;C1696073;C2945843;C3888021";NA;NA;us site of enrollment
 339;time from symptom onset to enrollment;"C0040223;C0449244;C1457887;C1516879;C1696073;C3541383;C3854129;C3888021;C4086878";NA;NA;time from symptom onset to enrollment
 339;time from hospital admission to enrollment;"C0019994;C0040223;C1510665;C1516879;C1696073;C1959907;C3541383;C3888021";NA;NA;time from hospital admission to enrollment
 339;thienopyridine at enrollment;"C1120149;C1516879;C1696073;C3888021";NA;NA;thienopyridine at enrollment
 339;symptom onset to enrollment;"C1516879;C1696073;C3888021;C4086878";NA;NA;symptom onset to enrollment
 339;primary enrollment diagnoses  n ( % );"C0332137;C0801658;C1516879;C1696073;C3888021";NA;NA;primary enrollment diagnoses n
 339;pre - enrollment antihyperglycemic therapy;"C0020616;C1516879;C1696073;C1882440;C3888021";NA;NA;pre enrollment antihyperglycemic therapy
 339;other medications at enrollment;"C0013227;C0802604;C1516879;C1696073;C2598133;C3888021;C4284232";NA;NA;other medications at enrollment
 339;medications at enrolment;"C0013227;C0802604;C1516879;C1696073;C2598133;C3888021;C4284232";NA;NA;medications at enrolment
 339;medications at enrollment  n ( % ) :;"C0013227;C0802604;C1516879;C1696073;C2598133;C3888021;C4284232";NA;NA;medications at enrollment n
 339;medication at enrollment — no . ( % );"C0013227;C1516879;C1696073;C3244316;C3888021;C4284232";NA;NA;medication at enrollment no
 339;medication after enrolment;"C0013227;C1516879;C1696073;C3244316;C3888021;C4284232";NA;NA;medication after enrolment
 339;hospitalization to enrollment;"C0019993;C1516879;C1696073;C3888021";NA;NA;hospitalization to enrollment
 339;enrollment to randomization;"C0034656;C1516879;C1696073;C3888021";NA;NA;enrollment to randomization
 339;enrollment in lmwh substudy;"C0019139;C1516879;C1696073;C3536766;C3888021";NA;NA;enrollment in lmwh substudy
 339;enrollment in lmwh;"C0019139;C1516879;C1696073;C3536766;C3888021";NA;NA;enrollment in lmwh
 339;ace inhibitor at enrollment;"C0003015;C1516879;C1696073;C3888021;C4541021";NA;NA;ace inhibitor at enrollment
 338;naproxen;C0027396;NA;NA;naproxen
 337;western europe / australia / israel;"C0004340;C0015176;C0022271;C0043128;C0043129";NA;NA;western europe australia israel
 337;western europe / australia;"C0004340;C0015176;C0043128;C0043129";NA;NA;western europe australia
 337;western europe  israel  australia  or south africa;"C0004340;C0015176;C0022271;C0037712;C0043128;C0043129";NA;NA;western europe israel australia or south africa
 337;w europe;C0015176;NA;NA;w europe
 337;w est europe;"C0015176;C3811127;C3890902";NA;NA;w est europe
 337;w . europe;C0015176;NA;NA;w europe
 337;region  europe;"C0015176;C0017446;C0205147";NA;NA;region europe
 337;non europe;"C0015176;C1518422";NA;NA;non europe
 337;geographic region - europe;"C0015176;C0017446";NA;NA;geographic region europe
 337;europe n z $nmbr$;C0015176;NA;NA;europe n z $nmbr$
 337;europe i;"C0015176;C0021966;C0221138";NA;NA;europe i
 337;europe and canada;"C0006823;C0015176";NA;NA;europe and canada
 337;europe and australia;"C0004340;C0015176";NA;NA;europe and australia
 337;europe / lsrael;C0015176;NA;NA;europe lsrael
 337;europe ( zone $nmbr$ );"C0015176;C1710706";NA;NA;europe zone $nmbr$
 337;europe ( plus south africa );"C0015176;C0037712;C0332287";NA;NA;europe plus south africa
 337;europe ( non - eu );"C0015176;C0015179;C1518422;C3665627";NA;NA;europe non eu
 337;europe ( including south africa );"C0015176;C0037712;C0332257";NA;NA;europe including south africa
 337;europe ( eu );"C0015176;C0015179;C3665627";NA;NA;europe eu
 337;europe $nmbr$ ¶;C0015176;NA;NA;europe $nmbr$
 337;europe $nmbr$ +;C0015176;NA;NA;europe $nmbr$
 337;europe $nmbr$ ( n = $nmbr$ );C0015176;NA;NA;europe $nmbr$ n $nmbr$
 337;europe $nmbr$ ( n = $nmbr$  $nmbr$ );C0015176;NA;NA;europe $nmbr$ n $nmbr$ $nmbr$
 337;europe $nmbr$;C0015176;NA;NA;europe $nmbr$
 337;europe  israel  or australia;"C0004340;C0015176;C0022271";NA;NA;europe israel or australia
 337;europe;C0015176;NA;NA;europe
 337;enrope + sonth afriea;NA;NA;NA;enrope sonth afriea
 337;east europe;"C0015176;C1707877";NA;NA;east europe
 337;e europe;C0015176;NA;NA;e europe
 337;e . europe;C0015176;NA;NA;e europe
 336;stroke or see;"C0038454;C0042789;C1947903;C4554100";NA;NA;stroke or see
 336;stroke / see;"C0038454;C0042789;C1947903;C4554100";NA;NA;stroke see
 336;stroke  see  or death;"C0011065;C0038454;C0042789;C1306577;C1947903;C4082313;C4552775;C4554100";NA;NA;stroke see or death
 336;stroke  see  or cv death;"C0011065;C0038454;C0042789;C1306577;C1947903;C3538987;C4048877;C4082313;C4318503;C4552775;C4554100";NA;NA;stroke see or cv death
 336;old stroke *;C1536121;NA;NA;old stroke
 336;ischemic stroke or see;"C0042789;C0948008;C1947903";NA;NA;ischemic stroke or see
 336;cvd / stroke / see;"C0007222;C0038454;C0042789;C1947903;C4554100";NA;NA;cvd stroke see
 335;unprovoked;NA;NA;NA;unprovoked
 335;provoked;C1444748;NA;NA;provoked
 334;nt - probnp values were reported in $nmbr$ of $nmbr$ patients enrolled in this stratum;"C0042295;C0588446;C0669479;C0754710;C4684790";NA;NA;nt probnp values were reported in $nmbr$ of $nmbr$ patients enrolled in this stratum
 334;enrolled into osler;C4684790;NA;NA;enrolled into osler
 332;uncontrolled on basal insulin;"C0205318;C0650607";NA;NA;uncontrolled on basal insulin
 332;uncontrolled;C0205318;NA;NA;uncontrolled
 331;western europe  australia  new zealand  middle eai;"C0043129;C0444598;C0549183;C1552826;C4289954";NA;NA;western europe australia new zealand middle eai
 331;tertile $nmbr$ : $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ );NA;NA;NA;tertile $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 331;tertile $nmbr$ ( n = $nmbr$ );NA;NA;NA;tertile $nmbr$ n $nmbr$
 331;middle third;C0442050;NA;NA;middle third
 331;middle tertile : > $nmbr$ . $nmbr$ to b $nmbr$ . $nmbr$;"C0444598;C0549183;C1552826";NA;NA;middle tertile $nmbr$ $nmbr$ to b $nmbr$ $nmbr$
 331;middle tertile ( range  $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ mg / dl  mean ± sd  $nmbr$ . $nmbr$ ± $nmbr$ . $nmbr$ mg / dl );"C0024671;C0026410;C0439269;C0444504;C0444598;C0549183;C1514721;C1552826;C1960952;C2346927;C2347634;C2348143;C2348147;C2699239;C3539687;C3542016;C4321396;C4521761";NA;NA;middle tertile range $nmbr$ $nmbr$ $nmbr$ $nmbr$ mg dl mean sd $nmbr$ $nmbr$ $nmbr$ $nmbr$ mg dl
 331;middle;"C0444598;C0549183;C1552826";NA;NA;middle
 331;$nmbr$ mgrdl;NA;NA;NA;$nmbr$ mgrdl
 338;ibuprofen;C0020740;FALSE;1844;ibuprofen
 339;statin at enrollment;"C0360714;C1516879;C1696073;C3888021";FALSE; 872;statin at enrollment
 339;loop at enrollment;"C0445022;C1516879;C1696073;C3888021";FALSE; 991;loop at enrollment
 335;unprovoked vte n ( % );C0630906;FALSE;2386;unprovoked vte n
 330;multiple tnfi and other bdmards §;C0439064;NA;NA;multiple tnfi and other bdmards
 330;multiple tnfi *;C0439064;NA;NA;multiple tnfi
 330;multiple diagnoses;"C0011900;C0439064";NA;NA;multiple diagnoses
 330;multiple;C0439064;NA;NA;multiple
 329;renal function  normal - mild;"C0205307;C0231683;C0232804;C0439166;C2347086;C2945599;C4553972";NA;NA;renal function normal mild
 329;normalfunction or mild impairment;"C0221099;C0684336;C2945599";NA;NA;normalfunction or mild impairment
 329;normal or mild ( iief - ef $nmbr$ - $nmbr$ )  n ( % );"C0205307;C0231683;C0439166;C2347086;C2945599;C3641331;C4553972";NA;NA;normal or mild iief ef $nmbr$ $nmbr$ n
 329;normal function or mild impairment;"C0221099;C0684336;C2945599;C4296962";NA;NA;normal function or mild impairment
 329;normal / mild ckd;"C0205307;C0231683;C0439166;C1561643;C2347086;C2945599;C4553972";NA;NA;normal mild ckd
 329;mildly impaired;"C0221099;C0750532;C2945599";NA;NA;mildly impaired
 329;mild teaes;C2945599;NA;NA;mild teaes
 329;mild impairment ( £ $nmbr$ to;"C0221099;C0684336;C2945599";NA;NA;mild impairment $nmbr$ to
 329;mild impairment ( egfr $nmbr$ – $nmbr$ )  n ( % );"C0221099;C0684336;C1739039;C2945599;C3811844;C3812682";NA;NA;mild impairment egfr $nmbr$ $nmbr$ n
 329;mild impairment ( egfr $nmbr$ - $nmbr$ ml / min / m ^ );"C0221099;C0369637;C0439445;C0441923;C0684336;C1739039;C2945599;C3811844;C3812682";NA;NA;mild impairment egfr $nmbr$ $nmbr$ ml min m
 329;mild impairment ( egfr $nmbr$ - $nmbr$ );"C0221099;C0684336;C1739039;C2945599;C3811844;C3812682";NA;NA;mild impairment egfr $nmbr$ $nmbr$
 329;mild impairment ( $nmbr$ to < $nmbr$ );"C0221099;C0684336;C2945599";NA;NA;mild impairment $nmbr$ to $nmbr$
 329;mild impairment ( $nmbr$ to $nmbr$ ml / min );"C0221099;C0439445;C0684336;C2945599";NA;NA;mild impairment $nmbr$ to $nmbr$ ml min
 329;mild impairment  < $nmbr$ to < $nmbr$;"C0221099;C0684336;C2945599";NA;NA;mild impairment $nmbr$ to $nmbr$
 329;mild impairment;"C0221099;C0684336;C2945599";NA;NA;mild impairment
 329;mild ed severe ed;"C0205082;C2945599;C3538926;C4050465;C4050466";NA;NA;mild ed severe ed
 329;mild ed;"C2945599;C3538926";NA;NA;mild ed
 329;mild ( n = $nmbr$ );C2945599;NA;NA;mild n $nmbr$
 329;mild ( n $nmbr$ = $nmbr$ ) $nmbr$;C2945599;NA;NA;mild n $nmbr$ $nmbr$ $nmbr$
 329;mild ( iief - ef $nmbr$ - $nmbr$ );"C2945599;C3641331";NA;NA;mild iief ef $nmbr$ $nmbr$
 329;mild ( gold $nmbr$ );"C0018026;C1304897;C2945599";NA;NA;mild gold $nmbr$
 329;mild ( > $nmbr$ to < $nmbr$ );C2945599;NA;NA;mild $nmbr$ to $nmbr$
 329;mild ( < $nmbr$ );C2945599;NA;NA;mild $nmbr$
 329;mild ( $nmbr$ - $nmbr$ );C2945599;NA;NA;mild $nmbr$ $nmbr$
 329;mild;C2945599;NA;NA;mild
 329;< mild;C2945599;NA;NA;mild
 329;$nmbr$ - $nmbr$ ( mild );C2945599;NA;NA;$nmbr$ $nmbr$ mild
 328;sustained mucosal healingc n / n ( % );"C0026724;C0443318";NA;NA;sustained mucosal healingc n n
 328;sustained mucosal healingc;"C0026724;C0443318";NA;NA;sustained mucosal healingc
 328;mucosal healingf;C0026724;NA;NA;mucosal healingf
 328;mucosal healingc n / n ( % );C0026724;NA;NA;mucosal healingc n n
 327;complete ulcer healing at week $nmbr$;"C0205197;C0332174;C0333293;C0439230;C0725685;C3853530;C4283785";NA;NA;complete ulcer healing at week $nmbr$
 327;complete healinga;"C0205197;C0725685;C3853530;C4283785";NA;NA;complete healinga
 326;health assessment questionnaire score;C2960025;NA;NA;health assessment questionnaire score
 325;self - rated health status;"C0018759;C0036588;C0871208;C1551994";NA;NA;self rated health status
 325;mental health;C0025353;NA;NA;mental health
 325;health practices;"C0018684;C0237607;C3245512";NA;NA;health practices
 325;general health ( self - reported );"C0424575;C0681906;C2700446;C4018875";NA;NA;general health self reported
 325;general health  self - reported;"C0424575;C0681906;C2700446;C4018875";NA;NA;general health self reported
 325;general health;"C0424575;C4018875";NA;NA;general health
 325;$nmbr$ mentis;NA;NA;NA;$nmbr$ mentis
 324;early death;C1836407;NA;NA;early death
 323;vascular death;"C0005847;C0011065;C1306577;C1558950;C1801960;C4082313;C4552775";NA;NA;vascular death
 323;stroke deaths;"C0011065;C0038454;C1306577;C4554100";NA;NA;stroke deaths
 323;s / se  mb or death;"C0011065;C0024853;C0036919;C0565930;C1306577;C2603362;C4082313;C4552775";NA;NA;s se mb or death
 323;patients with pneumonia resulting in death  n ( % );"C0011065;C0030705;C0032285;C0332294;C1306577;C4082313;C4552775";NA;NA;patients with pneumonia resulting in death n
 323;or death;"C0011065;C1306577;C4082313;C4552775";NA;NA;or death
 323;noncardiac death;"C0011065;C1306577;C4082313;C4552775";NA;NA;noncardiac death
 323;non - cvd deaths;"C0007222;C0011065;C1306577;C1518422";NA;NA;non cvd deaths
 323;no . of deaths;"C0011065;C1306577";NA;NA;no of deaths
 323;net clinical benefit : cv death  mi  stroke  gusto moderate / severe bleeding;"C0011065;C0019080;C0038454;C0205081;C0205082;C1306577;C1456447;C1881878;C3538987;C3810814;C3853572;C3887809;C3890893;C4048877;C4049705;C4049706;C4050465;C4050466;C4082313;C4085643;C4318503;C4321335;C4552775;C4554100;C4684590";NA;NA;net clinical benefit cv death mi stroke gusto moderate severe bleeding
 323;malignancy death;"C0006826;C0011065;C1306459;C1306577;C4082313;C4282132;C4552775";NA;NA;malignancy death
 323;macce ( death  mi  stroke );"C0011065;C0038454;C1306577;C3810814;C4082313;C4552775;C4554100";NA;NA;macce death mi stroke
 323;leading to death;"C0011065;C0332152;C1306577;C1522538;C4082313;C4552775";NA;NA;leading to death
 323;hf hospitalization or cardiovascular death;"C0007226;C0011065;C0018488;C0019993;C1306577;C1313497;C1538440;C3273279;C3887460;C4082313;C4552775";NA;NA;hf hospitalization or cardiovascular death
 323;hazard ratio for cardiovascular death;"C0007226;C0011065;C1306577;C2985465;C3887460;C4082313;C4552775";NA;NA;hazard ratio for cardiovascular death
 323;exploratory cardiovascular and death outcomes;"C0007226;C0011065;C1274040;C1306577;C3887460;C4082313;C4552775";NA;NA;exploratory cardiovascular and death outcomes
 323;drug discontinuation not due to death;"C0011065;C0013227;C0457454;C0678226;C1254351;C1306577;C1444662;C1518422;C4082313;C4552775;C4552847";NA;NA;drug discontinuation not due to death
 323;death or myocardial infarction;"C0011065;C0027051;C0428953;C1306577;C2926063;C3810814;C4082313;C4552775;C4552959";NA;NA;death or myocardial infarction
 323;death or mi at $nmbr$ days;"C0011065;C0439228;C1306577;C3810814;C4082313;C4552775";NA;NA;death or mi at $nmbr$ days
 323;death or ich;"C0011065;C0019191;C1306577;C3272597;C3281105;C4082313;C4552775";NA;NA;death or ich
 323;death from;"C0011065;C1306577;C4082313;C4552775";NA;NA;death from
 323;cvd deaths;"C0007222;C0011065;C1306577";NA;NA;cvd deaths
 207;£ l $nmbr$ kg;C1637390;NA;NA;l $nmbr$ kg
 323;death;"C0011065;C1306577;C4082313;C4552775";FALSE;1855;death
 323;death  n ( % );"C0011065;C1306577;C4082313;C4552775";FALSE;1855;death n
 323;deaths  n ( % );"C0011065;C1306577";FALSE;1855;deaths n
 324;sudden death;"C0011071;C1964022;C4554103";FALSE;2401;sudden death
 326;headache;"C0018681;C4553197";FALSE;2402;headache
 326;health habits;C0679786;FALSE;2403;health habits
 323;cvd death;"C0007222;C0011065;C1306577;C4082313;C4552775";NA;NA;cvd death
 323;cv death or ml;"C0011065;C0439526;C1306577;C1705224;C3538987;C3887665;C4048877;C4082313;C4318503;C4552775";NA;NA;cv death or ml
 323;cv death or hhf;"C0011065;C1306577;C3538987;C4048877;C4082313;C4318503;C4552775";NA;NA;cv death or hhf
 323;cv death or hf hospitalization n;"C0011065;C0018488;C0019993;C1306577;C1313497;C1538440;C3273279;C3538987;C4048877;C4082313;C4318503;C4552775";NA;NA;cv death or hf hospitalization n
 323;cv death or hf hosp .;"C0011065;C0018488;C1306577;C1313497;C1538440;C3273279;C3538987;C4048877;C4082313;C4318503;C4552775";NA;NA;cv death or hf hosp
 323;cv death n;"C0011065;C1306577;C3538987;C4048877;C4082313;C4318503;C4552775";NA;NA;cv death n
 323;cv death / mi / stroke;"C0011065;C0038454;C1306577;C3538987;C3810814;C4048877;C4082313;C4318503;C4552775;C4554100";NA;NA;cv death mi stroke
 323;cv death / hf hospitalization;"C0011065;C0018488;C0019993;C1306577;C1313497;C1538440;C3273279;C3538987;C4048877;C4082313;C4318503;C4552775";NA;NA;cv death hf hospitalization
 323;cv death + hf hospitalization;"C0011065;C0018488;C0019993;C1306577;C1313497;C1538440;C3273279;C3538987;C4048877;C4082313;C4318503;C4552775";NA;NA;cv death hf hospitalization
 323;cv death  myocardial infarction  stroke;"C0011065;C0027051;C0038454;C0428953;C1306577;C2926063;C3538987;C3810814;C4048877;C4082313;C4318503;C4552775;C4552959;C4554100";NA;NA;cv death myocardial infarction stroke
 323;cv death  ml or ischemic stroke;"C0011065;C0439526;C0948008;C1306577;C1705224;C3538987;C3887665;C4048877;C4082313;C4318503;C4552775";NA;NA;cv death ml or ischemic stroke
 323;cv death  ml  or stroke;"C0011065;C0038454;C0439526;C1306577;C1705224;C3538987;C3887665;C4048877;C4082313;C4318503;C4552775;C4554100";NA;NA;cv death ml or stroke
 323;cv death  ml  ischemic stroke  hospitalization for unstable angina  revascularization or heart failure;"C0002965;C0011065;C0018801;C0018802;C0019993;C0439526;C0581603;C0948008;C1306577;C1705224;C3538987;C3887665;C4048877;C4082313;C4318503;C4552775;C4554158";NA;NA;cv death ml ischemic stroke hospitalization for unstable angina revascularization or heart failure
 323;cv death  mi  stroke  recurrent ischemia;"C0011065;C0022116;C0038454;C1306577;C1455761;C2945760;C3538987;C3810814;C4048877;C4082313;C4318503;C4321499;C4552775;C4554100";NA;NA;cv death mi stroke recurrent ischemia
 323;cv death  mi  stroke  or urgent coronary revascularization;"C0011065;C0038454;C0439609;C0877341;C1306577;C3272275;C3538987;C3810814;C4048877;C4082313;C4318503;C4552775;C4554100";NA;NA;cv death mi stroke or urgent coronary revascularization
 323;cv death  mi  stroke;"C0011065;C0038454;C1306577;C3538987;C3810814;C4048877;C4082313;C4318503;C4552775;C4554100";NA;NA;cv death mi stroke
 323;cv death  mi  or stroke;"C0011065;C0038454;C1306577;C3538987;C3810814;C4048877;C4082313;C4318503;C4552775;C4554100";NA;NA;cv death mi or stroke
 323;cv death  mi  or ischemic stroke;"C0011065;C0948008;C1306577;C3538987;C3810814;C4048877;C4082313;C4318503;C4552775";NA;NA;cv death mi or ischemic stroke
 323;cv death  mi  ischemic stroke  hospitalization for hf  coronary revascularization  ua;"C0011065;C0018488;C0019993;C0041580;C0042014;C0376297;C0581603;C0877341;C0948008;C1306577;C1313497;C1538440;C3273279;C3538987;C3810814;C4048877;C4082313;C4318503;C4552775";NA;NA;cv death mi ischemic stroke hospitalization for hf coronary revascularization ua
 323;cv death  mi  ischemic stroke;"C0011065;C0948008;C1306577;C3538987;C3810814;C4048877;C4082313;C4318503;C4552775";NA;NA;cv death mi ischemic stroke
 323;cv death;"C0011065;C1306577;C3538987;C4048877;C4082313;C4318503;C4552775";NA;NA;cv death
 323;composite of death / mi / urg ent revasc;"C0011065;C0205199;C0378365;C0919420;C1306577;C1367721;C1547335;C1705448;C3810814;C3889152;C4082313;C4552775";NA;NA;composite of death mi urg ent revasc
 323;cardiovascular death ®;"C0007226;C0011065;C1306577;C3887460;C4082313;C4552775";NA;NA;cardiovascular death
 323;cardiovascular death or hospitalization for heart failure;"C0007226;C0011065;C1306577;C3887460;C3898876;C4082313;C4552775";NA;NA;cardiovascular death or hospitalization for heart failure
 323;cardiovascular death or heart failure hospitalization;"C0007226;C0011065;C1306577;C3887460;C3898876;C4082313;C4552775";NA;NA;cardiovascular death or heart failure hospitalization
 323;cardiovascular death and hospital admission for heart failure;"C0007226;C0011065;C0018801;C0018802;C0184666;C1306577;C3887460;C4082313;C4552775;C4554158";NA;NA;cardiovascular death and hospital admission for heart failure
 323;cardiovascular death / myocardial infarction / stroke;"C0011065;C0027051;C0428953;C1306577;C2926063;C3810814;C4082313;C4552775;C4552959";NA;NA;cardiovascular death myocardial infarction stroke
 323;cardiovascular death *;"C0007226;C0011065;C1306577;C3887460;C4082313;C4552775";NA;NA;cardiovascular death
 323;cardiovascular death ( n = $nmbr$ );"C0007226;C0011065;C1306577;C3887460;C4082313;C4552775";NA;NA;cardiovascular death n $nmbr$
 323;cardiovascular death !;"C0007226;C0011065;C1306577;C3887460;C4082313;C4552775";NA;NA;cardiovascular death
 323;cardiovascular death  nonfatal myocardial infarction  or nonfatal stroke;"C0007226;C0011065;C0027051;C0038454;C0428953;C1306577;C2926063;C3810814;C3887460;C4082313;C4552775;C4552959;C4554100";NA;NA;cardiovascular death nonfatal myocardial infarction or nonfatal stroke
 323;cardiovascular death  myocardial infarction  or stroke;"C0007226;C0011065;C0027051;C0038454;C0428953;C1306577;C2926063;C3810814;C3887460;C4082313;C4552775;C4552959;C4554100";NA;NA;cardiovascular death myocardial infarction or stroke
 323;cardiovascular death  mi  or stroke;"C0007226;C0011065;C0038454;C1306577;C3810814;C3887460;C4082313;C4552775;C4554100";NA;NA;cardiovascular death mi or stroke
 323;cardiovascular death;"C0007226;C0011065;C1306577;C3887460;C4082313;C4552775";NA;NA;cardiovascular death
 323;a cardiovascular death or hospitalization for heart failure;"C0007226;C0011065;C1306577;C3887460;C3898876;C4082313;C4552775";NA;NA;a cardiovascular death or hospitalization for heart failure
 322;severe / moderate;C1299393;NA;NA;severe moderate
 322;pfo with mild - to - moderate shunt and atrial septal aneurysm;"C0232180;C0521533;C0542331;C1299392;C1442858";NA;NA;pfo with mild to moderate shunt and atrial septal aneurysm
 322;moderate - to - severe copd exacerbation;"C0740304;C1299393";NA;NA;moderate to severe copd exacerbation
 322;mild to moderate;C1299392;NA;NA;mild to moderate
 322;mild - < moderate;C1299392;NA;NA;mild moderate
 322;gusto severe / moderate;C1299393;NA;NA;gusto severe moderate
 321;severe or moderate;"C0205081;C0205082;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335";NA;NA;severe or moderate
 321;renal function  moderate;"C0205081;C0232804;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;renal function moderate
 321;pedal edema  slight / moderate / marked;"C0205081;C0522501;C0574002;C1706089;C1881878;C2937276;C2945599;C4049705;C4049706;C4050469;C4085643;C4321335";NA;NA;pedal edema slight moderate marked
 321;patients with moderate - to - severe pain ( womac pain score  $nmbr$ - $nmbr$ );"C0030705;C0205081;C0205082;C0278140;C0449820;C0582148;C1881878;C4049705;C4049706;C4050231;C4050465;C4050466;C4085643;C4321335;C4521229";NA;NA;patients with moderate to severe pain womac pain score $nmbr$ $nmbr$
 321;moderatez;NA;NA;NA;moderatez
 321;moderatey;NA;NA;NA;moderatey
 321;moderately impaired;"C0205081;C0221099;C1881878;C4085643;C4321491";NA;NA;moderately impaired
 321;moderate ’;"C0205081;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate
 321;moderate trs : $nmbr$ - $nmbr$ ( n = $nmbr$  $nmbr$ );"C0205081;C0266427;C0968917;C1150746;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate trs $nmbr$ $nmbr$ n $nmbr$ $nmbr$
 321;moderate teaes;"C0205081;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate teaes
 321;moderate severity;"C0205081;C0439793;C0522510;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate severity
 317;delayed - start group ( n = $nmbr$ );"C0205421;C0439659;C0441848;C1545665;C3272602";NA;NA;delayed start group n $nmbr$
 321;moderate severe ( n = $nmbr$ ) ( n = $nmbr$ );"C0205081;C0205082;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335";NA;NA;moderate severe n $nmbr$ n $nmbr$
 321;moderate risk ( $nmbr$ - $nmbr$ );"C0035647;C0205081;C1881878;C4049705;C4049706;C4085643;C4321335;C4552904";NA;NA;moderate risk $nmbr$ $nmbr$
 321;moderate risk;"C0035647;C0205081;C1881878;C4049705;C4049706;C4085643;C4321335;C4552904";NA;NA;moderate risk
 321;moderate or severe impairment;"C0205081;C0205082;C0221099;C0684336;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335";NA;NA;moderate or severe impairment
 321;moderate or severe copd exacerbations;"C0205081;C0205082;C0740304;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335";NA;NA;moderate or severe copd exacerbations
 321;moderate or less airflow limitation;"C0205081;C0231999;C0439092;C0443288;C0449295;C0547044;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate or less airflow limitation
 321;moderate n z $nmbr$;"C0205081;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate n z $nmbr$
 321;moderate impairment ( $nmbr$ to < $nmbr$ );"C0205081;C0221099;C0684336;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate impairment $nmbr$ to $nmbr$
 321;moderate impairment ( $nmbr$ to $nmbr$ ml / min );"C0205081;C0221099;C0439445;C0684336;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate impairment $nmbr$ to $nmbr$ ml min
 321;moderate impairment  < $nmbr$ to < $nmbr$;"C0205081;C0221099;C0684336;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate impairment $nmbr$ to $nmbr$
 321;moderate impairment;"C0205081;C0221099;C0684336;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate impairment
 321;moderate disease activity : > $nmbr$ . $nmbr$ to < $nmbr$ . $nmbr$  n ( % );"C0012634;C0205081;C1292728;C1513375;C1881878;C3833417;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate disease activity $nmbr$ $nmbr$ to $nmbr$ $nmbr$ n
 321;moderate disease;"C0012634;C0205081;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate disease
 321;moderate copdb [ n z $nmbr$ ];"C0205081;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate copdb n z $nmbr$
 321;moderate copd;"C0024117;C0205081;C1412502;C1881878;C3714496;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate copd
 321;moderate chronic kidney disease;"C0205081;C1561643;C1881878;C4049705;C4049706;C4085643;C4321335;C4553188";NA;NA;moderate chronic kidney disease
 321;moderate - to -;"C0040363;C0041260;C0205081;C1881878;C1883351;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate to
 321;moderate - < severe;"C0205081;C0205082;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335";NA;NA;moderate severe
 321;moderate ( s $nmbr$ % . < $nmbr$ % );"C0205081;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate s $nmbr$ $nmbr$
 321;moderate ( n = $nmbr$ );"C0205081;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate n $nmbr$
 321;moderate ( n $nmbr$ = $nmbr$ );"C0205081;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate n $nmbr$ $nmbr$
 321;moderate ( iief - ef $nmbr$ - $nmbr$ )  n ( % );"C0205081;C1881878;C3641331;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate iief ef $nmbr$ $nmbr$ n
 321;moderate ( iief - ef $nmbr$ - $nmbr$ );"C0205081;C1881878;C3641331;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate iief ef $nmbr$ $nmbr$
 321;moderate ( > $nmbr$ to < $nmbr$ );"C0040363;C0041260;C0205081;C1881878;C1883351;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate $nmbr$ to $nmbr$
 321;moderate ( > $nmbr$ and < $nmbr$ );"C0205081;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate $nmbr$ and $nmbr$
 321;moderate ( > $nmbr$ % . < $nmbr$ % );"C0205081;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate $nmbr$ $nmbr$
 321;moderate ( $nmbr$ – $nmbr$ ml · min − $nmbr$ · $nmbr$ . $nmbr$ m − $nmbr$ )  n ( % );"C0205081;C0369637;C0439445;C0441923;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$ n
 321;moderate ( $nmbr$ risk factor );"C0035648;C0205081;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate $nmbr$ risk factor
 321;moderate ( $nmbr$ - $nmbr$ );"C0205081;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate $nmbr$ $nmbr$
 321;moderate ( $nmbr$ % < fev  < $nmbr$ % predicted );"C0205081;C0681842;C1881878;C1882327;C3714541;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate $nmbr$ fev $nmbr$ predicted
 321;moderate ( $nmbr$ % . < $nmbr$ % );"C0205081;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate $nmbr$ $nmbr$
 321;moderate  n ( % ) a;"C0205081;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate n a
 321;moderate;"C0205081;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate
 321;mild or moderate copd;"C0024117;C0205081;C1412502;C1881878;C2945599;C3714496;C4049705;C4049706;C4085643;C4321335";NA;NA;mild or moderate copd
 321;gusto moderate or severe bleeding;"C0019080;C0205081;C0205082;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335";NA;NA;gusto moderate or severe bleeding
 321;gusto moderate or severe;"C0205081;C0205082;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335";NA;NA;gusto moderate or severe
 321;gusto moderate;"C0205081;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;gusto moderate
 321;death  mi  idr  st  or gusto moderate / severe bleeding;"C0011065;C0019080;C0036056;C0205081;C0205082;C1306577;C1881878;C3272372;C3810814;C4049705;C4049706;C4050465;C4050466;C4082313;C4085643;C4321335;C4552775";NA;NA;death mi idr st or gusto moderate severe bleeding
 321;> $nmbr$ - $nmbr$ ( moderate risk );"C0035647;C0205081;C1881878;C4049705;C4049706;C4085643;C4321335;C4552904";NA;NA;$nmbr$ $nmbr$ moderate risk
 321;< $nmbr$ and no moderate or severe deformity ( n = $nmbr$ );"C0000768;C0205081;C0205082;C0221430;C0302142;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335";NA;NA;$nmbr$ and no moderate or severe deformity n $nmbr$
 321;$nmbr$ - $nmbr$ ( moderate );"C0205081;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;$nmbr$ $nmbr$ moderate
 321;$nmbr$ ( moderate disease );"C0012634;C0205081;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;$nmbr$ moderate disease
 320;renal disease );C0022658;NA;NA;renal disease
 320;renal disease;C0022658;NA;NA;renal disease
 320;previous renal disease  n ( % );"C0022658;C0205156;C1552607";NA;NA;previous renal disease n
 320;nephropathy;C0022658;NA;NA;nephropathy
 320;established renal disease *;"C0022658;C0443211;C1272684";NA;NA;established renal disease
 320;contrast nephropathy risk score;"C0009924;C0022658;C0035647;C0449820;C1979874;C4050231;C4552904";NA;NA;contrast nephropathy risk score
 320;albuminuria and previous maerovaseular disease without established renal disease;"C0001925;C0012634;C0022658;C0205156;C0443211;C1272684;C1552607";NA;NA;albuminuria and previous maerovaseular disease without established renal disease
 319;respiratory - related ^;"C0439849;C0445223;C0521346;C1546767";NA;NA;respiratory related
 319;ipf - related;"C0034069;C0439849;C0445223;C1800706";NA;NA;ipf related
 319;infarct - related vessel ( % );"C0005847;C0021308;C0439849;C0445223";NA;NA;infarct related vessel
 319;hospitalisation related to exacerbation  n ( % );"C0019993;C0439849;C0445223;C4086268";NA;NA;hospitalisation related to exacerbation n
 319;history of asthma - related intubation — no . ( % );"C0021925;C0439849;C0445223;C0455544";NA;NA;history of asthma related intubation no
 319;bph - related health status;"C0005001;C0018759;C0439849;C0445223;C1704272";NA;NA;bph related health status
 319;asthma - related health -;"C0004096;C0018684;C0439849;C0445223;C2984299";NA;NA;asthma related health
 318;vte / vte - related deathsb  n / n ( % );"C0439849;C0445223;C0630906";NA;NA;vte vte related deathsb n n
 318;vte / vte - related deathsa  n / n ( % );"C0439849;C0445223;C0630906";NA;NA;vte vte related deathsa n n
 318;any vte or vte - related death — no . ( % );"C0425043;C0630906";NA;NA;any vte or vte related death no
 318;any vte - related death;"C0425043;C0630906";NA;NA;any vte related death
 317;delighted;C3830544;NA;NA;delighted
 317;delayed reaction;"C0205421;C0443286;C1545665;C3272602";NA;NA;delayed reaction
 317;delayed eptifibatide;"C0205421;C0253563;C1545665;C3272602";NA;NA;delayed eptifibatide
 300;fatal and nonfatal ml;"C0439526;C1302234;C1705224;C1705232;C3887665";NA;NA;fatal and nonfatal ml
 317;delayed - eptifibatide group ( n = $nmbr$ );"C0205421;C0253563;C0441848;C1545665;C3272602";NA;NA;delayed eptifibatide group n $nmbr$
 317;delayed;"C0205421;C1545665;C3272602";NA;NA;delayed
 317;$nmbr$ mg / day early - start - delayed start;"C0205421;C0439422;C0439659;C1279919;C1545665;C3272602";NA;NA;$nmbr$ mg day early start delayed start
 317;$nmbr$ mg / day early - start - delayed - start;"C0205421;C0439422;C0439659;C1279919;C1545665;C3272602";NA;NA;$nmbr$ mg day early start delayed start
 317;$nmbr$ mg / day delayed - start;"C0205421;C0439422;C0439659;C1545665;C3272602";NA;NA;$nmbr$ mg day delayed start
 316;smoking ( ever );"C0037369;C0453996;C1881674";NA;NA;smoking ever
 316;never smoking;"C0037369;C0453996;C1881674;C2003901";NA;NA;never smoking
 316;never drink;"C0452428;C2003901";NA;NA;never drink
 316;never;C2003901;NA;NA;never
 316;ever;NA;NA;NA;ever
 315;vka naxve;NA;NA;NA;vka naxve
 315;vka naive  n ( % );NA;NA;NA;vka naive n
 315;vka naive;NA;NA;NA;vka naive
 315;uncover - $nmbr$;NA;NA;NA;uncover $nmbr$
 315;rarely / never;C4035880;NA;NA;rarely never
 315;never been on a vka;C2003901;NA;NA;never been on a vka
 315;ever been on a vka;NA;NA;NA;ever been on a vka
 314;triglyceride level;C0428475;NA;NA;triglyceride level
 314;doubling of creatinine level;"C0205173;C0428279;C1705764";NA;NA;doubling of creatinine level
 314;creatinine level;C0428279;NA;NA;creatinine level
 314;calcium level;"C0201925;C0428302";NA;NA;calcium level
 313;severely impaired;"C0205082;C0221099";NA;NA;severely impaired
 313;severe to end - stage impairment ( $nmbr$ ml / min );"C0205082;C0205088;C0221099;C0439445;C0684336;C4050465;C4050466";NA;NA;severe to end stage impairment $nmbr$ ml min
 313;severe teaes;"C0205082;C4050465;C4050466";NA;NA;severe teaes
 313;severe or worse airflow limitation;"C0205082;C0231999;C0332271;C0443288;C0449295;C1279889;C1457868;C4050465;C4050466";NA;NA;severe or worse airflow limitation
 313;severe oab subgroup;"C0205082;C1079230;C1515021;C4050465;C4050466";NA;NA;severe oab subgroup
 313;severe n z $nmbr$;"C0205082;C4050465;C4050466";NA;NA;severe n z $nmbr$
 313;severe impairment ( egfr < $nmbr$ ml / min / m ^ );"C0205082;C0221099;C0369637;C0439445;C0441923;C0684336;C1739039;C3811844;C3812682;C4050465;C4050466";NA;NA;severe impairment egfr $nmbr$ ml min m
 313;severe impairment ( egfr < $nmbr$ )  n ( % );"C0205082;C0221099;C0684336;C1739039;C3811844;C3812682;C4050465;C4050466";NA;NA;severe impairment egfr $nmbr$ n
 313;severe impairment ( egfr < $nmbr$ );"C0205082;C0221099;C0684336;C1739039;C3811844;C3812682;C4050465;C4050466";NA;NA;severe impairment egfr $nmbr$
 313;severe impairment ( < $nmbr$ );"C0205082;C0221099;C0684336;C4050465;C4050466";NA;NA;severe impairment $nmbr$
 313;severe hypoglycemia;"C0020615;C0205082;C4050465;C4050466;C4553659";NA;NA;severe hypoglycemia
 313;severe hyperkalemiac;"C0205082;C4050465;C4050466";NA;NA;severe hyperkalemiac
 313;severe hyperkalemia ‘ s;"C0020461;C0205082;C4050465;C4050466;C4552983";NA;NA;severe hyperkalemia s
 313;severe hyperkalemia ' s;"C0020461;C0205082;C4050465;C4050466;C4552983";NA;NA;severe hyperkalemia s
 313;severe exacerbations;"C0205082;C4050465;C4050466;C4086268";NA;NA;severe exacerbations
 313;severe ed;"C0205082;C3538926;C4050465;C4050466";NA;NA;severe ed
 313;severe copdc [ n z $nmbr$ ];"C0205082;C4050465;C4050466";NA;NA;severe copdc n z $nmbr$
 313;severe copd;"C0024117;C0205082;C1412502;C3714496;C4050465;C4050466";NA;NA;severe copd
 313;severe aes;"C0205082;C1412268;C2699274;C4050465;C4050466";NA;NA;severe aes
 313;severe / very severea;"C0205082;C0442824;C2984081;C4050465;C4050466";NA;NA;severe very severea
 313;severe / lite threatening;"C0205082;C4050465;C4050466";NA;NA;severe lite threatening
 313;severe / life ttireatening;"C0205082;C0376558;C4050465;C4050466";NA;NA;severe life ttireatening
 313;severe / life threatening;"C0205082;C1546953;C2826244;C3537125;C4050465;C4050466";NA;NA;severe life threatening
 313;severe - very severe;"C0205082;C0442824;C2984081;C4050465;C4050466";NA;NA;severe very severe
 313;severe ( n $nmbr$ = $nmbr$ );"C0205082;C4050465;C4050466";NA;NA;severe n $nmbr$ $nmbr$
 313;severe ( itt ) ( n = $nmbr$ );"C0205082;C4050465;C4050466";NA;NA;severe itt n $nmbr$
 313;severe ( iief - ef < $nmbr$ );"C0205082;C3641331;C4050465;C4050466";NA;NA;severe iief ef $nmbr$
 313;severe ( iief - ef $nmbr$ - $nmbr$ )  n ( % );"C0205082;C3641331;C4050465;C4050466";NA;NA;severe iief ef $nmbr$ $nmbr$ n
 313;severe ( > $nmbr$ );"C0205082;C4050465;C4050466";NA;NA;severe $nmbr$
 313;severe ( < $nmbr$ ml · min − $nmbr$ · $nmbr$ . $nmbr$ m − $nmbr$ )  n ( % );"C0205082;C0369637;C0439445;C0441923;C4050465;C4050466";NA;NA;severe $nmbr$ ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$ n
 313;severe  n ( % ) b;"C0205082;C4050465;C4050466";NA;NA;severe n b
 313;severe;"C0205082;C4050465;C4050466";NA;NA;severe
 313;risk of moderate / severe exacerbations;"C0205082;C0332166;C4050465;C4050466;C4086268";NA;NA;risk of moderate severe exacerbations
 313;renal function  severe;"C0205082;C0232804;C4050465;C4050466";NA;NA;renal function severe
 313;patients with glycated hemoglobin > $nmbr$ . $nmbr$ % and > $nmbr$ episode of severe hypoglycemia *;"C0017853;C0020615;C0030705;C0205082;C0332189;C4050465;C4050466;C4553659";NA;NA;patients with glycated hemoglobin $nmbr$ $nmbr$ and $nmbr$ episode of severe hypoglycemia
 313;patients with glycated hemoglobin < $nmbr$ . $nmbr$ % and no severe hypoglycemia or diabetic ketoacidosis;"C0011880;C0017853;C0020615;C0030705;C0205082;C4050465;C4050466;C4553659";NA;NA;patients with glycated hemoglobin $nmbr$ $nmbr$ and no severe hypoglycemia or diabetic ketoacidosis
 313;or severe;"C0205082;C4050465;C4050466";NA;NA;or severe
 313;no severe hypoglycemia;"C0020615;C0205082;C4050465;C4050466;C4553659";NA;NA;no severe hypoglycemia
 313;no . of moderate or severe exacerbations in previous;"C0205081;C0205082;C0205156;C1552607;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4086268;C4321335";NA;NA;no of moderate or severe exacerbations in previous
 313;more severe ^;"C0205082;C0205172;C4050465;C4050466";NA;NA;more severe
 313;more severe;"C0205082;C0205172;C4050465;C4050466";NA;NA;more severe
 313;moderate or severe decrease in gfr { < $nmbr$ ml / mln per $nmbr$ . $nmbr$ m ^ );"C0017654;C0205081;C0205082;C0369637;C0392756;C0439526;C0441923;C0547047;C1417190;C1424601;C1705224;C1881878;C3815103;C3887665;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335";NA;NA;moderate or severe decrease in gfr $nmbr$ ml mln per $nmbr$ $nmbr$ m
 313;moderate / severe exacerbations  patient subgroups  n ( % );"C0030705;C0205081;C0205082;C1079230;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4086268;C4321335";NA;NA;moderate severe exacerbations patient subgroups n
 313;moderate / severe exacerbation;"C0205081;C0205082;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4086268;C4321335";NA;NA;moderate severe exacerbation
 313;less severe $nmbr$;"C0205082;C0439092;C0547044;C4050465;C4050466";NA;NA;less severe $nmbr$
 313;less severe;"C0205082;C0439092;C0547044;C4050465;C4050466";NA;NA;less severe
 313;gusto severe or;"C0205082;C4050465;C4050466";NA;NA;gusto severe or
 313;gusto severe;"C0205082;C4050465;C4050466";NA;NA;gusto severe
 313;gusto moderate / severe bleeding;"C0019080;C0205081;C0205082;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335";NA;NA;gusto moderate severe bleeding
 313;gusto moderate / severe;"C0205081;C0205082;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335";NA;NA;gusto moderate severe
 313;grade $nmbr$ ( severe copd )  n ( % );"C0024117;C0205082;C0441800;C0919553;C1412502;C3244287;C3714496;C4050465;C4050466";NA;NA;grade $nmbr$ severe copd n
 313;first severe asthma exacerbation;"C0205082;C0205435;C0349790;C0581126;C1279901;C4050465;C4050466;C4086268";NA;NA;first severe asthma exacerbation
   7;genotype - by - treatment interaction p values *;"C0017431;C0039798;C0087111;C1522326;C1533734;C1704675;C1705169;C1709380;C3538994;C3887704";NA;NA;genotype by treatment interaction p values
 313;death / mi / idr / st / gusto - defined moderate or severe bleeding;"C0011065;C0019080;C0036056;C0205081;C0205082;C1306577;C1704788;C1881878;C3272372;C3539106;C3810814;C4049705;C4049706;C4050465;C4050466;C4082313;C4085643;C4321335;C4552775";NA;NA;death mi idr st gusto defined moderate or severe bleeding
 313;a severe hypoglycemia;"C0020615;C0205082;C4050465;C4050466;C4553659";NA;NA;a severe hypoglycemia
 313;$nmbr$ - $nmbr$ ( severe );"C0205082;C4050465;C4050466";NA;NA;$nmbr$ $nmbr$ severe
 312;type of vessel involved;"C1282017;C1314939";NA;NA;type of vessel involved
 312;nail involvement  %;"C0027342;C1314939;C1432728;C3538766";NA;NA;nail involvement
 312;involved gastrointestinal;"C0521362;C1314939";NA;NA;involved gastrointestinal
 312;gastrointestinal area involved  n / total n ( % );"C0017446;C0205146;C0369718;C0439175;C0439810;C0441922;C0521362;C1314939";NA;NA;gastrointestinal area involved n total n
 312;dip involvement  ! n ( % );"C1314939;C3539618";NA;NA;dip involvement n
 311;no . ( % ) of patients with ≥ $nmbr$ % bsa affected;"C0030705;C0392760;C1314939";NA;NA;no of patients with $nmbr$ bsa affected
 311;mean involved bsa  % ( $nmbr$ % ci );"C0008107;C0444504;C1314939;C2347634;C2348143;C3259781";NA;NA;mean involved bsa $nmbr$ ci
 311;bsa involved  % $nmbr$;C1314939;NA;NA;bsa involved $nmbr$
 311;bsa affected  mean ± sd  %;"C0392760;C0444504;C1314939;C2347634;C2348143;C2699239";NA;NA;bsa affected mean sd
 311;bsa affected  %;"C0392760;C1314939";NA;NA;bsa affected
 -10;ttf - fv;"C1332112;C1705840;C4087167";NA;NA;ttf fv
 309;op  vfx;NA;NA;NA;op vfx
 309;op  no vfx;NA;NA;NA;op no vfx
 309;no op  vfx;NA;NA;NA;no op vfx
 309;no op  no vfx;NA;NA;NA;no op no vfx
 309;and vfx status;C0449438;NA;NA;and vfx status
 309;> - $nmbr$ . $nmbr$ - vfx;NA;NA;NA;$nmbr$ $nmbr$ vfx
 309;> - $nmbr$ . $nmbr$ + vfx;NA;NA;NA;$nmbr$ $nmbr$ vfx
 309;< - $nmbr$ . $nmbr$ - vfx;NA;NA;NA;$nmbr$ $nmbr$ vfx
 309;< - $nmbr$ . $nmbr$ + vfx;NA;NA;NA;$nmbr$ $nmbr$ vfx
 308;— b - h —;"C0033727;C0369286;C0441932;C0564385;C4528284";NA;NA;b h
 308;within $nmbr$ h after;"C0033727;C0369286;C0441932;C0564385;C4528284";NA;NA;within $nmbr$ h after
 308;within $nmbr$ h;"C0033727;C0369286;C0441932;C0564385;C4528284";NA;NA;within $nmbr$ h
 308;use of h $nmbr$ bloekers  n ( % );"C0033727;C0369286;C0441932;C0564385;C1524063;C4528284";NA;NA;use of h $nmbr$ bloekers n
 308;urgency episodes / $nmbr$ h;"C0033727;C0332189;C0369286;C0439609;C0441932;C0564385;C4528284";NA;NA;urgency episodes $nmbr$ h
 308;time to randomization ( h );"C0033727;C0034656;C0040223;C0369286;C0441932;C0564385;C3541383;C4528284";NA;NA;time to randomization h
 308;time sample drawn ( h );"C0033727;C0040223;C0369286;C0370003;C0441932;C0564385;C2347026;C3541383;C4528284";NA;NA;time sample drawn h
 308;time from symptoms to randomization  h;"C0033727;C0034656;C0040223;C0369286;C0441932;C0564385;C0683368;C1457887;C3541383;C4528284";NA;NA;time from symptoms to randomization h
 308;time from onset to randomization  h  mean ± sd;"C0033727;C0034656;C0369286;C0441932;C0444504;C0449244;C0564385;C2347634;C2348143;C2699239;C4528284";NA;NA;time from onset to randomization h mean sd
 308;time from onset to medication  h  mean ± sd;"C0013227;C0033727;C0369286;C0441932;C0444504;C0449244;C0564385;C2347634;C2348143;C2699239;C3244316;C4284232;C4528284";NA;NA;time from onset to medication h mean sd
 308;symptom onset to pci  h;"C0033727;C0369286;C0441932;C0564385;C4049621;C4086878;C4528284";NA;NA;symptom onset to pci h
 308;ptca < $nmbr$ h;"C0033727;C0369286;C0441932;C0564385;C2936173;C4528284";NA;NA;ptca $nmbr$ h
 308;non - cabg related bleeding at $nmbr$ h;"C0010055;C0019080;C0033727;C0369286;C0439849;C0441932;C0445223;C0564385;C1518422;C4528284";NA;NA;non cabg related bleeding at $nmbr$ h
 308;nocturia episodes / $nmbr$ h;"C0028734;C0033727;C0332189;C0369286;C0441932;C0564385;C4528284";NA;NA;nocturia episodes $nmbr$ h
 308;migraine duration ( h );"C0033727;C0149931;C0369286;C0441932;C0449238;C0564385;C2926735;C4528284";NA;NA;migraine duration h
 308;micturitions / $nmbr$ h;"C0033727;C0042034;C0369286;C0441932;C0564385;C4528284";NA;NA;micturitions $nmbr$ h
 308;incontinence episodes / $nmbr$ h;"C0021167;C0033727;C0332189;C0369286;C0441932;C0564385;C4528284";NA;NA;incontinence episodes $nmbr$ h
 308;i - h;"C0021966;C0033727;C0221138;C0369286;C0441932;C0564385;C4528284";NA;NA;i h
 308;h;"C0033727;C0369286;C0441932;C0564385;C4528284";NA;NA;h
 308;fev auc i $nmbr$ h;"C0021966;C0033727;C0221138;C0369286;C0376690;C0441932;C0564385;C3714541;C4528284";NA;NA;fev auc i $nmbr$ h
 308;fev $nmbr$ auc $nmbr$ mine $nmbr$ h;"C0033727;C0369286;C0376690;C0441932;C0564385;C3714541;C4528284";NA;NA;fev $nmbr$ auc $nmbr$ mine $nmbr$ h
 308;duration of symptoms  h;"C0033727;C0369286;C0436359;C0441932;C0564385;C4528284";NA;NA;duration of symptoms h
 308;b + h ( n = $nmbr$ );"C0033727;C0369286;C0441932;C0564385;C4528284";NA;NA;b h n $nmbr$
 308;> = $nmbr$ h;"C0033727;C0369286;C0441932;C0564385;C4528284";NA;NA;$nmbr$ h
 308;> $nmbr$ to < $nmbr$ h  n ( % );"C0033727;C0369286;C0441932;C0564385;C4528284";NA;NA;$nmbr$ to $nmbr$ h n
 308;> $nmbr$ h  n ( % );"C0033727;C0369286;C0441932;C0564385;C4528284";NA;NA;$nmbr$ h n
 308;> $nmbr$ h;"C0033727;C0369286;C0441932;C0564385;C4528284";NA;NA;$nmbr$ h
 308;< $nmbr$ h  n ( % );"C0033727;C0369286;C0441932;C0564385;C4528284";NA;NA;$nmbr$ h n
 308;< $nmbr$ h;"C0033727;C0369286;C0441932;C0564385;C4528284";NA;NA;$nmbr$ h
 308;$nmbr$ — e - h;"C0033727;C0369286;C0441932;C0564385;C4528284";NA;NA;$nmbr$ e h
 308;$nmbr$ to < $nmbr$ h  n ( % );"C0033727;C0369286;C0441932;C0564385;C4528284";NA;NA;$nmbr$ to $nmbr$ h n
 308;$nmbr$ . $nmbr$ f $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ h;"C0016327;C0033727;C0369286;C0441932;C0564385;C4528284";NA;NA;$nmbr$ $nmbr$ f $nmbr$ $nmbr$ $nmbr$ $nmbr$ h
 308;$nmbr$ - $nmbr$ h;"C0033727;C0369286;C0441932;C0564385;C4528284";NA;NA;$nmbr$ $nmbr$ h
 307;〉 $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$  n ( % );"C0369637;C0439445;C0441923";NA;NA;$nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$ n
 307;≥ $nmbr$ to < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923";NA;NA;$nmbr$ to $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;≥ $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923";NA;NA;$nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;≥ $nmbr$ ml / min;C0439445;NA;NA;$nmbr$ ml min
 307;• ? sd ml / min;"C0439445;C2699239";NA;NA;sd ml min
 307;£ $nmbr$ ml / min;C0439445;NA;NA;$nmbr$ ml min
 307;s $nmbr$ ml / min;"C0439445;C0565930;C2603362";NA;NA;s $nmbr$ ml min
 307;renal function ( ml / min );"C0232804;C0439445";FALSE; 592;renal function ml min
 307;renal function < $nmbr$ egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0232804;C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;renal function $nmbr$ egfr ml min $nmbr$ $nmbr$ m $nmbr$
 307;stage $nmbr$ ckd egfr $nmbr$ to $nmbr$ ml / min ( n = $nmbr$ );"C0205390;C0439445;C1300072;C1306673;C1561643;C1739039;C3811844;C3812682";FALSE; 592;stage $nmbr$ ckd egfr $nmbr$ to $nmbr$ ml min n $nmbr$
 307;stage $nmbr$ : < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0439445;C0456533";FALSE; 592;stage $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;stage $nmbr$ : > $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0439445;C0456533";FALSE; 592;stage $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;stage $nmbr$ : $nmbr$ - $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0439445;C0456533";FALSE; 592;stage $nmbr$ $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;normal function ( crcl > $nmbr$ ml / min  n = $nmbr$ [ $nmbr$ . $nmbr$ % ] );"C0439445;C1846718;C4296962";NA;NA;normal function crcl $nmbr$ ml min n $nmbr$ $nmbr$ $nmbr$
 307;moderate or severe decrease in gfr ( < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ );"C0017654;C0205081;C0205082;C0369637;C0392756;C0439445;C0441923;C0547047;C1424601;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335";NA;NA;moderate or severe decrease in gfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;mildlydecreased baseline gfr ( $nmbr$ - $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ );"C0017654;C0168634;C0369637;C0439445;C0441923;C1424601;C1442488";NA;NA;mildlydecreased baseline gfr $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;mild or no dysfunction ( crcl > $nmbr$ ml / min  n = $nmbr$ $nmbr$  [ $nmbr$ . $nmbr$ % ] );"C0031847;C0277785;C0439445;C1846718;C2945599;C3887504;C3887505";NA;NA;mild or no dysfunction crcl $nmbr$ ml min n $nmbr$ $nmbr$ $nmbr$ $nmbr$
 307;mild dysfunction ( crcl > $nmbr$ - $nmbr$ ml / min  n = $nmbr$ [ $nmbr$ . $nmbr$ % ] );"C0439445;C1846718;C3274775";NA;NA;mild dysfunction crcl $nmbr$ $nmbr$ ml min n $nmbr$ $nmbr$ $nmbr$
 307;egfr ( ml / min );"C0439445;C1739039;C3811844;C3812682";FALSE; 592;egfr ml min
 307;mild decrease ( $nmbr$ - < $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$ );"C0369637;C0392756;C0439445;C0441923;C0547047;C2945599";NA;NA;mild decrease $nmbr$ $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$
 307;mild ( $nmbr$ – $nmbr$ ml · min − $nmbr$ · $nmbr$ . $nmbr$ m − $nmbr$ )  n ( % );"C0369637;C0439445;C0441923;C2945599";NA;NA;mild $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$ n
 307;median — ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median ml min $nmbr$ $nmbr$ m $nmbr$
 307;median — ml / min;"C0439445;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;median ml min
 307;median crcl — ml / min;"C0439445;C0549183;C0876920;C1846718;C2347635;C2348144;C2939193";NA;NA;median crcl ml min
 307;mean ± sd egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C0444504;C1739039;C2347634;C2348143;C2699239;C3811844;C3812682";NA;NA;mean sd egfr ml min $nmbr$ $nmbr$ m $nmbr$
 307;interquartile range — ml / min;"C0439445;C1711350";NA;NA;interquartile range ml min
 307;greater than or equal to $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0205163;C0369637;C0439093;C0439445;C0441923";NA;NA;greater than or equal to $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;estimated creatinine clearance — ml / min §;"C0439445;C0750572;C0812399";NA;NA;estimated creatinine clearance ml min
 307;estimated creatinine clearance — ml / min  i;"C0021966;C0023806;C0221138;C0439445;C0702093;C0750572;C0812399;C1524029;C3813700";NA;NA;estimated creatinine clearance ml min i
 307;estimated creatinine clearance < $nmbr$ ml / min *;"C0439445;C0750572;C0812399";NA;NA;estimated creatinine clearance $nmbr$ ml min
 307;estimated creatinine clearance ( ml / min );"C0439445;C0750572;C0812399";NA;NA;estimated creatinine clearance ml min
 307;egfrmdrd ， ml - min - $nmbr$ - $nmbr$ . $nmbr$ m_ $nmbr$;"C0369637;C0439445;C0441923";FALSE; 592;egfrmdrd ml min $nmbr$ $nmbr$ $nmbr$ m_ $nmbr$
 307;estimated gfr at baseline  ml • min $nmbr$;"C0017654;C0168634;C0439445;C0750572;C1424601;C1442488";FALSE; 592;estimated gfr at baseline ml min $nmbr$
 307;estimated gfr  ml / min;"C0017654;C0439445;C0750572;C1424601";FALSE; 592;estimated gfr ml min
 307;estimated gfr — ml / min / $nmbr$ . $nmbr$ m ^ |;"C0017654;C0369637;C0439445;C0441923;C0750572;C1424601";FALSE; 592;estimated gfr ml min $nmbr$ $nmbr$ m
 307;estimated gfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0017654;C0369637;C0439445;C0441923;C0750572;C1424601";FALSE; 592;estimated gfr ml min $nmbr$ $nmbr$ m $nmbr$
 307;estimated gfr ( ml / min / $nmbr$ . $nmbr$ m $nmbr$ );"C0017654;C0369637;C0439445;C0441923;C0750572;C1424601";FALSE; 592;estimated gfr ml min $nmbr$ $nmbr$ m $nmbr$
 307;estimated gfr ( ml / min / $nmbr$ . $nmbr$ m $nmbr$ ) ^ |;"C0017654;C0369637;C0439445;C0441923;C0750572;C1424601";FALSE; 592;estimated gfr ml min $nmbr$ $nmbr$ m $nmbr$
 307;estimated gfr — ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0017654;C0369637;C0439445;C0441923;C0750572;C1424601";FALSE; 592;estimated gfr ml min $nmbr$ $nmbr$ m $nmbr$
 307;estimated gfr ( ml / min / $nmbr$ . $nmbr$ m $nmbr$ )  mean ( sd );"C0017654;C0369637;C0439445;C0441923;C0444504;C0750572;C1424601;C2347634;C2348143;C2699239";FALSE; 592;estimated gfr ml min $nmbr$ $nmbr$ m $nmbr$ mean sd
 307;estimated gfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$   of body - surface area;"C0017446;C0017654;C0205146;C0369637;C0439445;C0441923;C0489451;C0750572;C1424601";FALSE; 592;estimated gfr ml min $nmbr$ $nmbr$ m $nmbr$ of body surface area
 307;estimated gfr  ml min - $nmbr$ $nmbr$ . $nmbr$ m - $nmbr$ ( sd ) a;"C0017654;C0369637;C0439445;C0441923;C0750572;C1424601;C2699239";FALSE; 592;estimated gfr ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$ sd a
 307;estimated gfr ( ml / min per $nmbr$ . $nmbr$ m $nmbr$ )  mean ( sd );"C0017654;C0369637;C0439445;C0441923;C0444504;C0750572;C1424601;C2347634;C2348143;C2699239";FALSE; 592;estimated gfr ml min per $nmbr$ $nmbr$ m $nmbr$ mean sd
 307;estimated gfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0017654;C0369637;C0439445;C0441923;C0750572;C1424601";FALSE; 592;estimated gfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;estimated gfr > $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0017654;C0369637;C0439445;C0441923;C0750572;C1424601";FALSE; 592;estimated gfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;estimated gfr  < $nmbr$ ml min - $nmbr$ $nmbr$ . $nmbr$ m - $nmbr$  n ( % ) a;"C0017654;C0369637;C0439445;C0441923;C0750572;C1424601";FALSE; 592;estimated gfr $nmbr$ ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$ n a
 307;gfr ( mdrd ) ( ml / min / $nmbr$ - $nmbr$ m $nmbr$ );"C0017654;C0369637;C0439445;C0441923;C1424601;C3839656";FALSE; 592;gfr mdrd ml min $nmbr$ $nmbr$ m $nmbr$
 307;gfr ( ml / min per $nmbr$ . $nmbr$ nr );"C0017654;C0027496;C0439445;C1424601;C3844738";FALSE; 592;gfr ml min per $nmbr$ $nmbr$ nr
 307;gfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0017654;C0369637;C0439445;C0441923;C1424601";FALSE; 592;gfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;mdrd egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682;C3839656";FALSE; 592;mdrd egfr ml min $nmbr$ $nmbr$ m $nmbr$
 307;mdrd - egfr ( ml / min per $nmbr$ . $nmbr$ m $nmbr$ );"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682;C3839656";FALSE; 592;mdrd egfr ml min per $nmbr$ $nmbr$ m $nmbr$
 307;mean ( s . d . ) egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C0444504;C1739039;C2347634;C2348143;C3811844;C3812682";FALSE; 592;mean s d egfr ml min $nmbr$ $nmbr$ m $nmbr$
 307;normal or high egfr ( > $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$ ) at baseline to low egfr ( < $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$ );"C0168634;C0205250;C0205251;C0205307;C0231683;C0369637;C0439166;C0439445;C0441923;C1299351;C1442488;C1550472;C1739039;C2347086;C2700149;C3811844;C3812682;C3887512;C3889660;C3890211;C4048187;C4321237;C4321351;C4522209;C4522223;C4553972";FALSE; 592;normal or high egfr $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$ at baseline to low egfr $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$
 307;outcome according to renal function level ( in ml / min );"C0022646;C0232804;C0439445;C0441889;C0456079;C0680240;C0935587;C1274040;C1547707;C2946261";FALSE; 592;outcome according to renal function level in ml min
 307;patients with egfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ at baseline;"C0030705;C0168634;C0369637;C0439445;C0441923;C1442488;C1739039;C3811844;C3812682";FALSE; 592;patients with egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ at baseline
 307;patients with egfr > $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ at baseline;"C0030705;C0168634;C0369637;C0439445;C0441923;C1442488;C1739039;C3811844;C3812682";FALSE; 592;patients with egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ at baseline
 307;patients with egfr > $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$  n;"C0030705;C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;patients with egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ n
 307;patients with egfr $nmbr$ > $nmbr$ to < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$  n;"C0030705;C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;patients with egfr $nmbr$ $nmbr$ to $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ n
 307;renal function ( egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$  according to mdrd )  n ( % );"C0232804;C0369637;C0439445;C0441923;C0680240;C1739039;C3811844;C3812682;C3839656";FALSE; 592;renal function egfr ml min $nmbr$ $nmbr$ m $nmbr$ according to mdrd n
   7;chi - square p value;"C1552646;C1709380";NA;NA;chi square p value
 307;egfr ( ckd - epi  cystatinc )  ml / min / $nmbr$ . $nmbr$ m $nmbr$  n ( % );"C0162734;C0369637;C0439445;C0441923;C1561643;C1739039;C3811844;C3812682;C4281721";FALSE; 592;egfr ckd epi cystatinc ml min $nmbr$ $nmbr$ m $nmbr$ n
 307;egfr crcl ml · min − $nmbr$ · $nmbr$ . $nmbr$ m − $nmbr$;"C0369637;C0439445;C0441923;C1739039;C1846718;C3811844;C3812682";FALSE; 592;egfr crcl ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$
 307;egfr crcl < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C1739039;C1846718;C3811844;C3812682";FALSE; 592;egfr crcl $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;egfr from the mdrd equation ( sd )  ml · min − $nmbr$ · $nmbr$ . $nmbr$ m − $nmbr$;"C0369637;C0439445;C0441923;C0552449;C1739039;C2699239;C3811844;C3812682;C3839656";FALSE; 592;egfr from the mdrd equation sd ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$
 307;egfr in ml / min / $nmbr$ . $nmbr$ m ^  median ( iqr );"C0369637;C0439445;C0441923;C0549183;C0876920;C1739039;C2347635;C2348144;C2939193;C3811844;C3812682";FALSE; 592;egfr in ml min $nmbr$ $nmbr$ m median iqr
 307;egfr ( mdrd )  ml / min / $nmbr$ . $nmbr$ m * *;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682;C3839656";FALSE; 592;egfr mdrd ml min $nmbr$ $nmbr$ m
 307;egfr ( mdrd )  ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682;C3839656";FALSE; 592;egfr mdrd ml min $nmbr$ $nmbr$ m $nmbr$
 307;egfr ( mdrd )  ml min − $nmbr$ $nmbr$ . $nmbr$   m − $nmbr$;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682;C3839656";FALSE; 592;egfr mdrd ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$
 307;egfr ( median  iqr )  ml / min / $nmbr$  $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C0549183;C0876920;C1739039;C2347635;C2348144;C2939193;C3811844;C3812682";FALSE; 592;egfr median iqr ml min $nmbr$ $nmbr$ m $nmbr$
 307;egfr — ml / min / $nmbr$ . $nmbr$ m ^;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr ml min $nmbr$ $nmbr$ m
 307;egfr — ml / min / $nmbr$ . $nmbr$ m * *;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr ml min $nmbr$ $nmbr$ m
 307;egfr ( ml / min / $nmbr$ . $nmbr$ m $nmbr$ );"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr ml min $nmbr$ $nmbr$ m $nmbr$
 307;egfr ( ml / min / $nmbr$ . $nmbr$ m $nmbr$ ) §;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr ml min $nmbr$ $nmbr$ m $nmbr$
 307;egfr — ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr ml min $nmbr$ $nmbr$ m $nmbr$
 307;egfr ( ml / min / $nmbr$ . $nmbr$ m $nmbr$ [ mdrdequation ] );"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr ml min $nmbr$ $nmbr$ m $nmbr$ mdrdequation
 307;egfr ( ml / min / $nmbr$ . $nmbr$ m $nmbr$ )  mean ( sd );"C0369637;C0439445;C0441923;C0444504;C1739039;C2347634;C2348143;C2699239;C3811844;C3812682";FALSE; 592;egfr ml min $nmbr$ $nmbr$ m $nmbr$ mean sd
 307;egfr +  ml / min / $nmbr$ . $nmbr$ m $nmbr$ ( mean ± sd );"C0369637;C0439445;C0441923;C0444504;C1739039;C2347634;C2348143;C2699239;C3811844;C3812682";FALSE; 592;egfr ml min $nmbr$ $nmbr$ m $nmbr$ mean sd
 307;egfr ( ml / min / $nmbr$ - $nmbr$ mz );"C0026655;C0439445;C1705291;C1739039;C3811844;C3812682";FALSE; 592;egfr ml min $nmbr$ $nmbr$ mz
 307;egfr ( ml / min per $nmbr$ - $nmbr$ m ' );"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr ml min per $nmbr$ $nmbr$ m
 307;egfr ( ml / min per $nmbr$ - $nmbr$ m $nmbr$ );"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr ml min per $nmbr$ $nmbr$ m $nmbr$
 307;egfr ( ml / min per $nmbr$ - $nmbr$ m $nmbr$ ) t;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr ml min per $nmbr$ $nmbr$ m $nmbr$ t
 307;egfr < $nmbr$ ml / min;"C0439445;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ ml min
 307;egfr > $nmbr$ ml / min;"C0439445;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ ml min
 307;egfr < $nmbr$  ml / min / m $nmbr$;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ ml min m $nmbr$
 307;egfr < $nmbr$ ml / min  n ( % );"C0439445;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ ml min n
 307;egfr > $nmbr$ ml / min  n ( % );"C0439445;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ ml min n
 307;egfr < $nmbr$ ml / min / $nmbr$ . $nmbr$;"C0439445;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ ml min $nmbr$ $nmbr$
 307;egfr < $nmbr$ ( ml / min / $nmbr$ . $nmbr$ m $nmbr$ );"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;egfr < $nmbr$ ml / min / $nmbr$ - $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;egfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;egfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ §;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;egfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ *;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;egfr > $nmbr$ ( ml / min / $nmbr$ . $nmbr$ m $nmbr$ );"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;egfr > $nmbr$ ml / min / $nmbr$ - $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;egfr > $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;egfr £ $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;egfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ ( mdrd );"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682;C3839656";FALSE; 592;egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ mdrd
 307;egfr . $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ ( n = $nmbr$  $nmbr$ );"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ n $nmbr$ $nmbr$
 307;egfr > = $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ n = $nmbr$  $nmbr$ ( $nmbr$ . $nmbr$ % );"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ n $nmbr$ $nmbr$ $nmbr$ $nmbr$
 307;egfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ mz;"C0026655;C0439445;C1705291;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ ml min $nmbr$ $nmbr$ mz
 307;egfr > $nmbr$ ml / min / $nmbr$ . $nmbr$ mz;"C0026655;C0439445;C1705291;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ ml min $nmbr$ $nmbr$ mz
 307;egfr $nmbr$ – $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;egfr $nmbr$ to < $nmbr$ ml / min / $nmbr$ . $nmbr$ m ^;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ to $nmbr$ ml min $nmbr$ $nmbr$ m
 307;egfr $nmbr$ to < $nmbr$ ml / min / $nmbr$ . $nmbr$ m ’;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ to $nmbr$ ml min $nmbr$ $nmbr$ m
 307;egfr $nmbr$ to < $nmbr$ ml / min / $nmbr$ . $nmbr$ m *;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ to $nmbr$ ml min $nmbr$ $nmbr$ m
 307;egfr $nmbr$ to < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ ( n = $nmbr$ );"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ to $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ n $nmbr$
 307;egfr via mdrd ( ml / min / $nmbr$ . $nmbr$ m $nmbr$ );"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682;C3839656";FALSE; 592;egfr via mdrd ml min $nmbr$ $nmbr$ m $nmbr$
 307;ecrcl < $nmbr$ ml / min;C0439445;NA;NA;ecrcl $nmbr$ ml min
 307;ecrcl  ml / min;C0439445;NA;NA;ecrcl ml min
 307;ecfr ( ml / min per $nmbr$ - $nmbr$ m ’ );"C0369637;C0439445;C0441923";NA;NA;ecfr ml min per $nmbr$ $nmbr$ m
 307;ecfr  ml / min per $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923";NA;NA;ecfr ml min per $nmbr$ $nmbr$ m $nmbr$
 307;creatinine clearance — ml / min;"C0439445;C0812399";NA;NA;creatinine clearance ml min
 307;creatinine clearance < $nmbr$ ml / min ( % );"C0439445;C0812399";NA;NA;creatinine clearance $nmbr$ ml min
 307;creatinine clearance < $nmbr$ ml / min;"C0439445;C0812399";NA;NA;creatinine clearance $nmbr$ ml min
 307;creatinine clearance ( ml / min )  mean ± sd;"C0439445;C0444504;C0812399;C2347634;C2348143;C2699239";NA;NA;creatinine clearance ml min mean sd
 307;creatinine clearance ( ml / min );"C0439445;C0812399";NA;NA;creatinine clearance ml min
 307;creatinine clearance  ml / min - $nmbr$ *;"C0439445;C0812399";NA;NA;creatinine clearance ml min $nmbr$
 307;creatinine clearance  ml / min;"C0439445;C0812399";NA;NA;creatinine clearance ml min
 307;creatine clearance  ml / min;"C0373595;C0439445";NA;NA;creatine clearance ml min
 307;creat clearance > $nmbr$ ml / min;"C0201975;C0439445;C0449297;C1382187;C2825073;C4554548";NA;NA;creat clearance $nmbr$ ml min
 307;creat clearance < $nmbr$ ml / min;"C0201975;C0439445;C0449297;C1382187;C2825073;C4554548";NA;NA;creat clearance $nmbr$ ml min
 307;crcl of $nmbr$ - $nmbr$ ml min '  n ( % );"C0439445;C1846718";NA;NA;crcl of $nmbr$ $nmbr$ ml min n
 307;crcl at randomization - ml / min;"C0034656;C0439445;C1846718";NA;NA;crcl at randomization ml min
 307;crcl at randomization  ml / min;"C0034656;C0439445;C1846718";NA;NA;crcl at randomization ml min
 307;crcl at baseline < $nmbr$ ml / min;"C0168634;C0439445;C1442488;C1846718";NA;NA;crcl at baseline $nmbr$ ml min
 307;crcl at baseline  ml / min;"C0168634;C0439445;C1442488;C1846718";NA;NA;crcl at baseline ml min
 307;crcl > $nmbr$ ml / min;"C0439445;C1846718";NA;NA;crcl $nmbr$ ml min
 307;crcl > $nmbr$ - < $nmbr$ ml / min;"C0439445;C1846718";NA;NA;crcl $nmbr$ $nmbr$ ml min
 307;crcl < $nmbr$ ml / min;"C0439445;C1846718";NA;NA;crcl $nmbr$ ml min
 307;crcl ( sd ) ml / min;"C0439445;C1846718;C2699239";NA;NA;crcl sd ml min
 307;crcl ( ml / min ) at randomization;"C0034656;C0439445;C1846718";NA;NA;crcl ml min at randomization
 307;crcl ( ml / min );"C0439445;C1846718";NA;NA;crcl ml min
 307;crcl  ml / min mean ( sd );"C0439445;C0444504;C1846718;C2347634;C2348143;C2699239";NA;NA;crcl ml min mean sd
 307;crcl  ml / min;"C0439445;C1846718";NA;NA;crcl ml min
 307;crcl  median ( iqr )  ml / min;"C0439445;C0549183;C0876920;C1846718;C2347635;C2348144;C2939193";NA;NA;crcl median iqr ml min
 307;crcl  mean  ml / min ( ± sd );"C0439445;C0444504;C1846718;C2347634;C2348143;C2699239";NA;NA;crcl mean ml min sd
 307;chronic kidney disease stage : egfr ( ml / min per $nmbr$ . $nmbr$ m $nmbr$ );"C0007591;C0439445;C0456533;C1561643;C1739039;C3811844;C3812682;C4553188";NA;NA;chronic kidney disease stage egfr ml min per $nmbr$ $nmbr$ m $nmbr$
 307;cgfrby ckd - epi  ml / min / $nmbr$ . $nmbr$ m $nmbr$  median ( iqr );"C0162734;C0369637;C0439445;C0441923;C0549183;C0876920;C1561643;C2347635;C2348144;C2939193;C4281721";NA;NA;cgfrby ckd epi ml min $nmbr$ $nmbr$ m $nmbr$ median iqr
 307;cgfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923";NA;NA;cgfr ml min $nmbr$ $nmbr$ m $nmbr$
   7;bonferroni - adjusted p value  d vs a;"C1709380;C1879894";NA;NA;bonferroni adjusted p value d vs a
 307;baseline ecrq $nmbr$ $nmbr$ to < $nmbr$ ml / min;"C0168634;C0439445;C1442488";NA;NA;baseline ecrq $nmbr$ $nmbr$ to $nmbr$ ml min
 307;baseline crcl  ml / min;"C0168634;C0439445;C1442488;C1846718";NA;NA;baseline crcl ml min
 307;egfr  mean ( sd )  ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C0444504;C1739039;C2347634;C2348143;C2699239;C3811844;C3812682";FALSE; 592;egfr mean sd ml min $nmbr$ $nmbr$ m $nmbr$
 307;egfr  median ( sd )  ml / min;"C0439445;C0549183;C0876920;C1739039;C2347635;C2348144;C2699239;C2939193;C3811844;C3812682";FALSE; 592;egfr median sd ml min
 307;egfr  ml / min;"C0439445;C1739039;C3811844;C3812682";FALSE; 592;egfr ml min
 307;egfr  ml / min / bsa;"C0439445;C1739039;C3811844;C3812682";FALSE; 592;egfr ml min bsa
 307;egfr  ml / min / m $nmbr$;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr ml min m $nmbr$
 307;egfr  * ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr ml min $nmbr$ $nmbr$ m $nmbr$
 307;egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr ml min $nmbr$ $nmbr$ m $nmbr$
 307;egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$ ( mdrd );"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682;C3839656";FALSE; 592;egfr ml min $nmbr$ $nmbr$ m $nmbr$ mdrd
 307;egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$ ( mdrd )  mean ( sd );"C0369637;C0439445;C0441923;C0444504;C1739039;C2347634;C2348143;C2699239;C3811844;C3812682;C3839656";FALSE; 592;egfr ml min $nmbr$ $nmbr$ m $nmbr$ mdrd mean sd
 307;egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$  mean ( sd );"C0369637;C0439445;C0441923;C0444504;C1739039;C2347634;C2348143;C2699239;C3811844;C3812682";FALSE; 592;egfr ml min $nmbr$ $nmbr$ m $nmbr$ mean sd
 307;egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$  mean ± sd;"C0369637;C0439445;C0441923;C0444504;C1739039;C2347634;C2348143;C2699239;C3811844;C3812682";FALSE; 592;egfr ml min $nmbr$ $nmbr$ m $nmbr$ mean sd
 307;egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$ ( sd );"C0369637;C0439445;C0441923;C1739039;C2699239;C3811844;C3812682";FALSE; 592;egfr ml min $nmbr$ $nmbr$ m $nmbr$ sd
 307;egfr  ml min $nmbr$ $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$
 307;egfr $nmbr$ ml / min / $nmbr$ . $nmbr$;"C0439445;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ ml min $nmbr$ $nmbr$
 307;egfr  $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ ( n = $nmbr$ );"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ n $nmbr$
 307;egfr $nmbr$ - $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;egfr $nmbr$ - $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ ( n = $nmbr$  $nmbr$ );"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ n $nmbr$ $nmbr$
 307;egfr $nmbr$ - $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ n = $nmbr$ ( $nmbr$ . $nmbr$ % );"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ n $nmbr$ $nmbr$ $nmbr$
 307;egfr $nmbr$ - $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ n = $nmbr$  $nmbr$ ( $nmbr$ . $nmbr$ % );"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ n $nmbr$ $nmbr$ $nmbr$ $nmbr$
 307;egfr $nmbr$ to < $nmbr$ ml / min  n ( % );"C0439445;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ to $nmbr$ ml min n
 307;egfr $nmbr$ to < $nmbr$ ml / min / $nmbr$ . $nmbr$;"C0439445;C1739039;C3811844;C3812682";FALSE; 592;egfr $nmbr$ to $nmbr$ ml min $nmbr$ $nmbr$
 307;baseline egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0168634;C0369637;C0439445;C0441923;C1442488;C1739039;C3811844;C3812682";FALSE; 592;baseline egfr ml min $nmbr$ $nmbr$ m $nmbr$
 306;men  no . ( % );C0025266;FALSE;1842;men no
 307;baseline ckd egfr > $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0168634;C0369637;C0439445;C0441923;C1442488;C1561643;C1739039;C3811844;C3812682";NA;NA;baseline ckd egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;^ $nmbr$ ml / min;C0439445;NA;NA;$nmbr$ ml min
 307;> l : $nmbr$ hrs : min ( n = $nmbr$ );"C0439393;C1568891";NA;NA;l $nmbr$ hrs min n $nmbr$
 307;> = $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923";NA;NA;$nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;> = $nmbr$ l_ / min;C0439393;NA;NA;$nmbr$ l_ min
 307;> = $nmbr$ l / min;C0439393;NA;NA;$nmbr$ l min
 307;> $nmbr$ to < $nmbr$ ml / min / $nmbr$ . $nmbr$ m ^;"C0369637;C0439445;C0441923";NA;NA;$nmbr$ to $nmbr$ ml min $nmbr$ $nmbr$ m
 307;> $nmbr$ to < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923";NA;NA;$nmbr$ to $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;> $nmbr$ to < $nmbr$ ml / min;C0439445;NA;NA;$nmbr$ to $nmbr$ ml min
 307;> $nmbr$ to < $nmbr$ egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$ a;"C0040363;C0041260;C0369637;C0439445;C0441923;C1739039;C1883351;C3811844;C3812682";NA;NA;$nmbr$ to $nmbr$ egfr ml min $nmbr$ $nmbr$ m $nmbr$ a
 307;> $nmbr$ ml min - $nmbr$ $nmbr$ . $nmbr$ m ' $nmbr$;"C0369637;C0439445;C0441923";NA;NA;$nmbr$ ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$
 307;> $nmbr$ ml min ) $nmbr$;C0439445;NA;NA;$nmbr$ ml min $nmbr$
 307;> $nmbr$ ml / min per $nmbr$ . $nmbr$ m ^;"C0369637;C0439445;C0441923";NA;NA;$nmbr$ ml min per $nmbr$ $nmbr$ m
 307;> $nmbr$ ml / min per $nmbr$ - $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923";NA;NA;$nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$
 307;> $nmbr$ ml / min / $nmbr$ . $nmbr$ m ^;"C0369637;C0439445;C0441923";NA;NA;$nmbr$ ml min $nmbr$ $nmbr$ m
 307;> $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923";NA;NA;$nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;> $nmbr$ ml / min / $nmbr$ . $nmbr$;C0439445;NA;NA;$nmbr$ ml min $nmbr$ $nmbr$
 307;> $nmbr$ ml / min ( n = $nmbr$ );C0439445;NA;NA;$nmbr$ ml min n $nmbr$
 307;> $nmbr$ ml / min;C0439445;NA;NA;$nmbr$ ml min
 307;< = $nmbr$ ml / min;C0439445;NA;NA;$nmbr$ ml min
 307;< $nmbr$ ml min ’ $nmbr$ $nmbr$ . $nmbr$ m  $nmbr$;"C0369637;C0439445;C0441923";NA;NA;$nmbr$ ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$
 307;< $nmbr$ ml / min — %;C0439445;NA;NA;$nmbr$ ml min
 307;< $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$  n ( % );"C0369637;C0439445;C0441923";NA;NA;$nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$ n
 307;< $nmbr$ ml / min per $nmbr$ - $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923";NA;NA;$nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$
 307;< $nmbr$ ml / min / $nmbr$ . $nmbr$ m ^;"C0369637;C0439445;C0441923";NA;NA;$nmbr$ ml min $nmbr$ $nmbr$ m
 307;< $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923";NA;NA;$nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;< $nmbr$ ml / min / $nmbr$  $nmbr$ m ^;"C0369637;C0439445;C0441923";NA;NA;$nmbr$ ml min $nmbr$ $nmbr$ m
 307;< $nmbr$ ml / min / $nmbr$  $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923";NA;NA;$nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;< $nmbr$ ml / min ( n = $nmbr$ );C0439445;NA;NA;$nmbr$ ml min n $nmbr$
 307;< $nmbr$ ml / min;C0439445;NA;NA;$nmbr$ ml min
 307;< $nmbr$ l / min;C0439393;NA;NA;$nmbr$ l min
 307;< $nmbr$ . $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923";NA;NA;$nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;( $nmbr$ - $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$ );"C0369637;C0439445;C0441923";NA;NA;$nmbr$ $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$
 307;( $ $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$ );"C0369637;C0439445;C0441923";NA;NA;$ $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$
 307;(  $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$ );"C0369637;C0439445;C0441923";NA;NA;$nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$
 307;$nmbr$ – ≤ $nmbr$ ml / min;C0439445;NA;NA;$nmbr$ $nmbr$ ml min
 307;$nmbr$ – < $nmbr$ ml / min;C0439445;NA;NA;$nmbr$ $nmbr$ ml min
 307;$nmbr$ to o $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C0483204";NA;NA;$nmbr$ to o $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 297;pain ( $nmbr$ - $nmbr$ mm vas );"C0042815;C4330985;C4554674";NA;NA;pain $nmbr$ $nmbr$ mm vas
 307;$nmbr$ to < $nmbr$ ml min ’ $nmbr$ $nmbr$ . $nmbr$ m ' $nmbr$;"C0369637;C0439445;C0441923";NA;NA;$nmbr$ to $nmbr$ ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$
 307;$nmbr$ to < $nmbr$ ml / min per $nmbr$ . $nmbr$ m ^;"C0369637;C0439445;C0441923";NA;NA;$nmbr$ to $nmbr$ ml min per $nmbr$ $nmbr$ m
 307;$nmbr$ to < $nmbr$ ml / min / $nmbr$ . $nmbr$ m ^;"C0369637;C0439445;C0441923";NA;NA;$nmbr$ to $nmbr$ ml min $nmbr$ $nmbr$ m
 307;$nmbr$ to < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923";NA;NA;$nmbr$ to $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;$nmbr$ to < $nmbr$ ml / min / $nmbr$ - $nmbr$;C0439445;NA;NA;$nmbr$ to $nmbr$ ml min $nmbr$ $nmbr$
 307;$nmbr$ to < $nmbr$ ml / min / $nmbr$  $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923";NA;NA;$nmbr$ to $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;$nmbr$ to < $nmbr$ ml / min ( n = $nmbr$ $nmbr$ );C0439445;NA;NA;$nmbr$ to $nmbr$ ml min n $nmbr$ $nmbr$
 307;$nmbr$ to < $nmbr$ ml / min;C0439445;NA;NA;$nmbr$ to $nmbr$ ml min
 307;$nmbr$ to $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$  n ( % );"C0369637;C0439445;C0441923";NA;NA;$nmbr$ to $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$ n
 307;$nmbr$ ml / min;C0439445;NA;NA;$nmbr$ ml min
 307;$nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923";NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;$nmbr$ - < $nmbr$ ml / min;C0439445;NA;NA;$nmbr$ $nmbr$ ml min
 307;$nmbr$ - $nmbr$ ml min ) $nmbr$;C0439445;NA;NA;$nmbr$ $nmbr$ ml min $nmbr$
 307;$nmbr$ - $nmbr$ ml min  $nmbr$;C0439445;NA;NA;$nmbr$ $nmbr$ ml min $nmbr$
 307;$nmbr$ - $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923";NA;NA;$nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;$nmbr$ - $nmbr$ ml / min;C0439445;NA;NA;$nmbr$ $nmbr$ ml min
 307;$nmbr$ - $nmbr$ ( < $nmbr$ ml / min );C0439445;NA;NA;$nmbr$ $nmbr$ $nmbr$ ml min
 307;$nmbr$ ( $nmbr$ to < $nmbr$ ml / min );C0439445;NA;NA;$nmbr$ $nmbr$ to $nmbr$ ml min
 307;$nmbr$ ( $ $nmbr$ ml / min );C0439445;NA;NA;$nmbr$ $ $nmbr$ ml min
 306;women men;"C0025266;C0043210";NA;NA;women men
 306;sex ( women  men );"C0009253;C0025266;C0036864;C0043210;C0079399;C0804628;C1314687;C1522384";NA;NA;sex women men
 306;sex ( men / women );"C0009253;C0025266;C0036864;C0043210;C0079399;C0804628;C1314687;C1522384";NA;NA;sex men women
 306;sex  men / women  %;"C0009253;C0025266;C0036864;C0043210;C0079399;C0804628;C1314687;C1522384";NA;NA;sex men women
 306;ratio of women to men — %;"C0025266;C0043210;C0456603;C1547037";NA;NA;ratio of women to men
 306;p ( women vs men );"C0025266;C0043210;C0369773;C2603361";NA;NA;p women vs men
 306;p $nmbr$ interaction women vs men;"C0025266;C0043210;C0369773;C1704675;C2603361";NA;NA;p $nmbr$ interaction women vs men
 306;no of events women men *;"C0025266;C0043210;C0441471;C3541888";NA;NA;no of events women men
 306;ment;"C0084844;C1538994";NA;NA;ment
 307;> $nmbr$ egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$ a;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;$nmbr$ egfr ml min $nmbr$ $nmbr$ m $nmbr$ a
 306;men ( % );C0025266;FALSE;1842;men
 306;men ( n  % );C0025266;FALSE;1842;men n
 306;men ( n [ % ] );C0025266;FALSE;1842;men n
 306;men : < $nmbr$ mg / dl ( < $nmbr$ . $nmbr$ mmol / l );"C0025266;C0439269;C1532563";FALSE;1842;men $nmbr$ mg dl $nmbr$ $nmbr$ mmol l
 306;men ( n = $nmbr$ );C0025266;FALSE;1842;men n $nmbr$
 306;men ( n = $nmbr$ vs $nmbr$ );C0025266;FALSE;1842;men n $nmbr$ vs $nmbr$
 306;men ( n 二 $nmbr$ );C0025266;FALSE;1842;men n $nmbr$
 306;men  total ( n = $nmbr$ );"C0025266;C0439175;C0439810";FALSE;1842;men total n $nmbr$
 306;men  total ( n 二 $nmbr$ );"C0025266;C0439175;C0439810";FALSE;1842;men total n $nmbr$
 306;men with ed ( n = $nmbr$ ) $nmbr$ . $nmbr$ ± $nmbr$ . $nmbr$;"C0025266;C3538926";FALSE;1842;men with ed n $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 306;men : women ( % );"C0025266;C0043210";FALSE;1842;men women
 306;men / women;"C0025266;C0043210";FALSE;1842;men women
 306;men    n   ( % );C0025266;FALSE;1842;men n
 306;no . men;C0025266;FALSE;1842;no men
 306;sex  men ( % );"C0009253;C0025266;C0036864;C0079399;C0804628;C1314687;C1522384";FALSE;1842;sex men
 306;low hdl - c ( for men < $nmbr$   mg / dl / for women < $nmbr$   mg / dl );"C0025266;C0043210;C0151691;C0439269";NA;NA;low hdl c for men $nmbr$ mg dl for women $nmbr$ mg dl
 306;high hdl - c ( for men ≥ $nmbr$   mg / dl / for women ≥ $nmbr$   mg / dl );"C0025266;C0043210;C0205250;C0439269;C1299351;C2700149;C3715113;C3887512;C3889660;C4321237;C4522209";NA;NA;high hdl c for men $nmbr$ mg dl for women $nmbr$ mg dl
 306;hemoglobin ( < $nmbr$ men  ， : : $nmbr$ women );"C0019046;C0025266;C0043210";NA;NA;hemoglobin $nmbr$ men $nmbr$ women
 306;hdl < $nmbr$ / $nmbr$ mg / dl ( $nmbr$ . $nmbr$ / $nmbr$ . $nmbr$ mmol / l ) for men / women;"C0025266;C0043210;C3642216;C3715113;C3898312";NA;NA;hdl $nmbr$ $nmbr$ mg dl $nmbr$ $nmbr$ $nmbr$ $nmbr$ mmol l for men women
 306;gmi ( men );C0025266;NA;NA;gmi men
 306;gender    n   ( % men );"C0025266;C0079399;C1522384";NA;NA;gender n men
 306;( _ > $nmbr$ . $nmbr$ mmol / l ) hdl - c women : < $nmbr$ mg / dl ( < $nmbr$ . $nmbr$ mmol / l ) men : < $nmbr$ mg / dl;"C0025266;C0043210;C3539687;C3715113;C3898312";NA;NA;_ $nmbr$ $nmbr$ mmol l hdl c women $nmbr$ mg dl $nmbr$ $nmbr$ mmol l men $nmbr$ mg dl
 306;$nmbr$ - $nmbr$ ( men );C0025266;NA;NA;$nmbr$ $nmbr$ men
 305;smmse < $nmbr$;NA;NA;NA;smmse $nmbr$
 305;smmse;NA;NA;NA;smmse
 305;mmse score *;"C0449820;C0451306;C4050231";NA;NA;mmse score
 305;mmse score;"C0449820;C0451306;C4050231";NA;NA;mmse score
 305;mmse > $nmbr$;C0451306;NA;NA;mmse $nmbr$
 305;mmse = mini - mental state examination  adas — cog = alzhei -;"C0451306;C3539026";NA;NA;mmse mini mental state examination adas cog alzhei
 305;mmse < $nmbr$;C0451306;NA;NA;mmse $nmbr$
 305;mmse ( points );"C0451306;C1552961;C2347617;C3714763";NA;NA;mmse points
 305;mmse $nmbr$ - $nmbr$;C0451306;NA;NA;mmse $nmbr$ $nmbr$
 305;mini - mental state examination  mean ( sd ) d;"C0444504;C0451306;C2347634;C2348143;C2699239";NA;NA;mini mental state examination mean sd d
 305;mini - mental state examination;C0451306;NA;NA;mini mental state examination
 305;mean mmse score;"C0451306;C3533236";NA;NA;mean mmse score
 305;> < $nmbr$ . $nmbr$  < $nmbr$ . $nmbr$  r < mmse = mini - mental;"C0205090;C0229992;C0445542;C0451306;C0684010;C2603358";NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ r mmse mini mental
 304;recent treatment ( < $nmbr$ months mmf / ggs );"C0039798;C0083765;C0087111;C0209368;C0332185;C0439231;C1522326;C1533734;C1705169;C3538994;C3848524;C3887704";NA;NA;recent treatment $nmbr$ months mmf ggs
 304;mycophenolate mofetil - cyclophosphamide;"C0010583;C0209368";NA;NA;mycophenolate mofetil cyclophosphamide
 304;mycophenolate mofetil;C0209368;NA;NA;mycophenolate mofetil
 304;mmf ( n = $nmbr$ );"C0083765;C0209368;C3848524";NA;NA;mmf n $nmbr$
 303;mn population  n;"C0026327;C0026405;C0032659;C1257890;C4285072";NA;NA;mn population n
 303;mn population;"C0026327;C0026405;C0032659;C1257890;C4285072";NA;NA;mn population
 303;mn - na ï ve population;"C0026327;C0026405;C0032659;C0042469;C0597484;C1257890;C1272460;C1546968;C1879645;C3714652;C4049872;C4285072;C4321495;C4552882";NA;NA;mn na ve population
 303;cardiac index  l • mn ' • m $nmbr$;"C0026327;C0026405;C0369637;C0428776;C0441923;C4285072";NA;NA;cardiac index l mn m $nmbr$
 303;all non - mn;"C0026327;C0026405;C1518422;C4285072";NA;NA;all non mn
 302;mh + crpnorr;"C0026514;C2930980";NA;NA;mh crpnorr
 302;cr + mh;"C0026514;C0201975;C2930980;C3539604;C3711669;C4084730;C4553336;C4553337";NA;NA;cr mh
 301;titre ( u / ml ) t;"C0439340;C0475208;C1880521;C2945590";NA;NA;titre u ml t
 301;serum total ige  iu / ml;"C0439458;C1441420";NA;NA;serum total ige iu ml
 301;anti - dsdna ( > $nmbr$ iu / ml )  %;"C0439458;C0741099";NA;NA;anti dsdna $nmbr$ iu ml
 300;type of ml  no . ( % );"C0332307;C0439526;C1547052;C1705224;C3887665";NA;NA;type of ml no
 300;treatment of the index ml;"C0039798;C0087111;C0439526;C0600653;C0918012;C1522326;C1533734;C1552854;C1637833;C1705169;C1705224;C2986546;C3538994;C3887665;C3887704";NA;NA;treatment of the index ml
 300;quartiles of fgf - $nmbr$ ( ru / ml );"C0016026;C0035970;C0439526;C0919505;C1425796;C1705224;C2828255;C3887665";NA;NA;quartiles of fgf $nmbr$ ru ml
 300;pvr volume  ml  mean ( sd );"C0242852;C0439526;C0444504;C0449468;C0456261;C1419141;C1690016;C1705102;C1705224;C2347634;C2348143;C2699239;C2700258;C3887665";NA;NA;pvr volume ml mean sd
 300;pvr  ml;"C0242852;C0439526;C0456261;C1419141;C1705224;C3887665";NA;NA;pvr ml
 300;pv  ml;"C0030840;C0032463;C0439526;C1705224;C3887665";NA;NA;pv ml
 300;prior ml / stroke;"C0038454;C0332152;C0439526;C1705224;C2826257;C3887665;C4554100";NA;NA;prior ml stroke
 300;prior ml;"C0332152;C0439526;C1705224;C2826257;C3887665";NA;NA;prior ml
 300;prior history of ml or ischemic stroke;"C0019664;C0019665;C0262512;C0262926;C0332152;C0439526;C0948008;C1705224;C1705255;C2004062;C2826257;C3887665";NA;NA;prior history of ml or ischemic stroke
 300;prior history ml or stroke;"C0019664;C0019665;C0038454;C0262512;C0262926;C0332152;C0439526;C1705224;C1705255;C2004062;C2826257;C3887665;C4554100";NA;NA;prior history ml or stroke
 300;previous ml ( interaction : p = $nmbr$ . $nmbr$ );"C0205156;C0439526;C1552607;C1704675;C1705224;C3887665";NA;NA;previous ml interaction p $nmbr$ $nmbr$
 300;previous ml ( before index acs );"C0205156;C0439526;C0600653;C0742343;C0918012;C1552607;C1552854;C1637833;C1705224;C2986546;C3887665;C4318612";NA;NA;previous ml before index acs
 300;previous ml;"C0205156;C0439526;C1552607;C1705224;C3887665";NA;NA;previous ml
 300;placebo  $nmbr$ . $nmbr$ ml ( n = $nmbr$ );"C0032042;C0439526;C1696465;C1705224;C1706408;C3887665";NA;NA;placebo $nmbr$ $nmbr$ ml n $nmbr$
 300;patients with > $nmbr$ % ■ $nmbr$ ml increase in fev $nmbr$ post - bronchodilator ( % );"C0030705;C0439526;C0442805;C1705224;C2599594;C3714541;C3887665";NA;NA;patients with $nmbr$ $nmbr$ ml increase in fev $nmbr$ post bronchodilator
 300;normal or increased gfr ( > $nmbr$ ml / mln per $nmbr$ . $nmbr$ m ^ );"C0017654;C0205217;C0205307;C0231683;C0369637;C0439166;C0439526;C0441923;C0442805;C1417190;C1424601;C1705224;C2347086;C3815103;C3887665;C4553972";NA;NA;normal or increased gfr $nmbr$ ml mln per $nmbr$ $nmbr$ m
 300;nontatal ml;"C0439526;C1705224;C3887665";NA;NA;nontatal ml
 300;nonfatal ml;"C0439526;C1705224;C3887665";NA;NA;nonfatal ml
 300;non - fatal ml;"C0439526;C1302234;C1518422;C1705224;C1705232;C3887665";NA;NA;non fatal ml
 300;no prior ml or stroke;"C0038454;C0332152;C0439526;C1705224;C2826257;C3887665;C4554100";NA;NA;no prior ml or stroke
 300;no prior ml;"C0332152;C0439526;C1705224;C2826257;C3887665";NA;NA;no prior ml
 300;ml c;"C0439526;C1705224;C3887665";NA;NA;ml c
 300;ml );"C0439526;C1705224;C3887665";NA;NA;ml
 300;ml;"C0439526;C1705224;C3887665";NA;NA;ml
   7;bonferroni - adjusted p value  c vs a;"C1709380;C1879894";NA;NA;bonferroni adjusted p value c vs a
 300;mild decrease in gfr ( $nmbr$ - $nmbr$ ml / mln per $nmbr$ . $nmbr$ m ^ );"C0017654;C0369637;C0392756;C0439526;C0441923;C0547047;C1417190;C1424601;C1705224;C2945599;C3815103;C3887665";NA;NA;mild decrease in gfr $nmbr$ $nmbr$ ml mln per $nmbr$ $nmbr$ m
 300;lvesv ( ml );"C0439526;C1705224;C3887665";NA;NA;lvesv ml
 300;lvedv ( ml );"C0439526;C1705224;C3887665";NA;NA;lvedv ml
 300;lav ( ml );"C0019682;C0439526;C1705224;C3887665";NA;NA;lav ml
 300;history of ml at baseline;"C0019664;C0019665;C0168634;C0262512;C0262926;C0439526;C1442488;C1705224;C1705255;C2004062;C3887665";NA;NA;history of ml at baseline
 300;history of ml;"C0019664;C0019665;C0262512;C0262926;C0439526;C1705224;C1705255;C2004062;C3887665";NA;NA;history of ml
 300;high eosinophil subgroup ( > $nmbr$ / ml ) ( n = $nmbr$ );"C0014457;C0439526;C1079230;C1515021;C1705224;C3887665";NA;NA;high eosinophil subgroup $nmbr$ ml n $nmbr$
 300;fvc  ml;"C0439526;C1705224;C3714541;C3887665";NA;NA;fvc ml
 300;fatal chd + nonfatal ml;"C0280604;C0439526;C1302234;C1705224;C1705232;C3542407;C3887665";NA;NA;fatal chd nonfatal ml
 300;fatal / nonfatal ml;"C0439526;C1302234;C1705224;C1705232;C3887665";NA;NA;fatal nonfatal ml
 300;decline #   ml · yr − $nmbr$;"C0439234;C0439526;C1705224;C3887665";NA;NA;decline ml yr $nmbr$
 300;contrast used ( ml ) *;"C0009924;C0439526;C1273517;C1705224;C1979874;C3887665";NA;NA;contrast used ml
 300;characteristics of the index ml;"C0439526;C0600653;C0918012;C1521970;C1552854;C1637833;C1705224;C2986546;C3887665";NA;NA;characteristics of the index ml
 300;alvesv ( per ml );"C0439526;C1705224;C3887665";NA;NA;alvesv per ml
 300;alvedv ( per ml );"C0439526;C1705224;C3887665";NA;NA;alvedv per ml
 300;alav ( per ml );"C0439526;C1705224;C3887665";NA;NA;alav per ml
 300;adjusted rate of fev $nmbr$   decline ( se )  ml / yr;"C0036919;C0439234;C0439526;C0456081;C0871208;C1521828;C1705224;C3714541;C3887665";NA;NA;adjusted rate of fev $nmbr$ decline se ml yr
 300;> = $nmbr$ ml / mln;"C0439526;C1417190;C1705224;C3815103;C3887665";NA;NA;$nmbr$ ml mln
 300;> $nmbr$ ml;"C0439526;C1705224;C3887665";NA;NA;$nmbr$ ml
 300;< $nmbr$ ml;"C0439526;C1705224;C3887665";NA;NA;$nmbr$ ml
 300;* nonfatal ml;"C0439526;C1705224;C3887665";NA;NA;nonfatal ml
 300;$nmbr$ to < $nmbr$ ml per $nmbr$ - $nmbr$ m $nmbr$;"C0369637;C0439526;C0441923;C1705224;C3887665";NA;NA;$nmbr$ to $nmbr$ ml per $nmbr$ $nmbr$ m $nmbr$
 300;$nmbr$ ml ( $nmbr$ to $nmbr$ ) ( n = $nmbr$ / $nmbr$ ) §;"C0439526;C1705224;C3887665";NA;NA;$nmbr$ ml $nmbr$ to $nmbr$ n $nmbr$ $nmbr$
 300;$nmbr$ ml ( $nmbr$ to $nmbr$ ) ( n = $nmbr$ / $nmbr$ );"C0439526;C1705224;C3887665";NA;NA;$nmbr$ ml $nmbr$ to $nmbr$ n $nmbr$ $nmbr$
 300;$nmbr$ ml ( $nmbr$ to $nmbr$ ) ( n - $nmbr$ / $nmbr$ );"C0439526;C1705224;C3887665";NA;NA;$nmbr$ ml $nmbr$ to $nmbr$ n $nmbr$ $nmbr$
 300;$nmbr$ - $nmbr$ ml / rain;"C0034640;C0439526;C1705224;C3887665";NA;NA;$nmbr$ $nmbr$ ml rain
 299;urine qmax  ml / s;"C0042036;C0042037;C0439390;C2963137";NA;NA;urine qmax ml s
 299;qmax ( ml / s );C0439390;NA;NA;qmax ml s
 299;qmax  ml / s  mean ( sd );"C0439390;C0444504;C2347634;C2348143;C2699239";NA;NA;qmax ml s mean sd
 299;qmax  ml / s;C0439390;NA;NA;qmax ml s
 299;> $nmbr$ ml / s;C0439390;NA;NA;$nmbr$ ml s
 299;< $nmbr$ ml / s;C0439390;NA;NA;$nmbr$ ml s
 298;mean ( sd ) esr  mm / h *;"C0444504;C0456680;C2347634;C2348143;C2699239;C3811131";NA;NA;mean sd esr mm h
 298;esr ( mm / h )  mean ( sd );"C0444504;C0456680;C2347634;C2348143;C2699239;C3811131";NA;NA;esr mm h mean sd
 298;esr ( mm / h );"C0456680;C3811131";NA;NA;esr mm h
 298;erythrocyte sedimentation rate ( mm / h );"C0456680;C1176468;C1619634";NA;NA;erythrocyte sedimentation rate mm h
 297;triglyceride ( mm;"C0041004;C4330985;C4554674";NA;NA;triglyceride mm
 297;total length of implanted stents  mm  mean ( sd );"C0021102;C0439175;C0439810;C0444504;C0449462;C2347634;C2348143;C2699239;C2828363;C4330985;C4554674";NA;NA;total length of implanted stents mm mean sd
 297;total back pain  $nmbr$ – $nmbr$ mm vas  mean ± sd;"C0004600;C0042815;C0205095;C0439175;C0439810;C0444504;C0460009;C1995000;C2347634;C2348143;C2699239;C4330985;C4554674";NA;NA;total back pain $nmbr$ $nmbr$ mm vas mean sd
 297;subcortical wml load diameter  mm  mean ( sd );"C0552409;C0815275;C1550025;C1704782;C1708715;C2699239;C4330985;C4554674";NA;NA;subcortical wml load diameter mm mean sd
 297;subcortical wml load diameter  mm   mean ( sd );"C0552409;C0815275;C1550025;C1704782;C1708715;C2699239;C4330985;C4554674";NA;NA;subcortical wml load diameter mm mean sd
 297;stsd > $nmbr$ mm on admission ( n = $nmbr$  $nmbr$ );"C0184666;C0809949;C4330985;C4554674";NA;NA;stsd $nmbr$ mm on admission n $nmbr$ $nmbr$
 297;sokolow - lyon voltage  mm;"C0598352;C4330985;C4554674";NA;NA;sokolow lyon voltage mm
 297;sokolow - lyon ( mm ) *;"C4330985;C4554674";NA;NA;sokolow lyon mm
 297;sokolow - lyon  mm;"C4330985;C4554674";NA;NA;sokolow lyon mm
 297;r wave in avl ( mm );"C0429091;C0449216;C4330985;C4554674";NA;NA;r wave in avl mm
 297;ptgada ( mm );"C4330985;C4554674";NA;NA;ptgada mm
 297;phgada ( mm );"C4330985;C4554674";NA;NA;phgada mm
 297;patient global assessment of pain ( vas $nmbr$ - $nmbr$ mm );"C0042815;C4054229;C4330985;C4554674";NA;NA;patient global assessment of pain vas $nmbr$ $nmbr$ mm
 297;pain vas  $nmbr$ - $nmbr$ mm;"C0042815;C4330985;C4554674";NA;NA;pain vas $nmbr$ $nmbr$ mm
 297;pain ( $nmbr$ mm vas );"C0042815;C4330985;C4554674";NA;NA;pain $nmbr$ mm vas
 297;pain  mm;"C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4330985;C4553004;C4554132;C4554674";NA;NA;pain mm
 297;pain  $nmbr$ - $nmbr$ mm vas;"C0042815;C4330985;C4554674";NA;NA;pain $nmbr$ $nmbr$ mm vas
 297;nocturnal back pain  $nmbr$ – $nmbr$ mm vas  mean ± sd;"C0042815;C0444504;C1970122;C2347634;C2348143;C2699239;C3536884;C3827561;C4330985;C4554674";NA;NA;nocturnal back pain $nmbr$ $nmbr$ mm vas mean sd
 297;no stsd > $nmbr$ mm on admission ( n = $nmbr$  $nmbr$ );"C0184666;C0809949;C4330985;C4554674";NA;NA;no stsd $nmbr$ mm on admission n $nmbr$ $nmbr$
 297;mssbp  mm hga;"C4330985;C4554674";NA;NA;mssbp mm hga
 297;msdbp  mm hga;"C4330985;C4554674";NA;NA;msdbp mm hga
 297;mean of mean cimt  mean ( sd )  mm;"C0444504;C2347634;C2348143;C2699239;C4330985;C4554674";NA;NA;mean of mean cimt mean sd mm
 297;mean of jsw ( mm );"C0444504;C2347634;C2348143;C4330985;C4554674";NA;NA;mean of jsw mm
 297;lvdd ( mm );"C4330985;C4554674";NA;NA;lvdd mm
   7;bonferroni - adjusted p value  b vs a;"C1709380;C1879894";NA;NA;bonferroni adjusted p value b vs a
   7;adjusted p - value for interaction;"C0456081;C1704675;C1709380";NA;NA;adjusted p value for interaction
 297;elevation of cardiac biomarker levels or st - seg - ment deviation > $nmbr$ mm — no . / total no . ( % );"C0084844;C0439175;C0439775;C0439810;C0441889;C0702240;C1114722;C1116089;C1271630;C1519133;C1538994;C1705293;C4330985;C4554674";NA;NA;elevation of cardiac biomarker levels or st seg ment deviation $nmbr$ mm no total no
 297;deviation  mm;"C0012727;C0205419;C1705236;C4330985;C4554674";NA;NA;deviation mm
 297;blood pressure  mean ( sd )  mm hgt;"C0428886;C2699239;C4330985;C4554674";NA;NA;blood pressure mean sd mm hgt
 297;baseline £ std  mm;"C0168634;C1442488;C4330985;C4554674";NA;NA;baseline std mm
 297;baseline ste in worst lead  mm;"C0023175;C0168634;C0181586;C1420459;C1442488;C1442948;C1522166;C1522538;C2348269;C3275067;C3811127;C4330985;C4554674";NA;NA;baseline ste in worst lead mm
 297;baseline sbp ( mm );"C0085805;C0168634;C1442488;C4330985;C4554674";NA;NA;baseline sbp mm
 297;baseline ^ ste  mm;"C0168634;C1420459;C1442488;C3811127;C4330985;C4554674";NA;NA;baseline ste mm
 297;arterial area ( mm $nmbr$ );"C0003842;C0017446;C0205146;C0221464;C4330985;C4554674";NA;NA;arterial area mm $nmbr$
 297;> $nmbr$ mm ( n = $nmbr$ );"C4330985;C4554674";NA;NA;$nmbr$ mm n $nmbr$
 297;> $nmbr$ mm;"C4330985;C4554674";NA;NA;$nmbr$ mm
 297;> $nmbr$ . $nmbr$ mm;"C4330985;C4554674";NA;NA;$nmbr$ $nmbr$ mm
 297;esr — mm / hr;"C3811131;C4330985;C4554674";FALSE; 298;esr mm hr
 297;esr  $nmbr$ - $nmbr$ mm / hour;"C0439227;C0564385;C3811131;C4330985;C4554674";FALSE; 298;esr $nmbr$ $nmbr$ mm hour
 297;platelet count  x $nmbr$ mm $nmbr$;"C0032181;C1287267;C4330985;C4554674";FALSE;2385;platelet count x $nmbr$ mm $nmbr$
 297;platelets xlooo / mm ^;"C0005821;C0443116;C1963076;C4330985;C4554674";FALSE;2385;platelets xlooo mm
 297;< = $nmbr$ . $nmbr$ mm;"C4330985;C4554674";NA;NA;$nmbr$ $nmbr$ mm
 297;< $nmbr$ mm;"C4330985;C4554674";NA;NA;$nmbr$ mm
 297;$nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ mm;"C4330985;C4554674";NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ mm
 297;$nmbr$ - $nmbr$ mm;"C4330985;C4554674";NA;NA;$nmbr$ $nmbr$ mm
 297;$nmbr$ - $nmbr$ . $nmbr$ mm;"C4330985;C4554674";NA;NA;$nmbr$ $nmbr$ $nmbr$ mm
 296;pre fvc % pred;"C0032952;C0044955;C0332152;C0740175;C2257086;C3669034;C3714541";NA;NA;pre fvc pred
 296;pre fev $nmbr$   % pred;"C0032952;C0044955;C0332152;C0740175;C2257086;C3669034;C3714541";NA;NA;pre fev $nmbr$ pred
 296;post fev $nmbr$   % pred;"C0032952;C0044955;C0687676;C1704687;C3469826;C3714541";NA;NA;post fev $nmbr$ pred
 296;fev $nmbr$ % pred;"C0032952;C0044955;C3714541";NA;NA;fev $nmbr$ pred
 296;% pred;"C0032952;C0044955";NA;NA;pred
 296;$nmbr$ ( fev $nmbr$ < $nmbr$ % pred );"C0032952;C0044955;C3714541";NA;NA;$nmbr$ fev $nmbr$ $nmbr$ pred
 295;predose fvc ( l ) *;"C0439565;C3714541;C3812758";NA;NA;predose fvc l
 295;predose fvc ( l );"C0439565;C3714541;C3812758";NA;NA;predose fvc l
 295;predose fev ^ at screening;"C0220908;C0220909;C0439565;C1698960;C1710031;C1710032;C1710477;C2348164;C3714541;C3812758";NA;NA;predose fev at screening
 295;predose fev / fvc;"C0439565;C3714541;C3812758";NA;NA;predose fev fvc
 295;predose fev -  at randomization;"C0034656;C0439565;C3714541;C3812758";NA;NA;predose fev at randomization
 295;predose fev $nmbr$ ( l ) *;"C0439565;C3714541;C3812758";NA;NA;predose fev $nmbr$ l
 294;st ‐ str ≥ $nmbr$ % pre ‐ ci;"C0008107;C0036056;C0332152;C0740175;C2257086;C3259781;C3272372;C3669034";NA;NA;st str $nmbr$ pre ci
 294;received > $nmbr$ prior anti - tnf therapies  n;"C0279936;C0332152;C0432633;C1514756;C2826257";NA;NA;received $nmbr$ prior anti tnf therapies n
 294;received $nmbr$ prior anti - tnf therapy  n;"C0279936;C0332152;C0432633;C1514756;C2826257";NA;NA;received $nmbr$ prior anti tnf therapy n
 294;prior vka use for > $nmbr$ d  %;"C0042153;C0332152;C0457083;C1947944;C2826257";NA;NA;prior vka use for $nmbr$ d
 294;prior use of systemic;"C0205373;C0332152;C1524063;C2826257";NA;NA;prior use of systemic
 294;prior use of conventional dmards only ( biologic - nai ' ve )  n ( % );"C0042469;C0205171;C0332152;C0439858;C1524063;C1720467;C2826257;C3537218;C3714652;C4055380;C4321495";NA;NA;prior use of conventional dmards only biologic nai ve n
 294;prior use of $ $nmbr$ systemic therapies;"C0205373;C0332152;C1514463;C1515119;C1524063;C2826257";NA;NA;prior use of $ $nmbr$ systemic therapies
 294;prior upper gi clinical event;"C0203057;C0205210;C0332152;C0441471;C2826257;C4019010";NA;NA;prior upper gi clinical event
 294;prior ugi event;"C0332152;C0441471;C0560042;C2826257;C4019010";NA;NA;prior ugi event
 294;prior peripheralarterialdisease;"C0332152;C2826257";NA;NA;prior peripheralarterialdisease
 294;prior pad;"C0182158;C0332152;C0332568;C2826257;C3540603;C3669270;C3814046;C4319657";NA;NA;prior pad
 294;prior oma use ( n = $nmbr$ );"C0042153;C0332152;C0457083;C1947944;C2826257";NA;NA;prior oma use n $nmbr$
 294;prior oma use;"C0042153;C0332152;C0457083;C1947944;C2826257";NA;NA;prior oma use
 294;prior om;"C0028971;C0332152;C1705272;C2826257";NA;NA;prior om
 294;prior oad :;"C0332152;C2826257";NA;NA;prior oad
 294;prior oac;"C0332152;C2826257";NA;NA;prior oac
 294;prior non - cns se;"C0036919;C0332152;C1518422;C2826257;C3714787";NA;NA;prior non cns se
 294;prior ml or stroke at baseline;"C0038454;C0168634;C0332152;C0439526;C1442488;C1705224;C2826257;C3887665;C4554100";NA;NA;prior ml or stroke at baseline
 294;prior mi / stroke;"C0038454;C0332152;C2826257;C3810814;C4554100";NA;NA;prior mi stroke
 294;prior medication use  n ( % );"C0240320;C0332152;C2826257";NA;NA;prior medication use n
 294;prior lower gi clinical event;"C0205210;C0332152;C0441471;C0441994;C1548802;C1708130;C2003888;C2826257;C3539617;C4019010;C4050121";NA;NA;prior lower gi clinical event
 294;prior llt;"C0332152;C2347090;C2826257";NA;NA;prior llt
 294;prior lipid - lowering agent use;"C0042153;C0086440;C0332152;C0457083;C1947944;C2826257";NA;NA;prior lipid lowering agent use
 294;prior lgi event;"C0332152;C0441471;C2826257;C4019010";NA;NA;prior lgi event
 294;prior lev use;"C0023556;C0042153;C0332152;C0457083;C1947944;C2826257";NA;NA;prior lev use
 294;prior lev;"C0023556;C0332152;C2826257";NA;NA;prior lev
 294;prior implantable cardiodefibrillator  n ( % );"C0021102;C0332152;C2826257";NA;NA;prior implantable cardiodefibrillator n
 294;prior immunosuppressive exposure  n ( % );"C0021081;C0274281;C0332152;C0332157;C2826257";NA;NA;prior immunosuppressive exposure n
 294;prior immunosuppressant failurec;"C0021081;C0332152;C2826257";NA;NA;prior immunosuppressant failurec
 294;prior tnfi  n ( % );"C0332152;C2826257";FALSE;2375;prior tnfi n
 294;prior therapy with tnf antagonist  n ( % );"C0231491;C0279936;C0332152;C1448177;C1514463;C2826257";FALSE;2376;prior therapy with tnf antagonist n
 294;prior use of synthetic dmards;"C0242708;C0332152;C1524063;C1883254;C2826257";FALSE;2377;prior use of synthetic dmards
 294;prior use of synthetic dmards  n ( % );"C0242708;C0332152;C1524063;C1883254;C2826257";FALSE;2377;prior use of synthetic dmards n
 193;> $nmbr$ mg / l;C0439268;NA;NA;$nmbr$ mg l
 294;with prior mi / stroke ( n = $nmbr$ );"C0038454;C0332152;C2826257;C3810814;C4554100";FALSE;2378;with prior mi stroke n $nmbr$
 294;ticagrelor pre ‐ hosp ( n = $nmbr$ );"C0332152;C0740175;C1999375;C2257086;C3669034";FALSE;2379;ticagrelor pre hosp n $nmbr$
 294;prior stroke;"C0038454;C0332152;C2826257;C4554100";FALSE;2380;prior stroke
 294;prior stroke ( % );"C0038454;C0332152;C2826257;C4554100";FALSE;2380;prior stroke
 294;prior stroke ( before index event );"C0332152;C0441471;C0456712;C2826257;C4019010";FALSE;2380;prior stroke before index event
 294;prior stroke / mi  n ( % );"C0038454;C0332152;C2826257;C3810814;C4554100";FALSE;2380;prior stroke mi n
 294;prior stroke — no . ( % );"C0038454;C0332152;C2826257;C4554100";FALSE;2380;prior stroke no
 294;prior stroke ( n = $nmbr$ );"C0038454;C0332152;C2826257;C4554100";FALSE;2380;prior stroke n $nmbr$
 294;prior stroke or tia;"C0007787;C0038454;C0332152;C0917805;C1054154;C2826257;C4554100";FALSE;2380;prior stroke or tia
 294;prior stroke or tia  %;"C0007787;C0038454;C0332152;C0917805;C1054154;C2826257;C4554100";FALSE;2380;prior stroke or tia
 294;prior stroke or tza;"C0038454;C0039298;C0332152;C2826257;C4554100";FALSE;2380;prior stroke or tza
 294;prior stroke / tia;"C0007787;C0038454;C0332152;C0917805;C1054154;C2826257;C4554100";FALSE;2380;prior stroke tia
 294;prior tia;"C0007787;C0332152;C0917805;C1054154;C2826257";FALSE;2380;prior tia
 294;prior transient ischemic attack;"C0007787;C0332152;C0917805;C2826257";FALSE;2380;prior transient ischemic attack
 294;prior pci  %;"C0332152;C2826257;C4049621";FALSE;1661;prior pci
 294;prior pci;"C0332152;C2826257;C4049621";FALSE;1661;prior pci
 294;prior pci or cabg;"C0010055;C0332152;C2826257;C4049621";FALSE;1661;prior pci or cabg
 294;prior ptca or pci;"C0332152;C2826257;C2936173;C4049621";FALSE;1661;prior ptca or pci
 294;prior ptca / pci;"C0332152;C2826257;C2936173;C4049621";FALSE;1661;prior ptca pci
 295;study medication  pre - dose;"C0013227;C0439565;C0557651;C2603343;C3244316;C3812758;C4284232";FALSE;2383;study medication pre dose
 295;pre - dose;"C0439565;C3812758";FALSE;2383;pre dose
 296;prednisone;C0032952;FALSE;2384;prednisone
 296;prednisone use  %;"C0032952;C0042153;C0457083;C1947944";FALSE;2384;prednisone use
 294;prior immunosuppressant failure;"C0021081;C0231174;C0332152;C0680095;C2826257";NA;NA;prior immunosuppressant failure
 294;prior hospitalizations  n ( % );"C0019993;C0332152;C2826257";NA;NA;prior hospitalizations n
 294;prior history of bleeding on oac;"C0019080;C0019664;C0019665;C0262512;C0262926;C0332152;C1705255;C2004062;C2826257";NA;NA;prior history of bleeding on oac
 294;prior failure of anti - tnf therapy — no . ( % );"C0231174;C0281481;C0332152;C0680095;C2826257";NA;NA;prior failure of anti tnf therapy no
 294;prior exposure to topiramate;"C0076829;C0274281;C0332152;C0332157;C2826257";NA;NA;prior exposure to topiramate
 294;prior corticosteroid failure only;"C0001617;C0205171;C0231174;C0332152;C0680095;C1720467;C2826257;C3536709";NA;NA;prior corticosteroid failure only
 294;prior conventional synthetic dmards  n ( % );"C0242708;C0332152;C0439858;C1883254;C2826257";NA;NA;prior conventional synthetic dmards n
 294;prior brachytherapy;"C0006098;C0332152;C2826257";NA;NA;prior brachytherapy
 294;prior bp use;"C0037623;C0042153;C0332152;C0457083;C1415692;C1708288;C1947944;C2826257;C4318478";NA;NA;prior bp use
 294;prior bisphosphonate usage;"C0012544;C0332152;C0457083;C2267018;C2826257";NA;NA;prior bisphosphonate usage
 294;prior aeds  ≥ $nmbr$  n ( % );"C0180309;C0332152;C2826257";NA;NA;prior aeds $nmbr$ n
 294;prior admb;"C0332152;C2826257";NA;NA;prior admb
 294;prior;"C0332152;C2826257";NA;NA;prior
 294;pre svc;"C0231957;C0332152;C0740175;C2257086;C3669034";NA;NA;pre svc
 294;pre fvc;"C0332152;C0740175;C2257086;C3669034;C3714541";NA;NA;pre fvc
 294;pre - treatedforhypertension [ n ( % ) ];"C0332152;C0740175;C2257086;C3669034";NA;NA;pre treatedforhypertension n
 294;pre - hospital;"C0019994;C0332152;C0740175;C1510665;C2257086;C3669034";NA;NA;pre hospital
 294;pre - h;"C0033727;C0332152;C0369286;C0441932;C0564385;C0740175;C2257086;C3669034;C4528284";NA;NA;pre h
 294;pre - bd fvc s $nmbr$ % of predicted;"C0005126;C0332152;C0681842;C0740175;C1882327;C2257086;C2344255;C3669034;C3714541;C4050145";NA;NA;pre bd fvc s $nmbr$ of predicted
 294;pre - bd fvc < $nmbr$ % of predicted;"C0005126;C0332152;C0681842;C0740175;C1882327;C2257086;C2344255;C3669034;C3714541;C4050145";NA;NA;pre bd fvc $nmbr$ of predicted
 294;no prior ugi event;"C0332152;C0441471;C0560042;C2826257;C4019010";NA;NA;no prior ugi event
 294;no prior statin ( n = $nmbr$  $nmbr$ );"C0332152;C0360714;C2826257";NA;NA;no prior statin n $nmbr$ $nmbr$
 294;no prior oma use ( n = $nmbr$ );"C0042153;C0332152;C0457083;C1947944;C2826257";NA;NA;no prior oma use n $nmbr$
 294;no prior oma use;"C0042153;C0332152;C0457083;C1947944;C2826257";NA;NA;no prior oma use
 294;no prior llt;"C0332152;C2347090;C2826257";NA;NA;no prior llt
 294;no prior lgi event;"C0332152;C0441471;C2826257;C4019010";NA;NA;no prior lgi event
 294;no prior admc;"C0332152;C2826257";NA;NA;no prior admc
 294;heparin pre - randomization;"C0019134;C0034656;C0332152;C0740175;C0770546;C2257086;C3669034";NA;NA;heparin pre randomization
 294;enrollment strata : prior hospitalization;"C0019993;C0332152;C1516879;C1696073;C2826257;C3888021";NA;NA;enrollment strata prior hospitalization
 294;duration of prior statin therapy ^;"C0332152;C0360714;C0444917;C2826257";NA;NA;duration of prior statin therapy
 294;duration of pre - randomization anticoagulant therapy;"C0034656;C0332152;C0740175;C2257086;C2711563;C3669034";NA;NA;duration of pre randomization anticoagulant therapy
 294;dissatisfied with / stopped $ $nmbr$ prior systemic therapy because of side effects;"C0001688;C0205373;C0332152;C0870433;C0877248;C0879626;C1272691;C1514463;C1515119;C2826257;C4085546";NA;NA;dissatisfied with stopped $ $nmbr$ prior systemic therapy because of side effects
 294;dissatisfied with / stopped $ $nmbr$ prior systemic therapies because of side effects;"C0001688;C0205373;C0332152;C0870433;C0877248;C0879626;C1272691;C1514463;C1515119;C2826257;C4085546";NA;NA;dissatisfied with stopped $ $nmbr$ prior systemic therapies because of side effects
 294;% predicted pre - bd;"C0005126;C0332152;C0681842;C0740175;C1882327;C2257086;C2344255;C3669034;C4050145";NA;NA;predicted pre bd
 293;presence of erosions  n ( % );"C0150312;C0333307;C0392148;C1959609;C3854307";NA;NA;presence of erosions n
 293;presence of dactylitis;"C0150312;C0239161;C0392148;C3854307";FALSE;2365;presence of dactylitis
 293;presence of angioedema at baseline;"C0002994;C0150312;C0168634;C0392148;C1442488;C3854307";FALSE;2366;presence of angioedema at baseline
 293;presence of enthesitis  n ( % );"C0150312;C0392148;C1282952;C3854307";FALSE;2367;presence of enthesitis n
 293;presence of tophi;"C0150312;C0221248;C0392148;C3854307";FALSE;2369;presence of tophi
 293;presence of tophi  n ( % );"C0150312;C0221248;C0392148;C3854307";FALSE;2369;presence of tophi n
 293;presence of honeycombing  $nmbr$ n ( % );"C0150312;C0332468;C0349384;C0392148;C3854307";FALSE;2371;presence of honeycombing $nmbr$ n
 294;$nmbr$ prior tnf antagonist failure  n ( % ) b;"C0231174;C0231491;C0332152;C0680095;C2826257;C3887647";FALSE;2372;$nmbr$ prior tnf antagonist failure n b
 294;no . of prior tnfi;"C0332152;C2826257";FALSE;2373;no of prior tnfi
 294;no . of prior aeds  c n ( % );"C0180309;C0332152;C2826257";FALSE;2374;no of prior aeds c n
 294;no . of prior aedsd;"C0332152;C2826257";FALSE;2374;no of prior aedsd
 294;no . of prior aeds  n ( % );"C0180309;C0332152;C2826257";FALSE;2374;no of prior aeds n
 294;prior anti - tnf exposure;"C0274281;C0332152;C0332157;C1448177;C2826257";FALSE;2375;prior anti tnf exposure
 294;prior anti - tnf therapy;"C0281481;C0332152;C2826257";FALSE;2375;prior anti tnf therapy
 294;prior anti - tnf therapy — no . ( % );"C0281481;C0332152;C2826257";FALSE;2375;prior anti tnf therapy no
 294;# of prior non - tnfi bdmards *;"C0332152;C1518422;C2826257";FALSE;2377;of prior non tnfi bdmards
 294;# of prior bdmards;"C0332152;C2826257";FALSE;2377;of prior bdmards
 193;> $nmbr$ . $nmbr$ mg / l;C0439268;NA;NA;$nmbr$ $nmbr$ mg l
 294;prior cardiovascular event;"C0332152;C1320716;C2826257";FALSE;2378;prior cardiovascular event
 294;prior cardiovascular event  ';"C0332152;C1320716;C2826257";FALSE;2378;prior cardiovascular event
 294;prior cardiovascular event — no . ( % );"C0332152;C1320716;C2826257";FALSE;2378;prior cardiovascular event no
 294;prior cardiovascular history;"C0332152;C1880008;C2826257";FALSE;2378;prior cardiovascular history
 294;patients with a prior mi or stroke at baseline;"C0030705;C0038454;C0168634;C0332152;C1442488;C2826257;C3810814;C4554100";FALSE;2378;patients with a prior mi or stroke at baseline
 294;patients without a prior mi or stroke at baseline;"C0030705;C0038454;C0168634;C0332152;C1442488;C2826257;C3810814;C4554100";FALSE;2378;patients without a prior mi or stroke at baseline
 294;pre hospital ticagrelor;"C0019994;C0332152;C0740175;C1510665;C1999375;C2257086;C3669034";FALSE;2379;pre hospital ticagrelor
 294;pre - hospital ticagrelor ( n = $nmbr$ );"C0019994;C0332152;C0740175;C1510665;C1999375;C2257086;C3669034";FALSE;2379;pre hospital ticagrelor n $nmbr$
 294;no prior stroke;"C0038454;C0332152;C2826257;C4554100";FALSE;2380;no prior stroke
 294;no prior stroke ( n = $nmbr$ );"C0038454;C0332152;C2826257;C4554100";FALSE;2380;no prior stroke n $nmbr$
 294;no prior stroke / tia;"C0007787;C0038454;C0332152;C0917805;C1054154;C2826257;C4554100";FALSE;2380;no prior stroke tia
 294;prior biologic exposure;"C0005515;C0205460;C0274281;C0332152;C0332157;C2826257";FALSE;2381;prior biologic exposure
 294;prior biologic use;"C0005515;C0042153;C0205460;C0332152;C0457083;C1947944;C2826257";FALSE;2381;prior biologic use
 294;prior antiinflammatory / antirheumatic products  n ( % );"C0003191;C0003209;C0332152;C1514468;C1515999;C2826257";FALSE;2382;prior antiinflammatory antirheumatic products n
 294;prior aspirin;"C0004057;C0332152;C2826257";FALSE;1366;prior aspirin
 294;prior aspirin use;"C0004057;C0042153;C0332152;C0457083;C1947944;C2826257";FALSE;1366;prior aspirin use
 292;prostate biopsy;C0194804;NA;NA;prostate biopsy
 291;proportion of days without heartburn at week $nmbr$  percentage;"C0018834;C0332174;C0439165;C0439228;C0439230;C1549488;C1561533;C1709707";NA;NA;proportion of days without heartburn at week $nmbr$ percentage
 291;percentages of patients with event;"C0030705;C0439165;C0441471;C1549488;C1561533;C4019010";NA;NA;percentages of patients with event
 291;percentages;"C0439165;C1549488;C1561533";NA;NA;percentages
 291;percentage points;"C0439165;C1549488;C1552961;C1561533;C2347617;C3714763";NA;NA;percentage points
 291;percentage of patients with event;"C0030705;C0439165;C0441471;C1549488;C1561533;C4019010";NA;NA;percentage of patients with event
 291;percentage of p;"C0439165;C1549488;C1561533";NA;NA;percentage of p
 291;percentage of fevj reversibility;"C0439165;C0449261;C1549488;C1561533";NA;NA;percentage of fevj reversibility
 291;percentage of females;"C0086287;C0439165;C1549488;C1561533";NA;NA;percentage of females
 291;percentage of days without heartburn;"C0018834;C0439165;C0439228;C1549488;C1561533";NA;NA;percentage of days without heartburn
 291;percentage of bsa involved;"C0439165;C1314939;C1549488;C1561533";NA;NA;percentage of bsa involved
 291;percentage;"C0439165;C1549488;C1561533";NA;NA;percentage
 291;mean percentage of nights without heartburn;"C0018834;C0240526;C0439165;C0444504;C1549488;C1561533;C2347634;C2348143";NA;NA;mean percentage of nights without heartburn
 290;within $nmbr$ h after first procedure;"C0033727;C0184661;C0205435;C0369286;C0441932;C0564385;C1279901;C2700391;C3274430;C3539779;C4528284";NA;NA;within $nmbr$ h after first procedure
 290;with dm ( n proactive intervention ( n = $nmbr$ a );"C0011816;C0184661;C0886296;C1273869;C3250443";NA;NA;with dm n proactive intervention n $nmbr$ a
 290;unsuccessful procedure;"C0184661;C1272705;C2700391;C3274430;C3539779";NA;NA;unsuccessful procedure
 290;time  mean ( sd )  min procedure;"C0040223;C0184661;C0444504;C0702093;C1524029;C2347634;C2348143;C2699239;C2700391;C3274430;C3539779;C3541383;C3813700";NA;NA;time mean sd min procedure
 290;procedures in the hospital — no . ( % );"C0019994;C0025664;C0184661;C1510665;C2700391;C3538935";NA;NA;procedures in the hospital no
 290;procedures after discharge — no . ( % );"C0012621;C0025664;C0030685;C0184661;C2700391;C2926602;C3538935";NA;NA;procedures after discharge no
 290;procedure * *;"C0184661;C2700391;C3274430;C3539779";NA;NA;procedure
 290;procedure;"C0184661;C2700391;C3274430;C3539779";NA;NA;procedure
 290;proactive intervention ( n = $nmbr$ a );"C0184661;C0886296;C1273869";NA;NA;proactive intervention n $nmbr$ a
 290;pro - active intervention;"C0033382;C0184661;C0205177;C0523852;C0886296;C1273869;C2987124;C3853793;C3888249";NA;NA;pro active intervention
 290;prior carotid intervention;"C0184661;C0332152;C0741968;C0886296;C1273869;C2826257";NA;NA;prior carotid intervention
 290;previous intervention ( % );"C0184661;C0205156;C0886296;C1273869;C1552607";NA;NA;previous intervention
 290;multivessel intervention  n ( % );"C0184661;C0886296;C1273869";NA;NA;multivessel intervention n
 290;intervention group ( n = $nmbr$ );"C0184661;C0441848;C0886296;C1273869";NA;NA;intervention group n $nmbr$
 290;intervention .;"C0184661;C0886296;C1273869";NA;NA;intervention
 290;intervention ( n = $nmbr$ );"C0184661;C0886296;C1273869";NA;NA;intervention n $nmbr$
 290;intervention;"C0184661;C0886296;C1273869";NA;NA;intervention
 290;interaction p values are as follows : amlodipine vs . chlorthalidone : age  p = $nmbr$ . $nmbr$  gender  p = $nmbr$ . $nmbr$  race  p = $nmbr$ . $nmbr$  history of chd  p = $nmbr$ . $nmbr$  history of diabetes  p = $nmbr$ . $nmbr$ . lisinopril vs . chlorthalidone : age  p = $nmbr$ . $nmbr$  gender  p = $nmbr$ . $nmbr$  race  p = $nmbr$ . $nmbr$  history of chd  p = $nmbr$ . $nmbr$  history of diabetes  p = $nmbr$ . $nmbr$ . peripheral arterial disease refers to in - trial hospitalization or lower extremity revascularization procedure .;"C0001779;C0008294;C0008976;C0011847;C0011849;C0015385;C0019664;C0019665;C0019993;C0034510;C0040363;C0041260;C0051696;C0065374;C0079399;C0085096;C0184661;C0205543;C0262512;C0262926;C0280604;C0332283;C0369773;C0441994;C0581603;C1522384;C1548802;C1704436;C1704675;C1705255;C1706779;C1709380;C1719822;C1883351;C2003888;C2004062;C2603361;C2700391;C3274430;C3539779;C3542407;C3853635;C4281991";NA;NA;interaction p values are as follows amlodipine vs chlorthalidone age p $nmbr$ $nmbr$ gender p $nmbr$ $nmbr$ race p $nmbr$ $nmbr$ history of chd p $nmbr$ $nmbr$ history of diabetes p $nmbr$ $nmbr$ lisinopril vs chlorthalidone age p $nmbr$ $nmbr$ gender p $nmbr$ $nmbr$ race p $nmbr$ $nmbr$ history of chd p $nmbr$ $nmbr$ history of diabetes p $nmbr$ $nmbr$ peripheral arterial disease refers to in trial hospitalization or lower extremity revascularization procedure
 290;first procedure;"C0184661;C0205435;C1279901;C2700391;C3274430;C3539779";NA;NA;first procedure
 290;experimental intervention group ( n = $nmbr$ );"C0184661;C0441848;C0886296;C1273869;C1517586";NA;NA;experimental intervention group n $nmbr$
 290;cystoscopic procedure;"C0184661;C0560573;C2700391;C3274430;C3539779";NA;NA;cystoscopic procedure
 290;baseline procedure  n ( % );"C0168634;C0184661;C1442488;C2700391;C3274430;C3539779";NA;NA;baseline procedure n
 -10;potential predictor;"C2698872;C3245505";NA;NA;potential predictor
 288;pulmonary function tests  % of predicted;"C0024119;C0681842;C1882327;C2598152";NA;NA;pulmonary function tests of predicted
 288;predicted normal ) t;"C0205307;C0231683;C0439166;C0681842;C1882327;C2347086;C4553972";NA;NA;predicted normal t
 288;predicted normal ( % );"C0205307;C0231683;C0439166;C0681842;C1882327;C2347086;C4553972";NA;NA;predicted normal
 288;prebronchodilator fev $nmbr$ ( % predicted normal ) t;"C0205307;C0231683;C0439166;C0681842;C1882327;C2347086;C2599602;C3714541;C4553972";NA;NA;prebronchodilator fev $nmbr$ predicted normal t
 288;postbronchodilator fevj ( % predicted );"C0681842;C1882327;C2599594";NA;NA;postbronchodilator fevj predicted
 288;pef  post - bronchodilator  % predicted normal;"C0030771;C0205307;C0231683;C0439166;C0681842;C1518922;C1542834;C1882327;C2347086;C2599594;C4553972";NA;NA;pef post bronchodilator predicted normal
 288;mean ( sd ) % of predicted normal fev $nmbr$;"C0444504;C0520835;C0681842;C1882327;C2347634;C2348143;C2699239";NA;NA;mean sd of predicted normal fev $nmbr$
 288;mean ( sd ) % of predicted normal eevi;"C0205307;C0231683;C0439166;C0444504;C0681842;C1882327;C2347086;C2347634;C2348143;C2699239;C4553972";NA;NA;mean sd of predicted normal eevi
 288;fevj % predicted !  t;"C0681842;C1882327";NA;NA;fevj predicted t
 288;fev $nmbr$   % of predicted normal post - bronchodilator;"C0520835;C0681842;C1882327;C2599594";NA;NA;fev $nmbr$ of predicted normal post bronchodilator
 226;coronary heart disease — no . ( % );"C0010054;C0010068;C1956346";NA;NA;coronary heart disease no
 288;fev $nmbr$ ( % predicted normal );"C0205307;C0231683;C0439166;C0681842;C1882327;C2347086;C3714541;C4553972";NA;NA;fev $nmbr$ predicted normal
 288;fev $nmbr$ % predicted normal;"C0205307;C0231683;C0439166;C0681842;C1882327;C2347086;C3714541;C4553972";NA;NA;fev $nmbr$ predicted normal
 288;diffusion capacity of the lung for carbon monoxide  % predicted !;"C0007018;C0231971;C0681842;C1882327;C4520712";NA;NA;diffusion capacity of the lung for carbon monoxide predicted
 288;b postbronchodilator fevl ( % predicted );"C0681842;C1882327;C2599594";NA;NA;b postbronchodilator fevl predicted
 288;> $nmbr$ % predicted to < $nmbr$ % predicted;"C0681842;C1882327";NA;NA;$nmbr$ predicted to $nmbr$ predicted
 288;> $nmbr$ % predicted;"C0681842;C1882327";NA;NA;$nmbr$ predicted
 288;< $nmbr$ % predicted;"C0681842;C1882327";NA;NA;$nmbr$ predicted
  77;mercaptopurine;C0000618;NA;NA;mercaptopurine
 290;non pci procedure;"C0184661;C1518422;C2700391;C3274430;C3539779;C4049621";FALSE;1661;non pci procedure
 290;percutaneous intervention;"C0184661;C0522523;C0886296;C1273869";FALSE;1661;percutaneous intervention
 290;pci procedure;"C0184661;C2700391;C3274430;C3539779;C4049621";FALSE;1661;pci procedure
 290;coronary intervention;"C0018787;C0184661;C0886296;C1273869";FALSE;1661;coronary intervention
 290;coronary angiography and intervention;"C0085532;C0184661;C0886296;C1273869;C1548829";FALSE;1661;coronary angiography and intervention
 293;baseline presence of nasal polyps;"C0027430;C0150312;C0168634;C0392148;C1442488;C3854307";FALSE;2368;baseline presence of nasal polyps
 293;history / presence of tophi;"C0019664;C0019665;C0150312;C0221248;C0262512;C0262926;C0392148;C1705255;C2004062;C3854307";FALSE;2369;history presence of tophi
 288;% predicted value ( sd );"C0681842;C1522609;C1882327;C2699239";NA;NA;predicted value sd
 288;% predicted;"C0681842;C1882327";NA;NA;predicted
 288;% of predicted normal value *;"C0086715;C0681842;C1882327";NA;NA;of predicted normal value
 288;% of predicted;"C0681842;C1882327";NA;NA;of predicted
 287;time from onset of symptoms to presentation — hr;"C0449450;C1320528";NA;NA;time from onset of symptoms to presentation hr
 287;syndesmophyte present  n ( % );"C0150312;C0221690;C0449450";NA;NA;syndesmophyte present n
 287;presentation to tertiary care hospital — %;"C0337954;C0449450";NA;NA;presentation to tertiary care hospital
 287;presentation *;C0449450;NA;NA;presentation
 287;present smokerc;"C0150312;C0449450";NA;NA;present smokerc
 287;present at screening;"C0150312;C0220908;C0220909;C0449450;C1698960;C1710031;C1710032;C1710477;C2348164";NA;NA;present at screening
 287;present ( £ $nmbr$ mg / dl );"C0150312;C0439269;C0449450";NA;NA;present $nmbr$ mg dl
 287;present ( > $nmbr$ mg / dl );"C0150312;C0439269;C0449450";NA;NA;present $nmbr$ mg dl
 287;present;"C0150312;C0449450";NA;NA;present
 287;number ( s ) of features present;"C0150312;C0237753;C0449450;C0449788;C1521970;C1706388;C2346469;C2348519";NA;NA;number s of features present
 287;not present at screening  but within previous year;"C0150312;C0205156;C0220908;C0220909;C0439234;C0439508;C0449450;C1518422;C1552607;C1698960;C1710031;C1710032;C1710477;C2348164";NA;NA;not present at screening but within previous year
 287;factor present;"C0150312;C0449450;C1521761;C2827422";NA;NA;factor present
 287;dx at presentation  n ( % );"C0449450;C3538936";NA;NA;dx at presentation n
 286;high - sensitivityc - reactive protein  mg / l;"C0033684;C0205250;C0205332;C0439268;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;high sensitivityc reactive protein mg l
 286;high - sensitivity c - reactive protein — mg / liter |;"C0006560;C0024671;C0026410;C0439269;C0475211;C1413716;C1441604;C1960952;C2346927;C4048285;C4321396;C4521761";NA;NA;high sensitivity c reactive protein mg liter
 286;high - sensitivity c - reactive protein stratification;"C0006560;C1413716;C1441604;C1514983;C4048285";NA;NA;high sensitivity c reactive protein stratification
 286;high - sensitivity c - reactive protein  mg / ltt;"C0006560;C0024671;C0026410;C0439269;C1413716;C1441604;C1960952;C2346927;C4048285;C4321396;C4521761";NA;NA;high sensitivity c reactive protein mg ltt
 286;das $nmbr$ ( c - reactive protein );"C0006560;C0051767;C0057671;C1413716;C4048285";NA;NA;das $nmbr$ c reactive protein
 286;c - reactive proteinc;C0205332;NA;NA;c reactive proteinc
 286;c - reactive protein — mg / literj;"C0006560;C0024671;C0026410;C0439269;C1413716;C1960952;C2346927;C4048285;C4321396;C4521761";NA;NA;c reactive protein mg literj
 286;c - reactive protein ( mg / dl_ );"C0006560;C0439269;C1413716;C4048285";NA;NA;c reactive protein mg dl_
 286;c - reactive protein ( mg / dl );"C0006560;C0439269;C1413716;C4048285";NA;NA;c reactive protein mg dl
 286;c - reactive protein  u / l;"C0006560;C0439339;C1413716;C4048285";NA;NA;c reactive protein u l
 286;c - reactive protein;"C0006560;C1413716;C4048285";NA;NA;c reactive protein
 286;batellna c - reective protein;C0033684;NA;NA;batellna c reective protein
 285;proteinuria ( > $nmbr$ g / $nmbr$ h )  %;"C0033687;C0560020;C1962972;C4554346";NA;NA;proteinuria $nmbr$ g $nmbr$ h
 285;proteinuria $nmbr$ ( g / day );"C0033687;C0439417;C1962972;C4554346";NA;NA;proteinuria $nmbr$ g day
 285;protein in urine    ≥ $nmbr$ +;C0033687;NA;NA;protein in urine $nmbr$
 284;oriental;"C0078988;C0699027";NA;NA;oriental
 284;oretal;NA;NA;NA;oretal
 284;asian or oriental;"C0078988;C0699027";NA;NA;asian or oriental
 284;asian / oriental;"C0078988;C0699027";NA;NA;asian oriental
 283;origin [ n ( % ) ];"C0079946;C0439659;C1550512";NA;NA;origin n
 282;worsened;"C1457868;C4084902";NA;NA;worsened
 282;incident or worsening nephropathy;"C0022658;C0332271;C1457868;C1546960;C1551358";NA;NA;incident or worsening nephropathy
 282;hf symptom worsened;"C0018488;C1313497;C1457868;C1457887;C1538440;C3273279;C3854129;C4084902";NA;NA;hf symptom worsened
 282;copd worsening;"C0024117;C0332271;C1412502;C1457868;C1546960;C3714496";NA;NA;copd worsening
 281;post - menopausal without hormone replacement;C0019930;NA;NA;post menopausal without hormone replacement
 281;post - menopausal with hormone replacement;C0019930;NA;NA;post menopausal with hormone replacement
 280;hormones;C0019932;NA;NA;hormones
 280;estrogen - containing hormones;"C0014939;C0019932;C0332256;C2700400;C2936882;C4542544";NA;NA;estrogen containing hormones
 279;orthopnea  frequent / continuous;"C0085619;C0332183;C0549178";NA;NA;orthopnea frequent continuous
 279;orthopnea  ( % );C0085619;NA;NA;orthopnea
 279;orthopnea;C0085619;NA;NA;orthopnea
 278;lipid trial participants - n ( % );"C0023779;C1997894;C2242969";NA;NA;lipid trial participants n
 278;lipid trial participants #;"C0023779;C1997894;C2242969";NA;NA;lipid trial participants
 278;lipid trial participants  no . ( % );"C0023779;C1997894;C2242969";NA;NA;lipid trial participants no
 278;lipid trial participants;"C0023779;C1997894;C2242969";NA;NA;lipid trial participants
 278;lioid trial participants;"C1997894;C2242969";NA;NA;lioid trial participants
 278;limited i -;"C0021966;C0221138;C0439801;C2674459;C3542948;C4050251";NA;NA;limited i
 278;limited;"C0439801;C2674459;C3542948;C4050251";NA;NA;limited
 277;albiglutide events / patients ( %;"C0030705;C0441471;C2607479;C3541888";NA;NA;albiglutide events patients
 277;albiglutide ( n = $nmbr$ );C2607479;NA;NA;albiglutide n $nmbr$
 276;visits $nmbr$ e $nmbr$;"C0545082;C1512346;C2826704";NA;NA;visits $nmbr$ e $nmbr$
 276;visit;"C0545082;C1512346;C2826704";NA;NA;visit
 276;randomisation visit ( baseline );"C0034656;C0168634;C0545082;C1442488;C1512346;C2826704";NA;NA;randomisation visit baseline
 276;number of er visits in last year prior to baseline;"C0168634;C0237753;C0439234;C0439508;C0449788;C0545082;C1442488;C1512346;C2826704;C3810541;C3811131";NA;NA;number of er visits in last year prior to baseline
 276;no . with visit;"C0545082;C1512346;C2826704";NA;NA;no with visit
 276;last study visit;"C0545082;C0557651;C1512346;C1517741;C2603343;C2826704";NA;NA;last study visit
 276;er visit;"C0545082;C1512346;C2826704;C3810541;C3811131";NA;NA;er visit
 276;ed visit related to exacerbation  n ( % );"C0439849;C0445223;C0545082;C1512346;C2826704;C3538926;C4086268";NA;NA;ed visit related to exacerbation n
 276;ed severity  visit $nmbr$ * *;"C0439793;C0522510;C0545082;C1512346;C2826704;C3538926";NA;NA;ed severity visit $nmbr$
 276;ed duration  visit $nmbr$ * *;"C0449238;C0545082;C1512346;C2826704;C2926735;C3538926";NA;NA;ed duration visit $nmbr$
 274;dip joint arthritis;"C0003864;C0932510;C4552845";NA;NA;dip joint arthritis
 279;orthopaedic;C0029355;FALSE; -10;orthopaedic
 281;thyroid hormone;"C0040135;C4522017";FALSE; -10;thyroid hormone
 286;probenecid;C0033209;FALSE; -10;probenecid
 276;visit $nmbr$ blood pressures :;"C0545082;C1272641;C1512346;C2826704";FALSE;  15;visit $nmbr$ blood pressures
 276;types of antihypertensive medications at last visit   §;"C0003364;C0332307;C0545082;C1512346;C1517741;C2826704";FALSE;1579;types of antihypertensive medications at last visit
 283;stroke of atherosclerotic origin;"C0038454;C0079946;C0333482;C0439659;C1550512;C4554100";FALSE; 336;stroke of atherosclerotic origin
 287;angioedema present  n ( % ) {;"C0002994;C0150312;C0449450";FALSE;2364;angioedema present n
 287;angioedema present  n ( % ) $nmbr$;"C0002994;C0150312;C0449450";FALSE;2364;angioedema present n $nmbr$
 287;dm present;"C0011816;C0150312;C0449450;C3250443";FALSE; 909;dm present
 274;arthritis type *;"C0003864;C0332307;C1547052;C4552845";NA;NA;arthritis type
 274;arthritis characteristics;"C0003864;C1521970;C4552845";NA;NA;arthritis characteristics
 274;arthritis;"C0003864;C4552845";NA;NA;arthritis
 273;pharyngitis;"C0031350;C4553308";NA;NA;pharyngitis
 273;nasopharyngitis;C0027441;NA;NA;nasopharyngitis
 272;rhinitis;C0035455;NA;NA;rhinitis
 272;allergic rhinitis — no . ( % );"C1334103;C2607914;C4552864";NA;NA;allergic rhinitis no
 272;allergic rhinitis duration  mean ± sd  y *;"C0444504;C0449238;C1334103;C2347634;C2348143;C2607914;C2699239;C2926735;C4552864";NA;NA;allergic rhinitis duration mean sd y
 272;allergic rhinitis;"C1334103;C2607914;C4552864";NA;NA;allergic rhinitis
 271;randomised patients with enthesitis at baselinet;"C0030705;C1282952";NA;NA;randomised patients with enthesitis at baselinet
 271;patients with enthesitis at week $nmbr$  n ( % );"C0030705;C0332174;C0439230;C1282952";NA;NA;patients with enthesitis at week $nmbr$ n
 271;patients with enthesitis at baseline  no .;"C0030705;C0168634;C1282952;C1442488";NA;NA;patients with enthesitis at baseline no
 271;patients with enthesitis  no . ( % );"C0030705;C1282952";NA;NA;patients with enthesitis no
 271;patients with enthesitis  n ( % );"C0030705;C1282952";NA;NA;patients with enthesitis n
 271;patients with enthesitis;"C0030705;C1282952";NA;NA;patients with enthesitis
 271;patients with $ $nmbr$ dactylitis digit at week $nmbr$ enthesitis;"C0030705;C0332174;C0439230;C1282952;C3863761";NA;NA;patients with $ $nmbr$ dactylitis digit at week $nmbr$ enthesitis
 271;enthesitis score at baseline  median ( iqr ) week $nmbr$;"C0168634;C0332174;C0439230;C0449820;C0549183;C0876920;C1282952;C1442488;C2347635;C2348144;C2939193;C4050231";NA;NA;enthesitis score at baseline median iqr week $nmbr$
 271;enthesitis score *;"C0449820;C1282952;C4050231";NA;NA;enthesitis score
 271;enthesitis  n ( % );C1282952;NA;NA;enthesitis n
 271;enthesitis  % §;C1282952;NA;NA;enthesitis
 271;enthesitis;C1282952;NA;NA;enthesitis
 271;% improvement in enthesitis score at week $nmbr$  n;"C0332174;C0439230;C0449820;C1282952;C2986411;C4050231";NA;NA;improvement in enthesitis score at week $nmbr$ n
 270;pancolitis;C0868908;NA;NA;pancolitis
 270;extensive / pancolitis;"C0205231;C0868908";NA;NA;extensive pancolitis
 269;spondylitis;C0038012;NA;NA;spondylitis
 269;randomised patients with spondylitis at baseline  n;"C0030705;C0038012;C0168634;C1442488";NA;NA;randomised patients with spondylitis at baseline n
 268;chronic bronchitis ( n = $nmbr$ );C0008677;NA;NA;chronic bronchitis n $nmbr$
 268;chronic bronchitis ( itt ) ( n = $nmbr$ );C0008677;NA;NA;chronic bronchitis itt n $nmbr$
 268;chronic bronchitis ( % );C0008677;NA;NA;chronic bronchitis
 268;chronic bronchitis !;C0008677;NA;NA;chronic bronchitis
 268;chronic bronchitis;C0008677;NA;NA;chronic bronchitis
 268;bronchitis;C0006277;NA;NA;bronchitis
 267;diagnostic catheterization;C0596429;NA;NA;diagnostic catheterization
 267;cardiac catheterization;C0018795;NA;NA;cardiac catheterization
 266;ambition;C0870128;NA;NA;ambition
 265;toast classification;"C1710306;C4521230";NA;NA;toast classification
 265;patient classification;"C0008902;C0008903;C0030705;C0678229";NA;NA;patient classification
 265;pah classification — no . ( % );"C0008902;C0008903;C0030123;C0678229;C3203102;C4284467";NA;NA;pah classification no
 265;pah classification;"C0008902;C0008903;C0030123;C0678229;C3203102;C4284467";NA;NA;pah classification
 265;classification of af  no . ( % );"C0008902;C0008903;C0344434;C0678229;C4049859";NA;NA;classification of af no
 264;heavy calcification;"C0006660;C0006663;C0175895;C0439539;C1533591;C1879982;C2242558";NA;NA;heavy calcification
 264;calcification  n ( % );"C0006660;C0006663;C0175895;C1533591;C1879982;C2242558";NA;NA;calcification n
 263;intermittent claudication;C0021775;NA;NA;intermittent claudication
 263;claudication only;"C0021775;C0205171;C0311395;C1456822;C1720467";NA;NA;claudication only
 263;claudication ( fontaine class > $nmbr$ );"C0021775;C0311395;C0456387;C1456822;C1518526;C1705943";NA;NA;claudication fontaine class $nmbr$
 263;claudication;"C0021775;C0311395;C1456822";NA;NA;claudication
 262;dcct a $nmbr$ c;NA;NA;NA;dcct a $nmbr$ c
 262;ccv history / condition at baseline;"C0168634;C0683519;C1442488";NA;NA;ccv history condition at baseline
 262;ccv history / condition;C0683519;NA;NA;ccv history condition
 261;medications in the hospital after randomization — no . ( % );"C0013227;C0019994;C0034656;C0802604;C1510665;C2598133;C4284232";NA;NA;medications in the hospital after randomization no
 261;in - hospital medication;"C0013227;C0019994;C1510665;C3244316;C4284232";NA;NA;in hospital medication
 261;in - hospital;"C0019994;C1510665";NA;NA;in hospital
 260;hospitalized pneumonia events  n;"C0032285;C0441471;C0701159;C3541888";NA;NA;hospitalized pneumonia events n
 260;hospitalized angina;"C0002962;C0701159";NA;NA;hospitalized angina
 260;hospitalized !;C0701159;NA;NA;hospitalized
 260;hospitalized;C0701159;NA;NA;hospitalized
 258;time to death due to pah or hospitalization due to pah up to the end of the treatment periodd;"C0019993;C0030123;C0039798;C0087111;C0444930;C0547043;C0678226;C1301931;C1522326;C1533734;C1705169;C2746065;C3203102;C3538994;C3887704;C4284467";NA;NA;time to death due to pah or hospitalization due to pah up to the end of the treatment periodd
 268;sinusitis;"C0037199;C4553555";FALSE;1838;sinusitis
 268;synovitis;C0039103;FALSE;1839;synovitis
 270;tendonitis;C0039503;FALSE; -10;tendonitis
 271;uniti - $nmbr$;NA;FALSE; -10;uniti $nmbr$
 271;uveitis;"C0042164;C1963266";FALSE; -10;uveitis
 271;im - uniti;NA;FALSE; -10;im uniti
 271;bursitis;C0006444;FALSE; -10;bursitis
 272;cystitis;"C0010692;C0600041;C1963088";FALSE; -10;cystitis
 272;osteitis;C0029400;FALSE; -10;osteitis
 259;hospitalisation for heart failure;C3898876;FALSE;  12;hospitalisation for heart failure
 259;required hospitalization;C1708385;FALSE;  12;required hospitalization
 261;pci - hospital;"C0019994;C1510665;C4049621";FALSE;1661;pci hospital
 261;community hospital;C0020003;FALSE;2361;community hospital
 259;hospitalization for heart failure within previous $nmbr$ mo — no . ( % );"C0026544;C0205156;C0332177;C1552607;C3898876";FALSE; 824;hospitalization for heart failure within previous $nmbr$ mo no
 259;previous hospitalization for heart failure;"C0205156;C1552607;C3898876";FALSE; 824;previous hospitalization for heart failure
 259;cardiovascular death / hospitalization for heart failure;"C0007226;C0011065;C1306577;C3887460;C3898876;C4082313;C4552775";FALSE;  12;cardiovascular death hospitalization for heart failure
 259;hospitalization for heart failure;C3898876;FALSE;  12;hospitalization for heart failure
 261;community hospital ( % );C0020003;FALSE;2361;community hospital
 261;community hospital  n ( % );C0020003;FALSE;2361;community hospital n
 265;gold classification;"C0008902;C0008903;C0018026;C0678229;C1304897";FALSE; 213;gold classification
 265;classification of epilepsy type  n ( % );"C0008902;C0008903;C0014544;C0332307;C0678229;C1547052";FALSE;2362;classification of epilepsy type n
 265;diabetes mellitus classification;"C0008902;C0008903;C0011849;C0678229";FALSE; 907;diabetes mellitus classification
 266;infliximab combination therapy;"C0009429;C0205195;C0556895;C0666743;C1947911;C3811910;C4076075";FALSE; 154;infliximab combination therapy
 266;combination therapy * *;"C0009429;C0556895";FALSE;2363;combination therapy
 266;combination therapy  n = $nmbr$;"C0009429;C0556895";FALSE;2363;combination therapy n $nmbr$
 266;combination therapy ( n = $nmbr$ );"C0009429;C0556895";FALSE;2363;combination therapy n $nmbr$
 267;cardiac catheterisation or pci for index event;"C0018795;C0441471;C0600653;C0918012;C1552854;C1637833;C2986546;C4019010;C4049621";FALSE;1661;cardiac catheterisation or pci for index event
 258;medical therapy during index hospitalization — %;"C0019993;C0418981;C0600653;C0918012;C1552854;C1637833;C2986546";NA;NA;medical therapy during index hospitalization
 257;ct ratio > $nmbr$ . $nmbr$;"C0007673;C0456603;C1547037;C3540513;C3813556;C3888140";NA;NA;ct ratio $nmbr$ $nmbr$
 257;ct ratio ( % );"C0007673;C0456603;C1547037;C3540513;C3813556;C3888140";NA;NA;ct ratio
 257;ct + tt;"C0007673;C1452561;C3540513;C3813556;C3888140;C4554543";NA;NA;ct tt
 257;ct;"C0007673;C3540513;C3813556;C3888140";NA;NA;ct
 256;icd or crt - d;C0021122;NA;NA;icd or crt d
 256;icd / crt - d  n ( % );C0021122;NA;NA;icd crt d n
 256;crt - p + d  n ( % );NA;NA;NA;crt p d n
 256;crt - p;NA;NA;NA;crt p
 256;crt - d;NA;NA;NA;crt d
 256;crt;NA;NA;NA;crt
 255;it $nmbr$ . $nmbr$;NA;NA;NA;it $nmbr$ $nmbr$
 255;copd assessment test ( cat ) score;"C0007450;C0325090;C0449820;C0524517;C1443200;C3665481;C4050231;C4050461;C4284282";NA;NA;copd assessment test cat score
 255;comparison : cat . $nmbr$ vs . cat . $nmbr$;"C0007450;C0325090;C0524517;C1443200;C1707455;C3665481;C4050461;C4284282";NA;NA;comparison cat $nmbr$ vs cat $nmbr$
 255;cat total score $nmbr$;"C0007450;C0325090;C0524517;C1443200;C2964552;C3665481;C4050461;C4284282";NA;NA;cat total score $nmbr$
 255;cat total score;"C0007450;C0325090;C0524517;C1443200;C2964552;C3665481;C4050461;C4284282";NA;NA;cat total score
 255;cat scoreff;"C0007450;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282";NA;NA;cat scoreff
 255;cat score category;"C0007450;C0325090;C0449820;C0524517;C0683312;C1443200;C3665481;C3889287;C4050231;C4050461;C4284282";NA;NA;cat score category
 255;cat score  mean ( sd );"C0007450;C0325090;C0444504;C0449820;C0524517;C1443200;C2347634;C2348143;C2699239;C3665481;C4050231;C4050461;C4284282";NA;NA;cat score mean sd
 255;cat score;"C0007450;C0325090;C0449820;C0524517;C1443200;C3665481;C4050231;C4050461;C4284282";NA;NA;cat score
 255;cat > = $nmbr$ ( n = $nmbr$  $nmbr$ );"C0007450;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282";NA;NA;cat $nmbr$ n $nmbr$ $nmbr$
 255;cat > = $nmbr$;"C0007450;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282";NA;NA;cat $nmbr$
 255;cat > $nmbr$;"C0007450;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282";NA;NA;cat $nmbr$
 255;cat < $nmbr$;"C0007450;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282";NA;NA;cat $nmbr$
 255;cat . $nmbr$ n / n ( % );"C0007450;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282";NA;NA;cat $nmbr$ n n
 255;$nmbr$ % cit;"C0008864;C0523573;C1427027;C4553421";NA;NA;$nmbr$ cit
 254;p value ( on vs off omt );C1709380;NA;NA;p value on vs off omt
 254;on omt ( n = $nmbr$ );NA;NA;NA;on omt n $nmbr$
 254;on omt;NA;NA;NA;on omt
 254;oma / oat ( n   =   $nmbr$ );"C0028753;C0331496;C0939905;C3539067;C3897364";NA;NA;oma oat n $nmbr$
 254;oma / oat;"C0028753;C0331496;C0939905;C3539067;C3897364";NA;NA;oma oat
 254;oat ( n   =   $nmbr$ );"C0028753;C0331496;C0939905;C3539067;C3897364";NA;NA;oat n $nmbr$
 254;oat;"C0028753;C0331496;C0939905;C3539067;C3897364";NA;NA;oat
 253;zt = $nmbr$;NA;NA;NA;zt $nmbr$
 253;ra ndosii zat ion;"C0022023;C1700702;C3538806;C4048756";NA;NA;ra ndosii zat ion
 252;without dvt dvt alone;"C0149871;C0205171;C0439044;C0679994;C2926618;C3899446";NA;NA;without dvt dvt alone
 252;treatment period index dvt : event;"C0039798;C0087111;C0149871;C0439531;C0441471;C0600653;C0918012;C1522326;C1533734;C1552854;C1637833;C1705169;C1948053;C2926618;C2986546;C3538994;C3887704;C3899446;C4019010";NA;NA;treatment period index dvt event
 252;only dvt;"C0149871;C0205171;C1720467;C2926618;C3899446";NA;NA;only dvt
 252;locafon of index dvt;"C0149871;C0600653;C0918012;C1552854;C1637833;C2926618;C2986546;C3899446";NA;NA;locafon of index dvt
 252;kheeatne index dvt;"C0149871;C0600653;C0918012;C1552854;C1637833;C2926618;C2986546;C3899446";NA;NA;kheeatne index dvt
 252;dvt only;"C0149871;C0205171;C1720467;C2926618;C3899446";NA;NA;dvt only
 252;dvt;"C0149871;C2926618;C3899446";NA;NA;dvt
 252;concomitant dvt — no . ( % ) baseline nt - probnp — no . ( % );"C0149871;C0168634;C0521115;C0669479;C0754710;C1442488;C2926618;C3899446";NA;NA;concomitant dvt no baseline nt probnp no
 252;concomitant dvt  n ( % );"C0149871;C0521115;C2926618;C3899446";NA;NA;concomitant dvt n
 252;acute dvt study;"C0149871;C0205178;C0557651;C2603343;C2926618;C3899446";NA;NA;acute dvt study
 251;tt;"C1452561;C4554543";NA;NA;tt
 251;tgt;"C1421391;C1428265;C4321338";NA;NA;tgt
 251;low tt < $nmbr$ . $nmbr$ ( n = $nmbr$ );"C0205251;C1452561;C1550472;C3890211;C4048187;C4321351;C4522223;C4554543";NA;NA;low tt $nmbr$ $nmbr$ n $nmbr$
 250;p value by gt;"C1435727;C1704693;C1709380;C2697657";NA;NA;p value by gt
 250;gt + tt;"C1435727;C1452561;C1704693;C2697657;C4554543";NA;NA;gt tt
 250;gt;"C1435727;C1704693;C2697657";NA;NA;gt
 249;psa ‐ modified shs of hands and feet;"C0016504;C0018563;C0347981;C0392747;C1552914;C3810537;C3813209;C3889737";NA;NA;psa modified shs of hands and feet
 249;psa - modified shs of hands & feet $nmbr$ ( $nmbr$ - $nmbr$ );"C0016504;C0018563;C0347981;C0392747;C1552914;C3810537;C3813209;C3889737";NA;NA;psa modified shs of hands feet $nmbr$ $nmbr$ $nmbr$
 257;ct findings;"C0007673;C2607943;C2926606;C3539655;C3540513;C3813556;C3888140";FALSE;2357;ct findings
 258;hospitalisation;C0019993;FALSE;2358;hospitalisation
 258;hospitalization;C0019993;FALSE;2358;hospitalization
 258;hospitalization for;C0019993;FALSE;2358;hospitalization for
 258;hospitalization for / due to;C0019993;FALSE;2358;hospitalization for due to
 258;hospitalizations;C0019993;FALSE;2358;hospitalizations
 258;hospitalization  n ( % );C0019993;FALSE;2358;hospitalization n
 258;hospitalizations  n;C0019993;FALSE;2358;hospitalizations n
 258;hospitalization stratum  n ( % );C0019993;FALSE;2358;hospitalization stratum n
 258;hf hospitalization;"C0018488;C0019993;C1313497;C1538440;C3273279";FALSE;2359;hf hospitalization
 258;hf hospitalizations  median ( iqr );"C0018488;C0019993;C0549183;C0876920;C1313497;C1538440;C2347635;C2348144;C2939193;C3273279";FALSE;2359;hf hospitalizations median iqr
 258;hospitalization for hf;"C0018488;C0019993;C1313497;C1538440;C3273279";FALSE;2359;hospitalization for hf
 258;prior hf hospitalization;"C0018488;C0019993;C0332152;C1313497;C1538440;C2826257;C3273279";FALSE;2359;prior hf hospitalization
 258;prior hf hospitalization ( n = $nmbr$ );"C0018488;C0019993;C0332152;C1313497;C1538440;C2826257;C3273279";FALSE;2359;prior hf hospitalization n $nmbr$
 258;prior hospitalization for hf  %;"C0018488;C0019993;C0332152;C1313497;C1538440;C2826257;C3273279";FALSE;2359;prior hospitalization for hf
 258;hospitalization for unstable ap;"C0002680;C0019993;C0443343;C1883468;C3887950";FALSE;2360;hospitalization for unstable ap
 258;previous hospitalization for unstable angina;"C0002965;C0019993;C0205156;C1552607";FALSE;2360;previous hospitalization for unstable angina
 258;pci during index hospitalization;"C0019993;C0600653;C0918012;C1552854;C1637833;C2986546;C4049621";FALSE;1661;pci during index hospitalization
 249;msfc timed $nmbr$ - foot walk test .;"C0016504;C0347981;C0392761;C2346504;C2348613;C2348704;C4277740";NA;NA;msfc timed $nmbr$ foot walk test
 249;feet;"C0016504;C0347981";NA;NA;feet
 248;patients ( ft );"C0030705;C1881534;C3890579";NA;NA;patients ft
 248;> $nmbr$ ft;"C1881534;C3890579";NA;NA;$nmbr$ ft
 248;< $nmbr$ ft;"C1881534;C3890579";NA;NA;$nmbr$ ft
 248;$nmbr$ - $nmbr$ ft;"C1881534;C3890579";NA;NA;$nmbr$ $nmbr$ ft
 247;rest ofworld;"C0035253;C1622890";NA;NA;rest ofworld
 247;rest ofthe world;"C0035253;C1622890;C2700280";NA;NA;rest ofthe world
 247;rest of world n z $nmbr$;"C0035253;C1622890;C2700280";NA;NA;rest of world n z $nmbr$
 247;rest of world;"C0035253;C1622890;C2700280";NA;NA;rest of world
 247;rest of the world;"C0035253;C1622890;C2700280";NA;NA;rest of the world
 247;rest - of - world ( n = $nmbr$ );"C0035253;C1622890;C2700280";NA;NA;rest of world n $nmbr$
 246;st - $nmbr$ ( ng / ml );"C0036056;C0439275;C3272372";NA;NA;st $nmbr$ ng ml
 246;st -;"C0036056;C3272372";NA;NA;st
 246;st +;"C0036056;C3272372";NA;NA;st
 246;st ( arc definite only );"C0036056;C0205171;C0439544;C1704787;C1720467;C3272372";NA;NA;st arc definite only
 246;st;"C0036056;C3272372";NA;NA;st
 246;key secondary end point : st;"C0036056;C3272372;C4528314";NA;NA;key secondary end point st
 246;death / st;"C0011065;C0036056;C1306577;C3272372;C4082313;C4552775";NA;NA;death st
 246;death / mi / idr / st;"C0011065;C0036056;C1306577;C3272372;C3810814;C4082313;C4552775";NA;NA;death mi idr st
 246;death  mi  idr  st  or gusto mod / sev bleeding;"C0011065;C0011860;C0019080;C0036056;C0439793;C0458216;C1306577;C2983285;C3272372;C3810814;C4082313;C4552775";NA;NA;death mi idr st or gusto mod sev bleeding
 246;death  mi  idr  st  or any timi bleeding;"C0011065;C0019080;C0036056;C1306577;C3272372;C3810814;C4082313;C4552775";NA;NA;death mi idr st or any timi bleeding
 246;death  mi  idr  or st;"C0011065;C0036056;C1306577;C3272372;C3810814;C4082313;C4552775";NA;NA;death mi idr or st
 246;copd medication taken for at least $nmbr$ months before st;"C0013227;C0024117;C0036056;C0439231;C1412502;C1883727;C3244316;C3272372;C3714496;C4284232";NA;NA;copd medication taken for at least $nmbr$ months before st
 246;> $nmbr$ st and < $nmbr$ nd quartile;"C0036056;C2828255;C3272372";NA;NA;$nmbr$ st and $nmbr$ nd quartile
 246;< $nmbr$ st quartile;"C0036056;C2828255;C3272372";NA;NA;$nmbr$ st quartile
 246;$nmbr$ st < $nmbr$ . $nmbr$;"C0036056;C3272372";NA;NA;$nmbr$ st $nmbr$ $nmbr$
 246;$nmbr$ st : $nmbr$ - $nmbr$ . $nmbr$ pmol / l;"C0036056;C0439284;C3272372";NA;NA;$nmbr$ st $nmbr$ $nmbr$ $nmbr$ pmol l
 246;$nmbr$ days definite st;"C0036056;C0439228;C0439544;C1704787;C3272372";NA;NA;$nmbr$ days definite st
 246;$nmbr$ days composite of death / new mi / urgent revascularization and definite st;"C0011065;C0036056;C0205199;C0439544;C0439609;C0581603;C1306577;C1547335;C1704787;C3272275;C3272372;C3810814;C4082313;C4552775;C4689466";NA;NA;$nmbr$ days composite of death new mi urgent revascularization and definite st
 245;post svc;"C0231957;C0687676;C1704687;C3469826";NA;NA;post svc
 245;post hoc analysis;"C0002778;C0687676;C0936012;C1524024;C1704687;C3469826";NA;NA;post hoc analysis
 244;post - mi;C0856742;NA;NA;post mi
 243;mostly satisfied;"C0205393;C0242428;C0750554;C4049977;C4084799";NA;NA;mostly satisfied
 242;trend / het . test;"C0022885;C0039593;C0392366;C0456984;C0898753;C1335803;C1515976;C1521798;C1704827;C3831328;C4318744;C4554533";NA;NA;trend het test
 242;test for trend;"C0022885;C0039593;C0392366;C0456984;C1515976;C1521798;C3831328;C4318744;C4554533";NA;NA;test for trend
 242;test for interaction between treatment and race;"C0022885;C0034510;C0039593;C0039798;C0087111;C0392366;C0456984;C1515976;C1522326;C1533734;C1704675;C1705169;C1706779;C3538994;C3831328;C3853635;C3887704;C4318744";NA;NA;test for interaction between treatment and race
 242;test for interaction;"C0022885;C0039593;C0392366;C0456984;C1515976;C1704675;C3831328;C4318744";NA;NA;test for interaction
 242;ppg post - meal test  mmol / l;"C0022885;C0039593;C0376674;C0392366;C0456984;C1418888;C1515976;C1532563;C3831328;C4318744";NA;NA;ppg post meal test mmol l
 242;positive orthostatic test };"C0022885;C0039593;C0231472;C0392366;C0439178;C0456984;C1446409;C1514241;C1515976;C2825490;C3812269;C3831328;C4318744";NA;NA;positive orthostatic test
 242;positive cu index test  z n ( % );"C0022885;C0039593;C0392366;C0439178;C0456984;C0600653;C0918012;C1177210;C1446409;C1514241;C1515976;C1552854;C1637833;C2347872;C2825490;C2986546;C3812269;C3831328;C4318744";NA;NA;positive cu index test z n
 242;positive cu index test;"C0022885;C0039593;C0392366;C0439178;C0456984;C0600653;C0918012;C1177210;C1446409;C1514241;C1515976;C1552854;C1637833;C2347872;C2825490;C2986546;C3812269;C3831328;C4318744";NA;NA;positive cu index test
 242;orthostatic test *;"C0022885;C0039593;C0231472;C0392366;C0456984;C1515976;C3831328;C4318744";NA;NA;orthostatic test
 242;likelihood test;"C0022885;C0033204;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744";NA;NA;likelihood test
 242;laboratory tests;C0022885;NA;NA;laboratory tests
 242;laboratory testing;C0022885;NA;NA;laboratory testing
 242;heterogeneity test;"C0019409;C0022885;C0039593;C0242960;C0392366;C0456984;C1515976;C3831328;C4318744";NA;NA;heterogeneity test
 242;heterogeneity / trend test;"C0019409;C0022885;C0039593;C0242960;C0392366;C0456984;C1515976;C1521798;C3831328;C4318744;C4554533";NA;NA;heterogeneity trend test
 243;most frequent infections;"C0205393;C0239998";FALSE;2353;most frequent infections
 243;mostly dissatisfied;"C0205393;C0750554;C0870433;C4085546";FALSE;2354;mostly dissatisfied
 244;timi flow grade $nmbr$ of mi culprit vessel post ‐ pci;"C0005847;C0441800;C0856742;C0919553;C3244287;C3272266;C4049621";FALSE;2355;timi flow grade $nmbr$ of mi culprit vessel post pci
 245;post fvc;"C0687676;C1704687;C3469826;C3714541";FALSE; 680;post fvc
 245;fev $nmbr$ / fvc  post - albuterol  %;"C0001927;C0687676;C1704687;C3469826;C3714541";FALSE; 680;fev $nmbr$ fvc post albuterol
 245;post - cabg;"C0010055;C0687676;C1704687;C3469826";FALSE; 389;post cabg
 246;st - t wavett;"C0036056;C3272372";FALSE;2356;st t wavett
 246;st - t wave  n ( % );"C0036056;C0429103;C3272372";FALSE;2356;st t wave n
 246;st - t wave  no . ( % );"C0036056;C0429103;C3272372";FALSE;2356;st t wave no
 246;st - t waveft;"C0036056;C3272372";FALSE;2356;st t waveft
 246;st - t wave changes;"C0036056;C0392747;C0429103;C0443172;C1705241;C3272372;C4319952";FALSE;2356;st t wave changes
 246;st / t wave;"C0036056;C0429103;C3272372";FALSE;2356;st t wave
 246;st - t wave abnormality d;"C0036056;C1839341;C3272372";FALSE;2356;st t wave abnormality d
 246;st ‐ str ≥ $nmbr$ % post pci;"C0036056;C0687676;C1704687;C3272372;C3469826;C4049621";FALSE;2356;st str $nmbr$ post pci
 246;st change > $nmbr$ mm;"C0036056;C0392747;C0443172;C1705241;C3272372;C4319952;C4330985;C4554674";FALSE;2356;st change $nmbr$ mm
 246;st - segment deviation > $nmbr$ mm — no . / total no . ( % );"C0012727;C0036056;C0205419;C0429029;C0429066;C0439175;C0439810;C0441635;C1114722;C1116089;C1705236;C3272372;C4330985;C4554674";FALSE;2356;st segment deviation $nmbr$ mm no total no
 246;triglycerides $nmbr$ st third;"C0036056;C0041004;C0205437;C3272372";FALSE; 209;triglycerides $nmbr$ st third
 247;aapo $nmbr$ at rest  mm hg;"C0035253;C0439475;C1622890";FALSE; -10;aapo $nmbr$ at rest mm hg
 247;pao $nmbr$ at rest  mm hg;"C0035253;C0232555;C0439475;C1423784;C1427155;C1622890;C4318615";FALSE; -10;pao $nmbr$ at rest mm hg
 242;dfisher ' s exact test .;"C0022885;C0039593;C0392366;C0456984;C1515976;C2828393;C3831328;C4050514;C4318744";NA;NA;dfisher s exact test
 242;cu index test  n ( % ) $nmbr$;"C0022885;C0039593;C0392366;C0456984;C0600653;C0918012;C1177210;C1515976;C1552854;C1637833;C2347872;C2986546;C3831328;C4318744";NA;NA;cu index test n $nmbr$
 242;cfisher ' s exact test .;"C0022885;C0039593;C0392366;C0456984;C1515976;C2828393;C3831328;C4050514;C4318744";NA;NA;cfisher s exact test
 241;ratio to baseline in total ige at week $nmbr$  geometric mean ( se on loge scale ) u / ml;"C0036919;C0168634;C0175659;C0332174;C0349674;C0439230;C0439340;C0456603;C0806481;C1442488;C1547037;C1880521;C1947916;C2697934;C2945590;C2986759";NA;NA;ratio to baseline in total ige at week $nmbr$ geometric mean se on loge scale u ml
 241;geometric mean uacr;C2986759;NA;NA;geometric mean uacr
 241;geometric mean of baseline;"C0168634;C1442488;C2986759";NA;NA;geometric mean of baseline
 241;geometric mean ige on loge scale — u / ml;"C0175659;C0349674;C0439340;C1880521;C1947916;C2697934;C2945590;C2986759";NA;NA;geometric mean ige on loge scale u ml
 241;geometric mean;C2986759;NA;NA;geometric mean
 241;baseline geometric mean ( $nmbr$ ® / l );"C0168634;C1442488;C2986759";NA;NA;baseline geometric mean $nmbr$ l
 239;no mra at baseline;"C0168634;C0243032;C1442488;C1609165;C3891069";NA;NA;no mra at baseline
 239;mra use;"C0042153;C0243032;C0457083;C1609165;C1947944;C3891069";NA;NA;mra use
 239;mra regimen ( n - $nmbr$ );"C0040808;C0243032;C1609165;C2945654;C3891069";NA;NA;mra regimen n $nmbr$
 239;mra at baseline;"C0168634;C0243032;C1442488;C1609165;C3891069";NA;NA;mra at baseline
 239;mra  ( % );"C0243032;C1609165;C3891069";NA;NA;mra
 239;mra;"C0243032;C1609165;C3891069";NA;NA;mra
 238;cuban;C1553379;NA;NA;cuban
 237;ua ( n = $nmbr$ );"C0041580;C0042014";NA;NA;ua n $nmbr$
 237;ua;"C0041580;C0042014";NA;NA;ua
 237;serum ua < $nmbr$ mg / dl by month $nmbr$;"C0041580;C0042014;C0229671;C0332177;C0439231;C0439269;C1546774;C1550100";NA;NA;serum ua $nmbr$ mg dl by month $nmbr$
 236;with treatment;"C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;with treatment
 236;vka therapy;"C0039798;C0087111;C1363945";NA;NA;vka therapy
 236;treatment   ×   lipid interaction;"C0023779;C0039798;C0087111;C1522326;C1533734;C1704675;C1705169;C3538994;C3887704";NA;NA;treatment lipid interaction
 236;treatment with candesartan;"C0039798;C0087111;C0717550;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;treatment with candesartan
 236;treatment with anti - platelet drugs;"C0039798;C0087111;C1522326;C1533734;C1705169;C2963157;C3538994;C3887704";NA;NA;treatment with anti platelet drugs
 236;treatment groups [ n / nb ( % ) ];"C0028101;C0039798;C0087111;C0441848;C0919442;C1522326;C1533734;C1705169;C1705347;C3538994;C3887704;C4553907";NA;NA;treatment groups n nb
 236;treatment groups  n ( % );"C0039798;C0087111;C0441848;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;treatment groups n
 236;treatment group;"C0039798;C0087111;C0441833;C0687744;C1257890;C1519504;C1522326;C1533734;C1705169;C1705428;C1705429;C3538994;C3887704";NA;NA;treatment group
 236;treatment glargine;"C0039798;C0087111;C0907402;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;treatment glargine
 236;treatment for latent tuberculosis ^;"C0039798;C0087111;C0205275;C0749724;C1522326;C1533734;C1609538;C1705169;C3538994;C3887704";NA;NA;treatment for latent tuberculosis
 236;treatment difference  ml;"C0039798;C0087111;C0439526;C1522326;C1533734;C1705169;C1705224;C1705241;C1705242;C3538994;C3887665;C3887704";NA;NA;treatment difference ml
 236;treatment difference;"C0039798;C0087111;C1522326;C1533734;C1705169;C1705241;C1705242;C3538994;C3887704";NA;NA;treatment difference
 236;treatment characteristics;"C0039798;C0087111;C1521970;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;treatment characteristics
 236;treatment by subgroup interaction;"C0039798;C0087111;C1079230;C1515021;C1522326;C1533734;C1704675;C1705169;C3538994;C3887704";NA;NA;treatment by subgroup interaction
  67;rolofylline;C0166128;NA;NA;rolofylline
 236;with corticosteroid treatment > $nmbr$;"C0001617;C0039798;C0087111;C1522326;C1533734;C1705169;C3536709;C3538994;C3887704";FALSE;1348;with corticosteroid treatment $nmbr$
 236;treatment with drugeluting stent;"C0039798;C0087111;C1322815;C1522326;C1533734;C1705169;C3538994;C3887704";FALSE; 365;treatment with drugeluting stent
 237;russia / ukraine / belarus;"C0006539;C0035970;C0041580";FALSE;2348;russia ukraine belarus
 238;riva roxa ban n / n { % ) $nmbr$ ( $nmbr$ . $nmbr$ );"C0683610;C4553947";FALSE;1792;riva roxa ban n n $nmbr$ $nmbr$ $nmbr$
 237;ukraine;C0041580;FALSE;2349;ukraine
 238;poba  n ( % );NA;FALSE; -10;poba n
 239;magnetic resonance angiography;C0243032;FALSE;2350;magnetic resonance angiography
 240;hbai;NA;FALSE; 820;hbai
 240;hbaic ( % );NA;FALSE; 820;hbaic
 240;hbaic — %;NA;FALSE; 820;hbaic
 240;hbaic ( % )  mean ± s . d .;"C0444504;C2347634;C2348143";FALSE; 820;hbaic mean s d
 240;hbaie ( % );NA;FALSE; 820;hbaie
 240;hbaie  %;NA;FALSE; 820;hbaie
 240;hbaie ( % ) mean ± sd;"C0444504;C2347634;C2348143;C2699239";FALSE; 820;hbaie mean sd
 240;hbalc  %;NA;FALSE; 820;hbalc
 240;hbalc ( % );NA;FALSE; 820;hbalc
 240;hbalc  %  mean ( sd );"C0444504;C2347634;C2348143;C2699239";FALSE; 820;hbalc mean sd
 240;hbalc  mean ( s . d . );"C0444504;C2347634;C2348143";FALSE; 820;hbalc mean s d
 240;hbalc ( % )  mean ( sd ) ^;"C0444504;C2347634;C2348143;C2699239";FALSE; 820;hbalc mean sd
 240;hbalc > = $nmbr$ % ( n - $nmbr$ );NA;FALSE; 820;hbalc $nmbr$ n $nmbr$
 240;mean hbaic = • = s . d .  %;"C0444504;C2347634;C2348143";FALSE; 820;mean hbaic s d
 240;mean ( s . d . ) hbalc  %;"C0444504;C2347634;C2348143";FALSE; 820;mean s d hbalc
 241;geometric mean blood eosinophil count on loge scale — cells / ^ ljj;"C0175659;C0200638;C0349674;C1947916;C2697934;C2986759";FALSE; 849;geometric mean blood eosinophil count on loge scale cells ljj
 241;geometric mean blood eosinophil count ( sd on a loge scale ) — cells / mm $nmbr$;"C0175659;C0200638;C0349674;C1947916;C2697934;C2699239;C2986759;C4330985;C4554674";FALSE; 849;geometric mean blood eosinophil count sd on a loge scale cells mm $nmbr$
 242;atopic ( based on phadiatop test );"C0022885;C0039593;C0392366;C0392707;C0456984;C1441070;C1515976;C1527178;C1705938;C3831328;C4318744";FALSE;2351;atopic based on phadiatop test
 242;atopy by phadiatop test  n ( % );"C0022885;C0039593;C0392366;C0392707;C0456984;C1441070;C1515976;C3539705;C3831328;C4318744";FALSE;2351;atopy by phadiatop test n
 236;treatment before randomization  %;"C0034656;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;treatment before randomization
 236;treatment before catheterization;"C0007430;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;treatment before catheterization
 236;treatment at baseline;"C0039798;C0087111;C0168634;C1442488;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;treatment at baseline
 236;treatment and parameter;"C0039798;C0087111;C0549193;C1522326;C1533734;C1704769;C1705169;C2350001;C3538994;C3887704";NA;NA;treatment and parameter
 236;treatment - by - subgroup interaction  p = $nmbr$ . $nmbr$;"C0039798;C0087111;C1079230;C1515021;C1522326;C1533734;C1704675;C1705169;C3538994;C3887704";NA;NA;treatment by subgroup interaction p $nmbr$ $nmbr$
 236;treatment - by - subgroup interaction;"C0039798;C0087111;C1079230;C1515021;C1522326;C1533734;C1704675;C1705169;C3538994;C3887704";NA;NA;treatment by subgroup interaction
 236;treatment  n ( % );"C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;treatment n
 236;treatment;"C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;treatment
 236;total by treatment;"C0039798;C0087111;C0439175;C0439810;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;total by treatment
 236;topical therapy;"C0039798;C0087111;C0332237;C1363945";NA;NA;topical therapy
 236;time since cessation of full - dose warfarin therapy;"C0039798;C0040223;C0087111;C0178602;C0366686;C0443225;C0869039;C1114758;C1363945;C1880019;C3541383;C4303340";NA;NA;time since cessation of full dose warfarin therapy
 236;time from symptoms to treatment;"C0039798;C0040223;C0087111;C0683368;C1457887;C1522326;C1533734;C1705169;C3538994;C3541383;C3887704";NA;NA;time from symptoms to treatment
 236;any treatment - emergent ae;"C0039798;C0087111;C0750573;C1522326;C1533734;C1705169;C3538994;C3887670;C3887704";NA;NA;any treatment emergent ae
 207;≤ $nmbr$ ug / g;C0439272;NA;NA;$nmbr$ ug g
 236;time between cessation of full - dose warfarin therapy and enrollment ( mo );"C0026544;C0039798;C0087111;C0178602;C0332177;C0366686;C0682295;C0869039;C1114758;C1363945;C1516879;C1696073;C1880019;C3888021;C4303340";NA;NA;time between cessation of full dose warfarin therapy and enrollment mo
 236;thrombolytic treatment before randomization;"C0016018;C0034656;C0039798;C0087111;C0520997;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;thrombolytic treatment before randomization
 236;therapy;"C0039798;C0087111;C1363945";NA;NA;therapy
 236;therapies;C0087111;NA;NA;therapies
 236;table $nmbr$ baseline characteristics of total study sample and stratified by treatment assignment and testosterone levela;"C0039224;C0039601;C0039798;C0087111;C0168634;C0205363;C0370003;C0947343;C1315074;C1442488;C1516050;C1522326;C1533734;C1705169;C1706074;C2347026;C3538994;C3887704;C4684572";NA;NA;table $nmbr$ baseline characteristics of total study sample and stratified by treatment assignment and testosterone levela
 236;sulfasalazine treatment;"C0036078;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;sulfasalazine treatment
 236;subgroup treatment;"C0039798;C0087111;C1079230;C1515021;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;subgroup treatment
 236;refractory to such therapy — no . ( % );"C0039798;C0087111;C0205269;C1363945";NA;NA;refractory to such therapy no
 236;receiving insulin therapy;"C0021641;C0039798;C0087111;C1363945;C1514756;C1533581;C1579433;C3714501";NA;NA;receiving insulin therapy
 236;randomized treatment  % ( n );"C0034656;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3815594;C3887704";NA;NA;randomized treatment n
 236;randomized treatment;"C0034656;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3815594;C3887704";NA;NA;randomized treatment
 236;randomised treatment;"C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;randomised treatment
 236;previous treatment with tnf antagonist — no . ( % ) §;"C0039798;C0087111;C0205156;C0231491;C1448177;C1522326;C1533734;C1552607;C1705169;C3538994;C3887704";NA;NA;previous treatment with tnf antagonist no
 236;previous treatment ?;"C0039798;C0087111;C0205156;C1522326;C1533734;C1552607;C1705169;C3538994;C3887704";NA;NA;previous treatment
 236;previous treatment;"C0039798;C0087111;C0205156;C1522326;C1533734;C1552607;C1705169;C3538994;C3887704";NA;NA;previous treatment
 236;pretreatment / concomitant treatment;"C0039798;C0087111;C0521115;C1522326;C1533734;C1550147;C1705169;C2709094;C3538994;C3539075;C3539076;C3887704";NA;NA;pretreatment concomitant treatment
 236;prestudy treatment ( % ) a;"C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;prestudy treatment a
 236;other treatment assignment;"C0039798;C0087111;C1516050;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;other treatment assignment
 236;oab therapy;"C0039798;C0087111;C1363945";NA;NA;oab therapy
 236;noninsulin therapy;"C0039798;C0087111;C1363945";NA;NA;noninsulin therapy
 236;no pah therapy;"C0030123;C0039798;C0087111;C1363945;C3203102;C4284467";NA;NA;no pah therapy
 236;no pah - specific therapy;"C0030123;C0039798;C0087111;C0205369;C1363945;C1552740;C3203102;C4284467";NA;NA;no pah specific therapy
 236;no . of background glucose - lowering therapies  no . ( % );"C0017725;C0087111;C0441994;C1706907;C2003888";NA;NA;no of background glucose lowering therapies no
 236;naive to antihyperglycemic agent therapy;"C0020616;C0039798;C0087111;C0450442;C1254351;C1363945;C1521826";NA;NA;naive to antihyperglycemic agent therapy
 236;month $nmbr$ subgroup x treatment interaction p - value;"C0039798;C0087111;C0332177;C0439231;C1079230;C1515021;C1522326;C1533734;C1704675;C1705169;C1709380;C3538994;C3887704";NA;NA;month $nmbr$ subgroup x treatment interaction p value
 236;mean treatment exposure  wk;"C0039798;C0087111;C0274281;C0332157;C0332174;C0439230;C0444504;C1522326;C1533734;C1705169;C2347634;C2348143;C3538994;C3887704";NA;NA;mean treatment exposure wk
 236;long term vka therapy;"C0039798;C0087111;C0443252;C1363945";NA;NA;long term vka therapy
 236;long - term vka therapy;"C0039798;C0087111;C0443252;C1363945";NA;NA;long term vka therapy
 236;initial treatment randomization;"C0034656;C0039798;C0087111;C0205265;C1279901;C1522326;C1533734;C1555582;C1705169;C1705685;C3538994;C3887704";NA;NA;initial treatment randomization
 236;ineffective therapy;"C0039798;C0087111;C1363945;C3242229";NA;NA;ineffective therapy
 236;icd therapy vs . placebo no . hazard ratio ( $nmbr$ . $nmbr$ % cl );"C0021122;C0032042;C0039798;C0087111;C0596019;C1363945;C1696465;C1706408;C2985465";NA;NA;icd therapy vs placebo no hazard ratio $nmbr$ $nmbr$ cl
 236;icd therapy ( n =;"C0021122;C0039798;C0087111;C1363945";NA;NA;icd therapy n
 236;h $nmbr$ blocker ( n  % ) long - term vka therapy;"C0033727;C0039798;C0087111;C0369286;C0441932;C0443252;C0564385;C1363945;C4528284";NA;NA;h $nmbr$ blocker n long term vka therapy
 236;epa treatment ( n = $nmbr$ );"C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;epa treatment n $nmbr$
 229;primary pci no .;"C0205225;C0439612;C0439631;C4049621";FALSE;2340;primary pci no
 236;insulin therapy;"C0021641;C0039798;C0087111;C1363945;C1533581;C1579433;C3714501";FALSE;2347;insulin therapy
 236;insulin therapy  n ( % );"C0021641;C0039798;C0087111;C1363945;C1533581;C1579433;C3714501";FALSE;2347;insulin therapy n
 236;insulin therapy  n ( % ) 本;"C0021641;C0039798;C0087111;C1363945;C1533581;C1579433;C3714501";FALSE;2347;insulin therapy n
 236;ldl cholesterol - lowering therapy;"C0023824;C0039798;C0087111;C0202117;C0441994;C1363945;C2003888";FALSE;1773;ldl cholesterol lowering therapy
 236;ics / laba therapy  n ( % );"C0039798;C0087111;C0815320;C1363945;C4551720";FALSE;2182;ics laba therapy n
 236;hypoglycaemic therapy;"C0020616;C0039798;C0087111;C1363945";FALSE;  33;hypoglycaemic therapy
 236;lipid treatment;"C0023779;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704";FALSE;1773;lipid treatment
 236;taking antihypertensive treatment at;"C0003364;C0039798;C0087111;C1515187;C1522326;C1533734;C1705169;C3538994;C3887704";FALSE;1579;taking antihypertensive treatment at
 236;currently on aha therapy;"C0039798;C0050451;C0087111;C0521116;C0772110;C1363945";NA;NA;currently on aha therapy
 236;concomitant treatment 一 no . ( % );"C0039798;C0087111;C0521115;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;concomitant treatment no
 236;concomitant treatment;"C0039798;C0087111;C0521115;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;concomitant treatment
 236;characteristic and treatment;"C0039798;C0087111;C1521970;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;characteristic and treatment
 236;background treatment  n ( % );"C0039798;C0087111;C1522326;C1533734;C1705169;C1706907;C3538994;C3887704";NA;NA;background treatment n
 236;background therapy;"C0039798;C0087111;C1363945;C1706907";NA;NA;background therapy
 236;background lipid therapy per acc / aha definition    n   ( % ) a;"C0023767;C0039798;C0087111;C1363945;C1550452;C1704788;C1706907;C3539107;C3888054;C4072694";NA;NA;background lipid therapy per acc aha definition n a
 236;background aha therapy at screening  n ( % ) §;"C0039798;C0050451;C0087111;C0220908;C0220909;C0772110;C1363945;C1698960;C1706907;C1710031;C1710032;C1710477;C2348164";NA;NA;background aha therapy at screening n
 236;background aha therapy at screening  n ( % );"C0039798;C0050451;C0087111;C0220908;C0220909;C0772110;C1363945;C1698960;C1706907;C1710031;C1710032;C1710477;C2348164";NA;NA;background aha therapy at screening n
 236;background aha therapy at screening  n;"C0039798;C0050451;C0087111;C0220908;C0220909;C0772110;C1363945;C1698960;C1706907;C1710031;C1710032;C1710477;C2348164";NA;NA;background aha therapy at screening n
 236;background aha therapy at screening  a   n ( % );"C0039798;C0050451;C0087111;C0220908;C0220909;C0369718;C0441922;C0772110;C1363945;C1698960;C1706907;C1710031;C1710032;C1710477;C2348164";NA;NA;background aha therapy at screening a n
 236;background aha therapy at screening  a;"C0039798;C0050451;C0087111;C0220908;C0220909;C0772110;C1363945;C1698960;C1706907;C1710031;C1710032;C1710477;C2348164";NA;NA;background aha therapy at screening a
 236;asian itt population by treatment group;"C0032659;C0039798;C0078988;C0087111;C0374505;C1257890;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;asian itt population by treatment group
 236;any therapy — no . ( % );"C0039798;C0087111;C1363945";NA;NA;any therapy no
 236;actual treatment strategy;"C0039798;C0087111;C0237400;C0679199;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;actual treatment strategy
 235;tests for categoric;C0589061;NA;NA;tests for categoric
 235;pfor heterogeneity;"C0019409;C0242960;C1151635";NA;NA;pfor heterogeneity
 235;pfor;C1151635;NA;NA;pfor
 234;poor;"C0032854;C0542537;C2700379";NA;NA;poor
 234;fair or poor;"C0032854;C0542537;C2700379;C2911689";NA;NA;fair or poor
 234;fair / poor;"C0032854;C0542537;C2700379;C2911689";NA;NA;fair poor
 233;pack - years ( iqr );C1277691;NA;NA;pack years iqr
 233;over past $nmbr$ years  n ( % );C4086728;NA;NA;over past $nmbr$ years n
 233;( iqr );NA;NA;NA;iqr
 232;war;C0043027;NA;NA;war
 232;mar imputation ( random . ) ( n = $nmbr$ );"C0034656;C0439605;C2699638;C3829202;C4255469";NA;NA;mar imputation random n $nmbr$
 232;mar ( itt ) ( n = $nmbr$ );"C3829202;C4255469";NA;NA;mar itt n $nmbr$
 231;previously taken any other dmards  n ( % );"C0242708;C1883727";NA;NA;previously taken any other dmards n
 231;other dmards;C0242708;NA;NA;other dmards
 231;other dmard use;"C0042153;C0242708;C0457083;C1947944";NA;NA;other dmard use
 231;dmard − ( n   =   $nmbr$ );C0242708;NA;NA;dmard n $nmbr$
 231;dmard | |;C0242708;NA;NA;dmard
 231;dmard + ( n   =   $nmbr$ );C0242708;NA;NA;dmard n $nmbr$
 231;concomitant use of conventional synthetic dmard up to $nmbr$ mo — no . { % ) methotrexate;"C0025677;C0026544;C0242708;C0332177;C0439858;C0521115;C1524063;C1883254";NA;NA;concomitant use of conventional synthetic dmard up to $nmbr$ mo no methotrexate
 231;concomitant conventional dmard use;"C0042153;C0242708;C0439858;C0457083;C0521115;C1947944";NA;NA;concomitant conventional dmard use
 230;primary trial end point;"C0008976;C2986535";NA;NA;primary trial end point
 230;primary safety end point : severe / life - threatening;"C0036043;C0205082;C1546953;C1705187;C2826244;C2986535;C3537125;C4050465;C4050466";NA;NA;primary safety end point severe life threatening
 230;primary indication;C1549995;NA;NA;primary indication
 230;primary endpoint ’;C2986535;NA;NA;primary endpoint
 230;primary endpoint death / mi / idr / st;"C0011065;C0036056;C1306577;C2986535;C3272372;C3810814;C4082313;C4552775";NA;NA;primary endpoint death mi idr st
 230;primary endpoint at $nmbr$ months;"C0439231;C2986535";NA;NA;primary endpoint at $nmbr$ months
 230;primary endpoint at $nmbr$ days;"C0439228;C2986535";NA;NA;primary endpoint at $nmbr$ days
 230;primary endpoint ^;C2986535;NA;NA;primary endpoint
 230;primary endpoint :;C2986535;NA;NA;primary endpoint
 230;primary endpoint $nmbr$;C2986535;NA;NA;primary endpoint $nmbr$
 230;primary endpoint;C2986535;NA;NA;primary endpoint
 230;primary end point |;C2986535;NA;NA;primary end point
 230;primary end point kaplan - meier rate  %;"C0871208;C1521828;C2986535";NA;NA;primary end point kaplan meier rate
 230;primary end point : death / mi / idr / st;"C0011065;C0036056;C1306577;C2986535;C3272372;C3810814;C4082313;C4552775";NA;NA;primary end point death mi idr st
 230;primary end point *;C2986535;NA;NA;primary end point
 230;primary end point;C2986535;NA;NA;primary end point
 230;primary end - point;C2986535;NA;NA;primary end point
 230;primary cv endpoint;"C2986535;C3538987;C4048877;C4318503";NA;NA;primary cv endpoint
 230;nace ( primary endpoint );C2986535;NA;NA;nace primary endpoint
 229;year of publication of primary results;"C0034036;C0034037;C0205225;C0439234;C0439508;C0439612;C0439631;C1274040;C1546471;C1704324;C2825142";NA;NA;year of publication of primary results
 229;third primary ( change in updrs score / wk  wk $nmbr$ - $nmbr$ );"C0205225;C0205437;C0332174;C0392747;C0439230;C0439612;C0439631;C0443172;C0449820;C1705241;C3639721;C4050231;C4319952";NA;NA;third primary change in updrs score wk wk $nmbr$ $nmbr$
 229;primary target vessel ( % );"C0205225;C0439612;C0439631;C0449618";NA;NA;primary target vessel
 229;primary study joint  n ( % );"C0022417;C0205225;C0392905;C0439612;C0439631;C0557651;C1706309;C2603343";NA;NA;primary study joint n
 209;tg > $nmbr$ . $nmbr$;C0337445;NA;NA;tg $nmbr$ $nmbr$
 229;primary pcit;"C0205225;C0439612;C0439631";FALSE;2340;primary pcit
 229;second co - primary;"C0205225;C0205436;C0439612;C0439631;C0457385;C0565930;C1561503;C1705190;C3245499";FALSE;2341;second co primary
 229;second primary composite outcome;"C0205199;C0205225;C0205436;C0439612;C0439631;C0457385;C0565930;C1274040;C1547335;C1561503;C1705190";FALSE;2342;second primary composite outcome
 233;exacerbations requiring hospitalisation ( past year ) ( % );"C0019993;C4086268;C4086728";FALSE;2345;exacerbations requiring hospitalisation past year
 233;no . of exacerbations in past year;"C4086268;C4086728";FALSE;2345;no of exacerbations in past year
 233;pneumonia in past year;"C0032285;C4086728";FALSE;2346;pneumonia in past year
 236;anti - platelet therapy;"C0005821;C0039798;C0087111;C1363945";FALSE;1191;anti platelet therapy
 236;anti platelet therapy;"C0005821;C0039798;C0087111;C1363945";FALSE;1191;anti platelet therapy
 236;antithrombotic therapy;"C0039798;C0087111;C1363945";FALSE;1191;antithrombotic therapy
 236;ace inhibitor treatment;"C0003015;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C4541021";FALSE; 811;ace inhibitor treatment
 236;chronic treatment with aspirin;"C0004057;C0039798;C0087111;C0205191;C1522326;C1533734;C1705169;C3538994;C3887704";FALSE;1366;chronic treatment with aspirin
 229;primary nonresponse;"C0205225;C0439612;C0439631";NA;NA;primary nonresponse
 229;primary analysis;"C0002778;C0205225;C0439612;C0439631;C0936012;C1524024";NA;NA;primary analysis
 229;primary *;"C0205225;C0439612;C0439631";NA;NA;primary
 229;primary;"C0205225;C0439612;C0439631";NA;NA;primary
 229;overall cohort ( primary analysis );"C0086027;C0205225;C0282416;C0439612;C0439631;C1561607";NA;NA;overall cohort primary analysis
 229;combo vs . primary;"C0205225;C0439612;C0439631";NA;NA;combo vs primary
 229;accord primary  n ( % );"C0205225;C0439612;C0439631;C0680240";NA;NA;accord primary n
 228;native coronary - artery lesions;"C0205042;C0221198;C0302891";NA;NA;native coronary artery lesions
 228;left main coronary artery bifurcation;C3898614;NA;NA;left main coronary artery bifurcation
 228;coronary artery stenosis > $nmbr$ %;C0242231;NA;NA;coronary artery stenosis $nmbr$
 228;coronary artery osteochondrosis;"C0029376;C0029429;C0205042;C0729346";NA;NA;coronary artery osteochondrosis
 228;coronary artery;C0205042;NA;NA;coronary artery
 228;> $nmbr$ % coronary stenosis;C0242231;NA;NA;$nmbr$ coronary stenosis
 227;previous coronary artery bypass surgery  no . ( % );C2144990;NA;NA;previous coronary artery bypass surgery no
 227;previous coronary artery bypass grafting;C2144990;NA;NA;previous coronary artery bypass grafting
 227;previous coronary artery bypass graft;C2144990;NA;NA;previous coronary artery bypass graft
 227;previous coronary - artery bypass grafting;C2144990;NA;NA;previous coronary artery bypass grafting
 226;• death from coronary heart disease;"C0010054;C0010068;C0011065;C1306577;C1956346;C4082313;C4552775";NA;NA;death from coronary heart disease
 226;stable coronary artery disease;"C0010054;C0010068;C0205360;C1547311;C1956346";NA;NA;stable coronary artery disease
 226;prior coronary artery disease yes;"C0010054;C0010068;C0332152;C1549445;C1705108;C1710701;C1956346;C2826257";NA;NA;prior coronary artery disease yes
 226;previous coronary heart disease;"C0010054;C0010068;C0205156;C1552607;C1956346";NA;NA;previous coronary heart disease
 226;previous coronary artery disease  n ( % );"C0010054;C0010068;C0205156;C1552607;C1956346";NA;NA;previous coronary artery disease n
 226;only coronary artery disease;"C0010054;C0010068;C0205171;C1720467;C1956346";NA;NA;only coronary artery disease
 226;multivessel coronary artery disease — no . / total no . ( % );"C0010054;C0010068;C0439175;C0439810;C1956346";NA;NA;multivessel coronary artery disease no total no
 226;multivessel coronary artery disease;"C0010054;C0010068;C1956346";NA;NA;multivessel coronary artery disease
 226;hope patients with coronary - artery disease ( n = $nmbr$ );"C0010054;C0010068;C0030705;C0392347;C1956346";NA;NA;hope patients with coronary artery disease n $nmbr$
 226;documented coronary artery disease;"C0010054;C0010068;C1301725;C1609436;C1956346";NA;NA;documented coronary artery disease
 226;coronary heart disease death;"C0010054;C0010068;C0011065;C1306577;C1956346;C4082313;C4552775";NA;NA;coronary heart disease death
 226;coronary heart disease ( % );"C0010054;C0010068;C1956346";NA;NA;coronary heart disease
 226;coronary heart disease  n ( % ) t;"C0010054;C0010068;C1956346";NA;NA;coronary heart disease n t
 226;coronary heart disease  n ( % ) b;"C0010054;C0010068;C1956346";NA;NA;coronary heart disease n b
 226;coronary heart disease;"C0010054;C0010068;C1956346";NA;NA;coronary heart disease
 226;coronary disease;"C0010068;C1956346";NA;NA;coronary disease
 226;coronary artery disease — no . / total no . ( % );"C0010054;C0010068;C0439175;C0439810;C1956346";NA;NA;coronary artery disease no total no
 226;coronary artery disease — no . ( % ) : c;"C0010054;C0010068;C1956346";NA;NA;coronary artery disease no c
 226;coronary artery disease — no . ( % ) : ! :;"C0010054;C0010068;C1956346";NA;NA;coronary artery disease no
 226;coronary artery disease — no . ( % );"C0010054;C0010068;C1956346";NA;NA;coronary artery disease no
 226;coronary artery disease — %;"C0010054;C0010068;C1956346";NA;NA;coronary artery disease
 226;coronary artery disease §;"C0010054;C0010068;C1956346";NA;NA;coronary artery disease
 226;coronary artery disease history;"C0010054;C0010068;C0019664;C0019665;C0262512;C0262926;C1705255;C1956346;C2004062";NA;NA;coronary artery disease history
 226;coronary artery disease ^;"C0010054;C0010068;C1956346";NA;NA;coronary artery disease
 226;coronary artery disease *;"C0010054;C0010068;C1956346";NA;NA;coronary artery disease
 226;coronary artery disease ( n = $nmbr$ $nmbr$ );"C0010054;C0010068;C1956346";NA;NA;coronary artery disease n $nmbr$ $nmbr$
 226;coronary artery disease ( % );"C0010054;C0010068;C1956346";NA;NA;coronary artery disease
 226;coronary artery disease    n   ( % );"C0010054;C0010068;C1956346";NA;NA;coronary artery disease n
 226;coronary artery disease  n ( % );"C0010054;C0010068;C1956346";NA;NA;coronary artery disease n
 226;coronary artery disease  %;"C0010054;C0010068;C1956346";NA;NA;coronary artery disease
 209;tg < = $nmbr$ . $nmbr$;C0337445;NA;NA;tg $nmbr$ $nmbr$
 226;voluntary;"C0439656;C3543419";FALSE; -10;voluntary
 229;first primary composite outcome;"C0205199;C0205225;C0205435;C0439612;C0439631;C1274040;C1279901;C1547335";FALSE;2339;first primary composite outcome
 229;primary composite ^;"C0205199;C0205225;C0439612;C0439631;C1547335";FALSE;2339;primary composite
 229;primary composite end points;"C0205199;C0205225;C0439612;C0439631;C1547335;C2349179";FALSE;2339;primary composite end points
 229;primary composite outcome;"C0205199;C0205225;C0439612;C0439631;C1274040;C1547335";FALSE;2339;primary composite outcome
 229;primary efficacy outcome;"C0205225;C0439612;C0439631;C1274040;C1280519;C1707887";FALSE;2339;primary efficacy outcome
 229;primary end points;"C0205225;C0439612;C0439631;C2349179";FALSE;2339;primary end points
 229;primary outcome;"C0205225;C0439612;C0439631;C1274040";FALSE;2339;primary outcome
 229;primary outcome !;"C0205225;C0439612;C0439631;C1274040";FALSE;2339;primary outcome
 229;primary outcome : $nmbr$ % decrease in womac pain score;"C0205225;C0392756;C0439612;C0439631;C0547047;C0582148;C1274040";FALSE;2339;primary outcome $nmbr$ decrease in womac pain score
 229;primary outcome ! ( n = $nmbr$ );"C0205225;C0439612;C0439631;C1274040";FALSE;2339;primary outcome n $nmbr$
 229;primary outcome plus revascularization or nonfatal hf;"C0018488;C0205225;C0332287;C0439612;C0439631;C0581603;C1274040;C1313497;C1538440;C3273279";FALSE;2339;primary outcome plus revascularization or nonfatal hf
 229;primary outcomes;"C0205225;C0439612;C0439631;C1274040";FALSE;2339;primary outcomes
 229;primary pci;"C0205225;C0439612;C0439631;C4049621";FALSE;2340;primary pci
 229;primary pci ( n = $nmbr$ );"C0205225;C0439612;C0439631;C4049621";FALSE;2340;primary pci n $nmbr$
 229;primary angioplasty ( n = $nmbr$ );"C0162577;C0205225;C0439612;C0439631;C1548817";FALSE;2340;primary angioplasty n $nmbr$
 229;primary pci n = $nmbr$;"C0205225;C0439612;C0439631;C4049621";FALSE;2340;primary pci n $nmbr$
 229;fibrinolysis primary pci ( n = $nmbr$ ) ( n = $nmbr$ ) no . of patients / total no . ( % );"C0016017;C0030705;C0205225;C0439175;C0439612;C0439631;C0439810;C1305868;C4049621";FALSE;2340;fibrinolysis primary pci n $nmbr$ n $nmbr$ no of patients total no
 229;primary cause of chf;"C0015127;C0018802;C0205225;C0439612;C0439631;C1524003";FALSE;2343;primary cause of chf
 229;primary cause of heart failure;"C0015127;C0018801;C0018802;C0205225;C0439612;C0439631;C1524003;C4554158";FALSE;2343;primary cause of heart failure
 229;primary ischemic stroke;"C0205225;C0439612;C0439631;C0948008";FALSE;2344;primary ischemic stroke
 226;coronary artery disease;"C0010054;C0010068;C1956346";NA;NA;coronary artery disease
 226;any established coronary artery disease;"C0010054;C0010068;C0443211;C1272684;C1956346";NA;NA;any established coronary artery disease
 226;any coronary artery disease;"C0010054;C0010068;C1956346";NA;NA;any coronary artery disease
 226;* atherosclerotic coronary heart disease  ischaemic stroke or peripheral arterial disease . † n / n = number of people in phase $nmbr$ studies only . ‡ high ‐ intensity statins were defined as atorvastatin $nmbr$ to $nmbr$ mg  rosuvastatin $nmbr$ to $nmbr$ mg or simvastatin $nmbr$ mg daily .;"C0003842;C0010054;C0010068;C0012634;C0018787;C0024671;C0026410;C0027361;C0074554;C0205100;C0205171;C0205390;C0221464;C0237753;C0286651;C0332173;C0333482;C0360714;C0439269;C0449788;C0557651;C0947630;C0948008;C0965129;C1704788;C1710475;C1720467;C1956346;C1960952;C2346927;C2603343;C3539106;C4081854;C4321396;C4521761";NA;NA;atherosclerotic coronary heart disease ischaemic stroke or peripheral arterial disease n n number of people in phase $nmbr$ studies only high intensity statins were defined as atorvastatin $nmbr$ to $nmbr$ mg rosuvastatin $nmbr$ to $nmbr$ mg or simvastatin $nmbr$ mg daily
 225;time from acute coronary syndrome to randomization ( days );"C0034656;C0040223;C0439228;C0948089;C3541383";NA;NA;time from acute coronary syndrome to randomization days
 225;median time from index acute coronary syndrome to randomization ( iqr ) — mo;"C0026544;C0034656;C0040223;C0332177;C0549183;C0600653;C0876920;C0918012;C0948089;C1552854;C1637833;C2347635;C2348144;C2939193;C2986546;C3541383";NA;NA;median time from index acute coronary syndrome to randomization iqr mo
 225;coronary events $nmbr$;C0741923;NA;NA;coronary events $nmbr$
 225;acute coronary syndrome $nmbr$;C0948089;NA;NA;acute coronary syndrome $nmbr$
 225;acute coronary syndrome;C0948089;NA;NA;acute coronary syndrome
 225;acute coronary event;"C0205178;C0741923";NA;NA;acute coronary event
 224;right coronary artery  n ( % );C1261316;NA;NA;right coronary artery n
 224;right coronary artery;C1261316;NA;NA;right coronary artery
 224;right coronary;C0225808;NA;NA;right coronary
 223;prior coronary revascularization — no . { % );"C0332152;C0877341;C2826257";NA;NA;prior coronary revascularization no
 223;prior coronary revascularization ( pci or cabg );"C0010055;C0332152;C0877341;C2826257;C4049621";NA;NA;prior coronary revascularization pci or cabg
 223;prior coronary revascularization  no . ( % );"C0332152;C0877341;C2826257";NA;NA;prior coronary revascularization no
 223;prior coronary revascularization  n / n ( % );"C0332152;C0877341;C2826257";NA;NA;prior coronary revascularization n n
 223;prior coronary revascularization  n ( % );"C0332152;C0877341;C2826257";NA;NA;prior coronary revascularization n
 223;prior coronary revascularization;"C0332152;C0877341;C2826257";NA;NA;prior coronary revascularization
 223;previous coronary revascularization — no . ( % );"C0205156;C0877341;C1552607";NA;NA;previous coronary revascularization no
 223;previous coronary revascularization;"C0205156;C0877341;C1552607";NA;NA;previous coronary revascularization
 223;previous coronary revascularisation;"C0205156;C0877341;C1552607";NA;NA;previous coronary revascularisation
 223;history ol coronary revascularization *;"C0019664;C0019665;C0262512;C0262926;C0877341;C1705255;C2004062";NA;NA;history ol coronary revascularization
 223;history of coronary revascularization  no . ( % );"C0019664;C0019665;C0262512;C0262926;C0877341;C1705255;C2004062";NA;NA;history of coronary revascularization no
 223;coronary revascularization procedure;C0877341;NA;NA;coronary revascularization procedure
 223;coronary revascularization;C0877341;NA;NA;coronary revascularization
 223;coronary revascularisation §;C0877341;NA;NA;coronary revascularisation
 223;coronary revascularisation;C0877341;NA;NA;coronary revascularisation
 223;any coronary revascularization;C0877341;NA;NA;any coronary revascularization
 222;rr *;NA;NA;NA;rr
 222;rr $nmbr$ . $nmbr$ < $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ ) *;NA;NA;NA;rr $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 222;rr $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ . $nmbr$ . $nmbr$ );NA;NA;NA;rr $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 222;rr $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ };NA;NA;NA;rr $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 222;rr $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ ) * *;NA;NA;NA;rr $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 222;rr $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ ) *;NA;NA;NA;rr $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 222;rr $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ );NA;NA;NA;rr $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 222;rr $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$  $nmbr$ . $nmbr$;NA;NA;NA;rr $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 222;rr $nmbr$ . $nmbr$ ( $nmbr$ - $nmbr$ . $nmbr$ . $nmbr$ ) *;NA;NA;NA;rr $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 222;rr $nmbr$ . $nmbr$ ( $nmbr$ - $nmbr$  $nmbr$ . $nmbr$ );NA;NA;NA;rr $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 222;rr $nmbr$ . $nmbr$;NA;NA;NA;rr $nmbr$ $nmbr$
 222;hr * or rr †;NA;NA;NA;hr or rr
 222;aml / val  $nmbr$ / $nmbr$ mg rr = $nmbr$ *;"C0023465;C0023467;C0024671;C0026410;C0042285;C0439269;C0523975;C1960952;C2346927;C4321396;C4521761;C4554402";NA;NA;aml val $nmbr$ $nmbr$ mg rr $nmbr$
 221;unadjusted irr;"C1439367;C4082285";NA;NA;unadjusted irr
 221;irr = $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ – $nmbr$ . $nmbr$ ) $nmbr$ . $nmbr$;C4082285;NA;NA;irr $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
 220;death / udmi / idr;"C0011065;C1306577;C4082313;C4552775";NA;NA;death udmi idr
 220;death / q - mi / idr;"C0011065;C1306577;C3810814;C4082313;C4552775";NA;NA;death q mi idr
 220;death  mi  idr  st or gusto severe bleeding;"C0011065;C0019080;C0036056;C0205082;C1306577;C3272372;C3810814;C4050465;C4050466;C4082313;C4552775";NA;NA;death mi idr st or gusto severe bleeding
 220;cv death / mi / stroke / ucr;"C0011065;C0038454;C1306577;C3538987;C3810814;C4048877;C4082313;C4318503;C4552775;C4554100";NA;NA;cv death mi stroke ucr
 219;prior oabg surgery;C0455610;NA;NA;prior oabg surgery
 219;prior cabg surgery;"C0010055;C0455610";NA;NA;prior cabg surgery
 219;prior aortocoronary bypass surgery 一 no . ( % );"C0010055;C0455610";NA;NA;prior aortocoronary bypass surgery no
 219;prior aortocoronary bypass surgery — no . ( % );"C0010055;C0455610";NA;NA;prior aortocoronary bypass surgery no
 219;prior aortocoronary bypass surgery;"C0010055;C0455610";NA;NA;prior aortocoronary bypass surgery
 218;cancer surgery;C0920424;NA;NA;cancer surgery
 217;use of clopidogrel;"C0070166;C1524063";NA;NA;use of clopidogrel
 217;timing of clopidogrel loading dose;"C0070166;C0449243;C1704250;C3714444";NA;NA;timing of clopidogrel loading dose
 217;open - label clopidogrel after completion of study drug;"C0013227;C0070166;C0205197;C1254351;C1554962;C1709323";NA;NA;open label clopidogrel after completion of study drug
 217;interval from clopidogrel loading  h;"C0033727;C0070166;C0369286;C0441932;C0564385;C1272706;C1552654;C1552713;C1708715;C4528284";NA;NA;interval from clopidogrel loading h
 217;interval clopidogrel to pci;"C0070166;C1272706;C1552654;C1552713;C4049621";NA;NA;interval clopidogrel to pci
 217;duration of clopidogrel pretreatment 一 hr median;"C0070166;C0449238;C0549183;C0876920;C1550147;C2347635;C2348144;C2709094;C2926735;C2939193;C3539075;C3539076";NA;NA;duration of clopidogrel pretreatment hr median
 217;clopiodogrel;NA;NA;NA;clopiodogrel
 217;clopidogrel pretreatment duration;"C0070166;C0449238;C1550147;C2709094;C2926735;C3539075;C3539076";NA;NA;clopidogrel pretreatment duration
 217;clopidogrel plus aspirin ( n = $nmbr$ );"C0004057;C0070166;C0332287";NA;NA;clopidogrel plus aspirin n $nmbr$
 217;clopidogrel plus aspirin % / yr;"C0004057;C0070166;C0332287;C0439234";NA;NA;clopidogrel plus aspirin yr
 219;prior surgery : no;C0455610;FALSE;2040;prior surgery no
 218;emergent / urgent surgery;"C0750573;C2188405";FALSE;2334;emergent urgent surgery
 218;urgent surgery;C2188405;FALSE;2334;urgent surgery
 218;major surgery;C0679637;FALSE;2335;major surgery
 218;minor surgery;C0038904;FALSE;2336;minor surgery
 218;other cardiac surgery  n ( % );"C0018821;C0524727";FALSE;2337;other cardiac surgery n
 218;undergoing major vascular surgery;"C0005847;C0042381;C0205082;C0205164;C0679637;C1558950;C1801960;C3714645;C4318856;C4521762";FALSE;2338;undergoing major vascular surgery
 218;otherb;NA;FALSE; -10;otherb
 220;idr;NA;FALSE; -10;idr
 220;ucr;NA;FALSE; -10;ucr
 220;upcr  n ( % );NA;FALSE; -10;upcr n
 217;clopidogrel plus aspirin;"C0004057;C0070166;C0332287";NA;NA;clopidogrel plus aspirin
 217;clopidogrel no . of patients % );"C0030705;C0070166";NA;NA;clopidogrel no of patients
 217;clopidogrel n / n { % );C0070166;NA;NA;clopidogrel n n
 217;clopidogrel n / n ( % );C0070166;NA;NA;clopidogrel n n
 217;clopidogrel given before procedure;"C0070166;C0184661;C1442162;C1550718;C1947971;C2700391;C3244317;C3274430;C3539779";NA;NA;clopidogrel given before procedure
 217;clopidogrel / total no . of patients % %;"C0030705;C0070166;C0439175;C0439810";NA;NA;clopidogrel total no of patients
 217;clopidogrel + aspirin ( n = $nmbr$ );"C0004057;C0070166";NA;NA;clopidogrel aspirin n $nmbr$
 217;clopidogrel ( n = $nmbr$ ) n / n ( % );C0070166;NA;NA;clopidogrel n $nmbr$ n n
 217;clopidogrel ( n = $nmbr$ );C0070166;NA;NA;clopidogrel n $nmbr$
 217;clopidogrel ( n = $nmbr$ $nmbr$ );C0070166;NA;NA;clopidogrel n $nmbr$ $nmbr$
 217;clopidogrel ( n = $nmbr$  $nmbr$ );C0070166;NA;NA;clopidogrel n $nmbr$ $nmbr$
 217;clopidogrel %;C0070166;NA;NA;clopidogrel
 217;clopidogrel  %;C0070166;NA;NA;clopidogrel
 217;clopidogrel;C0070166;NA;NA;clopidogrel
 217;aspirin plus clopidogrel ( n = $nmbr$ );"C0004057;C0070166;C0332287";NA;NA;aspirin plus clopidogrel n $nmbr$
 217;aspirin i clopidogrel ( n = $nmbr$  $nmbr$ );"C0004057;C0021966;C0070166;C0221138";NA;NA;aspirin i clopidogrel n $nmbr$ $nmbr$
 217;aspirin + clopidogrel ( n = $nmbr$ ) $nmbr$ . $nmbr$;"C0004057;C0070166";NA;NA;aspirin clopidogrel n $nmbr$ $nmbr$ $nmbr$
 217;aspirin $nmbr$ clopidogrel;"C0004057;C0070166";NA;NA;aspirin $nmbr$ clopidogrel
 216;loading dose of clopidogrel or ticlopidine;"C0040207;C0070166;C3714444";NA;NA;loading dose of clopidogrel or ticlopidine
 216;clopidogrel or ticlopidine;"C0040207;C0070166";NA;NA;clopidogrel or ticlopidine
 216;clopidogrel / ticlopidine;"C0040207;C0070166";NA;NA;clopidogrel ticlopidine
 216;clopidogrel  ticlopidine  or prasugrel;"C0040207;C0070166;C1620287";NA;NA;clopidogrel ticlopidine or prasugrel
 215;piroxicam;C0031990;NA;NA;piroxicam
 215;non - biological systemic;"C0205373;C0445097";NA;NA;non biological systemic
 215;meloxicam;C0083381;NA;NA;meloxicam
 215;biological;"C0005532;C0205460";NA;NA;biological
 214;prior use of biologics  n ( % );"C0005515;C0005522;C0332152;C1524063;C2826257;C4553887";NA;NA;prior use of biologics n
 214;prior use of biologic agents;"C0005515;C0332152;C1524063;C2826257";NA;NA;prior use of biologic agents
 214;prior biologic therapeutic failures  n ( % );"C0005515;C0087111;C0205460;C0231174;C0302350;C0332152;C0680095;C2826257";NA;NA;prior biologic therapeutic failures n
 214;other biologic agent;C0005515;NA;NA;other biologic agent
 214;biologic therapeutic failure;"C0005515;C0087111;C0205460;C0231174;C0302350;C0680095";NA;NA;biologic therapeutic failure
 214;biologic naive;"C0005515;C0205460";NA;NA;biologic naive
 214;biologic agents;C0005515;NA;NA;biologic agents
 214;biologic;"C0005515;C0205460";NA;NA;biologic
 213;severity ofcopd ( gold $nmbr$ )  n ( % );"C0018026;C0439793;C0522510;C1304897";NA;NA;severity ofcopd gold $nmbr$ n
 213;severity of the disease ( gold $nmbr$ )  n ( % );"C0018026;C0521117;C1304897";NA;NA;severity of the disease gold $nmbr$ n
 213;severity of copd  n ( % ) ( gold $nmbr$ ) : moderate;"C0018026;C0024117;C0205081;C0439793;C0522510;C1304897;C1412502;C1881878;C3714496;C4049705;C4049706;C4085643;C4321335";NA;NA;severity of copd n gold $nmbr$ moderate
 213;severity of airflow limitation ( gold $nmbr$ - $nmbr$ )  n ( % );"C0018026;C0231999;C0439793;C0443288;C0449295;C0522510;C1304897";NA;NA;severity of airflow limitation gold $nmbr$ $nmbr$ n
 213;severe ( gold $nmbr$ );"C0018026;C0205082;C1304897;C4050465;C4050466";NA;NA;severe gold $nmbr$
 213;severe  gold $nmbr$;"C0018026;C0205082;C1304897;C4050465;C4050466";NA;NA;severe gold $nmbr$
 213;moderate ( gold $nmbr$ );"C0018026;C0205081;C1304897;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate gold $nmbr$
 213;moderate  gold $nmbr$;"C0018026;C0205081;C1304897;C1881878;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate gold $nmbr$
 213;gold stage ( % ) : c;"C0018026;C0441785;C1304897";NA;NA;gold stage c
 213;gold ii;"C0018026;C1304897;C1710602;C4082587";NA;NA;gold ii
 213;gold groups a - d using mmrcb;"C0018026;C0441833;C0687744;C0718133;C1257890;C1304897;C1519504;C1524063;C1552839;C1705428;C1705429";NA;NA;gold groups a d using mmrcb
 213;gold group d — no . ( % ) | |;"C0018026;C0441838;C1304897";NA;NA;gold group d no
 213;gold group d;"C0018026;C0441838;C1304897";NA;NA;gold group d
 213;gold group b;"C0018026;C1304897;C4522078";NA;NA;gold group b
 213;gold group  n ( % );"C0018026;C0441848;C1304897";NA;NA;gold group n
 213;gold group;"C0018026;C0441833;C0687744;C1257890;C1304897;C1519504;C1705428;C1705429";NA;NA;gold group
 213;gold d;"C0018026;C1304897";NA;NA;gold d
 213;gold c;"C0018026;C1304897";NA;NA;gold c
 213;gold b;"C0018026;C1304897";NA;NA;gold b
 213;gold a;"C0018026;C1304897";NA;NA;gold a
 213;gold $nmbr$ groups  n ( % );"C0018026;C0369718;C0441833;C0441922;C0687744;C1257890;C1304897;C1519504;C1552839;C1705428;C1705429";NA;NA;gold $nmbr$ groups n
 213;gold $nmbr$ groups;"C0018026;C0441833;C0687744;C1257890;C1304897;C1519504;C1552839;C1705428;C1705429";NA;NA;gold $nmbr$ groups
 213;gold $nmbr$ - $nmbr$ ( « = $nmbr$ );"C0018026;C1304897";NA;NA;gold $nmbr$ $nmbr$ $nmbr$
 213;gold $nmbr$ - $nmbr$ ( n = $nmbr$ );"C0018026;C1304897";NA;NA;gold $nmbr$ $nmbr$ n $nmbr$
 213;gold $nmbr$ - $nmbr$;"C0018026;C1304897";NA;NA;gold $nmbr$ $nmbr$
 213;gold $nmbr$ ( « = $nmbr$ );"C0018026;C1304897";NA;NA;gold $nmbr$ $nmbr$
 213;gold $nmbr$;"C0018026;C1304897";NA;NA;gold $nmbr$
 213;gold  n ( % );"C0018026;C1304897";NA;NA;gold n
 212;good / moderate response;"C0205170;C4085643";NA;NA;good moderate response
 212;good;C0205170;NA;NA;good
 211;tnt and ideal ( pooled );"C1512612;C1709595;C2349200;C4522255";NA;NA;tnt and ideal pooled
 211;pooled itt;"C1709595;C2349200;C4522255";NA;NA;pooled itt
 211;pooled analysis sample;"C0002778;C0936012;C1303103;C1524024;C1709595;C2349200;C4522255";NA;NA;pooled analysis sample
 211;pooled analysis of sustain $nmbr$ — $nmbr$ trials;"C0002778;C0008976;C0443318;C0936012;C1524024;C1709595;C2349200;C2732140;C4522255";NA;NA;pooled analysis of sustain $nmbr$ $nmbr$ trials
 211;pooled analysis;"C0002778;C0936012;C1524024;C1709595;C2349200;C4522255";NA;NA;pooled analysis
 211;pooled;"C1709595;C2349200;C4522255";NA;NA;pooled
 210;ltg subgroup  n = $nmbr$;"C1079230;C1420817;C1515021;C4521367;C4521846";NA;NA;ltg subgroup n $nmbr$
 210;ltg - naive;"C1420817;C4521367;C4521846";NA;NA;ltg naive
 210;lrg;C1428862;NA;NA;lrg
 209;tg ’;C0337445;NA;NA;tg
 209;tg §;C0337445;NA;NA;tg
 212;good  tried previous glucocorticoid;"C0017710;C0205156;C0205170;C1552607";FALSE;1348;good tried previous glucocorticoid
 212;good  tried previous glucocorticoid + laba;"C0017710;C0205156;C0205170;C1552607";FALSE;1348;good tried previous glucocorticoid laba
 211;empagliflozin pooled ( n = $nmbr$ );"C1709595;C2349200;C3490348;C4522255";FALSE;2332;empagliflozin pooled n $nmbr$
 211;pooled empagliflozin ( n = $nmbr$ );"C1709595;C2349200;C3490348;C4522255";FALSE;2332;pooled empagliflozin n $nmbr$
 211;pooled secukinumab;"C1709595;C2349200;C3179547;C4522255";FALSE;2333;pooled secukinumab
 211;secukinumab pooled †   ( n   = $nmbr$ );"C1709595;C2349200;C3179547;C4522255";FALSE;2333;secukinumab pooled n $nmbr$
 211;pooled eze / simva;"C1709595;C2349200;C4522255";FALSE;1840;pooled eze simva
 211;pooled simva;"C1709595;C2349200;C4522255";FALSE;1840;pooled simva
 213;severity of airflow limitation ( gold $nmbr$ )  n ( % );"C0018026;C0231999;C0439793;C0443288;C0449295;C0522510;C1304897";FALSE; 213;severity of airflow limitation gold $nmbr$ n
 209;tg < $nmbr$  hdl > $nmbr$ ( n = $nmbr$ );"C0337445;C3715113";NA;NA;tg $nmbr$ hdl $nmbr$ n $nmbr$
 209;tg +;C0337445;NA;NA;tg
 209;tg *;C0337445;NA;NA;tg
 209;tg ( mmol / l ) c;"C0337445;C1532563";NA;NA;tg mmol l c
 209;tg ( mmol / l );"C0337445;C1532563";NA;NA;tg mmol l
 209;tg  median ( min  max );"C0337445;C0549183;C0702093;C0876920;C1524029;C2347635;C2348144;C2939193;C3813700";NA;NA;tg median min max
 209;tg;C0337445;NA;NA;tg
 209;middle tg tertile;"C0337445;C0444598;C0549183;C1552826";NA;NA;middle tg tertile
 209;median ( q $nmbr$ : q $nmbr$ ) tg - rich lipoprotein cholesterol;"C0065055;C0337445;C0549183;C0699759;C0876920;C2347635;C2348144;C2939193";NA;NA;median q $nmbr$ q $nmbr$ tg rich lipoprotein cholesterol
 209;lowest tg tertile;"C0337445;C1708760";NA;NA;lowest tg tertile
 209;highest tg tertile;"C0337445;C1522410";NA;NA;highest tg tertile
 209;hdl - c   high - density lipoprotein cholesterol    ldl - c   low - density lipoprotein cholesterol    sestandard error    tg   triglycerides .;"C0023822;C0337445;C0743559;C0858892;C1608199";NA;NA;hdl c high density lipoprotein cholesterol ldl c low density lipoprotein cholesterol sestandard error tg triglycerides
 209;elevated tg;"C0205250;C0337445;C3163633";NA;NA;elevated tg
 209;change in tg;"C0337445;C0392747;C0443172;C1705241;C4319952";NA;NA;change in tg
 209;baseline tg level { n = $nmbr$  $nmbr$ ) > $nmbr$ . $nmbr$ mg / dl;"C0168634;C0337445;C0439269;C0441889;C0456079;C1442488;C1547707;C2946261";NA;NA;baseline tg level n $nmbr$ $nmbr$ $nmbr$ $nmbr$ mg dl
 209;baseline tg level ( n = $nmbr$ . $nmbr$ ) > $nmbr$ . $nmbr$ mg / dl;"C0168634;C0337445;C0439269;C0441889;C0456079;C1442488;C1547707;C2946261";NA;NA;baseline tg level n $nmbr$ $nmbr$ $nmbr$ $nmbr$ mg dl
 209;baseline tg level ( n = $nmbr$  $nmbr$ ) s $nmbr$ . $nmbr$ mg / dl;"C0168634;C0337445;C0439269;C0441889;C0456079;C1442488;C1547707;C2946261";NA;NA;baseline tg level n $nmbr$ $nmbr$ s $nmbr$ $nmbr$ mg dl
 209;baseline tg level ( n = $nmbr$  $nmbr$ ) < $nmbr$ . $nmbr$ mg / dl;"C0168634;C0337445;C0439269;C0441889;C0456079;C1442488;C1547707;C2946261";NA;NA;baseline tg level n $nmbr$ $nmbr$ $nmbr$ $nmbr$ mg dl
 209;baseline tg > $nmbr$ . $nmbr$ mmol / l;"C0168634;C0337445;C1442488;C1532563";NA;NA;baseline tg $nmbr$ $nmbr$ mmol l
 209;baseline tg < $nmbr$ . $nmbr$ mmol / l;"C0168634;C0337445;C1442488;C1532563";NA;NA;baseline tg $nmbr$ $nmbr$ mmol l
 209;baseline tg;"C0168634;C0337445;C1442488";NA;NA;baseline tg
 208;sfc $nmbr$ / $nmbr$ pg twice daily ( n = $nmbr$ );"C0030827;C0072225;C0585361;C1266240;C4521536";NA;NA;sfc $nmbr$ $nmbr$ pg twice daily n $nmbr$
 208;sfc $nmbr$ / $nmbr$ pg b . i . d . n = $nmbr$;"C0021966;C0030827;C0072225;C0152277;C0221138;C1266240;C2827928;C4521536";NA;NA;sfc $nmbr$ $nmbr$ pg b i d n $nmbr$
 208;qva $nmbr$ / $nmbr$ pg once daily ( n = $nmbr$ );"C0030827;C0072225;C0332173;C1266240";NA;NA;qva $nmbr$ $nmbr$ pg once daily n $nmbr$
 208;nt - probnp  pg / mlt;"C0030827;C0072225;C0669479;C0754710;C1266240;C4553833";NA;NA;nt probnp pg mlt
 208;gly ( $nmbr$ . $nmbr$ pg b . i . d . ) n = $nmbr$;"C0030827;C0072225;C0152277;C1266240;C1415124";NA;NA;gly $nmbr$ $nmbr$ pg b i d n $nmbr$
 208;ff $nmbr$ pg ( n = $nmbr$ );"C0030827;C0072225;C1266240;C4554348";NA;NA;ff $nmbr$ pg n $nmbr$
 208;fdc $nmbr$ / $nmbr$ pg vs placebo;"C0030827;C0032042;C0072225;C0340427;C1266240;C1413520;C1696465;C1706408;C3539652";NA;NA;fdc $nmbr$ $nmbr$ pg vs placebo
 208;fdc $nmbr$ / $nmbr$ pg vs formoterol $nmbr$ pg;"C0030827;C0060657;C0072225;C0340427;C1266240;C1413520;C3539652";NA;NA;fdc $nmbr$ $nmbr$ pg vs formoterol $nmbr$ pg
 208;fdc $nmbr$ / $nmbr$ pg vs aclidinium $nmbr$ pg;"C0030827;C0072225;C0340427;C1266240;C1413520;C2699757;C3539652";NA;NA;fdc $nmbr$ $nmbr$ pg vs aclidinium $nmbr$ pg
 208;fdc $nmbr$ / $nmbr$ pg;"C0030827;C0072225;C0340427;C1266240;C1413520;C3539652";NA;NA;fdc $nmbr$ $nmbr$ pg
 208;difference vs ff $nmbr$ pg ( $nmbr$ % ci );"C0008107;C0030827;C0072225;C1266240;C1705241;C1705242;C3259781;C4554348";NA;NA;difference vs ff $nmbr$ pg $nmbr$ ci
 208;ab / ff $nmbr$ / $nmbr$ pg ( n = $nmbr$ );"C0030827;C0072225;C1266240;C4554348";NA;NA;ab ff $nmbr$ $nmbr$ pg n $nmbr$
 208;ab $nmbr$ pg ( n = $nmbr$ );"C0030827;C0072225;C1266240";NA;NA;ab $nmbr$ pg n $nmbr$
 208;$nmbr$ - h pg ( mmol / l );"C0030827;C0072225;C0439190;C1266240;C2827798;C2827804";NA;NA;$nmbr$ h pg mmol l
 207;tcz $nmbr$ mg / kg n = $nmbr$;C0439272;NA;NA;tcz $nmbr$ mg kg n $nmbr$
 207;mean ( sd )  mg / kg $nmbr$;"C0439272;C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd mg kg $nmbr$
 207;> $nmbr$ ug / g;C0439272;NA;NA;$nmbr$ ug g
 207;> $nmbr$ u / kg / day;C1532634;NA;NA;$nmbr$ u kg day
 207;$nmbr$ mg / kg ( n = $nmbr$ );C0439272;NA;NA;$nmbr$ mg kg n $nmbr$
 207;$nmbr$ mg / kg;C0439272;NA;NA;$nmbr$ mg kg
 206;≥ $nmbr$ kg / m $nmbr$;C1532718;NA;NA;$nmbr$ kg m $nmbr$
 206;≥ $nmbr$  kg / m $nmbr$;C1532718;NA;NA;$nmbr$ kg m $nmbr$
 206;£ $nmbr$ kg / m $nmbr$;C1532718;NA;NA;$nmbr$ kg m $nmbr$
 206;bmi  median ( iqr )  kg / m $nmbr$;"C0549183;C0578022;C0876920;C1532718;C2347635;C2348144;C2939193";NA;NA;bmi median iqr kg m $nmbr$
 206;bmi  mean ± sd kg / m $nmbr$;"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";NA;NA;bmi mean sd kg m $nmbr$
 206;bmi  mean ± sd  kg / m $nmbr$;"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";NA;NA;bmi mean sd kg m $nmbr$
 206;bmi  mean ( sd ) kg / m $nmbr$;"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";NA;NA;bmi mean sd kg m $nmbr$
 206;bmi  mean ( sd ) ( kg / m $nmbr$ );"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";NA;NA;bmi mean sd kg m $nmbr$
 206;bmi  mean ( sd )  kg / m ^;"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";NA;NA;bmi mean sd kg m
 206;bmi  mean ( sd )  kg / m $nmbr$ c;"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";NA;NA;bmi mean sd kg m $nmbr$ c
 206;bmi  mean  kg / m $nmbr$ ( ± sd );"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";NA;NA;bmi mean kg m $nmbr$ sd
 206;bmi  kg / m ^ *;"C0578022;C1532718";NA;NA;bmi kg m
 206;bmi  kg / m ^;"C0578022;C1532718";NA;NA;bmi kg m
 207;infliximab ( combined $nmbr$ mg / kg and $nmbr$ mg / kg )  n ( % );"C0205195;C0439272;C0666743";FALSE;2327;infliximab combined $nmbr$ mg kg and $nmbr$ mg kg n
 207;infliximab $nmbr$ mg / kg;"C0439272;C0666743";FALSE;2327;infliximab $nmbr$ mg kg
 207;golimumab $nmbr$ mg / kg + mtx;"C0025677;C0439272;C1417487;C2353893";FALSE;2328;golimumab $nmbr$ mg kg mtx
 208;aclidinium / formoterol $nmbr$ / $nmbr$ pg twice daily;"C0030827;C0060657;C0072225;C0585361;C1266240;C2699757";FALSE;2329;aclidinium formoterol $nmbr$ $nmbr$ pg twice daily
 208;aclidinium $nmbr$ pg;"C0030827;C0072225;C1266240;C2699757";FALSE;2329;aclidinium $nmbr$ pg
 208;aclidinium $nmbr$ pg vs placebo;"C0030827;C0032042;C0072225;C1266240;C1696465;C1706408;C2699757";FALSE;2329;aclidinium $nmbr$ pg vs placebo
 208;formoterol $nmbr$ pg;"C0030827;C0060657;C0072225;C1266240";FALSE;2330;formoterol $nmbr$ pg
 208;formoterol $nmbr$ pg vs placebo;"C0030827;C0032042;C0060657;C0072225;C1266240;C1696465;C1706408";FALSE;2330;formoterol $nmbr$ pg vs placebo
 208;indacaterol $nmbr$ pg;"C0030827;C0072225;C1266240;C1722260";FALSE;2331;indacaterol $nmbr$ pg
 206;s $nmbr$ kg / m ^;"C0565930;C1532718;C2603362";NA;NA;s $nmbr$ kg m
 206;s $nmbr$ kg / m $nmbr$;"C0565930;C1532718;C2603362";NA;NA;s $nmbr$ kg m $nmbr$
 206;patients with bw decrease of $ $nmbr$ % in patients with baseline bmi of $ $nmbr$ kg / m $nmbr$ +;"C0005910;C0006041;C0030705;C0168634;C0392756;C0547047;C0578022;C1442488;C1532718;C2986891";NA;NA;patients with bw decrease of $ $nmbr$ in patients with baseline bmi of $ $nmbr$ kg m $nmbr$
 206;obesity ( body mass index > $nmbr$ kg / m $nmbr$ );"C0005893;C0028754;C0578022;C1305855;C1532718;C1963185";NA;NA;obesity body mass index $nmbr$ kg m $nmbr$
 206;obesity ( bmi £ $nmbr$ kg / m $nmbr$ );"C0028754;C0578022;C1532718;C1963185";NA;NA;obesity bmi $nmbr$ kg m $nmbr$
 206;obesity ( bmi > $nmbr$ kg / m $nmbr$ )  %;"C0028754;C0578022;C1532718;C1963185";NA;NA;obesity bmi $nmbr$ kg m $nmbr$
 206;obese ( bmi > $nmbr$ kg / m $nmbr$ );"C0028754;C0578022;C1532718";NA;NA;obese bmi $nmbr$ kg m $nmbr$
 206;obese ( > $nmbr$ kg / m ^ $nmbr$ );"C0028754;C1532718";NA;NA;obese $nmbr$ kg m $nmbr$
 206;mean total ipss mean ipss by bmi ( < $nmbr$ / < $nmbr$ to < $nmbr$ / < $nmbr$ kg / m $nmbr$ );"C0439175;C0439810;C0444504;C0578022;C1019118;C1532718;C1998280;C2347634;C2348143;C2827405;C3811063";NA;NA;mean total ipss mean ipss by bmi $nmbr$ $nmbr$ to $nmbr$ $nmbr$ kg m $nmbr$
 206;mean qmax score by bmi ( < $nmbr$ / < $nmbr$ to < $nmbr$ / < $nmbr$ kg / m $nmbr$ );"C0578022;C1532718;C3533236";NA;NA;mean qmax score by bmi $nmbr$ $nmbr$ to $nmbr$ $nmbr$ kg m $nmbr$
 206;mean iief ef score mean iief domain score by bmi ( < $nmbr$ / < $nmbr$ to < $nmbr$ / < $nmbr$ kg / m $nmbr$ );"C0578022;C1532718;C1880389;C1883221;C3533236;C3541951;C3641331";NA;NA;mean iief ef score mean iief domain score by bmi $nmbr$ $nmbr$ to $nmbr$ $nmbr$ kg m $nmbr$
 206;mean bmii 士 s . d .  kg / m $nmbr$;"C0444504;C1532718;C2347634;C2348143";NA;NA;mean bmii s d kg m $nmbr$
 206;mean bmi ± sd ( kg / m $nmbr$ );"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";NA;NA;mean bmi sd kg m $nmbr$
 206;mean bmi ± s . d .  kg / m ^;"C0444504;C0578022;C1532718;C2347634;C2348143";NA;NA;mean bmi s d kg m
 206;mean bmi ± s . d .  kg / m $nmbr$;"C0444504;C0578022;C1532718;C2347634;C2348143";NA;NA;mean bmi s d kg m $nmbr$
 206;mean bmi ( sd )  kg / m $nmbr$;"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";NA;NA;mean bmi sd kg m $nmbr$
 206;mean bmi  kg / m $nmbr$ ± sd;"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";NA;NA;mean bmi kg m $nmbr$ sd
 206;mean ( sd ) bmi  kg / m $nmbr$;"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";NA;NA;mean sd bmi kg m $nmbr$
 206;low ( < $nmbr$ kg / m ^ ) baseline bmi;"C0168634;C0205251;C0578022;C1442488;C1532718;C1550472;C3890211;C4048187;C4321351;C4522223";NA;NA;low $nmbr$ kg m baseline bmi
 206;low ( < $nmbr$ kg / m $nmbr$ ) baseline bmi;"C0168634;C0205251;C0578022;C1442488;C1532718;C1550472;C3890211;C4048187;C4321351;C4522223";NA;NA;low $nmbr$ kg m $nmbr$ baseline bmi
 206;lean ( < $nmbr$ kg / m $nmbr$ );C1532718;NA;NA;lean $nmbr$ kg m $nmbr$
 206;kg / m $nmbr$ );C1532718;NA;NA;kg m $nmbr$
 206;kg / m $nmbr$;C1532718;NA;NA;kg m $nmbr$
 206;high ( i $nmbr$ kg / m $nmbr$ ) baseline bmi;"C0021966;C0168634;C0205250;C0221138;C0578022;C1299351;C1442488;C1532718;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;high i $nmbr$ kg m $nmbr$ baseline bmi
 206;high ( > $nmbr$ kg / m ^ ) baseline bmi;"C0168634;C0205250;C0578022;C1299351;C1442488;C1532718;C2700149;C3887512;C3889660;C4321237;C4522209";NA;NA;high $nmbr$ kg m baseline bmi
 206;egfr  ml / kg per $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439526;C0441923;C1300574;C1532718;C1705224;C1739039;C3811844;C3812682;C3887665";NA;NA;egfr ml kg per $nmbr$ $nmbr$ m $nmbr$
 206;bodymass index ( kg / m $nmbr$ );"C0005893;C0578022;C1305855;C1532718";NA;NA;bodymass index kg m $nmbr$
 206;body mass index group ( ≥ $nmbr$ kg / m $nmbr$ ) — no . ( % );"C0005893;C0022718;C0439209;C0441833;C0441847;C0578022;C0687744;C1257890;C1305855;C1519504;C1532718;C1705428;C1705429;C4054209";NA;NA;body mass index group $nmbr$ kg m $nmbr$ no
 206;body mass index > $nmbr$ kg / m $nmbr$ *;"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index $nmbr$ kg m $nmbr$
 206;body mass index > $nmbr$ kg / m $nmbr$  n ( % );"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index $nmbr$ kg m $nmbr$ n
 206;body mass index < $nmbr$ kg / m $nmbr$;"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index $nmbr$ kg m $nmbr$
 206;body mass index ( range ) ( kg / m $nmbr$ );"C0005893;C0578022;C1305855;C1514721;C1532718;C2348147;C3542016";NA;NA;body mass index range kg m $nmbr$
 206;body mass index ( kg / m ^ );"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index kg m
 206;body mass index ( kg / m $nmbr$ ) ∗;"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index kg m $nmbr$
 206;body mass index  kg / m ^ ^;"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index kg m
 206;body - mass index ( kg / m ’ );"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index kg m
 206;body - mass index ( kg / m - ) !;"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index kg m
 206;body - mass index  kg / m $nmbr$;"C0005893;C0578022;C1305855;C1532718";NA;NA;body mass index kg m $nmbr$
 206;bmp kg - m “ $nmbr$;"C0053932;C0279266;C1532718;C4281808";NA;NA;bmp kg m $nmbr$
 206;bmi kg - m - $nmbr$;"C0578022;C1532718";NA;NA;bmi kg m $nmbr$
 206;bmi group ( kg / m ^ );"C0022718;C0439209;C0441833;C0441847;C0578022;C0687744;C1257890;C1519504;C1532718;C1705428;C1705429;C4054209";NA;NA;bmi group kg m
 206;bmi at baseline ( kg / m $nmbr$ );"C0168634;C0578022;C1442488;C1532718";NA;NA;bmi at baseline kg m $nmbr$
 206;bmi > = $nmbr$ kg / m $nmbr$ population ( n = $nmbr$ );"C0032659;C0578022;C1257890;C1532718";NA;NA;bmi $nmbr$ kg m $nmbr$ population n $nmbr$
 206;bmi > $nmbr$ kg / m * ( n = $nmbr$ / $nmbr$ );"C0578022;C1532718";NA;NA;bmi $nmbr$ kg m n $nmbr$ $nmbr$
 206;bmi > $nmbr$ kg / m $nmbr$ ( n = $nmbr$ / $nmbr$ );"C0578022;C1532718";NA;NA;bmi $nmbr$ kg m $nmbr$ n $nmbr$ $nmbr$
 206;bmi > $nmbr$ kg / m $nmbr$ ( % );"C0578022;C1532718";NA;NA;bmi $nmbr$ kg m $nmbr$
 206;bmi ( sd )  kg / m $nmbr$;"C0578022;C1532718;C2699239";NA;NA;bmi sd kg m $nmbr$
 206;bmi ( kg / m $nmbr$ ) < $nmbr$;"C0578022;C1532718";NA;NA;bmi kg m $nmbr$ $nmbr$
 206;bmi ( kg / m $nmbr$ ) ( sd );"C0578022;C1532718;C2699239";NA;NA;bmi kg m $nmbr$ sd
 206;bmi ( kg / m $nmbr$ )  median ( range );"C0549183;C0578022;C0876920;C1514721;C1532718;C2347635;C2348144;C2348147;C2939193;C3542016";NA;NA;bmi kg m $nmbr$ median range
 206;bmi # kg - m “ $nmbr$;"C0578022;C1532718";NA;NA;bmi kg m $nmbr$
 204;psap - b ( ng / ml );"C0439275;C1418975;C1420002;C1425004";NA;NA;psap b ng ml
 206;bmi  kg / m $nmbr$ cholesterol  mg / dl;"C0008377;C0439269;C0578022;C1532718";NA;NA;bmi kg m $nmbr$ cholesterol mg dl
 206;bmi  kg / m $nmbr$ ( sd );"C0578022;C1532718;C2699239";NA;NA;bmi kg m $nmbr$ sd
 206;bmi  kg / m $nmbr$ ( mean $nmbr$ sd );"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";NA;NA;bmi kg m $nmbr$ mean $nmbr$ sd
 206;bmi  kg / m $nmbr$  n ( % );"C0578022;C1532718";NA;NA;bmi kg m $nmbr$ n
 206;bmi  kg / m $nmbr$  mean;"C0444504;C0578022;C1532718;C2347634;C2348143";NA;NA;bmi kg m $nmbr$ mean
 206;bm $nmbr$ ( kg / m $nmbr$ );"C0006416;C1532718";NA;NA;bm $nmbr$ kg m $nmbr$
 206;bl bm $nmbr$ < $nmbr$ kg / m ^;"C0005918;C0006413;C0006416;C1532718;C1552663;C2827109";NA;NA;bl bm $nmbr$ $nmbr$ kg m
 206;baseline bmi > $nmbr$ kg / m $nmbr$  n = $nmbr$  $nmbr$ change from baseline to $nmbr$ weeks;"C0168634;C0392747;C0439230;C0443172;C0578022;C1442488;C1532718;C1705241;C4319952";NA;NA;baseline bmi $nmbr$ kg m $nmbr$ n $nmbr$ $nmbr$ change from baseline to $nmbr$ weeks
 206;baseline bmi > $nmbr$ kg / m $nmbr$  n = $nmbr$  $nmbr$;"C0168634;C0578022;C1442488;C1532718";NA;NA;baseline bmi $nmbr$ kg m $nmbr$ n $nmbr$ $nmbr$
 206;baseline bmi > $nmbr$ kg / m $nmbr$  n = $nmbr$;"C0168634;C0578022;C1442488;C1532718";NA;NA;baseline bmi $nmbr$ kg m $nmbr$ n $nmbr$
 206;baseline bmi > $nmbr$ kg / m $nmbr$;"C0168634;C0578022;C1442488;C1532718";NA;NA;baseline bmi $nmbr$ kg m $nmbr$
 206;baseline bmi < $nmbr$ kg / m $nmbr$;"C0168634;C0578022;C1442488;C1532718";NA;NA;baseline bmi $nmbr$ kg m $nmbr$
 206;baseline bmi $nmbr$ to < $nmbr$ kg / m $nmbr$  n = $nmbr$ change from baseline to $nmbr$ weeks;"C0168634;C0392747;C0439230;C0443172;C0578022;C1442488;C1532718;C1705241;C4319952";NA;NA;baseline bmi $nmbr$ to $nmbr$ kg m $nmbr$ n $nmbr$ change from baseline to $nmbr$ weeks
 206;baseline bmi $nmbr$ to < $nmbr$ kg / m $nmbr$  n = $nmbr$  $nmbr$ change from baseline to $nmbr$ weeks;"C0168634;C0392747;C0439230;C0443172;C0578022;C1442488;C1532718;C1705241;C4319952";NA;NA;baseline bmi $nmbr$ to $nmbr$ kg m $nmbr$ n $nmbr$ $nmbr$ change from baseline to $nmbr$ weeks
 206;baseline bmi $nmbr$ to < $nmbr$ kg / m $nmbr$  n = $nmbr$  $nmbr$;"C0168634;C0578022;C1442488;C1532718";NA;NA;baseline bmi $nmbr$ to $nmbr$ kg m $nmbr$ n $nmbr$ $nmbr$
 206;baseline bmi $nmbr$ to < $nmbr$ kg / m $nmbr$  n = $nmbr$;"C0168634;C0578022;C1442488;C1532718";NA;NA;baseline bmi $nmbr$ to $nmbr$ kg m $nmbr$ n $nmbr$
 206;a $nmbr$ kg / m $nmbr$;C1532718;NA;NA;a $nmbr$ kg m $nmbr$
 206;[ kg / m ^ ];C1532718;NA;NA;kg m
 206;> = $nmbr$ kg / m $nmbr$;C1532718;NA;NA;$nmbr$ kg m $nmbr$
 206;> $nmbr$ kg / m ’;C1532718;NA;NA;$nmbr$ kg m
 206;> $nmbr$ kg / m ^ ( obesity );"C0028754;C1532718;C1963185";NA;NA;$nmbr$ kg m obesity
 206;> $nmbr$ kg / m ^;C1532718;NA;NA;$nmbr$ kg m
 206;> $nmbr$ kg / m $nmbr$ ( n — $nmbr$ );C1532718;NA;NA;$nmbr$ kg m $nmbr$ n $nmbr$
 206;> $nmbr$ kg / m $nmbr$ ( n = $nmbr$ );C1532718;NA;NA;$nmbr$ kg m $nmbr$ n $nmbr$
 206;> $nmbr$ kg / m $nmbr$;C1532718;NA;NA;$nmbr$ kg m $nmbr$
 206;> $nmbr$ . $nmbr$ kg / m $nmbr$ hypertension :;"C0020538;C1532718;C1963138";NA;NA;$nmbr$ $nmbr$ kg m $nmbr$ hypertension
 206;> $nmbr$ . $nmbr$ kg / m $nmbr$;C1532718;NA;NA;$nmbr$ $nmbr$ kg m $nmbr$
 206;> $nmbr$ - s $nmbr$ kg / m ’;"C0565930;C1532718;C2603362";NA;NA;$nmbr$ s $nmbr$ kg m
 206;> $nmbr$ - ^ $nmbr$ kg / m ’;C1532718;NA;NA;$nmbr$ $nmbr$ kg m
 206;> $nmbr$ - < s $nmbr$ kg / m ’;"C0565930;C1532718;C2603362";NA;NA;$nmbr$ s $nmbr$ kg m
 206;> $nmbr$ - < $nmbr$ kg / m $nmbr$ ( n = $nmbr$ );C1532718;NA;NA;$nmbr$ $nmbr$ kg m $nmbr$ n $nmbr$
 206;< $nmbr$ kg / m ^;C1532718;NA;NA;$nmbr$ kg m
 206;< $nmbr$ kg / m $nmbr$ ( n — $nmbr$ );C1532718;NA;NA;$nmbr$ kg m $nmbr$ n $nmbr$
 206;< $nmbr$ kg / m $nmbr$ ( n = $nmbr$ );C1532718;NA;NA;$nmbr$ kg m $nmbr$ n $nmbr$
 206;< $nmbr$ kg / m $nmbr$;C1532718;NA;NA;$nmbr$ kg m $nmbr$
 206;< $nmbr$ . $nmbr$ kg / m $nmbr$;C1532718;NA;NA;$nmbr$ $nmbr$ kg m $nmbr$
 206;< $nmbr$  kg / m $nmbr$;C1532718;NA;NA;$nmbr$ kg m $nmbr$
 206;$nmbr$ to < $nmbr$ kg / m $nmbr$;C1532718;NA;NA;$nmbr$ to $nmbr$ kg m $nmbr$
 206;$nmbr$ kg / m ’;C1532718;NA;NA;$nmbr$ kg m
 206;$nmbr$ kg / m $nmbr$ or more;"C0205172;C1532718";NA;NA;$nmbr$ kg m $nmbr$ or more
 206;$nmbr$ kg / m $nmbr$;C1532718;NA;NA;$nmbr$ kg m $nmbr$
 206;$nmbr$ bmi  kg / m;"C0578022;C1532718";NA;NA;$nmbr$ bmi kg m
 206;$nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ kg / m $nmbr$;C1532718;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ kg m $nmbr$
 206;$nmbr$ - < $nmbr$ kg / m $nmbr$;C1532718;NA;NA;$nmbr$ $nmbr$ kg m $nmbr$
 206;$nmbr$ - $nmbr$ kg / m $nmbr$;C1532718;NA;NA;$nmbr$ $nmbr$ kg m $nmbr$
 206;$nmbr$ - $nmbr$ . $nmbr$ kg / m $nmbr$;C1532718;NA;NA;$nmbr$ $nmbr$ $nmbr$ kg m $nmbr$
 206;$nmbr$ $nmbr$ to < $nmbr$ kg / m $nmbr$;C1532718;NA;NA;$nmbr$ $nmbr$ to $nmbr$ kg m $nmbr$
 205;« $nmbr$ kg;"C0022718;C0439209;C4054209";NA;NA;$nmbr$ kg
 205;£ $nmbr$ kg;"C0022718;C0439209;C4054209";NA;NA;$nmbr$ kg
 205;total daily insulin dose ( lu / kg );"C0021641;C0022718;C0024171;C0024176;C0439209;C1533581;C1579433;C2348070;C2697939;C3714501;C4054209";NA;NA;total daily insulin dose lu kg
 205;q $nmbr$ : > $nmbr$ . $nmbr$ kg ( n = $nmbr$ vs $nmbr$ );"C0022718;C0439209;C4054209";NA;NA;q $nmbr$ $nmbr$ $nmbr$ kg n $nmbr$ vs $nmbr$
  66;theophyllines;C0039771;NA;NA;theophyllines
 205;weight - kg;"C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C4054209";FALSE;2326;weight kg
 205;weight ( kg );"C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C4054209";FALSE;2326;weight kg
 205;weight — kg;"C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C4054209";FALSE;2326;weight kg
 205;weight ( kg ) a;"C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C4054209";FALSE;2326;weight kg a
 205;weight  kg ( mean $nmbr$ sd );"C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209";FALSE;2326;weight kg mean $nmbr$ sd
 205;weight  kg  mean ( sd );"C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209";FALSE;2326;weight kg mean sd
 205;weight  kg  mean ± sd;"C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209";FALSE;2326;weight kg mean sd
 205;weight  kg mean ( sd );"C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209";FALSE;2326;weight kg mean sd
 205;weight ( kg )  mean ± sd;"C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209";FALSE;2326;weight kg mean sd
 205;weight ( kg )  mean   ±   sd;"C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209";FALSE;2326;weight kg mean sd
 205;weight ( kg ) ( mean ± sd );"C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209";FALSE;2326;weight kg mean sd
 205;weight ( kg ) 十;"C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C4054209";FALSE;2326;weight kg
 205;weight  mean ( sd )  kg;"C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209";FALSE;2326;weight mean sd kg
 205;weight  mean ± sd kg;"C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209";FALSE;2326;weight mean sd kg
 205;weight  median ( sd )  kg;"C0005910;C0022718;C0043100;C0439209;C0549183;C0876920;C1305866;C1705104;C2347635;C2348144;C2699239;C2939193;C4054209";FALSE;2326;weight median sd kg
 205;weight < $nmbr$ kg  n ( % );"C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C4054209";FALSE;2326;weight $nmbr$ kg n
 205;weight > $nmbr$ kg  n ( % );"C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C4054209";FALSE;2326;weight $nmbr$ kg n
 205;weight 一 kg;"C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C4054209";FALSE;2326;weight kg
 205;q $nmbr$ : < $nmbr$ . $nmbr$ kg ( n = $nmbr$ vs $nmbr$ );"C0022718;C0439209;C4054209";NA;NA;q $nmbr$ $nmbr$ $nmbr$ kg n $nmbr$ vs $nmbr$
 205;o $nmbr$ kg  n ( % );"C0022718;C0439209;C0483204;C4054209";NA;NA;o $nmbr$ kg n
 205;lu / kg;"C0022718;C0024171;C0024176;C0439209;C2697939;C4054209";NA;NA;lu kg
 205;kg;"C0022718;C0439209;C4054209";NA;NA;kg
 205;grip strength ( kg );"C0022718;C0429271;C0439209;C2598165;C4054209";NA;NA;grip strength kg
 205;dose adjustment reason < $nmbr$ kg;"C0022718;C0439209;C2826286;C4054209";NA;NA;dose adjustment reason $nmbr$ kg
 205;difference vs . placebo  kg ( $nmbr$ % cl );"C0022718;C0032042;C0439209;C0596019;C1696465;C1705241;C1705242;C1706408;C4054209";NA;NA;difference vs placebo kg $nmbr$ cl
 205;daily total dose of insulin — lu / kg;"C0021641;C0022718;C0024171;C0024176;C0439209;C1533581;C1579433;C2348070;C2697939;C3714501;C4054209";NA;NA;daily total dose of insulin lu kg
 205;> = $nmbr$ kg;"C0022718;C0439209;C4054209";NA;NA;$nmbr$ kg
 205;> $nmbr$ kg — no . ( % );"C0022718;C0439209;C4054209";NA;NA;$nmbr$ kg no
 205;> $nmbr$ kg nr;"C0022718;C0027496;C0439209;C3844738;C4054209";NA;NA;$nmbr$ kg nr
 205;> $nmbr$ kg / nr;"C0022718;C0027496;C0439209;C3844738;C4054209";NA;NA;$nmbr$ kg nr
 205;> $nmbr$ kg;"C0022718;C0439209;C4054209";NA;NA;$nmbr$ kg
 205;> $nmbr$ . $nmbr$ kg;"C0022718;C0439209;C4054209";NA;NA;$nmbr$ $nmbr$ kg
 205;> $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ kg;"C0022718;C0439209;C4054209";NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ kg
 205;> $nmbr$ - $nmbr$ kg;"C0022718;C0439209;C4054209";NA;NA;$nmbr$ $nmbr$ kg
 205;< = € $nmbr$ kg;"C0022718;C0439209;C4054209";NA;NA;$nmbr$ kg
 205;< = $nmbr$ kg;"C0022718;C0439209;C4054209";NA;NA;$nmbr$ kg
 205;< $nmbr$ kg ' i ';"C0021966;C0022718;C0221138;C0439209;C4054209";NA;NA;$nmbr$ kg i
 205;< $nmbr$ kg  n ( % );"C0022718;C0439209;C4054209";NA;NA;$nmbr$ kg n
 205;< $nmbr$ kg;"C0022718;C0439209;C4054209";NA;NA;$nmbr$ kg
 205;< $nmbr$ . $nmbr$ kg;"C0022718;C0439209;C4054209";NA;NA;$nmbr$ $nmbr$ kg
 205;. $nmbr$ kg mtx use;"C0022718;C0025677;C0042153;C0439209;C0457083;C1417487;C1947944;C4054209";NA;NA;$nmbr$ kg mtx use
 205;. $nmbr$ kg;"C0022718;C0439209;C4054209";NA;NA;$nmbr$ kg
 205;$nmbr$ to < $nmbr$ kg;"C0022718;C0439209;C4054209";NA;NA;$nmbr$ to $nmbr$ kg
 205;$nmbr$ kg;"C0022718;C0439209;C4054209";NA;NA;$nmbr$ kg
 205;$nmbr$ - < $nmbr$ kg;"C0022718;C0439209;C4054209";NA;NA;$nmbr$ $nmbr$ kg
 205;$nmbr$ - $nmbr$ kg;"C0022718;C0439209;C4054209";NA;NA;$nmbr$ $nmbr$ kg
 205;# $nmbr$ kg;"C0022718;C0439209;C4054209";NA;NA;$nmbr$ kg
 204;≥ $nmbr$ ng / ml;C0439275;NA;NA;$nmbr$ ng ml
 204;wap $nmbr$ c ( ng / ml );C0439275;NA;NA;wap $nmbr$ c ng ml
 204;vegfr ( ng / ml );"C0439275;C1568520";NA;NA;vegfr ng ml
 204;troy ( ng / ml );"C0439275;C1420811;C1883402";NA;NA;troy ng ml
 204;tnf - r $nmbr$ a ( ng / ml );"C0439275;C1363984;C1706001";NA;NA;tnf r $nmbr$ a ng ml
 204;tertile $nmbr$ ( < $nmbr$ . $nmbr$ ng / ml ) n - $nmbr$;C0439275;NA;NA;tertile $nmbr$ $nmbr$ $nmbr$ ng ml n $nmbr$
 204;t $nmbr$ ( $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ ng / ml );"C0439275;C2603360";NA;NA;t $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ ng ml
 204;syndecan - $nmbr$ ( ng / ml );"C0075691;C0439275;C1419891";NA;NA;syndecan $nmbr$ ng ml
 204;sdc ( ng / ml );"C0439275;C1419891;C3273112";NA;NA;sdc ng ml
 204;sdc ( $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ ng / ml );"C0439275;C1419891;C3273112";NA;NA;sdc $nmbr$ $nmbr$ $nmbr$ $nmbr$ ng ml
 204;sdc $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ ng / ml;"C0439275;C1419891;C3273112";NA;NA;sdc $nmbr$ $nmbr$ $nmbr$ $nmbr$ ng ml
 204;rage ( ng / ml );"C0034634;C0439275;C3539760;C3815186";NA;NA;rage ng ml
 204;ptx $nmbr$ ( ng / ml );"C0030899;C0439275";NA;NA;ptx $nmbr$ ng ml
 205;body - mass index ( kg / mq;"C0005893;C0022718;C0024853;C0439209;C0578022;C1305855;C4054209";FALSE;1734;body mass index kg mq
 205;body mass index ( kg / nr );"C0005893;C0022718;C0027496;C0439209;C0578022;C1305855;C3844738;C4054209";FALSE;1734;body mass index kg nr
 205;body - mass index > $nmbr$ kg / nrn;"C0005893;C0022718;C0439209;C0578022;C1305855;C1425210;C4054209";FALSE;1734;body mass index $nmbr$ kg nrn
 205;body mass  kg;"C0022718;C0439209;C0518010;C4054209";FALSE;1734;body mass kg
 205;body weight  kg;"C0005910;C0022718;C0439209;C1305866;C4054209";FALSE;1734;body weight kg
 205;body weight  kg ^;"C0005910;C0022718;C0439209;C1305866;C4054209";FALSE;1734;body weight kg
 205;body weight ( kg );"C0005910;C0022718;C0439209;C1305866;C4054209";FALSE;1734;body weight kg
 205;body weight ( kg ) *;"C0005910;C0022718;C0439209;C1305866;C4054209";FALSE;1734;body weight kg
 205;mean body - mass index ( kg / mq;"C0005893;C0022718;C0024853;C0439209;C0444504;C0578022;C1305855;C2347634;C2348143;C4054209";FALSE;1734;mean body mass index kg mq
 205;bw at $nmbr$ weeks  kg +;"C0005910;C0006041;C0022718;C0439209;C0439230;C2986891;C4054209";FALSE;2326;bw at $nmbr$ weeks kg
 205;body weight  mean = sd  kg;"C0005910;C0022718;C0439209;C0444504;C1305866;C2347634;C2348143;C2699239;C4054209";FALSE;2326;body weight mean sd kg
 205;bw  kg;"C0005910;C0006041;C0022718;C0439209;C2986891;C4054209";FALSE;2326;bw kg
 205;body weight  kg ( sd );"C0005910;C0022718;C0439209;C1305866;C2699239;C4054209";FALSE;2326;body weight kg sd
 205;body weight ( kg )  n ( % );"C0005910;C0022718;C0439209;C1305866;C4054209";FALSE;2326;body weight kg n
 205;bodyweight ( kg );"C0005910;C0022718;C0439209;C1305866;C4054209";FALSE;2326;bodyweight kg
 205;bodyweight  kg;"C0005910;C0022718;C0439209;C1305866;C4054209";FALSE;2326;bodyweight kg
 205;adjusted mean change ( kg );"C0022718;C0392747;C0439209;C0443172;C0444504;C0456081;C1705241;C2347634;C2348143;C4054209;C4319952";FALSE;2326;adjusted mean change kg
 205;baseline weight  kg;"C0022718;C0439209;C1303013;C4054209";FALSE;2326;baseline weight kg
 205;body weight — kg;"C0005910;C0022718;C0439209;C1305866;C4054209";FALSE;2326;body weight kg
 205;actual or estimated weight  kg;"C0022718;C0237400;C0439209;C4054209;C4329797";FALSE;2326;actual or estimated weight kg
 205;low body weight ( < $nmbr$ kg );"C0022718;C0041667;C0439209;C4054209";FALSE;2326;low body weight $nmbr$ kg
 205;mean body weight  kg ( range );"C0005910;C0022718;C0439209;C0444504;C1305866;C1514721;C2347634;C2348143;C2348147;C3542016;C4054209";FALSE;2326;mean body weight kg range
 205;mean body weight ( sd )  kg;"C0005910;C0022718;C0439209;C0444504;C1305866;C2347634;C2348143;C2699239;C4054209";FALSE;2326;mean body weight sd kg
 205;median body weight ( kg );"C0005910;C0022718;C0043100;C0439209;C0549183;C0876920;C1305866;C1705104;C2347635;C2348144;C2939193;C3821165;C4054209";FALSE;2326;median body weight kg
 205;median body weight — kg;"C0005910;C0022718;C0043100;C0439209;C0549183;C0876920;C1305866;C1705104;C2347635;C2348144;C2939193;C3821165;C4054209";FALSE;2326;median body weight kg
 205;median m / kg $nmbr$ ( iqr );"C0022718;C0369637;C0439209;C0441923;C0549183;C0876920;C2347635;C2348144;C2939193;C4054209";FALSE;2326;median m kg $nmbr$ iqr
 205;median weight  kg ( iqr );"C0005910;C0022718;C0043100;C0439209;C0549183;C0876920;C1305866;C1705104;C2347635;C2348144;C2939193;C4054209";FALSE;2326;median weight kg iqr
 204;psa level  ng / ml;"C0439275;C4086720";NA;NA;psa level ng ml
 204;psa ( ng / ml );"C0439275;C3810537;C3813209";NA;NA;psa ng ml
 193;< $nmbr$ mg / l;C0439268;NA;NA;$nmbr$ mg l
 204;psa  ng / ml  mean ( sd );"C0439275;C0444504;C2347634;C2348143;C2699239;C3810537;C3813209";NA;NA;psa ng ml mean sd
 204;proprotein convertase subtil / kexin typ $nmbr$ ( ng / ml ) - baseline - > = median ( n = $nmbr$  $nmbr$ );"C0165249;C0168634;C0439275;C0549183;C0876920;C1100660;C1414185;C1442488;C2347635;C2348144;C2939193;C3811813";NA;NA;proprotein convertase subtil kexin typ $nmbr$ ng ml baseline median n $nmbr$ $nmbr$
 204;proprotein convertase subtil / kexin typ $nmbr$ ( ng / ml ) - baseline - < median ( n = $nmbr$  $nmbr$ );"C0165249;C0168634;C0439275;C0549183;C0876920;C1100660;C1414185;C1442488;C2347635;C2348144;C2939193;C3811813";NA;NA;proprotein convertase subtil kexin typ $nmbr$ ng ml baseline median n $nmbr$ $nmbr$
 204;procalcitonin ( ng / ml );"C0072027;C0439275";NA;NA;procalcitonin ng ml
 204;proadm ( ng / ml );C0439275;NA;NA;proadm ng ml
 204;pigr ( ng / ml );"C0439275;C1418569";NA;NA;pigr ng ml
 204;pentraxin - $nmbr$ ( ng / ml );C0439275;NA;NA;pentraxin $nmbr$ ng ml
 204;osteopontin ( ng / ml );"C0069676;C0439275;C1420369;C1505427;C4084879";NA;NA;osteopontin ng ml
 204;opg  ( ng / ml );"C0439275;C1262886;C1336645;C1412836;C1710303";NA;NA;opg ng ml
 204;ntpro - cnp ( ng / ml );"C0439275;C3889729";NA;NA;ntpro cnp ng ml
 204;nt probnp > $nmbr$ ng / ml n ( % ) §;"C0439275;C1317554;C2825907;C4284038";NA;NA;nt probnp $nmbr$ ng ml n
 204;ngal ( ng / ml );"C0215955;C0439275;C1416806;C2346625";NA;NA;ngal ng ml
 204;neuropilin ( ng / ml );"C0287275;C0439275";NA;NA;neuropilin ng ml
 204;mpo ( ng / ml );C0439275;NA;NA;mpo ng ml
 204;mmp - $nmbr$ ( ng / ml ) *;"C0439275;C0623362;C0919336";NA;NA;mmp $nmbr$ ng ml
 204;mmp - $nmbr$ ( ng / ml );"C0439275;C0623362;C0919336";NA;NA;mmp $nmbr$ ng ml
 204;mesothelin ( ng / ml );"C0380162;C0439275;C1334533";NA;NA;mesothelin ng ml
 204;ltbr ( ng / ml );"C0439275;C1416931";NA;NA;ltbr ng ml
 204;gdf - $nmbr$ ( ng / ml );"C0439275;C1418244";NA;NA;gdf $nmbr$ ng ml
 204;galectin - $nmbr$ ( ng / ml );"C0439275;C0607430";NA;NA;galectin $nmbr$ ng ml
 204;fasting c - peptide ( ng / ml );"C0006558;C0015663;C0439275";NA;NA;fasting c peptide ng ml
 204;fasting c - peptide  ng / ml;"C0006558;C0015663;C0439275";NA;NA;fasting c peptide ng ml
 204;esam ( ng / ml );"C0439275;C1424976";NA;NA;esam ng ml
 204;ctn - l  ng / ml;"C0439275;C0917591";NA;NA;ctn l ng ml
 204;ctn - i  ng / ml;"C0021966;C0221138;C0439275;C0917591";NA;NA;ctn i ng ml
 204;crp ( ng / ml );"C0439275;C3890735;C4048285";NA;NA;crp ng ml
 204;ck - mb  ng / ml;"C0010290;C0439275";NA;NA;ck mb ng ml
 204;cholesterol ( ng / ml );"C0008377;C0439275";NA;NA;cholesterol ng ml
 204;biomarker low ( periostin < $nmbr$ ng / ml or blood eosinophils < $nmbr$ cells per pl )  na;"C0005516;C0005773;C0007584;C0007634;C0014467;C0200638;C0205251;C0219433;C0439275;C0597484;C1272460;C1424662;C1546968;C1550472;C1879645;C3812270;C3890211;C3897966;C4048187;C4049765;C4049872;C4321351;C4522223;C4552882";NA;NA;biomarker low periostin $nmbr$ ng ml or blood eosinophils $nmbr$ cells per pl na
 204;angiogenin ( ng / ml );"C0051844;C0439275;C1367482";NA;NA;angiogenin ng ml
 204;> $nmbr$ . $nmbr$ ng / ml ( n = $nmbr$ );C0439275;NA;NA;$nmbr$ $nmbr$ ng ml n $nmbr$
 204;> $nmbr$ . $nmbr$ ng / ml;C0439275;NA;NA;$nmbr$ $nmbr$ ng ml
 204;< $nmbr$ ng / ml;C0439275;NA;NA;$nmbr$ ng ml
 204;< $nmbr$ . $nmbr$ ng / ml ( n = $nmbr$ );C0439275;NA;NA;$nmbr$ $nmbr$ ng ml n $nmbr$
 204;< $nmbr$ . $nmbr$ ng / ml;C0439275;NA;NA;$nmbr$ $nmbr$ ng ml
 203;ng ( n = $nmbr$  $nmbr$ );"C0017887;C0028074";NA;NA;ng n $nmbr$ $nmbr$
 203;ng;"C0017887;C0028074";NA;NA;ng
 203;median serum periostin  ng / mla;"C0017887;C0028074;C0219433;C0229671;C0549183;C0599973;C0876920;C1424662;C1546774;C1550100;C2347635;C2348144;C2939193;C3812270";NA;NA;median serum periostin ng mla
 202;tnf - alpha ( pg / ml );"C0439297;C1448177;C1456820;C1522669";NA;NA;tnf alpha pg ml
 202;kim $nmbr$ ( pg / ml );C0439297;NA;NA;kim $nmbr$ pg ml
 202;avp pg / ml;"C0439297;C1098706;C1568204;C1708407";NA;NA;avp pg ml
 202;> ulnand < $nmbr$ ng / l;C0439297;NA;NA;ulnand $nmbr$ ng l
 202;> = $nmbr$ to < $nmbr$ ng / l ( n = $nmbr$ ) n ( % );C0439297;NA;NA;$nmbr$ to $nmbr$ ng l n $nmbr$ n
 202;> = $nmbr$ ng / l ( n = $nmbr$ ) n ( % );C0439297;NA;NA;$nmbr$ ng l n $nmbr$ n
 202;> = $nmbr$ ng / l ( n = $nmbr$ );C0439297;NA;NA;$nmbr$ ng l n $nmbr$
 202;> = $nmbr$ . $nmbr$ to < $nmbr$ ng / l ( n = $nmbr$ ) n ( % );C0439297;NA;NA;$nmbr$ $nmbr$ to $nmbr$ ng l n $nmbr$ n
 202;> $nmbr$ ng / l;C0439297;NA;NA;$nmbr$ ng l
 202;< $nmbr$ . $nmbr$ ng / l ( n = $nmbr$ ) n ( % );C0439297;NA;NA;$nmbr$ $nmbr$ ng l n $nmbr$ n
 202;< $nmbr$ . $nmbr$ ng / l ( n = $nmbr$ );C0439297;NA;NA;$nmbr$ $nmbr$ ng l n $nmbr$
 202;% phg;NA;NA;NA;phg
 202;$nmbr$ . $nmbr$ - < $nmbr$ ng / l ( n = $nmbr$ );C0439297;NA;NA;$nmbr$ $nmbr$ $nmbr$ ng l n $nmbr$
 202;$nmbr$ - < $nmbr$ ng / l ( n = $nmbr$ );C0439297;NA;NA;$nmbr$ $nmbr$ ng l n $nmbr$
 201;mmp - $nmbr$  median ( iqr )  gg / l;"C0017454;C0018370;C0549183;C0623362;C0876920;C0919336;C2347635;C2348144;C2939193";NA;NA;mmp $nmbr$ median iqr gg l
 201;ind $nmbr$ gg q . d . n / n ( % );"C0017454;C0018370;C4049864";NA;NA;ind $nmbr$ gg q d n n
 201;gly $nmbr$ . $nmbr$ gg b . i . d n / n ( % );"C0017454;C0018370;C0152277;C1415124";NA;NA;gly $nmbr$ $nmbr$ gg b i d n n
 201;gg;"C0017454;C0018370";NA;NA;gg
 200;s $nmbr$ mg / mmol;"C0565930;C0567349;C2348885;C2603362";NA;NA;s $nmbr$ mg mmol
 200;s $nmbr$ . $nmbr$ mg / mmol;"C0565930;C0567349;C2348885;C2603362";NA;NA;s $nmbr$ $nmbr$ mg mmol
 200;mg / mmol;"C0567349;C2348885";NA;NA;mg mmol
 200;median ( sd )  mg / mmol;"C0549183;C0567349;C0876920;C2347635;C2348144;C2348885;C2699239;C2939193";NA;NA;median sd mg mmol
 200;mean a ± sd  mg / dl ( mmol / $nmbr$ );"C0439190;C0439269;C0444504;C0567349;C2347634;C2348143;C2348885;C2699239;C3642216";NA;NA;mean a sd mg dl mmol $nmbr$
 200;bl mean  mg / dl ( mmol / $nmbr$ );"C0005918;C0006413;C0439190;C0439269;C0444504;C0567349;C1552663;C2347634;C2348143;C2348885;C2827109;C3642216";NA;NA;bl mean mg dl mmol $nmbr$
 200;> $nmbr$ . $nmbr$ mg / mmol;"C0567349;C2348885";NA;NA;$nmbr$ $nmbr$ mg mmol
 200;< $nmbr$ . $nmbr$ mg / mmol;"C0567349;C2348885";NA;NA;$nmbr$ $nmbr$ mg mmol
 200;. $nmbr$ . $nmbr$ mg / mmol;"C0567349;C2348885";NA;NA;$nmbr$ $nmbr$ mg mmol
 200;$nmbr$ . $nmbr$ to # $nmbr$ . $nmbr$ mg / mmol;"C0567349;C2348885";NA;NA;$nmbr$ $nmbr$ to $nmbr$ $nmbr$ mg mmol
 200;$nmbr$ . $nmbr$ mg / mmol;"C0567349;C2348885";NA;NA;$nmbr$ $nmbr$ mg mmol
 202;troponin i ( pg / ml );"C0077401;C0439297";FALSE;2322;troponin i pg ml
 202;troponin t ( pg / ml );"C0077404;C0439297;C1420827";FALSE;2322;troponin t pg ml
 202;interleukin - $nmbr$ ( ng / l );"C0021764;C0439297;C1527200";FALSE;2322;interleukin $nmbr$ ng l
 202;interleukin $nmbr$ ( pg / ml );"C0021764;C0439297;C1527200";FALSE;2322;interleukin $nmbr$ pg ml
 202;b - natriuretic peptide . pg / ml;"C0070338;C0439297;C0597421";FALSE;2323;b natriuretic peptide pg ml
 202;n - terminal pro - brain natriuretic peptide  pg / ml;"C0439297;C3272900";FALSE;2323;n terminal pro brain natriuretic peptide pg ml
 202;endothelin $nmbr$ ( pg / ml );"C0079284;C0439297";FALSE;2324;endothelin $nmbr$ pg ml
 203;d - dimer level  mean ( sd )  ng / mld;"C0017887;C0023522;C0028074;C0060323;C0441889;C0444504;C0456079;C1539265;C1547707;C2347634;C2348143;C2699239;C2946261;C3539688;C3539689";FALSE;2325;d dimer level mean sd ng mld
 200;$nmbr$ . $nmbr$ - < $nmbr$ . $nmbr$ mg / mmol;"C0567349;C2348885";NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ mg mmol
 199;umec $nmbr$ . $nmbr$ mcg ( n = $nmbr$ );"C0439211;C3463985";NA;NA;umec $nmbr$ $nmbr$ mcg n $nmbr$
 199;tio i $nmbr$ mcg ( n = $nmbr$ );"C0021966;C0221138;C0439211;C3463985";NA;NA;tio i $nmbr$ mcg n $nmbr$
 198;rsg $nmbr$ mg / day;C0439422;NA;NA;rsg $nmbr$ mg day
 198;placebo + $nmbr$ mg / d of simvastatin ( n = $nmbr$ );"C0032042;C0074554;C0439422;C1696465;C1706408";NA;NA;placebo $nmbr$ mg d of simvastatin n $nmbr$
 198;no . of $nmbr$ - mg acetaminophen tablets / day;"C0439422;C1243102";NA;NA;no of $nmbr$ mg acetaminophen tablets day
 198;mg / day;C0439422;NA;NA;mg day
 193;< $nmbr$ mg / l ( n = $nmbr$ );C0439268;NA;NA;$nmbr$ mg l n $nmbr$
 198;mean dose ( sd ) ( mg / day );"C0178602;C0439422;C0444504;C0869039;C1114758;C2347634;C2348143;C2699239";NA;NA;mean dose sd mg day
 198;itca $nmbr$ $nmbr$ mg / day ( n = $nmbr$ );"C0165330;C0439422";NA;NA;itca $nmbr$ $nmbr$ mg day n $nmbr$
 198;ind $nmbr$ mg q . d . n = $nmbr$;"C0439422;C4049864";NA;NA;ind $nmbr$ mg q d n $nmbr$
 198;dose ( mg / day );"C0178602;C0439422;C0869039;C1114758";NA;NA;dose mg day
 198;dietary epa - dha intake ( mg / day ) *;"C0142831;C0439422;C1286104;C2348308";NA;NA;dietary epa dha intake mg day
 198;dapagliflozin $nmbr$ mg / day ( n = $nmbr$ );"C0439422;C2353951";NA;NA;dapagliflozin $nmbr$ mg day n $nmbr$
 198;brv dosage  mg / d;"C0155502;C0178602;C0439422;C2986497";NA;NA;brv dosage mg d
 198;brv > $nmbr$ mg / day;"C0155502;C0439422";NA;NA;brv $nmbr$ mg day
 198;brv $nmbr$   mg / day;"C0155502;C0439422";NA;NA;brv $nmbr$ mg day
 198;brv $nmbr$ mg / day ( n = $nmbr$ );"C0155502;C0439422";NA;NA;brv $nmbr$ mg day n $nmbr$
 198;brv $nmbr$ mg / day ( n =;"C0155502;C0439422";NA;NA;brv $nmbr$ mg day n
 198;> $nmbr$ mg / day;C0439422;NA;NA;$nmbr$ mg day
 198;> $nmbr$ mg / d peq;C0439422;NA;NA;$nmbr$ mg d peq
 198;> $nmbr$ . $nmbr$ mg / day  %;C0439422;NA;NA;$nmbr$ $nmbr$ mg day
 198;< $nmbr$ mg / day;C0439422;NA;NA;$nmbr$ mg day
 198;< $nmbr$ mg / d peq;C0439422;NA;NA;$nmbr$ mg d peq
 198;$nmbr$ mg / day;C0439422;NA;NA;$nmbr$ mg day
 198;$nmbr$ mg / d ( n = $nmbr$ );C0439422;NA;NA;$nmbr$ mg d n $nmbr$
 197;( pg / mg );C1627892;NA;NA;pg mg
 196;≥ $nmbr$ to < $nmbr$ mg / g;C1300563;NA;NA;$nmbr$ to $nmbr$ mg g
 196;≥ $nmbr$ mg / g;C1300563;NA;NA;$nmbr$ mg g
 196;mg / g;C1300563;NA;NA;mg g
 196;fcal  mg / g  mean ± sd;"C0444504;C1300563;C2347634;C2348143;C2699239";NA;NA;fcal mg g mean sd
 196;^ $nmbr$ mg / g  n ( % );C1300563;NA;NA;$nmbr$ mg g n
 196;> = $nmbr$ mg / g;C1300563;NA;NA;$nmbr$ mg g
 196;> $nmbr$ to $nmbr$ mg / g;C1300563;NA;NA;$nmbr$ to $nmbr$ mg g
 196;> $nmbr$ mg / g;C1300563;NA;NA;$nmbr$ mg g
 196;< $nmbr$ mg / g  n ( % );C1300563;NA;NA;$nmbr$ mg g n
 196;< $nmbr$ mg / g;C1300563;NA;NA;$nmbr$ mg g
 196;$nmbr$ − $nmbr$ mg / g;C1300563;NA;NA;$nmbr$ $nmbr$ mg g
 196;$nmbr$ to $nmbr$ mg / g;C1300563;NA;NA;$nmbr$ to $nmbr$ mg g
 196;$nmbr$ mg / g  n ( % );C1300563;NA;NA;$nmbr$ mg g n
 196;$nmbr$ mg / g;C1300563;NA;NA;$nmbr$ mg g
 196;$nmbr$ - $nmbr$ mg / g;C1300563;NA;NA;$nmbr$ $nmbr$ mg g
 197;$nmbr$ baricitinib $nmbr$ mg ■ baricitinib $nmbr$ mg;"C1319635;C4044947";FALSE;1956;$nmbr$ baricitinib $nmbr$ mg baricitinib $nmbr$ mg
 196;acr ( mg / g )  mean ( sd );"C0444504;C1300563;C1412134;C1515941;C2347634;C2348143;C2699239";FALSE;2315;acr mg g mean sd
 195;serum cholesterol  median ( iqr )  mg / dl;"C0439269;C0549183;C0587184;C0876920;C2347635;C2348144;C2939193";FALSE;1501;serum cholesterol median iqr mg dl
 198;methotrexate dose on day $nmbr$ — mg per wl < $nmbr$;"C0025677;C0178602;C0332173;C0439228;C0439422;C0439505;C0869039;C1114758;C4086581";FALSE;1408;methotrexate dose on day $nmbr$ mg per wl $nmbr$
 196;acr > $nmbr$ mg / g;"C1300563;C1412134;C1515941";FALSE;2315;acr $nmbr$ mg g
 196;baseline uacr < $nmbr$ mg / g;"C0168634;C1300563;C1442488";FALSE;2315;baseline uacr $nmbr$ mg g
 196;uac > $nmbr$ mg / g;C1300563;FALSE;2315;uac $nmbr$ mg g
 196;uac $nmbr$ - $nmbr$ mg / g;C1300563;FALSE;2315;uac $nmbr$ $nmbr$ mg g
 196;uacra  mg / g  gmean = gcv;"C0017066;C1300563";FALSE;2315;uacra mg g gmean gcv
 196;uacra  mg / g  n ( % );C1300563;FALSE;2315;uacra mg g n
 196;uacr  median ( iqr )  mg / g;"C0549183;C0876920;C1300563;C2347635;C2348144;C2939193";FALSE;2315;uacr median iqr mg g
 196;uacr ( mg / g );C1300563;FALSE;2315;uacr mg g
 196;uacr  mg / g  median ( iqr );"C0549183;C0876920;C1300563;C2347635;C2348144;C2939193";FALSE;2315;uacr mg g median iqr
 196;uacr ( mg / g  median [ iqr ] );"C0549183;C0876920;C1300563;C2347635;C2348144;C2939193";FALSE;2315;uacr mg g median iqr
 196;uacr — mg / g  median ( iqr );"C0549183;C0876920;C1300563;C2347635;C2348144;C2939193";FALSE;2315;uacr mg g median iqr
 196;uacr *  mg / g ( q $nmbr$  q $nmbr$ );C1300563;FALSE;2315;uacr mg g q $nmbr$ q $nmbr$
 196;urine acr geometric mean ( cv % )  a  b mg / g;"C0042036;C0042037;C1300563;C1412134;C1515941;C2963137;C2986759;C3538987;C4048877;C4318503";FALSE;2315;urine acr geometric mean cv a b mg g
 196;urine acr ( mg / g );"C0042036;C0042037;C1300563;C1412134;C1515941;C2963137";FALSE;2315;urine acr mg g
 196;prevalent kidney disease ( egfr < $nmbr$ ml / min / usm ^ or maeroalbuminuria uacr > $nmbr$ mg / g );"C0022658;C0033105;C0220900;C0439445;C1300563;C1739039;C3811844;C3812682";FALSE;2315;prevalent kidney disease egfr $nmbr$ ml min usm or maeroalbuminuria uacr $nmbr$ mg g
 196;normoalbuminuria ( uacr < $nmbr$ mg / g );C1300563;FALSE;2315;normoalbuminuria uacr $nmbr$ mg g
 196;normal acr ( < $nmbr$ mg / mg ) at baseline to albuminuria ( acr > $nmbr$ mg / g );"C0001925;C0168634;C0205307;C0231683;C0439166;C1300563;C1319635;C1412134;C1442488;C1515941;C2347086;C4553972";FALSE;2315;normal acr $nmbr$ mg mg at baseline to albuminuria acr $nmbr$ mg g
 196;- median urine acr ( mg / g ) ( iqr );"C0042036;C0042037;C0549183;C0876920;C1300563;C1412134;C1515941;C2347635;C2348144;C2939193;C2963137";FALSE;2315;median urine acr mg g iqr
 196;microalbuminuria  mg / g cr;"C0201975;C0730345;C1300563;C3539604;C3711669;C4084730;C4553336;C4553337";FALSE;2315;microalbuminuria mg g cr
 196;mean fecal calprotectin level  mg / g stool ( sd );"C0015733;C0183622;C0441889;C0444504;C0456079;C0950624;C1300563;C1335798;C1366582;C1547707;C2347634;C2348143;C2699239;C2946261";FALSE; 780;mean fecal calprotectin level mg g stool sd
 195;fg > $nmbr$;"C0016703;C0439214;C2348814";FALSE;  21;fg $nmbr$
 195;serum fg  mg / dl;"C0016703;C0229671;C0439214;C0439269;C1546774;C1550100;C1638318;C2348814;C3642216";FALSE;  21;serum fg mg dl
 197;uacr  pg / mg;C1627892;FALSE;2318;uacr pg mg
 197;urinary albumin : creatinine ratio ( pg / mg )  median ( iqr );"C0455271;C0549183;C0876920;C1318330;C1627892;C2347635;C2348144;C2939193";FALSE;2318;urinary albumin creatinine ratio pg mg median iqr
 197;urinary protein : creatinine ratioa ( mg / mg );"C0042027;C0369901;C0428627;C1319635;C1524119";FALSE;2318;urinary protein creatinine ratioa mg mg
 198;baseline corticosteroidst ( mean dose : $nmbr$ . $nmbr$ mg / day )  n ( % );"C0168634;C0178602;C0439422;C0444504;C0869039;C1114758;C1442488;C2347634;C2348143";FALSE;1348;baseline corticosteroidst mean dose $nmbr$ $nmbr$ mg day n
 198;leflunomide ( mean dose : $nmbr$ . $nmbr$ mg / day );"C0063041;C0178602;C0439422;C0444504;C0869039;C1114758;C2347634;C2348143";FALSE;2319;leflunomide mean dose $nmbr$ $nmbr$ mg day
 198;levodopa dose  mean ± sd  mg / day;"C0023570;C0178602;C0439422;C0444504;C0869039;C1114758;C2347634;C2348143;C2699239";FALSE;2320;levodopa dose mean sd mg day
 198;rasagiline  $nmbr$ mg / day;"C0439422;C0525678";FALSE;2321;rasagiline $nmbr$ mg day
 198;steroid use at baseline ( mg / day );"C0168634;C0281991;C0439422;C1442488";FALSE;1348;steroid use at baseline mg day
 194;$nmbr$ mg / $nmbr$ wk ( n = $nmbr$ );C1881833;NA;NA;$nmbr$ mg $nmbr$ wk n $nmbr$
 193;≤ $nmbr$ mg / l;C0439268;NA;NA;$nmbr$ mg l
 193;final median  mg / l;"C0205088;C0439268;C0549183;C0876920;C1546485;C2347635;C2348144;C2939193;C3853528";NA;NA;final median mg l
 193;cld $nmbr$ mg ( n = l $nmbr$ );C0439268;NA;NA;cld $nmbr$ mg n l $nmbr$
 193;baseline serum mg > = $nmbr$ . $nmbr$ mmol / l;"C0024671;C0026410;C0168634;C0229671;C0439190;C0439268;C0439269;C1442488;C1532563;C1546774;C1550100;C1960952;C2346927;C4321396;C4521761";NA;NA;baseline serum mg $nmbr$ $nmbr$ mmol l
 193;baseline serum mg < $nmbr$ . $nmbr$ mmol / l;"C0024671;C0026410;C0168634;C0229671;C0439190;C0439268;C0439269;C1442488;C1532563;C1546774;C1550100;C1960952;C2346927;C4321396;C4521761";NA;NA;baseline serum mg $nmbr$ $nmbr$ mmol l
 193;baseline median  mg / l;"C0168634;C0439268;C0549183;C0876920;C1442488;C2347635;C2348144;C2939193";NA;NA;baseline median mg l
 193;about $nmbr$ mg / l or more;"C0205172;C0439268";NA;NA;about $nmbr$ mg l or more
 193;about $nmbr$ mg / l;C0439268;NA;NA;about $nmbr$ mg l
 193;> $nmbr$ mg / l ( n = $nmbr$ );C0439268;NA;NA;$nmbr$ mg l n $nmbr$
 193;< $nmbr$ . $nmbr$ mg / l;C0439268;NA;NA;$nmbr$ $nmbr$ mg l
 193;( ≥ $nmbr$ mg / l );C0439268;NA;NA;$nmbr$ mg l
 193;( < $nmbr$ mg / l );C0439268;NA;NA;$nmbr$ mg l
 193;$nmbr$ to $nmbr$ mg / l ( n = $nmbr$ );C0439268;NA;NA;$nmbr$ to $nmbr$ mg l n $nmbr$
 193;$nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ mg / l;C0439268;NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ mg l
 192;≥ $nmbr$ to < $nmbr$ mg / dl;C0439269;NA;NA;$nmbr$ to $nmbr$ mg dl
 192;≥ $nmbr$ mg / dl;C0439269;NA;NA;$nmbr$ mg dl
 192;£ $nmbr$ mg / dl;C0439269;NA;NA;$nmbr$ mg dl
 192;with baseline crp level of > $nmbr$ mg / liter;"C0024671;C0026410;C0168634;C0439269;C0441889;C0456079;C0475211;C1442488;C1547707;C1960952;C2346927;C2946261;C3890735;C4048285;C4321396;C4521761";NA;NA;with baseline crp level of $nmbr$ mg liter
 192;week $nmbr$ ertugliflozin $nmbr$   mg vs . placebo;"C0024671;C0026410;C0032042;C0332174;C0439230;C0439269;C1696465;C1706408;C1960952;C2346927;C4079805;C4321396;C4521761";NA;NA;week $nmbr$ ertugliflozin $nmbr$ mg vs placebo
 192;week $nmbr$ ertugliflozin $nmbr$ mg vs placebo;"C0024671;C0026410;C0032042;C0332174;C0439230;C0439269;C1696465;C1706408;C1960952;C2346927;C4079805;C4321396;C4521761";NA;NA;week $nmbr$ ertugliflozin $nmbr$ mg vs placebo
 192;week $nmbr$ ertugliflozin $nmbr$ mg vs . placebo;"C0024671;C0026410;C0032042;C0332174;C0439230;C0439269;C1696465;C1706408;C1960952;C2346927;C4079805;C4321396;C4521761";NA;NA;week $nmbr$ ertugliflozin $nmbr$ mg vs placebo
 192;week $nmbr$ czp $nmbr$ mg q $nmbr$ w ( n = $nmbr$ );"C0024671;C0026410;C0054841;C0332174;C0439230;C0439269;C1861828;C1872109;C1960952;C2346927;C4321396;C4521761";NA;NA;week $nmbr$ czp $nmbr$ mg q $nmbr$ w n $nmbr$
 192;week $nmbr$ czp $nmbr$ mg q $nmbr$ w;"C0024671;C0026410;C0054841;C0332174;C0439230;C0439269;C1861828;C1872109;C1960952;C2346927;C4321396;C4521761";NA;NA;week $nmbr$ czp $nmbr$ mg q $nmbr$ w
 192;> $nmbr$ but < $nmbr$ mg / dl;C0439269;NA;NA;$nmbr$ but $nmbr$ mg dl
 193;crp  mg / l *;"C0439268;C3890735;C4048285";FALSE; 286;crp mg l
 193;crp — mg / l;"C0439268;C3890735;C4048285";FALSE; 286;crp mg l
 193;crp ( mg / l )  mean ( sd );"C0439268;C0444504;C2347634;C2348143;C2699239;C3890735;C4048285";FALSE; 286;crp mg l mean sd
 193;crp  mg / l : median ( range );"C0439268;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016;C3890735;C4048285";FALSE; 286;crp mg l median range
 193;crp ( mg / l )  median ± sd;"C0439268;C0549183;C0876920;C2347635;C2348144;C2699239;C2939193;C3890735;C4048285";FALSE; 286;crp mg l median sd
 193;crp ( mg / l )  n;"C0439268;C3890735;C4048285";FALSE; 286;crp mg l n
 193;crp ( mg / l ) : < $nmbr$;"C0439268;C3890735;C4048285";FALSE; 286;crp mg l $nmbr$
 193;crp < $nmbr$ mg / l  n;"C0439268;C3890735;C4048285";FALSE; 286;crp $nmbr$ mg l n
 193;crp $ $nmbr$ mg / l  n;"C0439268;C3890735;C4048285";FALSE; 286;crp $ $nmbr$ mg l n
 193;baseline crp category ( mg / l );"C0168634;C0439268;C0683312;C1442488;C3889287;C3890735;C4048285";FALSE; 286;baseline crp category mg l
 193;baseline crp levels < $nmbr$ mg / l;"C0168634;C0439268;C0441889;C1442488;C3890735;C4048285";FALSE; 286;baseline crp levels $nmbr$ mg l
 193;baseline crp levels ≥ $nmbr$ mg / l;"C0168634;C0439268;C0441889;C1442488;C3890735;C4048285";FALSE; 286;baseline crp levels $nmbr$ mg l
 193;high - sensitivity c - reactive protein  mg / l;"C0006560;C0439268;C1413716;C1441604;C4048285";FALSE; 286;high sensitivity c reactive protein mg l
 193;high - sensitivity c - reactive protein ( mg / l );"C0006560;C0439268;C1413716;C1441604;C4048285";FALSE; 286;high sensitivity c reactive protein mg l
 193;high sensitivity c - reactive protein ( mg / l );"C0006560;C0439268;C1413716;C1441604;C4048285";FALSE; 286;high sensitivity c reactive protein mg l
 193;hscrp > $nmbr$ to < $nmbr$ mg / l;C0439268;FALSE; 286;hscrp $nmbr$ to $nmbr$ mg l
 193;hscrp > $nmbr$ . $nmbr$ mg / l;C0439268;FALSE; 286;hscrp $nmbr$ $nmbr$ mg l
 193;hscrp < $nmbr$ . $nmbr$ mg / l;C0439268;FALSE; 286;hscrp $nmbr$ $nmbr$ mg l
 193;hscrp > $nmbr$ mg / l;C0439268;FALSE; 286;hscrp $nmbr$ mg l
 193;hscrp ( mg / l )  median ( minimum ‒ maximum );"C0439268;C0549183;C0806909;C0876920;C1524031;C1552614;C1552615;C2347635;C2348144;C2826545;C2826546;C2939193";FALSE; 286;hscrp mg l median minimum maximum
 193;hscrp ( mg / l )  median ( first  third quartiles );"C0205435;C0205437;C0439268;C0549183;C0876920;C1279901;C2347635;C2348144;C2828255;C2939193";FALSE; 286;hscrp mg l median first third quartiles
 193;hscrp ( mg / l ) c;C0439268;FALSE; 286;hscrp mg l c
 193;hscrp ( mg / l );C0439268;FALSE; 286;hscrp mg l
 193;hscrp  mg / l;C0439268;FALSE; 286;hscrp mg l
 193;hscrp  median ( iqr )  mg / l;"C0439268;C0549183;C0876920;C2347635;C2348144;C2939193";FALSE; 286;hscrp median iqr mg l
 193;mean crp level  mg / l ( sd );"C0439268;C0441889;C0444504;C0456079;C1547707;C2347634;C2348143;C2699239;C2946261;C3890735;C4048285";FALSE; 286;mean crp level mg l sd
 193;mean hscrp  mg / l ( sd );"C0439268;C0444504;C2347634;C2348143;C2699239";FALSE; 286;mean hscrp mg l sd
 193;mean ( sd ) crp  mg / l *;"C0439268;C0444504;C2347634;C2348143;C2699239;C3890735;C4048285";FALSE; 286;mean sd crp mg l
 193;canakinumab  hscrp < $nmbr$ - $nmbr$ mg / l at $nmbr$ months ( n = $nmbr$ );"C0439231;C0439268;C2718773";FALSE; 372;canakinumab hscrp $nmbr$ $nmbr$ mg l at $nmbr$ months n $nmbr$
 193;canakinumab  hscrp > $nmbr$ - $nmbr$ mg / l at $nmbr$ months ( n = $nmbr$ );"C0439231;C0439268;C2718773";FALSE; 372;canakinumab hscrp $nmbr$ $nmbr$ mg l at $nmbr$ months n $nmbr$
 193;% change median baseline crp > $nmbr$ mg / l;"C0168634;C0392747;C0439268;C0443172;C0549183;C0876920;C1442488;C1705241;C2347635;C2348144;C2939193;C3890735;C4048285;C4319952";FALSE; 286;change median baseline crp $nmbr$ mg l
 193;geometric mean crp concentration ( mg / l );"C0086045;C0439268;C1446561;C2986759;C3827302;C3890735;C4048285";FALSE; 286;geometric mean crp concentration mg l
 193;high - density lipoprotein cholesterol  mg / l;"C0023822;C0439268";FALSE; 821;high density lipoprotein cholesterol mg l
 193;upadacitinib $nmbr$ mg ( n = l $nmbr$ );C0439268;FALSE;2314;upadacitinib $nmbr$ mg n l $nmbr$
 193;mean baseline ibdq score ( sd ) § crp concentration  mg / l;"C0086045;C0168634;C0439268;C1442488;C1446561;C2699239;C3533236;C3827302;C3890735;C4048285";FALSE;2313;mean baseline ibdq score sd crp concentration mg l
 194;mtx ( mean dose : $nmbr$ . $nmbr$ mg / wk );"C0366550;C0444504;C1881833;C2347634;C2348143";FALSE; 716;mtx mean dose $nmbr$ $nmbr$ mg wk
 192;vonoprazan $nmbr$ mg n = $nmbr$;"C0024671;C0026410;C0439269;C1960952;C2346927;C4080009;C4321396;C4521761";NA;NA;vonoprazan $nmbr$ mg n $nmbr$
 192;upa $nmbr$ mg qd;"C0024671;C0026410;C0042071;C0332173;C0439269;C1706177;C1960952;C2346927;C4321396;C4521761";NA;NA;upa $nmbr$ mg qd
 192;u » c » ( mg / g );"C0024671;C0026410;C0439148;C0439267;C0439269;C1300563;C1532633;C1638407;C1960952;C2346927;C2608091;C4321396;C4521761";NA;NA;u c mg g
 192;t $nmbr$ . $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C2603360;C4321396;C4521761";NA;NA;t $nmbr$ $nmbr$ mg
 192;sita $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;sita $nmbr$ mg n $nmbr$
 192;silodosin $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1870115;C1960952;C2346927;C4321396;C4521761";NA;NA;silodosin $nmbr$ mg n $nmbr$
 192;> $nmbr$ and < $nmbr$ mg / dl;C0439269;NA;NA;$nmbr$ and $nmbr$ mg dl
 192;ticagrelor $nmbr$ mg diabetes n = $nmbr$;"C0011847;C0011849;C0024671;C0026410;C0439269;C1960952;C1999375;C2346927;C4321396;C4521761";FALSE;2299;ticagrelor $nmbr$ mg diabetes n $nmbr$
 192;ticagrelor $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C1999375;C2346927;C4321396;C4521761";FALSE;2299;ticagrelor $nmbr$ mg
 192;tiotropium $nmbr$ mg;"C0024671;C0026410;C0213771;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;2300;tiotropium $nmbr$ mg
 192;tiotropium $nmbr$ mg ( n = $nmbr$;"C0024671;C0026410;C0213771;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;2300;tiotropium $nmbr$ mg n $nmbr$
 192;tiotropium $nmbr$ mg respimat ® ( n = $nmbr$ );"C0024671;C0026410;C0213771;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;2300;tiotropium $nmbr$ mg respimat n $nmbr$
 192;tiotropium $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0213771;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;2300;tiotropium $nmbr$ mg n $nmbr$
 192;hdl ( mg / dl );"C0439269;C3715113";FALSE;1962;hdl mg dl
 192;tiotropium $nmbr$ mg respimat ® ( n z $nmbr$ );"C0024671;C0026410;C0213771;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;2300;tiotropium $nmbr$ mg respimat n z $nmbr$
 192;tiotropium $nmbr$ . $nmbr$ mg;"C0024671;C0026410;C0213771;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;2300;tiotropium $nmbr$ $nmbr$ mg
 192;tiotropium / olodaterol $nmbr$ / $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C4032878;C4321396;C4521761";FALSE;2301;tiotropium olodaterol $nmbr$ $nmbr$ mg
 192;tiotropium + olodaterol $nmbr$ / $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C4032878;C4321396;C4521761";FALSE;2301;tiotropium olodaterol $nmbr$ $nmbr$ mg
 192;tiotropium / olodaterol $nmbr$ / $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C4032878;C4321396;C4521761";FALSE;2301;tiotropium olodaterol $nmbr$ $nmbr$ mg n $nmbr$
 192;tiotropium / olodaterol $nmbr$ . $nmbr$ / $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C4032878;C4321396;C4521761";FALSE;2301;tiotropium olodaterol $nmbr$ $nmbr$ $nmbr$ mg
 192;tiotropium + olodaterol $nmbr$ . $nmbr$ / $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C4032878;C4321396;C4521761";FALSE;2301;tiotropium olodaterol $nmbr$ $nmbr$ $nmbr$ mg
 192;tofacitinib  $nmbr$ mg twice daily;"C0024671;C0026410;C0439269;C0585361;C1960952;C2346927;C2930696;C4321396;C4521761";FALSE;2302;tofacitinib $nmbr$ mg twice daily
 192;tofacitinib $nmbr$ mg twice daily n = $nmbr$;"C0024671;C0026410;C0439269;C0585361;C1960952;C2346927;C2930696;C4321396;C4521761";FALSE;2302;tofacitinib $nmbr$ mg twice daily n $nmbr$
 192;toricoxib $nmbr$ mg n = $nmbr$ ) ( % );"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;1130;toricoxib $nmbr$ mg n $nmbr$
 192;serum glucose ( mg / dl );"C0202041;C0439269;C3534430";FALSE;2305;serum glucose mg dl
 192;serum triglycerides  mg / dle;"C0024138;C0024671;C0026410;C0439269;C0542495;C1960952;C2346927;C3542918;C4321396;C4521761";FALSE;2306;serum triglycerides mg dle
 192;serum urea nitrogen  mg / dl;"C0028158;C0229671;C0439269;C0600137;C0856666;C1291218;C1546774;C1550100;C1550581;C3683557";FALSE;2271;serum urea nitrogen mg dl
 192;serum urate ( mg / dl );"C0439269;C0455272";FALSE;2308;serum urate mg dl
 192;serum urate ( mg / dl )  n ( % );"C0439269;C0455272";FALSE;2308;serum urate mg dl n
 192;serum uric acid ( mg / dl );"C0439269;C0455272;C0700634";FALSE;2308;serum uric acid mg dl
 192;serum uric acid  mg / dl;"C0439269;C0455272;C0700634";FALSE;2308;serum uric acid mg dl
 192;tanezumab $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346819;C2346927;C4321396;C4521761";FALSE;2309;tanezumab $nmbr$ mg
 192;tanezumab $nmbr$ . $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346819;C2346927;C4321396;C4521761";FALSE;2309;tanezumab $nmbr$ $nmbr$ mg
 192;tanezumab $nmbr$ mg + nsaid;"C0003211;C0024671;C0026410;C0439269;C1960952;C2346819;C2346927;C3536840;C4321396;C4521761";FALSE;2309;tanezumab $nmbr$ mg nsaid
 192;tanezumab $nmbr$ . $nmbr$ mg + nsaid;"C0003211;C0024671;C0026410;C0439269;C1960952;C2346819;C2346927;C3536840;C4321396;C4521761";FALSE;2309;tanezumab $nmbr$ $nmbr$ mg nsaid
 192;tg ( mg / dl );"C0337445;C0439269";FALSE; 368;tg mg dl
 192;tg  mg / dl  mean ± sd;"C0337445;C0439269;C0444504;C2347634;C2348143;C2699239";FALSE; 368;tg mg dl mean sd
 192;tg ( mg / dl )  median ± sd;"C0337445;C0439269;C0549183;C0876920;C2347635;C2348144;C2699239;C2939193";FALSE; 368;tg mg dl median sd
 192;tg mg / dl  median ( sd );"C0337445;C0439269;C0549183;C0876920;C2347635;C2348144;C2699239;C2939193";FALSE; 368;tg mg dl median sd
 192;tg > $nmbr$ . hdl < $nmbr$ ( mg / dl ) ( / ? = $nmbr$ );"C0337445;C0439269;C3715113";FALSE; 368;tg $nmbr$ hdl $nmbr$ mg dl $nmbr$
 192;tg > $nmbr$ mg / dl  n ( ° / o );"C0337445;C0439269";FALSE; 368;tg $nmbr$ mg dl n o
 192;triglyceride ( mg / dl );"C0041004;C0439269";FALSE; 368;triglyceride mg dl
 192;triglyceride  mg / dl  mean ( sd );"C0041004;C0439269;C0444504;C2347634;C2348143;C2699239";FALSE; 368;triglyceride mg dl mean sd
 192;triglycerides level  mg / dl;"C0428475;C0439269";FALSE; 368;triglycerides level mg dl
 192;triglycerides  mg / dl;"C0041004;C0439269";FALSE; 368;triglycerides mg dl
 192;triglycerides ( sd )  mg / dl;"C0041004;C0439269;C2699239";FALSE; 368;triglycerides sd mg dl
 192;uric acid fertile $nmbr$ ( > $nmbr$ . $nmbr$ mg / dl );"C0015895;C0041980;C0439269";FALSE;2310;uric acid fertile $nmbr$ $nmbr$ $nmbr$ mg dl
 192;uric acid tertile $nmbr$ ( < $nmbr$ . $nmbr$ mg / dl );"C0041980;C0439269";FALSE;2310;uric acid tertile $nmbr$ $nmbr$ $nmbr$ mg dl
 192;uric acid ( mg / dl );"C0041980;C0439269";FALSE;2310;uric acid mg dl
 192;uric acid ( mg / dl ) creatinine clearance ( ml / min per $nmbr$ . $nmbr$ m $nmbr$ );"C0024671;C0026410;C0041980;C0151280;C0369637;C0439269;C0441923;C1960952;C2346927;C3642208;C4321396;C4521761";FALSE;2310;uric acid mg dl creatinine clearance ml min per $nmbr$ $nmbr$ m $nmbr$
 192;viidagliptin $nmbr$ mg daily + glimepiride;"C0024671;C0026410;C0061323;C0332173;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;2068;viidagliptin $nmbr$ mg daily glimepiride
 192;sirukumab $nmbr$ mg q $nmbr$ w;"C0024671;C0026410;C0439269;C1960952;C2346927;C3254570;C4321396;C4521761";FALSE;2311;sirukumab $nmbr$ mg q $nmbr$ w
 192;total glucose mg / dl;"C0017725;C0439175;C0439269;C0439810";FALSE;2311;total glucose mg dl
 192;total intravenous loop diuretic ( mg ) median;"C0024671;C0026410;C0348016;C0354100;C0439175;C0439269;C0439810;C0549183;C0876920;C1960952;C2346927;C2347635;C2348144;C2939193;C3536704;C4321396;C4521761";FALSE; 991;total intravenous loop diuretic mg median
 192;sc belimumab $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0282380;C0439269;C1723401;C1960952;C2346927;C4321396;C4521761";NA;NA;sc belimumab $nmbr$ mg n $nmbr$
 192;saxa $nmbr$ mg ( n $nmbr$ $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;saxa $nmbr$ mg n $nmbr$ $nmbr$
 192;saxa $nmbr$ mg $nmbr$ metformin ( n $nmbr$ $nmbr$ );"C0024671;C0025598;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;saxa $nmbr$ mg $nmbr$ metformin n $nmbr$ $nmbr$
 192;saxa $nmbr$ . $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;saxa $nmbr$ $nmbr$ mg n $nmbr$
 192;saxa $nmbr$ . $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;saxa $nmbr$ $nmbr$ mg
 192;randomized to canakinumab $nmbr$ mg;"C0024671;C0026410;C0034656;C0040363;C0041260;C0439269;C1883351;C1960952;C2346927;C2718773;C3815594;C4321396;C4521761";NA;NA;randomized to canakinumab $nmbr$ mg
 192;r $nmbr$ mg + fa ( « = $nmbr$ );"C0024671;C0026410;C0205090;C0439269;C0684010;C1960952;C2346927;C2603358;C4321396;C4521761";NA;NA;r $nmbr$ mg fa $nmbr$
 192;r $nmbr$ mg + fa;"C0024671;C0026410;C0205090;C0439269;C0684010;C1960952;C2346927;C2603358;C4321396;C4521761";NA;NA;r $nmbr$ mg fa
 192;r $nmbr$ mg ( « = $nmbr$ );"C0024671;C0026410;C0205090;C0439269;C0684010;C1960952;C2346927;C2603358;C4321396;C4521761";NA;NA;r $nmbr$ mg $nmbr$
 192;r $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C0687673;C1960952;C2346927;C4321396;C4521761";NA;NA;r $nmbr$ mg n $nmbr$
 192;r $nmbr$ mg;"C0024671;C0026410;C0205090;C0439269;C0684010;C1960952;C2346927;C2603358;C4321396;C4521761";NA;NA;r $nmbr$ mg
 192;prednisone - equivalent dose — mg;"C0024671;C0026410;C0032952;C0178602;C0205163;C0439185;C0439269;C0869039;C1114758;C1960952;C2346927;C4321396;C4521761";NA;NA;prednisone equivalent dose mg
 192;ppg  mg / dl;"C0439269;C1418888";NA;NA;ppg mg dl
 192;plasma lipids ( mg / dl ) $nmbr$ total cholesterol mean;"C0023779;C0439269;C0444504;C0858034;C2347634;C2348143";NA;NA;plasma lipids mg dl $nmbr$ total cholesterol mean
 192;plasma cholesterol — mg / dl;"C0439269;C0858034";NA;NA;plasma cholesterol mg dl
 192;placebofigolimumab $nmbr$ mg / $nmbr$ mgt;"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;placebofigolimumab $nmbr$ mg $nmbr$ mgt
 192;periprocedural medications  n ( % ) clopidogrel  $nmbr$ mg *;"C0013227;C0024671;C0026410;C0070166;C0439269;C0802604;C1960952;C2346927;C2598133;C4284232;C4321396;C4521761";NA;NA;periprocedural medications n clopidogrel $nmbr$ mg
 192;pbo czp $nmbr$ mg q $nmbr$ w week $nmbr$ ( n = $nmbr$ );"C0024671;C0026410;C0031962;C0054841;C0332174;C0439230;C0439269;C1861828;C1872109;C1960952;C2346927;C4321396;C4521761";NA;NA;pbo czp $nmbr$ mg q $nmbr$ w week $nmbr$ n $nmbr$
 192;hdl < $nmbr$ mg / dl;"C0439269;C3715113";FALSE;1962;hdl $nmbr$ mg dl
 192;< $nmbr$ mg / dl eze / simva;C0439269;NA;NA;$nmbr$ mg dl eze simva
 192;patients receiving $nmbr$ mg of edoxaban at randomization — no . ( % ) f;"C0016327;C0024671;C0026410;C0030705;C0034656;C0439269;C1514756;C1960952;C2346927;C2975435;C4321396;C4521761";NA;NA;patients receiving $nmbr$ mg of edoxaban at randomization no f
 192;p - value d $nmbr$ mg vs . warfarin;"C0024671;C0026410;C0043031;C0439269;C1709380;C1960952;C2346927;C4321396;C4521761";NA;NA;p value d $nmbr$ mg vs warfarin
 192;on maximum tolerated medications ( % ) median ( $nmbr$ th to $nmbr$ th quartile ) sua ( mg / dl );"C0013227;C0039725;C0039738;C0439269;C0549183;C0802604;C0806909;C0876920;C1420718;C1552615;C2347635;C2348144;C2598133;C2826546;C2828255;C2939193;C4282123;C4284232;C4285344";NA;NA;on maximum tolerated medications median $nmbr$ th to $nmbr$ th quartile sua mg dl
 192;mtx ≤ $nmbr$ mg / week;"C0024671;C0025677;C0026410;C0332174;C0439230;C0439269;C1417487;C1960952;C2346927;C4321396;C4521761";FALSE; 716;mtx $nmbr$ mg week
 192;mtx > $nmbr$ mg / week;"C0024671;C0025677;C0026410;C0332174;C0439230;C0439269;C1417487;C1960952;C2346927;C4321396;C4521761";FALSE; 716;mtx $nmbr$ mg week
 192;mtx > $nmbr$ – $nmbr$ mg / week;"C0024671;C0025677;C0026410;C0332174;C0439230;C0439269;C1417487;C1960952;C2346927;C4321396;C4521761";FALSE; 716;mtx $nmbr$ $nmbr$ mg week
 192;elevated serum creatinine  > $nmbr$ . $nmbr$ mg / dl;"C0439269;C0700225";FALSE; 952;elevated serum creatinine $nmbr$ $nmbr$ mg dl
 192;non - hdl - c  mg / dl;"C0439269;C1518422;C3715113";FALSE;2291;non hdl c mg dl
 192;non - hdl - c ( mg / dl );"C0439269;C1518422;C3715113";FALSE;2291;non hdl c mg dl
 192;non - hdl ( mg / dl ) < $nmbr$;"C0439269;C1518422;C3715113";FALSE;2291;non hdl mg dl $nmbr$
 192;non - hdl - c ( mg / dl ) * *;"C0439269;C1518422;C3715113";FALSE;2291;non hdl c mg dl
 192;no . of $nmbr$ - mg tablets of acetaminophen;"C0024671;C0026410;C0439269;C1243102;C1960952;C2346927;C4321396;C4521761";FALSE;2292;no of $nmbr$ mg tablets of acetaminophen
 192;olmesartan medoxomil $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0386393;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;2293;olmesartan medoxomil $nmbr$ mg n $nmbr$
 192;olodaterol $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C2934193;C4321396;C4521761";FALSE;2294;olodaterol $nmbr$ mg
 192;olodaterol $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C2934193;C4321396;C4521761";FALSE;2294;olodaterol $nmbr$ mg n $nmbr$
 192;omalizumab $nmbr$ mg ( n [ $nmbr$ );"C0024671;C0026410;C0439269;C0966225;C1960952;C2346927;C4321396;C4521761";FALSE; 940;omalizumab $nmbr$ mg n $nmbr$
 192;pitavastatin $nmbr$ mg;"C0024671;C0026410;C0439269;C1101838;C1960952;C2346927;C4321396;C4521761";FALSE;2296;pitavastatin $nmbr$ mg
 192;secukinumab intravenous $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0348016;C0439269;C1960952;C2346927;C3179547;C4321396;C4521761";FALSE;2297;secukinumab intravenous $nmbr$ mg n $nmbr$
 192;secukinumab $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C3179547;C4321396;C4521761";FALSE;2297;secukinumab $nmbr$ mg
 192;secukinumab $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C3179547;C4321396;C4521761";FALSE;2297;secukinumab $nmbr$ mg n $nmbr$
 192;secukinumab $nmbr$   mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C3179547;C4321396;C4521761";FALSE;2297;secukinumab $nmbr$ mg
 192;rosiglitazone $nmbr$ mg daik;"C0024671;C0026410;C0289313;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;2298;rosiglitazone $nmbr$ mg daik
 192;rosiglitazone $nmbr$ mg daily;"C0024671;C0026410;C0289313;C0332173;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;2298;rosiglitazone $nmbr$ mg daily
 192;rosuva $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE; 886;rosuva $nmbr$ mg
 192;rosuva $nmbr$ mg n = $nmbr$;"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE; 886;rosuva $nmbr$ mg n $nmbr$
 192;oral glucocorticoid dose  mg ( prednisone equivalent );"C0017710;C0024671;C0026410;C0032952;C0178602;C0205163;C0439185;C0439269;C0442027;C0869039;C1114758;C1960952;C2346927;C4321396;C4521761;C4521986";FALSE;1348;oral glucocorticoid dose mg prednisone equivalent
 192;serum cholesterol  mean ( sd )  mg / dl;"C0439269;C0444504;C0587184;C2347634;C2348143;C2699239";FALSE;2303;serum cholesterol mean sd mg dl
 192;serum cholesterol  mean ( sd ) mg / dl;"C0439269;C0444504;C0587184;C2347634;C2348143;C2699239";FALSE;2303;serum cholesterol mean sd mg dl
 192;serum cholesterol  mg / dld;"C0024671;C0026410;C0439269;C0587184;C1414063;C1960952;C2346927;C2826331;C4321396;C4521761";FALSE;2303;serum cholesterol mg dld
 192;serum creatinine level  mean ( sd )  mg / dl;"C0439269;C0444504;C0600061;C2347634;C2348143;C2699239";FALSE;2304;serum creatinine level mean sd mg dl
 192;serum creatinine  mg / dlb;"C0024671;C0026410;C0201976;C0439269;C0600061;C0752347;C1960952;C2346927;C3890365;C4321396;C4521761";FALSE;2304;serum creatinine mg dlb
 192;mg daily );"C0024671;C0026410;C0332173;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;mg daily
 192;mg / dl;C0439269;NA;NA;mg dl
 192;metsyn with ldl > $nmbr$ . $nmbr$ mg / dl;C0439269;NA;NA;metsyn with ldl $nmbr$ $nmbr$ mg dl
 192;metformin dose  mg;"C0024671;C0025598;C0026410;C0178602;C0439269;C0869039;C1114758;C1960952;C2346927;C4321396;C4521761";NA;NA;metformin dose mg
 192;median c - reactive protein — mg / liter;"C0006560;C0024671;C0026410;C0439269;C0475211;C0549183;C0876920;C1413716;C1960952;C2346927;C2347635;C2348144;C2939193;C4048285;C4321396;C4521761";NA;NA;median c reactive protein mg liter
 192;mean — mg / dl level — no . ( % );"C0439269;C0441889;C0444504;C0456079;C1547707;C2347634;C2348143;C2946261";NA;NA;mean mg dl level no
 192;mean — mg / dl;"C0439269;C0444504;C2347634;C2348143";NA;NA;mean mg dl
 192;mean ± sd triglycerides  mg / dl;"C0041004;C0439269;C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd triglycerides mg dl
 192;mean serum potassium  mg / dl;"C0302353;C0439269;C0444504;C0543465;C2347634;C2348143";NA;NA;mean serum potassium mg dl
 192;mean serum glucose  mg / dl  mean = sd;"C0202041;C0439269;C0444504;C2347634;C2348143;C2699239;C3534430";NA;NA;mean serum glucose mg dl mean sd
 192;mean serum cholesterol  mg / dl;"C0439269;C0444504;C0587184;C2347634;C2348143";NA;NA;mean serum cholesterol mg dl
 192;mean sd ldl - c  mg / dl;"C0439269;C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd ldl c mg dl
 192;mean sd hdl - c  mg / dl;"C0439269;C0444504;C2347634;C2348143;C2699239;C3715113";NA;NA;mean sd hdl c mg dl
 192;mean sd fpg  mg / dl;"C0439269;C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd fpg mg dl
 192;mean lipid difference ( mg / dl ) hdl - c;"C0023779;C0439269;C0444504;C1705241;C1705242;C2347634;C2348143;C3715113";NA;NA;mean lipid difference mg dl hdl c
 192;mean dose ( sd ) ( mg / week );"C0024671;C0026410;C0178602;C0332174;C0439230;C0439269;C0444504;C0869039;C1114758;C1960952;C2346927;C2347634;C2348143;C2699239;C4321396;C4521761";NA;NA;mean dose sd mg week
 192;mean daily dose ( range ) — mg  i;"C0021966;C0024671;C0026410;C0221138;C0439269;C0444504;C1514721;C1960952;C2346927;C2347634;C2348070;C2348143;C2348147;C3542016;C4321396;C4521761";NA;NA;mean daily dose range mg i
 192;mean change in dbp from baseline  mg / dl  mean ( sd );"C0168634;C0392747;C0439269;C0443172;C0444504;C0536221;C1442488;C1705241;C2347634;C2348143;C2699239;C3813197;C4281799;C4319952";NA;NA;mean change in dbp from baseline mg dl mean sd
 192;mean ( sd ) mtx dose  mg / week;"C0024671;C0026410;C0332174;C0366550;C0439230;C0439269;C0444504;C1960952;C2346927;C2347634;C2348143;C2699239;C4321396;C4521761";NA;NA;mean sd mtx dose mg week
 192;mean ( sd ) calcium intake in mg daily;"C0024671;C0026410;C0332173;C0439269;C0444504;C0489458;C1960952;C2346927;C2347634;C2348143;C2699239;C4321396;C4521761";NA;NA;mean sd calcium intake in mg daily
 192;mean ( s . d . ) apoc - ll $nmbr$  mg / dl;"C0003594;C0439269;C0444504;C2347634;C2348143";NA;NA;mean s d apoc ll $nmbr$ mg dl
 192;mean ( s . d . ) apob  mg / dl;"C0003593;C0439269;C0444504;C2347634;C2348143;C3252643";NA;NA;mean s d apob mg dl
 192;mean ( median ) mtx dose  mg / week;"C0024671;C0026410;C0332174;C0366550;C0439230;C0439269;C0444504;C0549183;C0876920;C1960952;C2346927;C2347634;C2347635;C2348143;C2348144;C2939193;C4321396;C4521761";NA;NA;mean median mtx dose mg week
 192;mean  mg / dl;"C0439269;C0444504;C2347634;C2348143";NA;NA;mean mg dl
 192;< $nmbr$ mg / dl *;C0439269;NA;NA;$nmbr$ mg dl
 192;male acr definition  ^ . g / mg;"C0024671;C0026410;C0086582;C0439267;C0439269;C1412134;C1515941;C1550452;C1704788;C1706180;C1706428;C1706429;C1960952;C2346927;C3539107;C3888054;C4321396;C4521761";NA;NA;male acr definition g mg
 192;lpa  mg / dl;"C0439269;C1096202;C1439335;C3539666;C4049711;C4553379";NA;NA;lpa mg dl
 192;ldl cholesterol ( mg / dl )  mean + sd  available for $nmbr$ patients;"C0023824;C0030705;C0202117;C0439269;C0444504;C0470187;C2347634;C2348143;C2699239";FALSE;1963;ldl cholesterol mg dl mean sd available for $nmbr$ patients
 192;ldl cholesterol ( sd )  mg / dl;"C0023824;C0202117;C0439269;C2699239";FALSE;1963;ldl cholesterol sd mg dl
 192;ldl cholesterol  mean ( sd )  mg / dl;"C0023824;C0202117;C0439269;C0444504;C2347634;C2348143;C2699239";FALSE;1963;ldl cholesterol mean sd mg dl
 192;ldl - cholesterol ( mg / dl );"C0023824;C0202117;C0439269";FALSE;1963;ldl cholesterol mg dl
 192;ldl cholesterol  mg / dl;"C0023824;C0202117;C0439269";FALSE;1963;ldl cholesterol mg dl
 192;ldl cholesterol — mg / dl | |;"C0023824;C0202117;C0439269";FALSE;1963;ldl cholesterol mg dl
 192;ldl cholesterol — mg / dl;"C0023824;C0202117;C0439269";FALSE;1963;ldl cholesterol mg dl
 192;ldl - cholesterol  mg / dl  mean ( sd );"C0023824;C0202117;C0439269;C0444504;C2347634;C2348143;C2699239";FALSE;1963;ldl cholesterol mg dl mean sd
 192;ldl cholesterol ( mg / dl );"C0023824;C0202117;C0439269";FALSE;1963;ldl cholesterol mg dl
 192;mtx < $nmbr$ mg / week;"C0024671;C0025677;C0026410;C0332174;C0439230;C0439269;C1417487;C1960952;C2346927;C4321396;C4521761";FALSE; 716;mtx $nmbr$ mg week
 192;lipid levels — mg / dl;"C0428460;C0439269";FALSE;1967;lipid levels mg dl
 192;methotrexate dose | |  mg;"C0024671;C0025677;C0026410;C0178602;C0439269;C0869039;C1114758;C1960952;C2346927;C4321396;C4521761";FALSE;1408;methotrexate dose mg
 192;lipid difference ( mg / dl );"C0023779;C0439269;C1705241;C1705242";FALSE;1967;lipid difference mg dl
 192;lipid and lipoprotein values ( mg / dl );"C0023779;C0023820;C0042295;C0439269";FALSE;1967;lipid and lipoprotein values mg dl
 192;lipid parameters  mg / dl  mean ( sd );"C0023779;C0439269;C0444504;C0449381;C2347634;C2348143;C2699239";FALSE;1967;lipid parameters mg dl mean sd
 192;lipid levels — mg / dlj total cholesterol;"C0024671;C0026410;C0201950;C0428460;C0439269;C0543421;C1960952;C2346927;C4321396;C4521761";FALSE;1967;lipid levels mg dlj total cholesterol
 192;lipid measures at baseline — mg / dl;"C0023779;C0079809;C0168634;C0242485;C0439269;C1442488;C1879489";FALSE;1967;lipid measures at baseline mg dl
 192;lipids  mean ( sd )  mg / dlf;"C0023779;C0024671;C0026410;C0439269;C0444504;C1960952;C2346927;C2347634;C2348143;C2699239;C4321396;C4521761";FALSE;1967;lipids mean sd mg dlf
 192;lipids  mean ( sd )  mg / dlt;"C0023779;C0024671;C0026410;C0439269;C0444504;C1413248;C1960952;C2346927;C2347634;C2348143;C2699239;C3273706;C4321396;C4521761";FALSE;1967;lipids mean sd mg dlt
 192;lebrikizumab $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C2981360;C4321396;C4521761";FALSE;2287;lebrikizumab $nmbr$ mg
 192;lebrikizumab $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C2981360;C4321396;C4521761";FALSE;2287;lebrikizumab $nmbr$ mg n $nmbr$
 192;lebrikizumab $nmbr$ - $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C2981360;C4321396;C4521761";FALSE;2287;lebrikizumab $nmbr$ $nmbr$ mg n $nmbr$
 192;lebrikizumab $nmbr$ - $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C2981360;C4321396;C4521761";FALSE;2287;lebrikizumab $nmbr$ $nmbr$ mg
 192;llraglutide $nmbr$ - $nmbr$ mg mean ( n );"C0024671;C0026410;C0439269;C0444504;C1960952;C2346927;C2347634;C2348143;C4321396;C4521761";FALSE;1566;llraglutide $nmbr$ $nmbr$ mg mean n
 192;lovastatin $nmbr$ mg;"C0024027;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;2290;lovastatin $nmbr$ mg
 192;mepolizumab  $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C0969324;C1960952;C2346927;C4321396;C4521761";FALSE;2307;mepolizumab $nmbr$ mg n $nmbr$
 192;mepolizumab $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C0969324;C1960952;C2346927;C4321396;C4521761";FALSE;2307;mepolizumab $nmbr$ mg n $nmbr$
 192;iv - $nmbr$ mg;"C0022326;C0024671;C0026410;C0439269;C1960952;C2346927;C4265176;C4321396;C4521761";NA;NA;iv $nmbr$ mg
 192;initiation of dialysis  renal transplantation  or creatinine . $nmbr$ . $nmbr$ mg / dl ( $nmbr$ mmol / l );"C0010294;C0011945;C0011946;C0019004;C0022671;C0040732;C0040733;C0439269;C0589507;C1059964;C1158830;C1532563;C1561535;C1704686;C4551529";NA;NA;initiation of dialysis renal transplantation or creatinine $nmbr$ $nmbr$ mg dl $nmbr$ mmol l
 192;ind / gly $nmbr$ / $nmbr$ mg once daily ( n = $nmbr$ );"C0017890;C0024671;C0026410;C0332173;C0439269;C0523677;C1960952;C2346927;C4049864;C4321396;C4521761";NA;NA;ind gly $nmbr$ $nmbr$ mg once daily n $nmbr$
 192;ind / gly $nmbr$ / $nmbr$ mg once daily ( n = $nmbr$  $nmbr$ );"C0017890;C0024671;C0026410;C0332173;C0439269;C0523677;C1960952;C2346927;C4049864;C4321396;C4521761";NA;NA;ind gly $nmbr$ $nmbr$ mg once daily n $nmbr$ $nmbr$
 192;i - $nmbr$ mg / d ( n = $nmbr$ );"C0021966;C0024671;C0026410;C0152277;C0221138;C0439269;C0439422;C1960952;C2346927;C4321396;C4521761";NA;NA;i $nmbr$ mg d n $nmbr$
 192;glycopyrronium $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C3814772;C4321396;C4521761";NA;NA;glycopyrronium $nmbr$ mg n $nmbr$
 192;gly $nmbr$ . $nmbr$ mg b . i . d . n = $nmbr$;"C0024671;C0026410;C0152277;C0439269;C1415124;C1960952;C2346927;C4321396;C4521761";NA;NA;gly $nmbr$ $nmbr$ mg b i d n $nmbr$
 192;geometric mean ofcrp — mg / liter ( range );"C0024671;C0026410;C0439269;C0475211;C1514721;C1960952;C2346927;C2348147;C2986759;C3542016;C4321396;C4521761";NA;NA;geometric mean ofcrp mg liter range
 192;fsg ( mg / dl );C0439269;NA;NA;fsg mg dl
 192;fsg  mg / dl ( mean ± sd );"C0439269;C0444504;C2347634;C2348143;C2699239";NA;NA;fsg mg dl mean sd
 192;fpg month $nmbr$ ( mg / dl );"C0332177;C0439231;C0439269";NA;NA;fpg month $nmbr$ mg dl
 192;fpg change ( mg / dl ) *;"C0392747;C0439269;C0443172;C1705241;C4319952";NA;NA;fpg change mg dl
 192;fpg ( mg / dl ) x;C0439269;NA;NA;fpg mg dl x
 192;fpg ( mg / dl );C0439269;NA;NA;fpg mg dl
 192;fpg  mg / dl  mean ± sd;"C0439269;C0444504;C2347634;C2348143;C2699239";NA;NA;fpg mg dl mean sd
 192;fpg  mg / dl;C0439269;NA;NA;fpg mg dl
 192;hscrp — mg / liter;"C0024671;C0026410;C0439269;C0475211;C1960952;C2346927;C4321396;C4521761";FALSE; 286;hscrp mg liter
 192;hdl - cholesterol  mg / dl  mean ( sd );"C0023822;C0392885;C0439269;C0444504;C2347634;C2348143;C2699239";FALSE;1962;hdl cholesterol mg dl mean sd
 192;hdl - c level  mean ( sd )  mg / dl;"C0439269;C0441889;C0444504;C0456079;C1547707;C2347634;C2348143;C2699239;C2946261;C3715113";FALSE;1962;hdl c level mean sd mg dl
 192;hdl - c  mean ( sd )  mg / dl;"C0439269;C0444504;C2347634;C2348143;C2699239;C3715113";FALSE;1962;hdl c mean sd mg dl
 192;hdl - c level  mg / dl;"C0439269;C0441889;C0456079;C1547707;C2946261;C3715113";FALSE;1962;hdl c level mg dl
 192;hdl - c level  < $nmbr$ mg / dld;"C0024671;C0026410;C0439269;C0441889;C0456079;C1414063;C1547707;C1960952;C2346927;C2826331;C2946261;C3715113;C4321396;C4521761";FALSE;1962;hdl c level $nmbr$ mg dld
 192;hdl - c ( median  iqr )  mg / dl;"C0439269;C0549183;C0876920;C2347635;C2348144;C2939193;C3715113";FALSE;1962;hdl c median iqr mg dl
 192;hdl - c  mg / dl;"C0439269;C3715113";FALSE;1962;hdl c mg dl
 192;hdl - c ( mg / dl );"C0439269;C3715113";FALSE;1962;hdl c mg dl
 192;hdl - c ( mg / dl ) *;"C0439269;C3715113";FALSE;1962;hdl c mg dl
 192;hdl - c  mg / dl  mean + sd;"C0439269;C0444504;C2347634;C2348143;C2699239;C3715113";FALSE;1962;hdl c mg dl mean sd
 192;hdl - c ( mg / dl ) - mean ± sd;"C0439269;C0444504;C2347634;C2348143;C2699239;C3715113";FALSE;1962;hdl c mg dl mean sd
 192;hdl - c < $nmbr$ mg / dl_;"C0439269;C3715113";FALSE;1962;hdl c $nmbr$ mg dl_
 192;hdl - c < $nmbr$ mg / dl;"C0439269;C3715113";FALSE;1962;hdl c $nmbr$ mg dl
 192;hdl - c < $nmbr$ mg / dl  no . ( % );"C0439269;C3715113";FALSE;1962;hdl c $nmbr$ mg dl no
 192;hdl - c  $nmbr$ mg / dl  n ( % );"C0439269;C3715113";FALSE;1962;hdl c $nmbr$ mg dl n
 192;hdl - c < $nmbr$ mg / dl . n ( % );"C0439269;C3715113";FALSE;1962;hdl c $nmbr$ mg dl n
 192;< $nmbr$ mg / dl;C0439269;NA;NA;$nmbr$ mg dl
 192;hdl cholesterol  mean ( sd )  mg / dl;"C0023822;C0392885;C0439269;C0444504;C2347634;C2348143;C2699239";FALSE;1962;hdl cholesterol mean sd mg dl
 192;hdl - cholesterol  mean ( sd ) mg / dl;"C0023822;C0392885;C0439269;C0444504;C2347634;C2348143;C2699239";FALSE;1962;hdl cholesterol mean sd mg dl
 192;ldl - c $nmbr$ - $nmbr$ mg / dl;C0439269;FALSE;1963;ldl c $nmbr$ $nmbr$ mg dl
 192;ldl - c > $nmbr$ mg / dl;C0439269;FALSE;1963;ldl c $nmbr$ mg dl
 192;ldl - c < $nmbr$ mg / dl  no . ( % );C0439269;FALSE;1963;ldl c $nmbr$ mg dl no
 192;ldl - c < $nmbr$ mg / dl;C0439269;FALSE;1963;ldl c $nmbr$ mg dl
 192;ldl - c ( mg / dl ) < $nmbr$;C0439269;FALSE;1963;ldl c mg dl $nmbr$
 192;ldl - c  mg / dl  mean + sd;"C0439269;C0444504;C2347634;C2348143;C2699239";FALSE;1963;ldl c mg dl mean sd
 192;ldl - c ( mg / dl ) * *;C0439269;FALSE;1963;ldl c mg dl
 192;ldl - c  mg / dl;C0439269;FALSE;1963;ldl c mg dl
 192;ldl - c  mg / dl *;C0439269;FALSE;1963;ldl c mg dl
 192;ldl - c ( mg / dl );C0439269;FALSE;1963;ldl c mg dl
 192;ldl - c  mean ( sd )  mg / dl;"C0439269;C0444504;C2347634;C2348143;C2699239";FALSE;1963;ldl c mean sd mg dl
 192;ldl - c level  mean ( sd )  mg / dl;"C0439269;C0441889;C0444504;C0456079;C1547707;C2347634;C2348143;C2699239;C2946261";FALSE;1963;ldl c level mean sd mg dl
 192;ldl - c level  mg / dl;"C0439269;C0441889;C0456079;C1547707;C2946261";FALSE;1963;ldl c level mg dl
 192;ldl - c ( bq ) ( mg / dl ) - mean ± sd;"C0439269;C0444504;C0560038;C2346983;C2347634;C2348143;C2699239;C3541236;C3642216";FALSE;1963;ldl c bq mg dl mean sd
 192;ldl - c ( calculated )  mg / dl  mean ( sd );"C0439269;C0444504;C0444686;C1441506;C2347634;C2348143;C2699239";FALSE;1963;ldl c calculated mg dl mean sd
 192;ldl - cholesterol  mean ( sd ) mg / dl;"C0023824;C0202117;C0439269;C0444504;C2347634;C2348143;C2699239";FALSE;1963;ldl cholesterol mean sd mg dl
 192;ldl - c  mg / dl  mean ± sd;"C0439269;C0444504;C2347634;C2348143;C2699239";FALSE;1963;ldl c mg dl mean sd
 192;glucose ( mg / dl );"C0017725;C0439269";FALSE;2283;glucose mg dl
 192;glucose — mg / dl;"C0017725;C0439269";FALSE;2283;glucose mg dl
 192;glucose  mg / dl  mean;"C0017725;C0439269;C0444504;C2347634;C2348143";FALSE;2283;glucose mg dl mean
 192;glycemia  mg / dl;"C0005802;C0439269";FALSE;2283;glycemia mg dl
 192;increase creatinine  < $nmbr$ . $nmbr$ mg / dl;"C0010294;C0439269;C0442805;C1561535";FALSE;2284;increase creatinine $nmbr$ $nmbr$ mg dl
 192;increase creatinine  > $nmbr$ . $nmbr$ mg / dl;"C0010294;C0439269;C0442805;C1561535";FALSE;2284;increase creatinine $nmbr$ $nmbr$ mg dl
 192;i intensive  $nmbr$ mg of atorvastatin ( n = $nmbr$ );"C0021966;C0024671;C0026410;C0162425;C0221138;C0286651;C0439269;C0522510;C1283828;C1550453;C1960952;C2346927;C4321396;C4521761";FALSE; 885;i intensive $nmbr$ mg of atorvastatin n $nmbr$
 192;indacaterol $nmbr$ mg;"C0024671;C0026410;C0439269;C1722260;C1960952;C2346927;C4321396;C4521761";FALSE;2285;indacaterol $nmbr$ mg
 192;indacaterol $nmbr$ mg [ n z $nmbr$ ];"C0024671;C0026410;C0439269;C1722260;C1960952;C2346927;C4321396;C4521761";FALSE;2285;indacaterol $nmbr$ mg n z $nmbr$
 192;impaired fasting glucose ( > $nmbr$ mg / dl ) ( % );"C0439269;C1272092";FALSE;2286;impaired fasting glucose $nmbr$ mg dl
 192;lansoprazole $nmbr$ mg qd;"C0024671;C0026410;C0050940;C0332173;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;2288;lansoprazole $nmbr$ mg qd
 192;fpg  mean ( sd )  mg / dlt;"C0024671;C0026410;C0439269;C0444504;C1413248;C1960952;C2346927;C2347634;C2348143;C2699239;C3273706;C4321396;C4521761";NA;NA;fpg mean sd mg dlt
 192;fpg  mean ( sd )  mg / dlf;"C0024671;C0026410;C0439269;C0444504;C1960952;C2346927;C2347634;C2348143;C2699239;C4321396;C4521761";NA;NA;fpg mean sd mg dlf
 192;fpg  mean ( sd )  mg / dl;"C0439269;C0444504;C2347634;C2348143;C2699239";NA;NA;fpg mean sd mg dl
 192;fpg  ( mg / dl );C0439269;NA;NA;fpg mg dl
 192;female acr definition  ^ g / mg;"C0024671;C0026410;C0043210;C0086287;C0439267;C0439269;C1412134;C1515941;C1550452;C1704788;C1705497;C1705498;C1960952;C2346927;C3539107;C3888054;C4321396;C4521761";NA;NA;female acr definition g mg
 192;fbs > = $nmbr$ mg / dl;"C0439269;C3812213";NA;NA;fbs $nmbr$ mg dl
 192;fbs < $nmbr$ mg / dl;"C0439269;C3812213";NA;NA;fbs $nmbr$ mg dl
 192;fa $nmbr$ mg ( « = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;fa $nmbr$ mg $nmbr$
 192;fa $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;fa $nmbr$ mg
 192;eze = ezetimibe $nmbr$ mg  pooled sinva = simvastatin pooled across doses  pooled eze / sinva = ezetimibe / simvastatin tablet pooled across doses  bni = body mass index  ldl - c = low - density lipoprotein cholesterol  t g = triglycerides  t c = total cholesterol  hdl - c = high - density lipoprotein cholesterol  apo — apolipoprotein  c rp — c - neactive protein  rlp - c = remnant - like particle - cholesterol .;"C0003591;C0003594;C0008377;C0023821;C0023824;C0024671;C0026410;C0031529;C0033684;C0039225;C0041004;C0074554;C0178602;C0201950;C0242821;C0439267;C0439269;C0460148;C0543421;C0577559;C0577573;C0600653;C0674390;C0918012;C1096155;C1142985;C1268086;C1306372;C1532737;C1538326;C1552854;C1637833;C1705223;C1709595;C1960952;C2346927;C2349200;C2986546;C3152252;C3539882;C3541325;C3891451;C4054077;C4082212;C4283905;C4319774;C4321396;C4521761;C4522255";NA;NA;eze ezetimibe $nmbr$ mg pooled sinva simvastatin pooled across doses pooled eze sinva ezetimibe simvastatin tablet pooled across doses bni body mass index ldl c low density lipoprotein cholesterol t g triglycerides t c total cholesterol hdl c high density lipoprotein cholesterol apo apolipoprotein c rp c neactive protein rlp c remnant like particle cholesterol
 192;esrd saxa $nmbr$ . $nmbr$ mg ( n = $nmbr$ );"C0022661;C0024671;C0026410;C0035078;C0439269;C1960952;C2316810;C2346927;C4321396;C4521761";NA;NA;esrd saxa $nmbr$ $nmbr$ mg n $nmbr$
 192;elevated symptomatic serum creatinine  hypotension > $nmbr$ . $nmbr$ mg / dl;"C0020649;C0231220;C0439269;C0700225;C3163620";NA;NA;elevated symptomatic serum creatinine hypotension $nmbr$ $nmbr$ mg dl
  53;anesthesiad  n ( % );NA;NA;NA;anesthesiad n
 192;fasting cholesterol — mg / dl;"C0008377;C0015663;C0439269";FALSE;2000;fasting cholesterol mg dl
 192;elevated serum creatinine ( > $nmbr$ . $nmbr$ mg / dl_ );"C0439269;C0700225";FALSE; 952;elevated serum creatinine $nmbr$ $nmbr$ mg dl_
 192;fc - ldl - c  mg / dl;"C0439269;C2983605";FALSE;1963;fc ldl c mg dl
 192;empagiiflozin $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;2277;empagiiflozin $nmbr$ mg
 192;empaglifiozin $nmbr$ . $nmbr$ mg ( w = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;2277;empaglifiozin $nmbr$ $nmbr$ mg w $nmbr$
 192;empaglifiozin $nmbr$ mg ( w = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;2277;empaglifiozin $nmbr$ mg w $nmbr$
 192;erlugliflozin $nmbr$ mg vs placebo / glimepiride;"C0024671;C0026410;C0032042;C0061323;C0439269;C1696465;C1706408;C1960952;C2346927;C4321396;C4521761";FALSE;2278;erlugliflozin $nmbr$ mg vs placebo glimepiride
 192;ertuglifldzin $nmbr$ mg vs placebo / glinepiride;"C0024671;C0026410;C0032042;C0439269;C1696465;C1706408;C1960952;C2346927;C4321396;C4521761";FALSE;2278;ertuglifldzin $nmbr$ mg vs placebo glinepiride
 192;esr  mean ± sd mg / dl;"C0439269;C0444504;C2347634;C2348143;C2699239;C3811131";FALSE; 298;esr mean sd mg dl
 192;famotidine $nmbr$ mg ( n = $nmbr$ );"C0015620;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;2279;famotidine $nmbr$ mg n $nmbr$
 192;fasting glucose level  mg / dl;"C0202045;C0439269";FALSE;2280;fasting glucose level mg dl
 192;fasting glucose  mean ( sd )  mg / dl;"C0015663;C0017725;C0439269;C0444504;C2347634;C2348143;C2699239";FALSE;2280;fasting glucose mean sd mg dl
 192;fasting glucose  mg / dl;"C0015663;C0017725;C0439269";FALSE;2280;fasting glucose mg dl
 192;fasting glucose ( mg / dl );"C0015663;C0017725;C0439269";FALSE;2280;fasting glucose mg dl
 192;fasting glucose  mg / dl ';"C0015663;C0017725;C0439269";FALSE;2280;fasting glucose mg dl
 192;fasting glucose — mg / dl;"C0015663;C0017725;C0439269";FALSE;2280;fasting glucose mg dl
 192;fasting glucose mg / dl diabetes classification;"C0008902;C0008903;C0011847;C0011849;C0015663;C0017725;C0439269;C0678229";FALSE;2280;fasting glucose mg dl diabetes classification
 192;fasting glucose  mg / dl  mean ( sd ) §;"C0015663;C0017725;C0439269;C0444504;C2347634;C2348143;C2699239";FALSE;2280;fasting glucose mg dl mean sd
 192;fasting glucose > $nmbr$ mg / dl *;"C0015663;C0017725;C0439269";FALSE;2280;fasting glucose $nmbr$ mg dl
 192;fasting glucose > $nmbr$ mg / dl  n ( % );"C0015663;C0017725;C0439269";FALSE;2280;fasting glucose $nmbr$ mg dl n
 192;fasting serum glucose level  mean ( sd )  mg / dl;"C0015663;C0202045;C0229671;C0439269;C0444504;C0583332;C1546774;C1550100;C2347634;C2348143;C2699239";FALSE;2280;fasting serum glucose level mean sd mg dl
 192;fasting serum glucose  mean ( sd ) mg / dl;"C0015663;C0202041;C0439269;C0444504;C2347634;C2348143;C2699239;C3534430";FALSE;2280;fasting serum glucose mean sd mg dl
 192;fasting serum glucose  median ( sd )  mg / dl;"C0015663;C0202041;C0439269;C0549183;C0876920;C2347635;C2348144;C2699239;C2939193;C3534430";FALSE;2280;fasting serum glucose median sd mg dl
 192;fasting serum glucose  mg / dl;"C0015663;C0202041;C0439269;C3534430";FALSE;2280;fasting serum glucose mg dl
 192;fasting serum glucose ( mg / dl );"C0015663;C0202041;C0439269;C3534430";FALSE;2280;fasting serum glucose mg dl
 192;fasting serum glucose — mg / dl * *;"C0015663;C0202041;C0439269;C3534430";FALSE;2280;fasting serum glucose mg dl
 192;fasting serum glucose ( mg / dl )  median ( iqr );"C0015663;C0202041;C0439269;C0549183;C0876920;C2347635;C2348144;C2939193;C3534430";FALSE;2280;fasting serum glucose mg dl median iqr
 192;fasting triglyceride level  mean ( sd )  mg / dl;"C0015663;C0428475;C0439269;C0444504;C2347634;C2348143;C2699239";FALSE;2281;fasting triglyceride level mean sd mg dl
 192;fasting triglycerides  mean ( sd ) mg / dl;"C0015663;C0041004;C0439269;C0444504;C2347634;C2348143;C2699239";FALSE;2281;fasting triglycerides mean sd mg dl
 192;fbg ( mg / dl );C0439269;FALSE;2280;fbg mg dl
 192;febuxostat $nmbr$ mg;"C0024671;C0026410;C0249529;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;2282;febuxostat $nmbr$ mg
 192;febuxostat $nmbr$ mg daily n = $nmbr$;"C0024671;C0026410;C0249529;C0332173;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;2282;febuxostat $nmbr$ mg daily n $nmbr$
 192;febuxostat $nmbr$ mg daily n = $nmbr$ n ( % );"C0024671;C0026410;C0249529;C0332173;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;2282;febuxostat $nmbr$ mg daily n $nmbr$ n
 192;feno  $nmbr$ mg dn = $nmbr$ );"C0024671;C0026410;C0439269;C1333964;C1707618;C1960952;C2346927;C4321396;C4521761";FALSE; 803;feno $nmbr$ mg dn $nmbr$
 192;feno $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE; 803;feno $nmbr$ mg n $nmbr$
 192;dupiiumab  $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;dupiiumab $nmbr$ mg n $nmbr$
 192;dose equivalent  mg ( sd ) );"C0024671;C0026410;C0178602;C0205163;C0439185;C0439269;C0869039;C1114758;C1960952;C2346927;C2699239;C4321396;C4521761";NA;NA;dose equivalent mg sd
 192;dose ( mg / week );"C0024671;C0026410;C0178602;C0332174;C0439230;C0439269;C0869039;C1114758;C1960952;C2346927;C4321396;C4521761";NA;NA;dose mg week
 192;dose  mg;"C0024671;C0026410;C0178602;C0439269;C0869039;C1114758;C1960952;C2346927;C4321396;C4521761";NA;NA;dose mg
 192;dbp $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ ) baseline lipid profile  mg / dl  mean ( sd );"C0023779;C0168634;C0439269;C0444504;C0536221;C1442488;C1979963;C2003903;C2347634;C2348143;C2699239;C3813197;C4281799";NA;NA;dbp $nmbr$ $nmbr$ $nmbr$ $nmbr$ baseline lipid profile mg dl mean sd
 192;daily dose > $nmbr$ mg n = $nmbr$;"C0024671;C0026410;C0439269;C1960952;C2346927;C2348070;C4321396;C4521761";NA;NA;daily dose $nmbr$ mg n $nmbr$
 192;daily dose $nmbr$ mg n = $nmbr$;"C0024671;C0026410;C0439269;C1960952;C2346927;C2348070;C4321396;C4521761";NA;NA;daily dose $nmbr$ mg n $nmbr$
 192;daily dose $nmbr$ - $nmbr$ mg n = $nmbr$;"C0024671;C0026410;C0439269;C1960952;C2346927;C2348070;C4321396;C4521761";NA;NA;daily dose $nmbr$ $nmbr$ mg n $nmbr$
 192;d $nmbr$ mg vs . warfarin;"C0024671;C0026410;C0043031;C0073187;C0332173;C0439269;C1960952;C2346927;C4321396;C4484261;C4521761";NA;NA;d $nmbr$ mg vs warfarin
 188;non - hispanic black;"C0005680;C0027567;C0085756;C0439541;C1518424";NA;NA;non hispanic black
 192;crp  mg / dl;"C0439269;C3890735;C4048285";FALSE; 286;crp mg dl
 192;crp ( mg / dl );"C0439269;C3890735;C4048285";FALSE; 286;crp mg dl
 192;crp ( mg / dl ) * *;"C0439269;C3890735;C4048285";FALSE; 286;crp mg dl
 192;crp  mg / dl  mean ( sd );"C0439269;C0444504;C2347634;C2348143;C2699239;C3890735;C4048285";FALSE; 286;crp mg dl mean sd
 192;crp  mg / dl  median;"C0439269;C0549183;C0876920;C2347635;C2348144;C2939193;C3890735;C4048285";FALSE; 286;crp mg dl median
 192;crp ( mg / dl ) < $nmbr$ . $nmbr$;"C0439269;C3890735;C4048285";FALSE; 286;crp mg dl $nmbr$ $nmbr$
 192;crp ( mg / dl  per unit );"C0024671;C0026410;C0439148;C0439269;C0439453;C1509845;C1519795;C1532632;C1638407;C1704753;C1880519;C1960952;C2346927;C3642216;C3853603;C3890735;C4048285;C4321396;C4521761";FALSE; 286;crp mg dl per unit
 192;crp — mg / liter ^;"C0024671;C0026410;C0439269;C0475211;C1960952;C2346927;C3890735;C4048285;C4321396;C4521761";FALSE; 286;crp mg liter
 192;crp > $nmbr$ . $nmbr$ mg / dl  n ( % );"C0439269;C3890735;C4048285";FALSE; 286;crp $nmbr$ $nmbr$ mg dl n
 192;crp > $nmbr$ mg / $nmbr$  n [ % ];"C0024671;C0026410;C0439269;C1960952;C2346927;C3890735;C4048285;C4321396;C4521761";FALSE; 286;crp $nmbr$ mg $nmbr$ n
 192;crp ( normal < $nmbr$ . $nmbr$ mg / dl );"C0205307;C0231683;C0439166;C0439269;C2347086;C3890735;C4048285;C4553972";FALSE; 286;crp normal $nmbr$ $nmbr$ mg dl
 192;crp ( normal range : $nmbr$ - $nmbr$ . $nmbr$ )  mg / dl  mean ( sd );"C0086715;C0439269;C0444504;C2347634;C2348143;C2699239;C3890735;C4048285";FALSE; 286;crp normal range $nmbr$ $nmbr$ $nmbr$ mg dl mean sd
 192;dabigatran $nmbr$ mg bid vs warfarin;"C0024671;C0026410;C0043031;C0439269;C1960952;C2346927;C2348066;C4321396;C4521761";FALSE; 775;dabigatran $nmbr$ mg bid vs warfarin
 192;dabigatran $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C2348066;C4321396;C4521761";FALSE; 775;dabigatran $nmbr$ mg n $nmbr$
 192;dabigatran $nmbr$ mg ( n = $nmbr$  $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C2348066;C4321396;C4521761";FALSE; 775;dabigatran $nmbr$ mg n $nmbr$ $nmbr$
 192;dabigatran $nmbr$ mg versu swarfarin;"C0024671;C0026410;C0439269;C1960952;C2346927;C2348066;C4321396;C4521761";FALSE; 775;dabigatran $nmbr$ mg versu swarfarin
 192;dabigatran $nmbr$ mg versus warfarin;"C0024671;C0026410;C0043031;C0439269;C1960952;C2346927;C2348066;C4321396;C4521761";FALSE; 775;dabigatran $nmbr$ mg versus warfarin
 192;dabigatran  $nmbr$ mg  vs . warfarin;"C0024671;C0026410;C0043031;C0439269;C1960952;C2346927;C2348066;C4321396;C4521761";FALSE; 775;dabigatran $nmbr$ mg vs warfarin
 192;dabigatran $nmbr$ vs dabigatran $nmbr$ mg bid;"C0024671;C0026410;C0439269;C1960952;C2346927;C2348066;C4321396;C4521761";FALSE; 775;dabigatran $nmbr$ vs dabigatran $nmbr$ mg bid
 192;dabigatran $nmbr$   mg b . i . d .;"C0021966;C0024671;C0026410;C0152277;C0221138;C0439269;C0439422;C1960952;C2346927;C2348066;C4321396;C4521761";FALSE; 775;dabigatran $nmbr$ mg b i d
 192;czp $nmbr$ mg;"C0024671;C0026410;C0054841;C0439269;C1861828;C1872109;C1960952;C2346927;C4321396;C4521761";FALSE;2274;czp $nmbr$ mg
 192;czp $nmbr$ mg every $nmbr$ weeks ( n = $nmbr$ );"C0024671;C0026410;C0054841;C0439230;C0439269;C1861828;C1872109;C1960952;C2346927;C4321396;C4521761";FALSE;2274;czp $nmbr$ mg every $nmbr$ weeks n $nmbr$
 192;czp $nmbr$ mg ( n = lll );"C0024671;C0026410;C0054841;C0439269;C1261077;C1861828;C1872109;C1960952;C2346927;C4321396;C4521761";FALSE;2274;czp $nmbr$ mg n lll
 192;czp $nmbr$ mg  % ( n / n );"C0024671;C0026410;C0054841;C0439269;C1861828;C1872109;C1960952;C2346927;C4321396;C4521761";FALSE;2274;czp $nmbr$ mg n n
 192;dabigatran  $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C2348066;C4321396;C4521761";FALSE; 775;dabigatran $nmbr$ mg
 192;dabigatran $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C2348066;C4321396;C4521761";FALSE; 775;dabigatran $nmbr$ mg
 192;dabigatran  $nmbr$ mg bid;"C0024671;C0026410;C0439269;C1960952;C2346927;C2348066;C4321396;C4521761";FALSE; 775;dabigatran $nmbr$ mg bid
 192;dabigatran $nmbr$ mg bid;"C0024671;C0026410;C0439269;C1960952;C2346927;C2348066;C4321396;C4521761";FALSE; 775;dabigatran $nmbr$ mg bid
 192;czp $nmbr$ mg ( n $nmbr$ $nmbr$ );"C0024671;C0026410;C0054841;C0439269;C1861828;C1872109;C1960952;C2346927;C4321396;C4521761";FALSE;2274;czp $nmbr$ mg n $nmbr$ $nmbr$
 192;czp $nmbr$ mg q $nmbr$ w;"C0024671;C0026410;C0054841;C0439269;C1861828;C1872109;C1960952;C2346927;C4321396;C4521761";FALSE;2274;czp $nmbr$ mg q $nmbr$ w
 192;dapagliflozin $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C2353951;C4321396;C4521761";FALSE;2275;dapagliflozin $nmbr$ mg
 192;dapagliflozin $nmbr$ mg group ( n = $nmbr$ );"C0024671;C0026410;C0439269;C0441848;C1960952;C2346927;C2353951;C4321396;C4521761";FALSE;2275;dapagliflozin $nmbr$ mg group n $nmbr$
 192;dapagliflozin $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C2353951;C4321396;C4521761";FALSE;2275;dapagliflozin $nmbr$ mg n $nmbr$
 192;dulaglutide $nmbr$ . $nmbr$ mg *;"C0024671;C0026410;C0439269;C1960952;C2346927;C3179549;C4321396;C4521761";FALSE;2276;dulaglutide $nmbr$ $nmbr$ mg
 192;dulaglutide $nmbr$ . $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C3179549;C4321396;C4521761";FALSE;2276;dulaglutide $nmbr$ $nmbr$ mg
 192;dulaglutide $nmbr$ . $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C3179549;C4321396;C4521761";FALSE;2276;dulaglutide $nmbr$ $nmbr$ mg n $nmbr$
 192;dulaglutide $nmbr$ · $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C3179549;C4321396;C4521761";FALSE;2276;dulaglutide $nmbr$ $nmbr$ mg n $nmbr$
 192;cld $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;cld $nmbr$ mg
 192;change in fpg $nmbr$ to month $nmbr$ ( mg / dl );"C0332177;C0392747;C0439231;C0439269;C0443172;C1705241;C4319952";NA;NA;change in fpg $nmbr$ to month $nmbr$ mg dl
 192;change from baseline to eos  mg / dl;"C0168634;C0392747;C0439269;C0443172;C1442488;C1623465;C1705241;C1861303;C4319952";NA;NA;change from baseline to eos mg dl
 192;change from baseline  mg / dl  mean ( sd );"C0168634;C0392747;C0439269;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C2699239;C4319952";NA;NA;change from baseline mg dl mean sd
 192;cana $nmbr$ mg ( n = $nmbr$ ) *;"C0024671;C0026410;C0439269;C1418845;C1960952;C2346927;C4321396;C4521761";NA;NA;cana $nmbr$ mg n $nmbr$
 192;cana $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1418845;C1960952;C2346927;C4321396;C4521761";NA;NA;cana $nmbr$ mg n $nmbr$
 192;cana $nmbr$ mg ( n - $nmbr$ );"C0024671;C0026410;C0439269;C1418845;C1960952;C2346927;C4321396;C4521761";NA;NA;cana $nmbr$ mg n $nmbr$
 192;cana $nmbr$ mg ( n $nmbr$ $nmbr$ );"C0024671;C0026410;C0439269;C1418845;C1960952;C2346927;C4321396;C4521761";NA;NA;cana $nmbr$ mg n $nmbr$ $nmbr$
 192;cana $nmbr$ mg;"C0024671;C0026410;C0439269;C1418845;C1960952;C2346927;C4321396;C4521761";NA;NA;cana $nmbr$ mg
 192;baseline sildenafil dose mg;"C0024671;C0026410;C0168634;C0178602;C0439269;C0529793;C0869039;C1114758;C1442488;C1960952;C2346927;C4321396;C4521761";NA;NA;baseline sildenafil dose mg
 192;baseline serum urate ( mg / dl ) a;"C0168634;C0439269;C0455272;C1442488";NA;NA;baseline serum urate mg dl a
 192;baseline mean ( mg / dl ];"C0168634;C0439269;C0444504;C1442488;C2347634;C2348143";NA;NA;baseline mean mg dl
 192;baseline mean  mg / dl;"C0168634;C0439269;C0444504;C1442488;C2347634;C2348143";NA;NA;baseline mean mg dl
 192;baseline lp ( a )  mg / dl;"C0065058;C0168634;C0439269;C1439335;C1442488;C4553379";NA;NA;baseline lp a mg dl
 192;baseline fpg  mg / dl;"C0168634;C0439269;C1442488";NA;NA;baseline fpg mg dl
 192;baseline . mean _ sd . mg / dl;"C0168634;C0439269;C0444504;C1442488;C2347634;C2348143;C2699239";NA;NA;baseline mean _ sd mg dl
 192;baseline . mean _ sd  mg / dl;"C0168634;C0439269;C0444504;C1442488;C2347634;C2348143;C2699239";NA;NA;baseline mean _ sd mg dl
 192;baseline  mg / dl ( mmol / l );"C0168634;C0439269;C1442488;C1532563";NA;NA;baseline mg dl mmol l
 192;> $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ mg
 192;creatinine — mg / dl;"C0010294;C0439269;C1561535";FALSE; 952;creatinine mg dl
 192;creatinine ( mg / dl );"C0010294;C0439269;C1561535";FALSE; 952;creatinine mg dl
 192;creatinine  mg / dl_;"C0010294;C0439269;C1561535";FALSE; 952;creatinine mg dl_
 192;creatinine  mg / dl;"C0010294;C0439269;C1561535";FALSE; 952;creatinine mg dl
 192;creatinine  mean ( sd )  mg / dl;"C0010294;C0439269;C0444504;C1561535;C2347634;C2348143;C2699239";FALSE; 952;creatinine mean sd mg dl
 192;baseline crp ( mg / dl );"C0168634;C0439269;C1442488;C3890735;C4048285";FALSE; 286;baseline crp mg dl
 192;c - reactive protein — mg / liter * *;"C0006560;C0024671;C0026410;C0439269;C0475211;C1413716;C1960952;C2346927;C4048285;C4321396;C4521761";FALSE; 286;c reactive protein mg liter
 192;clopidogrel loading dose $nmbr$ mg;"C0024671;C0026410;C0070166;C0439269;C1960952;C2346927;C3714444;C4321396;C4521761";FALSE; 217;clopidogrel loading dose $nmbr$ mg
 192;clopidogrel  $nmbr$ mg *;"C0024671;C0026410;C0070166;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE; 217;clopidogrel $nmbr$ mg
 192;clopidogrel  $nmbr$ - mg loading dose;"C0024671;C0026410;C0070166;C0439269;C1708715;C1960952;C2346927;C3714444;C4086581;C4321396;C4521761";FALSE; 217;clopidogrel $nmbr$ mg loading dose
 192;baseline aspirin dose < $nmbr$ mg;"C0024671;C0026410;C0168634;C0439269;C1442488;C1960952;C2346927;C4321396;C4521761;C4696290";FALSE;1366;baseline aspirin dose $nmbr$ mg
 192;baseline hdl - c level ( n = $nmbr$ . $nmbr$ ) > $nmbr$ . $nmbr$ mg / dl;"C0168634;C0439269;C0441889;C0456079;C1442488;C1547707;C2946261;C3715113";FALSE;2001;baseline hdl c level n $nmbr$ $nmbr$ $nmbr$ $nmbr$ mg dl
 192;blood urea nitrogen  mg / dl;"C0005845;C0439269;C0600137";FALSE;2271;blood urea nitrogen mg dl
 192;blood urea nitrogen ( mg / dl );"C0005845;C0439269;C0600137";FALSE;2271;blood urea nitrogen mg dl
 192;bun ( mg / dl );C0439269;FALSE;2271;bun mg dl
 192;baseline ldlc level ( n = $nmbr$  $nmbr$ ) s $nmbr$ . $nmbr$ mg / dl;"C0168634;C0439269;C0441889;C0456079;C1416822;C1442488;C1547707;C2946261";FALSE;1964;baseline ldlc level n $nmbr$ $nmbr$ s $nmbr$ $nmbr$ mg dl
 192;baseline ldlc level ( n = $nmbr$  $nmbr$ ) ^ $nmbr$ . $nmbr$ mg / dl;"C0168634;C0439269;C0441889;C0456079;C1416822;C1442488;C1547707;C2946261";FALSE;1964;baseline ldlc level n $nmbr$ $nmbr$ $nmbr$ $nmbr$ mg dl
 192;baseline ldl - c  mg / dl;"C0168634;C0439269;C1442488";FALSE;1964;baseline ldl c mg dl
 192;baseline ldl - c > $nmbr$ mg / dl;"C0168634;C0439269;C1442488";FALSE;1964;baseline ldl c $nmbr$ mg dl
 192;baseline ldl ‐ c  mg / dl;"C0168634;C0439269;C1442488";FALSE;1964;baseline ldl c mg dl
 192;baseline ldl ( mg % );"C0024671;C0026410;C0168634;C0439269;C1442488;C1960952;C2346927;C4321396;C4521761";FALSE;1964;baseline ldl mg
 192;baseline low - density lipoprotein cholesterol ( mg / dl );"C0023824;C0168634;C0439269;C1442488";FALSE;1964;baseline low density lipoprotein cholesterol mg dl
 192;baseline ldlc level ( n = $nmbr$ . $nmbr$ ) > $nmbr$ . $nmbr$ mg / dl;"C0168634;C0439269;C0441889;C0456079;C1416822;C1442488;C1547707;C2946261";FALSE;1964;baseline ldlc level n $nmbr$ $nmbr$ $nmbr$ $nmbr$ mg dl
 192;bun  mg / dl;C0439269;FALSE;2271;bun mg dl
 192;baseline hdl ‐ c  mg / dl;"C0168634;C0439269;C1442488;C3715113";FALSE;2001;baseline hdl c mg dl
 192;baseline hdl - c  mg / dl;"C0168634;C0439269;C1442488;C3715113";FALSE;2001;baseline hdl c mg dl
 192;baseline hdl - c level ( n = s $nmbr$  $nmbr$ ) < $nmbr$ . $nmbr$ mg / dl;"C0168634;C0439269;C0441889;C0456079;C1442488;C1547707;C2946261;C3715113";FALSE;2001;baseline hdl c level n s $nmbr$ $nmbr$ $nmbr$ $nmbr$ mg dl
 192;cholesterol — mg / dl;"C0008377;C0439269";FALSE;2000;cholesterol mg dl
 192;cholesterol ( mg / dl );"C0008377;C0439269";FALSE;2000;cholesterol mg dl
 192;cholesterol  mg / dl;"C0008377;C0439269";FALSE;2000;cholesterol mg dl
 192;baseline hdl - c level ( n = $nmbr$  $nmbr$ ) s $nmbr$ . $nmbr$ mg / dl;"C0168634;C0439269;C0441889;C0456079;C1442488;C1547707;C2946261;C3715113";FALSE;2001;baseline hdl c level n $nmbr$ $nmbr$ s $nmbr$ $nmbr$ mg dl
 192;belimumab $nmbr$ mg sc ( n $nmbr$ );"C0024671;C0026410;C0282380;C0439269;C1723401;C1960952;C2346927;C4321396;C4521761";FALSE;2272;belimumab $nmbr$ mg sc n $nmbr$
 192;body mass index ( mg / m $nmbr$ );"C0005893;C0024671;C0026410;C0369637;C0439269;C0441923;C0578022;C1305855;C1960952;C2346927;C4321396;C4521761";FALSE;1734;body mass index mg m $nmbr$
 192;canakinumab $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C2718773;C4321396;C4521761";FALSE; 372;canakinumab $nmbr$ mg
 192;carisbamate $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1871983;C1960952;C2346927;C4321396;C4521761";FALSE;2273;carisbamate $nmbr$ mg n $nmbr$
 192;carisbamate $nmbr$  $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1871983;C1960952;C2346927;C4321396;C4521761";FALSE;2273;carisbamate $nmbr$ $nmbr$ mg n $nmbr$
 192;azl - m $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0369637;C0439269;C0441923;C1960952;C2346927;C4321396;C4521761";NA;NA;azl m $nmbr$ mg n $nmbr$
 192;average dose ( mg / week );"C0024671;C0026410;C0178602;C0332174;C0439230;C0439269;C0869039;C1114758;C1510992;C1960952;C2346927;C2825518;C4321396;C4521761";NA;NA;average dose mg week
 192;asa > $nmbr$ mg;"C0004057;C0024671;C0026410;C0439269;C1960952;C2346927;C3853627;C4321396;C4521761";NA;NA;asa $nmbr$ mg
 192;asa < $nmbr$ mg;"C0004057;C0024671;C0026410;C0439269;C1960952;C2346927;C3853627;C4321396;C4521761";NA;NA;asa $nmbr$ mg
 192;ami $nmbr$ mg n = $nmbr$;"C0024671;C0026410;C0439269;C1960952;C2346927;C4319936;C4321396;C4521761";NA;NA;ami $nmbr$ mg n $nmbr$
 192;ami $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C4319936;C4321396;C4521761";NA;NA;ami $nmbr$ mg
 192;> = $nmbr$ mg / dl;C0439269;NA;NA;$nmbr$ mg dl
 192;> $nmbr$ to < $nmbr$ mg dl;C0439269;NA;NA;$nmbr$ to $nmbr$ mg dl
 192;> $nmbr$ to < $nmbr$ mg / dl;C0439269;NA;NA;$nmbr$ to $nmbr$ mg dl
 192;> $nmbr$ to < $nmbr$ - $nmbr$ mg / week;"C0024671;C0026410;C0332174;C0439230;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ to $nmbr$ $nmbr$ mg week
 192;> $nmbr$ mg dl;C0439269;NA;NA;$nmbr$ mg dl
 192;> $nmbr$ mg / liter;"C0024671;C0026410;C0439269;C0475211;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ mg liter
 192;> $nmbr$ mg / dl — %;C0439269;NA;NA;$nmbr$ mg dl
 192;> $nmbr$ mg / dl simva ( „ = $nmbr$ );C0439269;NA;NA;$nmbr$ mg dl simva $nmbr$
 192;> $nmbr$ mg / dl simva $nmbr$ = $nmbr$ ];C0439269;NA;NA;$nmbr$ mg dl simva $nmbr$ $nmbr$
 192;> $nmbr$ mg / dl simva;C0439269;NA;NA;$nmbr$ mg dl simva
 192;> $nmbr$ mg / dl eze / simva ( „ = $nmbr$ );C0439269;NA;NA;$nmbr$ mg dl eze simva $nmbr$
 192;> $nmbr$ mg / dl eze / simva $nmbr$ = $nmbr$ };C0439269;NA;NA;$nmbr$ mg dl eze simva $nmbr$ $nmbr$
 192;> $nmbr$ mg / dl eze / simva;C0439269;NA;NA;$nmbr$ mg dl eze simva
 192;> $nmbr$ mg / dl;C0439269;NA;NA;$nmbr$ mg dl
 152;anemia;"C0002871;C1000483;C4554633";NA;NA;anemia
 192;aspirin $nmbr$ mg;"C0004057;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;1366;aspirin $nmbr$ mg
 192;alogliptin $nmbr$ mg + pioglitazone ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C3535925;C4321396;C4521761";FALSE;1955;alogliptin $nmbr$ mg pioglitazone n $nmbr$
 192;alogliptin $nmbr$ . $nmbr$ mg + pioglitazone ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C3535925;C4321396;C4521761";FALSE;1955;alogliptin $nmbr$ $nmbr$ mg pioglitazone n $nmbr$
 192;amlodipine / valsartan $nmbr$ to $nmbr$ / $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C1962523;C2346927;C4321396;C4521761";FALSE;  78;amlodipine valsartan $nmbr$ to $nmbr$ $nmbr$ mg n $nmbr$
 192;amlodipine / valsartan $nmbr$ / $nmbr$ vs $nmbr$ / $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C1962523;C2346927;C4321396;C4521761";FALSE;  78;amlodipine valsartan $nmbr$ $nmbr$ vs $nmbr$ $nmbr$ mg
 192;amlodipine $nmbr$ to $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0051696;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;  78;amlodipine $nmbr$ to $nmbr$ mg n $nmbr$
 192;amlodipine $nmbr$ mg / v = $nmbr$;"C0024671;C0026410;C0051696;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;  78;amlodipine $nmbr$ mg v $nmbr$
 192;apixaban  $nmbr$ mg;"C0024671;C0026410;C0439269;C1831808;C1960952;C2346927;C4321396;C4521761";FALSE;1224;apixaban $nmbr$ mg
 192;apixaban  $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1831808;C1960952;C2346927;C4321396;C4521761";FALSE;1224;apixaban $nmbr$ mg n $nmbr$
 192;apixaban $nmbr$ mg bid;"C0024671;C0026410;C0439269;C1831808;C1960952;C2346927;C4321396;C4521761";FALSE;1224;apixaban $nmbr$ mg bid
 192;apixaban  $nmbr$ . $nmbr$ mg;"C0024671;C0026410;C0439269;C1831808;C1960952;C2346927;C4321396;C4521761";FALSE;1224;apixaban $nmbr$ $nmbr$ mg
 192;apixaban $nmbr$ . $nmbr$ mg bid;"C0024671;C0026410;C0439269;C1831808;C1960952;C2346927;C4321396;C4521761";FALSE;1224;apixaban $nmbr$ $nmbr$ mg bid
 192;apixaban  $nmbr$ . $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1831808;C1960952;C2346927;C4321396;C4521761";FALSE;1224;apixaban $nmbr$ $nmbr$ mg n $nmbr$
 192;aplxaban $nmbr$ . $nmbr$ mg bid;"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;1224;aplxaban $nmbr$ $nmbr$ mg bid
 192;apolipoprotein a $nmbr$ ( mg / dl );"C0003592;C0439269;C0523508";FALSE;1028;apolipoprotein a $nmbr$ mg dl
 192;apolipoprotein b ( mg / dl );"C0003593;C0439269";FALSE;1028;apolipoprotein b mg dl
 192;apolipoprotein b $nmbr$  mg / dl;"C0003593;C0439269";FALSE;1028;apolipoprotein b $nmbr$ mg dl
 192;apolipoprotein b  mg / dl;"C0003593;C0439269";FALSE;1028;apolipoprotein b mg dl
 192;baricitinib $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C4044947;C4321396;C4521761";FALSE;1956;baricitinib $nmbr$ mg
 192;baricitinib  $nmbr$ mg daily ( n = $nmbr$ );"C0024671;C0026410;C0332173;C0439269;C1960952;C2346927;C4044947;C4321396;C4521761";FALSE;1956;baricitinib $nmbr$ mg daily n $nmbr$
 192;baricitinib $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C4044947;C4321396;C4521761";FALSE;1956;baricitinib $nmbr$ mg n $nmbr$
 192;baricitinib $nmbr$ mg qd ( n = $nmbr$ );"C0024671;C0026410;C0332173;C0439269;C1960952;C2346927;C4044947;C4321396;C4521761";FALSE;1956;baricitinib $nmbr$ mg qd n $nmbr$
 192;baricitinib $nmbr$ mg qd;"C0024671;C0026410;C0332173;C0439269;C1960952;C2346927;C4044947;C4321396;C4521761";FALSE;1956;baricitinib $nmbr$ mg qd
 192;baricitinib $nmbr$ / $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C4044947;C4321396;C4521761";FALSE;1956;baricitinib $nmbr$ $nmbr$ mg
 192;average weekly mtx dose ( mg / week );"C0024671;C0026410;C0332174;C0366550;C0439230;C0439269;C1510992;C1960952;C2346927;C2825518;C4321396;C4521761";FALSE; 716;average weekly mtx dose mg week
 192;average weekly mtx dose ( mg / week ) t;"C0024671;C0026410;C0332174;C0366550;C0439230;C0439269;C1510992;C1960952;C2346927;C2825518;C4321396;C4521761";FALSE; 716;average weekly mtx dose mg week t
 192;all dulaglutide $nmbr$ . $nmbr$ mg + insulin lispro / insulin glargine ( n = $nmbr$ );"C0024671;C0026410;C0293359;C0439269;C0907402;C1960952;C2346927;C3179549;C4321396;C4521761";FALSE;2268;all dulaglutide $nmbr$ $nmbr$ mg insulin lispro insulin glargine n $nmbr$
 192;apoal  mg / dl;C0439269;FALSE;2269;apoal mg dl
 192;apoal ( mg / dl ) *;C0439269;FALSE;2269;apoal mg dl
 192;apo a $nmbr$ ( mg / dl );"C0003592;C0439269;C0523508;C4553344;C4553379";FALSE;2269;apo a $nmbr$ mg dl
 192;apoa $nmbr$  mg / dl;"C0003592;C0439269;C0523508;C4553344;C4553379";FALSE;2269;apoa $nmbr$ mg dl
 192;apob  mg / dl;"C0003593;C0439269;C3252643";FALSE;2269;apob mg dl
 192;apob ( mg / dl );"C0003593;C0439269;C3252643";FALSE;2269;apob mg dl
 192;apremilast $nmbr$ mg bid n = $nmbr$;"C0024671;C0026410;C0439269;C1678805;C1960952;C2346927;C4321396;C4521761";FALSE;2270;apremilast $nmbr$ mg bid n $nmbr$
 192;ato $nmbr$ mg and sim $nmbr$ ^ $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1420068;C1960952;C2346927;C4321396;C4521761";FALSE;1840;ato $nmbr$ mg and sim $nmbr$ $nmbr$ mg n $nmbr$
 192;ato $nmbr$ mg and sim $nmbr$ - $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1420068;C1960952;C2346927;C4321396;C4521761";FALSE;1840;ato $nmbr$ mg and sim $nmbr$ $nmbr$ mg n $nmbr$
 192;ato $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE; 885;ato $nmbr$ mg n $nmbr$
 192;> $nmbr$ . $nmbr$ mg / liter;"C0024671;C0026410;C0439269;C0475211;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ $nmbr$ mg liter
 192;> $nmbr$ . $nmbr$ mg / dl;C0439269;NA;NA;$nmbr$ $nmbr$ mg dl
 192;> $nmbr$ & < $nmbr$ mg / dl;C0439269;NA;NA;$nmbr$ $nmbr$ mg dl
 192;> $nmbr$  < $nmbr$ mg / dl;C0439269;NA;NA;$nmbr$ $nmbr$ mg dl
 192;< $nmbr$ mg / liter;"C0024671;C0026410;C0439269;C0475211;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ mg liter
 192;< $nmbr$ mg / dl simva ( n = $nmbr$ ];C0439269;NA;NA;$nmbr$ mg dl simva n $nmbr$
 192;< $nmbr$ mg / dl simva ( n = $nmbr$ );C0439269;NA;NA;$nmbr$ mg dl simva n $nmbr$
 192;< $nmbr$ mg / dl simva;C0439269;NA;NA;$nmbr$ mg dl simva
 192;< $nmbr$ mg / dl eze / simva ( n = $nmbr$ };C0439269;NA;NA;$nmbr$ mg dl eze simva n $nmbr$
 192;< $nmbr$ mg / dl eze / simva ( n = $nmbr$ );C0439269;NA;NA;$nmbr$ mg dl eze simva n $nmbr$
 181;statistics;"C0038215;C0600673";NA;NA;statistics
 192;< $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ mg
 192;< $nmbr$ / $nmbr$ mmhg  ldl - c < $nmbr$ mg / dl;"C0439269;C0439475";NA;NA;$nmbr$ $nmbr$ mmhg ldl c $nmbr$ mg dl
 192;< $nmbr$ . $nmbr$ mg / liter;"C0024671;C0026410;C0439269;C0475211;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ $nmbr$ mg liter
 192;< $nmbr$ . $nmbr$ mg / dl;C0439269;NA;NA;$nmbr$ $nmbr$ mg dl
 192;- median fasting serum glucose ( mg / dl ) ( iqr );"C0015663;C0202041;C0439269;C0549183;C0876920;C2347635;C2348144;C2939193;C3534430";NA;NA;median fasting serum glucose mg dl iqr
 192;( sd )  mg / dl;"C0439269;C2699239";NA;NA;sd mg dl
 192;( mg / dl ± sd );"C0439269;C2699239";NA;NA;mg dl sd
 192;( mg / dl );C0439269;NA;NA;mg dl
 192;$nmbr$   mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ mg
 192;$nmbr$ to < $nmbr$ mg / dl;C0439269;NA;NA;$nmbr$ to $nmbr$ mg dl
 192;$nmbr$ mg vs placebo;"C0024671;C0026410;C0032042;C0439269;C1696465;C1706408;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ mg vs placebo
 192;$nmbr$ mg twice daily n = $nmbr$;"C0024671;C0026410;C0439269;C0585361;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ mg twice daily n $nmbr$
 192;$nmbr$ mg sirukumab every $nmbr$ weeks ( n = $nmbr$ );"C0024671;C0026410;C0439230;C0439269;C1960952;C2346927;C3254570;C4321396;C4521761";NA;NA;$nmbr$ mg sirukumab every $nmbr$ weeks n $nmbr$
 192;$nmbr$ mg qw $nmbr$ . $nmbr$ pt yrs;"C0024671;C0026410;C0032743;C0043011;C0439269;C0699718;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ mg qw $nmbr$ $nmbr$ pt yrs
 192;$nmbr$ mg qd ( n = $nmbr$ );"C0024671;C0026410;C0332173;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ mg qd n $nmbr$
 192;$nmbr$ mg q $nmbr$ w;"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ mg q $nmbr$ w
 192;$nmbr$ mg ew n = $nmbr$;"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ mg ew n $nmbr$
 192;$nmbr$ mg eow n = $nmbr$;"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ mg eow n $nmbr$
 192;$nmbr$ mg cohort;"C0009247;C0024671;C0026410;C0439269;C0599755;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ mg cohort
 192;$nmbr$ mg clopidogrel load;"C0024671;C0026410;C0070166;C0439269;C1550025;C1704782;C1708715;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ mg clopidogrel load
 192;$nmbr$ mg biw $nmbr$ . $nmbr$ pt yrs;"C0024671;C0026410;C0032743;C0439269;C0699718;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ mg biw $nmbr$ $nmbr$ pt yrs
 192;$nmbr$ mg bid;"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ mg bid
 192;$nmbr$ mg a;"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ mg a
 192;$nmbr$ mg / kgf ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ mg kgf n $nmbr$
 192;$nmbr$ mg / dl ldl cholesterol | |;"C0023824;C0202117;C0439269";NA;NA;$nmbr$ mg dl ldl cholesterol
 192;$nmbr$ mg / dl;C0439269;NA;NA;$nmbr$ mg dl
 192;$nmbr$ mg / $nmbr$ mgc;"C0024671;C0026410;C0439269;C1960952;C2346927;C3888239;C4321396;C4521761";NA;NA;$nmbr$ mg $nmbr$ mgc
 192;$nmbr$ mg / $nmbr$ mgb;"C0024671;C0026410;C0373680;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ mg $nmbr$ mgb
 192;$nmbr$ mg + mtx;"C0024671;C0025677;C0026410;C0439269;C1417487;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ mg mtx
 192;$nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ mg n $nmbr$
 192;$nmbr$ mg ( n $nmbr$ $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ mg n $nmbr$ $nmbr$
 192;$nmbr$ mg ( $nmbr$  $nmbr$ . $nmbr$ % );"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ mg $nmbr$ $nmbr$ $nmbr$
 192;$nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ mg
 192;$nmbr$ / $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ $nmbr$ mg n $nmbr$
 192;$nmbr$ / $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ $nmbr$ mg
 192;$nmbr$ . $nmbr$ mg bid;"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ $nmbr$ mg bid
 192;$nmbr$ . $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ $nmbr$ mg n $nmbr$
 192;$nmbr$ . $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;$nmbr$ $nmbr$ mg
 192;$nmbr$ - h pmg ( mg / dl );"C0033727;C0369286;C0439269;C0441932;C0564385;C4528284";NA;NA;$nmbr$ h pmg mg dl
 192;$nmbr$ - $nmbr$ mg / dl *;C0439269;NA;NA;$nmbr$ $nmbr$ mg dl
 192;$nmbr$ - $nmbr$ mg / dl;C0439269;NA;NA;$nmbr$ $nmbr$ mg dl
 192;$nmbr$ $nmbr$ mg / dl;C0439269;NA;NA;$nmbr$ $nmbr$ mg dl
 191;symptom onset to first medical contact : ambulance or emergency department;"C0002422;C0199168;C0205435;C0205476;C0332158;C0337611;C0562508;C1279901;C1705415;C3812666;C3846685;C4086878";NA;NA;symptom onset to first medical contact ambulance or emergency department
 191;non - pci hospital / ambulance;"C0002422;C0019994;C1510665;C1518422;C3846685;C4049621";NA;NA;non pci hospital ambulance
 191;in emergency department before ambulance transfer;"C0002422;C0040671;C0562508;C1705822;C3846685;C4319192";NA;NA;in emergency department before ambulance transfer
 191;in ambulance;"C0002422;C3846685";NA;NA;in ambulance
 191;first medical contact in ambulance;"C0002422;C0199168;C0205435;C0205476;C0332158;C0337611;C1279901;C1705415;C3812666;C3846685";NA;NA;first medical contact in ambulance
 191;ambulance ( % );"C0002422;C3846685";NA;NA;ambulance
 191;ambulance  n ( % );"C0002422;C3846685";NA;NA;ambulance n
 191;ambulance;"C0002422;C3846685";NA;NA;ambulance
 190;locally advanced;"C0205179;C1517927";NA;NA;locally advanced
 190;advanced  n ( % );C0205179;NA;NA;advanced n
 190;advanced;C0205179;NA;NA;advanced
 189;north america plus australia and new zealand;"C0004340;C0027978;C0028405;C0324547;C0332287";NA;NA;north america plus australia and new zealand
 189;north america ( plus australia and new zealand );"C0004340;C0027978;C0028405;C0324547;C0332287";NA;NA;north america plus australia and new zealand
 189;new zealand;"C0027978;C0324547";NA;NA;new zealand
 189;australia and new zealand;"C0004340;C0027978;C0324547";NA;NA;australia and new zealand
 189;austrafca and new zealand;"C0027978;C0324547";NA;NA;austrafca and new zealand
 188;worldwide non - black patients;"C0005680;C0027567;C0085756;C0439541;C1829939";NA;NA;worldwide non black patients
 188;u . s . non - black patients;"C0005680;C0027567;C0041703;C0085756;C0439541;C1829939";NA;NA;u s non black patients
 188;race  black or african - american  n ( % );"C0005680;C0027567;C0034510;C0085756;C0439541;C1706779;C3853635";NA;NA;race black or african american n
 188;non - hispanic black or african - american;"C0005680;C0027567;C0085756;C0439541;C1518424";NA;NA;non hispanic black or african american
 189;poland;C0032356;FALSE; -10;poland
 188;non - black participants;"C0005680;C0027567;C0085756;C0439541;C0679646;C1518422";NA;NA;non black participants
 188;non - black ( n = $nmbr$ );"C0005680;C0027567;C0085756;C0439541;C1518422";NA;NA;non black n $nmbr$
 188;non - black  worldwide;"C0005680;C0027567;C0085756;C0439541;C1518422";NA;NA;non black worldwide
 188;hispanic black;"C0005680;C0027567;C0085756;C0086409;C0439541";NA;NA;hispanic black
 188;black participants;"C0005680;C0027567;C0085756;C0439541;C0679646";NA;NA;black participants
 188;black or african ‐ american;"C0005680;C0027567;C0085756;C0439541";NA;NA;black or african american
 188;black or african heritage;"C0005680;C0027567;C0085756;C0439541;C2986513";NA;NA;black or african heritage
 188;black or african american;"C0005680;C0027567;C0085756;C0439541";NA;NA;black or african american
 188;black or african america;"C0005680;C0027567;C0085756;C0439541";NA;NA;black or african america
 188;black or african - american;"C0005680;C0027567;C0085756;C0439541";NA;NA;black or african american
 188;black or african;"C0005680;C0027567;C0085756;C0439541";NA;NA;black or african
 188;black non - hispanic - n ( % );"C0005680;C0027567;C0085756;C0439541;C1518422;C1518424;C1533017;C1533018";NA;NA;black non hispanic n
 188;black non - hispanic;"C0005680;C0027567;C0085756;C0439541;C1518422;C1518424;C1533017;C1533018";NA;NA;black non hispanic
 188;black / non - black;"C0005680;C0027567;C0085756;C0439541;C1518422";NA;NA;black non black
 188;black / african american *;C0085756;NA;NA;black african american
 188;black / african american;C0085756;NA;NA;black african american
 188;black / african - american ( $nmbr$ . $nmbr$ % );C0085756;NA;NA;black african american $nmbr$ $nmbr$
 188;black / african - american;C0085756;NA;NA;black african american
 188;black *;"C0005680;C0027567;C0085756;C0439541";NA;NA;black
 188;black ( n — $nmbr$ );"C0005680;C0027567;C0085756;C0439541";NA;NA;black n $nmbr$
 188;black ( n   = $nmbr$ );"C0005680;C0027567;C0085756;C0439541";NA;NA;black n $nmbr$
 188;black  worldwide;"C0005680;C0027567;C0085756;C0439541";NA;NA;black worldwide
 188;black  us;"C0005680;C0027567;C0085756;C0439541";NA;NA;black us
 188;black  no . ( % );"C0005680;C0027567;C0085756;C0439541";NA;NA;black no
 188;black  n ( % );"C0005680;C0027567;C0085756;C0439541";NA;NA;black n
 188;black;"C0005680;C0027567;C0085756;C0439541";NA;NA;black
 188;b : u . s . black and non - black patients;"C0005680;C0027567;C0041703;C0085756;C0439541;C1829939";NA;NA;b u s black and non black patients
 188;african americans;C0085756;NA;NA;african americans
 188;african american n = $nmbr$;C0085756;NA;NA;african american n $nmbr$
 188;african american / black;"C0005680;C0027567;C0085756;C0439541";NA;NA;african american black
 188;african american  n ( % );C0085756;NA;NA;african american n
 188;african american;C0085756;NA;NA;african american
 188;african america;C0085756;NA;NA;african america
 188;african - latin american;C0085756;NA;NA;african latin american
 188;african - american / african heritage ( n = $nmbr$ );"C0085756;C2986513";NA;NA;african american african heritage n $nmbr$
 188;african - american;C0085756;NA;NA;african american
 188;african;C0027567;NA;NA;african
 188;a : worldwide black and non - black patients;"C0005680;C0027567;C0085756;C0439541;C1829939";NA;NA;a worldwide black and non black patients
 188;* non - black *;"C0005680;C0027567;C0085756;C0439541;C1518422";NA;NA;non black
 187;uacr ( mgg - $nmbr$ );NA;NA;NA;uacr mgg $nmbr$
 187;uacr  n ( % ) †;NA;NA;NA;uacr n
 187;uacr  mgg $nmbr$ ( gm );"C0017480;C3854019";NA;NA;uacr mgg $nmbr$ gm
 187;uacr  mg / mmol ( interquartile range ) b;"C0567349;C1711350;C2348885";NA;NA;uacr mg mmol interquartile range b
 187;uacr;NA;NA;NA;uacr
 187;scr  gmol / l;"C1539487;C4050416";NA;NA;scr gmol l
 186;om $nmbr$ mg / aml $nmbr$ mg / hctz $nmbr$ mg;"C0020261;C0023465;C0023467;C0028971;C1319635;C1705272";NA;NA;om $nmbr$ mg aml $nmbr$ mg hctz $nmbr$ mg
 186;om $nmbr$ mg / aml $nmbr$ mg ( n = $nmbr$ );"C0023465;C0023467;C0028971;C1319635;C1705272";NA;NA;om $nmbr$ mg aml $nmbr$ mg n $nmbr$
 186;om $nmbr$ mg / aml $nmbr$ mg;"C0023465;C0023467;C0028971;C1319635;C1705272";NA;NA;om $nmbr$ mg aml $nmbr$ mg
 186;om $nmbr$ mg + aml $nmbr$ mg + hctz $nmbr$ mg ( n = $nmbr$ );"C0020261;C0023465;C0023467;C0028971;C1319635;C1705272";NA;NA;om $nmbr$ mg aml $nmbr$ mg hctz $nmbr$ mg n $nmbr$
 186;om $nmbr$ / aml $nmbr$ /;"C0023465;C0023467;C0028971;C1705272";NA;NA;om $nmbr$ aml $nmbr$
 186;aml / val $nmbr$ / $nmbr$ mg;"C0023465;C0023467;C0024671;C0026410;C0042285;C0439269;C0523975;C1960952;C2346927;C4321396;C4521761";NA;NA;aml val $nmbr$ $nmbr$ mg
 186;aml ( n = $nmbr$ );"C0023465;C0023467";NA;NA;aml n $nmbr$
 186;aml $nmbr$ /;"C0023465;C0023467";NA;NA;aml $nmbr$
 186;aml;"C0023465;C0023467";NA;NA;aml
 186;a / aml ( n = $nmbr$ );"C0023465;C0023467";NA;NA;a aml n $nmbr$
 185;ppi or h $nmbr$ receptor antagonist  n ( % );"C0033727;C0358591;C0369286;C0441932;C0564385;C0871125;C3811894;C4528284;C4543207";NA;NA;ppi or h $nmbr$ receptor antagonist n
 185;mineralocorticoid receptor antagonists;"C1373021;C1579268";NA;NA;mineralocorticoid receptor antagonists
 185;mineralocorticoid receptor antagonist n ( % );C1579268;NA;NA;mineralocorticoid receptor antagonist n
 185;mineralocorticoid receptor antagonist;C1579268;NA;NA;mineralocorticoid receptor antagonist
 185;mineralcorticoid receptor antagonist;C4543207;NA;NA;mineralcorticoid receptor antagonist
 185;leukotriene receptor antagonists;"C0595726;C2757015;C3542962";NA;NA;leukotriene receptor antagonists
 185;leukotriene - receptor antagonist;"C0595726;C3537183;C4521995";NA;NA;leukotriene receptor antagonist
 185;h $nmbr$ receptor antagonist;"C0033727;C0369286;C0441932;C0564385;C4528284;C4543207";NA;NA;h $nmbr$ receptor antagonist
 185;h $nmbr$ - receptor antagonist;"C0033727;C0369286;C0441932;C0564385;C4528284;C4543207";NA;NA;h $nmbr$ receptor antagonist
 185;endothelin - receptor antagonists plus phosphodiesterase type $nmbr$ inhibitors;"C0031638;C0332307;C1134681;C1547052;C1656262;C2266875;C3539996";NA;NA;endothelin receptor antagonists plus phosphodiesterase type $nmbr$ inhibitors
 185;endothelin - receptor antagonists;"C1134681;C2266875";NA;NA;endothelin receptor antagonists
 185;aldosterone receptor antagonists;C1579268;NA;NA;aldosterone receptor antagonists
 184;tnf antagonist;"C0231491;C1448177";NA;NA;tnf antagonist
 184;ras antagonist  %;"C0034678;C0231491;C0525678";NA;NA;ras antagonist
 184;no history of tnf antagonist treatment — no . ( % );"C0019664;C0019665;C0039798;C0087111;C0231491;C0262512;C0262926;C1448177;C1522326;C1533734;C1705169;C1705255;C2004062;C3538994;C3887704";NA;NA;no history of tnf antagonist treatment no
 184;miami k antagonist received;"C0231491;C0597277;C1514756;C1551421;C1708601";NA;NA;miami k antagonist received
 184;history of disease refractory to treatment with tnf antagonist — no . ( % );"C0039798;C0087111;C0205269;C0231491;C0683519;C0730226;C0850708;C0944983;C1448177;C1522326;C1533734;C1705169;C3538994;C3887704";NA;NA;history of disease refractory to treatment with tnf antagonist no
 184;antagonist;C0231491;NA;NA;antagonist
 184;adp antagonist;"C0231491;C0523452";NA;NA;adp antagonist
 183;total included in combined analysis;"C0002778;C0205195;C0332257;C0439175;C0439810;C0936012;C1524024";NA;NA;total included in combined analysis
 183;stratified analyses;"C0002778;C0205363;C0936012;C1524024";NA;NA;stratified analyses
 183;sensitivity analyses;"C0002778;C0020517;C0036667;C0312418;C0427965;C0936012;C1511883;C1522640;C1524024;C2346484;C2349185";NA;NA;sensitivity analyses
 183;responder analyses ( achieving alc < $nmbr$ . $nmbr$ % );"C0002778;C0936012;C1424945;C1524024;C3811058";NA;NA;responder analyses achieving alc $nmbr$ $nmbr$
 183;prespecified analysis;"C0002778;C0936012;C1524024";NA;NA;prespecified analysis
 183;patients included in analysis;"C0002778;C0030705;C0332257;C0936012;C1524024";NA;NA;patients included in analysis
 183;patients in analysis  n;"C0002778;C0030705;C0936012;C1524024";NA;NA;patients in analysis n
 183;patients ( full analysis sety )  n;"C0002778;C0030705;C0443225;C0936012;C1524024";NA;NA;patients full analysis sety n
 183;overall analysis;"C0002778;C0282416;C0936012;C1524024;C1561607";NA;NA;overall analysis
 183;integrated analysis set ( n = $nmbr$ );"C0002778;C0036849;C0369718;C0441922;C0936012;C1158478;C1442518;C1524024;C1705195;C1705422";NA;NA;integrated analysis set n $nmbr$
 183;included in analysis;"C0002778;C0332257;C0936012;C1524024";NA;NA;included in analysis
 183;full analysis set  n;"C0002778;C0036849;C0443225;C0936012;C1442518;C1524024;C1705195";NA;NA;full analysis set n
 183;full analysis set;"C0002778;C0036849;C0443225;C0936012;C1442518;C1524024;C1705195";NA;NA;full analysis set
 183;final analysis ( all patients );"C0002778;C0030705;C0205088;C0936012;C1524024;C1546485;C3853528";NA;NA;final analysis all patients
 183;analysis;"C0002778;C0936012;C1524024";NA;NA;analysis
 183;$nmbr$ days until end of study ( landmark analysis );"C0002778;C0444930;C0936012;C1524024;C2746065;C2826182";NA;NA;$nmbr$ days until end of study landmark analysis
 182;interim analysis ( all patients );"C0030705;C4684691";NA;NA;interim analysis all patients
 182;interim analysis;C4684691;NA;NA;interim analysis
 181;subgroup statistics;"C0038215;C0600673;C1079230;C1515021";NA;NA;subgroup statistics
 181;statisticd;NA;NA;NA;statisticd
 181;statistic * *;"C2348149;C2828391";NA;NA;statistic
 181;sample statistics;C2348149;NA;NA;sample statistics
 181;parameter statistics;C0681933;NA;NA;parameter statistics
 180;ugt induction status : as randomizeda  n ( % );"C0205263;C0449438;C0857127;C1420188;C4284131";NA;NA;ugt induction status as randomizeda n
 180;ish status  n ( % );C0449438;NA;NA;ish status n
 180;ish;NA;NA;NA;ish
 180;as;NA;NA;NA;as
 179;established maerovaseular disease and albuminuria;"C0001925;C0012634;C0443211;C1272684";NA;NA;established maerovaseular disease and albuminuria
 179;established disease;"C0012634;C0443211;C1272684";NA;NA;established disease
 179;established ( n = $nmbr$ );"C0443211;C1272684";NA;NA;established n $nmbr$
 179;established;"C0443211;C1272684";NA;NA;established
 178;drinker ( $nmbr$ to $nmbr$ drinks / week );"C0332174;C0439230;C0452428;C0556338";NA;NA;drinker $nmbr$ to $nmbr$ drinks week
 178;drinker ( $nmbr$ - $nmbr$ drinks / week );"C0332174;C0439230;C0452428;C0556338";NA;NA;drinker $nmbr$ $nmbr$ drinks week
 178;alcohol use  drinks / wk *;"C0001948;C0332174;C0439230;C0452428";NA;NA;alcohol use drinks wk
 178;alcohol use  drinks / wk;"C0001948;C0332174;C0439230;C0452428";NA;NA;alcohol use drinks wk
 178;> $nmbr$ drinks / wk;"C0332174;C0439230;C0452428";NA;NA;$nmbr$ drinks wk
 178;> $nmbr$ drinks / week;"C0332174;C0439230;C0452428";NA;NA;$nmbr$ drinks week
 178;> $nmbr$ drinks / dav;C0452428;NA;NA;$nmbr$ drinks dav
 178;> $nmbr$ drinks;C0452428;NA;NA;$nmbr$ drinks
 178;> $nmbr$ ( $nmbr$ ) drinks / day if male ( female );"C0043210;C0086287;C0086582;C0332173;C0439228;C0439505;C0452428;C1705497;C1705498;C1706180;C1706428;C1706429";NA;NA;$nmbr$ $nmbr$ drinks day if male female
 178;$nmbr$ drinks / wk;"C0332174;C0439230;C0452428";NA;NA;$nmbr$ drinks wk
 178;$nmbr$ drinks;C0452428;NA;NA;$nmbr$ drinks
 178;$nmbr$ - $nmbr$ drinks / wk;"C0332174;C0439230;C0452428";NA;NA;$nmbr$ $nmbr$ drinks wk
 178;$nmbr$ - $nmbr$ drinks / dav;C0452428;NA;NA;$nmbr$ $nmbr$ drinks dav
 178;$nmbr$ - $nmbr$ drinks;C0452428;NA;NA;$nmbr$ $nmbr$ drinks
 178;$nmbr$ + drinks / wk;"C0332174;C0439230;C0452428";NA;NA;$nmbr$ drinks wk
 177;handihaler and diskus  n;C1553480;NA;NA;handihaler and diskus n
 177;diskus only  n;"C0205171;C1553480;C1720467";NA;NA;diskus only n
 176;non - / ex - drinker;C0457801;NA;NA;non ex drinker
 176;former / non - drinker;"C0205156;C0457801;C0750523";NA;NA;former non drinker
 176;ex - drinker;C0337679;NA;NA;ex drinker
 176;drinker ( % ) a;C0556338;NA;NA;drinker a
 176;drinker ( % );C0556338;NA;NA;drinker
 176;drinker  n ( % );C0556338;NA;NA;drinker n
 176;alcohol drinker  n ( % );"C0001962;C0001975;C0556338";NA;NA;alcohol drinker n
 176;alcohol drinker;"C0001962;C0001975;C0556338";NA;NA;alcohol drinker
 175;three of seven risk factors;"C0035648;C0205449;C0205453;C1553898";NA;NA;three of seven risk factors
 175;temporary risk factor;"C0035648;C0205374;C1548539;C3245481";NA;NA;temporary risk factor
 175;risk factors — no . ( % );"C0035648;C1553898";NA;NA;risk factors no
 175;risk factors specified as inclusion criteria — no . ( % ) f;"C0016327;C0035648;C0205369;C1512693;C1553898";NA;NA;risk factors specified as inclusion criteria no f
 175;risk factors only;"C0035648;C0205171;C1553898;C1720467";NA;NA;risk factors only
 175;risk factors for stroke  no . ( % );"C0035648;C0038454;C1553898;C4554100";NA;NA;risk factors for stroke no
 175;risk factors for stroke;"C0035648;C0038454;C1553898;C4554100";NA;NA;risk factors for stroke
 175;risk factors for recurrent vte — no . ( % ) f;"C0016327;C0035648;C0630906;C1455761;C1553898;C2945760";NA;NA;risk factors for recurrent vte no f
 175;risk factors ( % );"C0035648;C1553898";NA;NA;risk factors
 175;risk factors  no . ( % );"C0035648;C1553898";NA;NA;risk factors no
 175;risk factors  %;"C0035648;C1553898";NA;NA;risk factors
 175;risk factors;"C0035648;C1553898";NA;NA;risk factors
 175;risk factor profile index event;"C0035648;C0441471;C0600653;C0918012;C1552854;C1637833;C1979963;C2003903;C2986546;C4019010";NA;NA;risk factor profile index event
 175;risk factor;C0035648;NA;NA;risk factor
 175;qualifying risk factors — no . ( % );"C0035648;C1514624;C1553898";NA;NA;qualifying risk factors no
 175;qualifying risk factor — no . ( % );"C0035648;C1514624";NA;NA;qualifying risk factor no
 175;qualifying risk factor  n ( % );"C0035648;C1514624";NA;NA;qualifying risk factor n
 175;qualifying risk factor;"C0035648;C1514624";NA;NA;qualifying risk factor
 175;psychosocial risk factors;"C0033963;C0035647;C0035648;C0542298;C1458132;C1553898;C4552904";NA;NA;psychosocial risk factors
 175;other risk factors;"C0035648;C1553898";NA;NA;other risk factors
 175;other major risk factors;"C0035648;C0205082;C0205164;C1553898;C4318856;C4521762";NA;NA;other major risk factors
 175;non - transient risk factors for recurrent vte  n ( % );"C0035648;C0040704;C0205374;C0439597;C0630906;C1553898";NA;NA;non transient risk factors for recurrent vte n
 175;no . of risk factors for venous thromboembolism  no . ( % );"C0035648;C1553898;C1861172";NA;NA;no of risk factors for venous thromboembolism no
 175;no . of risk factors ( % ) | |;"C0035648;C1553898";NA;NA;no of risk factors
 175;multiple risk factors;"C0035648;C0439064;C1553898";NA;NA;multiple risk factors
 175;multiple ( > $nmbr$ ) chd risk factors that confer a $nmbr$ - year risk of chd > $nmbr$ %;"C0035648;C0280604;C0439064;C0439234;C0439508;C1282512;C1553898;C3542407";NA;NA;multiple $nmbr$ chd risk factors that confer a $nmbr$ year risk of chd $nmbr$
 175;male sex — no . ( % ) risk factors;"C0035648;C0086582;C1553898";NA;NA;male sex no risk factors
 175;history of cvd and of cv risk factors - no . ( % );"C0007222;C0019664;C0019665;C0035648;C0262512;C0262926;C1553898;C1705255;C2004062;C3538987;C4048877;C4318503";NA;NA;history of cvd and of cv risk factors no
 179;> $nmbr$ cv risk factors 咐 or established atherosclerotic cv disease;"C0007222;C0035648;C0333482;C0443211;C1272684;C1553898;C3538987;C4048877;C4318503";FALSE;1698;$nmbr$ cv risk factors or established atherosclerotic cv disease
 179;established renal disease ( egfr $nmbr$ - < $nmbr$ ml / min / $nmbr$ . $nmbr$ m ^ with any uacr mg / g or egfr > $nmbr$ - $nmbr$ ml / inin / l $nmbr$ m $nmbr$ with an uacr > $nmbr$ mg / g ) without previous maerovaseular and albuminuria disease;"C0001925;C0012634;C0022658;C0205156;C0369637;C0439445;C0439526;C0441923;C0443211;C0456616;C1272684;C1300563;C1552607;C1705224;C1739039;C3811844;C3812682;C3887665";FALSE; 967;established renal disease egfr $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m with any uacr mg g or egfr $nmbr$ $nmbr$ ml inin l $nmbr$ m $nmbr$ with an uacr $nmbr$ mg g without previous maerovaseular and albuminuria disease
 175;diagnoses / risk factors  n ( % ];"C0011900;C0035648;C1553898";NA;NA;diagnoses risk factors n
 175;diagnoses / risk factors  n ( % );"C0011900;C0035648;C1553898";NA;NA;diagnoses risk factors n
 175;cv risk factors  % of patients;"C0030705;C0035648;C1553898;C3538987;C4048877;C4318503";NA;NA;cv risk factors of patients
 175;chd risk factors #;"C0035648;C0280604;C1553898;C3542407";NA;NA;chd risk factors
 175;baseline risk factors;"C0035648;C0168634;C1442488;C1553898";NA;NA;baseline risk factors
 175;any risk factor for stent thrombosis;"C0035648;C3897493";NA;NA;any risk factor for stent thrombosis
 175;> $nmbr$ chd risk factors;"C0035648;C0280604;C1553898;C3542407";NA;NA;$nmbr$ chd risk factors
 174;pci delay due to low risk;"C0205421;C0678226;C3272281;C3538919;C4049621";NA;NA;pci delay due to low risk
 174;lower risk ( n = $nmbr$ );"C3272281;C3538919";NA;NA;lower risk n $nmbr$
 174;lower risk;"C3272281;C3538919";NA;NA;lower risk
 174;low risk and fewer symptoms ( group a );"C0205388;C0441835;C0683368;C1457887;C3272281;C3538919;C4522145";NA;NA;low risk and fewer symptoms group a
 174;low risk ( ri = $nmbr$ - $nmbr$ );"C0035487;C1826843;C3272281;C3538919";NA;NA;low risk ri $nmbr$ $nmbr$
 174;low risk ( n $nmbr$ $nmbr$ );"C3272281;C3538919";NA;NA;low risk n $nmbr$ $nmbr$
 174;low risk ( ? ics );"C0815320;C3272281;C3538919;C4551720";NA;NA;low risk ics
 174;low risk ( - ics );"C0815320;C3272281;C3538919;C4551720";NA;NA;low risk ics
 174;low risk ( $nmbr$ - $nmbr$ );"C3272281;C3538919";NA;NA;low risk $nmbr$ $nmbr$
 174;low risk;"C3272281;C3538919";NA;NA;low risk
 174;group b ( low risk  more symptoms )  n ( % );"C0441848;C0683368;C1457887;C3272281;C3538919";NA;NA;group b low risk more symptoms n
 174;$nmbr$ - $nmbr$ ( low risk );"C3272281;C3538919";NA;NA;$nmbr$ $nmbr$ low risk
 173;shock risk indext;"C0035647;C0036974;C4552904";NA;NA;shock risk indext
 173;risk stratum;"C0035647;C4552904";NA;NA;risk stratum
 173;risk score category ( points );"C0035647;C0449820;C0683312;C1552961;C2347617;C3714763;C3889287;C4050231;C4552904";NA;NA;risk score category points
 173;risk category ( points );"C0035647;C0683312;C1552961;C2347617;C3714763;C3889287;C4552904";NA;NA;risk category points
 173;risk categories;"C0035647;C0683312;C4552904";NA;NA;risk categories
 173;risk at;"C0035647;C4552904";NA;NA;risk at
 173;risk *;"C0035647;C4552904";NA;NA;risk
 173;risk;"C0035647;C4552904";NA;NA;risk
 173;no increased risk for falls;"C0000921;C0035647;C0085639;C1849142;C4552904;C4699158";NA;NA;no increased risk for falls
 173;ncep risk category at study entry  n ( % );"C0035647;C1705654;C2983287;C2983669;C4552904";NA;NA;ncep risk category at study entry n
 173;moderate risk ( > $nmbr$ - $nmbr$ );"C0035647;C0205081;C1881878;C4049705;C4049706;C4085643;C4321335;C4552904";NA;NA;moderate risk $nmbr$ $nmbr$
 173;increased risk for falls;"C0000921;C0035647;C0085639;C1849142;C4552904;C4699158";NA;NA;increased risk for falls
 173;cardio - renal risk;"C0018787;C0022646;C0035647;C4552904";NA;NA;cardio renal risk
 173;cardiac risk;"C0018787;C0035647;C1522601;C4552904";NA;NA;cardiac risk
 173;> $nmbr$ ( moderate or high bleeding risk )  no . / total ( % );"C0019080;C0035647;C0205081;C0205250;C0439175;C0439810;C1299351;C1881878;C2700149;C3887512;C3889660;C4049705;C4049706;C4085643;C4321237;C4321335;C4522209;C4552904";NA;NA;$nmbr$ moderate or high bleeding risk no total
 172;unadjusted $nmbr$ - y risk per $nmbr$ population = se ( adjusted rate );"C0036919;C0242444;C0456081;C0871208;C1439367;C1521828;C2987720";NA;NA;unadjusted $nmbr$ y risk per $nmbr$ population se adjusted rate
 172;risk group;C0242444;NA;NA;risk group
 172;intermediate risk ( ri = $nmbr$ );"C0035487;C1826843;C3640764";NA;NA;intermediate risk ri $nmbr$
 172;intermediate risk;C3640764;NA;NA;intermediate risk
 171;risk reduction ( %  $nmbr$ % ci );"C0008107;C1137094;C3259781";NA;NA;risk reduction $nmbr$ ci
 171;risk reduction  %;C1137094;NA;NA;risk reduction
 171;reduction in risk ( $nmbr$ % ci ) %;"C0008107;C0035647;C0520870;C1137094;C3259781;C4552904";NA;NA;reduction in risk $nmbr$ ci
 171;reduction in risk % ( $nmbr$ % ci );"C0008107;C0035647;C0520870;C1137094;C3259781;C4552904";NA;NA;reduction in risk $nmbr$ ci
 171;absolute risk reductions;C3179139;NA;NA;absolute risk reductions
 171;absolute risk reduction ( $nmbr$ % cl ) *;"C0596019;C3179139";NA;NA;absolute risk reduction $nmbr$ cl
 171;absolute risk reduction ( $nmbr$ % ci )  % / y;"C0008107;C3179139;C3259781";NA;NA;absolute risk reduction $nmbr$ ci y
 171;* risk reduction  $nmbr$ percent confidence interval ( ci )  and p value are derived from cox models . for risk reductions  negative numbers indicate an increase in risk . † diabetes and hypertension were defined by clinical history . ‡ a family history was defined as having one or more first - degree relatives with either myocardial infarction or sudden death before the age of $nmbr$ . § hdl cholesterol levels are shown according to the median value ( $nmbr$ . $nmbr$ mg per deciliter [ $nmbr$ . $nmbr$ mmol per liter ] ) . ¶ triglyceride levels are shown according to the median value ( $nmbr$ mg per deciliter [ $nmbr$ . $nmbr$ mmol per liter ] ) . ¿ ldl cholesterol levels are shown according to the median value ( $nmbr$ mg per deciliter [ $nmbr$ . $nmbr$ mmol per liter ] ) and according to the values that divide the subjects into three equal groups ( < $nmbr$  $nmbr$ to $nmbr$  and > $nmbr$ mg per deciliter [ < $nmbr$ . $nmbr$  $nmbr$ . $nmbr$ to $nmbr$ . $nmbr$  and > $nmbr$ . $nmbr$ mmol per liter ] ) .;"C0008107;C0009667;C0010234;C0019664;C0019665;C0020538;C0023824;C0024671;C0026410;C0027051;C0042295;C0202069;C0202117;C0205163;C0205172;C0205210;C0205447;C0205449;C0241889;C0262512;C0262926;C0332849;C0392885;C0428475;C0428953;C0439165;C0439190;C0439241;C0439269;C0441833;C0441889;C0442805;C0475211;C0549183;C0567349;C0680240;C0681850;C0687744;C0876920;C1137094;C1171304;C1257890;C1276802;C1441547;C1518469;C1519504;C1522609;C1546180;C1547282;C1549782;C1550501;C1552839;C1704788;C1705255;C1705428;C1705429;C1706203;C1709380;C1960952;C1963138;C2004062;C2346927;C2347285;C2347635;C2348144;C2348885;C2349001;C2697811;C2825415;C2926063;C2939193;C3245521;C3259781;C3539106;C3810814;C4321396;C4521761;C4552959";NA;NA;risk reduction $nmbr$ percent confidence interval ci and p value are derived from cox models for risk reductions negative numbers indicate an increase in risk diabetes and hypertension were defined by clinical history a family history was defined as having one or more first degree relatives with either myocardial infarction or sudden death before the age of $nmbr$ hdl cholesterol levels are shown according to the median value $nmbr$ $nmbr$ mg per deciliter $nmbr$ $nmbr$ mmol per liter triglyceride levels are shown according to the median value $nmbr$ mg per deciliter $nmbr$ $nmbr$ mmol per liter ldl cholesterol levels are shown according to the median value $nmbr$ mg per deciliter $nmbr$ $nmbr$ mmol per liter and according to the values that divide the subjects into three equal groups $nmbr$ $nmbr$ to $nmbr$ and $nmbr$ mg per deciliter $nmbr$ $nmbr$ $nmbr$ $nmbr$ to $nmbr$ $nmbr$ and $nmbr$ $nmbr$ mmol per liter
 171;% risk reduction ( $nmbr$ % ci );"C0008107;C1137094;C3259781";NA;NA;risk reduction $nmbr$ ci
 170;sk . $nmbr$;NA;NA;NA;sk $nmbr$
 170;rash;C0015230;NA;NA;rash
 170;heart disease risk factors;C0741920;NA;NA;heart disease risk factors
 170;coronary heart disease risk equivalents  n ( % ) c;"C0439185;C1277690;C4049980";NA;NA;coronary heart disease risk equivalents n c
 173;vascular risk score |;"C0005847;C0035647;C0449820;C1558950;C1801960;C4050231;C4552904";FALSE;1953;vascular risk score
 173;vascular risk score *;"C0005847;C0035647;C0449820;C1558950;C1801960;C4050231;C4552904";FALSE;1953;vascular risk score
 173;vascular risk score — no . { % ) ^;"C0005847;C0035647;C0449820;C1558950;C1801960;C4050231;C4552904";FALSE;1953;vascular risk score no
 173;timi risk score category — no . ( % );"C0035647;C0449820;C0683312;C3889287;C4050231;C4552904";FALSE;1954;timi risk score category no
 173;timi risk score > $nmbr$  n ( % );"C0035647;C0449820;C4050231;C4552904";FALSE;1954;timi risk score $nmbr$ n
 173;timi risk score $nmbr$ - $nmbr$;"C0035647;C0449820;C4050231;C4552904";FALSE;1954;timi risk score $nmbr$ $nmbr$
 173;timi risk score  n / n ( % );"C0035647;C0449820;C4050231;C4552904";FALSE;1954;timi risk score n n
 170;$nmbr$ - yr risk of coronary heart disease ( % ) ^ |;"C0439234;C1277690";NA;NA;$nmbr$ yr risk of coronary heart disease
 169;nih stroke scale;"C1697238;C3484372";NA;NA;nih stroke scale
 169;$nmbr$ nil;C0442734;NA;NA;$nmbr$ nil
 168;india;"C0021201;C2700456";NA;NA;india
 168;* other - europe ( n = $nmbr$ )  australia ( n = $nmbr$ ) and india ( n = $nmbr$ ) - the data from these regions were collapsed due to the small numbers;"C0004340;C0015176;C0017446;C0021201;C0205147;C0237753;C0344329;C0392748;C0449788;C0678226;C0700321;C1511726;C2700456;C3245479;C3714741";NA;NA;other europe n $nmbr$ australia n $nmbr$ and india n $nmbr$ the data from these regions were collapsed due to the small numbers
 167;laba ( inhaled )  d   n ( % );"C0004048;C0073187;C0332173;C4484261";NA;NA;laba inhaled d n
 167;inhaledb;NA;NA;NA;inhaledb
 167;inhaled §;C0004048;NA;NA;inhaled
 167;inhaled j $nmbr$ - agonist §;"C0004048;C2987634";NA;NA;inhaled j $nmbr$ agonist
 167;inhaled anticholinergic §;"C0004048;C0242896;C3537004";NA;NA;inhaled anticholinergic
 167;inhaled ^;C0004048;NA;NA;inhaled
 167;a ) those receiving no inhaled pre - treatment maintenance medication;"C0004048;C0013227;C0021459;C0024501;C0039798;C0087111;C0332152;C0740175;C1514756;C1522326;C1533734;C1705169;C2257086;C2347660;C3244316;C3469597;C3538994;C3669034;C3887704;C4284232";NA;NA;a those receiving no inhaled pre treatment maintenance medication
 -10;unhappy;C1688635;NA;NA;unhappy
 -10;nap;"C0870935;C1423800;C4283878";NA;NA;nap
 164;enalapril lcz $nmbr$ ( n = $nmbr$ ) ( n = $nmbr$ );C0014025;NA;NA;enalapril lcz $nmbr$ n $nmbr$ n $nmbr$
 164;enalapril dm = $nmbr$ non - dm = $nmbr$;"C0011816;C0014025;C1518422;C3250443";NA;NA;enalapril dm $nmbr$ non dm $nmbr$
 164;enalapril + aliskiren ( n = $nmbr$ );"C0014025;C1120110";NA;NA;enalapril aliskiren n $nmbr$
 164;enalapril ( n = $nmbr$ );C0014025;NA;NA;enalapril n $nmbr$
 164;enalapril;C0014025;NA;NA;enalapril
 163;insulin detemir;C0537270;NA;NA;insulin detemir
 163;insulin aspart ( mealtime );"C0123677;C0587119;C1708521";NA;NA;insulin aspart mealtime
 163;insulin aspart;"C0123677;C1708521";NA;NA;insulin aspart
 163;detemir / insulin glargine  %;"C0537270;C0907402";NA;NA;detemir insulin glargine
 162;type of insulin therapy — no . ( % ) $nmbr$;"C0039798;C0087111;C0457592;C1363945";NA;NA;type of insulin therapy no $nmbr$
 162;type of insulin;C0457592;NA;NA;type of insulin
 162;type of basal insulin  n ( % );"C0205112;C0332307;C0457592;C0650607;C1547052";NA;NA;type of basal insulin n
 162;method of insulin administration;"C0025663;C0199782;C0449851;C0871511";NA;NA;method of insulin administration
 162;insulin type  n ( % );C0457592;NA;NA;insulin type n
 162;insulin administration;C0199782;NA;NA;insulin administration
 161;insulins and analogs;"C0021641;C0243071;C3537244;C4049919";NA;NA;insulins and analogs
 161;insulins;"C0021641;C3537244;C4049919";NA;NA;insulins
 161;insulin sensitivity — % §;"C0920563;C4049919";NA;NA;insulin sensitivity
 161;composite index of insulin sensitivity ( isi );"C0205199;C0600653;C0918012;C0920563;C1547335;C1552854;C1637833;C2986546;C4049919";NA;NA;composite index of insulin sensitivity isi
 160;insulin - dependent diabetes mellitus;C0011854;NA;NA;insulin dependent diabetes mellitus
 160;insulin - dependent diabetes;C0011854;NA;NA;insulin dependent diabetes
 159;oral antidiabetes combination therapy without insulina  n ( % );"C0009429;C0442027;C0556895;C4521986";NA;NA;oral antidiabetes combination therapy without insulina n
 159;insulina  n ( % );NA;NA;NA;insulina n
 159;insulina;NA;NA;NA;insulina
 158;octave induction $nmbr$ and $nmbr$;"C0205263;C0857127";NA;NA;octave induction $nmbr$ and $nmbr$
 158;octave induction $nmbr$;"C0205263;C0857127";NA;NA;octave induction $nmbr$
 158;noninducing;NA;NA;NA;noninducing
 158;non - enzyme inducing;"C0014442;C0205263;C1518422;C4521602";NA;NA;non enzyme inducing
 158;induction - trial group assignment — no . ( % );"C0205263;C0857127;C1320290;C1516050";NA;NA;induction trial group assignment no
 158;inducing;C0205263;NA;NA;inducing
 158;enzyme inducing;"C0014442;C0205263;C4521602";NA;NA;enzyme inducing
 157;yes  non - insulin - treated;"C0021641;C1518422;C1522326;C1533581;C1549445;C1579433;C1705108;C1710701;C3714501";NA;NA;yes non insulin treated
 157;yes  insulin - treated;"C0021641;C1522326;C1533581;C1549445;C1579433;C1705108;C1710701;C3714501";NA;NA;yes insulin treated
 157;without insulin or insulin - modifying therapy;"C0021641;C0039798;C0087111;C0392747;C1363945;C1533581;C1579433;C3714501";NA;NA;without insulin or insulin modifying therapy
 157;treated with insulin;"C0021641;C0332293;C1533581;C1579433;C3714501";NA;NA;treated with insulin
 157;total daily insulin dose ( u / day );"C0021641;C0456683;C1533581;C1579433;C2348070;C3714501";NA;NA;total daily insulin dose u day
 157;total daily insulin dose  units / kgt;"C0021641;C0439148;C1519795;C1533581;C1579433;C2348070;C3714501;C3853603";NA;NA;total daily insulin dose units kgt
 157;total daily insulin dose  u;"C0021641;C0439148;C1533581;C1579433;C2348070;C3714501";NA;NA;total daily insulin dose u
 157;total baseline insulin dose;"C0021641;C0168634;C0366513;C0439175;C0439810;C1442488;C1533581;C1579433;C2986497;C3714501";NA;NA;total baseline insulin dose
 157;sustain $nmbr$ : semaglutide add ‐ on to insulin vs . placebo;"C0021641;C0032042;C0443318;C1533581;C1579433;C1696465;C1706408;C1883712;C2732140;C3714501;C3885068";NA;NA;sustain $nmbr$ semaglutide add on to insulin vs placebo
 157;premixed insulin with oads ( % );"C0021641;C1533581;C1579433;C3714501";NA;NA;premixed insulin with oads
 157;premixed insulin only ( % );"C0021641;C0205171;C1533581;C1579433;C1720467;C3714501";NA;NA;premixed insulin only
 157;pre - mixed insulin;"C0021641;C0205430;C0332152;C0740175;C1533581;C1579433;C2257086;C3160715;C3669034;C3714501";NA;NA;pre mixed insulin
 157;placebo + insulin ( n   = $nmbr$ );"C0021641;C0032042;C1533581;C1579433;C1696465;C1706408;C3714501";NA;NA;placebo insulin n $nmbr$
 157;placebo + insulin ( n = $nmbr$ );"C0021641;C0032042;C1533581;C1579433;C1696465;C1706408;C3714501";NA;NA;placebo insulin n $nmbr$
 157;patients treated with insulin;"C0021641;C0030705;C0332293;C1533581;C1579433;C3714501";NA;NA;patients treated with insulin
 157;participants taking insulin;"C0021641;C0679646;C1515187;C1533581;C1579433;C3714501";NA;NA;participants taking insulin
 157;oad plus insulin;"C0021641;C1533581;C1579433;C3714501";NA;NA;oad plus insulin
 157;median fasting insulin ( iqr ) — pu per milliliter;"C0015663;C0018387;C0021641;C0439242;C0549183;C0876920;C1533581;C1579433;C2347635;C2348144;C2939193;C3714501";NA;NA;median fasting insulin iqr pu per milliliter
 157;mean ± sd fasting insulin  uu / ml;"C0015663;C0021641;C0439342;C0444504;C1533581;C1579433;C2347634;C2348143;C2699239;C3714501";NA;NA;mean sd fasting insulin uu ml
 157;insulin 一 no . ( % );"C0021641;C1533581;C1579433;C3714501";NA;NA;insulin no
 157;insulin — iu;"C0021641;C0049272;C0439453;C0694756;C1533581;C1579433;C3714501";NA;NA;insulin iu
 157;insulin — / tu / ml;"C0021641;C0041400;C0439526;C1532464;C1533581;C1579433;C1705224;C2700314;C3714501;C3811255;C3887665";NA;NA;insulin tu ml
 157;insulin yes;"C0021641;C1533581;C1549445;C1579433;C1705108;C1710701;C3714501";NA;NA;insulin yes
 157;insulin treated;"C0021641;C1522326;C1533581;C1579433;C3714501";NA;NA;insulin treated
 157;insulin secretagogue;"C0021641;C1533581;C1579433;C3714501;C4704833";NA;NA;insulin secretagogue
 157;insulin plus oral;"C0021641;C0442027;C1533581;C1579433;C3714501;C4521986";NA;NA;insulin plus oral
 157;insulin plus > $nmbr$ oral agent;"C0021641;C0442027;C0450442;C1254351;C1521826;C1533581;C1579433;C3714501;C4521986";NA;NA;insulin plus $nmbr$ oral agent
 157;insulin plus $nmbr$ oral agent;"C0021641;C0442027;C0450442;C1254351;C1521826;C1533581;C1579433;C3714501;C4521986";NA;NA;insulin plus $nmbr$ oral agent
 157;insulin only;"C0021641;C0205171;C1533581;C1579433;C1720467;C3714501";NA;NA;insulin only
 151;nyhaii;NA;NA;NA;nyhaii
 157;insulin glargin arm;"C0021641;C0446516;C1533581;C1579433;C3714501;C3715044;C4553528";NA;NA;insulin glargin arm
 157;insulin dependentc;"C0021641;C1533581;C1579433;C3714501";NA;NA;insulin dependentc
 157;insulin based;"C0021641;C1527178;C1533581;C1579433;C1705938;C3714501";NA;NA;insulin based
 157;insulin at baseline;"C0021641;C0168634;C1442488;C1533581;C1579433;C3714501";NA;NA;insulin at baseline
 157;insulin alone;"C0021641;C0205171;C0439044;C0679994;C1533581;C1579433;C3714501";NA;NA;insulin alone
 157;insulin : glucose ratio;"C0017725;C0021641;C0456603;C1533581;C1547037;C1579433;C3714501";NA;NA;insulin glucose ratio
 157;insulin - treated dm;"C0011816;C0021641;C1522326;C1533581;C1579433;C3250443;C3714501";NA;NA;insulin treated dm
 157;insulin - treated diabetes  %;"C0011847;C0011849;C0021641;C1522326;C1533581;C1579433;C3714501";NA;NA;insulin treated diabetes
 157;insulin - treated diabetes;"C0011847;C0011849;C0021641;C1522326;C1533581;C1579433;C3714501";NA;NA;insulin treated diabetes
 157;insulin - treated;"C0021641;C1522326;C1533581;C1579433;C3714501";NA;NA;insulin treated
 157;insulin - requiring diabetes;"C0011847;C0011849;C0021641;C1533581;C1579433;C3714501";NA;NA;insulin requiring diabetes
 157;insulin - requiring;"C0021641;C1533581;C1579433;C3714501";NA;NA;insulin requiring
 157;insulin - naive  n ( % );"C0021641;C1533581;C1579433;C3714501";NA;NA;insulin naive n
 157;insulin - dependent;"C0021641;C0429964;C0429986;C0851827;C1533581;C1579433;C1701901;C3244310;C3714501;C4321395";NA;NA;insulin dependent
 157;insulin + oad;"C0021641;C1533581;C1579433;C3714501";NA;NA;insulin oad
 157;insulin + metformin;"C0021641;C0025598;C1533581;C1579433;C3714501";NA;NA;insulin metformin
 157;insulin ( pmol / l ) t vital signs;"C0021641;C0150404;C0439284;C0518766;C1533581;C1579433;C3714501";NA;NA;insulin pmol l t vital signs
 157;insulin ( pmol / l );"C0021641;C0439284;C1533581;C1579433;C3714501";NA;NA;insulin pmol l
 157;insulin ( mu / ml );"C0021641;C0439339;C1533581;C1579433;C3714501";NA;NA;insulin mu ml
 157;insulin ( % );"C0021641;C1533581;C1579433;C3714501";NA;NA;insulin
 157;insulin  pmol / l;"C0021641;C0439284;C1533581;C1579433;C3714501";NA;NA;insulin pmol l
 157;insulin  n ( % );"C0021641;C1533581;C1579433;C3714501";NA;NA;insulin n
 157;insulin  iu / ml  median ( q $nmbr$  q $nmbr$ );"C0021641;C0439458;C0549183;C0876920;C1533581;C1579433;C2347635;C2348144;C2939193;C3714501";NA;NA;insulin iu ml median q $nmbr$ q $nmbr$
 157;insulin;"C0021641;C1533581;C1579433;C3714501";NA;NA;insulin
 157;initiation of insulin;"C0021641;C0589507;C1158830;C1533581;C1579433;C1704686;C3714501";NA;NA;initiation of insulin
 157;fasting insulin — pmol / liter;"C0015663;C0021641;C0439192;C0475211;C1533581;C1579433;C3714501";NA;NA;fasting insulin pmol liter
 157;fasting insulin — / tiu / ml §;"C0015663;C0021641;C0439526;C1533581;C1579433;C1705224;C3714501;C3887665";NA;NA;fasting insulin tiu ml
 157;fasting insulin ( pmol / l );"C0015663;C0021641;C0439284;C1533581;C1579433;C3714501";NA;NA;fasting insulin pmol l
 157;fasting insulin ( miu / ml );"C0015663;C0021641;C0439457;C1533581;C1579433;C3714501";NA;NA;fasting insulin miu ml
 157;fasting insulin ( giu / ml );"C0015663;C0021641;C0439526;C1533581;C1579433;C1705224;C3714501;C3887665";NA;NA;fasting insulin giu ml
 157;fasting insulin  pmol / l ( mean ± sd );"C0015663;C0021641;C0439284;C0444504;C1533581;C1579433;C2347634;C2348143;C2699239;C3714501";NA;NA;fasting insulin pmol l mean sd
 157;fasting insulin  iiiu / ml  mean ± sd;"C0015663;C0021641;C0439526;C0444504;C1533581;C1579433;C1705224;C2347634;C2348143;C2699239;C3714501;C3887665";NA;NA;fasting insulin iiiu ml mean sd
 157;fasting insulin  * median ( iqr )  gu / ml;"C0015663;C0021641;C0120446;C0439526;C0549183;C0876920;C1533581;C1579433;C1705224;C2347635;C2348144;C2939193;C3714501;C3887515;C3887665";NA;NA;fasting insulin median iqr gu ml
 157;fasting insulin;"C0015663;C0021641;C1533581;C1579433;C3714501";NA;NA;fasting insulin
 157;daily insulin dose  mean ( sd )  iu;"C0021641;C0049272;C0332173;C0366513;C0439453;C0444504;C0694756;C1533581;C1579433;C2347634;C2348070;C2348143;C2699239;C3714501";NA;NA;daily insulin dose mean sd iu
 157;bolus insulin doseh;"C0021641;C1186706;C1511237;C1533581;C1579433;C1705509;C3714501;C3812160";NA;NA;bolus insulin doseh
 157;baseline insulin;"C0021641;C0168634;C1442488;C1533581;C1579433;C3714501";NA;NA;baseline insulin
 157;$nmbr$ - h postprandial insulin ( miu / ml );"C0021641;C0033727;C0369286;C0376674;C0439457;C0441932;C0564385;C1533581;C1579433;C3714501;C4528284";NA;NA;$nmbr$ h postprandial insulin miu ml
 156;values are expressed as percentages unless otherwise indicated . bmi  body mass index  cabg  coronary artery bypass ischemic attack  nsaids  nonsteroidal anti - inflammatory drugs  sbp  systolic bp  dbp  diastolic bp . * history of or currently taking antidiabetic or lipid - lowering medications .;"C0003209;C0003211;C0010055;C0012000;C0013227;C0019664;C0019665;C0023779;C0042295;C0085805;C0242821;C0262512;C0262926;C0439165;C0441994;C0460148;C0521116;C0536221;C0577559;C0577573;C0578022;C0600653;C0745413;C0802604;C0871470;C0918012;C0935929;C1096155;C1268086;C1306372;C1444656;C1515187;C1549488;C1552854;C1561533;C1637833;C1705255;C2003888;C2004062;C2598133;C2986546;C3152252;C3539882;C3813197;C4082212;C4281799;C4283905;C4284232";NA;NA;values are expressed as percentages unless otherwise indicated bmi body mass index cabg coronary artery bypass ischemic attack nsaids nonsteroidal anti inflammatory drugs sbp systolic bp dbp diastolic bp history of or currently taking antidiabetic or lipid lowering medications
 156;previous anti - inflammatory / antirheumatic products n ( % );"C0003191;C0205156;C0333348;C0432633;C1514468;C1552607";NA;NA;previous anti inflammatory antirheumatic products n
 156;inflammatory;C0333348;NA;NA;inflammatory
 156;anti - inflammatory drugs;C0003209;NA;NA;anti inflammatory drugs
 155;inflammation;C0021368;NA;NA;inflammation
 155;baseline inflammation markers;"C0005516;C0021368;C0168634;C1442488";NA;NA;baseline inflammation markers
 154;previous treatment with infliximab;"C0039798;C0087111;C0205156;C0666743;C1522326;C1533734;C1552607;C1705169;C3538994;C3887704";NA;NA;previous treatment with infliximab
 154;no previous treatment with infliximab;"C0039798;C0087111;C0205156;C0666743;C1522326;C1533734;C1552607;C1705169;C3538994;C3887704";NA;NA;no previous treatment with infliximab
 154;infliximab monotherapy;C0666743;NA;NA;infliximab monotherapy
 154;infliximab - naive ( n = $nmbr$ );C0666743;NA;NA;infliximab naive n $nmbr$
 154;infliximab - experienced ( n = $nmbr$ );C0666743;NA;NA;infliximab experienced n $nmbr$
 154;infliximab ( n = $nmbr$ );C0666743;NA;NA;infliximab n $nmbr$
 154;infliximab;C0666743;NA;NA;infliximab
 154;inflix  yes;"C0666743;C1549445;C1705108;C1710701";NA;NA;inflix yes
 154;inflix  no;C0666743;NA;NA;inflix no
 154;combined infliximab;"C0205195;C0666743";NA;NA;combined infliximab
 153;npi;"C1412208;C1549728;C3539727";NA;NA;npi
 153;ni;"C0028075;C2348274;C3869926;C3869927";NA;NA;ni
 153;> $nmbr$ ml / niin / l $nmbr$ ni -;"C0028075;C1635169;C2348274;C3869926;C3869927";NA;NA;$nmbr$ ml niin l $nmbr$ ni
 153;< $nmbr$ ml / min / $nmbr$ . $nmbr$ ni -;"C0028075;C0439445;C2348274;C3869926;C3869927";NA;NA;$nmbr$ ml min $nmbr$ $nmbr$ ni
 152;no anemia bsl hb > $nmbr$ g i - $nmbr$  yr $nmbr$ > $nmbr$ g i - $nmbr$;"C0002871;C0019046;C0021966;C0221138;C0439234;C1000483;C1319635;C1549954;C4554633";NA;NA;no anemia bsl hb $nmbr$ g i $nmbr$ yr $nmbr$ $nmbr$ g i $nmbr$
 152;new anemia bsl hb > $nmbr$ g i - $nmbr$  yr $nmbr$ < $nmbr$ g i - $nmbr$;"C0002871;C0019046;C0021966;C0205314;C0221138;C0439234;C1000483;C1319635;C1549954;C4554633";NA;NA;new anemia bsl hb $nmbr$ g i $nmbr$ yr $nmbr$ $nmbr$ g i $nmbr$
 152;improving anemia bsl hb < $nmbr$ g i - $nmbr$  yr $nmbr$ > $nmbr$ g i - $nmbr$;"C0002871;C0019046;C0021966;C0221138;C0439234;C1000483;C1272745;C1319635;C1549954;C4554633";NA;NA;improving anemia bsl hb $nmbr$ g i $nmbr$ yr $nmbr$ $nmbr$ g i $nmbr$
 152;anemia — no . ( % ) | |;"C0002871;C1000483;C4554633";NA;NA;anemia no
 152;anemia ( % );"C0002871;C1000483;C4554633";NA;NA;anemia
 152;anemia  no . / total ( % ) ”;"C0002871;C0439175;C0439810;C1000483;C4554633";NA;NA;anemia no total
 152;anemia  %;"C0002871;C1000483;C4554633";NA;NA;anemia
 151;nyha iv  n ( % );"C0022326;C1275491;C4265176";NA;NA;nyha iv n
 151;nyha iv  %;"C0022326;C1275491;C4265176";NA;NA;nyha iv
 151;nyha iii or iv § ( n = $nmbr$ $nmbr$ );"C0022326;C0439070;C1275491;C1705160;C4265176";NA;NA;nyha iii or iv n $nmbr$ $nmbr$
 151;nyha iii or iv;"C0022326;C0439070;C1275491;C1705160;C4265176";NA;NA;nyha iii or iv
 151;nyha iii  n ( % );"C0439070;C1275491;C1705160";NA;NA;nyha iii n
 151;nyha ii  n ( % );"C1275491;C1710602;C4082587";NA;NA;nyha ii n
 151;nyha ii;"C1275491;C1710602;C4082587";NA;NA;nyha ii
 151;nyha;C1275491;NA;NA;nyha
 151;nph;"C0020258;C0027442";NA;NA;nph
 151;heart failure nyha ii - iii;"C0018801;C0018802;C0439070;C1275491;C1705160;C1710602;C4082587;C4554158";NA;NA;heart failure nyha ii iii
 151;heart failure ( nyha ii ‐ iii )  n ( % );"C0018801;C0018802;C0439070;C1275491;C1705160;C1710602;C4082587;C4554158";NA;NA;heart failure nyha ii iii n
 151;dyspnea at rest ( nyha iv )  ( % );"C0022326;C0743330;C1275491;C4265176";NA;NA;dyspnea at rest nyha iv
 151;( nyha grade iii or iv );"C0022326;C0205617;C0450094;C0475271;C0687697;C1275491;C3889290;C4050000;C4265176;C4283820;C4283821;C4283822";NA;NA;nyha grade iii or iv
 -10;has - bledo;C1019275;NA;NA;has bledo
 149;less than $nmbr$ y ears;"C0013443;C0439092;C0521421";NA;NA;less than $nmbr$ y ears
 149;< $nmbr$ y ears;"C0013443;C0521421";NA;NA;$nmbr$ y ears
 148;≥ $nmbr$ yearsa;NA;NA;NA;$nmbr$ yearsa
 148;£ $nmbr$ . $nmbr$ yrs;NA;NA;NA;$nmbr$ $nmbr$ yrs
 148;younger subjects ( aged < $nmbr$ years );"C0001779;C0001792;C0332239;C0439234;C0681850;C1550501;C1706203;C1999167;C2349001;C2697811";NA;NA;younger subjects aged $nmbr$ years
 148;younger patients ( aged $nmbr$ years );"C0001779;C0001792;C0030705;C0332239;C0439234;C1999167";NA;NA;younger patients aged $nmbr$ years
 148;older subjects ( aged > $nmbr$ years ';"C0001779;C0001792;C0439234;C0580836;C0681850;C1550501;C1706203;C1999167;C2349001;C2697811";NA;NA;older subjects aged $nmbr$ years
 148;older patients ( aged > $nmbr$ years );"C0001779;C0001792;C0030705;C0439234;C0580836;C1999167";NA;NA;older patients aged $nmbr$ years
 148;aged ≥ $nmbr$ years;"C0001779;C0001792;C0439234;C1999167";NA;NA;aged $nmbr$ years
 148;aged a $nmbr$ years;"C0001779;C0001792;C0439234;C1999167";NA;NA;aged a $nmbr$ years
 148;aged ^ $nmbr$ years;"C0001779;C0001792;C0439234;C1999167";NA;NA;aged $nmbr$ years
 148;aged < $nmbr$ years;"C0001779;C0001792;C0439234;C1999167";NA;NA;aged $nmbr$ years
 148;age ≥ $nmbr$ yearsa;C0001779;NA;NA;age $nmbr$ yearsa
 148;age ± sd ( yrs );"C0001779;C2699239";NA;NA;age sd yrs
 148;age ^ $nmbr$ yrs  n ( % );C0001779;NA;NA;age $nmbr$ yrs n
 148;age > $nmbr$ yrs  n ( % );C0001779;NA;NA;age $nmbr$ yrs n
 148;age ( yrs ) < $nmbr$;C0001779;NA;NA;age yrs $nmbr$
 148;age ( yrs ) $nmbr$ - $nmbr$;C0001779;NA;NA;age yrs $nmbr$ $nmbr$
 148;age $nmbr$ + yrs;C0001779;NA;NA;age $nmbr$ yrs
 148;age  yrs  median ( iqr );"C0001779;C0549183;C0876920;C2347635;C2348144;C2939193";NA;NA;age yrs median iqr
 148;age  yrs  median ( $nmbr$ th  $nmbr$ th );"C0001779;C0039725;C0039738;C0549183;C0876920;C1420718;C2347635;C2348144;C2939193;C4282123;C4285344";NA;NA;age yrs median $nmbr$ th $nmbr$ th
 148;< $nmbr$ yrs;NA;NA;NA;$nmbr$ yrs
 148;< $nmbr$ . $nmbr$ yrs;NA;NA;NA;$nmbr$ $nmbr$ yrs
 147;yes vs . no;"C1549445;C1705108;C1710701";NA;NA;yes vs no
 147;yes *;"C1549445;C1705108;C1710701";NA;NA;yes
 147;yes ( stopped for trial );"C0008976;C1272691;C1549445;C1705108;C1710701";NA;NA;yes stopped for trial
 147;yes ( n = $nmbr$ );"C1549445;C1705108;C1710701";NA;NA;yes n $nmbr$
 147;yes ( n  % );"C1549445;C1705108;C1710701";NA;NA;yes n
 147;yes ( any );"C1549445;C1705108;C1710701";NA;NA;yes any
 147;yes ( % );"C1549445;C1705108;C1710701";NA;NA;yes
 147;yes ';"C1549445;C1705108;C1710701";NA;NA;yes
 147;yes  z $nmbr$ cm;"C1549445;C1705108;C1710701";NA;NA;yes z $nmbr$ cm
 147;yes  yes;"C1549445;C1705108;C1710701";NA;NA;yes yes
 147;yes  unknown;"C0439673;C1549445;C1705108;C1710701;C3541433;C4050014";NA;NA;yes unknown
 147;yes  r $nmbr$ y;"C0205090;C0684010;C1549445;C1705108;C1710701;C2603358";NA;NA;yes r $nmbr$ y
 147;yes  proliferative;"C0334094;C1549445;C1705108;C1710701";NA;NA;yes proliferative
 147;yes  o $nmbr$ cm;"C1549445;C1705108;C1710701";NA;NA;yes o $nmbr$ cm
 147;yes  non - proliferative;"C0334094;C1518422;C1549445;C1705108;C1710701";NA;NA;yes non proliferative
 147;yes  n ( % );"C1549445;C1705108;C1710701";NA;NA;yes n
 147;yes  $nmbr$ $nmbr$ y;"C1549445;C1705108;C1710701";NA;NA;yes $nmbr$ $nmbr$ y
 147;yes;"C1549445;C1705108;C1710701";NA;NA;yes
 147;use of cgm ( yes );"C1524063;C1549445;C1705108;C1710701";NA;NA;use of cgm yes
 147;thiazolidinedione yes;"C0289779;C1257987;C1549445;C1705108;C1710701;C3537039";NA;NA;thiazolidinedione yes
 147;prior tnf antagonist treatment - yes;"C0231491;C1448177;C1514463;C1549445;C1705108;C1710701";NA;NA;prior tnf antagonist treatment yes
 147;prior hypertensiona yes;"C0332152;C1549445;C1705108;C1710701;C2826257";NA;NA;prior hypertensiona yes
 147;partner  n ( % yes );"C0682323;C1549445;C1705108;C1710701;C3887537";NA;NA;partner n yes
 147;parental history of ml before age $nmbr$ y yes;"C0001779;C0019664;C0019665;C0030551;C0262512;C0262926;C0439526;C1549445;C1705108;C1705224;C1705255;C1710701;C2004062;C3887665";NA;NA;parental history of ml before age $nmbr$ y yes
 147;no  yes;"C1549445;C1705108;C1710701";NA;NA;no yes
 147;naive : yes;"C1549445;C1705108;C1710701";NA;NA;naive yes
 147;metformin : no / yes  %;"C0025598;C1549445;C1705108;C1710701";NA;NA;metformin no yes
 147;long ( > $nmbr$ mm ) stenting yes ( n = $nmbr$ );"C0038257;C0205166;C1549445;C1705108;C1706317;C1710701;C2348535;C4330985;C4554674";NA;NA;long $nmbr$ mm stenting yes n $nmbr$
 147;ics use yes;"C0042153;C0457083;C0815320;C1549445;C1705108;C1710701;C1947944;C4551720";NA;NA;ics use yes
 147;ics : yes;"C0815320;C1549445;C1705108;C1710701;C4551720";NA;NA;ics yes
 147;etn  yes;"C0014758;C0717758;C1549445;C1705108;C1710701";NA;NA;etn yes
 147;ed history  n ( % yes );"C0019664;C0019665;C0262512;C0262926;C1549445;C1705108;C1705255;C1710701;C2004062;C3538926";NA;NA;ed history n yes
 147;diabetics - yes ( n = $nmbr$  $nmbr$ );"C0241863;C1549445;C1705108;C1710701";NA;NA;diabetics yes n $nmbr$ $nmbr$
 147;diabetic yes;"C0241863;C1549445;C1705108;C1710701";NA;NA;diabetic yes
 147;diabetic ( yes );"C0241863;C1549445;C1705108;C1710701";NA;NA;diabetic yes
 147;diabetesh yes;"C1549445;C1705108;C1710701";NA;NA;diabetesh yes
 147;diabetes | | yes;"C0011847;C0011849;C1549445;C1705108;C1710701";NA;NA;diabetes yes
 147;diabetes mellitus yes ( n  % ) hypertension;"C0011849;C0020538;C1549445;C1705108;C1710701;C1963138";NA;NA;diabetes mellitus yes n hypertension
 147;diabetes mellitus  n ( % ) yes;"C0011849;C1549445;C1705108;C1710701";NA;NA;diabetes mellitus n yes
 147;current smoker yes;"C1549445;C1705108;C1710701;C3173209;C3241966";NA;NA;current smoker yes
 147;corticosteroid use at baseline - yes;"C0168634;C0239126;C1442488;C1549445;C1705108;C1710701";NA;NA;corticosteroid use at baseline yes
 147;copd exacerbation : yes;"C0740304;C1549445;C1705108;C1710701";NA;NA;copd exacerbation yes
 147;concomitant medications ( yes )  n ( % };"C0013227;C0521115;C0802604;C1549445;C1705108;C1710701;C2598133;C4284232";NA;NA;concomitant medications yes n
 147;cardiac rhythm disorder at baseline yes;"C0168634;C0264886;C1442488;C1549445;C1705108;C1710701";NA;NA;cardiac rhythm disorder at baseline yes
 147;baseline sulfonylurea yes;"C0038766;C0168634;C1442488;C1549445;C1705108;C1710701;C3536898";NA;NA;baseline sulfonylurea yes
 147;baseline ocs use : yes;"C0042153;C0168634;C0457083;C1442488;C1549445;C1705108;C1710701;C1947944";NA;NA;baseline ocs use yes
 135;a vs . c;NA;NA;NA;a vs c
 147;baseline ics use : yes;"C0042153;C0168634;C0457083;C0815320;C1442488;C1549445;C1705108;C1710701;C1947944;C4551720";NA;NA;baseline ics use yes
 147;baseline calcium yes;"C0006675;C0006726;C0168634;C1442488;C1549445;C1705108;C1710701;C2936886;C3540037;C3714611";NA;NA;baseline calcium yes
 147;amiodarone use at baseline yes $nmbr$  $nmbr$;"C0002598;C0042153;C0168634;C0457083;C1442488;C1549445;C1705108;C1710701;C1947944";NA;NA;amiodarone use at baseline yes $nmbr$ $nmbr$
 147;ace inhibitor yes;"C0003015;C1549445;C1705108;C1710701;C4541021";NA;NA;ace inhibitor yes
 147;[ no / yes ] ( % );"C1549445;C1705108;C1710701";NA;NA;no yes
 146;tass ’;C0559483;NA;NA;tass
 146;mean body - mass indexj;"C0444504;C0518010;C2347634;C2348143";NA;NA;mean body mass indexj
 146;lv mass index ( mg / m $nmbr$ );"C0024671;C0026410;C0369637;C0439269;C0441923;C0455825;C0600653;C0918012;C1552854;C1637833;C1960952;C2346927;C2986546;C4321396;C4521761";NA;NA;lv mass index mg m $nmbr$
 146;lv mass;C0455825;NA;NA;lv mass
 145;vdhmtss;NA;NA;NA;vdhmtss
 145;mtss cfb mean ± sd;"C0009002;C0444504;C1824728;C2347634;C2348143;C2699239";NA;NA;mtss cfb mean sd
 145;mtss cfb;"C0009002;C1824728";NA;NA;mtss cfb
 -10;( fxs );C0016667;NA;NA;fxs
 143;mean score on das $nmbr$ - $nmbr$ ( crp ) ^;"C0051767;C0057671;C3533236;C3890735;C4048285";NA;NA;mean score on das $nmbr$ $nmbr$ crp
 143;das - $nmbr$ ( crp ) < $nmbr$ . $nmbr$  n ( % );"C0051767;C0057671;C3890735;C4048285";NA;NA;das $nmbr$ crp $nmbr$ $nmbr$ n
 143;das - $nmbr$ ( crp )  mean ( sd );"C0051767;C0057671;C0444504;C2347634;C2348143;C2699239;C3890735;C4048285";NA;NA;das $nmbr$ crp mean sd
 143;das $nmbr$ ‐ crp;"C0051767;C0057671;C3890735;C4048285";NA;NA;das $nmbr$ crp
 143;das $nmbr$ score;"C0051767;C0057671;C0449820;C4050231";NA;NA;das $nmbr$ score
 143;das $nmbr$ - hscrp;"C0051767;C0057671";NA;NA;das $nmbr$ hscrp
 143;das $nmbr$ - crp §;"C0051767;C0057671;C3890735;C4048285";NA;NA;das $nmbr$ crp
 143;das $nmbr$ - crp  ls mean change from baseline ( se ) ¥;"C0023668;C0036919;C0051767;C0057671;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C3890735;C4048285;C4319952";NA;NA;das $nmbr$ crp ls mean change from baseline se
 143;das $nmbr$ - crp;"C0051767;C0057671;C3890735;C4048285";NA;NA;das $nmbr$ crp
 143;das $nmbr$ ( crp )  mean ( sd );"C0051767;C0057671;C0444504;C2347634;C2348143;C2699239;C3890735;C4048285";NA;NA;das $nmbr$ crp mean sd
 143;das $nmbr$ ( crp );"C0051767;C0057671;C3890735;C4048285";NA;NA;das $nmbr$ crp
 143;das $nmbr$;"C0051767;C0057671";NA;NA;das $nmbr$
 143;c . das $nmbr$ - crp < $nmbr$ . $nmbr$;"C0051767;C0057671;C3890735;C4048285";NA;NA;c das $nmbr$ crp $nmbr$ $nmbr$
 142;time of symptom onset to randomization ( hrs );"C0034656;C1320528;C1568891";NA;NA;time of symptom onset to randomization hrs
 142;time of symptom onset to balloon inflation ( hrs );"C0021398;C0336867;C0441144;C1318493;C1320528;C1568891";NA;NA;time of symptom onset to balloon inflation hrs
 142;time of qualifying ecg to balloon inflation ( hrs );"C0021398;C0040223;C0336867;C0441144;C1318493;C1514624;C1568891;C1623258;C3541383";NA;NA;time of qualifying ecg to balloon inflation hrs
 142;hps;C0242994;NA;NA;hps
 142;^ $nmbr$ hrs;C1568891;NA;NA;$nmbr$ hrs
 142;> $nmbr$ hrs;C1568891;NA;NA;$nmbr$ hrs
 142;< $nmbr$ hrs;C1568891;NA;NA;$nmbr$ hrs
 141;qrs interval > $nmbr$ msec — no . ( % );"C0439223;C0520880";NA;NA;qrs interval $nmbr$ msec no
 141;qrs < $nmbr$ msec;C0439223;NA;NA;qrs $nmbr$ msec
 140;time since first af diagnosis  yrs;"C0011900;C0040223;C0205435;C0344434;C1279901;C1704338;C1704656;C3541383;C4049859";NA;NA;time since first af diagnosis yrs
 140;time since copd diagnosis ( yrs );"C0011900;C0024117;C0040223;C1412502;C1704338;C1704656;C3541383;C3714496";NA;NA;time since copd diagnosis yrs
 140;mras;"C1335594;C1367476";NA;NA;mras
 140;> $nmbr$ . $nmbr$ yrs;NA;NA;NA;$nmbr$ $nmbr$ yrs
 140;$nmbr$ yrs l;NA;NA;NA;$nmbr$ yrs l
 139;total pack - yrs;"C0439175;C0439810;C1968515;C2825051;C2828395";NA;NA;total pack yrs
 139;grs;"C1412761;C3539564";NA;NA;grs
 139;$nmbr$ yrs;NA;NA;NA;$nmbr$ yrs
 138;psoriasis duration  yrs *;"C0033860;C0449238;C2926735";NA;NA;psoriasis duration yrs
 138;duration of ra  mean ( min - max ) ( yrs );"C0444504;C0449238;C0702093;C1524029;C2347634;C2348143;C2926735;C3538806;C3813700;C4048756";NA;NA;duration of ra mean min max yrs
 138;duration of crohn ’ s disease ( yrs );"C0010346;C0449238;C2926735";NA;NA;duration of crohn s disease yrs
 138;duration of crohn ' s disease ( yrs );"C0010346;C0449238;C2926735";NA;NA;duration of crohn s disease yrs
 138;disease duration  yrs  mean ( sd );"C0444504;C0872146;C2347634;C2348143;C2699239";NA;NA;disease duration yrs mean sd
 138;> $nmbr$ yrs;NA;NA;NA;$nmbr$ yrs
 138;$nmbr$ . $nmbr$ yrs;NA;NA;NA;$nmbr$ $nmbr$ yrs
 138;$nmbr$ - < $nmbr$ yrs;NA;NA;NA;$nmbr$ $nmbr$ yrs
 138;$nmbr$ - $nmbr$ yrs;NA;NA;NA;$nmbr$ $nmbr$ yrs
 137;previous ics only;"C0205156;C0205171;C0815320;C1552607;C1720467;C4551720";NA;NA;previous ics only
 137;is only;"C0205171;C1720467";NA;NA;is only
 137;ics only;"C0205171;C0815320;C1720467;C4551720";NA;NA;ics only
 137;ibs ( $nmbr$ . $nmbr$ );"C0022104;C0432306";NA;NA;ibs $nmbr$ $nmbr$
 137;$nmbr$ is ( $nmbr$ . $nmbr$ );NA;NA;NA;$nmbr$ is $nmbr$ $nmbr$
 136;previous or current use of im or cs : no;"C0010182;C0205156;C0271160;C0521116;C1524063;C1552607;C1705970;C3540510;C4085345";NA;NA;previous or current use of im or cs no
 136;previous or current use of im and cs : no;"C0010182;C0205156;C0271160;C0521116;C1524063;C1552607;C1705970;C3540510;C4085345";NA;NA;previous or current use of im and cs no
 136;previous or current cs use : no;"C0010182;C0042153;C0205156;C0271160;C0457083;C0521116;C1552607;C1705970;C1947944;C3540510;C4085345";NA;NA;previous or current cs use no
 136;no cs and is;"C0010182;C0271160;C3540510;C4085345";NA;NA;no cs and is
 136;no cs and imm;"C0010182;C0205470;C0271160;C3540510;C4085345";NA;NA;no cs and imm
 136;neither cs nor imm;"C0010182;C0205470;C0271160;C3540510;C4085345";NA;NA;neither cs nor imm
 136;im or cs use : no;"C0010182;C0042153;C0271160;C0457083;C1947944;C3540510;C4085345";NA;NA;im or cs use no
 136;im and cs use : no;"C0010182;C0042153;C0271160;C0457083;C1947944;C3540510;C4085345";NA;NA;im and cs use no
 136;glycopyrrolate / glycopyrrolate / eflow cs $nmbr$ meg eflow cs $nmbr$ meg ( n = $nmbr$ ) ( n = $nmbr$ );"C0010182;C0017970;C0024489;C0025175;C0072225;C0271160;C3540510;C4085345";NA;NA;glycopyrrolate glycopyrrolate eflow cs $nmbr$ meg eflow cs $nmbr$ meg n $nmbr$ n $nmbr$
 136;glycopyrrolate / eflow cs $nmbr$ meg ( n = $nmbr$ );"C0010182;C0017970;C0024489;C0025175;C0072225;C0271160;C3540510;C4085345";NA;NA;glycopyrrolate eflow cs $nmbr$ meg n $nmbr$
 136;cs use : no;"C0010182;C0042153;C0271160;C0457083;C1947944;C3540510;C4085345";NA;NA;cs use no
 136;cs only;"C0010182;C0205171;C0271160;C1720467;C3540510;C4085345";NA;NA;cs only
 136;cs and is;"C0010182;C0271160;C3540510;C4085345";NA;NA;cs and is
 136;cs and imm;"C0010182;C0205470;C0271160;C3540510;C4085345";NA;NA;cs and imm
 136;cs and im;"C0010182;C0271160;C3540510;C4085345";NA;NA;cs and im
 136;cs;"C0010182;C0271160;C3540510;C4085345";NA;NA;cs
 135;p $nmbr$ vs no treatment $nmbr$;"C0039798;C0087111;C0369773;C1522326;C1533734;C1705169;C2603361;C3538994;C3887704";NA;NA;p $nmbr$ vs no treatment $nmbr$
 135;p  all vs all;"C0369773;C2603361";NA;NA;p all vs all
 146;body mass indexb;C0518010;FALSE;1734;body mass indexb
 146;body mass indexa < median;"C0518010;C0549183;C0876920;C2347635;C2348144;C2939193";FALSE;1734;body mass indexa median
 146;body mass indexa;C0518010;FALSE;1734;body mass indexa
 132;tp vs no tp;"C0036183;C3541334";NA;NA;tp vs no tp
 132;q $nmbr$ : $nmbr$ . $nmbr$ to < $nmbr$ . $nmbr$ kg ( n = $nmbr$ vs $nmbr$ );"C0022718;C0439209;C4054209";NA;NA;q $nmbr$ $nmbr$ $nmbr$ to $nmbr$ $nmbr$ kg n $nmbr$ vs $nmbr$
 132;ith vs . without );NA;NA;NA;ith vs without
 132;e $nmbr$ / s $nmbr$ vs s $nmbr$;"C0565930;C2603362;C3846405";NA;NA;e $nmbr$ s $nmbr$ vs s $nmbr$
 132;e $nmbr$ / s $nmbr$ vs e $nmbr$;C3846405;NA;NA;e $nmbr$ s $nmbr$ vs e $nmbr$
 132;> $nmbr$ to   ≤   $nmbr$   vs .   ≤   $nmbr$;NA;NA;NA;$nmbr$ to $nmbr$ vs $nmbr$
 132;> $nmbr$ and   ≤   $nmbr$   vs   ≤   $nmbr$;NA;NA;NA;$nmbr$ and $nmbr$ vs $nmbr$
 132;> $nmbr$ and   ≤   $nmbr$   vs .   ≤   $nmbr$;NA;NA;NA;$nmbr$ and $nmbr$ vs $nmbr$
 132;> $nmbr$ . $nmbr$   vs .   >   $nmbr$ . $nmbr$ and   ≤   $nmbr$ . $nmbr$;NA;NA;NA;$nmbr$ $nmbr$ vs $nmbr$ $nmbr$ and $nmbr$ $nmbr$
 131;notes :;C1317574;NA;NA;notes
 131;nos $nmbr$ glu $nmbr$ asp g . t  n ( % );"C0125690;C0326287;C0439267;C1518425;C2986835";NA;NA;nos $nmbr$ glu $nmbr$ asp g t n
 131;nos $nmbr$ $nmbr$ c . t  n ( % );"C0326287;C1518425";NA;NA;nos $nmbr$ $nmbr$ c t n
 131;nos $nmbr$ $nmbr$ a . g  n ( % );"C0326287;C0439267;C1518425";NA;NA;nos $nmbr$ $nmbr$ a g n
 130;tion  os = overall satisfaction  qmax = maximal urinary flow rate .;"C0229090;C0230028;C0262950;C0393706;C0429784;C1561953;C4086680";NA;NA;tion os overall satisfaction qmax maximal urinary flow rate
 130;os domain;"C0229090;C0230028;C0262950;C0393706;C1561953;C1880389;C1883221;C3541951";NA;NA;os domain
 130;ocs  n ( % );NA;NA;NA;ocs n
 130;no ocs;NA;NA;NA;no ocs
 130;- o . os;C2673162;NA;NA;o os
 130;$nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ - $nmbr$ . os );"C0229090;C0230028;C0262950;C0393706;C1561953";NA;NA;$nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ os
 129;sys : ns dia : < $nmbr$ . $nmbr$;"C0038944;C1112705;C1425041;C1705982;C1706546";NA;NA;sys ns dia $nmbr$ $nmbr$
 129;ns cardiac cisease;"C0018787;C0038944;C1112705;C1522601;C1705982";NA;NA;ns cardiac cisease
 129;ns;"C0038944;C1112705;C1705982";NA;NA;ns
 128;tgs ( mg / dl );"C0439269;C1156212;C1537574";NA;NA;tgs mg dl
 128;fasting tgs §;"C0015663;C1156212;C1537574";NA;NA;fasting tgs
 128;baseline fasting tgs  mg / dl;"C0015663;C0168634;C0439269;C1156212;C1442488;C1537574";NA;NA;baseline fasting tgs mg dl
 127;ssed as ls means;"C0023668;C1704970";NA;NA;ssed as ls means
 127;ls / ul $nmbr$ $nmbr$;"C0023668;C1300557";NA;NA;ls ul $nmbr$ $nmbr$
 127;lis;C2247545;NA;NA;lis
 127;lips;C0023759;NA;NA;lips
 127;aml vs . lis;"C0023465;C0023467;C2247545";NA;NA;aml vs lis
 126;qrs width  ms;"C0487742;C2349943;C3539704;C3713294";NA;NA;qrs width ms
 126;qrs duration > $nmbr$ ms  n ( % );"C0429025;C0488377;C2349943;C3539704;C3713294";NA;NA;qrs duration $nmbr$ ms n
 126;qrs duration  ms;"C0429025;C0488377;C2349943;C3539704;C3713294";NA;NA;qrs duration ms
 126;qrs > $nmbr$ ms *;"C2349943;C3539704;C3713294";NA;NA;qrs $nmbr$ ms
 126;qrs > $nmbr$ ms  n ( % )  available for $nmbr$ patients;"C0030705;C0470187;C2349943;C3539704;C3713294";NA;NA;qrs $nmbr$ ms n available for $nmbr$ patients
 126;qrs > $nmbr$ ms  % ( n );"C2349943;C3539704;C3713294";NA;NA;qrs $nmbr$ ms n
 126;qrs < $nmbr$ ms ( $nmbr$ % cl ) ( n - $nmbr$  $nmbr$ );"C0596019;C2349943;C3539704;C3713294";NA;NA;qrs $nmbr$ ms $nmbr$ cl n $nmbr$ $nmbr$
 126;qrs $ $nmbr$ ms ( $nmbr$ % cl ) ( n - $nmbr$ );"C0596019;C2349943;C3539704;C3713294";NA;NA;qrs $ $nmbr$ ms $nmbr$ cl n $nmbr$
 126;ms < $nmbr$  n [ % ];"C2349943;C3539704;C3713294";NA;NA;ms $nmbr$ n
 126;ms & ng;"C0017887;C0028074;C2349943;C3539704;C3713294";NA;NA;ms ng
 126;ms $nmbr$ - $nmbr$  n [ % ];"C2349943;C3539704;C3713294";NA;NA;ms $nmbr$ $nmbr$ n
 126;ms  mean [ sd ];"C0444504;C2347634;C2348143;C2349943;C2699239;C3539704;C3713294";NA;NA;ms mean sd
 126;cornell voltage x duration product  mm x ms;"C0449238;C0598352;C1514468;C1704444;C2349943;C2926735;C3539704;C3713294;C4330985;C4554674";NA;NA;cornell voltage x duration product mm x ms
 126;cornell voltage - duration product  mm × ms;"C0449238;C0598352;C1514468;C1704444;C2349943;C2926735;C3539704;C3713294;C4330985;C4554674";NA;NA;cornell voltage duration product mm ms
 126;cornell voltage - duration product  mm x ms;"C0449238;C0598352;C1514468;C1704444;C2349943;C2926735;C3539704;C3713294;C4330985;C4554674";NA;NA;cornell voltage duration product mm x ms
 126;corneii product  mm - ms;"C1514468;C1704444;C2349943;C3539704;C3713294;C4330985;C4554674";NA;NA;corneii product mm ms
 126;( n = ms );"C0369718;C0441922;C2349943;C3539704;C3713294";NA;NA;n ms
 126;$nmbr$ ms score †;"C0449820;C2349943;C3539704;C3713294;C4050231";NA;NA;$nmbr$ ms score
 125;psa ‐ modified mases score ( $nmbr$ – $nmbr$ scale );"C0175659;C0349674;C0392747;C0449820;C1947916;C3810537;C3813209;C3889737;C4050231";NA;NA;psa modified mases score $nmbr$ $nmbr$ scale
 125;psa subtypes  n ( % );"C0449560;C3810537;C3813209";NA;NA;psa subtypes n
 125;psa reported  n ( % );"C0369718;C0441922;C0684224;C0700287;C3810537;C3813209;C4319718";NA;NA;psa reported n
 125;psa pain ( vas );"C0042815;C3810537;C3813209";NA;NA;psa pain vas
 125;psa - modified total shs;"C0392747;C0439175;C0439810;C3810537;C3813209;C3889737";NA;NA;psa modified total shs
 125;psa - modified shs ( $nmbr$ - $nmbr$ );"C0392747;C3810537;C3813209;C3889737";NA;NA;psa modified shs $nmbr$ $nmbr$
 125;psa - modified mases score ( $nmbr$ - $nmbr$ );"C0392747;C0449820;C3810537;C3813209;C3889737;C4050231";NA;NA;psa modified mases score $nmbr$ $nmbr$
 125;psa ( n = $nmbr$ );"C3810537;C3813209";NA;NA;psa n $nmbr$
 125;psa;"C3810537;C3813209";NA;NA;psa
 125;patients with change from baseline in psa - modified total shs score # $nmbr$;"C0030705;C0168634;C0392747;C0439175;C0439810;C0443172;C0449820;C1442488;C1705241;C3810537;C3813209;C3889737;C4050231;C4319952";NA;NA;patients with change from baseline in psa modified total shs score $nmbr$
 125;no psa ( n = $nmbr$ );"C3810537;C3813209";NA;NA;no psa n $nmbr$
 125;no psa;"C3810537;C3813209";NA;NA;no psa
 125;no . of patients with psa;"C0030705;C3810537;C3813209";NA;NA;no of patients with psa
 124;total ipss;"C0439175;C0439810;C1019118;C1998280;C2827405;C3811063";NA;NA;total ipss
 124;severe ( ipss > $nmbr$ ) age group;"C0027362;C0205082;C1019118;C1998280;C2348001;C2827405;C3811063;C4050465;C4050466";NA;NA;severe ipss $nmbr$ age group
 124;severe ( ipss > $nmbr$ ) ( n = $nmbr$ );"C0205082;C1019118;C1998280;C2827405;C3811063;C4050465;C4050466";NA;NA;severe ipss $nmbr$ n $nmbr$
 124;severe ( ipss > $nmbr$ );"C0205082;C1019118;C1998280;C2827405;C3811063;C4050465;C4050466";NA;NA;severe ipss $nmbr$
 124;moderate ( ipss < $nmbr$ ) ( n = $nmbr$ );"C0205081;C1019118;C1881878;C1998280;C2827405;C3811063;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate ipss $nmbr$ n $nmbr$
 124;moderate ( $nmbr$ < ipss < $nmbr$ );"C0205081;C1019118;C1881878;C1998280;C2827405;C3811063;C4049705;C4049706;C4085643;C4321335";NA;NA;moderate $nmbr$ ipss $nmbr$
 124;mild / moderate ( ipss < $nmbr$ );"C1019118;C1299392;C1998280;C2827405;C3811063";NA;NA;mild moderate ipss $nmbr$
 124;mild - to - moderate ( ipss < $nmbr$ );"C1019118;C1299392;C1998280;C2827405;C3811063";NA;NA;mild to moderate ipss $nmbr$
 124;mild ( ipss < $nmbr$ );"C1019118;C1998280;C2827405;C2945599;C3811063";NA;NA;mild ipss $nmbr$
 124;ipss total score;"C1019118;C1998280;C2827405;C2964552;C3811063";NA;NA;ipss total score
 124;ipss hrql;"C1019118;C1998280;C2827405;C3811063";NA;NA;ipss hrql
 124;ipss categories;"C0683312;C1019118;C1998280;C2827405;C3811063";NA;NA;ipss categories
 124;ipss - v;"C1019118;C1998280;C2827405;C3811063";NA;NA;ipss v
 133;chlorthalidone vs lisinopril;"C0008294;C0065374";FALSE;  70;chlorthalidone vs lisinopril
 134;male vs . female;"C0043210;C0086287;C0086582;C1705497;C1705498;C1706180;C1706428;C1706429";FALSE;1970;male vs female
 134;women ( n = $nmbr$ vs $nmbr$ );C0043210;FALSE;1970;women n $nmbr$ vs $nmbr$
 124;ipss - s;"C1019118;C1998280;C2827405;C3811063";NA;NA;ipss s
 124;ipss ( unit );"C0439148;C0439453;C1019118;C1509845;C1519795;C1704753;C1880519;C1998280;C2827405;C3811063;C3853603";NA;NA;ipss unit
 124;ipss  “ / o;"C1019118;C1998280;C2827405;C3811063";NA;NA;ipss o
 124;ipss;"C1019118;C1998280;C2827405;C3811063";NA;NA;ipss
 124;erectile function  ipss;"C0030847;C0031843;C0542341;C0700205;C1019118;C1705273;C1998280;C2827405;C3811063";NA;NA;erectile function ipss
 124;baseline total ipss;"C0168634;C0439175;C0439810;C1019118;C1442488;C1998280;C2827405;C3811063";NA;NA;baseline total ipss
 124;= international prostate symptom score;C1998280;NA;NA;international prostate symptom score
 124;( ngml ' ' ) total mean ipss score;"C0439175;C0439810;C0444504;C1019118;C1998280;C2347634;C2348143;C2827405;C2964552;C3533236;C3811063";NA;NA;ngml total mean ipss score
 123;russia and georgia;"C0017452;C0017454;C0035970";NA;NA;russia and georgia
 123;russia / georgia ( n = $nmbr$ );"C0017452;C0017454;C0035970";NA;NA;russia georgia n $nmbr$
 123;russia / georgia;"C0017452;C0017454;C0035970";NA;NA;russia georgia
 123;russia;C0035970;NA;NA;russia
 123;europe and russia;"C0015176;C0035970";NA;NA;europe and russia
 123;enrolled in russia or georgia;"C0017452;C0017454;C0035970;C4684790";NA;NA;enrolled in russia or georgia
 122;prior insulin use ( years );"C0240016;C0332152;C0439234;C2826257";NA;NA;prior insulin use years
 123;rs - chest symptomsd;"C0035970;C0817096;C1527391;C3714753;C3813325";FALSE; -10;rs chest symptomsd
 123;rs - totala;"C0035970;C3714753;C3813325";FALSE; -10;rs totala
 122;insulin use at baseline;"C0168634;C0240016;C1442488";NA;NA;insulin use at baseline
 122;insulin use    n   ( % );C0240016;NA;NA;insulin use n
 122;insulin use;C0240016;NA;NA;insulin use
 122;heparin use;C0239945;NA;NA;heparin use
 121;us w = $nmbr$;NA;NA;NA;us w $nmbr$
 121;us resident;"C1320928;C1549439;C2347958;C3835651";NA;NA;us resident
 120;systemic corticosteroid use;"C0042153;C0205373;C0239126;C0457083;C1947944;C4053960";NA;NA;systemic corticosteroid use
 120;steroid use at baseline  n ( % );"C0168634;C0281991;C1442488";NA;NA;steroid use at baseline n
 120;steroid use at baseline;"C0168634;C0281991;C1442488";NA;NA;steroid use at baseline
 120;steroid use  %;C0281991;NA;NA;steroid use
 120;no steroid use at baseline ( ref );"C0168634;C0281991;C1425988;C1442488";NA;NA;no steroid use at baseline ref
 120;corticosteroid use at randomization    n   ( % );"C0034656;C0239126";NA;NA;corticosteroid use at randomization n
 120;corticosteroid use at randomization;"C0034656;C0239126";NA;NA;corticosteroid use at randomization
 120;corticosteroid use at baseline - no;"C0168634;C0239126;C1442488";NA;NA;corticosteroid use at baseline no
 120;corticosteroid use at baseline;"C0168634;C0239126;C1442488";NA;NA;corticosteroid use at baseline
 120;corticosteroid use  n ( % );C0239126;NA;NA;corticosteroid use n
 120;corticosteroid use  %;C0239126;NA;NA;corticosteroid use
 120;corticosteroid use  $nmbr$ n ( % );C0239126;NA;NA;corticosteroid use $nmbr$ n
 120;corticosteroid use;C0239126;NA;NA;corticosteroid use
 120;concomitant corticosteroid use  n ( % );"C0239126;C0521115";NA;NA;concomitant corticosteroid use n
 120;concomitant corticosteroid use;"C0239126;C0521115";NA;NA;concomitant corticosteroid use
 120;baseline corticosteroid use ( mg );"C0024671;C0026410;C0168634;C0239126;C0439269;C1442488;C1960952;C2346927;C4321396;C4521761";NA;NA;baseline corticosteroid use mg
 119;use of rescue medication;C0240320;NA;NA;use of rescue medication
 119;rescue medication use  inh / d {;"C0022209;C0240320";NA;NA;rescue medication use inh d
 119;no use ofdiabetes drugs — no . ( % );C0240320;NA;NA;no use ofdiabetes drugs no
 119;medication use before enrollment  no . ( % );"C0240320;C1516879;C1696073;C3888021";NA;NA;medication use before enrollment no
 119;medication use at entry ( % );"C0240320;C1705654";NA;NA;medication use at entry
 119;medication use ( % ) aspirin;"C0004057;C0240320";NA;NA;medication use aspirin
 119;medication use ( % );C0240320;NA;NA;medication use
 119;medication use  n ( % );C0240320;NA;NA;medication use n
 119;medication use;C0240320;NA;NA;medication use
 119;current medication use;"C0042153;C0240320;C0457083;C0521116;C0746467;C1705970;C1947944";NA;NA;current medication use
 119;concomitant medication use;"C0240320;C0521115";NA;NA;concomitant medication use
 119;blood pressure lowering medication use;"C0005823;C0240320;C0441994;C1271104;C1272641;C2003888";NA;NA;blood pressure lowering medication use
 118;use oforal glucose - lowering agent — no . ( % );"C0017725;C0042153;C0441994;C0450442;C0457083;C1254351;C1521826;C1947944;C2003888";NA;NA;use oforal glucose lowering agent no
 118;use ( % );"C0042153;C0457083;C1947944";NA;NA;use
 118;use;"C0042153;C0457083;C1947944";NA;NA;use
 118;triple therapy use at screening  n ( % );"C0039798;C0042153;C0087111;C0457083;C1363945;C1947944;C2121434";NA;NA;triple therapy use at screening n
 118;therapy use;"C0039798;C0042153;C0087111;C0457083;C1363945;C1947944";NA;NA;therapy use
 118;rotablator use  n ( % );"C0042153;C0457083;C1260867;C1947944";NA;NA;rotablator use n
 118;regular aspirin use;"C0004057;C0042153;C0205272;C0457083;C1947944";NA;NA;regular aspirin use
 118;recurrent vte ( statin use vs non - use );"C0042153;C0360714;C0457083;C0630906;C1455761;C1518422;C1947944;C2945760";NA;NA;recurrent vte statin use vs non use
 118;prior mesalazine use *;"C0042153;C0127615;C0332152;C0457083;C1947944;C2826257";NA;NA;prior mesalazine use
 118;previous or current im use : no;"C0042153;C0205156;C0457083;C0521116;C1552607;C1705970;C1947944";NA;NA;previous or current im use no
 118;p - gp use;"C0042153;C0369773;C0457083;C1705010;C1947944;C2603361;C3811116";NA;NA;p gp use
 118;no use;"C0042153;C0457083;C1947944";NA;NA;no use
 118;no regular aspirin use;"C0004057;C0042153;C0205272;C0457083;C1947944";NA;NA;no regular aspirin use
 118;no prior statin use;"C0042153;C0332152;C0360714;C0457083;C1947944;C2826257";NA;NA;no prior statin use
 118;no concomitant cortcosteroid use;"C0042153;C0457083;C0521115;C1947944";NA;NA;no concomitant cortcosteroid use
 118;mesalamine use  n ( % ) a;"C0042153;C0127615;C0457083;C1947944";NA;NA;mesalamine use n a
 118;major bleeding ( statin use vs non - use );"C0019080;C0042153;C0205082;C0205164;C0360714;C0457083;C1518422;C1947944;C4318856;C4521762";NA;NA;major bleeding statin use vs non use
 118;maintenance use — no . ( % );"C0024501;C0042153;C0457083;C1947944";NA;NA;maintenance use no
 118;no statin use;"C0042153;C0360714;C0457083;C1947944";FALSE; 872;no statin use
 118;methotrexate use;"C0025677;C0042153;C0457083;C1947944";FALSE; 716;methotrexate use
 118;methotrexate use at randomisation;"C0025677;C0034656;C0042153;C0457083;C1947944";FALSE; 716;methotrexate use at randomisation
 118;sulfasalazine use at randomization;"C0034656;C0036078;C0042153;C0457083;C1947944";FALSE;2184;sulfasalazine use at randomization
 118;sulfasalazine use at randomization    n   ( % );"C0034656;C0036078;C0042153;C0457083;C1947944";FALSE;2184;sulfasalazine use at randomization n
 118;saba use in past $nmbr$ days;"C0042153;C0439228;C0457083;C1444637;C1947944;C4284302";FALSE;2185;saba use in past $nmbr$ days
 118;saba use  occasions / weekt;"C0042153;C0457083;C1947944";FALSE;2185;saba use occasions weekt
 118;prior statin use;"C0042153;C0332152;C0360714;C0457083;C1947944;C2826257";FALSE;2186;prior statin use
 118;prior statin use ( n = $nmbr$ );"C0042153;C0332152;C0360714;C0457083;C1947944;C2826257";FALSE;2186;prior statin use n $nmbr$
 118;laba use at enrolment;"C0042153;C0457083;C1516879;C1696073;C1947944;C3888021";NA;NA;laba use at enrolment
 118;initiated use during double - blind treatment period;"C0013072;C0039798;C0042153;C0087111;C0439531;C0457083;C1522326;C1533734;C1548602;C1704686;C1705169;C1947944;C1948053;C3538994;C3887704";NA;NA;initiated use during double blind treatment period
 118;im use : no;"C0042153;C0457083;C1947944";NA;NA;im use no
 118;ezetimibe use;"C0042153;C0457083;C1142985;C1947944";NA;NA;ezetimibe use
 118;dopamine agonist use  no . ( % );"C0042153;C0178601;C0457083;C1947944;C3536925";NA;NA;dopamine agonist use no
 118;days without albuterol use  * %;"C0001927;C0042153;C0439228;C0457083;C1947944";NA;NA;days without albuterol use
 118;current lra use;"C0042153;C0457083;C0521116;C1705970;C1947944";NA;NA;current lra use
 118;current laba use;"C0042153;C0457083;C0521116;C1705970;C1947944";NA;NA;current laba use
 118;cse ] +;NA;NA;NA;cse
 118;concomitant mao - b inhibitor use;"C0042153;C0457083;C0521115;C0595265;C1947944;C2917433";NA;NA;concomitant mao b inhibitor use
 118;concomitant aspirin use;"C0004057;C0042153;C0457083;C0521115;C1947944";NA;NA;concomitant aspirin use
 118;concomitant antibiotic use  n [ % ];"C0003232;C0042153;C0457083;C0521115;C1947944";NA;NA;concomitant antibiotic use n
 118;cholinesterase inhibitor use at baseline  no . ( % );"C0008425;C0042153;C0168634;C0457083;C1442488;C1947944;C3536756;C4521309";NA;NA;cholinesterase inhibitor use at baseline no
 118;cholinesterase inhibitor use;"C0008425;C0042153;C0457083;C1947944;C3536756;C4521309";NA;NA;cholinesterase inhibitor use
 118;cgm use;"C0042153;C0457083;C1947944";NA;NA;cgm use
 118;before bronchodilator use;"C0006280;C0042153;C0457083;C1947944";NA;NA;before bronchodilator use
 118;baseline aspirin use strata;"C0004057;C0042153;C0168634;C0457083;C1442488;C1947944";NA;NA;baseline aspirin use strata
 118;baseline aspirin use;"C0004057;C0042153;C0168634;C0457083;C1442488;C1947944";NA;NA;baseline aspirin use
 118;background laba use - yes  n ( % );"C0042153;C0457083;C1549445;C1705108;C1706907;C1710701;C1947944";NA;NA;background laba use yes n
 118;background laba use;"C0042153;C0457083;C1706907;C1947944";NA;NA;background laba use
 118;any use;"C0042153;C0457083;C1947944";NA;NA;any use
 118;any glycoprotein iib / iiia inhibitor use;"C0016011;C0042153;C0457083;C1947944;C1999216";NA;NA;any glycoprotein iib iiia inhibitor use
 118;antithrombotic use before enrollment  no . ( % );"C0042153;C0457083;C1516879;C1696073;C1947944;C3888021";NA;NA;antithrombotic use before enrollment no
 118;antithrombotic use;"C0042153;C0457083;C1947944";NA;NA;antithrombotic use
 118;anorexigen use;"C0042153;C0457083;C1947944";NA;NA;anorexigen use
 118;aldosterone use;"C0002006;C0042153;C0457083;C1947944";NA;NA;aldosterone use
 118;albuterol use;"C0001927;C0042153;C0457083;C1947944";NA;NA;albuterol use
 118;after bronchodilator use;"C0006280;C0042153;C0457083;C1947944";NA;NA;after bronchodilator use
 117;ssi - $nmbr$;NA;NA;NA;ssi $nmbr$
 117;ss at baseline;"C0168634;C1442488;C2699257;C3891295;C4551874";NA;NA;ss at baseline
 117;ss > $nmbr$ ( n = $nmbr$ vs $nmbr$ );"C2699257;C3891295;C4551874";NA;NA;ss $nmbr$ n $nmbr$ vs $nmbr$
 117;ss < $nmbr$ ( n = $nmbr$ vs $nmbr$ );"C2699257;C3891295;C4551874";NA;NA;ss $nmbr$ n $nmbr$ vs $nmbr$
 116;js $nmbr$ - agonists;"C0243192;C1552154;C2987634";NA;NA;js $nmbr$ agonists
 116;$nmbr$ [ $nmbr$ - $nmbr$ js;C1552154;NA;NA;$nmbr$ $nmbr$ $nmbr$ js
 115;observed case;"C0868928;C1441672;C1706255;C1706256";NA;NA;observed case
 115;observed;C1441672;NA;NA;observed
 115;mbesc  n / n ( % );NA;NA;NA;mbesc n n
 115;mbesb  n / n ( % );NA;NA;NA;mbesb n n
 115;mbes / crbesc;NA;NA;NA;mbes crbesc
 115;mbes / crbesb  n / n ( % );NA;NA;NA;mbes crbesb n n
 115;$nmbr$ - $nmbr$ . $nmbr$ : obese class i;C3853264;NA;NA;$nmbr$ $nmbr$ $nmbr$ obese class i
 114;teaes  cases per $nmbr$ - patient years ( ci );"C0008107;C0030705;C0439234;C0868928;C1533148;C3259781";NA;NA;teaes cases per $nmbr$ patient years ci
 114;no cases;"C0868928;C1533148";NA;NA;no cases
 114;mtss at baseline observed case;"C0168634;C0868928;C1441672;C1442488;C1706255;C1706256";NA;NA;mtss at baseline observed case
 114;mtss at;NA;NA;NA;mtss at
 114;mtss ( $nmbr$ - $nmbr$ );NA;NA;NA;mtss $nmbr$ $nmbr$
 114;mtss;NA;NA;NA;mtss
 114;cases;"C0868928;C1533148";NA;NA;cases
 113;post - dose;C0439568;NA;NA;post dose
 113;percentage of patients receiving dose adjustment;"C0030705;C0439165;C1514756;C1549488;C1561533;C2826232";NA;NA;percentage of patients receiving dose adjustment
 113;first dose admin . $nmbr$ - $nmbr$ h / $nmbr$ - $nmbr$ h post onset of symptoms;"C0033727;C0205435;C0369286;C0439568;C0441932;C0564385;C1279901;C4084955;C4086878;C4528284";NA;NA;first dose admin $nmbr$ $nmbr$ h $nmbr$ $nmbr$ h post onset of symptoms
 113;dose adjustment n ( % );C2826232;NA;NA;dose adjustment n
 112;lower dose;"C0445550;C1708745";NA;NA;lower dose
 112;lower - dose;"C0445550;C1708745";NA;NA;lower dose
 112;low dose combination therapy;"C0009429;C0445550;C0556895;C1708745";NA;NA;low dose combination therapy
 112;low dose;"C0445550;C1708745";NA;NA;low dose
 112;low - dose statin;"C0360714;C0445550;C1708745";NA;NA;low dose statin
 112;fenofibric acid - i - low - dose statin;"C0021966;C0060179;C0221138;C0360714;C0445550;C1708745";NA;NA;fenofibric acid i low dose statin
 112;fenofibric acid - $nmbr$ - low - dose statin;"C0060179;C0360714;C0445550;C1708745";NA;NA;fenofibric acid $nmbr$ low dose statin
 112;fenofibric acid + low - dose statin;"C0060179;C0360714;C0445550;C1708745";NA;NA;fenofibric acid low dose statin
 112;edoxaban lower dose vs warfarin;"C0043031;C0445550;C1708745;C2975435";NA;NA;edoxaban lower dose vs warfarin
 111;higher dose;C0444956;NA;NA;higher dose
 111;higher - dose edoxaban vs warfarin;"C0043031;C0444956;C2975435";NA;NA;higher dose edoxaban vs warfarin
 111;higher - dose edoxaban ( n = $nmbr$ )  n ( % / y );"C0444956;C2975435";NA;NA;higher dose edoxaban n $nmbr$ n y
 111;higher - dose;C0444956;NA;NA;higher dose
 111;high dose statin ( n = $nmbr$  $nmbr$ );"C0360714;C0444956";NA;NA;high dose statin n $nmbr$ $nmbr$
 111;high dose;C0444956;NA;NA;high dose
 111;high - dose statin use at screening *;"C0042153;C0220908;C0220909;C0360714;C0444956;C0457083;C1698960;C1710031;C1710032;C1710477;C1947944;C2348164";NA;NA;high dose statin use at screening
  53;anaesthesia / analgesia;C0002905;NA;NA;anaesthesia analgesia
 118;aspirin use;"C0004057;C0042153;C0457083;C1947944";FALSE;1366;aspirin use
 118;aspirin use ( % );"C0004057;C0042153;C0457083;C1947944";FALSE;1366;aspirin use
 118;aspirin use ( p = $nmbr$ . $nmbr$ t );"C0004057;C0042153;C0457083;C1947944";FALSE;1366;aspirin use p $nmbr$ $nmbr$ t
 118;aspirin use ( p = $nmbr$ - $nmbr$ 十 );"C0004057;C0042153;C0457083;C1947944";FALSE;1366;aspirin use p $nmbr$ $nmbr$
 118;concomitant methotrexate use  n ( % );"C0025677;C0042153;C0457083;C0521115;C1947944";FALSE; 716;concomitant methotrexate use n
 118;low - dose aspirin use;"C0042153;C0457083;C1947944;C2608320";FALSE;2183;low dose aspirin use
 118;low - dose aspirin use at baseline;"C0042153;C0168634;C0457083;C1442488;C1947944;C2608320";FALSE;2183;low dose aspirin use at baseline
 118;low - dose aspirin use . strata *  n ( % );"C0042153;C0457083;C1947944;C2608320";FALSE;2183;low dose aspirin use strata n
 118;low - dose aspirin use strata * n ( % );"C0042153;C0457083;C1947944;C2608320";FALSE;2183;low dose aspirin use strata n
 118;cox - $nmbr$ selective inhibitor use;"C0036576;C0042153;C0085387;C0457083;C1707391;C1947944";FALSE;2123;cox $nmbr$ selective inhibitor use
 111;high - dose statin use  n ( % ) e;"C0042153;C0360714;C0444956;C0457083;C1947944";NA;NA;high dose statin use n e
 111;high - dose statin;"C0360714;C0444956";NA;NA;high dose statin
 111;high - dose edoxaban vs warfarin;"C0043031;C0444956;C2975435";NA;NA;high dose edoxaban vs warfarin
 111;high - dose edoxaban ( n = $nmbr$ );"C0444956;C2975435";NA;NA;high dose edoxaban n $nmbr$
 111;high - dose edoxaban;"C0444956;C2975435";NA;NA;high dose edoxaban
 111;high - dose arb ( n = $nmbr$ );"C0444956;C3888198";NA;NA;high dose arb n $nmbr$
 111;edoxaban higher dose vs warfarin;"C0043031;C0444956;C2975435";NA;NA;edoxaban higher dose vs warfarin
 110;tanezumab ( all doses combined ) + nsaida;"C0178602;C0205195;C2346819";NA;NA;tanezumab all doses combined nsaida
 110;tanezumab ( all doses combined );"C0178602;C0205195;C2346819";NA;NA;tanezumab all doses combined
 110;smedian prednisone dose  n ( % );"C0032952;C0178602;C0869039;C1114758";NA;NA;smedian prednisone dose n
 110;ras % target dose;"C0034678;C0178602;C0525678;C0869039;C1114758;C1521840;C2986546";NA;NA;ras target dose
 110;ptrend across doses;C0178602;NA;NA;ptrend across doses
 110;prednisone or equivalent dose ( mg / day );"C0032952;C0178602;C0205163;C0439185;C0439422;C0869039;C1114758";NA;NA;prednisone or equivalent dose mg day
 110;prednisone - equivalent dose  mg;"C0024671;C0026410;C0032952;C0178602;C0205163;C0439185;C0439269;C0869039;C1114758;C1960952;C2346927;C4321396;C4521761";NA;NA;prednisone equivalent dose mg
 110;patients with supplemental vitamin d dose of $nmbr$ iu / day starting at screeningc    n   ( % );"C0030705;C0178602;C0420176;C0439465;C0439659;C0869039;C1114758;C3541352";NA;NA;patients with supplemental vitamin d dose of $nmbr$ iu day starting at screeningc n
 110;oral corticosteroid dose ( mg / day );"C0001617;C0178602;C0439422;C0442027;C0869039;C1114758;C3536709;C4521986";NA;NA;oral corticosteroid dose mg day
 110;need for $nmbr$ ng edoxaban dose at;"C0017887;C0027552;C0028074;C0178602;C0686904;C0869039;C1114758;C2975435";NA;NA;need for $nmbr$ ng edoxaban dose at
 110;metformin dose;"C0025598;C0178602;C0869039;C1114758";NA;NA;metformin dose
 110;metformin - dose;"C0025598;C0178602;C0869039;C1114758";NA;NA;metformin dose
 110;mean ( s . d . ) metformin dose †  mg / day;"C0025598;C0178602;C0439422;C0444504;C0869039;C1114758;C2347634;C2348143";NA;NA;mean s d metformin dose mg day
 110;intended clopidogrel dose $nmbr$ mg;"C0024671;C0026410;C0070166;C0178602;C0439269;C0869039;C1114758;C1283828;C1551357;C1960952;C2346927;C4321396;C4521761";NA;NA;intended clopidogrel dose $nmbr$ mg
 110;edoxaban dose adjusted at randomisation  n ( % ) *;"C0034656;C0178602;C0456081;C0869039;C1114758;C2975435";NA;NA;edoxaban dose adjusted at randomisation n
 110;doubling statin dose;"C0178602;C0205173;C0360714;C0869039;C1114758;C1705764";NA;NA;doubling statin dose
 110;dose reduction at randomization — no . ( % )  i;"C0021966;C0034656;C0178602;C0221138;C0301630;C0392756;C0869039;C1114758;C1293152;C4551656";NA;NA;dose reduction at randomization no i
 110;dose reduction at randomization  %;"C0034656;C0178602;C0301630;C0392756;C0869039;C1114758;C1293152;C4551656";NA;NA;dose reduction at randomization
 110;dose reduction at randomization;"C0034656;C0178602;C0301630;C0392756;C0869039;C1114758;C1293152;C4551656";NA;NA;dose reduction at randomization
 110;dose reduction  n ( % );"C0178602;C0301630;C0392756;C0869039;C1114758;C1293152;C4551656";NA;NA;dose reduction n
 110;dose reduced at randomization *;"C0034656;C0178602;C0392756;C0869039;C1114758";NA;NA;dose reduced at randomization
 110;dose adjusted;"C0178602;C0456081;C0869039;C1114758";NA;NA;dose adjusted
 110;dose ( n );"C0178602;C0869039;C1114758";NA;NA;dose n
 110;corticosteroid dose ( prednisone;"C0001617;C0032952;C0178602;C0869039;C1114758;C3536709";NA;NA;corticosteroid dose prednisone
 110;clopidogrel dose;"C0070166;C0178602;C0869039;C1114758";NA;NA;clopidogrel dose
 110;canakinumab dose ( per month );"C0178602;C0332177;C0439231;C0869039;C1114758;C2718773";NA;NA;canakinumab dose per month
 110;canakinumab dose ( per mo );"C0026544;C0178602;C0332177;C0869039;C1114758;C2718773";NA;NA;canakinumab dose per mo
 110;canakinumab dose;"C0178602;C0869039;C1114758;C2718773";NA;NA;canakinumab dose
 110;any dose reduction;"C0178602;C0301630;C0392756;C0869039;C1114758;C1293152;C4551656";NA;NA;any dose reduction
 110;all doses ( n = $nmbr$ );C0178602;NA;NA;all doses n $nmbr$
 110;all doses;C0178602;NA;NA;all doses
 110;< median prednisone dose  n ( % );"C0032952;C0178602;C0549183;C0869039;C0876920;C1114758;C2347635;C2348144;C2939193";NA;NA;median prednisone dose n
 110;( phase $nmbr$ dose - finding trial );"C0008976;C0037088;C0178602;C0205390;C0243095;C0869039;C1114758;C1710475;C2825141";NA;NA;phase $nmbr$ dose finding trial
 -10;decreased appetite;C0232462;NA;NA;decreased appetite
 108;connective tissue disease;C0009782;NA;NA;connective tissue disease
 108;connective - tissue disease;C0009782;NA;NA;connective tissue disease
 108;associated with connective tissue disease;"C0009782;C0332281";NA;NA;associated with connective tissue disease
 108;assoc  with connective tissue disease;C0009782;NA;NA;assoc with connective tissue disease
 107;inflammatory disease;C1290884;NA;NA;inflammatory disease
 107;inflammatory bowel disease;C0021390;NA;NA;inflammatory bowel disease
 107;chronic inflammatory disease;C1290886;NA;NA;chronic inflammatory disease
 107;active inflammatory bowel disease;"C0021390;C0205177;C3853793;C3888249";NA;NA;active inflammatory bowel disease
 106;pulmonary disease — no . ( % );C0024115;NA;NA;pulmonary disease no
 106;pulmonary disease;C0024115;NA;NA;pulmonary disease
 106;chronic pulmonary disease;C0746102;NA;NA;chronic pulmonary disease
 105;thyroid disease;C0040128;NA;NA;thyroid disease
 105;patient history of disease n ( % );"C0030705;C0683519;C0730226;C0850708;C0944983";NA;NA;patient history of disease n
 105;patient history of disease;"C0030705;C0683519;C0730226;C0850708;C0944983";NA;NA;patient history of disease
 105;microvascular disease history  no . ( % );"C0443258;C0683519";NA;NA;microvascular disease history no
 105;microvascular disease history  n ( % );"C0443258;C0683519";NA;NA;microvascular disease history n
 105;microvascular disease history;"C0443258;C0683519";NA;NA;microvascular disease history
 105;history of thyroid disease  n ( % );"C0040132;C0683519;C0730226;C0850708;C0944983;C3540038";NA;NA;history of thyroid disease n
 105;history of peripheral arterial disease ( % );"C0003842;C0205100;C0221464;C0683519;C0730226;C0850708;C0944983";NA;NA;history of peripheral arterial disease
 105;history of peripheral arterial disease;"C0003842;C0205100;C0221464;C0683519;C0730226;C0850708;C0944983";NA;NA;history of peripheral arterial disease
 105;history of microvascular eye disease 本  n ( % );"C0015392;C0015397;C0019664;C0019665;C0262512;C0262926;C0443258;C0683519;C0700042;C0730226;C0850708;C0944983;C1705255;C2004062";NA;NA;history of microvascular eye disease n
 105;history of microvascular disease — no . ( % );"C0443258;C0683519;C0730226;C0850708;C0944983";NA;NA;history of microvascular disease no
 105;history of microvascular disease ( % );"C0443258;C0683519;C0730226;C0850708;C0944983";NA;NA;history of microvascular disease
 105;history of microvascular disease;"C0443258;C0683519;C0730226;C0850708;C0944983";NA;NA;history of microvascular disease
 105;history of major microvascular disease — no . ( % );"C0205082;C0205164;C0443258;C0683519;C0730226;C0850708;C0944983;C4318856;C4521762";NA;NA;history of major microvascular disease no
 105;history of major microvascular disease  n ( % );"C0205082;C0205164;C0443258;C0683519;C0730226;C0850708;C0944983;C4318856;C4521762";NA;NA;history of major microvascular disease n
 360;anti - p $nmbr$;NA;FALSE; -10;anti p $nmbr$
 105;history of major macrovascular disease — no . ( % );"C0205082;C0205164;C0683519;C0730226;C0850708;C0944983;C4318856;C4521762";FALSE;1698;history of major macrovascular disease no
 105;history of macrovascular disease ( % );"C0683519;C0730226;C0850708;C0944983";FALSE;1698;history of macrovascular disease
 105;history of ischemic heart disease — no . ( % );"C0018787;C0475224;C0683519;C0730226;C0850708;C0944983";NA;NA;history of ischemic heart disease no
 105;history of fistullzing disease  n ( % );"C0683519;C0730226;C0850708;C0944983";NA;NA;history of fistullzing disease n
 105;history of fistulizing disease  n ( % );"C0683519;C0730226;C0850708;C0944983";NA;NA;history of fistulizing disease n
 105;history of fistulising disease  n [ % ];"C0683519;C0730226;C0850708;C0944983";NA;NA;history of fistulising disease n
 105;history of cv disease;"C0683519;C0730226;C0850708;C0944983;C3538987;C4048877;C4318503";NA;NA;history of cv disease
 105;history of crohn ' s disease surgery  n ( % );"C0010346;C0455610";NA;NA;history of crohn s disease surgery n
 105;history of coronary heart disease at;"C0018787;C0683519;C0730226;C0850708;C0944983";NA;NA;history of coronary heart disease at
 105;history of coronary heart disease  no . ( % );"C0018787;C0683519;C0730226;C0850708;C0944983";NA;NA;history of coronary heart disease no
 105;history of coronary arteiy disease;"C0018787;C0683519;C0730226;C0850708;C0944983";NA;NA;history of coronary arteiy disease
 105;history of bone disease ( predefined )  n ( % );"C0005940;C0019664;C0019665;C0262512;C0262926;C0262950;C0369718;C0441922;C0683519;C0730226;C0850708;C0944983;C1705255;C2004062";NA;NA;history of bone disease predefined n
 105;disease history;C0683519;NA;NA;disease history
 105;crohn ' s disease;C0010346;NA;NA;crohn s disease
 105;concurrent treatment of crohn ' s disease at study entry — no . of patients ( % ) ff;"C0010346;C0030705;C0039798;C0087111;C0205420;C0557651;C1522326;C1533734;C1705169;C1705654;C2603343;C3538994;C3887704;C4554348";NA;NA;concurrent treatment of crohn s disease at study entry no of patients ff
 105;baseline history of vascular disease ( % );"C0005847;C0168634;C0683519;C0730226;C0850708;C0944983;C1442488;C1558950;C1801960";NA;NA;baseline history of vascular disease
 104;kidney disease ( usrds );C0022658;NA;NA;kidney disease usrds
 104;duration of chronic kidney disease * ( years );"C0022658;C0205191;C0439234;C0449238;C2926735";NA;NA;duration of chronic kidney disease years
 104;diabetic kidney disease;C0011881;NA;NA;diabetic kidney disease
 104;chronic kidney diseased;C2364010;NA;NA;chronic kidney diseased
 103;valvular heart disease — no . ( % );"C0018824;C1963123";NA;NA;valvular heart disease no
 103;valvular heart disease  n ( % );"C0018824;C1963123";NA;NA;valvular heart disease n
 103;valvular heart disease;"C0018824;C1963123";NA;NA;valvular heart disease
 103;valvular disease ( % );C3258293;NA;NA;valvular disease
 103;valvular disease  mitral;"C0746591;C3258293";NA;NA;valvular disease mitral
 103;valvular disease;C3258293;NA;NA;valvular disease
 103;mitral valve disease ( n = $nmbr$ $nmbr$ );"C0026265;C4553832";NA;NA;mitral valve disease n $nmbr$ $nmbr$
 103;cardiac valvular disease;C0018824;NA;NA;cardiac valvular disease
 102;vessel disease;C0042373;NA;NA;vessel disease
 102;vascular disease indicator no ( n = $nmbr$ );"C0021212;C0042373;C0369718;C0441922;C1235732;C1522602";NA;NA;vascular disease indicator no n $nmbr$
 102;vascular disease;C0042373;NA;NA;vascular disease
 102;single vessel disease;"C0037179;C0042373;C0087136;C0205171";NA;NA;single vessel disease
 102;single - vessel disease  n ( % );"C0037179;C0042373;C0087136;C0205171";NA;NA;single vessel disease n
 102;single - vessel disease;"C0037179;C0042373;C0087136;C0205171";NA;NA;single vessel disease
 102;other vascular disease — no . ( % );C0042373;NA;NA;other vascular disease no
 102;double - vessel disease  n ( % );"C0042373;C0205173;C1705764;C1705765";NA;NA;double vessel disease n
 102;any vascular disease;C0042373;NA;NA;any vascular disease
 101;simplified disease activity index score ( $nmbr$ - $nmbr$ );"C0449820;C3869582;C4050231";NA;NA;simplified disease activity index score $nmbr$ $nmbr$
 101;simplified disease activity index score;"C0449820;C3869582;C4050231";NA;NA;simplified disease activity index score
 101;simplified disease activity index;C3869582;NA;NA;simplified disease activity index
 101;ptga of disease activity ( $nmbr$ ‒ $nmbr$ mm )  mean ( sd ) †;"C0444504;C1292728;C2347634;C2348143;C2699239;C4330985;C4554674";NA;NA;ptga of disease activity $nmbr$ $nmbr$ mm mean sd
 101;high disease activity : > $nmbr$ . $nmbr$  n ( % );"C0012634;C0205250;C1292728;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209;C4699623";NA;NA;high disease activity $nmbr$ $nmbr$ n
 101;disease activity ];C1292728;NA;NA;disease activity
 101;disease activity ( n ( % ) );C1292728;NA;NA;disease activity n
 101;disease activity;C1292728;NA;NA;disease activity
 101;clinical disease activity index score ( $nmbr$ - $nmbr$ );"C0449820;C3869583;C4050231";NA;NA;clinical disease activity index score $nmbr$ $nmbr$
 101;clinical disease activity index;C3869583;NA;NA;clinical disease activity index
 100;ease activity ];"C0205177;C0439167;C0441655;C1331418;C1561536;C3668946;C4049938;C4049939";NA;NA;ease activity
 100;ease - $nmbr$;C1331418;NA;NA;ease $nmbr$
 100;base;"C0002055;C0178499;C1880279";NA;NA;base
  99;type of reflux disease;"C0232483;C0457464;C1882919;C4317146";NA;NA;type of reflux disease
  99;gastrooesophageal reflux disease;"C0017168;C4553201";NA;NA;gastrooesophageal reflux disease
  99;gastroesophageal reflux disease;"C0017168;C4553201";NA;NA;gastroesophageal reflux disease
  99;erosive reflux disease;"C0012634;C0232483;C0439679;C1882919;C4317146";NA;NA;erosive reflux disease
  98;polyvascular disease * status;C3176928;NA;NA;polyvascular disease status
  98;physician ' s global assessment of disease status score;"C0449820;C3176928;C4050231;C4050369";NA;NA;physician s global assessment of disease status score
  98;global assessment of disease status score;"C0281858;C0449820;C3176928;C4050231";NA;NA;global assessment of disease status score
  98;disease stage;C0699749;NA;NA;disease stage
  97;severe disease;C1836348;NA;NA;severe disease
  97;self - reported disease severity  $nmbr$ - $nmbr$ scale *;"C0175659;C0349674;C0521117;C0681906;C1947916;C2700446";NA;NA;self reported disease severity $nmbr$ $nmbr$ scale
  97;rheumatic heart disease;C0035439;NA;NA;rheumatic heart disease
  97;endoscopic disease severity;"C0014245;C0442418;C0521117";NA;NA;endoscopic disease severity
  97;disease severity;C0521117;NA;NA;disease severity
  97;congenital heart disease;C0152021;NA;NA;congenital heart disease
  97;$nmbr$ ( severe disease );C1836348;NA;NA;$nmbr$ severe disease
  96;cigarettesmoking  %;NA;NA;NA;cigarettesmoking
  96;cigarette users;"C0677453;C1704760;C1706077;C3890423";NA;NA;cigarette users
  95;unspecified;"C0205370;C1549663;C2983689;C4048188";NA;NA;unspecified
  95;unified parkinson disease;"C0030567;C1521736;C1548174;C1706076";NA;NA;unified parkinson disease
  95;unclassified;"C0205426;C1546437;C2347854;C4085229";NA;NA;unclassified
  94;or per unit for continuous variables;"C0439148;C0439453;C0439828;C0549178;C1509845;C1519795;C1704753;C1880519;C3853603";NA;NA;or per unit for continuous variables
  94;mtss units;"C0439148;C1519795;C3853603";NA;NA;mtss units
  94;insulin dose ( u );"C0366513;C0439148";NA;NA;insulin dose u
  94;insulin dose  u;"C0366513;C0439148";NA;NA;insulin dose u
  94;ae / e ' ratio ( per $nmbr$ unit );"C0439148;C0439453;C0456603;C1509845;C1519795;C1547037;C1704753;C1880519;C3853603;C3887670";NA;NA;ae e ratio per $nmbr$ unit
  90;( ne  ne );"C0027608;C0028219;C3538705";FALSE; -10;ne ne
 105;history of macrovascular disease;"C0683519;C0730226;C0850708;C0944983";FALSE;1698;history of macrovascular disease
  97;moderate or severe renal disease  b   n ( % );"C0022646;C0022658;C0205081;C0205082;C1836348;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335";FALSE; 937;moderate or severe renal disease b n
 105;history of carotid artery disease;"C0007273;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";FALSE;2195;history of carotid artery disease
 105;history of carotid disease - n ( % );"C0683519;C0730226;C0741968;C0850708;C0944983";FALSE;2195;history of carotid disease n
 105;carotid artery disease;C0007273;FALSE;2195;carotid artery disease
  94;ae / a ratio ( per $nmbr$ . $nmbr$ unit );"C0439148;C0439453;C0456603;C1509845;C1519795;C1547037;C1704753;C1880519;C3853603;C3887670";NA;NA;ae a ratio per $nmbr$ $nmbr$ unit
  93;unknown — no . { % );"C0439673;C3541433;C4050014";NA;NA;unknown no
  93;unknown type;"C0332307;C0439673;C1547052;C3541433;C4050014";NA;NA;unknown type
  93;unknown ( none of the above );"C0439673;C1282910;C1552828;C3541433;C4050014";NA;NA;unknown none of the above
  93;unknown ( % );"C0439673;C3541433;C4050014";NA;NA;unknown
  93;unknown;"C0439673;C3541433;C4050014";NA;NA;unknown
  93;non - detectable / unknown  n ( % );"C0439673;C1518422;C3541433;C3830527;C4050014";NA;NA;non detectable unknown n
  93;non - detectable / unknown;"C0439673;C1518422;C3541433;C3830527;C4050014";NA;NA;non detectable unknown
  93;no or unknown;"C0439673;C3541433;C4050014";NA;NA;no or unknown
  93;no / unknown;"C0439673;C3541433;C4050014";NA;NA;no unknown
  93;mi type unknown ( % );"C0332307;C0439673;C1547052;C3541433;C3810814;C4050014";NA;NA;mi type unknown
  93;ischaemic or unknown stroke;"C0038454;C0439673;C0475224;C3541433;C4050014;C4554100";NA;NA;ischaemic or unknown stroke
  93;indeterminate or unknown;"C0205258;C0439673;C3541433;C4050014";NA;NA;indeterminate or unknown
  93;a excludes two randomized patients with unknown diabetes status at baseline .;"C0034656;C0168634;C0205448;C0332196;C0439673;C1315719;C1442488;C2828389;C3541433;C3815594;C4050014";NA;NA;a excludes two randomized patients with unknown diabetes status at baseline
  92;uacr not available;C0686905;FALSE;  80;uacr not available
  92;not severe;C4316743;NA;NA;not severe
  92;not available;C0686905;NA;NA;not available
  92;not assessable;C1883425;NA;NA;not assessable
  92;nnt;C1417750;NA;NA;nnt
  90;ne;"C0027608;C0028219;C3538705";FALSE; -10;ne
  91;p - value ( ■ nt );"C0332126;C1449832;C1709380;C3889152;C4050156;C4283901;C4284038";NA;NA;p value nt
  91;nt estimated;"C0332126;C0750572;C1449832;C3889152;C4050156;C4283901;C4284038";NA;NA;nt estimated
  91;n nt;"C0332126;C0369718;C0441922;C1449832;C3889152;C4050156;C4283901;C4284038";NA;NA;n nt
  90;new - onset atrial fibrillation;C0741281;NA;NA;new onset atrial fibrillation
  90;lone atrial fibrillation — no . ( % ) §;C0340489;NA;NA;lone atrial fibrillation no
  90;duration of qualifying atrial fibrillation » $nmbr$ days — no . ( % );"C0004238;C0344434;C0439228;C0449238;C1514624;C1963067;C2926735";NA;NA;duration of qualifying atrial fibrillation $nmbr$ days no
  90;atrial fibrillation  duration — no . ( % );"C0004238;C0344434;C0449238;C1963067;C2926735";NA;NA;atrial fibrillation duration no
  89;nx *;C0445085;NA;NA;nx
  89;no . ( % ) $nmbr$ ( $nmbr$ );NA;NA;NA;no $nmbr$ $nmbr$
  89;modified rankin scale — no . ( % ) |;"C2984908;C3854213";NA;NA;modified rankin scale no
  88;traditional chinese medicine for respiratory disease — no . ( % );"C0025124;C0035204;C0035242;C1515884";NA;NA;traditional chinese medicine for respiratory disease no
  88;no po;"C0032729;C0442027";NA;NA;no po
  88;fluindione  no . ( % );C0117899;NA;NA;fluindione no
  88;chronic cardiovascular disease  no . ( % );C1290380;NA;NA;chronic cardiovascular disease no
  88;associatedproximaldeep - veinthrombosisatdiagnosis  no . ( % );NA;NA;NA;associatedproximaldeep veinthrombosisatdiagnosis no
  87;onsetofaf  no . ( % );NA;NA;NA;onsetofaf no
  87;nonsustained ventricular tachycardia — no . ( % ) - j -;"C0750194;C2919575";NA;NA;nonsustained ventricular tachycardia no j
  87;enox;C3147679;NA;NA;enox
  86;no ( $nmbr$ . $nmbr$ );NA;NA;NA;no $nmbr$ $nmbr$
  86;family history of cad ( diagnosed at < $nmbr$ yr of age ) — no . ( % ) cigarette smoker — no . ( % );"C0001779;C0011900;C0241889;C0337667;C0439234;C1504769;C2239547;C3813548;C4284121";NA;NA;family history of cad diagnosed at $nmbr$ yr of age no cigarette smoker no
  86;diagnosis at study entry — no . ( % );"C1704656;C1705654;C4068481";NA;NA;diagnosis at study entry no
  86;age > $nmbr$ yr  no . ( % );"C0001779;C0439234";NA;NA;age $nmbr$ yr no
  86;> $nmbr$  no . ( % );NA;NA;NA;$nmbr$ no
  86;< $nmbr$ yr — no . { % );C0439234;NA;NA;$nmbr$ yr no
  86;< $nmbr$ vr — no . ( % );C3476815;NA;NA;$nmbr$ vr no
  86;$nmbr$ - $nmbr$ vr — no . ( % );C3476815;NA;NA;$nmbr$ $nmbr$ vr no
  85;on non ‐ metformin aha;"C0025598;C0050451;C0772110;C1518422";NA;NA;on non metformin aha
  85;not tested;"C0392366;C1518422";NA;NA;not tested
  85;not reported / unknown;"C0439673;C0684224;C0700287;C1518422;C3541433;C4050014;C4319718";NA;NA;not reported unknown
  85;not reported;"C0684224;C0700287;C1518422;C4319718";NA;NA;not reported
  85;not provided;"C1518422;C1999230";NA;NA;not provided
  85;not perfused;"C1518422;C1549542";NA;NA;not perfused
  85;not on metformin;"C0025598;C1518422";NA;NA;not on metformin
  85;not on an aha;"C0050451;C0772110;C1518422";NA;NA;not on an aha
  85;not localized;"C0392752;C1518422";NA;NA;not localized
  85;not estimable;C1518422;NA;NA;not estimable
  85;not collected ^;"C1516695;C1516698;C1518422";NA;NA;not collected
  85;non diuretics;"C0012798;C1518422";NA;NA;non diuretics
  85;non - united states;"C0041703;C1518422";NA;NA;non united states
  85;non - u . s .;"C0041703;C1518422";NA;NA;non u s
  85;non - spondylitis;"C0038012;C1518422";NA;NA;non spondylitis
  85;non - severe hypoglycaemia;"C0020615;C0205082;C1518422;C4050465;C4050466;C4553659";NA;NA;non severe hypoglycaemia
  85;non - rollover;"C0517067;C0543436;C1518422";NA;NA;non rollover
  85;non - hispanicwhite;C1518422;NA;NA;non hispanicwhite
  85;non - hishnic;C1518422;NA;NA;non hishnic
  85;non - epa number of <;"C0237753;C0449788;C1518422";NA;NA;non epa number of
  85;non - epa ( n = $nmbr$ );C1518422;NA;NA;non epa n $nmbr$
  85;non - cabg or combined;"C0010055;C0205195;C1518422";NA;NA;non cabg or combined
  85;non - c;C1518422;NA;NA;non c
  85;no . of tnfi among non - tnfi naive;C1518422;NA;NA;no of tnfi among non tnfi naive
  85;no . of non - tnfi;C1518422;NA;NA;no of non tnfi
  85;nct $nmbr$;NA;NA;NA;nct $nmbr$
  85;major or clinically relevant non - major bleeding;"C0019080;C0205082;C0205164;C1518422;C2347946;C4318856;C4521762";NA;NA;major or clinically relevant non major bleeding
  85;major or clinically relevant non - major bleed;"C0019080;C0205082;C0205164;C1518422;C2347946;C4318856;C4521762";NA;NA;major or clinically relevant non major bleed
  85;infarction  date not reported;"C0011008;C0021308;C0684224;C0700287;C1518422;C2348077;C4319718";NA;NA;infarction date not reported
  85;did not enrol into osler;C1518422;NA;NA;did not enrol into osler
  85;clinically relevant non;"C1518422;C2347946";NA;NA;clinically relevant non
  84;white tcz + mtx ( n );"C0007457;C0025677;C0043157;C0220938;C1417487";NA;NA;white tcz mtx n
  84;tx $nmbr$;C0041403;NA;NA;tx $nmbr$
  84;tx;C0041403;NA;NA;tx
  84;tcz + mtx ( n );"C0025677;C1417487";NA;NA;tcz mtx n
  82;creatinine ciearance;"C0010294;C1561535";FALSE;  79;creatinine ciearance
  82;creatinine clearanceb  ml / min;"C0010294;C0439445;C1561535";FALSE;  79;creatinine clearanceb ml min
  82;estimated creatinine clearancet;"C0010294;C0750572;C1561535";FALSE;  79;estimated creatinine clearancet
  82;ratio of urinary albumin ( mg ) to creatinine ( g );"C0010294;C0024671;C0026410;C0439267;C0439269;C0456603;C1547037;C1561535;C1960952;C2346927;C2362049;C4321396;C4521761";FALSE;  80;ratio of urinary albumin mg to creatinine g
  82;ratio of urinary albumin ( mg ) to creatinine ( g ) median;"C0010294;C0024671;C0026410;C0439267;C0439269;C0456603;C0549183;C0876920;C1547037;C1561535;C1960952;C2346927;C2347635;C2348144;C2362049;C2939193;C4321396;C4521761";FALSE;  80;ratio of urinary albumin mg to creatinine g median
  90;$nmbr$ . $nmbr$ ( ne  ne );"C0027608;C0028219;C3538705";FALSE; -10;$nmbr$ $nmbr$ ne ne
  90;< $nmbr$ no . ( % );NA;FALSE; -10;$nmbr$ no
  85;non - rheumatic valvular heart disease;"C0264757;C1518422";FALSE; 103;non rheumatic valvular heart disease
  84;$nmbr$ tcz + mtx mtx;"C0025677;C1417487";NA;NA;$nmbr$ tcz mtx mtx
  84;$nmbr$ tcz + mtx;"C0025677;C1417487";NA;NA;$nmbr$ tcz mtx
  84;$nmbr$ tcz;NA;NA;NA;$nmbr$ tcz
  83;qtc > $nmbr$ n = $nmbr$;NA;NA;NA;qtc $nmbr$ n $nmbr$
  83;qtc < $nmbr$ n = $nmbr$;NA;NA;NA;qtc $nmbr$ n $nmbr$
  83;freedom from gtc seizures  n ( % );C1299590;NA;NA;freedom from gtc seizures n
  80;mean ( sd ) values are presented for all variables  except medical history  race or ethnic group  and sex ( n  % ) and urinary albumin / creatinine ratio ( median ( range ) ) . abody mass index is the weight in kilograms divided by the square of the height in meters . bto convert values to micromoles per liter  multiply by $nmbr$ . $nmbr$ . estimated using the modified equation from the modification of diet in renal disease study . dto convert values to millimoles per liter  multiply by $nmbr$ . $nmbr$ . eto convert values to millimoles per liter  multiply by $nmbr$ . $nmbr$ . ^ to convert values to millimoles per liter  multiply by $nmbr$ . $nmbr$ .;"C0005910;C0009253;C0015031;C0019664;C0019665;C0034510;C0036864;C0040363;C0041260;C0042027;C0042295;C0043100;C0079399;C0199168;C0205120;C0205476;C0262512;C0262926;C0332849;C0392747;C0439190;C0439194;C0439209;C0439828;C0441074;C0444504;C0449450;C0457987;C0475211;C0486293;C0489786;C0549183;C0552449;C0557651;C0577559;C0577573;C0600653;C0724655;C0750572;C0804628;C0876920;C0918012;C1096155;C1305866;C1306372;C1314687;C1318293;C1514721;C1522384;C1524063;C1524119;C1552595;C1552854;C1554963;C1637833;C1705104;C1705255;C1706779;C1719797;C1879937;C1883351;C2004062;C2347634;C2347635;C2348143;C2348144;C2348147;C2603343;C2699239;C2911648;C2939193;C2986546;C3152252;C3539882;C3542016;C3840684;C3853635;C3889737;C4283905";FALSE; -10;mean sd values are presented for all variables except medical history race or ethnic group and sex n and urinary albumin creatinine ratio median range abody mass index is the weight in kilograms divided by the square of the height in meters bto convert values to micromoles per liter multiply by $nmbr$ $nmbr$ estimated using the modified equation from the modification of diet in renal disease study dto convert values to millimoles per liter multiply by $nmbr$ $nmbr$ eto convert values to millimoles per liter multiply by $nmbr$ $nmbr$ to convert values to millimoles per liter multiply by $nmbr$ $nmbr$
  81;no colchicine ( n = $nmbr$ );C0009262;NA;NA;no colchicine n $nmbr$
  81;colchicine ( n = $nmbr$ );C0009262;NA;NA;colchicine n $nmbr$
  80;urine albumin / creatinine ratio ( mg / g );"C0455271;C1300563;C1318330";NA;NA;urine albumin creatinine ratio mg g
  80;urine albumin / creatinine ratio  mg / mmol;"C0455271;C0567349;C1318330;C2348885";NA;NA;urine albumin creatinine ratio mg mmol
  80;urine albumin / creatinine ( mg / mmol );"C0455271;C0567349;C1318330;C2348885";NA;NA;urine albumin creatinine mg mmol
  80;urine albumin - to - ereatinine ratio;"C0001924;C0042038;C0456603;C0587185;C1273442;C1547037;C2362049";NA;NA;urine albumin to ereatinine ratio
  80;urine albumin - to - creatinine ratio - no . ( % ) § §;"C0455271;C1318330";NA;NA;urine albumin to creatinine ratio no
  80;urine albumin - to - creatinine ratio;"C0455271;C1318330";NA;NA;urine albumin to creatinine ratio
  80;urinary protein - to - creatinine ratio | |;C1096054;NA;NA;urinary protein to creatinine ratio
  80;urinary albumin : creatinine ratioa ( mg / g );"C0455271;C1300563;C1318330";NA;NA;urinary albumin creatinine ratioa mg g
  80;urinary albumin : creatinine ratio ^;"C0455271;C1318330";NA;NA;urinary albumin creatinine ratio
  80;urinary albumin : creatinine ratio *;"C0455271;C1318330";NA;NA;urinary albumin creatinine ratio
  80;urinary albumin : creatinine ratio ( mg / g );"C0455271;C1300563;C1318330";NA;NA;urinary albumin creatinine ratio mg g
  80;urinary albumin - to - creatinine ratio — no . ( % ) §;"C0455271;C1318330";NA;NA;urinary albumin to creatinine ratio no
  80;urinary albumin - to - creatinine ratio §;"C0455271;C1318330";NA;NA;urinary albumin to creatinine ratio
  80;urinary albumin - to - creatinine ratio ^;"C0455271;C1318330";NA;NA;urinary albumin to creatinine ratio
  80;urinary albumimcreatinine ratio;C1273442;NA;NA;urinary albumimcreatinine ratio
  80;median albumin - to - creatinine ratio ( interquartile range );"C0486293;C0549183;C0876920;C1318293;C1711350;C2347635;C2348144;C2939193";NA;NA;median albumin to creatinine ratio interquartile range
  80;baseline albumin / creatinine ratio in $nmbr$ classes;"C0168634;C0456387;C0486293;C1318293;C1442488;C1518526;C1705943;C4019422";NA;NA;baseline albumin creatinine ratio in $nmbr$ classes
  80;albumin creatinine ratio;"C0486293;C1318293";NA;NA;albumin creatinine ratio
  80;albumin / creatinine ratio  n ( % );"C0486293;C1318293";NA;NA;albumin creatinine ratio n
  80;albumin - to - creatinine ratio ( acr );"C0486293;C1318293;C1412134;C1515941";NA;NA;albumin to creatinine ratio acr
  80;albumin - to - creatinine ratio;"C0486293;C1318293";NA;NA;albumin to creatinine ratio
  79;renal fmclicn : creatntoe clearance;"C0232813;C0699829";NA;NA;renal fmclicn creatntoe clearance
  79;estimated creatinine clearance < $nmbr$ rmb ' mint;"C0452249;C0522467;C0750572;C0812399;C1337213;C1576800;C3890003";NA;NA;estimated creatinine clearance $nmbr$ rmb mint
  79;estimated creatinine clearance < $nmbr$ ml / mint;"C0439526;C0452249;C0522467;C0750572;C0812399;C1337213;C1576800;C1705224;C3887665;C3890003";NA;NA;estimated creatinine clearance $nmbr$ ml mint
  79;estimated creatinine clearance  !;"C0750572;C0812399";NA;NA;estimated creatinine clearance
  79;estimated * creatinine clearance < $nmbr$ mlvmin  %;"C0750572;C0812399";NA;NA;estimated creatinine clearance $nmbr$ mlvmin
  79;creatinine clearance ， : : $nmbr$ ml / min  %;"C0439445;C0812399";NA;NA;creatinine clearance $nmbr$ ml min
  79;creatinine clearance — no . ( % );C0812399;NA;NA;creatinine clearance no
  79;creatinine clearance category [ ml / min ];"C0439445;C0683312;C0812399;C3889287";NA;NA;creatinine clearance category ml min
  79;creatinine clearance category  ml / min  no . ( % ) b;"C0439445;C0683312;C0812399;C3889287";NA;NA;creatinine clearance category ml min no b
  79;creatinine clearance at randomization ( ixrs );"C0034656;C0812399";NA;NA;creatinine clearance at randomization ixrs
  79;creatinine clearance at randomization;"C0034656;C0812399";NA;NA;creatinine clearance at randomization
  79;creatinine clearance < $nmbr$ ml / min — no . ( % ) weight < $nmbr$ kg — no . ( % );"C0005910;C0022718;C0043100;C0439209;C0439445;C0812399;C1305866;C1705104;C4054209";NA;NA;creatinine clearance $nmbr$ ml min no weight $nmbr$ kg no
  79;creatinine clearance < $nmbr$ ml / min  no . / total ( % );"C0439175;C0439445;C0439810;C0812399";NA;NA;creatinine clearance $nmbr$ ml min no total
  79;creatinine clearance  no . ( % );C0812399;NA;NA;creatinine clearance no
  79;creatinine clearance  n ( % );C0812399;NA;NA;creatinine clearance n
  79;creatinine clearance  an   ( % );C0812399;NA;NA;creatinine clearance an
  79;creatinine clearance;C0812399;NA;NA;creatinine clearance
  78;chlorthalidone vs amlodipine;"C0008294;C0051696";NA;NA;chlorthalidone vs amlodipine
  78;chlorthalidone - amlodipine - lisinopril;"C0008294;C0051696;C0065374";NA;NA;chlorthalidone amlodipine lisinopril
  78;benazepril / hydrochlorothiazide - benazepril / amlodipine;"C0051696;C0717481";NA;NA;benazepril hydrochlorothiazide benazepril amlodipine
  78;amlodipine vs chlorthalidone overweight;"C0008294;C0051696;C0497406";NA;NA;amlodipine vs chlorthalidone overweight
  78;amlodipine vs chlorthalidone obese;"C0008294;C0028754;C0051696";NA;NA;amlodipine vs chlorthalidone obese
  78;amlodipine / wlsartan i $nmbr$ / $nmbr$ mg;"C0021966;C0024671;C0026410;C0051696;C0221138;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;amlodipine wlsartan i $nmbr$ $nmbr$ mg
  78;amlodipine / vaisartan ( n = $nmbr$ );C0051696;NA;NA;amlodipine vaisartan n $nmbr$
  78;amlodipine / lisinopril $nmbr$;"C0051696;C0065374";NA;NA;amlodipine lisinopril $nmbr$
  78;amlodipine - amlodipine / valsartan;C1962523;NA;NA;amlodipine amlodipine valsartan
  78;amlodipine ( n = $nmbr$ );C0051696;NA;NA;amlodipine n $nmbr$
  78;amlodipine;C0051696;NA;NA;amlodipine
  78;! amlodipine;C0051696;NA;NA;amlodipine
  82;creatinine ratio;"C0010294;C0456603;C1547037;C1561535";FALSE; 952;creatinine ratio
  82;creatinine ratio $nmbr$ - $nmbr$;"C0010294;C0456603;C1547037;C1561535";FALSE; 952;creatinine ratio $nmbr$ $nmbr$
  82;doubling of creatinine;"C0010294;C0205173;C1561535;C1705764";FALSE; 952;doubling of creatinine
  82;doubling of creatinine †;"C0010294;C0205173;C1561535;C1705764";FALSE; 952;doubling of creatinine
  78;nilvadipine;C0132512;FALSE; -10;nilvadipine
  77;corticosteroid - azathioprine / $nmbr$ - mercaptopurine;"C0000618;C0001617;C0004482;C3536709";NA;NA;corticosteroid azathioprine $nmbr$ mercaptopurine
  77;$nmbr$ - mercaptopurine / azathioprine;"C0000618;C0004482";NA;NA;$nmbr$ mercaptopurine azathioprine
  77;$nmbr$ - mercaptopurine;C0000618;NA;NA;$nmbr$ mercaptopurine
 -10;leukotriene modifier;"C0023545;C0205349;C1514623;C1516451;C3542952";NA;NA;leukotriene modifier
  75;prior exposure to lamotrigine;"C0064636;C0274281;C0332152;C0332157;C0524166;C2826257";NA;NA;prior exposure to lamotrigine
  75;lamotrigine;"C0064636;C0524166";NA;NA;lamotrigine
  74;placebo - famotidine $nmbr$ - famotidine $nmbr$;"C0015620;C0032042;C1696465;C1706408";NA;NA;placebo famotidine $nmbr$ famotidine $nmbr$
  74;placebo - famotidine $nmbr$;"C0015620;C0032042;C1696465;C1706408";NA;NA;placebo famotidine $nmbr$
  74;famotidine $nmbr$ - famotidine $nmbr$;C0015620;NA;NA;famotidine $nmbr$ famotidine $nmbr$
  73;thienopyridine use;"C0042153;C0457083;C1120149;C1947944";NA;NA;thienopyridine use
  73;thienopyridine type;"C0332307;C1120149;C1547052";NA;NA;thienopyridine type
  73;thienopyridine n = $nmbr$;C1120149;NA;NA;thienopyridine n $nmbr$
  73;thienopyridine + dipyridamole;"C0012582;C1120149";NA;NA;thienopyridine dipyridamole
  73;thienopyridine ( n = $nmbr$ );C1120149;NA;NA;thienopyridine n $nmbr$
  73;thienopyridine;C1120149;NA;NA;thienopyridine
  73;prior thienopyridine ( - );"C0332152;C1120149;C2826257";NA;NA;prior thienopyridine
  73;prior thienopyridine ( + );"C0332152;C1120149;C2826257";NA;NA;prior thienopyridine
  73;planned thienopyridine at enrollment;"C1120149;C1709561";NA;NA;planned thienopyridine at enrollment
  73;no thienopyridine;C1120149;NA;NA;no thienopyridine
  73;aspirin and thienopyridine therapy;"C0004057;C0039798;C0087111;C1120149;C1363945";NA;NA;aspirin and thienopyridine therapy
  73;aspirin + thienopyridine;"C0004057;C1120149";NA;NA;aspirin thienopyridine
  73;- thienopyridine;C1120149;NA;NA;thienopyridine
  73;+ thienopyridine;C1120149;NA;NA;thienopyridine
  72;thiazolidinedionesc;NA;NA;NA;thiazolidinedionesc
  72;thiazolidinediones *;"C1257987;C3541957";NA;NA;thiazolidinediones
  72;thiazolidinediones;"C1257987;C3541957";NA;NA;thiazolidinediones
  72;thiazolidinedioneb;NA;NA;NA;thiazolidinedioneb
  72;thiazolidinedione 一 no . ( % );"C0289779;C1257987;C3537039";NA;NA;thiazolidinedione no
  72;thiazolidinedione use at baseline;"C0042153;C0168634;C0289779;C0457083;C1257987;C1442488;C1947944;C3537039";NA;NA;thiazolidinedione use at baseline
  72;thiazolidinedione no;"C0289779;C1257987;C3537039";NA;NA;thiazolidinedione no
  72;thiazolidinedione based;"C0289779;C1257987;C1527178;C1705938;C3537039";NA;NA;thiazolidinedione based
  72;thiazolidinedione ( includes pioglitazone );"C0071097;C0289779;C0332257;C1257987;C1552866;C2700399;C3537039";NA;NA;thiazolidinedione includes pioglitazone
  72;thiazolidinedione;"C0289779;C1257987;C3537039";NA;NA;thiazolidinedione
  72;any thiazolidinedione;"C0289779;C1257987;C3537039";NA;NA;any thiazolidinedione
  71;sulfasalazine;C0036078;NA;NA;sulfasalazine
  71;ranozaline;NA;NA;NA;ranozaline
  71;ranolazine n = $nmbr$;C0073633;NA;NA;ranolazine n $nmbr$
  71;ranolazine ( n = $nmbr$ );C0073633;NA;NA;ranolazine n $nmbr$
  71;ranolazine ( n = $nmbr$  $nmbr$ );C0073633;NA;NA;ranolazine n $nmbr$ $nmbr$
  71;ranolazine ( n $nmbr$ $nmbr$ );C0073633;NA;NA;ranolazine n $nmbr$ $nmbr$
  71;ranolazine  n   =   $nmbr$;C0073633;NA;NA;ranolazine n $nmbr$
  71;ranolazine  n = i $nmbr$ i $nmbr$;"C0021966;C0073633;C0221138";NA;NA;ranolazine n i $nmbr$ i $nmbr$
  71;ranolazine;C0073633;NA;NA;ranolazine
  71;prior sulfasalazine use *;"C0036078;C0042153;C0332152;C0457083;C1947944;C2826257";NA;NA;prior sulfasalazine use
  71;hydralazine;C0020223;NA;NA;hydralazine
  70;lisinopril vs chlorthalidone normal;"C0008294;C0065374;C0205307;C0231683;C0439166;C2347086;C4553972";NA;NA;lisinopril vs chlorthalidone normal
  70;lisinopril vs chlorthalidone;"C0008294;C0065374";NA;NA;lisinopril vs chlorthalidone
  70;lisinopril / chlorthalidone;"C0008294;C0065374";NA;NA;lisinopril chlorthalidone
  70;lisinopril - chlorthalidone;"C0008294;C0065374";NA;NA;lisinopril chlorthalidone
  70;favors lisinopril favors chlorthalidone;"C0008294;C0065374;C0309049";NA;NA;favors lisinopril favors chlorthalidone
  70;favors favors lisinopril chlorthalidone;"C0008294;C0065374;C0309049";NA;NA;favors favors lisinopril chlorthalidone
  70;favors favors amlodipine chlorthalidone;"C0008294;C0051696;C0309049";NA;NA;favors favors amlodipine chlorthalidone
  70;favors amlodipine favors chlorthalidone;"C0008294;C0051696;C0309049";NA;NA;favors amlodipine favors chlorthalidone
  70;chlorthalidone vs doxazosin;"C0008294;C0114873";NA;NA;chlorthalidone vs doxazosin
  70;chlorthalidone group;"C0008294;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429";NA;NA;chlorthalidone group
  70;chlorthalidone ( n = $nmbr$ );C0008294;NA;NA;chlorthalidone n $nmbr$
  70;chlorthalidone $nmbr$;C0008294;NA;NA;chlorthalidone $nmbr$
  70;chlorthalidone;C0008294;NA;NA;chlorthalidone
  70;amlodipione - chlorthalidone;C0008294;NA;NA;amlodipione chlorthalidone
  70;amlodipine vs chlorthalidone normal;"C0008294;C0051696;C0205307;C0231683;C0439166;C2347086;C4553972";NA;NA;amlodipine vs chlorthalidone normal
  70;amlodipine / lisinopril / chlorthalidone comparison;"C0008294;C0051696;C0065374;C1707455";NA;NA;amlodipine lisinopril chlorthalidone comparison
  70;amlodipine / chlorthalidone;"C0008294;C0051696";NA;NA;amlodipine chlorthalidone
  70;$nmbr$ lisinopril - chlorthalidone;"C0008294;C0065374";NA;NA;$nmbr$ lisinopril chlorthalidone
 959;$nmbr$ - blocker;NA;FALSE; -10;$nmbr$ blocker
  70;$nmbr$ chlorthalidone amlodipine;"C0008294;C0051696";NA;NA;$nmbr$ chlorthalidone amlodipine
  70;$nmbr$ chlorthalidone ( n = $nmbr$ );C0008294;NA;NA;$nmbr$ chlorthalidone n $nmbr$
  70;$nmbr$ chlorthalidone;C0008294;NA;NA;$nmbr$ chlorthalidone
  70;$nmbr$ amlodipine - chlorthalidone;"C0008294;C0051696";NA;NA;$nmbr$ amlodipine chlorthalidone
  69;placebo + insulin glargine ( award - $nmbr$  n = $nmbr$ );"C0004446;C0032042;C0907402;C1696465;C1706408";NA;NA;placebo insulin glargine award $nmbr$ n $nmbr$
  69;insulin glargine   ±   oad   +   od prandial;"C0229089;C0439164;C0907402;C1512019;C1998602;C3273373;C3665488;C4553624";NA;NA;insulin glargine oad od prandial
  69;insulin glargine   ±   oad   +   bd prandial;"C0005126;C0907402;C1998602;C2344255;C4050145;C4553624";NA;NA;insulin glargine oad bd prandial
  69;insulin glargine   ±   oad   +   > bd prandial;"C0005126;C0907402;C1998602;C2344255;C4050145;C4553624";NA;NA;insulin glargine oad bd prandial
  69;insulin glargine   ±   oad;C0907402;NA;NA;insulin glargine oad
  69;insulin glargine n ( x );C0907402;NA;NA;insulin glargine n x
  69;insulin glargine allocation;"C0907402;C1706778";NA;NA;insulin glargine allocation
  69;insulin glargine + insulin lispro ( award - $nmbr$  n = $nmbr$ );"C0004446;C0293359;C0907402";NA;NA;insulin glargine insulin lispro award $nmbr$ n $nmbr$
  69;insulin glargine ( n = $nmbr$ );C0907402;NA;NA;insulin glargine n $nmbr$
  69;insulin glargine;C0907402;NA;NA;insulin glargine
  69;insuiin giargine ± oad;NA;NA;NA;insuiin giargine oad
  69;iglar ( n   =   $nmbr$ );NA;NA;NA;iglar n $nmbr$
  69;iglar ( insulin glargine l $nmbr$ u );"C0439148;C0907402";NA;NA;iglar insulin glargine l $nmbr$ u
  69;glargine allocation;"C0907402;C1706778";NA;NA;glargine allocation
  69;glargine $nmbr$;C0907402;NA;NA;glargine $nmbr$
  69;glargine;C0907402;NA;NA;glargine
  69;giargine;NA;NA;NA;giargine
  68;ivabradine group ( n = $nmbr$ );"C0257190;C0441848";NA;NA;ivabradine group n $nmbr$
  68;ivabradine group;"C0257190;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429";NA;NA;ivabradine group
  68;ivabradine ( n = $nmbr$ );C0257190;NA;NA;ivabradine n $nmbr$
  68;ivabradine;C0257190;NA;NA;ivabradine
  67;rolofylline rx;"C0166128;C1425688;C1521941;C2709207";NA;NA;rolofylline rx
  67;rolofylline n;C0166128;NA;NA;rolofylline n
  67;rolofylline dose;"C0166128;C0178602;C0869039;C1114758";NA;NA;rolofylline dose
  67;rolofylline ( n = $nmbr$ );C0166128;NA;NA;rolofylline n $nmbr$
  67;rolofylline ( n = $nmbr$  $nmbr$ );C0166128;NA;NA;rolofylline n $nmbr$ $nmbr$
  67;rolofylline $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0166128;C0439269;C1960952;C2346927;C4321396;C4521761";NA;NA;rolofylline $nmbr$ mg n $nmbr$
  66;theophylline compound;"C0039771;C0205198;C1706082";NA;NA;theophylline compound
  65;prior angina pectoris — no . / total no . ( % );"C0002962;C0332152;C0439175;C0439810;C2826257";NA;NA;prior angina pectoris no total no
  65;prior angina pectoris;"C0002962;C0332152;C2826257";NA;NA;prior angina pectoris
  65;prior angina ( n = $nmbr$  $nmbr$ );"C0002962;C0332152;C2826257";NA;NA;prior angina n $nmbr$ $nmbr$
  65;prior angina  n / n ( % );"C0002962;C0332152;C2826257";NA;NA;prior angina n n
  65;prior angina;"C0002962;C0332152;C2826257";NA;NA;prior angina
  65;previous angina pectoris;"C0002962;C0205156;C1552607";NA;NA;previous angina pectoris
  65;previous angina  n ( % );"C0002962;C0205156;C1552607";NA;NA;previous angina n
  65;no prior angina ( n = $nmbr$  $nmbr$ );"C0002962;C0332152;C2826257";NA;NA;no prior angina n $nmbr$ $nmbr$
  65;myocardial infarction or angina;"C0002962;C0027051;C0428953;C2926063;C3810814;C4552959";NA;NA;myocardial infarction or angina
  65;hospitaiization for angina;C0002962;NA;NA;hospitaiization for angina
  65;angina symptoms ^;C0858277;NA;NA;angina symptoms
  65;angina pectorisf;C0002962;NA;NA;angina pectorisf
  65;angina pectoris 本;C0002962;NA;NA;angina pectoris
  65;angina pectoris — no . ( % );C0002962;NA;NA;angina pectoris no
  65;angina pectoris *;C0002962;NA;NA;angina pectoris
  65;angina pectoris  ( % );C0002962;NA;NA;angina pectoris
  65;angina pectoris;C0002962;NA;NA;angina pectoris
  65;angina or acute mi;"C0002962;C0155626";NA;NA;angina or acute mi
  65;angina .;C0002962;NA;NA;angina
  65;angina  n ( % );C0002962;NA;NA;angina n
  65;angina;C0002962;NA;NA;angina
  63;aii patients ( n = $nmbr$ );"C0030705;C1424250;C2698414";NA;NA;aii patients n $nmbr$
  63;aii participants ( n = $nmbr$ );"C0679646;C1424250;C2698414";NA;NA;aii participants n $nmbr$
  63;ai $nmbr$;"C0003504;C4551710";NA;NA;ai $nmbr$
  63;$nmbr$ i - $nmbr$ - $nmbr$ ai;"C0003504;C0021966;C0221138;C4551710";NA;NA;$nmbr$ i $nmbr$ $nmbr$ ai
  62;flex ain ' ’;C0347129;NA;NA;flex ain
  62;ain  no . ( % ) “ *;C0347129;NA;NA;ain no
  62;ain  no . ( % ) * *;C0347129;NA;NA;ain no
  61;insulin glargine - air insulin / insulin glargine;"C0001861;C0907402;C3536832";NA;NA;insulin glargine air insulin insulin glargine
  61;air insulin - insulin glargine - air insulin / insulin glargine;"C0001861;C0907402;C3536832";NA;NA;air insulin insulin glargine air insulin insulin glargine
  61;air insulin - air insulin / insulin glargine;"C0001861;C0907402;C3536832";NA;NA;air insulin air insulin insulin glargine
  61;air ( n = $nmbr$ );"C0001861;C3536832";NA;NA;air n $nmbr$
  60;s - asa compounds at baseline;"C0004057;C0010139;C0043474;C0168634;C1442488;C3853627";NA;NA;s asa compounds at baseline
  60;prior asa use;"C0004057;C0042153;C0332152;C0457083;C1947944;C2826257;C3853627";NA;NA;prior asa use
  60;pfo + asa;"C0004057;C3853627";NA;NA;pfo asa
  60;no asa use at baseline;"C0004057;C0042153;C0168634;C0457083;C1442488;C1947944;C3853627";NA;NA;no asa use at baseline
  60;no asa;"C0004057;C3853627";NA;NA;no asa
  64;due worsening angina;"C0002965;C0678226;C3146286";FALSE;  65;due worsening angina
  60;baseline $nmbr$ - asa;"C0004057;C0168634;C1442488;C3853627";NA;NA;baseline $nmbr$ asa
  64;rest angina;"C0002965;C0152172";FALSE;  65;rest angina
  64;rest angina but not past $nmbr$ h;"C0002965;C0033727;C0152172;C0369286;C0441932;C0564385;C1444637;C1518422;C4284302;C4528284";FALSE;  65;rest angina but not past $nmbr$ h
  64;unstable angina;C0002965;FALSE;  65;unstable angina
  64;unstable angina ( n = $nmbr$  $nmbr$ );C0002965;FALSE;  65;unstable angina n $nmbr$ $nmbr$
  64;unstable angina — no . ( % );C0002965;FALSE;  65;unstable angina no
  64;unstable but no rest angina;"C0002965;C0152172;C0443343;C1883468";FALSE;  65;unstable but no rest angina
  64;worsening angina;C0002965;FALSE;  65;worsening angina
  60;asas partial remission    n   ( % );"C0004057;C1521726;C3853627;C4552913;C4552914";NA;NA;asas partial remission n
  60;asas partial remission  %;"C0004057;C1521726;C3853627;C4552913;C4552914";NA;NA;asas partial remission
  60;asas $nmbr$ / $nmbr$    n   ( % );"C0004057;C3853627";NA;NA;asas $nmbr$ $nmbr$ n
  60;asas $nmbr$ / $nmbr$    %;"C0004057;C3853627";NA;NA;asas $nmbr$ $nmbr$
  60;asas $nmbr$    %;"C0004057;C3853627";NA;NA;asas $nmbr$
  60;asas $nmbr$  %;"C0004057;C3853627";NA;NA;asas $nmbr$
  60;asas $nmbr$;"C0004057;C3853627";NA;NA;asas $nmbr$
  60;asa use at baseline  n ( % );"C0004057;C0042153;C0168634;C0457083;C1442488;C1947944;C3853627";NA;NA;asa use at baseline n
  60;asa use at baseline;"C0004057;C0042153;C0168634;C0457083;C1442488;C1947944;C3853627";NA;NA;asa use at baseline
  60;asa  n ( % );"C0004057;C3853627";NA;NA;asa n
  60;asa;"C0004057;C3853627";NA;NA;asa
  59;myalgia;"C0231528;C4552646";NA;NA;myalgia
  59;malaysia;C0024552;NA;NA;malaysia
  58;prior analgesic products  n ( % );"C0002771;C0332152;C2826257";NA;NA;prior analgesic products n
  58;analgesic medication  n ( % );C0002771;NA;NA;analgesic medication n
  57;alpha reductase inhibitors;"C0439095;C0597153;C1655741;C2003941;C2350010";NA;NA;alpha reductase inhibitors
  28;placebo ( n   =   $nmbr$ );"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$
  56;corticosteroid or azathioprine / $nmbr$ - mercaptopurine;"C0000618;C0001617;C0004482;C3536709";NA;NA;corticosteroid or azathioprine $nmbr$ mercaptopurine
  56;azathioprine monotherapy;C0004482;NA;NA;azathioprine monotherapy
  56;azathioprine / $nmbr$ - mercaptopurine;"C0000618;C0004482";NA;NA;azathioprine $nmbr$ mercaptopurine
  56;azathioprine ( n = $nmbr$ );C0004482;NA;NA;azathioprine n $nmbr$
  56;azathioprine;C0004482;NA;NA;azathioprine
  56;aza ( n = $nmbr$ );C0004482;NA;NA;aza n $nmbr$
  56;and / or aza at baseline;"C0004482;C0168634;C1442488";NA;NA;and or aza at baseline
  56;$nmbr$ - up and / or aza at baseline;"C0004482;C0168634;C1442488";NA;NA;$nmbr$ up and or aza at baseline
  55;the netherlands  australia  new zealand  and south africa;"C0027778;C0037712;C4289954";NA;NA;the netherlands australia new zealand and south africa
  55;austria;C0004348;NA;NA;austria
  55;australia / new zealand / south africa;"C0037712;C4289954";NA;NA;australia new zealand south africa
  55;australia / new zealand;C4289954;NA;NA;australia new zealand
  55;asia / australia / new zealand;"C0003980;C4289954";NA;NA;asia australia new zealand
  54;western european includinq australia  israel  and south africa;"C0004340;C0022271;C0037712;C0043128;C0239307;C0239312;C1535514";NA;NA;western european includinq australia israel and south africa
  54;western europe and australia;"C0004340;C0043129";NA;NA;western europe and australia
  54;australia / nz;"C0004340;C0027978";NA;NA;australia nz
  54;australia;C0004340;NA;NA;australia
  54;australasia;"C0282279;C1257882";NA;NA;australasia
  53;regional anaesthesia;C0002911;NA;NA;regional anaesthesia
  53;paresthesia;"C0030554;C4553220";NA;NA;paresthesia
  53;general anaesthesia;"C0002915;C2930406";NA;NA;general anaesthesia
  60;aspirin at last follow - up;"C0004057;C0589120;C1522577;C1704685;C3274571";FALSE;1366;aspirin at last follow up
  60;aspirin group;"C0004057;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429";FALSE;1366;aspirin group
  60;aspirin group ( n = $nmbr$ );"C0004057;C0441848";FALSE;1366;aspirin group n $nmbr$
  60;aspirin $nmbr$;C0004057;FALSE;1366;aspirin $nmbr$
  60;aspirin $nmbr$  $nmbr$;C0004057;FALSE;1366;aspirin $nmbr$ $nmbr$
  60;aspirin ( n = $nmbr$ );C0004057;FALSE;1366;aspirin n $nmbr$
  60;baseiine aspirin;C0004057;FALSE;1366;baseiine aspirin
  60;high - dose aspirin;"C0004057;C0444956";FALSE;1366;high dose aspirin
  57;alpha receptor antagonist;"C0439095;C2003941;C2350010;C4543207";FALSE; 961;alpha receptor antagonist
  52;urinary acr;"C0042027;C1412134;C1515941;C1524119";NA;NA;urinary acr
  52;sprint acr > $nmbr$ - $nmbr$;"C1412134;C1515941";NA;NA;sprint acr $nmbr$ $nmbr$
  52;sprint acr < $nmbr$ - $nmbr$;"C1412134;C1515941";NA;NA;sprint acr $nmbr$ $nmbr$
  52;categories of urinary acr  ^ g / mg;"C0042027;C0683312;C1300563;C1412134;C1515941;C1524119";NA;NA;categories of urinary acr g mg
  52;b . acr $nmbr$;"C1412134;C1515941";NA;NA;b acr $nmbr$
  52;albuminuria ( acr > $nmbr$ m . g / g ) at baseline to normoalbuminuria;"C0001925;C0168634;C0369637;C0441923;C1319635;C1412134;C1442488;C1515941";NA;NA;albuminuria acr $nmbr$ m g g at baseline to normoalbuminuria
  52;acr response by baseline weight;"C0871261;C1303013;C1412134;C1515941;C1704632;C1706817;C2911692";NA;NA;acr response by baseline weight
  52;acr response by baseline mtx use  no . / total no . ( % ) acr $nmbr$;"C0025677;C0042153;C0168634;C0439175;C0439810;C0457083;C0871261;C1412134;C1417487;C1442488;C1515941;C1704632;C1706817;C1947944;C2911692";NA;NA;acr response by baseline mtx use no total no acr $nmbr$
  52;acr response  % acr $nmbr$;"C0871261;C1412134;C1515941;C1704632;C1706817;C2911692";NA;NA;acr response acr $nmbr$
  52;acr response  %;"C0871261;C1412134;C1515941;C1704632;C1706817;C2911692";NA;NA;acr response
  52;acr functional class  n ( % );"C0205245;C0456387;C0542341;C1412134;C1515941;C1518526;C1705943;C2700217";NA;NA;acr functional class n
  52;acr deciles;"C1412134;C1515941";NA;NA;acr deciles
  52;acr $nmbr$ response at week $nmbr$  n ( % );"C0332174;C0439230;C0871261;C1412134;C1515941;C1704632;C1706817;C2911692";NA;NA;acr $nmbr$ response at week $nmbr$ n
  52;acr $nmbr$ response  n / n ( % );"C0871261;C1412134;C1515941;C1704632;C1706817;C2911692";NA;NA;acr $nmbr$ response n n
  52;acr $nmbr$ response;"C0871261;C1412134;C1515941;C1704632;C1706817;C2911692";NA;NA;acr $nmbr$ response
  52;acr $nmbr$;"C1412134;C1515941";NA;NA;acr $nmbr$
  52;acr;"C1412134;C1515941";NA;NA;acr
  52;accord acr > $nmbr$ - $nmbr$;"C0680240;C1412134;C1515941";NA;NA;accord acr $nmbr$ $nmbr$
  52;accord acr < $nmbr$ - $nmbr$;"C0680240;C1412134;C1515941";NA;NA;accord acr $nmbr$ $nmbr$
  52;a . acr $nmbr$;"C1412134;C1515941";NA;NA;a acr $nmbr$
  51;arr ( % );"C2170357;C4084934";NA;NA;arr
  51;arr ( $nmbr$ % cl );"C0596019;C2170357;C4084934";NA;NA;arr $nmbr$ cl
  51;arr ( $nmbr$ % ci );"C0008107;C2170357;C3259781;C4084934";NA;NA;arr $nmbr$ ci
  51;arr;"C2170357;C4084934";NA;NA;arr
  51;> $nmbr$ % predicted arr ( n = $nmbr$ );"C0681842;C1882327;C2170357;C4084934";NA;NA;$nmbr$ predicted arr n $nmbr$
  51;> $nmbr$ % and < $nmbr$ % predicted arr ( n = $nmbr$  $nmbr$ );"C0681842;C1882327;C2170357;C4084934";NA;NA;$nmbr$ and $nmbr$ predicted arr n $nmbr$ $nmbr$
  51;< $nmbr$ % predicted arr ( n = $nmbr$  $nmbr$ );"C0681842;C1882327;C2170357;C4084934";NA;NA;$nmbr$ predicted arr n $nmbr$ $nmbr$
  50;diarrhoea;"C0011991;C1963091;C3641756;C4084784;C4084802;C4085317";NA;NA;diarrhoea
  50;diarrhea;"C0011991;C1963091;C3641756;C4084784;C4084802;C4085317";NA;NA;diarrhea
  49;married;"C0024841;C0555047";NA;NA;married
  49;marital status  married;"C0024819;C0024841;C0555047;C1716536;C3172566";NA;NA;marital status married
  48;middle east  africa  or asia - pacific;"C0001737;C0001741;C0003980;C0026068;C0444598;C0549183;C1552826";NA;NA;middle east africa or asia pacific
  48;asia pacific and africa;"C0001737;C0003980";NA;NA;asia pacific and africa
  48;africa or near east;"C0001737;C0205674";NA;NA;africa or near east
  48;africa *;C0001737;NA;NA;africa
  48;africa ! near east;"C0001737;C1707877";NA;NA;africa near east
  48;africa  asia  or the middle east;"C0001737;C0003980;C0026068";NA;NA;africa asia or the middle east
  48;africa;C0001737;NA;NA;africa
  47;≥ $nmbr$ ae;C3887670;NA;NA;$nmbr$ ae
  47;laboratory ae  n ( % };"C0022877;C3244292;C3887670;C4283904";NA;NA;laboratory ae n
  47;drug - related ae *;"C0013227;C0439849;C0445223;C1254351;C3887670";NA;NA;drug related ae
  47;clinical ae  n ( % };"C0205210;C3887670";NA;NA;clinical ae n
  47;because of ae;C3887670;NA;NA;because of ae
  47;any drug - related ae  n ( % );"C0013227;C0439849;C0445223;C1254351;C3887670";NA;NA;any drug related ae n
  47;any clinical ae;"C0205210;C3887670";NA;NA;any clinical ae
  47;any ae  n ( % ) ‡;C3887670;NA;NA;any ae n
  47;any ae;C3887670;NA;NA;any ae
  47;any adverse event ( ae );"C0877248;C3887670";NA;NA;any adverse event ae
  46;randomly assigned to ace;"C1452534;C1516050;C1552601;C4284014";NA;NA;randomly assigned to ace
  46;no ace - i / arb;"C0021966;C0221138;C1452534;C3888198;C4284014";NA;NA;no ace i arb
  46;neither ace - i nor arb use;"C0021966;C0042153;C0221138;C0457083;C1452534;C1947944;C3888198;C4284014";NA;NA;neither ace i nor arb use
  46;arb / ace;"C1452534;C3888198;C4284014";NA;NA;arb ace
  46;ace ‐ i or arb;"C0021966;C0221138;C1452534;C3888198;C4284014";NA;NA;ace i or arb
  46;ace or arb;"C1452534;C3888198;C4284014";NA;NA;ace or arb
  46;ace / arb users;"C1452534;C1706077;C3888198;C4284014";NA;NA;ace arb users
  46;ace / arb medication ( % );"C0013227;C1452534;C3244316;C3888198;C4284014;C4284232";NA;NA;ace arb medication
  46;ace / arb;"C1452534;C3888198;C4284014";NA;NA;ace arb
  46;ace - lorarb;"C1452534;C4284014";NA;NA;ace lorarb
  46;ace - l / arbs;"C1452534;C3888198;C4284014";NA;NA;ace l arbs
  28;placebo ( n   =   $nmbr$  $nmbr$ );"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$ $nmbr$
  46;ace - i or arb use at baseline;"C0021966;C0042153;C0168634;C0221138;C0457083;C1442488;C1452534;C1947944;C3888198;C4284014";NA;NA;ace i or arb use at baseline
  46;ace - i or arb use;"C0021966;C0042153;C0221138;C0457083;C1452534;C1947944;C3888198;C4284014";NA;NA;ace i or arb use
  46;ace - i or arb  % ( n );"C0021966;C0221138;C1452534;C3888198;C4284014";NA;NA;ace i or arb n
  46;ace - i or arb;"C0021966;C0221138;C1452534;C3888198;C4284014";NA;NA;ace i or arb
  46;ace - i / arb  ( % );"C0021966;C0221138;C1452534;C3888198;C4284014";NA;NA;ace i arb
  46;ace - i / arb;"C0021966;C0221138;C1452534;C3888198;C4284014";NA;NA;ace i arb
  46;ace - i ( n  % );"C0021966;C0221138;C1452534;C4284014";NA;NA;ace i n
  46;ace;"C1452534;C4284014";NA;NA;ace
  45;age — yr age group — no . ( % );"C0027362;C0439234;C2348001";NA;NA;age yr age group no
  45;age group 一 ％;"C0027362;C2348001";NA;NA;age group
  45;age group — no . ( % );"C0027362;C2348001";NA;NA;age group no
  45;age group ( ≥ $nmbr$ ) — no . ( % );"C0027362;C2348001";NA;NA;age group $nmbr$ no
  45;age group ( years );"C0027362;C0439234;C0441833;C0687744;C1257890;C1510829;C1519504;C1705428;C1705429;C2348001";NA;NA;age group years
  45;age group $nmbr$;"C0027362;C2348001";NA;NA;age group $nmbr$
  45;age group  no . ( % )  y;"C0027362;C2348001";NA;NA;age group no y
  45;age group  no . ( % );"C0027362;C2348001";NA;NA;age group no
  45;age group;"C0027362;C2348001";NA;NA;age group
  45;age cohort  no . ( % );C2348001;NA;NA;age cohort no
  44;without acei / arb;C3888198;NA;NA;without acei arb
  44;with acei / arb;C3888198;NA;NA;with acei arb
  44;use of ace inhibitors / arbs  n ( % );"C0003015;C1524063;C3888198";NA;NA;use of ace inhibitors arbs n
  44;use of ace inhibitor  arb  or both — no . ( % );"C0003015;C1524063;C3888198;C4541021";NA;NA;use of ace inhibitor arb or both no
  44;prior bb plus acbi plus arb use;"C0004739;C0042153;C0332152;C0332287;C0332297;C0457083;C1947944;C2826257;C3888198";NA;NA;prior bb plus acbi plus arb use
  44;prior acbi or arb use;"C0042153;C0332152;C0457083;C1947944;C2826257;C3888198";NA;NA;prior acbi or arb use
  44;previously on acei + arb;C3888198;NA;NA;previously on acei arb
  44;peri - op ace - inhibitors / arbs : no ( n = $nmbr$ );"C0003015;C0347985;C0369718;C0441922;C3888198";NA;NA;peri op ace inhibitors arbs no n $nmbr$
  44;no ace inhibitor / arb;"C0003015;C3888198;C4541021";NA;NA;no ace inhibitor arb
 367;drug eluting;"C0013227;C1254351";FALSE; 365;drug eluting
  44;neither ace inhibitor nor arb;"C0003015;C3888198;C4541021";NA;NA;neither ace inhibitor nor arb
  44;both ace inhibitor and arb;"C0003015;C3888198;C4541021";NA;NA;both ace inhibitor and arb
  44;baseiine acei / arb;C3888198;NA;NA;baseiine acei arb
  44;arbs or ace inhibitors;"C0003015;C3888198";NA;NA;arbs or ace inhibitors
  44;arbs;C3888198;NA;NA;arbs
  44;arb or ace inhibitor  n ( % );"C0003015;C3888198;C4541021";NA;NA;arb or ace inhibitor n
  44;arb or ace inhibitor;"C0003015;C3888198;C4541021";NA;NA;arb or ace inhibitor
  44;arb monotherapy;C3888198;NA;NA;arb monotherapy
  44;arb at enrollment;"C1516879;C1696073;C3888021;C3888198";NA;NA;arb at enrollment
  44;arb ( n  % );C3888198;NA;NA;arb n
  44;arb  n ( % );C3888198;NA;NA;arb n
  44;arb  %;C3888198;NA;NA;arb
  44;arb;C3888198;NA;NA;arb
  44;aceis / arbs;C3888198;NA;NA;aceis arbs
  44;aceis  n ( % );NA;NA;NA;aceis n
  44;aceis;NA;NA;NA;aceis
  44;acei or arb pre - randomisation;"C0034656;C0332152;C0740175;C2257086;C3669034;C3888198";NA;NA;acei or arb pre randomisation
  44;acei or arb post - randomisation;"C0034656;C0687676;C1704687;C3469826;C3888198";NA;NA;acei or arb post randomisation
  44;acei or arb;C3888198;NA;NA;acei or arb
  44;acei and / or arb;C3888198;NA;NA;acei and or arb
  44;acei / arb therapy  n ( % );"C0039798;C0087111;C1363945;C3888198";NA;NA;acei arb therapy n
  44;acei / arb;C3888198;NA;NA;acei arb
  44;ace inhibitors or arbs;"C0003015;C3888198";NA;NA;ace inhibitors or arbs
  44;ace inhibitors or arb;"C0003015;C3888198";NA;NA;ace inhibitors or arb
  44;ace inhibitors and arb;"C0003015;C3888198";NA;NA;ace inhibitors and arb
  44;ace inhibitors / arbs  n ( % );"C0003015;C3888198";NA;NA;ace inhibitors arbs n
  44;ace inhibitors / arbs;"C0003015;C3888198";NA;NA;ace inhibitors arbs
  44;ace inhibitors / arb;"C0003015;C3888198";NA;NA;ace inhibitors arb
  44;ace inhibitor or arb at enrollment;"C0003015;C1516879;C1696073;C3888021;C3888198;C4541021";NA;NA;ace inhibitor or arb at enrollment
  44;ace inhibitor or arb;"C0003015;C3888198;C4541021";NA;NA;ace inhibitor or arb
  44;ace inhibitor and / or arb;"C0003015;C3888198;C4541021";NA;NA;ace inhibitor and or arb
  44;ace inhibitor / arb therapy;"C1444755;C3888198";NA;NA;ace inhibitor arb therapy
  44;ace inhibitor / arb  %;"C0003015;C3888198;C4541021";NA;NA;ace inhibitor arb
  44;ace inhibitor / arb;"C0003015;C3888198;C4541021";NA;NA;ace inhibitor arb
  44;ace inhibitor  arb  or both;"C0003015;C3888198;C4541021";NA;NA;ace inhibitor arb or both
  44;ace / arb use;"C0042153;C0457083;C1452534;C1947944;C3888198;C4284014";NA;NA;ace arb use
  44;ace - inhibitors / arbs  n ( % );"C0003015;C3888198";NA;NA;ace inhibitors arbs n
  44;ace - inhibitor or arb ( % );"C0003015;C3888198;C4541021";NA;NA;ace inhibitor or arb
  43;limited to left side of colon;"C0227388;C0439801;C2674459;C3542948;C4050251";NA;NA;limited to left side of colon
  43;left sided colitis;C2887821;NA;NA;left sided colitis
  43;left side only;C3842976;NA;NA;left side only
  43;left side of colon;C0227388;NA;NA;left side of colon
  43;left shoulder;C0524469;NA;NA;left shoulder
  43;left - sided disease only;"C0012634;C3842976";NA;NA;left sided disease only
  43;left - sided colitis;C2887821;NA;NA;left sided colitis
  42;unprotected left main stented;"C0038257;C0205091;C0205225;C0443246;C1542147;C1552822";NA;NA;unprotected left main stented
  42;multivessel ( two vessel  three vessel  or left main );"C0205091;C0205225;C0205449;C0443246;C1542147;C1552822;C4012475;C4037954";NA;NA;multivessel two vessel three vessel or left main
  42;left side  n ( % );C0205091;NA;NA;left side n
  42;left main treated;"C0205091;C0205225;C0443246;C1522326;C1542147;C1552822";NA;NA;left main treated
  42;left main disease  n ( % );"C0012634;C0205091;C0205225;C0443246;C1542147;C1552822";NA;NA;left main disease n
  42;left main disease;"C0012634;C0205091;C0205225;C0443246;C1542147;C1552822";NA;NA;left main disease
  42;left main artery;"C0003842;C0205091;C0205225;C0226004;C0443246;C1542147;C1552822";NA;NA;left main artery
  42;left main;"C0205091;C0205225;C0443246;C1542147;C1552822";NA;NA;left main
  42;left - sided colitisz;"C0205091;C0443246";NA;NA;left sided colitisz
  42;left;"C0205091;C0443246;C1552822";NA;NA;left
  41;left atrial dimension  cm;"C0018792;C0439534;C2950135";NA;NA;left atrial dimension cm
  41;alert;"C0239110;C2004580;C3665546;C3669039;C4084853;C4553014";NA;NA;alert
  40;left ventricular systolic or diastolic dysfunction;"C0039155;C0225897;C0520863";NA;NA;left ventricular systolic or diastolic dysfunction
  40;left ventricular systolic dysfunction  n ( % );"C1277187;C1963159;C4553199";NA;NA;left ventricular systolic dysfunction n
  40;left ventricular ejection;C2733342;NA;NA;left ventricular ejection
  40;left ventricular dysfunction;C0242698;NA;NA;left ventricular dysfunction
  40;ecg left ventricular;"C0225897;C1623258";NA;NA;ecg left ventricular
  37;weight  mean $nmbr$ sd kg;"C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209";FALSE;1915;weight mean $nmbr$ sd kg
  37;weight  mean ( sd ) kg;"C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209";FALSE;1915;weight mean sd kg
  28;placebo ( n   = $nmbr$ );"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$
  40;af alone refers to atrial fi - brillation without coexisting cardiovascular conditions but with left atrial dilatation . ace denotes angiotensin - con - verting enzyme  hf heart failure  and lvd left ventricular dysfunction .;"C0003018;C0007226;C0012634;C0014442;C0018792;C0018801;C0205171;C0205543;C0242698;C0344434;C0344720;C0348080;C0387288;C0439044;C0679994;C1452534;C1705253;C3864998;C3887460;C4049859;C4050619;C4284014;C4521302;C4521602";NA;NA;af alone refers to atrial fi brillation without coexisting cardiovascular conditions but with left atrial dilatation ace denotes angiotensin con verting enzyme hf heart failure and lvd left ventricular dysfunction
  39;saxa + met n = $nmbr$;"C0369718;C0428210;C0441922;C1550543;C4317104";NA;NA;saxa met n $nmbr$
  39;saxa + dapa + met n = $nmbr$;"C0369718;C0428210;C0441922;C1550543;C4317104";NA;NA;saxa dapa met n $nmbr$
  39;no longer met study criteria;"C0205166;C0243161;C0428210;C0557651;C1550543;C1706317;C2603343;C4317104";NA;NA;no longer met study criteria
  39;met criterion at finalt;"C0243161;C0428210;C1550543;C4317104";NA;NA;met criterion at finalt
  39;met criterion at final ( n [ % ] );"C0205088;C0243161;C0428210;C1546485;C1550543;C3853528;C4317104";NA;NA;met criterion at final n
  39;met criterion at blt ( n [ % ] );"C0243161;C0428210;C1550543;C1563149;C1708627;C4317104";NA;NA;met criterion at blt n
  39;met criterion at bl ( n [ % ] );"C0005918;C0006413;C0243161;C0428210;C1550543;C1552663;C2827109;C4317104";NA;NA;met criterion at bl n
  39;met ( n = $nmbr$ );"C0428210;C1550543;C4317104";NA;NA;met n $nmbr$
  39;met % △ ( se );"C0036919;C0428210;C1550543;C4317104";NA;NA;met se
  39;mean ( $nmbr$ % ci ) difference vs saxa + dapa + met;"C0008107;C0428210;C0444504;C1550543;C1705241;C1705242;C2347634;C2348143;C3259781;C4317104";NA;NA;mean $nmbr$ ci difference vs saxa dapa met
  39;dapa + met n = $nmbr$;"C0369718;C0428210;C0441922;C1550543;C4317104";NA;NA;dapa met n $nmbr$
  39;cana $nmbr$ / met ( n = $nmbr$ );"C0369718;C0428210;C0441922;C1418845;C1550543;C4317104";NA;NA;cana $nmbr$ met n $nmbr$
  39;add - on to met + su $nmbr$;"C0038642;C0428210;C1550543;C1705534;C1883712;C4317104";NA;NA;add on to met su $nmbr$
  39;add - on to met + su;"C0038642;C0428210;C1550543;C1705534;C1883712;C4317104";NA;NA;add on to met su
  39;add - on to met $nmbr$;"C0428210;C1550543;C1883712;C4317104";NA;NA;add on to met $nmbr$
  39;add - on to met;"C0428210;C1550543;C1883712;C4317104";NA;NA;add on to met
  38;placeboa;NA;NA;NA;placeboa
  38;mean_delta;"C0439097;C0444504;C1705241;C2347634;C2348143;C3146239;C3538806;C3540585;C3815527";NA;NA;mean_delta
  38;difference from placeboa;"C1705241;C1705242";NA;NA;difference from placeboa
  38;am_delta;"C0439097;C1705241;C3146239;C3538806;C3540585;C3815527";NA;NA;am_delta
  38;am_ % delta;"C0439097;C1705241;C3146239;C3538806;C3540585;C3815527";NA;NA;am_ delta
  37;★ reported by physicians . tdata are median ( iqr ) . all data are mean ( sd ) or number ( % ) unless otherwise indicated .;"C0031831;C0237753;C0444504;C0449788;C0549183;C0876920;C1444656;C1511726;C1709908;C2347634;C2347635;C2348143;C2348144;C2699239;C2939193;C3245479;C3714741";NA;NA;reported by physicians tdata are median iqr all data are mean sd or number unless otherwise indicated
  37;years ( mean ± sd );"C0439234;C0444504;C2347634;C2348143;C2699239";NA;NA;years mean sd
  37;years  mean ( sd );"C0439234;C0444504;C2347634;C2348143;C2699239";NA;NA;years mean sd
  37;week $nmbr$ fpg  mean ( s . e . );"C0332174;C0439230;C0444504;C2347634;C2348143";NA;NA;week $nmbr$ fpg mean s e
  37;van der heijde mtss  mean ( sd );"C0444504;C0557775;C1511780;C2347634;C2348143;C2699239";NA;NA;van der heijde mtss mean sd
  37;ups score  mean ( sd );"C0334463;C0444504;C0449820;C2347634;C2348143;C2699239;C3542434;C4050231";NA;NA;ups score mean sd
  37;units per week  mean ( sd );"C0444504;C0560588;C2347634;C2348143;C2699239";NA;NA;units per week mean sd
  37;type $nmbr$ collagen  mean ( sd )  ng / ml £;"C0009325;C0332307;C0439275;C0444504;C1547052;C2347634;C2348143;C2699239";NA;NA;type $nmbr$ collagen mean sd ng ml
  37;treatment duration mean ( sd );"C0444504;C0444921;C2347634;C2348143;C2699239;C3259042";NA;NA;treatment duration mean sd
  37;total updrs score ( baseline )  mean ( sd );"C0168634;C0439175;C0439810;C0444504;C0449820;C1442488;C2347634;C2348143;C2699239;C3639721;C4050231";NA;NA;total updrs score baseline mean sd
  37;total pack - years mean ( sd );"C0439175;C0439810;C0444504;C1277691;C2347634;C2348143;C2699239";NA;NA;total pack years mean sd
  37;total daily dose of ics  mean  μ gc;"C0444504;C0815320;C2347634;C2348070;C2348143;C3537453;C4281799;C4551720";NA;NA;total daily dose of ics mean gc
  37;total cigarette pack - years  mean ( sd );"C0439175;C0439810;C0444504;C1303175;C2347634;C2348143;C2699239";NA;NA;total cigarette pack years mean sd
  37;total basdai score  mean   ±   sd;"C0439175;C0439810;C0444504;C0449820;C1998004;C2347634;C2348143;C2699239;C4050231";NA;NA;total basdai score mean sd
  37;time since start of fit  mean ( sd )  y;"C0036572;C0040223;C0439659;C0444504;C1711239;C2347634;C2348143;C2349186;C2699239;C3541383;C4048158;C4553125";NA;NA;time since start of fit mean sd y
  37;time since pd diagnosis  mean ± sd;"C0011900;C0040223;C0444504;C1704338;C1704656;C2347634;C2348143;C2699239;C3541383;C4553228;C4553229";NA;NA;time since pd diagnosis mean sd
  37;time since first psoriasis diagnosis ( y )  mean ( sd );"C0011900;C0033860;C0040223;C0205435;C0444504;C1279901;C1704338;C1704656;C2347634;C2348143;C2699239;C3541383";NA;NA;time since first psoriasis diagnosis y mean sd
  37;time since end of fit  mean ( sd )  y;"C0036572;C0040223;C0444504;C0444930;C1711239;C2347634;C2348143;C2349186;C2699239;C2746065;C3541383;C4048158;C4553125";NA;NA;time since end of fit mean sd y
  37;time since diagnosis of diabetes  mean ( sd );"C0011847;C0011849;C0011900;C0040223;C0444504;C1704338;C1704656;C2347634;C2348143;C2699239;C3541383";NA;NA;time since diagnosis of diabetes mean sd
  37;time since as diagnosis ( years )  mean ( sd );"C0011900;C0040223;C0439234;C0444504;C1704338;C1704656;C2347634;C2348143;C2699239;C3541383";NA;NA;time since as diagnosis years mean sd
  37;time since as diagnosis  mean ( sd ) years;"C0011900;C0040223;C0439234;C0444504;C1704338;C1704656;C2347634;C2348143;C2699239;C3541383";NA;NA;time since as diagnosis mean sd years
  37;tchdl - c  mean ( sd );"C0444504;C2347634;C2348143;C2699239";NA;NA;tchdl c mean sd
  37;tc level  mean ( sd ) mg / dl;"C0039411;C0040642;C0041405;C0041698;C0439269;C0441889;C0444504;C0456079;C1547707;C1824670;C2347634;C2348143;C2699239;C2946261;C3272447;C4522122";NA;NA;tc level mean sd mg dl
  37;tc  mg / dl  mean ± sd;"C0039411;C0040642;C0041405;C0041698;C0439269;C0444504;C1824670;C2347634;C2348143;C2699239;C3272447;C4522122";NA;NA;tc mg dl mean sd
  37;tc  mg / dl  mean + sd;"C0039411;C0040642;C0041405;C0041698;C0439269;C0444504;C1824670;C2347634;C2348143;C2699239;C3272447;C4522122";NA;NA;tc mg dl mean sd
  37;tc  mean ( sd )  rrig / dl;"C0039411;C0040642;C0041405;C0041698;C0444504;C1824670;C2347634;C2348143;C2699239;C3272447;C3642216;C4522122";NA;NA;tc mean sd rrig dl
  37;tc  mean ( sd );"C0039411;C0040642;C0041405;C0041698;C0444504;C1824670;C2347634;C2348143;C2699239;C3272447;C4522122";NA;NA;tc mean sd
  37;symptoms mean ( sd );"C0444504;C0683368;C1457887;C2347634;C2348143;C2699239";NA;NA;symptoms mean sd
  37;sulfasalazine ( mean dose : $nmbr$ . $nmbr$ g / day );"C0036078;C0178602;C0439417;C0444504;C0869039;C1114758;C2347634;C2348143";NA;NA;sulfasalazine mean dose $nmbr$ $nmbr$ g day
  37;standardized mean difference;"C0444504;C1705241;C1705242;C2347634;C2348143";NA;NA;standardized mean difference
  37;smoking history  pack - years  mean ( sd );"C0444504;C1277691;C1519384;C2347634;C2348143;C2699239";NA;NA;smoking history pack years mean sd
  37;smoking  mean;"C0037369;C0444504;C0453996;C1881674;C2347634;C2348143";NA;NA;smoking mean
  37;shs  mean ± sd;"C0444504;C2347634;C2348143;C2699239";NA;NA;shs mean sd
  37;shs  mean $nmbr$ sd;"C0444504;C2347634;C2348143;C2699239";NA;NA;shs mean $nmbr$ sd
  37;sgrq scores  mean ( sd );"C0444504;C0449820;C2347634;C2348143;C2699239;C4050231";NA;NA;sgrq scores mean sd
  37;weight ( kg )  mean ( s . e . );"C0005910;C0043100;C0444504;C1275571;C1305866;C1705104;C2347634;C2348143";FALSE;1915;weight kg mean s e
  37;mean or n;"C0369718;C0441922;C0444504;C2347634;C2348143";NA;NA;mean or n
  37;weight  mean ± sd ( kg );"C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209";FALSE;1915;weight mean sd kg
  37;triglycerides mean;"C0041004;C0444504;C2347634;C2348143";FALSE; 368;triglycerides mean
  37;triglycerides mean ( mg / dl ± sd );"C0041004;C0439269;C0444504;C2347634;C2348143;C2699239";FALSE; 368;triglycerides mean mg dl sd
  37;triglycerides ( mg / dl )  mean + sd  available for $nmbr$ patients;"C0030705;C0041004;C0439269;C0444504;C0470187;C2347634;C2348143;C2699239";FALSE; 368;triglycerides mg dl mean sd available for $nmbr$ patients
  37;sgrq score  mean ( sd );"C0444504;C0449820;C2347634;C2348143;C2699239;C4050231";NA;NA;sgrq score mean sd
  37;ses - cd  mean ( sd );"C0007928;C0034283;C0444504;C2347634;C2348143;C2699239;C4552032";NA;NA;ses cd mean sd
  37;serum $nmbr$ ( oh ) d concentrations  ng / ml  mean ( sd );"C0220853;C0439275;C0444504;C0683149;C2347634;C2348143;C2699239";NA;NA;serum $nmbr$ oh d concentrations ng ml mean sd
  37;sbp  mm hg ( mean $nmbr$ h )  mean ( sd );"C0025424;C0085805;C0428257;C0444504;C0456680;C2347108;C2347109;C2347634;C2348143;C2348272;C2699239";NA;NA;sbp mm hg mean $nmbr$ h mean sd
  37;sbp  mm hg  mean ± sdc;"C0085805;C0439475;C0444504;C1419891;C2347634;C2348143;C3273112";NA;NA;sbp mm hg mean sdc
  37;sbp  mm hg  mean + sdc;"C0085805;C0439475;C0444504;C1419891;C2347634;C2348143;C3273112";NA;NA;sbp mm hg mean sdc
  37;rescue use : mean no . of inhalations / d;"C0004048;C0042153;C0354922;C0444504;C0457083;C1947944;C2347634;C2348143";NA;NA;rescue use mean no of inhalations d
  37;rescue medication use  mean inhalations / previous $nmbr$ d;"C0004048;C0205156;C0240320;C0354922;C0444504;C1552607;C2347634;C2348143";NA;NA;rescue medication use mean inhalations previous $nmbr$ d
  37;pulse in beats / minute  mean ( sd );"C0232117;C0391850;C0439385;C0444504;C1947910;C2347634;C2348143;C2699239";NA;NA;pulse in beats minute mean sd
  37;previous dmards  mean ± sd;"C0205156;C0242708;C0444504;C1552607;C2347634;C2348143;C2699239";NA;NA;previous dmards mean sd
  37;plp - c  mean ( sd )  mg / dl;"C0034266;C0439269;C0444504;C1175541;C1257874;C1705623;C2347634;C2348143;C2699239";NA;NA;plp c mean sd mg dl
  37;placebo estimated mean;"C0032042;C0444504;C0750572;C1696465;C1706408;C2347634;C2348143";NA;NA;placebo estimated mean
  37;phosphatase  mean ( sd )  ng / ' mlf;"C0017887;C0028074;C0031678;C0066495;C0444504;C1149880;C2347634;C2348143;C2699239;C4522024";NA;NA;phosphatase mean sd ng mlf
  37;pasi score ( $nmbr$ - $nmbr$ ) t  mean ( sd );"C0444504;C0449820;C2347634;C2348143;C2699239;C4050231;C4528685";NA;NA;pasi score $nmbr$ $nmbr$ t mean sd
  37;pasi score ( $nmbr$ - $nmbr$ )  mean ( sd );"C0444504;C0449820;C2347634;C2348143;C2699239;C4050231;C4528685";NA;NA;pasi score $nmbr$ $nmbr$ mean sd
  37;pasi score  mean ± sd;"C0444504;C0449820;C2347634;C2348143;C2699239;C4050231;C4528685";NA;NA;pasi score mean sd
  37;pasi score  mean ( sd );"C0444504;C0449820;C2347634;C2348143;C2699239;C4050231;C4528685";NA;NA;pasi score mean sd
  37;pasi  mean ( sd );"C0444504;C2347634;C2348143;C2699239;C4528685";NA;NA;pasi mean sd
  37;pain vas ( range $nmbr$ - $nmbr$ )  mean ± sd;"C0042815;C0444504;C1514721;C2347634;C2348143;C2348147;C2699239;C3542016";NA;NA;pain vas range $nmbr$ $nmbr$ mean sd
  37;pain vas  range $nmbr$ - $nmbr$ mm  mean ( sd );"C0042815;C0444504;C1514721;C2347634;C2348143;C2348147;C2699239;C3542016;C4330985;C4554674";NA;NA;pain vas range $nmbr$ $nmbr$ mm mean sd
  37;pack - years  mean ( sd );"C0444504;C1277691;C2347634;C2348143;C2699239";NA;NA;pack years mean sd
  37;ocs dose *  mean ( sd );"C0178602;C0444504;C0869039;C1114758;C2347634;C2348143;C2699239";NA;NA;ocs dose mean sd
  37;number of visits  mean ± sd;"C0444504;C1549755;C2347634;C2348143;C2699239";NA;NA;number of visits mean sd
  37;number of implanted stents  n  mean ( sd );"C0237753;C0444504;C0449788;C0522776;C2347634;C2348143;C2699239";NA;NA;number of implanted stents n mean sd
  37;number of exacerbations in previous year  mean ( sd );"C0205156;C0237753;C0439234;C0439508;C0444504;C0449788;C1552607;C2347634;C2348143;C2699239;C4086268";NA;NA;number of exacerbations in previous year mean sd
  37;non - hdl - c ( mg / dl ) - mean ± sd;"C0439269;C0444504;C1518422;C2347634;C2348143;C2699239;C3715113";NA;NA;non hdl c mg dl mean sd
  37;non - hdl - c  mg / dl  mean ( sd );"C0439269;C0444504;C1518422;C2347634;C2348143;C2699239;C3715113";NA;NA;non hdl c mg dl mean sd
  37;no . previous dmard  mean ( sd );"C0205156;C0242708;C0444504;C1552607;C2347634;C2348143;C2699239";NA;NA;no previous dmard mean sd
  37;mtss  mean ( sd );"C0444504;C2347634;C2348143;C2699239";NA;NA;mtss mean sd
  37;msasss  mean ( sd );"C0444504;C2347634;C2348143;C2699239";NA;NA;msasss mean sd
  37;months since first ra symptom  mean ( sd ) f;"C0016327;C0205435;C0439231;C0444504;C1279901;C1457887;C2347634;C2348143;C2699239;C3538806;C3854129;C4048756";NA;NA;months since first ra symptom mean sd f
  37;modified hachinski ischemia scale  mean ( sd ) c;"C0022116;C0175659;C0349674;C0392747;C0444504;C1947916;C2347634;C2348143;C2699239;C3889737;C4321499";NA;NA;modified hachinski ischemia scale mean sd c
  37;mg / dl  mean ± sd;"C0439269;C0444504;C2347634;C2348143;C2699239";NA;NA;mg dl mean sd
  37;mean — ml / min / $nmbr$ . $nmbr$ m ^;"C0369637;C0439445;C0441923;C0444504;C2347634;C2348143";NA;NA;mean ml min $nmbr$ $nmbr$ m
  37;mean — ml / min / $nmbr$ . $nmbr$ m $nmbr$ of body - surface area;"C0017446;C0205146;C0369637;C0439445;C0441923;C0444504;C0489451;C2347634;C2348143";NA;NA;mean ml min $nmbr$ $nmbr$ m $nmbr$ of body surface area
  37;mean — ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C0444504;C2347634;C2348143";NA;NA;mean ml min $nmbr$ $nmbr$ m $nmbr$
  37;mean — ml / min;"C0439445;C0444504;C2347634;C2348143";NA;NA;mean ml min
  37;mean — kg;"C0022718;C0439209;C0444504;C2347634;C2348143;C4054209";NA;NA;mean kg
  37;mean — g / dl;"C0439267;C0444504;C2347634;C2348143";NA;NA;mean g dl
  37;mean — %;"C0444504;C2347634;C2348143";NA;NA;mean
  37;mean ±   sd;"C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd
  37;mean ± sd unless otherwise indicated;"C0444504;C1444656;C2347634;C2348143;C2699239";NA;NA;mean sd unless otherwise indicated
  37;mean ± sd mg ( n = $nmbr$  $nmbr$  $nmbr$ );"C0024671;C0026410;C0439269;C0444504;C1960952;C2346927;C2347634;C2348143;C2699239;C4321396;C4521761";NA;NA;mean sd mg n $nmbr$ $nmbr$ $nmbr$
  37;mean ± sd ( n );"C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd n
  37;mean ± sd  n;"C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd n
  37;mean ± sd;"C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd
  37;mean ± s . d . weight  kg;"C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C4054209";NA;NA;mean s d weight kg
  37;mean ± s . d . fpg;"C0444504;C2347634;C2348143";NA;NA;mean s d fpg
  37;mean ± s . d .;"C0444504;C2347634;C2348143";NA;NA;mean s d
  37;mean yearly decline;"C0332181;C0439508;C0444504;C2347634;C2348143";NA;NA;mean yearly decline
  37;mean weight ( sd )  kg;"C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209";NA;NA;mean weight sd kg
  37;mean weight  kg ( sd );"C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209";NA;NA;mean weight kg sd
  37;mean weight  kg  mean = sd;"C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209";NA;NA;mean weight kg mean sd
  37;mean time since diagnosis  y;"C0011900;C0040223;C0444504;C1704338;C1704656;C2347634;C2348143;C3541383";NA;NA;mean time since diagnosis y
  37;mean time since as diagnosis  years  mean ± sd;"C0011900;C0040223;C0439234;C0444504;C1704338;C1704656;C2347634;C2348143;C2699239;C3541383";NA;NA;mean time since as diagnosis years mean sd
  37;mean sitting systolic blood pressure;"C0277814;C0444504;C0488055;C0871470;C1306620;C2347634;C2348143;C2584297;C4050224";NA;NA;mean sitting systolic blood pressure
  37;mean sitting diastolic blood pressure;"C0444504;C1319894;C2347634;C2348143";NA;NA;mean sitting diastolic blood pressure
  37;mean score;C3533236;NA;NA;mean score
  37;mean prebronchodilation ( l );"C0444504;C2347634;C2348143";NA;NA;mean prebronchodilation l
  37;mean number of puffs per day;"C0237753;C0332173;C0439228;C0439505;C0444504;C0449788;C1533107;C2347634;C2348143";NA;NA;mean number of puffs per day
  37;mean number of exacerbations in previous y ( sd );"C0205156;C0237753;C0444504;C0449788;C1552607;C2347634;C2348143;C2699239;C4086268";NA;NA;mean number of exacerbations in previous y sd
  37;mean $nmbr$ mwd *  m ( sd );"C0369637;C0441923;C0444504;C2347634;C2348143;C2699239";NA;NA;mean $nmbr$ mwd m sd
  37;mean number of exacerbations in previous $nmbr$ months ( sd );"C0205156;C0237753;C0439231;C0444504;C0449788;C1552607;C2347634;C2348143;C2699239;C4086268";NA;NA;mean number of exacerbations in previous $nmbr$ months sd
  37;mean number of combined visits / hospitalizations †;"C0205195;C0444504;C0545082;C1512346;C2347634;C2348143;C4086639";NA;NA;mean number of combined visits hospitalizations
  37;mean number of caes in past $nmbr$ months ( number per patient ) ] |;"C0030705;C0237753;C0444504;C0449788;C2347634;C2348143;C4331910";NA;NA;mean number of caes in past $nmbr$ months number per patient
  37;mean iglar dose ± sd ( u / day );"C0178602;C0444504;C0456683;C0869039;C1114758;C2347634;C2348143;C2699239";NA;NA;mean iglar dose sd u day
  37;mean ics ( fluticasone propionate dpi or equivalent  pg per day );"C0117996;C0205163;C0439185;C0444504;C0815320;C2347634;C2348143;C2827928;C4551720";NA;NA;mean ics fluticasone propionate dpi or equivalent pg per day
  37;mean eosinophil count  per ml;"C0200638;C0439526;C0444504;C0750879;C1705224;C2347634;C2348143;C3887665";NA;NA;mean eosinophil count per ml
  37;mean doseb;"C0444504;C2347634;C2348143";NA;NA;mean doseb
  37;mean dose ' ’;"C0178602;C0444504;C0869039;C1114758;C2347634;C2348143";NA;NA;mean dose
  37;mean dlco ± sd;"C0444504;C1516251;C2347634;C2348143;C2699239";NA;NA;mean dlco sd
  37;mean difference = seb;"C0059386;C0444504;C1309881;C1423585;C1705241;C1705242;C2347634;C2348143;C3815268";NA;NA;mean difference seb
  37;mean change in total updrs scores adjusted according to baseline updrs;"C0168634;C0392747;C0439175;C0439810;C0443172;C0444504;C0456081;C0680240;C1442488;C1705241;C2347634;C2348143;C2964552;C3533236;C3639721;C4319952";NA;NA;mean change in total updrs scores adjusted according to baseline updrs
  37;mean change in radiographic end points shs  mean ± sd;"C0392747;C0443172;C0444504;C0444708;C1705241;C2347634;C2348143;C2349179;C2699239;C4319952";NA;NA;mean change in radiographic end points shs mean sd
  37;mean bm $nmbr$ ± s . d .  kg / m $nmbr$;"C0006416;C0444504;C1532718;C2347634;C2348143";NA;NA;mean bm $nmbr$ s d kg m $nmbr$
  37;mean blood eosinophil count ( cells per pl );"C0200638;C0444504;C2347634;C2348143;C3897966;C4049765";NA;NA;mean blood eosinophil count cells per pl
  37;mean asui scored;"C0444504;C0449820;C2347634;C2348143";NA;NA;mean asui scored
  37;mean annualized exacerbation rate;"C0444504;C0871208;C1521828;C2347634;C2348143;C4086268";NA;NA;mean annualized exacerbation rate
  37;mean age ( y ) ( sd );"C0001779;C0444504;C2347634;C2348143;C2699239";NA;NA;mean age y sd
  37;mean age ( sd );"C0001779;C0444504;C2347634;C2348143;C2699239";NA;NA;mean age sd
  37;mean age  years ( sd );"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;mean age years sd
  37;mean age  y ( sd );"C0001779;C0444504;C2347634;C2348143;C2699239";NA;NA;mean age y sd
  37;mean age  y  mean = sd;"C0001779;C0444504;C2347634;C2348143;C2699239";NA;NA;mean age y mean sd
  37;mean acrn;"C0444504;C2347634;C2348143";NA;NA;mean acrn
  37;mean acq - $nmbr$ scores;"C0444504;C0449820;C2347634;C2348143;C2919686;C4050231";NA;NA;mean acq $nmbr$ scores
  37;mean acq - $nmbr$ score at randomization  !;"C0034656;C0444504;C0449820;C2347634;C2348143;C2919686;C4050231";NA;NA;mean acq $nmbr$ score at randomization
  37;mean a ± sdt;"C0444504;C2347634;C2348143";NA;NA;mean a sdt
  37;mean = sd;"C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd
  37;mean *;"C0444504;C2347634;C2348143";NA;NA;mean
  37;mean ( ± s . d . );"C0444504;C2347634;C2348143";NA;NA;mean s d
  37;mean ( sd on loge scale ) u / ml;"C0175659;C0349674;C0439340;C0444504;C1880521;C1947916;C2347634;C2348143;C2697934;C2699239;C2945590";NA;NA;mean sd on loge scale u ml
  37;mean ( sd ) years daily ocs use  n ( % );"C0042153;C0332173;C0369718;C0439234;C0441922;C0444504;C0457083;C1947944;C2347634;C2348143;C2699239";NA;NA;mean sd years daily ocs use n
  37;mean ( sd ) weight  kg;"C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209";NA;NA;mean sd weight kg
  37;mean ( sd ) total asthma symptom scores;"C0004096;C0444504;C2347634;C2348143;C2699239;C2984299;C3533163";NA;NA;mean sd total asthma symptom scores
  37;mean ( sd ) periostin  ng / ml;"C0219433;C0439275;C0444504;C1424662;C2347634;C2348143;C2699239;C3812270";NA;NA;mean sd periostin ng ml
  37;mean ( sd ) number of exacerbations *;"C0237753;C0444504;C0449788;C2347634;C2348143;C2699239;C4086268";NA;NA;mean sd number of exacerbations
  37;mean ( sd ) number of albuterol per day  puff;"C0001927;C0237753;C0332173;C0439228;C0439505;C0444504;C0449788;C1533107;C1882376;C2347634;C2348143;C2699239";NA;NA;mean sd number of albuterol per day puff
  37;mean ( sd ) hba $nmbr$ c  %;"C0019016;C0444504;C1825777;C2347634;C2348143;C2699239;C3538758";NA;NA;mean sd hba $nmbr$ c
  37;mean ( sd ) duration of smoking  pack years;"C0037369;C0444504;C0449238;C0453996;C1277691;C1881674;C2347634;C2348143;C2699239;C2926735";NA;NA;mean sd duration of smoking pack years
  37;mean ( sd ) duration of smoking  pack - years;"C0037369;C0444504;C0449238;C0453996;C1277691;C1881674;C2347634;C2348143;C2699239;C2926735";NA;NA;mean sd duration of smoking pack years
  37;mean ( sd ) das $nmbr$ - $nmbr$ ( esr ) *;"C0051767;C0057671;C0444504;C2347634;C2348143;C2699239;C3811131";NA;NA;mean sd das $nmbr$ $nmbr$ esr
  37;mean ( sd ) d;"C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd d
  37;mean ( sd ) anthropometry;"C0003188;C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd anthropometry
  37;mean ( sd ) age in years;"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;mean sd age in years
  37;mean ( sd ) age ( years );"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;mean sd age years
  37;mean ( sd ) age  years;"C0444504;C1510829;C2347634;C2348143;C2699239";NA;NA;mean sd age years
  37;mean ( sd ) age;"C0001779;C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd age
  37;mean ( sd ) [ range ];"C0444504;C1514721;C2347634;C2348143;C2348147;C2699239;C3542016";NA;NA;mean sd range
  37;mean ( sd ) ( years );"C0439234;C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd years
  37;mean ( sd ) % of predicted normal fevi;"C0205307;C0231683;C0429706;C0439166;C0444504;C0681842;C0849974;C1561566;C1882327;C2347086;C2347634;C2348143;C2699239;C4528367;C4553972";NA;NA;mean sd of predicted normal fevi
  37;mean ( sd ) $nmbr$ . $nmbr$ ( $nmbr$ . $nmbr$ );"C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd $nmbr$ $nmbr$ $nmbr$ $nmbr$
  37;mean ( sd )  ng / ml £;"C0439275;C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd ng ml
  37;mean ( sd );"C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd
  37;mean ( s . e . ) t;"C0444504;C2347634;C2348143";NA;NA;mean s e t
  37;mean ( s . e . );"C0444504;C2347634;C2348143";NA;NA;mean s e
  37;mean ( s . d . ) weight  kg;"C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C4054209";NA;NA;mean s d weight kg
  37;mean ( s . d . ) total pcsk $nmbr$  ng / ml;"C0439175;C0439275;C0439810;C0444504;C2347634;C2348143";NA;NA;mean s d total pcsk $nmbr$ ng ml
  37;mean ( s . d . ) non - hdl cholesterol;"C0444504;C0729627;C1535899;C2347634;C2348143";NA;NA;mean s d non hdl cholesterol
  37;mean ( s . d . ) ldl particle number  nmol / l;"C0237753;C0439282;C0444504;C0449788;C2347634;C2348143;C2612459";NA;NA;mean s d ldl particle number nmol l
  37;mean ( s . d . ) hdl cholesterol;"C0023822;C0392885;C0444504;C2347634;C2348143";NA;NA;mean s d hdl cholesterol
  37;mean ( s . d . ) free pcsk $nmbr$  ng / ml;"C0332296;C0439275;C0444504;C1880497;C1996904;C2347634;C2348143";NA;NA;mean s d free pcsk $nmbr$ ng ml
  37;mean ( s . d . ) fpg;"C0444504;C2347634;C2348143";NA;NA;mean s d fpg
  37;mean ( s . d . );"C0444504;C2347634;C2348143";NA;NA;mean s d
  37;mean ( = sd ) days since;"C0439228;C0444504;C2347634;C2348143;C2699239";NA;NA;mean sd days since
  37;mean % predicted value prebronchodilation;"C0444504;C0681842;C1522609;C1882327;C2347634;C2348143";NA;NA;mean predicted value prebronchodilation
  37;mean % predicted dlco * ( sd );"C0444504;C0681842;C1516251;C1882327;C2347634;C2348143;C2699239";NA;NA;mean predicted dlco sd
  37;mean $nmbr$ sd;"C0444504;C2347634;C2348143;C2699239";NA;NA;mean $nmbr$ sd
 370;geographic region;C0017446;FALSE; 369;geographic region
  37;mean $nmbr$ - h sbp *;"C0033727;C0085805;C0369286;C0441932;C0444504;C0564385;C2347634;C2348143;C4528284";NA;NA;mean $nmbr$ h sbp
  37;mean  ml ( sd );"C0439526;C0444504;C1705224;C2347634;C2348143;C2699239;C3887665";NA;NA;mean ml sd
  37;mean;"C0444504;C2347634;C2348143";NA;NA;mean
  37;mases ( $nmbr$ - $nmbr$ )  mean ( sd );"C0444504;C2347634;C2348143;C2699239";NA;NA;mases $nmbr$ $nmbr$ mean sd
  37;lv ejection fraction  mean ( sd ) [ range ]  %;"C0023128;C0444504;C0489482;C0731033;C1514721;C1881413;C2347634;C2348143;C2348147;C2699239;C2700378;C3542016";NA;NA;lv ejection fraction mean sd range
  37;lung function  mean;"C0035245;C0444504;C2347634;C2348143";NA;NA;lung function mean
  37;ls mean difference ± seb;"C0023668;C0059386;C0444504;C1309881;C1423585;C1705241;C1705242;C2347634;C2348143;C3815268";NA;NA;ls mean difference seb
  37;ls mean change ± sea;"C0023668;C0036493;C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C4319952";NA;NA;ls mean change sea
  37;ls mean change;"C0023668;C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C4319952";NA;NA;ls mean change
  37;ls mean ( s . e . ) primary endpoint : % change from baseline to week $nmbr$;"C0023668;C0168634;C0332174;C0392747;C0439230;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C2986535;C4319952";NA;NA;ls mean s e primary endpoint change from baseline to week $nmbr$
  37;ls mean;"C0023668;C0444504;C2347634;C2348143";NA;NA;ls mean
  37;lp ( a )  nmol / l  mean ( sd );"C0065058;C0439282;C0444504;C1439335;C2347634;C2348143;C2699239;C4553379";NA;NA;lp a nmol l mean sd
  37;lp ( a )  mean ( sd );"C0065058;C0444504;C1439335;C2347634;C2348143;C2699239;C4553379";NA;NA;lp a mean sd
  37;lowest tertile ( range  $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ mg / dl  mean ± sd  $nmbr$ . $nmbr$ ± $nmbr$ . $nmbr$ mg / dl );"C0024671;C0026410;C0439269;C0444504;C1514721;C1708760;C1960952;C2346927;C2347634;C2348143;C2348147;C2699239;C3539687;C3542016;C4321396;C4521761";NA;NA;lowest tertile range $nmbr$ $nmbr$ $nmbr$ $nmbr$ mg dl mean sd $nmbr$ $nmbr$ $nmbr$ $nmbr$ mg dl
  37;leeds enthesitis index  mean ( sd ) ’ ’ * ’;"C0444504;C0451148;C2347634;C2348143;C2699239";NA;NA;leeds enthesitis index mean sd
  37;leeds dactylitis index - basic  mean ( sd ) ’ ' ^;"C0239161;C0444504;C0600653;C0918012;C1527178;C1552854;C1637833;C2347634;C2348143;C2699239;C2986546";NA;NA;leeds dactylitis index basic mean sd
  37;least square mean ( se );"C0023189;C0036919;C0444504;C2347634;C2348143";NA;NA;least square mean se
  37;ldl cholesterol mean ( mg / dl ± sd );"C0023824;C0202117;C0439269;C0444504;C2347634;C2348143;C2699239";NA;NA;ldl cholesterol mean mg dl sd
  37;ldl - cihdl - c  mean ( sd );"C0444504;C2347634;C2348143;C2699239";NA;NA;ldl cihdl c mean sd
  37;ldl - c ( calculated )  mean ( sd );"C0444504;C0444686;C1441506;C2347634;C2348143;C2699239";NA;NA;ldl c calculated mean sd
  37;ldl - c  mean ( sd );"C0444504;C2347634;C2348143;C2699239";NA;NA;ldl c mean sd
  37;insulin glargine vs standard care least - squares mean ( $nmbr$ % cl );"C0023189;C0444504;C0596019;C0907402;C1442989;C1947933;C2347634;C2348143;C2828392";NA;NA;insulin glargine vs standard care least squares mean $nmbr$ cl
  37;in previous year  mean ( sd );"C0205156;C0439234;C0439508;C0444504;C1552607;C2347634;C2348143;C2699239";NA;NA;in previous year mean sd
  37;imaging data  mean ( sd );"C0011923;C0079595;C0444504;C1511726;C2347634;C2348143;C2699239;C3245479;C3714741";NA;NA;imaging data mean sd
  37;ileum ses - cd score  mean ( sd );"C0007928;C0020885;C0034283;C0444504;C0449820;C2347634;C2348143;C2699239;C4050231;C4552032";NA;NA;ileum ses cd score mean sd
  37;ics use at enrollment  mean  mg / d;"C0042153;C0439422;C0444504;C0457083;C0815320;C1516879;C1696073;C1947944;C2347634;C2348143;C3888021;C4551720";NA;NA;ics use at enrollment mean mg d
  37;hscrp  mean ( sd );"C0444504;C2347634;C2348143;C2699239";NA;NA;hscrp mean sd
  37;highest tertile ( range  $nmbr$ . $nmbr$ - $nmbr$ . $nmbr$ mg / dl  mean ± sd  $nmbr$ . $nmbr$ ± $nmbr$ . $nmbr$ mg / dl );"C0024671;C0026410;C0439269;C0444504;C1514721;C1522410;C1960952;C2346927;C2347634;C2348143;C2348147;C2699239;C3539687;C3542016;C4321396;C4521761";NA;NA;highest tertile range $nmbr$ $nmbr$ $nmbr$ $nmbr$ mg dl mean sd $nmbr$ $nmbr$ $nmbr$ $nmbr$ mg dl
  37;hemoglobin a $nmbr$ c  mean ( sd )  % b;"C0062248;C0444504;C2347634;C2348143;C2699239";NA;NA;hemoglobin a $nmbr$ c mean sd b
  37;hemoglobin a $nmbr$ c  mean ( sd )  %;"C0019020;C0444504;C2347634;C2348143;C2699239;C3889898";NA;NA;hemoglobin a $nmbr$ c mean sd
  37;hdl cholesterol mean;"C0023822;C0392885;C0444504;C2347634;C2348143";NA;NA;hdl cholesterol mean
  37;hdl cholesterol  mmol / l  women  mean ± sd;"C0023822;C0043210;C0392885;C0444504;C1532563;C2347634;C2348143;C2699239";NA;NA;hdl cholesterol mmol l women mean sd
  37;hdl - c  mg / dl  mean ± sd;"C0439269;C0444504;C2347634;C2348143;C2699239;C3715113";NA;NA;hdl c mg dl mean sd
  37;hdl - c  mg / dl  mean ( sd );"C0439269;C0444504;C2347634;C2348143;C2699239;C3715113";NA;NA;hdl c mg dl mean sd
  37;hdl - c  mean ( sd );"C0444504;C2347634;C2348143;C2699239;C3715113";NA;NA;hdl c mean sd
  37;hdl  mean ( sd )  mg / dl;"C0439269;C0444504;C2347634;C2348143;C2699239;C3715113";NA;NA;hdl mean sd mg dl
  37;hba $nmbr$ ca  %  mean ± sd;"C0019016;C0444504;C1825777;C2347634;C2348143;C2699239;C3538758;C3887642";NA;NA;hba $nmbr$ ca mean sd
  37;haq pain scale  mean;"C0102923;C0444504;C0451208;C1504479;C2347634;C2348143";NA;NA;haq pain scale mean
  37;haemoglobin ( g / dl )  mean + sd  available for $nmbr$ patients;"C0019046;C0030705;C0439267;C0444504;C0470187;C1319312;C2347634;C2348143;C2699239;C3642216";NA;NA;haemoglobin g dl mean sd available for $nmbr$ patients
  37;glycated hemoglobin  mean ( sd )  %;"C0017853;C0444504;C2347634;C2348143;C2699239";NA;NA;glycated hemoglobin mean sd
  37;fpg ( mmol / l )  mean ± s . d .;"C0439433;C0444504;C2347634;C2348143";NA;NA;fpg mmol l mean s d
  37;fevi  l  mean ( sd ) $nmbr$;"C0429706;C0444504;C0849974;C1561566;C2347634;C2348143;C2699239;C4528367";NA;NA;fevi l mean sd $nmbr$
  37;fevi  % predicted  mean ( sd ) $nmbr$;"C0444504;C0681842;C0849974;C1561566;C1882327;C2347634;C2348143;C2699239;C4528367";NA;NA;fevi predicted mean sd $nmbr$
  37;fas  range $nmbr$ - $nmbr$  mean ( sd );"C0444504;C1514721;C2347634;C2348143;C2348147;C2699239;C3542016";NA;NA;fas range $nmbr$ $nmbr$ mean sd
  37;estimated mean;"C0444504;C0750572;C2347634;C2348143";NA;NA;estimated mean
  37;enthesitis score ( mases  $nmbr$ - $nmbr$ )  mean ( sd );"C0444504;C0449820;C1282952;C2347634;C2348143;C2699239;C4050231";NA;NA;enthesitis score mases $nmbr$ $nmbr$ mean sd
  37;ejection fraction ( mean );"C0444504;C0489482;C2347634;C2348143;C2700378";NA;NA;ejection fraction mean
  37;egfr — mean ( sd  n );"C0444504;C1739039;C2347634;C2348143;C2699239;C3811844;C3812682";NA;NA;egfr mean sd n
  37;egfr  mean ± sd;"C0444504;C1739039;C2347634;C2348143;C2699239;C3811844;C3812682";NA;NA;egfr mean sd
  37;duration of alendronate use  mean ( sd )  y;"C0102118;C0444504;C1881378;C2347634;C2348143;C2699239;C2826775";NA;NA;duration of alendronate use mean sd y
  37;duration  mean ( sd )  years;"C0439234;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735";NA;NA;duration mean sd years
  37;diagnosis ( y )  mean ( sd );"C0011900;C0444504;C1704338;C1704656;C2347634;C2348143;C2699239";NA;NA;diagnosis y mean sd
  37;diabetesduration  mean ( sd )  y;"C0444504;C2347634;C2348143;C2699239";NA;NA;diabetesduration mean sd y
  37;daily “ off ” time  mean ± sd  h / dayf;"C0033727;C0040223;C0332173;C0369286;C0441932;C0444504;C0564385;C2347634;C2348143;C2699239;C3541383;C4528284";NA;NA;daily off time mean sd h dayf
  28;statin + placebo ( n = $nmbr$ );"C0032042;C0360714;C1696465;C1706408";NA;NA;statin placebo n $nmbr$
  37;crcb - ( ml / min )  mean ( s . e . );"C0439390;C0439445;C0444504;C0702093;C1524029;C2347634;C2348143;C3813700";NA;NA;crcb ml min mean s e
  28;placebo ( n   =   $nmbr$ );"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$
  37;colon ' ses - cd score  mean ( sd );"C0007928;C0009368;C0034283;C0444504;C0449820;C2347634;C2348143;C2699239;C3888384;C4050231;C4552032";NA;NA;colon ses cd score mean sd
  37;cognitive subscale on alzheimer ' s disease assessment scale  mean ( sd ) e;"C0444504;C0450989;C1516691;C2347634;C2348143;C2699239";NA;NA;cognitive subscale on alzheimer s disease assessment scale mean sd e
  37;clinical dementia rating sum of boxes  mean ( sd ) f;"C0444504;C0451074;C1515051;C1517104;C2347634;C2348143;C2699239";NA;NA;clinical dementia rating sum of boxes mean sd f
  37;clean  n ( % ) a;C1947930;NA;NA;clean n a
  37;cigarette smoking  mean pack - years ( sd );"C0037369;C0444504;C0453996;C1303175;C1881674;C2347634;C2348143;C2699239";NA;NA;cigarette smoking mean pack years sd
  37;change from baseline in das $nmbr$ - esr  mean $nmbr$ sd;"C0051767;C0057671;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C2699239;C3811131;C4319952";NA;NA;change from baseline in das $nmbr$ esr mean $nmbr$ sd
  37;cclear < $nmbr$;NA;NA;NA;cclear $nmbr$
  37;cclear $nmbr$ - $nmbr$;NA;NA;NA;cclear $nmbr$ $nmbr$
  37;cclear $nmbr$ +;NA;NA;NA;cclear $nmbr$
  37;calculated annual decline  mean ± se;"C0036919;C0332181;C0444504;C0444686;C1441506;C2347634;C2348143";NA;NA;calculated annual decline mean se
  37;bm $nmbr$  kg / m $nmbr$ ( mean ± s . d . );"C0006416;C0022718;C0369637;C0439209;C0439493;C0441923;C0444504;C1275571;C1513009;C2347634;C2348143;C4054209";NA;NA;bm $nmbr$ kg m $nmbr$ mean s d
  37;blood eosinophils  mean ( range )  cells / ml;"C0014467;C0444504;C1514721;C2347634;C2348143;C2348147;C2699156;C3542016";NA;NA;blood eosinophils mean range cells ml
  37;biochemical parameters at randomization  mean;"C0034656;C0205474;C0444504;C0449381;C2347634;C2348143";NA;NA;biochemical parameters at randomization mean
  37;beam values ( mg / dl )  mean ( sd );"C0042295;C0338248;C0439269;C0444504;C2347634;C2347880;C2348143;C2699239;C4521565";NA;NA;beam values mg dl mean sd
  37;baseline haq mean ( s . e . );"C0102923;C0168634;C0444504;C0451208;C1442488;C2347634;C2348143";NA;NA;baseline haq mean s e
  37;baseline dyspnea index  mean total score;"C0439175;C0439810;C0444504;C1511069;C2347634;C2348143;C2964552;C3533236";NA;NA;baseline dyspnea index mean total score
  37;baseline daytime nasal symptoms score  mean ± sd;"C0168634;C0231918;C0332169;C0444504;C0449820;C1442488;C2347634;C2348143;C2699239;C4050231";NA;NA;baseline daytime nasal symptoms score mean sd
  37;basdai score ( $nmbr$ - $nmbr$ )  mean ( sd );"C0444504;C0449820;C1998004;C2347634;C2348143;C2699239;C4050231";NA;NA;basdai score $nmbr$ $nmbr$ mean sd
  37;basdai score  mean ( sd );"C0444504;C0449820;C1998004;C2347634;C2348143;C2699239;C4050231";NA;NA;basdai score mean sd
  37;basdai question $nmbr$ score ( $nmbr$ - $nmbr$ )  mean ( sd );"C0444504;C0449820;C1522634;C1998004;C2347634;C2348143;C2699239;C4050231";NA;NA;basdai question $nmbr$ score $nmbr$ $nmbr$ mean sd
  37;basdai  total  mean ± sd;"C0439175;C0439810;C0444504;C1998004;C2347634;C2348143;C2699239";NA;NA;basdai total mean sd
  37;asui score  mean ( sd );"C0444504;C0449820;C2347634;C2348143;C2699239;C4050231";NA;NA;asui score mean sd
  37;asui score  mean;"C0444504;C0449820;C2347634;C2348143;C4050231";NA;NA;asui score mean
  37;as duration  y  mean ( sd );"C0444504;C0449238;C2347634;C2348143;C2699239;C2926735";NA;NA;as duration y mean sd
  37;apob  g / l  mean ( sd );"C0003593;C0439294;C0444504;C0456615;C2347634;C2348143;C2699239;C3252643";NA;NA;apob g l mean sd
  37;adjusted ∗   mean of difference ( se ) ( ml );"C0036919;C0439526;C0444504;C0456081;C1705224;C1705241;C1705242;C2347634;C2348143;C3887665";NA;NA;adjusted mean of difference se ml
  37;adjusted mean ± se change from baseline;"C0036919;C0168634;C0392747;C0443172;C0444504;C0456081;C1442488;C1705241;C2347634;C2348143;C4319952";NA;NA;adjusted mean se change from baseline
  37;adjusted mean change;"C0392747;C0443172;C0444504;C0456081;C1705241;C2347634;C2348143;C4319952";NA;NA;adjusted mean change
  37;adjusted mean ( se );"C0036919;C0444504;C0456081;C2347634;C2348143";NA;NA;adjusted mean se
  37;> mean;"C0444504;C2347634;C2348143";NA;NA;mean
  37;> $nmbr$ months  mean ( sd );"C0439231;C0444504;C2347634;C2348143;C2699239";NA;NA;$nmbr$ months mean sd
  37;< mean;"C0444504;C2347634;C2348143";NA;NA;mean
  37;< $nmbr$ months  mean ( sd );"C0439231;C0444504;C2347634;C2348143;C2699239";NA;NA;$nmbr$ months mean sd
  28;serum uric acid  difference vs placebo ( $nmbr$ % cl );"C0032042;C0455272;C0596019;C0700634;C1696465;C1705241;C1705242;C1706408";NA;NA;serum uric acid difference vs placebo $nmbr$ cl
  37;age  mean ± sd years;"C0444504;C1510829;C2347634;C2348143;C2699239";FALSE;1907;age mean sd years
  37;age — mean ( sd ) ( years );"C0444504;C1510829;C2347634;C2348143;C2699239";FALSE;1907;age mean sd years
  37;age  mean years  [ sd ];"C0444504;C1510829;C2347634;C2348143;C2699239";FALSE;1907;age mean years sd
  37;age  mean years ( sd ) ’ gender  n ( % );"C0079399;C0444504;C1510829;C1522384;C2347634;C2348143;C2699239";FALSE;1907;age mean years sd gender n
  37;age when diabetes first diagnosed ( years )  mean ( sd );"C0001779;C0011847;C0011849;C0011900;C0205435;C0439234;C0444504;C1279901;C2347634;C2348143;C2699239";FALSE;1907;age when diabetes first diagnosed years mean sd
  37;age  years  mean + sd;"C0444504;C1510829;C2347634;C2348143;C2699239";FALSE;1907;age years mean sd
  37;age ( years ) mean ( sd );"C0444504;C1510829;C2347634;C2348143;C2699239";FALSE;1907;age years mean sd
  37;age ( years ) mean ± sd;"C0444504;C1510829;C2347634;C2348143;C2699239";FALSE;1907;age years mean sd
  37;age  y  mean ( sd );"C0001779;C0444504;C2347634;C2348143;C2699239";FALSE;1907;age y mean sd
  37;age  y ( mean ± sd );"C0001779;C0444504;C2347634;C2348143;C2699239";FALSE;1907;age y mean sd
  37;age  y mean ( sd );"C0001779;C0444504;C2347634;C2348143;C2699239";FALSE;1907;age y mean sd
  37;anthropometrics  mean ( sd );"C0444504;C2347634;C2348143;C2699239";FALSE;1908;anthropometrics mean sd
  37;anthropometry : mean ( sd );"C0003188;C0444504;C2347634;C2348143;C2699239";FALSE;1908;anthropometry mean sd
  37;apo a - l ( mg / dl ) - mean ± sd;"C0439269;C0444504;C1447574;C2347634;C2348143;C2699239;C4521365";FALSE;1909;apo a l mg dl mean sd
  37;apo a - $nmbr$  mean ( sd )  mg / dl;"C0003592;C0439269;C0444504;C0523508;C2347634;C2348143;C2699239;C4553344;C4553379";FALSE;1909;apo a $nmbr$ mean sd mg dl
  37;apo a $nmbr$  mg / dl  mean ( sd );"C0003592;C0439269;C0444504;C0523508;C2347634;C2348143;C2699239;C4553344;C4553379";FALSE;1909;apo a $nmbr$ mg dl mean sd
  37;apo b  mean ( sd );"C0003593;C0444504;C2347634;C2348143;C2699239;C3252643";FALSE;1910;apo b mean sd
  37;apo b  mg / dl  mean ( sd );"C0003593;C0439269;C0444504;C2347634;C2348143;C2699239;C3252643";FALSE;1910;apo b mg dl mean sd
  37;body massindex  mean ( sd ) a;"C0242821;C0444504;C0460148;C1268086;C2347634;C2348143;C2699239;C4082212";FALSE;1911;body massindex mean sd a
  37;body weight  kg ( mean ± sd );"C0005910;C0022718;C0439209;C0444504;C1305866;C2347634;C2348143;C2699239;C4054209";FALSE;1912;body weight kg mean sd
  37;body weight ( kg )  mean ± sd;"C0005910;C0022718;C0439209;C0444504;C1305866;C2347634;C2348143;C2699239;C4054209";FALSE;1912;body weight kg mean sd
  37;cholesterol  mg / dl  mean ( sd ) §;"C0008377;C0439269;C0444504;C2347634;C2348143;C2699239";FALSE;1501;cholesterol mg dl mean sd
  37;cholesterol - mean ( sd  n );"C0008377;C0444504;C2347634;C2348143;C2699239";FALSE;1501;cholesterol mean sd n
  37;* reported by physicians . † data are median ( iqr ) . all data are mean ( sd ) or number ( % ) unless otherwise indicated .;"C0031831;C0237753;C0444504;C0449788;C0549183;C0876920;C1444656;C1511726;C1709908;C2347634;C2347635;C2348143;C2348144;C2699239;C2939193;C3245479;C3714741";NA;NA;reported by physicians data are median iqr all data are mean sd or number unless otherwise indicated
  37;( % )  $nmbr$ mean ( sd );"C0444504;C2347634;C2348143;C2699239";NA;NA;$nmbr$ mean sd
  37;% \mean ± sd;"C0444504;C2347634;C2348143;C2699239";NA;NA;\mean sd
  36;weeko mean + sem;"C0444504;C2347634;C2348143";NA;NA;weeko mean sem
  36;week $nmbr$ mean ± sem;"C0332174;C0439230;C0444504;C2347634;C2348143";NA;NA;week $nmbr$ mean sem
  36;week $nmbr$ mean + sem;"C0332174;C0439230;C0444504;C2347634;C2348143";NA;NA;week $nmbr$ mean sem
  36;percent change from baseline to week $nmbr$ in auc ( mean  sem );"C0332174;C0376690;C0439230;C0444504;C2347634;C2348143;C3272907";NA;NA;percent change from baseline to week $nmbr$ in auc mean sem
  36;mean a ± sem ( % );"C0444504;C2347634;C2348143";NA;NA;mean a sem
  36;left ventricular ef  mean ( sd )  %;"C0225897;C0444504;C2347634;C2348143;C2699239";NA;NA;left ventricular ef mean sd
  36;hab $nmbr$ c ( mean ± sem )  %;"C0444504;C2347634;C2348143";NA;NA;hab $nmbr$ c mean sem
  36;ef > $nmbr$ % n = $nmbr$;NA;NA;NA;ef $nmbr$ n $nmbr$
  36;ef < $nmbr$ %;NA;NA;NA;ef $nmbr$
  36;ef ( % )  mean ( sd );"C0444504;C2347634;C2348143;C2699239";NA;NA;ef mean sd
  36;( sem );NA;NA;NA;sem
  35;nonsevere hypoglycemia;"C0020615;C4553659";NA;NA;nonsevere hypoglycemia
  35;no nonsevere hypoglycemia;"C0020615;C4553659";NA;NA;no nonsevere hypoglycemia
  35;major hypoglycemia;"C0020615;C0205082;C0205164;C4318856;C4521762;C4553659";NA;NA;major hypoglycemia
  35;investigator - reported hypoglycaemia *;"C0020615;C0035173;C0684224;C0700287;C4319718;C4553659";NA;NA;investigator reported hypoglycaemia
  35;investigator - reported hypoglycaemia;"C0020615;C0035173;C0684224;C0700287;C4319718;C4553659";NA;NA;investigator reported hypoglycaemia
  35;hypoglycemiat;NA;NA;NA;hypoglycemiat
  35;hypoglycemia ^;"C0020615;C4553659";NA;NA;hypoglycemia
  35;hypoglycemia;"C0020615;C4553659";NA;NA;hypoglycemia
  35;hosji fcrhypoglycemia;NA;NA;NA;hosji fcrhypoglycemia
  35;b nonsevere hypoglycemia;"C0020615;C4553659";NA;NA;b nonsevere hypoglycemia
  34;normoglycemic {;C0580545;NA;NA;normoglycemic
  34;normoglycemic ^;C0580545;NA;NA;normoglycemic
  34;normoglycemic $nmbr$;C0580545;NA;NA;normoglycemic $nmbr$
  34;normoglycemic;C0580545;NA;NA;normoglycemic
  34;normoglycemia ^;C0580545;NA;NA;normoglycemia
  34;normoglycemia;C0580545;NA;NA;normoglycemia
  34;baseline normoglycemia;"C0168634;C0580545;C1442488";NA;NA;baseline normoglycemia
  33;took prior antihyperglycemic agent ( any );"C0020616;C0332152;C0450442;C1254351;C1515187;C1521826;C2826257";NA;NA;took prior antihyperglycemic agent any
  33;other hypoglycemic agent  n ( % );C0020616;NA;NA;other hypoglycemic agent n
  33;hypoglycemic agent;C0020616;NA;NA;hypoglycemic agent
  33;hypoglycaemic agents;C0020616;NA;NA;hypoglycaemic agents
  33;antihyperglycemictherapies  %;NA;NA;NA;antihyperglycemictherapies
  33;antihyperglycemic medication usage;"C0013227;C0020616;C0457083;C3244316;C4284232";NA;NA;antihyperglycemic medication usage
  33;antihyperglycemic;C0020616;NA;NA;antihyperglycemic
  32;hypokalemia ‡   ( potassium < $nmbr$ . $nmbr$ mmol / l );"C0020621;C0032821;C0202194;C0304475;C0597277;C1532563;C3714637;C4553966";NA;NA;hypokalemia potassium $nmbr$ $nmbr$ mmol l
  32;hypokalemia;"C0020621;C4553966";NA;NA;hypokalemia
  32;hypokalaemia;"C0020621;C4553966";NA;NA;hypokalaemia
  32;hvookalemia;NA;NA;NA;hvookalemia
  32;olaemia  n ( % );NA;FALSE; -10;olaemia n
  32;hypovolaemia;C0546884;FALSE; -10;hypovolaemia
  31;hyponatremia;"C0020625;C4553967";NA;NA;hyponatremia
  30;hyperkalemiab;NA;NA;NA;hyperkalemiab
  30;hyperkalemia * ’;"C0020461;C4552983";NA;NA;hyperkalemia
  30;hyperkalemia ( > $nmbr$ . $nmbr$ meq / l );"C0020461;C0439375;C4552983";NA;NA;hyperkalemia $nmbr$ $nmbr$ meq l
  30;hyperkalemia  n ( % );"C0020461;C4552983";NA;NA;hyperkalemia n
  30;hyperkalaemia ( investigator reported );"C0020461;C0035173;C0684224;C0700287;C4319718;C4552983";NA;NA;hyperkalaemia investigator reported
  30;hyperkalaemia;"C0020461;C4552983";NA;NA;hyperkalaemia
  29;hyperlipidemia — no . / total no . ( % );"C0020473;C0428465;C0439175;C0439810;C4555212";NA;NA;hyperlipidemia no total no
  29;hyperlipidemia — no . ( % );"C0020473;C0428465;C4555212";NA;NA;hyperlipidemia no
  29;hyperlipidemia § yes;"C0020473;C0428465;C1549445;C1705108;C1710701;C4555212";NA;NA;hyperlipidemia yes
  29;hyperlipidemia §;"C0020473;C0428465;C4555212";NA;NA;hyperlipidemia
  29;hyperlipidemia | | yes;"C0020473;C0428465;C1549445;C1705108;C1710701;C4555212";NA;NA;hyperlipidemia yes
  29;hyperlipidemia | |;"C0020473;C0428465;C4555212";NA;NA;hyperlipidemia
  29;hyperlipidemia ^;"C0020473;C0428465;C4555212";NA;NA;hyperlipidemia
  29;hyperlipidemia ( % ) §;"C0020473;C0428465;C4555212";NA;NA;hyperlipidemia
  29;hyperlipidemia ( % );"C0020473;C0428465;C4555212";NA;NA;hyperlipidemia
  29;hyperlipidemia  n / n ( % );"C0020473;C0428465;C4555212";NA;NA;hyperlipidemia n n
  29;hyperlipidemia  n ( % );"C0020473;C0428465;C4555212";NA;NA;hyperlipidemia n
  29;hyperlipidemia  %;"C0020473;C0428465;C4555212";NA;NA;hyperlipidemia
  29;hyperlipidemia;"C0020473;C0428465;C4555212";NA;NA;hyperlipidemia
  29;hyperlipidaemia ( % );"C0020473;C0428465;C4555212";NA;NA;hyperlipidaemia
  29;hyperlipidaemia  n ( % ) yes;"C0020473;C0428465;C1549445;C1705108;C1710701;C4555212";NA;NA;hyperlipidaemia n yes
  29;hyperlipidaemia;"C0020473;C0428465;C4555212";NA;NA;hyperlipidaemia
  28;with placebo ( n $nmbr$ $nmbr$ );"C0032042;C1696465;C1706408";NA;NA;with placebo n $nmbr$ $nmbr$
  28;with placebo;"C0032042;C1696465;C1706408";NA;NA;with placebo
  28;we recorded no significant interactions for any subgroup analysis . pufa = polyunsaturated fatty acids . nyha = new york heart association . lvef = left ventricular ejection fraction . * $nmbr$ % cl was calculated with a cox proportional hazards model . tmedian value . data for total cholesterol were available for $nmbr$ patients ( $nmbr$ n - $nmbr$ pufa  $nmbr$ placebo ) .;"C0004083;C0018623;C0018787;C0027976;C0030705;C0032042;C0032615;C0034869;C0042508;C0201950;C0205091;C0205351;C0237688;C0237881;C0428772;C0439849;C0443246;C0444686;C0470187;C0488728;C0543421;C0596019;C0596306;C0699792;C0750502;C1079230;C1275491;C1441506;C1515021;C1546944;C1552822;C1565830;C1696465;C1704610;C1704675;C1706408;C2986480;C3853788";NA;NA;we recorded no significant interactions for any subgroup analysis pufa polyunsaturated fatty acids nyha new york heart association lvef left ventricular ejection fraction $nmbr$ cl was calculated with a cox proportional hazards model tmedian value data for total cholesterol were available for $nmbr$ patients $nmbr$ n $nmbr$ pufa $nmbr$ placebo
  28;we recorded no significant interactions for any subgroup analysis . nyha = new york heart association . lvef = left ventricular ejection fraction . ' $nmbr$ % cl was calculated by cox proportional hazards model . tmedian value . data for total cholesterol were available for $nmbr$ patients ( $nmbr$ rosuvastatin  $nmbr$ placebo ) .;"C0004083;C0018787;C0027976;C0030705;C0032042;C0033489;C0034869;C0201950;C0237688;C0237881;C0428772;C0439849;C0444686;C0470187;C0543421;C0596019;C0596306;C0699792;C0750502;C0965129;C1079230;C1275491;C1441506;C1515021;C1546944;C1565830;C1696465;C1704610;C1704675;C1706408;C2986480;C3853788";NA;NA;we recorded no significant interactions for any subgroup analysis nyha new york heart association lvef left ventricular ejection fraction $nmbr$ cl was calculated by cox proportional hazards model tmedian value data for total cholesterol were available for $nmbr$ patients $nmbr$ rosuvastatin $nmbr$ placebo
  28;vs . placebo;"C0032042;C1696465;C1706408";NA;NA;vs placebo
  28;vorapaxar placebo $nmbr$ - yr . km %;"C0032042;C0439234;C1696465;C1706408;C2974521;C3887676";NA;NA;vorapaxar placebo $nmbr$ yr km
  28;tiotropium + placebo ( n [ $nmbr$ );"C0032042;C0213771;C1696465;C1706408";NA;NA;tiotropium placebo n $nmbr$
  28;therapy ( asa $nmbr$ / placebo $nmbr$ );"C0004057;C0032042;C0039798;C0087111;C1363945;C1696465;C1706408;C3853627";NA;NA;therapy asa $nmbr$ placebo $nmbr$
  28;therapy ( asa $nmbr$  $nmbr$ / placebo $nmbr$ );"C0004057;C0032042;C0039798;C0087111;C1363945;C1696465;C1706408;C3853627";NA;NA;therapy asa $nmbr$ $nmbr$ placebo $nmbr$
 370;geographic site  %;C0017446;FALSE; 369;geographic site
  28;sbp  difference vs placebo ( $nmbr$ % cl );"C0032042;C0085805;C0596019;C1696465;C1705241;C1705242;C1706408";NA;NA;sbp difference vs placebo $nmbr$ cl
  28;s $nmbr$ vs placebo;"C0032042;C0565930;C1696465;C1706408;C2603362";NA;NA;s $nmbr$ vs placebo
  28;s $nmbr$ - $nmbr$ vs placebo;"C0032042;C0565930;C1696465;C1706408;C2603362";NA;NA;s $nmbr$ $nmbr$ vs placebo
  28;rerandomization to placebo ( n = $nmbr$ ) f;"C0016327;C0032042;C1696465;C1706408";NA;NA;rerandomization to placebo n $nmbr$ f
  28;rate ratio vs placebo ( $nmbr$ % ci );"C0008107;C0032042;C0456603;C0871208;C1521828;C1547037;C1696465;C1706408;C3259781";NA;NA;rate ratio vs placebo $nmbr$ ci
  28;ranolazine vs . placebo km failure rate;"C0032042;C0073633;C0231174;C0680095;C0871208;C1521828;C1696465;C1706408;C3887676";NA;NA;ranolazine vs placebo km failure rate
  28;ranolazine ( n = $nmbr$ ) placebo ( n = $nmbr$ );"C0032042;C0073633;C1696465;C1706408";NA;NA;ranolazine n $nmbr$ placebo n $nmbr$
  28;proportion ( % ) of individuals a alirocumab • placebo;"C0027361;C0032042;C0237401;C1696465;C1706408;C1709707;C3491162";NA;NA;proportion of individuals a alirocumab placebo
  28;pooled placebo;"C0032042;C1696465;C1706408;C1709595;C2349200;C4522255";NA;NA;pooled placebo
  28;plaeebo;NA;NA;NA;plaeebo
  28;placebo §;"C0032042;C1696465;C1706408";NA;NA;placebo
  28;placebo |;"C0032042;C1696465;C1706408";NA;NA;placebo
  28;placebo to ustekinumab $nmbr$ mgt;"C0032042;C1608841;C1696465;C1706408";NA;NA;placebo to ustekinumab $nmbr$ mgt
  28;placebo tiotropium n = $nmbr$ non - tiotropium n = $nmbr$;"C0032042;C0213771;C1518422;C1696465;C1706408";NA;NA;placebo tiotropium n $nmbr$ non tiotropium n $nmbr$
  28;placebo slope lsm ± se ( mm / year );"C0032042;C0036919;C0439234;C0439508;C0807955;C1696465;C1706408;C4330985;C4554674";NA;NA;placebo slope lsm se mm year
  28;placebo secukinumab pooled;"C0032042;C1696465;C1706408;C1709595;C2349200;C3179547;C4522255";NA;NA;placebo secukinumab pooled
  28;placebo r %;"C0032042;C0205090;C0684010;C1696465;C1706408;C2603358";NA;NA;placebo r
  28;placebo plus statin ( n = $nmbr$ );"C0032042;C0332287;C0360714;C1696465;C1706408";NA;NA;placebo plus statin n $nmbr$
  28;placebo plus aspirin;"C0004057;C0032042;C0332287;C1696465;C1706408";NA;NA;placebo plus aspirin
  28;placebo patients with events / total;"C0030705;C0032042;C0439175;C0439810;C0441471;C1696465;C1706408;C3541888";NA;NA;placebo patients with events total
  28;placebo patients with events;"C0030705;C0032042;C0441471;C1696465;C1706408;C3541888";NA;NA;placebo patients with events
  28;placebo patients / events n;"C0030705;C0032042;C0441471;C1696465;C1706408;C3541888";NA;NA;placebo patients events n
  28;placebo no diabetes n = $nmbr$;"C0011847;C0011849;C0032042;C1696465;C1706408";NA;NA;placebo no diabetes n $nmbr$
  28;placebo no . of events / total no . ( % );"C0032042;C0439175;C0439810;C0441471;C1696465;C1706408;C3541888";NA;NA;placebo no of events total no
  28;placebo no . of events / no .;"C0032042;C0441471;C1696465;C1706408;C3541888";NA;NA;placebo no of events no
  28;placebo no . / total no .;"C0032042;C0439175;C0439810;C1696465;C1706408";NA;NA;placebo no total no
  28;placebo no . / total ( % );"C0032042;C0439175;C0439810;C1696465;C1706408";NA;NA;placebo no total
  28;placebo no . ( $nmbr$ - y km % );"C0032042;C1696465;C1706408;C3887676";NA;NA;placebo no $nmbr$ y km
  28;placebo n [ $nmbr$;"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$
  28;placebo n = $nmbr$ subjects;"C0032042;C0681850;C1550501;C1696465;C1706203;C1706408;C2349001;C2697811";NA;NA;placebo n $nmbr$ subjects
  28;placebo n = $nmbr$ n ( % );"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$ n
  28;placebo n = $nmbr$;"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$
  28;placebo n / n ( % );"C0032042;C1696465;C1706408";NA;NA;placebo n n
  28;placebo n / n;"C0032042;C1696465;C1706408";NA;NA;placebo n n
  28;placebo n ( rate ) *;"C0032042;C0871208;C1521828;C1696465;C1706408";NA;NA;placebo n rate
  28;placebo n ( rate ) $nmbr$;"C0032042;C0871208;C1521828;C1696465;C1706408";NA;NA;placebo n rate $nmbr$
  28;placebo n ( % );"C0032042;C1696465;C1706408";NA;NA;placebo n
  28;placebo n;"C0032042;C1696465;C1706408";NA;NA;placebo n
  28;placebo mortality rate  events per $nmbr$ person - y;"C0026565;C0027361;C0032042;C0205848;C0441471;C1696465;C1706408;C2347489;C3541888";NA;NA;placebo mortality rate events per $nmbr$ person y
  28;placebo mean change ( sd );"C0032042;C0392747;C0443172;C0444504;C1696465;C1705241;C1706408;C2347634;C2348143;C2699239;C4319952";NA;NA;placebo mean change sd
  28;placebo mean ( n );"C0032042;C0444504;C1696465;C1706408;C2347634;C2348143";NA;NA;placebo mean n
  28;placebo mean;"C0032042;C0444504;C1696465;C1706408;C2347634;C2348143";NA;NA;placebo mean
  28;placebo mdi;"C0032042;C0993596;C1696465;C1706408;C1839839;C4049613";NA;NA;placebo mdi
  28;placebo ls means ( n );"C0023668;C0032042;C1696465;C1704970;C1706408";NA;NA;placebo ls means n
  28;placebo km %;"C0032042;C1696465;C1706408;C3887676";NA;NA;placebo km
  28;placebo group ( n = $nmbr$ ) ’ j ';"C0032042;C0441844;C1696465;C1706408";NA;NA;placebo group n $nmbr$ j
  28;placebo group ( n = $nmbr$ ) f;"C0016327;C0032042;C0441848;C1696465;C1706408";NA;NA;placebo group n $nmbr$ f
  28;placebo group ( n = $nmbr$ );"C0032042;C0441848;C1696465;C1706408";NA;NA;placebo group n $nmbr$
  28;placebo group ( n = $nmbr$ $nmbr$ ) ( $nmbr$ $nmbr$ person years );"C0027361;C0032042;C0439234;C0441848;C1696465;C1706408;C2347489";NA;NA;placebo group n $nmbr$ $nmbr$ $nmbr$ $nmbr$ person years
  28;placebo group;"C0032042;C0441833;C0687744;C1257890;C1519504;C1696465;C1705428;C1705429;C1706408";NA;NA;placebo group
  28;placebo every $nmbr$ weeks ( n = $nmbr$ );"C0032042;C0439230;C1696465;C1706408";NA;NA;placebo every $nmbr$ weeks n $nmbr$
  28;placebo events / patients ( % );"C0030705;C0032042;C0441471;C1696465;C1706408;C3541888";NA;NA;placebo events patients
  28;placebo events / patients (;"C0030705;C0032042;C0441471;C1696465;C1706408;C3541888";NA;NA;placebo events patients
  28;placebo events / n ( % );"C0032042;C0441471;C1696465;C1706408;C3541888";NA;NA;placebo events n
  28;placebo event rate ( n = $nmbr$ )  %;"C0032042;C0441471;C0871208;C1521828;C1696465;C1706408;C4019010";NA;NA;placebo event rate n $nmbr$
  28;placebo dr = $nmbr$ );"C0013014;C0031831;C0032042;C1696465;C1706408;C1707664;C2348314;C3540849";NA;NA;placebo dr $nmbr$
  28;placebo dn = $nmbr$ );"C0032042;C1333964;C1696465;C1706408;C1707618";NA;NA;placebo dn $nmbr$
  28;placebo diabetes n = $nmbr$;"C0011847;C0011849;C0032042;C1696465;C1706408";NA;NA;placebo diabetes n $nmbr$
  28;placebo croup  n / n ( % );"C0010380;C0032042;C1696465;C1706408";NA;NA;placebo croup n n
  28;placebo arm;"C0032042;C0446516;C1696465;C1706408;C3715044;C4553528";NA;NA;placebo arm
  28;placebo analysed ( % );"C0032042;C1696465;C1706408";NA;NA;placebo analysed
  28;placebo allocation;"C0032042;C1696465;C1706408;C1706778";NA;NA;placebo allocation
  28;placebo [ n z $nmbr$ ];"C0032042;C1696465;C1706408";NA;NA;placebo n z $nmbr$
  28;placebo [ n = $nmbr$ |;"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$
  28;placebo [ n = $nmbr$ ];"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$
  28;placebo / simva;"C0032042;C1696465;C1706408";NA;NA;placebo simva
  28;placebo /;"C0032042;C1696465;C1706408";NA;NA;placebo
  28;placebo - vonoprazan $nmbr$ - vonoprazan $nmbr$;"C0032042;C1696465;C1706408;C4080009";NA;NA;placebo vonoprazan $nmbr$ vonoprazan $nmbr$
  28;placebo - vonoprazan $nmbr$;"C0032042;C1696465;C1706408;C4080009";NA;NA;placebo vonoprazan $nmbr$
  28;placebo - dexlansoprazole;"C0032042;C1696465;C1706408;C2348248";NA;NA;placebo dexlansoprazole
  28;placebo - carisbamate $nmbr$ mg - carisbamate $nmbr$ mg;"C0032042;C1319635;C1696465;C1706408;C1871983";NA;NA;placebo carisbamate $nmbr$ mg carisbamate $nmbr$ mg
  28;placebo + statin ( n = $nmbr$  $nmbr$ );"C0032042;C0360714;C1696465;C1706408";NA;NA;placebo statin n $nmbr$ $nmbr$
  28;placebo + statin;"C0032042;C0360714;C1696465;C1706408";NA;NA;placebo statin
 219;hungary;C0020174;FALSE;2040;hungary
  28;placebo + pioglitazone ( n = $nmbr$ );"C0032042;C0071097;C1696465;C1706408";NA;NA;placebo pioglitazone n $nmbr$
  28;placebo + mtx ( n = $nmbr$ );"C0025677;C0032042;C1417487;C1696465;C1706408";NA;NA;placebo mtx n $nmbr$
  28;placebo + mtx;"C0025677;C0032042;C1417487;C1696465;C1706408";NA;NA;placebo mtx
  28;placebo ( » = $nmbr$ );"C0032042;C1696465;C1706408";NA;NA;placebo $nmbr$
  28;placebo ( « = $nmbr$ );"C0032042;C1696465;C1706408";NA;NA;placebo $nmbr$
  28;placebo ( w = $nmbr$ );"C0032042;C1696465;C1706408";NA;NA;placebo w $nmbr$
  28;placebo ( n — $nmbr$ );"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$
  28;placebo ( n   =   $nmbr$ ) b;"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$ b
  28;placebo ( n   =   $nmbr$ ) a;"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$ a
 466;esr;C3811131;FALSE; 298;esr
  28;placebo ( n   = $nmbr$  $nmbr$ );"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$ $nmbr$
  28;placebo ( n z $nmbr$ );"C0032042;C1696465;C1706408";NA;NA;placebo n z $nmbr$
  28;placebo ( n [ $nmbr$ );"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$
  28;placebo ( n = l $nmbr$ );"C0032042;C1696465;C1706408";NA;NA;placebo n l $nmbr$
  28;placebo ( n = $nmbr$ o );"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$ o
  28;placebo ( n = $nmbr$ l );"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$ l
  28;placebo ( n = $nmbr$ i $nmbr$ );"C0021966;C0032042;C0221138;C0369718;C0441922;C1696465;C1706408";NA;NA;placebo n $nmbr$ i $nmbr$
  28;placebo ( n = $nmbr$ * );"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$
  28;placebo ( n = $nmbr$ ) †;"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$
  28;placebo ( n = $nmbr$ ) n ( % );"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$ n
  28;placebo ( n = $nmbr$ ) i -;"C0021966;C0032042;C0221138;C0369718;C0441922;C1696465;C1706408";NA;NA;placebo n $nmbr$ i
  28;placebo ( n = $nmbr$ ) ';"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$
  28;placebo ( n = $nmbr$ ) $nmbr$ . $nmbr$ ± $nmbr$ . $nmbr$;"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
  28;placebo ( n = $nmbr$ )  n ( % );"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$ n
  28;placebo ( n = $nmbr$ );"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$
  28;placebo ( n = $nmbr$ $nmbr$ );"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$ $nmbr$
  28;placebo ( n = $nmbr$  $nmbr$ );"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$ $nmbr$
  28;placebo ( n = $nmbr$;"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$
  28;placebo ( n : $nmbr$ );"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$
  28;placebo ( n - $nmbr$ . $nmbr$ );"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$ $nmbr$
  28;placebo ( n - $nmbr$ );"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$
  28;placebo ( n $nmbr$ );"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$
  28;placebo ( n $nmbr$ $nmbr$ );"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$ $nmbr$
  28;placebo ( n $nmbr$ $nmbr$  $nmbr$ );"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$ $nmbr$ $nmbr$
  28;placebo ( lsm );"C0032042;C1696465;C1706408";NA;NA;placebo lsm
  28;placebo ( events / n ( % ) );"C0032042;C0441471;C1696465;C1706408;C3541888";NA;NA;placebo events n
  28;placebo ( dm - vs . dm + );"C0011816;C0032042;C1696465;C1706408;C3250443";NA;NA;placebo dm vs dm
  28;placebo ( % );"C0032042;C1696465;C1706408";NA;NA;placebo
  28;placebo ( $nmbr$ = $nmbr$ );"C0032042;C1696465;C1706408";NA;NA;placebo $nmbr$ $nmbr$
  28;placebo ( $nmbr$  $nmbr$ . $nmbr$ % );"C0032042;C1696465;C1706408";NA;NA;placebo $nmbr$ $nmbr$ $nmbr$
  28;placebo %;"C0032042;C1696465;C1706408";NA;NA;placebo
  28;placebo $nmbr$ yr km %;"C0032042;C0439234;C1696465;C1706408;C3887676";NA;NA;placebo $nmbr$ yr km
  28;placebo $nmbr$ year km ( % );"C0032042;C0439234;C0439508;C1696465;C1706408;C3887676";NA;NA;placebo $nmbr$ year km
  28;placebo $nmbr$ o $nmbr$;"C0032042;C1696465;C1706408";NA;NA;placebo $nmbr$ o $nmbr$
  28;placebo $nmbr$ / $nmbr$;"C0032042;C1696465;C1706408";NA;NA;placebo $nmbr$ $nmbr$
  28;placebo $nmbr$ . $nmbr$ pt yrs;"C0032042;C0032743;C0699718;C1696465;C1706408";NA;NA;placebo $nmbr$ $nmbr$ pt yrs
  28;placebo $nmbr$ . $nmbr$;"C0032042;C1696465;C1706408";NA;NA;placebo $nmbr$ $nmbr$
  28;placebo $nmbr$  $nmbr$;"C0032042;C1696465;C1706408";NA;NA;placebo $nmbr$ $nmbr$
  28;placebo $nmbr$;"C0032042;C1696465;C1706408";NA;NA;placebo $nmbr$
  28;placebo  n   =   $nmbr$;"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$
  28;placebo  n = l $nmbr$;"C0032042;C1696465;C1706408";NA;NA;placebo n l $nmbr$
  28;placebo  n = i $nmbr$;"C0021966;C0032042;C0221138;C0369718;C0441922;C1696465;C1706408";NA;NA;placebo n i $nmbr$
  28;placebo  n = $nmbr$;"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$
  28;placebo  n / n ( % );"C0032042;C1696465;C1706408";NA;NA;placebo n n
  28;placebo  n *;"C0032042;C1696465;C1706408";NA;NA;placebo n
  28;placebo  n ( rate );"C0032042;C0871208;C1521828;C1696465;C1706408";NA;NA;placebo n rate
  28;placebo  n ( % );"C0032042;C1696465;C1706408";NA;NA;placebo n
  28;placebo  n;"C0032042;C1696465;C1706408";NA;NA;placebo n
  28;placebo  events / patients ( % );"C0030705;C0032042;C0441471;C1696465;C1706408;C3541888";NA;NA;placebo events patients
  28;placebo  ( n = $nmbr$ );"C0032042;C1696465;C1706408";NA;NA;placebo n $nmbr$
  28;placebo  % > ( n / n );"C0032042;C1696465;C1706408";NA;NA;placebo n n
  28;placebo  % ( n / n );"C0032042;C1696465;C1706408";NA;NA;placebo n n
  28;placebo;"C0032042;C1696465;C1706408";NA;NA;placebo
  28;patients in the placebo group  nt - probnp values were reported for $nmbr$ patients;"C0030705;C0032042;C0042295;C0441833;C0588446;C0669479;C0687744;C0754710;C1257890;C1519504;C1696465;C1705428;C1705429;C1706408";NA;NA;patients in the placebo group nt probnp values were reported for $nmbr$ patients
  28;p   vs . placebo;"C0032042;C0369773;C1696465;C1706408;C2603361";NA;NA;p vs placebo
  28;p vs placebo;"C0032042;C0369773;C1696465;C1706408;C2603361";NA;NA;p vs placebo
  28;p value versus placebo;"C0032042;C1696465;C1706408;C1709380";NA;NA;p value versus placebo
  28;p $nmbr$ vs placebo;"C0032042;C0369773;C1696465;C1706408;C2603361";NA;NA;p $nmbr$ vs placebo
  28;or placebo treatment;"C0032042;C0039798;C0087111;C1522326;C1533734;C1696465;C1705169;C1706408;C3538994;C3887704";NA;NA;or placebo treatment
  28;omega - $nmbr$ fatty acid vs placebo least - squares mean ( $nmbr$ % cl );"C0015684;C0023189;C0032042;C0444504;C0596019;C1696465;C1706408;C1719844;C2347634;C2348143";NA;NA;omega $nmbr$ fatty acid vs placebo least squares mean $nmbr$ cl
  28;nominal p vs placebo;"C0032042;C1696465;C1706408";NA;NA;nominal p vs placebo
  28;no laba  no ics ( tiotropium n = $nmbr$  placebo n = $nmbr$ );"C0032042;C0213771;C0815320;C1696465;C1706408;C4551720";NA;NA;no laba no ics tiotropium n $nmbr$ placebo n $nmbr$
  28;no . of patients ( indacaterol / placebo );"C0030705;C0032042;C1696465;C1706408;C1722260";NA;NA;no of patients indacaterol placebo
  28;n ( indacaterol $nmbr$ ug / indacaterol $nmbr$ ug / placebo );"C0032042;C0369718;C0441922;C1319635;C1696465;C1706408;C1722260";NA;NA;n indacaterol $nmbr$ ug indacaterol $nmbr$ ug placebo
  28;mtx plus placebo;"C0025677;C0032042;C0332287;C1417487;C1696465;C1706408";NA;NA;mtx plus placebo
  28;ls mean difference vs placebo ( $nmbr$ % ci );"C0008107;C0023668;C0032042;C0444504;C1696465;C1705241;C1705242;C1706408;C2347634;C2348143;C3259781";NA;NA;ls mean difference vs placebo $nmbr$ ci
  28;ls mean difference ( se ) vs placebo;"C0023668;C0032042;C0036919;C0444504;C1696465;C1705241;C1705242;C1706408;C2347634;C2348143";NA;NA;ls mean difference se vs placebo
  27;previous tnf antagonist exposure  n ( % );"C0205156;C0231491;C0274281;C0332157;C1448177;C1552607";NA;NA;previous tnf antagonist exposure n
  28;ls mean [ $nmbr$ % ci ] treatment difference vs placebo;"C0008107;C0023668;C0032042;C0039798;C0087111;C0444504;C1522326;C1533734;C1696465;C1705169;C1705241;C1705242;C1706408;C2347634;C2348143;C3259781;C3538994;C3887704";NA;NA;ls mean $nmbr$ ci treatment difference vs placebo
  28;laba ( tiotropium n = $nmbr$  placebo n = $nmbr$ );"C0032042;C0213771;C1696465;C1706408";NA;NA;laba tiotropium n $nmbr$ placebo n $nmbr$
  28;ics ( tiotropium n = $nmbr$  placebo n = $nmbr$ );"C0032042;C0213771;C0815320;C1696465;C1706408;C4551720";NA;NA;ics tiotropium n $nmbr$ placebo n $nmbr$
  28;i placebo ( n = $nmbr$ );"C0021966;C0032042;C0221138;C1696465;C1706408";NA;NA;i placebo n $nmbr$
  28;i placebo;"C0021966;C0032042;C0221138;C1696465;C1706408";NA;NA;i placebo
  28;hba $nmbr$ c  difference vs placebo ( $nmbr$ % cl );"C0019016;C0032042;C0596019;C1696465;C1705241;C1705242;C1706408;C1825777;C3538758";NA;NA;hba $nmbr$ c difference vs placebo $nmbr$ cl
  25;use of parenteral antithrombotic;"C0030547;C1524063;C4522267";NA;NA;use of parenteral antithrombotic
  25;use of diuretics  n ( % );"C0012798;C1524063";NA;NA;use of diuretics n
  25;postoperative use of p - blocker;"C0032790;C1524063";NA;NA;postoperative use of p blocker
  25;new use of gpa;"C0205314;C1524063;C3495801;C4553145";NA;NA;new use of gpa
  28;figure $nmbr$ least squares ( ls ) mean differences between ro ﬂ umilast and placebo in ( a ) pre - and ( b ) postbronchodilator fev $nmbr$ in the itt population and subpopulations . copd  chronic obstructive pulmonary disease  fev $nmbr$  forced expiratory volume in $nmbr$ s  ics  inhaled corticosteroid  itt  intent to treat  laba  long - acting b $nmbr$ - agonist .;"C0001617;C0004048;C0016529;C0023189;C0023668;C0024117;C0032042;C0032659;C0035826;C0040363;C0041260;C0079613;C0087111;C0162425;C0205166;C0332152;C0444504;C0740175;C0815320;C1257890;C1283828;C1292734;C1306036;C1413096;C1522326;C1550453;C1696465;C1704930;C1705241;C1705242;C1706317;C1706408;C1869853;C1883351;C2257086;C2347634;C2348143;C2599594;C2987048;C2987634;C3536709;C3669034;C3714541;C3890007;C4048375;C4551720";NA;NA;figure $nmbr$ least squares ls mean differences between ro umilast and placebo in a pre and b postbronchodilator fev $nmbr$ in the itt population and subpopulations copd chronic obstructive pulmonary disease fev $nmbr$ forced expiratory volume in $nmbr$ s ics inhaled corticosteroid itt intent to treat laba long acting b $nmbr$ agonist
  28;feno placebo ( lsm );"C0032042;C1696465;C1706408";NA;NA;feno placebo lsm
  28;feno;NA;NA;NA;feno
  28;favors ffa / i favors placebo;"C0015688;C0021966;C0032042;C0221138;C0309049;C1696465;C1706408";NA;NA;favors ffa i favors placebo
  28;f $nmbr$ vs placebo;"C0016327;C0032042;C1696465;C1706408";NA;NA;f $nmbr$ vs placebo
  28;esrd on placebo ( % );"C0022661;C0032042;C0035078;C1696465;C1706408;C2316810";NA;NA;esrd on placebo
  28;duration from clopidogrel / placebo to pci  min ( median  iqr );"C0032042;C0070166;C0449238;C0549183;C0702093;C0876920;C1524029;C1696465;C1706408;C2347635;C2348144;C2926735;C2939193;C3813700;C4049621";NA;NA;duration from clopidogrel placebo to pci min median iqr
  28;dm - ( aliskiren vs . placebo );"C0011816;C0032042;C1120110;C1696465;C1706408;C3250443";NA;NA;dm aliskiren vs placebo
  28;dm + ( aliskiren vs . placebo );"C0011816;C0032042;C1120110;C1696465;C1706408;C3250443";NA;NA;dm aliskiren vs placebo
  28;differences between indacaterol + tiotropium versus tiotropium + placebo;"C0032042;C0213771;C1696465;C1705241;C1705242;C1706408;C1722260";NA;NA;differences between indacaterol tiotropium versus tiotropium placebo
  28;difference vs placebo * *;"C0032042;C1696465;C1705241;C1705242;C1706408";NA;NA;difference vs placebo
  28;difference vs placebo ( $nmbr$ % ci );"C0008107;C0032042;C1696465;C1705241;C1705242;C1706408;C3259781";NA;NA;difference vs placebo $nmbr$ ci
  28;difference vs placebo ';"C0032042;C1696465;C1705241;C1705242;C1706408";NA;NA;difference vs placebo
  28;difference vs placebo  % [ $nmbr$ % cl ]  p;"C0032042;C0596019;C1696465;C1705241;C1705242;C1706408";NA;NA;difference vs placebo $nmbr$ cl p
  28;difference vs placebo;"C0032042;C1696465;C1705241;C1705242;C1706408";NA;NA;difference vs placebo
  28;difference vs . placebo  % ( $nmbr$ % cl );"C0032042;C0596019;C1696465;C1705241;C1705242;C1706408";NA;NA;difference vs placebo $nmbr$ cl
  28;difference vs . placebo;"C0032042;C1696465;C1705241;C1705242;C1706408";NA;NA;difference vs placebo
  28;difference from placebo ¥;"C0032042;C1696465;C1705241;C1705242;C1706408";NA;NA;difference from placebo
  28;difference from placebo * ( $nmbr$ % ci );"C0008107;C0032042;C1696465;C1705241;C1705242;C1706408;C3259781";NA;NA;difference from placebo $nmbr$ ci
  28;difference from placebo ( $nmbr$ % cl );"C0032042;C0596019;C1696465;C1705241;C1705242;C1706408";NA;NA;difference from placebo $nmbr$ cl
  28;difference from placebo ( $nmbr$ % ci );"C0008107;C0032042;C1696465;C1705241;C1705242;C1706408;C3259781";NA;NA;difference from placebo $nmbr$ ci
  28;difference from placebo;"C0032042;C1696465;C1705241;C1705242;C1706408";NA;NA;difference from placebo
  28;difference ( n - $nmbr$ fa - placebo ) lsm ± se ( mm / year );"C0032042;C0036919;C0439234;C0439508;C1696465;C1705241;C1705242;C1706408;C4330985;C4554674";NA;NA;difference n $nmbr$ fa placebo lsm se mm year
  28;difference ( a ) vs placebo ( $nmbr$ % cl );"C0032042;C0596019;C1696465;C1705241;C1705242;C1706408";NA;NA;difference a vs placebo $nmbr$ cl
  28;dapagliflozin placebo no . of events / no . of patients;"C0030705;C0032042;C0441471;C1696465;C1706408;C2353951;C3541888";NA;NA;dapagliflozin placebo no of events no of patients
  28;copd - placebo ( n = $nmbr$ );"C0024117;C0032042;C1412502;C1696465;C1706408;C3714496";NA;NA;copd placebo n $nmbr$
  28;copd - placebo ( $nmbr$ pt ) n . ( % );"C0024117;C0032042;C0032743;C0699718;C1412502;C1696465;C1706408;C3714496";NA;NA;copd placebo $nmbr$ pt n
  28;comparison with placebo ( mean;"C0032042;C0444504;C1696465;C1706408;C1707455;C2347634;C2348143";NA;NA;comparison with placebo mean
  28;comparison with placebo;"C0032042;C1696465;C1706408;C1707455";NA;NA;comparison with placebo
  28;chf on placebo ( % );"C0018802;C0032042;C1696465;C1706408";NA;NA;chf on placebo
  28;baseline to eom placebo ( n = $nmbr$ );"C0032042;C0168634;C0241886;C1442488;C1696465;C1706408";NA;NA;baseline to eom placebo n $nmbr$
  28;b digit symbol substitution  omega - $nmbr$ fatty acids vs placebo;"C0015684;C0032042;C0582802;C0679214;C1555721;C1696465;C1698987;C1706204;C1706408;C1719844;C3241971";NA;NA;b digit symbol substitution omega $nmbr$ fatty acids vs placebo
  28;assigned to placebo;"C0032042;C1516050;C1552601;C1696465;C1706408";NA;NA;assigned to placebo
  28;any placebo;"C0032042;C1696465;C1706408";NA;NA;any placebo
  28;ambulatory sbp  difference vs placebo ( $nmbr$ % cl );"C0032042;C0085805;C0439841;C0596019;C1696465;C1705241;C1705242;C1706408";NA;NA;ambulatory sbp difference vs placebo $nmbr$ cl
  28;active   versus   placebo;"C0032042;C0205177;C1696465;C1706408;C3853793;C3888249";NA;NA;active versus placebo
  28;active vs placebo;"C0032042;C0205177;C1696465;C1706408;C3853793;C3888249";NA;NA;active vs placebo
  28;absolutedifferenceestimate vs placebo ( $nmbr$ % ci );"C0008107;C0032042;C1696465;C1706408;C3259781";NA;NA;absolutedifferenceestimate vs placebo $nmbr$ ci
  28;absolute difference estimate vs placebo ( $nmbr$ % ci );"C0008107;C0032042;C0750572;C1549031;C1696465;C1706408;C3259781";NA;NA;absolute difference estimate vs placebo $nmbr$ ci
  28;a $nmbr$ vs placebo;"C0032042;C1696465;C1706408";NA;NA;a $nmbr$ vs placebo
  28;[ } ifrerence vs . placebo  % ( $nmbr$ % cl );"C0032042;C0596019;C1696465;C1706408";NA;NA;ifrerence vs placebo $nmbr$ cl
  28;= placebo  eze : tes ( fc j > $nmbr$ rr $nmbr$ definition ) .;"C0032042;C0076172;C1422793;C1550452;C1696465;C1704788;C1706408;C2983605;C3539107;C3888054;C4554402";NA;NA;placebo eze tes fc j $nmbr$ rr $nmbr$ definition
  28;- $nmbr$ placebo;"C0032042;C1696465;C1706408";NA;NA;$nmbr$ placebo
  28;( tiotropium n = $nmbr$  placebo n =;"C0032042;C0213771;C1696465;C1706408";NA;NA;tiotropium n $nmbr$ placebo n
  28;( tiotropium n = $nmbr$  placebo n;"C0032042;C0213771;C1696465;C1706408";NA;NA;tiotropium n $nmbr$ placebo n
  28;$nmbr$ placebo n = $nmbr$;"C0032042;C1696465;C1706408";NA;NA;$nmbr$ placebo n $nmbr$
  28;$nmbr$ placebo ( n = $nmbr$ $nmbr$ );"C0032042;C1696465;C1706408";NA;NA;$nmbr$ placebo n $nmbr$ $nmbr$
  28;$nmbr$ placebo;"C0032042;C1696465;C1706408";NA;NA;$nmbr$ placebo
  28;$nmbr$ mg / day - placebo;"C0032042;C0439422;C1696465;C1706408";NA;NA;$nmbr$ mg day placebo
  28;$nmbr$ - year rates in placebo groups;"C0032042;C0439234;C0439508;C0441833;C0687744;C0871208;C1257890;C1519504;C1521828;C1552839;C1696465;C1705428;C1705429;C1706408";NA;NA;$nmbr$ year rates in placebo groups
  27;tnfi exposed;C0332157;NA;NA;tnfi exposed
  27;tnfi - exposed †;C0332157;NA;NA;tnfi exposed
  27;tnf antagonist - exposed;"C0231491;C0332157;C1448177";NA;NA;tnf antagonist exposed
  27;ltg - exposed;"C0332157;C1420817;C4521367;C4521846";NA;NA;ltg exposed
  27;exposure;"C0274281;C0332157";NA;NA;exposure
  27;exposed ( n = $nmbr$ );C0332157;NA;NA;exposed n $nmbr$
  27;exposed;C0332157;NA;NA;exposed
  26;participated in a previous febuxostat studyb  n ( % );"C0205156;C0249529;C1552607";NA;NA;participated in a previous febuxostat studyb n
  26;febuxostat - febuxostat / lesinurad $nmbr$ - febuxostat / lesinurad $nmbr$;"C0249529;C3886073";NA;NA;febuxostat febuxostat lesinurad $nmbr$ febuxostat lesinurad $nmbr$
  26;febuxostat - febuxostat / lesinurad $nmbr$;"C0249529;C3886073";NA;NA;febuxostat febuxostat lesinurad $nmbr$
  26;febuxostat;C0249529;NA;NA;febuxostat
  26;completed prior febuxostat studya;"C0205197;C0249529;C0332152;C2826257;C3854010";NA;NA;completed prior febuxostat studya
  26;completed previous febuxostat study;"C0205156;C0249529;C1552607;C2348557";NA;NA;completed previous febuxostat study
  25;use of ticagrelor;"C1524063;C1999375";NA;NA;use of ticagrelor
  25;use of proton inhibitors  n ( % );"C0033727;C0243077;C1524063";NA;NA;use of proton inhibitors n
  25;menopausal status and use of ht;"C0018510;C0677607;C1513126;C1524063";NA;NA;menopausal status and use of ht
  25;menopausal status and use of hrt ( % ) y;"C0282402;C1513126;C1524063";NA;NA;menopausal status and use of hrt y
  25;diabetes with use of oral diabetes drugs;"C0011847;C0011849;C0020616;C0029167;C0175795;C0304289;C0442027;C1524063;C4521986";NA;NA;diabetes with use of oral diabetes drugs
  25;diabetes with no use of diabetes drugs;"C0020616;C1524063";NA;NA;diabetes with no use of diabetes drugs
  25;continued use of gpa;"C0549178;C1524063;C3495801;C4553145";NA;NA;continued use of gpa
  24;ocs use;"C0042153;C0457083;C1947944";NA;NA;ocs use
  24;ocs;NA;NA;NA;ocs
  24;oam use [ n ( % ) ];"C0042153;C0457083;C1947944";NA;NA;oam use n
  24;oad use  n ( % );"C0042153;C0457083;C1947944";NA;NA;oad use n
  24;maintenance ocs use  n ( % );"C0024501;C0042153;C0369718;C0441922;C0457083;C1947944";NA;NA;maintenance ocs use n
  24;$nmbr$ oam;NA;NA;NA;$nmbr$ oam
  24;$nmbr$ oad;NA;NA;NA;$nmbr$ oad
  23;tobacco user;C3853727;NA;NA;tobacco user
  23;tobacco use — no . ( % );"C0040335;C0543414;C0841002;C3853727";NA;NA;tobacco use no
  23;tobacco use ( % );"C0040335;C0543414;C0841002;C3853727";NA;NA;tobacco use
  23;tobacco use  yes  n ( % );"C0040335;C0543414;C0841002;C1549445;C1705108;C1710701;C3853727";NA;NA;tobacco use yes n
  23;tobacco use  n ( % );"C0040335;C0543414;C0841002;C3853727";NA;NA;tobacco use n
  23;tobacco use;"C0040335;C0543414;C0841002;C3853727";NA;NA;tobacco use
  23;tobacco abuse;C0040336;NA;NA;tobacco abuse
  23;prior tobacco use  n ( % );"C0040335;C0332152;C0543414;C0841002;C2826257;C3853727";NA;NA;prior tobacco use n
  23;non - / ex - tobacco user;"C1518422;C3853727";NA;NA;non ex tobacco user
  23;no current tobacco use;"C0040335;C0521116;C0543414;C0841002;C1705970;C3853727";NA;NA;no current tobacco use
  23;current tobacco use;"C0040335;C0521116;C0543414;C0841002;C1705970;C3853727";NA;NA;current tobacco use
  23;baseline tobacco use;"C0040335;C0168634;C0543414;C0841002;C1442488;C3853727";NA;NA;baseline tobacco use
  22;glucose in urine    ≥ $nmbr$ +;C0004076;NA;NA;glucose in urine $nmbr$
  22;dosing;NA;NA;NA;dosing
  22;$nmbr$ - h plasma glucose during ogtt ( mmol / l );"C0029161;C0202042;C0455280;C2827804";NA;NA;$nmbr$ h plasma glucose during ogtt mmol l
  21;fasting plasma glucose — mg / dl;"C0015663;C0202042;C0439269;C0455280";NA;NA;fasting plasma glucose mg dl
  21;fasting plasma glucose categories  n ( % );"C0015663;C0202042;C0455280;C0683312";NA;NA;fasting plasma glucose categories n
  21;fasting plasma glucose *;"C0015663;C0202042;C0455280";NA;NA;fasting plasma glucose
  21;fasting plasma glucose ( mg / dl ) $nmbr$;"C0015663;C0202042;C0439269;C0455280";NA;NA;fasting plasma glucose mg dl $nmbr$
  21;fasting plasma glucose ( mg / dl );"C0015663;C0202042;C0439269;C0455280";NA;NA;fasting plasma glucose mg dl
  21;fasting plasma glucose $nmbr$ medan;"C0015663;C0202042;C0455280";NA;NA;fasting plasma glucose $nmbr$ medan
  21;fasting plasma glucose  mg / dl  mean ( sd ) b;"C0015663;C0202042;C0439269;C0444504;C0455280;C2347634;C2348143;C2699239";NA;NA;fasting plasma glucose mg dl mean sd b
  21;fasting plasma glucose  mg / dl  mean ( sd );"C0015663;C0202042;C0439269;C0444504;C0455280;C2347634;C2348143;C2699239";NA;NA;fasting plasma glucose mg dl mean sd
  21;fasting plasma glucose  mg / dl;"C0015663;C0202042;C0439269;C0455280";NA;NA;fasting plasma glucose mg dl
  21;fasting plasma glucose;"C0015663;C0202042;C0455280";NA;NA;fasting plasma glucose
  21;fascng plasma glucose a medan;"C0202042;C0455280";NA;NA;fascng plasma glucose a medan
  21;casual plasma glucose ( mg / dl );"C0202042;C0439269;C0455280";NA;NA;casual plasma glucose mg dl
  21;baseline fasting plasma glucose;"C0015663;C0168634;C0202042;C0455280;C1442488";NA;NA;baseline fasting plasma glucose
  21;$nmbr$ - hr plasma glucose — mg / dl;"C0202042;C0439269;C0455280";NA;NA;$nmbr$ hr plasma glucose mg dl
  20;who / idf impaired fasting glucose;C1272092;NA;NA;who idf impaired fasting glucose
  20;impaired glucose tolerance or impaired fasting glucose — no . ( % );"C0271650;C1272092";NA;NA;impaired glucose tolerance or impaired fasting glucose no
  20;impaired glucose tolerance or impaired fasting glucose;"C0271650;C1272092";NA;NA;impaired glucose tolerance or impaired fasting glucose
  20;impaired fasting glucose §;C1272092;NA;NA;impaired fasting glucose
  20;impaired fasting glucose level ( n = $nmbr$ );"C0202045;C0221099;C0441889;C0456079;C1272092;C1547707;C2946261";NA;NA;impaired fasting glucose level n $nmbr$
  20;impaired fasting glucose;C1272092;NA;NA;impaired fasting glucose
  20;both impaired glucose tolerance and impaired fasting glucose tolerance — no .;"C0013220;C0015663;C0020963;C0220929;C0231197;C0271650;C1272092;C1704410";NA;NA;both impaired glucose tolerance and impaired fasting glucose tolerance no
  19;salmeterol / fluticasone $nmbr$ / $nmbr$   μ g b . i . d .;"C0086706;C0939232";NA;NA;salmeterol fluticasone $nmbr$ $nmbr$ g b i d
  19;salmeterol / fluticasone $nmbr$ / $nmbr$ pg twice daily;"C0030827;C0072225;C0585361;C0939232;C1266240";NA;NA;salmeterol fluticasone $nmbr$ $nmbr$ pg twice daily
  19;salmeterol - fluticasone group ( n = $nmbr$ );"C0441848;C0939232";NA;NA;salmeterol fluticasone group n $nmbr$
  19;fluticasone furoate  n = $nmbr$;C1948374;NA;NA;fluticasone furoate n $nmbr$
  19;fluticasone - salmeterol ( n = $nmbr$ );C0939232;NA;NA;fluticasone salmeterol n $nmbr$
  19;fluticasone - fluticasone / salmeterol;C0939232;NA;NA;fluticasone fluticasone salmeterol
  17;red blood cell counting  $nmbr$ / l;"C0005767;C0005768;C0022827;C0229664;C0332575;C0750480;C1260956;C1705566;C4049926";NA;NA;red blood cell counting $nmbr$ l
  25;use of low - dose aspirin ( < $nmbr$;"C1524063;C2608320";FALSE;1366;use of low dose aspirin $nmbr$
  25;use of systemic glucocorticoid at random -;"C0017710;C0034656;C0205373;C0439605;C1524063";FALSE;1348;use of systemic glucocorticoid at random
  25;use of methotrexate at randomization —;"C0025677;C0034656;C1524063";FALSE;1408;use of methotrexate at randomization
  20;glucose test;"C0337438;C0595310";FALSE;2317;glucose test
  18;fasting blood glucose;"C0428568;C1261430";FALSE;2280;fasting blood glucose
  18;fasting blood glucose ( mg / dl );"C0428568;C0439269;C1261430";FALSE;2280;fasting blood glucose mg dl
  17;any blood;"C0005767;C0005768;C0229664";NA;NA;any blood
  15;weight  kg blood pressure  mm hg;"C0005823;C0005910;C0022718;C0043100;C0439209;C0439475;C1271104;C1272641;C1305866;C1705104;C4054209";NA;NA;weight kg blood pressure mm hg
  15;treatment with any blood - pressure -;"C0005823;C0033095;C0039798;C0087111;C0460139;C0596197;C1271104;C1272641;C1306345;C1522326;C1533734;C1705169;C3538994;C3887704;C4284008";NA;NA;treatment with any blood pressure
  15;preoperative blood pressure ( mm hg ) patients fulfilling eligibility criteria;"C0005823;C0030705;C0439475;C0445204;C1271104;C1272641;C1512693;C1550543";NA;NA;preoperative blood pressure mm hg patients fulfilling eligibility criteria
  15;lvh by ecgt blood pressure  mm hg;"C0005823;C0149721;C0439475;C1271104;C1272641";NA;NA;lvh by ecgt blood pressure mm hg
  15;body - mass index : ! : blood pressure — mm hg;"C0005823;C0005893;C0439475;C0578022;C1271104;C1272641;C1305855";NA;NA;body mass index blood pressure mm hg
  15;blood pressure — mmhg;"C0005823;C0439475;C1271104;C1272641";NA;NA;blood pressure mmhg
  15;blood pressure — mm hg;"C0005823;C0439475;C1271104;C1272641";NA;NA;blood pressure mm hg
  15;blood pressure while seated — mm hg;"C0005823;C0277814;C0439475;C1271104;C1272641;C1283233";NA;NA;blood pressure while seated mm hg
  15;blood pressure eontrolt;"C0005823;C1271104;C1272641";NA;NA;blood pressure eontrolt
  15;blood pressure at target level ( % ) §;"C0005823;C0441889;C0456079;C1271104;C1272641;C1521840;C1547707;C2946261;C2986546";NA;NA;blood pressure at target level
  15;blood pressure at entry ( mm   hg );"C0005823;C0439475;C1271104;C1272641;C1705654";NA;NA;blood pressure at entry mm hg
  15;blood pressure > $nmbr$ mm hg;"C0005823;C0439475;C1271104;C1272641";NA;NA;blood pressure $nmbr$ mm hg
  15;blood pressure < $nmbr$ mm hg;"C0005823;C0439475;C1271104;C1272641";NA;NA;blood pressure $nmbr$ mm hg
  15;blood pressure < $nmbr$ / $nmbr$ mmhg  n ( % );"C0005823;C0439475;C1271104;C1272641";NA;NA;blood pressure $nmbr$ $nmbr$ mmhg n
  15;blood pressure - lowering treatment;"C0005823;C0033095;C0039798;C0087111;C0441994;C0460139;C0596197;C1271104;C1272641;C1306345;C1522326;C1533734;C1705169;C2003888;C3538994;C3887704;C4284008";NA;NA;blood pressure lowering treatment
  15;blood pressure ( mmhg );"C0005823;C0439475;C1271104;C1272641";NA;NA;blood pressure mmhg
  15;blood pressure ( mm hg ) *;"C0005823;C0439475;C1271104;C1272641";NA;NA;blood pressure mm hg
  15;blood pressure ( mm hg );"C0005823;C0439475;C1271104;C1272641";NA;NA;blood pressure mm hg
  15;blood pressure ( % );"C0005823;C1271104;C1272641";NA;NA;blood pressure
  15;blood pressure  mmhg systolic;"C0005823;C0039155;C0439475;C1271104;C1272641";NA;NA;blood pressure mmhg systolic
  15;blood pressure  mmhg;"C0005823;C0439475;C1271104;C1272641";NA;NA;blood pressure mmhg
  15;blood pressure  mm hg;"C0005823;C0439475;C1271104;C1272641";NA;NA;blood pressure mm hg
  15;blood pressure  mm;"C0005823;C1271104;C1272641;C4330985;C4554674";NA;NA;blood pressure mm
  15;blood pressure;"C0005823;C1271104;C1272641";NA;NA;blood pressure
  15;arterial blood pressure  mm hg;"C0439475;C1272641";NA;NA;arterial blood pressure mm hg
  14;rosigiitazone ± oad;NA;NA;NA;rosigiitazone oad
  14;previous oral glucose - lowering agents  % of patients;"C0205156;C0441994;C0600419;C1552607;C1955477;C2003888";NA;NA;previous oral glucose lowering agents of patients
  14;previous oad ( % );"C0205156;C1552607";NA;NA;previous oad
  14;previous limb or foot amputation;"C0015385;C0188605;C0205156;C1552607";NA;NA;previous limb or foot amputation
  14;previous aorta - femoral or lower extremity bypass surgery  pta of iliac  or infrainguinal artery;"C0003483;C0003842;C0015811;C0020889;C0187763;C0205156;C0226004;C0741847;C1552607;C3274435";NA;NA;previous aorta femoral or lower extremity bypass surgery pta of iliac or infrainguinal artery
  14;oralb;NA;NA;NA;oralb
  14;or $nmbr$;NA;NA;NA;or $nmbr$
  14;oad;NA;NA;NA;oad
  14;glulisine + oad;NA;NA;NA;glulisine oad
  14;giimepiride ± oad;NA;NA;NA;giimepiride oad
  13;smoking status  n ( % ) former;"C0205156;C0750523;C1519386";NA;NA;smoking status n former
  13;smoker ( current / former );"C0205156;C0337664;C0521116;C0750523;C1705970";NA;NA;smoker current former
  13;previous exposure to a vitamin k antagonist — no . ( % ) current or former never;"C0042839;C0087161;C0205156;C0231491;C0332157;C0521116;C0597277;C0750523;C1552607;C1705970;C1708601;C2003901;C2825076;C3714656";NA;NA;previous exposure to a vitamin k antagonist no current or former never
  13;previous a - blocker use;"C0042153;C0205156;C0457083;C1552607;C1947944";NA;NA;previous a blocker use
  13;previous a - blocker;"C0205156;C1552607";NA;NA;previous a blocker
  13;former smoking;"C0037369;C0205156;C0453996;C0750523;C1881674";NA;NA;former smoking
  13;former or never diabetes;"C0011847;C0011849;C0205156;C0750523;C2003901";NA;NA;former or never diabetes
  13;former or never;"C0205156;C0750523;C2003901";NA;NA;former or never
  13;former n z $nmbr$;"C0205156;C0750523";NA;NA;former n z $nmbr$
  13;former / current smoker ( n = $nmbr$ $nmbr$ );"C0205156;C0337671;C0521116;C0750523;C1705970;C3173209;C3241966";NA;NA;former current smoker n $nmbr$ $nmbr$
  13;former / current smoker  n ( % );"C0205156;C0337671;C0521116;C0750523;C1705970;C3173209;C3241966";NA;NA;former current smoker n
  13;former ( n   = $nmbr$  $nmbr$ );"C0205156;C0750523";NA;NA;former n $nmbr$ $nmbr$
  13;former  n ( % );"C0205156;C0750523";NA;NA;former n
  13;former;"C0205156;C0750523";NA;NA;former
  13;ever smoked ( current / former );"C0037366;C0205156;C0439994;C0521116;C0750523;C1705970;C1881674";NA;NA;ever smoked current former
  13;b - blocker;NA;NA;NA;b blocker
  13;a - blocker;NA;NA;NA;a blocker
  12;worsening heart failure;"C0018801;C0018802;C0332271;C1457868;C1546960;C4554158";NA;NA;worsening heart failure
  12;time since diagnosis of heart failure;"C0011900;C0018801;C0018802;C0040223;C1704338;C1704656;C3541383;C4554158";NA;NA;time since diagnosis of heart failure
  12;score on the minnesota living with heart failure scaled;"C0018801;C0018802;C0026183;C0175659;C0349674;C0449820;C0595998;C1947916;C4050231;C4520849;C4551704;C4554158";NA;NA;score on the minnesota living with heart failure scaled
  12;recurrent heart failure;"C0018801;C0018802;C1455761;C2945760;C4554158";NA;NA;recurrent heart failure
  12;priorheartfailure  %;NA;NA;NA;priorheartfailure
  12;prior heart failure — no . { % );"C0018801;C0018802;C0332152;C2826257;C4554158";NA;NA;prior heart failure no
  12;prior heart failure yes;"C0018801;C0018802;C0332152;C1549445;C1705108;C1710701;C2826257;C4554158";NA;NA;prior heart failure yes
  12;prior heart failure ( n = $nmbr$  $nmbr$ );"C0018801;C0018802;C0332152;C2826257;C4554158";NA;NA;prior heart failure n $nmbr$ $nmbr$
  12;prior heart failure  n / n ( % );"C0018801;C0018802;C0332152;C2826257;C4554158";NA;NA;prior heart failure n n
  12;prior heart failure  n ( % );"C0018801;C0018802;C0332152;C2826257;C4554158";NA;NA;prior heart failure n
  12;prior heart failure  %;"C0018801;C0018802;C0332152;C2826257;C4554158";NA;NA;prior heart failure
  12;prior heart failure;"C0018801;C0018802;C0332152;C2826257;C4554158";NA;NA;prior heart failure
  12;previous hospital admission for heart failure;"C0018801;C0018802;C0184666;C0205156;C1552607;C4554158";NA;NA;previous hospital admission for heart failure
  12;participants without heart failure;"C0018801;C0018802;C0679646;C4554158";NA;NA;participants without heart failure
  12;participants with heart failure;"C0018801;C0018802;C0679646;C4554158";NA;NA;participants with heart failure
 307;> $nmbr$ egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;$nmbr$ egfr ml min $nmbr$ $nmbr$ m $nmbr$
  17;baseline diastolic blood;"C0005767;C0005768;C0012000;C0168634;C0229664;C1442488";FALSE;1469;baseline diastolic blood
  17;blood pressure at baseline :;"C0005767;C0005768;C0005823;C0168634;C0229664;C0443150;C1271104;C1272641;C1442488";FALSE;1469;blood pressure at baseline
  17;blood bilirubin increased;"C0005437;C0005767;C0005768;C0205217;C0229664;C0442805";FALSE;1684;blood bilirubin increased
  12;not hospitalized for heart failure in the year prior to study enrollment;"C0018801;C0018802;C0332152;C0701159;C1516879;C1518422;C1696073;C3258203;C3888021;C4554158";NA;NA;not hospitalized for heart failure in the year prior to study enrollment
  12;no prior heart failure ( n = $nmbr$  $nmbr$ );"C0018801;C0018802;C0332152;C2826257;C4554158";NA;NA;no prior heart failure n $nmbr$ $nmbr$
  12;no prior heart failure;"C0018801;C0018802;C0332152;C2826257;C4554158";NA;NA;no prior heart failure
  12;no heart failure;"C0018801;C0018802;C4554158";NA;NA;no heart failure
  12;mortality  shock or congestive heart failure within $nmbr$ days;"C0018802;C0026565;C0026566;C0036974;C0439228";NA;NA;mortality shock or congestive heart failure within $nmbr$ days
  12;medical history of cv disease or heart failure  n ( % );"C0007222;C0018801;C0018802;C0262926;C4554158";NA;NA;medical history of cv disease or heart failure n
  12;hospitalized heart failure;"C0018801;C0018802;C0701159;C4554158";NA;NA;hospitalized heart failure
  12;hospitalized for heart failure during that time period;"C0018801;C0018802;C0701159;C1948053;C4554158";NA;NA;hospitalized for heart failure during that time period
  12;hospitalized / fatal heart failure;"C0018801;C0018802;C0701159;C1302234;C1705232;C4554158";NA;NA;hospitalized fatal heart failure
  12;hospital admission for heart failure;"C0018801;C0018802;C0184666;C4554158";NA;NA;hospital admission for heart failure
  12;histor y of heart failure;"C0018801;C0018802;C4554158";NA;NA;histor y of heart failure
  12;histor y of congestive heart failure — no . ( % );C0018802;NA;NA;histor y of congestive heart failure no
  12;heart failure ‡;"C0018801;C0018802;C4554158";NA;NA;heart failure
  12;heart failure — no . / total no . ( % );"C0018801;C0018802;C0439175;C0439810;C4554158";NA;NA;heart failure no total no
  12;heart failure — no . ( % );"C0018801;C0018802;C4554158";NA;NA;heart failure no
  12;heart failure history;"C0018801;C0018802;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C4554158";NA;NA;heart failure history
  12;heart failure criteria met;"C0018801;C0018802;C0243161;C0428210;C1550543;C4317104;C4554158";NA;NA;heart failure criteria met
  12;heart failure cause;"C0015127;C0018801;C0018802;C1524003;C4554158";NA;NA;heart failure cause
  12;heart failure at entry  no . ( % );"C0018801;C0018802;C1705654;C4554158";NA;NA;heart failure at entry no
  12;heart failure *;"C0018801;C0018802;C4554158";NA;NA;heart failure
   1;weeks_measured;"C0439230;C0444706;C3541902";NA;NA;weeks_measured
  12;heart failure ( treated / hospitalized / fatal );"C0018801;C0018802;C0701159;C1302234;C1522326;C1705232;C4554158";NA;NA;heart failure treated hospitalized fatal
  12;heart failure  no . / total no . ( % );"C0018801;C0018802;C0439175;C0439810;C4554158";NA;NA;heart failure no total no
  12;heart failure  n ( % );"C0018801;C0018802;C4554158";NA;NA;heart failure n
  12;heart failure  hospitalized or fatal;"C0018801;C0018802;C0701159;C1302234;C1705232;C4554158";NA;NA;heart failure hospitalized or fatal
  12;heart failure;"C0018801;C0018802;C4554158";NA;NA;heart failure
  12;fatal & nonfatal hospitalized heart failure;"C0018801;C0018802;C0701159;C1302234;C1705232;C4554158";NA;NA;fatal nonfatal hospitalized heart failure
  12;congestive heart failure †;C0018802;NA;NA;congestive heart failure
  12;congestive heart failure — no . ( % ) | |;C0018802;NA;NA;congestive heart failure no
  12;congestive heart failure — no . ( % ) |;C0018802;NA;NA;congestive heart failure no
  12;congestive heart failure — no . ( % );C0018802;NA;NA;congestive heart failure no
  12;congestive heart failure — %;C0018802;NA;NA;congestive heart failure
  12;congestive heart failure §;C0018802;NA;NA;congestive heart failure
  12;congestive heart failure at randomisation;"C0018802;C0034656";NA;NA;congestive heart failure at randomisation
  12;congestive heart failure ( definite );"C0018802;C0439544;C1704787";NA;NA;congestive heart failure definite
  12;congestive heart failure ( chf ) ( in past $nmbr$ weeks );"C0018802;C2987125";NA;NA;congestive heart failure chf in past $nmbr$ weeks
  12;congestive heart failure ( < $nmbr$ wk );"C0018802;C0332174;C0439230";NA;NA;congestive heart failure $nmbr$ wk
  12;congestive heart failure  n ( % );C0018802;NA;NA;congestive heart failure n
  12;congestive heart failure;C0018802;NA;NA;congestive heart failure
  12;combined cardiac failure  cardiomyopathy or other cardiac disorder  n ( % ) luts severity  n ( % );"C0018787;C0018799;C0018801;C0018802;C0205195;C0439793;C0521117;C0522510;C0574785;C0878544;C1292730;C1522601";NA;NA;combined cardiac failure cardiomyopathy or other cardiac disorder n luts severity n
  12;chronic heart failure class ii - iii;"C0018802;C0264716;C0439070;C0441886;C0441887;C1705160;C1710602;C2698968;C2698969;C4082587";NA;NA;chronic heart failure class ii iii
  12;chronic heart failure;"C0018802;C0264716";NA;NA;chronic heart failure
  12;cause of heart failure — no . ( % );"C0015127;C0018801;C0018802;C1524003;C4554158";NA;NA;cause of heart failure no
  12;cause of heart failure;"C0015127;C0018801;C0018802;C1524003;C4554158";NA;NA;cause of heart failure
  12;cardiac failure —;"C0018801;C0018802";NA;NA;cardiac failure
  12;cardiac failure §;"C0018801;C0018802";NA;NA;cardiac failure
  12;cardiac failure *;"C0018801;C0018802";NA;NA;cardiac failure
  12;cardiac failure  n ( % );"C0018801;C0018802";NA;NA;cardiac failure n
  12;cardiac failure;"C0018801;C0018802";NA;NA;cardiac failure
  12;baseline heart failure severity amongthose with priorheartfailure  %;"C0018801;C0018802;C0168634;C0439793;C0522510;C1442488;C4554158";NA;NA;baseline heart failure severity amongthose with priorheartfailure
  11;type of tnf failure  n ( % ) b;"C0231174;C0332307;C0680095;C1547052;C3887647";NA;NA;type of tnf failure n b
  11;type of tnf antagonist failure  n ( “ / o ) ”;"C0231174;C0231491;C0332307;C0680095;C1448177;C1547052";NA;NA;type of tnf antagonist failure n o
  11;type of tnf antagonist failure  n ( % ) ' ’;"C0231174;C0231491;C0332307;C0680095;C1448177;C1547052";NA;NA;type of tnf antagonist failure n
  11;tnf antagonist - failure population ( n - $nmbr$ );"C0032659;C0231174;C0231491;C0680095;C1257890;C1448177";NA;NA;tnf antagonist failure population n $nmbr$
  11;tnf - failure patientsa;"C0231174;C0680095;C1448177";NA;NA;tnf failure patientsa
  11;prior immunnosupressive failure but no anti - tnf failure;"C0231174;C0332152;C0680095;C1448177;C2826257";NA;NA;prior immunnosupressive failure but no anti tnf failure
  11;prior anti - tnf failure;"C0231174;C0332152;C0680095;C1448177;C2826257";NA;NA;prior anti tnf failure
  11;any prior anti - tnf treatment failure;"C0162643;C0231174;C0235828;C0332152;C0521983;C0680095;C1448177;C1514463;C1547544;C2826257";NA;NA;any prior anti tnf treatment failure
  10;question $nmbr$ ( fatigue / tiredness );"C0015672;C1522634;C3463815;C4050243;C4553152;C4554645";NA;NA;question $nmbr$ fatigue tiredness
  10;fatigue ( range $nmbr$ - $nmbr$ );"C0015672;C1514721;C2348147;C3463815;C3542016;C4050243;C4554645";NA;NA;fatigue range $nmbr$ $nmbr$
  10;fatigue;"C0015672;C3463815;C4050243;C4554645";NA;NA;fatigue
  10;facit - fatigue . mean $nmbr$ sd ( range $nmbr$ - $nmbr$ );"C0015672;C0444504;C1514721;C2347634;C2348143;C2348147;C2699239;C3463815;C3476791;C3542016;C4050243;C4554645";NA;NA;facit fatigue mean $nmbr$ sd range $nmbr$ $nmbr$
  10;energy / fatigue;"C0015672;C0424589;C0542479;C1442080;C3463815;C4050243;C4330907;C4554645";NA;NA;energy fatigue
   9;value for nteraction;C1522609;NA;NA;value for nteraction
   9;value *;C1522609;NA;NA;value
   9;value;C1522609;NA;NA;value
   9;troponin or ckmb value;"C0010290;C0041199;C0523584;C1522609";NA;NA;troponin or ckmb value
   9;proportion of predicted normal fev $nmbr$ value   §;"C0086715;C0520835;C0681842;C1522609;C1709707;C1882327;C3714541";FALSE;1197;proportion of predicted normal fev $nmbr$ value
  11;heat failure;"C0018837;C0231174;C0680095";FALSE; -10;heat failure
  11;> $nmbr$ failure;"C0231174;C0680095";FALSE;1969;$nmbr$ failure
  11;failure;"C0231174;C0680095";FALSE;1969;failure
   9;or_value;C1522609;NA;NA;or_value
   9;or $nmbr$ _value;C1522609;NA;NA;or $nmbr$ _value
   9;l ’ - value ’;"C0439394;C1522609;C1706495;C3642217";NA;NA;l value
   9;d - value;C1522609;NA;NA;d value
   9;baseline value;"C0168634;C1442488;C1522609";NA;NA;baseline value
   9;/ ’ - value $nmbr$ ’;C1522609;NA;NA;value $nmbr$
   9;/ ’ - value;C1522609;NA;NA;value
   8;valve replacement / repair with or without cabg;"C0010055;C0035139;C0043240;C0184252;C0374711;C0559956;C1186983;C1555302;C1704414;C3888056;C4319951;C4553149";NA;NA;valve replacement repair with or without cabg
   7;* the p ‐ value is from the test statistic for testing the interaction between the treatment group and diabetes group .;"C0011847;C0011849;C0039593;C0237913;C0374505;C0392366;C0441833;C0687744;C1257890;C1519504;C1704675;C1705428;C1705429;C1709380";NA;NA;the p value is from the test statistic for testing the interaction between the treatment group and diabetes group
   7;* p value;C1709380;NA;NA;p value
   7;$nmbr$ p value;C1709380;NA;NA;$nmbr$ p value
   6;plaque score ( $nmbr$ - $nmbr$ );C0429153;NA;NA;plaque score $nmbr$ $nmbr$
   6;plaque ( n  % );"C0011389;C0241148;C0332461;C0333463;C4316797";NA;NA;plaque n
   6;percent of predicted value before bronchodilation ^;"C1371299;C1882327;C3537072";NA;NA;percent of predicted value before bronchodilation
   6;/ j - valuc ! l;NA;NA;NA;j valuc l
   5;pvalue ∗;NA;NA;NA;pvalue
   5;pvalue for heterogeneity;"C0019409;C0242960";NA;NA;pvalue for heterogeneity
   5;pvalue;NA;NA;NA;pvalue
   5;p value for heterogeneity （ rosiglitazone versus metformin ）;"C0019409;C0025598;C0242960;C0289313;C1709380";NA;NA;p value for heterogeneity rosiglitazone versus metformin
   5;p value for heterogeneity;"C0019409;C0242960;C1709380";NA;NA;p value for heterogeneity
   4;prasugrel or ticagrelor;"C1620287;C1999375";NA;NA;prasugrel or ticagrelor
   4;prasugrel;C1620287;NA;NA;prasugrel
   3;outcome measure;C0086749;NA;NA;outcome measure
   3;leisure;C0086542;NA;NA;leisure
   2;physiological measures;"C0079809;C0205463;C1879489";NA;NA;physiological measures
   2;measures of lung function;"C0035245;C0079809;C1879489";NA;NA;measures of lung function
   2;measures ( mmol / l );"C0079809;C0242485;C1532563;C1879489";NA;NA;measures mmol l
   2;measures ( % );"C0079809;C1879489";NA;NA;measures
   2;measures;"C0079809;C1879489";NA;NA;measures
   2;measure;"C0079809;C0242485";NA;NA;measure
   2;lipid measure *;"C0023779;C0079809;C0242485";NA;NA;lipid measure
   2;efficacy measures;"C0079809;C0242485;C1280519;C1707887;C1879489";NA;NA;efficacy measures
   2;diff_measure;"C0079809;C0242485";NA;NA;diff_measure
   2;biochemical measures  mean ( sd );"C0079809;C0205474;C0444504;C1879489;C2347634;C2348143;C2699239";NA;NA;biochemical measures mean sd
 358;fasting glucose ( mmol / l );"C0015663;C0017725;C1532563";FALSE;1846;fasting glucose mmol l
 367;drug - eluting;"C0013227;C1254351";FALSE; 365;drug eluting
  18;blood - glucose control;C3267174;FALSE;  18;blood glucose control
 909;apo  apolipoprotein  dm  diabetes mellitus  hdl - c  high - density lipoprotein cholesterol  ldl - c  low - density lipoprotein cholesterol  tc  total cholesterol;"C0003591;C0003594;C0008377;C0011849;C0023824;C0039411;C0040642;C0041405;C0041698;C0392885;C0428471;C1824670;C3272447;C3715113;C4522122";FALSE; -10;apo apolipoprotein dm diabetes mellitus hdl c high density lipoprotein cholesterol ldl c low density lipoprotein cholesterol tc total cholesterol
 913;extreme tortuosity;"C0205403;C0333076;C3641272;C4085555";FALSE; -10;extreme tortuosity
 913;severe or very severe copd;"C0024117;C0205082;C1412502;C3641272;C3714496;C4050419;C4050465;C4050466";FALSE;1836;severe or very severe copd
 913;very severe  gold $nmbr$;"C0018026;C1304897;C3641272;C4050419";FALSE;1836;very severe gold $nmbr$
 913;very severe ( gold $nmbr$ );"C0018026;C1304897;C3641272;C4050419";FALSE;1836;very severe gold $nmbr$
 216;ticlopidin;NA;FALSE;1837;ticlopidin
 216;ticlopidine;C0040207;FALSE;1837;ticlopidine
 216;ticlopidine after completion of study drug;"C0013175;C0013227;C0040207;C0205197;C1254351;C1554962;C2348557";FALSE;1837;ticlopidine after completion of study drug
 216;ticlopidine ( n = $nmbr$ );C0040207;FALSE;1837;ticlopidine n $nmbr$
 224;coronary risk factors — no . ( % );C2024776;FALSE; -10;coronary risk factors no
 227;previous coronary angioplasty  n ( % );C2114427;FALSE;1722;previous coronary angioplasty n
 264;calcitonin;"C0006668;C0770558;C1704385;C2825090;C4520796";FALSE; -10;calcitonin
 268;chronic sinusitis + nasal polypsd  n ( % );"C0028429;C0149516;C4520890";FALSE;1838;chronic sinusitis nasal polypsd n
 271;uniti - $nmbr$ and uniti - $nmbr$ im - uniti;NA;FALSE; -10;uniti $nmbr$ and uniti $nmbr$ im uniti
 275;asymmetric peripheral arthritis;"C0238694;C0332514";FALSE; 274;asymmetric peripheral arthritis
 275;spondylitis with peripheral arthritis;"C0038012;C0238694";FALSE; 274;spondylitis with peripheral arthritis
 307;egfr at baseline  $nmbr$ ml / min ( % ) b;"C0168634;C0439445;C1442488;C1739039;C3811844;C3812682";FALSE; 592;egfr at baseline $nmbr$ ml min b
 307;egfr by creatinine ( ml / min per $nmbr$ · $nmbr$ m $nmbr$ );"C0010294;C0369637;C0439445;C0441923;C1561535;C1739039;C3811844;C3812682";FALSE; 592;egfr by creatinine ml min per $nmbr$ $nmbr$ m $nmbr$
 307;egfr by creatinine ( ml / min per $nmbr$ · $nmbr$ m $nmbr$  geometric mean [ se ] );"C0010294;C0036919;C0369637;C0439445;C0441923;C1561535;C1739039;C2986759;C3811844;C3812682";FALSE; 592;egfr by creatinine ml min per $nmbr$ $nmbr$ m $nmbr$ geometric mean se
 307;egfr by cystatin c ( ml / min per $nmbr$ · $nmbr$ m $nmbr$  geometric mean [ se ] );"C0036919;C0071744;C0369637;C0439445;C0441923;C1413772;C1739039;C2986759;C3811844;C3812682";FALSE; 592;egfr by cystatin c ml min per $nmbr$ $nmbr$ m $nmbr$ geometric mean se
 307;egfr ( ckd - epi  cystatin c )  ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0071744;C0162734;C0369637;C0439445;C0441923;C1413772;C1561643;C1739039;C3811844;C3812682;C4281721";FALSE; 592;egfr ckd epi cystatin c ml min $nmbr$ $nmbr$ m $nmbr$
 307;egfr by cystatin c ( ml / min per $nmbr$ · $nmbr$ m $nmbr$  mean [ se ] );"C0036919;C0071744;C0369637;C0439445;C0441923;C0444504;C1413772;C1739039;C2347634;C2348143;C3811844;C3812682";FALSE; 592;egfr by cystatin c ml min per $nmbr$ $nmbr$ m $nmbr$ mean se
 307;egfrmdrd  ml / min / $nmbr$ . $nmbr$ m $nmbr$ bsa;"C0369637;C0439445;C0441923";FALSE; 592;egfrmdrd ml min $nmbr$ $nmbr$ m $nmbr$ bsa
 307;egfrmdrd  ml - min - $nmbr$ - $nmbr$ . $nmbr$ m - $nmbr$;"C0369637;C0439445;C0441923";FALSE; 592;egfrmdrd ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$
 307;egfrmdrd < $nmbr$ ml - min - $nmbr$ - $nmbr$ . $nmbr$ m - $nmbr$  n ( % );"C0369637;C0439445;C0441923";FALSE; 592;egfrmdrd $nmbr$ ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$ n
 307;egfr  mean = sd  ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C0444504;C1739039;C2347634;C2348143;C2699239;C3811844;C3812682";FALSE; 592;egfr mean sd ml min $nmbr$ $nmbr$ m $nmbr$
 307;egfr  ml / min ( mdrd );"C0439445;C1739039;C3811844;C3812682;C3839656";FALSE; 592;egfr ml min mdrd
 307;egfr  ml / min per $nmbr$ . $nmbr$ m $nmbr$  mean ( sd );"C0369637;C0439445;C0441923;C0444504;C1739039;C2347634;C2348143;C2699239;C3811844;C3812682";FALSE; 592;egfr ml min per $nmbr$ $nmbr$ m $nmbr$ mean sd
 307;estimated gfr ( ml / min / $nmbr$ . $nmbr$ m $nmbr$ ) lipid baseline lipid profile;"C0017654;C0023779;C0168634;C0369637;C0439445;C0441923;C0750572;C1424601;C1442488;C1979963;C2003903";FALSE; 592;estimated gfr ml min $nmbr$ $nmbr$ m $nmbr$ lipid baseline lipid profile
 307;mean ( sd ) egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C0444504;C1739039;C2347634;C2348143;C2699239;C3811844;C3812682";FALSE; 592;mean sd egfr ml min $nmbr$ $nmbr$ m $nmbr$
 370;geographic region — number ( % );"C0017446;C0237753;C0449788";FALSE; 369;geographic region number
   1;ldl - c ( measured ) *;"C0444706;C3541902";FALSE;1068;ldl c measured
   1;ldl - c ( measured )  mean ( sd );"C0444504;C0444706;C2347634;C2348143;C2699239;C3541902";FALSE;1068;ldl c measured mean sd
 307;normal or increased baseline gfr ( > $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ );"C0017654;C0168634;C0205217;C0205307;C0231683;C0369637;C0439166;C0439445;C0441923;C0442805;C1424601;C1442488;C2347086;C4553972";FALSE; 592;normal or increased baseline gfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;renal impairment ( crcl < $nmbr$ ml / min );"C0439445;C1565489;C1846718";FALSE; 592;renal impairment crcl $nmbr$ ml min
 307;stage i ( gfr > $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$ ) and stage v ( gfr < $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$ ) were not considered because they included only $nmbr$ and $nmbr$ patient  respectively . chf  congestive;"C0007591;C0017654;C0018802;C0021966;C0023806;C0030705;C0205171;C0221138;C0332257;C0369637;C0439445;C0441766;C0441777;C0441923;C0456533;C0702093;C0742742;C0750591;C1424601;C1518422;C1524029;C1720467;C3813700";FALSE; 592;stage i gfr $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$ and stage v gfr $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$ were not considered because they included only $nmbr$ and $nmbr$ patient respectively chf congestive
 307;renal function ( egfr  ml / min / $nmbr$ . $nmbr$ m $nmbr$ );"C0232804;C0369637;C0439445;C0441923;C1739039;C3811844;C3812682";FALSE; 592;renal function egfr ml min $nmbr$ $nmbr$ m $nmbr$
 307;baseline egfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0168634;C0369637;C0439445;C0441923;C1442488;C1739039;C3811844;C3812682";FALSE; 592;baseline egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;baseline egfr > $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0168634;C0369637;C0439445;C0441923;C1442488;C1739039;C3811844;C3812682";FALSE; 592;baseline egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$
 307;baseline egfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$ c;"C0168634;C0369637;C0439445;C0441923;C1442488;C1739039;C3811844;C3812682";FALSE; 592;baseline egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ c
 307;baseline gfr < $nmbr$ ml / min / $nmbr$ . $nmbr$ m $nmbr$  n ( % );"C0017654;C0168634;C0369637;C0439445;C0441923;C1424601;C1442488";FALSE; 592;baseline gfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ n
 307;baseline gfr < $nmbr$ ml / min per $nmbr$ . $nmbr$ m $nmbr$  n ( % );"C0017654;C0168634;C0369637;C0439445;C0441923;C1424601;C1442488";FALSE; 592;baseline gfr $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$ n
 338;improved;"C0184511;C0332272;C1561611;C4084203";FALSE; -10;improved
 873;simvastatin;C0074554;FALSE;1840;simvastatin
 873;simvastatin  n ( % );C0074554;FALSE;1840;simvastatin n
 873;simvastatin $nmbr$ mg ( n = $nmbr$ ) *;"C0024671;C0026410;C0074554;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;1840;simvastatin $nmbr$ mg n $nmbr$
 873;simvastatin monotherapy ( n = $nmbr$  $nmbr$ * );C0074554;FALSE;1840;simvastatin monotherapy n $nmbr$ $nmbr$
 873;simvastatin $nmbr$ mg;"C0024671;C0026410;C0074554;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;1840;simvastatin $nmbr$ mg
 873;simvastatin $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0074554;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;1840;simvastatin $nmbr$ mg n $nmbr$
 882;pravastatin;C0085542;FALSE;1841;pravastatin
 882;pravastatin $nmbr$ mg;"C0024671;C0026410;C0085542;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;1841;pravastatin $nmbr$ mg
 882;pravastatin ( n = $nmbr$ >;C0085542;FALSE;1841;pravastatin n $nmbr$
 882;pravastatin ( n = $nmbr$ );C0085542;FALSE;1841;pravastatin n $nmbr$
 882;pravastatin n = $nmbr$;C0085542;FALSE;1841;pravastatin n $nmbr$
 882;pravastatin vs usual care;"C0085542;C1947933;C3538928";FALSE;1841;pravastatin vs usual care
1763;any llt other than statins  n ( % ) b;"C0360714;C2347090";FALSE; 872;any llt other than statins n b
1763;no statin vs statin alone vs any statin plus other llt;"C0205171;C0360714;C0439044;C0679994;C2347090";FALSE; 872;no statin vs statin alone vs any statin plus other llt
1763;any statin + other llt;"C0360714;C2347090";FALSE; 872;any statin other llt
1763;statin + fibrate or niacin;"C0027996;C0360714;C1142562";FALSE; 872;statin fibrate or niacin
1763;other statin;C0360714;FALSE; 872;other statin
1763;statin + fibrate or;C0360714;FALSE; 872;statin fibrate or
 836;high - intensity statin;"C0360714;C4081854";FALSE; 872;high intensity statin
 836;high ‐ intensity statins ‡;"C0360714;C4081854";FALSE; 872;high intensity statins
 836;high - intensity statin *;"C0360714;C4081854";FALSE; 872;high intensity statin
 836;high - intensity statin vs medium - or low - intensity statin at randomization;"C0009458;C0034656;C0360714;C0439536;C0596836;C1705217;C3244283;C4081854;C4085196;C4522282;C4522283";FALSE; 872;high intensity statin vs medium or low intensity statin at randomization
 836;no high - intensity statin;"C0360714;C4081854";FALSE; 872;no high intensity statin
 836;high - intensity statin use;"C0042153;C0360714;C0457083;C1947944;C4081854";FALSE; 872;high intensity statin use
1166;placebo - ezetimibe $nmbr$ / simvastatin $nmbr$ - fenofibrate $nmbr$ - ezetimibe $nmbr$ / simvastatin $nmbr$ / ezetimibe $nmbr$;"C0032042;C0033228;C1532737;C1696465;C1706408";FALSE;1840;placebo ezetimibe $nmbr$ simvastatin $nmbr$ fenofibrate $nmbr$ ezetimibe $nmbr$ simvastatin $nmbr$ ezetimibe $nmbr$
1166;ezetimibe / simvastatin - double dose statin - rosuvastatin;"C0178602;C0205173;C0360714;C0869039;C0965129;C1114758;C1532737;C1705764;C1705765";FALSE;1840;ezetimibe simvastatin double dose statin rosuvastatin
1166;ezetimibe + simvastatin ( n = $nmbr$ * );C1532737;FALSE;1840;ezetimibe simvastatin n $nmbr$
1166;ezetimibe + simvastatin ( n = $nmbr$  $nmbr$ * );C1532737;FALSE;1840;ezetimibe simvastatin n $nmbr$ $nmbr$
1166;ezetimibe / simvastatin;C1532737;FALSE;1840;ezetimibe simvastatin
1166;chd  coronary heart disease  eze / simva  ezetimibe / simvastatin combination tablet  fpg  fasting plasma glucose  pvd  peripheral vascular disease;"C0010068;C0015663;C0039225;C0074554;C0085096;C0202042;C0455280;C1532737;C1705223;C4319774";FALSE; -10;chd coronary heart disease eze simva ezetimibe simvastatin combination tablet fpg fasting plasma glucose pvd peripheral vascular disease
 198;simvastatin ( $nmbr$ / $nmbr$ mg / d );"C0074554;C0439422";FALSE;1840;simvastatin $nmbr$ $nmbr$ mg d
 198;simvastatin ( $nmbr$ / $nmbr$ mg / d ) ( n = $nmbr$ );"C0074554;C0439422";FALSE;1840;simvastatin $nmbr$ $nmbr$ mg d n $nmbr$
 589;estonia;C0014908;FALSE; -10;estonia
 599;southern europe;C0037724;FALSE; -10;southern europe
 306;all men;C0025266;FALSE;1842;all men
 306;chd + cerebrovascular disease men $nmbr$ / $nmbr$ ( $nmbr$ . $nmbr$ );"C0007820;C0025266;C0280604;C3542407";FALSE;1842;chd cerebrovascular disease men $nmbr$ $nmbr$ $nmbr$ $nmbr$
 306;chd men;"C0025266;C0280604;C3542407";FALSE;1842;chd men
 306;men;C0025266;FALSE;1842;men
 306;men  %;C0025266;FALSE;1842;men
 306;men  n ( % );C0025266;FALSE;1842;men n
 306;men  < $nmbr$ cm;C0025266;FALSE;1842;men $nmbr$ cm
 306;men  > $nmbr$ cm;C0025266;FALSE;1842;men $nmbr$ cm
 306;men ( n = $nmbr$ $nmbr$ );C0025266;FALSE;1842;men n $nmbr$ $nmbr$
 306;men ( n = $nmbr$ )  n / n ( % );C0025266;FALSE;1842;men n $nmbr$ n n
 306;men without ed ( n = $nmbr$ ) $nmbr$ . $nmbr$ ± $nmbr$ . $nmbr$;"C0025266;C3538926";FALSE;1842;men without ed n $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$
1323;hdl cholesterol < $nmbr$ ( men ) or < $nmbr$ mg / dl ( women );"C0023822;C0025266;C0043210;C0392885;C0439269";FALSE; -10;hdl cholesterol $nmbr$ men or $nmbr$ mg dl women
1323;history of gestational diabetes mellitus — no . ( % of women );"C0043210;C2183115";FALSE; -10;history of gestational diabetes mellitus no of women
1323;p value ( men versus women );"C0025266;C0043210;C1709380";FALSE; -10;p value men versus women
 975;tio ( n $nmbr$ $nmbr$ );NA;FALSE; -10;tio n $nmbr$ $nmbr$
 975;tio;NA;FALSE; -10;tio
 975;primary and secondary prevention subgroups  adjusted for age  gender  hypertension  diabetes mellitus  and smoking . hr indicates hazard ratio  $nmbr$ % cl  $nmbr$ % confidence interval  tia  transient ischemic attack .;"C0007787;C0011849;C0020538;C0037369;C0079399;C0205225;C0237529;C0439612;C0439631;C0453996;C0596019;C0679699;C1079230;C1272706;C1522384;C1552654;C1552713;C1704725;C1704726;C1881674;C1963138;C2985465;C4300468";FALSE; -10;primary and secondary prevention subgroups adjusted for age gender hypertension diabetes mellitus and smoking hr indicates hazard ratio $nmbr$ cl $nmbr$ confidence interval tia transient ischemic attack
 355;diagnosis of heterozygous familial hypercholester;"C0011900;C0015576;C0019425;C0241888;C1704338;C1704656";FALSE; -10;diagnosis of heterozygous familial hypercholester
 358;fasting glucose  mmol / l  mean ± sd;"C0015663;C0017725;C0444504;C1532563;C2347634;C2348143;C2699239";FALSE;1846;fasting glucose mmol l mean sd
 358;impaired fasting giucose levei ( n = $nmbr$ );"C0015663;C0221099";FALSE;1846;impaired fasting giucose levei n $nmbr$
 358;glucose  non - fasting or random ( nmol / l );"C0015663;C0017725;C0034656;C0439282;C0439605;C1518422";FALSE;1846;glucose non fasting or random nmol l
 370;geographic location;C0017446;FALSE; 369;geographic location
 370;geographic region ?;C0017446;FALSE; 369;geographic region
 377;micro / macroalbuminuria;"C0085672;C1553035;C3811161;C4049106";FALSE; 376;micro macroalbuminuria
 377;micro / macroaibuminuria;"C0085672;C1553035;C3811161;C4049106";FALSE; 376;micro macroaibuminuria
 903;prothrombin mutation ( % );C1610621;FALSE; -10;prothrombin mutation
 386;death  q wave mi or ischemia - driven revasc;"C0011065;C0022116;C0378365;C0861151;C1306577;C4082313;C4321499;C4552775;C4683688";FALSE; 385;death q wave mi or ischemia driven revasc
 397;at increased fall risk ( n - $nmbr$ );"C0085639;C0205217;C0238715;C0442805;C1268740;C4553726;C4699158";FALSE;1850;at increased fall risk n $nmbr$
 397;notatincreased fall risk ( n - $nmbr$  $nmbr$ );C1268740;FALSE;1850;notatincreased fall risk n $nmbr$ $nmbr$
 399;previous labd alone;"C0205156;C0205171;C0396059;C0439044;C0679994;C1552607";FALSE;1508;previous labd alone
 975;bp : blood pressure  ci : confidence interval  esrd : end - stage renal disease  hr  hazard ratio . all patients ( except patients with other race ) were included with missing covariates imputed . event : no . of patients with esrd  rate : event rate per $nmbr$ years of follow - up  pre - specified : a cox model with treatment group and region as covariates and baseline proteinuria level ( o or x $nmbr$ g / g ) as strata  adjusted : a multivariate cox model with treatment group  time - varying systolic and diastolic bp as covariates . pre - specified analysis and adjusted for time - varying bp;"C0002778;C0005823;C0008107;C0009667;C0012634;C0017446;C0022646;C0022661;C0030705;C0033687;C0034510;C0035078;C0037623;C0039155;C0039798;C0040223;C0087111;C0168634;C0205088;C0205147;C0332257;C0332283;C0428883;C0439234;C0441471;C0441833;C0441835;C0441889;C0456079;C0456081;C0679845;C0687744;C0871208;C0936012;C1257890;C1319635;C1415692;C1442488;C1519504;C1521828;C1522326;C1524024;C1533734;C1547707;C1551393;C1565830;C1705169;C1705428;C1705429;C1705492;C1706779;C1708288;C1719822;C1962972;C2316810;C2699638;C2826245;C2946261;C2985465;C3161035;C3259781;C3272743;C3274659;C3538994;C3541383;C3714583;C3853635;C3853906;C3887704;C4019010;C4281991;C4318478;C4522145;C4554346";FALSE; -10;bp blood pressure ci confidence interval esrd end stage renal disease hr hazard ratio all patients except patients with other race were included with missing covariates imputed event no of patients with esrd rate event rate per $nmbr$ years of follow up pre specified a cox model with treatment group and region as covariates and baseline proteinuria level o or x $nmbr$ g g as strata adjusted a multivariate cox model with treatment group time varying systolic and diastolic bp as covariates pre specified analysis and adjusted for time varying bp
 192;creatinine $nmbr$ . $nmbr$ mg / dl medications;"C0010294;C0013227;C0439269;C0802604;C1561535;C2598133;C4284232";FALSE; 952;creatinine $nmbr$ $nmbr$ mg dl medications
 192;creatinine — mg / dl urinary albumin - to - creatinine ratio §;"C0010294;C0439269;C0456603;C1547037;C1561535;C2362049";FALSE; 952;creatinine mg dl urinary albumin to creatinine ratio
 192;creatinine ≥ $nmbr$ . $nmbr$ mg / dl;"C0010294;C0439269;C1561535";FALSE; 952;creatinine $nmbr$ $nmbr$ mg dl
 192;creatinine  mg / dl ( sd );"C0010294;C0439269;C1561535;C2699239";FALSE; 952;creatinine mg dl sd
 192;creatinine ( mg / dl )  mean ( sd );"C0010294;C0439269;C0444504;C1561535;C2347634;C2348143;C2699239";FALSE; 952;creatinine mg dl mean sd
 192;creatinine  mg / dl  mean;"C0010294;C0439269;C0444504;C1561535;C2347634;C2348143";FALSE; 952;creatinine mg dl mean
  82;creatinine;"C0010294;C1561535";FALSE; 952;creatinine
  82;creatinine  mmol 八;"C0010294;C0439190;C1561535";FALSE; 952;creatinine mmol
  82;creatinine ( µ mol / l );"C0010294;C0347982;C1561535";FALSE; 952;creatinine mol l
  82;creatinine ( p  mol / l );"C0010294;C0347982;C1561535";FALSE; 952;creatinine p mol l
  82;creatinine  pmol / l;"C0010294;C0439284;C1561535";FALSE; 952;creatinine pmol l
  82;creatinine ( ^ mol / l ) ( median  iqr );"C0010294;C0347982;C0549183;C0876920;C1561535;C2347635;C2348144;C2939193";FALSE; 952;creatinine mol l median iqr
 200;acr  mg / mmol;"C0567349;C1412134;C1515941;C2348885";FALSE;  80;acr mg mmol
 200;albumin / creatinine ratio - mg / mmol  median ( iqr );"C0486293;C0549183;C0567349;C0876920;C1318293;C2347635;C2348144;C2348885;C2939193";FALSE;  80;albumin creatinine ratio mg mmol median iqr
 200;uacr   < $nmbr$   mg / mmol ∗;"C0567349;C2348885";FALSE;  80;uacr $nmbr$ mg mmol
 200;urine acr ( mg / mmol );"C0042036;C0042037;C0567349;C1412134;C1515941;C2348885;C2963137";FALSE;  80;urine acr mg mmol
 200;uacr   ≥ $nmbr$   mg / mmol ∗;"C0567349;C2348885";FALSE;  80;uacr $nmbr$ mg mmol
 200;urinary acr ( mg / mmol );"C0042027;C0567349;C1412134;C1515941;C1524119;C2348885";FALSE;  80;urinary acr mg mmol
 389;ace = angiotensin - converting enzyme  cabg = coronary artery bypass graft  ccsc = canadian cardiovascular society classification  mi = myocardial infarction  pci = percutaneous coronary;"C0010055;C0022709;C0027051;C0189695;C0545743;C3640258";FALSE; -10;ace angiotensin converting enzyme cabg coronary artery bypass graft ccsc canadian cardiovascular society classification mi myocardial infarction pci percutaneous coronary
 389;data are expressed as n / total ( % ) unless otherwise speci ﬁ ed . systeme international unit conversion : to convert creatinine clearance to ml / s  multiply by $nmbr$ . $nmbr$ . * estimated with cockroft - gault equation  † at discharge . ace angiotensin - converting enzyme  cabg coronary artery bypass graft  ccsc canadian cardiovascular society classi ﬁ cation  mi myocardial infarction  pci percutaneous coronary intervention .;"C0007226;C0007447;C0010055;C0012621;C0018787;C0022709;C0027051;C0030685;C0037455;C0040363;C0041260;C0184661;C0238884;C0439175;C0439453;C0439526;C0439810;C0439836;C0522523;C0552449;C0565930;C0750572;C0812399;C0886296;C1273869;C1511726;C1516705;C1705224;C1719797;C1883351;C2603362;C2911648;C2926602;C3245479;C3538926;C3714741;C3887460;C3887665;C4049621";FALSE; -10;data are expressed as n total unless otherwise speci ed systeme international unit conversion to convert creatinine clearance to ml s multiply by $nmbr$ $nmbr$ estimated with cockroft gault equation at discharge ace angiotensin converting enzyme cabg coronary artery bypass graft ccsc canadian cardiovascular society classi cation mi myocardial infarction pci percutaneous coronary intervention
 389;pci = percutaneous coronary intervention . cabg = coronary - artery bypass graft . for hope > $nmbr$ mg / l  for europa > $nmbr$ mg / l or on a lipid - lowering treatment  for peace  data are mean ( sd ) . data are mean ( sd ) unless otherwise indicated .;"C0010055;C0023779;C0039798;C0087111;C0184661;C0189695;C0242751;C0392347;C0441994;C0444504;C0522523;C0545743;C0680443;C0886296;C1273869;C1444656;C1511726;C1522326;C1533734;C1705169;C2003888;C2347634;C2348143;C2699239;C2827881;C3245479;C3538994;C3714741;C3887704;C4049621";FALSE; -10;pci percutaneous coronary intervention cabg coronary artery bypass graft for hope $nmbr$ mg l for europa $nmbr$ mg l or on a lipid lowering treatment for peace data are mean sd data are mean sd unless otherwise indicated
 432;creatinine clearance > $nmbr$ to < $nmbr$ ml / min — no . ( % ) f;"C0016327;C0151280";FALSE;  79;creatinine clearance $nmbr$ to $nmbr$ ml min no f
 461;coronary - artery bypass grafting;C0010055;FALSE;1843;coronary artery bypass grafting
 461;coronar y - artery bypass grafting;"C0450140;C0741847";FALSE;1843;coronar y artery bypass grafting
 461;coronary artery bypass grafting;C0010055;FALSE;1843;coronary artery bypass grafting
 461;coronary artery bypass grafting n ( % );C0010055;FALSE;1843;coronary artery bypass grafting n
 461;coronary - artery bypass grafting §;C0010055;FALSE;1843;coronary artery bypass grafting
 461;coronary artery bypass graft — no . ( % );"C0010055;C1260596";FALSE;1843;coronary artery bypass graft no
 470;creatinine clearance at admission ( ml / min );"C0151280;C0184666;C0809949";FALSE;  79;creatinine clearance at admission ml min
 666;elevated creatinine ( > $nmbr$ pmol / l );"C0151578;C0439284;C0700225";FALSE; 952;elevated creatinine $nmbr$ pmol l
1036;normoalbuminuria §;NA;FALSE;  80;normoalbuminuria
1036;patients with macroalbuminuria at baseline;"C0030705;C0168634;C1442488";FALSE;  80;patients with macroalbuminuria at baseline
1036;patients with normoalbuminuria at baseline;"C0030705;C0168634;C1442488";FALSE;  80;patients with normoalbuminuria at baseline
1579;“ relative risk of outcome in acei group iw control group . bbaseline variables for models included : logarithm of age  reciprocal of serum creatinine  sbp  up excretion  treatment assignment and terms for studies $nmbr$  $nmbr$ $nmbr$ and $nmbr$ ( see footnotes of table $nmbr$ ) . other baseline variables considered for analysis ( p < $nmbr$ . $nmbr$ in univariate analysis ) included dp mean arterial pressure  type of antihypertensive regimen in the control group  planned duration of follow - up  whether or not the investigators were blinded  whether or not dietary advice was given and the year of publication .;"C0001779;C0002778;C0003364;C0009932;C0034036;C0034037;C0035173;C0039224;C0039798;C0040808;C0042789;C0085805;C0087111;C0150108;C0168634;C0201976;C0204932;C0221102;C0232108;C0233324;C0242492;C0243148;C0332257;C0332307;C0439234;C0439508;C0439828;C0441833;C0444504;C0504085;C0600061;C0683962;C0687744;C0750591;C0936012;C0947630;C1257890;C1272641;C1274040;C1442162;C1442488;C1515273;C1516050;C1518422;C1519504;C1522326;C1524024;C1531217;C1533734;C1547052;C1550141;C1550718;C1704324;C1705169;C1705313;C1705428;C1705429;C1706074;C1882911;C1882979;C1947903;C1947971;C2347634;C2348143;C2587213;C2699704;C2825232;C2826302;C2945654;C2986775;C3161035;C3244317;C3274648;C3538994;C3887704;C4288391;C4553389";FALSE; -10;relative risk of outcome in acei group iw control group bbaseline variables for models included logarithm of age reciprocal of serum creatinine sbp up excretion treatment assignment and terms for studies $nmbr$ $nmbr$ $nmbr$ and $nmbr$ see footnotes of table $nmbr$ other baseline variables considered for analysis p $nmbr$ $nmbr$ in univariate analysis included dp mean arterial pressure type of antihypertensive regimen in the control group planned duration of follow up whether or not the investigators were blinded whether or not dietary advice was given and the year of publication
 343;digoxin scd  no . ( % / y );C0012265;FALSE; 989;digoxin scd no y
 990;digitalis;"C0012252;C0304520";FALSE; 989;digitalis
 990;digitalis glycoside;C0012253;FALSE; 989;digitalis glycoside
 990;digoxin / digitalis glycoside;"C0012253;C0012265";FALSE; 989;digoxin digitalis glycoside
 990;digitalis  n ( % );"C0012252;C0304520";FALSE; 989;digitalis n
 990;digoxin or digitalis glycoside;"C0012253;C0012265";FALSE; 989;digoxin or digitalis glycoside
 356;radial;"C0442038;C0920847";FALSE; -10;radial
 414;serious adverse events;C1519255;FALSE;1851;serious adverse events
 416;elevated crp  n ( % );C0742906;FALSE; 286;elevated crp n
 416;elevated crp ( > ulnt )  n ( % );C0742906;FALSE; 286;elevated crp ulnt n
 416;elevated baseline crp;"C0168634;C0742906;C1442488";FALSE; 286;elevated baseline crp
 422;nonsmoker;"C0337672;C0425293;C4554605";FALSE; 420;nonsmoker
 422;current smoker — no . ( % ) blood pressure — mm hg;"C0005823;C0439475;C1271104;C1272641;C3173209;C3241966";FALSE; 420;current smoker no blood pressure mm hg
 423;smoking history : ex - smoker;"C0337664;C1519384";FALSE; 420;smoking history ex smoker
 423;smokers : qva $nmbr$ - $nmbr$ fc;"C0337664;C2983605";FALSE; 420;smokers qva $nmbr$ $nmbr$ fc
 423;smokers  no . ( % );C0337664;FALSE; 420;smokers no
 423;smokers  n ( % );C0337664;FALSE; 420;smokers n
 423;smokers ( at baseline );"C0168634;C0337664;C1442488";FALSE; 420;smokers at baseline
 423;smokers  %;C0337664;FALSE; 420;smokers
 424;former smokers;C0337671;FALSE; 420;former smokers
 424;smoking : ex - smoker;"C0037369;C0337671;C0453996;C1881674;C4555205";FALSE; 420;smoking ex smoker
 426;apo a - i ( mg / dl ) *;"C0085201;C0439269;C1677784";FALSE;1852;apo a i mg dl
 426;apo a - l ( g / l );C0628062;FALSE;1852;apo a l g l
 428;apoal;NA;FALSE; 427;apoal
 428;apob : apoal;"C0003593;C3252643";FALSE; 426;apob apoal
 428;apo b *;"C0003593;C3252643";FALSE; 426;apo b
 428;apob : apoal ratio;"C0003593;C0456603;C1547037;C3252643";FALSE; 426;apob apoal ratio
 428;apo bt;NA;FALSE; 426;apo bt
 438;no aspirin or ppi;"C0004057;C0358591;C0871125;C3811894";FALSE;1366;no aspirin or ppi
 438;aspirin — no . ( % );C0004057;FALSE;1366;aspirin no
 439;antihypertensive medication  open - label  no . ( % );"C0003364;C1709323";FALSE;1579;antihypertensive medication open label no
 439;antihypertensive randomization  no . ( % ) a;"C0003364;C0034656";FALSE;1579;antihypertensive randomization no a
 439;any blood - pressure - lowering drug 一 no . ( % );C0003364;FALSE;1579;any blood pressure lowering drug no
 439;> $nmbr$ antihypertensive medication  no . ( % );C0003364;FALSE;1579;$nmbr$ antihypertensive medication no
 440;no current smoking;"C0037369;C0453996;C0521116;C1705970;C1881674";FALSE; 420;no current smoking
 959;j $nmbr$ - blocker;NA;FALSE; -10;j $nmbr$ blocker
 959;( $nmbr$ blocker;NA;FALSE; -10;$nmbr$ blocker
 959;/ $nmbr$ - blockers;NA;FALSE; -10;$nmbr$ blockers
 454;heart failure ( class i — iii );"C0018801;C0018802;C0021966;C0221138;C0439070;C0441885;C0441887;C1319793;C1705160;C2698967;C2698969;C4554158";FALSE; 453;heart failure class i iii
 455;nyha classes iii - iv;C0278962;FALSE; 453;nyha classes iii iv
 455;nyha class ii;C1882085;FALSE; 453;nyha class ii
 455;nyha class i;C1882084;FALSE; 453;nyha class i
 455;nyha class > ii;C1882085;FALSE; 453;nyha class ii
 455;nyha class iii;C1882086;FALSE; 453;nyha class iii
 811;dipeptidyl peptidase - $nmbr$ inhibitor;"C0003015;C2757044;C3536837";FALSE;1854;dipeptidyl peptidase $nmbr$ inhibitor
 811;dipeptidyl peptidase $nmbr$ inhibitor;"C0003015;C2757044;C3536837";FALSE;1854;dipeptidyl peptidase $nmbr$ inhibitor
 811;dipeptidyl peptidase $nmbr$ inhibitors;C0003015;FALSE;1854;dipeptidyl peptidase $nmbr$ inhibitors
 779;ace inhibitor or angiotensin ii receptor blocker;"C0003015;C0521942;C3536793;C4541021";FALSE; 811;ace inhibitor or angiotensin ii receptor blocker
 779;ace inhibitor or angiotensin receptor blocker;"C0003015;C0034787;C1622222;C4541021";FALSE; 811;ace inhibitor or angiotensin receptor blocker
 779;ace inhibitors or angiotensin - receptor blockers;"C0003015;C0521942;C0815017";FALSE; 811;ace inhibitors or angiotensin receptor blockers
 779;ace inhibitors or angiotensin - receptor blockers ^;"C0003015;C0521942;C0815017";FALSE; 811;ace inhibitors or angiotensin receptor blockers
1396;denotes angiotensin - converting enzyme .;"C0022709;C1452534";FALSE; 811;denotes angiotensin converting enzyme
1396;converting enzyme inhibitor;"C0014432;C0919438;C4521603";FALSE; 811;converting enzyme inhibitor
1396;angiotension converting enzyme - inhibitor;"C0014432;C0919438;C4521603";FALSE; 811;angiotension converting enzyme inhibitor
1396;angiotensin - eonverting enzyme inhibitors / angiotensin reeeptor bloekers;"C0003018;C0014432;C1152555;C2756995;C4521302";FALSE; 811;angiotensin eonverting enzyme inhibitors angiotensin reeeptor bloekers
1396;ace = angiotensin - converting enzyme . arb = angiotensin receptor blockers .;"C0022709;C0597357;C3888198";FALSE; 811;ace angiotensin converting enzyme arb angiotensin receptor blockers
1396;angiotensin - eonverting enzyme inhibitors;"C0003018;C0014432;C1152555;C2756995;C4521302";FALSE; 811;angiotensin eonverting enzyme inhibitors
 522;ace inhibitors or angiotensin ii;"C0003009;C0003015;C1366631;C3714928";FALSE; 811;ace inhibitors or angiotensin ii
 522;ace inhibitors or angiotensin ii blockers;"C0003009;C0003015;C1366631;C3714928";FALSE; 811;ace inhibitors or angiotensin ii blockers
 522;angiotensin ii antagonists;"C0003009;C0243076;C1366631;C3714928";FALSE; 811;angiotensin ii antagonists
  12;data are mean ( sd ) or n ( % ) . ace = angiotensin - converting enzyme  arb = angiotensin - receptor blocker . chf = congestive heart failure . * any use in $nmbr$ h before surgery except for aspirin which only required any use in the $nmbr$ days before surgery .;"C0004057;C0018802;C0022709;C0033727;C0034787;C0038894;C0038895;C0042153;C0205171;C0369286;C0369718;C0439228;C0441922;C0441932;C0444504;C0457083;C0543467;C0564385;C1274039;C1511726;C1514873;C1622222;C1720467;C1947944;C2347634;C2348143;C2699239;C3245479;C3714741;C3888198;C4528284";FALSE; -10;data are mean sd or n ace angiotensin converting enzyme arb angiotensin receptor blocker chf congestive heart failure any use in $nmbr$ h before surgery except for aspirin which only required any use in the $nmbr$ days before surgery
 758;thiazide;C0541746;FALSE; 993;thiazide
 758;thiazide at enrollment;"C0541746;C1516879;C1696073;C3888021";FALSE; 993;thiazide at enrollment
 758;thiazides;C0541746;FALSE; 993;thiazides
 758;thiazide users;"C0541746;C1706077";FALSE; 993;thiazide users
1638;antiplatelet - onl group ( n = $nmbr$ );C0441848;FALSE;1191;antiplatelet onl group n $nmbr$
1638;antiplatelet - only group ( n = $nmbr$ );"C0205171;C0441848;C1720467";FALSE;1191;antiplatelet only group n $nmbr$
1192;other antiplatelet agents  n ( % );C0085826;FALSE;1191;other antiplatelet agents n
1192;other antiplatelet agents;C0085826;FALSE;1191;other antiplatelet agents
1192;other anti - platelet agents;"C0005821;C0040616";FALSE;1191;other anti platelet agents
1192;other antiplatelet;NA;FALSE;1191;other antiplatelet
1192;aspirin or other antiplatelet agents;"C0004057;C0085826";FALSE;1191;aspirin or other antiplatelet agents
1192;aspirin / other antiplatelet agents  n ( % );"C0004057;C0085826";FALSE;1191;aspirin other antiplatelet agents n
 555;antiplatelet or anticoagulant therapy;C0150457;FALSE;1191;antiplatelet or anticoagulant therapy
 555;antiplatelet therapy;C1096021;FALSE;1191;antiplatelet therapy
 555;antiplatelet therapy §;C1096021;FALSE;1191;antiplatelet therapy
 555;antiplatelet therapy dual;"C0205173;C1096021;C1554184";FALSE;1191;antiplatelet therapy dual
 555;no antiplatelet therapy;C1096021;FALSE;1191;no antiplatelet therapy
 555;long - term antiplatelet therapy;"C0443252;C1096021";FALSE;1191;long term antiplatelet therapy
 509;antiplatelet — no . / total no . ( % );"C0439175;C0439810";FALSE;1191;antiplatelet no total no
 861;nonaspirin antiplatelet;C0722138;FALSE;1191;nonaspirin antiplatelet
 861;nonaspirin antiplatelet agent;"C0085826;C0722138";FALSE;1191;nonaspirin antiplatelet agent
1624;dual antiplatelet therapy;"C0205173;C1096021;C1554184";FALSE;1191;dual antiplatelet therapy
1624;dual therapy;"C0039798;C0087111;C0205173;C1363945;C1554184";FALSE;1191;dual therapy
1624;dual antiplatelet;"C0205173;C1554184";FALSE;1191;dual antiplatelet
1773;^ - blockers;NA;FALSE; -10;blockers
 118;antiplatelet use;"C0042153;C0457083;C1947944";FALSE;1191;antiplatelet use
 692;antiplatelet at randomization;C0034656;FALSE;1191;antiplatelet at randomization
 156;antiplatelet or anti - inflammatory drugs;C0003209;FALSE;1191;antiplatelet or anti inflammatory drugs
 366;aspirin / antiplatelet medication;"C0004057;C0013227;C0085826;C3244316;C4284232";FALSE;1191;aspirin antiplatelet medication
1476;antiplatelet within $nmbr$ mo before randomization;"C0026544;C0034656;C0332177";FALSE;1191;antiplatelet within $nmbr$ mo before randomization
1020;non - trial antiplatelet;"C0008976;C1518422";FALSE;1191;non trial antiplatelet
1730;duration antiplatelet use as % of study duration ( sd );"C0557651;C1881378;C2603343;C2699239;C2826775";FALSE;1191;duration antiplatelet use as of study duration sd
 118;statin use;"C0042153;C0360714;C0457083;C1947944";FALSE; 872;statin use
 118;statin use ( % );"C0042153;C0360714;C0457083;C1947944";FALSE; 872;statin use
 118;statin use — no . { % );"C0042153;C0360714;C0457083;C1947944";FALSE; 872;statin use no
 118;concomitant statin use;"C0042153;C0360714;C0457083;C0521115;C1947944";FALSE; 872;concomitant statin use
 534;statin non - users ( n = $nmbr$ );"C0360714;C1518422;C1706077";FALSE; 872;statin non users n $nmbr$
 534;statin users;"C0360714;C1706077";FALSE; 872;statin users
 534;statin users ( n = $nmbr$ );"C0360714;C1706077";FALSE; 872;statin users n $nmbr$
 625;baseline statin;"C0168634;C0360714;C1442488";FALSE; 872;baseline statin
 625;baseline statin usec;"C0168634;C0360714;C0439224;C1442488";FALSE; 872;baseline statin usec
 625;statin use at baseline :;"C0042153;C0168634;C0360714;C0457083;C1442488;C1947944";FALSE; 872;statin use at baseline
 294;prior statin ( n = $nmbr$  $nmbr$ );"C0332152;C0360714;C2826257";FALSE; 872;prior statin n $nmbr$ $nmbr$
 545;fenofibric acid - i - moderate - dose statin;"C0021966;C0060179;C0221138;C0360714;C1709056";FALSE; 872;fenofibric acid i moderate dose statin
 545;moderate - dose statin;"C0360714;C1709056";FALSE; 872;moderate dose statin
 545;statin with fibrate;C0360714;FALSE; 872;statin with fibrate
 603;type of concomitant statin;"C0332307;C0360714;C0521115;C1547052";FALSE; 872;type of concomitant statin
1832;atorvastatin $nmbr$ mg ( zi = $nmbr$ );"C0024671;C0026410;C0043476;C0286651;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE; 885;atorvastatin $nmbr$ mg zi $nmbr$
 469;st depression or elevation;"C0439775;C0520887;C0702240";FALSE;1856;st depression or elevation
 469;st depression ( without st elevation );"C0011570;C0011581;C0344315;C0439775;C0460137;C0520886;C0520887;C0702240;C4049644;C4084909;C4085311;C4553827";FALSE;1856;st depression without st elevation
 469;st segment depression;C0520887;FALSE;1856;st segment depression
 469;st - segment depression;C0520887;FALSE;1856;st segment depression
 469;st - segment depression > $nmbr$ mm;"C0520887;C4330985;C4554674";FALSE;1856;st segment depression $nmbr$ mm
 118;aspirin use at randomization;"C0004057;C0034656;C0042153;C0457083;C1947944";FALSE;1366;aspirin use at randomization
 118;aspirin use n ( % );"C0004057;C0042153;C0457083;C1947944";FALSE;1366;aspirin use n
1054;colon only;"C0009368;C0205171;C1720467;C3888384";FALSE;1971;colon only
  41;$nmbr$ s = scandinavian simvastatin survival study . $nmbr$ woscops = west of scotland coronary prevention study . $nmbr$ care = cholesterol and recurrent events . $nmbr$ post - cabg = post - coronary artery bypass graft . $nmbr$ afcaps / texcaps = air force / texas coronary atherosclerosis prevention study . $nmbr$ lipid = long - term intervention with pravastatin in ischaemic disease . $nmbr$ gissi prevention = gruppo italiano per lo studio della sopravvivenza nell ’ infarto miocardico . $nmbr$ lips = lescol intervention prevention study . $nmbr$ hps = heart protection study . $nmbr$ prosper = prospective study of pravastatin in the elderly at risk . $nmbr$ allhat - llt = antihypertensive and lipid - lowering treatment to prevent heart attack trial . $nmbr$ ascot - lla = anglo - scandinavian cardiac outcomes trial - lipid lowering arm . $nmbr$ alert = assessment of lescol in renal transplantation . $nmbr$ cards = collaborative atorvastatin diabetes study . $nmbr$ s = simvastatin . l = lovastatin . p = pravastatin . f = ﬂ uvastatin . a = atorvastatin . * mean duration of follow - up based on survival times within each trial . overall mean is weighted by trial - speci ﬁ c variances of logrank ( o – e ) for major vascular events . † all trials included dietary intervention : woscops  gissi prevention  lipid  $nmbr$ s  lips  and hps provided dietary advice  afcaps / texcaps  post - cabg  care  allhat  alert  cards  and prosper used american heart association ( aha ) step $nmbr$ diet and care intensi ﬁ ed to step $nmbr$ diet if ldl cholesterol $nmbr$ · $nmbr$ mmol / l ( $nmbr$ mg / dl ) . ‡ other chd includes patients with a history of other symptomatic chd but excludes those with a history of mi ( as already counted in mi column ) . § other vascular includes history of intracerebral bleed  transient ischaemic attack  ischaemic stroke  unknown stroke  and peripheral artery disease . ¶ none includes individuals without a history of mi  symptomatic chd  intracerebral bleed  transient ischaemic attack  ischaemic stroke  unknown stroke  or peripheral artery disease;"C0001792;C0002458;C0003364;C0005847;C0005910;C0008377;C0008976;C0010054;C0010055;C0011847;C0011849;C0012155;C0012159;C0012171;C0016327;C0018787;C0019664;C0019665;C0022671;C0023759;C0023779;C0023824;C0023981;C0024027;C0027051;C0027361;C0030705;C0033522;C0035647;C0036453;C0038454;C0038952;C0039711;C0039798;C0040363;C0040704;C0041260;C0043100;C0050451;C0074554;C0085542;C0085565;C0086153;C0087111;C0150158;C0184661;C0199176;C0202117;C0204932;C0205082;C0205164;C0205374;C0206579;C0220921;C0231220;C0237401;C0239110;C0240951;C0242994;C0262512;C0262926;C0277793;C0280604;C0282416;C0286651;C0309872;C0332196;C0332257;C0420180;C0439394;C0439673;C0441471;C0441994;C0444504;C0446516;C0449238;C0455536;C0475224;C0489835;C0557651;C0565930;C0589120;C0591720;C0679698;C0680782;C0681804;C0687676;C0718674;C0745413;C0750480;C0772110;C0870136;C0886296;C0948008;C1096775;C1185738;C1232424;C1260596;C1261512;C1261552;C1273517;C1273869;C1304680;C1305866;C1455761;C1519433;C1522326;C1522577;C1522601;C1527178;C1533734;C1545588;C1552866;C1558950;C1561607;C1704379;C1704436;C1704685;C1704687;C1705117;C1705169;C1705255;C1705493;C1705566;C1705938;C1706132;C1706420;C1706495;C1709709;C1711260;C1736144;C1801960;C1883351;C1947933;C1999167;C1999230;C2003888;C2004062;C2004580;C2347090;C2347634;C2348143;C2348152;C2603343;C2603362;C2700399;C2700409;C2825408;C2828389;C2919552;C2926735;C2930619;C2937358;C2945760;C2983588;C3274571;C3275277;C3469826;C3538926;C3538994;C3541433;C3541888;C3542407;C3642216;C3642217;C3665546;C3668949;C3669039;C3715044;C3810814;C3814463;C3887704;C3889123;C3898312;C4025272;C4050014;C4084853;C4318856;C4521762;C4552904;C4553014;C4553528;C4554100";FALSE; -10;$nmbr$ s scandinavian simvastatin survival study $nmbr$ woscops west of scotland coronary prevention study $nmbr$ care cholesterol and recurrent events $nmbr$ post cabg post coronary artery bypass graft $nmbr$ afcaps texcaps air force texas coronary atherosclerosis prevention study $nmbr$ lipid long term intervention with pravastatin in ischaemic disease $nmbr$ gissi prevention gruppo italiano per lo studio della sopravvivenza nell infarto miocardico $nmbr$ lips lescol intervention prevention study $nmbr$ hps heart protection study $nmbr$ prosper prospective study of pravastatin in the elderly at risk $nmbr$ allhat llt antihypertensive and lipid lowering treatment to prevent heart attack trial $nmbr$ ascot lla anglo scandinavian cardiac outcomes trial lipid lowering arm $nmbr$ alert assessment of lescol in renal transplantation $nmbr$ cards collaborative atorvastatin diabetes study $nmbr$ s simvastatin l lovastatin p pravastatin f uvastatin a atorvastatin mean duration of follow up based on survival times within each trial overall mean is weighted by trial speci c variances of logrank o e for major vascular events all trials included dietary intervention woscops gissi prevention lipid $nmbr$ s lips and hps provided dietary advice afcaps texcaps post cabg care allhat alert cards and prosper used american heart association aha step $nmbr$ diet and care intensi ed to step $nmbr$ diet if ldl cholesterol $nmbr$ $nmbr$ mmol l $nmbr$ mg dl other chd includes patients with a history of other symptomatic chd but excludes those with a history of mi as already counted in mi column other vascular includes history of intracerebral bleed transient ischaemic attack ischaemic stroke unknown stroke and peripheral artery disease none includes individuals without a history of mi symptomatic chd intracerebral bleed transient ischaemic attack ischaemic stroke unknown stroke or peripheral artery disease
1494;history of heart failure;C0455531;FALSE;  12;history of heart failure
1494;history of heart failure at baseline;"C0168634;C0455531;C1442488";FALSE;  12;history of heart failure at baseline
1494;history of heart failure  n ( % );C0455531;FALSE;  12;history of heart failure n
1494;history of heart failure — no . ( % );C0455531;FALSE;  12;history of heart failure no
1494;history of heart failure — no . { % );C0455531;FALSE;  12;history of heart failure no
1494;history of heart failure  no . ( % );C0455531;FALSE;  12;history of heart failure no
1044;previous congestive heart failure;"C0018802;C0205156;C1552607";FALSE;  12;previous congestive heart failure
1044;previous congestive heart failure — no . ( % );"C0018802;C0205156;C1552607";FALSE;  12;previous congestive heart failure no
1044;previous congestive heart failure ( % );"C0018802;C0205156;C1552607";FALSE;  12;previous congestive heart failure
1475;baseline heart rate ( beat / min );"C0168634;C0425583;C0702093;C0871208;C1442488;C1521828;C1524029;C3813700";FALSE;1105;baseline heart rate beat min
1475;heart rate at rest — beats / min;"C0018810;C0035253;C0702093;C1524029;C1622890;C3813700";FALSE;1105;heart rate at rest beats min
1475;heart rate  beats / min;"C0018810;C0702093;C1524029;C3813700";FALSE;1105;heart rate beats min
1475;heart rate ( beats / min );"C0018810;C0702093;C1524029;C3813700";FALSE;1105;heart rate beats min
1475;heart rate — beats / min;"C0018810;C0702093;C1524029;C3813700";FALSE;1105;heart rate beats min
1475;heart rate at rest in the supine position ( beats / min );"C0018810;C0035253;C0038846;C0702093;C1524029;C1622890;C3813700";FALSE;1105;heart rate at rest in the supine position beats min
 323;all - cause death n;"C0011065;C0015127;C1306577;C1524003;C4082313;C4552775";FALSE;1855;all cause death n
 323;all - cause death;"C0011065;C0015127;C1306577;C1524003;C4082313;C4552775";FALSE;1855;all cause death
 323;all - cause death / stroke / see;"C0011065;C0015127;C0038454;C0042789;C1306577;C1524003;C1947903;C4082313;C4552775;C4554100";FALSE;1855;all cause death stroke see
 323;all death;"C0011065;C1306577;C4082313;C4552775";FALSE;1855;all death
 323;any death;"C0011065;C1306577;C4082313;C4552775";FALSE;1855;any death
 323;dead ( n = $nmbr$ );C0011065;FALSE;1855;dead n $nmbr$
 323;death *;"C0011065;C1306577;C4082313;C4552775";FALSE;1855;death
 323;death ( all - cause );"C0011065;C0015127;C1306577;C1524003;C4082313;C4552775";FALSE;1855;death all cause
 323;death ( all cause );"C0011065;C0015127;C1306577;C1524003;C4082313;C4552775";FALSE;1855;death all cause
 323;deaths;"C0011065;C1306577";FALSE;1855;deaths
 323;data are reported as n ( % ) . event rates in parentheses are kaplan - meier estimates ( % ) at $nmbr$ year . * cardiovascular ( cv ) death  myocardial infarction ( mi )  or recurrent ischemia . † cv death  mi  or severe recurrent ischemia;"C0007226;C0011065;C0022116;C0027051;C0205082;C0428953;C0439234;C0439508;C0441471;C0684224;C0700287;C0871208;C1306577;C1455761;C1511726;C1521828;C1720943;C2926063;C2945760;C3245479;C3538987;C3714741;C3810814;C3887460;C4019010;C4048877;C4050465;C4050466;C4082313;C4318503;C4319718;C4321499;C4552775;C4552959";FALSE; -10;data are reported as n event rates in parentheses are kaplan meier estimates at $nmbr$ year cardiovascular cv death myocardial infarction mi or recurrent ischemia cv death mi or severe recurrent ischemia
 712;heart rate at baseline  bpm;"C0018810;C0168634;C1442488";FALSE;1105;heart rate at baseline bpm
 712;heart rate at baseline ( bpm;"C0018810;C0168634;C1442488";FALSE;1105;heart rate at baseline bpm
 712;heart rate  bpm;C0018810;FALSE;1105;heart rate bpm
 712;heart rate  bpm  mean ( sd );"C0018810;C0444504;C2347634;C2348143;C2699239";FALSE;1105;heart rate bpm mean sd
 712;heart rate  mean ( sd )  bpm ( n = $nmbr$ $nmbr$ );"C0018810;C0444504;C2347634;C2348143;C2699239";FALSE;1105;heart rate mean sd bpm n $nmbr$ $nmbr$
 712;heart rate < $nmbr$ bpm;C0018810;FALSE;1105;heart rate $nmbr$ bpm
1287;heart rate  beats / min  mean ± sd;"C0018810;C0444504;C0702093;C1524029;C2347634;C2348143;C2699239;C3813700";FALSE;1105;heart rate beats min mean sd
1287;heart rate  b . p . m . mean ± sd;"C0018810;C0369637;C0441923;C0444504;C2347634;C2348143;C2699239";FALSE;1105;heart rate b p m mean sd
1287;heart rate  mean ( sd );"C0018810;C0444504;C2347634;C2348143;C2699239";FALSE;1105;heart rate mean sd
1287;heart rate ( b . p . m . )  mean ± sd;"C0018810;C0369637;C0441923;C0444504;C2347634;C2348143;C2699239";FALSE;1105;heart rate b p m mean sd
1287;heart rate  mean ( sd )  beats / min;"C0018810;C0444504;C0702093;C1524029;C2347634;C2348143;C2699239;C3813700";FALSE;1105;heart rate mean sd beats min
1287;heart rate  mean ± sd ( b . p . m . );"C0018810;C0369637;C0441923;C0444504;C2347634;C2348143;C2699239";FALSE;1105;heart rate mean sd b p m
1564;any history of congestive heart failure;"C0455531;C0742742";FALSE;  12;any history of congestive heart failure
1564;congestive heart;"C0018787;C0742742";FALSE;  12;congestive heart
1564;history of congestive heart failure;"C0455531;C0742742";FALSE;  12;history of congestive heart failure
1564;infarction ( yr ) history of congestive heart failure ( % );"C0021308;C0439234;C0455531;C0742742";FALSE;  12;infarction yr history of congestive heart failure
1747;oral medications;C0304289;FALSE;1921;oral medications
1481;cardiac failurec;"C0018787;C1522601";FALSE;  12;cardiac failurec
1481;heart failurea;C0018787;FALSE;  12;heart failurea
1476;heart failure $nmbr$ month before admission;"C0018801;C0018802;C0184666;C0332177;C0439231;C0809949;C4554158";FALSE;  12;heart failure $nmbr$ month before admission
 561;statin intensity $nmbr$ * $nmbr$;"C0360714;C0522510";FALSE; 872;statin intensity $nmbr$ $nmbr$
 561;statin intensity per acc / ahac;"C0175754;C0282160;C0360714;C0522510;C3541413";FALSE; 872;statin intensity per acc ahac
 297;esr  median ( range ) mm / hour;"C0439227;C0549183;C0564385;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016;C3811131;C4330985;C4554674";FALSE; 298;esr median range mm hour
 297;esr  mm / hour;"C0439227;C0564385;C3811131;C4330985;C4554674";FALSE; 298;esr mm hour
 297;erythrocyte sedimentation rate  mm / hour;"C0439227;C0564385;C1176468;C1619634;C4330985;C4554674";FALSE; 298;erythrocyte sedimentation rate mm hour
 297;esr ( mm / hour );"C0439227;C0564385;C3811131;C4330985;C4554674";FALSE; 298;esr mm hour
 297;esr ( mm / hour ) git config - - global user . name  your name;"C0027365;C0205246;C0439227;C0564385;C1418224;C1547383;C1548600;C1706077;C2348867;C2827597;C3811131;C4330985;C4522128;C4554674";FALSE; 298;esr mm hour git config global user name your name
 297;esr ( mm / hour  per unit );"C0456685;C3811131;C4330985;C4554674";FALSE; 298;esr mm hour per unit
 466;das $nmbr$ - esr  mean ( sd );"C0051767;C0057671;C0444504;C2347634;C2348143;C2699239;C3811131";FALSE; 298;das $nmbr$ esr mean sd
 466;das $nmbr$ - esr  mean ± sd das $nmbr$ - esr remission  %;"C0051767;C0057671;C0444504;C0544452;C0687702;C2347634;C2348143;C2699239;C3811131";FALSE; 298;das $nmbr$ esr mean sd das $nmbr$ esr remission
 826;erythrocyte sedimentation rate — mm / hr | |;"C1176468;C1619634;C4330985;C4554674";FALSE; 298;erythrocyte sedimentation rate mm hr
 118;aspirin use at randomization - n ( % );"C0004057;C0034656;C0042153;C0457083;C1947944";FALSE;1366;aspirin use at randomization n
 118;aspirin use ( p = $nmbr$ - $nmbr$ t );"C0004057;C0042153;C0457083;C1947944";FALSE;1366;aspirin use p $nmbr$ $nmbr$ t
  60;acetyl - salicylic acid;C0004057;FALSE;1366;acetyl salicylic acid
  60;acetylsalicylic acid;C0004057;FALSE;1366;acetylsalicylic acid
  60;aspirin ( asa ) ( » = $nmbr$ $nmbr$ );"C0004057;C3853627";FALSE;1366;aspirin asa $nmbr$ $nmbr$
  60;aspirin at enrollment;"C0004057;C1516879;C1696073;C3888021";FALSE;1366;aspirin at enrollment
1367;aspirin at any dose;C4696290;FALSE;1366;aspirin at any dose
1367;aspirin dose;C4696290;FALSE;1366;aspirin dose
1367;aspirin + dipyridamole ( n = $nmbr$ );C0732279;FALSE;1366;aspirin dipyridamole n $nmbr$
1367;aspirin + dipyridamole;C0732279;FALSE;1366;aspirin dipyridamole
1367;aspirin dose  mg / d;"C0439422;C4696290";FALSE;1366;aspirin dose mg d
1367;dose of aspirin;C4696290;FALSE;1366;dose of aspirin
 192;aspirin dose at baseline  mg;"C0004057;C0024671;C0026410;C0168634;C0439269;C1442488;C1960952;C2346927;C4086581;C4321396;C4521761;C4696290";FALSE;1366;aspirin dose at baseline mg
 192;aspirin $nmbr$ mg ( n = $nmbr$ );"C0004057;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;1366;aspirin $nmbr$ mg n $nmbr$
 192;aspirin use ( > $nmbr$ mg );"C0004057;C0024671;C0026410;C0042153;C0439269;C0457083;C1947944;C1960952;C2346927;C4321396;C4521761";FALSE;1366;aspirin use $nmbr$ mg
 625;aspirin at baseline;"C0004057;C0168634;C1442488";FALSE;1366;aspirin at baseline
 625;aspirin use at baseline;"C0004057;C0042153;C0168634;C0457083;C1442488;C1947944";FALSE;1366;aspirin use at baseline
 294;no prior aspirin;"C0004057;C0332152;C2826257";FALSE;1366;no prior aspirin
 438;drug therapy at admission 一 no . ( % ) aspirin;"C0004057;C0013216;C0013217;C0184666;C0809949";FALSE;1366;drug therapy at admission no aspirin
  25;use of low - dose aspirin ( < $nmbr$ mg daily );"C0024671;C0026410;C0332173;C0439269;C1524063;C1960952;C2346927;C2608320;C4321396;C4521761";FALSE;1366;use of low dose aspirin $nmbr$ mg daily
  28;aspirin plus placebo ( n = $nmbr$ );"C0004057;C0032042;C0332287;C1696465;C1706408";FALSE;1366;aspirin plus placebo n $nmbr$
 925;aspirin only;"C0004057;C0205171;C1720467";FALSE;1366;aspirin only
 925;aspirin only ( n = $nmbr$  $nmbr$ );"C0004057;C0205171;C1720467";FALSE;1366;aspirin only n $nmbr$ $nmbr$
 110;aspirin ( any dose );"C0004057;C0178602;C0869039;C1114758";FALSE;1366;aspirin any dose
 483;aqc < $nmbr$;NA;FALSE; -10;aqc $nmbr$
 483;aqe i $nmbr$;"C0021966;C0221138";FALSE; -10;aqe i $nmbr$
 483;aqe ^ $nmbr$;NA;FALSE; -10;aqe $nmbr$
 483;aqe < $nmbr$;NA;FALSE; -10;aqe $nmbr$
 483;no ocs use  no nasal polyps  pre - bd fvc s $nmbr$ % of predicted and age at diagnosis < $nmbr$ years;"C0005126;C0027430;C0042153;C0332152;C0439234;C0457083;C0681842;C0740175;C1828181;C1882327;C1947944;C2257086;C2344255;C3173302;C3669034;C3714541;C4050145";FALSE; -10;no ocs use no nasal polyps pre bd fvc s $nmbr$ of predicted and age at diagnosis $nmbr$ years
 480;goncomitant treatment with age inhibitors / angiotensin;"C0001779;C0003018;C0039798;C0087111;C0243077;C1522326;C1533734;C1705169;C3538994;C3887704;C4521302";FALSE; -10;goncomitant treatment with age inhibitors angiotensin
1826;l compared wit;"C0043197;C0439394;C1706495;C1707455;C3642217";FALSE; -10;l compared wit
1826;l $nmbr$;"C0439394;C1706495;C3642217";FALSE; -10;l $nmbr$
1826;l ( % );"C0439394;C1706495;C3642217";FALSE; -10;l
1826;l . i ( $nmbr$ . $nmbr$ );"C0021966;C0221138;C0439394;C1706495;C3642217";FALSE; -10;l i $nmbr$ $nmbr$
1827;$nmbr$ . l ( $nmbr$ . l );C3539687;FALSE; -10;$nmbr$ l $nmbr$ l
1828;gfr $nmbr$ - $nmbr$;"C0017654;C1424601";FALSE; 592;gfr $nmbr$ $nmbr$
1828;estimated gfr  mean ( sd )  mlvmin per $nmbr$ . $nmbr$ m ^ *;"C0017654;C0369637;C0441923;C0444504;C0750572;C1424601;C2347634;C2348143;C2699239";FALSE; 592;estimated gfr mean sd mlvmin per $nmbr$ $nmbr$ m
1828;estimated gfr ^;"C0017654;C0750572;C1424601";FALSE; 592;estimated gfr
1829;other glp - $nmbr$ receptor agonist;"C0018301;C1422069;C1425391;C1539338;C2350813;C4543206";FALSE;1153;other glp $nmbr$ receptor agonist
1831;eze / simva  $nmbr$ / $nmbr$ mg dn = $nmbr$ c $nmbr$ );"C0024671;C0026410;C0439269;C1333964;C1707618;C1960952;C2346927;C4321396;C4521761";FALSE;1862;eze simva $nmbr$ $nmbr$ mg dn $nmbr$ c $nmbr$
1165;ezetimibe $nmbr$ mg + statin ( n = $nmbr$  $nmbr$ );"C0024671;C0026410;C0360714;C0439269;C1142985;C1960952;C2346927;C4321396;C4521761";FALSE;1862;ezetimibe $nmbr$ mg statin n $nmbr$ $nmbr$
1165;statin and / or ezetimibe;"C0360714;C1142985";FALSE;1862;statin and or ezetimibe
1165;statin + ezetimibe;"C0360714;C1142985";FALSE;1862;statin ezetimibe
1165;statin + ezetimibe  n ( % );"C0360714;C1142985";FALSE;1862;statin ezetimibe n
1165;statin + ezetimibe ( n = $nmbr$ . $nmbr$ );"C0360714;C1142985";FALSE;1862;statin ezetimibe n $nmbr$ $nmbr$
1806;< $nmbr$ cells / pl;"C0007584;C0007634;C3897966;C4049765";FALSE; -10;$nmbr$ cells pl
1806;> $nmbr$ cells / pl;"C0007584;C0007634;C3897966;C4049765";FALSE; -10;$nmbr$ cells pl
1806;/ pl $nmbr$ $nmbr$;"C3897966;C4049765";FALSE; -10;pl $nmbr$ $nmbr$
1815;asia ( excluding japan );"C0003980;C0022341;C0332196;C2828389";FALSE;1864;asia excluding japan
1814;japanese subpopulation;"C0376247;C1257890;C1556094";FALSE;1815;japanese subpopulation
1814;japanese subgroup ( n = $nmbr$ );"C0376247;C1079230;C1515021;C1556094";FALSE;1815;japanese subgroup n $nmbr$
1814;no . japanese;"C0376247;C1556094";FALSE;1815;no japanese
1749;tah ( n = $nmbr$ );C0404079;FALSE; -10;tah n $nmbr$
1819;pancreatic cancer;"C0235974;C0346647;C2984259";FALSE;1865;pancreatic cancer
1697;atherosclerotic cvd;"C0007222;C0333482";FALSE;1698;atherosclerotic cvd
1697;atherosclerotic cvd §;"C0007222;C0333482";FALSE;1698;atherosclerotic cvd
1697;other atherosclerotic;C0333482;FALSE;1698;other atherosclerotic
1697;other atherosclerotic cvd;"C0007222;C0333482";FALSE;1698;other atherosclerotic cvd
1697;atherosclerotic cvdj;C0333482;FALSE;1698;atherosclerotic cvdj
1697;other atherosclerotic cvd * *;"C0007222;C0333482";FALSE;1698;other atherosclerotic cvd
1279;atherosclerotic disease ( % );"C0012634;C0333482";FALSE;1698;atherosclerotic disease
 179;established ascvd;"C0443211;C1272684;C3665365";FALSE;1698;established ascvd
1279;atherosclerotic disease *;"C0012634;C0333482";FALSE;1698;atherosclerotic disease
 179;established atherosclerotic disease  n ( % );"C0012634;C0333482;C0443211;C1272684";FALSE;1698;established atherosclerotic disease n
 179;established ascvd or > $nmbr$ cv risk factors;"C0035648;C0443211;C1272684;C1553898;C3538987;C3665365;C4048877;C4318503";FALSE;1698;established ascvd or $nmbr$ cv risk factors
 179;established atherosclerotic;"C0333482;C0443211;C1272684";FALSE;1698;established atherosclerotic
 832;atherosclerotic vascular disease history  no . ( % ) ‡;"C0004153;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";FALSE;1698;atherosclerotic vascular disease history no
1790;established atherosclerotic cv disease §;"C0007222;C0333482;C0443211;C1272684";FALSE;1698;established atherosclerotic cv disease
 105;history of atherosclerotic vascular disease — no . ( % ) §;"C0005847;C0333482;C0683519;C0730226;C0850708;C0944983;C1558950;C1801960";FALSE;1698;history of atherosclerotic vascular disease no
 105;history of major macrovascular disease  n ( % );"C0205082;C0205164;C0683519;C0730226;C0850708;C0944983;C4318856;C4521762";FALSE;1698;history of major macrovascular disease n
 105;history of macrovascular disease at baseline  n ( % );"C0168634;C0683519;C0730226;C0850708;C0944983;C1442488";FALSE;1698;history of macrovascular disease at baseline n
 747;large vessel atherosclerosis;"C0003850;C0004153;C0225990";FALSE;1698;large vessel atherosclerosis
1530;symptoms of atrial fibrillation in the $nmbr$ months before randomization — no . ( % );"C0004238;C0034656;C0344434;C0439231;C0683368;C1457887;C1963067";FALSE;  90;symptoms of atrial fibrillation in the $nmbr$ months before randomization no
  37;das $nmbr$  mean ± sd;"C0051767;C0057671;C0444504;C2347634;C2348143;C2699239";FALSE;1914;das $nmbr$ mean sd
  37;das $nmbr$  mean ( sd );"C0051767;C0057671;C0444504;C2347634;C2348143;C2699239";FALSE;1914;das $nmbr$ mean sd
  37;das $nmbr$ - hscrp  mean ( sd );"C0051767;C0057671;C0444504;C2347634;C2348143;C2699239";FALSE;1914;das $nmbr$ hscrp mean sd
 933;values expressed as mean sd or number ( percent ) . * two patients were missing values for body mass index . † other forms of atherosclerosis are peripheral arterial disease  abdom - inal aortic aneurysm  symptomatic carotid artery disease  transient isch - emic attack  and stroke . ‡ family history of premature chd de ﬁ ned as chd in male ﬁ rst - degree relative aged $nmbr$ years or female ﬁ rst - degree relative $nmbr$ years . § blood pressure $nmbr$ / $nmbr$ mm hg  on antihypertensive medication  or diagnosis of hypertension based on medical history . n number of randomly assigned patients  ncep atp national cholesterol education program adult treatment panel .;"C0001675;C0001779;C0001792;C0003364;C0003486;C0003850;C0004153;C0005823;C0005893;C0007273;C0008377;C0011198;C0011900;C0015576;C0017480;C0019664;C0019665;C0020538;C0030688;C0030705;C0038454;C0040704;C0042295;C0043210;C0080103;C0085096;C0086287;C0086582;C0151526;C0205252;C0205345;C0205374;C0205448;C0231220;C0237753;C0262512;C0262926;C0277793;C0280604;C0340629;C0348078;C0376315;C0439165;C0439234;C0439475;C0441833;C0441889;C0444504;C0449286;C0449788;C0542560;C0578022;C0679841;C1261512;C1271104;C1272641;C1304680;C1305855;C1425219;C1516050;C1518340;C1527178;C1547039;C1551393;C1552601;C1704338;C1704436;C1704656;C1704727;C1705255;C1705492;C1705497;C1705498;C1705938;C1706180;C1706365;C1706428;C1706429;C1706450;C1963138;C1999167;C1999270;C2004062;C2347634;C2348088;C2348143;C2699239;C2744579;C3245503;C3272743;C3541240;C3542407;C4018905;C4552600;C4554100";FALSE; -10;values expressed as mean sd or number percent two patients were missing values for body mass index other forms of atherosclerosis are peripheral arterial disease abdom inal aortic aneurysm symptomatic carotid artery disease transient isch emic attack and stroke family history of premature chd de ned as chd in male rst degree relative aged $nmbr$ years or female rst degree relative $nmbr$ years blood pressure $nmbr$ $nmbr$ mm hg on antihypertensive medication or diagnosis of hypertension based on medical history n number of randomly assigned patients ncep atp national cholesterol education program adult treatment panel
1790;> $nmbr$ cv risk factors ^ or established atherosclerotic cv disease;"C0007222;C0035648;C0333482;C0443211;C1272684;C1553898;C3538987;C4048877;C4318503";FALSE;1698;$nmbr$ cv risk factors or established atherosclerotic cv disease
1279;multivessel disease 一 no . ( % );C0012634;FALSE;1867;multivessel disease no
1279;multivessel disease — no . ( % );C0012634;FALSE;1867;multivessel disease no
1279;multivessel disease  n ( % );C0012634;FALSE;1867;multivessel disease n
1279;polyvascular disease and type $nmbr$ diabetes ( n = $nmbr$ );"C0012634;C1320657";FALSE;1868;polyvascular disease and type $nmbr$ diabetes n $nmbr$
1279;polyvascular disease ( n = $nmbr$ );C0012634;FALSE;1868;polyvascular disease n $nmbr$
1279;polyvascular disease * ( n = $nmbr$ );C0012634;FALSE;1868;polyvascular disease n $nmbr$
1810;number of lesions  n ( % ) a;C0449791;FALSE;1870;number of lesions n a
1823;p - val . ( $nmbr$ );"C0042285;C0369773;C0523975;C2603361";FALSE;1872;p val $nmbr$
1823;p - valuea;"C0369773;C2603361";FALSE;1872;p valuea
1823;p valuea;"C0369773;C2603361";FALSE;1872;p valuea
1823;p valueb;"C0369773;C2603361";FALSE;1872;p valueb
1823;p - valueb;"C0369773;C2603361";FALSE;1872;p valueb
1823;p inleraclion;"C0369773;C2603361";FALSE;1874;p inleraclion
1824;$nmbr$ - $nmbr$ ( o - $nmbr$ i - o - $nmbr$ );"C0021966;C0221138;C0483204";FALSE; -10;$nmbr$ $nmbr$ o $nmbr$ i o $nmbr$
1824;$nmbr$ $nmbr$ ( o - $nmbr$ - i - o $nmbr$ );"C0021966;C0221138;C0483204";FALSE; -10;$nmbr$ $nmbr$ o $nmbr$ i o $nmbr$
1824;$nmbr$ - $nmbr$ { o - $nmbr$ - $nmbr$ - o $nmbr$ );C0483204;FALSE; -10;$nmbr$ $nmbr$ o $nmbr$ $nmbr$ o $nmbr$
1509;indacaterol group ( n = $nmbr$ );"C0441848;C1722260";FALSE;1875;indacaterol group n $nmbr$
1509;indacaterol $nmbr$ ug ( n = $nmbr$ );"C0041573;C0439211;C1722260";FALSE;1875;indacaterol $nmbr$ ug n $nmbr$
1509;indacaterol $nmbr$ ug versus indacaterol $nmbr$ ug;"C0041573;C0439211;C1722260";FALSE;1875;indacaterol $nmbr$ ug versus indacaterol $nmbr$ ug
1509;indacaterol $nmbr$ ug versus placebo;"C0032042;C0041573;C0439211;C1696465;C1706408;C1722260";FALSE;1875;indacaterol $nmbr$ ug versus placebo
1509;indacaterol n = $nmbr$;C1722260;FALSE;1875;indacaterol n $nmbr$
1509;indacaterol + tiotropium ( n [ $nmbr$ );"C0213771;C1722260";FALSE;1875;indacaterol tiotropium n $nmbr$
1785;$nmbr$ < $nmbr$ s ) n $nmbr$ ( $nmbr$ . $nmbr$ );C2986823;FALSE; -10;$nmbr$ $nmbr$ s n $nmbr$ $nmbr$ $nmbr$
1785;s $nmbr$ gallop  n ( % );C2986823;FALSE; -10;s $nmbr$ gallop n
1785;s $nmbr$ ( n = $nmbr$ );C2986823;FALSE; -10;s $nmbr$ n $nmbr$
1795;( e ) aza treatment ( ref );"C0004482;C0039798;C0087111;C1425988;C1522326;C1533734;C1705169;C3538994;C3887704";FALSE;1881;e aza treatment ref
1795;( a ) aza treatment ( ref );"C0004482;C0039798;C0087111;C1425988;C1522326;C1533734;C1705169;C3538994;C3887704";FALSE;1881;a aza treatment ref
1795;( c ) ' ' kza treatment ( ref );"C0039798;C0087111;C1425988;C1522326;C1533734;C1705169;C3538994;C3887704";FALSE;1881;c kza treatment ref
1795;( b ) aza treatment ( ref );"C0004482;C0039798;C0087111;C1425988;C1522326;C1533734;C1705169;C3538994;C3887704";FALSE;1881;b aza treatment ref
1273;values are mean ± sd  median [ quartile range ]  or % . ace indicates angiotensin - converting enzyme  arb  angiotensin receptor blocker  bnp  b - type natriuretic peptide  bp  blood pressure  bun  blood urea nitrogen  lvef  left ventricular ejection fraction  and nt - probnp  n - terminal pro - b - type natriuretic peptide .;"C0005823;C0022709;C0033382;C0042295;C0054015;C0205088;C0332307;C0428772;C0444504;C0488728;C0523852;C0549183;C0597357;C0600137;C0876920;C1095989;C1144709;C1291218;C1317554;C1417808;C1452534;C1514721;C1547052;C1705314;C1705315;C2347634;C2347635;C2348143;C2348144;C2348147;C2699239;C2709270;C2825907;C2828255;C2939193;C2982014;C2987124;C3537020;C3542016;C3683557;C3888198;C4284014;C4284038";FALSE; -10;values are mean sd median quartile range or ace indicates angiotensin converting enzyme arb angiotensin receptor blocker bnp b type natriuretic peptide bp blood pressure bun blood urea nitrogen lvef left ventricular ejection fraction and nt probnp n terminal pro b type natriuretic peptide
1536;right ventricular dysfunction  n / n ( % ) j;"C0242707;C1556315";FALSE;1882;right ventricular dysfunction n n j
1536;right ventricular dysfunction — no . / total no . ( % ) §;"C0242707;C0439175;C0439810;C1556315";FALSE;1882;right ventricular dysfunction no total no
1801;hbalc;NA;FALSE;1176;hbalc
1801;hbalc < $nmbr$ %;NA;FALSE;1176;hbalc $nmbr$
1801;hbalc ( mmol / mol );C3829066;FALSE;1176;hbalc mmol mol
1801;hbalc £ $nmbr$ mmol / mol ( > $nmbr$ . $nmbr$ % ) ( n = $nmbr$ / $nmbr$ );C3829066;FALSE;1176;hbalc $nmbr$ mmol mol $nmbr$ $nmbr$ n $nmbr$ $nmbr$
1801;hbalc < $nmbr$ % ( $nmbr$ mmol / mol );C3829066;FALSE;1176;hbalc $nmbr$ $nmbr$ mmol mol
 960;calcium channel blocker;"C0006684;C3536851;C4521885";FALSE;1884;calcium channel blocker
 960;= calcium channel blocker  bmi = body;"C0006684;C0242821;C0460148;C0578022;C1268086;C3536851;C4082212;C4521885";FALSE;1884;calcium channel blocker bmi body
 960;calcium channel blocker ( % );"C0006684;C3536851;C4521885";FALSE;1884;calcium channel blocker
 960;ca - channel blockers  n ( % );"C0870261;C3887642";FALSE;1884;ca channel blockers n
 644;cardiac glycosides;C0007158;FALSE; 989;cardiac glycosides
 644;cardiac resynchronization therapy n ( % );C1167956;FALSE;1885;cardiac resynchronization therapy n
 644;cardiac resynchronization therapy;C1167956;FALSE;1885;cardiac resynchronization therapy
 644;prior cardiac resynchronization therapy  n ( % );"C0332152;C1167956;C2826257";FALSE;1885;prior cardiac resynchronization therapy n
 644;d includes cardiac glycosides  antiarrhythmics classes i and iii  vasodilators used in cardiac disease and other cardiac preparations .;"C0003195;C0007158;C0018787;C0018799;C0042402;C0073187;C0332173;C0332257;C0439070;C0441885;C1273517;C1319793;C1521827;C1522601;C1552866;C1705160;C2698967;C2700399;C3812761;C4484261";FALSE; -10;d includes cardiac glycosides antiarrhythmics classes i and iii vasodilators used in cardiac disease and other cardiac preparations
1492;history of atrial fibrillation;C0729790;FALSE;1009;history of atrial fibrillation
1492;history of atrial fibrillation and / or flutter;"C0016385;C0729790;C2242390";FALSE;1009;history of atrial fibrillation and or flutter
1492;history of atrial fibrillation  n ( % );C0729790;FALSE;1009;history of atrial fibrillation n
1492;history of atrial fibrillation  type 一 no . ( % );"C0332307;C0729790;C1547052";FALSE;1009;history of atrial fibrillation type no
1492;history of atrial fibrillation or flutter;"C0016385;C0729790;C2242390";FALSE;1009;history of atrial fibrillation or flutter
1492;history of atrial fibrillation or flutter treatment at randomisation;"C0016385;C0034656;C0039798;C0087111;C0729790;C1522326;C1533734;C1705169;C2242390;C3538994;C3887704";FALSE;1009;history of atrial fibrillation or flutter treatment at randomisation
1446;paroxysmal  n ( % );C0205311;FALSE;1886;paroxysmal n
1446;paroxysmal ( n  % );C0205311;FALSE;1886;paroxysmal n
1446;paroxysmal;C0205311;FALSE;1886;paroxysmal
1446;paroxysmal !;C0205311;FALSE;1886;paroxysmal
1500;data are presented as mean sd . * n $nmbr$ for ldl cholesterol . † n $nmbr$ for ldl cholesterol . ‡ signi ﬁ cantly different from baseline values by repeated measures ( analysis of variance )  p $nmbr$ . $nmbr$ . § signi ﬁ cantly different from baseline values by repeated measures ( analysis of variance )  p $nmbr$ . $nmbr$ . ¶ signi ﬁ cantly different from baseline values by repeated measures ( analysis of variance )  p $nmbr$ . $nmbr$ .;"C0002778;C0002780;C0023824;C0042295;C0168634;C0202117;C0369718;C0441922;C0444504;C0449450;C0565965;C0871881;C0936012;C1442488;C1511726;C1524024;C1705242;C1711260;C2347634;C2348143;C2348152;C2699239;C3245479;C3714741";FALSE; -10;data are presented as mean sd n $nmbr$ for ldl cholesterol n $nmbr$ for ldl cholesterol signi cantly different from baseline values by repeated measures analysis of variance p $nmbr$ $nmbr$ signi cantly different from baseline values by repeated measures analysis of variance p $nmbr$ $nmbr$ signi cantly different from baseline values by repeated measures analysis of variance p $nmbr$ $nmbr$
1500;* data are given as percentage of subjects unless otherwise specified . ptca indicates percutaneous transluminal coronary angioplasty  cabg  coronary artery bypass graft  ace  angiotensin - converting enzyme  bmi  body mass index ( calculated as weight in kilograms divided by square of height in meters )  hdl - c  high - density lipoprotein cholesterol  ldl - c  low - density lipoprotein cholesterol  fpg  fasting plasma glucose  and fpi  fasting plasma insulin . tto convert cholesterol values to micromoles per liter  multiply by $nmbr$ . $nmbr$ . to convert triglycerides to micromoles per liter  multiply by $nmbr$ . $nmbr$ . to convert fpg to micromoles per liter  multiply by $nmbr$ . $nmbr$ . to convert fpi to picomoles per liter  multiply by $nmbr$ . $nmbr$ .;"C0003842;C0005910;C0008377;C0010055;C0015663;C0022709;C0023821;C0023824;C0040363;C0041004;C0041061;C0041260;C0042295;C0043100;C0185098;C0202042;C0205120;C0205369;C0226004;C0332849;C0439165;C0439192;C0439194;C0439209;C0441074;C0444686;C0455280;C0475211;C0489786;C0681850;C0857690;C1305855;C1305866;C1441506;C1442162;C1511726;C1549488;C1550501;C1550718;C1552595;C1561533;C1705104;C1706203;C1719797;C1883351;C1947971;C2349001;C2697811;C2911648;C2936173;C3244317;C3245479;C3714741";FALSE; -10;data are given as percentage of subjects unless otherwise specified ptca indicates percutaneous transluminal coronary angioplasty cabg coronary artery bypass graft ace angiotensin converting enzyme bmi body mass index calculated as weight in kilograms divided by square of height in meters hdl c high density lipoprotein cholesterol ldl c low density lipoprotein cholesterol fpg fasting plasma glucose and fpi fasting plasma insulin tto convert cholesterol values to micromoles per liter multiply by $nmbr$ $nmbr$ to convert triglycerides to micromoles per liter multiply by $nmbr$ $nmbr$ to convert fpg to micromoles per liter multiply by $nmbr$ $nmbr$ to convert fpi to picomoles per liter multiply by $nmbr$ $nmbr$
1500;* the $nmbr$ substrata with baseline ( bl ) ldl cholesterol $nmbr$ to $nmbr$ mg / dl and $nmbr$ to $nmbr$ mg / dl were combined to make $nmbr$ group with bl ldl cholesterol $nmbr$ to $nmbr$ mg / dl because of small numbers of patients included in the substrata with $nmbr$ to $nmbr$ mg / dl . † bl hdl cholesterol cutoffs were $nmbr$ or $nmbr$ mg / dl for men and $nmbr$ or $nmbr$ mg / dl for women . bars indicate se . bmi body mass index  e ezetimibe $nmbr$ mg  hdl - c hdl cholesterol  ldl - c ldl cholesterol  tg triglycerides;"C0005918;C0006413;C0023822;C0023824;C0024671;C0025266;C0026410;C0036919;C0040363;C0041260;C0043210;C0168634;C0202117;C0205195;C0332257;C0337445;C0368910;C0392885;C0439269;C0441833;C0687744;C0687760;C0700321;C1142985;C1257890;C1305855;C1442160;C1442488;C1519504;C1552663;C1704759;C1705428;C1705429;C1707156;C1881534;C1883351;C1960952;C2346927;C2360800;C2827109;C3274014;C3541345;C3642216;C3715113;C3889135;C4321396;C4521761";FALSE; -10;the $nmbr$ substrata with baseline bl ldl cholesterol $nmbr$ to $nmbr$ mg dl and $nmbr$ to $nmbr$ mg dl were combined to make $nmbr$ group with bl ldl cholesterol $nmbr$ to $nmbr$ mg dl because of small numbers of patients included in the substrata with $nmbr$ to $nmbr$ mg dl bl hdl cholesterol cutoffs were $nmbr$ or $nmbr$ mg dl for men and $nmbr$ or $nmbr$ mg dl for women bars indicate se bmi body mass index e ezetimibe $nmbr$ mg hdl c hdl cholesterol ldl c ldl cholesterol tg triglycerides
1469;iop  mm hg;"C0439475;C0578862";FALSE;1887;iop mm hg
1469;< $nmbr$ mm hg;C0439475;FALSE;1888;$nmbr$ mm hg
1469;> $nmbr$ mmhg;C0439475;FALSE;1888;$nmbr$ mmhg
1469;> = $nmbr$ mmhg;C0439475;FALSE;1888;$nmbr$ mmhg
1469;> $nmbr$ mm hg;C0439475;FALSE;1888;$nmbr$ mm hg
1469;< $nmbr$ mm hg — no . ( % );C0439475;FALSE;1888;$nmbr$ mm hg no
1469;< $nmbr$ / < $nmbr$ mm hg;C0439475;FALSE;1888;$nmbr$ $nmbr$ mm hg
1469;$nmbr$ . $nmbr$ to < $nmbr$ . $nmbr$ mm hg;C0439475;FALSE;1888;$nmbr$ $nmbr$ to $nmbr$ $nmbr$ mm hg
1469;$nmbr$ to < $nmbr$ mm hg — no . { % );C0439475;FALSE;1888;$nmbr$ to $nmbr$ mm hg no
 635;age in years  median ( iqr );"C0549183;C0876920;C1510829;C2347635;C2348144;C2939193";FALSE;1890;age in years median iqr
 635;age < median;"C0001779;C0549183;C0876920;C2347635;C2348144;C2939193";FALSE;1890;age median
 635;age  median ( iqr );"C0001779;C0549183;C0876920;C2347635;C2348144;C2939193";FALSE;1890;age median iqr
 635;age ( median  iqr )  y;"C0001779;C0549183;C0876920;C2347635;C2348144;C2939193";FALSE;1890;age median iqr y
 635;age  median ( iqr )  y;"C0001779;C0549183;C0876920;C2347635;C2348144;C2939193";FALSE;1890;age median iqr y
 635;age > - median;"C0001779;C0549183;C0876920;C2347635;C2348144;C2939193";FALSE;1890;age median
 635;body mass index ( median;"C0005893;C0549183;C0578022;C0876920;C1305855;C2347635;C2348144;C2939193";FALSE;1891;body mass index median
 635;body mass index  median ( iqr ) b;"C0005893;C0549183;C0578022;C0876920;C1305855;C2347635;C2348144;C2939193";FALSE;1891;body mass index median iqr b
 635;body mass index  median ( iqr );"C0005893;C0549183;C0578022;C0876920;C1305855;C2347635;C2348144;C2939193";FALSE;1891;body mass index median iqr
 635;duration of pci ( min )  median n ( iqr );"C0449238;C0549183;C0702093;C0876920;C1524029;C2347635;C2348144;C2926735;C2939193;C3813700;C4049621";FALSE;1895;duration of pci min median n iqr
 635;fasting plasma glucose < median;"C0015663;C0202042;C0455280;C0549183;C0876920;C2347635;C2348144;C2939193";FALSE;1896;fasting plasma glucose median
 635;fastng plasma glucose < median;"C0202042;C0455280;C0549183;C0876920;C2347635;C2348144;C2939193";FALSE;1896;fastng plasma glucose median
 635;hba $nmbr$ c  %  median ( q $nmbr$  q $nmbr$ );"C0019016;C0549183;C0876920;C1825777;C2347635;C2348144;C2939193;C3538758";FALSE;1897;hba $nmbr$ c median q $nmbr$ q $nmbr$
 635;hba $nmbr$ c  median ( q $nmbr$  q $nmbr$ )  %;"C0019016;C0549183;C0876920;C1825777;C2347635;C2348144;C2939193;C3538758";FALSE;1897;hba $nmbr$ c median q $nmbr$ q $nmbr$
1749;ta ( n = $nmbr$ );"C0039297;C1506978;C1705538;C3272501;C4553364";FALSE; -10;ta n $nmbr$
 926;methotrexate alone ^;"C0025677;C0205171;C0439044;C0679994";FALSE; 716;methotrexate alone
1115;clinical fracture;"C0016658;C0205210";FALSE;2026;clinical fracture
 635;hba $nmbr$ c tx difference vs pbo  median change from baseline ( se ) $nmbr$;"C0019016;C0031962;C0036919;C0041403;C0168634;C0392747;C0443172;C0549183;C0876920;C1442488;C1705241;C1705242;C1825777;C2347635;C2348144;C2939193;C3538758;C4319952";FALSE;1897;hba $nmbr$ c tx difference vs pbo median change from baseline se $nmbr$
 635;hba $nmbr$ c  median ( q $nmbr$ – q $nmbr$ );"C0019016;C0549183;C0876920;C1825777;C2347635;C2348144;C2939193;C3538758";FALSE;1897;hba $nmbr$ c median q $nmbr$ q $nmbr$
 635;median age ( iqr  years );"C0549183;C0876920;C1510829;C2347635;C2348144;C2939193";FALSE;1901;median age iqr years
 635;median age  y ( range );"C0001779;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016";FALSE;1901;median age y range
 635;median cardiac troponin t ( iqr ) 一 pg / ml;"C0439297;C0549183;C0876920;C2347635;C2348144;C2939193;C3538889";FALSE;1903;median cardiac troponin t iqr pg ml
1118;pollen exposure;"C0032385;C0274281;C0332157;C0795585;C1320238";FALSE;1905;pollen exposure
1118;pollent s $nmbr$;NA;FALSE;1906;pollent s $nmbr$
  16;baseline systolic blood pressure;C4274438;FALSE;1469;baseline systolic blood pressure
  16;pulsed blood pressure;C0232108;FALSE;1469;pulsed blood pressure
  16;systolic blood pressure ( change from baseline );"C0392747;C0443172;C1705241;C4274438;C4319952";FALSE;1469;systolic blood pressure change from baseline
  37;age at baseline in years  mean ( sd );"C0001779;C0168634;C0439234;C0444504;C1442488;C2347634;C2348143;C2699239";FALSE;1907;age at baseline in years mean sd
  37;age at enrollment ( years )  mean ( sd );"C0444504;C1510829;C1516879;C1696073;C2347634;C2348143;C2699239;C3888021";FALSE;1907;age at enrollment years mean sd
  37;age at first seizure  years  mean ( sd );"C0036572;C0205435;C0444504;C1279901;C1510829;C1959629;C2347634;C2348143;C2699239;C4553401";FALSE;1907;age at first seizure years mean sd
  37;age  mean $nmbr$ sd years;"C0444504;C1510829;C2347634;C2348143;C2699239";FALSE;1907;age mean $nmbr$ sd years
  37;age  mean ( sd );"C0001779;C0444504;C2347634;C2348143;C2699239";FALSE;1907;age mean sd
  37;age  mean ± sd;"C0001779;C0444504;C2347634;C2348143;C2699239";FALSE;1907;age mean sd
  37;das $nmbr$  range $nmbr$ - $nmbr$  mean ( sd );"C0051767;C0057671;C0444504;C1514721;C2347634;C2348143;C2348147;C2699239;C3542016";FALSE;1914;das $nmbr$ range $nmbr$ $nmbr$ mean sd
  37;das $nmbr$ ( esr )  mean ( sd );"C0051767;C0057671;C0444504;C2347634;C2348143;C2699239;C3811131";FALSE;1914;das $nmbr$ esr mean sd
  37;weight in kg ( baseline : mean ( sd ) [ n ]  wk $nmbr$ and change : mean ( se ) [ n ] );"C0022718;C0036919;C0332174;C0392747;C0439209;C0439230;C0443172;C0444504;C1303013;C1705241;C2347634;C2348143;C2699239;C4054209;C4319952";FALSE;1915;weight in kg baseline mean sd n wk $nmbr$ and change mean se n
  37;weight in kg  mean ( sd );"C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209";FALSE;1915;weight in kg mean sd
  37;weight ( kg )  mean ( s . d . );"C0005910;C0043100;C0444504;C1275571;C1305866;C1705104;C2347634;C2348143";FALSE;1915;weight kg mean s d
  37;weight  kg : mean ( sd );"C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209";FALSE;1915;weight kg mean sd
  37;weight ( kg )  mean ( sd );"C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209";FALSE;1915;weight kg mean sd
  37;weight  kg ( mean ± s . d . );"C0005910;C0043100;C0444504;C1275571;C1305866;C1705104;C2347634;C2348143";FALSE;1915;weight kg mean s d
 366;concomitant medication | |;"C0013227;C0521115;C3244316;C4284232";FALSE;1916;concomitant medication
 366;concomitant medication ( % );"C0013227;C0521115;C3244316;C4284232";FALSE;1916;concomitant medication
 366;concomitant medication after randomisation;"C0013227;C0034656;C0521115;C3244316;C4284232";FALSE;1916;concomitant medication after randomisation
 366;concomitant medication  n ( % );"C0013227;C0521115;C3244316;C4284232";FALSE;1916;concomitant medication n
 366;concomitant medication  n [ % ];"C0013227;C0521115;C3244316;C4284232";FALSE;1916;concomitant medication n
 366;concomitant medication — no . { % ) | ace inhibitor;"C0003015;C0013227;C0521115;C3244316;C4284232;C4541021";FALSE;1916;concomitant medication no ace inhibitor
 614;systolic;C0039155;FALSE;1917;systolic
 635;crp  median ( range ) mg / literl;"C0024671;C0026410;C0439269;C0549183;C0876920;C1514721;C1960952;C2346927;C2347635;C2348144;C2348147;C2939193;C3542016;C3890735;C4048285;C4321396;C4521761";FALSE; 286;crp median range mg literl
 193;c - reactive protein concentration ( mg / l );"C0006560;C0086045;C0439268;C1413716;C1446561;C3827302;C4048285";FALSE; 286;c reactive protein concentration mg l
 193;c - reactive protein  * mg / l;"C0006560;C0439268;C1413716;C4048285";FALSE; 286;c reactive protein mg l
 193;c - reactive protein  mg / l;"C0006560;C0439268;C1413716;C4048285";FALSE; 286;c reactive protein mg l
 193;c - reactive protein ( mg / l );"C0006560;C0439268;C1413716;C4048285";FALSE; 286;c reactive protein mg l
 193;crp  mean mg / l ( sd );"C0439268;C0444504;C2347634;C2348143;C2699239;C3890735;C4048285";FALSE; 286;crp mean mg l sd
 193;crp  mg / l;"C0439268;C3890735;C4048285";FALSE; 286;crp mg l
 625;c - reactive protein ( high - sensitivity assay )  mitt = modified intent - to - treat  pbo cholesterol  cl = confidence intervals  hdl - c = high - density lipoprotein cholest = national cholesterol education program adult treatment panel y patients with diabetes ( fc > _ $nmbr$ mg / dl [ > $nmbr$ . $nmbr$ mmol / l ] ) . to qualify as having acteristics described in methods ( ncep atp iii definition )  + baseline values are rr d hs - crr for which medians are presented  * * p < $nmbr$ . $nmbr$  § p = $nmbr$ . $nmbr$  * p = $nmbr$ . $nmbr$ . nteractions were not statistically significant ( p > $nmbr$ . $nmbr$ ) .;"C0001675;C0005507;C0006560;C0009667;C0011847;C0011849;C0023822;C0025663;C0025664;C0030705;C0031962;C0040363;C0041260;C0042295;C0065055;C0087111;C0150375;C0162425;C0168634;C0178587;C0205250;C0243073;C0369773;C0392747;C0439070;C0449450;C0449851;C0549183;C0596019;C0679841;C1273937;C1283828;C1292734;C1299351;C1413716;C1441604;C1442488;C1510438;C1522326;C1550452;C1550453;C1552738;C1704788;C1705160;C1706450;C1883351;C2603361;C2700149;C2744579;C2983605;C3245503;C3539107;C3642216;C3887512;C3888054;C3889660;C3889737;C3898312;C4048285;C4321237;C4522209;C4552600;C4554402";FALSE; -10;c reactive protein high sensitivity assay mitt modified intent to treat pbo cholesterol cl confidence intervals hdl c high density lipoprotein cholest national cholesterol education program adult treatment panel y patients with diabetes fc _ $nmbr$ mg dl $nmbr$ $nmbr$ mmol l to qualify as having acteristics described in methods ncep atp iii definition baseline values are rr d hs crr for which medians are presented p $nmbr$ $nmbr$ p $nmbr$ $nmbr$ p $nmbr$ $nmbr$ nteractions were not statistically significant p $nmbr$ $nmbr$
 192;crp level  mean ± sd mg / dl;"C0439269;C0441889;C0444504;C0456079;C1547707;C2347634;C2348143;C2699239;C2946261;C3890735;C4048285";FALSE; 286;crp level mean sd mg dl
 192;crp mean ( mg / dl ± sd );"C0439269;C0444504;C2347634;C2348143;C2699239;C3890735;C4048285";FALSE; 286;crp mean mg dl sd
 192;crp  median  mg / dl;"C0439269;C0549183;C0876920;C2347635;C2348144;C2939193;C3890735;C4048285";FALSE; 286;crp median mg dl
 192;crp  mean [ sd ] mg / $nmbr$;"C0024671;C0026410;C0439269;C0444504;C1960952;C2346927;C2347634;C2348143;C2699239;C3890735;C4048285;C4321396;C4521761";FALSE; 286;crp mean sd mg $nmbr$
 192;hscrp  mg / dl;C0439269;FALSE; 286;hscrp mg dl
 192;high - sensitivity crp — mg / liter | |;"C0024671;C0026410;C0439269;C0475211;C1441604;C1960952;C2346927;C3890735;C4048285;C4321396;C4521761";FALSE; 286;high sensitivity crp mg liter
1776;st - segment depression > $nmbr$ . $nmbr$ mv;"C0520887;C1454484;C1705503;C4281602";FALSE;1920;st segment depression $nmbr$ $nmbr$ mv
1776;st - segment depression < $nmbr$ . $nmbr$ mv  %;"C0520887;C1454484;C1705503;C4281602";FALSE;1920;st segment depression $nmbr$ $nmbr$ mv
1776;st - segment depression > $nmbr$ . $nmbr$ mv on admission  %;"C0457453;C0520887;C1454484;C1705503;C4281602";FALSE;1920;st segment depression $nmbr$ $nmbr$ mv on admission
1747;oral contraceptives;C0009905;FALSE;1921;oral contraceptives
1757;* hypercholesterolemia was defined as a low - density lipoprotein cholesterol level at enrollment of more than $nmbr$ mg per deciliter ( $nmbr$ . $nmbr$ mmol per liter ) after an overnight fast . † nonsustained ventricular tachycardia was defined as $nmbr$ or more consecutive ventricular beats at a heart rate of more than $nmbr$ beats per minute . ‡ to convert weight to kilograms  divide by $nmbr$ . $nmbr$ . § to convert values for creatinine to micromoles per liter  multiply by $nmbr$ . $nmbr$ . ¶ data for follow - up medication were available for $nmbr$ patients ( amiodarone  $nmbr$  placebo  $nmbr$  and icd  $nmbr$ ) . ace de - notes angiotensin - converting enzyme  and arb angiotensin ii – receptor blocker . ¿ p < $nmbr$ . $nmbr$ for the comparison among the groups;"C0002598;C0005910;C0010294;C0011198;C0013227;C0015663;C0017480;C0018827;C0020443;C0021122;C0022709;C0023824;C0030705;C0032042;C0040363;C0041260;C0042295;C0043100;C0205172;C0332849;C0369773;C0425583;C0439209;C0439241;C0439300;C0439385;C0439583;C0441833;C0441889;C0456079;C0456962;C0470187;C0475211;C0521942;C0567349;C0589120;C0687744;C0750194;C0871208;C1257890;C1305866;C1316572;C1317574;C1452534;C1511726;C1516879;C1519504;C1521828;C1522133;C1522565;C1522577;C1547707;C1552839;C1561535;C1696073;C1696465;C1704685;C1704788;C1705104;C1705428;C1705429;C1706408;C1707455;C1707491;C1719797;C1883351;C2347285;C2348885;C2603361;C2911648;C2919575;C2946261;C2985769;C3244316;C3245479;C3274571;C3536793;C3539106;C3541240;C3714741;C3888021;C3888198;C4284014;C4284232";FALSE; -10;hypercholesterolemia was defined as a low density lipoprotein cholesterol level at enrollment of more than $nmbr$ mg per deciliter $nmbr$ $nmbr$ mmol per liter after an overnight fast nonsustained ventricular tachycardia was defined as $nmbr$ or more consecutive ventricular beats at a heart rate of more than $nmbr$ beats per minute to convert weight to kilograms divide by $nmbr$ $nmbr$ to convert values for creatinine to micromoles per liter multiply by $nmbr$ $nmbr$ data for follow up medication were available for $nmbr$ patients amiodarone $nmbr$ placebo $nmbr$ and icd $nmbr$ ace de notes angiotensin converting enzyme and arb angiotensin ii receptor blocker p $nmbr$ $nmbr$ for the comparison among the groups
1734;the test for heterogeneity ( interaction ) indicates whether the treatment effect varied significantly among the sub - groups . the hochberg method was applied to each of the two comparisons of the treatment groups . bmi denotes body - mass index ( the weight in kilograms divided by the square of the height in meters ) .;"C0005893;C0005910;C0019409;C0022885;C0025663;C0039593;C0039798;C0043100;C0087111;C0205120;C0205448;C0242960;C0332849;C0392366;C0439209;C0441074;C0441833;C0449851;C0456984;C0489786;C0542339;C0578022;C0687744;C0871511;C1257890;C1264637;C1305855;C1305866;C1515976;C1518681;C1519504;C1522326;C1533734;C1552595;C1552839;C1704675;C1705104;C1705169;C1705428;C1705429;C1707455;C3538994;C3831328;C3887704;C4048755;C4318744";FALSE; -10;the test for heterogeneity interaction indicates whether the treatment effect varied significantly among the sub groups the hochberg method was applied to each of the two comparisons of the treatment groups bmi denotes body mass index the weight in kilograms divided by the square of the height in meters
 205;bmi ( kg / rrr );"C0022718;C0439209;C0578022;C4054209";FALSE;1734;bmi kg rrr
 205;bmi $nmbr$ - < $nmbr$ kg / ni - ( n = $nmbr$ / $nmbr$ );"C0022718;C0028075;C0439209;C0578022;C2348274;C3869926;C3869927;C4054209";FALSE;1734;bmi $nmbr$ $nmbr$ kg ni n $nmbr$ $nmbr$
1050;dyslipidaemia and hypertensiont;C0242339;FALSE;1364;dyslipidaemia and hypertensiont
 205;body - mass index ( kg / mj ) previous diagnosis;"C0005893;C0022718;C0332132;C0439209;C0439254;C0578022;C1305855;C4054209;C4284025";FALSE;1734;body mass index kg mj previous diagnosis
 205;bmi : < $nmbr$ kg / nr;"C0022718;C0027496;C0439209;C0578022;C3844738;C4054209";FALSE;1734;bmi $nmbr$ kg nr
 205;bmi  mean ( sd )  kg / rn $nmbr$;"C0022718;C0439209;C0444504;C0578022;C2347634;C2348143;C2699239;C2827110;C3540639;C4054209;C4281819";FALSE;1734;bmi mean sd kg rn $nmbr$
 205;body mass index ( bmi  kg / m $nmbr$ )  n ( % ) < $nmbr$ kg / m $nmbr$;"C0005893;C0022718;C0439209;C0578022;C1305855;C1709500;C4054209";FALSE;1734;body mass index bmi kg m $nmbr$ n $nmbr$ kg m $nmbr$
1250;data are number of patients ( % ) or hazard ratio ( $nmbr$ % cl )  p values are forthe test of heterogeneity . cad = coronary artery disease . bmi = body - mass index  which is weight in kg divided by the square of height in metres . ldl = low - density lipoprotein . hdl = high - density lipoprotein . there is a deficit of clinical data in some patients with the events .;"C0005910;C0018787;C0019409;C0022718;C0022885;C0023820;C0023821;C0030705;C0039593;C0042295;C0043100;C0162429;C0178587;C0205120;C0205251;C0242960;C0332849;C0392366;C0439209;C0441471;C0456984;C0475209;C0489786;C0596019;C0852949;C1305855;C1305866;C1504769;C1511726;C1515976;C1516606;C1550472;C1552595;C1705104;C2239547;C2360800;C2985465;C2987487;C3245479;C3541888;C3714741;C3813548;C3831328;C3890211;C4048187;C4054209;C4284121;C4318744;C4321351;C4522223";FALSE; -10;data are number of patients or hazard ratio $nmbr$ cl p values are forthe test of heterogeneity cad coronary artery disease bmi body mass index which is weight in kg divided by the square of height in metres ldl low density lipoprotein hdl high density lipoprotein there is a deficit of clinical data in some patients with the events
 146;body mass indext;C0518010;FALSE;1734;body mass indext
 146;body mass indexf  < $nmbr$;C0518010;FALSE;1734;body mass indexf $nmbr$
 146;body mass indexf;C0518010;FALSE;1734;body mass indexf
 146;body - mass indexj;C0518010;FALSE;1734;body mass indexj
 146;body - mass indexf;C0518010;FALSE;1734;body mass indexf
 146;body mass indexc;C0518010;FALSE;1734;body mass indexc
 817;alpha - blocker / other vasodilator;"C0001641;C0042402;C3537240";FALSE; 961;alpha blocker other vasodilator
 961;^ - blocker;NA;FALSE;1926;blocker
 961;$nmbr$ blocker;NA;FALSE;1926;$nmbr$ blocker
 961;p - blocker use;"C0042153;C0369773;C0457083;C1947944;C2603361";FALSE;1926;p blocker use
 961;preoperative p - blocker use yes;"C0042153;C0445204;C0457083;C1549445;C1705108;C1710701;C1947944";FALSE;1926;preoperative p blocker use yes
 961;preoperative use p - blocker;"C0042153;C0445204;C0457083;C1947944";FALSE;1926;preoperative use p blocker
 961;prior a - blocker use;"C0042153;C0332152;C0457083;C1947944;C2826257";FALSE;1926;prior a blocker use
 820;hbau  %;NA;FALSE;1928;hbau
 820;patients with possible new dm at randomization ( hba $nmbr$ c > $nmbr$ . $nmbr$ - $nmbr$ % );"C0011816;C0019016;C0030705;C0034656;C0205314;C0332149;C1705910;C1825777;C2362652;C3250443;C3538758";FALSE;1928;patients with possible new dm at randomization hba $nmbr$ c $nmbr$ $nmbr$ $nmbr$
 820;pen - label empagliflozin $nmbr$ mg ( baseline hba $nmbr$ c > $nmbr$ % );"C0019016;C0024671;C0026410;C0168634;C0181496;C0439269;C1424886;C1442488;C1825777;C1960952;C2346927;C2827499;C3273588;C3490348;C3538758;C4319659;C4321396;C4521761;C4522130;C4551445";FALSE;1928;pen label empagliflozin $nmbr$ mg baseline hba $nmbr$ c $nmbr$
 822;ldlc : hdlc;"C1416822;C1704429";FALSE; 821;ldlc hdlc
 822;non - hdlc;"C1518422;C1704429";FALSE; 821;non hdlc
 822;non - hdlc concentration;"C0086045;C1446561;C1518422;C1704429;C3827302";FALSE; 821;non hdlc concentration
 823;low hdl cholesterol;C0151691;FALSE; 821;low hdl cholesterol
 823;non ‐ hdl cholesterol;"C0729627;C1535899";FALSE; 821;non hdl cholesterol
 823;non - hdl cholesterol;"C0729627;C1535899";FALSE; 821;non hdl cholesterol
 847;losartan + lisinopril;"C0065374;C0126174";FALSE;1930;losartan lisinopril
 847;losartan plus lisinopril ( n = $nmbr$ );"C0065374;C0126174;C0332287";FALSE;1930;losartan plus lisinopril n $nmbr$
 133;$nmbr$ . $nmbr$ vs $nmbr$ . $nmbr$;NA;FALSE; -10;$nmbr$ $nmbr$ vs $nmbr$ $nmbr$
 133;lisinopril vs amlodipineb;C0065374;FALSE;1931;lisinopril vs amlodipineb
 133;lisinopril vs chlorthalidone obese;"C0008294;C0028754;C0065374";FALSE;  70;lisinopril vs chlorthalidone obese
 852;low - density lipoprotein;C0023823;FALSE;1932;low density lipoprotein
 852;low - density lipoprotein ^;C0023823;FALSE;1932;low density lipoprotein
 852;low - density lipoprotein choles -;C0023823;FALSE;1932;low density lipoprotein choles
 852;low - density lipoprotein  mg / dl;"C0023823;C0439269";FALSE;1932;low density lipoprotein mg dl
 192;low density lipoprotein cholesterol - mg / dltt;"C0023824;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;1963;low density lipoprotein cholesterol mg dltt
 192;low - density lipoprotein cholesterol  mg / dl;"C0023824;C0439269";FALSE;1963;low density lipoprotein cholesterol mg dl
 192;eze $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;1165;eze $nmbr$ mg n $nmbr$
 192;eze $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;1165;eze $nmbr$ mg
 192;ezetimibe $nmbr$ mg ( n — $nmbr$ );"C0024671;C0026410;C0439269;C1142985;C1960952;C2346927;C4321396;C4521761";FALSE;1165;ezetimibe $nmbr$ mg n $nmbr$
 192;mtx > $nmbr$ and si $nmbr$ mg / week;"C0024671;C0025677;C0026410;C0332174;C0439230;C0439269;C1417487;C1960952;C2346927;C4321396;C4521761";FALSE; 716;mtx $nmbr$ and si $nmbr$ mg week
 192;mtx dose > $nmbr$ mg / week  %;"C0024671;C0026410;C0332174;C0366550;C0439230;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE; 716;mtx dose $nmbr$ mg week
 219;bypass surgery;C1536078;FALSE;2040;bypass surgery
1144;* subgroups were defined on the basis of variables assessed before randomization . the lipid levels represent the averages of the values measured four weeks before randomization and those measured at randomization . to convert values for cholesterol to millimoles per liter  multiply by $nmbr$ . $nmbr$  to convert values for triglycerides to millimoles per liter  multiply by $nmbr$ . $nmbr$ . ci denotes confidence interval  ldl low - density lipoprotein  and hdl high - density lipoprotein . tests for heterogeneity of treatment effect were undertaken across each of the subgroups . in addition  we performed tests for interaction between treatment and the following continuous base - line variables : age  total  ldl  and hdl cholesterol  and triglyceride levels . there was no evidence of significant heterogeneity of treat - ment effect in any prespecified subgroup ( p » $nmbr$ . $nmbr$ ) . † data were missing for three patients  two in the placebo group and one in the pravastatin group .;"C0001779;C0008107;C0008377;C0009667;C0019409;C0022885;C0023820;C0023821;C0030705;C0032042;C0034656;C0039593;C0039798;C0040363;C0041004;C0041260;C0042295;C0084844;C0085542;C0087111;C0168634;C0178587;C0205251;C0205447;C0205448;C0205449;C0205450;C0231290;C0237881;C0242960;C0332282;C0332287;C0392366;C0428460;C0428475;C0439175;C0439190;C0439230;C0439810;C0439828;C0441833;C0444706;C0456984;C0475211;C0549178;C0687744;C0750502;C0884358;C1079230;C1257890;C1280500;C1292734;C1442488;C1510992;C1511726;C1515021;C1515976;C1516048;C1518681;C1519504;C1522326;C1527178;C1532563;C1533734;C1538994;C1546944;C1550472;C1551393;C1696465;C1704675;C1704788;C1705169;C1705428;C1705429;C1705492;C1706408;C1719797;C1874451;C1882932;C1883351;C1883712;C2348382;C2825518;C2911648;C3245479;C3259781;C3272743;C3538994;C3539106;C3541902;C3714741;C3715113;C3831328;C3887511;C3887704;C3890211;C4048187;C4318744;C4321351;C4522223";FALSE; -10;subgroups were defined on the basis of variables assessed before randomization the lipid levels represent the averages of the values measured four weeks before randomization and those measured at randomization to convert values for cholesterol to millimoles per liter multiply by $nmbr$ $nmbr$ to convert values for triglycerides to millimoles per liter multiply by $nmbr$ $nmbr$ ci denotes confidence interval ldl low density lipoprotein and hdl high density lipoprotein tests for heterogeneity of treatment effect were undertaken across each of the subgroups in addition we performed tests for interaction between treatment and the following continuous base line variables age total ldl and hdl cholesterol and triglyceride levels there was no evidence of significant heterogeneity of treat ment effect in any prespecified subgroup p $nmbr$ $nmbr$ data were missing for three patients two in the placebo group and one in the pravastatin group
 292;scarring on renal biopsy;"C0005558;C0008767;C0194073;C0220797;C1700247;C2004491";FALSE;1943;scarring on renal biopsy
 894;st elevation;C0520886;FALSE;1944;st elevation
 894;st - segment elevation;C0520886;FALSE;1944;st segment elevation
 894;st - elevation mi;"C0520886;C3810814";FALSE;1944;st elevation mi
 894;st segment elevation;C0520886;FALSE;1944;st segment elevation
 906;anterior infarct location;"C0340293;C0450429;C1515974;C2349195;C4284930;C4284931";FALSE;1948;anterior infarct location
 906;infarct location ( interactsn $ : p = $nmbr$ . $nmbr$ );"C0021308;C0450429;C1515974;C4284930;C4284931";FALSE;1948;infarct location interactsn $ p $nmbr$ $nmbr$
 906;infarct location — no . / total no . ( % );"C0021308;C0439175;C0439810;C0450429;C1515974;C4284930;C4284931";FALSE;1948;infarct location no total no
 906;infarct related artery location;"C0003842;C0021308;C0226004;C0439849;C0445223;C0450429;C1515974;C4284930;C4284931";FALSE;1948;infarct related artery location
 906;location of infarction;"C0021308;C0450429;C1515974;C4284930;C4284931";FALSE;1948;location of infarction
1611;acute rheumatic disorders;C0001314;FALSE;1950;acute rheumatic disorders
  97;moderate or severe renal disease  n ( % );"C0022646;C0022658;C0205081;C0205082;C1836348;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335";FALSE; 937;moderate or severe renal disease n
 173;framingham risk score;"C0035647;C0449820;C3166866;C4050231;C4552904";FALSE;1952;framingham risk score
 173;framingham risk score ( % );"C0035647;C0449820;C3166866;C4050231;C4552904";FALSE;1952;framingham risk score
 173;framingham risk score *;"C0035647;C0449820;C3166866;C4050231;C4552904";FALSE;1952;framingham risk score
 173;framingham risk score  arbitrary units;"C0035647;C0439183;C0449820;C3166866;C4050231;C4552904";FALSE;1952;framingham risk score arbitrary units
 173;timi risk scoret;"C0035647;C4552904";FALSE;1954;timi risk scoret
 173;timi risk score — no . / total no . ( % ) : c;"C0035647;C0439175;C0439810;C0449820;C4050231;C4552904";FALSE;1954;timi risk score no total no c
 192;amlodipine / valsartan $nmbr$ / $nmbr$ mg / v = $nmbr$;"C0024671;C0026410;C0439269;C1960952;C1962523;C2346927;C4321396;C4521761";FALSE;  78;amlodipine valsartan $nmbr$ $nmbr$ mg v $nmbr$
 192;amlodipine / valsartan $nmbr$ / $nmbr$ mg;"C0024671;C0026410;C0439269;C1960952;C1962523;C2346927;C4321396;C4521761";FALSE;  78;amlodipine valsartan $nmbr$ $nmbr$ mg
 192;amlodipine / valsartan $nmbr$ / $nmbr$ mg ( n = $nmbr$ i );"C0021966;C0024671;C0026410;C0221138;C0369718;C0439269;C0441922;C1960952;C1962523;C2346927;C4321396;C4521761";FALSE;  78;amlodipine valsartan $nmbr$ $nmbr$ mg n $nmbr$ i
 192;amlodipine / valsartan $nmbr$ / $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C1962523;C2346927;C4321396;C4521761";FALSE;  78;amlodipine valsartan $nmbr$ $nmbr$ mg n $nmbr$
 192;clopidogrel  $nmbr$ mg loading dose !;"C0024671;C0026410;C0070166;C0439269;C1708715;C1960952;C2346927;C3714444;C4086581;C4321396;C4521761";FALSE; 217;clopidogrel $nmbr$ mg loading dose
 192;clopidogrel  $nmbr$ mg loading doset;"C0024671;C0026410;C0070166;C0439269;C1708715;C1960952;C2346927;C4321396;C4521761";FALSE; 217;clopidogrel $nmbr$ mg loading doset
 192;dabigatran $nmbr$ mg bid events / n ( % / y );"C0024671;C0026410;C0439269;C0441471;C1960952;C2346927;C2348066;C3541888;C4321396;C4521761";FALSE; 775;dabigatran $nmbr$ mg bid events n y
 192;dabigatran $nmbr$ mg bid ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C2346927;C2348066;C4321396;C4521761";FALSE; 775;dabigatran $nmbr$ mg bid n $nmbr$
 678;amended dabigatran protocol;"C0442711;C1507394;C1522729;C1691222;C2348066;C2348563;C2599718;C3715209;C4282383";FALSE; 775;amended dabigatran protocol
1096;dabigatran $nmbr$ vs . warfarin p ( inter );"C0043031;C0205103;C1548610;C2348066";FALSE; 775;dabigatran $nmbr$ vs warfarin p inter
1099;dabigatran $nmbr$ mg $nmbr$ mg % per yr;"C0439234;C1319635;C2348066";FALSE; 775;dabigatran $nmbr$ mg $nmbr$ mg per yr
   9;fev $nmbr$ ( % of predicted value );"C0681842;C1522609;C1882327;C3714541";FALSE;1197;fev $nmbr$ of predicted value
   9;fev $nmbr$ — % of predicted value;"C0681842;C1522609;C1882327;C3714541";FALSE;1197;fev $nmbr$ of predicted value
   9;post - bronchodilator fev $nmbr$  reversibility percentage of baseline value;"C0168634;C0439165;C0449261;C1442488;C1522609;C1549488;C1561533;C2599594;C3714541";FALSE;1197;post bronchodilator fev $nmbr$ reversibility percentage of baseline value
 681;spirometry after bronchodilation §;"C0037981;C1371299;C3537072";FALSE;1197;spirometry after bronchodilation
 192;low - density lipoprotein cholesterol  median  ( $nmbr$ th — $nmbr$ th percentiles )  mg / dl;"C0023824;C0039725;C0039738;C0439269;C0549183;C0876920;C1264641;C1420718;C2347635;C2348144;C2939193;C4282123;C4285344";FALSE;1963;low density lipoprotein cholesterol median $nmbr$ th $nmbr$ th percentiles mg dl
 192;low - density lipoprotein cholesterol — mg / dlf;"C0023824;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;1963;low density lipoprotein cholesterol mg dlf
 192;ezetimibe $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1142985;C1960952;C2346927;C4321396;C4521761";FALSE;1165;ezetimibe $nmbr$ mg n $nmbr$
 192;ezetimibe / simvastatin $nmbr$ / $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1532737;C1960952;C2346927;C4321396;C4521761";FALSE;1165;ezetimibe simvastatin $nmbr$ $nmbr$ mg n $nmbr$
 192;ezetimibe $nmbr$ mg ( n = $nmbr$ * );"C0024671;C0026410;C0439269;C1142985;C1960952;C2346927;C4321396;C4521761";FALSE;1165;ezetimibe $nmbr$ mg n $nmbr$
 192;mtx > $nmbr$ and £ $nmbr$ mg / week;"C0024671;C0025677;C0026410;C0332174;C0439230;C0439269;C1417487;C1960952;C2346927;C4321396;C4521761";FALSE; 716;mtx $nmbr$ and $nmbr$ mg week
 192;mtx average weekly dose  mg / week  mean ( sd );"C0024671;C0026410;C0332174;C0366550;C0439230;C0439269;C0444504;C1510992;C1960952;C2346927;C2347634;C2348143;C2699239;C2825518;C4321396;C4521761";FALSE; 716;mtx average weekly dose mg week mean sd
1332;previously taken methotrexate  %;"C0025677;C1883727";FALSE; 716;previously taken methotrexate
 118;methotrexate use at randomization;"C0025677;C0034656;C0042153;C0457083;C1947944";FALSE; 716;methotrexate use at randomization
 118;methotrexate use at randomization    n   ( % );"C0025677;C0034656;C0042153;C0457083;C1947944";FALSE; 716;methotrexate use at randomization n
1408;nonbiologic disease - modifying drug other than methotrexate : :;"C0025677;C0392747;C4036059";FALSE; 231;nonbiologic disease modifying drug other than methotrexate
1501;abbreviations : chd  coronary heart disease  cl  confidence interval  ml  myocardial infarction  rr  relative risk . ^ defined as a composite end point comprising the first of any of these events : nonfatal ml  nonfatal stroke  or cardiovascular death . tp value for interaction < . $nmbr$ for major cardiovascular event . no other interactions are significant . ^ calculated as weight in kilograms divided by the square of height in meters . § hypertension was defined as a self - reported systolic blood pressure > $nmbr$ mm hg  a diastolic blood pressure > $nmbr$ mm hg  or physician - diagnosed hypertension . | | hyperlipidemia was defined as a self - reported total cholesterol > $nmbr$ mg / dl_ ( $nmbr$ . $nmbr$ mmol / l ) or physician - diagnosed high cholesterol . ^ diabetes defined by self - report . # calculated using the framingham risk score among $nmbr$ $nmbr$ women who provided a blood sample at baseline .;"C0000723;C0005767;C0005768;C0005910;C0007226;C0008377;C0009667;C0010068;C0011065;C0011847;C0011849;C0011900;C0020473;C0020538;C0021308;C0027061;C0031831;C0033095;C0035647;C0036183;C0038454;C0039155;C0043100;C0043210;C0168634;C0178913;C0201950;C0205082;C0205120;C0205164;C0205199;C0205250;C0205435;C0229664;C0237881;C0242492;C0332849;C0428465;C0428883;C0439209;C0439269;C0439475;C0439526;C0441074;C0441471;C0444686;C0444930;C0449820;C0460139;C0475209;C0489786;C0543421;C0596019;C0681906;C0750502;C0804815;C1279901;C1299351;C1305849;C1305866;C1306345;C1306577;C1320716;C1441506;C1442488;C1522564;C1522609;C1524063;C1532563;C1546944;C1547335;C1552595;C1704675;C1704788;C1705104;C1705224;C1706378;C1963138;C1999230;C2700149;C2700400;C2700446;C2746065;C2924612;C3166866;C3539106;C3541334;C3541888;C3887460;C3887512;C3887665;C3889660;C4050231;C4082313;C4284008;C4318856;C4321237;C4521762;C4522209;C4552775;C4552904;C4554100;C4554402;C4555212";FALSE; -10;abbreviations chd coronary heart disease cl confidence interval ml myocardial infarction rr relative risk defined as a composite end point comprising the first of any of these events nonfatal ml nonfatal stroke or cardiovascular death tp value for interaction $nmbr$ for major cardiovascular event no other interactions are significant calculated as weight in kilograms divided by the square of height in meters hypertension was defined as a self reported systolic blood pressure $nmbr$ mm hg a diastolic blood pressure $nmbr$ mm hg or physician diagnosed hypertension hyperlipidemia was defined as a self reported total cholesterol $nmbr$ mg dl_ $nmbr$ $nmbr$ mmol l or physician diagnosed high cholesterol diabetes defined by self report calculated using the framingham risk score among $nmbr$ $nmbr$ women who provided a blood sample at baseline
 670;total c ( mmol / l  mean );"C0439175;C0439810;C0444504;C1532563;C2347634;C2348143";FALSE;1504;total c mmol l mean
 670;serum total cholesterol  mmol / l ( sd );"C0587184;C1287371;C1532563;C2699239";FALSE;1504;serum total cholesterol mmol l sd
1012;hdl cholesterol ( week $nmbr$ ) a;"C0023822;C0332174;C0392885;C0439230";FALSE; 821;hdl cholesterol week $nmbr$ a
1012;ldl particle numbers ( week $nmbr$ );"C0237753;C0332174;C0439230;C0449788;C2612459";FALSE;1068;ldl particle numbers week $nmbr$
 195;serum cholesterol ( mg / l ) *;"C0439268;C0587184";FALSE;1501;serum cholesterol mg l
 195;serum cholesterol  mg / dl;"C0439269;C0587184";FALSE;1501;serum cholesterol mg dl
1052;alcohol users  n ( % );C0556297;FALSE;1053;alcohol users n
1054;colon only  ' n ( % );"C0009368;C0205171;C1720467;C3888384";FALSE;1971;colon only n
 209;* p < $nmbr$ . $nmbr$ for eze / simva ( pooled across doses ) vs . simva ( pooled across doses ) for the entire cohort data are presented as least squares mean ± standard error ( † median ± se for tg ) for the entire cohort and also for each selected subgroup simva = simvastatin  eze = ezetimibe  tc = total cholesterol  tg = triglycerides  hdl - c = high - density lipoprotein - cholesterol  non - hdl - c = non - high - density lipoprotein cholesterol  apo = apolipoprotein;"C0003591;C0008377;C0009247;C0023189;C0023821;C0023822;C0036919;C0039411;C0040642;C0041004;C0041405;C0041698;C0062152;C0065055;C0074554;C0178587;C0178602;C0201950;C0205250;C0337445;C0369773;C0439175;C0439751;C0439810;C0444504;C0444667;C0449450;C0543421;C0549183;C0599755;C0729627;C0876920;C1079230;C1142985;C1299351;C1511726;C1515021;C1518422;C1707391;C1708438;C1709595;C1710181;C1824670;C2347634;C2347635;C2348143;C2348144;C2349200;C2603361;C2700149;C2939193;C3245479;C3272447;C3714741;C3715113;C3887512;C3889660;C4321237;C4522122;C4522209;C4522255";FALSE; -10;p $nmbr$ $nmbr$ for eze simva pooled across doses vs simva pooled across doses for the entire cohort data are presented as least squares mean standard error median se for tg for the entire cohort and also for each selected subgroup simva simvastatin eze ezetimibe tc total cholesterol tg triglycerides hdl c high density lipoprotein cholesterol non hdl c non high density lipoprotein cholesterol apo apolipoprotein
 670;fasting plasma glucose ( mmol / l ) $nmbr$;"C0015663;C0202042;C0455280;C1532563";FALSE;1960;fasting plasma glucose mmol l $nmbr$
 670;fpg  mean ( sd )  mg / dl [ mmol / l ];"C0439269;C0444504;C1532563;C2347634;C2348143;C2699239";FALSE;1960;fpg mean sd mg dl mmol l
 670;fbg ( mmol / l );C1532563;FALSE;1960;fbg mmol l
 670;serum potassium ( mmol / l );"C0302353;C0543465;C1532563";FALSE;1959;serum potassium mmol l
1501;hdl cholesterol ^ :;"C0023822;C0392885";FALSE; 821;hdl cholesterol
1501;hdl cholesterol §;"C0023822;C0392885";FALSE; 821;hdl cholesterol
1501;hdl cholesterol *;"C0023822;C0392885";FALSE; 821;hdl cholesterol
1501;hdl cholesterol ( mmol / l )  mean ( sd );"C0023822;C0392885;C0444504;C1532563;C2347634;C2348143;C2699239";FALSE; 821;hdl cholesterol mmol l mean sd
1501;high - density lipoprotein cholesterol  median  ( $nmbr$ th — $nmbr$ th percentiles )  mg / dl;"C0023822;C0039725;C0039738;C0439269;C0549183;C0876920;C1264641;C1420718;C2347635;C2348144;C2939193;C4282123;C4285344";FALSE; 821;high density lipoprotein cholesterol median $nmbr$ th $nmbr$ th percentiles mg dl
1390;acholesterol ( % );NA;FALSE;1957;acholesterol
 670;ldl - cholesterol ( mmol / l );"C0023824;C0202117;C1532563";FALSE;1068;ldl cholesterol mmol l
 670;ldl cholesterol  mmol / l;"C0023824;C0202117;C1532563";FALSE;1068;ldl cholesterol mmol l
 670;ldl - cholesterol  mmol / l;"C0023824;C0202117;C1532563";FALSE;1068;ldl cholesterol mmol l
 670;ldl cholesterol  mmol / l *;"C0023824;C0202117;C1532563";FALSE;1068;ldl cholesterol mmol l
 670;ldl cholesterol ( mmol / l ) :;"C0023824;C0202117;C1532563";FALSE;1068;ldl cholesterol mmol l
 670;ldl cholesterol ( mmol / l );"C0023824;C0202117;C1532563";FALSE;1068;ldl cholesterol mmol l
 670;low - density lipoprotein cholesterol  mean ( sd )  mmol / l;"C0023824;C0444504;C1532563;C2347634;C2348143;C2699239";FALSE;1068;low density lipoprotein cholesterol mean sd mmol l
 987;glucose — mmol / liter;"C0017725;C0439190;C0475211";FALSE;1958;glucose mmol liter
 987;plasma glucose $nmbr$ hr after glucose load — mmol / liter;"C0202042;C0439190;C0455280;C0475211;C1550025;C1704782;C1708715";FALSE;1958;plasma glucose $nmbr$ hr after glucose load mmol liter
 987;plasma glucose — mmol per liter;"C0202042;C0439190;C0455280;C0475211";FALSE;1958;plasma glucose mmol per liter
1066;ldl  - c;NA;FALSE;1068;ldl c
1066;ldl;NA;FALSE;1068;ldl
1066;ldl choleslerol;NA;FALSE;1068;ldl choleslerol
1066;ldl cholesterohhdl cholesterol ratio;"C0023824;C0202117;C0456603;C1547037";FALSE;1068;ldl cholesterohhdl cholesterol ratio
1066;ldl cholesterolt;NA;FALSE;1068;ldl cholesterolt
1678;total cholesterol > $nmbr$ ' $nmbr$ mmol / lt;"C0023376;C0201950;C0230426;C0439190;C0543421;C3887647;C4521399";FALSE;1504;total cholesterol $nmbr$ $nmbr$ mmol lt
1678;total cholesterol  mmol / lt;"C0023376;C0201950;C0230426;C0439190;C0543421;C3887647;C4521399";FALSE;1504;total cholesterol mmol lt
1678;total cholesterol > $nmbr$ - $nmbr$ mmol / lt;"C0023376;C0201950;C0230426;C0439190;C0543421;C3887647;C4521399";FALSE;1504;total cholesterol $nmbr$ $nmbr$ mmol lt
1678;total cholesterol < $nmbr$ - $nmbr$ mmol / lt;"C0023376;C0201950;C0230426;C0439190;C0543421;C3887647;C4521399";FALSE;1504;total cholesterol $nmbr$ $nmbr$ mmol lt
1678;total cholesterol < $nmbr$ $nmbr$ mmol / lt;"C0023376;C0201950;C0230426;C0439190;C0543421;C3887647;C4521399";FALSE;1504;total cholesterol $nmbr$ $nmbr$ mmol lt
 192;hdl cholesterol ( mg / dl )  mean + sd  available for $nmbr$ patients;"C0023822;C0030705;C0392885;C0439269;C0444504;C0470187;C2347634;C2348143;C2699239";FALSE;1962;hdl cholesterol mg dl mean sd available for $nmbr$ patients
 192;hdl cholesterol — mg / dl triglycerides — mg / dl;"C0023822;C0024671;C0026410;C0041004;C0392885;C0439269;C1960952;C2346927;C3539687;C4321396;C4521761";FALSE;1962;hdl cholesterol mg dl triglycerides mg dl
 192;h dl cholesterol < $nmbr$ mg / dl;"C0008377;C0024671;C0026410;C0033727;C0369286;C0439269;C0441932;C0564385;C1960952;C2346927;C3539687;C4321396;C4521761;C4528284";FALSE;1962;h dl cholesterol $nmbr$ mg dl
 192;low density lipoprotein cholesterol  mg / dl * *;"C0023824;C0439269";FALSE;1963;low density lipoprotein cholesterol mg dl
 987;triglycerides — mmol / liter;"C0041004;C0439190;C0475211";FALSE; 368;triglycerides mmol liter
 987;serum triglycerides — mmol / liter;"C0439190;C0475211;C0542495";FALSE; 368;serum triglycerides mmol liter
1408;concomitant csdmards other than methotrexate  n ( % );"C0025677;C0521115";FALSE; 231;concomitant csdmards other than methotrexate n
 625;median ( iqr ) mean $nmbr$ sdchange from baseline to week $nmbr$ by weight group and mtx use : weight;"C0005910;C0025677;C0042153;C0043100;C0168634;C0332174;C0439230;C0441833;C0444504;C0457083;C0549183;C0687744;C0876920;C1257890;C1305866;C1417487;C1442488;C1519504;C1705104;C1705428;C1705429;C1947944;C2347634;C2347635;C2348143;C2348144;C2939193";FALSE;1408;median iqr mean $nmbr$ sdchange from baseline to week $nmbr$ by weight group and mtx use weight
1584;potassium - sparing at last follow - up;"C0032821;C0202194;C0304475;C0589120;C0597277;C1522577;C1704685;C3274571;C3714637";FALSE;1966;potassium sparing at last follow up
 192;toial cholcsierol ( mg / dl );C0439269;FALSE;1968;toial cholcsierol mg dl
 192;total cholesterol level  mg / dl;"C0439269;C0878805;C1445957";FALSE;1968;total cholesterol level mg dl
 192;total chol  mg / dl;"C0201950;C0439175;C0439269;C0439810";FALSE;1968;total chol mg dl
 192;total c ( mg / dl ) *;"C0439175;C0439269;C0439810";FALSE;1968;total c mg dl
 824;all cause mortality or hosp . for worsening hf hs - crp < $nmbr$ . $nmbr$ mg / l;"C0015127;C0018488;C0026565;C0026566;C0332271;C0439268;C0444868;C1313497;C1457868;C1524003;C1538440;C1546960;C3273279;C3539085;C3890735;C4048285";FALSE;  12;all cause mortality or hosp for worsening hf hs crp $nmbr$ $nmbr$ mg l
 824;congestive hf;"C0018488;C0742742;C1313497;C1538440;C3273279";FALSE;  12;congestive hf
 259;heart failure hospitalizations;C3898876;FALSE;  12;heart failure hospitalizations
 259;hospitalization for heart failure n ( % );C3898876;FALSE;  12;hospitalization for heart failure n
 259;hospitalization for heart failure within $nmbr$ mo;"C0026544;C0332177;C3898876";FALSE;  12;hospitalization for heart failure within $nmbr$ mo
1379;pravastatin sodium;C0700474;FALSE;1841;pravastatin sodium
1028;= placebo  eze = ezetimibe  erol  apo = apolipoprotein  metabolic syndrome  patients were eans and percentage changes are;"C0003591;C0030705;C0032042;C0392747;C0439165;C0443172;C0524620;C1142985;C1549488;C1561533;C1696465;C1706408";FALSE; -10;placebo eze ezetimibe erol apo apolipoprotein metabolic syndrome patients were eans and percentage changes are
1033;by gfr stratum tor all participants  ml / min per $nmbr$ . $nmbr$ m ^ !;"C0017654;C0076836;C0369637;C0439445;C0441923;C0679646;C1199517;C1419603;C1424601;C3539732";FALSE; 592;by gfr stratum tor all participants ml min per $nmbr$ $nmbr$ m
1033;by gfr stratum for all participants  ml / min per $nmbr$ . $nmbr$ m ’ !;"C0017654;C0369637;C0439445;C0441923;C0679646;C1424601";FALSE; 592;by gfr stratum for all participants ml min per $nmbr$ $nmbr$ m
1037;female patients  n ( % );C0150905;FALSE;1970;female patients n
1036;supplementary table $nmbr$ . change from baseline in urine albumin - to - creatinine ratio by hba $nmbr$ c at baseline in patients with normoalbuminuria microalbuminuria and macroalbuminuria .;"C0019016;C0030705;C0039224;C0168634;C0392747;C0443172;C0455271;C0730345;C1318330;C1442488;C1705241;C1706074;C1825777;C3538758;C4319952";FALSE; -10;supplementary table $nmbr$ change from baseline in urine albumin to creatinine ratio by hba $nmbr$ c at baseline in patients with normoalbuminuria microalbuminuria and macroalbuminuria
1054;colon or rectum;"C0009368;C0034896;C3888384";FALSE;1971;colon or rectum
1054;colon;"C0009368;C3888384";FALSE;1971;colon
1054;colon only  n ( % );"C0009368;C0205171;C1720467;C3888384";FALSE;1971;colon only n
1055;bmi  body mass index  hrt  hormone replacement therapy  lvh  left ventricular hypertrophy  nsaids  nonsteroidal anti - inflammatory drugs  pvd  peripheral vascular disease  tia  transient ischemic attack . ahistory of and / or currently taking lipid - lowering or antidiabetic medications . bp < $nmbr$ . $nmbr$ for verapamil sustained - release ( sr ) vs . atenolol . chistory of or currently have elevated serum creatinine but less than $nmbr$ mg / dl . dblood pressure control defined as < $nmbr$ / $nmbr$ or < $nmbr$ / $nmbr$ in patients with diabetes or a history of renal insufficiency .;"C0003211;C0004147;C0007787;C0011847;C0011849;C0012634;C0019664;C0019665;C0023779;C0030685;C0030705;C0033095;C0035078;C0037623;C0042523;C0085096;C0149721;C0150936;C0201976;C0205091;C0205250;C0243148;C0262512;C0262926;C0282402;C0340279;C0391871;C0439092;C0439180;C0439269;C0441994;C0443246;C0443318;C0460139;C0521116;C0600061;C0680255;C0753208;C0935929;C0947487;C1283071;C1305855;C1306345;C1415692;C1515187;C1550141;C1552822;C1565489;C1704788;C1705255;C1708288;C1709991;C1882979;C1963578;C2003888;C2004062;C2587213;C3163633;C3274648;C3539106;C3813610;C3890900;C3891546;C4284008;C4318478;C4521226;C4553389";FALSE; -10;bmi body mass index hrt hormone replacement therapy lvh left ventricular hypertrophy nsaids nonsteroidal anti inflammatory drugs pvd peripheral vascular disease tia transient ischemic attack ahistory of and or currently taking lipid lowering or antidiabetic medications bp $nmbr$ $nmbr$ for verapamil sustained release sr vs atenolol chistory of or currently have elevated serum creatinine but less than $nmbr$ mg dl dblood pressure control defined as $nmbr$ $nmbr$ or $nmbr$ $nmbr$ in patients with diabetes or a history of renal insufficiency
1524;history of pci / ptca;"C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C2936173;C4049621";FALSE;1661;history of pci ptca
1063;any ae leading to discontinuation  n ( % );"C0332152;C0457454;C1444662;C1522538;C3887670;C4552847";FALSE;1974;any ae leading to discontinuation n
1063;aes leading to discontinuation of study drugb;"C0332152;C0457454;C0557651;C1412268;C1444662;C1522538;C2603343;C2699274;C4552847";FALSE;1974;aes leading to discontinuation of study drugb
1113;vertebral fracture and / or t score s - $nmbr$ . $nmbr$;"C0080179;C0449820;C0718146;C4050231";FALSE;2023;vertebral fracture and or t score s $nmbr$ $nmbr$
1115;fracture history  n ( % );"C0016658;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";FALSE;2026;fracture history n
1115;fracture history;"C0016658;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";FALSE;2026;fracture history
1119;contrast volume ( ml );"C0009924;C0439526;C0449468;C1690016;C1705102;C1705224;C1979874;C2700258;C3887665";FALSE;2030;contrast volume ml
1119;contrast volume;"C0009924;C0449468;C1690016;C1705102;C1979874;C2700258";FALSE;2030;contrast volume
1119;contrast volume  ml;"C0009924;C0439526;C0449468;C1690016;C1705102;C1705224;C1979874;C2700258;C3887665";FALSE;2030;contrast volume ml
1125;nitrate ( oral or topical );"C0028125;C0332237;C0442027;C0699857;C3848573;C4521986";FALSE;2031;nitrate oral or topical
1129;history of lvh on electrocardiogram;"C0013798;C0019664;C0019665;C0149721;C0262512;C0262926;C1547122;C1623258;C1705255;C2004062";FALSE;1496;history of lvh on electrocardiogram
1129;lvh by electrocardiogram  n ( % );"C0013798;C0149721;C1547122;C1623258";FALSE;1496;lvh by electrocardiogram n
1129;lvh ( from electrocardiogram );"C0013798;C0149721;C1547122;C1623258";FALSE;1496;lvh from electrocardiogram
1389;dactylitis count ( $nmbr$ - $nmbr$ )  mean ( sd );"C0239161;C0444504;C0750480;C1705566;C2347634;C2348143;C2699239";FALSE; 492;dactylitis count $nmbr$ $nmbr$ mean sd
1417;current dactylitis  n;"C0239161;C0521116;C1705970";FALSE; 492;current dactylitis n
 219;lower - limb angioplasty or bypass surgery;"C0745788;C1536078";FALSE;2040;lower limb angioplasty or bypass surgery
 219;previous bypass surgery  n ( % );"C0205156;C1536078;C1552607";FALSE;2040;previous bypass surgery n
 832;cabg history;"C0010055;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";FALSE; 389;cabg history
 832;history of cabg;"C0010055;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";FALSE; 389;history of cabg
 832;participants with a history of cabg;"C0010055;C0019664;C0019665;C0262512;C0262926;C0679646;C1705255;C2004062";FALSE; 389;participants with a history of cabg
 832;history of cabg  n ( % );"C0010055;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062";FALSE; 389;history of cabg n
 832;participants without a history of cabg;"C0010055;C0019664;C0019665;C0262512;C0262926;C0679646;C1705255;C2004062";FALSE; 389;participants without a history of cabg
 258;cabg during index hospitalization;"C0010055;C0019993;C0600653;C0918012;C1552854;C1637833;C2986546";FALSE; 389;cabg during index hospitalization
1069;ap = $nmbr$ . $nmbr$  bp $nmbr$ . $nmbr$  cp = $nmbr$ . $nmbr$ . * the study - speci ﬁ c bp targets were sbp $nmbr$ mm hg and dbp $nmbr$ mm hg ( or sbp $nmbr$ mm hg and dbp $nmbr$ mm hg in those with dm ) . the ldl - c target was $nmbr$ mg / dl or $nmbr$ mg / dl  depending on risk factor status at baseline in accordance with ncep atp iii guidelines . odds ratio and p value calculated based on generalized linear mixed model with generalized estimating equations method that includes compound symmetry covariance matrix for subjects from the same site . an interaction between treatment effect and dm status was observed for bp goal attainment ( p = $nmbr$ . $nmbr$ ) and dual bp / ldl - c goal attainment ( p = $nmbr$ . $nmbr$ ) among patients with or without dm calculated based on a mixed - effects linear model ( not adjusted for differences in baseline values ) . abbreviations : bp  blood pressure  dbp  diastolic blood pressure  dm  diabetes mellitus  ldl - c  low - density lipoprotein cholesterol  ncep atp iii  national cholesterol education program – adult treatment panel iii  or  odds ratio  sbp  systolic blood pressure;"C0000723;C0001675;C0002680;C0005767;C0005768;C0005823;C0006938;C0011816;C0011849;C0023732;C0025424;C0025663;C0028873;C0030705;C0033095;C0035648;C0037623;C0039155;C0039798;C0042295;C0065055;C0085805;C0086858;C0087111;C0162791;C0168634;C0178587;C0205145;C0205173;C0205198;C0205246;C0205251;C0205430;C0220845;C0229664;C0282423;C0332257;C0332516;C0428257;C0428883;C0439070;C0439269;C0439475;C0441833;C0444686;C0445247;C0449438;C0449851;C0456081;C0460139;C0536221;C0552449;C0557651;C0680230;C0681850;C0725813;C0750572;C0871511;C1280500;C1306345;C1415692;C1441506;C1441672;C1442488;C1515974;C1518422;C1518681;C1521840;C1522326;C1527178;C1533734;C1550472;C1550501;C1552866;C1554184;C1704640;C1704675;C1705160;C1705169;C1705241;C1705242;C1705938;C1706082;C1706203;C1706365;C1706450;C1706515;C1708288;C1709380;C1999270;C2347108;C2347109;C2348272;C2349001;C2603343;C2697811;C2700399;C2744579;C2825164;C2825575;C2946465;C2986546;C3160715;C3245503;C3250443;C3538994;C3813197;C3887704;C3887950;C3890211;C4048187;C4050020;C4050026;C4068104;C4281799;C4284008;C4318478;C4319583;C4321351;C4330985;C4522223;C4552600;C4553629;C4554674";FALSE; -10;ap $nmbr$ $nmbr$ bp $nmbr$ $nmbr$ cp $nmbr$ $nmbr$ the study speci c bp targets were sbp $nmbr$ mm hg and dbp $nmbr$ mm hg or sbp $nmbr$ mm hg and dbp $nmbr$ mm hg in those with dm the ldl c target was $nmbr$ mg dl or $nmbr$ mg dl depending on risk factor status at baseline in accordance with ncep atp iii guidelines odds ratio and p value calculated based on generalized linear mixed model with generalized estimating equations method that includes compound symmetry covariance matrix for subjects from the same site an interaction between treatment effect and dm status was observed for bp goal attainment p $nmbr$ $nmbr$ and dual bp ldl c goal attainment p $nmbr$ $nmbr$ among patients with or without dm calculated based on a mixed effects linear model not adjusted for differences in baseline values abbreviations bp blood pressure dbp diastolic blood pressure dm diabetes mellitus ldl c low density lipoprotein cholesterol ncep atp iii national cholesterol education program adult treatment panel iii or odds ratio sbp systolic blood pressure
1078;dd;"C3538867;C3814791";FALSE; -10;dd
1078;dd ( n = $nmbr$ );"C3538867;C3814791";FALSE; -10;dd n $nmbr$
1077;budesonide / formoterol fdc;"C0340427;C1276807;C1413520;C3539652";FALSE;1978;budesonide formoterol fdc
1080;below - knee popliteal crural;"C0022742;C0022745;C0023216;C0442037;C0542339;C1140621;C1552829;C1963703";FALSE;1979;below knee popliteal crural
1093;potential injection site reactions;"C0151735;C3245505";FALSE;1983;potential injection site reactions
1094;intolerance ';"C0231199;C1744706;C2355652";FALSE;1984;intolerance
1094;intolerance ®;"C0231199;C1744706;C2355652";FALSE;1984;intolerance
1096;p ( inter );"C0205103;C0369773;C1548610;C2603361";FALSE;1986;p inter
1096;p ( inter - action );"C0205103;C0369773;C0441472;C1548610;C2603361;C3266814";FALSE;1986;p inter action
1096;inter . p - value;"C0205103;C1548610;C1709380";FALSE;1986;inter p value
1099;admission for hf in previous year;"C0018488;C0184666;C0205156;C0439234;C0439508;C0809949;C1313497;C1538440;C1552607;C3273279";FALSE;  12;admission for hf in previous year
1099;admission for hf in previous year  n ( % );"C0018488;C0184666;C0205156;C0439234;C0439508;C0809949;C1313497;C1538440;C1552607;C3273279";FALSE;  12;admission for hf in previous year n
1099;copd exacerbation history in the previous year  n ( % );"C0019664;C0019665;C0205156;C0262512;C0262926;C0439234;C0439508;C0740304;C1552607;C1705255;C2004062";FALSE;1987;copd exacerbation history in the previous year n
1099;duration of diabetes in years  median ( iqr );"C0011847;C0011849;C0439234;C0449238;C0549183;C0876920;C2347635;C2348144;C2926735;C2939193";FALSE;1988;duration of diabetes in years median iqr
1456;unacceptable side effects;"C0001688;C0877248;C0879626;C1883420";FALSE;  47;unacceptable side effects
1099;duration diabetes ( years );"C0011847;C0011849;C0439234;C0449238;C2926735";FALSE;1988;duration diabetes years
1099;duration dm in dm ( years );"C0011816;C0439234;C0449238;C2926735;C3250443";FALSE;1988;duration dm in dm years
1099;diabetes duration ( years ) *;"C0011847;C0011849;C0439234;C0449238;C2926735";FALSE;1988;diabetes duration years
1099;disease duration ( years )  mean ± s . d .;"C0439234;C0444504;C0872146;C2347634;C2348143";FALSE;1989;disease duration years mean s d
1099;education < $nmbr$ years;"C0013621;C0013622;C0013658;C0039401;C0439234";FALSE;1990;education $nmbr$ years
1099;exacerbations in previous year;"C0205156;C0439234;C0439508;C1552607;C4086268";FALSE;1991;exacerbations in previous year
1099;exacerbations in previous year requiring hospitalization  n ( % );"C0019993;C0205156;C0439234;C0439508;C1552607;C4086268";FALSE;1991;exacerbations in previous year requiring hospitalization n
1099;exacerbations in previous year requiring hospitalization and / or ed visit  n ( % );"C0019993;C0205156;C0439234;C0439508;C0545082;C1512346;C1552607;C2826704;C3538926;C4086268";FALSE;1991;exacerbations in previous year requiring hospitalization and or ed visit n
1099;exacerbations in the year before study;"C0439234;C0439508;C0557651;C2603343;C4086268";FALSE;1991;exacerbations in the year before study
1099;exacerbations in the prev . year : $nmbr$;"C0439234;C0439508;C1552852;C4086268";FALSE;1991;exacerbations in the prev year $nmbr$
 192;baseline hdl - c level ( n = $nmbr$ �� $nmbr$ ) > $nmbr$ . $nmbr$ mg / dl;"C0168634;C0439269;C0441889;C0456079;C1442488;C1547707;C2946261;C3715113";FALSE;2001;baseline hdl c level n $nmbr$ $nmbr$ $nmbr$ $nmbr$ mg dl
 192;baseline hdl - c level ( n = $nmbr$ » $nmbr$ ) > $nmbr$ . $nmbr$ mg / dl;"C0168634;C0439269;C0441889;C0456079;C1442488;C1547707;C2946261;C3715113";FALSE;2001;baseline hdl c level n $nmbr$ $nmbr$ $nmbr$ $nmbr$ mg dl
 614;systolic  total;"C0039155;C0439175;C0439810";FALSE;1917;systolic total
1100;white race;"C0007457;C0043157";FALSE;2003;white race
1100;white race ( n = $nmbr$ $nmbr$ );"C0007457;C0043157";FALSE;2003;white race n $nmbr$ $nmbr$
1100;white race — number ( % );"C0007457;C0043157;C0237753;C0449788";FALSE;2003;white race number
1103;adjusted exacerbation rate { per patient peryear );"C0030705;C0456081;C0871208;C1521828;C4086268";FALSE;2005;adjusted exacerbation rate per patient peryear
1103;annual exacerbation rate;"C0332181;C0871208;C1521828;C4086268";FALSE;2005;annual exacerbation rate
1103;annual asthma exacerbation rates;"C0332181;C0349790;C0871208;C1521828";FALSE;2005;annual asthma exacerbation rates
1103;event rate ( per $nmbr$ person - years );"C0027361;C0439234;C0441471;C0871208;C1521828;C2347489;C4019010";FALSE;2007;event rate per $nmbr$ person years
1103;event rate ( per $nmbr$ person years );"C0027361;C0439234;C0441471;C0871208;C1521828;C2347489;C4019010";FALSE;2007;event rate per $nmbr$ person years
1103;rate †;"C0871208;C1521828";FALSE;2009;rate
1103;rate ‡;"C0871208;C1521828";FALSE;2009;rate
1103;rate per $nmbr$ - patient - years ( control vs alirocumab ) *;"C0030705;C0243148;C0439234;C0871208;C1521828;C1550141;C1882979;C2587213;C3274648;C3491162;C4553389";FALSE;2009;rate per $nmbr$ patient years control vs alirocumab
1103;rate per $nmbr$ - patient - years ( control vs alirocumab ) i;"C0021966;C0030705;C0221138;C0243148;C0439234;C0871208;C1521828;C1550141;C1882979;C2587213;C3274648;C3491162;C4553389";FALSE;2009;rate per $nmbr$ patient years control vs alirocumab i
1107;female race white;"C0007457;C0034510;C0043157;C0043210;C0086287;C0220938;C1705497;C1705498;C1706779;C3853635";FALSE;2014;female race white
1107;female sex — no . ( % ) race — no . ( % ) f;"C0016327;C0034510;C0086287;C1706779;C3853635";FALSE;2014;female sex no race no f
1107;female sex  n ( % ) race  n ( % );"C0034510;C0086287;C1706779;C3853635";FALSE;2014;female sex n race n
1109;adjudicated mace $nmbr$;"C0349381;C0949745;C1445339";FALSE; 414;adjudicated mace $nmbr$
1109;b mace;"C0349381;C0949745;C1445339";FALSE; 414;b mace
1109;expanded mace;"C0205229;C0349381;C0949745;C1445339";FALSE; 414;expanded mace
1109;hard mace;"C0018599;C0349381;C0949745;C1445339";FALSE; 414;hard mace
1109;first mace;"C0205435;C0349381;C0949745;C1279901;C1445339";FALSE; 414;first mace
1109;mace;"C0349381;C0949745;C1445339";FALSE; 414;mace
1109;$nmbr$ - point mace ( $nmbr$ - point mace plus hospitalization for unstable angina );"C0002965;C0019993;C0349381;C0949745;C1445339;C1552961;C2347617;C3714763";FALSE; 414;$nmbr$ point mace $nmbr$ point mace plus hospitalization for unstable angina
1113;vertebral fracture;C0080179;FALSE;2023;vertebral fracture
 258;cabg performed during index hospitalization;"C0010055;C0019993;C0600653;C0884358;C0918012;C1552854;C1637833;C2986546";FALSE; 389;cabg performed during index hospitalization
1145;wssng;NA;FALSE; -10;wssng
1148;morning peak expiratory flow — liters / min;"C0332170;C0475211;C0702093;C1518922;C1524029;C3813700";FALSE;2042;morning peak expiratory flow liters min
1151;hbalc tx difference vs pbo  median change from baseline ( se ) $nmbr$;"C0031962;C0036919;C0041403;C0168634;C0392747;C0443172;C0549183;C0876920;C1442488;C1705241;C1705242;C2347635;C2348144;C2939193;C4319952";FALSE;1176;hbalc tx difference vs pbo median change from baseline se $nmbr$
1155;ertuglrflozin $nmbr$ mg vs placebo / glimepiride;"C0024671;C0026410;C0032042;C0061323;C0439269;C1696465;C1706408;C1960952;C2346927;C4321396;C4521761";FALSE;2045;ertuglrflozin $nmbr$ mg vs placebo glimepiride
1163;acpa positive ( > $nmbr$ iu / ml )  n ( % );"C0439178;C0439458;C1446409;C1514241;C1525410;C1706063;C2825490;C3812269";FALSE;2051;acpa positive $nmbr$ iu ml n
1163;acpa positive  no . ( % );"C0439178;C1446409;C1514241;C1525410;C1706063;C2825490;C3812269";FALSE;2051;acpa positive no
 748;timi risk score;"C0035647;C0449820;C4050231;C4552904";FALSE;2052;timi risk score
 748;timi risk score  %;"C0035647;C0449820;C4050231;C4552904";FALSE;2052;timi risk score
 748;timi risk score !;"C0035647;C0449820;C4050231;C4552904";FALSE;2052;timi risk score
 748;timi risk score *;"C0035647;C0449820;C4050231;C4552904";FALSE;2052;timi risk score
 748;timi risk score — %;"C0035647;C0449820;C4050231;C4552904";FALSE;2052;timi risk score
 748;timi risk score ( interaction : p = $nmbr$ . $nmbr$ );"C0035647;C0449820;C1704675;C4050231;C4552904";FALSE;2052;timi risk score interaction p $nmbr$ $nmbr$
 748;jsn score ( $nmbr$ - $nmbr$ );"C0449820;C4050231";FALSE;2055;jsn score $nmbr$ $nmbr$
 748;crusade bleeding score  mean ( sd ) ^;"C0019080;C0444504;C0449820;C2347634;C2348143;C2699239;C4050231";FALSE;2056;crusade bleeding score mean sd
 748;crusade score;"C0449820;C4050231";FALSE;2056;crusade score
 748;aqlq ( s ) + $nmbr$ score : §;"C0449820;C4050231;C4055434";FALSE;2057;aqlq s $nmbr$ score
 748;aqlq ( s ) + $nmbr$ scored;"C0449820;C4055434";FALSE;2057;aqlq s $nmbr$ scored
 748;aqlq ( s ) score;"C0449820;C4050231;C4055434";FALSE;2057;aqlq s score
  94;% anti - ccp + ( > $nmbr$ units );"C0439148;C1519795;C3853603;C4318437";FALSE; 360;anti ccp $nmbr$ units
1179;hemoglobin a ^ c  %;"C0019020;C3889898";FALSE;1176;hemoglobin a c
1179;serum haemoglobin a $nmbr$ c concentration ( % )  mean ( sd );"C0019020;C0444504;C0683149;C2347634;C2348143;C2699239;C3889898";FALSE;1176;serum haemoglobin a $nmbr$ c concentration mean sd
1180;dapagliflozin $nmbr$ mg + insulin ( n   = $nmbr$ );"C0021641;C0024671;C0026410;C0439269;C1533581;C1579433;C1960952;C2346927;C2353951;C3714501;C4321396;C4521761";FALSE;2066;dapagliflozin $nmbr$ mg insulin n $nmbr$
1180;dapagliflozin $nmbr$ mg + insulin ( n = $nmbr$ );"C0021641;C0024671;C0026410;C0439269;C1533581;C1579433;C1960952;C2346927;C2353951;C3714501;C4321396;C4521761";FALSE;2066;dapagliflozin $nmbr$ mg insulin n $nmbr$
1180;dapagliflozin;C2353951;FALSE;2066;dapagliflozin
1183;vildagliptin $nmbr$ mg daily + glimepiride;"C0024671;C0026410;C0061323;C0332173;C0439269;C1570906;C1960952;C2346927;C4321396;C4521761";FALSE;2068;vildagliptin $nmbr$ mg daily glimepiride
1183;vildagliptin $nmbr$ mg bid n = $nmbr$;"C0024671;C0026410;C0439269;C1570906;C1960952;C2346927;C4321396;C4521761";FALSE;2068;vildagliptin $nmbr$ mg bid n $nmbr$
1188;teaes;NA;FALSE;  47;teaes
1456;adverse event;C0877248;FALSE;  47;adverse event
1456;any early adverse event;"C0877248;C1279919";FALSE;  47;any early adverse event
1456;unacceptable adverse events;"C0877248;C1705413;C1883420";FALSE;  47;unacceptable adverse events
 724;insulin treatment;C0745343;FALSE;2075;insulin treatment
 724;insulin treatment  n ( % );C0745343;FALSE;2075;insulin treatment n
1472;gastrointestinal major bleed;"C0017181;C0205082;C0205164;C4318856;C4521762";FALSE;2076;gastrointestinal major bleed
1472;gi major bleeding;"C0017181;C0205082;C0205164;C4318856;C4521762";FALSE;2076;gi major bleeding
1472;- major bleed;"C0019080;C0205082;C0205164;C4318856;C4521762";FALSE;2076;major bleed
1472;major bleed;"C0019080;C0205082;C0205164;C4318856;C4521762";FALSE;2076;major bleed
1472;major bleeding events *;"C0019080;C0205082;C0205164;C0441471;C3541888;C4318856;C4521762";FALSE;2076;major bleeding events
1472;major bleeding;"C0019080;C0205082;C0205164;C4318856;C4521762";FALSE;2076;major bleeding
1472;major coronary disease event ( fatal / non - fatal mi );"C0010068;C0012634;C0205082;C0205164;C0441471;C0741923;C1302234;C1518422;C1705232;C1956346;C3810814;C4019010;C4318856;C4521762";FALSE;2077;major coronary disease event fatal non fatal mi
1194;effect size ^;C0814843;FALSE;2080;effect size
1194;effect size !;C0814843;FALSE;2080;effect size
1195;type ii diabetes;C0011860;FALSE;2081;type ii diabetes
1206;sacubitril / valsartan ( n = $nmbr$ );C4033631;FALSE;2084;sacubitril valsartan n $nmbr$
1207;serum creatinine concentration and randomization to losartan;"C0010294;C0034656;C0086045;C0126174;C0201976;C0600061;C0683149;C1446561;C1561535;C3827302";FALSE; 952;serum creatinine concentration and randomization to losartan
1208;aceis  angiotensin - converting enzyme inhibitors  c  candesartan  des  drug - eluting stent  egfr  estimated glomerular filtration rate  hdl  high - density lipoprotein  ldl  low - density lipoprotein  nc  non - candesartan .;"C0003015;C0011702;C0013227;C0017654;C0023821;C0023823;C0027964;C0028407;C0038257;C0067895;C0265987;C0717550;C0750572;C1254351;C1518422;C1561549;C1739039;C2757044;C3811844;C3812682;C4551552";FALSE; -10;aceis angiotensin converting enzyme inhibitors c candesartan des drug eluting stent egfr estimated glomerular filtration rate hdl high density lipoprotein ldl low density lipoprotein nc non candesartan
1210;intestinal area involved — no . ( % );"C0017446;C0021853;C0205146;C1314939";FALSE;2088;intestinal area involved no
1215;estimated glomerular filtration rate — ml / min / $nmbr$ . $nmbr$ m $nmbr$;"C0369637;C0439445;C0441923;C3811844";FALSE; 592;estimated glomerular filtration rate ml min $nmbr$ $nmbr$ m $nmbr$
1215;estimated glomerular filtration rate — ml / min / $nmbr$ . $nmbr$ m $nmbr$ of body - surface area §;"C0017446;C0205146;C0369637;C0439445;C0441923;C0489451;C3811844";FALSE; 592;estimated glomerular filtration rate ml min $nmbr$ $nmbr$ m $nmbr$ of body surface area
1220;low - dose edoxaban;"C0445550;C1708745;C2975435";FALSE;2091;low dose edoxaban
1220;low - dose edoxaban ( n = $nmbr$ );"C0445550;C1708745;C2975435";FALSE;2091;low dose edoxaban n $nmbr$
1220;lower dose edoxaban regimen;"C0441994;C1548802;C2003888;C2348331;C2975435";FALSE;2091;lower dose edoxaban regimen
1235;taci ( n = $nmbr$ );"C0666480;C1425349;C4284230";FALSE;2094;taci n $nmbr$
1237;number omega - $nmbr$ number placeb fatty acid;"C0015684;C0237753;C0449788;C1719844";FALSE;1236;number omega $nmbr$ number placeb fatty acid
1237;fatty acid profile;"C0015684;C1979963;C2003903";FALSE;1236;fatty acid profile
1237;omega - $nmbr$ fatty acid;"C0015684;C1719844";FALSE;1236;omega $nmbr$ fatty acid
1237;omega - $nmbr$ fatty acid ( n = $nmbr$ );"C0015684;C1719844";FALSE;1236;omega $nmbr$ fatty acid n $nmbr$
1237;omega - $nmbr$ fatty acids;"C0015684;C1719844";FALSE;1236;omega $nmbr$ fatty acids
1243;left anterior descending coronary artery;C0226032;FALSE;2098;left anterior descending coronary artery
1243;left anterior descending artery  n ( % );C0226032;FALSE;2098;left anterior descending artery n
1243;l eft anterior descending coronary artery;"C0226032;C0439394;C0451214;C1706495;C3642217";FALSE;2098;l eft anterior descending coronary artery
1256;combination treatment ifx + aza;"C0004482;C0020823;C0039798;C0087111;C0205195;C1522326;C1533734;C1705169;C1947911;C3538994;C3811910;C3887704";FALSE;2099;combination treatment ifx aza
1256;ifx + aza ( n = $nmbr$ );"C0004482;C0020823";FALSE;2099;ifx aza n $nmbr$
1266;glycoprotein llb / llla inhibitors;"C0017968;C0243077";FALSE;2104;glycoprotein llb llla inhibitors
1253;insulin glargine dose at screening visit  iu;"C0049272;C0178602;C0220908;C0220909;C0366513;C0439453;C0545082;C0694756;C0869039;C0907402;C1114758;C1512346;C1698960;C1710031;C1710032;C1710477;C2348164;C2826704";FALSE;2100;insulin glargine dose at screening visit iu
1276;[ cm { female ) / cm { male ) ];"C0043210;C0086287;C0086582;C1705497;C1705498;C1706180;C1706428;C1706429";FALSE;2109;cm female cm male
1276;caleitonin  ng / l  males mean ± sd;"C0086582;C0439297;C0444504;C2347634;C2348143;C2699239";FALSE;2109;caleitonin ng l males mean sd
1279;priorvascular disease  %;C0012634;FALSE;2113;priorvascular disease
1279;previous disease — no . ( % ) f;"C0012634;C0016327;C0205156;C1552607";FALSE;2120;previous disease no f
1279;previous disease and drug use;"C0012634;C0205156;C0242510;C1552607";FALSE;2120;previous disease and drug use
1280;prior nsaid use;"C0003211;C0042153;C0332152;C0457083;C1947944;C2826257;C3536840";FALSE;2121;prior nsaid use
1280;prior nsaid  n ( % ) a;"C0003211;C0332152;C2826257;C3536840";FALSE;2121;prior nsaid n a
1280;nsaid   at   least   once;"C0003211;C3536840";FALSE;2121;nsaid at least once
1280;traditional nsaid;"C0003211;C0443324;C1548559;C3536840";FALSE;2121;traditional nsaid
1280;traditional nsaid use;"C0003211;C3536840;C3897349";FALSE;2121;traditional nsaid use
1280;abbreviations : bmi  body mass index  cabg  coronary artery bypass graft  nsaids  nonsteroidal anti - inflammatory drugs  pci  percutaneous coronary interventions . * values expressed as number ( percentage ) unless otherwise indicated . percentages may not equal $nmbr$ due to rounding . fhistory of or currently taking antidiabetic or lipid - lowering medications . ^ history of or currently have elevated serum creatinine level but less than $nmbr$ mg / dl_ ( < $nmbr$ pmol / l ) . § patients with a history of skin  prostate  and other cancers with long survival expectancy were not excluded . | | lnsulin and / or oral hypoglycemics . ildata for women only ( n = $nmbr$ for calcium antagonist strategy and n = $nmbr$ for non - calcium antagonist strategy ) .;"C0000723;C0003211;C0006684;C0006826;C0010055;C0023779;C0033572;C0038952;C0042295;C0043210;C0205163;C0205166;C0205171;C0205250;C0220921;C0237753;C0332196;C0332490;C0359086;C0369718;C0439092;C0439165;C0441922;C0441994;C0444099;C0449788;C0521116;C0600061;C0678226;C0679138;C0679199;C0679831;C0935929;C0998265;C1123023;C1305855;C1306459;C1444656;C1515187;C1518422;C1532338;C1549488;C1553893;C1554077;C1561533;C1706317;C1720467;C2003888;C2828389;C3146286;C3163633;C3642216;C3898174;C4520765";FALSE; -10;abbreviations bmi body mass index cabg coronary artery bypass graft nsaids nonsteroidal anti inflammatory drugs pci percutaneous coronary interventions values expressed as number percentage unless otherwise indicated percentages may not equal $nmbr$ due to rounding fhistory of or currently taking antidiabetic or lipid lowering medications history of or currently have elevated serum creatinine level but less than $nmbr$ mg dl_ $nmbr$ pmol l patients with a history of skin prostate and other cancers with long survival expectancy were not excluded lnsulin and or oral hypoglycemics ildata for women only n $nmbr$ for calcium antagonist strategy and n $nmbr$ for non calcium antagonist strategy
1287;bmi in kg / m $nmbr$  mean ( sd );"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";FALSE;2125;bmi in kg m $nmbr$ mean sd
1287;bmi  kg / m ^  mean ( sd );"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";FALSE;2125;bmi kg m mean sd
1287;bmi  kg / m $nmbr$  mean ± sd;"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";FALSE;2125;bmi kg m $nmbr$ mean sd
1287;bmi ( kg / m $nmbr$ ) ( mean ± sd );"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";FALSE;2125;bmi kg m $nmbr$ mean sd
1287;bmi  kg / m $nmbr$  mean + sd;"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";FALSE;2125;bmi kg m $nmbr$ mean sd
1287;bmi ( kg / m ^ )  mean ( sd );"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";FALSE;2125;bmi kg m mean sd
1287;sbp  mean ( sd )  mmhg;"C0085805;C0439475;C0444504;C2347634;C2348143;C2699239";FALSE;2127;sbp mean sd mmhg
1287;sbp ( mmhg )  mean ( sd );"C0085805;C0439475;C0444504;C2347634;C2348143;C2699239";FALSE;2127;sbp mmhg mean sd
1287;sbp  mean = sd  mmhg;"C0085805;C0439475;C0444504;C2347634;C2348143;C2699239";FALSE;2127;sbp mean sd mmhg
1287;sbp ( mmhg )  mean ± sd;"C0085805;C0439475;C0444504;C2347634;C2348143;C2699239";FALSE;2127;sbp mmhg mean sd
1287;sbp ( mmghg )  mean ( sd );"C0085805;C0444504;C2347634;C2348143;C2699239";FALSE;2127;sbp mmghg mean sd
1287;sbp  mean ± sd ( mmhg );"C0085805;C0439475;C0444504;C2347634;C2348143;C2699239";FALSE;2127;sbp mean sd mmhg
1381;sa acs;"C0036243;C0038702;C0742343;C1539696;C1825840;C3539736;C4318612;C4521691";FALSE; -10;sa acs
1383;whole cohort;"C0009247;C0444667;C0599755";FALSE;2208;whole cohort
1287;hba $nmbr$ c in patients with baseline hba $nmbr$ c > $nmbr$ % ( > $nmbr$ mmol / mol )  % [ mmol / mol ]  la  n baseline ( sd ) adjusted mean change ( $nmbr$ % ci ) placebo - subtracted change ( se );"C0008107;C0019016;C0023031;C0023749;C0027960;C0030705;C0032042;C0036919;C0168634;C0230347;C0324740;C0392747;C0439189;C0443172;C0444504;C0456081;C1442488;C1456781;C1696465;C1705241;C1706408;C1719767;C1824986;C1825777;C1960955;C2346906;C2347634;C2348143;C2348589;C2699239;C3259781;C3538758;C3665593;C4319952;C4553351";FALSE;2139;hba $nmbr$ c in patients with baseline hba $nmbr$ c $nmbr$ $nmbr$ mmol mol mmol mol la n baseline sd adjusted mean change $nmbr$ ci placebo subtracted change se
1287;mean ± sd bmi  kg / m $nmbr$;"C0444504;C0578022;C1532718;C2347634;C2348143;C2699239";FALSE;2141;mean sd bmi kg m $nmbr$
1287;post - bronchodilator reversibility fev $nmbr$ ( % ) mean ( sd );"C0444504;C0449261;C2347634;C2348143;C2599594;C2699239;C3714541";FALSE;2142;post bronchodilator reversibility fev $nmbr$ mean sd
1287;pulmonary function tests ( post - bronchodilator )  mean ( sd );"C0024119;C0444504;C2347634;C2348143;C2598152;C2599594;C2699239";FALSE;2142;pulmonary function tests post bronchodilator mean sd
1294;acs ( n = $nmbr$  $nmbr$ );"C0742343;C4318612";FALSE;2147;acs n $nmbr$ $nmbr$
1294;acs event;"C0441471;C0742343;C4019010;C4318612";FALSE;2147;acs event
1294;acs treatment;"C0039798;C0087111;C0742343;C1522326;C1533734;C1705169;C3538994;C3887704;C4318612";FALSE;2147;acs treatment
1294;acs presentation;"C0449450;C0742343;C4318612";FALSE;2147;acs presentation
1294;acs ( n - $nmbr$  $nmbr$ );"C0742343;C4318612";FALSE;2147;acs n $nmbr$ $nmbr$
1294;index acs — no . ( % );"C0600653;C0742343;C0918012;C1552854;C1637833;C2986546;C4318612";FALSE;2147;index acs no
1304;univariable or ( $nmbr$ % ci )  p value *;"C0008107;C1709380;C3259781";FALSE;2154;univariable or $nmbr$ ci p value
1304;multivariable adjusted model hr ( $nmbr$ % ci );"C0008107;C0456081;C3161035;C3259781;C3274659;C3714583;C3853906";FALSE; 975;multivariable adjusted model hr $nmbr$ ci
1305;ics ? laba ( free or fdc );"C0332296;C0340427;C0815320;C1413520;C1880497;C1996904;C3539652;C4551720";FALSE;1650;ics laba free or fdc
1305;+ ics / + laba n z $nmbr$;"C0815320;C4551720";FALSE;1650;ics laba n z $nmbr$
1305;ics / labd;"C0396059;C0815320;C4551720";FALSE;1650;ics labd
 699;chad $nmbr$ > $nmbr$;"C0007928;C1413373";FALSE;2128;chad $nmbr$ $nmbr$
 699;chadsj < $nmbr$;NA;FALSE;2128;chadsj $nmbr$
 699;chadsa < $nmbr$;NA;FALSE;2128;chadsa $nmbr$
 699;chads $nmbr$;"C0007928;C1413373";FALSE;2128;chads $nmbr$
 699;chadsj > $nmbr$;NA;FALSE;2128;chadsj $nmbr$
 699;chads $nmbr$ ^;"C0007928;C1413373";FALSE;2128;chads $nmbr$
 699;chads $nmbr$ scoreb;"C0007928;C1413373";FALSE;2128;chads $nmbr$ scoreb
 699;chads $nmbr$ score per outcome stroke or systemic embolism;"C0007928;C0013922;C0038454;C0205373;C0449820;C1274040;C1413373;C1704212;C4050231;C4554100";FALSE;2128;chads $nmbr$ score per outcome stroke or systemic embolism
1312;cardiovascular mortality ( per $nmbr$ person - years );"C0007226;C0026565;C0026566;C0027361;C0439234;C2347489;C3887460";FALSE;2157;cardiovascular mortality per $nmbr$ person years
1312;cvd mortality;"C0007222;C0026565;C0026566";FALSE;2157;cvd mortality
1315;reversibility s $nmbr$ % ( itt ) ( n = $nmbr$ );C0449261;FALSE;2160;reversibility s $nmbr$ itt n $nmbr$
1315;reversibility > $nmbr$ % ( n = $nmbr$ );C0449261;FALSE;2160;reversibility $nmbr$ n $nmbr$
1325;omega - $nmbr$ fa intake $nmbr$  d third;"C0205437;C1512806;C1719844";FALSE;1236;omega $nmbr$ fa intake $nmbr$ d third
1325;omega - $nmbr$ fa intake $nmbr$ st third;"C0036056;C0205437;C1512806;C1719844;C3272372";FALSE;1236;omega $nmbr$ fa intake $nmbr$ st third
1325;omega - $nmbr$ fa ( n = $nmbr$ );C1719844;FALSE;1236;omega $nmbr$ fa n $nmbr$
1325;phospholipid omega - $nmbr$ levels : < $nmbr$ % ( n = $nmbr$ );"C0031676;C0202177;C0441889;C1719844";FALSE;1236;phospholipid omega $nmbr$ levels $nmbr$ n $nmbr$
1338;time from onset of pain to randomization — hr;"C0030193;C0034656;C0449244;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132";FALSE;2169;time from onset of pain to randomization hr
1338;time from onset of pain to randomization  median ( iqr )  h;"C0030193;C0033727;C0034656;C0369286;C0441932;C0449244;C0518090;C0549183;C0564385;C0876920;C1962977;C2347635;C2348144;C2939193;C2984058;C4085210;C4085211;C4085212;C4528284;C4553004;C4554132";FALSE;2169;time from onset of pain to randomization median iqr h
1339;sf - $nmbr$ bodily pain  mean change from baselineb;"C0037712;C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C3890602;C4319952";FALSE;1338;sf $nmbr$ bodily pain mean change from baselineb
1351;glycemic status;C1320980;FALSE;2174;glycemic status
1351;glycemic status f;"C0016327;C1320980";FALSE;2174;glycemic status f
1353;previous vka use ( stratified randomization );"C0042153;C0205156;C0457083;C1552607;C1947944;C4687737";FALSE;1352;previous vka use stratified randomization
1355;selena - sledai > $nmbr$  %;C0451528;FALSE;2175;selena sledai $nmbr$
1357;psoriatic arthropathy;C0003872;FALSE;2176;psoriatic arthropathy
1357;time from psoriatic arthritis diagnosis [ a ]  years;"C0003872;C0011900;C0040223;C0439234;C1704338;C1704656;C3541383";FALSE;2176;time from psoriatic arthritis diagnosis a years
1358;£ $nmbr$ % bsa psoriasis  no . ( % );C0033860;FALSE;2177;$nmbr$ bsa psoriasis no
1358;previous exposure to systemic psoriasis therapyb ( yes )  n ( % );"C0033860;C0205156;C0205373;C0332157;C1549445;C1552607;C1705108;C1710701";FALSE;2181;previous exposure to systemic psoriasis therapyb yes n
1359;baseline ics;"C0168634;C0815320;C1442488;C4551720";FALSE;2182;baseline ics
1359;baseline ics use  n ( % );"C0042153;C0168634;C0369718;C0441922;C0457083;C0815320;C1442488;C1947944;C4551720";FALSE;2182;baseline ics use n
1359;baseline ics > $nmbr$ pg per day ( fluticasone propionate dpi or equivalent ) and laba;"C0117996;C0168634;C0205163;C0439185;C0815320;C1442488;C2827928;C4551720";FALSE;2182;baseline ics $nmbr$ pg per day fluticasone propionate dpi or equivalent and laba
1359;baseline ics use : no;"C0042153;C0168634;C0457083;C0815320;C1442488;C1947944;C4551720";FALSE;2182;baseline ics use no
1359;baseline ics dose  n ( % );"C0168634;C0178602;C0815320;C0869039;C1114758;C1442488;C4551720";FALSE;2182;baseline ics dose n
1370;east asian;"C0078988;C1707877";FALSE;1369;east asian
1373;calcium channelantagonist;"C0006675;C0006726;C2936886;C3540037;C3714611";FALSE;1884;calcium channelantagonist
1373;taking calcium supplements at baseline  n ( % );"C0006675;C0006726;C0168634;C0242295;C1442488;C1515187;C1947943;C2348609;C2936886;C3540037;C3714611";FALSE;2187;taking calcium supplements at baseline n
1374;calcium antagonist strategy ( cas ) ( events / n );"C0006684;C0441471;C0679199;C3541888";FALSE;1884;calcium antagonist strategy cas events n
1374;calcium antagonists;C0006684;FALSE;1884;calcium antagonists
1374;calcium antagonists  n ( % );C0006684;FALSE;1884;calcium antagonists n
 625;baseline hbalc ’;"C0168634;C1442488";FALSE;2188;baseline hbalc
 625;baseline hbalc < $nmbr$ %;"C0168634;C1442488";FALSE;2188;baseline hbalc $nmbr$
 625;baseline hbalc > $nmbr$ mmol / mol ( > $nmbr$ . $nmbr$ % );"C0168634;C1442488;C3829066";FALSE;2188;baseline hbalc $nmbr$ mmol mol $nmbr$ $nmbr$
 625;baseline hbalc > $nmbr$ %;"C0168634;C1442488";FALSE;2188;baseline hbalc $nmbr$
 625;baseline lipids;"C0023779;C0168634;C1442488";FALSE;2190;baseline lipids
 625;baseline lipid / lipoprotem values;"C0023779;C0042295;C0168634;C1442488";FALSE;2190;baseline lipid lipoprotem values
 625;baseline lipids  mean ± sd ( mmol / $nmbr$ );"C0023779;C0168634;C0439190;C0444504;C1442488;C2347634;C2348143;C2699239";FALSE;2190;baseline lipids mean sd mmol $nmbr$
1359;laba / ics use at screening  n ( % );"C0042153;C0220908;C0220909;C0457083;C0815320;C1698960;C1710031;C1710032;C1710477;C1947944;C2348164;C4551720";FALSE;2193;laba ics use at screening n
1376;average maximum common and bifurcation cimt ( mm );"C0184906;C0205214;C0806909;C1510992;C1522138;C1552615;C2825518;C2826546;C3146289;C3245511;C4330985;C4554674";FALSE;1262;average maximum common and bifurcation cimt mm
1376;maximum cimt a med an;"C0806909;C1552615;C2826546;C4321267";FALSE;1262;maximum cimt a med an
1376;mean of maximum cimt  mean ( sd )  mm;"C0444504;C0806909;C1552615;C2347634;C2348143;C2699239;C2826546;C4330985;C4554674";FALSE;1262;mean of maximum cimt mean sd mm
1547;carotid endarterectomy;C0014099;FALSE;2194;carotid endarterectomy
 290;carotid artery intervention *;"C0007272;C0162859;C0184661;C0397581;C0741968;C0886296;C1273869";FALSE;2197;carotid artery intervention
1383;cohort $nmbr$ ( n = $nmbr$ ) f;"C0009247;C0016327;C0599755";FALSE;2208;cohort $nmbr$ n $nmbr$ f
1383;entire cohort;"C0009247;C0439751;C0444667;C0599755";FALSE;2208;entire cohort
1387;use $nmbr$ - asa compounds;"C0004057;C0042153;C0205198;C0457083;C1706082;C1947944;C3853627";FALSE;1691;use $nmbr$ asa compounds
1406;czp + mtx n = $nmbr$;"C0025677;C0054841;C1417487;C1861828;C1872109";FALSE;2217;czp mtx n $nmbr$
1406;czp + mtx to mtx;"C0025677;C0054841;C1417487;C1861828;C1872109";FALSE;2217;czp mtx to mtx
1407;ez / simva $nmbr$ / $nmbr$ mg;"C0024671;C0026410;C0206578;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;1862;ez simva $nmbr$ $nmbr$ mg
1409;* $nmbr$ to < $nmbr$ y;NA;FALSE; -10;$nmbr$ to $nmbr$ y
1417;current alcohol drinking  n ( % );"C0001948;C0521116;C0556297;C1705970";FALSE;2219;current alcohol drinking n
1417;current smoking *;"C0037369;C0453996;C0521116;C1705970;C1881674";FALSE;2224;current smoking
1417;current smoking  n ( % );"C0037369;C0453996;C0521116;C1705970;C1881674";FALSE;2224;current smoking n
1417;current tobacco abuse  n ( % );"C0040336;C0521116;C1705970";FALSE;2224;current tobacco abuse n
1417;smoking — current;"C0037369;C0453996;C0521116;C1705970;C1881674";FALSE;2224;smoking current
1417;smoking status current;"C0521116;C1519386;C1705970";FALSE;2224;smoking status current
1421;transaminases increased;"C0002594;C0205217;C0442805;C0919834";FALSE;2227;transaminases increased
1423;time to first cv hospitalization or death from any cause;"C0007465;C0019993;C0040223;C0205435;C1279901;C3538987;C3541383;C4048877;C4318503";FALSE; 323;time to first cv hospitalization or death from any cause
1426;acenocoumaroi;NA;FALSE; -10;acenocoumaroi
1427;angiographic data;"C0002978;C1511726;C3245479;C3714741";FALSE;2231;angiographic data
1427;angiographic data and treatment :;"C0002978;C0039798;C0087111;C1511726;C1522326;C1533734;C1705169;C3245479;C3538994;C3714741;C3887704";FALSE;2231;angiographic data and treatment
1429;randomized to receive beta carotene;"C0034656;C0040363;C0041260;C0053396;C0696105;C1514756;C1883351;C3815594";FALSE;2233;randomized to receive beta carotene
1063;aes leading to;"C0332152;C1412268;C1522538;C2699274";FALSE;  47;aes leading to
 431;any adverse event leading to study drug discontinuation  n ( % );"C0013175;C0040363;C0041260;C0332152;C0457454;C0877248;C1444662;C1522538;C1883351;C4552847";FALSE;1974;any adverse event leading to study drug discontinuation n
1433;age  median ( $nmbr$ th — $nmbr$ th percentiles )  y;"C0001779;C0039725;C0039738;C0549183;C0876920;C1264641;C1420718;C2347635;C2348144;C2939193;C4282123;C4285344";FALSE;2234;age median $nmbr$ th $nmbr$ th percentiles y
1433;age ( y )  median ( $nmbr$ th to $nmbr$ th percentiles );"C0001779;C0039725;C0039738;C0549183;C0876920;C1264641;C1420718;C2347635;C2348144;C2939193;C4282123;C4285344";FALSE;2234;age y median $nmbr$ th to $nmbr$ th percentiles
1433;age  median ( $nmbr$ th  $nmbr$ th )  y;"C0001779;C0039725;C0039738;C0549183;C0876920;C1420718;C2347635;C2348144;C2939193;C4282123;C4285344";FALSE;2234;age median $nmbr$ th $nmbr$ th y
1434;tc / hdl - c;"C0039411;C0040642;C0041405;C0041698;C1824670;C3272447;C3715113;C4522122";FALSE;2236;tc hdl c
1434;tc / hdl - c ratio;"C0039411;C0040642;C0041405;C0041698;C0456603;C1547037;C1824670;C3272447;C3715113;C4522122";FALSE;2236;tc hdl c ratio
1453;aes leading to dose reduction of study drugb;"C0178602;C0557651;C0861063;C0869039;C1114758;C1412268;C2603343;C2699274";FALSE;  47;aes leading to dose reduction of study drugb
1453;aes related to;"C0040363;C0041260;C0439849;C0445223;C1412268;C1883351;C2699274";FALSE;  47;aes related to
1453;any aes  n ( % );"C1412268;C2699274";FALSE;  47;any aes n
1453;any aes;"C1412268;C2699274";FALSE;  47;any aes
1466;absolute risk difference ( $nmbr$ % cl );"C0035647;C0596019;C1519101;C1549031;C1705241;C1705242;C4552904";FALSE;2259;absolute risk difference $nmbr$ cl
1417;current cigarette use;"C0521116;C0694535;C1705970";FALSE; 420;current cigarette use
 625;baseline anti - hyperglycemic medications  n ( % );"C0013227;C0168634;C0432633;C0802604;C1442488;C2598133;C4284232";FALSE;  33;baseline anti hyperglycemic medications n
 294;no . of prior aeds  n ( % ) $nmbr$ - $nmbr$;"C0180309;C0332152;C2826257";FALSE;2374;no of prior aeds n $nmbr$ $nmbr$
1082;number of tender joints ( $nmbr$ - $nmbr$ )  mean ( sd );"C0234234;C0444504;C0449813;C2347634;C2348143;C2699239";FALSE;1139;number of tender joints $nmbr$ $nmbr$ mean sd
1417;current cigarette use  n ( % );"C0521116;C0694535;C1705970";FALSE; 420;current cigarette use n
 557;antihypertensive therapy — no . ( % );C0585941;FALSE;1579;antihypertensive therapy no
 557;anti - hypertensive therapy - no . ( % );C0585941;FALSE;1579;anti hypertensive therapy no
 731;receiving antihypertensive treatment -;"C0003364;C0039798;C0087111;C1514756;C1522326;C1533734;C1705169;C3538994;C3887704";FALSE;1579;receiving antihypertensive treatment
 731;receiving antihypertensive;"C0003364;C1514756";FALSE;1579;receiving antihypertensive
 366;medication at randomization  %;"C0013227;C0034656;C3244316;C4284232";FALSE;2263;medication at randomization
 366;medication at randomization  n ( % );"C0013227;C0034656;C3244316;C4284232";FALSE;2263;medication at randomization n
 366;medication at time of randomization;"C0013227;C0034656;C0040223;C3244316;C3541383;C4284232";FALSE;2263;medication at time of randomization
 366;medication at time of randomization — no . ( % );"C0013227;C0034656;C0040223;C3244316;C3541383;C4284232";FALSE;2263;medication at time of randomization no
 366;prior use of osteoporosis medications;"C0013227;C0029456;C0332152;C0802604;C1524063;C2598133;C2826257;C4284232;C4554622";FALSE;2264;prior use of osteoporosis medications
 366;prior use of osteoporosis medications  n ( % );"C0013227;C0029456;C0332152;C0802604;C1524063;C2598133;C2826257;C4284232;C4554622";FALSE;2264;prior use of osteoporosis medications n
 366;lipid - lowering medications;"C0013227;C0023779;C0441994;C0802604;C2003888;C2598133;C4284232";FALSE;2265;lipid lowering medications
 366;lipids medications;"C0013227;C0023779;C0802604;C2598133;C4284232";FALSE;2265;lipids medications
 366;lipid medication  n ( % );"C0013227;C0023779;C3244316;C4284232";FALSE;2265;lipid medication n
 366;cardiac medications during index hospitalization — no . ( % );"C0013227;C0019993;C0428776;C0802604;C2598133;C4284232";FALSE;2266;cardiac medications during index hospitalization no
 366;periprocedural medications — no . / total no . ( % );"C0013227;C0439175;C0439810;C0802604;C2598133;C4284232";FALSE;2267;periprocedural medications no total no
 192;czp $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0054841;C0439269;C1861828;C1872109;C1960952;C2346927;C4321396;C4521761";FALSE;2274;czp $nmbr$ mg n $nmbr$
 192;czp $nmbr$ mg ( n $nmbr$ );"C0024671;C0026410;C0054841;C0439269;C1861828;C1872109;C1960952;C2346927;C4321396;C4521761";FALSE;2274;czp $nmbr$ mg n $nmbr$
 192;febuxostat $nmbr$ mg n = $nmbr$;"C0024671;C0026410;C0249529;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;2282;febuxostat $nmbr$ mg n $nmbr$
 192;febuxostat $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0249529;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;2282;febuxostat $nmbr$ mg n $nmbr$
 192;febuxostat $nmbr$ mg daily n = $nmbr$ % ( n / n );"C0024671;C0026410;C0249529;C0332173;C0439269;C1960952;C2346927;C4321396;C4521761";FALSE;2282;febuxostat $nmbr$ mg daily n $nmbr$ n n
 832;history of omalizumab treatment :;"C0019664;C0019665;C0039798;C0087111;C0262512;C0262926;C0966225;C1522326;C1533734;C1705169;C1705255;C2004062;C3538994;C3887704";FALSE; 940;history of omalizumab treatment
 192;secukinumab $nmbr$   mg no load ( n   =   $nmbr$ );"C0024671;C0026410;C0439269;C1550025;C1704782;C1708715;C1960952;C2346927;C3179547;C4321396;C4521761";FALSE;2297;secukinumab $nmbr$ mg no load n $nmbr$
  28;placebo / rosu vastatin;"C0032042;C1099881;C1696465;C1706408";FALSE; 886;placebo rosu vastatin
 396;all rosuva;NA;FALSE; 886;all rosuva
 798;inhaled glucocorticoid use at screening;"C0004048;C0017710;C0042153;C0220908;C0220909;C0457083;C1698960;C1710031;C1710032;C1710477;C1947944;C2348164";FALSE;2182;inhaled glucocorticoid use at screening
 798;use of inhaled glucocorticoids at screening — no . ( % );"C0004048;C0017710;C0220908;C0220909;C1524063;C1698960;C1710031;C1710032;C1710477;C2348164;C3540777;C3540778";FALSE;2182;use of inhaled glucocorticoids at screening no
 167;daily dose of inhaled glucocorticoid — no . ( % ) §;"C0004048;C0017710;C2348070";FALSE;2182;daily dose of inhaled glucocorticoid no
 167;use of high - dose inhaled glucocorticoid — no . { % );"C0004048;C0017710;C0444956;C1524063";FALSE;2182;use of high dose inhaled glucocorticoid no
 234;poor  tried previous glucocorticoid + laba;"C0017710;C0032854;C0205156;C0542537;C1552607;C2700379";FALSE;2182;poor tried previous glucocorticoid laba
 234;poor  tried previous glucocorticoid / non - laba;"C0017710;C0032854;C0205156;C0542537;C1518422;C1552607;C2700379";FALSE;2182;poor tried previous glucocorticoid non laba
 192;ticagrelor $nmbr$ mg km %;"C0024671;C0026410;C0439269;C1960952;C1999375;C2346927;C3887676;C4321396;C4521761";FALSE;2299;ticagrelor $nmbr$ mg km
 192;ticagrelor  $nmbr$ mg ( n = $nmbr$ );"C0024671;C0026410;C0439269;C1960952;C1999375;C2346927;C4321396;C4521761";FALSE;2299;ticagrelor $nmbr$ mg n $nmbr$
 192;ticagrelor $nmbr$ mg $nmbr$ year km ( % );"C0024671;C0026410;C0439234;C0439269;C0439508;C1960952;C1999375;C2346927;C3887676;C4321396;C4521761";FALSE;2299;ticagrelor $nmbr$ mg $nmbr$ year km
 192;ticagrelor $nmbr$ mg no diabetes n = $nmbr$;"C0011847;C0011849;C0024671;C0026410;C0439269;C1960952;C1999375;C2346927;C4321396;C4521761";FALSE;2299;ticagrelor $nmbr$ mg no diabetes n $nmbr$
 236;glucose - lowering therapies;"C0017725;C0087111;C0441994;C2003888";FALSE;  33;glucose lowering therapies
 236;glucose - lowering therapy;"C0017725;C0039798;C0087111;C0441994;C1363945;C2003888";FALSE;  33;glucose lowering therapy
 236;glucose - lowering therapies — no . { % );"C0017725;C0087111;C0441994;C2003888";FALSE;  33;glucose lowering therapies no
 236;glucose - lowering therapy  n ( % );"C0017725;C0039798;C0087111;C0441994;C1363945;C2003888";FALSE;  33;glucose lowering therapy n
 236;glucose - lowering therapy - no . ( % );"C0017725;C0039798;C0087111;C0441994;C1363945;C2003888";FALSE;  33;glucose lowering therapy no
 987;serum triglycerides — pmol / liter;"C0439192;C0475211;C0542495";FALSE; 368;serum triglycerides pmol liter
 192;uric acid tertile $nmbr$ ( > $nmbr$ . $nmbr$ mg / dl );"C0041980;C0439269";FALSE;2310;uric acid tertile $nmbr$ $nmbr$ $nmbr$ mg dl
 192;uric acid tertile $nmbr$ ( $nmbr$ . $nmbr$ to < $nmbr$ . $nmbr$ mg / dl );"C0041980;C0439269";FALSE;2310;uric acid tertile $nmbr$ $nmbr$ $nmbr$ to $nmbr$ $nmbr$ mg dl
 540;ibdq total score  mean [ sd ];"C0444504;C2347634;C2348143;C2699239;C2964552";FALSE;2313;ibdq total score mean sd
 196;cohort $nmbr$ ( uacr > $nmbr$ . $nmbr$ mg / g );"C0009247;C0599755;C1300563";FALSE;2315;cohort $nmbr$ uacr $nmbr$ $nmbr$ mg g
 196;baseline uacr > $nmbr$ mg / g;"C0168634;C1300563;C1442488";FALSE;2315;baseline uacr $nmbr$ mg g
 196;cohort $nmbr$ ( uacr < $nmbr$ . $nmbr$ mg / g );"C0009247;C0599755;C1300563";FALSE;2315;cohort $nmbr$ uacr $nmbr$ $nmbr$ mg g
  18;fasting blood glucose  mean ( sd )  mg / dlt;"C0024671;C0026410;C0428568;C0439269;C0444504;C1261430;C1413248;C1960952;C2346927;C2347634;C2348143;C2699239;C3273706;C4321396;C4521761";FALSE;2280;fasting blood glucose mean sd mg dlt
  18;fasting blood glucose > $nmbr$ mg / dl;"C0428568;C0439269;C1261430";FALSE;2280;fasting blood glucose $nmbr$ mg dl
  18;fasting blood glucose > $nmbr$ mg / dl ( > $nmbr$ . $nmbr$ mmol / l );"C0428568;C0439269;C1261430;C1532563";FALSE;2280;fasting blood glucose $nmbr$ mg dl $nmbr$ $nmbr$ mmol l
 205;weight at randomization ( kg );"C0022718;C0439209;C2985844;C4054209";FALSE;2326;weight at randomization kg
 205;weight  kg;"C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C4054209";FALSE;2326;weight kg
 205;weight  kg *;"C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C4054209";FALSE;2326;weight kg
 205;weight [ kg ];"C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C4054209";FALSE;2326;weight kg
 205;weight  mean ( sd ) ( kg );"C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209";FALSE;2326;weight mean sd kg
 294;prior tnf antagonist failure  n ( % ) b;"C0231174;C0231491;C0332152;C0680095;C2826257;C3887647";FALSE;2375;prior tnf antagonist failure n b
 294;prior tnf antagonist failure - no;"C0231174;C0231491;C0332152;C0680095;C1448177;C2826257";FALSE;2375;prior tnf antagonist failure no
 294;prior tnf antagonist  n [ % ] ‘ *;"C0231491;C0332152;C1448177;C2826257";FALSE;2375;prior tnf antagonist n
 294;prior tnf antagonist failure  n [ % ];"C0231174;C0231491;C0332152;C0680095;C1448177;C2826257";FALSE;2375;prior tnf antagonist failure n
 206;values are presented as mean sd unless stated otherwise . data shown are for the randomized population . * body mass index values were missing from $nmbr$ patients in the aliskiren group and $nmbr$ patients in the hydrochlorothiazide group . † obesity was defined as body mass index $nmbr$ kg / m $nmbr$ . ‡ metabolic syndrome was defined according to the third report of the national cholesterol education program expert panel on detection  evaluation  and treatment of high blood cholesterol in adults ( adult treatment panel iii ) criteria $nmbr$ as any $nmbr$ of the following : waist circumference $nmbr$ cm for men or $nmbr$ cm for women  triglycerides $nmbr$ mg / dl  high - density lipoprotein cholesterol $nmbr$ mg / dl for men or $nmbr$ mg / dl for women  mssbp $nmbr$ mm hg or msdbp $nmbr$ mm hg  fasting glucose $nmbr$ mg / dl . § by medical history . aliskiren  n $nmbr$  hydrochlorothiazide  n $nmbr$ .;"C0001675;C0005893;C0008377;C0015663;C0017725;C0020261;C0023822;C0024671;C0025266;C0026410;C0028754;C0030705;C0032659;C0034656;C0039798;C0041004;C0042295;C0043210;C0086858;C0087111;C0150375;C0205437;C0220825;C0231290;C0243161;C0262926;C0332282;C0376691;C0439070;C0439269;C0439475;C0441833;C0444504;C0449450;C0455829;C0518010;C0524620;C0578022;C0600653;C0680240;C0684224;C0687744;C0700287;C0918012;C1120110;C1257890;C1261322;C1301808;C1305855;C1442792;C1511726;C1511790;C1519504;C1522326;C1532718;C1533734;C1547282;C1551393;C1552854;C1637833;C1704706;C1704788;C1705160;C1705169;C1705428;C1705429;C1705492;C1706365;C1709697;C1960952;C1963185;C1999270;C2241628;C2346927;C2347634;C2348143;C2699239;C2728259;C2986546;C3245479;C3245503;C3272743;C3273238;C3484370;C3538994;C3539106;C3539687;C3714741;C3815594;C3842522;C3887704;C4068104;C4255046;C4321396;C4521761";FALSE; -10;values are presented as mean sd unless stated otherwise data shown are for the randomized population body mass index values were missing from $nmbr$ patients in the aliskiren group and $nmbr$ patients in the hydrochlorothiazide group obesity was defined as body mass index $nmbr$ kg m $nmbr$ metabolic syndrome was defined according to the third report of the national cholesterol education program expert panel on detection evaluation and treatment of high blood cholesterol in adults adult treatment panel iii criteria $nmbr$ as any $nmbr$ of the following waist circumference $nmbr$ cm for men or $nmbr$ cm for women triglycerides $nmbr$ mg dl high density lipoprotein cholesterol $nmbr$ mg dl for men or $nmbr$ mg dl for women mssbp $nmbr$ mm hg or msdbp $nmbr$ mm hg fasting glucose $nmbr$ mg dl by medical history aliskiren n $nmbr$ hydrochlorothiazide n $nmbr$
 229;a . primary composite outcome;"C0205199;C0205225;C0439612;C0439631;C1274040;C1547335";FALSE;2339;a primary composite outcome
 229;first co - primary outcome;"C0205225;C0205435;C0439612;C0439631;C1274040;C1279901;C3245499";FALSE;2339;first co primary outcome
 229;first co - primary;"C0205225;C0205435;C0439612;C0439631;C1279901;C3245499";FALSE;2339;first co primary
 229;chd ( primary outcome );"C0205225;C0280604;C0439612;C0439631;C1274040;C3542407";FALSE;2339;chd primary outcome
 229;or primary outcome;"C0205225;C0439612;C0439631;C1274040";FALSE;2339;or primary outcome
 229;second co - primary outcome;"C0205225;C0205436;C0439612;C0439631;C0457385;C0565930;C1274040;C1561503;C1705190;C3245499";FALSE;2341;second co primary outcome
 229;medical history duration of heart failure ( years ) primary cause of heart failure;"C0015127;C0199168;C0205225;C0205476;C0439234;C0439612;C0439631;C0449238;C0455531;C1524003;C2926735";FALSE;2343;medical history duration of heart failure years primary cause of heart failure
 236;with corticosteroid treatment < $nmbr$;"C0001617;C0039798;C0087111;C1522326;C1533734;C1705169;C3536709;C3538994;C3887704";FALSE;1348;with corticosteroid treatment $nmbr$
 236;treatment with sulphonylurea + biguanide  n ( % );"C0005382;C0038766;C0039798;C0087111;C1522326;C1533734;C1705169;C3536898;C3537187;C3538994;C3887704;C4317165";FALSE; 752;treatment with sulphonylurea biguanide n
 236;treatment with sulphonylurea + biguanide  n { % );"C0005382;C0038766;C0039798;C0087111;C1522326;C1533734;C1705169;C3536898;C3537187;C3538994;C3887704;C4317165";FALSE; 752;treatment with sulphonylurea biguanide n
 236;treatment with sulphonylurea  n ( % );"C0038766;C0039798;C0087111;C1522326;C1533734;C1705169;C3536898;C3538994;C3887704";FALSE; 752;treatment with sulphonylurea n
 668;baseline hba $nmbr$ c ≤ median $nmbr$ . $nmbr$ % ( $nmbr$ mmol / mol );"C0019016;C0168634;C0549183;C0876920;C1442488;C1825777;C2347635;C2348144;C2939193;C3538758;C3829066";FALSE; 820;baseline hba $nmbr$ c median $nmbr$ $nmbr$ $nmbr$ mmol mol
 668;baseline hba $nmbr$ c > median $nmbr$ . $nmbr$ % ( $nmbr$ mmol / mol );"C0019016;C0168634;C0549183;C0876920;C1442488;C1825777;C2347635;C2348144;C2939193;C3538758;C3829066";FALSE; 820;baseline hba $nmbr$ c median $nmbr$ $nmbr$ $nmbr$ mmol mol
 668;baseline hba $nmbr$ c ≥ $nmbr$ . $nmbr$ % ( $nmbr$ mmol / mol );"C0019016;C0168634;C1442488;C1825777;C3538758;C3829066";FALSE; 820;baseline hba $nmbr$ c $nmbr$ $nmbr$ $nmbr$ mmol mol
 668;baseline hba $nmbr$ c ≥ $nmbr$ . $nmbr$ % to < $nmbr$ . $nmbr$ % ( $nmbr$ – $nmbr$ mmol / mol );"C0019016;C0168634;C1442488;C1825777;C3538758;C3829066";FALSE; 820;baseline hba $nmbr$ c $nmbr$ $nmbr$ to $nmbr$ $nmbr$ $nmbr$ $nmbr$ mmol mol
 668;baseline hba $nmbr$ c < $nmbr$ . $nmbr$ % ( $nmbr$ mmol / mol );"C0019016;C0168634;C1442488;C1825777;C3538758;C3829066";FALSE; 820;baseline hba $nmbr$ c $nmbr$ $nmbr$ $nmbr$ mmol mol
 668;baseline hba $nmbr$ c ≥ $nmbr$ mmol / mol ( ≥ $nmbr$ . $nmbr$ % )  n ( % );"C0019016;C0168634;C1442488;C1825777;C3538758;C3829066";FALSE; 820;baseline hba $nmbr$ c $nmbr$ mmol mol $nmbr$ $nmbr$ n
 241;gm  geometric mean  gmr  geometric mean ratio over baseline  uacr  urinary albumimcreatinine ratio . % reduction : $nmbr$ x ( $nmbr$ — ratio of gmr for losartan versus gmr for placebo ) . amean of change  with change calculated as difference between time indicated and baseline as measured for each participant  difference of changes between treatment groups . cp - values compare differences from no change .;"C0006938;C0017480;C0032042;C0039798;C0042295;C0087111;C0126174;C0168634;C0301630;C0392747;C0392756;C0441833;C0443172;C0444686;C0444706;C0456603;C0679646;C0687744;C1257890;C1273442;C1293152;C1441506;C1442103;C1442488;C1444656;C1519504;C1522326;C1522544;C1533734;C1547037;C1547049;C1552839;C1696465;C1704695;C1705169;C1705241;C1705242;C1705428;C1705429;C1706408;C1707455;C2698741;C2986759;C3538994;C3541902;C3854019;C3887704;C4050020;C4319952;C4551656;C4554048";FALSE; -10;gm geometric mean gmr geometric mean ratio over baseline uacr urinary albumimcreatinine ratio reduction $nmbr$ x $nmbr$ ratio of gmr for losartan versus gmr for placebo amean of change with change calculated as difference between time indicated and baseline as measured for each participant difference of changes between treatment groups cp values compare differences from no change
 243;most frequent aesa;"C0205393;C0332183";FALSE;2352;most frequent aesa
 243;most frequent non - infectious teaesb;"C0205393;C0239998;C1518422";FALSE;2352;most frequent non infectious teaesb
 243;most frequent serious teaes;"C0205393;C0205404;C0332183";FALSE;2352;most frequent serious teaes
 245;fev $nmbr$ / fvc ( post - albuterol );"C0001927;C0687676;C1704687;C3469826;C3714541";FALSE; 680;fev $nmbr$ fvc post albuterol
 245;post fvc % pred;"C0032952;C0044955;C0687676;C1704687;C3469826;C3714541";FALSE; 680;post fvc pred
 246;st - t wave;"C0036056;C0429103;C3272372";FALSE;2356;st t wave
 257;ct or mr scan of the brain *;"C0007673;C0024485;C0034606;C0441633;C0596217;C0881827;C1417249;C2347167;C2826292;C3254418;C3540513;C3813556;C3888140;C4050513";FALSE;2357;ct or mr scan of the brain
 258;no prior hf hospitalization;"C0018488;C0019993;C0332152;C1313497;C1538440;C2826257;C3273279";FALSE;2359;no prior hf hospitalization
 258;hospitalisation for chf within $nmbr$ years of randomisation;"C0018802;C0019993;C0034656;C0439234";FALSE;2359;hospitalisation for chf within $nmbr$ years of randomisation
 258;no prior hf hospitalization ( n = $nmbr$  $nmbr$ );"C0018488;C0019993;C0332152;C1313497;C1538440;C2826257;C3273279";FALSE;2359;no prior hf hospitalization n $nmbr$ $nmbr$
 734;percutaneous coronary intervention or coronary - artery bypass grafting for index acute coronary syndrome — no . { % );"C0010055;C0600653;C0918012;C0948089;C1532338;C1552854;C1637833;C2986546";FALSE;1661;percutaneous coronary intervention or coronary artery bypass grafting for index acute coronary syndrome no
 290;previous coronary intervention;"C0018787;C0184661;C0205156;C0886296;C1273869;C1552607";FALSE;1661;previous coronary intervention
1524;percutaneous transluminal coronary angioplasty;C2936173;FALSE;1661;percutaneous transluminal coronary angioplasty
1524;previous ptca;"C0205156;C1552607;C2936173";FALSE;1661;previous ptca
1524;ptca;C2936173;FALSE;1661;ptca
 276;dbp at visit $nmbr$;"C0536221;C0545082;C1512346;C2826704;C3813197;C4281799";FALSE;  15;dbp at visit $nmbr$
 276;sbp at visit $nmbr$;"C0085805;C0545082;C1512346;C2826704";FALSE;  15;sbp at visit $nmbr$
 276;mean number of antihypertensive medication at last visit   ‡;"C0003364;C0237753;C0444504;C0449788;C0545082;C1512346;C1517741;C2347634;C2348143;C2826704";FALSE;1579;mean number of antihypertensive medication at last visit
 293;presence of dactylitis  n ( % );"C0150312;C0239161;C0392148;C3854307";FALSE;2365;presence of dactylitis n
 293;presence of enthesitis;"C0150312;C0392148;C1282952;C3854307";FALSE;2367;presence of enthesitis
 294;$nmbr$ prior tnf antagonist failures  n ( % ) b;"C0231174;C0231491;C0332152;C0680095;C2826257;C3887647";FALSE;2372;$nmbr$ prior tnf antagonist failures n b
 294;prior tnf antagonist failure - yes;"C0231174;C0231491;C0332152;C0680095;C1448177;C1549445;C1705108;C1710701;C2826257";FALSE;2375;prior tnf antagonist failure yes
 294;prior cardiovascular event — no . ( % ) - j -;"C0332152;C1320716;C2826257";FALSE;2378;prior cardiovascular event no j
1044;previous infliximab therapy — no . of patients ( % ) * *;"C0030705;C0205156;C1552607;C4076075";FALSE;2387;previous infliximab therapy no of patients
1044;previous cvd ^;"C0007222;C0205156;C1552607";FALSE;2390;previous cvd
1044;previous infarction;"C0021308;C0205156;C1552607";FALSE;2390;previous infarction
1044;previous use of biologic systemic therapy  n ( % );"C0005515;C0005527;C0205156;C0205373;C0205460;C1515119;C1524063;C1552607";FALSE;2391;previous use of biologic systemic therapy n
1044;previous use of nonbiologic systemic therapy  n ( % );"C0205156;C1515119;C1524063;C1552607";FALSE;2391;previous use of nonbiologic systemic therapy n
1044;previous use of other biologic agents in addition to tne;"C0005515;C0205156;C1524063;C1552607;C3896585";FALSE;2391;previous use of other biologic agents in addition to tne
 628;thromboembolism;C0040038;FALSE;2399;thromboembolism
1044;previous pci ( % total );"C0205156;C0439175;C0439810;C1552607;C4049621";FALSE;1661;previous pci total
 318;deathsb;NA;FALSE;2400;deathsb
